Psyllid ID: psy18163
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1028 | 2.2.26 [Sep-21-2011] | |||||||
| Q9VPC0 | 952 | Serine/threonine-protein | yes | N/A | 0.342 | 0.369 | 0.749 | 1e-162 | |
| Q9UQ88 | 783 | Cyclin-dependent kinase 1 | yes | N/A | 0.371 | 0.487 | 0.697 | 1e-161 | |
| P46892 | 436 | Cyclin-dependent kinase 1 | no | N/A | 0.401 | 0.947 | 0.659 | 1e-157 | |
| Q7XUF4 | 710 | Cyclin-dependent kinase G | yes | N/A | 0.375 | 0.543 | 0.556 | 1e-122 | |
| A2XUW1 | 710 | Cyclin-dependent kinase G | N/A | N/A | 0.375 | 0.543 | 0.556 | 1e-122 | |
| Q09437 | 719 | Putative serine/threonine | yes | N/A | 0.318 | 0.454 | 0.621 | 1e-121 | |
| Q6K5F8 | 693 | Cyclin-dependent kinase G | no | N/A | 0.321 | 0.476 | 0.594 | 1e-115 | |
| A2X6X1 | 693 | Cyclin-dependent kinase G | N/A | N/A | 0.321 | 0.476 | 0.594 | 1e-115 | |
| Q54RB2 | 358 | Cyclin-dependent kinase 1 | yes | N/A | 0.305 | 0.877 | 0.524 | 1e-98 | |
| Q3UMM4 | 360 | Cyclin-dependent kinase 1 | yes | N/A | 0.312 | 0.891 | 0.507 | 2e-88 |
| >sp|Q9VPC0|KP58_DROME Serine/threonine-protein kinase PITSLRE OS=Drosophila melanogaster GN=Pitslre PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 573 bits (1478), Expect = e-162, Method: Compositional matrix adjust.
Identities = 269/359 (74%), Positives = 303/359 (84%), Gaps = 7/359 (1%)
Query: 348 LPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT 407
LP Y P +QGCRSVEEF+CLNRIEEGTYGVVYRAKDKRT+EIVALKRLKMEKEKEGFPIT
Sbjct: 542 LPNYYPGVQGCRSVEEFQCLNRIEEGTYGVVYRAKDKRTNEIVALKRLKMEKEKEGFPIT 601
Query: 408 SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE 467
SLREINTLLK QHPNIVTVREIVVGSNMDKIFIVMDYVEHD+KSLMETM+++KQ F PGE
Sbjct: 602 SLREINTLLKGQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLMETMKNRKQSFFPGE 661
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
VKCL QQLL AVAHLHDNWILHRDLKTSNLLLSH+GILKVGDFGLAREYGSP+K YT +V
Sbjct: 662 VKCLTQQLLRAVAHLHDNWILHRDLKTSNLLLSHKGILKVGDFGLAREYGSPIKKYTSLV 721
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
VTLWYR+PELLL YSTPID+WSVGCIFAEFL M PLF GKS++++L+RIFK +GTPN
Sbjct: 722 VTLWYRAPELLLCSPVYSTPIDVWSVGCIFAEFLQMLPLFPGKSEIDELNRIFKELGTPN 781
Query: 588 EKIWPGFSKLPAVQKMT-----FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR 642
EKIWPG+++LPAV+ M F EYP V L+ +E+G LL LTYDP R
Sbjct: 782 EKIWPGYTELPAVKNMLSQNSQFTEYP-VSQLRKHFQEKT-SEMGLSLLQGLLTYDPKQR 839
Query: 643 ITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDNE 701
++AD AL+H +F E PLPIDP+MFPTWPAKSEL +KA +SPKPPSGG +KQL +E
Sbjct: 840 LSADAALKHGFFKELPLPIDPSMFPTWPAKSELGARKAQASSPKPPSGGSQFKQLGRDE 898
|
Acts as a negative regulator of the normal cell cycle progression. May function in regulating proliferation by the phosphorylation and subsequent plasma membrane targeting of galactosyltransferase. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2 |
| >sp|Q9UQ88|CD11A_HUMAN Cyclin-dependent kinase 11A OS=Homo sapiens GN=CDK11A PE=1 SV=4 | Back alignment and function description |
|---|
Score = 568 bits (1464), Expect = e-161, Method: Compositional matrix adjust.
Identities = 274/393 (69%), Positives = 322/393 (81%), Gaps = 11/393 (2%)
Query: 332 IMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 391
+ D + IEL K LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVA
Sbjct: 395 VPDSPALLPIEL-KQELPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVA 453
Query: 392 LKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKS 451
LKRLKMEKEKEGFPITSLREINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KS
Sbjct: 454 LKRLKMEKEKEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKS 513
Query: 452 LMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFG 511
LMETM KQ F+PGEVK LM QLL V HLHDNWILHRDLKTSNLLLSH GILKVGDFG
Sbjct: 514 LMETM---KQPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFG 570
Query: 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS 571
LAREYGSPLK YTP+VVT WYR+PELLLG KEYST +DMWSVGCIF E L +PLF G S
Sbjct: 571 LAREYGSPLKAYTPVVVTQWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGNS 630
Query: 572 DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLL 631
+++Q++++FK +GTP+EKIWPG+S+LP V+KMTF+E+P L+ + G++L++ G+DL+
Sbjct: 631 EIDQINKVFKELGTPSEKIWPGYSELPVVKKMTFSEHP-YNNLRKRF-GALLSDQGFDLM 688
Query: 632 CKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGG 691
KFLTY P RI+A++ L+H+YF E+PLPIDP+MFPTWPAKSE K SP+PP GG
Sbjct: 689 NKFLTYFPGRRISAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRG-TSPRPPEGG 747
Query: 692 HNYKQLEDN---EEGFHMGMMER-SRAPVPGFS 720
Y QL D+ E GFH+ + + A PGFS
Sbjct: 748 LGYSQLGDDDLKETGFHLTTTNQGASAAGPGFS 780
|
Appears to play multiple roles in cell cycle progression, cytokinesis and apoptosis. The p110 isoforms have been suggested to be involved in pre-mRNA splicing, potentially by phosphorylating the splicing protein SFRS7. The p58 isoform may act as a negative regulator of normal cell cycle progression. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P46892|CD11B_RAT Cyclin-dependent kinase 11B OS=Rattus norvegicus GN=Cdk11b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 556 bits (1433), Expect = e-157, Method: Compositional matrix adjust.
Identities = 283/429 (65%), Positives = 331/429 (77%), Gaps = 16/429 (3%)
Query: 281 SEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDME 340
SE S S E E + K KK K P E + + D
Sbjct: 3 SEKSRTTSWLFQSHEVTEILGRVKKNRKKLVKGLHRAGPPPEK------NYLPDSPALSP 56
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE 400
IEL+++ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVALKRLKMEKE
Sbjct: 57 IELKQE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE 115
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
KEGFP+TS+REINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KSLMETM K
Sbjct: 116 KEGFPLTSIREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETM---K 172
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
Q F+PGEVK LM QLL+ V HLHDNWILHRDLKTSNLLL+H GILKVGDFGLAREYGSPL
Sbjct: 173 QPFLPGEVKTLMIQLLSGVKHLHDNWILHRDLKTSNLLLTHAGILKVGDFGLAREYGSPL 232
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
K YTP+VVTLWYR+PELLLG KEYST DMWSVGCIF E L +PLF GKSD++Q+++IF
Sbjct: 233 KAYTPVVVTLWYRAPELLLGAKEYSTACDMWSVGCIFGELLTQKPLFPGKSDIDQINKIF 292
Query: 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV 640
K +GTP+EKIWPG+S+LPAV+KMTF+E P L+ + G++L++ G+DL+ KFLTY P
Sbjct: 293 KDIGTPSEKIWPGYSELPAVKKMTFSELP-YNNLRKRF-GALLSDQGFDLMNKFLTYYPG 350
Query: 641 TRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDN 700
RI A++ L+H+YF E+PLPIDP+MFPTWPAKSE K SPKPP GG Y QL D+
Sbjct: 351 RRINAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQCVKRG-TSPKPPEGGLGYSQLGDD 409
Query: 701 ---EEGFHM 706
E GFH+
Sbjct: 410 DLKETGFHL 418
|
Acts as a negative regulator of the normal cell cycle progression. In vitro, this protein kinase has been shown to phosphorylate a number of substrates, including histone h1, casein, and galactosyltransferase. May function in regulating proliferation by the phosphorylation and subsequent plasma membrane targeting of galactosyltransferase. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q7XUF4|CDKG2_ORYSJ Cyclin-dependent kinase G-2 OS=Oryza sativa subsp. japonica GN=CDKG-2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-122, Method: Compositional matrix adjust.
Identities = 231/415 (55%), Positives = 291/415 (70%), Gaps = 29/415 (6%)
Query: 288 SSSSDEEENDENED-KADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKD 346
SS S DENED + DK + R + S D++ H +D E E+ +
Sbjct: 290 SSDSGRLGADENEDLEVDKDDYMDVDRDDDGNS------DIANH---QSGMDSEYEVRRS 340
Query: 347 TLP-PYLP------AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK 399
P P P +QGCRSV+EF+ LN+I EGTYGVVYRA+DK+T EIVALK++KMEK
Sbjct: 341 ETPEPVKPPHRCINMLQGCRSVDEFERLNKINEGTYGVVYRARDKKTGEIVALKKVKMEK 400
Query: 400 EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK 459
E+EGFP+TSLREIN LL HP+IV V+E+VVGS++D IF+VM+Y+EHD+K +ME M
Sbjct: 401 EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGVMEAM--- 457
Query: 460 KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519
KQ + EVKCLM QLL V +LHDNW+LHRDLKTSNLLL++RG LK+ DFGL+R+YGSP
Sbjct: 458 KQPYSQSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSP 517
Query: 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
LK YT +VVTLWYR+PELLLG KEYST IDMWSVGCI AE L EPLF GK++ EQL +I
Sbjct: 518 LKPYTQLVVTLWYRAPELLLGTKEYSTAIDMWSVGCIMAELLAKEPLFNGKTEFEQLDKI 577
Query: 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGS------ILTELGYDLLCK 633
F+T+GTPNEKIWPG++KLP V K+ F + P L+ K + IL+E G+DLL
Sbjct: 578 FRTLGTPNEKIWPGYAKLPGV-KVNFVKQP-YNRLRDKFPAASFSGRPILSEAGFDLLNN 635
Query: 634 FLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHK-KAAMASPKP 687
LTYDP R++AD AL+H++F E PLP PT+PA +EL + K + SP P
Sbjct: 636 LLTYDPEKRLSADAALQHEWFREVPLPKSKDFMPTFPALNELDRRTKRYLKSPDP 690
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|A2XUW1|CDKG2_ORYSI Cyclin-dependent kinase G-2 OS=Oryza sativa subsp. indica GN=CDKG-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-122, Method: Compositional matrix adjust.
Identities = 231/415 (55%), Positives = 291/415 (70%), Gaps = 29/415 (6%)
Query: 288 SSSSDEEENDENED-KADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKD 346
SS S DENED + DK + R + S D++ H +D E E+ +
Sbjct: 290 SSDSGRLGADENEDLEVDKDDYMDVDRDDDGNS------DIANH---QSGMDSEYEVRRS 340
Query: 347 TLP-PYLP------AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK 399
P P P +QGCRSV+EF+ LN+I EGTYGVVYRA+DK+T EIVALK++KMEK
Sbjct: 341 ETPEPVKPPHRCINMLQGCRSVDEFERLNKINEGTYGVVYRARDKKTGEIVALKKVKMEK 400
Query: 400 EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK 459
E+EGFP+TSLREIN LL HP+IV V+E+VVGS++D IF+VM+Y+EHD+K +ME M
Sbjct: 401 EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGVMEAM--- 457
Query: 460 KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519
KQ + EVKCLM QLL V +LHDNW+LHRDLKTSNLLL++RG LK+ DFGL+R+YGSP
Sbjct: 458 KQPYSQSEVKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSP 517
Query: 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
LK YT +VVTLWYR+PELLLG KEYST IDMWSVGCI AE L EPLF GK++ EQL +I
Sbjct: 518 LKPYTQLVVTLWYRAPELLLGTKEYSTAIDMWSVGCIMAELLAKEPLFNGKTEFEQLDKI 577
Query: 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGS------ILTELGYDLLCK 633
F+T+GTPNEKIWPG++KLP V K+ F + P L+ K + IL+E G+DLL
Sbjct: 578 FRTLGTPNEKIWPGYAKLPGV-KVNFVKQP-YNRLRDKFPAASFSGRPILSEAGFDLLNN 635
Query: 634 FLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHK-KAAMASPKP 687
LTYDP R++AD AL+H++F E PLP PT+PA +EL + K + SP P
Sbjct: 636 LLTYDPEKRLSADAALQHEWFREVPLPKSKDFMPTFPALNELDRRTKRYLKSPDP 690
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q09437|YP62_CAEEL Putative serine/threonine-protein kinase B0495.2 OS=Caenorhabditis elegans GN=B0495.2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1126), Expect = e-121, Method: Compositional matrix adjust.
Identities = 204/328 (62%), Positives = 260/328 (79%), Gaps = 1/328 (0%)
Query: 348 LPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT 407
LP + P + GCR+++E++C+NR++EGT+GVVYR KDKRTDEIVALKRLKMEKEKEGFPIT
Sbjct: 340 LPVFYPGLMGCRNIDEYECVNRVDEGTFGVVYRGKDKRTDEIVALKRLKMEKEKEGFPIT 399
Query: 408 SLREINTLLKA-QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPG 466
+LREIN LLKA HPNIV V+EI++GSNMDKI++ M++VEHDMKSL++TM + + F G
Sbjct: 400 ALREINMLLKAGNHPNIVNVKEILLGSNMDKIYMAMEFVEHDMKSLLDTMSRRNKRFSIG 459
Query: 467 EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526
E K L+QQLL+ + H+H WILHRDLKTSNLL+SH+GILK+ DFGLAREYG PLK +T I
Sbjct: 460 EQKTLLQQLLSGIEHMHKLWILHRDLKTSNLLMSHKGILKIADFGLAREYGDPLKKFTSI 519
Query: 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586
VVTLWYRSPELLLG + YSTP+DMWSVGCI AEF+ ++PLF G+ +LEQ+ +IF MGTP
Sbjct: 520 VVTLWYRSPELLLGTRLYSTPVDMWSVGCIMAEFILLKPLFPGRGELEQIKKIFMEMGTP 579
Query: 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD 646
E IWPG ++L + +TF +YP K +AG +L + G+ LL LT DP R +A
Sbjct: 580 TESIWPGVTELDGWKALTFEKYPYNQLRKRFLAGRLLNDTGFKLLNGLLTLDPKNRFSAT 639
Query: 647 EALRHDYFSESPLPIDPAMFPTWPAKSE 674
+AL H++F+E P P+ P FPT+PAKSE
Sbjct: 640 QALDHEWFTEEPYPVPPEEFPTFPAKSE 667
|
Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6K5F8|CDKG1_ORYSJ Cyclin-dependent kinase G-1 OS=Oryza sativa subsp. japonica GN=CDKG-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1070), Expect = e-115, Method: Compositional matrix adjust.
Identities = 201/338 (59%), Positives = 253/338 (74%), Gaps = 8/338 (2%)
Query: 355 IQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINT 414
+QGCRSV+EF+ LN I EGTYGVV+R +DKRT EIVALK++KMEKE+EGFP+TSLRE+N
Sbjct: 340 LQGCRSVDEFERLNTINEGTYGVVFRVRDKRTGEIVALKKVKMEKEREGFPLTSLREMNI 399
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
LL HP+IV V+E+VVGSN IF+VM+Y+EHD+K +METM KQ + EVKCLM Q
Sbjct: 400 LLSFHHPSIVEVKEVVVGSNDRDIFMVMEYMEHDLKGVMETM---KQPYSQSEVKCLMLQ 456
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
LL V +LHDNW+LHRDLKTSNLLL++RG LK+ DFGL+R+YGSPLK YT +VVTLWYR+
Sbjct: 457 LLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVVTLWYRA 516
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
PELLLG K+YST IDMWS+GCI E L PLF GKS+++QL +IF+T+GTP+E IWPG+
Sbjct: 517 PELLLGAKDYSTAIDMWSLGCIMGELLSKGPLFNGKSEIDQLDKIFRTLGTPDENIWPGY 576
Query: 595 SKLPAVQ----KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650
SKLP K T + + G +L+E G+DLL + LTYDP RI+A++AL
Sbjct: 577 SKLPGATVKFGKQTHNRLRDKFRAVSFTGGPMLSEAGFDLLNRLLTYDPEKRISAEDALN 636
Query: 651 HDYFSESPLPIDPAMFPTWPAKSELAHK-KAAMASPKP 687
H++F E PLP PT+PA +E + K M SP P
Sbjct: 637 HEWFRELPLPRSKDFMPTFPALNEQDRRFKKHMKSPDP 674
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|A2X6X1|CDKG1_ORYSI Cyclin-dependent kinase G-1 OS=Oryza sativa subsp. indica GN=CDKG-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1070), Expect = e-115, Method: Compositional matrix adjust.
Identities = 201/338 (59%), Positives = 253/338 (74%), Gaps = 8/338 (2%)
Query: 355 IQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINT 414
+QGCRSV+EF+ LN I EGTYGVV+R +DKRT EIVALK++KMEKE+EGFP+TSLRE+N
Sbjct: 340 LQGCRSVDEFERLNTINEGTYGVVFRVRDKRTGEIVALKKVKMEKEREGFPLTSLREMNI 399
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
LL HP+IV V+E+VVGSN IF+VM+Y+EHD+K +METM KQ + EVKCLM Q
Sbjct: 400 LLSFHHPSIVEVKEVVVGSNDRDIFMVMEYMEHDLKGVMETM---KQPYSQSEVKCLMLQ 456
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
LL V +LHDNW+LHRDLKTSNLLL++RG LK+ DFGL+R+YGSPLK YT +VVTLWYR+
Sbjct: 457 LLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVVTLWYRA 516
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
PELLLG K+YST IDMWS+GCI E L PLF GKS+++QL +IF+T+GTP+E IWPG+
Sbjct: 517 PELLLGAKDYSTAIDMWSLGCIMGELLSKGPLFNGKSEIDQLDKIFRTLGTPDENIWPGY 576
Query: 595 SKLPAVQ----KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650
SKLP K T + + G +L+E G+DLL + LTYDP RI+A++AL
Sbjct: 577 SKLPGATVKFGKQTHNRLRDKFRAVSFTGGPMLSEAGFDLLNRLLTYDPEKRISAEDALN 636
Query: 651 HDYFSESPLPIDPAMFPTWPAKSELAHK-KAAMASPKP 687
H++F E PLP PT+PA +E + K M SP P
Sbjct: 637 HEWFRELPLPRSKDFMPTFPALNEQDRRFKKHMKSPDP 674
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q54RB2|CDK11_DICDI Cyclin-dependent kinase 11 OS=Dictyostelium discoideum GN=cdk11 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 362 bits (929), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 170/324 (52%), Positives = 235/324 (72%), Gaps = 10/324 (3%)
Query: 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
CRSV+ FK L I EG +GVVY A+DK T+EIVALK++KME+E+EG PITS+REI L+
Sbjct: 45 ACRSVDCFKKLYTINEGAFGVVYCAQDKETEEIVALKKIKMEREREGIPITSVREIKVLM 104
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+ +H NIV ++EIV+G N++ IF+ M++++HD++ LME + K+ F+P E+K L+QQLL
Sbjct: 105 ELKHDNIVQIKEIVLGKNINSIFMAMEFIDHDLRGLMEVI---KKPFLPSEIKTLIQQLL 161
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
N V+++HDNW++HRDLKT+NLL +++G+LK+ DFGLAREYGSPLK + VVTLWYR+PE
Sbjct: 162 NGVSYMHDNWVIHRDLKTANLLYTNKGVLKIADFGLAREYGSPLKPLSKGVVTLWYRAPE 221
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
LLL + Y+ ID+WSVGCIFAE + E L G S+++Q+ +IFK GTP EK WP F K
Sbjct: 222 LLLDTEIYTPAIDIWSVGCIFAEIISKEVLLQGSSEIDQMDKIFKLFGTPTEKSWPAFFK 281
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
LP + + P LK+K +T+ +DLL K L +P RI+A +AL+H YF E
Sbjct: 282 LPLAKYFNLTDQP-YNNLKSKFPH--ITDNAFDLLNKLLELNPEARISASDALKHPYFFE 338
Query: 657 SPLPIDPAMFPTWPAKSELAHKKA 680
+P P DP + PTWP+ +HKK
Sbjct: 339 NPQPRDPLLMPTWPS----SHKKT 358
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q3UMM4|CDK10_MOUSE Cyclin-dependent kinase 10 OS=Mus musculus GN=Cdk10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 169/333 (50%), Positives = 226/333 (67%), Gaps = 12/333 (3%)
Query: 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK 417
CRSV+EF+ LNRI EGTYG+VYRA+D +TDEIVALK+++M+KEK+G PI+SLREI LL+
Sbjct: 33 CRSVKEFEKLNRIGEGTYGIVYRARDTQTDEIVALKKVRMDKEKDGIPISSLREITLLLR 92
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
+HPNIV ++E+VVG++++ IF+VM Y E D+ SL+E M + F +VKC+M Q+L
Sbjct: 93 LRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTP---FSEAQVKCIMLQVLR 149
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ +LH N+I+HRDLK SNLL++ +G +K DFGLAR YG P+K TP VVTLWYR+PEL
Sbjct: 150 GLQYLHRNFIIHRDLKVSNLLMTDKGCVKTADFGLARAYGVPVKPMTPKVVTLWYRAPEL 209
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
LLG +T IDMW+VGCI AE L +PL G S++ Q+ I + +GTP+E IWPGFSKL
Sbjct: 210 LLGTTTQTTSIDMWAVGCILAELLAHKPLLPGTSEIHQIDLIVQLLGTPSENIWPGFSKL 269
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657
P + + + P LK K L+E G LL YDP R T+ + L YF E
Sbjct: 270 PLAGQYSLRKQP-YNNLKHKFPW--LSEAGLRLLNFLFMYDPKKRATSGDCLESSYFKEK 326
Query: 658 PLPIDPAMFPTWPAKSELAHKKAAMASPKPPSG 690
PLP +P + PT+P H + A+P G
Sbjct: 327 PLPCEPELMPTFP------HHRNKRAAPAAAEG 353
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1028 | ||||||
| 307173221 | 856 | PITSLRE serine/threonine-protein kinase | 0.558 | 0.670 | 0.550 | 1e-180 | |
| 350406578 | 863 | PREDICTED: hypothetical protein LOC10074 | 0.360 | 0.429 | 0.786 | 1e-179 | |
| 340721434 | 863 | PREDICTED: hypothetical protein LOC10065 | 0.360 | 0.429 | 0.786 | 1e-178 | |
| 322798653 | 835 | hypothetical protein SINV_13494 [Solenop | 0.569 | 0.700 | 0.557 | 1e-178 | |
| 332017880 | 866 | PITSLRE serine/threonine-protein kinase | 0.360 | 0.428 | 0.773 | 1e-176 | |
| 345482026 | 914 | PREDICTED: hypothetical protein LOC10012 | 0.387 | 0.435 | 0.729 | 1e-175 | |
| 156545446 | 897 | PREDICTED: hypothetical protein LOC10012 | 0.387 | 0.443 | 0.729 | 1e-175 | |
| 157104530 | 839 | cdk10/11 [Aedes aegypti] gi|108880315|gb | 0.368 | 0.451 | 0.763 | 1e-175 | |
| 383849918 | 863 | PREDICTED: uncharacterized protein LOC10 | 0.355 | 0.422 | 0.775 | 1e-174 | |
| 307199072 | 854 | PITSLRE serine/threonine-protein kinase | 0.357 | 0.430 | 0.763 | 1e-174 |
| >gi|307173221|gb|EFN64283.1| PITSLRE serine/threonine-protein kinase CDC2L1 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1648), Expect = e-180, Method: Compositional matrix adjust.
Identities = 363/659 (55%), Positives = 442/659 (67%), Gaps = 85/659 (12%)
Query: 89 HKSHRRRDEDRKHRD-ERKAREAQKSKEYTAREIDELKAK-EADLRARLERKRYSNPLRE 146
H R RD+++ R+ E + ++ +++ E E++E++ + E ++ + +P
Sbjct: 253 HDRVRERDQEKMEREKEHREKQLRETMEIVTDEVNEMEVQNEIPIQIK-------DP--- 302
Query: 147 KEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNEMDVDEAH 206
KE E+ELRKERLLEA+R KE + + R+ R R SP N
Sbjct: 303 KEMTEQELRKERLLEADREMARRKEVSRLELEARRMKRGEKRPLSPDNN----------- 351
Query: 207 QRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAGS 266
P P+ +V L+DES SPT EG + S
Sbjct: 352 -----------PDPS--------------IVELSDESPSPT----------HSEGMRSKS 376
Query: 267 AES--SAGSEESSQDGSED----------------SSQDSSSSDEEENDENEDKADKKEK 308
AES S+ E S +D S D S++ + + + ND +ED +
Sbjct: 377 AESRHSSEGERSLRDRSLDRHSSDTSESSSDDDDDSNESNKGTGGDSNDGSEDYNNPSPL 436
Query: 309 KAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLN 368
+ K D S +S V + + + E + E+ LP YLPAIQGCRSVEEF+CLN
Sbjct: 437 SVDRLAKSDQSDGDSPGHVDSNNPVKTTKEEEKKEEEPDLPHYLPAIQGCRSVEEFQCLN 496
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
RIEEGTYGVVYRA+DKRT+EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE
Sbjct: 497 RIEEGTYGVVYRARDKRTEEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 556
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWIL 488
IVVGSNMDKIFIVMDYVEHD+KSLMETM+ KKQVFIPGEVKCLMQQLL AVAHLHDNWIL
Sbjct: 557 IVVGSNMDKIFIVMDYVEHDLKSLMETMKQKKQVFIPGEVKCLMQQLLRAVAHLHDNWIL 616
Query: 489 HRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPI 548
HRDLKTSNLLLSHRGILKVGDFGLAREYGSPL+ YTPIVVTLWYR+PELLL KEYSTP+
Sbjct: 617 HRDLKTSNLLLSHRGILKVGDFGLAREYGSPLRQYTPIVVTLWYRAPELLLSDKEYSTPV 676
Query: 549 DMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEY 608
DMWSVGCIFAE L MEPLF GKSD++QL++IFK +GTP+E+IWPG+ KLP VQK+ F+ Y
Sbjct: 677 DMWSVGCIFAELLRMEPLFPGKSDIDQLNKIFKELGTPSERIWPGYIKLPMVQKIPFSHY 736
Query: 609 PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPT 668
P V L+ + + S L++LG +LL KFLTYDP RITA++AL H+YF+E+PLPIDP MFPT
Sbjct: 737 P-VNNLRQRFSLS-LSDLGVELLNKFLTYDPRQRITAEDALNHEYFTEAPLPIDPQMFPT 794
Query: 669 WPAKSELAHKKAAMASPKPPSGGHNYKQLEDNEE------GFHMGMMERSRAPVPGFSW 721
WPAKSE + ASPKPPSGG YKQL D ++ GFHMG++E SRAP G +
Sbjct: 795 WPAKSEQG-TRTTNASPKPPSGGREYKQLGDGDDADLSNSGFHMGLIEGSRAPPIGGGF 852
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350406578|ref|XP_003487816.1| PREDICTED: hypothetical protein LOC100740133 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1635), Expect = e-179, Method: Compositional matrix adjust.
Identities = 299/380 (78%), Positives = 331/380 (87%), Gaps = 9/380 (2%)
Query: 348 LPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT 407
LPPYLPAIQGCRSVEEF+CLNRIEEGTYGVVYRA+DKRTDEIVALKRLKMEKEKEGFPIT
Sbjct: 483 LPPYLPAIQGCRSVEEFQCLNRIEEGTYGVVYRARDKRTDEIVALKRLKMEKEKEGFPIT 542
Query: 408 SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE 467
SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD+KSLMETM+ KKQVFIPGE
Sbjct: 543 SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLMETMKQKKQVFIPGE 602
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
VKCLMQQLL AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL+ YTPIV
Sbjct: 603 VKCLMQQLLRAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLRQYTPIV 662
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
VTLWYR+PELLL KEYSTPIDMWSVGCIFAE L ME LF GKS+++QL+RIFK +GTPN
Sbjct: 663 VTLWYRAPELLLSGKEYSTPIDMWSVGCIFAELLRMEALFPGKSEIDQLNRIFKELGTPN 722
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
++IWPG+SKLP VQK+ FA YP V L+ + + S L++LG +LL KFLTYDP RI+A++
Sbjct: 723 DRIWPGYSKLPMVQKIPFAHYP-VNNLRQRFSLS-LSDLGIELLNKFLTYDPQQRISAED 780
Query: 648 ALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDNEE----- 702
AL+H YF+E+PLPIDP MFPTWPAKSEL + A ASPKPPSGG YKQL D ++
Sbjct: 781 ALKHGYFTEAPLPIDPQMFPTWPAKSELG-VRTANASPKPPSGGREYKQLGDGDDADLSN 839
Query: 703 -GFHMGMMERSRAPVPGFSW 721
GFHMG+ E R P G +
Sbjct: 840 SGFHMGLTEGGRQPPIGGGF 859
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340721434|ref|XP_003399125.1| PREDICTED: hypothetical protein LOC100650971 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1633), Expect = e-178, Method: Compositional matrix adjust.
Identities = 299/380 (78%), Positives = 331/380 (87%), Gaps = 9/380 (2%)
Query: 348 LPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT 407
LPPYLPAIQGCRSVEEF+CLNRIEEGTYGVVYRA+DKRTDEIVALKRLKMEKEKEGFPIT
Sbjct: 483 LPPYLPAIQGCRSVEEFQCLNRIEEGTYGVVYRARDKRTDEIVALKRLKMEKEKEGFPIT 542
Query: 408 SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE 467
SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD+KSLMETM+ KKQVFIPGE
Sbjct: 543 SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLMETMKQKKQVFIPGE 602
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
VKCLMQQLL AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL+ YTPIV
Sbjct: 603 VKCLMQQLLRAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLRQYTPIV 662
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
VTLWYR+PELLL KEYSTPIDMWSVGCIFAE L ME LF GKS+++QL+RIFK +GTPN
Sbjct: 663 VTLWYRAPELLLSGKEYSTPIDMWSVGCIFAELLRMEALFPGKSEIDQLNRIFKELGTPN 722
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
++IWPG+SKLP VQK+ FA YP V L+ + + S L++LG +LL KFLTYDP RI+A++
Sbjct: 723 DRIWPGYSKLPMVQKIPFAHYP-VNNLRQRFSLS-LSDLGIELLNKFLTYDPQQRISAED 780
Query: 648 ALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDNEE----- 702
AL+H YF+E+PLPIDP MFPTWPAKSEL + A ASPKPPSGG YKQL D ++
Sbjct: 781 ALKHGYFTEAPLPIDPQMFPTWPAKSELG-VRTANASPKPPSGGKEYKQLGDGDDADLSN 839
Query: 703 -GFHMGMMERSRAPVPGFSW 721
GFHMG+ E R P G +
Sbjct: 840 SGFHMGLTEGGRQPPIGGGF 859
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322798653|gb|EFZ20257.1| hypothetical protein SINV_13494 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1626), Expect = e-178, Method: Compositional matrix adjust.
Identities = 362/649 (55%), Positives = 441/649 (67%), Gaps = 64/649 (9%)
Query: 89 HKSHRRRDEDRKHRD-ERKAREAQKSKEYTAREIDELKAK-EADLRARLERKRYSNPLRE 146
H R RD+++ R+ E + ++ + + E A EI+E+ + E ++ + +P
Sbjct: 231 HDRVRERDQEKMEREKEHREKQLRNAMEIVADEINEMDVQNEISIQIK-------DP--- 280
Query: 147 KEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNEM-DVDEA 205
KE E+ELRKERLLEA+R KE + + R+ R R SP N + ++ +
Sbjct: 281 KEMTEQELRKERLLEADREMARRKEVSRMELEARRMKRGEKRPMSPNNNPDPSIVELSDE 340
Query: 206 HQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAG 265
+GAR+ + ESR ++E RSP + E+ + E A
Sbjct: 341 SISPHSEGARS----KSAESRHSSEVE-----------RSPHERSSERHSSDSSESSSAD 385
Query: 266 SA---ESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNE 322
ES+ GS S DGSE ++ S D + AK + SP
Sbjct: 386 DDESNESNKGSAGDSNDGSEYNNPSPLSVD---------------RLAKSDHSDGDSPGH 430
Query: 323 SERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAK 382
+ + + ++++ E + E+ LPPYLPAIQGCRSVEEF+CLNRIEEGTYGVVYRA+
Sbjct: 431 VDSNNA-----SKNIEEEKKAEEPELPPYLPAIQGCRSVEEFQCLNRIEEGTYGVVYRAR 485
Query: 383 DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442
DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM
Sbjct: 486 DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 545
Query: 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502
DYVEHD+KSL+ETM+ KKQVFIPGEVKCLMQQLL AVAHLHDNWILHRDLKTSNLLLSHR
Sbjct: 546 DYVEHDLKSLIETMKQKKQVFIPGEVKCLMQQLLRAVAHLHDNWILHRDLKTSNLLLSHR 605
Query: 503 GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE----YSTPIDMWSVGCIFA 558
GILKVGDFGLAREYGSPL+ YTPIVVTLWYR+PELLL KE YSTPIDMWSVGCIFA
Sbjct: 606 GILKVGDFGLAREYGSPLRQYTPIVVTLWYRAPELLLCDKEYAGLYSTPIDMWSVGCIFA 665
Query: 559 EFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKV 618
E L MEPLF GKSD++QL++IFK +GTP+++IWPG+SKLP VQK+ FA YP V L+ +
Sbjct: 666 ELLRMEPLFPGKSDIDQLNKIFKELGTPSDRIWPGYSKLPIVQKIPFAHYP-VNNLRQRF 724
Query: 619 AGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHK 678
+ S L++LG +LL KFLTYDP R+TA++AL HDYF E+P PIDP MFPTWPAKSE
Sbjct: 725 SLS-LSDLGIELLNKFLTYDPRQRVTAEKALDHDYFIEAPKPIDPQMFPTWPAKSEQG-S 782
Query: 679 KAAMASPKPPSGGHNYKQLEDNEE------GFHMGMMERSRAPVPGFSW 721
+ ASPKPPSGG YKQL D ++ GFHMG+ E RAP G +
Sbjct: 783 RTTNASPKPPSGGREYKQLGDGDDADFSNSGFHMGLTEGGRAPPVGGGF 831
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332017880|gb|EGI58540.1| PITSLRE serine/threonine-protein kinase CDC2L1 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1615), Expect = e-176, Method: Compositional matrix adjust.
Identities = 297/384 (77%), Positives = 330/384 (85%), Gaps = 13/384 (3%)
Query: 348 LPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT 407
LPPYLPAIQGCRSVEEF+CLNRIEEGTYGVVYRA+DKRTDEIVALKRLKMEKEKEGFPIT
Sbjct: 482 LPPYLPAIQGCRSVEEFQCLNRIEEGTYGVVYRARDKRTDEIVALKRLKMEKEKEGFPIT 541
Query: 408 SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE 467
SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD+KSL+ETM+ KKQVFIPGE
Sbjct: 542 SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLIETMKQKKQVFIPGE 601
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
VKCLMQQLL AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL+ YTPIV
Sbjct: 602 VKCLMQQLLRAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLRQYTPIV 661
Query: 528 VTLWYRSPELLLGCKE----YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTM 583
VTLWYR+PELLL KE YSTPIDMWSVGCIFAE L MEPLF GKSD++QL++IFK +
Sbjct: 662 VTLWYRAPELLLCDKEYLGIYSTPIDMWSVGCIFAELLRMEPLFPGKSDIDQLNKIFKEL 721
Query: 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI 643
GTP+E+IWPG++KLP VQK+ FA YP V L+ + + S L++LG +LL KFLTYDP R+
Sbjct: 722 GTPSERIWPGYAKLPIVQKIPFAHYP-VNNLRQRFSLS-LSDLGIELLNKFLTYDPRQRV 779
Query: 644 TADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDNEE- 702
TA++AL H YF+E+PLPIDP MFPTWPAKSE + ASPKPPSGG YKQL D ++
Sbjct: 780 TAEDALNHGYFTEAPLPIDPQMFPTWPAKSEQG-IRTTNASPKPPSGGREYKQLGDGDDA 838
Query: 703 -----GFHMGMMERSRAPVPGFSW 721
GFHMG+ E RAP G +
Sbjct: 839 DLSNSGFHMGLTEGGRAPPVGGGF 862
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345482026|ref|XP_003424512.1| PREDICTED: hypothetical protein LOC100123143 isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 623 bits (1607), Expect = e-175, Method: Compositional matrix adjust.
Identities = 302/414 (72%), Positives = 339/414 (81%), Gaps = 16/414 (3%)
Query: 318 ASPNESERDVSP-HVIMDQDVDMEIELEKDT------LPPYLPAIQGCRSVEEFKCLNRI 370
A + SER SP HV + E +KD LPPY PAIQGCRSVEE+KCLNRI
Sbjct: 498 AKSDRSERSDSPGHVDTNGSAKPTNETKKDVIDIGLDLPPYFPAIQGCRSVEEYKCLNRI 557
Query: 371 EEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIV 430
EGTYGVVYRA+D+RT EIVALKRLKMEKEK+GFPITSLREINTLLKAQHPNIVTVREIV
Sbjct: 558 AEGTYGVVYRAEDRRTKEIVALKRLKMEKEKDGFPITSLREINTLLKAQHPNIVTVREIV 617
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHR 490
VGSNMDKIFIVMDYVEHD+KSLMETM+SK QVFIPGE+KCLMQQLL AVAHLHDNWILHR
Sbjct: 618 VGSNMDKIFIVMDYVEHDLKSLMETMKSKNQVFIPGEIKCLMQQLLRAVAHLHDNWILHR 677
Query: 491 DLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDM 550
DLKTSNLLLSHRGILKVGDFGLAREYGSPLK YT +VVTLWYR+PELLLG KEYSTPIDM
Sbjct: 678 DLKTSNLLLSHRGILKVGDFGLAREYGSPLKQYTSVVVTLWYRAPELLLGMKEYSTPIDM 737
Query: 551 WSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPN 610
WSVGCIFAE L ME LF GKS+++ L+R+FK +GTP+++IWPG+SKLP V+K+ FA YP
Sbjct: 738 WSVGCIFAELLRMEALFPGKSEIDYLNRVFKELGTPSDRIWPGYSKLPLVKKIPFAHYP- 796
Query: 611 VGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWP 670
V ++ + + S L++ G +LL KFLTYDP RITAD+AL+H YF+ESPLPIDPAMFPTWP
Sbjct: 797 VNNIRQRFSLS-LSDAGIELLAKFLTYDPAQRITADDALKHTYFTESPLPIDPAMFPTWP 855
Query: 671 AKSELAHKKAAMASPKPPSGGHNYKQL-----EDNEEGFHMGMMERSRA-PVPG 718
AKSE + ASPKPPSGG +KQL ED+ GFHMG E SR PV G
Sbjct: 856 AKSEFG-ARTLNASPKPPSGGKEFKQLGENDDEDSASGFHMGSREASRQLPVGG 908
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156545446|ref|XP_001606753.1| PREDICTED: hypothetical protein LOC100123143 isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1604), Expect = e-175, Method: Compositional matrix adjust.
Identities = 302/414 (72%), Positives = 339/414 (81%), Gaps = 16/414 (3%)
Query: 318 ASPNESERDVSP-HVIMDQDVDMEIELEKDT------LPPYLPAIQGCRSVEEFKCLNRI 370
A + SER SP HV + E +KD LPPY PAIQGCRSVEE+KCLNRI
Sbjct: 481 AKSDRSERSDSPGHVDTNGSAKPTNETKKDVIDIGLDLPPYFPAIQGCRSVEEYKCLNRI 540
Query: 371 EEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIV 430
EGTYGVVYRA+D+RT EIVALKRLKMEKEK+GFPITSLREINTLLKAQHPNIVTVREIV
Sbjct: 541 AEGTYGVVYRAEDRRTKEIVALKRLKMEKEKDGFPITSLREINTLLKAQHPNIVTVREIV 600
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHR 490
VGSNMDKIFIVMDYVEHD+KSLMETM+SK QVFIPGE+KCLMQQLL AVAHLHDNWILHR
Sbjct: 601 VGSNMDKIFIVMDYVEHDLKSLMETMKSKNQVFIPGEIKCLMQQLLRAVAHLHDNWILHR 660
Query: 491 DLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDM 550
DLKTSNLLLSHRGILKVGDFGLAREYGSPLK YT +VVTLWYR+PELLLG KEYSTPIDM
Sbjct: 661 DLKTSNLLLSHRGILKVGDFGLAREYGSPLKQYTSVVVTLWYRAPELLLGMKEYSTPIDM 720
Query: 551 WSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPN 610
WSVGCIFAE L ME LF GKS+++ L+R+FK +GTP+++IWPG+SKLP V+K+ FA YP
Sbjct: 721 WSVGCIFAELLRMEALFPGKSEIDYLNRVFKELGTPSDRIWPGYSKLPLVKKIPFAHYP- 779
Query: 611 VGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWP 670
V ++ + + S L++ G +LL KFLTYDP RITAD+AL+H YF+ESPLPIDPAMFPTWP
Sbjct: 780 VNNIRQRFSLS-LSDAGIELLAKFLTYDPAQRITADDALKHTYFTESPLPIDPAMFPTWP 838
Query: 671 AKSELAHKKAAMASPKPPSGGHNYKQL-----EDNEEGFHMGMMERSRA-PVPG 718
AKSE + ASPKPPSGG +KQL ED+ GFHMG E SR PV G
Sbjct: 839 AKSEFG-ARTLNASPKPPSGGKEFKQLGENDDEDSASGFHMGSREASRQLPVGG 891
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157104530|ref|XP_001648451.1| cdk10/11 [Aedes aegypti] gi|108880315|gb|EAT44540.1| AAEL004110-PA [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1603), Expect = e-175, Method: Compositional matrix adjust.
Identities = 297/389 (76%), Positives = 327/389 (84%), Gaps = 10/389 (2%)
Query: 339 MEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME 398
ME+E E + LPPY P IQGCRSVEEF+CLNRIEEGTYGVVYRAKDKRT+EIVALKRLKME
Sbjct: 451 MEVEPE-EQLPPYFPGIQGCRSVEEFQCLNRIEEGTYGVVYRAKDKRTEEIVALKRLKME 509
Query: 399 KEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRS 458
KEKEGFPITSLREINTLLK QHPNIVTVREIVVGSNMDKIFIVMDYVEHD+KSLMETM+
Sbjct: 510 KEKEGFPITSLREINTLLKGQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLMETMKH 569
Query: 459 KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518
KKQVF+PGEVKCL QQLL AVAHLHDNWILHRDLKTSNLLLSH+GILKVGDFGLAREYGS
Sbjct: 570 KKQVFLPGEVKCLTQQLLRAVAHLHDNWILHRDLKTSNLLLSHKGILKVGDFGLAREYGS 629
Query: 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSR 578
PLK YT IVVTLWYR+PELLL CKEYSTPID+WSVGCIFAEFL M LF GK++L+QL+R
Sbjct: 630 PLKAYTSIVVTLWYRAPELLLCCKEYSTPIDIWSVGCIFAEFLAMTALFPGKTELDQLNR 689
Query: 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYD 638
IFK +GTPNEKIWPG+++LPAVQKMTF EYP V L+ + A +ELG LL LT+D
Sbjct: 690 IFKELGTPNEKIWPGYNQLPAVQKMTFTEYP-VSNLRKRFAHQT-SELGISLLQGLLTFD 747
Query: 639 PVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLE 698
P R+TA+ L+H YF E PLPIDPAMFPTWPAKSEL KKA +SPKPPSGG +K+L
Sbjct: 748 PKQRLTAEAGLKHSYFKELPLPIDPAMFPTWPAKSELGLKKALASSPKPPSGGGEFKKLG 807
Query: 699 D----NEEGFHMGMM---ERSRAPVPGFS 720
D + GFH+G R A PGFS
Sbjct: 808 DDPVADNPGFHLGATYAESRQMAMGPGFS 836
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383849918|ref|XP_003700580.1| PREDICTED: uncharacterized protein LOC100874920 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1595), Expect = e-174, Method: Compositional matrix adjust.
Identities = 290/374 (77%), Positives = 325/374 (86%), Gaps = 9/374 (2%)
Query: 354 AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREIN 413
AIQGCRSVEEF+CLNRI EGTYGVVYRA+DKRTDEIVALKRLKMEKEKEGFPITSLREIN
Sbjct: 489 AIQGCRSVEEFQCLNRIAEGTYGVVYRARDKRTDEIVALKRLKMEKEKEGFPITSLREIN 548
Query: 414 TLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ 473
TLL+AQHPNIVTVREIVVGSNMDKIFIVMDYVEHD+KSLMETM+ KKQVFIPGEVKCLMQ
Sbjct: 549 TLLQAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLMETMKQKKQVFIPGEVKCLMQ 608
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
QLL AVAHLHDNWILHRDLKTSNLLLSHRG+LKVGDFGLAREYGSPL+ YTPIVVTLWYR
Sbjct: 609 QLLRAVAHLHDNWILHRDLKTSNLLLSHRGVLKVGDFGLAREYGSPLRQYTPIVVTLWYR 668
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
+PELLL KEYSTP+DMWSVGCIFAE L ME LF GKS+++QL+RIFK +GTPN++IWPG
Sbjct: 669 APELLLSEKEYSTPVDMWSVGCIFAELLRMEALFPGKSEIDQLNRIFKELGTPNDRIWPG 728
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
+SKLP VQK+ FA YP V L+ + + S L++LG +LL KFLTYDP RI+A++AL+H Y
Sbjct: 729 YSKLPMVQKIPFAHYP-VNNLRQRFSLS-LSDLGIELLNKFLTYDPQQRISAEDALKHGY 786
Query: 654 FSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDNEE------GFHMG 707
F+E+PLPIDP MFPTWPAKSEL + A ASPKPPSGG YKQL D ++ GFHMG
Sbjct: 787 FTEAPLPIDPQMFPTWPAKSELG-LRTANASPKPPSGGKEYKQLGDGDDADLSNSGFHMG 845
Query: 708 MMERSRAPVPGFSW 721
+ME R P G +
Sbjct: 846 LMEGGRQPPVGGGF 859
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307199072|gb|EFN79782.1| PITSLRE serine/threonine-protein kinase CDC2L1 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1592), Expect = e-174, Method: Compositional matrix adjust.
Identities = 288/377 (76%), Positives = 324/377 (85%), Gaps = 9/377 (2%)
Query: 351 YLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR 410
YLPAIQGCRSVEEF+CLNRIEEGTYGVVYRA+DKRTDEIVALKRLKMEKEKEGFPITSLR
Sbjct: 477 YLPAIQGCRSVEEFQCLNRIEEGTYGVVYRARDKRTDEIVALKRLKMEKEKEGFPITSLR 536
Query: 411 EINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKC 470
EINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD+KSLMETM+ KKQVFIPGEVKC
Sbjct: 537 EINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLMETMKQKKQVFIPGEVKC 596
Query: 471 LMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL 530
LMQQLL AV HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL+ YTP+VVTL
Sbjct: 597 LMQQLLRAVTHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLRQYTPVVVTL 656
Query: 531 WYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590
WYR+PELLL KEYSTP+DMWSVGCIFAE L ME LF GKS+++QL++IFK +GTP+E++
Sbjct: 657 WYRAPELLLSDKEYSTPVDMWSVGCIFAELLRMEALFPGKSEMDQLNKIFKELGTPSERV 716
Query: 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650
WPG+++LP V K+ FA YP V L+ + + S L+ELG +LL KFLTYDP R+TA++AL
Sbjct: 717 WPGYNRLPLVPKIPFAHYP-VNSLRQRFSLS-LSELGIELLNKFLTYDPRQRVTAEDALG 774
Query: 651 HDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDNEE------GF 704
H YF+E+PLPIDP MFPTWPAKSE + ASPKPPSGG YKQL D ++ GF
Sbjct: 775 HGYFTEAPLPIDPQMFPTWPAKSEQG-TRTTNASPKPPSGGREYKQLGDGDDADLSNSGF 833
Query: 705 HMGMMERSRAPVPGFSW 721
HMG+ E RAP G +
Sbjct: 834 HMGLTESGRAPSVGGGF 850
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1028 | ||||||
| MGI|MGI:88353 | 784 | Cdk11b "cyclin-dependent kinas | 0.362 | 0.475 | 0.721 | 6.2e-152 | |
| UNIPROTKB|F1RJC5 | 784 | CDK11B "Uncharacterized protei | 0.362 | 0.475 | 0.716 | 1.3e-151 | |
| UNIPROTKB|P21127 | 795 | CDK11B "Cyclin-dependent kinas | 0.362 | 0.469 | 0.716 | 2.1e-151 | |
| UNIPROTKB|E2R4W7 | 801 | CDK11A "Uncharacterized protei | 0.362 | 0.465 | 0.713 | 4.3e-151 | |
| UNIPROTKB|J9NW55 | 787 | CDK11A "Uncharacterized protei | 0.362 | 0.473 | 0.713 | 4.3e-151 | |
| UNIPROTKB|J9P8L3 | 748 | CDK11A "Uncharacterized protei | 0.362 | 0.498 | 0.713 | 4.3e-151 | |
| UNIPROTKB|F1N5K1 | 771 | CDC2L1 "Uncharacterized protei | 0.362 | 0.483 | 0.713 | 5.5e-151 | |
| UNIPROTKB|E1BWQ7 | 772 | CDC2L1 "Uncharacterized protei | 0.371 | 0.494 | 0.699 | 1.1e-150 | |
| ZFIN|ZDB-GENE-041212-74 | 800 | cdk11b "cyclin-dependent kinas | 0.362 | 0.466 | 0.713 | 2.5e-149 | |
| FB|FBgn0016696 | 952 | Pitslre "Pitslre" [Drosophila | 0.342 | 0.369 | 0.752 | 4.3e-149 |
| MGI|MGI:88353 Cdk11b "cyclin-dependent kinase 11B" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1437 (510.9 bits), Expect = 6.2e-152, Sum P(3) = 6.2e-152
Identities = 277/384 (72%), Positives = 323/384 (84%)
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE 400
IEL+++ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVALKRLKMEKE
Sbjct: 405 IELKQE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE 463
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
KEGFPITSLREINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KSLMETM K
Sbjct: 464 KEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETM---K 520
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
Q F+PGEVK LM QLL+ V HLHDNWILHRDLKTSNLLLSH GILKVGDFGLAREYGSPL
Sbjct: 521 QPFLPGEVKTLMIQLLSGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPL 580
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
K YTP+VVTLWYR+PELLLG KEYST +DMWSVGCIF E L +PLF GKSD++Q+++IF
Sbjct: 581 KAYTPVVVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSDIDQINKIF 640
Query: 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV 640
K +GTP+EKIWPG++ LPAV+KMTF+EYP L+ + G++L++ G+DL+ KFLTY P
Sbjct: 641 KDLGTPSEKIWPGYNDLPAVKKMTFSEYP-YNNLRKRF-GALLSDQGFDLMNKFLTYYPG 698
Query: 641 TRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDN 700
RI A++ L+H+YF E+PLPIDP+MFPTWPAKSE K SP+PP GG Y QL D+
Sbjct: 699 RRINAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRG-TSPRPPEGGLGYSQLGDD 757
Query: 701 ---EEGFHMGMMER-SRAPVPGFS 720
E GFH+ + + A PGFS
Sbjct: 758 DLKETGFHLTTTNQGASAAGPGFS 781
|
|
| UNIPROTKB|F1RJC5 CDK11B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1434 (509.9 bits), Expect = 1.3e-151, Sum P(3) = 1.3e-151
Identities = 275/384 (71%), Positives = 322/384 (83%)
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE 400
IEL+++ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVALKRLKMEKE
Sbjct: 405 IELKQE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE 463
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
KEGFPITSLREINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KSLMETM K
Sbjct: 464 KEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETM---K 520
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
Q F+PGEVK LM QLL V HLHDNWILHRDLKTSNLLLSH GILKVGDFGLAREYGSPL
Sbjct: 521 QPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPL 580
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
K YTP+VVTLWYR+PELLLG KEYST +DMWSVGCIF E L +PLF GKSD++Q++++F
Sbjct: 581 KAYTPVVVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSDIDQINKVF 640
Query: 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV 640
K +GTP+EKIWPG++ LPAV+KMTF EYP L+ + G++L++ G+DL+ KFLTY P
Sbjct: 641 KDLGTPSEKIWPGYNDLPAVKKMTFTEYP-YNNLRKRF-GALLSDQGFDLMNKFLTYFPG 698
Query: 641 TRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDN 700
R++A++ L+H+YF E+PLPIDP+MFPTWPAKSE K SP+PP GG Y QL D+
Sbjct: 699 RRVSAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRG-TSPRPPEGGLGYSQLGDD 757
Query: 701 ---EEGFHMGMMER-SRAPVPGFS 720
E GFH+ + + A PGFS
Sbjct: 758 DLKETGFHLTTTNQGASAAGPGFS 781
|
|
| UNIPROTKB|P21127 CDK11B "Cyclin-dependent kinase 11B" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1432 (509.1 bits), Expect = 2.1e-151, Sum P(3) = 2.1e-151
Identities = 275/384 (71%), Positives = 324/384 (84%)
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE 400
IEL+++ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVALKRLKMEKE
Sbjct: 416 IELKQE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE 474
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
KEGFPITSLREINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KSLMETM K
Sbjct: 475 KEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETM---K 531
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
Q F+PGEVK LM QLL V HLHDNWILHRDLKTSNLLLSH GILKVGDFGLAREYGSPL
Sbjct: 532 QPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPL 591
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
K YTP+VVTLWYR+PELLLG KEYST +DMWSVGCIF E L +PLF GKS+++Q++++F
Sbjct: 592 KAYTPVVVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVF 651
Query: 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV 640
K +GTP+EKIWPG+S+LPAV+KMTF+E+P L+ + G++L++ G+DL+ KFLTY P
Sbjct: 652 KDLGTPSEKIWPGYSELPAVKKMTFSEHP-YNNLRKRF-GALLSDQGFDLMNKFLTYFPG 709
Query: 641 TRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDN 700
RI+A++ L+H+YF E+PLPIDP+MFPTWPAKSE K SP+PP GG Y QL D+
Sbjct: 710 RRISAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRG-TSPRPPEGGLGYSQLGDD 768
Query: 701 ---EEGFHMGMMER-SRAPVPGFS 720
E GFH+ + + A PGFS
Sbjct: 769 DLKETGFHLTTTNQGASAAGPGFS 792
|
|
| UNIPROTKB|E2R4W7 CDK11A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1430 (508.4 bits), Expect = 4.3e-151, Sum P(3) = 4.3e-151
Identities = 274/384 (71%), Positives = 322/384 (83%)
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE 400
IEL+++ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVALKRLKMEKE
Sbjct: 422 IELKQE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE 480
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
KEGFPITSLREINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KSLMETM K
Sbjct: 481 KEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETM---K 537
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
Q F+PGEVK LM QLL V HLHDNWILHRDLKTSNLLLSH GILKVGDFGLAREYGSPL
Sbjct: 538 QPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPL 597
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
K YTP+VVTLWYR+PELLLG KEYST +DMWSVGCIF E L +PLF GKS+++Q++++F
Sbjct: 598 KAYTPVVVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVF 657
Query: 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV 640
K +GTP+EKIWPG++ LPAV+KMTF EYP L+ + G++L++ G+DL+ KFLTY P
Sbjct: 658 KDLGTPSEKIWPGYNDLPAVKKMTFTEYP-YNNLRKRF-GALLSDQGFDLMNKFLTYFPG 715
Query: 641 TRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDN 700
R++A++ L+H+YF E+PLPIDP+MFPTWPAKSE K SP+PP GG Y QL D+
Sbjct: 716 RRVSAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRG-TSPRPPEGGLGYSQLGDD 774
Query: 701 ---EEGFHMGMMER-SRAPVPGFS 720
E GFH+ + + A PGFS
Sbjct: 775 DLKETGFHLTTTNQGASAAGPGFS 798
|
|
| UNIPROTKB|J9NW55 CDK11A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1430 (508.4 bits), Expect = 4.3e-151, Sum P(3) = 4.3e-151
Identities = 274/384 (71%), Positives = 322/384 (83%)
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE 400
IEL+++ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVALKRLKMEKE
Sbjct: 408 IELKQE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE 466
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
KEGFPITSLREINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KSLMETM K
Sbjct: 467 KEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETM---K 523
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
Q F+PGEVK LM QLL V HLHDNWILHRDLKTSNLLLSH GILKVGDFGLAREYGSPL
Sbjct: 524 QPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPL 583
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
K YTP+VVTLWYR+PELLLG KEYST +DMWSVGCIF E L +PLF GKS+++Q++++F
Sbjct: 584 KAYTPVVVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVF 643
Query: 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV 640
K +GTP+EKIWPG++ LPAV+KMTF EYP L+ + G++L++ G+DL+ KFLTY P
Sbjct: 644 KDLGTPSEKIWPGYNDLPAVKKMTFTEYP-YNNLRKRF-GALLSDQGFDLMNKFLTYFPG 701
Query: 641 TRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDN 700
R++A++ L+H+YF E+PLPIDP+MFPTWPAKSE K SP+PP GG Y QL D+
Sbjct: 702 RRVSAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRG-TSPRPPEGGLGYSQLGDD 760
Query: 701 ---EEGFHMGMMER-SRAPVPGFS 720
E GFH+ + + A PGFS
Sbjct: 761 DLKETGFHLTTTNQGASAAGPGFS 784
|
|
| UNIPROTKB|J9P8L3 CDK11A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1430 (508.4 bits), Expect = 4.3e-151, Sum P(3) = 4.3e-151
Identities = 274/384 (71%), Positives = 322/384 (83%)
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE 400
IEL+++ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVALKRLKMEKE
Sbjct: 369 IELKQE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE 427
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
KEGFPITSLREINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KSLMETM K
Sbjct: 428 KEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETM---K 484
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
Q F+PGEVK LM QLL V HLHDNWILHRDLKTSNLLLSH GILKVGDFGLAREYGSPL
Sbjct: 485 QPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPL 544
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
K YTP+VVTLWYR+PELLLG KEYST +DMWSVGCIF E L +PLF GKS+++Q++++F
Sbjct: 545 KAYTPVVVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVF 604
Query: 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV 640
K +GTP+EKIWPG++ LPAV+KMTF EYP L+ + G++L++ G+DL+ KFLTY P
Sbjct: 605 KDLGTPSEKIWPGYNDLPAVKKMTFTEYP-YNNLRKRF-GALLSDQGFDLMNKFLTYFPG 662
Query: 641 TRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDN 700
R++A++ L+H+YF E+PLPIDP+MFPTWPAKSE K SP+PP GG Y QL D+
Sbjct: 663 RRVSAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRG-TSPRPPEGGLGYSQLGDD 721
Query: 701 ---EEGFHMGMMER-SRAPVPGFS 720
E GFH+ + + A PGFS
Sbjct: 722 DLKETGFHLTTTNQGASAAGPGFS 745
|
|
| UNIPROTKB|F1N5K1 CDC2L1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1429 (508.1 bits), Expect = 5.5e-151, Sum P(3) = 5.5e-151
Identities = 274/384 (71%), Positives = 321/384 (83%)
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE 400
IEL+++ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVALKRLKMEKE
Sbjct: 392 IELKQE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE 450
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
KEGFPITSLREINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KSLMETM K
Sbjct: 451 KEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETM---K 507
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
Q F+PGEVK LM QLL V HLHDNWILHRDLKTSNLLLSH GILKVGDFGLAREYGSPL
Sbjct: 508 QPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPL 567
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
K YTP+VVTLWYR+PELLLG KEYST +DMWSVGCIF E L +PLF GKS+++Q++++F
Sbjct: 568 KAYTPVVVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVF 627
Query: 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV 640
K +GTP+EKIWPG++ LPAV+KMTF EYP L+ + G++L++ G+DL+ KFLTY P
Sbjct: 628 KDLGTPSEKIWPGYNDLPAVKKMTFTEYP-YNNLRKRF-GALLSDQGFDLMNKFLTYFPG 685
Query: 641 TRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDN 700
R+ A++ L+H+YF E+PLPIDP+MFPTWPAKSE K SP+PP GG Y QL D+
Sbjct: 686 RRVNAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRG-TSPRPPEGGLGYSQLGDD 744
Query: 701 ---EEGFHMGMMER-SRAPVPGFS 720
E GFH+ + + A PGFS
Sbjct: 745 DLKETGFHLTTTNQGASAAGPGFS 768
|
|
| UNIPROTKB|E1BWQ7 CDC2L1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1427 (507.4 bits), Expect = 1.1e-150, Sum P(3) = 1.1e-150
Identities = 275/393 (69%), Positives = 323/393 (82%)
Query: 332 IMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 391
+ D IEL+++ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVA
Sbjct: 384 VPDSPASSPIELKQE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVA 442
Query: 392 LKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKS 451
LKRLKMEKEKEGFPITSLREINT+LKAQH NIVTVREIVVGSNMDKI+IVM+YVEHD+KS
Sbjct: 443 LKRLKMEKEKEGFPITSLREINTILKAQHLNIVTVREIVVGSNMDKIYIVMNYVEHDLKS 502
Query: 452 LMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFG 511
LMETM KQ F+PGEVK LM QLL V HLHDNWILHRDLKTSNLLLSH GILKVGDFG
Sbjct: 503 LMETM---KQPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHSGILKVGDFG 559
Query: 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS 571
LAREYGSPLK YTP+VVTLWYR+PELLLG KEYST IDMWSVGCIF E L +PLF GKS
Sbjct: 560 LAREYGSPLKPYTPVVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFGELLTQKPLFPGKS 619
Query: 572 DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLL 631
+++Q++++FK +GTP+EKIWPG+++LPAV+KMTF EYP L+ + G++L++ G+DL+
Sbjct: 620 EIDQINKVFKDLGTPSEKIWPGYNELPAVKKMTFTEYP-YNNLRKRF-GALLSDQGFDLM 677
Query: 632 CKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGG 691
FLTY P RITA++ L+H+YF E+PLPIDP+MFPTWPAKSE K SP+PP GG
Sbjct: 678 NNFLTYYPARRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRG-TSPRPPEGG 736
Query: 692 HNYKQLEDNE---EGFHMGMMER-SRAPVPGFS 720
Y QL D++ GFH+ + + A PGFS
Sbjct: 737 LGYSQLGDDDLKDTGFHLTTTNQGASAAGPGFS 769
|
|
| ZFIN|ZDB-GENE-041212-74 cdk11b "cyclin-dependent kinase 11B" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1436 (510.6 bits), Expect = 2.5e-149, Sum P(2) = 2.5e-149
Identities = 274/384 (71%), Positives = 323/384 (84%)
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE 400
+EL+K+ LP YLPA+QGCRSVEEF+CLNRIEEGTYGVVYRAKDK+TDEIVALKRLKMEKE
Sbjct: 421 VELKKE-LPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE 479
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
KEGFPITSLREINT+LKAQHPNIVTVREIVVGSNMDKI+IVM+YVEHD+KSLMETM K
Sbjct: 480 KEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETM---K 536
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
Q F+PGEVK LM QLL V HLHDNWILHRDLKTSNLLLSH+GILK+GDFGLAREYGSPL
Sbjct: 537 QPFLPGEVKTLMIQLLRGVRHLHDNWILHRDLKTSNLLLSHKGILKIGDFGLAREYGSPL 596
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
K YTP+VVTLWYRSP+LLLG KEYST +DMWSVGCIF E L +PLF GKS+++Q+++IF
Sbjct: 597 KPYTPVVVTLWYRSPDLLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKIF 656
Query: 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV 640
K +G+P+EKIWPG+S+ PAV+KMTF EYP L+ + G++L++ G+DL+ KFLTY P
Sbjct: 657 KDLGSPSEKIWPGYSEPPAVKKMTFTEYP-YNNLRKRF-GALLSDQGFDLMNKFLTYCPA 714
Query: 641 TRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDN 700
RI+ADEAL+H+YF ESPLPIDP+MFPTWPAKSE K SP+ P GG ++ QL D+
Sbjct: 715 KRISADEALKHEYFRESPLPIDPSMFPTWPAKSEQQRVKRG-TSPRAPEGGQDFSQLGDD 773
Query: 701 E---EGFHMGMMERSRAPV-PGFS 720
+ GFH+ + + PGFS
Sbjct: 774 DLKDTGFHLTTANKGASMAGPGFS 797
|
|
| FB|FBgn0016696 Pitslre "Pitslre" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1400 (497.9 bits), Expect = 4.3e-149, Sum P(3) = 4.3e-149
Identities = 270/359 (75%), Positives = 304/359 (84%)
Query: 348 LPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT 407
LP Y P +QGCRSVEEF+CLNRIEEGTYGVVYRAKDKRT+EIVALKRLKMEKEKEGFPIT
Sbjct: 542 LPNYYPGVQGCRSVEEFQCLNRIEEGTYGVVYRAKDKRTNEIVALKRLKMEKEKEGFPIT 601
Query: 408 SLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE 467
SLREINTLLK QHPNIVTVREIVVGSNMDKIFIVMDYVEHD+KSLMETM+++KQ F PGE
Sbjct: 602 SLREINTLLKGQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLMETMKNRKQSFFPGE 661
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
VKCL QQLL AVAHLHDNWILHRDLKTSNLLLSH+GILKVGDFGLAREYGSP+K YT +V
Sbjct: 662 VKCLTQQLLRAVAHLHDNWILHRDLKTSNLLLSHKGILKVGDFGLAREYGSPIKKYTSLV 721
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
VTLWYR+PELLL YSTPID+WSVGCIFAEFL M PLF GKS++++L+RIFK +GTPN
Sbjct: 722 VTLWYRAPELLLCSPVYSTPIDVWSVGCIFAEFLQMLPLFPGKSEIDELNRIFKELGTPN 781
Query: 588 EKIWPGFSKLPAVQKMT-----FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR 642
EKIWPG+++LPAV+ M F EYP V L+ K +E+G LL LTYDP R
Sbjct: 782 EKIWPGYTELPAVKNMLSQNSQFTEYP-VSQLR-KHFQEKTSEMGLSLLQGLLTYDPKQR 839
Query: 643 ITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDNE 701
++AD AL+H +F E PLPIDP+MFPTWPAKSEL +KA +SPKPPSGG +KQL +E
Sbjct: 840 LSADAALKHGFFKELPLPIDPSMFPTWPAKSELGARKAQASSPKPPSGGSQFKQLGRDE 898
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q7XUF4 | CDKG2_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5566 | 0.3754 | 0.5436 | yes | N/A |
| Q9UQ88 | CD11A_HUMAN | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6972 | 0.3715 | 0.4878 | yes | N/A |
| Q3UMM4 | CDK10_MOUSE | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5075 | 0.3122 | 0.8916 | yes | N/A |
| Q09437 | YP62_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.6219 | 0.3180 | 0.4547 | yes | N/A |
| Q54RB2 | CDK11_DICDI | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5246 | 0.3054 | 0.8770 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.22 | 0.824 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1028 | |||
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.0 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-151 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-143 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-123 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-113 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-105 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-100 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-100 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-98 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-94 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-93 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-93 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-91 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-89 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-89 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-88 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-85 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-85 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-84 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-82 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-79 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-79 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-78 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-76 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-74 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-68 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-65 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-65 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-64 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-62 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-60 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-60 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-60 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-60 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-59 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-58 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-58 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-57 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-55 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-54 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-52 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-49 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-49 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-48 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-46 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-46 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-44 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-43 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-42 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-41 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-39 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-38 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-37 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-36 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-35 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-33 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-32 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-29 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-08 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 3e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 2e-07 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 3e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-07 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 8e-07 | |
| pfam04147 | 809 | pfam04147, Nop14, Nop14-like family | 8e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-06 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| TIGR00927 | 1096 | TIGR00927, 2A1904, K+-dependent Na+/Ca+ exchanger | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-05 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 6e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 7e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| PTZ00108 | 1388 | PTZ00108, PTZ00108, DNA topoisomerase 2-like prote | 3e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-04 | |
| pfam03344 | 715 | pfam03344, Daxx, Daxx Family | 3e-04 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 4e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 4e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-04 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 5e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 6e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-04 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 8e-04 | |
| PHA02664 | 534 | PHA02664, PHA02664, hypothetical protein; Provisio | 8e-04 | |
| COG2433 | 652 | COG2433, COG2433, Uncharacterized conserved protei | 9e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 0.001 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 0.001 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 0.001 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.001 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 0.002 | |
| TIGR00927 | 1096 | TIGR00927, 2A1904, K+-dependent Na+/Ca+ exchanger | 0.002 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 0.002 | |
| pfam04615 | 728 | pfam04615, Utp14, Utp14 protein | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.002 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.002 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.003 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.003 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.003 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 0.003 | |
| PRK00409 | 782 | PRK00409, PRK00409, recombination and DNA strand e | 0.003 | |
| PRK00247 | 429 | PRK00247, PRK00247, putative inner membrane protei | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.004 | |
| pfam10577 | 805 | pfam10577, UPF0560, Uncharacterized protein family | 0.004 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 579 bits (1495), Expect = 0.0
Identities = 215/297 (72%), Positives = 254/297 (85%), Gaps = 4/297 (1%)
Query: 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK 417
CRSV+E++ LNRIEEGTYGVVYRA+DK+T EIVALK+LKMEKEKEGFPITSLREIN LLK
Sbjct: 1 CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLK 60
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
QHPNIVTV+E+VVGSN+DKI++VM+YVEHD+KSLMETM KQ F+ EVKCLM QLL+
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLS 117
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
VAHLHDNWILHRDLKTSNLLL++RGILK+ DFGLAREYGSPLK YT +VVTLWYR+PEL
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
LLG KEYST IDMWSVGCIFAE L +PLF GKS+++QL++IFK +GTP EKIWPGFS+L
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
P +K TF +YP L+ K L++ G+DLL + LTYDP RI+A++AL+H YF
Sbjct: 238 PGAKKKTFTKYPY-NQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 449 bits (1158), Expect = e-151
Identities = 178/313 (56%), Positives = 222/313 (70%), Gaps = 6/313 (1%)
Query: 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK 417
CRSV EF+ LNRI EGTYG+VYRA+D + EIVALK+++M+ E++G PI+SLREI LL
Sbjct: 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
+HPNIV ++E+VVG ++D IF+VM+Y E D+ SL++ M F +VKCLM QLL
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLR 119
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ +LH+N+I+HRDLK SNLLL+ +G LK+ DFGLAR YG P K TP VVTLWYR+PEL
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
LLGC Y+T IDMW+VGCI AE L +PL GKS++EQL I + +GTPNE IWPGFS L
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657
P V K T + P LK K L+E G LL L YDP R TA+EAL YF E
Sbjct: 240 PLVGKFTLPKQP-YNNLKHKF--PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296
Query: 658 PLPIDPAMFPTWP 670
PLP +P M PT+P
Sbjct: 297 PLPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 428 bits (1104), Expect = e-143
Identities = 138/291 (47%), Positives = 200/291 (68%), Gaps = 9/291 (3%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
++ L ++ EGTYGVVY+A+DK+T EIVALK+++++ E+EG P T+LREI+ L + +HPNI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
V + +++ K+++V +Y + D+K ++ P +K +M QLL +A+ H
Sbjct: 61 VKLLDVIHTER--KLYLVFEYCDMDLKKYLDKRPGP---LSPNLIKSIMYQLLRGLAYCH 115
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
+ ILHRDLK N+L++ G+LK+ DFGLAR +G PL+ YT VVTLWYR+PE+LLG K
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603
YST +D+WSVGCIFAE + +PLF G S+++QL +IF+ +GTP E+ WPG +KLP K
Sbjct: 176 YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKP 234
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
TF ++P L+ + L G DLL K L Y+P RI+A EAL+H YF
Sbjct: 235 TFPKFPPK-DLEKVL--PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 376 bits (968), Expect = e-123
Identities = 137/293 (46%), Positives = 195/293 (66%), Gaps = 8/293 (2%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
++ + +I EGTYG VY+A++K+T E+VALK+++ME EKEGFPIT++REI L K +HPNI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
V ++EIV I++V +Y++HD+ L+ S + F ++KC M+QLL + +LH
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLL---DSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH-YTPIVVTLWYRSPELLLGCK 542
N ILHRD+K SN+L+++ G+LK+ DFGLAR Y YT V+TLWYR PELLLG
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 543 EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602
Y +DMWSVGCI AE +P+F G ++LEQL +IF+ G+P ++ WPG SKLP +
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237
Query: 603 MTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ + Y L+ ++ DLL K LT DP RI+AD+AL+H+YF
Sbjct: 238 LKPKKPYKRR--LREFF-KHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 351 bits (903), Expect = e-113
Identities = 131/300 (43%), Positives = 183/300 (61%), Gaps = 15/300 (5%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKE---GFPITSLREINTLLKAQHPNIVTVRE 428
EGTY VVY+A+DK T IVA+K++K+ + KE G T+LREI L + +HPNI+ + +
Sbjct: 10 EGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLD 69
Query: 429 I-VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI 487
+ SN I +V +++E D++ ++ + K V P ++K M L + +LH NWI
Sbjct: 70 VFGHKSN---INLVFEFMETDLEKVI---KDKSIVLTPADIKSYMLMTLRGLEYLHSNWI 123
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTP 547
LHRDLK +NLL++ G+LK+ DFGLAR +GSP + T VVT WYR+PELL G + Y
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVG 183
Query: 548 IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAE 607
+DMWSVGCIFAE L P G SD++QL +IF+ +GTP E+ WPG + LP + E
Sbjct: 184 VDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP-----DYVE 238
Query: 608 YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFP 667
+ K ++ DLL + LT +P RITA +AL H YFS P P P+ P
Sbjct: 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 329 bits (846), Expect = e-105
Identities = 140/291 (48%), Positives = 198/291 (68%), Gaps = 8/291 (2%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
++ + +I EGTYGVVY+A+DK T EIVALK++++E E EG P T++REI+ L + HPNI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
V + ++V N K+++V ++++ D+K M++ S P +K + QLL +A+ H
Sbjct: 61 VRLLDVVHSEN--KLYLVFEFLDLDLKKYMDS--SPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
+ +LHRDLK NLL+ G LK+ DFGLAR +G P++ YT VVTLWYR+PE+LLG ++
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603
YSTP+D+WS+GCIFAE + PLF G S+++QL RIF+T+GTP+E +WPG + LP K
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY-KP 235
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
TF ++ L V L E G DLL K L YDP RI+A AL+H YF
Sbjct: 236 TFPKWAR-QDLSKVVPN--LDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 318 bits (818), Expect = e-100
Identities = 133/317 (41%), Positives = 191/317 (60%), Gaps = 25/317 (7%)
Query: 356 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTL 415
GC + +++ L ++ EGT+G VY+A+ +T +VALK++ M EK+GFPIT+LREI L
Sbjct: 2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKIL 61
Query: 416 LKAQHPNIVTVREIVV------GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVK 469
K +HPN+V + ++ V +++V Y++HD+ L+E K ++K
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIK 118
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY----------GSP 519
C M QLL + +LH+N ILHRD+K +N+L+ ++GILK+ DFGLAR Y G
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 520 LKH-YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSR 578
YT +VVT WYR PELLLG + Y+T +D+W +GC+FAE P+ GKSD++QL
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238
Query: 579 IFKTMGTPNEKIWPGFSKLPAVQ-KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTY 637
IFK GTP E+ WPG+ LP + +F YP L+ + L G DLL K L+
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT--LEERFGK--LGPEGLDLLSKLLSL 294
Query: 638 DPVTRITADEALRHDYF 654
DP R+TA +AL H YF
Sbjct: 295 DPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 316 bits (813), Expect = e-100
Identities = 133/291 (45%), Positives = 191/291 (65%), Gaps = 8/291 (2%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
++ L +I EGTYGVVY+A+DK T EIVA+K++K+ E EG P T+LREI L + HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ + + V +++V ++++ D L + ++ +++ +K + QLL +A H
Sbjct: 61 IKLLD-VFRHK-GDLYLVFEFMDTD---LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
+ ILHRDLK NLL++ G+LK+ DFGLAR +GSP++ YT VVT WYR+PELLLG K
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603
YSTP+D+WSVGCIFAE L PLF GKS+++QL +IF+T+GTP+ ++WP F+ L K
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+F + + L + DLL + L YDP RITA++AL H YF
Sbjct: 236 SFPKKAGM-PLPKLF--PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 312 bits (801), Expect = 1e-98
Identities = 128/294 (43%), Positives = 185/294 (62%), Gaps = 11/294 (3%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN 422
+K L RI EG +G+V++AKD+ T E VALK++ + + + G P +LREI L QHP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 423 IVTVREIV-VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
+V + ++ GS +VM+Y+ D L E +R +++ +VK M+ LL VA+
Sbjct: 61 VVKLLDVFPHGSGF---VLVMEYMPSD---LSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP-LKHYTPIVVTLWYRSPELLLG 540
+H N I+HRDLK +NLL+S G+LK+ DFGLAR + + Y+ V T WYR+PELL G
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
++Y +D+W+VGCIFAE L PLF G++D+EQL+ +F+T+GTPNE+ WPG + LP
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
K+TF E + L+ + + DLL L YDP R++A EALRH YF
Sbjct: 235 NKITFPESKPI-PLEEIFPDA--SPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 300 bits (771), Expect = 2e-94
Identities = 127/292 (43%), Positives = 200/292 (68%), Gaps = 7/292 (2%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN 422
++ + +I EGTYGVVY+ ++K+T +IVA+K++++E E+EG P T++REI+ L + QHPN
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
IV ++++++ + +++++ +++ D+K ++++ + + VK + Q+L +
Sbjct: 61 IVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYM-DAELVKSYLYQILQGILFC 117
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCK 542
H +LHRDLK NLL+ ++G++K+ DFGLAR +G P++ YT VVTLWYR+PE+LLG
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 543 EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602
YSTP+D+WS+G IFAE +PLF G S+++QL RIF+ +GTP E +WPG + LP K
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY-K 236
Query: 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
TF ++ G L++ V L E G DLL K L YDP RI+A +AL H YF
Sbjct: 237 NTFPKWKK-GSLRSAVKN--LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 296 bits (761), Expect = 7e-93
Identities = 128/298 (42%), Positives = 182/298 (61%), Gaps = 18/298 (6%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK----AQ 419
++ L I EG YG VY+A+D T VALK++++ +EG P+++LREI LLK +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59
Query: 420 HPNIVTVREIVVGSNMD---KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
HPNIV + ++ G D K+ +V ++V+ D+ + + + K P +K LM+QLL
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLS--KCPKPGLPPETIKDLMRQLL 117
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
V LH + I+HRDLK N+L++ G +K+ DFGLAR Y + T +VVTLWYR+PE
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPE 176
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
+LL Y+TP+DMWSVGCIFAE PLF G S+ +QL +IF +G P+E+ WP
Sbjct: 177 VLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
LP + +F Y K+ V + E G DLL K LT++P RI+A EAL+H YF
Sbjct: 236 LP---RSSFPSYT-PRSFKSFVPE--ICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 296 bits (759), Expect = 9e-93
Identities = 130/291 (44%), Positives = 193/291 (66%), Gaps = 8/291 (2%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
F+ + +I EGTYGVVY+A++K T E+VALK+++++ E EG P T++REI+ L + HPNI
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
V + +++ +K+++V +++ D+K M+ + +P +K + QLL +A H
Sbjct: 62 VKLLDVI--HTENKLYLVFEFLHQDLKKFMDAS-PLSGIPLP-LIKSYLFQLLQGLAFCH 117
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
+ +LHRDLK NLL++ G +K+ DFGLAR +G P++ YT VVTLWYR+PE+LLGCK
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603
YST +D+WS+GCIFAE + LF G S+++QL RIF+T+GTP+E +WPG + LP K
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY-KP 236
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+F ++ V L E G DLL + L YDP RI+A AL H +F
Sbjct: 237 SFPKWA-RQDFSKVV--PPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 293 bits (753), Expect = 3e-91
Identities = 130/315 (41%), Positives = 189/315 (60%), Gaps = 24/315 (7%)
Query: 364 FKCLNRIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQH 420
++ I GTYG VY+AK K + + A+K+ K +KE+ G ++ REI L + +H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-GEVKCLMQQLLNAV 479
N+V++ E+ + ++++ DY EHD+ +++ R K+V IP VK L+ Q+LN V
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 480 AHLHDNWILHRDLKTSNLLL----SHRGILKVGDFGLAREYGSPLK---HYTPIVVTLWY 532
+LH NW+LHRDLK +N+L+ RG++K+GD GLAR + +PLK P+VVT+WY
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---------LEQLSRIFKTM 583
R+PELLLG + Y+ ID+W++GCIFAE L +EP+F G+ +QL RIF+ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 584 GTPNEKIWPGFSKLP---AVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDP 639
GTP EK WP K+P + K + YP+ K G+DLL K L YDP
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301
Query: 640 VTRITADEALRHDYF 654
RITA+EAL H YF
Sbjct: 302 TKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 287 bits (736), Expect = 3e-89
Identities = 133/297 (44%), Positives = 202/297 (68%), Gaps = 9/297 (3%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
+++++ + +I EGTYGVVY+A+D+ T+E +ALK++++E+E EG P T++REI+ L + QH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
NIV ++++V + ++++V +Y++ D+K M++ S P +K + Q+L +A
Sbjct: 61 GNIVRLQDVV--HSEKRLYLVFEYLDLDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIA 116
Query: 481 HLHDNWILHRDLKTSNLLLSHR-GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+ H + +LHRDLK NLL+ R LK+ DFGLAR +G P++ +T VVTLWYR+PE+LL
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
G + YSTP+D+WSVGCIFAE + +PLF G S++++L +IF+ +GTPNE+ WPG + LP
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
K F ++P L T V L G DLL K L DP RITA AL H+YF +
Sbjct: 237 Y-KSAFPKWPPK-DLATVVPT--LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 288 bits (738), Expect = 3e-89
Identities = 128/309 (41%), Positives = 181/309 (58%), Gaps = 18/309 (5%)
Query: 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK 417
C V +++ L +I +GT+G V++A+ K+T +IVALK++ ME EKEGFPIT+LREI L
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQL 67
Query: 418 AQHPNIVTVREI----VVGSNMDK--IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCL 471
+H N+V + EI N K ++V ++ EHD+ L+ K F E+K +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKV 124
Query: 472 MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK----HYTPIV 527
M+ LLN + ++H N ILHRD+K +N+L++ GILK+ DFGLAR + YT V
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
VTLWYR PELLLG ++Y PIDMW GCI AE P+ G ++ QL+ I + G+
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVG--GLKTKVAGSILTELGYDLLCKFLTYDPVTRITA 645
++WPG KL +KM E P +K ++ + DL+ K L DP RI A
Sbjct: 245 PEVWPGVDKLELFKKM---ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA 301
Query: 646 DEALRHDYF 654
D AL HD+F
Sbjct: 302 DTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 284 bits (728), Expect = 3e-88
Identities = 130/290 (44%), Positives = 177/290 (61%), Gaps = 12/290 (4%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
L +I EGTYG V++AK++ T EIVALKR++++ + EG P ++LREI L + +H NIV +
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
+++ K+ +V +Y + D+K ++ P VK M QLL +A H +
Sbjct: 65 YDVLHSDK--KLTLVFEYCDQDLKKYFDSCNGDID---PEIVKSFMFQLLKGLAFCHSHN 119
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST 546
+LHRDLK NLL++ G LK+ DFGLAR +G P++ Y+ VVTLWYR P++L G K YST
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179
Query: 547 PIDMWSVGCIFAEFL-CMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605
IDMWS GCIFAE PLF G +QL RIF+ +GTP E+ WPG SKLP +
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP-----DY 234
Query: 606 AEYPNVGGLKTKVA-GSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
YP + V L G DLL L +PV RI+A+EAL+H YF
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 275 bits (706), Expect = 2e-85
Identities = 102/292 (34%), Positives = 156/292 (53%), Gaps = 39/292 (13%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
++ L ++ EG++G VY A+DK+T ++VA+K +K +K K+ LREI L K +HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNI 59
Query: 424 VTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
V + ++ + DK+++VM+Y E D+ L++ K+ E + ++Q+L+A+ +L
Sbjct: 60 VRLYDVFE--DEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYL 113
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCK 542
H I+HRDLK N+LL G +K+ DFGLAR+ K T V T Y +PE+LLG K
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLG-K 171
Query: 543 EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602
Y +D+WS+G I E L +P F G +QL +FK +G P P +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEWDIS---- 224
Query: 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
DL+ K L DP R+TA+EAL+H +F
Sbjct: 225 ----------------------PEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 276 bits (707), Expect = 4e-85
Identities = 132/299 (44%), Positives = 188/299 (62%), Gaps = 11/299 (3%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQH 420
+ ++ L +I EGTYG VY+A+DK T ++VALK+ ++E ++EG P T+LREI+ L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 421 PNIVTVREIV-VGSNMDK--IFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLL 476
IV + ++ V K +++V +Y++ D+K M++ +P + +K M QLL
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 477 NAVAHLHDNWILHRDLKTSNLLL-SHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
VAH H + ++HRDLK NLL+ +G+LK+ D GL R + P+K YT +VTLWYR+P
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
E+LLG YSTP+D+WSVGCIFAE +PLF G S+L+QL IFK +GTP E++WPG S
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
KL + E+P A L+ G DLL K L YDP RI+A AL H YF
Sbjct: 241 KL-----RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 273 bits (699), Expect = 4e-84
Identities = 126/291 (43%), Positives = 184/291 (63%), Gaps = 8/291 (2%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
FK L ++ EGTY VY+ +++ T EIVALK + ++ E EG P T++REI+ + + +H NI
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENI 60
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
V + +++ +K+ +V +Y++ D+K M+T + P VK QLL +A H
Sbjct: 61 VRLHDVI--HTENKLMLVFEYMDKDLKKYMDT-HGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
+N +LHRDLK NLL++ RG LK+ DFGLAR +G P+ ++ VVTLWYR+P++LLG +
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603
YST ID+WSVGCI AE + PLF G ++ +QL +IF+ MGTP E WPG S+LP +
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP- 236
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
TF YP + LG DLL + L +P RI+A +AL+H +F
Sbjct: 237 TFPRYPPQ---DLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 270 bits (692), Expect = 2e-82
Identities = 125/328 (38%), Positives = 187/328 (57%), Gaps = 37/328 (11%)
Query: 366 CLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE------------GFPITSLREIN 413
+ EGTYG V +A D T +IVA+K++K+ + G T+LRE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 414 TLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ 473
+ + +H NI+ + ++ V D I +VMD + D+K +++ +K +VKC++
Sbjct: 73 IMNEIKHENIMGLVDVYV--EGDFINLVMDIMASDLKKVVD----RKIRLTESQVKCILL 126
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL------------- 520
Q+LN + LH + +HRDL +N+ ++ +GI K+ DFGLAR YG P
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 521 -KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
+ T VVTLWYR+PELL+G ++Y +DMWSVGCIFAE L +PLF G+++++QL RI
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDP 639
F+ +GTPNE WP KLP + T + + LKT ++ DLL L +P
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKD---LKTIF--PNASDDAIDLLQSLLKLNP 301
Query: 640 VTRITADEALRHDYFSESPLPIDPAMFP 667
+ RI+A EAL+H+YF PLP DP+ P
Sbjct: 302 LERISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 1e-81
Identities = 124/301 (41%), Positives = 177/301 (58%), Gaps = 20/301 (6%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
+E +K L+++ EG+Y VY+ + K T ++VALK +++E E EG P T++RE + L +H
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKH 62
Query: 421 PNIVTVREIVVGSNMDKIF-IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
NIVT+ +I+ + K +V +Y++ D+K M+ V+ + QLL +
Sbjct: 63 ANIVTLHDII---HTKKTLTLVFEYLDTDLKQYMDDCGGGLS---MHNVRLFLFQLLRGL 116
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
A+ H +LHRDLK NLL+S RG LK+ DFGLAR P K Y+ VVTLWYR P++LL
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL 176
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD-LEQLSRIFKTMGTPNEKIWPGFSKLP 598
G EYST +DMW VGCIF E PLF G +D +QL +IF+ +GTP E+ WPG S P
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGY-----DLLCKFLTYDPVTRITADEALRHDY 653
+ +F YP + + L +L KFL Y+P RI+A EA++H Y
Sbjct: 237 EFKPYSFPFYPP------RPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
Query: 654 F 654
F
Sbjct: 291 F 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 2e-79
Identities = 100/291 (34%), Positives = 147/291 (50%), Gaps = 31/291 (10%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
++ L ++ G++G VY+AK K T +IVA+K LK EK T+ REI L + HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
V + + D +++VM+Y E L + + E K + Q+L + +LH
Sbjct: 61 VRLIDAFEDK--DHLYLVMEYCEG--GDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH 115
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
N I+HRDLK N+LL G++K+ DFGLA++ T V T WY +PE+LLG
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603
Y +D+WS+G I E L +P F+G++ L+QL I + +G P E P +S
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS----- 230
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
E DL+ K L DP R TA+E L+H +F
Sbjct: 231 ---------------------EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 259 bits (664), Expect = 6e-79
Identities = 126/310 (40%), Positives = 176/310 (56%), Gaps = 23/310 (7%)
Query: 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
G R V++F + +I EGTYG VY+A+DK T E+VALK+++++ EKEGFPIT++REI L
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR 61
Query: 417 KAQHPNIVTVREIVVGSNMDKI------------FIVMDYVEHDMKSLMETMRSKKQVFI 464
+ H NIV ++EIV DK ++V +Y++HD+ L+E S F
Sbjct: 62 QLNHRNIVNLKEIVT----DKQDALDFKKDKGAFYLVFEYMDHDLMGLLE---SGLVHFS 114
Query: 465 PGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH-Y 523
+K M+QLL + + H LHRD+K SN+LL+++G +K+ DFGLAR Y S Y
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTM 583
T V+TLWYR PELLLG + Y ID+WS GCI E +P+F +L QL I +
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234
Query: 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI 643
G+P +WP KLP M + + + S + DLL LT DP R
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYR---RRLREEFSFIPTPALDLLDHMLTLDPSKRC 291
Query: 644 TADEALRHDY 653
TA+EAL +
Sbjct: 292 TAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 5e-78
Identities = 105/301 (34%), Positives = 158/301 (52%), Gaps = 34/301 (11%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVV 431
G YGVV A DKRT VA+K++ + LREI LL+ +H NI+ + +I+
Sbjct: 11 GAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREI-KLLRHLRHENIIGLLDILR 69
Query: 432 ---GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWIL 488
+ + ++IV + +E D+ ++++ Q ++ + Q+L + +LH ++
Sbjct: 70 PPSPEDFNDVYIVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSANVI 125
Query: 489 HRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY---TPIVVTLWYRSPELLLGCKEYS 545
HRDLK SN+L++ LK+ DFGLAR T VVT WYR+PELLL Y+
Sbjct: 126 HRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYT 185
Query: 546 TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK--------- 596
ID+WSVGCIFAE L +PLF G+ ++QL+ I + +GTP+E+ +
Sbjct: 186 KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKS 245
Query: 597 LPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655
LP K ++ +P + DLL K L +DP RITADEAL H Y +
Sbjct: 246 LPKKPKKPLSKLFPGA------------SPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293
Query: 656 E 656
+
Sbjct: 294 Q 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 252 bits (647), Expect = 1e-76
Identities = 110/294 (37%), Positives = 173/294 (58%), Gaps = 14/294 (4%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPN 422
+K + ++ +GT+G VY A++K T E+VA+K++K +K +LRE+ +L K HPN
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
IV ++E+ + D+++ V +Y+E ++ LM K + F ++ ++ Q+L +AH+
Sbjct: 60 IVKLKEVFREN--DELYFVFEYMEGNLYQLM--KDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS--PLKHYTPIVVTLWYRSPELLLG 540
H + HRDLK NLL+S ++K+ DFGLARE S P YT V T WYR+PE+LL
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLR 172
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
YS+P+D+W++GCI AE + PLF G S+++QL +I +GTP ++ WP KL
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL--A 230
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
K+ F ++ + E DL+ L +DP R TA +AL+H YF
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEA-IDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (629), Expect = 4e-74
Identities = 110/294 (37%), Positives = 161/294 (54%), Gaps = 7/294 (2%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+++ L + EG YGVV + ++K T EIVA+K+ K ++ E T+LRE+ L + +H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV ++E ++++V +YVE + L+E P V+ + QLL A+A+
Sbjct: 61 NIVNLKEAFRRKG--RLYLVFEYVERTLLELLEASPGGLP---PDAVRSYIWQLLQAIAY 115
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-GSPLKHYTPIVVTLWYRSPELLLG 540
H + I+HRD+K N+L+S G+LK+ DFG AR P T V T WYR+PELL+G
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
Y P+D+W++GCI AE L EPLF G SD++QL I K +G FS P
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ F E L+ + G ++ D L L DP R+T DE L+H YF
Sbjct: 236 AGVAFPEPSQPESLERRYPG-KVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 4e-68
Identities = 119/295 (40%), Positives = 176/295 (59%), Gaps = 11/295 (3%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
+E + L+++ EGTY V++ + K T+ +VALK +++E E EG P T++RE++ L +H
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKH 62
Query: 421 PNIVTVREIVVGSNMDK-IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
NIVT+ +I+ + ++ + +V +Y++ D+K ++ + + VK M QLL +
Sbjct: 63 ANIVTLHDII---HTERCLTLVFEYLDSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGL 116
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
++ H ILHRDLK NLL++ +G LK+ DFGLAR P K Y+ VVTLWYR P++LL
Sbjct: 117 SYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
G EYSTPIDMW VGCI E P+F G + E+L IF+ +GTP E+ WPG +
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ F +Y L L G DLL L Y+ +RI+A+ ALRH YF
Sbjct: 237 FRSYLFPQY-RAQPLINHAPR--LDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 1e-65
Identities = 125/299 (41%), Positives = 181/299 (60%), Gaps = 11/299 (3%)
Query: 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
G +E + L ++ EGTY V++ + K T+ +VALK +++E E EG P T++RE++ L
Sbjct: 1 GFGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLK 59
Query: 417 KAQHPNIVTVREIVVGSNMDK-IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
+H NIVT+ +IV + DK + +V +Y++ D+K M+ + + VK + Q+
Sbjct: 60 DLKHANIVTLHDIV---HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMH---NVKIFLYQI 113
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
L +A+ H +LHRDLK NLL++ RG LK+ DFGLAR P K Y+ VVTLWYR P
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 173
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
++LLG EYST IDMW VGCIF E PLF G + ++L IF+ +GTP E+ WPG S
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ F +Y + A + TE G +LL KFL Y+ RI+A+EA++H YF
Sbjct: 234 SNDEFKNYNFPKYKPQPLINH--APRLDTE-GIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 1e-65
Identities = 118/293 (40%), Positives = 174/293 (59%), Gaps = 26/293 (8%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA----QHPNIVTVRE 428
G YG VY+A+D + VALK ++++ ++G P++++RE+ LLK HPNIV + +
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIVRLMD 69
Query: 429 IVVGSNMD---KIFIVMDYVEHDMKSLMETMRSKKQVFIPG----EVKCLMQQLLNAVAH 481
+ S D K+ +V ++V+ D+++ ++ +V PG +K LM+Q L +
Sbjct: 70 VCATSRTDRETKVTLVFEHVDQDLRTYLD------KVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
LH N I+HRDLK N+L++ G +K+ DFGLAR Y + TP+VVTLWYR+PE+LL
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLLQ- 181
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601
Y+TP+DMWSVGCIFAE +PLF G S+ +QL +IF +G P E WP LP
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP--- 238
Query: 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ F+ P V I E G LL + LT++P RI+A AL+H +F
Sbjct: 239 RGAFS--PRGPRPVQSVVPEI-EESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 1e-64
Identities = 119/300 (39%), Positives = 174/300 (58%), Gaps = 9/300 (3%)
Query: 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
G +E + L+++ EGTY VY+ + K TD +VALK +++E E EG P T++RE++ L
Sbjct: 1 GFGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLK 59
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+H NIVT+ +I+ + +V +Y++ D+K ++ + + VK + QLL
Sbjct: 60 DLKHANIVTLHDII--HTEKSLTLVFEYLDKDLKQYLDDCGNSINMH---NVKLFLFQLL 114
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+ + H +LHRDLK NLL++ RG LK+ DFGLAR P K Y+ VVTLWYR P+
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD 174
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
+LLG +YST IDMW VGCIF E PLF G + EQL IF+ +GTP E+ WPG
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG--- 231
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
+ + ++ YP L G +LL K L ++ RI+A+EA++H YF
Sbjct: 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 6e-62
Identities = 113/291 (38%), Positives = 163/291 (56%), Gaps = 12/291 (4%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
L ++ EG+Y VY+ + ++VALK + M+ E EG P T++RE + L +H NIV +
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLL 68
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
+I+ + + V +Y+ D L + M P V+ M QLL +A++H
Sbjct: 69 HDII--HTKETLTFVFEYMHTD---LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST 546
ILHRDLK NLL+S+ G LK+ DFGLAR P + Y+ VVTLWYR P++LLG +YS+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 547 PIDMWSVGCIFAEFLCMEPLFTGKSD-LEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605
+D+W GCIF E L +P F G SD EQL +I+ +G P E WPG SKLP + F
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243
Query: 606 --AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ + + +++ E DL + L P RI+A +AL H YF
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAE---DLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-60
Identities = 107/320 (33%), Positives = 165/320 (51%), Gaps = 55/320 (17%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF-----------PITSLREI 412
++ L ++ +G YG+V++A D+RT E+VALK K + F I L+E+
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQRTFREIMFLQEL 63
Query: 413 NTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLM 472
HPNIV + ++ N I++V +Y+E D+ +++ + + + +M
Sbjct: 64 G-----DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVHKRYIM 113
Query: 473 QQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-------EYGSPLKHYTP 525
QLL A+ ++H ++HRDLK SN+LL+ +K+ DFGLAR +P+ T
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV--LTD 171
Query: 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585
V T WYR+PE+LLG Y+ +DMWSVGCI E L +PLF G S L QL +I + +G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 586 PN----EKIWPGF-----SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLT 636
P+ E I F LP+ + E L ++ DLL K L
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDEL-----LPKASDDAL------DLLKKLLV 280
Query: 637 YDPVTRITADEALRHDYFSE 656
++P R+TA+EAL H Y ++
Sbjct: 281 FNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 2e-60
Identities = 121/303 (39%), Positives = 169/303 (55%), Gaps = 18/303 (5%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ ++ L ++ EG+Y VY+ K K ++VALK +++++E EG P T++RE + L +H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHA 63
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV + +I+ + + +V +YV D L + M P VK + QLL +++
Sbjct: 64 NIVLLHDII--HTKETLTLVFEYVHTD---LCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
+H +ILHRDLK NLL+S G LK+ DFGLAR P Y+ VVTLWYR P++LLG
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE-QLSRIFKTMGTPNEKIWPGFSKLPAV 600
EYST +DMW VGCIF E + F G D++ QL RIF +GTPNE WPG LP
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGY-----DLLCKFLTYDPVTRITADEALRHDYFS 655
+ F Y K +L Y DL K L P R++A AL H+YFS
Sbjct: 239 KPERFTLY------SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292
Query: 656 ESP 658
+ P
Sbjct: 293 DLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 7e-60
Identities = 107/293 (36%), Positives = 167/293 (56%), Gaps = 13/293 (4%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPN 422
+K L +I EGT+ V +A+ ++T + A+K +K + K + +LREI L + + HPN
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
I+ + E++ ++ +V + + DM +L E ++ +K+ VK M QLL ++ H+
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELM--DM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYTPIVVTLWYRSPELLLGC 541
H N I HRD+K N+L+ ILK+ DFG R Y P YT + T WYR+PE LL
Sbjct: 117 HRNGIFHRDIKPENILI-KDDILKLADFGSCRGIYSKP--PYTEYISTRWYRAPECLLTD 173
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601
Y +D+W+VGC+F E L + PLF G ++L+Q+++I +GTP+ ++ F K +
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS---R 230
Query: 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
M + +P+ G + + G DLL K L YDP RITA +ALRH YF
Sbjct: 231 HMNYN-FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 9e-60
Identities = 114/336 (33%), Positives = 166/336 (49%), Gaps = 45/336 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++ L+ I EG YG+V A K T VA+K++ E + F +LREI L + +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHE 63
Query: 422 NIVTVREIVVGSN---MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
NI+ + +I+ + + ++IV + +E D+ L++T Q ++ + Q+L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRG 118
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY---TPIVVTLWYRSP 535
+ ++H +LHRDLK SNLLL+ LK+ DFGLAR H T V T WYR+P
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP--------- 586
E++L K Y+ ID+WSVGCI AE L PLF GK L QL+ I +GTP
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238
Query: 587 NEKIWPGFSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA 645
+ + LP K+ + + +PN DLL K LT++P RIT
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKLFPNA------------DPKALDLLDKMLTFNPHKRITV 286
Query: 646 DEALRHDY-----------FSESPLPIDPAMFPTWP 670
+EAL H Y +E P P D +F P
Sbjct: 287 EEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLP 322
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 4e-59
Identities = 110/317 (34%), Positives = 170/317 (53%), Gaps = 21/317 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+K + I G YGVV A D R+ + VA+K++ + +LRE+ L +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 422 NIVTVREIVV--GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
NI+ +R+I+ G++ +++VMD +E D+ ++ + Q ++ + QLL +
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGL 120
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-GSPLKH---YTPIVVTLWYRSP 535
++H ++HRDLK SNLL++ L++GDFG+AR SP +H T V T WYR+P
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
ELLL EY+T IDMWSVGCIFAE L LF GK+ + QL I +G+P+E++
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV----- 235
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSIL----TELGYDLLCKFLTYDPVTRITADEALRH 651
L + +Y K V S + + DLL + L +DP RIT ++AL+H
Sbjct: 236 -LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 652 DYFSESPLPID-PAMFP 667
+ ++ P D P P
Sbjct: 295 PFLAQYHDPDDEPTCPP 311
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 4e-58
Identities = 117/314 (37%), Positives = 183/314 (58%), Gaps = 32/314 (10%)
Query: 369 RIEEGTYGVVYRAK--DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
++ GTYG VY+AK D + D ALK++ E G +++ REI L + +HPN++++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISL 63
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRS----KKQVFIP-GEVKCLMQQLLNAVAH 481
+++ + K++++ DY EHD+ +++ R+ KK V +P G VK L+ Q+L+ + +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 482 LHDNWILHRDLKTSNLLL----SHRGILKVGDFGLAREYGSPLK---HYTPIVVTLWYRS 534
LH NW+LHRDLK +N+L+ RG +K+ D G AR + SPLK P+VVT WYR+
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---------LEQLSRIFKTMGT 585
PELLLG + Y+ ID+W++GCIFAE L EP+F + + +QL RIF MG
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 586 PNEKIWPGFSKLPA----VQKMTFAEYPNVGGLKTKVAGSILTE-LGYDLLCKFLTYDPV 640
P +K W K+P ++ Y N +K + + + LL K LT DP+
Sbjct: 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 303
Query: 641 TRITADEALRHDYF 654
RIT+++A++ YF
Sbjct: 304 KRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 7e-58
Identities = 112/299 (37%), Positives = 158/299 (52%), Gaps = 29/299 (9%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREI 429
I G YG+V AK+ T+E VA+K++ + +LREI L H N++ +++I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 430 VVGSNMDK---IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
+ + + ++IV + ++ D L + +RS Q + + QLL + ++H
Sbjct: 73 MPPPHREAFNDVYIVYELMDTD---LHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN 128
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST 546
+LHRDLK SNLLL+ LK+ DFGLAR T VVT WYR+PELLL C EY+T
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTT 188
Query: 547 PIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP---------NEKIWPGFSKL 597
ID+WSVGCIFAE L +PLF GK + QL I + +G+P NEK L
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248
Query: 598 PAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655
P + +FA +P+ L DLL K L +DP RIT +EAL H Y +
Sbjct: 249 PYTPRQSFARLFPHA------------NPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 1e-57
Identities = 116/300 (38%), Positives = 180/300 (60%), Gaps = 17/300 (5%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKD-KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ- 419
++++C+ I EG YG V++A+D K VALKR++++ +EG P++++RE+ L +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 420 --HPNIVTVREIVVGSNMD---KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
HPN+V + ++ S D K+ +V ++V+ D+ + ++ + + +K +M Q
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQ 118
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
LL + LH + ++HRDLK N+L++ G +K+ DFGLAR Y S T +VVTLWYR+
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRA 177
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
PE+LL Y+TP+D+WSVGCIFAE +PLF G SD++QL +I +G P E+ WP
Sbjct: 178 PEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236
Query: 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
LP + F ++ V + ELG DLL K LT++P RI+A AL H YF
Sbjct: 237 VALP---RQAFHSKS-AQPIEKFVTD--IDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 1e-55
Identities = 118/322 (36%), Positives = 182/322 (56%), Gaps = 48/322 (14%)
Query: 369 RIEEGTYGVVYRA--KDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
++ GTYG VY+A KD + ++ ALK++ E G +++ REI L + +HPN++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIAL 63
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-----VKCLMQQLLNAVAH 481
+++ + + K++++ DY EHD+ +++ R+ K P + VK L+ Q+L+ + +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 482 LHDNWILHRDLKTSNLLL----SHRGILKVGDFGLAREYGSPLK---HYTPIVVTLWYRS 534
LH NW+LHRDLK +N+L+ RG +K+ D G AR + SPLK P+VVT WYR+
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---------LEQLSRIFKTMGT 585
PELLLG + Y+ ID+W++GCIFAE L EP+F + + +QL RIF MG
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGG--LKTKVAGSILTELG-----------YDLLC 632
P +K W K+P EYP + +T A S L + + LL
Sbjct: 244 PADKDWEDIRKMP--------EYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQ 295
Query: 633 KFLTYDPVTRITADEALRHDYF 654
K LT DP RIT+++AL+ YF
Sbjct: 296 KLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 2e-54
Identities = 102/301 (33%), Positives = 164/301 (54%), Gaps = 23/301 (7%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKR-LKMEKEKEGFPITSLREINTLLKAQH 420
E+++ L + EG+YG+V + K K T +IVA+K+ L+ E +K I ++REI L + +H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKI-AMREIRMLKQLRH 59
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLME-------TMRSKKQVFIPGEVKCLMQ 473
N+V + E V ++++V ++V+H + +E R +K +F
Sbjct: 60 ENLVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF---------- 107
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
Q+L + H + I+HRD+K N+L+S G++K+ DFG AR +P + YT V T WYR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR 167
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
+PELL+G +Y +D+W+VGC+ E L EPLF G SD++QL I K +G +
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
F K P M E + L+ + L+ L DL + L DP R ++ + L H++
Sbjct: 228 FQKNPLFAGMRLPEVKEIEPLEKRFPK--LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
Query: 654 F 654
F
Sbjct: 286 F 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 3e-52
Identities = 103/299 (34%), Positives = 170/299 (56%), Gaps = 19/299 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT---SLREINTLLKA 418
E+++ L++I EG+YGVV++ +++ T +IVA+K+ +E E + P+ +LREI L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF-VESEDD--PVIKKIALREIRMLKQL 57
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+HPN+V + E V K+ +V +Y +H +++ + + +K ++ Q L A
Sbjct: 58 KHPNLVNLIE--VFRRKRKLHLVFEYCDH---TVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
V H + +HRD+K N+L++ +G +K+ DFG AR P YT V T WYR+PELL
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT---PNEKIWPGFS 595
+G +Y P+D+W++GC+FAE L +PL+ GKSD++QL I KT+G +++I FS
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI---FS 229
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ ++ E L++K L L L DP R++ +E L H YF
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPAL--SFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 3e-52
Identities = 70/192 (36%), Positives = 105/192 (54%), Gaps = 6/192 (3%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREI 429
+ EG +G VY A+DK+T + VA+K +K E LREI L K HPNIV + +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGV 59
Query: 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILH 489
+ + +++VM+Y E SL + ++ + E+ ++ Q+L + +LH N I+H
Sbjct: 60 F--EDENHLYLVMEYCEG--GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 490 RDLKTSNLLLSHR-GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPI 548
RDLK N+LL G +K+ DFGL++ S IV T Y +PE+LLG YS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 549 DMWSVGCIFAEF 560
D+WS+G I E
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-49
Identities = 102/314 (32%), Positives = 162/314 (51%), Gaps = 39/314 (12%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRT--DEIVALKRLKMEKEKEGFPITSLREINTLLK--AQ 419
++ + + +G YG+V A++ T +E VA+K++ K+ +LRE+ LL+
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALREL-KLLRHFRG 60
Query: 420 HPNIVTV--REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
H NI + +IV N +++++ + +E D+ ++ RS Q + + Q+L
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII---RSG-QPLTDAHFQSFIYQILC 116
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK-----HYTPIVVTLWY 532
+ ++H +LHRDLK NLL++ LK+ DFGLAR + S T V T WY
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF-SENPGENAGFMTEYVATRWY 175
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE---- 588
R+PE++L + Y+ ID+WSVGCI AE L +P+F GK ++QL++I + +GTP+E
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235
Query: 589 -----KIWPGFSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR 642
K LP + K F +PN L DLL K L +DP R
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNA------------NPLALDLLEKLLAFDPTKR 283
Query: 643 ITADEALRHDYFSE 656
I+ +EAL H Y +
Sbjct: 284 ISVEEALEHPYLAI 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 1e-49
Identities = 111/294 (37%), Positives = 162/294 (55%), Gaps = 10/294 (3%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN 422
+F+ L + EG YGVV + + K T EIVA+K+ K +E E T+LRE+ L + N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
IV ++E K+++V +YVE +M L+E M + P +V+ + QL+ A+
Sbjct: 62 IVELKEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGV---PPEKVRSYIYQLIKAIHWC 116
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK-HYTPIVVTLWYRSPELLLGC 541
H N I+HRD+K NLL+SH +LK+ DFG AR +YT V T WYRSPELLLG
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT-PNEKIWPGFSKLPAV 600
Y +DMWSVGCI E +PLF G+S+++QL I K +G P E++ +S P
Sbjct: 177 P-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN-PRF 234
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ F + L+ + G IL+ + DL+ L +P R ++ L H F
Sbjct: 235 HGLRFPAVNHPQSLERRYLG-ILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-48
Identities = 105/319 (32%), Positives = 162/319 (50%), Gaps = 52/319 (16%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG 432
G+ G+V+ A D D+ VA+K++ + + +LREI + + H NIV V E++
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALREIKIIRRLDHDNIVKVYEVLGP 73
Query: 433 SN------------MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAV 479
S ++ ++IV +Y+E D+ +++E Q + E + M QLL +
Sbjct: 74 SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE------QGPLSEEHARLFMYQLLRGL 127
Query: 480 AHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAR----EYGSPLKHYTPIVVTLWYRS 534
++H +LHRDLK +N+ ++ +LK+GDFGLAR Y S + + +VT WYRS
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY-SHKGYLSEGLVTKWYRS 186
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
P LLL Y+ IDMW+ GCIFAE L +PLF G +LEQ+ I ++
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES------------ 234
Query: 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSI----LTEL-------GYDLLCKFLTYDPVTRI 643
+P V++ E NV + G L +L D L + LT++P+ R+
Sbjct: 235 --VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292
Query: 644 TADEALRHDYFSESPLPID 662
TA+EAL H Y S P D
Sbjct: 293 TAEEALMHPYMSCYSCPFD 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-48
Identities = 99/309 (32%), Positives = 151/309 (48%), Gaps = 32/309 (10%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
L+ + G YG V A D +T VA+K+L + + RE+ L H N++ +
Sbjct: 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGL 79
Query: 427 REI----VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
++ + +++V + D+ +++ K Q ++ L+ Q+L + ++
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLMGADLNNIV-----KCQKLSDDHIQFLVYQILRGLKYI 134
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCK 542
H I+HRDLK SN+ ++ LK+ DFGLAR + Y V T WYR+PE++L
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWM 191
Query: 543 EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS------- 595
Y+ +D+WSVGCI AE L + LF G ++QL RI +GTP+E++ S
Sbjct: 192 HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNY 251
Query: 596 --KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
LP + K F E +G+ L DLL K L DP RITA EAL H Y
Sbjct: 252 IQSLPQMPKKDFKEV---------FSGA--NPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 654 FSESPLPID 662
+E P D
Sbjct: 301 LAEYHDPED 309
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 70/232 (30%), Positives = 118/232 (50%), Gaps = 15/232 (6%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKM----EKEKEGFPITSLREINTLLKAQHPNIVT 425
I +G++G VY + K ++ LK + + EKE+E +L E+ L K HPNI+
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE----DALNEVKILKKLNHPNIIK 63
Query: 426 VREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD 484
E K+ IVM+Y + D+ ++ + + + F ++ QL A+ +LH
Sbjct: 64 YYESFEEK--GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEY 544
ILHRD+K N+ L+ G++K+GDFG+++ S + +V T +Y SPEL K Y
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPY 180
Query: 545 STPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
+ D+WS+GC+ E ++ F G++ L +L K + I +S
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGEN-LLEL--ALKILKGQYPPIPSQYSS 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-46
Identities = 101/307 (32%), Positives = 154/307 (50%), Gaps = 41/307 (13%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS----LREINTLLKAQHPNIVTVRE 428
G +GVV+ D R + VALK KM + + S RE+ L +H N+++ +
Sbjct: 11 GAFGVVWSVTDPRDGKRVALK--KMPNVFQN--LVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 429 IVVGSNMD---KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
I+ ++D +I++V + ++ D+ ++ Q VK + Q+L + +LH
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKII----VSPQPLSSDHVKVFLYQILRGLKYLHSA 122
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAR-EYGSPLKHYTPIVVTLWYRSPELLLGCKEY 544
ILHRD+K NLL++ +LK+ DFGLAR E KH T VVT +YR+PE+L+G + Y
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHY 182
Query: 545 STPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN------------EKIWP 592
++ +D+WSVGCIFAE L LF +S ++QL I +GTP+ I
Sbjct: 183 TSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILR 242
Query: 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHD 652
G K P++ + T LLC+ L +DP RI+A +AL H
Sbjct: 243 GPHKPPSLPVLYTLSSQA-------------THEAVHLLCRMLVFDPDKRISAADALAHP 289
Query: 653 YFSESPL 659
Y E L
Sbjct: 290 YLDEGRL 296
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-44
Identities = 103/306 (33%), Positives = 163/306 (53%), Gaps = 28/306 (9%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ ++ L ++ G YG V A D+RT VA+K+L + E F + RE+ L +H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 422 NIVTVREIVVG-SNMDKI---FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
N++ + ++ ++D+ ++VM ++ D+ LM+ + + ++ L+ Q+L
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED-----RIQFLVYQMLK 129
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ ++H I+HRDLK NL ++ LK+ DFGLAR+ S + Y VVT WYR+PE+
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY---VVTRWYRAPEV 186
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
+L Y+ +D+WSVGCI AE L +PLF G L+QL I K GTP+++
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF------- 239
Query: 598 PAVQKMTFAEYPN----VGGLKTKVAGSILTE---LGYDLLCKFLTYDPVTRITADEALR 650
VQK+ + N + + K S+L L ++L K L D +RITA EAL
Sbjct: 240 --VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297
Query: 651 HDYFSE 656
H YF E
Sbjct: 298 HPYFEE 303
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-44
Identities = 106/309 (34%), Positives = 157/309 (50%), Gaps = 35/309 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E + L ++ G YG V A DKRT E VA+K+L + E F + RE+ L QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 422 NIVTVREI----VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
N++ + ++ V G ++VM Y++ D++ +M S+ +V + L+ Q+L
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV------QYLVYQMLC 128
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ ++H I+HRDLK NL ++ LK+ DFGLAR + + Y VVT WYR+PE+
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEV 185
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP--------NEK 589
+L Y+ +D+WSVGCI AE L + LF GK L+QL++I K G P +K
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245
Query: 590 IWPGFSK-LPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
+ K LP + F+ +P + DLL K L D R+TA E
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPKA------------SPQAVDLLEKMLELDVDKRLTATE 293
Query: 648 ALRHDYFSE 656
AL H YF
Sbjct: 294 ALEHPYFDS 302
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 92/298 (30%), Positives = 149/298 (50%), Gaps = 52/298 (17%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN 422
F+ L +I +G +G VY+A+ KRT + VA+K +K+E +++ I + EI L K +HPN
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI--INEIQILKKCKHPN 58
Query: 423 IVTVREIVVGSNM--DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
IV GS + D+++IVM++ SL + ++S Q ++ + ++LL +
Sbjct: 59 IVKYY----GSYLKKDELWIVMEFC--SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
+LH N I+HRD+K +N+LL+ G +K+ DFGL+ + S K +V T ++ +PE++ G
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ-LSDTKARNTMVGTPYWMAPEVING 171
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGK---SDLEQLSRIFKTM--GTPNEKIWPGFS 595
K Y D+WS+G E L GK S+L + +FK G P
Sbjct: 172 -KPYDYKADIWSLGITAIE------LAEGKPPYSELPPMKALFKIATNGPP--------- 215
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
GL+ S E D L K L +P R TA++ L+H +
Sbjct: 216 -----------------GLRNPEKWS--DEF-KDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-42
Identities = 106/313 (33%), Positives = 153/313 (48%), Gaps = 43/313 (13%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
+K I +G+YGVV A D T E VA+K++ E LREI L +HP+I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 424 VTVREIVVGSN---MDKIFIVMDYVEHDMKSLMET----MRSKKQVFIPGEVKCLMQQLL 476
V ++ I++ + I++V + +E D+ +++ Q F + QLL
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFF--------LYQLL 113
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY---GSPLKHYTPIVVTLWYR 533
A+ ++H + HRDLK N+L + LK+ DFGLAR +T V T WYR
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 534 SPELLLGC--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP----- 586
+PEL G +Y+ ID+WS+GCIFAE L +PLF GK+ + QL I +GTP
Sbjct: 174 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232
Query: 587 ----NEKIWPGFSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT 641
NEK S + Q + F++ +PN L LL + L +DP
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNA------------DPLALRLLERLLAFDPKD 280
Query: 642 RITADEALRHDYF 654
R TA+EAL YF
Sbjct: 281 RPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 5e-41
Identities = 95/306 (31%), Positives = 154/306 (50%), Gaps = 31/306 (10%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
L + G +G+V A+D+ T + VA+K++ + RE+ L +H NI+++
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
+I + S ++ I+ V + + D+ L+ + +KQ ++ + Q+L + ++H
Sbjct: 75 SDIFI-SPLEDIYFVTELLGTDLHRLLTSRPLEKQF-----IQYFLYQILRGLKYVHSAG 128
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST 546
++HRDLK SN+L++ LK+ DFGLAR T V T +YR+PE++L ++Y
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 547 PIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS---------KL 597
+D+WS GCIFAE L +PLF GK + Q S I +GTP + + L
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245
Query: 598 PAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
P + + F+E + N DLL K L +DP RI+A EAL H Y +
Sbjct: 246 PKREPVPFSEKFKNA------------DPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293
Query: 657 SPLPID 662
P D
Sbjct: 294 YHDPTD 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-40
Identities = 89/315 (28%), Positives = 139/315 (44%), Gaps = 42/315 (13%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-FPITSLREINTLLKAQHP 421
++ L ++ EG++G VY A+D++ +VALK L + E + LREI L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 422 -NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
NIV + + +++VM+YV+ + +K E ++ Q+L+A+
Sbjct: 58 PNIVKLYDFFQDEG--SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 481 HLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYGSPLKH------YTPIVVTLWYR 533
+LH I+HRD+K N+LL G ++K+ DFGLA+ P + V T Y
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 534 SPELLLGCKE--YSTPIDMWSVGCIFAEFLCMEPLF---TGKSDLEQLSRIFKTMGTPNE 588
+PE+LLG S+ D+WS+G E L P F S Q +I + TP+
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS- 234
Query: 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA 648
+ P+ L +K A DLL K L DP R+++
Sbjct: 235 --------------LASPLSPSNPELISKAA--------SDLLKKLLAKDPKNRLSSSSD 272
Query: 649 LRHDYFSESPLPIDP 663
L HD + L
Sbjct: 273 LSHDLLAHLKLKESD 287
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 84/298 (28%), Positives = 131/298 (43%), Gaps = 50/298 (16%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQHP 421
E+ + G++G VY A DK T E++A+K +++ + E + +L REI L QHP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHP 59
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV + + I ++YV SL ++ K ++ +Q+L +A+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYV--SGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY--TPIVVTLWYRSPELLL 539
LH N I+HRD+K +N+L+ G++K+ DFG A+ G + T ++ +PE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
G +EY D+WS+GC E + TGK W A
Sbjct: 177 G-EEYGRAADIWSLGCTVIE------MATGK------------------PPWSELGNPMA 211
Query: 600 VQKMTFAEYPNVGGLKTKVAGSI------LTELGYDLLCKFLTYDPVTRITADEALRH 651
K +G L+E D L K L DP R TADE L+H
Sbjct: 212 A------------LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 5e-38
Identities = 98/305 (32%), Positives = 157/305 (51%), Gaps = 14/305 (4%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E ++ L + G YG V A D R + VA+K+L + + RE+ L +H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 422 NIVTVREIVV----GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
N++ + ++ N +++++V + + D+ +++ K Q V+ L+ QLL
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV-----KCQKLSDEHVQFLIYQLLR 129
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ ++H I+HRDLK SN+ ++ L++ DFGLAR+ + Y V T WYR+PE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VATRWYRAPEI 186
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
+L Y+ +D+WSVGCI AE L + LF G ++QL RI + +GTP+ ++ S
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657
A + + + LK G+ L DLL K L D RI+A EAL H YFS+
Sbjct: 247 HARKYIQSLPHMPQQDLKKIFRGA--NPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304
Query: 658 PLPID 662
P D
Sbjct: 305 HDPED 309
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 91/312 (29%), Positives = 148/312 (47%), Gaps = 44/312 (14%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
L I G G+V A D T + VA+K+L + + RE+ + H NI+ +
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 427 REIVVG----SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
+ +++VM+ ++ ++ +++ +++ L+ Q+L + HL
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM------SYLLYQMLCGIKHL 134
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCK 542
H I+HRDLK SN+++ LK+ DFGLAR G+ TP VVT +YR+PE++LG
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILGMG 193
Query: 543 EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL----- 597
Y +D+WSVGCI E + LF G ++Q ++I + +GTP+++ S+L
Sbjct: 194 -YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF---MSRLQPTVR 249
Query: 598 ------PAVQKMTF----------AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT 641
P +F + + LK A DLL K L DP
Sbjct: 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQA--------RDLLSKMLVIDPEK 301
Query: 642 RITADEALRHDY 653
RI+ D+AL+H Y
Sbjct: 302 RISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 100/310 (32%), Positives = 150/310 (48%), Gaps = 24/310 (7%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E ++ L+ + G YG V A D +T VA+K+L + + RE+ L +H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
N++ + ++ + + F + V H M + + + K Q V+ L+ Q+L + +
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKY 135
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
+H I+HRDLK SNL ++ LK+ DFGLAR + Y V T WYR+PE++L
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNW 192
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS------ 595
Y+ +D+WSVGCI AE L LF G ++QL I + +GTP ++ S
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252
Query: 596 ---KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHD 652
L + KM FA +G L DLL K L D RITA +AL H
Sbjct: 253 YIQSLTQMPKMNFANV-FIGA----------NPLAVDLLEKMLVLDSDKRITAAQALAHA 301
Query: 653 YFSESPLPID 662
YF++ P D
Sbjct: 302 YFAQYHDPDD 311
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 74/228 (32%), Positives = 120/228 (52%), Gaps = 17/228 (7%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL---KM-EKEKEGFPITSLREINTLLKA 418
+++ L I +G++G V + + K +I+ K + M EKEK+ + S E+N L +
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ--QLVS--EVNILREL 56
Query: 419 QHPNIVT-VREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+HPNIV I+ SN ++IVM+Y E D+ L++ + +++ + ++ QLL
Sbjct: 57 KHPNIVRYYDRIIDRSN-QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 477 NAVAHLH-----DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
A+ H N +LHRDLK +N+ L +K+GDFGLA+ G V T +
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
Y SPE L Y D+WS+GC+ E + P FT ++ L+ S+I
Sbjct: 176 YMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 9e-35
Identities = 107/378 (28%), Positives = 177/378 (46%), Gaps = 41/378 (10%)
Query: 292 DEEENDENEDKADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLPPY 351
DE+ N E + + K + D +E ER + + D+D + I+ + + P
Sbjct: 7 DEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPN- 65
Query: 352 LPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLRE 411
+ +K N I G++GVVY A T E VA+K++ + P RE
Sbjct: 66 ----------KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRE 109
Query: 412 INTLLKAQHPNIVTVREI----VVGSNMDKIF--IVMDYVEHDMKSLMETMRSKKQVFIP 465
+ + H NI+ +++ N IF +VM+++ + M+
Sbjct: 110 LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL 169
Query: 466 GEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYGSPLKHYT 524
VK QL A+A++H +I HRDLK NLL+ LK+ DFG A+ + + +
Sbjct: 170 FLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 525 PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMG 584
I + +YR+PEL+LG Y+T ID+WS+GCI AE + P+F+G+S ++QL RI + +G
Sbjct: 230 YIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288
Query: 585 TPNEK----IWPGFS--KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYD 638
TP E + P ++ K P V+ KV + + + +FL Y+
Sbjct: 289 TPTEDQLKEMNPNYADIKFPDVKPKDL----------KKVFPKGTPDDAINFISQFLKYE 338
Query: 639 PVTRITADEALRHDYFSE 656
P+ R+ EAL +F +
Sbjct: 339 PLKRLNPIEALADPFFDD 356
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 90/308 (29%), Positives = 155/308 (50%), Gaps = 21/308 (6%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
++ ++ L I G G+V A D D VA+K+L + + + RE+ + H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 421 PNIVTVREIVVGSN----MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
NI+++ + +++VM+ ++ ++ +++ +++ L+ Q+L
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQML 129
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+ HLH I+HRDLK SN+++ LK+ DFGLAR G+ TP VVT +YR+PE
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPE 188
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP----NEKIWP 592
++LG Y +D+WSVGCI E + + LF G+ ++Q +++ + +GTP +K+ P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 593 GFSKL----PAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
P +TF + +P+ + DLL K L DP RI+ DE
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307
Query: 648 ALRHDYFS 655
AL+H Y +
Sbjct: 308 ALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 67/298 (22%)
Query: 373 GTYGVVYRAKDKRTDEIVALK-----RLKMEKEKEGFPITSLREINTLLKAQHPNIVTVR 427
G++G V + K T ++ A+K ++ KE E +L E N L + HP IV
Sbjct: 4 GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE----HTLTERNILSRINHPFIV--- 56
Query: 428 EIVVGSNM-------DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
+ +K+++V++Y ++ S + SK+ F + +++ A+
Sbjct: 57 ------KLHYAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLAL 106
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+LH I++RDLK N+LL G +K+ DFGLA+E S T Y +PE+LL
Sbjct: 107 EYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
G K Y +D WS+G + E L +P F D +++
Sbjct: 167 G-KGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKD---------------- 208
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT---ADEALRHDYF 654
+ F E+ L+ DL+ L DP R+ A+E H +F
Sbjct: 209 --PLRFPEF--------------LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 93/324 (28%), Positives = 156/324 (48%), Gaps = 29/324 (8%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
++ ++ L I G G+V A D + VA+K+L + + + RE+ + H
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 421 PNIVTVREIVVGSN----MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
NI+ + + ++IVM+ ++ ++ +++ +++ L+ Q+L
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM------SYLLYQML 136
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+ HLH I+HRDLK SN+++ LK+ DFGLAR G+ TP VVT +YR+PE
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPE 195
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP----NEKIWP 592
++LG Y +D+WSVGCI E + LF G ++Q +++ + +GTP +K+ P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 593 G----FSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
P +F + +P+V + DLL K L D RI+ DE
Sbjct: 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314
Query: 648 ALRHDYF--------SESPLPIDP 663
AL+H Y +E+P P P
Sbjct: 315 ALQHPYINVWYDPSEAEAPPPKIP 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 88/308 (28%), Positives = 149/308 (48%), Gaps = 21/308 (6%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
++ ++ L I G G+V A D VA+K+L + + + RE+ L H
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 421 PNIVTVREIVVGSN----MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
NI+++ + +++VM+ ++ ++ ++ +++ L+ Q+L
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERM------SYLLYQML 133
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+ HLH I+HRDLK SN+++ LK+ DFGLAR + TP VVT +YR+PE
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM-MTPYVVTRYYRAPE 192
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
++LG Y +D+WSVGCI E + +F G ++Q +++ + +GTP+ +
Sbjct: 193 VILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 597 L--------PAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
P ++F E +P+ + T DLL K L DP RI+ DE
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311
Query: 648 ALRHDYFS 655
ALRH Y +
Sbjct: 312 ALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 92/301 (30%), Positives = 139/301 (46%), Gaps = 53/301 (17%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
I +G YG V+ AK K T +I A+K + K + ++ L E + L +AQ P +V +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 429 IVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI 487
G +++VM+Y+ D+ SL+E + S + + +++ A+ +LH N I
Sbjct: 61 SFQGKK--NLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHSNGI 114
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLARE--------YGSPLKHYTPIVVTLWYRSPELLL 539
+HRDLK N+L+ G LK+ DFGL++ K IV T Y +PE++L
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI-WPGFSKLP 598
G + +S +D WS+GCI EFL P F G++ E IF N KI WP
Sbjct: 175 G-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IF--QNILNGKIEWP------ 221
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA---DEALRHDYFS 655
E V + A DL+ K L DP R+ A +E H +F
Sbjct: 222 --------EDVEV----SDEA--------IDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
Query: 656 E 656
Sbjct: 262 G 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 69/220 (31%), Positives = 116/220 (52%), Gaps = 14/220 (6%)
Query: 372 EGTYG--VVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREI 429
+G +G +YR + D +V K + + + E +L EI L QHPNI+
Sbjct: 10 KGAFGEATLYRRTED--DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY--- 64
Query: 430 VVGSNMDK--IFIVMDYVEHDMKSLMETM-RSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
MD + I M+Y + +L + + R K Q+F V + Q+++AV+++H
Sbjct: 65 -YNHFMDDNTLLIEMEYA--NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST 546
ILHRD+KT N+ L+ G++K+GDFG+++ GS +V T +Y SPEL G +Y+
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG-VKYNF 180
Query: 547 PIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586
D+W++GC+ E L ++ F + L + +I + TP
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 80/306 (26%), Positives = 138/306 (45%), Gaps = 51/306 (16%)
Query: 356 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTL 415
+G E +K L +I EG G VY+A D+ T + VA+K++++ K+ + I EI +
Sbjct: 14 EGDPR-ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN---EILIM 69
Query: 416 LKAQHPNIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ 473
+HPNIV S D++++VM+Y+ D SL + + ++ + +
Sbjct: 70 KDCKHPNIVDY----YDSYLVGDELWVVMEYM--DGGSLTDIITQNFVRMNEPQIAYVCR 123
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
++L + +LH ++HRD+K+ N+LLS G +K+ DFG A + +V T ++
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM 183
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
+PE++ K+Y +D+WS+G + E EP + + L L I T G P
Sbjct: 184 APEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI-TTKGIP------- 234
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKF----LTYDPVTRITADEAL 649
L +K + F L DP R +A+E L
Sbjct: 235 --PLKNPEKWS------------------------PEFKDFLNKCLVKDPEKRPSAEELL 268
Query: 650 RHDYFS 655
+H +
Sbjct: 269 QHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 81/288 (28%), Positives = 137/288 (47%), Gaps = 44/288 (15%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREI 429
I G +GVVY+ + T + VA+K++ +EK KE + ++EI+ L +HPNIV
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILH 489
+ S D ++I+++Y E+ SL + K F V + Q+L +A+LH+ ++H
Sbjct: 68 IETS--DSLYIILEYAEN--GSL-RQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 490 RDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPID 549
RD+K +N+L + G++K+ DFG+A + K +V T ++ +PE++ ST D
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASD 181
Query: 550 MWSVGCIFAEFLCMEPLFTGK---SDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606
+WS+GC E L TG DL ++ +F+ + + + G S
Sbjct: 182 IWSLGCTVIE------LLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPE--------- 226
Query: 607 EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
LK D L + DP R TA + L+H +
Sbjct: 227 -------LK-------------DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 10/202 (4%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ + + + +G+ GVVY+ + K T +I ALK++ + E F LRE+ TL + P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESP 59
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEV-KCLMQQLLNAVA 480
+V I IV++Y+ D SL + + KK IP V + +Q+L +
Sbjct: 60 YVVKCYGAFYKEGE--ISIVLEYM--DGGSLADLL--KKVGKIPEPVLAYIARQILKGLD 113
Query: 481 HLH-DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+LH I+HRD+K SNLL++ +G +K+ DFG+++ + L V T+ Y SPE +
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 540 GCKEYSTPIDMWSVGCIFAEFL 561
G + YS D+WS+G E
Sbjct: 174 G-ESYSYAADIWSLGLTLLECA 194
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 79/328 (24%), Positives = 123/328 (37%), Gaps = 83/328 (25%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL------KMEKEKEGFPITSLREINTL 415
++FK I EG++ V AK+K T++ A+K L K +K K E L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY-----VKIEKEVL 55
Query: 416 LK-AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL-- 471
+ HP I+ + + + ++ V++Y + ++ + S + KC
Sbjct: 56 TRLNGHPGII--KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL-------DEKCTRF 106
Query: 472 -MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH------YT 524
++L A+ +LH I+HRDLK N+LL +K+ DFG A+ T
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 525 PI--------------VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK 570
I V T Y SPELL D+W++GCI + L +P F G
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGS 225
Query: 571 SDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDL 630
++ +I K P F P + DL
Sbjct: 226 NEYLTFQKILKL----EYSFPPNFP--PDAK---------------------------DL 252
Query: 631 LCKFLTYDPVTRITA----DEALRHDYF 654
+ K L DP R+ DE H +F
Sbjct: 253 IEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 78/239 (32%), Positives = 125/239 (52%), Gaps = 18/239 (7%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME----KEKEGFPITSLREINTLLKAQ 419
++ + +I EG++G +Y AK K E +K + + KEKE S +E+ L K +
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEA----SKKEVILLAKMK 57
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQV-FIPGEVKCLMQQLLNA 478
HPNIVT + ++FIVM+Y D LM+ + ++ V F ++ Q+
Sbjct: 58 HPNIVTFFASFQENG--RLFIVMEYC--DGGDLMKRINRQRGVLFSEDQILSWFVQISLG 113
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ H+HD ILHRD+K+ N+ LS G + K+GDFG+AR+ ++ V T +Y SPE+
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
+ Y+ D+WS+GC+ E ++ F G + L QL + K I P FS+
Sbjct: 174 CQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKICQGYFAPISPNFSR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 84/302 (27%), Positives = 141/302 (46%), Gaps = 43/302 (14%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQ 419
+F+ L ++ +G YG V+ AK K T EIVALKR+K + K E + + R+I L +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDI--LTTTK 59
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+V + + + + +++ M+YV D ++L+ + + + M ++ A
Sbjct: 60 SEWLV--KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSE----DHARFYMAEMFEA 113
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
V LH+ +HRDLK N L+ G +K+ DFGL++ + + +V + Y +PE+L
Sbjct: 114 VDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVVGSPDYMAPEVL 170
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
G K Y +D WS+GC+ EFLC P F+G + E N K W + P
Sbjct: 171 RG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---------NLKYWKETLQRP 220
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR-HDYFSES 657
F L++ +DL+ K + DP R + E ++ H +F E
Sbjct: 221 VYDDPRFN----------------LSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEV 263
Query: 658 PL 659
Sbjct: 264 DW 265
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 64/200 (32%), Positives = 108/200 (54%), Gaps = 10/200 (5%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG 432
G +G+V+ + K ++V +K++ +E+ + + + E L HPNI+ E +
Sbjct: 11 GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL- 69
Query: 433 SNMDK-IFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAVAHLHDNWILHR 490
DK + IVM+Y +L E ++ + + + + Q+L A+ H+H ILHR
Sbjct: 70 --EDKALMIVMEYAPGG--TLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 491 DLKTSNLLLS-HRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPID 549
DLKT N+LL H+ ++K+GDFG+++ S K YT +V T Y SPEL G K Y+ D
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEG-KPYNQKSD 183
Query: 550 MWSVGCIFAEFLCMEPLFTG 569
+W++GC+ E ++ F
Sbjct: 184 IWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 74/238 (31%), Positives = 125/238 (52%), Gaps = 17/238 (7%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM----EKEKEGFPITSLREINTLLKAQ 419
FK L ++ +G+YG VY+ K ++ ALK + + +KE+E ++ EI L
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE----DAVNEIRILASVN 57
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HPNI++ +E + N K+ IVM+Y D+ + + K+++ E+ + QLL
Sbjct: 58 HPNIISYKEAFLDGN--KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+ LH+ ILHRDLK++N+LL ++K+GD G+++ + T I T Y +PE+
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA-KTQI-GTPHYMAPEVW 173
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
G + YS D+WS+GC+ E P F +S ++ L +K I P +S+
Sbjct: 174 KG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLR--YKVQRGKYPPIPPIYSQ 227
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 83/299 (27%), Positives = 133/299 (44%), Gaps = 56/299 (18%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
N+I GT+G VY A + T E++A+K ++++ E+ L +HPN+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ---QLLNAVAHLH 483
+ V + +K++I M+Y +L E + + I E + QLL +A+LH
Sbjct: 65 YGVEV--HREKVYIFMEYCSGG--TLEELLEHGR---ILDE-HVIRVYTLQLLEGLAYLH 116
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLA-------REYGSPLKHY--TPIVVTLWYRS 534
+ I+HRD+K +N+ L H G++K+GDFG A G ++ TP Y +
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA-----YMA 171
Query: 535 PELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592
PE++ G K + D+WS+GC+ E + TGK +L F+ M
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLE------MATGKRPWSELDNEFQIM--------- 216
Query: 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
+ A K + L+ G D L + L DP R TA E L+H
Sbjct: 217 --FHVGAGHKPPIPDSLQ------------LSPEGKDFLDRCLESDPKKRPTASELLQH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 368 NRIEEGTYGVVYRAKDKR---TDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHP 421
++ EG +G VY+ K K VA+K LK E+E++ F L+E + K HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF----LKEARVMKKLGHP 56
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCL-MQQLL---- 476
N+V + + + +++V++Y+E L++ +R + VF E L ++ LL
Sbjct: 57 NVVRLLGVCTEE--EPLYLVLEYMEG--GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 477 ---NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PI 526
+ +L +HRDL N L+ ++K+ DFGL+R +Y PI
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPI 171
Query: 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGC 555
W +PE L +++ D+WS G
Sbjct: 172 ---RWM-APESLKD-GIFTSKSDVWSFGV 195
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/196 (28%), Positives = 103/196 (52%), Gaps = 15/196 (7%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQH 420
E F L ++ EG+YG VY+A K T ++VA+K + +E++ + + +EI+ L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDS 57
Query: 421 PNIVTVREIVVGSNM--DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
P IV GS ++IVM+Y S+ + M+ + E+ ++ Q L
Sbjct: 58 PYIVKY----YGSYFKNTDLWIVMEYC--GAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+ +LH N +HRD+K N+LL+ G K+ DFG++ + + ++ T ++ +PE++
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 539 LGCKEYSTPIDMWSVG 554
Y+ D+WS+G
Sbjct: 172 QEIG-YNNKADIWSLG 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 372 EGTYGVVYRAK----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNIV 424
EG +G VY+ + T+ VA+K LK E+E+E F L E + + K HPNIV
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKKLSHPNIV 64
Query: 425 TVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ + + ++IV +Y+ D+ + R + ++ + Q+ + +L
Sbjct: 65 RLLGVCTQG--EPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAR------EYGSPLKHYTPIVVTLWYRSPEL 537
+HRDL N L++ ++K+ DFGL+R Y PI W +PE
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWM-APES 175
Query: 538 LLGCKEYSTPIDMWSVGC----IFAEFLCMEPLFTGKSDLEQLSRIFK 581
L K +++ D+WS G IF L +P + G S+ E L +
Sbjct: 176 LKDGK-FTSKSDVWSFGVLLWEIFT--LGEQP-YPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 59/212 (27%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM-----EKEKEGFPITSLREINTLLKA 418
FK +I +G + VVY+A +VALK++++ K ++ L+EI+ L +
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ----DCLKEIDLLKQL 59
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
HPN++ + +N + IV++ + D+ +++ + +K++ + QL +
Sbjct: 60 DHPNVIKYLASFIENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
A+ H+H I+HRD+K +N+ ++ G++K+GD GL R + S +V T +Y SPE
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG 569
+ Y+ D+WS+GC+ E ++ F G
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 365 KCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLK 417
++ EG +G VY+ + VA+K LK E++ E F LRE + K
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF----LREARIMRK 57
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLM-QQL 475
HPNIV + + V + + + IVM+Y+ D+ + R + + Q+
Sbjct: 58 LDHPNIV--KLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQI 112
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL---WY 532
+ +L +HRDL N L+ ++K+ DFGL+R+ +Y L W
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD-LYDDDYYKVKGGKLPIRWM 171
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT 568
+PE L K +++ D+WS G L E +FT
Sbjct: 172 -APESLKEGK-FTSKSDVWSFGV-----LLWE-IFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 63/202 (31%), Positives = 114/202 (56%), Gaps = 22/202 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E+++ + RI GTYG VY+A+D T E+VA+K +K+E + F I +EI+ L + +HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-PGDDFEIIQ-QEISMLKECRHP 60
Query: 422 NIVTVREIVVGS--NMDKIFIVMDYVE----HDMKSLMETMRSKKQV-FIPGEVKCLMQQ 474
NIV GS DK++IVM+Y D+ + S+ Q+ ++ C ++
Sbjct: 61 NIVA----YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYV-----C--RE 109
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
L +A+LH+ +HRD+K +N+LL+ G +K+ DFG++ + + + + T ++ +
Sbjct: 110 TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMA 169
Query: 535 PELLLGCKE--YSTPIDMWSVG 554
PE+ ++ Y D+W++G
Sbjct: 170 PEVAAVERKGGYDGKCDIWALG 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 79/302 (26%), Positives = 132/302 (43%), Gaps = 74/302 (24%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKM--EKEKEGFPITSL-REINTLLKAQHPNIV-- 424
+ G++G VY + + A+K + + + + + L +EI L K QHPNIV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 425 --TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
T RE D ++I ++ V SL + ++ K F ++ +Q+L + +L
Sbjct: 68 LGTERE------EDNLYIFLELVP--GGSLAKLLK-KYGSFPEPVIRLYTRQILLGLEYL 118
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY----------GSPLKHYTPIVVTLWY 532
HD +HRD+K +N+L+ G++K+ DFG+A++ GSP ++
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSP-----------YW 167
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK---SDLEQLSRIFKTMGTPNEK 589
+PE++ Y D+WS+GC E + TGK S LE ++ +FK +
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLE------MATGKPPWSQLEGVAAVFKIGRSKE-- 219
Query: 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
LP + P+ L++ D + K L DP R TA E L
Sbjct: 220 -------LPPI--------PDH-----------LSDEAKDFILKCLQRDPSLRPTAAELL 253
Query: 650 RH 651
H
Sbjct: 254 EH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 45/223 (20%)
Query: 365 KCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLK 417
++ EG +G VY+ K + VA+K LK E++ E F LRE + K
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF----LREARIMRK 57
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
HPN+V + + V + + ++IVM+Y+E D+ S + R + ++ Q+
Sbjct: 58 LDHPNVV--KLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIA 112
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS-----------PLKHYTP 525
+ +L +HRDL N L+ ++K+ DFGL+R+ P++
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR---- 168
Query: 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT 568
W +PE L K +++ D+WS G L E +FT
Sbjct: 169 -----WM-APESLKEGK-FTSKSDVWSFGV-----LLWE-IFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 7/210 (3%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN 422
++ L + EG++G + +D+ A+K +++ K S +E L K +HPN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPN 59
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAH 481
IV +E ++IVM+Y D LM+ ++ ++ ++F + Q+ V H
Sbjct: 60 IVAFKESFEADG--HLYIVMEYC--DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
+H+ +LHRD+K+ N+ L+ G +K+GDFG AR SP + V T +Y PE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKS 571
Y+ D+WS+GCI E ++ F S
Sbjct: 176 P-YNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 78/294 (26%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
L I +G +G VY AK + T + A+K LK +T+++ ++ Q +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 427 REIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAVAHLHD 484
+ + D +++VM+Y+ D SL++T+ +P + K + +++ V LH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEY 544
I+HRD+K NLL+ G LK+ DFGL+R K V T Y +PE +LG
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK----FVGTPDYLAPETILG-VGD 170
Query: 545 STPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604
D WS+GC+ EFL P F ++ I WP K
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-----RRINWPEEVK-------E 218
Query: 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD---EALRHDYFS 655
F + A DL+ + L DP R+ A+ E H +F
Sbjct: 219 FC---------SPEA--------VDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 25/201 (12%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR-EINTLLK-AQHPNIVTV- 426
I EGTYG VY+A+ K+T ++VA+K + + +++E ++ E N L K + HPNI T
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSNHPNIATFY 69
Query: 427 ---REIVVGSNMDKIFIVMDYVEH----DM-KSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+ N D++++VM+ D+ K L + + K+ +I ++++ L
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI----AYILRETLRG 125
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+A+LH+N ++HRD+K N+LL+ +K+ DFG++ + S L + T ++ +PE++
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI 185
Query: 539 LGCKEYSTP-----IDMWSVG 554
C E D+WS+G
Sbjct: 186 A-CDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 6/202 (2%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
+ +I EG++G K K + +K + + K S +E+ L +HPNIV
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-GEVKCLMQQLLNAVAHLHDN 485
+E + ++IVMDY E L + + +++ V P ++ Q+ A+ H+HD
Sbjct: 65 QESFEENG--NLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYS 545
ILHRD+K+ N+ L+ G +K+GDFG+AR S ++ + T +Y SPE+ + Y+
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN-RPYN 179
Query: 546 TPIDMWSVGCIFAEFLCMEPLF 567
D+W++GC+ E ++ F
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 11/222 (4%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVV 431
G +G V K K + ALK +K E G E L + HP IV +
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63
Query: 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491
I+++M+Y L +R + F + + ++ A +LH+ I++RD
Sbjct: 64 DKK--YIYMLMEYC--LGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 492 LKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMW 551
LK NLLL G +K+ DFG A++ S K +T T Y +PE++L K Y +D W
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILN-KGYDFSVDYW 176
Query: 552 SVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI-WP 592
S+G + E L P F D + + I+ + N K+ +P
Sbjct: 177 SLGILLYELLTGRPPFGE-DDEDPM-EIYNDILKGNGKLEFP 216
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 85/300 (28%), Positives = 141/300 (47%), Gaps = 53/300 (17%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKM-------EKEKEGFPITSLR-EINTLLKAQHP 421
I +GTYG VY A + T E++A+K++++ ++ + +LR EI TL H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV IF ++YV S+ +R+ + F V+ +Q+L +A+
Sbjct: 69 NIVQYLGFETTEEYLSIF--LEYVPGG--SIGSCLRTYGR-FEEQLVRFFTEQVLEGLAY 123
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE----YGSPLKHYTPIVVTLWYRSPEL 537
LH ILHRDLK NLL+ GI K+ DFG++++ Y + + ++++ +PE+
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN--DQNMSMQGSVFWMAPEV 181
Query: 538 L-LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK---SDLEQLSRIFKTMGTPNEKIWPG 593
+ + YS +D+WS+GC+ E +F G+ SD E ++ +FK +G
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLE------MFAGRRPWSDEEAIAAMFK-LGNK------- 227
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
P + P+V + VA L C T +P R TA E L+H +
Sbjct: 228 -RSAPPIP-------PDVSMNLSPVALDFLNA------C--FTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 40/300 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++++ + I G VVY A +E VA+KR+ +EK + +E+ + + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHP 59
Query: 422 NIVTVR-EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK--KQVFIPGEVKCLMQQLLNA 478
N+V VVG D++++VM Y+ SL++ M+S + + +++++L
Sbjct: 60 NVVKYYTSFVVG---DELWLVMPYLSGG--SLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFG----LAREYGSPLKHYTPIVVTLWYRS 534
+ +LH N +HRD+K N+LL G +K+ DFG LA K V T + +
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
PE++ Y D+WS G E L TG +
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIE------LATGA---------------------APY 207
Query: 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
SK P ++ + + L+T ++ ++ L DP R TA+E L+H +F
Sbjct: 208 SKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 59/206 (28%), Positives = 111/206 (53%), Gaps = 12/206 (5%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQH 420
E F L I +G++G VY+A DKRT+++VA+K + +E+ ++ I + +EI L + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRS 58
Query: 421 PNIVTVRE-IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
P I + GS + +I+M+Y S ++ ++ K + +++++L +
Sbjct: 59 PYITKYYGSFLKGSKL---WIIMEYC--GGGSCLDLLKPGK--LDETYIAFILREVLLGL 111
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+LH+ +HRD+K +N+LLS G +K+ DFG++ + S + V T ++ +PE++
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEP 565
Y D+WS+G E EP
Sbjct: 172 -QSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN 422
+F+ LN+I +G++GVV++ K + A+K++ + K ++ E L K
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
I+ E + K+ IVM+Y E+ D+ L++ R + +V Q+L +AH
Sbjct: 61 IIRYYESFLDKG--KLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAH 116
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
LH ILHRD+K+ NL L +K+GD G+A+ IV T +Y SPEL C
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL---C 173
Query: 542 --KEYSTPIDMWSVGCIFAEFLCM 563
K Y+ D+W++G + E C
Sbjct: 174 EDKPYNEKSDVWALGVVLYE-CCT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 70/215 (32%), Positives = 103/215 (47%), Gaps = 8/215 (3%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFP---ITSLREINTLLKAQHPNIVT 425
R+ +G++G VY KDK+ LK LK E P + + +E L K HP IV
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 426 VREIVVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD 484
+ D I+ +Y E D+ +E ++ + +V QLL V ++H
Sbjct: 67 FHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEY 544
ILHRDLK N+ L +LK+GDFG++R T T +Y SPE L + Y
Sbjct: 125 RRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL-KHQGY 182
Query: 545 STPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
+ D+WS+GCI E C+ F G++ L + RI
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 75/302 (24%), Positives = 138/302 (45%), Gaps = 45/302 (14%)
Query: 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIV-TV 426
+I EG+ G+V A DK T VA+K++ + K++ + E+ + QHPNIV
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL--FNEVVIMRDYQHPNIVEMY 82
Query: 427 REIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+VG D++++VM+++E + ++ R ++ ++ + +L A++ LH
Sbjct: 83 SSYLVG---DELWVVMEFLEGGALTDIVTHTRMNEE-----QIATVCLAVLKALSFLHAQ 134
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYS 545
++HRD+K+ ++LL+ G +K+ DFG + + +V T ++ +PE ++ Y
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-VISRLPYG 193
Query: 546 TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605
T +D+WS+G + E + EP + + L+ + RI + P K
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPPKLK---------------- 236
Query: 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP--IDP 663
L L + L DP R TA E L H + +++ P I P
Sbjct: 237 ---------NLHKVSPRLRS----FLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
Query: 664 AM 665
M
Sbjct: 284 LM 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-22
Identities = 66/243 (27%), Positives = 126/243 (51%), Gaps = 19/243 (7%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDE-IVALKRL--------KMEKEKEGFPITSLREIN 413
E+ L + G +G VY+ + K + ++ALK + K ++E++ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV- 59
Query: 414 TLLKAQ--HPNIVTVREIVVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKC 470
T++K Q HPNIV + + + D+++IVMD +E + +++ KKQ F +
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 471 LMQQLLNAVAHLH-DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVT 529
+ Q++ A+ +LH + I+HRDL +N++L + + DFGLA++ P T +V T
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGT 176
Query: 530 LWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP-NE 588
+ Y PE++ + Y D+W+ GCI + ++P F + L ++I + + P E
Sbjct: 177 ILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE 235
Query: 589 KIW 591
++
Sbjct: 236 GMY 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-21
Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 32/216 (14%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE--------KEGFPITSLREINTL 415
++ L I G YG VYR K T +VALK + ++ +E ++ LR+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ---- 58
Query: 416 LKAQHPNIVTVREIVVGSNMD--KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKC-- 470
+Q PNI GS + +++I+M+Y E +++LM+ P K
Sbjct: 59 --SQPPNITKYY----GSYLKGPRLWIIMEYAEGGSVRTLMKAG--------PIAEKYIS 104
Query: 471 -LMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVT 529
+++++L A+ ++H ++HRD+K +N+L+++ G +K+ DFG+A + V T
Sbjct: 105 VIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGT 164
Query: 530 LWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEP 565
++ +PE++ K Y T D+WS+G E P
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 24/229 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME-KEKEGFPITSLREINTLLKAQH 420
++ + L + G GVV + + T +I+A+K +++E E I LRE++ L K
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI--LRELDILHKCNS 58
Query: 421 PNIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEV-KCLMQQLLN 477
P IV G+ N I I M+Y+ D SL + ++ + IP + + +L
Sbjct: 59 PYIVGF----YGAFYNNGDISICMEYM--DGGSLDKILKEVQGR-IPERILGKIAVAVLK 111
Query: 478 AVAHLHDNW-ILHRDLKTSNLLLSHRGILKVGDFGLAREY-GSPLKHYTPIVVTLWYRSP 535
+ +LH+ I+HRD+K SN+L++ RG +K+ DFG++ + S K + V T Y +P
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAP 168
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAE-----FLCMEPLFTGKSDLEQLSRI 579
E + G YS D+WS+G E F E L I
Sbjct: 169 ERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 79/292 (27%), Positives = 137/292 (46%), Gaps = 46/292 (15%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKR--LKMEKEKEGFPITSLREINTLLKAQHPNIVTVREI 429
+G +G VY+A+ K T A K ++ E+E E F + EI+ L + +HPNIV + E
Sbjct: 15 DGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDF----MVEIDILSECKHPNIVGLYE- 69
Query: 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILH 489
+K++I++++ D +L M ++ +++ + +Q+L A+ LH + ++H
Sbjct: 70 -AYFYENKLWILIEFC--DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 490 RDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE-----Y 544
RDLK N+LL+ G +K+ DFG++ + S L+ + T ++ +PE++ C+ Y
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA-CETFKDNPY 185
Query: 545 STPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604
D+WS+G E MEP +L + + K + K
Sbjct: 186 DYKADIWSLGITLIELAQMEP---PHHELNPMRVLLK------------------ILK-- 222
Query: 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
+E P T S + D L L DP R TA E L+H + S+
Sbjct: 223 -SEPP------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 5/202 (2%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREI 429
+ +G+YG V + + + +K+L + + +E L + +HPNIV RE
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-GEVKCLMQQLLNAVAHLHDNWIL 488
G + ++IVM + E L ++ +K +P +V Q+ A+ +LH+ IL
Sbjct: 68 WEGED-GLLYIVMGFCEGG--DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124
Query: 489 HRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPI 548
HRDLKT N+ L+ I+KVGD G+AR + + ++ T +Y SPEL K Y+
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNYKS 183
Query: 549 DMWSVGCIFAEFLCMEPLFTGK 570
D+W++GC E ++ F K
Sbjct: 184 DVWALGCCVYEMATLKHAFNAK 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR-------EINT 414
++F+ + + G++G V + K + + ALK L K I L+ E
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK------IVKLKQVEHVLNEKRI 54
Query: 415 LLKAQHPNIVTVREIVVGSNMD--KIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCL 471
L +HP +V + GS D +++VM+YV ++ S + K F +
Sbjct: 55 LQSIRHPFLVNL----YGSFQDDSNLYLVMEYVPGGELFSHLR----KSGRFPEPVARFY 106
Query: 472 MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
Q++ A+ +LH I++RDLK NLLL G +K+ DFG A+ + YT + T
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--RTYT-LCGTPE 163
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLF 567
Y +PE++L K Y +D W++G + E L P F
Sbjct: 164 YLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 5e-20
Identities = 73/329 (22%), Positives = 129/329 (39%), Gaps = 75/329 (22%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK----MEKEKEGFPITSLREINTLLK 417
++F+ + I G +G V+ +DK T ++ A+K L+ +++ + R+I L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE-RDI--LAD 57
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
A P IV + + + +++VM+Y+ D+ +L+ +K VF + + +L+
Sbjct: 58 ADSPWIV--KLYYSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEETARFYIAELV 111
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS------------------ 518
A+ +H +HRD+K N+L+ G +K+ DFGL ++
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 519 -PLKHYTP----------IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLF 567
L V T Y +PE+L G Y D WS+G I E L P F
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 568 TGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELG 627
+ E ++I W + P ++
Sbjct: 231 YSDTLQETYNKIIN---------WKESLRFPPDPP--------------------VSPEA 261
Query: 628 YDLLCKFLTYDPVTRIT-ADEALRHDYFS 655
DL+C+ L DP R+ +E H +F
Sbjct: 262 IDLICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 72/247 (29%), Positives = 113/247 (45%), Gaps = 44/247 (17%)
Query: 365 KCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-----KEGFPITSLR-EINTLLKA 418
K L + G +G VY D T +A+K++ + + KE + +L EI L
Sbjct: 8 KLLGQ---GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKE---VNALECEIQLLKNL 61
Query: 419 QHPNIVTVREIVVGSNMD--KIFIVMDY-----VEHDMKS---LMETMRSKKQVFIPGEV 468
QH IV G D + I M+Y V+ +K+ L ET+ K
Sbjct: 62 QHERIVQY----YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK--------- 108
Query: 469 KCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT---P 525
+Q+L V +LH N I+HRD+K +N+L G +K+GDFG ++ + T
Sbjct: 109 --YTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166
Query: 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585
+ T ++ SPE++ G + Y D+WSVGC E L +P + ++ E ++ IFK
Sbjct: 167 VTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQ 222
Query: 586 PNEKIWP 592
P P
Sbjct: 223 PTNPQLP 229
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 60/217 (27%), Positives = 113/217 (52%), Gaps = 6/217 (2%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM-EKEKEGFPITSLREINTLLKAQHP 421
F+ +I G + VYRA + VALK++++ E ++EI+ L + HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
N++ + + N ++ IV++ + D+ +++ + +K++ V QL +AV
Sbjct: 63 NVIKYLDSFIEDN--ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
H+H ++HRD+K +N+ ++ G++K+GD GL R + S +V T +Y SPE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 541 CKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQL 576
Y+ D+WS+GC+ E ++ P + K +L L
Sbjct: 181 -NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
+GTYG+VY A+D T +A+K + + P+ EI +H NIV
Sbjct: 18 KGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL--HEEIALHSYLKHRNIVQYLGSDS 75
Query: 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE--VKCLMQQLLNAVAHLHDNWILH 489
+ KIF M+ V SL +RSK E + +Q+L + +LHDN I+H
Sbjct: 76 ENGFFKIF--MEQVPGG--SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 490 RDLKTSNLLL-SHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL-LGCKEYSTP 547
RD+K N+L+ ++ G++K+ DFG ++ TL Y +PE++ G + Y P
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAP 191
Query: 548 IDMWSVGCIFAEFLCMEPLF 567
D+WS+GC E +P F
Sbjct: 192 ADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 4e-19
Identities = 68/233 (29%), Positives = 124/233 (53%), Gaps = 16/233 (6%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVT- 425
+I +G G VY A D T + VA+K++ ++++ + I + EI + + +HPNIV
Sbjct: 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNY 81
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+ +VG D++++VM+Y+ SL + + + G++ + ++ L A+ LH N
Sbjct: 82 LDSYLVG---DELWVVMEYLAGG--SLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYS 545
++HRD+K+ N+LL G +K+ DFG + + +V T ++ +PE++ K Y
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYG 193
Query: 546 TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN----EKIWPGF 594
+D+WS+G + E + EP + ++ L L I T GTP EK+ F
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIF 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 12/221 (5%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK----MEKEKEGFPITSLREINTLLKAQ 419
F+ +I G + VYRA VALK+++ M+ + ++EI+ L +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQLN 60
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HPN++ + N ++ IV++ + D+ +++ + +K++ V QL +A
Sbjct: 61 HPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+ H+H ++HRD+K +N+ ++ G++K+GD GL R + S +V T +Y SPE +
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSR 578
Y+ D+WS+GC+ E ++ P + K +L L +
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 4e-19
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQHPN 422
F L I G++G VY A+D R E+VA+K++ ++ + +E+ L K +HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
+ R + + ++VM+Y L+E + Q E+ + L +A+L
Sbjct: 77 TIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEV---EIAAVTHGALQGLAYL 131
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCK 542
H + ++HRD+K N+LLS G++K+GDFG A S + V T ++ +PE++L
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANXFVGTPYWMAPEVILAMD 187
Query: 543 E--YSTPIDMWSVGCIFAEFLCMEP 565
E Y +D+WS+G E +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 59/216 (27%), Positives = 111/216 (51%), Gaps = 29/216 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E+F+ + RI GTYG VY+A++ T E+ A+K +K+E E F + +EI + +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQ-QEIIMMKDCKHS 66
Query: 422 NIVTVREIVVGSNM--DKIFIVMDY--------VEHDMKSLMETMRSKKQVFIPGEVKCL 471
NIV GS + DK++I M++ + H L E+ ++ +
Sbjct: 67 NIVAY----FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES-----------QIAYV 111
Query: 472 MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
++ L + +LH +HRD+K +N+LL+ G +K+ DFG++ + + + + T +
Sbjct: 112 SRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY 171
Query: 532 YRSPELLLGCKE--YSTPIDMWSVGCIFAEFLCMEP 565
+ +PE+ ++ Y+ D+W+VG E ++P
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 1e-18
Identities = 64/226 (28%), Positives = 123/226 (54%), Gaps = 12/226 (5%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+++ +I +G G VY A D T + VA+K++ ++++ + I + EI + + ++P
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNP 76
Query: 422 NIVT-VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
NIV + +VG D++++VM+Y+ SL + + + G++ + ++ L A+
Sbjct: 77 NIVNYLDSYLVG---DELWVVMEYLAGG--SLTDVV--TETCMDEGQIAAVCRECLQALD 129
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
LH N ++HRD+K+ N+LL G +K+ DFG + + +V T ++ +PE++
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586
K Y +D+WS+G + E + EP + ++ L L I T GTP
Sbjct: 190 -KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 16/235 (6%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS-LREINTLLKAQHPN 422
F+ L I +G +G V + + T ++ A+K + +K E + + L E L + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMR---SKKQVFIPGEVKCLMQQLLNAV 479
+V + + + +++V+D + L +R S+K F +VK + +++ A+
Sbjct: 62 LVNLWYSF--QDEENMYLVVDLL------LGGDLRYHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+LH I+HRD+K N+LL +G + + DF +A + +P T T Y +PE+L
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTSGTPGYMAPEVLC 172
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL--EQLSRIFKTMGTPNEKIWP 592
+ YS +D WS+G E L + + G S +Q+ +T W
Sbjct: 173 R-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWS 226
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 1e-18
Identities = 63/226 (27%), Positives = 123/226 (54%), Gaps = 12/226 (5%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+++ +I +G G VY A D T + VA++++ ++++ + I + EI + + ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77
Query: 422 NIVT-VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
NIV + +VG D++++VM+Y+ SL + + + G++ + ++ L A+
Sbjct: 78 NIVNYLDSYLVG---DELWVVMEYLAGG--SLTDVV--TETCMDEGQIAAVCRECLQALE 130
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
LH N ++HRD+K+ N+LL G +K+ DFG + + +V T ++ +PE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586
K Y +D+WS+G + E + EP + ++ L L I T GTP
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 61/232 (26%), Positives = 115/232 (49%), Gaps = 36/232 (15%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRL-------KMEKEKEGFPITSLREINTLLKAQHPN 422
I G++G VY + + E++A+K++ + K REI L + QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 423 IVTVREIVVGSNMDK--IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
IV +GS++D + I ++YV + + + F V+ ++Q+L +
Sbjct: 68 IVQY----LGSSLDADHLNIFLEYVP---GGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY------GSPLKHYTPIVVTLWYRS 534
+LH+ I+HRD+K +N+L+ ++G +K+ DFG++++ + ++++ +
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 535 PELLLGCKE--YSTPIDMWSVGCIFAEFLCMEPLFTGK---SDLEQLSRIFK 581
PE++ K+ Y+ D+WS+GC+ E + TGK D QL IFK
Sbjct: 181 PEVV---KQTSYTRKADIWSLGCLVVE------MLTGKHPFPDCTQLQAIFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-18
Identities = 68/231 (29%), Positives = 124/231 (53%), Gaps = 16/231 (6%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVT-VR 427
+I +G G V+ A D T + VA+K++ ++K+ + I + EI + + ++PNIV +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPNIVNFLD 83
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI 487
+VG D++F+VM+Y+ SL + + + ++ + ++ L A+ LH N +
Sbjct: 84 SFLVG---DELFVVMEYLAGG--SLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTP 547
+HRD+K+ N+LL G +K+ DFG + + +V T ++ +PE++ K Y
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 195
Query: 548 IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN----EKIWPGF 594
+D+WS+G + E + EP + ++ L L I T GTP EK+ P F
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSPIF 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL----KMEKEKEGFPITSLREINTLLKAQ 419
F L I G++G VY A+D RT+E+VA+K++ K EK ++E+ L + +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQQLR 73
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
HPN + + + + ++VM+Y ++E + Q E+ + L +
Sbjct: 74 HPNTIEYKGCYLREHT--AWLVMEYCLGSASDILEVHKKPLQEV---EIAAICHGALQGL 128
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
A+LH + +HRD+K N+LL+ G +K+ DFG A SP + V T ++ +PE++L
Sbjct: 129 AYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA-SLVSPANSF---VGTPYWMAPEVIL 184
Query: 540 GCKE--YSTPIDMWSVG--CI 556
E Y +D+WS+G CI
Sbjct: 185 AMDEGQYDGKVDVWSLGITCI 205
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 4e-18
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQHPN 422
F L I G++G VY A+D RT+E+VA+K++ ++ + +E+ L + +HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
+ + + + ++VM+Y L+E + Q E+ + L +A+L
Sbjct: 87 SIEYKGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEV---EIAAITHGALQGLAYL 141
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCK 542
H + ++HRD+K N+LL+ G +K+ DFG A SP + V T ++ +PE++L
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSA-SIASPANSF---VGTPYWMAPEVILAMD 197
Query: 543 E--YSTPIDMWSVGCIFAEFLCMEP 565
E Y +D+WS+G E +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEK----EKEGFPITSLREINTLLKAQHPNIVTVRE 428
G + Y+A+D +T ++A+K++ + E+E +EI + + HP+I+ +
Sbjct: 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWIL 488
+ +F+ E + + SK F + +QLL +++LH+N I+
Sbjct: 71 ATCEDSHFNLFV-----EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 489 HRDLKTSNLLLSHRG-ILKVGDFGLAREYGSPL----KHYTPIVVTLWYRSPELLLGCKE 543
HRD+K +NLL+ G L++ DFG A + + ++ T+ + +PE+L G ++
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQ 184
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
Y D+WSVGC+ E +P + + L+ IFK
Sbjct: 185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 78/302 (25%), Positives = 148/302 (49%), Gaps = 47/302 (15%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV-R 427
+I EG+ G+V A K + ++VA+K++ + K++ + E+ + QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYN 84
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKS--LMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+VG D++++VM+++E + + T +++Q+ CL +L A++ LH
Sbjct: 85 SYLVG---DELWVVMEFLEGGALTDIVTHTRMNEEQI----AAVCL--AVLKALSVLHAQ 135
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYS 545
++HRD+K+ ++LL+H G +K+ DFG + + +V T ++ +PEL+ Y
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YG 194
Query: 546 TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605
+D+WS+G + E + EP + + L K M + + P KL + K++
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNLPP---KLKNLHKVS- 243
Query: 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES--PLPIDP 663
P++ G L + L DP R TA E L+H + +++ P I P
Sbjct: 244 ---PSLKG----------------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284
Query: 664 AM 665
M
Sbjct: 285 LM 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E+ L+R+ EG G V + + K T I ALK + LRE+ + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSP 59
Query: 422 NIVTVREIVVGSNMDK----IFIVMDYVEHDMKSLMETM-RSKKQVFIPGE--VKCLMQQ 474
IV G+ +D+ I I M+Y E SL + KK+ GE + + +
Sbjct: 60 YIVKY----YGAFLDESSSSIGIAMEYCEG--GSLDSIYKKVKKRGGRIGEKVLGKIAES 113
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
+L +++LH I+HRD+K SN+LL+ +G +K+ DFG++ E + L T +Y +
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMA 171
Query: 535 PELLLGCKEYSTPIDMWSVG 554
PE + G K YS D+WS+G
Sbjct: 172 PERIQG-KPYSITSDVWSLG 190
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 58/212 (27%), Positives = 113/212 (53%), Gaps = 17/212 (8%)
Query: 362 EEF-KCLNRIEEGTYGVVYRAKDKRTDEIVALKRL--KMEKEKEGFPITSLREINTLLKA 418
EEF + + + +G +G VY+A++K T + A K + K E+E E + + EI+ L
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV----EIDILASC 59
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HPNIV + + N ++I++++ ++ M ++ +++ + +Q L A
Sbjct: 60 DHPNIVKLLDAFYYEN--NLWILIEFCAGG--AVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+ +LH+N I+HRDLK N+L + G +K+ DFG++ + ++ + T ++ +PE++
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 539 LGC-----KEYSTPIDMWSVGCIFAEFLCMEP 565
+ C + Y D+WS+G E +EP
Sbjct: 176 M-CETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 27/34 (79%), Positives = 32/34 (94%)
Query: 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
CRSV+E++ LNRIEEGTYGVVYRA+DK+T EIVA
Sbjct: 1 CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVA 34
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 67/294 (22%), Positives = 143/294 (48%), Gaps = 43/294 (14%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV-R 427
+I EG+ G+V A++K + VA+K + + K++ + E+ + QH N+V + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHQNVVEMYK 85
Query: 428 EIVVGSNMDKIFIVMDYVEHD-MKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
+VG ++++++M++++ + ++ R ++ ++ + + +L A+ +LH
Sbjct: 86 SYLVG---EELWVLMEFLQGGALTDIVSQTRLNEE-----QIATVCESVLQALCYLHSQG 137
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST 546
++HRD+K+ ++LL+ G +K+ DFG + + +V T ++ +PE ++ Y T
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE-VISRTPYGT 196
Query: 547 PIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606
+D+WS+G + E + EP + S ++ + R+ +P K+ K+ V +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---RDSPPPKL-KNAHKISPVLR---- 248
Query: 607 EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660
D L + LT +P R TA E L H + ++ LP
Sbjct: 249 ----------------------DFLERMLTREPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 75/294 (25%), Positives = 135/294 (45%), Gaps = 44/294 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E F L RI +G++G V++ D RT ++VA+K + +E+ ++ +EI L + P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSP 62
Query: 422 NIVTVREIVVGSNM--DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
+ GS + K++I+M+Y+ S ++ +R+ F ++ +++++L +
Sbjct: 63 YVTKY----YGSYLKGTKLWIIMEYLGGG--SALDLLRAGP--FDEFQIATMLKEILKGL 114
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+LH +HRD+K +N+LLS +G +K+ DFG+A + V T ++ +PE++
Sbjct: 115 DYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
Y + D+WS+G E EP SD+ + +F + FSK
Sbjct: 175 Q-SAYDSKADIWSLGITAIELAKGEP---PNSDMHPMRVLFLIPKNNPPTLTGEFSK--- 227
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
F E+ + C L DP R TA E L+H +
Sbjct: 228 ----PFKEFIDA--------------------C--LNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS-LREINTLLKAQH 420
E F L+ I G++G VY A + T+E+VA+K++ ++ ++E+ L + +H
Sbjct: 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
PN + + + + ++VM+Y L+E + Q E+ + L +A
Sbjct: 81 PNTIEYKGCYLKEHT--AWLVMEYCLGSASDLLEVHKKPLQEV---EIAAITHGALQGLA 135
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
+LH + ++HRD+K N+LL+ G +K+ DFG A SP + V T ++ +PE++L
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA-SKSSPANSF---VGTPYWMAPEVILA 191
Query: 541 CKE--YSTPIDMWSVGCIFAEFLCMEP 565
E Y +D+WS+G E +P
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 57/214 (26%), Positives = 118/214 (55%), Gaps = 15/214 (7%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV-R 427
+I EG+ G+V A +K T + VA+K++ + K++ + E+ + H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHENVVDMYN 86
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKS--LMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+VG D++++VM+++E + + T +++Q+ CL +L A+++LH+
Sbjct: 87 SYLVG---DELWVVMEFLEGGALTDIVTHTRMNEEQI----ATVCL--SVLRALSYLHNQ 137
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYS 545
++HRD+K+ ++LL+ G +K+ DFG + + +V T ++ +PE++ Y
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YG 196
Query: 546 TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
T +D+WS+G + E + EP + + L+ + RI
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 28/233 (12%)
Query: 365 KCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQ 419
K + ++ EG +G V + T E VA+K L E + REI L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN--HSGEEQHRSDFEREIEILRTLD 64
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
H NIV + + + ++M+Y+ SL + ++ + + Q+ +
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSG--SLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIVVTLWY 532
+L +HRDL N+L+ ++K+ DFGLA+ +Y PI WY
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---FWY 179
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT-GKSDLEQLSRIFKTMG 584
+PE L K S D+WS G E LFT G + + +G
Sbjct: 180 -APECLRTSKFSSAS-DVWSFGVTLYE------LFTYGDPSQSPPAEFLRMIG 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG 432
G G V AK E A+K + ME E + E+ LL +IV E
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102
Query: 433 S------NMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
N+ I +V+DY D++ +++ + F E L Q+L AV H+H
Sbjct: 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK 162
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV---------TLWYRSPE 536
++HRD+K++N+LL G++K+GDFG + K Y V T +Y +PE
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFS-------KMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS 571
+ YS DM+S+G + E L ++ F G++
Sbjct: 216 IWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLREINTLLK-AQHPNIVT 425
I +G++G V AK K + A+K L+ + K+KE I + R N LLK +HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAER--NVLLKNVKHPFLVG 60
Query: 426 VREIVVGSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
+ DK++ V+DYV +S E R++ F E+
Sbjct: 61 LHYSF--QTADKLYFVLDYVNGGELFFHLQRERSFPEP-RAR---FYAAEIAS------- 107
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
A+ +LH I++RDLK N+LL +G + + DFGL +E K + T Y +PE+
Sbjct: 108 ALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
L + Y +D W +G + E L P F + E I
Sbjct: 168 LRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE----KEGFPITSLREINTLLKA 418
E L + G +GVV+ K + ++ +KM +E ++ F + E ++K
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVA----IKMIREGAMSEDDF----IEEAKVMMKL 56
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HPN+V + + + IFIV +Y+ + L+ +R +K + + + A
Sbjct: 57 SHPNLVQLYGVC--TKQRPIFIVTEYMANG--CLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYR 533
+ +L N +HRDL N L+ ++KV DFGLAR +Y S P+ +
Sbjct: 113 MEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK----WA 168
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAE-FLCMEPLFTGKSDLEQLSRI 579
PE+ + +S+ D+WS G + E F + + S+ E + +
Sbjct: 169 PPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 58/216 (26%), Positives = 110/216 (50%), Gaps = 29/216 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+++ + R+ GTYG VY+A++ T E+ A+K +K+E + F + +EI + + +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQ-QEIFMVKECKHC 66
Query: 422 NIVTVREIVVGSNM--DKIFIVMDY--------VEHDMKSLMETMRSKKQVFIPGEVKCL 471
NIV GS + +K++I M+Y + H L E ++ +
Sbjct: 67 NIVAY----FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-----------QIAYV 111
Query: 472 MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
++ L +A+LH +HRD+K +N+LL+ G +K+ DFG+A + + + + T +
Sbjct: 112 CRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171
Query: 532 YRSPELLLGCKE--YSTPIDMWSVGCIFAEFLCMEP 565
+ +PE+ K Y+ D+W+VG E ++P
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 370 IEEGTYGVVYRA---KDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
I G +G V R + + VA+K LK +K++ F L E + + + HPNI
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF----LTEASIMGQFDHPNI 67
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ + +V S + I+ +Y+E+ SL + +R F G++ +++ + + + +L
Sbjct: 68 IRLEGVVTKSR--PVMIITEYMENG--SLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT------PIVVTLWYRSPEL 537
+ +HRDL N+L++ + KV DFGL+R YT PI T +PE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE- 178
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFL 561
+ +++++ D+WS G + E +
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL--KMEKEKEGFPITSLREINTLLKAQ 419
E ++ + + +G +G VY+AK+K T + A K + K E+E E + + EI L
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV----EIEILATCN 67
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
HP IV + K++I++++ ++ M + +++ + +Q+L A+
Sbjct: 68 HPYIVKLLGAFYWDG--KLWIMIEFCPGG--AVDAIMLELDRGLTEPQIQVICRQMLEAL 123
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+LH I+HRDLK N+LL+ G +K+ DFG++ + L+ + T ++ +PE+++
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 540 GCKE-----YSTPIDMWSVGCIFAEFLCMEP 565
C+ Y D+WS+G E +EP
Sbjct: 184 -CETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 52/231 (22%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREI-------NT 414
++ + + + GT+G V+ +D+ ++ ALK + + + + L++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE------VIRLKQEQHVHNEKRV 54
Query: 415 LLKAQHPNIVTVREIVVGSNMDK--IFIVMDYVEH-DMKSLMETMR---SKKQVFIPGEV 468
L + HP I+ + + D+ ++++M+YV ++ S + + +F E+
Sbjct: 55 LKEVSHPFIIRL----FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 469 KCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV 528
C A+ +LH I++RDLK N+LL G +K+ DFG A++ + +T +
Sbjct: 111 VC-------ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWT-LCG 160
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
T Y +PE ++ K ++ +D W++G + E L P F + +I
Sbjct: 161 TPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (198), Expect = 3e-15
Identities = 73/249 (29%), Positives = 116/249 (46%), Gaps = 33/249 (13%)
Query: 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
G + E++ + +I G +G V+ K KRT E K + KE + E+N +
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLM---Q 473
+ +H NIV + + K++I+M++ D L ++ ++F E ++ +
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFC--DAGDLSRNIQKCYKMFGKIEEHAIVDITR 125
Query: 474 QLLNAVAHLHD-------NWILHRDLKTSNLLLSH-----------------RGILKVGD 509
QLL+A+A+ H+ +LHRDLK N+ LS R I K+GD
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 510 FGLAREYG-SPLKHYTPIVVTLWYRSPELLLG-CKEYSTPIDMWSVGCIFAEFLCMEPLF 567
FGL++ G + H V T +Y SPELLL K Y DMW++GCI E + F
Sbjct: 186 FGLSKNIGIESMAH--SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 568 TGKSDLEQL 576
++ QL
Sbjct: 244 HKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL----REINTLLKAQ 419
F+CL + G +G V A+ K+T E+ A+K LK + SL R T +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHD--MKSLMETMRSKKQ-VFIPGEVKCLMQQLL 476
HP +V + D + VM+Y M + + S+ + VF V L
Sbjct: 61 HPFLVNLFACF--QTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACV-VL----- 112
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE---YGSPLKHY--TPIVVTLW 531
+ +LH+N I++RDLK NLLL G +K+ DFGL +E +G + TP
Sbjct: 113 -GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTP-----E 166
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE 574
+ +PE+L Y+ +D W +G + E L E F G + E
Sbjct: 167 FLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME-KEKEGFPITSLREINTLLKA 418
+ +E K I +G +G V + + VA+K LK + + F L E + +
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAF----LAEASVMTTL 57
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ---QL 475
+HPN+V + +V+ N ++IV +Y+ SL++ +RS+ + I + + +
Sbjct: 58 RHPNLVQLLGVVLQGN--PLYIVTEYMAKG--SLVDYLRSRGRAVI--TLAQQLGFALDV 111
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT---PIVVTLWY 532
+ +L + +HRDL N+L+S + KV DFGLA+E + + P+ T
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE--ASQGQDSGKLPVKWT--- 166
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAE 559
+PE L K++ST D+WS G + E
Sbjct: 167 -APEALRE-KKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 25/233 (10%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR------EINTLLKAQHPNIVT 425
+G +G VY D T +A+K+++ + E P TS EI L H IV
Sbjct: 12 QGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+ + I M+++ S+ + ++S + +Q+L V++LH N
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGG--SIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSN 125
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREY------GSPLKHYTPIVVTLWYRSPELLL 539
I+HRD+K +N+L G +K+GDFG ++ G+ +K T T ++ SPE++
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG---TPYWMSPEVIS 182
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592
G + Y D+WSVGC E L +P + ++ E ++ IFK P + P
Sbjct: 183 G-EGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 21/224 (9%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E F L RI +G++G VY+ D RT E+VA+K + +E+ ++ +EI L + P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSP 62
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-----VKCLMQQLL 476
I + K++I+M+Y+ S + PG + +++++L
Sbjct: 63 YITRYYGSYLKGT--KLWIIMEYLGGG---------SALDLLKPGPLEETYIATILREIL 111
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+ +LH +HRD+K +N+LLS +G +K+ DFG+A + V T ++ +PE
Sbjct: 112 KGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
++ Y D+WS+G E EP SDL + +F
Sbjct: 172 VIKQ-SAYDFKADIWSLGITAIELAKGEPPN---SDLHPMRVLF 211
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 78/315 (24%), Positives = 142/315 (45%), Gaps = 32/315 (10%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLK----MEKEKEGFPITSLREINTLLKAQHPNIVTVR 427
+G++G V A+ K + + A+K LK ++ + +T R ++ L HP + +
Sbjct: 5 KGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILS--LARNHPFLTQL- 61
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI 487
D++F VM++V + LM ++ K + F + ++ +A+ LHD I
Sbjct: 62 -YCCFQTPDRLFFVMEFV--NGGDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHDKGI 117
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTP 547
++RDLK N+LL H G K+ DFG+ +E K + T Y +PE+L Y
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPS 176
Query: 548 IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ--KMTF 605
+D W++G + E LC F +++ + I +E ++P + AV K
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTWLSQDAVDILKAFM 231
Query: 606 AEYP-------NVGGLKTKVAGSILTELGYDLLCKFLTYDPVT-RITADEALRH---DYF 654
+ P +GG + + EL ++ L + P RI + E + + D+
Sbjct: 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFI 291
Query: 655 SESPL--PIDPAMFP 667
E P+ PI+ ++ P
Sbjct: 292 KEDPVLTPIEESLLP 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 89/408 (21%), Positives = 146/408 (35%), Gaps = 64/408 (15%)
Query: 271 AGSEESSQDGSEDSSQDSSSSDEEEN-DENEDKADKKEKKAKKRKKEDASPNESERDVSP 329
+ S G++ S ++ D+ ++ DE D D +E SP
Sbjct: 19 YEAIFSLTGGTDTSDSKDTTGDKFDDCDELGDSDDVTHATDYDADEESLSPQTDVCQEPC 78
Query: 330 HVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDK-RTDE 388
D + ++ + L P +G E F C +E V+ +A +T
Sbjct: 79 ETTSSSDPASVVRMQYNILSSLTPGSEG----EVFVCTKHGDEQRKKVIVKAVTGGKTPG 134
Query: 389 IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD 448
REI+ L H I+ I + +VM + D
Sbjct: 135 ---------------------REIDILKTISHRAII--NLIHAYRWKSTVCMVMPKYKCD 171
Query: 449 MKSLMETMR--SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILK 506
+ + ++ +Q + ++LL A+A+LH I+HRD+KT N+ L
Sbjct: 172 LFTYVDRSGPLPLEQAIT------IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV 225
Query: 507 VGDFGLAREYGSPLKHYTP----IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC 562
+GDFG A + + TP TL SPE LL Y D+WS G + E
Sbjct: 226 LGDFGAACKLDAHP--DTPQCYGWSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSV 282
Query: 563 MEPLFTGK---SDLEQLSRIFKTMGT--------PNEKIWPGFSKLPAVQKMTFAEYPNV 611
GK S QL I + M + + F + V + + P V
Sbjct: 283 KNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYT-IPPV 341
Query: 612 GGLKTKVAGSILT-ELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658
+ + ++ Y L+ K LT+D R +A + L F++ P
Sbjct: 342 ------IRKYGMHMDVEY-LIAKMLTFDQEFRPSAQDILSLPLFTKEP 382
|
Length = 392 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 69/303 (22%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKM--------EKEKEGFPITSLREINTLLKA-QHPN 422
+G YG VY +++A+K++++ EKE E L+E LLK+ +H N
Sbjct: 10 KGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYE-----KLQEEVDLLKSLKHVN 63
Query: 423 IVTVREIVVGSNMDK--IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKC-LMQQLLNA 478
IV +G+ +D I I M++V + S++ +P V C +Q+L+
Sbjct: 64 IVQY----LGTCLDDNTISIFMEFVPGGSISSILNRFGP-----LPEPVFCKYTKQILDG 114
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE------YGSPLKHYTPIVVTLWY 532
VA+LH+N ++HRD+K +N++L GI+K+ DFG AR +G+ + T ++
Sbjct: 115 VAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 533 RSPELLLGCKE--YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590
+PE++ E Y D+WS+GC E +P + +++L+ +F I
Sbjct: 175 MAPEVI---NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF--------YI 220
Query: 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650
+P + + D + LT D R +A + LR
Sbjct: 221 GAHRGLMPRLPDS-------------------FSAAAIDFVTSCLTRDQHERPSALQLLR 261
Query: 651 HDY 653
HD+
Sbjct: 262 HDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 81/351 (23%), Positives = 149/351 (42%), Gaps = 45/351 (12%)
Query: 326 DVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEE---FKCLNRIEEGTYGVVYRAK 382
D+S + D D E + D +P Q R V + + + G+ G V+ A
Sbjct: 27 DISDGDLEYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT 86
Query: 383 DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442
+ V LK G T+L E L HP+++ +++ +V + +V+
Sbjct: 87 KPGQPDPVVLKI--------GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAI--TCMVL 136
Query: 443 DYVEHDMKSLMETMRSKKQVFIP-GEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501
+ D+ + + T RS+ +P + + +Q+L + +LH I+HRD+KT N+ ++
Sbjct: 137 PHYSSDLYTYL-TKRSRP---LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND 192
Query: 502 RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL 561
+ +GD G A+ + + + T+ +PE+L K Y++ D+WS G + E L
Sbjct: 193 VDQVCIGDLGAAQ-FPVVAPAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEML 250
Query: 562 CM------EPLFTG----KSDLEQLSRIFKTMGT--------PNEKIWPGFSKLPAVQKM 603
+P T KS L +I T+ P ++ GF + ++++
Sbjct: 251 AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQ 310
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ YP + + G L K LT+D R +A+E L + F
Sbjct: 311 PYTRYPCFQRVNLPIDGEFLVH-------KMLTFDAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-14
Identities = 48/148 (32%), Positives = 78/148 (52%), Gaps = 4/148 (2%)
Query: 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKT 494
DK+ ++M+Y D+ ++ + F EV L Q++ A+ +H ++HRDLK+
Sbjct: 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 495 SNLLLSHRGILKVGDFGLAREYGS--PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWS 552
+N+ L GI+K+GDFG +++Y L + T +Y +PEL K YS DMWS
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWS 256
Query: 553 VGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
+G I E L + F G S E + ++
Sbjct: 257 LGVILYELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLK-----MEKEKEGFPITSLREINTLLKAQHPNIVTVR 427
G++G V A+ K TDE+ A+K LK + + E +T R + L +HP + +
Sbjct: 6 GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVE-CTMTEKRVLA--LAGKHPFLTQLH 62
Query: 428 EIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQ---VFIPGEVKCLMQQLLNAVAHLH 483
D++F VM+YV D+ ++ + F E+ + + LH
Sbjct: 63 SCF--QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI-------VLGLQFLH 113
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLARE---YGSPLKHY--TPIVVTLWYRSPELL 538
+ I++RDLK N+LL G +K+ DFG+ +E G + TP Y +PE+L
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD-----YIAPEIL 168
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD 572
+ Y +D W++G + E L + F G +
Sbjct: 169 SY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQHPNIVTV 426
+++ G YG VY K+ VA+K LK + E E F L+E + + +HPN+V
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLV-- 65
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLM-QQLLNAVAHLHDN 485
+ + V + +I+ +++ + +L++ +R + + V M Q+ +A+ +L
Sbjct: 66 QLLGVCTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYRSPELLLG 540
+HRDL N L+ ++KV DFGL+R Y + PI T +PE L
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APE-SLA 178
Query: 541 CKEYSTPIDMWSVGCIFAE 559
++S D+W+ G + E
Sbjct: 179 YNKFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 7e-14
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEK--EKEGFPITSLREINTLLKAQHPNIVTVREI 429
+G++G V A+ K TDE+ A+K LK + + + T + L A+HP + +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCC 64
Query: 430 VVGSNMDKIFIVMDYVEHDMKSLM-ETMRSKK-----QVFIPGEVKCLMQQLLNAVAHLH 483
D++F VM+YV + LM + RS+K F EV + LH
Sbjct: 65 F--QTKDRLFFVMEYV--NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALM-------FLH 113
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
+ +++RDLK N+LL G K+ DFG+ +E T T Y +PE+L E
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LE 172
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLF 567
Y +D W++G + E + +P F
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 67/204 (32%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLREINTLLKAQHPNIVT 425
+I +G +G VY+ K E VA+K + K F L+E L + HPNIV
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKF----LQEAEILKQYDHPNIV- 55
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA---HL 482
+ I V I+IVM+ V SL+ +R KK VK L+Q L+A A +L
Sbjct: 56 -KLIGVCVQKQPIYIVMELVPGG--SLLTFLRKKKNRL---TVKKLLQMSLDAAAGMEYL 109
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-------YGSPLKHYTPIVVTLWYRSP 535
+HRDL N L+ +LK+ DFG++RE LK PI T +P
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ-IPIKWT----AP 164
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAE 559
E L Y++ D+WS G + E
Sbjct: 165 E-ALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 52/202 (25%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPN 422
F+ + + GTYG VY+ + +T ++ A+K + + ++E +EIN L K + H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHHRN 64
Query: 423 IVTVREIVVGSNM----DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLLN 477
I T + N D++++VM++ S+ + +++ K + E + + +++L
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFC--GAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
++HLH + ++HRD+K N+LL+ +K+ DFG++ + + + T ++ +PE
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE- 181
Query: 538 LLGCKE-----YSTPIDMWSVG 554
++ C E Y D+WS+G
Sbjct: 182 VIACDENPDATYDFKSDLWSLG 203
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E F L +I +G++G V++ D RT ++VA+K + +E+ ++ +EI L + P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSP 62
Query: 422 NIVTVREIVVGSNMD--KIFIVMDYVEHDMKSLMETMRSKKQVFIPG-----EVKCLMQQ 474
+ GS + K++I+M+Y+ S + PG ++ ++++
Sbjct: 63 YVTKY----YGSYLKDTKLWIIMEYLGGG---------SALDLLEPGPLDETQIATILRE 109
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
+L + +LH +HRD+K +N+LLS G +K+ DFG+A + V T ++ +
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEP 565
PE++ Y + D+WS+G E EP
Sbjct: 170 PEVIKQ-SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 363 EFKCLNRIE---EGTYGVV----YRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINT 414
E + L RI EG +G V Y + T E VA+K LK E G I L +EI
Sbjct: 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEI 59
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETM-RSKKQVFIPGEVKCLMQ 473
L H NIV + I + I ++M+++ SL E + R+K ++ + ++K +Q
Sbjct: 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG--SLKEYLPRNKNKINLKQQLKYAVQ 117
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PI 526
+ + +L +HRDL N+L+ +K+GDFGL + + ++YT P+
Sbjct: 118 -ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL 561
WY +PE L+ K Y D+WS G E L
Sbjct: 177 ---FWY-APECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 82/332 (24%), Positives = 136/332 (40%), Gaps = 95/332 (28%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E+F+ + I G YG VY + K T + A+K K+ K+ N +L+ Q
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMK--KINKQ------------NLILRNQIQ 46
Query: 422 NIVTVREI--------VVG-----SNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGE 467
+ R+I VV + +VM+YVE D +L++ + + +P +
Sbjct: 47 QVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA-----LPVD 101
Query: 468 -VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL-------------- 512
+ + + A+ +LH+ I+HRDLK NLL++ G +K+ DFGL
Sbjct: 102 MARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161
Query: 513 ------AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPL 566
RE+ TP Y +PE++L + Y P+D W++G I EFL
Sbjct: 162 GHIEKDTREFLDKQVCGTP-----EYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVP 215
Query: 567 FTGKSDLEQLSRIFKTMGTPNEKIWP-GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTE 625
F G + E ++ ++ WP G LPA +
Sbjct: 216 FFGDTPEELFGQVIS-----DDIEWPEGDEALPADAQ----------------------- 247
Query: 626 LGYDLLCKFLTYDPVTRI---TADEALRHDYF 654
DL+ + L +P+ R+ A E +H +F
Sbjct: 248 ---DLISRLLRQNPLERLGTGGAFEVKQHRFF 276
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 54/204 (26%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM-EKEKEGFPITSLREINTLLK-AQHP 421
F+ + + GTYG VY+ + +T ++ A+K + + E E+E + EIN L K + H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL----EINMLKKYSHHR 73
Query: 422 NIVT-----VREIVVGSNMDKIFIVMDYVEHDMKSLMETMR-SKKQVFIPGEVKCLMQQL 475
NI T +++ G + D++++VM++ S+ + ++ +K + + +++
Sbjct: 74 NIATYYGAFIKKSPPGHD-DQLWLVMEFC--GAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
L +AHLH + ++HRD+K N+LL+ +K+ DFG++ + + + T ++ +P
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
Query: 536 ELLLGCKE-----YSTPIDMWSVG 554
E ++ C E Y D+WS+G
Sbjct: 191 E-VIACDENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 372 EGTYGVV----YRAKDKRTDEIVALKRLKME---KEKEGFPITSLREINTLLKAQHPNIV 424
EG +G V Y + T E+VA+K LK E + G+ +EIN L H NIV
Sbjct: 14 EGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGW----KKEINILKTLYHENIV 69
Query: 425 TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD 484
+ + ++M+YV + SL + + K ++ QQ+ +A+LH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVP--LGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY-------TPIVVTLWYRSPEL 537
+HRDL N+LL + ++K+GDFGLA+ ++Y +P+ WY + E
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FWY-AVEC 181
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFL 561
L K +S D+WS G E L
Sbjct: 182 LKENK-FSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 26/207 (12%)
Query: 360 SVEEFKCLNRIEEGTYGVV----YRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTL 415
+++E K L I +G +G V YR VA+K +K + + F L E + +
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYRGNK------VAVKCIKNDATAQAF----LAEASVM 53
Query: 416 LKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
+ +H N+V + ++V ++IV +Y+ SL++ +RS+ + + G+ CL++
Sbjct: 54 TQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKG--SLVDYLRSRGRSVLGGD--CLLKFS 108
Query: 476 LN---AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWY 532
L+ A+ +L N +HRDL N+L+S + KV DFGL +E S T + W
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVKW- 165
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAE 559
+PE L K++ST D+WS G + E
Sbjct: 166 TAPEALRE-KKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++ L + G +GVV K + ++ +KM KE + E ++K H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVA----IKMIKEGSMSEDEFIEEAKVMMKLSHE 59
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
+V + V + I+IV +Y+ + L+ +R + F P ++ + + + +A+
Sbjct: 60 KLVQLYG--VCTKQRPIYIVTEYMSNG--CLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYRSPE 536
L +HRDL N L+ +G +KV DFGL+R EY S + P+ + PE
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPE 171
Query: 537 LLLGCKEYSTPIDMWSVGCIFAE 559
+LL K +S+ D+W+ G + E
Sbjct: 172 VLLYSK-FSSKSDVWAFGVLMWE 193
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 25/232 (10%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKM-----EKEKEGFPITSLR-EINTLLKAQHPNIVTV 426
G +G VY D T +A+K++ E KE + +L EI L +H IV
Sbjct: 13 GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE---VNALECEIQLLKNLRHDRIVQY 69
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
+ K+ I ++Y+ S+ + +++ + +Q+L V++LH N
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGG--SIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM 126
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREY------GSPLKHYTPIVVTLWYRSPELLLG 540
I+HRD+K +N+L G +K+GDFG ++ G+ +K T T ++ SPE++ G
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG---TPYWMSPEVISG 183
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592
+ Y D+WSV C E L +P + ++ E ++ IFK P + + P
Sbjct: 184 -EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 10/219 (4%)
Query: 372 EGTYGVVYRAKDKR---TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
+G++G V+ + ++ A+K LK K + + E + L + HP IV +
Sbjct: 6 QGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHY 65
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWIL 488
K+++++D++ + T SK+ +F +VK + +L A+ HLH I+
Sbjct: 66 AF--QTEGKLYLILDFLR---GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 489 HRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPI 548
+RDLK N+LL G +K+ DFGL++E K T+ Y +PE ++ + ++
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSA 179
Query: 549 DMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT-MGTP 586
D WS G + E L F GK E ++ I K +G P
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 28/231 (12%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLK-----MEKEKEGFPITSLREINTLLKAQHPNIVTV 426
+G++G V A+ K E A+K LK ++ + E T + + L ++P + +
Sbjct: 5 KGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVE---CTMVEKRVLALAWENPFLTHL 61
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK------KQVFIPGEVKCLMQQLLNAVA 480
+ +F VM+++ + LM ++ K + F E+ C +Q
Sbjct: 62 --YCTFQTKEHLFFVMEFL--NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQ------- 110
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
LH I++RDLK N++L G +K+ DFG+ +E + T Y +PE+L G
Sbjct: 111 FLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591
K Y+ +D WS G + E L + F G + E I + TP+ W
Sbjct: 171 LK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPRW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR------EINTLLKAQHPNIVT 425
+G +G VY D T +A K+++ + E P TS EI L QH IV
Sbjct: 12 QGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 426 VREIVVGSNMDKIFIVMDY-----VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
+ + I M+Y V+ +K+ S + + +Q+L ++
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY--------TRQILEGMS 120
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT---PIVVTLWYRSPEL 537
+LH N I+HRD+K +N+L G +K+GDFG ++ + T + T ++ SPE+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592
+ G + Y D+WS+GC E L +P + ++ E ++ IFK P P
Sbjct: 181 ISG-EGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-13
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREI 429
I +GT+G VY+ + K T I A+K L S +EI + K + + + R I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------------SKKEI--VAKKEVAHTIGERNI 46
Query: 430 VVGSNMDKI-FIV---------MD-YVEHDMKSLMETM--RSKKQVFIPGEVKCLMQQLL 476
+V + +D+ FIV D Y+ D S E K+ F K + +L+
Sbjct: 47 LVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELV 106
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
A+ HLH I++RDLK N+LL G + + DFGL++ + K T Y +PE
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLC 562
+LL K Y+ +D WS+G + E C
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 23/200 (11%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKME----KEKEGFPITSLREINTLLKAQHPNIVTVR 427
+GT+G V ++K T + A+K LK E K++ +T R L +HP + ++
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR---VLQNTRHPFLTALK 61
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI 487
D++ VM+Y + S+++VF + ++++A+ +LH +
Sbjct: 62 YSF--QTHDRLCFVMEYAN---GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLARE---YGSPLKHY--TPIVVTLWYRSPELLLGCK 542
++RDLK NL+L G +K+ DFGL +E G+ +K + TP Y +PE+L
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-----EYLAPEVLED-N 170
Query: 543 EYSTPIDMWSVGCIFAEFLC 562
+Y +D W +G + E +C
Sbjct: 171 DYGRAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ 419
S+ E + +NRI G G VY+ + T + ALK + E + REI L
Sbjct: 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVN 130
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
HPN+V ++ + +I ++++++ D SL E + F+ + +Q+L+ +
Sbjct: 131 HPNVVKCHDMF--DHNGEIQVLLEFM--DGGSL-EGTHIADEQFLAD----VARQILSGI 181
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL- 538
A+LH I+HRD+K SNLL++ +K+ DFG++R + V T+ Y SPE +
Sbjct: 182 AYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241
Query: 539 --LGCKEYSTPI-DMWSVGCIFAEF 560
L Y D+WS+G EF
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEF 266
|
Length = 353 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
E K ++ G +G V+ T + VA+K LK M E F L+E + K
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPE--AF----LQEAQIMKKL 58
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK--KQVFIPGEVKCLMQQLL 476
+H +V + + S + I+IV +Y+ SL++ ++S K++ +P V + Q+
Sbjct: 59 RHDKLVQLYAVC--SEEEPIYIVTEYMSKG--SLLDFLKSGEGKKLRLPQLVD-MAAQIA 113
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLW 531
+A+L +HRDL N+L+ + K+ DFGLAR EY + PI T
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT-- 171
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFL----CMEPLFTGKSDLEQLSR 578
+PE ++ D+WS G + E + P T + LEQ+ R
Sbjct: 172 --APEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEK--EKEGFPITSLREINTLLKAQHPNIVTVREI 429
+G++G V A+ K T+E A+K LK + E + T + L +HP + +
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL--F 62
Query: 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQV------FIPGEVKCLMQQLLNAVAHLH 483
+ +F VM+Y+ + LM ++S + F E+ C +Q LH
Sbjct: 63 CTFQTKEHLFFVMEYL--NGGDLMFHIQSSGRFDEARARFYAAEIICGLQ-------FLH 113
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
I++RDLK N+LL G +K+ DFG+ +E + + T Y +PE+L G K
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK- 172
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576
Y+ +D WS G + E L + F G+ D ++L
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGE-DEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 12/215 (5%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLREINTLLK-AQHPNIVT 425
I +G++G V A+ K ++ A+K L+ + K+KE I S R N LLK +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSER--NVLLKNVKHPFLVG 60
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+ DK++ V+DY+ + L ++ +++ F+ + ++ +A+ +LH
Sbjct: 61 LH--FSFQTADKLYFVLDYI--NGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHSL 115
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYS 545
I++RDLK N+LL +G + + DFGL +E + T Y +PE+L + Y
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYD 174
Query: 546 TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
+D W +G + E L P F ++ E I
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 369 RIEEGTYGVVYRA--KDKRTDEI-VALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVT 425
++ +G++GVV R I VA+K LK +K + L+E + H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIR 60
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ-QLLNAVAHLHD 484
+ +V+ + +V + + SL++ +R C Q+ N + +L
Sbjct: 61 LYGVVLT---HPLMMVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP---IVVTLWYRSPELLLGC 541
+HRDL N+LL+ +K+GDFGL R HY + V + +PE L
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLRT 174
Query: 542 KEYSTPIDMWSVG-CIFAEF-LCMEPLFTGKSDLEQLSRI 579
+ +S D+W G ++ F EP + G S + L +I
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP-WAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 72/242 (29%), Positives = 120/242 (49%), Gaps = 31/242 (12%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLREINTLLKAQ 419
+F+ + G++G V AK K T E A+K LK K K+ + +E + L++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHV--AQEKSILMELS 76
Query: 420 HPNIVTVREIVVGSNMD--KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEV-KCLMQQLL 476
HP IV + + S D +++ ++++V + + T K F P +V K +L+
Sbjct: 77 HPFIVNM----MCSFQDENRVYFLLEFV---VGGELFTHLRKAGRF-PNDVAKFYHAELV 128
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
A +LH I++RDLK NLLL ++G +KV DFG A++ P + +T + T Y +PE
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV--PDRTFT-LCGTPEYLAPE 185
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
++ K + +D W++G + EF+ P F + RI+ EKI G K
Sbjct: 186 VIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIY-------EKILAGRLK 233
Query: 597 LP 598
P
Sbjct: 234 FP 235
|
Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 65/258 (25%), Positives = 123/258 (47%), Gaps = 31/258 (12%)
Query: 348 LPPYLPAIQGCRSVEE----FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK----MEK 399
L PY ++ G S+ + ++ + I +GTYG VY+ +K+ + A+K L +++
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE 63
Query: 400 EKEGFPITSLREINTLLK-AQHPNIVTVREIVVGSNM---DKIFIVMDYVEH-DMKSLME 454
E E E N L HPN+V + ++ ++++V++ + L++
Sbjct: 64 EIEA-------EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK 116
Query: 455 TMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514
+ Q + ++ L + HLH+N I+HRD+K +N+LL+ G +K+ DFG++
Sbjct: 117 GLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKE-----YSTPIDMWSVGCIFAEFLCME-PLFT 568
+ S V T ++ +PE ++ C++ Y D+WS+G E + PLF
Sbjct: 177 QLTSTRLRRNTSVGTPFWMAPE-VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF- 234
Query: 569 GKSDLEQLSRIFKTMGTP 586
D+ + +FK P
Sbjct: 235 ---DMHPVKTLFKIPRNP 249
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 80/325 (24%), Positives = 136/325 (41%), Gaps = 61/325 (18%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
F L G G + D +T E V +K ++ LR IN HP+I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIK--AGQRGGTATEAHILRAIN------HPSI 145
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-GEVKCLMQQLLNAVAHL 482
+ ++ + +++ + D+ + R+ I ++ + + +L A+ +L
Sbjct: 146 IQLKGTFTYNKF--TCLILPRYKTDLYCYLAAKRN-----IAICDILAIERSVLRAIQYL 198
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLA---------REYGSPLKHYTPIVVTLWYR 533
H+N I+HRD+K N+ ++H G + +GDFG A + YG T+
Sbjct: 199 HENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG--------WAGTIATN 250
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEF-LCMEPLFT-----GKSDLE-QLSRIFKTMGT- 585
+PE LL Y +D+WS G + E C + LF G D + Q+ I + GT
Sbjct: 251 APE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309
Query: 586 PNE----------KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFL 635
PNE +I+ G +K + + + + N+ L +L Y L+CK L
Sbjct: 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELP--------IDLEY-LICKML 360
Query: 636 TYDPVTRITADEALRHDYFSESPLP 660
+D R +A+ L F + P P
Sbjct: 361 AFDAHHRPSAEALLDFAAFQDIPDP 385
|
Length = 391 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLREINTLLKA-QHPNIVT 425
I +G++G V AK K A+K L+ + K+KE I + R N LLK +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAER--NVLLKNLKHPFLVG 60
Query: 426 VREIVVGSNMDKIFIVMDYVE------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
+ +K++ V+DYV H + + F EV A+
Sbjct: 61 LHYSF--QTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVAS-------AI 109
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+LH I++RDLK N+LL +G + + DFGL +E P + + T Y +PE+L
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR 169
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576
+ Y +D W +G + E L P F + D+ Q+
Sbjct: 170 K-EPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLK-----MEKEKEGFPITSLREINTL-LKAQHPNIVT 425
+G++G V+ A+ K T++ A+K LK M+ + E ++ E L L +HP +
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVE----CTMVEKRVLSLAWEHPFLTH 60
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRS------KKQVFIPGEVKCLMQQLLNAV 479
+ + +F VM+Y+ + LM ++S + F E+ C +Q
Sbjct: 61 L--YCTFQTKENLFFVMEYL--NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQ------ 110
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
LH I++RDLK N+LL G +K+ DFG+ +E T Y +PE+LL
Sbjct: 111 -FLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
G K Y+T +D WS G + E L + F G + E I
Sbjct: 170 GQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-12
Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKME----KEKEGFPITSLREINTLLKAQHPNIVTVR 427
+GT+G V ++K + + A+K LK E K++ +T R L +HP + +++
Sbjct: 5 KGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESR---VLKNTRHPFLTSLK 61
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI 487
D++ VM+YV + S+++VF + ++++A+ +LH I
Sbjct: 62 YSF--QTKDRLCFVMEYVN---GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTP 547
++RDLK NL+L G +K+ DFGL +E + T Y +PE+L +Y
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRA 175
Query: 548 IDMWSVGCIFAEFLC 562
+D W +G + E +C
Sbjct: 176 VDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 363 EFKCLNRIEEGTYGVVY---RAKDKRTDEIVALKRLK----MEKEKEGFPITSLREINTL 415
F+ L + G YG V+ + T ++ A+K L+ ++K K + R +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 416 LKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
++ Q P +VT+ K+ +++DYV M T ++ F EV+ ++
Sbjct: 61 VR-QSPFLVTLHYAF--QTEAKLHLILDYVS---GGEMFTHLYQRDNFSEDEVRFYSGEI 114
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-PIVVTLWYRS 534
+ A+ HLH I++RD+K N+LL G + + DFGL++E+ S K T T+ Y +
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT 568
PE++ G + +D WS+G + E L FT
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 6e-12
Identities = 84/347 (24%), Positives = 143/347 (41%), Gaps = 40/347 (11%)
Query: 361 VEEFKCLNRIEEGTYGVVY--------------RAKDKRTDEIVALKRLKMEKEKEGFPI 406
+ F+ ++ + G +G ++ R + +RL ++ K G
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 407 TSL--REINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLM--ETMRSKKQV 462
EI L + H NI+ + EI+ + +++ + D+ S M E K +
Sbjct: 207 AIQLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRP 264
Query: 463 FIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522
+ + + +M+QLL AV ++HD ++HRD+K N+ L+ G + +GDFG A + +
Sbjct: 265 LL-KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 523 YT-PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME--PLF-TGKSDLEQLSR 578
+ V T+ SPE+L G Y D+WS G I + L + P+ G +QL +
Sbjct: 324 FDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382
Query: 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDL-----LCK 633
I ++ +E+ KL + AE + G ++ LG L K
Sbjct: 383 IIDSLSVCDEEFPDPPCKL--FDYIDSAEIDHAG----HSVPPLIRNLGLPADFEYPLVK 436
Query: 634 FLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKA 680
LT+D R A E L FS + + KS AH K
Sbjct: 437 MLTFDWHLRPGAAELLALPLFSAE---EEEEILFIHGLKSGAAHFKP 480
|
Length = 501 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 21/224 (9%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM-EKEKEGFPITSLREINTLLKAQHP 421
E + + G +GVV+ K R VA+K + +E F + E ++K HP
Sbjct: 5 ELTFMKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDF----IEEAKVMMKLSHP 59
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
+V + V + ++IV +++E+ L+ +R ++ + + Q + + +
Sbjct: 60 KLVQLYG--VCTQQKPLYIVTEFMENG--CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEY 115
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYRSPE 536
L N +HRDL N L+S G++KV DFG+ R EY S P+ + PE
Sbjct: 116 LERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----WSPPE 171
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPL-FTGKSDLEQLSRI 579
+ K YS+ D+WS G + E + F KS+ E + I
Sbjct: 172 VFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRL--KMEKEKEGFPITSLREINTLLKAQHPNIVTVR 427
+ +G +G V + K T ++ A K+L K K+++G + +L E L K IV++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQM-ALNEKKILEKVSSRFIVSLA 59
Query: 428 EIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSK-----KQVFIPGEVKCLMQQLLNAVAH 481
D + +VM + D+K + + + +F ++ C ++ H
Sbjct: 60 YAF--ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE-------H 110
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY--GSPLKHYTPIVVTLWYRSPELLL 539
LH I++RDLK N+LL G +++ D GLA E G +K T Y +PE+L
Sbjct: 111 LHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQ 167
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTG---KSDLEQLSRIFKTM 583
G + Y +D +++GC E + F K + E+L R M
Sbjct: 168 G-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 63/237 (26%), Positives = 109/237 (45%), Gaps = 28/237 (11%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDE-----IVALKRLKMEKEKEGFPITSLREINT 414
+++E L R G +G V+ AK K +E +V +K L+ K+ E RE++
Sbjct: 6 NLQEITTLGR---GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDM 61
Query: 415 LLKAQHPNIVT----VREIVVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPG--- 466
K H N+V RE + +++++Y + D+K + +SK + P
Sbjct: 62 FRKLSHKNVVRLLGLCRE------AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 467 --EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHY 523
+ L Q+ + HL + +HRDL N L+S + +KV L+++ Y S
Sbjct: 116 TKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL 175
Query: 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPL-FTGKSDLEQLSRI 579
++ L + +PE + ++ST D+WS G + E L F G SD E L+R+
Sbjct: 176 RNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 24/34 (70%), Positives = 28/34 (82%)
Query: 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
CRSV EF+ LNRI EGTYG+VYRA+D + EIVA
Sbjct: 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA 36
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-11
Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 386 TDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDY 444
T VA+K L+ + +E RE + HPNIV + + +F V +Y
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEY 60
Query: 445 VEHDMKSLMETMRSKKQ---VFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501
V T+R GE LM Q+L+A+A H+ I+HRDLK N+++S
Sbjct: 61 VPG------RTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 502 RGI---LKVGDFGL------AREYG-SPLKHYTPIVVTLWYRSPELLLGCKEYSTP-IDM 550
G+ KV DFG+ R+ + L T ++ T Y +PE L G E TP D+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG--EPVTPNSDL 172
Query: 551 WSVGCIFAEFLCMEPLFTGKSDLEQLSR 578
++ G IF E L + + G S E L +
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 36/204 (17%)
Query: 368 NRIEEGTYGVV----YRAKDKRTDEIVALKRLKMEKEKEG---FPITSLREINTLLKAQH 420
+ G +G V Y K + E VA+K LK E G F LRE + + + H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVE-VAVKTLKQEHIAAGKKEF----LREASVMAQLDH 55
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
P IV + + G + + +VM+ + L++ ++ K++ ++K L Q+ +A
Sbjct: 56 PCIVRLIGVCKG---EPLMLVMELAP--LGPLLKYLK-KRREIPVSDLKELAHQVAMGMA 109
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIVVTLWYR 533
+L +HRDL N+LL +R K+ DFG++R G+ +Y P+ WY
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK---WY- 165
Query: 534 SPELLLGCKEY---STPIDMWSVG 554
+PE C Y S+ D+WS G
Sbjct: 166 APE----CINYGKFSSKSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLREINTLLK-AQHPNIVT 425
I +G++G V AK K + A+K L+ + KE I + R N LLK +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAER--NVLLKNVKHPFLVG 60
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+ +K++ V+D+V + L ++ +++ F + ++ +A+ +LH
Sbjct: 61 LHYSF--QTTEKLYFVLDFV--NGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSI 115
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYS 545
I++RDLK N+LL +G + + DFGL +E + T T Y +PE++ + Y
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYD 174
Query: 546 TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
+D W +G + E L P F + E I
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA 418
R EEF ++ G +G V+ K VA+K LK + + E+ L +
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQK--EVQALKRL 59
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLN 477
+H +++++ + + ++I+ + +E SL+ +RS + QV + + Q+
Sbjct: 60 RHKHLISLFAVCSVG--EPVYIITELMEKG--SLLAFLRSPEGQVLPVASLIDMACQVAE 115
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR--SP 535
+A+L + +HRDL N+L+ + KV DFGLAR + Y + Y+ +P
Sbjct: 116 GMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAP 173
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAE 559
E +ST D+WS G + E
Sbjct: 174 E-AASHGTFSTKSDVWSFGILLYE 196
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME------------KEKEGFPITSLR 410
+F L + +G++G V A+ K TDE+ A+K LK + EK + +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKR---VLALP 57
Query: 411 EINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD--MKSLMETMRSKK--QVFIPG 466
L H T MD+++ VM+YV M + + + K+ VF
Sbjct: 58 GKPPFLTQLHSCFQT---------MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAA 108
Query: 467 EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526
E+ + LH I++RDLK N++L G +K+ DFG+ +E K
Sbjct: 109 EIAI-------GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF 161
Query: 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
T Y +PE++ + Y +D W+ G + E L +P F G+ + E I
Sbjct: 162 CGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 12/208 (5%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK--AQHPNIVTVR 427
I G+Y V + K+T+ I A+K +K E + I ++ + + + HP +V +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAVAHLHDNW 486
++F V++YV + LM M+ +++ +P E + ++ A+ +LH+
Sbjct: 63 SCF--QTESRLFFVIEYV--NGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERG 116
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST 546
I++RDLK N+LL G +K+ D+G+ +E P + T Y +PE+L G ++Y
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGF 175
Query: 547 PIDMWSVGCIFAEFLCMEPLF--TGKSD 572
+D W++G + E + F G SD
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 79/306 (25%), Positives = 121/306 (39%), Gaps = 50/306 (16%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKA 418
E+F + I G +G V + K + ++ A+K L K E K E + + A
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 419 QHPNIVTVREIVVGSNMDK-IFIVMDYVEH-DMKSLMET--MRSKKQVFIPGEVKCLMQQ 474
IV ++ DK +++VM+Y+ D+ +LM + K F EV
Sbjct: 101 NSEWIV---QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEV------ 151
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP-LKHYTPIVVTLWYR 533
+ A+ +H +HRD+K N+LL G LK+ DFG + + + V T Y
Sbjct: 152 -VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210
Query: 534 SPELLL---GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590
SPE+L G Y D WSVG E L + F S + S+I + K
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM------DHK- 263
Query: 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEA 648
+TF + + ++ DL+C FLT V R DE
Sbjct: 264 ----------NSLTFPDDIEI------------SKQAKDLICAFLTDREVRLGRNGVDEI 301
Query: 649 LRHDYF 654
H +F
Sbjct: 302 KSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
+G +G V++ K VA+K K + +E I L E L + HPNIV + I V
Sbjct: 5 KGNFGEVFKGTLKDKTP-VAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIVKL--IGV 60
Query: 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA---VAHLHDNWIL 488
+ I+IVM+ V + +R KK + K L++ L+A +A+L +
Sbjct: 61 CTQRQPIYIVMELVPGG--DFLSFLRKKKDEL---KTKQLVKFALDAAAGMAYLESKNCI 115
Query: 489 HRDLKTSNLLLSHRGILKVGDFGLARE-----YGSPLKHYTPIVVTLWYRSPELLLGCKE 543
HRDL N L+ +LK+ DFG++R+ Y S PI T +PE L
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APE-ALNYGR 170
Query: 544 YSTPIDMWSVGCI----FAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE 588
YS+ D+WS G + F+ +C P T + EQ+ + ++ M P +
Sbjct: 171 YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-MSCPQK 218
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/243 (23%), Positives = 110/243 (45%), Gaps = 15/243 (6%)
Query: 364 FKCLNRIEEGTYGVVY---RAKDKRTDEIVALKRLK----MEKEKEGFPITSLREINTLL 416
F+ L + G YG V+ + ++ A+K LK ++K K + R++ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+ + P +VT+ K+ +++DYV + T +++ F EV+ + +++
Sbjct: 62 R-RCPFLVTLHYAFQTDT--KLHLILDYVN---GGELFTHLYQREHFTESEVRVYIAEIV 115
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-PIVVTLWYRSP 535
A+ HLH I++RD+K N+LL G + + DFGL++E+ + + T+ Y +P
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 536 ELLLGCKE-YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
E++ G + +D WS+G + E L FT + S I + +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTM 235
Query: 595 SKL 597
S
Sbjct: 236 SAE 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 26/230 (11%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK--EKEGFPITSLREINTLLKAQH 420
+F L + +G++G V A+ K TDE+ A+K LK + + + T + + L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHD--MKSLMETMRSKK--QVFIPGEVKCLMQQLL 476
P + + MD+++ VM+YV M + + R K+ VF E+
Sbjct: 61 PFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------ 112
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY---GSPLKHY--TPIVVTLW 531
+ LH I++RDLK N++L G +K+ DFG+ +E G K + TP
Sbjct: 113 -GLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD----- 166
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
Y +PE ++ + Y +D W+ G + E L + F G+ + E I +
Sbjct: 167 YIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 372 EGTYGVVYRAK---DKRTDEIVALKRLKMEKEKEGFPIT--SLREINTLLKAQHPNIVTV 426
+G YG V++ + T +I A+K LK T + E N L +HP IV
Sbjct: 6 KGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV-- 63
Query: 427 REIVVGSNMD-KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+++ K++++++Y+ + M R + +F+ + ++ A+ HLH
Sbjct: 64 -DLIYAFQTGGKLYLILEYLSGG-ELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLARE--YGSPLKHYTPIVVTLWYRSPELLLGCKE 543
I++RDLK N+LL +G +K+ DFGL +E + + H T+ Y +PE+L+
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH--TFCGTIEYMAPEILMRSG- 176
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
+ +D WS+G + + L P FT ++ + + +I K
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKME----KEKEGFPITSLREINTLLKAQHPNIVTVR 427
+GT+G V ++K T A+K L+ E K++ +T R L +HP + ++
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR---VLQNTRHPFLTALK 61
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI 487
D++ VM+Y + S+++VF + ++++A+ +LH +
Sbjct: 62 YAF--QTHDRLCFVMEYAN---GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTP 547
++RD+K NL+L G +K+ DFGL +E S T Y +PE+L +Y
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRA 175
Query: 548 IDMWSVGCIFAEFLC 562
+D W +G + E +C
Sbjct: 176 VDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS--LREINTLLKAQ 419
E + I G +G+V+ + VA+K ++ EG + E ++K
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIR-----EGAMSEEDFIEEAQVMMKLS 57
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
HP +V + + + I +V +++EH L + +R+++ F + + + +
Sbjct: 58 HPKLVQLYGVCTERS--PICLVFEFMEHG--CLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYRS 534
A+L + ++HRDL N L+ ++KV DFG+ R +Y S P+ + S
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSS 169
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAE 559
PE+ K YS+ D+WS G + E
Sbjct: 170 PEVFSFSK-YSSKSDVWSFGVLMWE 193
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
RI G +G V+ + + + VA+K + E L+E L + HPNIV R
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIV--RL 58
Query: 429 IVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA---HLHD 484
I V + I+IVM+ V+ D + + T + +V K L+Q + NA A +L
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV------KELIQMVENAAAGMEYLES 112
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV--VTLWYRSPELLLGCK 542
+HRDL N L++ + +LK+ DFG++RE + T + + + + +PE L
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYG 171
Query: 543 EYSTPIDMWSVGCIFAE 559
YS+ D+WS G + E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
I EG +G V + + T + VA+K +K + + F L E + K H N+V +
Sbjct: 13 IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAF----LEETAVMTKLHHKNLVRLLG 66
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN---AVAHLHDN 485
+++ + + +IVM+ + +L+ +R++ + + V L+Q L+ + +L
Sbjct: 67 VILHNGL---YIVMELMSKG--NLVNFLRTRGRALVS--VIQLLQFSLDVAEGMEYLESK 119
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYS 545
++HRDL N+L+S G+ KV DFGLAR + + W +PE L K++S
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPVKW-TAPEALKH-KKFS 175
Query: 546 TPIDMWSVGCIFAE 559
+ D+WS G + E
Sbjct: 176 SKSDVWSYGVLLWE 189
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 48/221 (21%)
Query: 370 IEEGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHP 421
+ EG +G V+ + + E+VA+K LK ++ F RE L QH
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDF----EREAELLTNFQHE 68
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEH-DMKSL----------METMRSKKQVFIPGEVKC 470
NIV + D +V +Y+EH D+ +++ S ++
Sbjct: 69 NIVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 471 LMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL 530
+ Q+ + + +L +HRDL T N L+ + ++K+GDFG++R+ + T
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD----------VYTTD 176
Query: 531 WYR------------SPELLLGCKEYSTPIDMWSVGCIFAE 559
+YR PE ++ ++++T D+WS G + E
Sbjct: 177 YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWE 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 61/243 (25%), Positives = 112/243 (46%), Gaps = 47/243 (19%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ 419
+ + + L I GT G VY+ + K+T ++A+K+++ KE L +++ +LK+
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK-RILMDLDVVLKSH 71
Query: 420 H-PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ-QLLN 477
P IV + ++ D +FI M+ M + ++ + + Q IP ++ M ++
Sbjct: 72 DCPYIVKCYGYFI-TDSD-VFICMEL----MSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 478 AVAHLHDNW-ILHRDLKTSNLLLSHRGILKVGDFGLA----------REYGSPLKHYTPI 526
A+ +L + ++HRD+K SN+LL G +K+ DFG++ R G
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA------ 179
Query: 527 VVTLWYRSPELL---LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG-------KSDLEQL 576
Y +PE + +Y D+WS+G E L TG K++ E L
Sbjct: 180 -----YMAPERIDPPDPNPKYDIRADVWSLGISLVE------LATGQFPYKNCKTEFEVL 228
Query: 577 SRI 579
++I
Sbjct: 229 TKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/236 (25%), Positives = 112/236 (47%), Gaps = 27/236 (11%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLK----MEKEKEGFPITSLREINTLLKA--QHPNI 423
I +GTYG V++ +K+ A+K L +++E E E N +LKA HPN+
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA-------EYN-ILKALSDHPNV 77
Query: 424 VTVREIVVGS---NMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
V + N D++++V++ + L++ + + + ++ + L +
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
HLH N +HRD+K +N+LL+ G +K+ DFG++ + S V T ++ +PE ++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE-VI 196
Query: 540 GCKE-----YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590
C++ Y D+WS+G E +P +DL + +FK P +
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNPPPTL 249
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 77/312 (24%), Positives = 135/312 (43%), Gaps = 26/312 (8%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREI 429
I G+Y V + K+ D+I A+K +K E + I ++ + + N V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAVAHLHDNWIL 488
++F+V++YV + LM M+ +++ +P E + ++ A+ LH+ I+
Sbjct: 63 SCFQTTSRLFLVIEYV--NGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGII 118
Query: 489 HRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPI 548
+RDLK N+LL G +K+ D+G+ +E P + T Y +PE+L G +EY +
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSV 177
Query: 549 DMWSVGCIFAEFLCMEPLFTGKSD--------------LEQLSRIFKTMGTPNEKIWPGF 594
D W++G + E + F +D LE+ RI + + + GF
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT-RITADEALRH-- 651
L K P G K + + + +DLL K P +IT D L +
Sbjct: 238 --LNKDPKERLGCQPQTGFSDIK-SHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFD 294
Query: 652 DYFSESPLPIDP 663
F+ P+ + P
Sbjct: 295 TQFTSEPVQLTP 306
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALK-----RLKMEKEKEGFPITSLREINTLLKAQHPNIV 424
I G +G VY + T ++ A+K R+KM K+ E + ++ + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60
Query: 425 TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD 484
+ DK+ ++D + + S+ VF E++ +++ + H+H+
Sbjct: 61 CM--TYAFHTPDKLCFILDLMN---GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEY 544
++++RDLK +N+LL G +++ D GLA ++ H + V T Y +PE+L Y
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGTAY 173
Query: 545 STPIDMWSVGCIFAEFL 561
+ D +S+GC+ + L
Sbjct: 174 DSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 36/235 (15%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK------------EKEGFPITSLR 410
+F L + +G++G V A+ K TDE+ A+K LK + EK + +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKR---VLALQ 57
Query: 411 EINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETM---RSKKQVFIPG 466
+ L H TV D+++ VM+YV D+ ++ + + + VF
Sbjct: 58 DKPPFLTQLHSCFQTV---------DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA 108
Query: 467 EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526
E+ + LH I++RDLK N++L G +K+ DFG+ +E+
Sbjct: 109 EISV-------GLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF 161
Query: 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
T Y +PE ++ + Y +D W+ G + E L +P F G+ + E I +
Sbjct: 162 CGTPDYIAPE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 7/213 (3%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT-SLREINTLLKAQHPNIVTVRE 428
I +G++G V + + + T I ALK ++ +T +L E L + P IV ++
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWIL 488
+ +K+++V+ ++ + L ++ ++ F + +LL A+ +LH ++
Sbjct: 60 -FSFQSPEKLYLVLAFI--NGGELFHHLQ-REGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 489 HRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPI 548
+RDLK N+LL ++G + + DFGL + T Y +PELLLG Y+ +
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAV 174
Query: 549 DMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
D W++G + E L P F ++ E +I +
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 32/212 (15%)
Query: 369 RIEE----GTYGVVYRAKDK---RTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
+IEE G +G V R + K + + VA+K LK EK++ F L E + + +
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDF----LSEASIMGQF 62
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HPNI+ + +V S + I+ +++E+ +L +R F ++ +++ +
Sbjct: 63 DHPNIIHLEGVVTKSR--PVMIITEFMENG--ALDSFLRQNDGQFTVIQLVGMLRGIAAG 118
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR---------EYGSPLKHYTPIVVT 529
+ +L + +HRDL N+L++ + KV DFGL+R Y S L PI T
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 530 LWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL 561
+PE + +++++ D+WS G + E +
Sbjct: 179 ----APE-AIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 14/226 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKAQH 420
++F+ + I G +G V K K T+ I A+K L K E K E N L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 421 PNIVTVREIVVGSNMDKIFIVMDY-VEHDMKSLMETMRSKKQVFIPGEV-KCLMQQLLNA 478
I T+ N +++VMDY V D+ +L+ + +P ++ + + +++ A
Sbjct: 61 QWITTLHYAFQDENY--LYLVMDYYVGGDLLTLLSKFEDR----LPEDMARFYIAEMVLA 114
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV-TLWYRSPEL 537
+ +H +HRD+K N+LL G +++ DFG + + + V T Y SPE+
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 538 LL----GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
L G +Y D WS+G E L E F +S +E +I
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 54/214 (25%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 364 FKCLNRIEEGTYGVVY---RAKDKRTDEIVALKRLK----MEKEKEGFPITSLREINTLL 416
F+ L + G YG V+ + + ++ A+K LK ++K K + R++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+ Q P +VT+ K+ +++DY+ + T S+++ F EV+ +++
Sbjct: 62 R-QSPFLVTLHYAF--QTDTKLHLILDYIN---GGELFTHLSQRERFKEQEVQIYSGEIV 115
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-GSPLKHYTPIVVTLWYRSP 535
A+ HLH I++RD+K N+LL G + + DFGL++E+ ++ T+ Y +P
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 536 ELLLGCKE-YSTPIDMWSVGCIFAEFLCMEPLFT 568
+++ G + +D WS+G + E L FT
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA--QHPNIVTVR 427
I G+Y V + K+T I A+K +K E + I ++ + + HP +V +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAVAHLHDNW 486
++F V+++V LM M+ +++ +P E + ++ A+ LH+
Sbjct: 63 SCF--QTESRLFFVIEFVSGG--DLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERG 116
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST 546
I++RDLK N+LL G +K+ D+G+ +E P + T Y +PE+L G ++Y
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGF 175
Query: 547 PIDMWSVGCIFAEFL 561
+D W++G + E +
Sbjct: 176 SVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++ + + G G VY+A T I+A+K + ++ E + E+ L K P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSP 59
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
I+ N +I I +++ D SL + + V G + ++ + +
Sbjct: 60 YIIGFYGAFFVEN--RISICTEFM--DGGSLDVYRKIPEHVL--GRIAV---AVVKGLTY 110
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-GSPLKHYTPIVVTLWYRSPELLLG 540
L ILHRD+K SN+L++ RG +K+ DFG++ + S K Y V T Y +PE + G
Sbjct: 111 LWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISG 167
Query: 541 CKEYSTPIDMWSVGCIFAE 559
++Y D+WS+G F E
Sbjct: 168 -EQYGIHSDVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKME----KEKEGFPITSLREINTLLKAQHPNIVTVR 427
+GT+G V K+K T A+K LK E K++ +T R L ++HP + ++
Sbjct: 5 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR---VLQNSRHPFLTALK 61
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH-DNW 486
D++ VM+Y + S+++VF + ++++A+ +LH +
Sbjct: 62 YSF--QTHDRLCFVMEYAN---GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREY---GSPLKHYTPIVVTLWYRSPELLLGCKE 543
+++RDLK NL+L G +K+ DFGL +E G+ +K + T Y +PE+L +
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG---TPEYLAPEVLED-ND 172
Query: 544 YSTPIDMWSVGCIFAEFLC 562
Y +D W +G + E +C
Sbjct: 173 YGRAVDWWGLGVVMYEMMC 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 50/218 (22%)
Query: 372 EGTYGVVYR--AKDKRTDEI---VALKRLKMEKEKEGFPITSLREINTLL------KAQH 420
+G++G+VY AK E VA+K + S+RE L K +
Sbjct: 16 QGSFGMVYEGLAKGVVKGEPETRVAIKTV--------NENASMRERIEFLNEASVMKEFN 67
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQ------ 473
+ V VR + V S +VM+ + D+KS + + R + + L +
Sbjct: 68 CHHV-VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
++ + +A+L +HRDL N +++ +K+GDFG+ R+ I T +YR
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRD----------IYETDYYR 176
Query: 534 ------------SPELLLGCKEYSTPIDMWSVGCIFAE 559
+PE L ++T D+WS G + E
Sbjct: 177 KGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWE 213
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 14/227 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKAQH 420
E+F+ L I G +G V K K D++ A+K L K E K E + L+ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 421 PNIVTVREIVVGSNMDKIFIVMDY-VEHDMKSLMETMRSKKQVFIPGEV-KCLMQQLLNA 478
I T+ N +++VMDY V D+ +L+ SK + +P ++ + + +++ A
Sbjct: 61 QWITTLHYAFQDEN--NLYLVMDYYVGGDLLTLL----SKFEDRLPEDMARFYLAEMVIA 114
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV-TLWYRSPEL 537
+ +H +HRD+K N+L+ G +++ DFG + + + V T Y SPE+
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 538 LLGCKE----YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580
L ++ Y D WS+G E L E F +S +E +I
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 25/199 (12%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF-PITSLREIN--TLLKAQHPNIVT 425
++ +G +G V K K T ++ K +K + F I E L+K +PN +
Sbjct: 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN----FNAI----EPMVHQLMK-DNPNFIK 73
Query: 426 VREIVVGSNMDKIFIVMDYV-EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD 484
+ V + + ++MDY+ + D L + ++ + ++ EVK +++QL+ A+ LH
Sbjct: 74 LYYSV--TTLKGHVLIMDYIKDGD---LFDLLKKEGKLSEA-EVKKIIRQLVEALNDLHK 127
Query: 485 NWILHRDLKTSNLLLS-HRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
+ I+H D+K N+L + + + D+GL + G+P + TL Y SPE + G
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG----TLDYFSPEKIKGHN- 182
Query: 544 YSTPIDMWSVGCIFAEFLC 562
Y D W+VG + E L
Sbjct: 183 YDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 57/251 (22%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK----MEKEKEGFPITSLREINTLLK 417
++F+ + I G +G V + K T I A+K+L+ +EKE+ + + R+I L +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAH-VRAERDI--LAE 57
Query: 418 AQHPNIVTVREIVVGSNMDK--IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQ 474
A +P +V + S D+ ++++M+Y+ DM +L+ KK F E + + +
Sbjct: 58 ADNPWVVKLYY----SFQDENYLYLIMEYLPGGDMMTLL----MKKDTFTEEETRFYIAE 109
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA--------REYGSPLKHYTP- 525
+ A+ +H +HRD+K NLLL +G +K+ DFGL E+ L H P
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 526 -----------------------------IVVTLWYRSPELLLGCKEYSTPIDMWSVGCI 556
V T Y +PE+ L Y+ D WS+G I
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVI 228
Query: 557 FAEFLCMEPLF 567
E L P F
Sbjct: 229 MYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 51/198 (25%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALK-----RLKMEKEKEGFPITSLREINTLLKAQHPNIV 424
I G +G VY + T ++ A+K R+KM K+ E + ++ + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60
Query: 425 TVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ DK+ ++D + D+ + S+ VF E++ +++ + H+H
Sbjct: 61 CMSYAF--HTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
+ ++++RDLK +N+LL G +++ D GLA ++ H + V T Y +PE+L
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVA 172
Query: 544 YSTPIDMWSVGCIFAEFL 561
Y + D +S+GC+ + L
Sbjct: 173 YDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 48/234 (20%)
Query: 370 IEEGTYGVVYRAK-----DKRTDEIVALKRLK------MEKEKEGFPITSLREINTLLKA 418
I +G +G V++A+ +VA+K LK M+ + + RE + +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-------REAALMAEF 65
Query: 419 QHPNIVTVREI-VVGSNMDKIFIVM------DYVEHDM-KSLMETMRSKKQVFIPGEVK- 469
HPNIV + + VG M +F M +++ H ++ S G
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 470 --------CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE------ 515
C+ +Q+ +A+L + +HRDL T N L+ ++K+ DFGL+R
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC--MEPLF 567
Y + PI + PE + + Y+T D+W+ G + E M+P +
Sbjct: 186 YKASENDAIPIR----WMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYY 234
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 370 IEEGTYGVVYRAKDK---RTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
I G +G V + K + + VA+K LK EK++ F L E + + + HPNI
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDF----LSEASIMGQFDHPNI 67
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ + +V S + IV +Y+E+ SL +R F ++ +++ + + + +L
Sbjct: 68 IHLEGVVTKSK--PVMIVTEYMENG--SLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-GSPLKHYT------PIVVTLWYRSPE 536
D +HRDL N+L++ + KV DFGL+R P YT PI T +PE
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT----APE 179
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFL 561
+ +++++ D+WS G + E +
Sbjct: 180 -AIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 73/329 (22%), Positives = 123/329 (37%), Gaps = 75/329 (22%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL---KMEKEKEGFPITSLREINTLLKAQH 420
FK + + +G G V+ + K T ++ ALK L +M K + + + +EI L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDH 60
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
P + T+ + +VMDY ++ L++ K + ++L A+
Sbjct: 61 PFLPTLYASFQTE--TYLCLVMDYCPGGELFRLLQRQPGK--CLSEEVARFYAAEVLLAL 116
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA-----------------REYGSPLKH 522
+LH I++RDLK N+LL G + + DF L+ S
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 523 YTPIVV------------TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK 570
+ T Y +PE++ G + + +D W++G + E L F G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGS 235
Query: 571 SDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDL 630
+ E S I K +++TF P V + DL
Sbjct: 236 NRDETFSNILK-------------------KEVTFPGSPPV------------SSSARDL 264
Query: 631 LCKFLTYDPVTRI----TADEALRHDYFS 655
+ K L DP R+ A E +H +F
Sbjct: 265 IRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++F+ ++ + G GVV + + K + I+A K + +E K +RE+ L + P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 63
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ-QLLNAVA 480
IV +I I M+++ D SL + ++ K+ IP E+ + +L +A
Sbjct: 64 YIVGFYGAFYSDG--EISICMEHM--DGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLA 117
Query: 481 HLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+L + + I+HRD+K SN+L++ RG +K+ DFG++ + + + V T Y SPE L
Sbjct: 118 YLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQ 175
Query: 540 GCKEYSTPIDMWSVGCIFAEF 560
G YS D+WS+G E
Sbjct: 176 G-THYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 19/229 (8%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME----KEKEGFPITSLREINTLLK 417
++F + + G +G V ++K T +I A+K +K +E F R+I L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSF-FEEERDI--LSI 57
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
+ P I ++ + D +++VM+Y L+ + + F + + +L+
Sbjct: 58 SNSPWIPQLQYAF--QDKDNLYLVMEY--QPGGDLLSLLNRYEDQFDEDMAQFYLAELVL 113
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI--VVTLWYRSP 535
A+ +H +HRD+K N+L+ G +K+ DFG A + K V T Y +P
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSKLPVGTPDYIAP 172
Query: 536 ELLLGCK-----EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
E+L Y D WS+G I E + F + + + I
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E K + ++ G +G V+ + VA+K LK + P L E N + + QHP
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLK---QGSMSPEAFLAEANLMKQLQHP 61
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-GEVKCLMQQLLNAVA 480
+V + +V + I+I+ +Y+E+ SL++ +++ + + + ++ + Q+ +A
Sbjct: 62 RLVRLYAVV---TQEPIYIITEYMENG--SLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYRSP 535
+ +HRDL+ +N+L+S K+ DFGLAR EY + PI T +P
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----AP 172
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAE 559
E + ++ D+WS G + E
Sbjct: 173 E-AINYGTFTIKSDVWSFGILLTE 195
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 338 DMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTD-EIVALKRL- 395
++++ +KD+ P + E+F + + G++G V A K D VA+KR
Sbjct: 6 NLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE 65
Query: 396 --KMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK--IFIVMDYVEHDMKS 451
K+ K+K+ + S R+I + HP V + GS D+ +++V+++V
Sbjct: 66 KSKIIKQKQVDHVFSERKILNYIN--HPFCVNLY----GSFKDESYLYLVLEFVIGG--E 117
Query: 452 LMETMRSKKQVFIPGEVKCL-MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDF 510
+R K+ P +V C Q++ +L I++RDLK NLLL G +K+ DF
Sbjct: 118 FFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDF 175
Query: 511 GLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK 570
G A+ + + YT + T Y +PE+LL + D W++G E L P F
Sbjct: 176 GFAKVVDT--RTYT-LCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYAN 231
Query: 571 SDLEQLSRIFK 581
L +I +
Sbjct: 232 EPLLIYQKILE 242
|
Length = 340 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-09
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS---LREINTLLKAQHPNIVTV 426
I +G G VY A D VALK+++ ++ P+ LRE HP IV V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIR--EDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 427 REIVVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLN-------A 478
I S+ D ++ M Y+E + +KSL++++ K+ + K + L+
Sbjct: 68 YSIC--SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA---------------REYGSPLKHY 523
+ ++H +LHRDLK N+LL G + + D+G A E
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 524 T---PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL 561
T IV T Y +PE LLG S D++++G I + L
Sbjct: 186 TIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 365 KCLNRIEEGTYGVV----YRAKDKRTDEIVALKRLKMEKEK--EGFPITSLREINTLLKA 418
K + ++ +G +G V Y T E+VA+K+L+ + F REI L
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE----REIEILKSL 62
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
QH NIV + + + + +VM+Y+ + SL + ++ ++ ++ Q+
Sbjct: 63 QHDNIVKYKGVCYSAGRRNLRLVMEYLPYG--SLRDYLQKHRERLDHRKLLLYASQICKG 120
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIVVTLW 531
+ +L +HRDL T N+L+ +K+GDFGL + ++Y PI W
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT 568
Y +PE L K +S D+WS G + E LFT
Sbjct: 178 Y-APESLTESK-FSVASDVWSFGVVLYE------LFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKAQHPNIVTVREIV 430
+G +G V + K T ++ A K+L K +K+ +L E L K P IV +
Sbjct: 3 KGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF 62
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ-------QLLNAVAHLH 483
+ + +VM SLM K ++ GE M+ Q+ + HLH
Sbjct: 63 --ESKTHLCLVM--------SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
I++RD+K N+LL +G ++ D GLA E K T T Y +PE+L +
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNGYMAPEILKE-EP 170
Query: 544 YSTPIDMWSVGCIFAEFL 561
YS P+D +++GC E +
Sbjct: 171 YSYPVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 48/257 (18%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK----MEKEKEGFPITSLREINTLLK 417
E+F+ L I G +G V + K T + A+K L+ +EKE+ G I + R+I L++
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGH-IRAERDI--LVE 57
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
A ++ V+ + ++++M+++ DM +L+ KK E + + + +
Sbjct: 58 AD--SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETV 111
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA--------REYGSPLKHYTPIVV 528
A+ +H +HRD+K NLLL +G +K+ DFGL E+ L H P
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 529 TL-----------WYRSPELL----LGCKEYSTP-----------IDMWSVGCIFAEFLC 562
T W R+ L +G +Y P D WS+G I E L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 563 MEPLFTGKSDLEQLSRI 579
P F ++ E ++
Sbjct: 232 GYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 373 GTYGVVYRA--KDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIV 430
G +G V + K K++++ VA+K LK + LRE N + + +P IV + I
Sbjct: 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC 65
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHR 490
+ +VM+ E + L + ++ K V + L+ Q+ + +L + +HR
Sbjct: 66 EAESW---MLVMELAE--LGPLNKFLQKNKHVTEKNITE-LVHQVSMGMKYLEETNFVHR 119
Query: 491 DLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW---YRSPELLLGCKEYSTP 547
DL N+LL + K+ DFGL++ G+ +Y W + +PE + K +S+
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-FSSK 178
Query: 548 IDMWSVGCIFAE 559
D+WS G + E
Sbjct: 179 SDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 51/236 (21%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
EG +G V+ A+ ++ +VA+K LK E E+ T+L+ QH V
Sbjct: 15 EGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH----IV 70
Query: 427 REIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQ-----------Q 474
R V + + +V +Y+ H D+ + + ++ GE Q Q
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR- 533
+ + + +L +HRDL T N L+ ++K+GDFG++R+ I T +YR
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD----------IYSTDYYRV 180
Query: 534 -----------SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT-GKSDLEQLS 577
PE +L ++++T D+WS G + E +FT GK QLS
Sbjct: 181 GGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWE------IFTYGKQPWYQLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 365 KCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHP 421
+ L ++ G +G V+ T VA+K LK M+ P L E + K +HP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMD------PKDFLAEAQIMKKLRHP 61
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK--QVFIPGEVKCLMQQLLNAV 479
++ + V + + I+IV + +++ SL+E ++ + +P + + Q+ + +
Sbjct: 62 KLIQL--YAVCTLEEPIYIVTELMKYG--SLLEYLQGGAGRALKLPQLID-MAAQVASGM 116
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYRS 534
A+L +HRDL N+L+ I KV DFGLAR Y + PI T +
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT----A 172
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCM----EPLFTGKSDLEQLSRIFK 581
PE L + +S D+WS G + E + P T L+Q+ + ++
Sbjct: 173 PEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR 222
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 370 IEEGTYGVVYRAKDK---RTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
I G +G V+R K R + VA+K LK EK+++ F L E + + + H NI
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF----LSEASIMGQFSHHNI 68
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ + +V + I+ +Y+E+ +L + +R F ++ +++ + + +L
Sbjct: 69 IRLEGVV--TKFKPAMIITEYMENG--ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-GSPLKHYTPI--VVTLWYRSPELLLG 540
D +HRDL N+L++ KV DFGL+R P YT + + + +PE +
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIA 183
Query: 541 CKEYSTPIDMWSVGCIFAEFL 561
+++++ D+WS G + E +
Sbjct: 184 YRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 467 EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFG---LAREYGSPLKHY 523
+V + +QLL+A+ ++H I+HRD+KT N+L++ + +GDFG AR S HY
Sbjct: 261 QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
Query: 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVG-CIFAEFLCMEPLFTGKSDLE------QL 576
I T+ +PE+L G Y+ +D+WS G IF + LF+ E Q+
Sbjct: 321 G-IAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378
Query: 577 SRIFKTMGT-PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYD---LLC 632
RI + +E S+L + + A N T+ A + +L D L+C
Sbjct: 379 LRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR--NRRPAYTRPAWTRYYKLDLDVEYLVC 436
Query: 633 KFLTYDPVTRITADEALRHDYFSES 657
+ LT+D R +A E LR F
Sbjct: 437 RALTFDGARRPSAAELLRLPLFQSK 461
|
Length = 461 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 57/242 (23%), Positives = 107/242 (44%), Gaps = 52/242 (21%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKM---EKEKEGFPITSLREINTLLKAQH-PN 422
L I G +G V + K + I+A+KR++ EKE++ L +++ ++++ P
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRL----LMDLDVVMRSSDCPY 64
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEV--KCLMQQLLNAVA 480
IV + +I M+ ++ + + + + IP E+ K + + A+
Sbjct: 65 IVKFYGALF--REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-TVKALN 121
Query: 481 HLHDNW-ILHRDLKTSNLLLSHRGILKVGDFGLA----------REYG-SPLKHYTPIVV 528
+L + I+HRD+K SN+LL G +K+ DFG++ R+ G P
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP--------- 172
Query: 529 TLWYRSPELLL--GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK-------SDLEQLSRI 579
Y +PE + Y D+WS+G + + + TGK S +QL+++
Sbjct: 173 ---YMAPERIDPSARDGYDVRSDVWSLG------ITLYEVATGKFPYPKWNSVFDQLTQV 223
Query: 580 FK 581
K
Sbjct: 224 VK 225
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++F+ L + G GVV + + + I+A K + +E K +RE+ L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSP 59
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP----GEVKCLMQQLLN 477
IV +I I M+++ D SL + ++ + IP G++ +L
Sbjct: 60 YIVGFYGAFYSDG--EISICMEHM--DGGSLDQVLKKAGR--IPENILGKISI---AVLR 110
Query: 478 AVAHLHDNW-ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+ +L + I+HRD+K SN+L++ RG +K+ DFG++ + + + V T Y SPE
Sbjct: 111 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 168
Query: 537 LLLGCKEYSTPIDMWSVG 554
L G Y+ D+WS+G
Sbjct: 169 RLQGTH-YTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 63/258 (24%), Positives = 120/258 (46%), Gaps = 28/258 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM-EKEKEGFPITSLREINTLLKAQH 420
E K + ++ G +G V+ + + VA+K LK + F L E N + QH
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAF----LEEANLMKTLQH 60
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK--QVFIPGEVKCLMQQLLNA 478
+V + +V + + I+I+ +Y+ SL++ ++S + +V +P + Q+
Sbjct: 61 DKLVRLYAVV--TKEEPIYIITEYMAKG--SLLDFLKSDEGGKVLLPKLID-FSAQIAEG 115
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYR 533
+A++ +HRDL+ +N+L+S + K+ DFGLAR EY + PI T
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT---- 171
Query: 534 SPELL-LGCKEYSTPIDMWSVGCIFAEFLCMEPL-FTGKSDLEQLSRIFKTMGTPNEKIW 591
+PE + G ++ D+WS G + E + + + G S+ + +S + + P +
Sbjct: 172 APEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENC 229
Query: 592 PGFSKLPAVQKMTFAEYP 609
P +L + K + E
Sbjct: 230 P--DELYDIMKTCWKEKA 245
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 66/237 (27%), Positives = 112/237 (47%), Gaps = 36/237 (15%)
Query: 368 NRIEEGTYGVVYR--AKD---KRTDEI-VALKRLK---MEKEKEGFPITSLREINTLLKA 418
N + G +G VY A D + I VA+K L+ ++EK+ F L+E + +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEF----LKEAHLMSNF 56
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPG---EVKCLMQQL 475
HPNIV + + + + + +I+M+ +E L+ +R + +K L+
Sbjct: 57 NHPNIVKLLGVCLLN--EPQYIIMELMEGG--DLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 476 L---NAVAHLHDNWILHRDLKTSNLLLSHRG-----ILKVGDFGLARE-YGSPL--KHYT 524
L +L +HRDL N L+S +G ++K+GDFGLAR+ Y S K
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172
Query: 525 PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM--EPLFTGKSDLEQLSRI 579
++ W +PE LL K ++T D+WS G + E L + +P + ++ E L +
Sbjct: 173 GLLPVRWM-APESLLDGK-FTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 62/238 (26%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E + ++ +G +G V+ T VA+K LK P L+E + K +H
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS---PEAFLQEAQVMKKLRHE 61
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK--KQVFIPGEVKCLMQQLLNAV 479
+V + +V + + I+IV +Y+ SL++ ++ + K + +P V + Q+ + +
Sbjct: 62 KLVQLYAVV---SEEPIYIVTEYM--SKGSLLDFLKGEMGKYLRLPQLVD-MAAQIASGM 115
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYRS 534
A++ +HRDL+ +N+L+ + KV DFGLAR EY + PI T +
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----A 171
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCM----EPLFTGKSDLEQLSRIFKTMGTPNE 588
PE L + ++ D+WS G + E P + L+Q+ R ++ M P E
Sbjct: 172 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++F+ ++ + G GVV++ K + I+A K + +E K +RE+ L + P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 63
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQV--FIPGEVKCLMQQLLNAV 479
IV +I I M+++ D SL + ++ ++ I G+V + + L +
Sbjct: 64 YIVGFYGAFYSDG--EISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
H I+HRD+K SN+L++ RG +K+ DFG++ + + + V T Y SPE L
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQ 175
Query: 540 GCKEYSTPIDMWSVGCIFAE 559
G YS D+WS+G E
Sbjct: 176 G-THYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 18/183 (9%)
Query: 378 VYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437
VY+ + K+ D VA+K LK E EK +RE + + +P IV R I V +
Sbjct: 15 VYKMRKKQID--VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIV--RMIGV-CEAEA 68
Query: 438 IFIVMDYVEHDMKS---LMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKT 494
+ +VM+ M S L + + KK V LM Q+ + +L +HRDL
Sbjct: 69 LMLVME-----MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAA 123
Query: 495 SNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW---YRSPELLLGCKEYSTPIDMW 551
N+LL ++ K+ DFGL++ G+ +Y W + +PE + +++S+ D+W
Sbjct: 124 RNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN-FRKFSSRSDVW 182
Query: 552 SVG 554
S G
Sbjct: 183 SYG 185
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 22/180 (12%)
Query: 390 VALKRLKME---KEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446
VA+K LK E+E ++ L+ ++ L H NIV + I ++ +Y
Sbjct: 68 VAVKMLKPTAHSSEREAL-MSELKIMSHL--GNHENIVNLLGACTIGG--PILVITEYCC 122
Query: 447 HDMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGIL 505
+ L+ +R K++ F+ E + Q+ +A L +HRDL N+LL+H I+
Sbjct: 123 YG--DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIV 180
Query: 506 KVGDFGLAREYGSPLKHYTPIVVT------LWYRSPELLLGCKEYSTPIDMWSVGCIFAE 559
K+ DFGLAR+ + + + VV + + +PE + C Y+ D+WS G + E
Sbjct: 181 KICDFGLARD----IMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWE 235
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKAQH 420
++F+ L I G +G V K K T ++ A+K L K E K E + L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 421 PNIVTVREIVVGSNMDKIFIVMDY-VEHDMKSLMETMRSKKQVFIPGEV-KCLMQQLLNA 478
I + + + +++VMDY V D+ +L+ SK + +P ++ + + +++ A
Sbjct: 61 RWITNLHYAF--QDENNLYLVMDYYVGGDLLTLL----SKFEDRLPEDMARFYLAEMVLA 114
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV-------TLW 531
+ +H +HRD+K N+LL G +++ DF GS L+ V T
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADF------GSCLRLLADGTVQSNVAVGTPD 168
Query: 532 YRSPELLL----GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
Y SPE+L G Y D WS+G E L E F +S +E +I
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 56/195 (28%), Positives = 86/195 (44%), Gaps = 28/195 (14%)
Query: 383 DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442
D RT + LK L+ E RE T++ PN+V + + +V D +F+V+
Sbjct: 14 DTRTQQTFILKGLRKSSEYS-------RERLTIIPHCVPNMVCLHKYIVSE--DSVFLVL 64
Query: 443 DYVEHDMKSLMETMRS--KKQVFIPGE-VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499
+ E + S K + IP E VK +++ A+ LH I+ RDL +N+LL
Sbjct: 65 QHAEGG------KLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL 118
Query: 500 SHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAE 559
RG +++ F E V Y +PE + G E + D WS+G I E
Sbjct: 119 DDRGHIQLTYFSRWSEVEDSCDGEA---VENMYCAPE-VGGISEETEACDWWSLGAILFE 174
Query: 560 FLCMEPLFTGKSDLE 574
L TGK+ +E
Sbjct: 175 ------LLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 40/231 (17%)
Query: 372 EGTYGVVYRA--------KDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
EG +G V+ A KDK + ALK + K+ RE L QH +I
Sbjct: 15 EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-----FQREAELLTNLQHEHI 69
Query: 424 VTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKC------------ 470
V + + D + +V +Y++H D+ + + + G+ +
Sbjct: 70 VKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 471 LMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT---PIV 527
+ Q+ + + +L +HRDL T N L+ ++K+GDFG++R+ S +Y +
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST-DYYRVGGHTM 186
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT-GKSDLEQLS 577
+ + + PE ++ ++++T D+WS G I E +FT GK QLS
Sbjct: 187 LPIRWMPPESIM-YRKFTTESDVWSFGVILWE------IFTYGKQPWFQLS 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-08
Identities = 107/455 (23%), Positives = 171/455 (37%), Gaps = 101/455 (22%)
Query: 253 KPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKA-- 310
K G+ + +SA S +D +S DS + E +A
Sbjct: 33 KANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVE 92
Query: 311 -----KKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFK 365
KK+K A PN+S + +V++ +D+D+ S + FK
Sbjct: 93 VAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDV--------------------STQRFK 132
Query: 366 CLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVT 425
L+ + EGT+G V A D+ K KE + +R + + I
Sbjct: 133 ILSLLGEGTFGKVVEAWDR--------------KRKEYCAVKIVRNVPKYTRDAKIEI-Q 177
Query: 426 VREIVVGSNMDKIFIVMD---YVEHDMKSLMETMRS----------KKQVFIPGEVKCLM 472
E V ++ F +M Y +++ + M K F + ++
Sbjct: 178 FMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQII 237
Query: 473 QQLLNAVAHLHDNW-ILHRDLKTSNLLL----------SHRGI------LKVGDFG-LAR 514
Q A+ + H ++H DLK N+L+ ++R + +++ D G
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297
Query: 515 EYGSPLKHYTPIVVTLWYRSPELLLGCK-EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL 573
E S T IV T YRSPE++LG YST DMWS+GCI E + L+ +L
Sbjct: 298 ERHS----RTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNL 351
Query: 574 EQLSRIFKTMGT-PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKT--------------KV 618
E L + KT+G P+E W G + + Y + G L+ V
Sbjct: 352 EHLHLMEKTLGRLPSE--WAGRCGTEEARLL----YNSAGQLRPCTDPKHLARIARARPV 405
Query: 619 AGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
I +L DL+ L YD R+ A + H Y
Sbjct: 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-08
Identities = 55/321 (17%), Positives = 134/321 (41%), Gaps = 8/321 (2%)
Query: 8 DSLEIKPPQASTQLHKSHHRSHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRHRDERD 67
D+ + K +A + + + + ++++ K ++ K+ + +E+
Sbjct: 1332 DAAKKKAEEAKKAAEAAKAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAEEKK 1391
Query: 68 RRHHHKEK-ERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKA 126
+ K+K E D+ K+D+ + ++ DE +K +E+K + K K A++ DE K
Sbjct: 1392 KADEAKKKAEEDKKKADELKKAAAAKKKADEAKKKAEEKKKADEAKKKAEEAKKADEAKK 1451
Query: 127 KEADLRARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTR 186
K + + E K+ + ++ ++ +++ + + +A+ K+ +E K ++ +K +
Sbjct: 1452 KAEEAKKAEEAKKKAEEAKKADEAKKKAEEAK--KADEAKKKAEEAKKKADEAKKAAEAK 1509
Query: 187 SRSRSPINKAKNEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSP 246
++ KA+ DEA + ++ + A E + +L+ A + +E +
Sbjct: 1510 KKADE-AKKAEEAKKADEA--KKAEEAKKADEAKKAEEKKKADELKKAEELKKAEEKKKA 1566
Query: 247 TPQR--DEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKAD 304
+ +E + E A AE + E E + + EE ++
Sbjct: 1567 EEAKKAEEDKNMALRKAEEAKKAEEARIEEVMKLYEEEKKMKAEEAKKAEEAKIKAEELK 1626
Query: 305 KKEKKAKKRKKEDASPNESER 325
K E++ KK ++ E ++
Sbjct: 1627 KAEEEKKKVEQLKKKEAEEKK 1647
|
Length = 2084 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-08
Identities = 70/292 (23%), Positives = 112/292 (38%), Gaps = 88/292 (30%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG 432
G +G V A+ T + A+K +LR+ + LL+ Q ++ R+I+
Sbjct: 12 GAFGEVCLARKVDTKALYAMK--------------TLRKKDVLLRNQVAHVKAERDILAE 57
Query: 433 SN-------------MDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
++ D ++ VMDY+ DM SL+ M +F + + +L A
Sbjct: 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCA 113
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL-------------------------- 512
V +H +HRD+K N+L+ G +K+ DFGL
Sbjct: 114 VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 513 -----------------------AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPID 549
AR++ L H +V T Y +PE+LL Y+ D
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAH--SLVGTPNYIAPEVLLRTG-YTQLCD 230
Query: 550 MWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT----PNEKIWPGFSKL 597
WSVG I E L +P F ++ LE ++ + P K+ P S L
Sbjct: 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDL 282
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-08
Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 22/164 (13%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR-EINTLLKA 418
S+EEF + I G +G VY + K ++ A+K +K + ++ E + L +
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDY-VEHDMKSLM-------ETMRSKKQVFIPGEVKC 470
+ P IV + + +N +++VM+Y + D+KSL+ E M V EV
Sbjct: 62 KSPFIVHLYYSLQSAN--NVYLVMEYLIGGDVKSLLHIYGYFDEEM----AVKYISEVAL 115
Query: 471 LMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514
A+ +LH + I+HRDLK N+L+S+ G +K+ DFGL++
Sbjct: 116 -------ALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK--MEKEKEGFPITSLREINTLLKAQHPNIV 424
EG +G V+ A+ ++ +VA+K LK + ++ F RE L QH +IV
Sbjct: 15 EGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH----REAELLTNLQHEHIV 70
Query: 425 TVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPG---------EVKCLMQQ 474
+ V D + +V +Y++H D+ + + G ++ + QQ
Sbjct: 71 KFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP--IVVTLWY 532
+ + +L +HRDL T N L+ ++K+GDFG++R+ S + ++ + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT-GKSDLEQLS 577
PE ++ ++++T D+WS+G + E +FT GK QLS
Sbjct: 189 MPPESIM-YRKFTTESDVWSLGVVLWE------IFTYGKQPWYQLS 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 15/225 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKAQH 420
E++ + I G +G V + K + ++ A+K L K E K E + + A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 421 PNIVTVREIVVGSNMDK-IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
P +V ++ DK +++VM+Y+ D+ +LM ++ K +++ A
Sbjct: 103 PWVV---QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKW-----AKFYTAEVVLA 154
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG-SPLKHYTPIVVTLWYRSPEL 537
+ +H ++HRD+K N+LL G LK+ DFG + + + V T Y SPE+
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 538 LL---GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
L G Y D WSVG E L + F S + S+I
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+E + L+ + +G YG VY+ + T +A+K +++E ++ F + E++ L KA P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN-QIIMELDILHKAVSP 59
Query: 422 NIVTVRE--IVVGSNMDKIFIVMDYVEHDMKSLME-TMRSKKQVFIPGEVKCLMQQLLNA 478
IV + G+ +++ M+Y+ D SL + IP +V ++++ A
Sbjct: 60 YIVDFYGAFFIEGA----VYMCMEYM--DAGSLDKLYAGGVATEGIPEDV---LRRITYA 110
Query: 479 VAH-----LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
V ++ I+HRD+K +N+L++ G +K+ DFG++ + L T I Y
Sbjct: 111 VVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK-TNIGCQS-YM 168
Query: 534 SPELL-----LGCKEYSTPIDMWSVG 554
+PE + Y+ D+WS+G
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLG 194
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E+ + ++ + G G V + K T ++A K + + K LRE+ + + + P
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSP 63
Query: 422 NIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKK--QVFIPGEVKCLMQQLLN 477
IV+ G+ N + I + M+++ D SL + V I G++ + + L
Sbjct: 64 YIVSF----YGAFLNENNICMCMEFM--DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLT 117
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ ++H I+HRD+K SN+L++ RG +K+ DFG++ E + + V T Y SPE
Sbjct: 118 YLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPER 173
Query: 538 LLGCKEYSTPIDMWSVG 554
+ G K Y+ D+WS+G
Sbjct: 174 IQGGK-YTVKSDVWSLG 189
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 57/246 (23%)
Query: 367 LNRIEE---GTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLREINTLLKAQH 420
L IEE G YGVV + + T I+A+KR++ +E++ L +++ +++
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRL----LMDLDISMRSVD 58
Query: 421 -PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRS----------KKQVFIPGEVK 469
P VT F + E D+ ME M + K + IP ++
Sbjct: 59 CPYTVT-------------FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDIL 105
Query: 470 CLMQ-QLLNAVAHLHDNW-ILHRDLKTSNLLLSHRGILKVGDFG--------LAREYGSP 519
+ ++ A+ +LH ++HRD+K SN+L++ G +K+ DFG +A+ +
Sbjct: 106 GKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165
Query: 520 LKHYTPIVVTLWYRSPELL---LGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQ 575
K Y PE + L K Y D+WS+G E P + K+ +Q
Sbjct: 166 CKPYMA---------PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
Query: 576 LSRIFK 581
L ++ +
Sbjct: 217 LKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 56/247 (22%), Positives = 100/247 (40%), Gaps = 37/247 (14%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAK-----DKRTDEIVALKRLKMEKE---KEGFPITSLRE 411
+ + L + EG +G VY+ + ++ + VA+K LK E ++ F +E
Sbjct: 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEF----RQE 58
Query: 412 INTLLKAQHPNIVTVREIVVGSN-MDKIFIVMDYVE----------HDMKSLMETMRSKK 460
+ QHPNIV + + +F + + + H + K
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE----- 515
+ + Q+ + +L + +HRDL N L+ +K+ DFGL+R+
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 516 -YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC--MEPLFTGKSD 572
Y K P+ W PE +L K ++T D+WS G + E ++P + G S+
Sbjct: 179 YYRVQSKSLLPV---RWM-PPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYY-GFSN 232
Query: 573 LEQLSRI 579
E + I
Sbjct: 233 QEVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 49/214 (22%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 389 IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH- 447
+VA+K L+ + K L+EI + + ++PNI+ + + V D + ++ +Y+E+
Sbjct: 46 LVAVKMLRADVTKTARN-DFLKEIKIMSRLKNPNIIRLLGVCVSD--DPLCMITEYMENG 102
Query: 448 DMKSLMETMRSKKQVFIPGEVKC--------LMQQLLNAVAHLHDNWILHRDLKTSNLLL 499
D+ + + + + Q+ + + +L +HRDL T N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 500 SHRGILKVGDFGLAREYGSPLKHY----TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGC 555
+ +K+ DFG++R S +Y ++ W +LLG +++T D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSG-DYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGV 219
Query: 556 IFAEF--LCMEPLFTGKSD---LEQLSRIFKTMG 584
E LC E ++ SD +E F+ G
Sbjct: 220 TLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQG 253
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 13/105 (12%)
Query: 459 KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-- 516
++ VF E+ C ++ LH I++RDLK N+LL G +++ D GLA E
Sbjct: 102 ERAVFYAAEITCGLE-------DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154
Query: 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL 561
G ++ V T+ Y +PE++ + Y+ D W +GC+ E +
Sbjct: 155 GETIRGR---VGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 370 IEEGTYGVVYRA--KDKRTDEI-VALKRLKMEKE---KEGFPITSLREINTLLKAQHPNI 423
I EG +G VY+ ++I VA+K K +E F L+E + + HP+I
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKF----LQEAYIMRQFDHPHI 69
Query: 424 VTVREIVVGSNMDKIFIVMD-YVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
V + ++ + ++IVM+ +++S ++ + + + QL A+A+L
Sbjct: 70 VKLIGVITE---NPVWIVMELAPLGELRSYLQVNKYSLDL---ASLILYSYQLSTALAYL 123
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL---WYRSPELLL 539
+HRD+ N+L+S +K+GDFGL+R Y +Y L W +PE +
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWM-APE-SI 180
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGK 570
+ +++ D+W G +CM E L G
Sbjct: 181 NFRRFTSASDVWMFG------VCMWEILMLGV 206
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 46/193 (23%), Positives = 90/193 (46%), Gaps = 23/193 (11%)
Query: 376 GVVYRAKDKRTDEIVALKRLKME-KEKEGFPITSL-REINTLLKAQHPNIVTVREIVVGS 433
+V+ AK K T+ +VA+K++ ++ KE L +EI T + QHPNI+ +
Sbjct: 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDL--KLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 434 NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCL-MQQLLNAVAHLHDNWILHRDL 492
+ ++++V + + + +++ +P ++ +LNA+ ++H +HR +
Sbjct: 72 S--ELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 493 KTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI-------VVTLWYRSPELL----LGC 541
K S++LLS G + + + K + V L + SPE+L G
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG- 186
Query: 542 KEYSTPIDMWSVG 554
Y+ D++SVG
Sbjct: 187 --YNEKSDIYSVG 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 1/88 (1%)
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
Q+++ + HLH I++RDLK N+LL + G +++ D GLA E T +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFL 561
+PELL G +EY +D +++G E +
Sbjct: 165 APELLQG-EEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 1e-07
Identities = 17/28 (60%), Positives = 24/28 (85%)
Query: 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++ L ++ EGTYGVVY+A+DK+T EIVA
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVA 28
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 48/303 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKAQH 420
E+++ + I G +G V + K T ++ A+K L K E K E + + A
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 421 PNIVTVREIVVGSNMDK-IFIVMDYVEH-DMKSLMETMRSKKQVFIPGE-VKCLMQQLLN 477
P +V ++ D+ +++VM+Y+ D+ +LM +P + + +++
Sbjct: 103 PWVV---QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVL 153
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP-LKHYTPIVVTLWYRSPE 536
A+ +H +HRD+K N+LL G LK+ DFG + + V T Y SPE
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 213
Query: 537 LLL---GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
+L G Y D WSVG E L + F S + S+I M N +P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI---MNHKNSLTFPD 270
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEALRH 651
+ + K +L+C FLT V R +E RH
Sbjct: 271 DNDISKEAK--------------------------NLICAFLTDREVRLGRNGVEEIKRH 304
Query: 652 DYF 654
+F
Sbjct: 305 LFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 66/265 (24%), Positives = 104/265 (39%), Gaps = 64/265 (24%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++F+ L I G +G V + K T I A+K LR+ + L K Q
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMK--------------ILRKADMLEKEQVA 46
Query: 422 NIVTVREIVVGSNMDKIFIV-MDYVEHDMKSL-----------METMRSKKQVFIPGEVK 469
+I R+I+V + D ++V M Y D ++L M T+ KK +
Sbjct: 47 HIRAERDILVEA--DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQ 104
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA--------REYGSPLK 521
+ + + A+ +H +HRD+K NLLL +G +K+ DFGL E+ L
Sbjct: 105 FYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 522 HYTP---------------------------IVVTLWYRSPELLLGCKEYSTPIDMWSVG 554
H P V T Y +PE+ + Y+ D WS+G
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLG 223
Query: 555 CIFAEFLCMEPLFTGKSDLEQLSRI 579
I E L P F ++ E ++
Sbjct: 224 VIMYEMLIGYPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-07
Identities = 54/308 (17%), Positives = 132/308 (42%), Gaps = 19/308 (6%)
Query: 27 RSHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNKSDQSD 86
R++++ + + +Q ++ + E ++ +K ++ K+D++
Sbjct: 1249 RNNEEIRKFEEARMAHFARRQAAIKAEEARKADELKKAEEKKKADEAKKAEEKKKADEAK 1308
Query: 87 GGHKSHRRRDEDRKHRDERKAR-EAQKSKEYTAREIDELKAKEAD-----LRARLERKRY 140
+ ++ DE +K +E K + +A K K A++ E EA+ A E+
Sbjct: 1309 KKAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAEAAEEKAEA 1368
Query: 141 SNPLREKEKIERELRKERLLEAERVKEAYK---ERVKDVEQKRKRYRTRSRSRSPINKAK 197
+ +E+ K + + K++ E ++ EA K E K ++ +K + ++ KA+
Sbjct: 1369 AEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDKKKADELKKAAAAKKKADEAKKKAE 1428
Query: 198 NEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTG 257
+ DEA ++ E+ A E++ ++ + ++ ++ ++
Sbjct: 1429 EKKKADEAKKKAEEAKKADEAKKKAEEAKKAEEA----------KKKAEEAKKADEAKKK 1478
Query: 258 QEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKED 317
EE + A A+ A + D ++ +++ +DE + E KAD+ +K + +K ++
Sbjct: 1479 AEEAKKADEAKKKAEEAKKKADEAKKAAEAKKKADEAKKAEEAKKADEAKKAEEAKKADE 1538
Query: 318 ASPNESER 325
A E ++
Sbjct: 1539 AKKAEEKK 1546
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 3e-07
Identities = 63/383 (16%), Positives = 148/383 (38%), Gaps = 18/383 (4%)
Query: 20 QLHKSHHRSHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDR 79
+ K + K + + + + K ++ + E + E ++
Sbjct: 1306 EAKKKAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAEAAEEK 1365
Query: 80 NKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKR 139
++ + + +K +++KA EA+K E ++ DELK A + E K+
Sbjct: 1366 AEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDKKKADELKKAAAAKKKADEAKK 1425
Query: 140 YSNPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNE 199
+ ++ ++ +++ + + +A+ K+ +E K E+ +K+ ++ KA+
Sbjct: 1426 KAEEKKKADEAKKKAEEAK--KADEAKKKAEEA-KKAEEAKKKAEEAKKADEAKKKAEEA 1482
Query: 200 MDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQE 259
DEA ++ E+ + A E++ + DE++ + E
Sbjct: 1483 KKADEAKKKAEEAKKKADEAKKAAEAKKK-----------ADEAKKAEEAKKADEAKKAE 1531
Query: 260 EGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDAS 319
E + A A+ + E + E + EE+ E K +++K RK E+A
Sbjct: 1532 EAKKADEAKKA----EEKKKADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAEEAK 1587
Query: 320 PNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVY 379
E R + +++ M+ E K + A + ++ EE K + ++++
Sbjct: 1588 KAEEARIEEVMKLYEEEKKMKAEEAKKAEEAKIKAEELKKAEEEKKKVEQLKKKEAEEKK 1647
Query: 380 RAKDKRTDEIVALKRLKMEKEKE 402
+A++ + E + E +K
Sbjct: 1648 KAEELKKAEEENKIKAAEEAKKA 1670
|
Length = 2084 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAK-DKRTDEIVALKRLKM-EKEKEGFPITSLREINTLLKAQ 419
E K ++ G +G V+ A +K T VA+K +K E F L E N + Q
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAF----LAEANVMKTLQ 59
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK--QVFIPGEVKCLMQQLLN 477
H +V + +V + I+I+ +++ SL++ ++S + + +P + Q+
Sbjct: 60 HDKLVKLHAVV---TKEPIYIITEFMAKG--SLLDFLKSDEGSKQPLPKLID-FSAQIAE 113
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWY 532
+A + +HRDL+ +N+L+S + K+ DFGLAR EY + PI T
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT--- 170
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFL 561
+PE + ++ D+WS G + E +
Sbjct: 171 -APE-AINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 57/231 (24%), Positives = 108/231 (46%), Gaps = 26/231 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E + + ++ G +G V+ + VA+K LK P + L E + K +H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMS---PESFLEEAQIMKKLRHD 61
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMR--SKKQVFIPGEVKCLMQQLLNAV 479
+V + +V + + I+IV +Y+ SL++ ++ + + +P V + Q+ +
Sbjct: 62 KLVQLYAVV---SEEPIYIVTEYMSKG--SLLDFLKDGEGRALKLPNLVD-MAAQVAAGM 115
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYRS 534
A++ +HRDL+++N+L+ + K+ DFGLAR EY + PI T +
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----A 171
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCM----EPLFTGKSDLEQLSRIFK 581
PE L + ++ D+WS G + E + P + LEQ+ R ++
Sbjct: 172 PEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 82/353 (23%), Positives = 130/353 (36%), Gaps = 82/353 (23%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG 432
G +G V A T + A+K L+ + + ++ +L A+ N V+
Sbjct: 12 GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNEWVVKLYYSF 70
Query: 433 SNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491
+ D ++ VMDY+ DM SL+ M +VF + + +L A+ +H +HRD
Sbjct: 71 QDKDNLYFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 492 LKTSNLLLSHRGILKVGDFGLAREY-----------GSPLKHYTPIVVTLW--------- 531
+K N+L+ G +K+ DFGL + GS ++ + LW
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 532 ---------------------------YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME 564
Y +PE+LL K Y+ D WSVG I E L +
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQ 245
Query: 565 PLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILT 624
P F + E ++ W +P K++ P L TK+ S
Sbjct: 246 PPFLAPTPTETQLKVIN---------WENTLHIPPQVKLS----PEAVDLITKLCCSAEE 292
Query: 625 ELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAH 677
LG R AD+ H +FSE D P P +++H
Sbjct: 293 RLG--------------RNGADDIKAHPFFSEVDFSSDIRTQPA-PYVPKISH 330
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 8e-07
Identities = 53/271 (19%), Positives = 112/271 (41%), Gaps = 30/271 (11%)
Query: 60 SRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAR 119
++ + E R+ K D K++++ R+ ++ ++ RKA +A+K++E AR
Sbjct: 1120 AKKKAEDARKAEEARKAEDARKAEEA-------RKAEDAKRVEIARKAEDARKAEE--AR 1170
Query: 120 EIDELKAKEADLRA----RLERKRYSNPLREKEKIERELRKERLLEAERVKEAYK-ERVK 174
+ ++ K EA +A + E R + R+ E + + + EA + ++A K E VK
Sbjct: 1171 KAEDAKKAEAARKAEEVRKAEELRKAEDARKAEAARKAEEERKAEEARKAEDAKKAEAVK 1230
Query: 175 DVEQKRKRYRTRSRSRSPINKAKNEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEAA 234
E+ +K ++ + +N ++ + + AR A E+R +L+ A
Sbjct: 1231 KAEEAKKDAEEAKKAE----EERNNEEIRKFEEARMAHFARRQAAIKAEEARKADELKKA 1286
Query: 235 GLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEE 294
DE++ ++ E AE + ++E+ + E + +D
Sbjct: 1287 EEKKKADEAKKAEEKKKAD--------EAKKKAEEAKKADEAKKKAEEAKKK----ADAA 1334
Query: 295 ENDENEDKADKKEKKAKKRKKEDASPNESER 325
+ E K + KA+ D + E+
Sbjct: 1335 KKKAEEAKKAAEAAKAEAEAAADEAEAAEEK 1365
|
Length = 2084 |
| >gnl|CDD|217927 pfam04147, Nop14, Nop14-like family | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 8e-07
Identities = 44/230 (19%), Positives = 75/230 (32%), Gaps = 50/230 (21%)
Query: 108 REAQKSKEYTAREIDELKAKEADLRARLERKRYSNPLREKEKIERELRKE---------- 157
E QK+KE +EL DL + L R P + E E
Sbjct: 191 AERQKAKEEDEDLREELDDDFKDLMSLL---RTVKPPPKPPMTPEEKDDEYDQRVRELTF 247
Query: 158 --------RLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNEMDVDEAHQRG 209
R E + + ER+K +E +R R R R + D+ +
Sbjct: 248 DRRAQPTDRTKTEEELAKEEAERLKKLEAERLR-RMR------------GEEEDDEEEED 294
Query: 210 EDDGARTPPGPAAPESRSRQDLEAAGLVVLTDE--SRSPTPQRDEKPGTGQEEGELAGSA 267
S DL+ D +E+ +E E
Sbjct: 295 SK--------------ESADDLDDEFEPDDDDNFGLGQGEEDEEEEEDGVDDEDEEDDDD 340
Query: 268 ESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKED 317
+ E+ E+ +D S DE++ +E E++ +KK+KK+ + + +
Sbjct: 341 DLEEEEEDVDLSDEEEDEEDEDSDDEDDEEEEEEEKEKKKKKSAESTRSE 390
|
Emg1 and Nop14 are novel proteins whose interaction is required for the maturation of the 18S rRNA and for 40S ribosome production. Length = 809 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 26/224 (11%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
++ +G +G V+ T + VA+K LK P L+E + K +H +V +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSK--KQVFIPGEVKCLMQQLLNAVAHLHDNW 486
+V + + I+IV +++ SL++ ++ K + +P V + Q+ + +A++
Sbjct: 69 VV---SEEPIYIVTEFMGKG--SLLDFLKEGDGKYLKLPQLVD-MAAQIADGMAYIERMN 122
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYRSPELLLGC 541
+HRDL+ +N+L+ + K+ DFGLAR EY + PI T +PE L
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYG 178
Query: 542 KEYSTPIDMWSVGCIFAEFLCM----EPLFTGKSDLEQLSRIFK 581
+ ++ D+WS G + E + P + LEQ+ R ++
Sbjct: 179 R-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 31/223 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRA---KD--KRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
E+ K + I EG +G V RA KD K I LK E + F E+ L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA----GELEVLC 57
Query: 417 K-AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-------GEV 468
K HPNI+ + + N ++I ++Y + +L++ +R + + G
Sbjct: 58 KLGHHPNIINL--LGACENRGYLYIAIEYAPYG--NLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 469 KCLM-QQLL-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
L QQLL + +L + +HRDL N+L+ K+ DFGL+R +
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV 173
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
K + W L Y+T D+WS G + E + +
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 35/206 (16%)
Query: 373 GTYGVVYRA---KDKRTDEI-VALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
G +G VY+ + +I VA+K L+ E + L E + HP++V +
Sbjct: 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASVDHPHVVRLLG 76
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN-------AVAH 481
I + S + I +M L++ +R+ K Q LLN +++
Sbjct: 77 ICLSSQVQLITQLMPL-----GCLLDYVRNHKDNIGS-------QYLLNWCVQIAKGMSY 124
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY------TPIVVTLWYRSP 535
L + ++HRDL N+L+ +K+ DFGLA+ K Y PI W
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK---WMALE 181
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFL 561
+L Y+ D+WS G E +
Sbjct: 182 SILHR--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (124), Expect = 2e-06
Identities = 57/238 (23%), Positives = 106/238 (44%), Gaps = 23/238 (9%)
Query: 94 RRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRA----RLERKRYSNPLREKEK 149
++ E K + RKA EA+K E AR+ +E + E +A + E + R+ E
Sbjct: 1104 KKTETGKAEEARKAEEAKKKAE-DARKAEEARKAEDARKAEEARKAEDAKRVEIARKAED 1162
Query: 150 IERELRKERLLEAERVKEAYK-ERVKDVEQKRKRYRTRSRSRSPINKAKNEMDVDEAHQR 208
+ + +A++ + A K E V+ E+ RK R + KA+ E +EA R
Sbjct: 1163 ARKAEEARKAEDAKKAEAARKAEEVRKAEELRKAEDARKAEAA--RKAEEERKAEEA--R 1218
Query: 209 GEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAE 268
+D + A E++ +E++ +R+ + EE +A A
Sbjct: 1219 KAEDAKKAEAVKKAEEAKKDA-----------EEAKKAEEERNNEEIRKFEEARMAHFAR 1267
Query: 269 SSAG--SEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNESE 324
A +EE+ + +++ +DE + E + KAD+ +KKA++ KK D + ++E
Sbjct: 1268 RQAAIKAEEARKADELKKAEEKKKADEAKKAEEKKKADEAKKKAEEAKKADEAKKKAE 1325
|
Length = 2084 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 54/219 (24%)
Query: 373 GTYGVVY----RAKDKRTDEI-VALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVR 427
G +G VY R +D E+ VA+K L E E L E + K H NIV +
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLP-ESCSEQDESDFLMEALIMSKFNHQNIVRL- 74
Query: 428 EIVVGSNMDKI--FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL-MQQLLNA---VA 480
+G + +++ FI+++ + D+KS + R + P L M+ LL VA
Sbjct: 75 ---IGVSFERLPRFILLELMAGGDLKSFLRENRPR-----PERPSSLTMKDLLFCARDVA 126
Query: 481 ----HLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLARE-YGS-----------PLK 521
+L +N +HRD+ N LL+ +G + K+ DFG+AR+ Y + P+K
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 522 HYTPIVVTLWYRSPELLL-GCKEYSTPIDMWSVGCIFAE 559
+ P PE L G +++ D+WS G + E
Sbjct: 187 -WMP---------PEAFLDGI--FTSKTDVWSFGVLLWE 213
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 389 IVALKRLKMEKEKEG---FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445
+VA+K L+ + K F L+EI + + + PNI+ + + + S D + ++ +Y+
Sbjct: 48 LVAVKMLREDANKNARNDF----LKEIKIMSRLKDPNIIRLLAVCITS--DPLCMITEYM 101
Query: 446 EH-DMKSLMETMRSKKQVFIP-------GEVKCLMQQLLNAVAHLHDNWILHRDLKTSNL 497
E+ D+ + ++ + + Q+ + + +L +HRDL T N
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161
Query: 498 LLSHRGILKVGDFGLARE------YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMW 551
L+ +K+ DFG++R Y + PI W +LLG +++T D+W
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPI---RWMSWESILLG--KFTTASDVW 216
Query: 552 SVGCIFAEFL--CMEPLFTGKSDLEQL 576
+ G E L C E ++ SD EQ+
Sbjct: 217 AFGVTLWEILTLCKEQPYSQLSD-EQV 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 3e-06
Identities = 63/302 (20%), Positives = 127/302 (42%), Gaps = 33/302 (10%)
Query: 49 KSSSQHKSHHRSRHRDERDRRHHHKEKERDRNKSD---------------QSDGGHKSHR 93
K+ K+ + + + K+ E +RN + Q+ + R
Sbjct: 1219 KAEDAKKAEAVKKAEEAKKDAEEAKKAEEERNNEEIRKFEEARMAHFARRQAAIKAEEAR 1278
Query: 94 RRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKRYSNPLRE-----KE 148
+ DE +K +++KA EA+K++E ++ DE K K + + E K+ + ++ K+
Sbjct: 1279 KADELKKAEEKKKADEAKKAEE--KKKADEAKKKAEEAKKADEAKKKAEEAKKKADAAKK 1336
Query: 149 KIERELRKERLLEAE---RVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNEMDVDEA 205
K E + +AE EA K ++K+ + ++ + KA+ + DEA
Sbjct: 1337 KAEEAKKAAEAAKAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAEEKKKADEA 1396
Query: 206 HQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAG 265
++ E+D + A ++ + D EA E + + +K ++ E
Sbjct: 1397 KKKAEEDKKKADELKKAAAAKKKAD-EAKK----KAEEKKKADEAKKKAEEAKKADEAKK 1451
Query: 266 SAESSAGSEESSQDGSEDSSQDSSSSDEEEN---DENEDKADKKEKKAKKRKKEDASPNE 322
AE + +EE+ + E D + EE DE + KA++ +KKA + KK + +
Sbjct: 1452 KAEEAKKAEEAKKKAEEAKKADEAKKKAEEAKKADEAKKKAEEAKKKADEAKKAAEAKKK 1511
Query: 323 SE 324
++
Sbjct: 1512 AD 1513
|
Length = 2084 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 60/273 (21%), Positives = 104/273 (38%), Gaps = 76/273 (27%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
F + I G +G V + T+ + A+K +LR+ + L++ Q ++
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMK--------------TLRKADVLMRNQAAHV 48
Query: 424 VTVREIVVGSN-------------MDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVK 469
R+I+ ++ D ++ VMDY+ DM SL+ + +F +
Sbjct: 49 KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRLGIFEEDLAR 104
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA--------REYGSPLK 521
+ +L A+ +H +HRD+K N+L+ G +K+ DFGL +Y
Sbjct: 105 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 522 HYT-----------------------------------PIVVTLWYRSPELLLGCKEYST 546
H+ +V T Y +PE+LL Y+
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQ 223
Query: 547 PIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
D WSVG I E L +P F + E ++
Sbjct: 224 LCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 382 KDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438
+ +VA+K L+ + +E F L+E+ L + PNI R + V + +
Sbjct: 41 DNADAPVLVAVKVLRPDASDNAREDF----LKEVKILSRLSDPNIA--RLLGVCTVDPPL 94
Query: 439 FIVMDYVEH-DM-----KSLMETMRSKKQV-FIPGEVKCLMQ---QLLNAVAHLHDNWIL 488
++M+Y+E+ D+ K + ET + L+ Q+ + + +L +
Sbjct: 95 CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS--FSTLLYMATQIASGMRYLESLNFV 152
Query: 489 HRDLKTSNLLLSHRGILKVGDFGLARE-YGS---------PLKHYTPIVVTLWYRSPELL 538
HRDL T N L+ +K+ DFG++R Y S PL PI W E +
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPL----PIRWMAW----ESV 204
Query: 539 LGCKEYSTPIDMWSVGCIFAEF--LCMEPLFTGKSD---LEQLSRIFKTMGTP 586
L K ++T D+W+ G E LC E + +D +E F+ G
Sbjct: 205 LLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ 256
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 40/213 (18%)
Query: 370 IEEGTYGVVYRAKDKRTDEI---VALKRLKMEKEKEGFPITSLREINTLLKA-------Q 419
I +G +G VY +D A+K L IT L E+ LK
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--------ITDLEEVEQFLKEGIIMKDFS 54
Query: 420 HPNIVTVREIVV---GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ--- 473
HPN++++ I + GS + +V+ Y++H L +RS+ VK L+
Sbjct: 55 HPNVLSLLGICLPSEGSPL----VVLPYMKHG--DLRNFIRSETH---NPTVKDLIGFGL 105
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVV 528
Q+ + +L +HRDL N +L +KV DFGLAR EY S H +
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL 561
W L ++++T D+WS G + E +
Sbjct: 166 VKWMALES--LQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 45/193 (23%), Positives = 85/193 (44%), Gaps = 23/193 (11%)
Query: 408 SLREINTLLKA-------QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
S +E N L+ QHPNI+ +G ++ I ++ + ++ L + ++
Sbjct: 35 SSKEQNEFLQQGDPYRILQHPNILQC----LGQCVEAIPYLLVFEYCELGDLKSYLSQEQ 90
Query: 461 QVFIPGEVKCLMQ---QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL--ARE 515
++ L + ++ V H+H + LH DL N L+ +KVGD+G+ +R
Sbjct: 91 WHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150
Query: 516 YGSPLKHYTPIVVTLWYRSPELL------LGCKEYSTPIDMWSVGCIFAE-FLCMEPLFT 568
++ V L + +PEL+ L E + P ++W++G E F ++
Sbjct: 151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
Query: 569 GKSDLEQLSRIFK 581
SD E L+ + K
Sbjct: 211 HLSDREVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 46/167 (27%), Positives = 84/167 (50%), Gaps = 20/167 (11%)
Query: 426 VREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQ---VFIPGEVKCLMQ---QLLNA 478
VR + V S ++M+ + D+KS + ++R + + V P +K ++Q ++ +
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE------YGSPLKHYTPIVVTLWY 532
+A+L+ N +HRDL N +++ +K+GDFG+ R+ Y K P+ +
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----W 187
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSR 578
SPE L ++T D+WS G + E + E + G S+ EQ+ R
Sbjct: 188 MSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 19/125 (15%)
Query: 459 KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-- 516
+ VF E+ C ++ LH I++RDLK N+LL G +++ D GLA
Sbjct: 102 GRAVFYAAEICCGLE-------DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154
Query: 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576
G +K V T+ Y +PE++ + Y+ D W++GC+ E + G+S +Q
Sbjct: 155 GQTIKGR---VGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYE------MIAGQSPFQQR 204
Query: 577 SRIFK 581
+ K
Sbjct: 205 KKKIK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYR--AKDKRTDEIVALKRLKMEKEKEGFPITSLRE----IN-- 413
E+ L + +G++G+VY A+D E +K E SLRE +N
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-----ASLRERIEFLNEA 60
Query: 414 TLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRS---KKQVFIPGEVK 469
+++K + V VR + V S +VM+ + H D+KS + ++R P ++
Sbjct: 61 SVMKGFTCHHV-VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 470 CLMQ---QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE------YGSPL 520
++Q ++ + +A+L+ +HRDL N +++H +K+GDFG+ R+ Y
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAE 559
K P+ W L G ++T DMWS G + E
Sbjct: 180 KGLLPV---RWMAPESLKDGV--FTTSSDMWSFGVVLWE 213
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR----EINTLLKAQHPNIVTVR 427
EG +G V +A R + ++ KE + LR E N L + HP+++ +
Sbjct: 10 EGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKL- 68
Query: 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQV----------------FIPGEVKCL 471
S + ++++Y ++ SL +R ++V P E
Sbjct: 69 -YGACSQDGPLLLIVEYAKYG--SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 472 MQQLLN-------AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR---EYGSPLK 521
M L++ + +L + ++HRDL N+L++ +K+ DFGL+R E S +K
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
+ W + E L Y+T D+WS G + E + +
Sbjct: 186 RSKGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVTL 225
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 50/235 (21%), Positives = 97/235 (41%), Gaps = 54/235 (22%)
Query: 354 AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT-----S 408
AI R + ++EGT+G ++ L K KE+E F T S
Sbjct: 2 AISRDR----VTLSDLLQEGTFGRIFYGI---------LIDEKPGKEEEVFVKTVKDHAS 48
Query: 409 LREINTLLK-------AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMR--- 457
++ LL+ H NI+ + + + + + F++ Y+ ++K ++ R
Sbjct: 49 EIQVTLLLQESCLLYGLSHQNILPILHVCI-EDGEPPFVLYPYMNWGNLKLFLQQCRLGE 107
Query: 458 -SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-- 514
+ Q ++ + Q+ +++LH ++H+D+ N ++ +K+ D L+R
Sbjct: 108 ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167
Query: 515 ---EYGS-------PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAE 559
+Y P+K W + E L+ KEYS+ D+WS G + E
Sbjct: 168 FPMDYHCLGDNENRPVK---------WM-ALESLVN-KEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 17/28 (60%), Positives = 23/28 (82%)
Query: 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++ + +I EGTYGVVY+A+DK T EIVA
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA 28
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 59/268 (22%), Positives = 108/268 (40%), Gaps = 58/268 (21%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL---KMEKEKEGFPITSLREINTLLKA 418
E+F + I +G +G V + K T +I A+K L +M K+ + + + R++ L ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV--LAES 58
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
P +V++ + ++++M+++ LM TM K F + M + + A
Sbjct: 59 DSPWVVSLYYSFQDAQY--LYLIMEFLPGG--DLM-TMLIKYDTFSEDVTRFYMAECVLA 113
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA---------REYGSPL--------- 520
+ +H +HRD+K N+L+ G +K+ DFGL+ Y L
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 521 -KHYTPIVVTLW----------------------------YRSPELLLGCKEYSTPIDMW 551
+ V ++ Y +PE+ L + Y D W
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWW 232
Query: 552 SVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
S+G I E L P F ++ E +I
Sbjct: 233 SLGAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|233191 TIGR00927, 2A1904, K+-dependent Na+/Ca+ exchanger | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-05
Identities = 44/263 (16%), Positives = 99/263 (37%), Gaps = 8/263 (3%)
Query: 55 KSHHRSRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSK 114
++ H E R E E +++ ++ + + + + + + Q+ +
Sbjct: 637 EAEHTGERTGEEGERPTEAEGENGEESGGEAEQEGETETKGENESEGEIPAERKGEQEGE 696
Query: 115 EYTAREIDELKAKEADLRARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYKERVK 174
+ + K + E + + ++ +IE E +E E EA +
Sbjct: 697 GEIEAKEADHKGETEAEEVEHEGETEAEGTEDEGEIETGEEGE-EVEDEGEGEAEGKHEV 755
Query: 175 DVEQKRKRYRTRSRSRSPINKAKNEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEAA 234
+ E RK + + + ++E ++ +A + GE G G E + +
Sbjct: 756 ETEGDRKETEHEGETEAEGKEDEDEGEI-QAGEDGEMKGDEGAEGKVEHEGETEAGEKDE 814
Query: 235 GLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEE 294
E +S T D + E EL + A +E DG S S +EE
Sbjct: 815 H------EGQSETQADDTEVKDETGEQELNAENQGEAKQDEKGVDGGGGSDGGDSEEEEE 868
Query: 295 ENDENEDKADKKEKKAKKRKKED 317
E +E E++ +++E++ ++ ++ +
Sbjct: 869 EEEEEEEEEEEEEEEEEEEEENE 891
|
[Transport and binding proteins, Cations and iron carrying compounds]. Length = 1096 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 369 RIEEGTYGVVYRAK----DKRTDEI-VALKRLKMEK-EKEGFPITSLREINTLLKAQHPN 422
+ EG +G V +A+ D + VA+K LK + EK+ + S E+ ++ +H N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI-GKHKN 77
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMR------SKKQVFIPGE---VKCLM 472
I+ + + V + +++V++Y H +++ + R S P E K L+
Sbjct: 78 IINL--LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 473 Q---QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515
Q+ + L +HRDL N+L++ ++K+ DFGLAR+
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 32/116 (27%), Positives = 58/116 (50%), Gaps = 13/116 (11%)
Query: 459 KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-- 516
++ +F E+ C ++ LH ++RDLK N+LL G +++ D GLA +
Sbjct: 102 ERALFYAAEILCGLE-------DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154
Query: 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD 572
G ++ V T+ Y +PE+L + Y+ D W +GC+ E + + F G+ +
Sbjct: 155 GESIRGR---VGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 19/35 (54%), Positives = 26/35 (74%)
Query: 748 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
G R V++F + +I EGTYG VY+A+DK T E+VA
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVA 36
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 360 SVEEFKCLNRIEEGTYGVVYR------AKDKRTDEIVALKRLKMEKEKEGFPITSLRE-- 411
++ + + + E +G VY+ A ++T + VA+K LK + E LRE
Sbjct: 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQT-QAVAIKTLKDKAE------GPLREEF 55
Query: 412 -INTLLKA--QHPNIVTVREIVVGSN-MDKIF-----------IVMDYVEHDMKSLMETM 456
++++ QHPNIV + +V + IF +VM D+ S +
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS-TDDD 114
Query: 457 RSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516
++ K P + ++ Q+ + L + ++H+DL T N+L+ + +K+ D GL RE
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 517 GSP--LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAE 559
+ K ++ + + SPE ++ K +S D+WS G + E
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 30/105 (28%), Positives = 55/105 (52%), Gaps = 13/105 (12%)
Query: 459 KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY-- 516
++ +F E+ C ++ L I++RDLK N+LL RG +++ D GLA +
Sbjct: 102 QRAIFYAAELCCGLEDL-------QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154
Query: 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL 561
G ++ V T+ Y +PE++ ++Y+ D W +GC+ E +
Sbjct: 155 GETVRGR---VGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-05
Identities = 23/81 (28%), Positives = 35/81 (43%), Gaps = 2/81 (2%)
Query: 37 RTHGSSSSSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNKSDQ--SDGGHKSHRR 94
R SS++ + S+ +S R RHR R+R + + RDR + D S R
Sbjct: 13 RGRDRDRSSERPRRRSRDRSRFRDRHRRSRERSYREDSRPRDRRRYDSRSPRSLRYSSVR 72
Query: 95 RDEDRKHRDERKAREAQKSKE 115
R DR R R R ++ +
Sbjct: 73 RSRDRPRRRSRSVRSIEQHRR 93
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-05
Identities = 31/141 (21%), Positives = 55/141 (39%), Gaps = 8/141 (5%)
Query: 73 KEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLR 132
+E E + + R + E + E + E REI+ L+ + L
Sbjct: 361 EELEEKLSALLEELEELFEALREELAEL---EAELAEIRNELEELKREIESLEERLERLS 417
Query: 133 ARLERKRYS----NPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTR-S 187
RLE + E+ + E E E L E E E ++R+K++E++ +
Sbjct: 418 ERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEELRDRLKELERELAELQEELQ 477
Query: 188 RSRSPINKAKNEMDVDEAHQR 208
R ++ + +D EA QR
Sbjct: 478 RLEKELSSLEARLDRLEAEQR 498
|
Length = 1163 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 38/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 372 EGTYGVVYRAKDKRTDEI---VALKRLKME----KEKEGFPITSLREINTLLKAQHPNIV 424
EG +G V + + D VA+K +K++ E E F L E + HPN++
Sbjct: 9 EGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEF----LSEAACMKDFDHPNVM 64
Query: 425 TVREIVV-GSNMDKI---FIVMDYVEH-DMKSLMETMRSKKQ-VFIPGEVKCL-MQQLLN 477
+ + S++ KI +++ +++H D+ S + R +P + M +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514
+ +L + +HRDL N +L + V DFGL++
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 370 IEEGTYGVVYRA---KD--KRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPNI 423
I EG +G V +A KD + I +K + + F E+ L K HPNI
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA----GELEVLCKLGHHPNI 58
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-------GEVKCLM-QQL 475
+ + + + +++ ++Y H +L++ +R + + L QQL
Sbjct: 59 INL--LGACEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 476 L-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV 528
L + +L +HRDL N+L+ + K+ DFGL+R +K +
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
W L Y+T D+WS G + E + +
Sbjct: 175 VRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSL 207
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-04
Identities = 13/123 (10%), Positives = 36/123 (29%)
Query: 204 EAHQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGEL 263
+ + G A P A +R AA + + + + P
Sbjct: 56 KEARGGGAAAAAATPAAPAAAARRAARAAAAARQAEQPAAEAAAAKAEAAPAARAAAAAA 115
Query: 264 AGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNES 323
A +A + ++ + ++++ ++ E E + + + ++E
Sbjct: 116 AEAASAPEAAQARERRERGEAARRGAARKAGEGGEQPATEARADAAERTEEEERDERRRR 175
Query: 324 ERD 326
Sbjct: 176 GDR 178
|
Length = 672 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 3/96 (3%)
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSP-LKHYTPIV 527
C Q+ + L +HRDL N+LLS ++K+ DFGLAR+ Y P
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
+ L + +PE + K Y+T D+WS G + E +
Sbjct: 238 LPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSL 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSR-IRTYHLQVESELNH 813
++ L +I EGTYGVVY+A+DK T EIVA K +F E P +R +++ ELNH
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVA-IKKIKLRFESEGIPKTALR--EIKLLKELNH 57
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 2e-04
Identities = 48/277 (17%), Positives = 106/277 (38%), Gaps = 15/277 (5%)
Query: 63 RDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKS-----KEYT 117
+ E R+ K D K++ + + R+ +E RK D +KA +K+
Sbjct: 1183 KAEEVRKAEELRKAEDARKAEAARK-AEEERKAEEARKAEDAKKAEAVKKAEEAKKDAEE 1241
Query: 118 AREIDELKAKEADLRARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYK----ERV 173
A++ +E + E + R + + K E + + L +AE K+A + E
Sbjct: 1242 AKKAEEERNNEEIRKFEEARMAHFARRQAAIKAEEARKADELKKAEEKKKADEAKKAEEK 1301
Query: 174 KDVEQKRKRYRTRSRSRSPINKAKNEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEA 233
K ++ +K+ ++ KA+ +A ++ ++ + A + + EA
Sbjct: 1302 KKADEAKKKAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAEA 1361
Query: 234 A-----GLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDS 288
A +E++ +K ++ E AE + + + +
Sbjct: 1362 AEEKAEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDKKKADELKKAAAAKKKAD 1421
Query: 289 SSSDEEENDENEDKADKKEKKAKKRKKEDASPNESER 325
+ + E + D+A KK ++AKK + E+++
Sbjct: 1422 EAKKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAKK 1458
|
Length = 2084 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 3/96 (3%)
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSP-LKHYTPIV 527
C Q+ + L +HRDL N+LLS ++K+ DFGLAR+ Y P
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
+ L + +PE + + Y+ D+WS G + E +
Sbjct: 243 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 42/266 (15%), Positives = 89/266 (33%), Gaps = 11/266 (4%)
Query: 37 RTHGSSSSSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRD 96
R S K+ + + S +E+++ +EK++ + K + K
Sbjct: 79 RVEKGGSKGPAAKTKPAKEPKNESGKEEEKEKEQVKEEKKKKKEKPKEEPKDRKPKEEAK 138
Query: 97 EDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKRYSNPLREKEKIERELRK 156
E R +++ K +E +K +E RE ++ + + + + P ++KE E E ++
Sbjct: 139 EKRPPKEKEKEKE-KKVEEPRDREEEKKRERVRAKSRPKKPPKKKPPNKKKEPPEEEKQR 197
Query: 157 ERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNEMDVDEAHQRGEDDGART 216
+ E VK +E + E++++ + R + ++E R +
Sbjct: 198 QA--AREAVKGKPEEPDVNEEREKEEDDGKDRETTTSPMEEDESRQSSEISRRSSSSLKK 255
Query: 217 PPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAESSAGSEES 276
P P R+ +P + + A
Sbjct: 256 P----DPSPSMASPETRESSKRTETRPRTSLRPPSARPASARP----APPRVKRKEIVTV 307
Query: 277 SQDGSEDSSQDSSSSDEEENDENEDK 302
QD S+ E + E+ED
Sbjct: 308 LQDAQGVGKIVSNVILEGKKSEDEDD 333
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 53/218 (24%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 372 EGTYGVVYRA------KDKRTDEI-VALKRLKME-KEKEGFPITSLREINTLLKAQHPNI 423
EG +G V A KDK + + VA+K LK + EK+ + S E+ ++ +H NI
Sbjct: 25 EGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-GKHKNI 83
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK----------------QVFIPGE 467
+ + + + ++++++Y +L E +R+++ Q+
Sbjct: 84 INL--LGACTQDGPLYVIVEYASKG--NLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP--LKHYTP 525
V C Q+ + +L +HRDL N+L++ ++K+ DFGLAR+ + K T
Sbjct: 140 VSC-TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
+ + + +PE L + Y+ D+WS G + E +
Sbjct: 199 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 40/213 (18%)
Query: 372 EGTYGVVYRAKDKRTDEI--VALKRLKM----EKEKEGFPITSLREINTLLKAQHPNIVT 425
EG +G V + + D I VA+K +K+ E E F L E + + HPN++
Sbjct: 9 EGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMR 64
Query: 426 VREIVVGSNMDKIF----IVMDYVEH-DMKSLMETMRSKKQ-VFIPGE--VKCLMQQLLN 477
+ + + + + + +++ +++H D+ S + R ++P + VK M + +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIAS 123
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ +L +HRDL N +L+ + V DFGL+++ I +YR +
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK----------IYNGDYYRQGRI 173
Query: 538 L-----------LGCKEYSTPIDMWSVGCIFAE 559
L + Y+T D+WS G E
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 16/28 (57%), Positives = 23/28 (82%)
Query: 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
F+ + +I EGTYGVVY+A++K T E+VA
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVA 29
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 15/30 (50%), Positives = 22/30 (73%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
E+++ + RI GTYG VY+A+D T E+VA
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVA 32
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-04
Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 38/195 (19%)
Query: 348 LPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRA----KDKRTDEIVALKRLKMEKEKEG 403
L P + ++F ++ EG +GVVY+A K + + LK+ E
Sbjct: 118 LAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI 177
Query: 404 FPITSLREINTLLKAQHPN-----IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRS 458
+ +N ++ PN + E V D+ ++V Y +L + M+S
Sbjct: 178 W-------MNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGES--TLADLMQS 228
Query: 459 KK-----QVFIPGEVKCL--------------MQQLLNAVAHLHDNWILHRDLKTSNLLL 499
K+ + ++ G+V+ L M+Q+L A+ LH I+HRD+K N++
Sbjct: 229 KEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288
Query: 500 SH-RGILKVGDFGLA 513
S G K+ D G A
Sbjct: 289 SEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|240271 PTZ00108, PTZ00108, DNA topoisomerase 2-like protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-04
Identities = 34/248 (13%), Positives = 84/248 (33%), Gaps = 9/248 (3%)
Query: 60 SRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAR 119
+E++ + K + + K+ + K ++ E +K + + + R
Sbjct: 1144 QEEVEEKEIAKEQRLKSKTKGKASKLR---KPKLKKKEKKKKKSSADKSKKASVVGNSKR 1200
Query: 120 EIDELKAKEADLRARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQK 179
+ K K D + + + E+ + + +K + + K + +D ++
Sbjct: 1201 VDSDEKRKLDDKPDNKKSNSSGSDQEDDEEQKTKPKKSSVKRLKSKKNNSSKSSEDNDEF 1260
Query: 180 RKRYRTRSRSR----SPINKAKNEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEAAG 235
++ ++ + GE +G P P + + R + A
Sbjct: 1261 SSDDLSKEGKPKNAPKRVSAVQYSPPPPSKRPDGESNGGSKPSSPTKKKVKKRLEGSLAA 1320
Query: 236 LVVLTDESRSPTPQRDEKPGTGQEEGELAGSAES--SAGSEESSQDGSEDSSQDSSSSDE 293
L + ++ K Q + +SS + +DS D S ++
Sbjct: 1321 LKKKKKSEKKTARKKKSKTRVKQASASQSSRLLRRPRKKKSDSSSEDDDDSEVDDSEDED 1380
Query: 294 EENDENED 301
+E+DE++D
Sbjct: 1381 DEDDEDDD 1388
|
Length = 1388 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 44/196 (22%), Positives = 90/196 (45%), Gaps = 24/196 (12%)
Query: 410 REINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSK--------- 459
+E + + + HPNIV + +V + + ++ +Y+ D+ + MRS
Sbjct: 56 QEASLMAELHHPNIVCLLGVV--TQEQPVCMLFEYLNQGDLHEFL-IMRSPHSDVGCSSD 112
Query: 460 -----KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514
K G+ + Q+ + +L ++ +H+DL N+L+ + +K+ D GL+R
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 515 E-YGSPLKHYTP-IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC--MEPLFTGK 570
E Y + P ++ + + PE ++ K +S+ D+WS G + E ++P + G
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYY-GF 230
Query: 571 SDLEQLSRIFKTMGTP 586
S+ E + + K P
Sbjct: 231 SNQEVIEMVRKRQLLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYT---PIVVTLWYRSPELLLGCKE 543
+HRDL N+LLS ++K+ DFGLAR+ Y P Y + L + +PE + K
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGDARLPLKWMAPESIFD-KV 251
Query: 544 YSTPIDMWSVGCIFAE 559
Y+T D+WS G + E
Sbjct: 252 YTTQSDVWSFGVLLWE 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|217503 pfam03344, Daxx, Daxx Family | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 22/107 (20%), Positives = 50/107 (46%)
Query: 241 DESRSPTPQRDEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENE 300
+E R +R+ + + + S+ S +SQ+ E+ S + +EEE +E E
Sbjct: 400 EEERRKRQERERQGTSSRSSDPSKASSTSGESPSMASQESEEEESVEEEEEEEEEEEEEE 459
Query: 301 DKADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDT 347
+++++E + ++ ++E + N SE ++ D D + E +
Sbjct: 460 QESEEEEGEDEEEEEEVEADNGSEEEMEGSSEGDGDGEEPEEDAERR 506
|
The Daxx protein (also known as the Fas-binding protein) is thought to play a role in apoptosis, but precise role played by Daxx remains to be determined. Daxx forms a complex with Axin. Length = 715 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 24/110 (21%), Positives = 42/110 (38%), Gaps = 13/110 (11%)
Query: 44 SSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRD 103
S +D+ S + RSR R R R H + +ER + R DR+ D
Sbjct: 12 SRGRDRDRSSERPRRRSRDRS-RFRDRHRRSRERSYREDS-----------RPRDRRRYD 59
Query: 104 ERKAREAQKSKEYTAREIDELKAKEADLRAR-LERKRYSNPLREKEKIER 152
R R + S +R+ +++ + R R +P + K ++
Sbjct: 60 SRSPRSLRYSSVRRSRDRPRRRSRSVRSIEQHRRRLRDRSPSNQWRKDDK 109
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 440 IVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLL 498
IVM+Y+E +K L+ + E L +++ V LH I+H DL TSN++
Sbjct: 76 IVMEYIEGEPLKDLINSNGM--------EELELSREIGRLVGKLHSAGIIHGDLTTSNMI 127
Query: 499 LSHRGILKVGDFGLAR 514
LS I + DFGLA
Sbjct: 128 LSGGKIYLI-DFGLAE 142
|
Length = 211 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 11/82 (13%)
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVT------LWYRSPELLLGC 541
+HRDL N+LL+H I K+ DFGLAR+ +++ + VV + + +PE + C
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARD----IRNDSNYVVKGNARLPVKWMAPESIFNC 291
Query: 542 KEYSTPIDMWSVGCIFAEFLCM 563
Y+ D+WS G + E +
Sbjct: 292 V-YTFESDVWSYGILLWEIFSL 312
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 11/82 (13%)
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLARE------YGSPLKHYTPIVVTLWYRSPELLLGC 541
+HRDL N+LL+ I+K+ DFGLAR+ Y S + P+ + +PE +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPESIFD- 313
Query: 542 KEYSTPIDMWSVGCIFAEFLCM 563
Y+T D+WS G + E +
Sbjct: 314 NLYTTLSDVWSYGILLWEIFSL 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-04
Identities = 36/214 (16%), Positives = 86/214 (40%), Gaps = 6/214 (2%)
Query: 41 SSSSSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRR-RDEDR 99
S + + K+ + + +R + + ++R+ + + + + R R+E+R
Sbjct: 581 SGGEETKPQEQPAPKAEAKPERQQDRRKPRQNNRRDRNERRDTRDNRTRREGRENREENR 640
Query: 100 KHRDERKAREAQKSKEYTAREIDELKAKEADLRA-RLERKRYSNPLREKEKIERELRKER 158
++R + + + A+ + A ++ + ++ +A R ER+R N EK + ++E +
Sbjct: 641 RNRRQAQQQTAETRESQQAEVTEKARTQDEQQQAPRRERQRRRN--DEKRQAQQEAKALN 698
Query: 159 LLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNEMDVDEAHQRGEDDGARTPP 218
+ E + +ERV+ V+ +RK+ + + R I ++ E V +
Sbjct: 699 VEEQSVQETEQEERVQQVQPRRKQRQLNQKVR--IEQSVAEEAVAPVVEETVAAEPVVQE 756
Query: 219 GPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDE 252
PA + L + + RD
Sbjct: 757 VPAPRTELVKVPLPVVAQTAPEQDEENNAENRDN 790
|
Length = 1068 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 14/31 (45%), Positives = 26/31 (83%)
Query: 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+++++ + +I EGTYGVVY+A+D+ T+E +A
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIA 31
|
Length = 294 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-04
Identities = 29/126 (23%), Positives = 49/126 (38%), Gaps = 24/126 (19%)
Query: 104 ERKAREAQKSKEYTAREIDELKAKEADLRARLE--RKRY----------SNPLREKEKIE 151
E +E +K E REI+E+ ++ +LR LE K +E E +E
Sbjct: 192 EELIKEKEKELEEVLREINEISSELPELREELEKLEKEVKELEELKEEIEELEKELESLE 251
Query: 152 RELRK--ERLLEAERVKEAYKERVKDVEQKRKR----------YRTRSRSRSPINKAKNE 199
RK E++ E E E K+ ++++E+K K Y S E
Sbjct: 252 GSKRKLEEKIRELEERIEELKKEIEELEEKVKELKELKEKAEEYIKLSEFYEEYLDELRE 311
Query: 200 MDVDEA 205
++ +
Sbjct: 312 IEKRLS 317
|
Length = 880 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 27/80 (33%), Positives = 39/80 (48%), Gaps = 13/80 (16%)
Query: 436 DKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKT 494
D IVM+Y+E +K +E R L++++ V LH I+H DL T
Sbjct: 72 DNGLIVMEYIEGELLKDALEEARPD-----------LLREVGRLVGKLHKAGIVHGDLTT 120
Query: 495 SNLLLSHRGILKVGDFGLAR 514
SN++LS I + DFGL
Sbjct: 121 SNIILSGGRIYFI-DFGLGE 139
|
Length = 204 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 6e-04
Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 29/274 (10%)
Query: 55 KSHHRSRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSK 114
K+ ++ + + +K+ + D + +++D + + E+ K + KA EA+K++
Sbjct: 1059 KAEAKAHVGQDEGLKPSYKDFDFDAKEDNRADEATEEAFGKAEEAKKTETGKAEEARKAE 1118
Query: 115 EYTAREIDELKAKEADLRARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYK-ERV 173
E + D KA+EA + E R + R+ E +R + +A + +EA K E
Sbjct: 1119 EAKKKAEDARKAEEA---RKAEDARKAEEARKAEDAKRVEIARKAEDARKAEEARKAEDA 1175
Query: 174 KDVEQKRKRYRTRSRSRSPINKAKNEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEA 233
K E RK R + KA++ + A + E+ A E+R +D +
Sbjct: 1176 KKAEAARKAEEVRKAEE--LRKAEDARKAEAARKAEEERKAE--------EARKAEDAKK 1225
Query: 234 AGLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDE 293
A V +E++ ++ E A AE +EE + E +
Sbjct: 1226 AEAVKKAEEAK--------------KDAEEAKKAEEERNNEEIRK-FEEARMAHFARRQA 1270
Query: 294 EENDENEDKADKKEKKAKKRKKEDASPNESERDV 327
E KAD+ +K +K+K ++A E ++
Sbjct: 1271 AIKAEEARKADELKKAEEKKKADEAKKAEEKKKA 1304
|
Length = 2084 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 28/111 (25%), Positives = 55/111 (49%), Gaps = 5/111 (4%)
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV---VTL 530
Q+ + +L +HRDL N+L++ ++K+ DFGLAR+ + + +Y + +
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN-IDYYKKTTNGRLPV 200
Query: 531 WYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
+ +PE L + Y+ D+WS G + E + +E+L ++ K
Sbjct: 201 KWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 7e-04
Identities = 14/28 (50%), Positives = 23/28 (82%)
Query: 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++ + +I EGTYG VY+A++K+T E+VA
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA 28
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 8e-04
Identities = 59/306 (19%), Positives = 117/306 (38%), Gaps = 35/306 (11%)
Query: 89 HKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLER--KRYSNPLRE 146
+ E+ R E + E Q+ E +EI+ELK++ +LR LE + E
Sbjct: 237 LRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREELEELQEELLELKEE 296
Query: 147 KEKIERELR--KERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPI--NKAKNEMDV 202
E++E E+ +ERL E E E +ER++++++K + + R + + ++
Sbjct: 297 IEELEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAEL 356
Query: 203 DEAHQRGEDDGARTPPGPAAPESRSRQDLEAAG---------LVVLTDESRSPTPQRDEK 253
+EA + E+ + R++L L L E S + +
Sbjct: 357 EEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEERLER- 415
Query: 254 PGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKR 313
+ +L + E Q E+ +++ +E+ + + + + + A+ +
Sbjct: 416 --LSERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEELRDRLKELERELAELQ 473
Query: 314 KKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEG 373
++ E+++S +E D L A QG R+V E G
Sbjct: 474 EELQ----RLEKELS-----------SLEARLDRLEAEQRASQGVRAVLEAL--ESGLPG 516
Query: 374 TYGVVY 379
YG V
Sbjct: 517 VYGPVA 522
|
Length = 1163 |
| >gnl|CDD|177447 PHA02664, PHA02664, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-04
Identities = 22/97 (22%), Positives = 31/97 (31%), Gaps = 9/97 (9%)
Query: 212 DGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAESSA 271
+GAR P A R AA D+ + G ++
Sbjct: 399 NGARGSP--MAAPEEGRAAAAAAAANAPADQDVEAEAHDEFDQDPGAPAHADRADSDEDD 456
Query: 272 GSEESSQDGSEDSSQDSSSSD-------EEENDENED 301
E+ S D D DS SS E+E+D +D
Sbjct: 457 MDEQESGDERADGEDDSDSSYSYSTTSSEDESDSADD 493
|
Length = 534 |
| >gnl|CDD|225288 COG2433, COG2433, Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 9e-04
Identities = 31/113 (27%), Positives = 56/113 (49%), Gaps = 10/113 (8%)
Query: 73 KEKER---DRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEA 129
KE+ER ++ + +R + + ER E + K RE++ELK +
Sbjct: 398 KEEERPREKEGTEEEERREITVYEKRIKKLEETVERLEEENSELK----RELEELKREIE 453
Query: 130 DLRARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKR 182
L + LER R +R+K + +RE+R R ER+++ +E+ K VE+ ++
Sbjct: 454 KLESELERFRRE--VRDKVRKDREIR-ARDRRIERLEKELEEKKKRVEELERK 503
|
Length = 652 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 16/30 (53%), Positives = 19/30 (63%)
Query: 763 EGTYGVVYRAKDKRTDEIVAPCKSGNGKFW 792
EGTY VVY+A+DK T IVA K G+
Sbjct: 10 EGTYAVVYKARDKETGRIVAIKKIKLGERK 39
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 0.001
Identities = 12/28 (42%), Positives = 22/28 (78%)
Query: 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++ L ++ EG++G VY A+DK+T ++VA
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVA 28
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 30/98 (30%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 63 RDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRD-ERKAREAQKSKE---YTA 118
RDE R K + RDR++S + R R DR R ER RE + ++ Y +
Sbjct: 1 RDEEPDREREKSRGRDRDRSSERPRRRSRDRSRFRDRHRRSRERSYREDSRPRDRRRYDS 60
Query: 119 REIDELKAKEADLRARLERKRYSNPLREKEKIERELRK 156
R L+ + R+R +R S +R E+ R LR
Sbjct: 61 RSPRSLR-YSSVRRSRDRPRRRSRSVRSIEQHRRRLRD 97
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 372 EGTYGVVYRAK----DKRTDEIVALKRLKMEKE----KEGFPITSLREINTLLKAQHPNI 423
EG +G V RA+ DK + +KM K+ K+ + S E+ L+ +H NI
Sbjct: 22 EGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI-GKHKNI 80
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK----------------QVFIPGE 467
+ + + V + ++++++Y +L E +R+++ Q+
Sbjct: 81 INL--LGVCTQEGPLYVIVEYAAKG--NLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE------YGSPLK 521
V C Q + + +L +HRDL N+L++ ++K+ DFGLAR Y
Sbjct: 137 VSCAYQ-VARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
P+ + +PE L + Y+ D+WS G + E +
Sbjct: 196 GRLPVK----WMAPEALFD-RVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.001
Identities = 20/46 (43%), Positives = 31/46 (67%)
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA 513
+K +M+Q+L + LH I+HRD+K NLL++ G +K+ DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 44/204 (21%), Positives = 84/204 (41%), Gaps = 36/204 (17%)
Query: 376 GVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435
G +R K + L+ E+ F L+E+ + HPN++ +G +
Sbjct: 14 GEAHRGMSKARVVVKELRASATPDEQLLF----LQEVQPYRELNHPNVLQC----LGQCI 65
Query: 436 DKI--FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQ-----LLNAVAHLHDNWI 487
+ I +V+++ D+K+ + + + + + Q + + + LH
Sbjct: 66 ESIPYLLVLEFCPLGDLKNYLR----SNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLARE------YGSPLKHYTPIVVTLWYRSPELL--- 538
+H DL N L+ +K+GD+GLA E Y + H P L + +PEL+
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP----LRWLAPELVEIR 177
Query: 539 ---LGCKEYSTPIDMWSVGCIFAE 559
L K+ + ++WS+G E
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 37/148 (25%), Positives = 64/148 (43%), Gaps = 16/148 (10%)
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
H IV + I G+++ +V SL++ +R + P + Q+ +
Sbjct: 68 HAYIVRLLGICPGASLQ---LVTQLSPLG--SLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY------TPIVVTLWYR 533
+L ++ ++HR+L N+LL I+++ DFG+A K Y TPI W
Sbjct: 123 YYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK---WMA 179
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFL 561
+L G Y+ D+WS G E +
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 21/209 (10%)
Query: 363 EFKCLNRIEEGTYGVVYRA----KDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA 418
EFK + + G +G VY+ + ++ VA+K L+ E L E +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASV 66
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+P++ + I + S + I +M + L++ +R K + Q+
Sbjct: 67 DNPHVCRLLGICLTSTVQLITQLMPF-----GCLLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY------TPIVVTLWY 532
+ +L + ++HRDL N+L+ +K+ DFGLA+ G+ K Y PI W
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK---WM 178
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFL 561
+L + Y+ D+WS G E +
Sbjct: 179 ALESILH--RIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 13/28 (46%), Positives = 17/28 (60%)
Query: 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++ L I EG YG VY+A+D T VA
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVA 28
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|233191 TIGR00927, 2A1904, K+-dependent Na+/Ca+ exchanger | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 36/169 (21%), Positives = 62/169 (36%), Gaps = 12/169 (7%)
Query: 189 SRSPINKAK-----NEMDVDEAHQRGEDDG-----ARTPPGPAAPESRSRQDLEAAGLVV 238
SR P+ K ++ DV EA GE G G ES + E
Sbjct: 617 SRRPVAKVMALGDLSKGDVAEAEHTGERTGEEGERPTEAEGENGEESGGEAEQEGETETK 676
Query: 239 LTDESRSPTPQRDEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDE 298
+ES P E+ G + EGE+ G E+ + E ++ + DE E +
Sbjct: 677 GENESEGEIPA--ERKGEQEGEGEIEAKEADHKGETEAEEVEHEGETEAEGTEDEGEIET 734
Query: 299 NEDKADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDT 347
E+ + +++ + + + E +R + H + E E E +
Sbjct: 735 GEEGEEVEDEGEGEAEGKHEVETEGDRKETEHEGETEAEGKEDEDEGEI 783
|
[Transport and binding proteins, Cations and iron carrying compounds]. Length = 1096 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 21/109 (19%), Positives = 37/109 (33%), Gaps = 3/109 (2%)
Query: 7 PDSLEIKPPQASTQLHKSHHR--SHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRHRD 64
PD K R S R S S ++ S + + + SR
Sbjct: 5 PDREREKSRGRDRDRSSERPRRRSRDRSRFRDRHRRSRERSYREDSRPRDRRRYDSRSPR 64
Query: 65 ERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKS 113
+ ++R R +S + HRRR DR ++ + + ++S
Sbjct: 65 SLRYSSVRRSRDRPRRRSRSVRSIEQ-HRRRLRDRSPSNQWRKDDKKRS 112
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|218177 pfam04615, Utp14, Utp14 protein | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.002
Identities = 52/282 (18%), Positives = 98/282 (34%), Gaps = 25/282 (8%)
Query: 73 KEKERDRNKSDQSDGGHKSHRRRDEDRKHRD---ERKAREAQKSKEYTAREIDELKAKEA 129
+ K ++ S++ + DED D E +K + E DE +
Sbjct: 315 RRKIEGKSVSEEDEDEDSDSEEEDEDDDEDDDDGENPWMLRKKLGKLKEGEDDEENSGLL 374
Query: 130 DLR--ARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRS 187
++ R E ++ E E++ REL E E E E R+++ +
Sbjct: 375 SMKFMQRAEARKKEENDAEIEELRRELEGE-----EESDEEENEEPSKKNVGRRKFGPEN 429
Query: 188 RSRSPINKAKNEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPT 247
+ +K + + +E ++ E D + EA ++ +
Sbjct: 430 GEKEAESKKLKKENKNEFKEKKESDEEEE----------LEDEEEAK-----VEKVANKL 474
Query: 248 PQRDEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKE 307
+R EK +EE EL + + + S+ SSS ++ KA K
Sbjct: 475 LKRSEKAQKEEEEEELDEENPWLKTTSSVGKSAKKQDSKKKSSSKLDKAANKISKAAVKV 534
Query: 308 KKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLP 349
KK KK++K ++ + + D + E + E L
Sbjct: 535 KKKKKKEKSIDLDDDLIDEEDSIKLDVDDEEDEDDEELPFLF 576
|
This protein is found to be part of a large ribonucleoprotein complex containing the U3 snoRNA. Depletion of the Utp proteins impedes production of the 18S rRNA, indicating that they are part of the active pre-rRNA processing complex. This large RNP complex has been termed the small subunit (SSU) processome. Length = 728 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 24/78 (30%), Positives = 41/78 (52%), Gaps = 11/78 (14%)
Query: 488 LHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVT------LWYRSPELLLGC 541
+HRD+ N+LL+ + K+ DFGLAR+ + + + VV + + +PE + C
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARD----IMNDSNYVVKGNARLPVKWMAPESIFDC 289
Query: 542 KEYSTPIDMWSVGCIFAE 559
Y+ D+WS G + E
Sbjct: 290 V-YTVQSDVWSYGILLWE 306
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 370 IEEGTYGVVYRAKDK----RTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPNIV 424
I EG +G V +A+ K R D A+KR+K K+ + E+ L K HPNI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMD--AAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNII 71
Query: 425 TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQV------FIPGEVKCLM--QQLL 476
+ + + +++ ++Y H +L++ +R + + I + QQLL
Sbjct: 72 NL--LGACEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 477 NAVA-------HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVT 529
+ A +L +HRDL N+L+ + K+ DFGL+R +K +
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 187
Query: 530 LWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
W L Y+T D+WS G + E + +
Sbjct: 188 RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSL 219
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE--YGSPLKHYTPIVVTLW 531
Q+ + +L +HRDL N+L++ ++K+ DFGLAR+ + K T + +
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 207
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
+ +PE L + Y+ D+WS G + E +
Sbjct: 208 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 14/29 (48%), Positives = 23/29 (79%)
Query: 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++ + +I EGTYGVVY+ ++K+T +IVA
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVA 29
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.003
Identities = 46/240 (19%), Positives = 95/240 (39%), Gaps = 16/240 (6%)
Query: 74 EKERDRNKSDQSDGGHKSHRRRDEDRKHRDE---RKAREAQKSKEYTAREIDELKAKEAD 130
+ + K+++ + ++ +ED K E ++A EA+K++E +E +E K E
Sbjct: 1662 KAAEEAKKAEEDKKKAEEAKKAEEDEKKAAEALKKEAEEAKKAEELKKKEAEEKKKAEEL 1721
Query: 131 LRARLERKRYSNPLREKEKIER----ELRKERLLEAERVKEAYKERVKDVEQKRKRYRTR 186
+A E K + +++ + ++ E +K+ E +++ KE K E+ RK
Sbjct: 1722 KKAEEENKIKAEEAKKEAEEDKKKAEEAKKDE-EEKKKIAHLKKEEEKKAEEIRKEKEAV 1780
Query: 187 SRSRSPINKAKNEMDVDEAHQRGEDDGARTPPG-----PAAPESRSRQDLEAAGLVVLTD 241
K M+VD+ + D+ A G +S+ +D + +
Sbjct: 1781 IEEELDEEDEKRRMEVDKKIKDIFDNFANIIEGGKEGNLVINDSKEMEDSAIKEVADSKN 1840
Query: 242 ESRSPTPQRDEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENED 301
++ E G+ E+ E +D ED ++ +DE E + +D
Sbjct: 1841 MQLEEADAFEKHKFNKNNENGEDGNKEADFNKE---KDLKEDDEEEIEEADEIEKIDKDD 1897
|
Length = 2084 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.003
Identities = 72/378 (19%), Positives = 139/378 (36%), Gaps = 30/378 (7%)
Query: 48 DKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDE-DRKHRDERK 106
+ S S R + R E+E ++ + ++E +
Sbjct: 647 EPSGSITGGSRNKRSSLAQKRELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEE 706
Query: 107 AREAQKSKEYTAREIDELKAKEADLRARLER--KRYSNPLREKEKIERELRK--ERLLEA 162
R + E R+++ELK + A L LE+ R E E++E EL + ERL E
Sbjct: 707 LRRQLEELE---RQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEEL 763
Query: 163 ERVKEAYKERVKDVEQKRKRYRTRSRS----RSPINKAKNEMDVDEAHQRGEDDGARTPP 218
E E+ +E + ++++ + + ++ + + E + E +
Sbjct: 764 EEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRR 823
Query: 219 GPAAPESRSRQ----DLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAESSAGSE 274
E + +LE L L +E + +E +E E
Sbjct: 824 ERLEQEIEELEEEIEELEEK-LDELEEELEELEKELEELKEELEELEAEKEELEDELKEL 882
Query: 275 ESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNESERDVSPHVIMD 334
E ++ E+ ++ S E +E E ++ E+ K ++ + E E ++
Sbjct: 883 EEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLERLEVELPELEEELEEEYEDT 942
Query: 335 QDVDME-----IELEKDTLPPYLPAIQGCRSVEEF-KCLNRIEE--GTYGVVYRAKDKRT 386
+ ++E +E E + L P R++EE+ + R EE + AK+K
Sbjct: 943 LETELEREIERLEEEIEALGPVNL-----RAIEEYEEVEERYEELKSQREDLEEAKEKLL 997
Query: 387 DEIVALKRLKMEKEKEGF 404
+ I L + K E+ KE F
Sbjct: 998 EVIEELDKEKRERFKETF 1015
|
Length = 1163 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.003
Identities = 33/139 (23%), Positives = 44/139 (31%), Gaps = 27/139 (19%)
Query: 207 QRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKP-------GTGQE 259
Q+ D ++T + S DL+ L+ S Q EKP
Sbjct: 336 QKQYDPSSKTSTNSQSGTSMLEDDLK------LSSSEDSDEEQATEKPPSRNTPPSAPSS 389
Query: 260 EGELAGSAESSAGSE-ESSQDGSEDSSQDSSSSDEEENDENEDKA-------------DK 305
E A S+ S+ S S DS +SSSSD EEN+ + D
Sbjct: 390 NPEPAASSSGSSSSSSGSESSSGSDSESESSSSDSEENEPPRTASPEPEPPSTNKWQLDN 449
Query: 306 KEKKAKKRKKEDASPNESE 324
K K A S
Sbjct: 450 WLNKVNPHKVSPAESVSSN 468
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|234750 PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.003
Identities = 24/111 (21%), Positives = 47/111 (42%), Gaps = 11/111 (9%)
Query: 93 RRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKRYSNPLR----EKE 148
R E + E +EA+K KE + ++L+ +E L E++ ++ E +
Sbjct: 529 ERELEQKAEEAEALLKEAEKLKEELEEKKEKLQEEEDKLLEEAEKE-AQQAIKEAKKEAD 587
Query: 149 KIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNE 199
+I +ELR+ + VK ++ + RKR + + K + E
Sbjct: 588 EIIKELRQLQKGGYASVKA------HELIEARKRLNKANEKKEKKKKKQKE 632
|
Length = 782 |
| >gnl|CDD|178945 PRK00247, PRK00247, putative inner membrane protein translocase component YidC; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 24/150 (16%), Positives = 51/150 (34%), Gaps = 14/150 (9%)
Query: 51 SSQHKSHHRSRHRDERDRRHHHKEKERDRNK------------SDQSDGGHKSHRRRDED 98
+ + K HH + R+++ K + + + + R +
Sbjct: 280 TDEFKEHHAEQRAQYREKQKEKKAFLWTLRRNRLRMIITPWRAPELHAENAEIKKTRTAE 339
Query: 99 RKHRDERKAREAQKSKEYTAREIDELKAKEADLR-ARLERKRYSNPLREKEKIERELRKE 157
+ RK AQK + REI+ +E AR +R + ++K I+ ++
Sbjct: 340 KNEAKARKKEIAQKRRA-AEREINREARQERAAAMARARARRAAVKAKKKGLIDASPNED 398
Query: 158 RLLEAERVKEAYKERVKDVEQKRKRYRTRS 187
E E K + + + R ++
Sbjct: 399 TPSENEESKGSPPQVEATTTAEPNREPSQE 428
|
Length = 429 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.004
Identities = 51/220 (23%), Positives = 82/220 (37%), Gaps = 16/220 (7%)
Query: 39 HGSSSSSQQDKSSSQHKSHHRS--RHRDERDRRHHHKEKERDRNKSDQSDGGHKSHR--- 93
HG SSS + S+ + ++ S +D K Q DG H
Sbjct: 366 HGRRSSSCASRQSANNVTNITSITSVTSVASVASVASVPSKDDRKYPQ-DGATHCHAVNG 424
Query: 94 ----RRDEDRKHRDERKAREAQ-KSKEYTAREIDELKAKEADLRARLERKRYSNPLREK- 147
R D+D R + A K+ E E ++ E + R RLER+R RE+
Sbjct: 425 HYGGRVDKDHAERARIEKENAHRKALEMKILEKKRIERLEREERERLERERMERIERERL 484
Query: 148 --EKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNEMDVDEA 205
E++ERE + LE +R+ +ERV +E R R R+ + +N +
Sbjct: 485 ERERLERERLERDRLERDRLDRLERERVDRLE--RDRLEKARRNSYFLKGMENGLSAGGG 542
Query: 206 HQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRS 245
G GA G + R+ + + + +R
Sbjct: 543 PGDGPGVGAGVGAGVGTSDGRNHSGVRSGIHCSIQSSARG 582
|
Length = 1021 |
| >gnl|CDD|220815 pfam10577, UPF0560, Uncharacterized protein family UPF0560 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 26/118 (22%), Positives = 43/118 (36%), Gaps = 10/118 (8%)
Query: 207 QRGEDDGARTPPGPAAPE-----SRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEG 261
+ E G +T P A + V + E S P DE G
Sbjct: 684 EEREQTGEKTAPPSTAYTKLVYLEDGDPSSSESRTTVCSPEDSSLRPLLDEGSKV---SG 740
Query: 262 ELAGSAESSAGSEESSQDGSEDSS--QDSSSSDEEENDENEDKADKKEKKAKKRKKED 317
E A + E S G + SS + E+E D+++ ++KK+ +K+E+
Sbjct: 741 EQAPTVEESRGRSSTDSSREPLSSPRRRRGRRPEDELDDDDGDDAGEDKKSPWQKREE 798
|
This family of proteins has no known function. Length = 805 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1028 | |||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG1026|consensus | 774 | 99.98 | ||
| KOG0603|consensus | 612 | 99.98 | ||
| KOG4257|consensus | 974 | 99.97 | ||
| KOG0199|consensus | 1039 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| KOG0196|consensus | 996 | 99.96 | ||
| KOG1094|consensus | 807 | 99.96 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0984|consensus | 282 | 99.96 | ||
| KOG1152|consensus | 772 | 99.96 | ||
| KOG0576|consensus | 829 | 99.96 | ||
| KOG4278|consensus | 1157 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0200|consensus | 609 | 99.95 | ||
| KOG2052|consensus | 513 | 99.95 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG3653|consensus | 534 | 99.95 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1025|consensus | 1177 | 99.94 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1345|consensus | 378 | 99.93 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0590|consensus | 601 | 99.91 | ||
| KOG1164|consensus | 322 | 99.9 | ||
| KOG1165|consensus | 449 | 99.89 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0606|consensus | 1205 | 99.88 | ||
| KOG1163|consensus | 341 | 99.87 | ||
| KOG1024|consensus | 563 | 99.87 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1240|consensus | 1431 | 99.8 | ||
| KOG0590|consensus | 601 | 99.8 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG4158|consensus | 598 | 99.75 | ||
| KOG1166|consensus | 974 | 99.75 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG1033|consensus | 516 | 99.66 | ||
| KOG0195|consensus | 448 | 99.64 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| KOG1023|consensus | 484 | 99.54 | ||
| KOG0606|consensus | 1205 | 99.52 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0601|consensus | 524 | 99.43 | ||
| KOG1035|consensus | 1351 | 99.36 | ||
| KOG0595|consensus | 429 | 99.29 | ||
| KOG1266|consensus | 458 | 99.25 | ||
| KOG1243|consensus | 690 | 99.24 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG0601|consensus | 524 | 99.18 | ||
| KOG0663|consensus | 419 | 99.17 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| KOG0593|consensus | 396 | 99.13 | ||
| KOG0600|consensus | 560 | 98.97 | ||
| KOG0659|consensus | 318 | 98.96 | ||
| KOG3741|consensus | 655 | 98.93 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.84 | |
| KOG0591|consensus | 375 | 98.8 | ||
| KOG0661|consensus | 538 | 98.79 | ||
| KOG0611|consensus | 668 | 98.77 | ||
| KOG0615|consensus | 475 | 98.72 | ||
| KOG3087|consensus | 229 | 98.7 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.7 | |
| KOG0605|consensus | 550 | 98.69 | ||
| KOG0598|consensus | 357 | 98.68 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.66 | |
| KOG0580|consensus | 281 | 98.66 | ||
| KOG0662|consensus | 292 | 98.65 | ||
| KOG2137|consensus | 700 | 98.65 | ||
| KOG0597|consensus | 808 | 98.63 | ||
| KOG0594|consensus | 323 | 98.58 | ||
| KOG0583|consensus | 370 | 98.55 | ||
| KOG0694|consensus | 694 | 98.53 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 98.48 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 98.48 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 98.44 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 98.43 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 98.43 | |
| KOG0574|consensus | 502 | 98.42 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 98.41 | |
| KOG0581|consensus | 364 | 98.41 | ||
| KOG0575|consensus | 592 | 98.4 | ||
| KOG0589|consensus | 426 | 98.39 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 98.38 | |
| KOG0586|consensus | 596 | 98.38 | ||
| KOG1152|consensus | 772 | 98.37 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 98.36 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 98.35 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 98.33 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 98.33 | |
| KOG0032|consensus | 382 | 98.33 | ||
| KOG0201|consensus | 467 | 98.32 | ||
| KOG0616|consensus | 355 | 98.31 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 98.31 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 98.3 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 98.29 | |
| KOG0592|consensus | 604 | 98.29 | ||
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 98.29 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 98.29 | |
| KOG4717|consensus | 864 | 98.29 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 98.28 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 98.27 | |
| KOG0585|consensus | 576 | 98.26 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 98.25 |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-69 Score=586.26 Aligned_cols=339 Identities=73% Similarity=1.212 Sum_probs=313.9
Q ss_pred CCCCCCCccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEE
Q psy18163 347 TLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426 (1028)
Q Consensus 347 ~lp~y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L 426 (1028)
.+|.+.+...+|+++++|+++++|++|+||.||+|+++.|++.||+|.++.+....+++...+|||++|.+++|||||.+
T Consensus 61 ~~p~~~~~l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~v 140 (419)
T KOG0663|consen 61 PIPLKQELLGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEV 140 (419)
T ss_pred CCccccccccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeee
Confidence 34555566899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEE
Q psy18163 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILK 506 (1028)
Q Consensus 427 ~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lK 506 (1028)
.+++++.+.+.+|||||||++||.+|++.+. ++|...++++++.||+.||+|||.++|+||||||+|+|+++.|.+|
T Consensus 141 kEVVvG~~~d~iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lK 217 (419)
T KOG0663|consen 141 KEVVVGSNMDKIYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILK 217 (419)
T ss_pred EEEEeccccceeeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEE
Confidence 9999999999999999999999999999874 6799999999999999999999999999999999999999999999
Q ss_pred EeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q psy18163 507 VGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586 (1028)
Q Consensus 507 L~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p 586 (1028)
|+|||+|+.++++...+|..+.|.||+|||+|+|++.|++++||||+|||+.|||+++|.|.|.++.+++.+||..+|+|
T Consensus 218 iaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP 297 (419)
T KOG0663|consen 218 IADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP 297 (419)
T ss_pred ecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCC
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMF 666 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~ 666 (1028)
++.+|+++..+|.+..+.|...|... +..+.....+++.+.+||..||.+||.+|+||.++|.|+||.+.|.|++|.++
T Consensus 298 te~iwpg~~~lp~~k~~~f~~~pyn~-lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFSEHPYNN-LRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMF 376 (419)
T ss_pred ccccCCCccccchhhccccCCCCchh-hhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhc
Confidence 99999999999999888888877642 22222222288999999999999999999999999999999999999999999
Q ss_pred CCCccchhHHHhhhhcCCCCCCCC
Q psy18163 667 PTWPAKSELAHKKAAMASPKPPSG 690 (1028)
Q Consensus 667 pt~p~~~~~~~~~~~~~sp~pp~g 690 (1028)
||||++++..++.. ..+++|+.+
T Consensus 377 Pt~P~k~~~~~~~~-~~~~~~~~~ 399 (419)
T KOG0663|consen 377 PTWPAKSEQQRVKR-GTSPRPPEG 399 (419)
T ss_pred CCCccccccccCCC-CCCCCCCcc
Confidence 99999998877533 455666655
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-59 Score=529.55 Aligned_cols=315 Identities=44% Similarity=0.808 Sum_probs=280.5
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
+..+.|+.+++||+|+||.||+|++..||+.||||.+..+.....+.....|||.||++|.||||++|.++++......+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 45678999999999999999999999999999999999999889999999999999999999999999999987766789
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||++||..|+. .....|++.++++||.||+.||+|||++||+|||||.+|||||++|++||+|||||+++..
T Consensus 194 YlVFeYMdhDL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 194 YLVFEYMDHDLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEecccchhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999999998887765 3455799999999999999999999999999999999999999999999999999997765
Q ss_pred CC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 519 PL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 519 ~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ..+|..+.|+||+|||+|+|...|+.++||||+||||.||++|+|+|.|.++.+++..|++.+|.|.+.+|+ ..++
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kL 349 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKL 349 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccC
Confidence 43 358999999999999999999999999999999999999999999999999999999999999999999999 7777
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCCCCCccchhHHH
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAH 677 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~pt~p~~~~~~~ 677 (1028)
|.+..+.. ..+....+. .....++..+.+||..||.+||.+|.||.++|+|+||...|.+.+|..+|.++...+...
T Consensus 350 P~~~~~kp-~~~y~r~l~--E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~ 426 (560)
T KOG0600|consen 350 PHATIFKP-QQPYKRRLR--ETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELDA 426 (560)
T ss_pred CcccccCC-CCcccchHH--HHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHHH
Confidence 75433211 111111111 114568899999999999999999999999999999999999999999999999888766
Q ss_pred hhh
Q psy18163 678 KKA 680 (1028)
Q Consensus 678 ~~~ 680 (1028)
+.+
T Consensus 427 K~r 429 (560)
T KOG0600|consen 427 KRR 429 (560)
T ss_pred HHH
Confidence 554
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-57 Score=480.41 Aligned_cols=300 Identities=42% Similarity=0.795 Sum_probs=274.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|..+++||+|+||+||+|++..||+.||||.++.....++.....+|||..|+.++|+||+.|+++| ...+.+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF--PHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc--cCCCceEEE
Confidence 578899999999999999999999999999999999988888899999999999999999999999988 455689999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
+|||..||... ++.+...++..+++.|+.+++.||+|||+++|+||||||.|+||+.+|.+||+|||+|+.++.+..
T Consensus 80 fEfm~tdLe~v---Ikd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 80 FEFMPTDLEVV---IKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEeccccHHHH---hcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99999766554 456677899999999999999999999999999999999999999999999999999999999888
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
..+..+.|.||+|||+|.|.+.|+..+||||+|||+.||+.|.|.|.|.+|.+++..|+..+|+|.+..||+...+|.+.
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 88888999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCCCCCcc
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPA 671 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~pt~p~ 671 (1028)
.+.+...+.... ..+..+.++.|||.+||.+||.+|+|+.|+|.|+||+..|.|..+..+|....
T Consensus 237 ~~~~~P~~~~~~-----lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 237 KIQQFPKPPLNN-----LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred HHhcCCCCcccc-----ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 877544443322 33556788899999999999999999999999999999999988887776444
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-55 Score=466.96 Aligned_cols=287 Identities=36% Similarity=0.624 Sum_probs=249.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.|+.+.++|+|+||+||+|+++.||+.||||.+..+..+.......+|||.+|+++.|+|+|.|+++|- ....++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEEE
Confidence 5689999999999999999999999999999999776555555566789999999999999999988884 45689999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||||++++.+.++.+ ...++...++.|+.|++.|+.|||+++||||||||+||||+.+|.+||||||+|+.+..+..
T Consensus 80 FE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 80 FEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred eeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 999998766666654 44578889999999999999999999999999999999999999999999999999988888
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.+|.++.|+||+|||++.|...|+.++||||+||++.||++|.++|+|.++.|++..|...+|...+.-..-|+.-+.+.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 99999999999999999998889999999999999999999999999999999999999999987665444455555555
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
...++.......+..+ .+.++..+.||+.+||..||.+|++.+++|.||||.
T Consensus 237 Gv~lP~~~~~epLe~k--~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERK--YPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhh--cccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 5555544433333222 245677899999999999999999999999999994
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=483.58 Aligned_cols=289 Identities=35% Similarity=0.683 Sum_probs=253.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|.++++||.|+||.||+|+.+.++..||||.++..... .....-+||+..|++++ |||||+|.+++...+. ++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-IL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence 357899999999999999999999999999999999865432 22345689999999999 9999999999876543 99
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+|||||++||..|+.. +..+|++..++.|+.||++||+|+|.+|++||||||+||||.....|||+|||+|+.+.+
T Consensus 86 ~fVfE~Md~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhhhhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999988777764 477899999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. ..+|.++.|+||+|||+|+....|+.++|||++|||++|+.+-+|+|.|.++.|++.+|++.+|+|....|+....+.
T Consensus 163 k-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 K-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred C-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 4 678999999999999999988999999999999999999999999999999999999999999999999998754444
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
......+ |.+.+......-+..+.++.+||.+||.+||.+||||.++|+||||+..
T Consensus 242 ~~mnf~~---P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 242 SAMNFRF---PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHhccCC---CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 4333333 3333344444445588999999999999999999999999999999864
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=459.32 Aligned_cols=296 Identities=47% Similarity=0.870 Sum_probs=261.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCC-eeEEEEEEeecC----C
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN-IVTVREIVVGSN----M 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPN-IV~L~~i~~~~~----~ 435 (1028)
...|+.+++||+|+||+||+|+.+.+|+.||||++......++.+...++|+.+|+.++|+| ||.|++++...+ .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 35688889999999999999999999999999999988777778889999999999999999 999999987654 2
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..++|||||+..||..+++.+......++...++.+++||+.||+|||+++|+||||||.||||+.+|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 47899999999999988887754324467788999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
++-+...+++.++|.||+|||+|+|+..|++.+||||+|||++||+++.+.|.|.++.+++..|++.+|+|++..||+..
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 88888889999999999999999999899999999999999999999999999999999999999999999999999999
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
.++.... .+..++. ........+.++..+.+||.+||++||.+|+||..+|.||||...+.
T Consensus 250 ~~~~~k~-~f~~~~~--~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 250 SLPDYKA-PFPKWPG--PKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccccccc-cCcCCCC--ccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 8887654 2322221 11122223445578999999999999999999999999999987643
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=464.10 Aligned_cols=264 Identities=31% Similarity=0.457 Sum_probs=221.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-----CccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-----FPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-----~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
..+.|.+.+.||.|+||.|-+|..+.||+.||||++.+.+.... ......+|+++|++++|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 34678999999999999999999999999999999987654331 12234689999999999999999999964
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC---CcEEEeccC
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR---GILKVGDFG 511 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~---g~lKL~DFG 511 (1028)
.+..||||||++| |+|++.+..++ .+.+...+.|+.||+.||.|||++||+||||||+||||..+ -.+||+|||
T Consensus 248 ~ds~YmVlE~v~G--GeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 248 PDSSYMVLEYVEG--GELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred CCceEEEEEEecC--ccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 4578999999999 99999887654 57888899999999999999999999999999999999876 689999999
Q ss_pred CccccCCCCCcccccccCccccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGC--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE-QLSRIFKTMGTPNE 588 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~g~--~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d-~l~kI~~~lg~p~~ 588 (1028)
+|+..+. ...+.++||||.|.|||++.+. ..|..++||||||||||.+|+|.+||.+..... ...+|.+.-..+.+
T Consensus 325 lAK~~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 325 LAKVSGE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred hhhcccc-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 9998873 4667789999999999999652 235568999999999999999999998865443 55555443222222
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.. +..+++.+++||.+||.+||++|||+.|+|+||||+..+
T Consensus 404 ~~-----------------------------w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 404 LQ-----------------------------WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hh-----------------------------hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 22 234789999999999999999999999999999999754
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=466.34 Aligned_cols=260 Identities=29% Similarity=0.440 Sum_probs=230.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.+|...+.||+|+|+.||.+++..+|+.||+|++.+... +........+||+|.+.|+|||||+++.+|.+ .+++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 579999999999999999999999999999999987543 34455677899999999999999999999854 459999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|+|+|.. ++|++.++ ....++|.+++.|++||+.||.|||+++|||||||..||||+.+.+|||+|||||+.+..+.
T Consensus 96 vLELC~~--~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 96 VLELCHR--GSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEecCC--ccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999987 66666655 56679999999999999999999999999999999999999999999999999999998776
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
....+.||||.|+||||+.. ..++..+||||+|||||.||+|+|||...+-.+++.+|...-..
T Consensus 173 Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--------------- 236 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--------------- 236 (592)
T ss_pred cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc---------------
Confidence 77778999999999999987 67999999999999999999999999998888888888653111
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
+...++..|.|||.+||..||.+|||+++||.|+||+....|
T Consensus 237 ------------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 237 ------------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred ------------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 112478899999999999999999999999999999765444
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=445.22 Aligned_cols=264 Identities=31% Similarity=0.462 Sum_probs=230.5
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-CccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-FPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
....++|++++.||+|+||+||.++.+.|++.||+|++++...-.. .......|.++|..++||+||.|+ |.+++..
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~--ysFQt~~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLI--YSFQTEE 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeE--EecccCC
Confidence 3456899999999999999999999999999999999988764332 345567899999999999999994 5667888
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
++|||+||+.| |+|+..+.+ .+.|++..++.|+..|+.||.|||++|||||||||+|||||..|+++|+|||||+..
T Consensus 99 kLylVld~~~G--GeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNG--GELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCC--ccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999998 888888755 456999999999999999999999999999999999999999999999999999966
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
-.......++|||+.|||||++.+ .+|+.++|||||||++|+||+|.+||.+.+......+|...-.
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------------ 242 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------------ 242 (357)
T ss_pred ccCCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------------
Confidence 554455567899999999999998 5799999999999999999999999999998888888865310
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC----CHHHHHhCCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI----TADEALRHDYFSESPL 659 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP----TA~ElL~HPfF~e~p~ 659 (1028)
......++..++|||.+||..||.+|. ++.+|-+||||....|
T Consensus 243 --------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 243 --------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred --------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 011223788999999999999999996 7999999999987654
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=441.95 Aligned_cols=295 Identities=36% Similarity=0.564 Sum_probs=247.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEee---cCCCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG---SNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~---~~~~~l 438 (1028)
..|..++.||.|+||.|+.|.+..||+.||||.+.......-.....+||+.+|+.++|+||+.+++++.. .....+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45666899999999999999999999999999997554444456677899999999999999999999865 345679
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+|+|+|+.||..++.. ...+++..+..++.||+.||+|+|+.||+||||||.|+|++.+..+||||||+|+....
T Consensus 102 YiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999998766666542 44589999999999999999999999999999999999999999999999999998753
Q ss_pred --CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 --PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 --~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
....+|..+.|.||+|||+++....|+.++||||+||||.|||+|++.|.|.+..+++..|+..+|+|.+........
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 234568889999999999999989999999999999999999999999999999999999999999998766544432
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPID 662 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~ 662 (1028)
..... .....|......+....+..++.|.|||.+||..||.+|+||+|+|.||||.....|.+
T Consensus 258 ~~ar~--yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 258 EKARP--YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHH--HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 11111 11122333333344455678999999999999999999999999999999987655543
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=447.80 Aligned_cols=268 Identities=28% Similarity=0.443 Sum_probs=224.8
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
....+++|+++..||+|+||.||+|+.+.||.+||||+++++..- .+.......|-++|....+|+||+|+ |.+++.
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy--YsFQD~ 213 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY--YSFQDK 213 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE--EEecCC
Confidence 345789999999999999999999999999999999999887543 34445566799999999999999995 555788
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
+++||||||++| |+++..+. +...|++..++.|+.+++.||..||..|||||||||+|+|||..|++||+|||||.-
T Consensus 214 ~~LYLiMEylPG--GD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 214 EYLYLIMEYLPG--GDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred CeeEEEEEecCC--ccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccch
Confidence 899999999998 55555443 355799999999999999999999999999999999999999999999999999853
Q ss_pred cCC-----------------------CCC------------------------cccccccCccccCcccccCCCCCCchh
Q psy18163 516 YGS-----------------------PLK------------------------HYTPIVVTLWYRSPELLLGCKEYSTPI 548 (1028)
Q Consensus 516 ~~~-----------------------~~~------------------------~~t~~vGT~~Y~APEvL~g~~~ys~ks 548 (1028)
+.. ... ...+.+|||.|||||||++ +.|+..|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~c 369 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKEC 369 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccc
Confidence 210 000 0124689999999999999 6699999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHH
Q psy18163 549 DMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGY 628 (1028)
Q Consensus 549 DIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~ 628 (1028)
||||||||+||||.|+|||.+.+..++..+|+..-. .+.++.. ..++++|+
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-----------------~l~fP~~------------~~~s~eA~ 420 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-----------------TLKFPEE------------VDLSDEAK 420 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-----------------hccCCCc------------CcccHHHH
Confidence 999999999999999999999999999999987421 1111111 22668999
Q ss_pred HHHHHhcccCcCCCC---CHHHHHhCCCCCCCCCC
Q psy18163 629 DLLCKFLTYDPVTRI---TADEALRHDYFSESPLP 660 (1028)
Q Consensus 629 DLL~kcL~~DP~kRP---TA~ElL~HPfF~e~p~p 660 (1028)
|||.+||+ ||++|. +++||..||||+...|.
T Consensus 421 DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 421 DLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 99999999 999998 59999999999987764
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=435.14 Aligned_cols=283 Identities=35% Similarity=0.584 Sum_probs=238.8
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC---eEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD---KIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~---~l~ 439 (1028)
.|.-.+++|.|+||+||.|....+++.||||.+-.+... --+|+.+|+.+.|||||.|..+|...... ++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 588899999999999999999999999999988654321 13799999999999999999888755444 567
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC-CcEEEeccCCccccCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR-GILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~-g~lKL~DFGlAr~~~~ 518 (1028)
||||||+.+|...+..+...+..++.-+++-|+.||+.||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+..
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 899999998888888776667778888999999999999999999999999999999999965 9999999999998754
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. ....+...|+.|+|||+|.|+..|++++||||.||++.|||-|.+.|.|.+..+++..|++.+|.|+........ +
T Consensus 179 ~-epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn--~ 255 (364)
T KOG0658|consen 179 G-EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN--P 255 (364)
T ss_pred C-CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC--c
Confidence 3 344677889999999999999999999999999999999999999999999999999999999999865432221 1
Q ss_pred hhhhhccccCCCCCCCcc-ccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKT-KVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~-~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+.... .+|.+....+ +.+...+++++.+||.++|.++|.+|.++.|+|.||||.+-
T Consensus 256 ~y~~~---~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 256 NYTEF---KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred ccccc---cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 11111 2222222222 23566789999999999999999999999999999999864
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-50 Score=427.81 Aligned_cols=299 Identities=43% Similarity=0.820 Sum_probs=252.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCe----EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDE----IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~----~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
+..|+++..||+|+||.||+|....++. .||||.++.++...+......+|+.+++.++||||+.|..+|... ..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 4579999999999999999997665543 799999998877778888889999999999999999999988764 56
Q ss_pred eEEEEEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC----CcEEEeccC
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR----GILKVGDFG 511 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~----g~lKL~DFG 511 (1028)
.++|++||.++||..++..-+.. ...++...++.|+.||+.|+.|||+++|+||||||.||||..+ |.|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 89999999999999988776543 3457888999999999999999999999999999999999877 899999999
Q ss_pred CccccCCCCCcc---cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHH
Q psy18163 512 LAREYGSPLKHY---TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS---------DLEQLSRI 579 (1028)
Q Consensus 512 lAr~~~~~~~~~---t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s---------d~d~l~kI 579 (1028)
+++.+.++...+ ...+.|.||+|||+|+|...|+.++|||++|||+.||||-.|.|.+.. ..+++.+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999998875543 467889999999999999999999999999999999999999998753 35889999
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhh--ccc--cCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKM--TFA--EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l--~~~--~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
++.+|.|.+..|+...++|..+.. .|. .+.+++-..+-.....-++.+.+||.+||.+||.+|+|++++|+|+||+
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 999999999999999888876432 111 1111111111111222345689999999999999999999999999999
Q ss_pred CCCCC
Q psy18163 656 ESPLP 660 (1028)
Q Consensus 656 e~p~p 660 (1028)
+++.|
T Consensus 342 ~d~lp 346 (438)
T KOG0666|consen 342 EDPLP 346 (438)
T ss_pred cCCCC
Confidence 99776
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=439.78 Aligned_cols=263 Identities=28% Similarity=0.413 Sum_probs=225.7
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCC
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~ 435 (1028)
.+...+|.+.+.||+|+|++||+|+++.+++.||||++.+... ++.......+|-++|..| .||.|++|+ |.+++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy--~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLY--FTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEE--EEeecc
Confidence 4567899999999999999999999999999999999976542 233444556788888888 799999995 555677
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+|+|+||+.+ |+|+..|... +.|.+..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||.|+.
T Consensus 147 ~sLYFvLe~A~n--Gdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 147 ESLYFVLEYAPN--GDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred cceEEEEEecCC--CcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 799999999997 6666666443 5699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCC-----------C--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q psy18163 516 YGSPL-----------K--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT 582 (1028)
Q Consensus 516 ~~~~~-----------~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~ 582 (1028)
+.... . ...+++||..|.+||+|.. ...++.+|||+||||||+||.|.|||.+.++.-++++|+.+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 64311 1 1256999999999999987 67899999999999999999999999999999999999986
Q ss_pred cCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
...++ ..+++.+.|||.++|..||.+|+|+.+|.+||||....|
T Consensus 303 ~y~fp---------------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 303 DYEFP---------------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred cccCC---------------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 43222 225678999999999999999999999999999987655
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=414.91 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=227.0
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
..+++|+++..||.|+||.|.+++++.+|.+||+|++.+... +........+|..+|+.+.||+++.|+..| .+...
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee--ccCCe
Confidence 457899999999999999999999999999999999987642 222334556899999999999999997666 45569
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+||||||++| |.|+..++.. +.|++..++.|+.||+.||+|||+++|++|||||+|||||.+|++||+|||+|+.+.
T Consensus 119 lymvmeyv~G--GElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 119 LYMVMEYVPG--GELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEEEeccCC--ccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999998 8888877654 469999999999999999999999999999999999999999999999999999886
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ..+.||||.|+|||++.. ++|+.++|||||||++|||+.|++||...+...+..+|++.--
T Consensus 196 ~r---T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v------------- 258 (355)
T KOG0616|consen 196 GR---TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV------------- 258 (355)
T ss_pred Cc---EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-------------
Confidence 32 456899999999999988 7899999999999999999999999999999988888876421
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESPL 659 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p~ 659 (1028)
.+.+.++.+++|||.++|++|-.+|. ...+|.+||||+...|
T Consensus 259 --------------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 259 --------------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred --------------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 12244788999999999999999994 6889999999998654
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=389.17 Aligned_cols=287 Identities=43% Similarity=0.790 Sum_probs=257.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
..|...++||+|+||+||+|++..|++.||+|.++.+..+++.+...++||.+|+.+.|.|||+|+++... ...+-||
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 35777889999999999999999999999999999998888888899999999999999999999988754 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
+|||..+|..+++.+ .+.+....++.++.|++.||.|||+++++||||||.|+||+.+|.+||+|||+|+.++.+..
T Consensus 80 fe~cdqdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHHhhHHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 999998777777665 55688889999999999999999999999999999999999999999999999999999988
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
.+...+.|.||++|.++.|.+-|++++||||.|||+.|+.. |.|.|.|.+-.+++.+|+..+|.|.+..||+...+|.+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 88889999999999999999999999999999999999975 88999999999999999999999999999999988876
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
... +.||.. ..+...-+.++...+|||+++|.-+|.+|++|+.+|+||||...
T Consensus 237 k~y--p~ypat--tswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPY--PIYPAT--TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccc--CCcccc--chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 432 223322 22233445677789999999999999999999999999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=409.37 Aligned_cols=285 Identities=41% Similarity=0.742 Sum_probs=236.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|+++++||.|+||+||+|++..++..||+|+++.... ........+|+.++..++||||+++++++.. ...+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 4689999999999999999999999999999999975532 2233456789999999999999999988754 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.++|.+++ ......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 v~e~~~~~l~~~l---~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 81 VFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EEeCCCcCHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 9999987665554 3344567888999999999999999999999999999999999999999999999998765444
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|+.+.....+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 44556688999999999987677899999999999999999999999999999999999999999998888876544333
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
....++.+.. .........++..++|||.+||.+||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~---~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRA---QPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCC---CchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 3322222111 01111224577889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=429.39 Aligned_cols=259 Identities=32% Similarity=0.432 Sum_probs=225.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc---cCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK---EGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~---~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~ 435 (1028)
....|.+.+.||+|+||+|++|.+..++..||+|++...... ......+.+|+.+++.+. ||||+++++++...+
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 457899999999999999999999999999999988765322 123445568999999999 999999999997655
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC-CcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR-GILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~-g~lKL~DFGlAr 514 (1028)
.+|+|||||.+ |+|++.+.. .+.+.+.+++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++.
T Consensus 94 -~~~ivmEy~~g--GdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 -KIYIVMEYCSG--GDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred -eEEEEEEecCC--ccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 69999999998 899999887 6779999999999999999999999999999999999999998 999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCK-EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~-~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
........+.+.|||+.|+|||+|.+.. +.+.++||||+|||||.|++|+.||...+...+...|......
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~-------- 241 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK-------- 241 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc--------
Confidence 7743345678899999999999999865 4469999999999999999999999998877777776542110
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccc-cHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSIL-TELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~L-s~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
+...+ ++.+++||.+||..||.+|+|+.+++.||||+.
T Consensus 242 -------------------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 242 -------------------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11124 788999999999999999999999999999997
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=422.41 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=218.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++.+.++.||+|..|+||+++++.|++.+|+|++..... .....++++|+.+++.++|||||.+|+.|+.+.. .++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~-~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID-PALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEE
Confidence 34677888999999999999999999999999999954432 4456678999999999999999999999986654 699
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|+||||++ +|..++.. .+.+++.....++.+|++||.|||+ ++||||||||+||||+..|.|||||||.+..+.
T Consensus 155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 99999987 44444432 3568999999999999999999996 999999999999999999999999999999876
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhcCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK-----SDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~-----sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
+. ..++++||..|||||.+.+ ..|+.++||||||++|+||++|+.||... +..+.+..|+. .|++....
T Consensus 231 nS--~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~lP~ 304 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPRLPE 304 (364)
T ss_pred hh--hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCCCCc
Confidence 53 5678999999999999999 57999999999999999999999999875 44555555543 22221110
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..+|+++++||..||++||.+|+|+.|+|+|||++..
T Consensus 305 ----------------------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 305 ----------------------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred ----------------------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 1368899999999999999999999999999999864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=409.21 Aligned_cols=307 Identities=57% Similarity=1.014 Sum_probs=260.2
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
|..+++|++.+.||.|+||.||+|.+..+|..||+|+++.............+|+.++..++|+||+++++++.+...+.
T Consensus 3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 56778999999999999999999999999999999999766544444455678999999999999999999988766678
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|+||||+.++|.+++... ...+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.
T Consensus 83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999999998887777643 3568899999999999999999999999999999999999999999999999998876
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
......+...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..+...++.+....|+.+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 54444555567889999999987667899999999999999999999999999999999999999998888888877665
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCCCCCc
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWP 670 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~pt~p 670 (1028)
+..........+.. ........+++.+.+||.+||..||.+|||+.++|.||||...+.|+.+.++|+||
T Consensus 240 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 240 PLVGKFTLPKQPYN---NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred cccccccccCCCCC---chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 54333222211110 01111233578899999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=438.28 Aligned_cols=263 Identities=27% Similarity=0.436 Sum_probs=225.3
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
+...+++|.++++||+|+||+|+++..+.++++||||++++...- .+.....+.|-.|+... +||+++.|+..| ++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT 440 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QT 440 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--cc
Confidence 455789999999999999999999999999999999999987532 23334445677776665 499999997766 56
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
.+++|+||||+.| |+ +..+ .....|++..++.|+..|+.||+|||++||||||||.+|||||.+|++||+|||||+
T Consensus 441 ~~~l~fvmey~~G--gd-m~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 441 KEHLFFVMEYVAG--GD-LMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred CCeEEEEEEecCC--Cc-EEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence 6799999999998 66 3333 334569999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.........+++||||.|||||+|.+ +.|+.++|||||||+|||||+|.+||.|.++.+.+..|+.. +..
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-----~~~---- 586 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-----EVR---- 586 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----CCC----
Confidence 77655567788999999999999998 67999999999999999999999999999999999998763 111
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESPL 659 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p~ 659 (1028)
|| ..++.++.++|.+||..||++|.. +++|..||||+...|
T Consensus 587 -------------yP-----------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 587 -------------YP-----------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred -------------CC-----------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 11 237889999999999999999994 689999999998654
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=439.08 Aligned_cols=293 Identities=33% Similarity=0.505 Sum_probs=231.7
Q ss_pred ccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-C-----CCeeEEEEE
Q psy18163 356 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-H-----PNIVTVREI 429 (1028)
Q Consensus 356 ~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-H-----PNIV~L~~i 429 (1028)
......-+|.+++.||+|+||.|.+|.+..|++.||||+++.... +......||.+|..++ | -|||+++++
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 333334489999999999999999999999999999999987643 3445678999998887 3 589999999
Q ss_pred EeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC--CCcEEE
Q psy18163 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH--RGILKV 507 (1028)
Q Consensus 430 ~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~--~g~lKL 507 (1028)
|.+.+ ++|||+|+++.||.+|+..- +...|+...++.|+.||+.||.+||..||||+|||||||||.. ...|||
T Consensus 257 F~fr~--HlciVfELL~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 257 FYFRN--HLCIVFELLSTNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred ccccc--ceeeeehhhhhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeE
Confidence 98765 99999999998888888753 3445889999999999999999999999999999999999974 347999
Q ss_pred eccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 508 GDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 508 ~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
+|||+|+.... ..+ +.+.++.|+|||||+| .+|+.++||||||||++||++|.|+|.|.++.+++..|++.+|.|+
T Consensus 333 IDFGSSc~~~q--~vy-tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 333 IDFGSSCFESQ--RVY-TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred EecccccccCC--cce-eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99999998763 333 7899999999999999 5699999999999999999999999999999999999999999987
Q ss_pred CCCCCCCCCChhh-hh-hccccC-----------------------CCCCCC-ccccccc----cccHHHHHHHHHhccc
Q psy18163 588 EKIWPGFSKLPAV-QK-MTFAEY-----------------------PNVGGL-KTKVAGS----ILTELGYDLLCKFLTY 637 (1028)
Q Consensus 588 ~~~w~~~s~lp~~-~~-l~~~~~-----------------------p~~~~l-~~~~~~~----~Ls~~a~DLL~kcL~~ 637 (1028)
........+...+ .+ ..++.+ ...... ....... .-...+.|||.+||.+
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 6543322211100 00 000000 000000 0000011 1224578999999999
Q ss_pred CcCCCCCHHHHHhCCCCCCCCC
Q psy18163 638 DPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 638 DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
||.+|+|+.++|+||||.....
T Consensus 489 dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 489 DPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred CchhcCCHHHHhcCcccccccc
Confidence 9999999999999999996543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=406.28 Aligned_cols=291 Identities=40% Similarity=0.720 Sum_probs=231.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||.|+||+||+|.+..+++.||||++...... .......+|+.+++.+.||||+.+++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 47899999999999999999999999999999999765322 223456789999999999999999998864 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.++|.+++ ......+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 v~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 81 VFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EEECCCcCHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9999987665554 3344568889999999999999999999999999999999999999999999999998665444
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD-LEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd-~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+..+ .+.+..++..++.+....|++....+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 4455678899999999998767789999999999999999999999988544 566777878788888777776654433
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.....+..+.. ..+........++..+.+||.+||++||.+|||+.++|+||||+..+
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 238 FKPERFTLYSP-KNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccccCC-ccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 22111111000 00000011112457789999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=414.84 Aligned_cols=263 Identities=30% Similarity=0.501 Sum_probs=220.8
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
....+|.+...||.|+||+||+|+++.++..||||.+.+.............||.+|+.++|||||.|++++... +.+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~~i 84 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--DFI 84 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--CeE
Confidence 346789999999999999999999999999999999987754444455567899999999999999999998654 499
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC------CcEEEeccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR------GILKVGDFGL 512 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~------g~lKL~DFGl 512 (1028)
|||||||.| |+|-.+++.. +.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+
T Consensus 85 ~lVMEyC~g--GDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 85 YLVMEYCNG--GDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEEEEeCCC--CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999986 5555555544 368999999999999999999999999999999999999864 4699999999
Q ss_pred ccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
|+.+.. .....+.||++.|||||++.. +.|+.++|+||+|+|||+|++|++||...+..+.+..+-+.-. ..
T Consensus 162 AR~L~~-~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~-----~~- 233 (429)
T KOG0595|consen 162 ARFLQP-GSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE-----IV- 233 (429)
T ss_pred hhhCCc-hhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-----cc-
Confidence 998864 345567899999999999987 5699999999999999999999999999998887775533210 00
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
......++....+|+..+|..||..|.+..+-+.|+|+...+
T Consensus 234 ------------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 234 ------------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ------------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 011122445566999999999999999999999999998765
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=399.21 Aligned_cols=262 Identities=30% Similarity=0.420 Sum_probs=229.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..+.|.+.+.||+|.|++||++.+..||+.+|+|++...+........+.+|+.|.+.++|||||.|.+.+. .....|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc--ccceeE
Confidence 347899999999999999999999999999999999877665555567789999999999999999988774 344789
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEeccCCcccc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDFGLAREY 516 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DFGlAr~~ 516 (1028)
||||+|.| ++|...+-.. ..+++..+..+++||+.||.|||.+||||||+||+|+|+-. ..-+||+|||+|..+
T Consensus 87 lvFe~m~G--~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 87 LVFDLVTG--GELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEEecccc--hHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999998 7777776554 56889999999999999999999999999999999999963 456999999999999
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
+ .......++|||.|||||++.. .+|+.++|||+.|||||.||.|++||.+.+......+|...-...+...|+
T Consensus 164 ~-~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~---- 237 (355)
T KOG0033|consen 164 N-DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD---- 237 (355)
T ss_pred C-CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC----
Confidence 8 4466778999999999999987 679999999999999999999999999999888899988765544444443
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.+++.+++|+.+||..||.+|+||.|+|+|||+.+-
T Consensus 238 -------------------------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 238 -------------------------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred -------------------------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 377899999999999999999999999999999863
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=426.33 Aligned_cols=260 Identities=28% Similarity=0.402 Sum_probs=228.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecc-ccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME-KEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~-~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
+.-|++.+.||.|+-|.|.+|++..||+.+|||++.+. .........+.+||-+|+.+.||||+.||+++. +..++|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe--~~~~ly 88 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE--NKQHLY 88 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec--cCceEE
Confidence 45689999999999999999999999999999999876 334455667789999999999999999999885 556999
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||+||+.+ |.|++++..++ ++++.++..|++||+.|+.|||..+|+||||||+|+||+..++|||+|||+|.... +
T Consensus 89 lvlEyv~g--GELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~ 164 (786)
T KOG0588|consen 89 LVLEYVPG--GELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-P 164 (786)
T ss_pred EEEEecCC--chhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-C
Confidence 99999998 89999887755 58899999999999999999999999999999999999999999999999997653 3
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
...+-+.||+|.|.|||++.|..+.+.++||||+|||||.||||..||++.+-...+.++.... +.
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~--f~------------ 230 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV--FE------------ 230 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc--cc------------
Confidence 4667788999999999999998888999999999999999999999999877777676665421 11
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
+...++.+++|||.+||.+||.+|+|.+||+.|||+...+.
T Consensus 231 -------------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 231 -------------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred -------------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 11347899999999999999999999999999999987544
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=394.89 Aligned_cols=286 Identities=37% Similarity=0.624 Sum_probs=223.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||.|+||+||+|++..++..||||+++.............+|+.++..++||||+++++++.. .+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 46999999999999999999999999999999998664444444566789999999999999999888754 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC-
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL- 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~- 520 (1028)
|||+.+++..++ ......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+....
T Consensus 79 ~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999997544433 2334568889999999999999999999999999999999999999999999999998764322
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+..+...+..+...+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 22345679999999999987 55899999999999999999999999998888877777766655443322222211211
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
....++........ .......++..+.+||.+||.+||.+|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSL-ERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccH-HHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11111111000000 011223477889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=393.15 Aligned_cols=283 Identities=39% Similarity=0.749 Sum_probs=226.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECC-CCeEEEEEEeeccccccCCccchHHHHHHHHHc---CCCCeeEEEEEEee---cC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKR-TDEIVALKRLKMEKEKEGFPITSLREINTLLKA---QHPNIVTVREIVVG---SN 434 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~-tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l---~HPNIV~L~~i~~~---~~ 434 (1028)
.+|++++.||+|+||+||+|.+.. ++..||||+++.............+|+.++..+ .||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999864 578999999976654444444566788777665 69999999998753 23
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
...+++||||+.++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 45699999999988777765432 3347889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.++.+.+..|+...+.+....|+..
T Consensus 159 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCC-cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 76543 33445689999999999977 56899999999999999999999999999999999999998887776666543
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
..++.. .+. ...........+.++..+.+||.+||..||.+|||+.++|+||||
T Consensus 237 ~~~~~~---~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQ---AFH---SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccch---hcc---CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 322211 010 000011111223467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=396.23 Aligned_cols=288 Identities=42% Similarity=0.748 Sum_probs=236.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|.+++.||+|+||.||+|++..++..||||+++.... ........+|+.++..++||||+.+++++... +.+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEE
Confidence 4789999999999999999999999999999999976543 22334567899999999999999999988643 48999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.++|.+++ ......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 82 VFEYLDKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EEeCCCCCHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9999987665544 3344567888999999999999999999999999999999999999999999999998765444
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|+.+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 44455678999999999987667899999999999999999999999999988999999999998888888766543322
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....++.+... ........++..+.+||.+||..||.+|||+.|+|.||||+..
T Consensus 239 ~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 239 KNYNFPKYKPQ---PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhcCccCCC---chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 22222221111 1111223478889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=400.22 Aligned_cols=290 Identities=33% Similarity=0.528 Sum_probs=223.8
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC---CCeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN---MDKIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~---~~~l~ 439 (1028)
+|++.+.||+|+||.||+|++..++..||||++............+.+|+.+|..++||||+++++++...+ ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 599999999999999999999999999999998754332223345678999999999999999999876433 23589
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+|||||+++|.+++. . ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~~~L~~~l~---~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELMESDLHQVIK---A-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCCCCHHHHHH---h-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999999876665553 2 345889999999999999999999999999999999999999999999999999864322
Q ss_pred C---CcccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 520 L---KHYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 520 ~---~~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
. ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 123456899999999998652 468999999999999999999999999998888888888877776544332221
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
....... +...............+.+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 237 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 237 NEKARRY--LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhHHHH--HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 1100000 000000000000111123567889999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=419.73 Aligned_cols=285 Identities=31% Similarity=0.524 Sum_probs=228.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC------
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN------ 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~------ 434 (1028)
..+|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++||||++++++|....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 357999999999999999999999999999999885432 22347999999999999999998875432
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-cEEEeccCCc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLA 513 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-~lKL~DFGlA 513 (1028)
...+++||||+.++|..++.........+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 235779999999988887776655667789999999999999999999999999999999999999654 7999999999
Q ss_pred cccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 514 REYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 514 r~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
+.+... ......+||+.|+|||++.+...|+.++||||||||||+|++|.+||.+.+..+.+.+++..++.|....+..
T Consensus 219 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 219 KNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred hhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 876432 2334568899999999998766799999999999999999999999999999999999999888776543321
Q ss_pred CCCChhhhhhccccCCCCCCCc-cccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLK-TKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~-~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.. +.+....+ +...... ...+....+..+++||.+||.+||.+|||+.++|.||||...
T Consensus 298 ~~--~~~~~~~~---~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 298 MN--PNYADIKF---PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred hc--hhhhcccC---CccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 11 11111111 1111000 111223467889999999999999999999999999999764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=385.55 Aligned_cols=282 Identities=39% Similarity=0.742 Sum_probs=225.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc---CCCCeeEEEEEEeec---CCC
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA---QHPNIVTVREIVVGS---NMD 436 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l---~HPNIV~L~~i~~~~---~~~ 436 (1028)
+|++++.||+|+||+||+|.+..+++.||||+++.............+|+.++..+ .||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999986544333344456777777655 699999999987542 235
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+++||||+.++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 68999999998776666532 2234889999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ...+...||..|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+.+++...+.+....|+....
T Consensus 159 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 159 SCQ-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cCc-ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 532 23345678999999999987 5689999999999999999999999999999999999998888776666654322
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+.. .+............+.++..+.+||.+||.+||.+|||+.++|.||||
T Consensus 237 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRG------AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccc------ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 2110 011111111122234567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=410.84 Aligned_cols=303 Identities=27% Similarity=0.423 Sum_probs=240.6
Q ss_pred cCCCCCCCCccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCC----
Q psy18163 345 KDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH---- 420 (1028)
Q Consensus 345 ~~~lp~y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H---- 420 (1028)
+++..+||.+..|+....+|.+....|+|-||+|..|.+...|..||||+|... +-+....+.|+++|++|+.
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPE 491 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCch
Confidence 445569999999999999999999999999999999999999999999999865 3345567899999999962
Q ss_pred --CCeeEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCccccccccccee
Q psy18163 421 --PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLL 498 (1028)
Q Consensus 421 --PNIV~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNIL 498 (1028)
-|++.|+..|. ..+++|||||-+..||..++..+..+-+ |....++.|+.||+.||..|-.+||+|.||||+|||
T Consensus 492 dk~Hclrl~r~F~--hknHLClVFE~LslNLRevLKKyG~nvG-L~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 492 DKFHCLRLFRHFK--HKNHLCLVFEPLSLNLREVLKKYGRNVG-LHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNIL 568 (752)
T ss_pred hhhHHHHHHHHhh--hcceeEEEehhhhchHHHHHHHhCcccc-eeehHHHHHHHHHHHHHHHHHhcCeeecccCccceE
Confidence 46777766664 4569999999999999999988865543 667789999999999999999999999999999999
Q ss_pred ecC-CCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy18163 499 LSH-RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLS 577 (1028)
Q Consensus 499 Ld~-~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~ 577 (1028)
++. ...+||||||.|...+. ...|++..+..|+|||+|+| ..|++.+|+||+||+||||.||+.+|+|.++.+++.
T Consensus 569 VNE~k~iLKLCDfGSA~~~~e--neitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASE--NEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred eccCcceeeeccCcccccccc--ccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 985 56799999999988764 45788899999999999999 679999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCC--CCCChhhhhhccc--------------cCCCCCC---Ccccc--------ccccccHHHHHH
Q psy18163 578 RIFKTMGTPNEKIWPG--FSKLPAVQKMTFA--------------EYPNVGG---LKTKV--------AGSILTELGYDL 630 (1028)
Q Consensus 578 kI~~~lg~p~~~~w~~--~s~lp~~~~l~~~--------------~~p~~~~---l~~~~--------~~~~Ls~~a~DL 630 (1028)
..+.+-|.++...... |..--.-+.+.|. .+..+.+ +...+ ....+-..+.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 9999888776443211 0000000000110 0000000 00000 001122367899
Q ss_pred HHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 631 LCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 631 L~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
|.+||.+||++|+|..++|.||||++
T Consensus 726 Ldkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHhccChhhcCCHHHHhcCCcccC
Confidence 99999999999999999999999975
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=418.95 Aligned_cols=256 Identities=31% Similarity=0.487 Sum_probs=224.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|.+.+.||+|+||.||+|+.+.|.+.||||++.+....+.....+.+|+.|++.++|||||.+++.|. +..++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE--t~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE--TSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc--ccceEEEE
Confidence 6799999999999999999999999999999999887655544556778999999999999999998885 45599999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
.|||.|+|..++.. ...++++.++.|+.+|+.||.|||+++|+|||+||.|||++..|++|+||||+|+..+....
T Consensus 80 te~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 99998766655543 55689999999999999999999999999999999999999999999999999998877666
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
..+..-|||.|||||++.+ ++|+..+|+||||||+|||++|+|||-..+-.+....|... +..|+
T Consensus 156 vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-----~v~~p--------- 220 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-----PVKPP--------- 220 (808)
T ss_pred eeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-----CCCCc---------
Confidence 7788899999999999987 88999999999999999999999999888777767666542 11121
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+.++..+.+||..+|.+||.+|+|..+++.|||+++.
T Consensus 221 -------------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 221 -------------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred -------------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 1367889999999999999999999999999999753
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=395.36 Aligned_cols=301 Identities=42% Similarity=0.753 Sum_probs=260.6
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEee----
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG---- 432 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~---- 432 (1028)
+|...+.|.-+.+||+|+||.||+|+.+.+|+.||+|++-.+..+.++....++|+.+|..+.|+|++.|++++..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 3455678999999999999999999999999999999998888889999999999999999999999999877632
Q ss_pred --cCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEecc
Q psy18163 433 --SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDF 510 (1028)
Q Consensus 433 --~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DF 510 (1028)
.+...+||||.+|++||..|+.. ....|+..+++.++.+|+.||.|+|++.|+|||+|+.|+||+.+|.+||+||
T Consensus 92 ~~r~r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cccccceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 12235899999999988887753 3466899999999999999999999999999999999999999999999999
Q ss_pred CCccccCCC----CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q psy18163 511 GLAREYGSP----LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586 (1028)
Q Consensus 511 GlAr~~~~~----~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p 586 (1028)
|+++.+... ...++..+.|.||++||.|+|...|++++|||..|||+.||.|+.+.|.++++..++..|...+|..
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 999765332 3457888999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCcc-ccccc-cccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKT-KVAGS-ILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~-~~~~~-~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
....||+...+|..+.+..+..+....... ....+ .-++.+.|||.+||.+||.+|+++.++|+|.||...|.|
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 999999999999888876654443211110 00011 124578999999999999999999999999999988766
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=409.64 Aligned_cols=268 Identities=27% Similarity=0.437 Sum_probs=224.6
Q ss_pred ccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCC------------ccchHHHHHHHHHcCCCCe
Q psy18163 356 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF------------PITSLREINTLLKAQHPNI 423 (1028)
Q Consensus 356 ~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~------------~~~~lrEi~iL~~l~HPNI 423 (1028)
.++..+++|+++..||.|.||+|.+|++..+++.||||++.+....... .....+||.+|++|.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 4566789999999999999999999999999999999999765422111 1245689999999999999
Q ss_pred eEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC
Q psy18163 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG 503 (1028)
Q Consensus 424 V~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g 503 (1028)
|+|+++.-....+.+|||+|||.. |.+... .....-+.+.+++.|++.++.||+|||.+|||||||||+|+||+.+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~--G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSK--GEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccC--CccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 999999988888999999999974 655432 22222288999999999999999999999999999999999999999
Q ss_pred cEEEeccCCccccCC-----CCCcccccccCccccCcccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy18163 504 ILKVGDFGLAREYGS-----PLKHYTPIVVTLWYRSPELLLG---CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ 575 (1028)
Q Consensus 504 ~lKL~DFGlAr~~~~-----~~~~~t~~vGT~~Y~APEvL~g---~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~ 575 (1028)
++||+|||.+..+.. ....+...+|||.|+|||++.+ ....+.+.|||||||+||.||.|..||.+....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 999999999986622 1223445799999999999876 23457899999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 576 LSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 576 l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
..+|++.- +.|+..+ .+.++++|||.+||++||.+|+++.+|..|||..
T Consensus 328 ~~KIvn~p-------------------L~fP~~p------------e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 328 FDKIVNDP-------------------LEFPENP------------EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HHHHhcCc-------------------ccCCCcc------------cccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 99997631 1222222 3678899999999999999999999999999997
Q ss_pred CC
Q psy18163 656 ES 657 (1028)
Q Consensus 656 e~ 657 (1028)
..
T Consensus 377 ~~ 378 (576)
T KOG0585|consen 377 RD 378 (576)
T ss_pred cC
Confidence 64
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=402.34 Aligned_cols=305 Identities=26% Similarity=0.355 Sum_probs=248.0
Q ss_pred CCCCCCCCcccccccc-CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-----
Q psy18163 346 DTLPPYLPAIQGCRSV-EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ----- 419 (1028)
Q Consensus 346 ~~lp~y~p~~~g~~~~-d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~----- 419 (1028)
+...+|+|+..|.... .+|.+.++||+|.|++||+|+|..+.++||||+++... .+....+.||.+|++++
T Consensus 61 Y~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~ 137 (590)
T KOG1290|consen 61 YRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPN 137 (590)
T ss_pred hhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCC
Confidence 3456999999999987 89999999999999999999999999999999998764 34456789999998874
Q ss_pred ---CCCeeEEEEEEe--ecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-Cccccccc
Q psy18163 420 ---HPNIVTVREIVV--GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLK 493 (1028)
Q Consensus 420 ---HPNIV~L~~i~~--~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLK 493 (1028)
..+||+|++.|. +.++.++|||||+++.+|..++.+.. .+.++...|+.|++||+.||.|||.. ||||.|||
T Consensus 138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK 215 (590)
T KOG1290|consen 138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK 215 (590)
T ss_pred CCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence 346999999985 67888999999999998888887643 44578889999999999999999975 79999999
Q ss_pred ccceeecCC-----------------------------------------------------------------------
Q psy18163 494 TSNLLLSHR----------------------------------------------------------------------- 502 (1028)
Q Consensus 494 PeNILLd~~----------------------------------------------------------------------- 502 (1028)
|+||||..+
T Consensus 216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~ 295 (590)
T KOG1290|consen 216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE 295 (590)
T ss_pred cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence 999997100
Q ss_pred --------------------------------------------------------------------------------
Q psy18163 503 -------------------------------------------------------------------------------- 502 (1028)
Q Consensus 503 -------------------------------------------------------------------------------- 502 (1028)
T Consensus 296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~ 375 (590)
T KOG1290|consen 296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA 375 (590)
T ss_pred ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence
Q ss_pred ---------------CcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy18163 503 ---------------GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLF 567 (1028)
Q Consensus 503 ---------------g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF 567 (1028)
-.+||+|||.|+++. .++|.-+.|..|+|||||+| ..|++.+||||++||+|||+||..+|
T Consensus 376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~---khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLF 451 (590)
T KOG1290|consen 376 SNPLVNPDIPLPECDIRVKIADLGNACWVH---KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLF 451 (590)
T ss_pred cccccCCCCCCCccceeEEEeeccchhhhh---hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceee
Confidence 016889999998874 67788899999999999999 56999999999999999999999999
Q ss_pred CCC------ChHHHHHHHHHhcCCCCCC----------CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHH
Q psy18163 568 TGK------SDLEQLSRIFKTMGTPNEK----------IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLL 631 (1028)
Q Consensus 568 ~g~------sd~d~l~kI~~~lg~p~~~----------~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL 631 (1028)
... .+.+.+..|++++|..+.. ++.....|.++.++.++.+-.+...++... ..-...+.|||
T Consensus 452 ePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s-~e~A~~fsdFL 530 (590)
T KOG1290|consen 452 EPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWS-EEDAQQFSDFL 530 (590)
T ss_pred cCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCC-HHHHHHHHHHH
Confidence 764 3789999999999876543 334444566666666654433322222111 11223577999
Q ss_pred HHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 632 CKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 632 ~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
.-||+.+|.+||||.++|+||||+..+.|
T Consensus 531 ~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 531 SPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHhcCccccccHHHHhcCccccCCCCC
Confidence 99999999999999999999999987665
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=399.45 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=224.4
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
+.....+|+++++||.|.||.||++.+..+|..||+|.+.....+.......+.||.+|++|+|||||+++..-+..+..
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 34456789999999999999999999999999999999987766666667788999999999999999998744444445
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh--CC--cccccccccceeecCCCcEEEeccC
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD--NW--ILHRDLKTSNLLLSHRGILKVGDFG 511 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs--~g--IVHRDLKPeNILLd~~g~lKL~DFG 511 (1028)
-++||||||++ ||..++.+++..+..+++..++.|+.||+.||.+||+ .. |+||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 69999999984 8999999999999999999999999999999999999 44 9999999999999999999999999
Q ss_pred CccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
|++.+.+......+++|||.||+||++.+ .+|+.++|||||||++|||+.-.+||.|.+-.+...+|...-.+
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~------ 246 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP------ 246 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC------
Confidence 99999877666778999999999999988 67999999999999999999999999999777777776543110
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA 645 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA 645 (1028)
.+| ..+.|..+..||..||.+||..||+.
T Consensus 247 ----~~p---------------------~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 247 ----PLP---------------------DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ----CCc---------------------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 011 13467888899999999999999986
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=412.70 Aligned_cols=286 Identities=25% Similarity=0.343 Sum_probs=214.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCC------CCeeEEEEEEeec
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH------PNIVTVREIVVGS 433 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H------PNIV~L~~i~~~~ 433 (1028)
..++|+++++||+|+||+||+|.+..+++.||||+++.... .......|+.++..+.| .+|+.++++|...
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 35789999999999999999999999999999999964321 12233457777776654 4588888877543
Q ss_pred CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCC---------
Q psy18163 434 NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRG--------- 503 (1028)
Q Consensus 434 ~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g--------- 503 (1028)
..++||||++++++|.+++.. ...+++..+..|+.||+.||.|||+ .|||||||||+||||+.++
T Consensus 204 -~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 204 -TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred -CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 458999999998766555432 3468899999999999999999998 5999999999999998765
Q ss_pred -------cEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy18163 504 -------ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576 (1028)
Q Consensus 504 -------~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l 576 (1028)
.+||+|||++.... ...+..+||+.|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+.+
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred ccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 49999999986543 23456789999999999988 56999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCC--hhhhhhccccCCCCC-----CCc--cccccccccHHHHHHHHHhcccCcCCCCCHHH
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKL--PAVQKMTFAEYPNVG-----GLK--TKVAGSILTELGYDLLCKFLTYDPVTRITADE 647 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~l--p~~~~l~~~~~p~~~-----~l~--~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~E 647 (1028)
..+...++.++..++..+..- ..+........+... ... .......-++.++|||.+||++||.+|||+.|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 988888887654433211100 000000000000000 000 00001112467889999999999999999999
Q ss_pred HHhCCCCCCC
Q psy18163 648 ALRHDYFSES 657 (1028)
Q Consensus 648 lL~HPfF~e~ 657 (1028)
+|+||||...
T Consensus 435 ~L~Hp~~~~~ 444 (467)
T PTZ00284 435 MTTHPYVLKY 444 (467)
T ss_pred HhcCcccccc
Confidence 9999999863
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=400.92 Aligned_cols=290 Identities=30% Similarity=0.492 Sum_probs=224.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----M 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~ 435 (1028)
..++|++++.||.|+||.||+|.+..++..||||++..............+|+.++..++||||+++++++.... .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 468999999999999999999999999999999999765433333455678999999999999999999885432 2
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+|+||||+.++|..++. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 3589999999976555442 2377888999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... ...+...||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+...++....
T Consensus 173 ~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 173 ACTN-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccC-ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 5432 23445688999999999987 568999999999999999999999999998888888888877766543322111
Q ss_pred CChhhhhhccccCC---------CCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYP---------NVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p---------~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..........+.++ ..............+..+.+||.+||.+||.+|||+.|+|+||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 00000000000000 000000001122356788999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=379.99 Aligned_cols=285 Identities=44% Similarity=0.856 Sum_probs=235.1
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++++.||.|+||.||+|.+..++..||||+++.............+|+.++..+.||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 5899999999999999999999999999999997654444444566789999999999999999998864 45899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.++|.+++..... ...+++..+..++.||+.||.|||++||+|+||||+|||++.+|.++|+|||++...+.+...
T Consensus 79 e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred ecCCCCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 9998877776654332 346889999999999999999999999999999999999999999999999999876655444
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.....+++.|+|||++.+...++.++|||||||++|+|+||.+||.+.+..+.+..++..++.+....|+....++....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 55567899999999987766689999999999999999999999999988888888888888888888877665544321
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. + +.............+++.+.+||.+||..||.+|||+.+||.||||
T Consensus 238 ~-~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 T-F---PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred h-c---cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1 1 1111111111123478889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=391.10 Aligned_cols=283 Identities=40% Similarity=0.778 Sum_probs=219.3
Q ss_pred EEeeecCcEEEEEEEEC--CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~--~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
.+||+|+||+||+|++. .+++.||||.+.... ......+|+.+|..++||||+++++++.......+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 57999999999999976 467899999986532 233467899999999999999999998776667899999999
Q ss_pred ccchHHHHHHHhh-----cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee----cCCCcEEEeccCCcccc
Q psy18163 446 EHDMKSLMETMRS-----KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL----SHRGILKVGDFGLAREY 516 (1028)
Q Consensus 446 ~gdLgsLl~~l~~-----~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL----d~~g~lKL~DFGlAr~~ 516 (1028)
+++|..++..... ....+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+|+.+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 9888777654321 12357889999999999999999999999999999999999 45679999999999876
Q ss_pred CCCC---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcC
Q psy18163 517 GSPL---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---------LEQLSRIFKTMG 584 (1028)
Q Consensus 517 ~~~~---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---------~d~l~kI~~~lg 584 (1028)
.... ......+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+... .+++..++..++
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 5432 2234578899999999998866789999999999999999999999976543 467788888888
Q ss_pred CCCCCCCCCCCCChhhhhhc--c--ccCCCCCCCc-cccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 585 TPNEKIWPGFSKLPAVQKMT--F--AEYPNVGGLK-TKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~--~--~~~p~~~~l~-~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+....|......+...... + ..+....... ........+..+.+||.+||++||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 88777776544332211100 0 0000000000 001112245678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=403.77 Aligned_cols=261 Identities=31% Similarity=0.497 Sum_probs=228.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-CccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-FPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~ 437 (1028)
..+.|++.+.||.|.||+||+|+++.||+.||+|++.+...... ......+|+.+|+.+. |||||.++++|...+ .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--S 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--e
Confidence 34679999999999999999999999999999999987764332 2346678999999999 999999999996554 8
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC----CcEEEeccCCc
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR----GILKVGDFGLA 513 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~----g~lKL~DFGlA 513 (1028)
+++|||+|.| ++|++.+... .+++.++..++.||+.|+.|||+.||+||||||+|||+... +.+|++|||++
T Consensus 111 ~~lvmEL~~G--GeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 111 VYLVMELCEG--GELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEEecCC--chHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999998 8888888766 39999999999999999999999999999999999999743 57999999999
Q ss_pred cccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 514 REYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 514 r~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
..+.. .......|||+.|+|||++.. ..|+..+||||+||++|.||+|.+||.+.+.......|...-..+....|+
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~- 263 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD- 263 (382)
T ss_pred eEccC-CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc-
Confidence 98876 556778999999999999986 679999999999999999999999999999888888776654333333333
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.++..+++||.+||..||.+|+||.++|+|||++..
T Consensus 264 ----------------------------~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 264 ----------------------------DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ----------------------------ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 367889999999999999999999999999999875
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=382.79 Aligned_cols=289 Identities=40% Similarity=0.712 Sum_probs=233.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||.|+||.||+|.+..++..||||.++..... .......+|+.++..++||||+++++++.. .+.+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEE
Confidence 357899999999999999999999999999999999765432 233456789999999999999999998864 35899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.++|..++. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....+
T Consensus 81 lv~e~~~~~l~~~l~---~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 81 LVFEYLDKDLKQYLD---DCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEEeccccCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 999999876655443 33456788899999999999999999999999999999999999999999999999876544
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
........+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+.+.....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 44444567899999999988766789999999999999999999999999988888888988888888777765432211
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..... ++.............+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 238 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 238 FKSYN---YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccc---cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 11111 11111101112234577889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=395.63 Aligned_cols=288 Identities=33% Similarity=0.533 Sum_probs=225.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec----CCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS----NMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~----~~~ 436 (1028)
.++|++++.||.|+||+||+|.+..++..||||++............+.+|+.+|+.++||||+++++++... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 3689999999999999999999999999999999976433222334466899999999999999999877532 224
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|++|++++++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 689999999877765553 235899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. ..+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.....
T Consensus 169 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 43 234568999999999998766789999999999999999999999999888888888888777665443322211
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.... . .....+..............++.+.+||.+||..||.+|||+.++|.||||....
T Consensus 246 ~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 246 EHAR-K-YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhHH-H-HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0000 0 0001111111111111223567789999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=394.71 Aligned_cols=290 Identities=30% Similarity=0.504 Sum_probs=226.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----M 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~ 435 (1028)
..++|++++.||+|+||.||+|.+..+++.||||++..............+|+.+++.++||||+.+++++.... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999999999999999999765433333456678999999999999999998875332 2
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+|+||||+.++|..++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 4689999999986655542 2367888999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... ...+..+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..++..++.+...++..+.
T Consensus 176 ~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 176 AGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cCCC-CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 6543 23345689999999999987 568999999999999999999999999999999999998888877654433322
Q ss_pred CChhhhhhccccC---------CCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEY---------PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~---------p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..........+.+ +..............+..+++||.+||..||.+|||+.++|+||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 1100000000000 0000000001112245678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=394.74 Aligned_cols=271 Identities=25% Similarity=0.361 Sum_probs=225.4
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
....+.|++++.||.|.-|+||+|+...++..+|||++.+.... .....+...|-+||..+.||.++.||..|. ...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe--t~~ 150 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE--TDK 150 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee--ccc
Confidence 34467899999999999999999999999999999999876532 333445567889999999999999998885 445
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+|||||||.| ||..|... +....|++..++.|+..|+.||+|||-.|||+|||||+||||..+|+|.|+||.|+..
T Consensus 151 ~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 89999999987 55544432 3466799999999999999999999999999999999999999999999999998753
Q ss_pred cCC---------------------------------C-C----------------------CcccccccCccccCccccc
Q psy18163 516 YGS---------------------------------P-L----------------------KHYTPIVVTLWYRSPELLL 539 (1028)
Q Consensus 516 ~~~---------------------------------~-~----------------------~~~t~~vGT~~Y~APEvL~ 539 (1028)
... . . ...++++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 0 0 0123578999999999999
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccc
Q psy18163 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVA 619 (1028)
Q Consensus 540 g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~ 619 (1028)
| ...+.++|||+|||+|||||.|..||.|.+..+++..|+..- ..|+..+
T Consensus 309 G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-------------------l~Fp~~~---------- 358 (459)
T KOG0610|consen 309 G-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-------------------LKFPEEP---------- 358 (459)
T ss_pred c-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-------------------CcCCCCC----------
Confidence 9 558999999999999999999999999999999999886531 1122222
Q ss_pred cccccHHHHHHHHHhcccCcCCCCC----HHHHHhCCCCCCCCCCCCCC
Q psy18163 620 GSILTELGYDLLCKFLTYDPVTRIT----ADEALRHDYFSESPLPIDPA 664 (1028)
Q Consensus 620 ~~~Ls~~a~DLL~kcL~~DP~kRPT----A~ElL~HPfF~e~p~p~~p~ 664 (1028)
.++..++|||.+||.+||.+|+. |.||.+||||+...|+.--.
T Consensus 359 --~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~ 405 (459)
T KOG0610|consen 359 --EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRC 405 (459)
T ss_pred --cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheec
Confidence 25678999999999999999998 99999999999998875433
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=394.74 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=207.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.+|...+.||+|+||.||++.+..+|..+|||.+....... ...+.+|+.+|.+++|||||++++.........++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45788899999999999999999999999999997763222 3446789999999999999999886432222368999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEeccCCccccCC--
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLAREYGS-- 518 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~DFGlAr~~~~-- 518 (1028)
|||+.+ |+|-+.+...+..|++..++.|++||+.||.|||++|||||||||+||||+. ++.+||+|||++.....
T Consensus 95 mEy~~~--GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPG--GSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCC--CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999987 4444444444446999999999999999999999999999999999999999 79999999999987763
Q ss_pred -CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 -PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK-SDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 -~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~-sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.........||+.|||||++........++|||||||++.||+||.+||... ...+.+..|... ...
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~~~-------- 241 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---DSL-------- 241 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---CCC--------
Confidence 1122346799999999999985233345999999999999999999999873 323323332211 000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+ .....+++++++||.+||..||++||||.++|.|||.+..
T Consensus 242 ---------P-----------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 242 ---------P-----------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ---------C-----------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 0 1123378999999999999999999999999999999874
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=380.05 Aligned_cols=291 Identities=73% Similarity=1.213 Sum_probs=242.3
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
+..++|++.+.||.|+||.||+|.+..+++.||||.++...........+.+|+.++..+.||||+++++++.+.+...+
T Consensus 2 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred cchhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 34578999999999999999999999999999999998665444444456789999999999999999999877766789
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||+.++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+..
T Consensus 82 ~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcCcCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99999999877776654 234689999999999999999999999999999999999999999999999999988766
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.........+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.+++..++.+....|+.+..++
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 54455566789999999999875667899999999999999999999999999999999999999888888888776655
Q ss_pred hhhhhccccCCCCCCCcccccccc-ccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSI-LTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~-Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
............ ..+. ..+... +++.+.+||.+||..||.+|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPY-NQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccc-hhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 443322211111 0111 112222 57889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=408.83 Aligned_cols=257 Identities=29% Similarity=0.492 Sum_probs=222.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
..|....+||+|+.|.||.|....+++.||||.+...... ....+++|+.+|+..+|+|||.+++.|.-. +.+|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEE
Confidence 5688889999999999999999999999999999776532 345678999999999999999998877544 589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||||+| +.|.+... ...++|.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 349 MEym~g--gsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 349 MEYMEG--GSLTDVVT--KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EeecCC--Cchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999997 44444332 23489999999999999999999999999999999999999999999999999998877666
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.-.+.+|||+|||||++.. +.|++++||||||+|++||+-|.|||-..+....+..|... |.|.-.
T Consensus 425 KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk------------ 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK------------ 490 (550)
T ss_pred ccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC------------
Confidence 7778999999999999987 77999999999999999999999999988888877777653 322211
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....+|+.++|||.+||+.||.+|++|.|||+||||+..
T Consensus 491 -----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 491 -----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred -----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 113478999999999999999999999999999999653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=392.19 Aligned_cols=290 Identities=30% Similarity=0.538 Sum_probs=224.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----M 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~ 435 (1028)
..++|++++.||+|+||.||+|.+..+++.||||++..............+|+.+++.++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457999999999999999999999999999999999765433333455678999999999999999999875432 2
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+|+||||+.+++...+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 4689999999876555442 2377888999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..++..++.+....+....
T Consensus 169 ~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 169 AGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred CCCc-cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 6543 23355689999999999987 568999999999999999999999999998888888888877766543332211
Q ss_pred CC--------hhhhhhccccC-CCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KL--------PAVQKMTFAEY-PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~l--------p~~~~l~~~~~-p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.. +....+.+... +..............+..+.+||.+||..||.+|||+.|+|+||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 00000000000 0000000011122345678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=389.96 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=213.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++.+.||.|+||.||+|++..+++.||||+++..... ......+.+|+.+|..++||||+++++++.. .+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEE
Confidence 357899999999999999999999999999999999765321 1223456789999999999999999988854 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+||||+.+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 94 ~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVG--GELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCC--ChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999986 555555544 34578889999999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.... +
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~------------ 232 (329)
T PTZ00263 171 R---TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--L------------ 232 (329)
T ss_pred C---cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--c------------
Confidence 2 234689999999999987 568999999999999999999999999887766665554310 0
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~ 657 (1028)
.+ ...++..+.+||.+||..||.+|++ +.+++.||||...
T Consensus 233 --------~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 233 --------KF-----------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred --------CC-----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 00 0125667889999999999999997 7999999999874
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=376.07 Aligned_cols=283 Identities=45% Similarity=0.797 Sum_probs=229.6
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++++.||.|+||.||+|.+..+|..||+|.++...........+.+|+.++..++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4899999999999999999999999999999997654444444566789999999999999999888754 45899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.++|.++ +......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..++.....
T Consensus 79 e~~~~~l~~~---~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 79 EYCDQDLKKY---FDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred ecCCCCHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 9998755444 3333456899999999999999999999999999999999999999999999999999877655445
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPL-FTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pP-F~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.....+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..++..++.+....|+.....+...
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 55667899999999998766689999999999999999998865 67777778888888888887776666544433321
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+..++.. ..+....+.++..+.+||.+||..||.+|||+.++|.||||
T Consensus 236 --~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 --PYPMYPAT--TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred --ccCCCCCc--chhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11111110 11112224578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=397.82 Aligned_cols=284 Identities=23% Similarity=0.325 Sum_probs=215.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
...|++++.||+|+||.||+|++..+++.||||.... ....+|+.+|..++||||++++++|.. ....|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEE
Confidence 3579999999999999999999999999999997542 235789999999999999999998864 347999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC-
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP- 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~- 519 (1028)
|||++.++|..++ .. ...+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 161 v~e~~~~~L~~~l---~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYKTDLYCYL---AA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCCCCHHHHH---Hh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 9999987654444 22 345788999999999999999999999999999999999999999999999999754321
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK-------SDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~-------sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
.......+||+.|+|||++.+ ..|+.++||||||||||+|++|..||... ....++..++...+.++..++.
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 223445789999999999987 56999999999999999999999776443 2345677777777766544321
Q ss_pred CCC-CChhhh-hhcc--ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCC
Q psy18163 593 GFS-KLPAVQ-KMTF--AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPI 661 (1028)
Q Consensus 593 ~~s-~lp~~~-~l~~--~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~ 661 (1028)
... .+.... .... ...+...... .....++..+.+||.+||.+||.+||||.|+|+||||+..+.|.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 386 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLW--TNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPY 386 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCH--HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCC
Confidence 111 000000 0000 0000000000 00012456788999999999999999999999999998865543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=389.80 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=206.9
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
+.||+|+||.||+|.+..+++.||||+++..... .......++|+.+|..+.||||+.+++++.. .+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 3699999999999999999999999999865321 1223355689999999999999999887754 458999999998
Q ss_pred cchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccccc
Q psy18163 447 HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526 (1028)
Q Consensus 447 gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~ 526 (1028)
+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++............
T Consensus 79 ~--~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 79 G--GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred C--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 7 555555543 4468999999999999999999999999999999999999999999999999998654333344567
Q ss_pred ccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccc
Q psy18163 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606 (1028)
Q Consensus 527 vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~ 606 (1028)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---------------------- 212 (323)
T cd05571 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------------------- 212 (323)
T ss_pred ecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 89999999999987 5689999999999999999999999988776555554432100
Q ss_pred cCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 607 EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 607 ~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
.+ ...++..+.+||.+||..||.+|| ++.++|+||||...
T Consensus 213 ~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 213 RF-----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CC-----------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00 122677889999999999999999 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=397.56 Aligned_cols=290 Identities=33% Similarity=0.527 Sum_probs=225.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC---CCeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN---MDKIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~---~~~l~ 439 (1028)
+|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|..++|+||+.+++++.... ...+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999998654322222345678999999999999999999886432 12689
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 999999876554442 2446889999999999999999999999999999999999999999999999999865432
Q ss_pred -CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 520 -LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 520 -~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
....+..++|+.|+|||++.+...|+.++||||||||+|+|++|++||.+.+..+++..|...++.+....+.....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-- 234 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-- 234 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH--
Confidence 22334567899999999998866789999999999999999999999999999999999998888765432211110
Q ss_pred hhhhh--ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 599 AVQKM--TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 599 ~~~~l--~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
..... .....+... ..........++.+.+||.+||..||.+|||+.++|.||||.+...
T Consensus 235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 235 GARAHILRGPHKPPSL-PVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRL 296 (372)
T ss_pred HHHHHHHhCCCCCCch-HHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcc
Confidence 00000 000000000 0000122345788999999999999999999999999999988543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=379.95 Aligned_cols=271 Identities=27% Similarity=0.415 Sum_probs=225.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCC------ccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF------PITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~------~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
..|.-.+.||.|..++|.+|.++.|+..+|+|++......... ......|+.||+++ .||+|+.|.++|..+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~- 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD- 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc-
Confidence 4566678899999999999999999999999999765432211 12234689999986 599999999999544
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..+|+|+|.|.. |.|++.+.. ...+++.+.+.||+||+.|+.|||.++||||||||+|||++.+.++||+|||+|+
T Consensus 96 -sF~FlVFdl~pr--GELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 -AFVFLVFDLMPR--GELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred -chhhhhhhhccc--chHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 479999999987 888887754 4568999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccCccccCccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLL-----GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~-----g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
.+.. ...+...||||+|+|||.+. +...|+..+|+|++|||+|.||.|.+||......-++..|++....+...
T Consensus 172 ~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 172 QLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred ccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 8854 56788899999999999874 34679999999999999999999999999877777778887765555544
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFP 667 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~p 667 (1028)
.|.+ ++..++|||.+||++||.+|+|++|+|.||||.+...-..+.|.|
T Consensus 251 eWad-----------------------------is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 251 EWAD-----------------------------ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred chhh-----------------------------ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence 4432 567789999999999999999999999999996533222334444
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=378.74 Aligned_cols=283 Identities=39% Similarity=0.742 Sum_probs=218.6
Q ss_pred EEeeecCcEEEEEEEECC--CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKR--TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~--tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
.+||+|+||+||+|.+.. ++..||+|.+.... ......+|+.+|..++||||+++++++.......+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999999754 66899999986432 233467899999999999999999998776677899999999
Q ss_pred ccchHHHHHHHhh-----cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee----cCCCcEEEeccCCcccc
Q psy18163 446 EHDMKSLMETMRS-----KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL----SHRGILKVGDFGLAREY 516 (1028)
Q Consensus 446 ~gdLgsLl~~l~~-----~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL----d~~g~lKL~DFGlAr~~ 516 (1028)
+++|.+++..... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9887777653321 12347888899999999999999999999999999999999 45679999999999876
Q ss_pred CCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcC
Q psy18163 517 GSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---------LEQLSRIFKTMG 584 (1028)
Q Consensus 517 ~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---------~d~l~kI~~~lg 584 (1028)
..... .....+||+.|+|||++.+...++.++|||||||++|+|+||.+||....+ ..++..++..++
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 54322 234568899999999998766789999999999999999999999976442 356777888888
Q ss_pred CCCCCCCCCCCCChhhhhhcc----ccCCCCCCC-ccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 585 TPNEKIWPGFSKLPAVQKMTF----AEYPNVGGL-KTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~~----~~~p~~~~l-~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+....|..+...+....... ..+...... .........+..+++||.+||..||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888777766544332211110 000000000 0011112245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=381.70 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=211.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||.|+||.||+|.+..+++.||||++...... ......+.+|+.+|..+.||||+++++++. +...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEE
Confidence 4799999999999999999999999999999999754321 122334668999999999999999987764 4458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 79 v~e~~~~--~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 79 LMEYVPG--GELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EEeCCCC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999986 445554443 345889999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 155 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------------- 215 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---------------- 215 (291)
T ss_pred --cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----------------
Confidence 234689999999999987 5689999999999999999999999998887776666643210
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESP 658 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p 658 (1028)
.+ ...++..+.+||.+||..||.+|++ +.+++.||||....
T Consensus 216 ------~~-----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 216 ------EF-----------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred ------CC-----------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 00 1124677899999999999999995 99999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=376.60 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=208.6
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++..+.|+||+.+++++.. .+.+|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 388999999999999999999999999999998765322 1223346789999999999999999887754 4589999
Q ss_pred EeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ ++|...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~e~~~~--g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 79 LTIMNG--GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred EEecCC--CcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 999986 344333322 2335888999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.........+..........
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 223 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE----------- 223 (285)
T ss_pred CeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccccc-----------
Confidence 23345689999999999987 568999999999999999999999998866543333332221111000
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESP 658 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p 658 (1028)
....++..+.+||.+||..||.+||| ++++++||||.+..
T Consensus 224 ------------------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 224 ------------------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ------------------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 11225678899999999999999997 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=390.40 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=209.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.++..++|+||+++++.+. ....+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~--~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ--DKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCeEEE
Confidence 4799999999999999999999999999999999764322 122234567999999999999999988775 4458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||||.+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 79 v~E~~~g--g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPG--GDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999986 555555543 3468999999999999999999999999999999999999999999999999997543210
Q ss_pred -----------------------------------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q psy18163 521 -----------------------------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEP 565 (1028)
Q Consensus 521 -----------------------------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~p 565 (1028)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCC
Confidence 01134689999999999987 568999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcC---CC
Q psy18163 566 LFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPV---TR 642 (1028)
Q Consensus 566 PF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~---kR 642 (1028)
||.+.+..+.+..+....... .+ |. ...+++.+.+||.+|+. +|. .|
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~-----------------~~---p~---------~~~~s~~~~~li~~l~~-~~~~r~~r 284 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETL-----------------IF---PP---------EVPISEKAKDLILRFCC-EWEHRIGA 284 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcc-----------------cC---CC---------cCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence 999988777777665421110 00 00 01257789999999876 454 45
Q ss_pred CCHHHHHhCCCCCCCCC
Q psy18163 643 ITADEALRHDYFSESPL 659 (1028)
Q Consensus 643 PTA~ElL~HPfF~e~p~ 659 (1028)
|++++|++||||+...+
T Consensus 285 ~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 285 PGVEEIKTNPFFEGVDW 301 (363)
T ss_pred CCHHHHhCCCCCCCCCH
Confidence 89999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=390.95 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=223.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..+|++.+.||+|+||+|-+|++...|+.||||.|++++... .....+.+||+||..|+||||+.+|++| ++.+.++
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEE
Confidence 358999999999999999999999999999999998876443 3345677999999999999999999888 5677999
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||||..+ |+|++++... +.+++.+++.|++||++|+.|||.++++|||||.+|||+|.++++||+||||+..+..
T Consensus 130 ivMEYaS~--GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 130 IVMEYASG--GELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEEEecCC--ccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 99999987 7888877554 4589999999999999999999999999999999999999999999999999988865
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
...++++||++.|.+||++.|..+-++.+|.|||||+||.|+.|..||+|.+....+.+|-..-.
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY--------------- 270 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY--------------- 270 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc---------------
Confidence 36678999999999999999977678999999999999999999999999887777777644211
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
..+.-+.++.-||..||.+||.+|.|+++|..|=|.+
T Consensus 271 -------------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 271 -------------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -------------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 0111334678999999999999999999999998875
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=374.16 Aligned_cols=292 Identities=43% Similarity=0.813 Sum_probs=236.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc---cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK---EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~---~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
+|++.+.||.|+||.||+|.+..+++.||||.++..... ......+..|+.++..++|+||+++++++.. .+.+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488999999999999999999999999999999765433 2233445679999999999999999998865 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.++|.+++. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 79 lv~e~~~~~L~~~i~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 79 LVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEcccCCCHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999999666655543 33336899999999999999999999999999999999999999999999999999887665
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+.+++..++.+....|+.+..++.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 44455557788999999987656789999999999999999999999999998888888888888777777766554433
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPA 664 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~ 664 (1028)
...... .+. .........++..+.+||.+||..||.+|||+.++|.||||++.+.|..++
T Consensus 236 ~~~~~~--~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~ 295 (298)
T cd07841 236 YVEFKP--FPP---TPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS 295 (298)
T ss_pred cccccc--cCC---cchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCC
Confidence 221111 000 111112234577899999999999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=389.71 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=211.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||.|+||+||+|++..+++.||||++...... ......+.+|+.+|..++||||+.+++++.. .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 4799999999999999999999999999999999765321 2223345679999999999999999888754 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||||.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.++|+|||++..+....
T Consensus 79 v~E~~~~--g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPG--GDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCC--cHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999987 566655544 3468999999999999999999999999999999999999999999999999987543210
Q ss_pred C--------------------------------------cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh
Q psy18163 521 K--------------------------------------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC 562 (1028)
Q Consensus 521 ~--------------------------------------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT 562 (1028)
. ...+.+||+.|+|||++.+ ..|+.++||||||||+|+|++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhc
Confidence 0 1123579999999999977 568999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCC
Q psy18163 563 MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR 642 (1028)
Q Consensus 563 G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kR 642 (1028)
|.+||.+.+..+.+..+....... . ++. ...+++.+.+||.+||. ||.+|
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~-----------------~---~~~---------~~~~s~~~~~li~~ll~-~p~~R 284 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETL-----------------Q---FPD---------EVPLSPEAKDLIKRLCC-EAERR 284 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCcc-----------------C---CCC---------CCCCCHHHHHHHHHHcc-CHhhc
Confidence 999999888777666654321000 0 000 01267889999999997 99999
Q ss_pred CC---HHHHHhCCCCCCC
Q psy18163 643 IT---ADEALRHDYFSES 657 (1028)
Q Consensus 643 PT---A~ElL~HPfF~e~ 657 (1028)
++ +.++|.||||+..
T Consensus 285 ~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 285 LGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 98 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=384.93 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=213.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++.+.||+|+||+||+|.+..+++.||||+++..... ......+.+|+.++..+.|+||+.+++++.. .+.+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 4699999999999999999999999999999999865431 2223445678999999999999999887754 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 79 v~e~~~~--~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 79 VMEYQPG--GDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred EECCCCC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999976 44555454444568999999999999999999999999999999999999999999999999998765432
Q ss_pred Cc-ccccccCccccCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 521 KH-YTPIVVTLWYRSPELLLG-----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 521 ~~-~t~~vGT~~Y~APEvL~g-----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.. ....+||+.|+|||++.. ...++.++||||||||+|+|++|..||...+....+..+......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--------- 227 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF--------- 227 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc---------
Confidence 21 233579999999999863 356789999999999999999999999988877766666542100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
..++. ...++..+.+||.+||. ||.+|||+.+++.||||....+
T Consensus 228 -----------~~~~~---------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 228 -----------LKFPE---------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred -----------cCCCC---------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 00010 11256788999999998 9999999999999999987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=370.61 Aligned_cols=289 Identities=44% Similarity=0.795 Sum_probs=233.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCC---Ce
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNM---DK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~---~~ 437 (1028)
++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.++..+. ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998766544444456778999999995 6999999988754332 23
Q ss_pred EEEEEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEeccCCccc
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLARE 515 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~DFGlAr~ 515 (1028)
+|+||||+.++|..++...... ...+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999998877776543322 346889999999999999999999999999999999999998 89999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
+..+....+...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+..++..++.+....|+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 65544445556789999999998776678999999999999999999999999999988888888888888777776554
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
.+..... ++...........+.++..+.+||.+||..||.+|||+.++|.||||+
T Consensus 241 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHE-----FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhh-----cCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 3322111 111111111122234778899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=371.06 Aligned_cols=284 Identities=45% Similarity=0.849 Sum_probs=233.2
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++++.||.|+||.||+|++..++..||||.+............+.+|+.++..++||||+++++++. ..+.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEe
Confidence 489999999999999999999999999999998765443334456778999999999999999999875 445899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.++|.+++... ....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..+......
T Consensus 79 e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 79 EFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 99987666655432 2345788999999999999999999999999999999999999999999999999877654444
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.....+++.|+|||++.+...++.++|||||||++|+|+||..||.+.++.+.+.+++..++.+....|+.+..++....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 55567899999999988766678999999999999999999999999999889999999888888877776554433222
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+..+ .........+.++..+.+||.+||..||.+|||+.++|.||||
T Consensus 237 -~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 -SFPKW---ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred -hcccc---cccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11111 1111111123467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=393.01 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=234.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..-|.+.+.||.|.|++|.+|++.-||..||||++.+.+.+.-....++.|+..|+.++|||||.||+++.. ...+||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEE
Confidence 456999999999999999999999999999999999988777666778899999999999999999998854 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec-CCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS-HRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd-~~g~lKL~DFGlAr~~~~~ 519 (1028)
|+|+-.+ |+|++++-.....+.+..++.|+.||+.||.|||...+|||||||+||.+- .-|.|||+|||++..+. |
T Consensus 95 iLELGD~--GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-P 171 (864)
T KOG4717|consen 95 ILELGDG--GDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-P 171 (864)
T ss_pred EEEecCC--chHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-C
Confidence 9999776 777777777777799999999999999999999999999999999998764 67999999999998774 4
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
...+++.||+..|-|||+|+|..+..+++||||||||||-|+||.+||...++.+.+..|+..-.+
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-------------- 237 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-------------- 237 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc--------------
Confidence 577889999999999999999777778999999999999999999999999999999998764221
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPI 661 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~ 661 (1028)
....++.+++|||..||..||.+|.|.++|..|+|++....+.
T Consensus 238 -------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 238 -------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred -------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 2245788999999999999999999999999999999765443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=383.59 Aligned_cols=263 Identities=28% Similarity=0.440 Sum_probs=213.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||+|+||.||+|++..+++.||||+++..... ......+.+|+.++..++||||+++++++. ..+.+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEE
Confidence 3699999999999999999999999999999999865322 122345678999999999999999988775 4458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 v~e~~~g--~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 79 AMEYVPG--GDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEeCCCC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999976 344433332 34688999999999999999999999999999999999999999999999999986643
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...........+
T Consensus 154 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 222 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY--------- 222 (333)
T ss_pred -ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC---------
Confidence 3345689999999999987 47999999999999999999999999988877766665432111100000
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
. .....++..+.+||.+||..+|.+|||+.+++.||||....
T Consensus 223 --------~--------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 223 --------D--------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred --------C--------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 0 00023678899999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=386.46 Aligned_cols=262 Identities=27% Similarity=0.458 Sum_probs=213.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||.|+||+||+|++..+++.||||+++...... .....+.+|+.++..+.||||+++++++. ..+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEE
Confidence 47999999999999999999999999999999998654322 23345667999999999999999987775 4458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~~--~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 79 VMEYMPG--GDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEcCCCC--CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999976 4444444333 568899999999999999999999999999999999999999999999999998765432
Q ss_pred -----------------------------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy18163 521 -----------------------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS 571 (1028)
Q Consensus 521 -----------------------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s 571 (1028)
......+||+.|+|||++.+ ..++.++||||||||||+|++|..||.+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 22345689999999999988 578999999999999999999999999888
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-HHHHHh
Q psy18163 572 DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-ADEALR 650 (1028)
Q Consensus 572 d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-A~ElL~ 650 (1028)
.......+....... . ++. ...+++.+.+||.+||. ||.+|++ +.++|.
T Consensus 235 ~~~~~~~i~~~~~~~---------~-----------~p~---------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 235 LQETYNKIINWKESL---------R-----------FPP---------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHHHHHHhccCCcc---------c-----------CCC---------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 776666665421100 0 000 01157889999999998 9999999 999999
Q ss_pred CCCCCCCCC
Q psy18163 651 HDYFSESPL 659 (1028)
Q Consensus 651 HPfF~e~p~ 659 (1028)
||||....+
T Consensus 285 hp~~~~~~~ 293 (350)
T cd05573 285 HPFFKGIDW 293 (350)
T ss_pred CCCcCCCCH
Confidence 999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=380.24 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=206.7
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
+.||+|+||.||+|++..+|..||+|+++..... ......+.+|+.++..++||||+.++++|.. .+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 3699999999999999999999999999765321 1222345679999999999999999888754 458999999998
Q ss_pred cchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccccc
Q psy18163 447 HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526 (1028)
Q Consensus 447 gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~ 526 (1028)
+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 79 ~--~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 79 G--GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred C--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 7 455544433 3468899999999999999999999999999999999999999999999999997643333344557
Q ss_pred ccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccc
Q psy18163 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606 (1028)
Q Consensus 527 vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~ 606 (1028)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~---------------------- 212 (323)
T cd05595 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------------------- 212 (323)
T ss_pred cCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------------
Confidence 89999999999977 5689999999999999999999999988776665555432100
Q ss_pred cCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 607 EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 607 ~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
.+ ...+++.+.+||.+||..||.+|+ ++.++++||||....
T Consensus 213 ~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 213 RF-----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CC-----------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 00 112567889999999999999998 999999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=391.25 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=208.4
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.|+++++||+|+||+||+|++..+++.||||++...... ......+.+|+.+|..+.||||+++++++.. .+.+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 599999999999999999999999999999999764321 2223456689999999999999999988854 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC--
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP-- 519 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~-- 519 (1028)
||||.+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..+...
T Consensus 80 ~E~~~g--g~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 80 MDYIPG--GDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EeCCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999986 455544433 345889999999999999999999999999999999999999999999999997532100
Q ss_pred ---------------------------------------------CCcccccccCccccCcccccCCCCCCchhhHHHHH
Q psy18163 520 ---------------------------------------------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVG 554 (1028)
Q Consensus 520 ---------------------------------------------~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLG 554 (1028)
.......+||+.|+|||++.+ ..|+.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG 235 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVG 235 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEech
Confidence 000123579999999999987 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHh
Q psy18163 555 CIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKF 634 (1028)
Q Consensus 555 vILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kc 634 (1028)
||||+|++|.+||.+.+..+....+........ .+ ....+++.+.+||.+|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------~p---------~~~~~s~~~~~li~~l 286 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLH--------------------IP---------PQAKLSPEASDLIIKL 286 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC--------------------CC---------CcccCCHHHHHHHHHH
Confidence 999999999999998887766666543211000 00 0123678899999998
Q ss_pred cccCcCCCCC---HHHHHhCCCCCCCC
Q psy18163 635 LTYDPVTRIT---ADEALRHDYFSESP 658 (1028)
Q Consensus 635 L~~DP~kRPT---A~ElL~HPfF~e~p 658 (1028)
+ .||.+|++ +.++++||||+...
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 6 59999997 99999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.94 Aligned_cols=285 Identities=43% Similarity=0.779 Sum_probs=235.5
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++.+.||.|+||.||+|.+..+|..||||++............+.+|+.++..+.||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 5899999999999999999999999999999998765434444567789999999999999999998854 45899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC-C
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL-K 521 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~-~ 521 (1028)
||++++|.+++. .....+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... .
T Consensus 79 e~~~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 79 EYMPSDLSEVLR---DEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cccCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 999666655544 334568999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......||..|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+..+...++.+....|+.+..++...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 24456889999999999876668999999999999999999999999999999999999988888887887776655443
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
...+..... .........++..+++||.+||..||.+|||++++|.||||.
T Consensus 236 ~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 236 KITFPESKP---IPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cccCCCCCc---chHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 333222111 111112234568899999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=390.12 Aligned_cols=261 Identities=26% Similarity=0.365 Sum_probs=207.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.|++++.||+|+||+||+|++..++..||||++...... ......+.+|+.+|..++||||+++++++.. .+.+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 589999999999999999999999999999999764321 2223456789999999999999999988854 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC-
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL- 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~- 520 (1028)
|||+.+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 80 ~E~~~g--g~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPG--GDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999976 444444433 3458889999999999999999999999999999999999999999999999986431100
Q ss_pred ----------------------------------------------CcccccccCccccCcccccCCCCCCchhhHHHHH
Q psy18163 521 ----------------------------------------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVG 554 (1028)
Q Consensus 521 ----------------------------------------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLG 554 (1028)
....+.+||+.|+|||++.+ ..|+.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG 235 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVG 235 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehh
Confidence 00124689999999999987 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHh
Q psy18163 555 CIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKF 634 (1028)
Q Consensus 555 vILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kc 634 (1028)
||+|+|++|.+||...+..+....+....... . ++. ...+++.+.+||.+|
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------~-----------~~~---------~~~~s~~~~dli~~l 286 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL---------H-----------IPP---------QVKLSPEAVDLITKL 286 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------C-----------CCC---------CCCCCHHHHHHHHHH
Confidence 99999999999999887766655554311100 0 000 012678899999997
Q ss_pred cccC--cCCCCCHHHHHhCCCCCCCC
Q psy18163 635 LTYD--PVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 635 L~~D--P~kRPTA~ElL~HPfF~e~p 658 (1028)
|..+ |..|+++.+++.||||++..
T Consensus 287 l~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 287 CCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred ccCcccccCCCCHHHHhcCcccCCCC
Confidence 7654 44599999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=366.07 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=228.3
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccc-cccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~-~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.+.++++|++.+.||+|-||.||+|+.+.++-.||+|++.++. ........+.+|++|...|+||||+++|++|..+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-- 94 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-- 94 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--
Confidence 4557899999999999999999999999999999999997654 3345566777899999999999999999999654
Q ss_pred CeEEEEEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..+||++||... ++++..+... ...|.+..+..|+.|++.||.|||.++||||||||+|+|++..|.+||+|||.+.
T Consensus 95 ~riyLilEya~~--gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 95 KRIYLILEYAPR--GELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred ceeEEEEEecCC--chHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 489999999987 8888887643 3458999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
... ...-.+.|||..|.+||+..+ ..++..+|+|++|++.||+|.|.+||...+..+...+|.+.-..
T Consensus 173 ~~p--~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~--------- 240 (281)
T KOG0580|consen 173 HAP--SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK--------- 240 (281)
T ss_pred ecC--CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc---------
Confidence 554 455677899999999999988 67999999999999999999999999999988888888764211
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
+...++..+.|||.+||.++|.+|++..|++.|||+..
T Consensus 241 ------------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 ------------------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ------------------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 11347888999999999999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=379.72 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=205.6
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccccc
Q psy18163 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD 448 (1028)
Q Consensus 370 LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~gd 448 (1028)
||+|+||+||+|++..+++.||||+++.... .........+|+.+|..++||||+++++++.. .+.+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~- 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFING- 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCC-
Confidence 7999999999999999999999999975432 12223455689999999999999999887754 4589999999987
Q ss_pred hHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccccccc
Q psy18163 449 MKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV 528 (1028)
Q Consensus 449 LgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vG 528 (1028)
++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 78 -g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 78 -GELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred -CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 566655544 345889999999999999999999999999999999999999999999999999865433334456789
Q ss_pred CccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccC
Q psy18163 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEY 608 (1028)
Q Consensus 529 T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~ 608 (1028)
|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~------------------------ 210 (312)
T cd05585 156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL------------------------ 210 (312)
T ss_pred CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC------------------------
Confidence 999999999987 5689999999999999999999999998777666555543100
Q ss_pred CCCCCCccccccccccHHHHHHHHHhcccCcCCCC---CHHHHHhCCCCCCC
Q psy18163 609 PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI---TADEALRHDYFSES 657 (1028)
Q Consensus 609 p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP---TA~ElL~HPfF~e~ 657 (1028)
.+...+++.+.+||.+||..||.+|| ++.++|.||||...
T Consensus 211 ---------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 211 ---------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 00122567889999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=377.35 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=207.7
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHH---HHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTL---LKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL---~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
|++++.||+|+||.||+|.+..+++.||||+++..... ......+.+|+.++ ..+.||||+++++++.. .+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 78899999999999999999999999999999765321 11223344555544 45679999999998854 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ ++|...+. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 79 lv~E~~~~--~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAG--GDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCC--CcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999987 55555443 345899999999999999999999999999999999999999999999999998764433
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-------------- 219 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-------------- 219 (324)
T ss_pred CCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 333456789999999999987 56899999999999999999999999988877766665442100
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
....++..+.+||.+||..||.+|| ++.++++||||+..
T Consensus 220 -------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 220 -------------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 0112567788999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.55 Aligned_cols=290 Identities=44% Similarity=0.830 Sum_probs=228.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECC--CCeEEEEEEeeccc-cccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKR--TDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~--tg~~VAIKvlk~~~-~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.|+++++||.|+||.||+|.+.. ++..||||++.... ..........+|+.++..++||||+++++++.......+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 89999999998643 1223344567899999999999999999999776557899
Q ss_pred EEEeccccchHHHHHHHhhcC-CcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC----CCcEEEeccCCcc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH----RGILKVGDFGLAR 514 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~-~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~----~g~lKL~DFGlAr 514 (1028)
+||||++++|.+++....... ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 999999988887776554433 36889999999999999999999999999999999999999 9999999999998
Q ss_pred ccCCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHh
Q psy18163 515 EYGSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---------LEQLSRIFKT 582 (1028)
Q Consensus 515 ~~~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---------~d~l~kI~~~ 582 (1028)
....... .....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+... ...+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7644322 233457899999999988766789999999999999999999999987553 2456777777
Q ss_pred cCCCCCCCCCCCCCChhhhhhc----cccCCCCCCCcccccc--ccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMT----FAEYPNVGGLKTKVAG--SILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~----~~~~p~~~~l~~~~~~--~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
++.+....|..+..++...... ...++. ..+ ..... ...+..+.+||.+||..||.+|||+.+++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS-NSL-AKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCC-ccH-HHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 7777666665444443322210 001110 000 00011 1456788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=382.53 Aligned_cols=270 Identities=24% Similarity=0.394 Sum_probs=220.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++...||.|.-++||+|+...++++||||++..++.+.. ...+.+|+..|..+.||||+.++..|+... .+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS--ELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc--eeE
Confidence 35789999999999999999999999999999999998877655 466788999999999999999988887554 899
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+||.||.+ ++.+++..... ..|.|..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 101 vVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred EeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999986 44444443322 3388999999999999999999999999999999999999999999999998765533
Q ss_pred CCC----cccccccCccccCccc-ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 519 PLK----HYTPIVVTLWYRSPEL-LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 519 ~~~----~~t~~vGT~~Y~APEv-L~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
... .+++++||++|||||+ +.....|+.++||||||++..||.+|..||....+..++..-+ .+.|+...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~~--- 253 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTLL--- 253 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCcc---
Confidence 221 2367899999999999 5566789999999999999999999999999888776664433 33433222
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.+.++.-+ ...++..++.||..||.+||.+||||.++|+|+||+..
T Consensus 254 t~~~~~d~------------------~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 TSGLDKDE------------------DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred cccCChHH------------------hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 11111111 12245578899999999999999999999999999875
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=378.40 Aligned_cols=262 Identities=27% Similarity=0.430 Sum_probs=224.7
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
...++|..+++||+|+||+|-+|+.+.++++||||++++...-. ......+.|-.+|..++||.+..|...| +..++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~dr 242 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDR 242 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCce
Confidence 35789999999999999999999999999999999998865322 2234456788899999999999986444 66779
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|+||||+.| |.|+.++.. ...|++..++.|...|++||.|||+++||+||||.+|+|+|.+|++||+|||||+.--
T Consensus 243 lCFVMeyanG--GeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 243 LCFVMEYANG--GELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEEEccC--ceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999988 888877644 4569999999999999999999999999999999999999999999999999998755
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.......++||||.|+|||+|.. ..|+.++|||.+||++|||+||+.||...+....+..|+-.-
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-------------- 384 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-------------- 384 (516)
T ss_pred cccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh--------------
Confidence 55566778999999999999988 679999999999999999999999999887766666554321
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESPL 659 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p~ 659 (1028)
+ .+...++++++.||..+|.+||.+|. .|.||.+|+||....|
T Consensus 385 -----~--------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 385 -----L--------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred -----c--------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 0 12234889999999999999999998 6899999999987644
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=384.75 Aligned_cols=258 Identities=24% Similarity=0.322 Sum_probs=211.9
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCC-eEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTD-EIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg-~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
...++|++++.||.|+||.||+|.+..++ ..||||++...... ......+.+|+.++..++||||+++++++... +
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 104 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--S 104 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--C
Confidence 34678999999999999999999976655 78999999754321 22234566899999999999999999988544 5
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+||||||+.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~--g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIG--GEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 89999999976 444444433 345889999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ....+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.+.+.......+......
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~----------- 246 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY----------- 246 (340)
T ss_pred CCC---cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-----------
Confidence 432 245689999999999987 56899999999999999999999999988776666665432100
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
+...++..+.+||.+||..||.+|+ |+.++++||||....
T Consensus 247 ----------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 247 ----------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred ----------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0122567789999999999999995 899999999998743
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=365.77 Aligned_cols=285 Identities=44% Similarity=0.777 Sum_probs=226.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||.|+||.||+|.+..+++.||||.+..... ......+.+|+.+++.++|+||+++++++.. .+.+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 5789999999999999999999999999999999976432 2223446789999999999999999998753 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.++|.+++. .....+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....+.
T Consensus 81 v~e~~~~~L~~~~~---~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 81 VFEYLDTDLKQYMD---DCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EEecCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 99999977666554 334467889999999999999999999999999999999999999999999999997654433
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS-DLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s-d~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..+...++.+....|+.......
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 333445678899999998876668999999999999999999999998766 5677777888888887777765543332
Q ss_pred hhhhccccCCCCCCCcccccccccc--HHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILT--ELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls--~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.....+....... + ......++ ..+.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRP-L--INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChh-H--HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 2222111110000 0 00011233 678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=378.23 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=209.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCC-CeeEEEEEEeecCCCeEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHP-NIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HP-NIV~L~~i~~~~~~~~l~L 440 (1028)
+|++++.||+|+||.||+|.+..+++.||||++...... .........|+.++..+.|+ +|+.+++++.. .+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 589999999999999999999999999999999865321 22234456788888888765 57778777653 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 79 v~E~~~~--g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNG--GDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999986 555555543 3458899999999999999999999999999999999999999999999999987543333
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---------------- 218 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---------------- 218 (324)
T ss_pred CceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 34455789999999999987 5689999999999999999999999998887776666643210
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH-----HHHHhCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA-----DEALRHDYFSES 657 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA-----~ElL~HPfF~e~ 657 (1028)
.+ ...++..+.+||.+||..||.+|+++ .++++||||...
T Consensus 219 ------~~-----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 219 ------SY-----------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred ------CC-----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 11256788999999999999999976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=388.83 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=207.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||.|+||+||+|.+..+++.||||++..... .......+.+|+.++..+.||||+++++++.. ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 479999999999999999999999999999999876432 12222345679999999999999999988854 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 79 v~E~~~g--g~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 79 IMEFLPG--GDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEeCCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999976 455544433 3468899999999999999999999999999999999999999999999999996432100
Q ss_pred --------------C---------------------------------cccccccCccccCcccccCCCCCCchhhHHHH
Q psy18163 521 --------------K---------------------------------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSV 553 (1028)
Q Consensus 521 --------------~---------------------------------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSL 553 (1028)
. .....+||+.|+|||++.+ ..|+.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl 234 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSL 234 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEec
Confidence 0 0013579999999999987 568999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHH
Q psy18163 554 GCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCK 633 (1028)
Q Consensus 554 GvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~k 633 (1028)
|||||+|++|.+||.+.+..+.+..+....... . ++. ...++..+.+||.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------~---~p~---------~~~~s~~~~dli~~ 285 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETL-----------------Y---FPD---------DIHLSVEAEDLIRR 285 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc-----------------C---CCC---------CCCCCHHHHHHHHH
Confidence 999999999999999888777666665421000 0 000 01256789999999
Q ss_pred hcccCcCCC---CCHHHHHhCCCCCCCC
Q psy18163 634 FLTYDPVTR---ITADEALRHDYFSESP 658 (1028)
Q Consensus 634 cL~~DP~kR---PTA~ElL~HPfF~e~p 658 (1028)
||. +|.+| +|+.++|.||||+...
T Consensus 286 lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 286 LIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred Hhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 998 77765 5999999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.31 Aligned_cols=292 Identities=45% Similarity=0.895 Sum_probs=233.9
Q ss_pred ccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC-
Q psy18163 356 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN- 434 (1028)
Q Consensus 356 ~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~- 434 (1028)
.||...++|+++++||.|+||.||+|.+..++..||||++..............+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred CCCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 3566789999999999999999999999999999999998765443334445678999999999999999988775433
Q ss_pred -----CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEec
Q psy18163 435 -----MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGD 509 (1028)
Q Consensus 435 -----~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~D 509 (1028)
...+++||+|+.+++..++. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|
T Consensus 82 ~~~~~~~~~~lv~~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDHDLSGLLE---NPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred cccccCceEEEEEecCCcCHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence 33689999999876555443 3345689999999999999999999999999999999999999999999999
Q ss_pred cCCccccCCCC-----------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy18163 510 FGLAREYGSPL-----------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSR 578 (1028)
Q Consensus 510 FGlAr~~~~~~-----------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~k 578 (1028)
||++....... ..++...+|+.|+|||++.+...++.++||||||||+|+|++|.+||.+.+.......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99997654321 1223456789999999987756689999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCChhhhhh-ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 579 IFKTMGTPNEKIWPGFSKLPAVQKM-TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 579 I~~~lg~p~~~~w~~~s~lp~~~~l-~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
++...+.+.+..|+.+..++..... .....+.. + ......+...+.+||.+||..||.+|||+.++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT--L--EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCcc--H--HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 9998888877777666554433210 11111110 0 00112345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=388.25 Aligned_cols=261 Identities=25% Similarity=0.378 Sum_probs=208.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|..+.|+||+++++++.. .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEE
Confidence 3699999999999999999999999999999999754321 2223446689999999999999999888754 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC-
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP- 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~- 519 (1028)
|||||.+ ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|..+...
T Consensus 79 v~E~~~~--g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPG--GDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999976 445544433 345788999999999999999999999999999999999999999999999998532100
Q ss_pred ------------------------------------------CCcccccccCccccCcccccCCCCCCchhhHHHHHHHH
Q psy18163 520 ------------------------------------------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIF 557 (1028)
Q Consensus 520 ------------------------------------------~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvIL 557 (1028)
.......+||+.|+|||++.+ ..++.++|||||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil 234 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL 234 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeecccee
Confidence 000123589999999999987 6689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhccc
Q psy18163 558 AEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTY 637 (1028)
Q Consensus 558 yELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~ 637 (1028)
|+|++|.+||.+.+..+....+........ .+. ...++..+.+||.+|+ .
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------~~~---------~~~~s~~~~~li~~l~-~ 284 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLH--------------------IPS---------QAKLSREASDLILRLC-C 284 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCcccc--------------------CCC---------CCCCCHHHHHHHHHHh-c
Confidence 999999999998887666555532110000 000 1126778899999977 5
Q ss_pred CcCCCC---CHHHHHhCCCCCCCC
Q psy18163 638 DPVTRI---TADEALRHDYFSESP 658 (1028)
Q Consensus 638 DP~kRP---TA~ElL~HPfF~e~p 658 (1028)
||.+|+ |+.++++||||+...
T Consensus 285 ~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 285 GAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred CHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999999 999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=381.05 Aligned_cols=251 Identities=26% Similarity=0.420 Sum_probs=205.4
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
+.||+|+||.||+|.+..++..||||++...... ........+|+.+|..+.||||+.+++++. ..+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence 3699999999999999999999999999765321 222345678999999999999999987775 4458999999998
Q ss_pred cchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccccc
Q psy18163 447 HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526 (1028)
Q Consensus 447 gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~ 526 (1028)
+ ++|...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++............
T Consensus 79 ~--g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 79 G--GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred C--CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 6 455544433 3468899999999999999999999999999999999999999999999999998644333344557
Q ss_pred ccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccc
Q psy18163 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606 (1028)
Q Consensus 527 vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~ 606 (1028)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~-------------------- 212 (328)
T cd05593 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--I-------------------- 212 (328)
T ss_pred cCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--c--------------------
Confidence 89999999999987 568999999999999999999999998877655544432110 0
Q ss_pred cCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 607 EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 607 ~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
. +...++..+.+||.+||..||.+|+ ++.++++||||...
T Consensus 213 ~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 213 K-----------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred c-----------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0122567889999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=365.43 Aligned_cols=291 Identities=42% Similarity=0.761 Sum_probs=228.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC-----
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----- 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----- 434 (1028)
..++|+++++||.|+||.||+|.+..++..||||++..............+|+.+++.+.||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 457899999999999999999999999999999998765444444445568999999999999999999875432
Q ss_pred -CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCc
Q psy18163 435 -MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA 513 (1028)
Q Consensus 435 -~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlA 513 (1028)
....|+||||+.++|.+++. .....+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLS---NKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 24679999999876655543 33446899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC----CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 514 REYGSPL----KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 514 r~~~~~~----~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
..+.... ......+++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+..+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 8664322 122345678999999998775667899999999999999999999999988888888887777777776
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.|+............++.... ............+..+.+||.+||..||.+|||++++|+||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQK-RKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccc-hhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 666554333222211111000 0000011111245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=380.59 Aligned_cols=279 Identities=22% Similarity=0.327 Sum_probs=207.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
..|++++.||+|+||.||+|.+..++..||+|+.... ....|+.++..++||||+++++++... ...|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeEEE
Confidence 4699999999999999999999999999999975432 235799999999999999999988644 478999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.++|.+++ ......+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++..... .
T Consensus 136 ~e~~~~~l~~~l---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 211 (357)
T PHA03209 136 LPHYSSDLYTYL---TKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-P 211 (357)
T ss_pred EEccCCcHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-c
Confidence 999987655544 444567899999999999999999999999999999999999999999999999999754322 2
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCC---------hHHHHHHHHHhcCCCCCCCC
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKS---------DLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~-pPF~g~s---------d~d~l~kI~~~lg~p~~~~w 591 (1028)
......||+.|+|||++.+ ..|+.++|||||||++|+|+++. ++|.... ....+..++..++..+..+.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 3345679999999999987 56899999999999999999855 5554422 12344455555554333222
Q ss_pred CCCCCChhhhhh-ccccCCCCCCCcc-ccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 592 PGFSKLPAVQKM-TFAEYPNVGGLKT-KVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 592 ~~~s~lp~~~~l-~~~~~p~~~~l~~-~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..... ...... ............+ ......++..+.+||.+||..||.+||||.|+|+||||++
T Consensus 291 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGS-RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCcc-HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 11000 000000 0000000000000 0011235667889999999999999999999999999975
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=365.69 Aligned_cols=288 Identities=44% Similarity=0.854 Sum_probs=234.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++.+.||.|+||+||+|.+..+++.||||.+............+.+|+.+++.+.||||+++++++.. ...+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 67999999999999999999999999999999987654333334456789999999999999999998864 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||++++|...+.. .....+.+..+..++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++.......
T Consensus 80 ~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 80 FEYLDLDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EecccccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 99998655554432 12223577888999999999999999999999999999999985 5679999999998765544
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
...+...+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.+++...+.+....|.++..++..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 44555678999999999877566899999999999999999999999998888889999999999999999887776655
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
... +..++. .......+.++..+++||.+||..||.+||++.++|.||||...
T Consensus 238 ~~~-~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 238 KSA-FPKWPP---KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhh-cccCCC---CCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 321 111111 11112234467889999999999999999999999999999864
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=385.25 Aligned_cols=265 Identities=25% Similarity=0.362 Sum_probs=213.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||.||+|++..++..||||++...... ......+.+|+.++..++||||+.+++++. ..+.+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCEE
Confidence 457899999999999999999999999999999999754321 122234567999999999999999988775 44589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||+.+ ++|...+.. ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 119 ~lv~Ey~~g--g~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPG--GDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCC--CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999976 444444432 2478888999999999999999999999999999999999999999999999987643
Q ss_pred CC-CcccccccCccccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 519 PL-KHYTPIVVTLWYRSPELLLGC---KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 519 ~~-~~~t~~vGT~~Y~APEvL~g~---~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.. ......+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+..|....... .+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---~~--- 268 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL---TF--- 268 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC---CC---
Confidence 22 123456899999999998653 247899999999999999999999999988777666665421100 00
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC--CCCHHHHHhCCCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEALRHDYFSESPL 659 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k--RPTA~ElL~HPfF~e~p~ 659 (1028)
+. ...++..+.+||.+||..+|.+ |+|+.++++||||+...+
T Consensus 269 --------------~~---------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 269 --------------PD---------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred --------------CC---------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 00 1126788999999999999998 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=375.74 Aligned_cols=257 Identities=24% Similarity=0.371 Sum_probs=209.8
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+|++++.||+|+||.||+|++..++..||||+++...... ........|+.++..+ .|++|+.+++++.. .+.+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 5899999999999999999999999999999998654221 2223345677777766 48889989887754 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~~--g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNG--GDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999986 555555543 3458899999999999999999999999999999999999999999999999998654333
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------- 219 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--------------- 219 (323)
T ss_pred CccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 34456789999999999987 66999999999999999999999999998877776666542100
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESP 658 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p 658 (1028)
+ ...++..+.+||.+||..||.+|++ ..++++||||+...
T Consensus 220 -------~-----------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 220 -------Y-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred -------C-----------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 0 0125678899999999999999997 58999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=377.79 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=204.1
Q ss_pred CeEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccc--cCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCC
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEK--EGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~--~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~ 436 (1028)
+|++++.||+|+||+||+|++. .++..||+|++...... .........|+.+|..+. ||||+.+++++. ..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence 5899999999999999999874 57899999999764321 122234567899999984 999999987774 345
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+||||+.+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+
T Consensus 79 ~~~lv~e~~~~--g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 79 KLHLILDYVSG--GEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEEEeCCCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 89999999987 555555543 345889999999999999999999999999999999999999999999999999865
Q ss_pred CCCC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 517 GSPL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 517 ~~~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... ......+||+.|+|||++.+...++.++||||||||+|+|++|..||...........+.........
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------- 228 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP------- 228 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC-------
Confidence 4322 22335689999999999987556899999999999999999999999754322111111111100000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|| ++.++++||||+..
T Consensus 229 ----------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 229 ----------------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 01123567889999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=377.04 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=206.0
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||+||+|++..+++.||||+++..... .........|+.++..+ .||||+.+++++.. .+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999999765321 22233456788888765 69999999988754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 79 ~~--g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 79 NG--GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CC--chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 87 566555543 346889999999999999999999999999999999999999999999999998764333333455
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------------------- 214 (320)
T cd05590 156 FCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-------------------- 214 (320)
T ss_pred cccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--------------------
Confidence 689999999999987 56899999999999999999999999998877776666432100
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH------HHHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA------DEALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA------~ElL~HPfF~e~ 657 (1028)
....++..+.+||.+||..||.+|+++ .+++.||||...
T Consensus 215 -------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 215 -------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred -------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 011256788999999999999999998 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=360.91 Aligned_cols=287 Identities=39% Similarity=0.669 Sum_probs=223.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..+|++++.||+|+||.||+|.+..++..||||++..... ........+|+.++..++|+||+++++++.. .+..|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 4689999999999999999999999999999999975432 2233456789999999999999999998754 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+++.+.+ ......+.+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++......
T Consensus 81 v~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 81 VFEYMHTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred EEecccCCHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9999987554433 3334457788899999999999999999999999999999999999999999999998665444
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS-DLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s-d~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......++++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+.++...++.|....|+....++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 444556789999999998775568899999999999999999999998755 3466777777777777666665554443
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.....+..... ............+..+.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKP-QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCC-cchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 22211111100 0000000000125678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=361.08 Aligned_cols=284 Identities=43% Similarity=0.818 Sum_probs=230.2
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++++.||.|+||.||+|.+..++..||||+++..... .....+.+|+.++..++|+||+++++++... +.++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence 589999999999999999999999999999999765432 2234566899999999999999999988654 4789999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.++|.+++.... ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.........
T Consensus 78 e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred ecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 999987666554322 1245889999999999999999999999999999999999999999999999999876554444
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
....++|..|++||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++.....+....|......+...
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 235 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK- 235 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc-
Confidence 4556789999999998776668999999999999999999999999999888899998888877776665554333221
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
..++...........+.++..+.+||.+||..||.+|||+.++++||||
T Consensus 236 ---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 ---PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ---ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1111111111111223457789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=382.71 Aligned_cols=262 Identities=24% Similarity=0.384 Sum_probs=210.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.++..++||||+++++.+. ..+.+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 4799999999999999999999999999999999754321 222345567999999999999999988775 4458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||||.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.++|+|||++..+....
T Consensus 79 v~E~~~g--g~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 79 IMEFLPG--GDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEeCCCC--ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999986 455555443 3458899999999999999999999999999999999999999999999999987542210
Q ss_pred -----------------------------------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q psy18163 521 -----------------------------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEP 565 (1028)
Q Consensus 521 -----------------------------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~p 565 (1028)
......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCC
Confidence 01124589999999999987 669999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC--
Q psy18163 566 LFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-- 643 (1028)
Q Consensus 566 PF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-- 643 (1028)
||.+.+....+..+....... . ++. ...++..+++||.+|+ .||.+|+
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~-----------------~---~p~---------~~~~s~~~~~li~~l~-~~p~~R~~~ 284 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETL-----------------V---FPP---------EVPISEKAKDLILRFC-TDSENRIGS 284 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCce-----------------e---cCC---------CCCCCHHHHHHHHHhc-cChhhcCCC
Confidence 999888777666665311000 0 000 0126788999999987 4999998
Q ss_pred -CHHHHHhCCCCCCCCC
Q psy18163 644 -TADEALRHDYFSESPL 659 (1028)
Q Consensus 644 -TA~ElL~HPfF~e~p~ 659 (1028)
++.+++.||||....+
T Consensus 285 ~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 285 NGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CCHHHHhcCCCCCCCCH
Confidence 5899999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=375.93 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=206.6
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||.||+|++..+++.||||+++..... .........|+.++..+ .||||+.+++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 3699999999999999999999999999765322 22223456788888765 79999999988854 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 79 ~~--~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 79 NG--GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 87 455555443 345888999999999999999999999999999999999999999999999999865443344456
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~-------------------- 214 (321)
T cd05591 156 FCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-------------------- 214 (321)
T ss_pred cccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence 789999999999877 56899999999999999999999999998887777766542100
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-------CHHHHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-------TADEALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-------TA~ElL~HPfF~e~ 657 (1028)
+ ...++..+.+||.+||..||.+|+ ++.++++||||...
T Consensus 215 --~-----------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 215 --Y-----------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred --C-----------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 0 112567889999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.52 Aligned_cols=286 Identities=34% Similarity=0.597 Sum_probs=218.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|+++..||+|+||.||+|.+..+++.||+|++............+.+|+.++..++|+||+++++++.. ...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 46999999999999999999999999999999987654333333456789999999999999999998864 3589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+++. .+ ..+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 79 ~e~~~~~--~l-~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHT--VL-NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCcc--HH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999873 22 22333344588999999999999999999999999999999999999999999999999987755433
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++........-+.......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 34456788999999998876678999999999999999999999999988877777666554432211000000000000
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+..+...... ........++..+.+||.+||..||.+|||+.++|.||||
T Consensus 236 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETRE--PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCccccc--CHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00000000000 0011122357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=372.71 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=206.2
Q ss_pred EEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccc--cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 367 LNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEK--EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 367 l~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~--~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++.||+|+||.||+|++. .+++.||||+++..... .........|+.+|..++||||+++++++.. .+.+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 367999999999999874 57889999999764321 1222345679999999999999999888754 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ ++|...+.. ...+.+..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.......
T Consensus 79 ~e~~~~--~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 79 LEYLSG--GELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EeCCCC--chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999987 566655544 34578888999999999999999999999999999999999999999999999976543333
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~----------------- 217 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL----------------- 217 (323)
T ss_pred cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 3445689999999999987 5689999999999999999999999998887766666543210
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
. ....+++.+.+||.+||..||.+|| ++.+++.||||...
T Consensus 218 -----~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 218 -----N-----------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred -----C-----------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0122567889999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=365.67 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=203.5
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecccc-
Q psy18163 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH- 447 (1028)
Q Consensus 370 LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~g- 447 (1028)
||+|+||+||+|.+..+++.||+|++....... .....+..|+.++..+.|+||+.+.+++.. ...+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 799999999999999999999999997643221 122345679999999999999999887754 4579999999976
Q ss_pred chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccccc
Q psy18163 448 DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527 (1028)
Q Consensus 448 dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~v 527 (1028)
+|..++.........+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...........
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 55544433333445689999999999999999999999999999999999999999999999999987655434444568
Q ss_pred cCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcccc
Q psy18163 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAE 607 (1028)
Q Consensus 528 GT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~ 607 (1028)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........
T Consensus 159 g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------- 218 (280)
T cd05608 159 GTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV------------------- 218 (280)
T ss_pred CCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC-------------------
Confidence 9999999999987 56899999999999999999999999875432222222211100000
Q ss_pred CCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 608 YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 608 ~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
.....++..+.+||.+||..||.+|| |++++++||||+...
T Consensus 219 ----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 219 ----------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred ----------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 01123667889999999999999999 899999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=374.22 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=210.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||+|+||+||++++..+++.||||++.+... .......+.+|+.++..+.|+||+.+++++. ..+++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEE
Confidence 479999999999999999999999999999999975322 1222234567889999999999999988875 4458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~g--~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 79 VMDYYVG--GDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEecCCC--CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999976 44554444445568999999999999999999999999999999999999999999999999997654322
Q ss_pred C-cccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 521 K-HYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 521 ~-~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
. .....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------- 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ-------- 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc--------
Confidence 2 2233579999999999863 34578899999999999999999999998877666666543211000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC--CCCHHHHHhCCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEALRHDYFSESPL 659 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k--RPTA~ElL~HPfF~e~p~ 659 (1028)
++ .....++..+.+||.+||..++.+ |+++.++|+||||....+
T Consensus 229 ------------~~--------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 229 ------------FP--------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred ------------CC--------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 00 001226788999999999875554 889999999999987543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=383.18 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=211.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.++..+.||||+++++++.. ...+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEE
Confidence 357899999999999999999999999999999999753321 1223345689999999999999999988754 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+|||||.+ ++|...+.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|..+..
T Consensus 119 ~lv~Ey~~g--g~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPG--GDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCC--CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999976 444444432 2478889999999999999999999999999999999999999999999999987643
Q ss_pred CC-CcccccccCccccCcccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 519 PL-KHYTPIVVTLWYRSPELLLGCK---EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 519 ~~-~~~t~~vGT~~Y~APEvL~g~~---~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.. ......+||+.|+|||++.+.. .++.++|||||||+||+|++|.+||.+.+....+..|......+. +
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~--- 268 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---F--- 268 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---C---
Confidence 22 1234678999999999997532 378999999999999999999999999887777776654211100 0
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC--CCCHHHHHhCCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEALRHDYFSESP 658 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k--RPTA~ElL~HPfF~e~p 658 (1028)
+. ...++..+.+||.+||..+|.+ |+|+.++|+||||+...
T Consensus 269 --------------p~---------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 269 --------------PE---------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred --------------CC---------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 00 0125778899999999866654 89999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=419.16 Aligned_cols=266 Identities=24% Similarity=0.348 Sum_probs=223.8
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccc-cccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~-~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
...++|.+++.||+|+||.|.+++++.|++.||+|++.+-. .+......+..|-.+|...+.+-|+.|+ |.+++..+
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh--yAFQD~~~ 149 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH--YAFQDERY 149 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH--HHhcCccc
Confidence 35689999999999999999999999999999999997632 2233344567788899888899999994 55577789
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+||||||+.| |+|+..+.... .+++.-+++|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.|-.+.
T Consensus 150 LYlVMdY~pG--GDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 150 LYLVMDYMPG--GDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred eEEEEecccC--chHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 9999999988 66666554444 79999999999999999999999999999999999999999999999999998776
Q ss_pred CC-CCcccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 518 SP-LKHYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 518 ~~-~~~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
.. .-.....+|||.|++||+|.. ...|+..||||||||++||||+|..||...+-.++..+|+..-.
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~-------- 298 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE-------- 298 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh--------
Confidence 43 334667899999999999852 24699999999999999999999999999999999999986410
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC---HHHHHhCCCCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT---ADEALRHDYFSESPL 659 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT---A~ElL~HPfF~e~p~ 659 (1028)
.+.|+.- ..+|+.++|||+++|+ +|..|.. ++++..||||.+.+|
T Consensus 299 ---------~l~FP~~------------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 299 ---------SLSFPDE------------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ---------hcCCCcc------------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 1112100 1278999999999987 7899998 999999999999877
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=377.90 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=204.9
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
+.||+|+||+||+|.+..++..||+|+++..... ........+|+.++..+.||||+.+++++.. .+.+||||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 3699999999999999999999999999865322 1223345678999999999999999887754 458999999998
Q ss_pred cchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 447 HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 447 gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
+ ++|...+.. ...+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++...........
T Consensus 79 ~--~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 79 G--GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred C--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 7 555554433 3468999999999999999999997 79999999999999999999999999999764333333445
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+....+..+.....
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~--------------------- 213 (325)
T cd05594 156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------------------- 213 (325)
T ss_pred ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC---------------------
Confidence 689999999999977 5689999999999999999999999988776555554432100
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
.+ ...+++.+.+||.+||..||.+|+ ++.++|+||||...
T Consensus 214 -~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 214 -RF-----------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred -CC-----------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 00 112567889999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=371.94 Aligned_cols=252 Identities=27% Similarity=0.362 Sum_probs=203.4
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHH-HHHHcCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREIN-TLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~-iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||+||+|++..+++.||||++....... .....++.|+. ++..++||||+.+++++.. .+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 36999999999999999999999999997653221 12233445554 4567899999999887754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++............
T Consensus 79 ~~--g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 79 NG--GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CC--CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 87 555555543 346889999999999999999999999999999999999999999999999999764333334456
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------------- 213 (323)
T cd05575 156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--------------------- 213 (323)
T ss_pred ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 789999999999987 5689999999999999999999999998877666665543100
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH----HHHHhCCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA----DEALRHDYFSESP 658 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA----~ElL~HPfF~e~p 658 (1028)
.....++..+.+||.+||..||.+||++ .++++||||....
T Consensus 214 ------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 214 ------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 0012256788999999999999999987 6999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=368.98 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=204.9
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||+||+|.+..++..||||+++..... .........|+.++..+ .||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999999865321 22233456788888777 69999999998754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 79 ~~--~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 79 NG--GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 86 455555443 346899999999999999999999999999999999999999999999999999754333333445
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 156 ~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--------------------- 213 (318)
T cd05570 156 FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--------------------- 213 (318)
T ss_pred eecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 689999999999987 5689999999999999999999999998877666555532100
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH-----HHHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA-----DEALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA-----~ElL~HPfF~e~ 657 (1028)
. ....++..+.+||.+||..||.+|||+ .+++.||||+..
T Consensus 214 -~-----------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 214 -R-----------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -C-----------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 011256788999999999999999999 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.55 Aligned_cols=283 Identities=47% Similarity=0.887 Sum_probs=230.7
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
|++++.||.|+||.||+|.+..+|..||||++............+.+|+.++..++||||+++++++.. .+..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 678899999999999999999999999999998665444444566789999999999999999988754 468999999
Q ss_pred ccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcc
Q psy18163 444 YVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY 523 (1028)
Q Consensus 444 y~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~ 523 (1028)
|++++|.+++.... ...+++..+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++..........
T Consensus 79 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 79 FLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred ccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 99876666554321 1357899999999999999999999999999999999999999999999999998765444444
Q ss_pred cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l 603 (1028)
+...++..|+|||++.+...++.++|||||||++|+|++|.+||...++...+..++...+.+....|+....++.....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 55577899999999877566899999999999999999999999999988888888888888877777665544433221
Q ss_pred ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 604 ~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
+.... ..........++..+.+||.+||..||.+|||+.+++.||||
T Consensus 237 -~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 -FPKWA---RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred -ccccc---ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 11111 111112234567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=370.14 Aligned_cols=287 Identities=22% Similarity=0.310 Sum_probs=211.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||.|+||.||+|++..++..||+|++..... ......+.+|+.+|..++||||+++++++... +.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEE
Confidence 4789999999999999999999999999999999976432 12234577899999999999999999988644 48999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||+.+ +|.+++ .. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 v~e~~~~~~L~~~l---~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 81 CMEHMDGGSLDQVL---KE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EeecCCCCcHHHHH---HH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999986 444443 33 34578889999999999999999986 699999999999999999999999999986643
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+...........+......+
T Consensus 157 ~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 157 S--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred c--ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 2 2345679999999999987 568999999999999999999999998766544322211110000000010000000
Q ss_pred hhh-----hhccccCCCC----------CCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQ-----KMTFAEYPNV----------GGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~-----~l~~~~~p~~----------~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
... .......+.. ...........++..+.+||.+||.+||++|||+.+||+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 0000000000 0000011122467889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=378.09 Aligned_cols=284 Identities=24% Similarity=0.291 Sum_probs=215.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC--CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~--~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..+|++++.||.|+||.||+|... .++..||+|.+.... ...+|+.+|..++||||+++++++.. ...+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW--KSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee--CCEE
Confidence 457999999999999999999764 456789999886431 23589999999999999999988754 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+|||++.++|..++ .....+++.++..|+.||+.||.|||++|||||||||+||||+.++.++|+|||+++.+..
T Consensus 162 ~lv~e~~~~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYKCDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999999987665555 2345689999999999999999999999999999999999999999999999999986643
Q ss_pred CC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCCC
Q psy18163 519 PL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS---DLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 519 ~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s---d~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.. ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+.. ....+..+++.++..+..+...
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 22 12234689999999999977 568999999999999999999999997653 4566777777666544333221
Q ss_pred CCCC--hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 594 FSKL--PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 594 ~s~l--p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
.... ...........+.. ..........++..+.+||.+||.+||.+|||+.++|.||||...++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPY-TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred cchhHHHHHHhhcccccCCc-cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 1100 00001110000000 00000111235667899999999999999999999999999987654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=371.44 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=202.6
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHH-cCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLK-AQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~-l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||.||+|++..++..||||+++..... .........|+.++.. +.||||+.+++++.. .+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 3699999999999999999999999999865321 1222344567777765 489999999988754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...........
T Consensus 79 ~~--g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 79 NG--GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 86 555555543 345888999999999999999999999999999999999999999999999999754333334456
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+... .+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~------------------- 213 (316)
T cd05620 156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP------------------- 213 (316)
T ss_pred cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------------
Confidence 789999999999987 56899999999999999999999999988776655554321 00
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH-HHHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA-DEALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA-~ElL~HPfF~e~ 657 (1028)
.+ ...++..+.+||.+||..||.+|+++ +++++||||...
T Consensus 214 -~~-----------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 214 -HY-----------PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -CC-----------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 00 11256788999999999999999997 589999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.28 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=208.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.|++++.||+|+||+||++.+..+++.||||++...... ......+.+|+.+++.++||||+.+++++.. .+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 489999999999999999999999999999999764322 1223345689999999999999999888754 3589999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ +|.+++.. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 79 LTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG- 155 (285)
T ss_pred EeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence 999986 44433322 12345889999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 223 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE----------- 223 (285)
T ss_pred CccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccc-----------
Confidence 23345689999999999987 568999999999999999999999998876544443333221100000
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
....++..+.+||.+||..||.+|| ++++++.||||....
T Consensus 224 ------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 224 ------------------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred ------------------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 0122567788999999999999999 999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=371.25 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=202.5
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHH-cCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLK-AQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~-l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||+||+|.+..+++.||||+++..... .........|..++.. ..||||+.+++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999999865422 1222334456666654 479999999888754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 79 ~g--g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 79 NG--GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 76 555555543 346899999999999999999999999999999999999999999999999999865433344456
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~------------------- 213 (316)
T cd05592 156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--P------------------- 213 (316)
T ss_pred ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C-------------------
Confidence 789999999999987 568999999999999999999999999988766665553210 0
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH-HHHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA-DEALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA-~ElL~HPfF~e~ 657 (1028)
.+ ...++..+.+||.+||..||.+||++ .+++.||||...
T Consensus 214 -~~-----------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 214 -HF-----------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -CC-----------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 00 11256778899999999999999986 588999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.03 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=210.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||+|+||.||++++..+++.||+|++.+... .......+.+|+.++..+.|+||+.+++++. ..+.+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ--DENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCEEEE
Confidence 479999999999999999999999999999999965322 1222233567888999999999999988775 4458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 79 v~ey~~~--g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 79 VMDYYVG--GDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEeccCC--CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999976 45555554445568899999999999999999999999999999999999999999999999997654322
Q ss_pred C-cccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 521 K-HYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 521 ~-~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
. .....+||+.|+|||++.+ ...++.++|||||||+||+|++|..||.+.+..+.+..+.......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 227 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--------- 227 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc---------
Confidence 2 2234689999999999863 3468999999999999999999999999888777766664321000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC--CCCHHHHHhCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEALRHDYFSESP 658 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k--RPTA~ElL~HPfF~e~p 658 (1028)
.++. ....++..+.+||.+||..++.+ |+++.++++||||....
T Consensus 228 -----------~~p~--------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 228 -----------QFPA--------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred -----------cCCC--------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 0000 01225788999999999876655 78999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=354.16 Aligned_cols=259 Identities=31% Similarity=0.499 Sum_probs=209.8
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.++..+.||||+++++++.. ...+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 899999999999999999999999999999998775443333344569999999999999999998865 458999999
Q ss_pred cccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 444 YVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 444 y~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
|+.+ +|..++. ....+++..+..++.||+.||.+||++||+|+||||+|||++.++.++|+|||++.........
T Consensus 79 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 79 YCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccccc----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9998 6665555 3445789999999999999999999999999999999999999999999999999864333445
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
....++|..|+|||++.....++.++|||||||++|+|++|..||......+....+...........+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS----------- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-----------
Confidence 566789999999999883367899999999999999999999999987444444333332211000000
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. ........+.+||.+||..||.+|||+.++++||||
T Consensus 224 ------~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 ------Q---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------T---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------c---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0 000123678899999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=374.37 Aligned_cols=290 Identities=30% Similarity=0.534 Sum_probs=224.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----M 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~ 435 (1028)
..++|++++.||+|+||.||+|.+..++..||||++..............+|+.++..++||||++++++|.... .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357899999999999999999999999999999998654333333345668999999999999999999875332 2
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+|+||||+.++|..++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 46899999998766655432 278888999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...++.|...++..+.
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCC-CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 6543 22345678999999999987 668999999999999999999999999988888888888888877654333221
Q ss_pred CChhhhh---hccccC------CCCC-CCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQK---MTFAEY------PNVG-GLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~---l~~~~~------p~~~-~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....... ...... +... ...........+..+.+||.+||..||.+|||+.++|.||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 1100000 000000 0000 000000012345678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=376.74 Aligned_cols=258 Identities=25% Similarity=0.336 Sum_probs=203.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|+++++||.|+||.||+|.+..+++.||||++..... ......+.+|+.+|..++|+||+++++++.. .+.+|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEE
Confidence 3678889999999999999999999999999999965432 2223456789999999999999999988753 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|.. ...+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 150 v~e~~~~--~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDG--GSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCC--Ccccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986 33322 2235667788999999999999999999999999999999999999999999998765443
Q ss_pred CcccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 521 KHYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
......+||..|+|||++.. ...++.++||||||||+|+|++|+.||......+....+........
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 293 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--------- 293 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC---------
Confidence 34456789999999998743 23456799999999999999999999974432222222211100000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
......++..+.+||.+||..||.+|||+.|+|+||||...
T Consensus 294 --------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 294 --------------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred --------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 00112356788999999999999999999999999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=366.66 Aligned_cols=294 Identities=41% Similarity=0.727 Sum_probs=233.1
Q ss_pred CCeEE-EEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC------------CccchHHHHHHHHHcCCCCeeEEEE
Q psy18163 362 EEFKC-LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG------------FPITSLREINTLLKAQHPNIVTVRE 428 (1028)
Q Consensus 362 d~Y~i-l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~------------~~~~~lrEi~iL~~l~HPNIV~L~~ 428 (1028)
++|.. .+.||.|+||+||+|.+..+++.||||+++....... ....+.+|+.++..++|+||+.+++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56764 4679999999999999999999999999875432210 1124578999999999999999999
Q ss_pred EEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEe
Q psy18163 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVG 508 (1028)
Q Consensus 429 i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~ 508 (1028)
++.. .+.+|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+
T Consensus 88 ~~~~--~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEec--CCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence 8854 458999999998876665532 3458889999999999999999999999999999999999999999999
Q ss_pred ccCCccccCC--------------CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy18163 509 DFGLAREYGS--------------PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE 574 (1028)
Q Consensus 509 DFGlAr~~~~--------------~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d 574 (1028)
|||++..... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999987651 11223345678899999999876668999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 575 QLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 575 ~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+..++..++.+....|+....++..... ...............+..+.+||.+||..||.+|||++++|.||||
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEF-----TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhccccccc-----CcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 99999998888887777654433322110 0000001111123457788999999999999999999999999999
Q ss_pred CCCCCCCCCCCC
Q psy18163 655 SESPLPIDPAMF 666 (1028)
Q Consensus 655 ~e~p~p~~p~~~ 666 (1028)
+..+.++.+...
T Consensus 317 ~~~~~~~~~~~~ 328 (335)
T PTZ00024 317 KSDPLPCDPSQL 328 (335)
T ss_pred CCCCCCCCcccC
Confidence 998777665543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=373.24 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=207.6
Q ss_pred EEeeecCcEEEEEEEE---CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEec
Q psy18163 368 NRIEEGTYGVVYRAKD---KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDY 444 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d---~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy 444 (1028)
+.||+|+||.||++++ ..++..||+|+++.............+|+.+|..++||||+++++++.. .+.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 6799999999999987 3678999999998654333233445679999999999999999888754 4589999999
Q ss_pred cccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccc
Q psy18163 445 VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT 524 (1028)
Q Consensus 445 ~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t 524 (1028)
+.+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 80 ~~~--~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRG--GDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence 986 555555533 34689999999999999999999999999999999999999999999999999987654434445
Q ss_pred ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhc
Q psy18163 525 PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604 (1028)
Q Consensus 525 ~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~ 604 (1028)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 157 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~------------------- 216 (318)
T cd05582 157 SFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG------------------- 216 (318)
T ss_pred cccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 6789999999999977 56899999999999999999999999988877766665432100
Q ss_pred cccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCC
Q psy18163 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSES 657 (1028)
Q Consensus 605 ~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~ 657 (1028)
....++..+.+||.+||..||.+||| +.+++.||||...
T Consensus 217 --------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 217 --------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred --------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 01125678899999999999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.83 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=202.4
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHH-HHHHcCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREIN-TLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~-iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||+||+|++..+++.||+|++....... .....+..|+. ++..+.||||+.+++++.. .+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 36999999999999999999999999997643211 11223344444 4577899999999887754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 79 ~~--~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NG--GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 87 455554443 345788899999999999999999999999999999999999999999999999865433334456
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..... .
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----~---------------- 214 (325)
T cd05602 156 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----Q---------------- 214 (325)
T ss_pred ccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc----C----------------
Confidence 789999999999987 6689999999999999999999999998887776666543210 0
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHH----HHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD----EALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~----ElL~HPfF~e~ 657 (1028)
..+.++..+.+||.+||..||.+|+++. ++++|+||...
T Consensus 215 -------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 215 -------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred -------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 0123567889999999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=381.31 Aligned_cols=280 Identities=23% Similarity=0.305 Sum_probs=206.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
...|.+.+.||+|+||.||+|.+..++..||||.... ....+|+.+|.+++|+|||++++++... ...||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEE
Confidence 4579999999999999999999999999999996432 2346899999999999999999887543 47899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||+++.++|..++ ......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 238 v~e~~~~~L~~~l---~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 238 VLPKYRSDLYTYL---GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEccCCCHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999987655544 3334568999999999999999999999999999999999999999999999999998654321
Q ss_pred C--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCC------hHHHHHHHHHhcCCCCCCCC
Q psy18163 521 K--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPL-FTGKS------DLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 521 ~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pP-F~g~s------d~d~l~kI~~~lg~p~~~~w 591 (1028)
. .....+||+.|+|||++.+ ..++.++||||||||||||++|..+ |.... ...++.+++...+..... +
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~-~ 392 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE-F 392 (461)
T ss_pred ccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc-C
Confidence 1 1234679999999999987 5689999999999999999998754 43321 124455555543332221 1
Q ss_pred CCCCC--C-hhhhhhcc-ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 592 PGFSK--L-PAVQKMTF-AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 592 ~~~s~--l-p~~~~l~~-~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
+.... + ..+..... ...+......+.. ...++..+.+||.+||.+||.+|||+.|||+||||+.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11110 0 00000000 0000000000000 1135667899999999999999999999999999974
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=377.56 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=210.3
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
...++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.++..++||||+++++++.. ...
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRY 117 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCE
Confidence 345789999999999999999999999999999999975332 11222345678999999999999999888754 458
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|+||||+.+ ++|...+.. ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.
T Consensus 118 ~~lv~Ey~~g--g~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPG--GDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCC--CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999976 344443332 247888899999999999999999999999999999999999999999999998764
Q ss_pred CCC-CcccccccCccccCcccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPL-KHYTPIVVTLWYRSPELLLGCK---EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~-~~~t~~vGT~~Y~APEvL~g~~---~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
... ......+||+.|+|||++.+.. .++.++|||||||+||+|++|.+||.+.+.......|........ +
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~-- 268 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---F-- 268 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---C--
Confidence 322 2234578999999999987532 378999999999999999999999999887776666654211100 0
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC--CCCHHHHHhCCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEALRHDYFSESP 658 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k--RPTA~ElL~HPfF~e~p 658 (1028)
+. ...++..+.+||.+||..++.+ |+++.++++||||++..
T Consensus 269 ---------------~~---------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 269 ---------------PD---------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred ---------------CC---------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 00 1136788999999999844443 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=355.11 Aligned_cols=281 Identities=36% Similarity=0.641 Sum_probs=219.3
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEEEEE
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
|++++.||.|+||.||+|.+..++..||+|+++...... ......+|+.++..+. |+||+++++++.....+.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 788999999999999999999999999999987643221 2234467888888885 99999999998766556899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.++|. ..+......+++..+..++.||+.||.|||+.||+|+||||+|||++. +.+||+|||++..+... ..
T Consensus 80 e~~~~~l~---~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-~~ 154 (282)
T cd07831 80 ELMDMNLY---ELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-PP 154 (282)
T ss_pred ecCCccHH---HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC-CC
Confidence 99986544 444444456899999999999999999999999999999999999999 99999999999876543 23
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.+...+|..|+|||++.....++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+.......+... . .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~ 231 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS-R--H 231 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc-c--c
Confidence 344678999999998766566889999999999999999999999999988888888877766554321111000 0 0
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
....++.............++..+.+||.+||.+||.+|||+.++|.||||
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 -MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred -ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000111111111111223467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=368.07 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=208.1
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+|++.+.||+|+||.||+|.+..+++.||||++...... .........|+.++..+. |++|+.+++++.. .+.+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 488899999999999999999999999999999865322 222234567888887776 5677788777654 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+.. ...+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~Ey~~~--g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNG--GDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999986 455555433 3458999999999999999999999999999999999999999999999999998654333
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+......
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--------------- 219 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--------------- 219 (323)
T ss_pred ccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 33445679999999999977 66899999999999999999999999998877666666542100
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESP 658 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p 658 (1028)
++ ..++..+.+||.+||..||.+|++ ..++++||||....
T Consensus 220 -------~p-----------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 220 -------YP-----------KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred -------CC-----------ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 00 125677899999999999999997 58999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=368.10 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=203.0
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHH-cCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLK-AQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~-l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||+||+|++..+++.||||+++..... .........|+.++.. +.||||+++++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 3699999999999999999999999999865321 1222344567777765 489999999988754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 79 ~~--g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 79 NG--GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 86 455555543 345788899999999999999999999999999999999999999999999999764333333455
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+... .+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~------------------- 213 (316)
T cd05619 156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP------------------- 213 (316)
T ss_pred ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------------
Confidence 689999999999987 56899999999999999999999999988766655554321 00
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHH-HHHhCCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD-EALRHDYFSESP 658 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~-ElL~HPfF~e~p 658 (1028)
.+ ...++..+.+||.+||..||.+||++. ++++||||....
T Consensus 214 -~~-----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 214 -CY-----------PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -CC-----------CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 00 012567789999999999999999996 999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=370.46 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=199.3
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||.||+|.+..+++.||||+++...... .....+.+|+.++..+ .||||+.+++++.. ...+|||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 36999999999999999999999999998654322 1223456788888888 69999999988854 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 79 ~~--g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 79 SG--GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 87 455554433 346899999999999999999999999999999999999999999999999999754333334456
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD--------LEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd--------~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .+.+.+.+..
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------------- 219 (329)
T cd05588 156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------------- 219 (329)
T ss_pred ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------------
Confidence 789999999999987 6689999999999999999999999963211 1111111100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC------HHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT------ADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT------A~ElL~HPfF~e~ 657 (1028)
.. ......++..+.+||.+||..||.+|+| +.++++||||...
T Consensus 220 --------~~---------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 220 --------KQ---------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred --------CC---------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 00 0011235678899999999999999997 7999999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=374.25 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=202.0
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHc---CCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKA---QHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 370 LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l---~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
||+|+||+||+|++..+++.||||++...... .........|..++..+ .||||+.++.++.. .+.+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 79999999999999999999999999754321 11122344566666655 69999999887754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++............
T Consensus 79 ~~--g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 79 SG--GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CC--ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 86 556555543 446899999999999999999999999999999999999999999999999999765433334456
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------------- 214 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--------------------- 214 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 78999999999998756689999999999999999999999988776665555432100
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC----CHHHHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI----TADEALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP----TA~ElL~HPfF~e~ 657 (1028)
.++ ...++..+.+||.+||..||.+|| ++.++++||||...
T Consensus 215 -~~~----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 215 -RFP----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred -CCC----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 000 012567889999999999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=357.58 Aligned_cols=291 Identities=42% Similarity=0.749 Sum_probs=231.7
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC---
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN--- 434 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~--- 434 (1028)
.+..++|++.+.||+|+||.||+|.+..+++.||||+++.............+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45578999999999999999999999999999999999765443444456678999999999999999998875432
Q ss_pred -----CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEec
Q psy18163 435 -----MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGD 509 (1028)
Q Consensus 435 -----~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~D 509 (1028)
...+|+||||+.+++..++ ......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~l~~~l---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDHDLMGLL---ESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hccccCCcEEEEEcccCccHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 3479999999987555443 33344688999999999999999999999999999999999999999999999
Q ss_pred cCCccccCCCC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 510 FGLAREYGSPL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 510 FGlAr~~~~~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
||++..+.... ..+....++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99998764332 22333466888999999876556789999999999999999999999999988989899888888877
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
..|+.....+......... .... ........++..+.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKK--QYRR-RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhccccccccccccccccc--cccc-chhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 7776554433221110000 0000 0011122367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.04 Aligned_cols=286 Identities=33% Similarity=0.596 Sum_probs=220.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|+++++||.|+||.||+|.+..+++.||||++............+.+|+.++..+.||||+++++++. ....+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEE
Confidence 4699999999999999999999999999999998665433333445678999999999999999988875 44589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ +.+.. +......+.+..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 79 ~e~~~~--~~l~~-~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDH--TVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCc--cHHHH-HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999986 23322 223334588999999999999999999999999999999999999999999999999987655444
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
..+...++..|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+....+.........+...+...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 45566789999999999875668899999999999999999999999888877777777665543221111111111111
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+..+....... .....+.++..+.+||.+||..||.+|||+.++|.||||
T Consensus 236 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEP--LEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcch--HHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 111111111000 001123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=369.78 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=198.1
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||+||+|++..+++.||+|++++..... .....+.+|+.++..+ .||||+.+++++... +.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence 36999999999999999999999999998654322 1223355788887766 799999999988644 5899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...........
T Consensus 79 ~~--~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 79 NG--GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 86 455544433 346899999999999999999999999999999999999999999999999999764333333455
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS--------DLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s--------d~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+.+.+... .
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---~---------- 221 (329)
T cd05618 156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---Q---------- 221 (329)
T ss_pred ccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC---C----------
Confidence 789999999999987 568999999999999999999999995311 111111111000 0
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC------HHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT------ADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT------A~ElL~HPfF~e~ 657 (1028)
..+...++..+.+||.+||..||.+||| +.++++||||+..
T Consensus 222 -------------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 222 -------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0011235678899999999999999998 5899999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=368.16 Aligned_cols=293 Identities=35% Similarity=0.604 Sum_probs=230.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec--CCCeEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--NMDKIF 439 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~--~~~~l~ 439 (1028)
++|++.+.||.|+||.||+|.+..++..||+|++............+.+|+.+|..++||||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 689999999999999999999999999999999976543333445567899999999999999998877533 345789
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.++|..+ +.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~~~l~~~---~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLMESDLHHI---IHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhhhhHHHH---hcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999998654443 332 345899999999999999999999999999999999999999999999999999765432
Q ss_pred CC----cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 520 LK----HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 520 ~~----~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.. .....+||.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+...+|.++...+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 12345789999999998775668999999999999999999999999998888888888888887766554332
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
..... . ....++......+....+.++..+.+||.+||..||.+|||+.++|.||||.+.+.+
T Consensus 241 ~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 241 SDRVR-K-YIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hhhHH-H-HHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 21100 0 000111111111122223467889999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=365.20 Aligned_cols=290 Identities=36% Similarity=0.557 Sum_probs=223.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC---CCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN---MDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~---~~~ 437 (1028)
.++|++.+.||+|+||.||+|.+..+|..||||++..... ........+|+.++..++|+||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3689999999999999999999999999999999864321 223345678999999999999999998765432 246
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|+||||+.++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 89999999876654442 2358899999999999999999999999999999999999999999999999998654
Q ss_pred CCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 518 SPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 518 ~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...++.+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3221 2234578999999999876567899999999999999999999999998888888888877776654433221
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
........ +...+...........+.++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 238 ISLRARNY--IKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hchhhhhH--HhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 11000000 000000000001111223567889999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=363.01 Aligned_cols=258 Identities=31% Similarity=0.436 Sum_probs=212.3
Q ss_pred cCCeEEE-EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEee--cCCC
Q psy18163 361 VEEFKCL-NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVG--SNMD 436 (1028)
Q Consensus 361 ~d~Y~il-~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~--~~~~ 436 (1028)
+++|.+- .+||-|-.|+|..|.++.|++.+|+|++... ....+|+++.-.. .|||||.++++|.. ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4667664 5799999999999999999999999998643 2345788765444 69999999999863 3445
Q ss_pred eEEEEEeccccchHHHHHHHhhcC-CcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEeccCC
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDFGL 512 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~-~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DFGl 512 (1028)
++.+|||+|+| |+|+.++...+ ..|++.++..|++||..||.|||+.+|.||||||+|+|+.. +..+||+|||+
T Consensus 133 cLLiVmE~meG--GeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 133 CLLIVMECMEG--GELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeEeeeecccc--hHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 78999999999 99999997764 46999999999999999999999999999999999999974 45799999999
Q ss_pred ccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD----LEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd----~d~l~kI~~~lg~p~~ 588 (1028)
|+....+ ..+.+.|-||+|.|||++-. ..|+..+|+||||||+|.||||+|||.+... ..+-.+|......++.
T Consensus 211 AK~t~~~-~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 211 AKETQEP-GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccCCC-ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 9976543 45667799999999999865 5699999999999999999999999987543 2233344333222222
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.. ++.+|++++|||++||..+|.+|+|+.++++|||+.+..
T Consensus 289 pE-----------------------------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 289 PE-----------------------------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hh-----------------------------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 22 234788999999999999999999999999999998753
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.70 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=202.0
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHH-HHHHcCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREIN-TLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~-iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||+||+|.+..+|+.||||++...... ......+..|+. ++..++||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 3699999999999999999999999999765321 112233445554 4567899999999887754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++............
T Consensus 79 ~~--~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 79 NG--GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 87 455554433 456899999999999999999999999999999999999999999999999999764433334456
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--------------------- 213 (325)
T cd05604 156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--------------------- 213 (325)
T ss_pred ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---------------------
Confidence 789999999999987 5689999999999999999999999998877666655543100
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH----HHHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA----DEALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA----~ElL~HPfF~e~ 657 (1028)
...+.++..+.+||.+||..||.+||++ .+++.||||...
T Consensus 214 ------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 214 ------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0011256778899999999999999976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=366.53 Aligned_cols=290 Identities=36% Similarity=0.589 Sum_probs=226.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC---CCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN---MDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~---~~~l 438 (1028)
.+|.+++.||.|+||+||+|.+..++..||||.+..............+|+.++..++|+||+++++++.... ...+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999999999999999998754332323345678999999999999999998775432 2458
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||+.++|.+++. . ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~L~~~~~---~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMDTDLHQIIR---S-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCCCCHHHHHh---c-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 9999999876554443 2 34689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.........+|..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.+....+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE- 239 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch-
Confidence 4333445678999999999876456899999999999999999999999998888888888888777665544222111
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..... ....+...........+.++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 240 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRY-IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHH-HHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 00011111111111223477889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=383.36 Aligned_cols=259 Identities=29% Similarity=0.474 Sum_probs=228.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|.++++||.|+||.+++++++..+..|+||.+...............|+.++.++.|||||.++++|+..+ ..+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEE
Confidence 46899999999999999999999999999999999988766655667789999999999999999999997544 34999
Q ss_pred EEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||+||+| |++.+.+... +..|++..+..|+.||+.||.|||++.|+|||||+.|||+..++.|+|+|||+|+..+.+
T Consensus 82 vm~Y~eG--g~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 82 VMEYCEG--GDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEeecCC--CCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999997 4444444333 477999999999999999999999999999999999999999999999999999999877
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.....+.+||+.||.||++.+ .+|+.++|||||||++|||++-+++|.+.+-...+.+|+.....|-+
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp----------- 227 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP----------- 227 (426)
T ss_pred hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-----------
Confidence 656678899999999999988 78999999999999999999999999999999999999886543322
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
...+.++..||..||..+|..||+|.++|.+|.+.
T Consensus 228 ---------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 ---------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ---------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 22566788999999999999999999999998876
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=352.38 Aligned_cols=285 Identities=36% Similarity=0.633 Sum_probs=224.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++.+.||.|+||.||+|.+..+++.||||+++...........+.+|+.+++.+.|+||+++++++.. .+.+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 36999999999999999999999999999999987654444445567889999999999999999998865 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+++.. .+......+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||++........
T Consensus 79 ~e~~~~~~l~---~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLE---LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999874333 2233345588999999999999999999999999999999999999999999999999987655432
Q ss_pred -cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 522 -HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 522 -~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
.....+++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++......+..+...+..
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 3455678999999999988547899999999999999999999999998888877777776665544333222211111
Q ss_pred hhhccccCCCCCCC--ccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 601 QKMTFAEYPNVGGL--KTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l--~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
... .++..... ........++..+.+||.+||..||.+|||+.+++.||||
T Consensus 236 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGV---AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccc---ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 100 01110000 0011223357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=388.04 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=214.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC-----
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM----- 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~----- 435 (1028)
.++|++.+.||+|+||+||+|.+..+++.||||++..............+|+.+|..+.|+||+.++..+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 468999999999999999999999999999999997654333333456789999999999999999877653321
Q ss_pred -CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCc
Q psy18163 436 -DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA 513 (1028)
Q Consensus 436 -~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlA 513 (1028)
..+++||||+.+ +|.+++.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 247899999986 555544433333456899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 514 REYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 514 r~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+.+.... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+.+..+.+..+......+
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~----- 264 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP----- 264 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC-----
Confidence 8764321 22345689999999999987 569999999999999999999999999887766665554321000
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
....+++.+.+||.+||..||.+|||+.++|+|||++.
T Consensus 265 ---------------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 265 ---------------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ---------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 11225678899999999999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.86 Aligned_cols=286 Identities=47% Similarity=0.864 Sum_probs=230.4
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
|++++.||.|+||.||+|.+..++..||+|++............+.+|+.++..+.|+||+++++++.......+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78899999999999999999999999999999876533344456778999999999999999999886543468999999
Q ss_pred ccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC-c
Q psy18163 444 YVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK-H 522 (1028)
Q Consensus 444 y~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~-~ 522 (1028)
|+.++|.+++ ......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ .
T Consensus 81 ~~~~~l~~~~---~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDHDLTGLL---DSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccccHHHHH---hccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9987655544 33335688999999999999999999999999999999999999999999999999987654321 2
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.+...++..|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+...++.+....|+.+..+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 34457788999999887756689999999999999999999999999998888999998888888777776655422211
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.... ..........+...++..+.+||.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPK--KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccc--ccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 1110 0000000011112247889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=367.10 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=209.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||+|+||.||++++..+++.||||++...... ......+.+|+.++..+.|+||+.+++++.. .+.+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 4799999999999999999999999999999999753221 1222335678889999999999999888754 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~Ey~~g--g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 79 VMDYYVG--GDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEeCCCC--CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999976 45555554434568899999999999999999999999999999999999999999999999998765432
Q ss_pred C-cccccccCccccCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 521 K-HYTPIVVTLWYRSPELLLGC----KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 521 ~-~~t~~vGT~~Y~APEvL~g~----~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
. .....+||+.|+|||++.+. ..++.++|||||||+||+|++|..||.+.+..+.+..+......+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 227 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF--------- 227 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc---------
Confidence 2 12345799999999998642 357889999999999999999999999887776666654321100
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC--CCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k--RPTA~ElL~HPfF~e~ 657 (1028)
.++. ....++..+.+||.+||..++.+ |+++++++.||||...
T Consensus 228 -----------~~p~--------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 228 -----------QFPS--------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred -----------cCCC--------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 0000 01125678999999999977655 5799999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=366.05 Aligned_cols=251 Identities=27% Similarity=0.391 Sum_probs=200.3
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHH-HHHHcCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREIN-TLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~-iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||.|+||+||+|++..++..||||++...... ......++.|+. ++..++||||+++++++. ..+.+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 3699999999999999999999999999764321 112233445554 567889999999988775 445899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...........
T Consensus 79 ~~--~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 79 NG--GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 87 455554433 345888999999999999999999999999999999999999999999999999864433334455
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+... +. .
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~-~---------------- 214 (321)
T cd05603 156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---PL-Q---------------- 214 (321)
T ss_pred ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---CC-C----------------
Confidence 789999999999977 56899999999999999999999999988766555554321 00 0
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH----HHHHhCCCCCCC
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA----DEALRHDYFSES 657 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA----~ElL~HPfF~e~ 657 (1028)
.....+..+.+||.+||..||.+|+++ .++++||||...
T Consensus 215 -------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 215 -------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred -------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 011245678899999999999999975 599999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=402.76 Aligned_cols=270 Identities=29% Similarity=0.421 Sum_probs=218.5
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
+...+++|++++.||.|+||+||+|.+..++..||+|++............+..|+.+|..+.|||||+++++|......
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 44566899999999999999999999999999999999976544333345677899999999999999999998777667
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-------CcccccccccceeecC-------
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-------WILHRDLKTSNLLLSH------- 501 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-------gIVHRDLKPeNILLd~------- 501 (1028)
.+||||||+.+ +|..++.........+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 89999999985 66666655444445689999999999999999999985 4999999999999964
Q ss_pred ----------CCcEEEeccCCccccCCCCCcccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy18163 502 ----------RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGK 570 (1028)
Q Consensus 502 ----------~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~ 570 (1028)
.+.+||+|||++..+... ......+||+.|+|||++.+. ..++.++||||||||||+|++|.+||...
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 345899999999876533 223456899999999998642 45889999999999999999999999877
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 571 SDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 571 sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+....+..++... +. ++ ....+..+.+||..||.+||.+|||+.++|.
T Consensus 247 ~~~~qli~~lk~~--p~--------------------lp----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQLISELKRG--PD--------------------LP----------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHHHHHHHhcC--CC--------------------CC----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 6655544433211 00 00 0114567889999999999999999999999
Q ss_pred CCCCCCCCC
Q psy18163 651 HDYFSESPL 659 (1028)
Q Consensus 651 HPfF~e~p~ 659 (1028)
||||.....
T Consensus 295 h~~ik~i~~ 303 (1021)
T PTZ00266 295 YQIIKNVGP 303 (1021)
T ss_pred cHHHhhcCC
Confidence 999986543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.05 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=208.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
.|++++.||.|+||.||++.+..+++.||||.+............+.+|+.+++.++|+||+++++.+.. ....+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence 4899999999999999999999999999999997654333333456789999999999999999887643 234689999
Q ss_pred eccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ +++...+.. ....+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 80 e~~~~--~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 80 GFCEG--GDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cccCC--CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99976 344444433 234588999999999999999999999999999999999999999999999999987755444
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+..... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--~-------------- 220 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--P-------------- 220 (257)
T ss_pred ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--C--------------
Confidence 4455678999999999887 5688999999999999999999999987765554444432110 0
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. ....++..+.+||.+||..||.+|||+.+++.||||
T Consensus 221 -----~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 221 -----P-----------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----C-----------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 011256778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=370.37 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=206.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeE-EEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEI-VALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~-VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+...+...||.|+||+||+|.+. |.. ||||++............+.+|+.+|.+++|||||.+++++..... .++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEE
Confidence 34555666999999999999997 444 9999998655433335578899999999999999999999865432 6899
Q ss_pred EEeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCC-cccccccccceeecCCC-cEEEeccCCccccC
Q psy18163 441 VMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNW-ILHRDLKTSNLLLSHRG-ILKVGDFGLAREYG 517 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~g-IVHRDLKPeNILLd~~g-~lKL~DFGlAr~~~ 517 (1028)
||||+.+ |+|...+.. ....++...+..++.+|+.||.|||+++ ||||||||+||||+.++ ++||||||+++...
T Consensus 118 VtEy~~~--GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 118 VTEYMPG--GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEeCCC--CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 9999987 666665555 3667999999999999999999999999 99999999999999998 99999999998776
Q ss_pred CCCCcccccccCccccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLG-CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g-~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
......+...||+.|||||++.+ ...|+.++||||||++||||+||..||.+.........++.....|.
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~--------- 266 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP--------- 266 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC---------
Confidence 43344555799999999999985 36799999999999999999999999999888655555543221111
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+| ..+++.+..||..|+..||.+||++.+++.
T Consensus 267 -----------~p-----------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 -----------IP-----------KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -----------CC-----------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 00 114566789999999999999999999976
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=378.36 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=214.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
..|..+.+||.|.||.||+|.+..|++.||||++..+.... ....+.+|+.+|..+.++||..+|+.|.... .++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~g~--~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLKGT--KLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheeecc--cHHHH
Confidence 35888899999999999999999999999999998875433 2345678999999999999999998887554 79999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||||.| |++.+.+.. +..+.+.++..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 90 Mey~~g--Gsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGG--GSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcC--cchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999987 666555533 44558888999999999999999999999999999999999999999999999988876555
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
...+++||+.||||||+.+ ..|+.++||||||++.|||++|.|||....+...+..|-+ ..
T Consensus 167 rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------~~----------- 227 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------SA----------- 227 (467)
T ss_pred ccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-------CC-----------
Confidence 5578999999999999985 7899999999999999999999999987655222211111 00
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.| .....+++.+++|+..||.+||+.||||.++|.|+|++.
T Consensus 228 ------PP--------~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 228 ------PP--------RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ------CC--------ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 01 111247788999999999999999999999999999987
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=362.43 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=199.8
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||+|+||+||+|.+..+++.||||+++...... .....+.+|+.++..+ .||||+.+++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 36999999999999999999999999998654322 2223456788888887 59999999988754 45899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~ 525 (1028)
.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 79 ~~--~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 79 NG--GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 76 455444433 345899999999999999999999999999999999999999999999999999764333334456
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD------LEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd------~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.+||+.|+|||++.+ ..++.++|||||||+||+|++|..||..... .+.+..+... .+.
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~------------ 220 (327)
T cd05617 156 FCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KPI------------ 220 (327)
T ss_pred ccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CCC------------
Confidence 789999999999987 6689999999999999999999999964321 1122221110 000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC------HHHHHhCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT------ADEALRHDYFSESP 658 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT------A~ElL~HPfF~e~p 658 (1028)
.....++..+.+||.+||..||.+|++ +.+++.||||....
T Consensus 221 ------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 221 ------------------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred ------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 011235678899999999999999998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=350.70 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=208.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.|+..+.||.|+||+||+|.+..+++.||+|++....... .......+|+.+|..++|+||+.+.+.+.. .+.+|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 3788899999999999999999999999999997653222 223345789999999999999999877753 4589999
Q ss_pred EeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ ++|...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05632 79 LTIMNG--GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG- 155 (285)
T ss_pred EEeccC--ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence 999986 333333322 2335899999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
.......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+..+......+..........
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~----------- 223 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV----------- 223 (285)
T ss_pred CcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc-----------
Confidence 23345689999999999987 568999999999999999999999998876654444443321111110
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESP 658 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p 658 (1028)
....++..+.+||.+||..||.+||| +.+++.|+||+..+
T Consensus 224 ------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 224 ------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred ------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 01225667889999999999999999 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=340.27 Aligned_cols=259 Identities=28% Similarity=0.480 Sum_probs=214.4
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++++.||.|+||.||+|.+..++..||+|++............+..|+.++..++|+||+++++++.......+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999976543333334567899999999999999999988766667899999
Q ss_pred ecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH-----hCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 443 DYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH-----DNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLH-----s~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
||+.+ +|.+++.........+++..+..++.||+.||.||| +.+|+|+||||+|||++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99975 677777665555667899999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
...........+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 226 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK------------- 226 (265)
T ss_pred cCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC-------------
Confidence 654333445678999999999977 558899999999999999999999998877544433332110
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
+.. ....++..+.+||.+||..||.+|||+.++|+|||+
T Consensus 227 --------~~~-----------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 --------FRR-----------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred --------CCC-----------CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 000 011255778899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=362.18 Aligned_cols=286 Identities=22% Similarity=0.321 Sum_probs=208.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.++||.|+||.||+|.+..++..||+|++..... ......+.+|+.+|..++||||+++++++... +.+||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEE
Confidence 4789999999999999999999999999999999876432 12234567899999999999999999988654 58999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||+.+ +|.+++ .. ...+.+..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+..
T Consensus 81 v~e~~~~~~L~~~l---~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 81 CMEHMDGGSLDQVL---KK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEecCCCCcHHHHH---HH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999976 554444 33 34578888999999999999999985 799999999999999999999999999976543
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh--cCCCCCCCCC-CCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT--MGTPNEKIWP-GFS 595 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~--lg~p~~~~w~-~~s 595 (1028)
. .....+||..|+|||++.+ ..++.++|||||||++|+|++|..||......+.. .++.. .+.+...... ...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 S--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred h--ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccC
Confidence 2 2344679999999999987 56899999999999999999999999876543322 22211 0111100000 000
Q ss_pred CChh-hhhhccccCCCC----------CCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPA-VQKMTFAEYPNV----------GGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~-~~~l~~~~~p~~----------~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.... .........+.. ...........++..+.+||.+||.+||.+|||+.++|.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 000000000000 0000001112356788999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.49 Aligned_cols=289 Identities=36% Similarity=0.567 Sum_probs=229.5
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC---CCeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN---MDKIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~---~~~l~ 439 (1028)
+|++.+.||.|+||.||+|.+..++..||||++............+.+|+.+++.++|+||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999999999999999999765432334456778999999999999999998875432 34789
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||+|+.++|..++ .. ...+++..+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||++......
T Consensus 81 lv~e~~~~~l~~~l---~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMETDLHKVI---KS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhhhHHHHH---hC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999986544443 33 337899999999999999999999999999999999999999999999999999877554
Q ss_pred C---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 520 L---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 520 ~---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. .......+|..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....+..+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 3 2344567899999999998854789999999999999999999999999999999999999888777655442211
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...... ....+...........+.++..+.+||.+||..||.+|||+.++|.||||+..
T Consensus 237 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 237 EKARNY--LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred cchhhH--HhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 100000 00011111111122233467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.67 Aligned_cols=282 Identities=49% Similarity=0.912 Sum_probs=232.1
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
|++.+.||.|+||.||+|.+..+++.||+|++...............|+.+++.+.|+||+++++++... ..+++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 6778899999999999999999999999999987654444455667899999999999999999887543 58999999
Q ss_pred ccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcc
Q psy18163 444 YVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY 523 (1028)
Q Consensus 444 y~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~ 523 (1028)
|+.++|.+++.. ....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 79 YCDMDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred CcCcCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 998776666543 22468899999999999999999999999999999999999999999999999998776554455
Q ss_pred cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l 603 (1028)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+....++.. ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 234 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY-KP 234 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc-cc
Confidence 55677889999999987557899999999999999999999999999999999999998888888777766554311 11
Q ss_pred ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 604 ~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+..+.. .......+.++..+.+||.+||..||.+||++.+++.||||
T Consensus 235 ~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPP---KDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCc---cchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111111 11111122347789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=345.14 Aligned_cols=257 Identities=22% Similarity=0.402 Sum_probs=204.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC----CC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN----MD 436 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~----~~ 436 (1028)
+.|++.+.||.|+||.||+|.+..+++.||||++..... ....+..|+.++..+ .|+||+++++++.... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 568899999999999999999999999999999975432 234567899999888 6999999999886432 24
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+|+||||+.+ +|.+++... ....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 68999999986 454444321 234688899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
............||+.|+|||++.+ ...|+.++|||||||++|+|++|..||...........+... +..
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~--- 234 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PAP--- 234 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CCC---
Confidence 6443344456789999999999863 235888999999999999999999999765543333222110 000
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
......++..+.+||.+||..||.+|||+.+++.||||
T Consensus 235 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 -------------------------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00011255678899999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.35 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=198.1
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecccc-
Q psy18163 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH- 447 (1028)
Q Consensus 370 LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~g- 447 (1028)
||+|+||.||++.+..+|+.||+|++....... ........|++++..++||||+++++++. ....+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence 799999999999999999999999997543322 12234456999999999999999988775 34589999999976
Q ss_pred chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccccc
Q psy18163 448 DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527 (1028)
Q Consensus 448 dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~v 527 (1028)
+|..++.. .....+.+..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+... .......
T Consensus 79 ~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05607 79 DLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA 155 (277)
T ss_pred CHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence 44443322 12334788888999999999999999999999999999999999999999999999876542 2334567
Q ss_pred cCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcccc
Q psy18163 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAE 607 (1028)
Q Consensus 528 GT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~ 607 (1028)
||..|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 156 ~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 214 (277)
T cd05607 156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE-------------------- 214 (277)
T ss_pred CCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc--------------------
Confidence 8999999999987 4599999999999999999999999976543211111211100000
Q ss_pred CCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH----HHHHhCCCCCCCCC
Q psy18163 608 YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA----DEALRHDYFSESPL 659 (1028)
Q Consensus 608 ~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA----~ElL~HPfF~e~p~ 659 (1028)
. ......++..+.+||.+||..||.+||++ .+++.||||+...+
T Consensus 215 ~--------~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 215 V--------KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred c--------ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 0 00012367788999999999999999999 77889999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=339.68 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=210.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|.+.+.||+|+||.||+|.+..++..|++|.+............+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 5889999999999999999999999999999997654333344566789999999999999999988754 35899999
Q ss_pred ecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ +|.+++... ....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 79 EYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99975 555554432 245688889999999999999999999999999999999999999999999999987765444
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 219 (256)
T cd08529 157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP---------------- 219 (256)
T ss_pred hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 4445678999999999987 56899999999999999999999999888766555554331100
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. ....++..+.+||.+||..||.+||++.+++.|||+
T Consensus 220 -----~-----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 220 -----P-----------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----C-----------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0 001256778899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.70 Aligned_cols=283 Identities=47% Similarity=0.855 Sum_probs=229.9
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
|++.+.||.|+||.||+|.+..+++.||+|.+..............+|+.+|+.++|+||+++++++... +.+++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 6778999999999999999999999999999876544333445677899999999999999999887544 58999999
Q ss_pred ccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcc
Q psy18163 444 YVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY 523 (1028)
Q Consensus 444 y~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~ 523 (1028)
|+.++|..++ ......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 79 ~~~~~l~~~l---~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 79 FMDTDLYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred ccCCCHHHHH---HhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 9987655444 3334568899999999999999999999999999999999999999999999999998776544344
Q ss_pred cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l 603 (1028)
....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....|+.+...-.....
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 45678899999999987547899999999999999999999999999999999999888888777776655432111111
Q ss_pred ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 604 ~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+... .........+.++..+.+||.+||..||.+||++.+++.||||
T Consensus 236 ~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKK---AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccc---cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111 1111112223467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=350.26 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=208.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.|+++++||.|+||.||+|.+..++..||+|++..... .....+.+|+.++..+.||||+++++++... ..+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEEE
Confidence 679999999999999999999999999999999875422 1234466799999999999999999987644 489999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ +.+...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 88 ~e~~~~--~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 88 IEFCPG--GAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EecCCC--CcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999987 344444444445688999999999999999999999999999999999999999999999999876544333
Q ss_pred cccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 522 HYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
......+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+.++.... . +..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~----~~~--- 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---P----PTL--- 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC---C----ccC---
Confidence 3455678999999999853 2457889999999999999999999998776554444432210 0 000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+||++.++|+||||...
T Consensus 236 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 236 --------------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred --------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0011255678899999999999999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=378.13 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=211.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCC-CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRT-DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~t-g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..|.+.+.||.|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+|..++|||||++++++... +.+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--RQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEE
Confidence 3499999999999999999999877 78899998754322 1223456799999999999999999988644 58999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++.........+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999975 666555443334556889999999999999999999999999999999999999999999999999876532
Q ss_pred C--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 L--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----------- 290 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP----------- 290 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 2 12345689999999999977 568999999999999999999999999887776666654321100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
....++..+.+||.+||..||.+|||+.++|.|||++.
T Consensus 291 ---------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 291 ---------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ---------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 01125677899999999999999999999999999864
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=346.74 Aligned_cols=261 Identities=20% Similarity=0.322 Sum_probs=207.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHH-HHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINT-LLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~i-L~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||.|+||.||+|.+..+|+.||||+++...... .....+.|+.+ ++.+.||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 47999999999999999999999999999999997653221 12344556665 566789999999998864 347999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||++++|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999988888876555556789999999999999999999997 9999999999999999999999999999876432
Q ss_pred CCcccccccCccccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGC---KEYSTPIDMWSVGCIFAEFLCMEPLFTGK-SDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~---~~ys~ksDIWSLGvILyELLTG~pPF~g~-sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
...+...||..|+|||++.+. ..++.++|||||||++|+|++|..||... ...+.+..+.... ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~------- 226 (283)
T cd06617 158 -VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP---SP------- 226 (283)
T ss_pred -cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC---CC-------
Confidence 222345789999999988642 34788999999999999999999999653 2333333332210 00
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.+ ....++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 227 -----------~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 227 -----------QL----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -----------CC----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00 011256778999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=363.44 Aligned_cols=290 Identities=33% Similarity=0.544 Sum_probs=227.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----CC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----MD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~~ 436 (1028)
.++|++...||.|+||.||+|++..++..||||++..............+|+.+++.+.||||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46899999999999999999999999999999998754322223345668999999999999999987764332 23
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+|+||++++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 5899999998777666542 35899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... .....+|..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+.+.++..+..
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 432 34457899999999987645688999999999999999999999999888888888888877776655544332
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
.... .. ....+.............++..+.+||.+||..||.+|||+.+||.||||.+...+
T Consensus 246 ~~~~-~~-~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 246 ESAR-NY-IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hhHH-HH-HHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 1100 00 00000000000011112357889999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=351.43 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=204.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.|++.+.||+|+||.||+|.+..+++.||||.+....... ........|+.++..++|+||+.+++.+.. .+.+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 3788899999999999999999999999999987543222 122345689999999999999999887754 4589999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ +|.+++... ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05630 79 LTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 155 (285)
T ss_pred EEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-
Confidence 999975 555544322 2235888899999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE---QLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d---~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
......+||..|+|||++.+ ..++.++|||||||++|+|++|.+||....... ....+.... ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~--------- 222 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QE--------- 222 (285)
T ss_pred ccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hh---------
Confidence 22344589999999999987 568999999999999999999999998654321 111111100 00
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~ 657 (1028)
.....+++.+.+||.+||..||.+||| +.++++||||++.
T Consensus 223 --------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 223 --------------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred --------------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 001225677899999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=360.26 Aligned_cols=287 Identities=34% Similarity=0.557 Sum_probs=222.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC----C
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM----D 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~----~ 436 (1028)
.++|++++.||.|+||.||+|.+..++..||||++............+.+|+.+|..+.||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 468999999999999999999999999999999986543222233456789999999999999999998864321 3
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+||+|++++|..++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 569999999776665553 235889999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... .....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++...+.+...++.....
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 23457799999999987655688999999999999999999999999888878877777655443332222211
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.... . .....+.............++..+.+||.+||..||.+|||+.+++.||||+..
T Consensus 246 ~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 246 EDAK-N-YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhHH-H-HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 1000 0 000011111111122234567789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=358.87 Aligned_cols=285 Identities=35% Similarity=0.561 Sum_probs=222.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----CCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----MDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~~~ 437 (1028)
++|.+.+.||.|+||.||+|.+..++..||||++............+.+|+.++..+.||||+++++++.... ...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6899999999999999999999999999999998764333333445678999999999999999999875332 245
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|+||||+..+|..+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 7999999976544332 2357889999999999999999999999999999999999999999999999997653
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. ......+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+...++......
T Consensus 169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 A---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred C---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 2 2344578999999999877556899999999999999999999999998888888888887766654433322211
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..... ....+...........+.++..+.+||.+||..||.+|||+.++|.||||...
T Consensus 246 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 246 AAKSY--IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred chHHH--HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 00001111111111123356788999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=359.35 Aligned_cols=287 Identities=32% Similarity=0.525 Sum_probs=223.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec----CCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS----NMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~----~~~ 436 (1028)
.++|.+++.||+|+||.||+|.+..++..||||++..............+|+.++..++||||+++++++... ...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 4789999999999999999999999999999999976432222234566899999999999999999887532 224
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+++++++++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 96 ~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 96 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 589999999877666553 234888999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. ......+|..|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+....+.+....+.....
T Consensus 171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 171 DD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 42 234457899999999987756689999999999999999999999998888787888877766655444433321
Q ss_pred Chhhhhh-ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 597 LPAVQKM-TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 597 lp~~~~l-~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
....... .....+.. .........++.+.+||.+||..||.+|||+.++|.||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 248 ESARNYIQSLTQMPKM---NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HhHHHHHHHhcccCCc---chhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 1100000 00111110 00111113567889999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=381.98 Aligned_cols=262 Identities=26% Similarity=0.432 Sum_probs=219.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+-|.|+..||.|+||+||+|.++.++...|.|+|..... .....++-||.||..|.||+||.|++.|++.+ .++|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse--EELEDylVEIeILa~CdHP~ivkLl~ayy~en--kLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE--EELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch--hHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ceEEE
Confidence 457889999999999999999999999999999865432 22345678999999999999999999887665 79999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
+|||+| |-.-..+..-+..+++.++..+++|++.||.|||+++|||||||..|||+..+|.|+|+|||.+........
T Consensus 108 iEFC~G--GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 108 IEFCGG--GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EeecCC--chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 999998 333333444577899999999999999999999999999999999999999999999999999876655445
Q ss_pred cccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 522 HYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
...+++|||+||||||++. .++|++++||||||++|.||..+.||....+..-.+.+|.+. .|+.-.-
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePPTLlq------ 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPTLLQ------ 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCCcccC------
Confidence 5668999999999999853 468999999999999999999999999988888888877653 1111111
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
....+..+.|||.+||.+||..||++.+||.||||+..+.
T Consensus 258 ----------------------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 258 ----------------------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred ----------------------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 1224566889999999999999999999999999986543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=360.29 Aligned_cols=291 Identities=34% Similarity=0.596 Sum_probs=224.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++.+.||.|+||.||+|.+..++..||||.+..............+|+.++..+ +||||+++++++...+...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 35789999999999999999999999999999999865332222234456899999999 99999999998866666679
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+||||+.++|..++. .. .+.+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..
T Consensus 85 ~lv~e~~~~~L~~~~~---~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYMETDLHAVIR---AN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccccCHHHHHh---cC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9999999876655443 22 578888899999999999999999999999999999999999999999999986543
Q ss_pred CC-----CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 519 PL-----KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 519 ~~-----~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.. .......||..|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+.++....+.+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 22 1233457899999999987756788999999999999999999999999888888888887766554432221
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.... .... .................+.++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 240 ~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 240 IKSP-FAAT-MLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHhh-hHHH-hhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 1100 0000 000000000000011122367889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.90 Aligned_cols=261 Identities=26% Similarity=0.423 Sum_probs=211.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC----C
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN----M 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~----~ 435 (1028)
.++|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.++..+ .|+||+++++++.... .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4789999999999999999999999999999999876532 224567899999998 6999999999987543 4
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..+|+||||+.+ +|.+++.........+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 568999999986 6667766655445678999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
.............||..|+|||++.. ...++.++||||||||||+|++|.+||........+..+... +...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~- 237 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPPT- 237 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCCC-
Confidence 76543344455678999999998853 234778999999999999999999999876555444443221 0000
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. .....++..+.+||.+||..||.+|||+.+++.|||+
T Consensus 238 ---~-----------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 ---L-----------------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---C-----------------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0001245678899999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.98 Aligned_cols=290 Identities=32% Similarity=0.577 Sum_probs=223.9
Q ss_pred CeEEEEEeeecCcEEEEEEEECCC--CeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEee--cCCCe
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRT--DEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVG--SNMDK 437 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~t--g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~--~~~~~ 437 (1028)
+|++.+.||.|+||.||++.+..+ +..||||++..............+|+.++..+ .||||++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 489999999999999999999988 89999999875433333344567899999998 59999999886532 23356
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|++|+|++++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 81 ~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 89999999876655543 24568899999999999999999999999999999999999999999999999998654
Q ss_pred CCCC----cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPLK----HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~~----~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.... .....+||..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....+..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 123457899999999987656789999999999999999999999999998999999999888776543322
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
+.... .... ................+.++..+.+||.+||..||.+|||+.++|.||||++..
T Consensus 237 ~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 237 IGSPK-AQNY-IRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhh-HHHH-HHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 21110 0000 000000001111112233577899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=343.52 Aligned_cols=263 Identities=22% Similarity=0.363 Sum_probs=210.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC---C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN---M 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~---~ 435 (1028)
..++|.+...||.|+||.||+|.+..+++.||+|++..... ....+.+|+.++.++ .||||+++++++...+ .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 35789999999999999999999999999999999865321 223456788899888 7999999999886433 3
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..+|+||||+.+ +|.+++.........+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 478999999976 6666666544455678999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCK----EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~----~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
.+..........+|+..|+|||++.... .++.++||||||||+|+|++|.+||........+..+... +....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~ 253 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPTL 253 (291)
T ss_pred hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCCC
Confidence 7654333334467899999999986432 3688999999999999999999999877655554443221 00000
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
. ........+.+||.+||..||.+||++.++|+||||+
T Consensus 254 ~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 L---------------------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred C---------------------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 0011345688999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.78 Aligned_cols=281 Identities=44% Similarity=0.775 Sum_probs=219.3
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc---CCCCeeEEEEEEeecCC---Ce
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA---QHPNIVTVREIVVGSNM---DK 437 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l---~HPNIV~L~~i~~~~~~---~~ 437 (1028)
|++.+.||.|+||.||+|.+..++..||||+++...........+.+|+.++..+ .|+||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998999999999976544333334455777777665 59999999998865432 24
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
++++|||+.++|.+++.... ...+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..+.
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 89999999877766654321 2358899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|+.....
T Consensus 159 ~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 159 FE-MALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred CC-cccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 43 22334568899999999987 56899999999999999999999999999999999988887665544444322111
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
+ ... ++...........+.++..+.+||.+||..||.+||++.++|.||||
T Consensus 237 ~---~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 P---RSS---FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred c---hhh---cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 000 11111111111223456788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=346.19 Aligned_cols=259 Identities=24% Similarity=0.413 Sum_probs=209.2
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
-|++++.||.|+||.||+|.+..++..+|+|.+..... .....+.+|+.++..+.||||+++++++... ...|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEE
Confidence 37889999999999999999999999999999865432 1233467899999999999999999988654 4899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.+ +.+...+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.........
T Consensus 82 e~~~~--~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 82 EFCAG--GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred EecCC--CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 99987 3444444444556899999999999999999999999999999999999999999999999999766443333
Q ss_pred ccccccCccccCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 523 YTPIVVTLWYRSPELLL----GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~----g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.....+|..|+|||++. ....++.++|||||||++|+|++|.+||...+..+....+...... . .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~-----~---- 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--T-----L---- 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC--C-----C----
Confidence 44567899999999984 2245788999999999999999999999887766655554332100 0 0
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++++||||...
T Consensus 229 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 229 -------------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0011246778999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.49 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=204.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC---CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG---FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~---~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
++|++.+.||.|+||.||+|.+..++..||||++........ ....+.+|+.++..+.||||+++++++... +.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeE
Confidence 469999999999999999999999999999999875432211 123456799999999999999999988644 489
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
++||||+.+ +.|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+..
T Consensus 80 ~~v~e~~~~--~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 80 SIFMEYMPG--GSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEEECCC--CcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999976 333333332 34578889999999999999999999999999999999999999999999999976543
Q ss_pred CCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 PLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
... ......|+..|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+..... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~------- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT---N------- 225 (263)
T ss_pred cccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC---C-------
Confidence 211 1134578899999999987 5589999999999999999999999987665544433322100 0
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. .....++..+.+||.+||..||.+|||+.++|.||||
T Consensus 226 ----------~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 ----------P-----------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ----------C-----------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0 0112256778899999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=347.13 Aligned_cols=260 Identities=28% Similarity=0.471 Sum_probs=210.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||.|+||.||+|.+..++..||+|++...... ....+.+|+.++..++||||+++++++.. ...+|+|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEE
Confidence 6799999999999999999999989999999998754321 22356689999999999999999998864 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ ++|...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~e~~~~--~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 81 IEFCDG--GALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred eeccCC--CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999987 344444444455689999999999999999999999999999999999999999999999999876654434
Q ss_pred cccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 522 HYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
......+|+.|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+.... + +.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-----~~~--- 228 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--P-----PTL--- 228 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--C-----CCc---
Confidence 4455678999999999852 2457889999999999999999999998876655444442210 0 000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 229 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 229 --------------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred --------------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0011256678899999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.98 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=209.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++.+.||.|+||+||+|....++..||+|++....... ....+.+|+.+|+.+.|+||+++++.+.. .+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 47999999999999999999999999999999997654333 34556789999999999999999887754 4589999
Q ss_pred EeccccchHHHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 442 MDYVEHDMKSLMETMRSK--KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~--~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||+.+ +.|...+... ...+.+..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+...
T Consensus 78 ~e~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 78 MPYLSG--GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EeccCC--CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999976 3444444332 245788999999999999999999999999999999999999999999999999876543
Q ss_pred CCc----ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 520 LKH----YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 520 ~~~----~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
... ....+|+..|+|||++.....++.++|+|||||++|+|++|..||...+....+.++... .... + .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-~---~ 228 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS-L---E 228 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC-c---C
Confidence 222 234578999999999887557899999999999999999999999877665544444321 0000 0 0
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. ......++..+.+||.+||..||.+|||+.+++.||||
T Consensus 229 --------------~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 229 --------------T------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------------C------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 00012356788999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=349.17 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=212.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++.+.||.|+||+||+|.+..+++.||||.+....... .....+..|+.++..+.|+||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 36999999999999999999999999999999997654322 223456789999999999999999988754 458999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++.. .....+++..+..++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 79 VMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999976 55554432 12356889999999999999999999999999999999999999999999999998754321
Q ss_pred CC-----------------------------cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy18163 520 LK-----------------------------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK 570 (1028)
Q Consensus 520 ~~-----------------------------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~ 570 (1028)
.. .....+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 10 1123478999999999987 45899999999999999999999999888
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC----HH
Q psy18163 571 SDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT----AD 646 (1028)
Q Consensus 571 sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT----A~ 646 (1028)
+....+..+..... .++ . ...++..+.+||.+||..||.+||| ++
T Consensus 236 ~~~~~~~~~~~~~~-----~~~-----------------~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 236 NRDETFSNILKKEV-----TFP-----------------G---------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred chHHHHHHHhcCCc-----cCC-----------------C---------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 77666655432100 000 0 0115678899999999999999999 99
Q ss_pred HHHhCCCCCCCCCCC
Q psy18163 647 EALRHDYFSESPLPI 661 (1028)
Q Consensus 647 ElL~HPfF~e~p~p~ 661 (1028)
++|.||||+...++.
T Consensus 285 ~ll~~~~~~~~~~~~ 299 (316)
T cd05574 285 EIKQHPFFRGVNWAL 299 (316)
T ss_pred HHHcCchhhcCChhh
Confidence 999999999865543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=356.53 Aligned_cols=273 Identities=22% Similarity=0.317 Sum_probs=215.9
Q ss_pred eEEE-EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEEEE
Q psy18163 364 FKCL-NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 364 Y~il-~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
|++. +.||+|+|+.|--|....|+..||||+|.+.. .......++|++++..++ |+||+.|+++|. +...+|||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFE--dd~~FYLV 154 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFE--DDTRFYLV 154 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhc--ccceEEEE
Confidence 4443 57999999999999999999999999998763 344567889999999986 999999999885 44589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC---cEEEeccCCccccCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGS 518 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g---~lKL~DFGlAr~~~~ 518 (1028)
||-|.| |.|+..+... ..|++.++..+++.|+.||.|||.+||.||||||+|||..... -||||||.|+..+..
T Consensus 155 fEKm~G--GplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 155 FEKMRG--GPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EecccC--chHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 999998 8999888654 4699999999999999999999999999999999999997554 489999998764321
Q ss_pred --C-----CCcccccccCccccCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 519 --P-----LKHYTPIVVTLWYRSPELLL----GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 519 --~-----~~~~t~~vGT~~Y~APEvL~----g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
+ ...+.+.||+..|||||+.. ....|+..+|.||||||||.||+|++||.|....
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~-------------- 297 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA-------------- 297 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC--------------
Confidence 1 23355779999999999863 2356999999999999999999999999886542
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+--|..-...+..+.+.|..+...........+..+|.+++|||+.+|..|+..|.+|.++|+|||++..
T Consensus 298 dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 298 DCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred cCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 1223333333333333333222211111123345688999999999999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=357.15 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=195.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
.++|++.+.||.|+||.||+|.+. .++..||||+++.... ......+.+|+.+|..+ +||||+.+++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 368999999999999999999852 4457899999975322 12234567899999999 899999999887543
Q ss_pred CCeEEEEEecccc-chHHHHHHHhh-------------------------------------------------------
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRS------------------------------------------------------- 458 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~------------------------------------------------------- 458 (1028)
...+++||||+.+ +|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 3468999999986 44444432110
Q ss_pred ---cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC--cccccccCcccc
Q psy18163 459 ---KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYR 533 (1028)
Q Consensus 459 ---~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~ 533 (1028)
....+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ......+|+.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 012467788899999999999999999999999999999999999999999999986533211 122345678899
Q ss_pred CcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCC
Q psy18163 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVG 612 (1028)
Q Consensus 534 APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~ 612 (1028)
|||++.+ ..|+.++|||||||+||||++ |.+||.+....+.+...+.. +.. +
T Consensus 244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~----~--------------------- 296 (338)
T cd05102 244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR----M--------------------- 296 (338)
T ss_pred CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC----C---------------------
Confidence 9999977 568999999999999999997 99999886543333332221 000 0
Q ss_pred CCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 613 GLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 613 ~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 297 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 -----RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001125677889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=366.74 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=217.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.+.|...+.||+|+||.||-|+-+.||+.||+|.+.+...+ ..-....++|-.+|.+++.++||.|- |.+++.+.+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsla--YAfeTkd~LC 261 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLA--YAFETKDALC 261 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEe--eeecCCCceE
Confidence 46789999999999999999999999999999998655422 33345568899999999999999994 5557788999
Q ss_pred EEEeccccchHHHHHHHhhcC-CcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~-~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||..|+| |+|-.++.+.+ ..|++..++.|+.+|+.||++||+.+||+|||||+|||+|..|++.|+|+|||..+..
T Consensus 262 lVLtlMNG--GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 262 LVLTLMNG--GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEEeecC--CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999988 77766665543 4599999999999999999999999999999999999999999999999999998865
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE---QLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d---~l~kI~~~lg~p~~~~w~~~s 595 (1028)
. ...+..+||.+|||||++.+. .|+.+.|||||||+||||+.|..||...-.-. .+.+.... -+.
T Consensus 340 g-~~~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~---~~~------- 407 (591)
T KOG0986|consen 340 G-KPIRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE---DPE------- 407 (591)
T ss_pred C-CccccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc---chh-------
Confidence 3 445667999999999999984 49999999999999999999999997643221 12221110 000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESPLP 660 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p~p 660 (1028)
+ ....+|+++++|...+|+.||.+|. ++.++.+||||+...|.
T Consensus 408 -----------e-----------y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 408 -----------E-----------YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred -----------h-----------cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 1 1134789999999999999999998 68899999999987664
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=355.35 Aligned_cols=283 Identities=21% Similarity=0.248 Sum_probs=203.0
Q ss_pred EEEEeeec--CcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 366 CLNRIEEG--TYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 366 il~~LG~G--~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
++++||+| +|++||++.+..+|+.||||+++...........+.+|+.+++.++||||+++++++... +.+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 46789999 789999999999999999999976544333334556799999999999999999988654 48999999
Q ss_pred cccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC-
Q psy18163 444 YVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK- 521 (1028)
Q Consensus 444 y~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~- 521 (1028)
|+.+ +|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||.+........
T Consensus 80 ~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 80 FMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred ccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9985 555555332 123478899999999999999999999999999999999999999999999987644321111
Q ss_pred ------cccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 522 ------HYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 522 ------~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.....+++..|+|||++.+. ..|+.++|||||||++|+|++|..||........+...... .... .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~-~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG--TVPC-LLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC--Cccc-ccccc
Confidence 01223567889999998753 45899999999999999999999999876654433333221 1110 00000
Q ss_pred CCChhh------------hhhccc-----cCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 595 SKLPAV------------QKMTFA-----EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 595 s~lp~~------------~~l~~~-----~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..+.. ...... ..+.............+++.+.+||.+||++||.+|||+.++|+||||++
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 235 -TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred -chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 00000 000000 00000000001112335778999999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=341.69 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=207.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEee---cCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVG---SNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~---~~~ 435 (1028)
..++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.++..+ .||||+++++++.. ...
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 35789999999999999999999999999999998864321 123456789999998 69999999998753 234
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
+.+|+||||+.+ +|.+++.........+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 579999999975 6666655443444568888999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
.+...........||+.|+|||++.. ...++.++|||||||++|+|++|..||........+..+... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~--- 246 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---PP--- 246 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---CC---
Confidence 76543333345679999999999853 244788999999999999999999999876544333222110 00
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
+.. ......+..+.+||.+||..||.+|||+.++|+|+||
T Consensus 247 -~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 -PTL-----------------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -Ccc-----------------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000 0011245678899999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.33 Aligned_cols=256 Identities=20% Similarity=0.318 Sum_probs=202.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++.++.||||+++++++... +..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEE
Confidence 468899999999999999999999999999999875432 11234567899999999999999999988654 478999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ +.+... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+...
T Consensus 78 ~e~~~~--~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 78 TEFMDG--GSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred EecCCC--CChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999987 333221 23678889999999999999999999999999999999999999999999999866432
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ---LSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~---l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.....+||..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+.........
T Consensus 149 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------- 217 (279)
T cd06619 149 IAKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP---------- 217 (279)
T ss_pred cccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC----------
Confidence 2345689999999999987 5689999999999999999999999965321110 0011111100000
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+ ......+++.+.+||.+||..||.+||++.+++.||||...
T Consensus 218 ----------~-------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 218 ----------P-------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ----------C-------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0 00112256778999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.23 Aligned_cols=258 Identities=29% Similarity=0.438 Sum_probs=208.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++.+.||.|+||.||+|.+..++..||+|++...... ....+.+|+.++..++||||+++++++.. ...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 6799999999999999999999999999999999765432 33566789999999999999999988754 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ +.|...+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 79 ~e~~~~--~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 79 MEYCGG--GSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred EeCCCC--CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999986 333333333335688999999999999999999999999999999999999999999999999987654333
Q ss_pred cccccccCccccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 HYTPIVVTLWYRSPELLLGC--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~--~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.....+++..|+|||++.+. ..++.++|||||||++|+|++|.+||...+.......+......+ . ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-~----~~----- 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-P----KL----- 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-c----cc-----
Confidence 34556889999999998763 267889999999999999999999998877655444332210000 0 00
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPf 653 (1028)
......+..+.+||.+||..||..|||+.+++.|+|
T Consensus 227 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 227 ------------------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 001124567889999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.21 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=221.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~ 437 (1028)
...+|.++..||+|+||+|.+|..+.|.+.||||+++++..-. +.....+.|-.+|... +-|.+++|+..| ++.+.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDR 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDR 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhh
Confidence 4578999999999999999999999999999999998875322 2222234455555443 467888887666 67789
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|+||||+.| |+|+..+.+- +.|.+..+..|+..|+.||-|||++|||+||||.+||||+.+|++||+|||+++..-
T Consensus 425 LyFVMEyvnG--GDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNG--GDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecC--chhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999998 9999988664 458999999999999999999999999999999999999999999999999999766
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.+.....++||||.|+|||++.- ++|+.++||||+||+|||||.|.+||.|.++.+.+..|.+..-.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs------------ 568 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS------------ 568 (683)
T ss_pred cCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc------------
Confidence 55566678999999999999987 78999999999999999999999999999999999998764211
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESPL 659 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p~ 659 (1028)
| ...+|.++.++...+|.+.|.+|.. -.+|-.||||+...|
T Consensus 569 ----------y-----------PKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 569 ----------Y-----------PKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred ----------C-----------cccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 1 1237889999999999999999984 468999999987655
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=364.11 Aligned_cols=289 Identities=31% Similarity=0.477 Sum_probs=217.6
Q ss_pred ccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCC--C----CeeEEEEE
Q psy18163 356 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH--P----NIVTVREI 429 (1028)
Q Consensus 356 ~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H--P----NIV~L~~i 429 (1028)
.+.....+|.++.+||+|+||.|..+.+..++..||||+++.-.. .....+-||++|.++.+ | -+|.+.++
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k---YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK---YREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH---HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 344556899999999999999999999999999999999975432 23345678999998842 2 25666666
Q ss_pred EeecCCCeEEEEEeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-------
Q psy18163 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH------- 501 (1028)
Q Consensus 430 ~~~~~~~~l~LVmEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~------- 501 (1028)
| +..+++|||+|.++- ++++.+.. +..+|+...++.+..||+.++.|||+.+|+|.||||+|||+.+
T Consensus 160 F--dyrghiCivfellG~---S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 160 F--DYRGHICIVFELLGL---STFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred h--hccCceEEEEeccCh---hHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 6 445699999999974 45555554 4567899999999999999999999999999999999999832
Q ss_pred -------------CCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy18163 502 -------------RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT 568 (1028)
Q Consensus 502 -------------~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~ 568 (1028)
+..|+|+|||.|+.... ..++.+.|..|+|||++++ -+++.++||||+||||+||.||..+|.
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecc
Confidence 22589999999987643 3367899999999999999 569999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCC---cccc-----------ccccccHHHHHHHHHh
Q psy18163 569 GKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGL---KTKV-----------AGSILTELGYDLLCKF 634 (1028)
Q Consensus 569 g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l---~~~~-----------~~~~Ls~~a~DLL~kc 634 (1028)
+.++.+++..+-..+|+++............+... --.++..... .+.. ..+.--..+.|||.+|
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 99999999887778886654322211111111111 0011111100 0000 0011112578999999
Q ss_pred cccCcCCCCCHHHHHhCCCCCCC
Q psy18163 635 LTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 635 L~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
|.+||.+|+|+.|+|.||||+..
T Consensus 390 L~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HccCccccccHHHHhcCHHhhcC
Confidence 99999999999999999999864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.92 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=209.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.+.|+||+++++++... ..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEE
Confidence 468899999999999999999999999999999976532 12223456899999999999999999988654 589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
+||+.+ ++|.+.+... .+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||+++.+.....
T Consensus 78 ~e~~~~--~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGG--GSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCC--CcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999987 4444444332 688999999999999999999999999999999999999999999999999988765444
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.... +.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~-------------- 216 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PP-------------- 216 (274)
T ss_pred ccccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--CC--------------
Confidence 4455688999999999987 458999999999999999999999998766544433332210 00
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..+ ...++..+.+||.+||..||.+|||+.+++.||||+..
T Consensus 217 -----~~~----------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 217 -----SLE----------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----CCc----------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 000 00145678899999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=333.59 Aligned_cols=255 Identities=28% Similarity=0.475 Sum_probs=211.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++++.||.|+||.||.+++..++..|++|.+............+.+|+.++++++|+||+++++++.. .+.+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5899999999999999999999999999999987654333334556789999999999999999998865 35899999
Q ss_pred eccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ ++|.+.+... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus 79 e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 79 EYANG--GTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EecCC--CcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99976 3444444333 44688899999999999999999999999999999999999999999999999987655433
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+... .+..
T Consensus 157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~------------- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYTP------------- 220 (256)
T ss_pred cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCC-------------
Confidence 4455678999999999987 45889999999999999999999999887776666665431 1100
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
....++..+.+||.+||..||.+|||+.++|.|||+
T Consensus 221 -----------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 -----------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 001256678899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=341.06 Aligned_cols=266 Identities=28% Similarity=0.412 Sum_probs=212.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|+.++.||.|+||.||+|.+..++..||+|++...... .....+.+|++++..++||||++++++|.......+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4699999999999999999999999999999998754321 233457789999999999999999999876666789999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ +|.+++..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999975 7777776665556678889999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS-----DLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s-----d~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+....+... .... .
T Consensus 160 --~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~----~- 228 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNPE----L- 228 (287)
T ss_pred --cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cchh----h-
Confidence 224567889999999876 568999999999999999999999997652 12222221110 0000 0
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...+ ......++.+.+||.+||..||.+|||+.|++.||||+..
T Consensus 229 ----------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 229 ----------KDEP--------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred ----------ccCC--------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 0000 0001145678899999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=354.58 Aligned_cols=285 Identities=34% Similarity=0.562 Sum_probs=215.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC-------
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN------- 434 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~------- 434 (1028)
.+|.+.+.||.|+||.||+|.+..++..||+|++..... .......+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 689999999999999999999999999999999876543 22345678999999999999999987664322
Q ss_pred -----CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEe
Q psy18163 435 -----MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVG 508 (1028)
Q Consensus 435 -----~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~ 508 (1028)
...+|+||||+.++|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 13579999999876655442 235889999999999999999999999999999999999984 5678999
Q ss_pred ccCCccccCCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q psy18163 509 DFGLAREYGSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 509 DFGlAr~~~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
|||++..+..... .....++|..|+|||++.+...++.++|||||||++|+|++|..||.+.++.+.+..+......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999986543211 1223467899999998876567899999999999999999999999998888777777665433
Q ss_pred CCCCCCCCCC-CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 586 PNEKIWPGFS-KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 586 p~~~~w~~~s-~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....+..+. .++......... +. .........++..+.+||.+||..||.+|||+.++|.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGE-PR---RPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccc-cC---CCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 2221111111 011000000000 00 00011123467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=343.37 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=208.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||.|+||.||++.+..+++.||||++...... ......+.+|+.+|+.+.||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 4699999999999999999999999999999999754321 1223456789999999999999999988854 458999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++ .. ...+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~---~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 79 VMEYVPGGELFSHL---RK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEecCCCCCHHHHH---HH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999954 444443 33 346889999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
....+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+... .+
T Consensus 155 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------- 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KV------------- 215 (290)
T ss_pred ---CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc-------------
Confidence 334578999999999876 56889999999999999999999999887755545444321 00
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
.+ ...++..+.+||.+||..||.+|+ ++.++++||||....
T Consensus 216 -------~~-----------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 216 -------RF-----------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -------cC-----------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 00 012457788999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.41 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=203.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||.|+||.||+|.+..+++.||||+++..... ....+.+|+.++..++||||+++++++.. .+.+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEE
Confidence 35799999999999999999999999999999998765321 12345679999999999999999988754 458999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+++ +|.+++ .. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~---~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 84 CMEFCGGGSLQDIY---HV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEeccCCCcHHHHH---Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999986 444443 32 346889999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccCccccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLL--GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~--g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
........||..|+|||++. ....++.++|||||||++|+|++|.+||........+..+... ......+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~------ 231 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQPPKL------ 231 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCCCCcc------
Confidence 33344568999999999974 2245889999999999999999999998765543333222111 0000000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPf 653 (1028)
. ....++..+.+||.+||..||.+|||+.++|.|||
T Consensus 232 -----------~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 232 -----------K---------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----------c---------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 00124567889999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.13 Aligned_cols=255 Identities=25% Similarity=0.455 Sum_probs=208.6
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++++.||.|+||.||++.+..+++.||||.+............+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 4899999999999999999999999999999997653322233456789999999999999999988754 45899999
Q ss_pred eccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ ++|...+... ...+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++..+.....
T Consensus 79 e~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 79 DYCEG--GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred ecCCC--CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99976 3444444332 33578889999999999999999999999999999999999999999999999987654433
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... ...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~~------------- 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YPP------------- 220 (256)
T ss_pred hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--CCC-------------
Confidence 3334568899999999877 568899999999999999999999998777666655553321 000
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
....++..+.+||.+||..||.+||++.++|.||||
T Consensus 221 -----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 -----------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 011256678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.38 Aligned_cols=254 Identities=27% Similarity=0.464 Sum_probs=208.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.++|+||+++++++... ..+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEE
Confidence 579999999999999999999999899999999976532 34667899999999999999999988644 589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
+||+.+ +.|.+.+......+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 77 ~e~~~~--~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 77 MEYCGA--GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred EecCCC--CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999986 444444444456789999999999999999999999999999999999999999999999999987755433
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......++..|+|||++.+ ..++.++||||||||+|+|++|.+||...........+... .. ..+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~----~~~------- 219 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP----PTL------- 219 (256)
T ss_pred ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC----CCC-------
Confidence 3445568999999999877 56899999999999999999999999876554333222110 00 000
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.....++..+.+||.+||..||.+|||+.++|.||||
T Consensus 220 ----------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 220 ----------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ----------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0012256778999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=337.55 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=202.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC---CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG---FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~---~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
.+|++.+.||+|+||.||+|.+..++..||+|++........ ....+.+|+.++..++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368999999999999999999999999999999875432211 12345679999999999999999998876555688
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+++|||+.+ ++|...+.. ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++..+..
T Consensus 82 ~l~~e~~~~--~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPG--GSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 999999976 344444333 33578888999999999999999999999999999999999999999999999976532
Q ss_pred C---CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 P---LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~---~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
. ........++..|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+.. .+.. +
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~---~--- 228 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN---P--- 228 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC---C---
Confidence 1 112233568999999999977 5689999999999999999999999987654443333211 1100 0
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
. ....+++.+.+|| +||..||.+|||++++++||||+
T Consensus 229 -----------~-----------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 -----------Q-----------LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -----------C-----------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0 0112456778888 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=379.06 Aligned_cols=293 Identities=24% Similarity=0.324 Sum_probs=203.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCC-CeEEEEEEee--------------cc-ccccCCccchHHHHHHHHHcCCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRT-DEIVALKRLK--------------ME-KEKEGFPITSLREINTLLKAQHPNI 423 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~t-g~~VAIKvlk--------------~~-~~~~~~~~~~lrEi~iL~~l~HPNI 423 (1028)
..++|+++++||+|+||+||+|..+.. +..+++|.+. +. .........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 357899999999999999999976532 2223333111 00 0111122345689999999999999
Q ss_pred eEEEEEEeecCCCeEEEEEeccccchHHHHHHHh-hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC
Q psy18163 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMR-SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502 (1028)
Q Consensus 424 V~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~-~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~ 502 (1028)
+++++++... +..|+||+++.++|..++.... ..........++.|+.||+.||.|||++|||||||||+||||+.+
T Consensus 226 v~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999988644 4789999999876655443211 111223456788899999999999999999999999999999999
Q ss_pred CcEEEeccCCccccCCCCC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCC-CCCC--CChHHHHHH
Q psy18163 503 GILKVGDFGLAREYGSPLK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEP-LFTG--KSDLEQLSR 578 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~p-PF~g--~sd~d~l~k 578 (1028)
|.+||+|||+++.+..... .....+||+.|+|||++.+ ..|+.++||||||||||||++|.. ||.. ......+.+
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999987754322 2234689999999999987 569999999999999999999884 4433 234566666
Q ss_pred HHHhcCCCCCCCCCCCCCCh-hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 579 IFKTMGTPNEKIWPGFSKLP-AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 579 I~~~lg~p~~~~w~~~s~lp-~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
++..++.+...+......+. .+....+...+. .+........++..+.+||.+||.+||.+|||+.|+|.||||...
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGH--SVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCcc--chhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 66655543332211100000 000000000000 000000112356778899999999999999999999999999864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=341.49 Aligned_cols=258 Identities=23% Similarity=0.404 Sum_probs=205.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeec----CC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGS----NM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~----~~ 435 (1028)
.+.|++...||.|+||.||+|.+..+++.||+|++..... ....+..|+.++..+ .|+||+++++++... ..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH---HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 3679999999999999999999999999999999865432 223456788888888 699999999988532 34
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
+.+|+||||+.+ +|.+++... ....+.+..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 678999999986 566655432 23457788889999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
............+|++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+... ...
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~-- 244 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PPP-- 244 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CCC--
Confidence 66543334455689999999999863 245788999999999999999999999776544333322110 000
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
......++..+.+||.+||..||.+|||+.+||.||||
T Consensus 245 --------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 --------------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00012256788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.46 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=202.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..+.||||+++++++... +.+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEE
Confidence 3579999999999999999999999999999999975432 1223456899999999999999999888644 58999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+....
T Consensus 84 v~e~~~~--~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGG--GSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999986 334333332 3467889999999999999999999999999999999999999999999999998765433
Q ss_pred CcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 KHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.......|++.|+|||++.+ ...++.++|||||||++|+|++|.+||......+....+.... .....
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~-------- 230 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN--FQPPK-------- 230 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC--CCCCC--------
Confidence 33445678999999998852 2457889999999999999999999986544332221111100 00000
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPf 653 (1028)
.. ....++..+.+||.+||..||.+|||++++|+|+|
T Consensus 231 ---------~~---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 231 ---------LK---------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ---------Cc---------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00 01125678899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=343.65 Aligned_cols=257 Identities=27% Similarity=0.469 Sum_probs=209.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.+|++++.||.|+||.||+|.+..+++.||||.+..... .....+.+|+.++..++||||+.+++++.. .+.+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 579999999999999999999999999999999875432 223456789999999999999999998854 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ ++|...+.. ..+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 95 ~e~~~~--~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 95 MEYLAG--GSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEecCC--CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999986 344443332 3478999999999999999999999999999999999999999999999999886654333
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+... ..+. +.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---~~--------- 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---LQ--------- 236 (296)
T ss_pred cCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc---cC---------
Confidence 3345678999999999876 56899999999999999999999999888776555444321 1000 00
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....+++.+.+||.+||..||.+|||+.+++.||||+..
T Consensus 237 -----------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 237 -----------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred -----------------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 011256778899999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.24 Aligned_cols=264 Identities=20% Similarity=0.294 Sum_probs=208.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|+.+..||+|+||.||++.+..++..||||.+...... .....+.+|+.++.++. |+||+++++++.. ....++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 4677888999999999999999999999999998754332 22345678999999986 9999999998754 347899
Q ss_pred EEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 441 VMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+|||+..++.++...+... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9999998888877654332 35689999999999999999999975 999999999999999999999999999987654
Q ss_pred CCCcccccccCccccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGC--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~--~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. ......||+.|+|||++.+. ..++.++|||||||++|+|++|.+||..... ....+.............
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~---- 233 (288)
T cd06616 161 SI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSN---- 233 (288)
T ss_pred CC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCC----
Confidence 32 22344789999999999774 3689999999999999999999999976542 222222211111000000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.....++..+.+||.+||..||.+|||+.+++.||||+.
T Consensus 234 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 234 ---------------------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ---------------------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 001225678899999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=343.47 Aligned_cols=258 Identities=27% Similarity=0.479 Sum_probs=207.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..+|++++.||.|+||.||+|.+..++..||+|.+...... ....+.+|+.++..+.|+||+++++++.. ...+|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEE
Confidence 35899999999999999999999999999999998765432 23456789999999999999999998864 348999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+.. ..+++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 95 v~e~~~~--~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 95 VMEYLAG--GSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred eecccCC--CCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999976 333333322 347888999999999999999999999999999999999999999999999988654433
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
.......|++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+... +.+. ++
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---~~-------- 237 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE---LQ-------- 237 (296)
T ss_pred cccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC---CC--------
Confidence 33445688999999999876 56889999999999999999999999877654433322210 0000 00
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....++..+.+||.+||..||.+|||+.++|.||||...
T Consensus 238 ------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 238 ------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ------------------CccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 011255678899999999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.03 Aligned_cols=288 Identities=30% Similarity=0.512 Sum_probs=223.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||.|+||.||+|.+..++..||||++............+.+|+.++..+.||||++++++|... ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEE
Confidence 35789999999999999999999999999999999865433333345567899999999999999999887542 34789
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||++++|..++. ...+.+..+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||++.....
T Consensus 87 lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 87 FVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 999999876655543 23477888899999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.........+.+.++.++..++........
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 234457889999999987656789999999999999999999999999887777777777777766544332211000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
..- +...+.............++..+.+||.+||..||.+|||+.++|.||||....
T Consensus 239 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 239 LRF--VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHH--HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 000 000000001111111234677899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=344.46 Aligned_cols=258 Identities=27% Similarity=0.466 Sum_probs=207.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..+|++++.||.|+||.||+|.+..++..||||.+...... ....+.+|+.++..+.|+||+++++++.. .+.+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 36899999999999999999999999999999999754322 23446789999999999999999998864 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+.. ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 94 v~e~~~~--~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAG--GSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCC--CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999976 344444332 347888999999999999999999999999999999999999999999999998664433
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.. .+.+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~------------- 234 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE------------- 234 (297)
T ss_pred cCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC-------------
Confidence 33445678999999999877 6689999999999999999999999977654332221110 00000
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
. .....++..+.+||.+||..||.+|||+.++|.||||...
T Consensus 235 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 235 -------L---------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred -------C---------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 0 0012256778899999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.68 Aligned_cols=262 Identities=20% Similarity=0.325 Sum_probs=205.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||.|+||.||+|.+..++..||+|.++.... ......+.+|+.++..+.|+||+++++++.. .+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 468999999999999999999999999999999875422 1122456789999999999999999987754 4589999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||+.+ +|..++... .....+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999987 444443321 112368999999999999999999997 59999999999999999999999999999866432
Q ss_pred CCcccccccCccccCcccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCK-----EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~-----~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.....++++.|+|||++.+.. .++.++|||||||++|+|++|..||...........+..........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 229 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT----- 229 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC-----
Confidence 223457889999999985422 35889999999999999999999997755444333332221111100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
....++..+.+||.+||..||.+||++.++++||||....
T Consensus 230 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 230 ------------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ------------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 1122567889999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.70 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=203.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC---CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG---FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~---~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
.+|++.+.||+|+||.||+|.+..++..||||++........ ....+.+|+.++..+.||||+++++++.......+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999999865432211 12345679999999999999999998765545678
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
++||||+.+ ++|...+.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~--~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPG--GSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 999999976 344444433 23478888999999999999999999999999999999999999999999999976532
Q ss_pred C---CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 P---LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~---~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
. ........||..|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+. ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~------ 228 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTNP------ 228 (265)
T ss_pred ccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCCC------
Confidence 1 112334578999999999987 568999999999999999999999998765444433322 111100
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
.....++..+.+||.+||. +|.+|||+++++.|||++
T Consensus 229 ----------------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 229 ----------------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0112356778899999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=340.37 Aligned_cols=282 Identities=38% Similarity=0.692 Sum_probs=222.0
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEEEEE
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
|++.+.||.|+||+||+|.+..+++.||||.+...... .......+|+..+..+. |+||+.+++++.. .+..|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 67889999999999999999999999999998654321 12233457899999999 9999999888754 56899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.++|.+++... ....+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++...... ..
T Consensus 78 e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~ 154 (283)
T cd07830 78 EYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PP 154 (283)
T ss_pred ecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CC
Confidence 99976655544321 1246789999999999999999999999999999999999999999999999999876542 23
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.+...++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|.....+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 45567899999999987666789999999999999999999999999999999999988888877666644322111111
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
..+.... ...........+..+.+||.+||..||.+|||+.|++.||||
T Consensus 235 ~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFA---PTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccc---cccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 1111110 000011112236788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=346.95 Aligned_cols=283 Identities=22% Similarity=0.295 Sum_probs=207.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++.+.||+|+||.||++.+..++..||+|.+..... ......+.+|+.++..++||||+++++++.. .+.+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 469999999999999999999999999999999875422 1223456789999999999999999998864 4589999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||+.+ +|.+++ .. ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++......
T Consensus 78 ~ey~~~~~L~~~l---~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 78 MEHMDGGSLDQVL---KK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eeccCCCcHHHHH---Hh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999986 444444 33 3457888999999999999999998 58999999999999999999999999998765432
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+... +..++...... ..+......+.
T Consensus 154 --~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~ 227 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSE--GEAKESHRPVS 227 (308)
T ss_pred --ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCcccc--ccccCCccccc
Confidence 2345688999999999877 568999999999999999999999998765333 22222211000 00000000000
Q ss_pred hhhhccccC-------CC-CCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEY-------PN-VGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~-------p~-~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
......... .. ............++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000000000 00 00000011112367789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.30 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=202.2
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-------CccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-------FPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-------~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
+|.+...||.|+||.||+|.+..++..||+|.+........ ....+.+|+.++..++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 37788899999999999999999999999999865432211 12345679999999999999999988754 3
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
+.+++||||+.+ +|.+++. . ...+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||+++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~---~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLN---N-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred CccEEEEEecCCCCHHHHHH---h-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 588999999976 4444443 2 3457888899999999999999999999999999999999999999999999998
Q ss_pred ccCCCC------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 515 EYGSPL------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 515 ~~~~~~------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
.+.... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~ 230 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SP 230 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CC
Confidence 765321 11223568899999999877 568899999999999999999999998766554443332210 00
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. ....++..+.+||.+||..||.+||++.++++||||
T Consensus 231 ------------------~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 231 ------------------E-----------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ------------------c-----------CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0 011256778899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=357.44 Aligned_cols=257 Identities=25% Similarity=0.443 Sum_probs=217.1
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
-|.++.+||+|+||.||+|.++.+|..||||.+..+. ..+.++.||.+|.++..|++|++|+.|+... .+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceEeeh
Confidence 4888999999999999999999999999999998753 3456789999999999999999999876443 699999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
|||+. |++-+.++.++.++++.++..+++..+.||+|||...-||||||..|||++.+|+.||+|||.|..+.+....
T Consensus 108 EYCGA--GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 108 EYCGA--GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred hhcCC--CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99986 6666667777888999999999999999999999999999999999999999999999999999888766566
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.++.+|||.|||||++.. -.|++++||||||++..||.-|+|||..-.+ +..||-.-..|+ |.|.+
T Consensus 186 RNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PP----PTF~K------ 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPP----PTFKK------ 251 (502)
T ss_pred hCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCC----CCCCC------
Confidence 678899999999999987 4599999999999999999999999976443 223322111111 11111
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
....+.++.||+.+||.+.|++|.||.++++|||++..+
T Consensus 252 -----------------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 252 -----------------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred -----------------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 012456788999999999999999999999999999753
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=369.08 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=222.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.+..|.++.+||+|.|++|.+|++..|+..||||++.++...........+|+.+|+.+.|||||+|+.++..+. .+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~--~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA--TLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc--eeE
Confidence 456799999999999999999999999999999999988766655566789999999999999999999986554 899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ +.+++++...+. +.+.+++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++..+..
T Consensus 132 lV~eya~~--ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 132 LVMEYASG--GELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EEEEeccC--chhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-
Confidence 99999988 888888876554 56689999999999999999999999999999999999999999999999998864
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.....++||++.|.|||++.+..+.++.+|+||||++||.|++|..||++.+-.+.-.+.+. +..
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-----------gk~---- 272 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-----------GKY---- 272 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-----------eee----
Confidence 45677899999999999999988889999999999999999999999998753221111110 000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...-.++.++.+||++||.++|.+|++.++++.|.|....
T Consensus 273 ------------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 273 ------------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ------------------cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 0112367788999999999999999999999999998753
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.17 Aligned_cols=254 Identities=25% Similarity=0.425 Sum_probs=206.3
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++++.||.|+||.||+|.+..++..||||.+............+.+|+.+|+.++||||+.+++++.. .+.+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 5899999999999999999999999999999997654333334566789999999999999999987753 45899999
Q ss_pred ecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC-CcEEEeccCCccccCCCC
Q psy18163 443 DYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR-GILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~-g~lKL~DFGlAr~~~~~~ 520 (1028)
||+.+ +|.+++... ....+++..+..++.||+.||.|||++||+|+||||+|||++.+ +.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99976 555544321 23457888999999999999999999999999999999999854 568999999998775432
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
. .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 219 (256)
T cd08220 157 K-AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA--------------- 219 (256)
T ss_pred c-ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---------------
Confidence 2 234578999999999987 56889999999999999999999999887765555444321100
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. ....++..+.+||.+||..||.+|||+.++|.||||
T Consensus 220 ------~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ------P-----------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------C-----------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0 011246678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=344.29 Aligned_cols=260 Identities=24% Similarity=0.439 Sum_probs=208.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.|.....||.|+||.||++.+..++..||||.+..... .....+.+|+.++..++|+||+++++.+.. .+..|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEE
Confidence 456667889999999999999999999999999865432 123346789999999999999999888754 4589999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ +|.+++ . ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 98 ~e~~~~~~L~~~~---~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 98 MEFLEGGALTDIV---T--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EeCCCCCcHHHHH---h--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 999986 343333 2 2347889999999999999999999999999999999999999999999999998665443
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||..|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+...... . ..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~---~-~~-------- 239 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP---R-VK-------- 239 (292)
T ss_pred ccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---c-cc--------
Confidence 33445678999999999876 56899999999999999999999999887766555444321100 0 00
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPI 661 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~ 661 (1028)
....++..+.+||.+||..||.+|||+.++|+||||...+.|.
T Consensus 240 ------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 240 ------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred ------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 0112566788999999999999999999999999999765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=338.47 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=206.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||.|+||.||++.+..+++.||||.+...... ......+.+|+.++..++||||+++++++.. .+.+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 4699999999999999999999999999999998765321 1122345689999999999999999888754 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||+++......
T Consensus 79 v~e~~~g--~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 79 VMEYVEG--GDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEecCCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999986 334333333 3458889999999999999999999999999999999999999999999999986321100
Q ss_pred ---------------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q psy18163 521 ---------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 521 ---------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 01123467889999999877 56899999999999999999999999887766655554432100
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC---HHHHHhCCCCCCCC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT---ADEALRHDYFSESP 658 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT---A~ElL~HPfF~e~p 658 (1028)
++ . ....++..+.+||.+||..||.+||+ +.++|+||||....
T Consensus 235 -----~~-----------------~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 235 -----WP-----------------E--------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred -----CC-----------------C--------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 00 0 00125677899999999999999997 89999999998743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.48 Aligned_cols=258 Identities=24% Similarity=0.434 Sum_probs=202.4
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC----CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG----FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~----~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
+|+..+.||+|+||.||+|.+..++..||||++........ ....+.+|+.+++.++|+||+++++++. ..+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeE
Confidence 47888999999999999999999999999999975432111 2345678999999999999999999875 44589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-cEEEeccCCcccc
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREY 516 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-~lKL~DFGlAr~~ 516 (1028)
++||||+.+ +|.+++. . ...+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++..+
T Consensus 79 ~~v~e~~~~~~L~~~l~---~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 79 NLFVEWMAGGSVSHLLS---K-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEEEeccCCCcHHHHHH---H-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999986 4544443 2 34678899999999999999999999999999999999998765 6999999999876
Q ss_pred CCCCCc----ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 517 GSPLKH----YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 517 ~~~~~~----~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
...... ....+||..|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT----- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-----
Confidence 543211 123568899999999877 5689999999999999999999999976543332222222110000
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
. ......++..+.+||.+||..||.+|||+.++|+||||+
T Consensus 229 ------------~-----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 229 ------------A-----------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ------------C-----------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0 001123567889999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.06 Aligned_cols=257 Identities=28% Similarity=0.486 Sum_probs=212.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|.+.+.||.|+||.||++.+..++..||+|++............+.+|+.+++.++|+|++++++.+... ..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 58999999999999999999999999999999976544333445567899999999999999999887654 6899999
Q ss_pred ecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ +|.+++.........+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 99986 56555554332346789999999999999999999999999999999999999999999999999987765433
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.....+|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 220 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----------------- 220 (258)
T ss_pred eecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC-----------------
Confidence 3445678999999999877 5589999999999999999999999987765554444322110
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
... ...++..+.++|.+||..||.+|||+.++|.||||
T Consensus 221 ----~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 ----PPI-----------PSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ----CCC-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 000 11255678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=328.03 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=204.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++.+.||.|+||.||++.+..++..||+|.++..... .......+|+.++..+.|+||+++++.+... +.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence 589999999999999999999999999999998754322 2234566899999999999999999888544 5899999
Q ss_pred eccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ +++...+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 78 e~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 78 EYCDG--GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eeCCC--CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99976 444444433 344578899999999999999999999999999999999999999999999999987655433
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 218 (255)
T cd08219 156 YACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK---------------- 218 (255)
T ss_pred ccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC----------------
Confidence 3445678999999999877 56899999999999999999999999887655544444321100
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. ....++..+.+||.+||..||.+|||+.++|.-
T Consensus 219 -----~-----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -----P-----------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----C-----------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 011245678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=363.62 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=211.6
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
....-|..++.||-|+||.|.++....|...||+|.+.+... ..+.......|-.||.....+-||+|| |.+++.++
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy--ySFQDkdn 703 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY--YSFQDKDN 703 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE--EEeccCCc
Confidence 345679999999999999999999999999999999976542 233444556788999999999999994 55678889
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|+||+|+.| |+++..+.. .+.|.|..+++|+..|.+||+++|..|+|||||||+|||||.+|+|||+|||||+-+.
T Consensus 704 LYFVMdYIPG--GDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 704 LYFVMDYIPG--GDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eEEEEeccCC--ccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 9999999987 555554433 3579999999999999999999999999999999999999999999999999996331
Q ss_pred C---------C-----------------CC----------------cccccccCccccCcccccCCCCCCchhhHHHHHH
Q psy18163 518 S---------P-----------------LK----------------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGC 555 (1028)
Q Consensus 518 ~---------~-----------------~~----------------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGv 555 (1028)
. . .. .....+||+.|+|||||.. ..|+..|||||.||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGV 859 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhH
Confidence 0 0 00 0124689999999999988 66999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhc
Q psy18163 556 IFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFL 635 (1028)
Q Consensus 556 ILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL 635 (1028)
||||||.|.+||...+..+.-.+|++ |..+..++. ...|+.++.+||.+|.
T Consensus 860 il~em~~g~~pf~~~tp~~tq~kv~n---------w~~~l~~~~--------------------~~~ls~e~~~li~kLc 910 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQYKVIN---------WRNFLHIPY--------------------QGNLSKEALDLIQKLC 910 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcceeeeee---------hhhcccccc--------------------ccccCHHHHHHHHHHh
Confidence 99999999999988776554444432 433322211 1237889999999865
Q ss_pred ccCcCCCC---CHHHHHhCCCCCCCC
Q psy18163 636 TYDPVTRI---TADEALRHDYFSESP 658 (1028)
Q Consensus 636 ~~DP~kRP---TA~ElL~HPfF~e~p 658 (1028)
+ ++..|+ .++++..||||+...
T Consensus 911 ~-sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 911 C-SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred c-ChhhhhcccchhhhhcCccccccc
Confidence 5 788887 578899999998753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=338.27 Aligned_cols=260 Identities=18% Similarity=0.275 Sum_probs=196.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECC----------------CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKR----------------TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVT 425 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~----------------tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~ 425 (1028)
++|++.++||+|+||.||+|.+.. ++..||||++..... ......+.+|+.+|..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCeeE
Confidence 579999999999999999998642 345799999875432 112345678999999999999999
Q ss_pred EEEEEeecCCCeEEEEEecccc-chHHHHHHHhh---------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy18163 426 VREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRS---------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILH 489 (1028)
Q Consensus 426 L~~i~~~~~~~~l~LVmEy~~g-dLgsLl~~l~~---------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVH 489 (1028)
+++++... +.+||||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+|
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 84 LLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99988654 479999999975 55555533210 1123567788999999999999999999999
Q ss_pred ccccccceeecCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh--CCC
Q psy18163 490 RDLKTSNLLLSHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC--MEP 565 (1028)
Q Consensus 490 RDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT--G~p 565 (1028)
|||||+||||+.++.+||+|||+++.+..... ......+|..|+|||++.+ ..++.++|||||||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999986543211 1223456788999999876 568999999999999999986 568
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH
Q psy18163 566 LFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA 645 (1028)
Q Consensus 566 PF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA 645 (1028)
||.+.+..+.+..+...+.......+. ...+.++..+.+||.+||..||.+|||+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYL-------------------------FRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccc-------------------------cCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 888777666555443321110000000 0012356778999999999999999999
Q ss_pred HHHHh
Q psy18163 646 DEALR 650 (1028)
Q Consensus 646 ~ElL~ 650 (1028)
.+|..
T Consensus 296 ~~i~~ 300 (304)
T cd05096 296 SDIHA 300 (304)
T ss_pred HHHHH
Confidence 99954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.74 Aligned_cols=255 Identities=27% Similarity=0.506 Sum_probs=206.2
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|.+.+.||.|+||.||+|.+..++..||+|.+............+.+|+.+++.++|+||+++++++. ....+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEE
Confidence 589999999999999999999999999999999765433333345678999999999999999998774 345899999
Q ss_pred eccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-cEEEeccCCccccCCCC
Q psy18163 443 DYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-~lKL~DFGlAr~~~~~~ 520 (1028)
||+.+ ++|...+... ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .++|+|||++.......
T Consensus 79 e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDG--GDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCC--CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99976 3444444332 33578889999999999999999999999999999999999875 57999999998776543
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
.......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+.+..+.... +.
T Consensus 157 ~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~-------- 220 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------FA-------- 220 (257)
T ss_pred ccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------CC--------
Confidence 33444578999999999876 458899999999999999999999998776655444432210 00
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
...+.++..+.+||.+||..+|.+|||+.+++.||||
T Consensus 221 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 221 -----------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0012256678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=328.69 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=205.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++.+.||.|+||.||+|++..++..||||.++.... .......+.+|+.+++.++||||+++++++... +.+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEE
Confidence 679999999999999999999999999999998865322 122233467899999999999999999888644 48899
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999986 777777666555566888899999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD-LEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd-~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
........|++.|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+...+...+.++.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 228 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL---------- 228 (267)
T ss_pred hHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC----------
Confidence 333345678999999999977 5589999999999999999999999865432 1122222211111100
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++..+.+||.+||..||.+|||+.++|+.
T Consensus 229 --------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 --------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred --------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 011245678899999999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=328.07 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=200.8
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc----CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE----GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~----~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
+|++.+.||.|+||.||+|.+. ++..||||.+....... .....+.+|+.+|..++|+||+++++++... +.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeE
Confidence 4788899999999999999874 78899999987543211 1123466799999999999999999988543 589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+||||+.+ ++|...+.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 78 ~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 78 SIFMEFVPG--GSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEEecCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999976 333333333 24578889999999999999999999999999999999999999999999999986532
Q ss_pred C------CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 519 P------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 519 ~------~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
. ........||..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 227 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM------ 227 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC------
Confidence 1 112234578999999999877 568999999999999999999999998765544333332211100
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
+ .....++..+.+||.+||..||.+|||+.++|.||||
T Consensus 228 ----------------~--------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 228 ----------------P--------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------C--------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0012256778999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=360.70 Aligned_cols=253 Identities=28% Similarity=0.389 Sum_probs=212.0
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecccc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH 447 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~g 447 (1028)
+.||.|-||+||-|+++.+|+.||||+|.+............+|+.||.++.||.||.|...| ++.+.+|+|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhhcc
Confidence 789999999999999999999999999988877666666778899999999999999996544 677799999999998
Q ss_pred chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC---CcEEEeccCCccccCCCCCccc
Q psy18163 448 DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR---GILKVGDFGLAREYGSPLKHYT 524 (1028)
Q Consensus 448 dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~---g~lKL~DFGlAr~~~~~~~~~t 524 (1028)
|+...+ +....+.+++...+.++.||+.||.|||.+||+|.||||+|||+... -++||||||+|+.++.. ....
T Consensus 648 DMLEMI--LSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRr 724 (888)
T KOG4236|consen 648 DMLEMI--LSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRR 724 (888)
T ss_pred hHHHHH--HHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhh
Confidence 654433 33446679999999999999999999999999999999999999753 47999999999999864 3345
Q ss_pred ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhc
Q psy18163 525 PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604 (1028)
Q Consensus 525 ~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~ 604 (1028)
+.+|||.|+|||+|.. +.|+..-||||+|||+|--|.|..||+...+ +-.+|.+.-...+..
T Consensus 725 sVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~--------------- 786 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPN--------------- 786 (888)
T ss_pred hhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCC---------------
Confidence 6899999999999988 7899999999999999999999999976443 333333221111111
Q ss_pred cccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 605 ~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.+..+++.++|||..+|++.-.+|.|.+..|.|||+++.
T Consensus 787 --------------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 787 --------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred --------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 123478899999999999999999999999999999874
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=333.37 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=205.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.+.||||+++++++... ..+++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEE
Confidence 3688899999999999999999999999999998765432 2334567899999999999999999887654 589999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||+.+ +|.+++.. ....+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++..+...
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999994 66655543 23568889999999999999999999 99999999999999999999999999999766432
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS-----DLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s-----d~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
... ...++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.+..+.. ....
T Consensus 155 ~~~--~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~------ 222 (265)
T cd06605 155 LAK--TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPP------ 222 (265)
T ss_pred Hhh--cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCC------
Confidence 221 2678999999999987 568999999999999999999999997642 1222222211 0000
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
. .....++..+.+||.+||..||.+|||+.+++.||||+.
T Consensus 223 ---------------~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 223 ---------------R-------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ---------------C-------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0 000115677899999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.75 Aligned_cols=258 Identities=25% Similarity=0.425 Sum_probs=205.6
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC---CCCeeEEEEEEeecCCCeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ---HPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~---HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.|++++.||.|+||.||+|.+..++..||||++...... .....+.+|+.++..+. ||||+++++++.. ...+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 478889999999999999999999999999998754322 22334567899998886 9999999998754 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ ++|...+.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 79 lv~e~~~~--~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 79 IIMEYAEG--GSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEecCCC--CcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999976 344433332 25888999999999999999999999999999999999999999999999999877654
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
........|+..|+|||.+.+...++.++|||||||++|+|++|.+||.+.........+... .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~------------- 218 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---K------------- 218 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---C-------------
Confidence 444455679999999999876566899999999999999999999999876543322111000 0
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.+. .....++..+.+||.+||..||.+|||+.+++.||||++..
T Consensus 219 --------~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 219 --------PPR-------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred --------CCC-------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 000 00011456788999999999999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=363.04 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=208.4
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecccc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH 447 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~g 447 (1028)
-+||+|+||+||-|+|..|...+|||-+..... ...+-..+||.+.+.++|.|||++++.+ +..+.+-|.||-+.|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVPG 656 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCCC
Confidence 469999999999999999999999999975443 2344567899999999999999998886 344578899999988
Q ss_pred chHHHHHHHhhcCCcC--CHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec-CCCcEEEeccCCccccCCCCCccc
Q psy18163 448 DMKSLMETMRSKKQVF--IPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS-HRGILKVGDFGLAREYGSPLKHYT 524 (1028)
Q Consensus 448 dLgsLl~~l~~~~~~~--se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd-~~g~lKL~DFGlAr~~~~~~~~~t 524 (1028)
|+|-..++.+-+++ .+..+..|.+||+.||.|||++.|||||||-+||||+ -.|.+||+|||.++.+..-....-
T Consensus 657 --GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 657 --GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred --CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 66666666677777 7888999999999999999999999999999999998 589999999999998765444555
Q ss_pred ccccCccccCccccc-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhh
Q psy18163 525 PIVVTLWYRSPELLL-GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603 (1028)
Q Consensus 525 ~~vGT~~Y~APEvL~-g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l 603 (1028)
++.||..|||||++. |...|+.++|||||||++.||.||+|||..-.... ..+|+. |+.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV----------GmyK------- 795 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV----------GMYK------- 795 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh----------ccee-------
Confidence 789999999999994 55679999999999999999999999996533221 112221 0000
Q ss_pred ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 604 ~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
..+.+ ...++..++.||.+|+..||..||+|.++|..||++..+.
T Consensus 796 vHP~i-----------Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 796 VHPPI-----------PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred cCCCC-----------cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence 01111 2337889999999999999999999999999999987643
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=324.80 Aligned_cols=258 Identities=29% Similarity=0.472 Sum_probs=204.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++.+.||+|+||.||+|.+..++..||||+++...........+.+|+.++..++|+||+++++++. ..+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence 589999999999999999999999999999999876543234456778999999999999999998764 445899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.+ ++|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++.........
T Consensus 79 e~~~~--~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSG--GTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCC--CcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99986 344444433 345788899999999999999999999999999999999999999999999999876543222
Q ss_pred c----cccccCccccCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 523 Y----TPIVVTLWYRSPELLLGCK--EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 523 ~----t~~vGT~~Y~APEvL~g~~--~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. ....++..|+|||++.+.. .++.++|||||||++|+|++|..||............... +.. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~-~-------- 225 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK-P-------- 225 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC-C--------
Confidence 2 2357889999999987632 3789999999999999999999999765433222221111 100 0
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.++. ...++..+.+||.+||..||.+|||+.+++.|||+
T Consensus 226 ----------~~~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 ----------PIPD---------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----------CCCc---------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 01146678899999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.47 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=205.4
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+|++.+.||.|+||.||+|.+..++..||+|++....... .....+.+|+.++..++||||+++++++. ....+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEE
Confidence 4899999999999999999999999999999997654322 23456678999999999999999987774 44589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ ++|...+... ..+.+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~~--~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 79 VDLLLG--GDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EeCCCC--CCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 999987 4554444433 468899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD--LEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd--~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+. .+.+...... ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~----------- 219 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADV----------- 219 (258)
T ss_pred cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccc-----------
Confidence 3345678899999999877 5589999999999999999999999987664 2222221110 000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH--HHHHhCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA--DEALRHDYF 654 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA--~ElL~HPfF 654 (1028)
.....++..+.+||.+||..||.+||++ .++++||||
T Consensus 220 ------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 220 ------------------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ------------------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0111245778899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=354.53 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=200.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~ 439 (1028)
...|+++++||.||.+.||++.... ...||+|.+.....+.....-+.+||..|.+|+ |.+||.|++|-+++ +.+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~lY 436 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYLY 436 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceEE
Confidence 4579999999999999999998764 456777766554444444556779999999996 99999999998764 4899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||||-+.||..++.. ....+....++.|..|++.|+.++|.+||||.||||.|||+ -.|.+||+|||+|..+...
T Consensus 437 mvmE~Gd~DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 437 MVMECGDIDLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEeecccccHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 9999998888777654 23333434799999999999999999999999999999999 4699999999999877544
Q ss_pred CCc--ccccccCccccCcccccCCC----------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 520 LKH--YTPIVVTLWYRSPELLLGCK----------EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 520 ~~~--~t~~vGT~~Y~APEvL~g~~----------~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
... ..+.+||+.||+||.|.... ..++++||||||||||+|+.|++||..-.+ .+.++..+ ..|+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI-~~P~ 589 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAI-TDPN 589 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhh-cCCC
Confidence 322 23579999999999985421 256889999999999999999999964221 22222221 1221
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.+ +.|+..+. ...+++++..||..||.+|||+.++|+|||++-.+
T Consensus 590 ~~-------------Iefp~~~~-------------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 590 HE-------------IEFPDIPE-------------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred cc-------------ccccCCCC-------------chHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 11 11221111 12388999999999999999999999999997543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.25 Aligned_cols=258 Identities=24% Similarity=0.457 Sum_probs=207.3
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
|.....||.|+||.||+|.+..++..||||++..... .....+.+|+.++..+.||||+++++++.. .+.+|+|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEe
Confidence 4555689999999999999999999999999865432 223456789999999999999999988754 358999999
Q ss_pred ccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcc
Q psy18163 444 YVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY 523 (1028)
Q Consensus 444 y~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~ 523 (1028)
|+.+ ++|...+. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.......
T Consensus 99 ~~~~--~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 99 FLQG--GALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred cCCC--CCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 9986 33333332 2357889999999999999999999999999999999999999999999999997665443344
Q ss_pred cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l 603 (1028)
...+|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+... + ...+.
T Consensus 175 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~-~~~~~----------- 238 (297)
T cd06659 175 KSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---P-PPKLK----------- 238 (297)
T ss_pred cceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---C-CCCcc-----------
Confidence 55689999999999977 56899999999999999999999999877766555443211 0 00000
Q ss_pred ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 604 ~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
....++..+.+||.+||..||.+||++.++++||||.+...|
T Consensus 239 ---------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 239 ---------------NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred ---------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 011245678899999999999999999999999999876554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=333.27 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=206.6
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
.|...+.||.|+||.||++.+..++..||||++..... .....+.+|+.++..+.||||+.+++++.. .+..|+|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 45666899999999999999999999999999864322 223346789999999999999999998754 45899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.+ +.|...+.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.........
T Consensus 96 e~~~~--~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 96 EFLEG--GALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred eccCC--CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 99976 333333333 35788899999999999999999999999999999999999999999999998765443333
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+.... .+. .
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~---~----------- 235 (285)
T cd06648 172 RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPK---L----------- 235 (285)
T ss_pred cccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCC---C-----------
Confidence 344678999999999877 568999999999999999999999998877665555443210 000 0
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
. ....++..+.+||.+||..||.+|||+.++|.||||+...
T Consensus 236 ------~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 236 ------K---------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ------c---------ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0 0012456788999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=327.92 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=196.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.+.....||+|+||.||+|.+..++..||+|.+...... ....+.+|+.++..++|+||+++++++.. .+.+++|
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEE
Confidence 3444557899999999999999999999999988654321 22356789999999999999999988754 3589999
Q ss_pred EeccccchHHHHHHHhhcCCcC--CHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEeccCCccccCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVF--IPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLAREYGS 518 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~--se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~DFGlAr~~~~ 518 (1028)
|||+.+ ++|...+......+ .+..+..++.||+.||.|||++||+||||||+|||++. .+.++|+|||++..+..
T Consensus 84 ~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 84 MEQVPG--GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EecCCC--CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999976 34444443333344 77788899999999999999999999999999999986 67999999999976643
Q ss_pred CCCcccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.........|+..|+|||++.+. ..++.++|||||||++|+|++|.+||.................
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 228 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK------------- 228 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc-------------
Confidence 33333345689999999998653 3478999999999999999999999975432211110000000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
..+. ....+++.+.+||.+||..+|.+|||+.+++.||||
T Consensus 229 ------~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 ------IHPE-----------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ------cCCC-----------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0000 112356778999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=362.64 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=215.5
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.|.-++.||.|+||.||.|++..+.+.||||.+..+... ......++.|+..|.++.|||++.+.++|.-+. ..|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--hHHHH
Confidence 367788999999999999999999999999999765432 233457889999999999999999999997654 57999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||||-|+-.+|++.. ..++-+.++..|+.+.+.||.|||+++.||||||..|||+...|.|||+|||.|....
T Consensus 105 MEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 999999888888876 4568899999999999999999999999999999999999999999999999997653
Q ss_pred cccccccCccccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 HYTPIVVTLWYRSPELLL--GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~--g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
..++++|||+|||||||+ ..+.|+-++||||||++..||.-.+||+-.-+....+..|...-. |
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-------P------- 243 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------P------- 243 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-------C-------
Confidence 346789999999999985 345699999999999999999999988766666665655544210 0
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.+.....+..++.|+..||.+-|..|||.+++|.|+|....
T Consensus 244 -----------------tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 244 -----------------TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -----------------CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 01112356778999999999999999999999999998764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=330.40 Aligned_cols=252 Identities=18% Similarity=0.232 Sum_probs=198.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++..... .....+.+|+.++..++||||+++++++.. .+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCC
Confidence 357999999999999999999875 45678999999765321 223456789999999999999999998854 458
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+||||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~--~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSN--GALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCC--CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999987 34444444444568899999999999999999999999999999999999999999999999876543
Q ss_pred CCCC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 518 SPLK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 518 ~~~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 229 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-------- 229 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC--------
Confidence 2211 1112345678999999877 668999999999999999775 9999998877766555532211000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
...++..+.+|+.+||..||.+|||+.+|++
T Consensus 230 ------------------------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 230 ------------------------PRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0124567889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=327.96 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=201.6
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCC--------ccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF--------PITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~--------~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
+|.+.+.||.|+||.||+|.+..++..||||.++........ ...+..|+.++..++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 488899999999999999999999999999998653221111 1234578999999999999999988754
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
.+.+++||||+.+ ++|...+... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~--~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 80 EEYLSIFLEYVPG--GSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred CCceEEEEecCCC--CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 4589999999976 3444444333 468888999999999999999999999999999999999999999999999997
Q ss_pred ccCCCC--CcccccccCccccCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 515 EYGSPL--KHYTPIVVTLWYRSPELLLGCK-EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 515 ~~~~~~--~~~t~~vGT~~Y~APEvL~g~~-~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
...... .......|+..|+|||++.+.. .++.++|||||||++|+|++|..||........+..+.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~- 232 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR---SAPP- 232 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc---cCCc-
Confidence 654321 1233457899999999987633 47899999999999999999999997655443333221110 0000
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
++ ......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 233 ----------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 ----------------IP-------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------CC-------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00 00112256788999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=332.91 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=206.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
..|+.++.||.|+||.||+|.+..++..||||++...... .....+.+|+.++..+.|+||+++++++... ..+|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEE
Confidence 3588889999999999999999999999999998754321 1234567899999999999999999988654 489999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ ++|.+.+.. ..+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..+.....
T Consensus 81 ~e~~~~--~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 81 MEYLGG--GSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EecCCC--CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999987 445554433 3578889999999999999999999999999999999999999999999999977654333
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+... .+
T Consensus 157 ~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~--------------- 218 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--NP--------------- 218 (277)
T ss_pred ccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--CC---------------
Confidence 3344578999999999877 56899999999999999999999999876654433222110 00
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
......++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 219 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 219 ---------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ---------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 00111245678899999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=330.95 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=199.4
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccccc
Q psy18163 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD 448 (1028)
Q Consensus 370 LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~gd 448 (1028)
||.|+||+||+|.+..+++.||+|++...... ......+..|+.+|+.++||||+.+++++.. .+.+|+||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~- 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNG- 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCC-
Confidence 69999999999999999999999999764322 2223445689999999999999999888754 4589999999986
Q ss_pred hHHHHHHHhhcC-CcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccccc
Q psy18163 449 MKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527 (1028)
Q Consensus 449 LgsLl~~l~~~~-~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~v 527 (1028)
++|...+.... ..+++.++..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++..... ........
T Consensus 78 -~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 155 (277)
T cd05577 78 -GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA 155 (277)
T ss_pred -CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence 34444433322 3588999999999999999999999999999999999999999999999999976543 22334457
Q ss_pred cCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcccc
Q psy18163 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAE 607 (1028)
Q Consensus 528 GT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~ 607 (1028)
++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 156 ~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 214 (277)
T cd05577 156 GTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA-------------------- 214 (277)
T ss_pred CCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc--------------------
Confidence 7889999999887 4589999999999999999999999977543211112211100000
Q ss_pred CCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCCC
Q psy18163 608 YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESPL 659 (1028)
Q Consensus 608 ~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p~ 659 (1028)
......+++.+.+||.+||..||.+|| ++.+++.||||....+
T Consensus 215 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 215 ---------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred ---------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 001122577889999999999999999 9999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=324.02 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=208.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++.+.||.|+||.||+|.+..+++.||||++...... .....+.+|+.++..++|+||+++++++... ..+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEE
Confidence 4689999999999999999999999999999998765432 2345577899999999999999999988644 589999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||+.+ +|.+++. . ...+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~l~---~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 78 LEYMDGGSLADLLK---K-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred EEecCCCcHHHHHH---H-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999985 4544443 2 2568999999999999999999999 99999999999999999999999999999877554
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS---DLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s---d~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
........++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.... ..+....+... ...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~~-------- 221 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PPP-------- 221 (264)
T ss_pred CCcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CCC--------
Confidence 444445678999999999877 578999999999999999999999998764 22222222210 000
Q ss_pred ChhhhhhccccCCCCCCCcccccccc-ccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSI-LTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~-Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..... ++..+.+||.+||..+|..|||+.++|+||||+.
T Consensus 222 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 222 ---------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ---------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 00011 5677889999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.27 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=203.5
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc---CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE---GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~---~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
+|+..+.||.|+||+||+|.+..++..||||.+....... .....+.+|+.++..++|+||+++++++. ....+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER--EEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe--cCCeEE
Confidence 4778899999999999999999899999999987543211 12345678999999999999999998775 345899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ ++|...+.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 79 lv~e~~~~--~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 79 IFLELVPG--GSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEEecCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999976 333333333 235788899999999999999999999999999999999999999999999999866443
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
. ......|+..|+|||.+.....++.++|+|||||++|+|++|.+||......+....+......
T Consensus 156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------- 220 (258)
T cd06632 156 S-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-------------- 220 (258)
T ss_pred c-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC--------------
Confidence 2 2345678999999999876334899999999999999999999999876654444333221000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 221 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 -----------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -----------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00112356778899999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=331.77 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=191.7
Q ss_pred EeeecCcEEEEEEEECCCCeEEEEEEeeccccccCC-ccchHHHHHHHH---HcCCCCeeEEEEEEeecCCCeEEEEEec
Q psy18163 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF-PITSLREINTLL---KAQHPNIVTVREIVVGSNMDKIFIVMDY 444 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~-~~~~lrEi~iL~---~l~HPNIV~L~~i~~~~~~~~l~LVmEy 444 (1028)
.||+|+||.||++.+..++..||||++......... .....++..++. ...||||+.+++++.. .+.+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 489999999999999999999999999765432111 122334443333 3479999999887754 3479999999
Q ss_pred cccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccc
Q psy18163 445 VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT 524 (1028)
Q Consensus 445 ~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t 524 (1028)
+.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ...
T Consensus 79 ~~~--~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~ 153 (279)
T cd05633 79 MNG--GDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPH 153 (279)
T ss_pred CCC--CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Ccc
Confidence 986 444444433 345899999999999999999999999999999999999999999999999999766432 223
Q ss_pred ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 525 PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL--EQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 525 ~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~--d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
...||..|+|||++.+...++.++|||||||++|+|++|..||...... ..+..+.. ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~--------------- 215 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TVN--------------- 215 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cCC---------------
Confidence 4579999999999875456899999999999999999999999764321 11111110 000
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
......++..+.+||.+||..||.+|+ |+.++++||||+..
T Consensus 216 --------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 216 --------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred --------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 001122567889999999999999999 69999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=335.30 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=206.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..|++++.||.|+||+||+|.+..+++.||||++...... ......+.+|+.++..++||||+++++++... +..|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeEEE
Confidence 5699999999999999999999999999999998654321 11223467899999999999999999988654 47899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+++.+++.. ....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 93 VMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 999998876665542 234588999999999999999999999999999999999999999999999999876532
Q ss_pred CcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 KHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.....++..|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.......+... .+.
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~----------- 232 (307)
T cd06607 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP----------- 232 (307)
T ss_pred --CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCC-----------
Confidence 234578899999999853 345889999999999999999999999887665544333211 000
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
. .....++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 233 -----------~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 233 -----------T-------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred -----------C-------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0 0001145678899999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.21 Aligned_cols=244 Identities=16% Similarity=0.168 Sum_probs=196.7
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-CccchHHHHHHHHHcCCCCeeEEEEEEee--cCCCeEEEEEec
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-FPITSLREINTLLKAQHPNIVTVREIVVG--SNMDKIFIVMDY 444 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-~~~~~lrEi~iL~~l~HPNIV~L~~i~~~--~~~~~l~LVmEy 444 (1028)
..||+|++|.||+|.. +|+.||||+++....... ....+.+|+.+|.+++||||+++++++.. .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 688999999976532221 12345689999999999999999999876 444578999999
Q ss_pred cccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccCCCCCcc
Q psy18163 445 VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY 523 (1028)
Q Consensus 445 ~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~ 523 (1028)
+.+ ++|...+.. ...+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+....
T Consensus 104 ~~~--g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTR--GYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCC--CcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 987 455555443 3457888899999999999999998 499999999999999999999999999998764321
Q ss_pred cccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
...+||..|+|||++.+. ..|+.++|||||||++|||++|..||.+.+..+....+......+.
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 242 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--------------- 242 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC---------------
Confidence 345789999999998652 4689999999999999999999999998877666655543211110
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....++.+.+||.+||..||.+|||+.+++.
T Consensus 243 -----~-----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 -----L-----------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -----C-----------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0 0124567889999999999999999999986
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.15 Aligned_cols=257 Identities=30% Similarity=0.473 Sum_probs=206.4
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++.+.||.|+||.||+|.+..++..|++|++............+.+|+.+++.+.|+||+++++++.......+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 48889999999999999999999999999999976653323345667899999999999999999888655336899999
Q ss_pred ecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ +|.+++. ... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~---~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLK---KFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHH---HcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 99954 5544443 322 688999999999999999999999999999999999999999999999999987765432
Q ss_pred --cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 --HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 --~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+ ....+.......
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~------------- 220 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSG------------- 220 (260)
T ss_pred cccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccC-------------
Confidence 1345678999999999877 4589999999999999999999999987662 222222211000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
... .....++..+.+||.+||..||.+||++.++|.||||
T Consensus 221 ----~~~-----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 221 ----EPP-----------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ----CCc-----------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000 0112246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.05 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=206.4
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
-|++++.||.|+||.||+|.+..++..||||++...... .....+.+|+.++..+.||||+++++++... ..+|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEE
Confidence 488899999999999999999999999999998654322 1234566899999999999999999988644 4799999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.+ ++|...+.. ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+......
T Consensus 82 e~~~~--~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 82 EYLGG--GSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EeCCC--CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 99986 444444432 35788899999999999999999999999999999999999999999999999766543333
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+... .+ +
T Consensus 158 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~-----~---------- 219 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP-----P---------- 219 (277)
T ss_pred hccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC-----C----------
Confidence 445678999999999876 56788999999999999999999999876654444333211 00 0
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+||++.++++||||.+.
T Consensus 220 ---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 220 ---------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0112256778899999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=328.82 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=205.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~ 439 (1028)
++|.+.+.||.|+||.||+|.+..++..||||++...... ......+.+|+.++..+. |+||+++++++. ..+.++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEE
Confidence 4799999999999999999999999999999999764321 122345678899999998 999999988774 345899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ ++|...+.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~--~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPN--GELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999954 344443333 336899999999999999999999999999999999999999999999999999866543
Q ss_pred C--------------------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy18163 520 L--------------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579 (1028)
Q Consensus 520 ~--------------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI 579 (1028)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 2 12234567899999999877 45889999999999999999999999988765555544
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH----HHHHhCCCC
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA----DEALRHDYF 654 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA----~ElL~HPfF 654 (1028)
...... ....+++.+.+||.+||..||.+|||+ .++|+||||
T Consensus 235 ~~~~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 LKLEYS---------------------------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhcCCC---------------------------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 321100 011246678899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.63 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=201.3
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccccc
Q psy18163 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD 448 (1028)
Q Consensus 370 LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~gd 448 (1028)
||.|+||.||+|.+..++..||+|++...... ......+.+|+.++..+.||||+++++++.. ...+|+||||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~- 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLG- 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCC-
Confidence 79999999999999999999999999765432 2233456789999999999999999988754 4579999999975
Q ss_pred hHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccccccc
Q psy18163 449 MKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV 528 (1028)
Q Consensus 449 LgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vG 528 (1028)
++|...+.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .....++
T Consensus 78 -~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 154 (262)
T cd05572 78 -GELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCG 154 (262)
T ss_pred -CcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccC
Confidence 445444433 3457888999999999999999999999999999999999999999999999998775432 2234578
Q ss_pred CccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccc
Q psy18163 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS--DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606 (1028)
Q Consensus 529 T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s--d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~ 606 (1028)
+..|+|||++.+ ..++.++|+|||||++|+|++|..||.... ..+.+..+...... .
T Consensus 155 ~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------~ 213 (262)
T cd05572 155 TPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK--------------------L 213 (262)
T ss_pred CcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC--------------------C
Confidence 999999999876 568999999999999999999999998766 44444443321000 0
Q ss_pred cCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCC
Q psy18163 607 EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSES 657 (1028)
Q Consensus 607 ~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~ 657 (1028)
.++ ..++..+.+||.+||..||.+||| +.|+++||||++.
T Consensus 214 ~~~-----------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 214 EFP-----------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCC-----------cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 001 113567889999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=360.90 Aligned_cols=245 Identities=30% Similarity=0.481 Sum_probs=204.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHH-cCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~-l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..+.|.+...||.|+|+.|..+.+..+++.+++|++...... ..+|+.++.. -.||||+++.+++.+ ..++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYED--GKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecC--Ccee
Confidence 357799999999999999999999999999999999776221 1256645444 469999999998854 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee-cCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL-SHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL-d~~g~lKL~DFGlAr~~~ 517 (1028)
|+|||++.+ +.+++.+..... +. .++..|+.+|+.||.|||++|||||||||+|||+ +..|+++|+|||.++...
T Consensus 392 ~~v~e~l~g--~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 392 YLVMELLDG--GELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eeeehhccc--cHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999998 778888766543 33 6788899999999999999999999999999999 689999999999999876
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. +.+.|-|..|.|||++.. .+|+.+|||||||++||+||+|..||...... ..|...++.+..
T Consensus 468 ~~---~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~--------- 531 (612)
T KOG0603|consen 468 RS---CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF--------- 531 (612)
T ss_pred hh---hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc---------
Confidence 43 556688999999999985 78999999999999999999999999886655 222222222211
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
...+|+.|+|||+.||++||.+|+++.+++.||||
T Consensus 532 ----------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 ----------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 12378999999999999999999999999999999
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=334.84 Aligned_cols=258 Identities=28% Similarity=0.481 Sum_probs=207.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||.|+||.||++.+..++..||+|.+..... .....+.+|+.+++.++||||+.+++++... +..|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVG--DELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEEE
Confidence 3689999999999999999999998999999999865432 2234567899999999999999999888654 47899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|...+.. ..+++.++..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 94 v~e~~~~--~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAG--GSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCC--CcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999986 445444433 247888999999999999999999999999999999999999999999999987665443
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+... +.+ .
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~---~---------- 234 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP---E---------- 234 (293)
T ss_pred cccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCC---C----------
Confidence 33445678999999999877 56899999999999999999999999876654433222110 000 0
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
++ ....++..+.+||.+||..||.+||++.+++.||||+..
T Consensus 235 -------~~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 235 -------LQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred -------CC---------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 00 011255678899999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=337.35 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=199.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeE----EEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEI----VALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~----VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.+|++++.||+|+||+||+|.+..++.. ||||+++.... ......+.+|+.++..+.||||+++++++.. ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLT---ST 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CC
Confidence 5799999999999999999998766654 89999864322 2223456789999999999999999998854 35
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
.++|++|+.+ ++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 83 ~~~v~e~~~~--g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCC--CCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 7899999976 66777666656668888899999999999999999999999999999999999999999999998765
Q ss_pred CCCCcc--cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 518 SPLKHY--TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 518 ~~~~~~--t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
...... ....+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+. ..++.....+ +
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~-----~-- 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL-----P-- 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC-----C--
Confidence 432222 22344678999999977 568999999999999999997 9999987665443 3333211000 0
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.....+..+.+||.+||..||.+|||+.+++.+
T Consensus 232 ------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 232 ------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001134567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=330.85 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=205.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||++.+..++..||+|++..... ......+.+|+.++..++||||+++++++... +.+||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEE
Confidence 4679999999999999999999999999999999875432 22345667899999999999999999988654 58999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ ++|...+.. ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++......
T Consensus 81 v~e~~~~--~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDC--GSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCC--CCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999986 344443333 3458899999999999999999997 68999999999999999999999999998755322
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH----HH---HHHHhcCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ----LS---RIFKTMGTPNEKIWP 592 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~----l~---kI~~~lg~p~~~~w~ 592 (1028)
.....+||..|+|||++.+ ..++.++|||||||++|+|++|..||........ .. .++......
T Consensus 158 --~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 228 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------ 228 (284)
T ss_pred --ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence 1234578999999999877 4689999999999999999999999987554210 00 111100000
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
..+. .....++..+.+||.+||..||.+|||+.++++||||.+..
T Consensus 229 --------------~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 229 --------------PPPR-------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred --------------cCCC-------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0000 00011456788999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=328.60 Aligned_cols=283 Identities=28% Similarity=0.525 Sum_probs=224.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++++|.|-|+.||.|.+..+++.++||+++.-+ ...+.+||.+|..+. ||||+.|++++..+.....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 5689999999999999999999999999999999997543 245679999999997 9999999999987777778
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEeccCCcccc
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLAREY 516 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~DFGlAr~~ 516 (1028)
.|||||+.+ |...|+. .++.-+++.|+.+|+.||.|||+.||+|||+||.|++||. .-.++|+|+|+|.++
T Consensus 111 aLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999987 4444443 3667789999999999999999999999999999999995 457999999999887
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCCCCC-CCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRIFKTMGTPNEKIW-PGF 594 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~-pPF~g~sd~d~l~kI~~~lg~p~~~~w-~~~ 594 (1028)
. +...++-.+.+..|--||+|...+.|+++-|||||||+|..|+..+ |+|.|.++.+++.+|.+.+|+-.-..+ ..+
T Consensus 184 H-p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 184 H-PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred C-CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 5 4567788889999999999999899999999999999999999877 778899999999999999886421100 000
Q ss_pred --CCChhhhhhccccCCCC--CCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 595 --SKLPAVQKMTFAEYPNV--GGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 595 --s~lp~~~~l~~~~~p~~--~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..-|.+..+ ....... ............++++.|||.++|.+|-..|+||.|++.||||..
T Consensus 263 ~i~Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 263 QIDLDPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ccCCChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 000000000 0000000 000000111235689999999999999999999999999999963
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=329.71 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=200.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCC-----eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTD-----EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg-----~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|++++.||+|+||.||+|.+...+ ..||+|.++.... ......+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcC--C
Confidence 467999999999999999999986655 6899999864432 1223346789999999999999999988753 3
Q ss_pred CeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~ 502 (1028)
...|++|||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 578999999975 55554433211 01347788899999999999999999999999999999999999
Q ss_pred CcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy18163 503 GILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRI 579 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI 579 (1028)
+.++|+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999997653321 12334567889999999877 568999999999999999998 99999887776655554
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
......+ ....++..+.+|+.+||..||.+|||+.+++++
T Consensus 240 ~~~~~~~--------------------------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLP--------------------------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCC--------------------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3311000 011256788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.60 Aligned_cols=255 Identities=26% Similarity=0.476 Sum_probs=203.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++.+.||.|+||.||+|.+..+++.||+|.++..... ......+.+|+.++..+.|+||+.+++++... +.+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 5799999999999999999999999999999998754322 22244567899999999999999999988654 57899
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++.........+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999985 666666554444566889999999999999999999999999999999999999999999999999876544
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD--LEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd--~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
........++..|+|||++.+ ..++.++|||||||++|+|++|..||..... .+....+....
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 224 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-------------- 224 (267)
T ss_pred CcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--------------
Confidence 333445678999999999877 5689999999999999999999999965431 11111111100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+...+ ...++..+.+||.+||..||.+|||+.+|++
T Consensus 225 -------~~~~~----------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 -------YPPLP----------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -------CCCCC----------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00000 1124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.97 Aligned_cols=255 Identities=27% Similarity=0.507 Sum_probs=209.1
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++.+.||.|+||.||++.+..++..||||.+............+.+|+.+++.++|+||+++++++... ...|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 58999999999999999999999999999999976543333344567899999999999999998887644 6899999
Q ss_pred ecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ +|..++.........+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99965 566655544334456888999999999999999999999999999999999999999999999999877543
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.... +
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------~---------- 218 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-------Y---------- 218 (256)
T ss_pred CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------C----------
Confidence 2334578999999999977 568899999999999999999999998877654433332110 0
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
+. ....++..+.+||.+||..||.+|||+.++|+||++
T Consensus 219 -------~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 -------PP--------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -------CC--------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 011256778999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.81 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=192.9
Q ss_pred EeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-CccchHHHH---HHHHHcCCCCeeEEEEEEeecCCCeEEEEEec
Q psy18163 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-FPITSLREI---NTLLKAQHPNIVTVREIVVGSNMDKIFIVMDY 444 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-~~~~~lrEi---~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy 444 (1028)
.||+|+||.||+|.+..+++.||||++........ .......|. .++....||||+.+++++.. .+.+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 38999999999999999999999999876432211 111223333 33444579999999887754 3589999999
Q ss_pred cccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccc
Q psy18163 445 VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT 524 (1028)
Q Consensus 445 ~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t 524 (1028)
+.+ ++|...+.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..+... ...
T Consensus 79 ~~g--~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 153 (278)
T cd05606 79 MNG--GDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPH 153 (278)
T ss_pred CCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCc
Confidence 986 444444433 456899999999999999999999999999999999999999999999999999766432 223
Q ss_pred ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhc
Q psy18163 525 PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604 (1028)
Q Consensus 525 ~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~ 604 (1028)
..+||..|+|||++.+...++.++|||||||++|+|++|..||.......... +.........
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~---------------- 216 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAV---------------- 216 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhccCC----------------
Confidence 45799999999999765568999999999999999999999997753221111 1110000000
Q ss_pred cccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 605 ~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
. ....++..+.+||.+||..||.+|| ++.++++||||+...
T Consensus 217 --~-----------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 217 --E-----------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred --C-----------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 0 0112467889999999999999999 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.48 Aligned_cols=253 Identities=28% Similarity=0.492 Sum_probs=207.2
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|++.+.||.|+||.||++.+..++..||+|.+............+.+|++++..+.|+||+++++++.. ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4889999999999999999999999999999997664332334456789999999999999999888754 35899999
Q ss_pred ecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ +|.+++. .. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~---~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 79 EYAENGSLRQIIK---KF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred ecCCCCcHHHHHH---hc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99986 4444433 22 4688999999999999999999999999999999999999999999999999987765444
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+... ..
T Consensus 155 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~-------------- 216 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---DH-------------- 216 (254)
T ss_pred cccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---CC--------------
Confidence 3445678999999999877 44889999999999999999999999876654444333210 00
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. .....++..+.+||.+||..||.+|||+.+++.||||
T Consensus 217 ----~-----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 217 ----P-----------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----C-----------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0 0112256778899999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=314.41 Aligned_cols=253 Identities=31% Similarity=0.512 Sum_probs=205.2
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+|.+.+.||.|+||.||++.+..++..|++|++..... .....+.+|+.++..+.|+||+.+++++... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence 48899999999999999999999999999999976543 2334567899999999999999999988654 5799999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
||+.+ .+|...+......+++..+..++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++........
T Consensus 77 e~~~~--~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 77 EFCSG--GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred ecCCC--CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99985 333333333335689999999999999999999999999999999999999999999999999987754322
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+... ....
T Consensus 154 ~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-------------- 216 (253)
T cd05122 154 RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--GPPG-------------- 216 (253)
T ss_pred ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CCCC--------------
Confidence 345678999999999877 45889999999999999999999999877654444333221 0000
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPf 653 (1028)
.+. ...++..+.+||.+||..||.+|||+.++|.|||
T Consensus 217 -----~~~---------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 -----LRN---------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -----cCc---------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000 0113567889999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=349.23 Aligned_cols=255 Identities=18% Similarity=0.259 Sum_probs=194.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCC-----eEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTD-----EIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg-----~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
.++|++.+.||+|+||.||+|++..++ ..||||+++...... ....+.+|+.++..+ +|+||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD-EREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH-HHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 468999999999999999999975443 579999997643221 234567899999999 899999999987544
Q ss_pred CCeEEEEEecccc-chHHHHHHHhh-------------------------------------------------------
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRS------------------------------------------------------- 458 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~------------------------------------------------------- 458 (1028)
..+|||||||.+ +|.+++.....
T Consensus 115 -~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 115 -GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred -CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 479999999986 44444322110
Q ss_pred -----------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC--cccc
Q psy18163 459 -----------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK--HYTP 525 (1028)
Q Consensus 459 -----------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~--~~t~ 525 (1028)
....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 012467788999999999999999999999999999999999999999999999986543221 1122
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~ 604 (1028)
..++..|+|||++.+ ..|+.++|||||||++|+|++ |..||........+..+......+
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~------------------ 334 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM------------------ 334 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc------------------
Confidence 345678999999977 569999999999999999997 999998765443333333211000
Q ss_pred cccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 605 ~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 335 -------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 -------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001124678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.75 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=204.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.|+.++.||.|+||.||+|.+..++..||||++....... ....+.+|+.++..+.||||+++++++.. .+.+|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEE
Confidence 34777888999999999999999999999999987543222 23456789999999999999999988864 3479999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ ++|...+. ...+.+..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~e~~~~--~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 81 MEYLGG--GSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEccCC--CcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999986 44444443 24578899999999999999999999999999999999999999999999999987654333
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+... ..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~~--------- 219 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-------SPP--------- 219 (277)
T ss_pred hhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-------CCC---------
Confidence 3344578999999999977 56899999999999999999999999765543332221110 000
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.....++..+.+||.+||..+|.+|||+.++|.||||..
T Consensus 220 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 220 ----------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 001124567889999999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.52 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=198.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||.|+||.||++.... +..||+|.+..... ....+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence 579999999999999999998764 55799998864322 23456789999999999999999988754 4579999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ ++|.+.+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.......
T Consensus 78 ~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 78 TEFMEN--GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEcCCC--CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999976 445555544444578889999999999999999999999999999999999999999999999986543221
Q ss_pred c-ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 H-YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 ~-~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
. .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+.......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~------------- 221 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY------------- 221 (256)
T ss_pred eccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-------------
Confidence 1 122345668999999876 568999999999999999999 899998887776666654321000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....+..+.+||.+||..||.+|||+.++++
T Consensus 222 --------~-----------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 --------R-----------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --------C-----------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 0113456789999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.68 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=192.0
Q ss_pred CCeEEEEEe--eecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHH-cCCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNRI--EEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~L--G~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~-l~HPNIV~L~~i~~~~~~~~l 438 (1028)
+.|++.+.+ |.|+||.||++.+..++..||+|++....... .|+..... ..||||+++++++... +.+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~--~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL--KGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC--Cee
Confidence 456666665 99999999999999999999999987543211 12222222 2699999999888654 489
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-cEEEeccCCccccC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-~lKL~DFGlAr~~~ 517 (1028)
|+||||+.+ ++|...+... ..+++.++..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++....
T Consensus 85 ~iv~e~~~~--~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 85 VLIMDYIKD--GDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEEEcCCC--CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999976 4555544443 3789999999999999999999999999999999999999888 99999999998664
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ-LSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~-l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. ....+|..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ....
T Consensus 162 ~~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-------- 227 (267)
T PHA03390 162 TP----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL-------- 227 (267)
T ss_pred CC----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC--------
Confidence 32 23468999999999987 5689999999999999999999999986543321 11111110 0000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-HHHHHhCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-ADEALRHDYFS 655 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-A~ElL~HPfF~ 655 (1028)
.....+++.+.+||.+||+.||.+||+ ++++|+||||.
T Consensus 228 ---------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 228 ---------------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ---------------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 001136788999999999999999996 59999999996
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=321.57 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=204.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc---cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK---EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~---~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
.+|++.+.||+|+||.||+|.+..++..||+|.+...... ......+.+|+.++..++|+||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999999999999999998643211 1122355679999999999999999998866556679
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
++||||+.+ ++|...+... ..+.+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~--~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPG--GSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCC--CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 999999976 3444444332 3478888999999999999999999999999999999999999999999999986533
Q ss_pred CC---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 PL---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.. ...+...+|..|+|||++.+ ..++.++|||||||++|+|++|.+||........+.++. ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~------ 228 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTKP------ 228 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCCC------
Confidence 11 12234578999999999987 558899999999999999999999998765554443332 111110
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.....+++.+.+||.+||. +|.+|||+.++|.|||.
T Consensus 229 ----------------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 ----------------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ----------------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0112366788999999999 67999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.05 Aligned_cols=251 Identities=28% Similarity=0.443 Sum_probs=195.6
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHH-HHHcCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINT-LLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~i-L~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.||.|+||.||+|.+..+++.||||++....... ........|..+ +....|+||+++++++.. .+.+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 56999999999999999999999999987543211 111222344433 344589999999988854 45899999999
Q ss_pred cc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccc
Q psy18163 446 EH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT 524 (1028)
Q Consensus 446 ~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t 524 (1028)
.+ +|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..... ..
T Consensus 80 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 80 NGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 76 55555432 34578899999999999999999999999999999999999999999999999876543 23
Q ss_pred ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhc
Q psy18163 525 PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604 (1028)
Q Consensus 525 ~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~ 604 (1028)
...++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+...... |+.
T Consensus 152 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~----------- 214 (260)
T cd05611 152 KFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-----WPE----------- 214 (260)
T ss_pred cCCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-----CCC-----------
Confidence 4578899999999987 44899999999999999999999999887766555544321100 000
Q ss_pred cccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC---HHHHHhCCCCCCCC
Q psy18163 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT---ADEALRHDYFSESP 658 (1028)
Q Consensus 605 ~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT---A~ElL~HPfF~e~p 658 (1028)
.....++..+.+||.+||..||.+||| +.|+|.||||+...
T Consensus 215 -------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 215 -------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred -------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 001135678899999999999999995 57999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=346.43 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=195.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEE-----CCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d-----~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
.++|++.+.||+|+||+||+|.+ ..++..||||+++..... .....+.+|+.+|..+ .||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 35799999999999999999974 356778999999754321 2234567899999999 89999999998854
Q ss_pred CCeEEEEEeccccchHHHHHHHhhc-------------------------------------------------------
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSK------------------------------------------------------- 459 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~------------------------------------------------------- 459 (1028)
.+..++|||||.+ ++|...+...
T Consensus 111 ~~~~~lv~E~~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 GGPTLVITEYCCY--GDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred CCcceeeehhccC--CcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 3478999999986 4444444321
Q ss_pred -------------------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 460 -------------------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 460 -------------------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1246778889999999999999999999999999999999999999999999998664322
Q ss_pred C--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 521 K--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 521 ~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+.+++.....+
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------- 336 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM----------- 336 (375)
T ss_pred cccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-----------
Confidence 1 1122345678999999987 568999999999999999998 889998765444333333211000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. .....+..+.+||.+||..||.+|||+.++++.
T Consensus 337 ---------~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 337 ---------L-----------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ---------C-----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 001245678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.39 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=202.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|++.+.||.|+||.||+|.++. .+..||+|.+...... .....+.+|+.++..+.||||+++++++.. .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSK--G 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 4689999999999999999997652 3558999988644321 122346789999999999999999988754 3
Q ss_pred CeEEEEEecccc-chHHHHHHHhhc------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEe
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSK------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVG 508 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~ 508 (1028)
+..|+||||+.+ +|.+++...... ...+....+..++.||+.||.|||+++|+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 478999999975 666665443211 1234566788999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q psy18163 509 DFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 509 DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
|||+++.+..... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-- 238 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-- 238 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--
Confidence 9999986543211 1222345778999999877 568999999999999999998 789998877666555443210
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh------CCCCCCCC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR------HDYFSESP 658 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~------HPfF~e~p 658 (1028)
.+. . ....++.+.+||.+||..||.+|||+.++++ ||||+...
T Consensus 239 ----~~~---------------~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 239 ----YLD---------------Q-----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred ----CCC---------------C-----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 000 0 0113567889999999999999999999987 99998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.20 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=203.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++.+.||.|+||.||+|.+..++..||||.+...... ......+.+|+.+++.+.|+||+++++++... +.+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEE
Confidence 5789999999999999999999999999999988654321 12234567899999999999999999888643 48999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++.........+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999986 677777655444556889999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL--EQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~--d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.......+|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+... .
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 224 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-D------------- 224 (267)
T ss_pred CcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-C-------------
Confidence 333345678999999999977 56889999999999999999999999764321 111111110 0
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
++. .....++..+.+||.+||..||.+|||+.+|++
T Consensus 225 ----------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 ----------YPP-------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------CCC-------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000 001225678899999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=328.92 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=205.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++.+.||.|+||.||+|.+..++..||||+++..... ......+.|+.++..+. |+||+.+++++.. ...+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeE
Confidence 357899999999999999999999999999999999754321 12234556777666665 9999999998854 3479
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|+||||+.+++.+++... ...+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+.
T Consensus 90 ~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 90 FICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999999988777777654 3468888999999999999999997 599999999999999999999999999998764
Q ss_pred CCCCcccccccCccccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGC---KEYSTPIDMWSVGCIFAEFLCMEPLFTGKS-DLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~---~~ys~ksDIWSLGvILyELLTG~pPF~g~s-d~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
... ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.... +.+.+..++.... ..++
T Consensus 167 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~- 240 (296)
T cd06618 167 DSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----PSLP- 240 (296)
T ss_pred CCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC----CCCC-
Confidence 432 22344678899999998753 247889999999999999999999997633 2334443332110 0000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
. ...++..+.+||.+||..||.+|||+.+++.||||..
T Consensus 241 ----------------~---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 241 ----------------P---------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred ----------------C---------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0 0024567889999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=353.80 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=202.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.+++.+...||.|.||+||+|++..+ ||||++............+.+|+.+|++-+|-||+-+.+++... .+.|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLAI 464 (678)
T ss_pred HHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---ceee
Confidence 35678889999999999999999754 99999998876655667788999999999999999998888533 4599
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC--C
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG--S 518 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~--~ 518 (1028)
|+.+|+| .+|+..+......|.....+.|++||++|+.|||.++|||||||..||||.+++.|||+||||+..-. .
T Consensus 465 iTqwCeG--sSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 465 ITQWCEG--SSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eehhccC--chhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 9999999 66777776666778888999999999999999999999999999999999999999999999996321 2
Q ss_pred CCCcccccccCccccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLL--GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLS-RIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~--g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~-kI~~~lg~p~~~~w~~~s 595 (1028)
....+....|...|||||++. ...+|+..+|||||||++|||+||..||...+ .+++. .+-...+.|
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIifmVGrG~l~p--------- 612 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQIIFMVGRGYLMP--------- 612 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheEEEecccccCc---------
Confidence 223344556788899999985 34579999999999999999999999998444 33331 111110000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.. .......+.++++||..|+.++++.||++.+||.
T Consensus 613 --------------d~-----s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 --------------DL-----SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------------cc-----hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 00 0111224568899999999999999999999987
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.35 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=199.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|.+++.||.|+||.||+|.+.. ++..||||+++..... .....+.+|+++|..+.|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 3579999999999999999998753 4678999998754322 1234667899999999999999999988654
Q ss_pred CeEEEEEecccc-chHHHHHHHh----------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMR----------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI 504 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~----------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~ 504 (1028)
..+++||||+.+ +|.+++.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 589999999976 4544443221 11234678889999999999999999999999999999999999999
Q ss_pred EEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy18163 505 LKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFK 581 (1028)
Q Consensus 505 lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~ 581 (1028)
++|+|||++..+.... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999997653221 11223456788999999987 568999999999999999998 9999988776665555432
Q ss_pred hcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 582 TMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 582 ~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....+ ....++..+.+||.+||..||.+|||+.|+++
T Consensus 240 ~~~~~--------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQ--------------------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCC--------------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11000 00124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=366.00 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=199.7
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEE-EEe---ec
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVRE-IVV---GS 433 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~-i~~---~~ 433 (1028)
....+++|.+.|.+|||+.||+|.+...+..||+|++... +......+.+||++|++|. |+|||.+++ ... +.
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 3345788999999999999999999988899999998765 2334456779999999997 999999988 332 22
Q ss_pred C-CCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecCCCcEEEec
Q psy18163 434 N-MDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSHRGILKVGD 509 (1028)
Q Consensus 434 ~-~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~~g~lKL~D 509 (1028)
+ ...++|+||||.+ .|-+++...... .|++.+|..|+.+++.||.+||... |||||||-|||||+.+|++||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 2 3468999999995 555555443333 3999999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCc---------ccccccCccccCcccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy18163 510 FGLAREYGSPLKH---------YTPIVVTLWYRSPELL--LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSR 578 (1028)
Q Consensus 510 FGlAr~~~~~~~~---------~t~~vGT~~Y~APEvL--~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~k 578 (1028)
||.|+..-..... --...-|+.|+|||++ ..+.+.+.|+|||+|||+||-||....||.......++
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl-- 267 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL-- 267 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE--
Confidence 9999744222110 0112458999999997 34467899999999999999999999999876433211
Q ss_pred HHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCC
Q psy18163 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHD 652 (1028)
Q Consensus 579 I~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HP 652 (1028)
+. ...|+.+ +.++..+.+||..||+.||.+||++.+++.+-
T Consensus 268 --ng-------------------~Y~~P~~------------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 268 --NG-------------------NYSFPPF------------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred --ec-------------------cccCCCC------------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 11 0111211 23677889999999999999999999999863
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=319.36 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=191.0
Q ss_pred EeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccccc
Q psy18163 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD 448 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~gd 448 (1028)
.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+.||||+++++++.. ...+|+||||+.+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~- 77 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG- 77 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC-
Confidence 69999999999999999999999998864321 2223456789999999999999999988754 3479999999976
Q ss_pred hHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcc--ccc
Q psy18163 449 MKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY--TPI 526 (1028)
Q Consensus 449 LgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~--t~~ 526 (1028)
++|...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......... ...
T Consensus 78 -~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 78 -GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred -CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 45555554445568899999999999999999999999999999999999999999999999997654221111 111
Q ss_pred ccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcc
Q psy18163 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605 (1028)
Q Consensus 527 vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~ 605 (1028)
.++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-------------------- 215 (252)
T cd05084 157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-------------------- 215 (252)
T ss_pred CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC--------------------
Confidence 23456999999877 558999999999999999998 88999776654443333221000
Q ss_pred ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 606 ~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. .....+..+.+||.+||..||.+|||+.++++
T Consensus 216 -~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -P-----------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -C-----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 01124567889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=324.33 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=198.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCe----EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDE----IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~----~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..++|++++.||.|+||+||+|.+..++. .||||+++.... ......+.+|+.++..+.||||+.+++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT--- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---
Confidence 34689999999999999999999877766 489999865432 1223456789999999999999999988753
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
...+++|+|+.+ +++.+.+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~l~~~~~~~--g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 STVQLVTQLMPY--GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred CCcEEEEEcCCC--CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 357899999976 566666655556689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc--ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 516 YGSPLKH--YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 516 ~~~~~~~--~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
+...... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.......... ++.....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~----- 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLP----- 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC-----
Confidence 6532221 122344678999999977 568999999999999999998 899998765544333 222111100
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+..+.+||.+||..||..|||+.+++.
T Consensus 232 --------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 --------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00124567889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.11 Aligned_cols=250 Identities=33% Similarity=0.507 Sum_probs=201.1
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecccc-
Q psy18163 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH- 447 (1028)
Q Consensus 370 LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~g- 447 (1028)
||.|+||.||+|.+..+++.||||++...... ......+.+|+.++..+.||||+++++.+. ....+|+||||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCCC
Confidence 68999999999999999999999999754321 123345678999999999999999987774 34589999999975
Q ss_pred chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC------
Q psy18163 448 DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK------ 521 (1028)
Q Consensus 448 dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~------ 521 (1028)
+|.+++.. . ..+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++........
T Consensus 79 ~L~~~l~~---~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 79 DLASLLEN---V-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred cHHHHHHH---c-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 55555543 2 3688999999999999999999999999999999999999999999999999876543211
Q ss_pred --cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 --HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 --~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.....+++..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+... .. .|+..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~---~~~~~----- 223 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KI---EWPED----- 223 (265)
T ss_pred cccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc---CCCcc-----
Confidence 2344578899999999877 44889999999999999999999999887766655544321 00 01000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH---HHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA---DEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA---~ElL~HPfF~e~ 657 (1028)
..++..+.+||.+||..||.+|||+ .++|+||||+..
T Consensus 224 ---------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 224 ---------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ---------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0146778899999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=329.23 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=207.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+.|...++||.|+||+||+|.+..++..||||++....... .....+.+|+.++..++|||++.+++++... ...|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEE
Confidence 34777889999999999999999999999999997543221 1223467899999999999999999988654 47899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+++.+++. .....+.+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 99 v~e~~~~~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 99 VMEYCLGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred EEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 99999876555543 334568888999999999999999999999999999999999999999999999986432
Q ss_pred CcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 KHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
......|+..|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+..+.... .+.
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~----------- 239 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPT----------- 239 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCC-----------
Confidence 2235678999999999852 2458889999999999999999999998877665555443210 000
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.....++..+.+||.+||..+|.+||++.++|.||||+..+
T Consensus 240 -------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 240 -------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred -------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00112456688999999999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.01 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=199.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC---CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT---DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t---g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|++.+.||+|+||+||+|.+..+ ...||||+++.... ......+.+|+.++..++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCc
Confidence 36799999999999999999998644 45899999875432 2223456789999999999999999998754 347
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+++||||+.+ ++|...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.
T Consensus 80 ~~iv~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 80 VMIITEYMEN--GSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred eEEEEEcCCC--CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 8999999976 34444444444568899999999999999999999999999999999999999999999999998775
Q ss_pred CCCCccc--ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 518 SPLKHYT--PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 518 ~~~~~~t--~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
....... ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 229 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP------- 229 (266)
T ss_pred ccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 3222222 2344678999999876 568999999999999999998 9999987766655554432110000
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+..+.+|+.+||..||.+||++.+++++
T Consensus 230 -------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 -------------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01245678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=325.36 Aligned_cols=258 Identities=28% Similarity=0.482 Sum_probs=210.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.+.|++...||.|+||.||+|.+..++..||+|++..... ....+.+|+.++..++|+||+++++++... ..+|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEE
Confidence 4668999999999999999999998999999999976533 234567899999999999999999988655 58999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++. .....++...+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 93 VMEYMDGGSLTDIIT---QNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEeccCCCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999985 5555554 33346889999999999999999999999999999999999999999999999998766543
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
........++..|+|||++.+ ..++.++||||||||+|+|++|..||...+.......+.... .+. .
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~------~----- 236 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPP------L----- 236 (286)
T ss_pred hhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCC------C-----
Confidence 333344568899999999877 568999999999999999999999998877655544443210 000 0
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++|.||||...
T Consensus 237 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 237 ------------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ------------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 0001145678899999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.74 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=202.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
...+|+++++||.|+||.||+|.+.. +..||+|++...... ....+.+|+.+++.++|+||+++++++.. ...++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeE
Confidence 34679999999999999999999987 889999998765321 23356789999999999999999888754 45799
Q ss_pred EEEeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+||||+.+ ++|.+.+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 79 lv~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 79 IITELMEK--GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EEEeeccc--CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999986 344444433 234578889999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 224 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP----------- 224 (261)
T ss_pred ccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-----------
Confidence 4333334456778999999876 568999999999999999998 899998877766666554321100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 225 ---------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 ---------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01125677889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=321.62 Aligned_cols=254 Identities=18% Similarity=0.233 Sum_probs=195.2
Q ss_pred EEEEEeeecCcEEEEEEEECCCCe--EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec----CCCeE
Q psy18163 365 KCLNRIEEGTYGVVYRAKDKRTDE--IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS----NMDKI 438 (1028)
Q Consensus 365 ~il~~LG~G~FG~Vyla~d~~tg~--~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~----~~~~l 438 (1028)
.+.+.||+|+||.||+|.+..++. .||+|.++...........+.+|+.++..++|+||+++++++... .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999987775 699999876533333344567899999999999999999876432 22357
Q ss_pred EEEEecccc-chHHHHHHH--hhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 439 FIVMDYVEH-DMKSLMETM--RSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l--~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
++||||+.+ +|.+++..- ......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 999999985 554443221 12234578889999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 516 YGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 516 ~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.........+..... +
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~------ 233 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-L------ 233 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C------
Confidence 643221 1122345778999999877 568999999999999999999 8899988766554444332100 0
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 234 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 -------------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011245668899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=320.12 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=197.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.+|.+.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.++..++|+||+++++++.. .+.+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch---HHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEE
Confidence 569999999999999999999999999999999875421 12356789999999999999999988754 3478999
Q ss_pred EeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ ++|.+.+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~e~~~~--~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 81 TEFMTY--GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEeCCC--CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999975 3444444332 3457888899999999999999999999999999999999999999999999998765432
Q ss_pred Ccc-cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 KHY-TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~~~-t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
... ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..... .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~---------- 224 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---M---------- 224 (263)
T ss_pred eeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---C----------
Confidence 111 12234668999999877 568999999999999999998 9999988766554444322100 0
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....++..+.+||.+||..||.+|||+.++++
T Consensus 225 --------~-----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 225 --------E-----------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --------C-----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 01125677899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=315.67 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=199.3
Q ss_pred EEeeecCcEEEEEEEECCC---CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEec
Q psy18163 368 NRIEEGTYGVVYRAKDKRT---DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDY 444 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~t---g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy 444 (1028)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.++..++|+||+++++++.. ...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 3699999999999999866 8899999997654332 34566789999999999999999988864 5589999999
Q ss_pred ccc-chHHHHHHHhhc-----CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 445 VEH-DMKSLMETMRSK-----KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 445 ~~g-dLgsLl~~l~~~-----~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+.+ +|.+++...... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 954 555544432111 36689999999999999999999999999999999999999999999999999987654
Q ss_pred CC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 PL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~-------- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--RL-------- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC--------
Confidence 32 22344567889999999877 468999999999999999999 699999887666555543210 00
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 227 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 227 ----------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011246778899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=319.71 Aligned_cols=255 Identities=19% Similarity=0.241 Sum_probs=197.2
Q ss_pred eEEEEEeeecCcEEEEEEEECC---CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC----C
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKR---TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM----D 436 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~---tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~----~ 436 (1028)
|++.+.||+|+||.||+|.... ++..||||.++...........+.+|+.+++.+.||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5778999999999999998765 34789999997643322223456789999999999999999988754332 3
Q ss_pred eEEEEEecccc-chHHHHHHHh--hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMR--SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA 513 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~--~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlA 513 (1028)
..++||||+.+ +|..++.... .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 47999999985 5555543322 12235788899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCc--ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 514 REYGSPLKH--YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 514 r~~~~~~~~--~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
+.+...... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+..... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~-- 234 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR---L-- 234 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---C--
Confidence 866432211 112235678999999876 668999999999999999999 8999988776665544432110 0
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. .....+..+.+||.+||..||.+|||+.+++.+
T Consensus 235 ----------------~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 ----------------K-----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------C-----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 001245678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=354.40 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=223.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccc-cccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~-~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
.+.+++++..||-|+||.|=++........+|+|++++.. .+......+..|-++|..+..|+||+||..|- +...+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~kyv 495 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR--DSKYV 495 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cchhh
Confidence 3567889999999999999999888766679999998754 33344456678999999999999999987774 44589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|++||-|-| |++...++. ++.|.+..++.|+..++.|++|||++|||+|||||+|+|++.+|.+||.|||+|+.++.
T Consensus 496 YmLmEaClG--GElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 496 YMLMEACLG--GELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhHHhhcC--chhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999876 666665554 45689999999999999999999999999999999999999999999999999999987
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.... .++||||.|.|||++++ +..+.++|.||||+++||||+|.|||.+.+...+...|++.+.
T Consensus 573 g~KT-wTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-------------- 636 (732)
T KOG0614|consen 573 GRKT-WTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-------------- 636 (732)
T ss_pred CCce-eeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--------------
Confidence 6544 46899999999999998 7799999999999999999999999999999999998887532
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESPL 659 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p~ 659 (1028)
.+.++ ..++..+.+||.++...+|..|.. +.+|..|-||....|
T Consensus 637 ---~i~~P--------------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 637 ---KIEFP--------------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ---hhhcc--------------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 11111 236678899999999999999985 899999999987655
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.39 Aligned_cols=256 Identities=30% Similarity=0.469 Sum_probs=204.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc---cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK---EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~---~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
+|.+.+.||.|+||+||++.+..++..+++|+++..... .........|+.++..++||||+++++++.. ....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 589999999999999999999988877888877643321 1222345578899999999999999887754 34789
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+||||+.+ +|.+++.........+++..+..++.||+.||.|||++||+|+||||+||+++. +.++|+|||++..+..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999986 666666554445567899999999999999999999999999999999999975 6799999999987654
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.........|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+... .++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~----------- 223 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTP----------- 223 (260)
T ss_pred CcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCC-----------
Confidence 4344445678999999999876 56888999999999999999999999876665544443321 000
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.....++..+.+||.+||..||.+||++.++++||||
T Consensus 224 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 -------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0011255678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.08 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=206.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..|..++.||+|+||.||+|.+..++..||||++...... ......+.+|+.++..++|||++++++++... ...||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEE
Confidence 3488899999999999999999999999999998754322 12233567899999999999999999988654 47899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.++|.+++. .....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 103 VMEYCLGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEeCCCCCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 99999876655543 3345688899999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 KHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.....|++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+..+......+
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 243 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT------------ 243 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC------------
Confidence 234578999999999852 2458899999999999999999999998776655555544321100
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
......+..+.+||.+||..||.+|||+.++++|+|+...
T Consensus 244 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 -------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0011245678899999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=318.68 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=197.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.+|++.+.||+|+||.||+|.+. ++..+|||++..... ....+.+|+.++..++||||+++++++.. .+.+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence 46889999999999999999886 466799999864322 22346789999999999999999888754 3578999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ ++|.+.+......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~e~~~~--~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 78 TEYMAN--GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred EecCCC--CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999976 455555544445688999999999999999999999999999999999999999999999999986643221
Q ss_pred c-ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 H-YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 ~-~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
. .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...++.+....+......+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 221 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY------------- 221 (256)
T ss_pred cccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC-------------
Confidence 1 111223457999999887 568999999999999999999 899998877766555443211000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.....+..+.+|+.+||..+|.+|||+.++++.
T Consensus 222 -------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 222 -------------------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 001246778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=328.94 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=204.7
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
|+...+||+|+||.||++.+..++..||||++..... .....+.+|+.++..+.|+||+++++++... +..|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEe
Confidence 3445779999999999999999999999998854322 2234567899999999999999999988654 58999999
Q ss_pred ccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcc
Q psy18163 444 YVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY 523 (1028)
Q Consensus 444 y~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~ 523 (1028)
|+.+ +.|.+.+. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+.......
T Consensus 98 ~~~~--~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 98 FLEG--GALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred cCCC--CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 9987 33433332 2347888999999999999999999999999999999999999999999999987665433334
Q ss_pred cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l 603 (1028)
....||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+......+..+..... ..+.
T Consensus 174 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-------~~~~-------- 237 (292)
T cd06657 174 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-------PKLK-------- 237 (292)
T ss_pred cccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-------cccC--------
Confidence 45678999999998876 5688999999999999999999999988766555444322110 0000
Q ss_pred ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 604 ~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
....++..+.+||.+||..||.+||++.++|.||||....
T Consensus 238 ---------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 238 ---------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ---------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 0012456788999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=323.11 Aligned_cols=255 Identities=19% Similarity=0.319 Sum_probs=197.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.++|++.+.||+|+||+||+|.+. .++..||+|.+...... .....+.+|+.++..+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CC
Confidence 467999999999999999999863 45678999998753321 122346689999999999999999988754 34
Q ss_pred eEEEEEecccc-chHHHHHHHh-------------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMR-------------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~-------------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~ 502 (1028)
..|+||||+.+ +|.+++..-. .....+++..+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 78999999986 5555442110 001246778889999999999999999999999999999999999
Q ss_pred CcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy18163 503 GILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRI 579 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI 579 (1028)
+.+||+|||+++...... .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999998654321 12233456778999999977 558999999999999999998 99999887765554444
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.... .+ . ....++..+.+||.+||..||.+||++.+|+++
T Consensus 240 ~~~~-~~--~-----------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQ-LL--P-----------------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCC-cC--C-----------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3210 00 0 001245678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=321.88 Aligned_cols=255 Identities=20% Similarity=0.316 Sum_probs=196.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|++.+.||+|+||+||+|.+.. ++..||||++...... .....+.+|+.++..++||||+++++++. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVS--QG 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence 4689999999999999999998752 4568999988643211 12234678999999999999999998874 34
Q ss_pred CeEEEEEecccc-chHHHHHHHhhc------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEe
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSK------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVG 508 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~ 508 (1028)
..+++||||+.+ +|.+++...... ...++...+..++.||+.||.|||+.||+|+||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 579999999985 555554432211 1234667788999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q psy18163 509 DFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 509 DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
|||++..+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL- 239 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 9999976543211 1122356788999999877 568999999999999999999 7899988776655554432110
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
+ .. ...++..+.+||.+||..||.+|||+.+++.+
T Consensus 240 ~--------------------~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 L--------------------DK-----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred C--------------------CC-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00 01245678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=335.37 Aligned_cols=286 Identities=19% Similarity=0.210 Sum_probs=199.0
Q ss_pred EEeeec--CcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEG--TYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G--~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
..||.| +||+||+|.+..+++.||||++............+.+|+.++..++||||++++++|.. .+.+|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 356666 99999999999999999999987654332233456678888888999999999998864 45799999999
Q ss_pred cc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc--
Q psy18163 446 EH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH-- 522 (1028)
Q Consensus 446 ~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~-- 522 (1028)
.+ +|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.........
T Consensus 82 ~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 82 AYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred cCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 86 5655554432 234788889999999999999999999999999999999999999999999865432211100
Q ss_pred -----ccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--CCCCCC
Q psy18163 523 -----YTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE--KIWPGF 594 (1028)
Q Consensus 523 -----~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~--~~w~~~ 594 (1028)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||........+..++......+. ..++..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0112346679999998763 34789999999999999999999999887665554444332111000 000000
Q ss_pred CCChhhhh--hc--------cccC-CCCCC-CccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 595 SKLPAVQK--MT--------FAEY-PNVGG-LKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 595 s~lp~~~~--l~--------~~~~-p~~~~-l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
........ .. .... ..... .........++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00000000 00 0000 00000 00001112356788999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=334.18 Aligned_cols=285 Identities=32% Similarity=0.573 Sum_probs=230.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----CC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----MD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~~ 436 (1028)
..+|.-+..+|.|.- .|..|.|.-+++.||+|.+..............+|..++..+.|+||+.++.+|.... ..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888899999998 8899999999999999998766544445566789999999999999999999886432 23
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+|||||..+|..++. +. +.-..+..|+.|++.|++|||+.||+||||||+||++..++.+||+|||+|+..
T Consensus 95 e~y~v~e~m~~nl~~vi~-~e-----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL-ME-----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhhhhHHHHHHH-Hh-----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 589999999988877665 22 333568999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC-
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS- 595 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s- 595 (1028)
+.. -..++.++|+.|+|||++.+.+ |...+||||+|||+.||++|...|.|.+..++..+|.+.+|.|.+.+.....
T Consensus 169 ~~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 169 DTD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred Ccc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 543 4678899999999999999965 9999999999999999999999999999999999999999999866543221
Q ss_pred -------CChhhhhhcccc-CCCCCCCccccccc-cccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 596 -------KLPAVQKMTFAE-YPNVGGLKTKVAGS-ILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 596 -------~lp~~~~l~~~~-~p~~~~l~~~~~~~-~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
..|..+...|.. +|+..- .....+. .-...+.|||.+||..||++|.+++++|+||||+
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f-~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLF-PVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccc-cccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 122222222221 222111 1111122 3345789999999999999999999999999998
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=330.44 Aligned_cols=276 Identities=22% Similarity=0.256 Sum_probs=196.0
Q ss_pred CcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecccc-chHHH
Q psy18163 374 TYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSL 452 (1028)
Q Consensus 374 ~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~g-dLgsL 452 (1028)
++|.||.++...+++.||||++............+.+|+.++..++|+||+++++++... +.+|++|||+.+ +|.++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHHHH
Confidence 556677777777999999999976533333345677899999999999999999888543 478999999985 45555
Q ss_pred HHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC-------cccc
Q psy18163 453 METMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK-------HYTP 525 (1028)
Q Consensus 453 l~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~-------~~t~ 525 (1028)
+... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+..+..... ....
T Consensus 90 l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 90 LKTH--FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence 4432 233478889999999999999999999999999999999999999999999999875532111 1233
Q ss_pred cccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh-hh
Q psy18163 526 IVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ-KM 603 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~-~l 603 (1028)
..++..|+|||++.+. ..|+.++|||||||++|+|++|..||........+...... ..... +. ....+... .+
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~-~~-~~~~~~~~~~~ 243 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRG--TVPCL-LD-KSTYPLYEDSM 243 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCccc-cc-cCchhhhcCCc
Confidence 4678899999998653 35889999999999999999999999876655443332221 11100 00 00000000 00
Q ss_pred cc----ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 604 TF----AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 604 ~~----~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.. ...+.............++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00 0000000000011122356788999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.98 Aligned_cols=287 Identities=34% Similarity=0.558 Sum_probs=225.9
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC---CeEEEEEec
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM---DKIFIVMDY 444 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~---~~l~LVmEy 444 (1028)
+-||.|+||+||.+.|..+|+.||+|.+..-...-.......+|+.+|.-++|.|++.++++....+. ..+|+|+|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 55999999999999999999999999886543332333456799999999999999999888754332 247888999
Q ss_pred cccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC-CCCcc
Q psy18163 445 VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS-PLKHY 523 (1028)
Q Consensus 445 ~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~-~~~~~ 523 (1028)
|..||..++ -..+.++...++-++.||+.||+|||+.||+||||||.|+|++.+..+||||||+|+.... ....+
T Consensus 139 mQSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 139 MQSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 876554443 3456788899999999999999999999999999999999999999999999999986543 33456
Q ss_pred cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l 603 (1028)
+..+.|.+|+|||+++|...|+.++||||+|||+.|||..+.+|...++.+++..|...+|+|..+....-..-.....+
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 77889999999999999999999999999999999999999999999999999999999999976532111100000111
Q ss_pred ccc-cCCCCCCCccccc-cccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 604 TFA-EYPNVGGLKTKVA-GSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 604 ~~~-~~p~~~~l~~~~~-~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
.-. ..|+.. ..++.. ...-...+.+++..||..||.+|++.++++.|+|+.+...
T Consensus 295 R~~~k~Ps~~-vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 295 RAGLRAPDTQ-RLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred ccCCCCCCcc-ceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 111 111111 112221 1233457889999999999999999999999999987644
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.17 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=197.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|+++++||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.++..++|+||+++++++. ..+.+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEE
Confidence 478999999999999999999975 556799998865322 2345678999999999999999988774 4457899
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++... ....++...+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999975 555544321 2345788889999999999999999999999999999999999999999999999876532
Q ss_pred CC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 LK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+...... +
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------~----- 224 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM------P----- 224 (261)
T ss_pred ceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------C-----
Confidence 21 1223345778999999876 568999999999999999998 99999887776665555332100 0
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+|||++++++
T Consensus 225 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 225 ---------------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ---------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00124567889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=324.75 Aligned_cols=260 Identities=23% Similarity=0.376 Sum_probs=217.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.++.+.+..||.|+.|+||+++.+.+|...|||.+......+. ...++..+.++.+.. +|+||+.+++|+... .++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~ 167 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVF 167 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-HHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHH
Confidence 4567788999999999999999999999999999987654432 356677788777665 899999999998765 688
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|.||.|...+..|+..+ .++++|..+-.+...++.||.||..+ ||||||+||+|||+|..|++||||||++-.+.+
T Consensus 168 IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 99999987777887776 45689988899999999999999975 799999999999999999999999999987754
Q ss_pred CCCcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGK-SDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~-sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
. ...+...|.+.|||||.|.- ...|+..+||||||+.|+||.||..||.+. .+.+.+.+|.+... |. .+
T Consensus 245 S-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~---L~--- 316 (391)
T KOG0983|consen 245 S-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PL---LP--- 316 (391)
T ss_pred c-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CC---CC---
Confidence 3 34456689999999999853 346899999999999999999999999984 68888888876321 10 00
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
. ...+++++++|+..||.+|+.+||.-.++|+|||+...
T Consensus 317 --------------~---------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 317 --------------G---------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred --------------c---------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 0 01167889999999999999999999999999999763
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.94 Aligned_cols=249 Identities=21% Similarity=0.339 Sum_probs=197.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||+|+||+||+|.+.. +..||||.+..... ....+.+|+.++..++||||+++++++.. .+.+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEE
Confidence 579999999999999999998764 44699998864422 22456789999999999999999988753 3478999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ ++|...+......+++..+..++.||+.||.|||+.||+|+||||.|||++.++.+||+|||+++.......
T Consensus 78 ~e~~~~--~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 78 TEYMSN--GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEcCCC--CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999976 344444444444688999999999999999999999999999999999999999999999999986643321
Q ss_pred -cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 -HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 -~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......+.
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 222 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR------------ 222 (256)
T ss_pred eecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC------------
Confidence 1112345678999999976 558999999999999999998 9999988776665555533211000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+..+.+||.+||..||.+|||+.+|+.+
T Consensus 223 --------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 223 --------------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred --------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 01135678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=363.84 Aligned_cols=148 Identities=29% Similarity=0.470 Sum_probs=125.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
+++|+++++||+|+||+||+|++..+++.||||+++..... ......+..|+.++..++||||+.++.++.. .+.+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 47899999999999999999999999999999999764321 1222456678999999999999999877653 45899
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
|||||+.+ +|.+++.. ...+.+..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999965 55555432 3457888999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.96 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=196.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|+++++||.|+||.||+|... ++..||+|.+..... ....+.+|+.+++.++|+||+++++++. .+.+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEE
Confidence 367999999999999999999865 567899999875432 2345678999999999999999998763 346899
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++.. .....++...+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999975 44444322 22345788899999999999999999999999999999999999999999999999876522
Q ss_pred -CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 -LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 -~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------- 223 (260)
T ss_pred CcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-----------
Confidence 112223456778999999876 568999999999999999999 999998877666555442211100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+|||+++++.
T Consensus 224 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 ---------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ---------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=337.85 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=196.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~ 435 (1028)
++|++++.||.|+||.||+|.+.. +++.||+|+++...... ....+..|+.++..+ .|+||+++++++.. ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-EYKALMTELKILIHIGHHLNVVNLLGACTK-PG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-HHHHHHHHHHHHHhhccCcchhheeeeEec-CC
Confidence 589999999999999999997543 45789999987543211 123456899999999 79999999987754 34
Q ss_pred CeEEEEEecccc-chHHHHHHHhh--------------------------------------------------------
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRS-------------------------------------------------------- 458 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~-------------------------------------------------------- 458 (1028)
..+++||||+.+ +|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 578999999986 55544432111
Q ss_pred -cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC--cccccccCccccCc
Q psy18163 459 -KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSP 535 (1028)
Q Consensus 459 -~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~AP 535 (1028)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 012578888999999999999999999999999999999999999999999999987643211 12234567789999
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCC
Q psy18163 536 ELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGL 614 (1028)
Q Consensus 536 EvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l 614 (1028)
|++.+ ..++.++|||||||+||+|++ |..||.+....+.+...+.....+
T Consensus 245 E~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------- 295 (337)
T cd05054 245 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM---------------------------- 295 (337)
T ss_pred HHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC----------------------------
Confidence 99987 569999999999999999998 999998755444333332210000
Q ss_pred ccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 615 KTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 615 ~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
......++.+.+|+.+||..+|.+|||+.++++|
T Consensus 296 ---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 ---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011245678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=318.00 Aligned_cols=243 Identities=23% Similarity=0.293 Sum_probs=192.0
Q ss_pred EeeecCcEEEEEEEE--CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 369 RIEEGTYGVVYRAKD--KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d--~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
.||+|+||.||+|.+ ..++..||||+++...........+.+|+.++..+.||||+++++++. .+..++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEecCC
Confidence 589999999999965 467889999998755433333445678999999999999999998773 346799999998
Q ss_pred cchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc---c
Q psy18163 447 HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH---Y 523 (1028)
Q Consensus 447 gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~---~ 523 (1028)
+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++..+...... .
T Consensus 79 ~--~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 L--GPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred C--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 6 344444433 345889999999999999999999999999999999999999999999999999876543221 1
Q ss_pred cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
....++..|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+.+... +
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~---------------- 217 (257)
T cd05116 156 THGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M---------------- 217 (257)
T ss_pred CCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C----------------
Confidence 22344678999999866 568899999999999999998 9999988777665555432110 0
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.. ...++..+.+||.+||..||..||++.+|..
T Consensus 218 ----~~-----------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 ----EC-----------PQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ----CC-----------CCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 00 0125678899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.70 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=195.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|+++++||.|+||.||+|.+. .+..||+|.+..... ....+.+|+.++++++|+||+++++++. ...+|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEE
Confidence 467999999999999999999876 556799999875432 2345678999999999999999988763 346899
Q ss_pred EEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ ++|.+.+... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 78 v~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 78 VTEYMSK--GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEecCC--CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999976 3444433332 345788899999999999999999999999999999999999999999999999876432
Q ss_pred CC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 LK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 223 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP----------- 223 (260)
T ss_pred ccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 21 1122345678999999876 568999999999999999999 899998877666665543211000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+..+.+||.+||..||.+|||+.+++.
T Consensus 224 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 224 ---------------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ---------------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00124567889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.36 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=198.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEE-----CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d-----~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.+|.+.+.||.|+||+||++.+ ..++..||+|.+..... .....+.+|+.++.+++||||+++++++.. .+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 5799999999999999999986 34567799998865421 123356789999999999999999988854 45
Q ss_pred eEEEEEecccc-chHHHHHHHh---------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEE
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMR---------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILK 506 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~---------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lK 506 (1028)
.+|+||||+.+ +|.+++.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 89999999975 5554443221 1123488899999999999999999999999999999999999999999
Q ss_pred EeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q psy18163 507 VGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTM 583 (1028)
Q Consensus 507 L~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~l 583 (1028)
|+|||++..+..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986543211 1223455788999999977 568999999999999999998 999998887766665554321
Q ss_pred CCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 584 g~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
... ....++..+.+||.+||..||.+|||+.+++.
T Consensus 240 ~~~--------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQ--------------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCC--------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 00124567889999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.47 Aligned_cols=255 Identities=20% Similarity=0.312 Sum_probs=198.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... .....+.+|+.++..++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIVRLIGVSFER-- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence 4679999999999999999999987 7889999988644321 1234567899999999999999999877543
Q ss_pred CeEEEEEecccc-chHHHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC---cEEEe
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRS---KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG---ILKVG 508 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~---~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g---~lKL~ 508 (1028)
...++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||+++|+|+||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 468999999965 66666654321 112478889999999999999999999999999999999998654 69999
Q ss_pred ccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q psy18163 509 DFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 509 DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
|||+++.+..... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 9999986632211 1112234567999999977 569999999999999999997 99999887766544433221 00
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
+ .. ...++..+.+||.+||..||.+|||+.++|+|
T Consensus 240 ~--------------------~~-----------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L--------------------DP-----------PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C--------------------CC-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00 01245678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=323.46 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=198.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCC-----eEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTD-----EIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg-----~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
.++|++.+.||+|+||.||++.+.... ..||+|.+....... ....+.+|+.++..+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 468999999999999999999986443 789999987543221 223467899999999 79999999988754
Q ss_pred CCeEEEEEecccc-chHHHHHHHh------------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMR------------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~------------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~ 501 (1028)
...+++||||+.+ +|..++.... .....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 3479999999976 5555543211 22345788899999999999999999999999999999999999
Q ss_pred CCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy18163 502 RGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSR 578 (1028)
Q Consensus 502 ~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~k 578 (1028)
++.+||+|||+++.+..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 99999999999987653211 1122345678999999876 568999999999999999997 9999988776555444
Q ss_pred HHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 579 I~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
+..... + . .....+..+.+||.+||..||.+|||+.+++++
T Consensus 247 ~~~~~~------~---------------~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYR------M---------------E-----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCc------C---------------C-----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 322100 0 0 001245678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.79 Aligned_cols=262 Identities=25% Similarity=0.417 Sum_probs=202.6
Q ss_pred CeEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccc--cCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCC
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEK--EGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~--~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~ 436 (1028)
+|++.+.||.|+||.||+|.+. .+|..||+|+++..... ......+.+|+.+|..+ +|+||+.+++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4899999999999999999885 47899999999764321 12223456799999999 59999999877753 35
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+||||+.+ ++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+
T Consensus 79 ~~~lv~e~~~~--~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 79 KLHLILDYING--GELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred eEEEEEecCCC--CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 78999999986 5566555443 45788899999999999999999999999999999999999999999999999866
Q ss_pred CCCC-CcccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 517 GSPL-KHYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 517 ~~~~-~~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.... ......+|+..|+|||++.+. ..++.++|||||||++|+|++|..||...........+.........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 229 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------ 229 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC------
Confidence 4321 122345789999999998652 34788999999999999999999999754332222222221100000
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
.+ ...++..+.+||.+||..||.+|| ++.+++.||||....
T Consensus 230 ------------~~-----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 230 ------------PY-----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ------------CC-----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 00 112567788999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.59 Aligned_cols=261 Identities=19% Similarity=0.289 Sum_probs=200.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCC----------------eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCee
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTD----------------EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIV 424 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg----------------~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV 424 (1028)
..+|++++.||+|+||.||+|.+..++ ..||+|++...... .....+.+|+.++..+.||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEe
Confidence 357999999999999999999886544 56899998765332 2234566899999999999999
Q ss_pred EEEEEEeecCCCeEEEEEecccc-chHHHHHHHhh-------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccc
Q psy18163 425 TVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRS-------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSN 496 (1028)
Q Consensus 425 ~L~~i~~~~~~~~l~LVmEy~~g-dLgsLl~~l~~-------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeN 496 (1028)
++++++... +.+++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+|+||||+|
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999887543 589999999975 55555443221 11257889999999999999999999999999999999
Q ss_pred eeecCCCcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCh
Q psy18163 497 LLLSHRGILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC--MEPLFTGKSD 572 (1028)
Q Consensus 497 ILLd~~g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT--G~pPF~g~sd 572 (1028)
||++.++.++|+|||+++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999998654321 11223456788999999877 568999999999999999998 7789988776
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 573 LEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 573 ~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.+.+..+...+........ . .....++..+.+||.+||..||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~----------------~---------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIY----------------L---------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcccccccccc----------------C---------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6665555432111100000 0 001225578899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=353.89 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=209.6
Q ss_pred EEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCC--ccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 365 KCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF--PITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 365 ~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~--~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
++...||+|+|-+||+|.|..+|..||.-.++........ ...+..|+.+|+.|+||||+++|.+++......+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 5567899999999999999999999998777655433322 25778999999999999999999999887777899999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeec-CCCcEEEeccCCccccCCC
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLS-HRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd-~~g~lKL~DFGlAr~~~~~ 519 (1028)
|++.. |.|..+.+. .+.+....++.|++||+.||.|||++. |||||||.+||+|+ +.|.|||+|+|||+....
T Consensus 123 EL~TS--GtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~- 198 (632)
T KOG0584|consen 123 ELFTS--GTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK- 198 (632)
T ss_pred ecccC--CcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc-
Confidence 99975 555554433 344677889999999999999999997 99999999999998 569999999999998764
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......+|||.|||||++.. .|+..+||||||++++||+|+.+||.......++.+-+.. |..+
T Consensus 199 -s~aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP------------ 262 (632)
T KOG0584|consen 199 -SHAKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKP------------ 262 (632)
T ss_pred -cccceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCH------------
Confidence 34556899999999999874 6999999999999999999999999877665554443321 1111
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
..+...-.+.+++||.+||.. ...|+|+.|||.||||....
T Consensus 263 -----------------~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 263 -----------------AALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred -----------------HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 111122357889999999999 99999999999999998753
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.22 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=196.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||.|+||.||+|.+.. +..||||.++.... ....+.+|+.++..++||||+++++++.. .+.+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeee
Confidence 3679999999999999999999764 56799999875432 23456789999999999999999987754 347899
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++... ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 79 VTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999954 554444321 1245788999999999999999999999999999999999999999999999999877532
Q ss_pred CCc-ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 LKH-YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~~~-~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
... ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+......+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 224 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP----------- 224 (261)
T ss_pred cccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 211 111223457999999877 568999999999999999999 999998877666555543211000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+||++.+++.
T Consensus 225 ---------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 225 ---------------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 00124567889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.04 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=195.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++.++||+|+||.||+|.+..++ .||||+++.... ....+.+|+.++..+.||||+++++++. ....|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEEE
Confidence 57999999999999999999987664 599999975332 2235678999999999999999988763 3468999
Q ss_pred EeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ ++|.+.+... ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++..+....
T Consensus 79 ~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 79 TEYMSK--GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEcCCC--CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999986 3444444332 3357888899999999999999999999999999999999999999999999998664322
Q ss_pred Cc-ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 KH-YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~~-~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+......+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------ 223 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------ 223 (262)
T ss_pred cccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC------------
Confidence 11 123346678999998876 568999999999999999999 889998877666555443211000
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+|||+.+++.
T Consensus 224 --------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 --------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred --------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01124567889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.54 Aligned_cols=254 Identities=21% Similarity=0.324 Sum_probs=198.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC-----CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT-----DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t-----g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|++.+.||.|+||.||+|.+... +..||+|.+..... ......+.+|+.+|..+.||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 46899999999999999999998644 47899999864421 11233567899999999999999999988543
Q ss_pred CeEEEEEecccc-chHHHHHHHhh------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEe
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRS------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVG 508 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~ 508 (1028)
..+|+||||+.+ +|.+++..... ....+.+..+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 579999999974 66666543221 12236778899999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q psy18163 509 DFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 509 DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
|||+++.+.... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CC
Confidence 999998654321 12234467889999999876 568999999999999999998 99999887766655444311 00
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+ .. ....+..+.+||.+||..||.+|||+.+++.
T Consensus 240 ~--------------------~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 L--------------------DL-----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C--------------------CC-----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00 0113567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.27 Aligned_cols=251 Identities=20% Similarity=0.240 Sum_probs=193.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeE----EEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEI----VALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~----VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.++|++++.||.|+||+||+|.+..++.. |++|.+..... ......+..|+.++..+.||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---~~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICP---GA 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEEC---CC
Confidence 36799999999999999999999877764 66666643211 111234456777888999999999998873 34
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
..++|+||+.+ ++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~~i~e~~~~--gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 82 SLQLVTQLSPL--GSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred ccEEEEEeCCC--CcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 57899999975 5555555555567899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 517 GSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 517 ~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
..... ..+...++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....... .++.....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~------ 231 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLA------ 231 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCC------
Confidence 43221 2334567788999999977 568999999999999999998 99999887654432 2322110000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....+..+.+|+.+||..||.+|||+.++++
T Consensus 232 --------------~-----------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 --------------Q-----------PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred --------------C-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 0113456789999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.53 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=193.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCe--EEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDE--IVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~--~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l 438 (1028)
++|++.+.||.|+||.||+|.+..++. .+++|.++.... ......+.+|+.++.++ .||||+++++++.. .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 579999999999999999999987764 478888764221 11223467899999998 79999999988754 3479
Q ss_pred EEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcE
Q psy18163 439 FIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGIL 505 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~l 505 (1028)
|+||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999975 44444432110 11247788999999999999999999999999999999999999999
Q ss_pred EEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q psy18163 506 KVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMG 584 (1028)
Q Consensus 506 KL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg 584 (1028)
||+|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 159 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 159 KIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred EECCcCCCccccceec-cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999999864322111 111233567999999876 568999999999999999997 9999988776655544422110
Q ss_pred CCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 585 TPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. .....++..+.+||.+||..||.+|||++++++.
T Consensus 237 ~--------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 M--------------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C--------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0011256778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=323.53 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=197.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC-----CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT-----DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t-----g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..+|++++.||.|+||+||+|.+..+ +..||||+++..... .....+.+|+.++..++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-- 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-PLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-- 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence 35688899999999999999987643 578999999754321 1223456789999999999999999888544
Q ss_pred CeEEEEEecccc-chHHHHHHH------------hhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETM------------RSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l------------~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~ 502 (1028)
..+++++||+.+ +|.+++..- ......+.+..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 478999999975 444444210 0112347788899999999999999999999999999999999999
Q ss_pred CcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy18163 503 GILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRI 579 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI 579 (1028)
+.+||+|||+++...... .......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999988654321 11233456789999999876 458999999999999999998 88999887776666555
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
......+ ....++..+.+|+.+||..||.+||++.+++..
T Consensus 240 ~~~~~~~--------------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLP--------------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCC--------------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 4321100 011245678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.46 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=197.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCC---eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTD---EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg---~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
.+|++.+.||.|+||.||+|.+..++ ..||+|.++..... .....+.+|+.++..++||||+++++++.. .+.+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcc
Confidence 57999999999999999999986444 37999998654321 123456789999999999999999988754 4579
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+||||+.+ ++|...+......+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~lv~e~~~~--~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 81 MIVTEYMEN--GSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEEcCCC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999976 344444444445688899999999999999999999999999999999999999999999999987654
Q ss_pred CCCcc---cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 519 PLKHY---TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 519 ~~~~~---t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
..... ....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||......+....+......+
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 229 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP-------- 229 (267)
T ss_pred ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC--------
Confidence 32211 12233568999999987 568999999999999999886 999998876655555443221100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ...++..+.+|+.+||..+|.+|||+.++++
T Consensus 230 ---------------~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 ---------------A---------PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---------------C---------CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0 0124567889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.50 Aligned_cols=243 Identities=23% Similarity=0.304 Sum_probs=191.1
Q ss_pred EEeeecCcEEEEEEEECCCC---eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEec
Q psy18163 368 NRIEEGTYGVVYRAKDKRTD---EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDY 444 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg---~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy 444 (1028)
++||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.++..+.|+||+++++++. .+.+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEe
Confidence 36999999999999876555 78999998765432 23345678999999999999999998774 3468999999
Q ss_pred cccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccc
Q psy18163 445 VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT 524 (1028)
Q Consensus 445 ~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t 524 (1028)
+.+ ++|.+.+.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||+++.+......+.
T Consensus 77 ~~~--~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APL--GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCC--CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 975 44555444333 678899999999999999999999999999999999999999999999999987654332221
Q ss_pred ---ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 525 ---PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 525 ---~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.... +.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~~------------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--RL------------- 217 (257)
T ss_pred cccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--cC-------------
Confidence 1223467999999877 568999999999999999998 999998877655444432210 00
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....++..+.+||.+||..||.+|||+.+++.
T Consensus 218 ------~-----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 218 ------P-----------RPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------C-----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 01124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=312.84 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=195.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++...||.|+||.||+|.+..+. .||||.+.... .....+.+|+.++..+.|+||+++++++. .+..|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEE
Confidence 57999999999999999999987654 59999876432 12345678999999999999999988763 3468999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ +|.+++.. .....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 79 TEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999986 55544432 123347888899999999999999999999999999999999999999999999998664322
Q ss_pred -CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 -KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 -~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+..+.+....+..... ..
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~--------- 223 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---MP--------- 223 (260)
T ss_pred ccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CC---------
Confidence 11223346778999998876 568999999999999999999 8999988777665555432110 00
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+||++.++++
T Consensus 224 --------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 224 --------------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred --------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00124567889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.75 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=198.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCe---EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~---~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|+..+.||+|+||.||+|.+..++. .||||.++..... .....+..|+.++..+.||||+++.+++. ..+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNIIRLEGVVT--KFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCCCeeEEEEEEc--cCCC
Confidence 3579999999999999999999876554 7999998654221 12345678999999999999999998875 3457
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|+||||+.+ ++|...+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMEN--GALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 8999999986 34444444445568889999999999999999999999999999999999999999999999997664
Q ss_pred CCCCc-cc--ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPLKH-YT--PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~~~-~t--~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
..... .+ ....+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~------ 231 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA------ 231 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC------
Confidence 32111 11 1223457999999877 568999999999999999997 9999988777666655543211000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
...++..+.+|+.+||..||..||++.++++
T Consensus 232 --------------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 --------------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred --------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0114567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=342.97 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=205.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.+++++.||+|.||.||+|.+..+ ..||+|.++.... ....+++|+++|++|+|+|||+|++++..+. .+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEE
Confidence 4567789999999999999999743 3699999986532 2346779999999999999999999996543 79999
Q ss_pred EeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||.. |+|++.++. .+..+...+...++.||+.|++||.++++|||||-..||||+.+..+||+|||||+.+.+.
T Consensus 280 tE~m~~--GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~- 356 (468)
T KOG0197|consen 280 TEYMPK--GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD- 356 (468)
T ss_pred EEeccc--CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-
Confidence 999986 788888876 5667888899999999999999999999999999999999999999999999999965542
Q ss_pred Cccccccc---CccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 521 KHYTPIVV---TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 521 ~~~t~~vG---T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.++...| ..-|.|||.+.. ..++.++|||||||+||||+| |+.||.+.+..+.+..+-+...-|.+
T Consensus 357 -~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P-------- 426 (468)
T KOG0197|consen 357 -EYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP-------- 426 (468)
T ss_pred -ceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC--------
Confidence 2333233 456999999987 459999999999999999998 88999999999998888654322211
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
..+++.+.+|+..|+..+|++|||++.+..
T Consensus 427 ------------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 427 ------------------------EGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred ------------------------CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 125678889999999999999999997653
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=310.18 Aligned_cols=249 Identities=21% Similarity=0.341 Sum_probs=198.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.+|++.+.||.|+||.||+|.+. .+..+|+|.+..... ....+.+|+.+++.+.||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEE
Confidence 57999999999999999999886 467899998865432 12356789999999999999999888754 3478999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+ +.|...+......+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 78 FEFMEH--GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EEcCCC--CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999986 445555554455678889999999999999999999999999999999999999999999999986643211
Q ss_pred -cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 -HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 -~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||........+..+......
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 220 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL-------------- 220 (256)
T ss_pred cccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC--------------
Confidence 1122345678999999876 568999999999999999998 99999887766555544221000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
......+..+.+|+.+||..||.+|||+.+++++
T Consensus 221 ------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 221 ------------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0011245778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.65 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=213.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchH-HHHHHHHH-cCCCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLK-AQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~l-rEi~iL~~-l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.+.+|.++..||.|+|++|.+++++.|.+.||+|+++++..+.+...... .|-.+..+ .+||.+|-|+..|. +...
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq--tesr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ--TESR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc--ccce
Confidence 45789999999999999999999999999999999998876554433333 34444443 46999999988774 4458
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|+|.||+.| ++|+..+.... .++++.++.|...|+.||.|||+.|||+||||.+|+||+..|++||+|+|+++.--
T Consensus 326 lffvieyv~g--gdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNG--GDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecC--cceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999998 88888876544 58999999999999999999999999999999999999999999999999999776
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHHHhcCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG-------KSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g-------~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
.+.....++||||.|+|||+|.| ..|+.++|||+|||+++||+.|+.||+- .+..+.+.+++-.-.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------ 475 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------ 475 (593)
T ss_pred CCCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc------
Confidence 66667778999999999999998 6799999999999999999999999953 122233333221100
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC------CHHHHHhCCCCCCCCC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI------TADEALRHDYFSESPL 659 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP------TA~ElL~HPfF~e~p~ 659 (1028)
-.....++-.+..+|...|.+||..|. ...++..|+||+...|
T Consensus 476 --------------------------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 476 --------------------------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred --------------------------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 001112455567899999999999997 5789999999997654
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=311.96 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=194.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..+|++.+.||+|+||.||++... +..||+|.++... ....+.+|+.++..++|+||+++++++.. ....+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEE
Confidence 467999999999999999999875 7789999986432 23456789999999999999999987643 3457899
Q ss_pred EEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ ++|...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 78 VTEYMAK--GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEECCCC--CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999986 3444444433 234788889999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+..... .
T Consensus 156 ~---~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~---------- 218 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---M---------- 218 (256)
T ss_pred C---CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---C----------
Confidence 1 23345678999999876 568999999999999999997 9999987665554444322100 0
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 219 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 -------------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001225677889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=324.68 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=204.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..|..++.||.|+||.||+|++..++..||||.+...... ......+.+|+.+++.++|+|++++++++... ...++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEE
Confidence 4588889999999999999999999999999998653221 12223466899999999999999999988654 47899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+++.+++. .....+.+..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++......
T Consensus 93 v~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 93 VMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEccCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99999876555443 33455888999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 KHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
....+|+.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+.+..+..... +
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~------------ 232 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P------------ 232 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C------------
Confidence 34578899999999853 24578899999999999999999999977655444433322100 0
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
. .....++..+.+||.+||..+|.+||++.+++.||||...
T Consensus 233 -----------~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 -----------A-------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -----------C-------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0 0011255678899999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.47 Aligned_cols=243 Identities=23% Similarity=0.277 Sum_probs=191.2
Q ss_pred EeeecCcEEEEEEEEC--CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 369 RIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~--~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
.||+|+||.||+|.+. .++..||+|++..... ......+.+|+.+++.++||||+++++++. ...+++||||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCC
Confidence 3899999999999775 4566799999875432 222345678999999999999999998873 346899999997
Q ss_pred cchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc---c
Q psy18163 447 HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH---Y 523 (1028)
Q Consensus 447 gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~---~ 523 (1028)
+ ++|...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...... .
T Consensus 78 ~--~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 78 G--GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred C--CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 6 4455555444556899999999999999999999999999999999999999999999999999865433221 1
Q ss_pred cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
+...++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+.... .+
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------- 217 (257)
T cd05115 156 SAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RL---------------- 217 (257)
T ss_pred CCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CC----------------
Confidence 12233578999999876 568999999999999999996 999998877766554443210 00
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
......++.+.+||.+||..||.+||++.++++
T Consensus 218 ---------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 218 ---------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001124678889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=310.45 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=198.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|.+.+.||.|+||+||+|.+. .+..||||.+..... ....+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEE
Confidence 478999999999999999999976 457799999875432 23456789999999999999999888753 357899
Q ss_pred EEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ ++|.+.+... ...++...+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 79 v~e~~~~--~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 79 VTEYMSK--GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEeccCC--CCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999976 3444444333 245788999999999999999999999999999999999999999999999999876532
Q ss_pred CC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 LK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+....+..+......+.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 225 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---------- 225 (261)
T ss_pred hhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 11 1112234568999999986 568999999999999999998 9999988877766666543211100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....+..+.+||.+||..||.+||++.+++.
T Consensus 226 ----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 226 ----------------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0113467889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.80 Aligned_cols=246 Identities=30% Similarity=0.466 Sum_probs=198.8
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccccc
Q psy18163 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD 448 (1028)
Q Consensus 370 LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~gd 448 (1028)
||.|+||.||++.+..+++.||+|++....... .....+..|+.+++.+.|+||+++++++. ....+|+||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~- 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPG- 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCC-
Confidence 799999999999999899999999987654322 12345678999999999999999987764 45589999999954
Q ss_pred hHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccccccc
Q psy18163 449 MKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV 528 (1028)
Q Consensus 449 LgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vG 528 (1028)
++|.+.+... ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++..............+
T Consensus 78 -~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 78 -GELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred -CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 3344443332 35788999999999999999999999999999999999999999999999999876543233455678
Q ss_pred CccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccC
Q psy18163 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEY 608 (1028)
Q Consensus 529 T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~ 608 (1028)
+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+... .+
T Consensus 156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------------------- 210 (250)
T cd05123 156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PL---------------------- 210 (250)
T ss_pred CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CC----------------------
Confidence 999999999877 45788999999999999999999999877664444444320 00
Q ss_pred CCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH---HHHHhCCCC
Q psy18163 609 PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA---DEALRHDYF 654 (1028)
Q Consensus 609 p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA---~ElL~HPfF 654 (1028)
.....++..+.+||.+||..||..|||+ .++++||||
T Consensus 211 ---------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 ---------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0011245678899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.43 Aligned_cols=254 Identities=21% Similarity=0.299 Sum_probs=193.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeE--EEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEI--VALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~--VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|++.+.||.|+||.||+|.+..++.. +|+|.++.... ......+.+|+.++.++ .|+||+++++++.. .+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC-HHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence 46899999999999999999999877754 57776653221 12233556799999999 89999999998754 457
Q ss_pred EEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI 504 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~ 504 (1028)
+|+||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 9999999975 55555432210 1235788899999999999999999999999999999999999999
Q ss_pred EEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q psy18163 505 LKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTM 583 (1028)
Q Consensus 505 lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~l 583 (1028)
+||+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|+| |.+||.+.+..+....+....
T Consensus 163 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred EEeCccccCcccchhh-hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9999999986432111 1112234667999998876 568999999999999999998 999998776554443321100
Q ss_pred CCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 584 g~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.+. ....++..+.+||.+||..||.+|||+.++|.+
T Consensus 241 ------~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 ------RLE--------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ------cCC--------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 001145678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=315.53 Aligned_cols=267 Identities=22% Similarity=0.330 Sum_probs=194.1
Q ss_pred CCeEEEEEeeecCcEEEEEEE----ECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~----d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.+|++++.||+|+||.||+|. +..++..||||.+..... .....+.+|+.++..++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 479999999999999999997 456788999999865432 12235678999999999999999999876656667
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+++||||+.+ ++|...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~--~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPY--GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCC--CCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999975 34444443334457888999999999999999999999999999999999999999999999998764
Q ss_pred CCCCc---ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 518 SPLKH---YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 518 ~~~~~---~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|..++..... ..+.. .+.... +.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~----~~~~~~----~~ 229 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRM----MGNDKQ----GQ 229 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhh----cccccc----cc
Confidence 32211 112233456999999977 5689999999999999999999877644321 11111 110000 00
Q ss_pred CCChhhhh-hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 595 SKLPAVQK-MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 595 s~lp~~~~-l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
........ +..... ......++..+.+||.+||..||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 230 MIVYHLIELLKNNGR--------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cchHHHHHHHhcCCc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000000 000000 0011235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=321.19 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=197.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEE-----CCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeec
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGS 433 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d-----~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~ 433 (1028)
..++|.+.+.||+|+||.||+|.+ ..++..||||+++.... ......+.+|+.++.++ +||||+++++++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 346899999999999999999986 34566899999875432 11223567899999999 799999999887544
Q ss_pred CCCeEEEEEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCC
Q psy18163 434 NMDKIFIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512 (1028)
Q Consensus 434 ~~~~l~LVmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGl 512 (1028)
+.+|+||||+.+ ++|...+... ...+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+
T Consensus 112 --~~~~lv~e~~~~--~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 --GPILVITEYCCY--GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred --CceEEEEEcCCC--CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 479999999975 4444444332 23478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 513 AREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 513 Ar~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
+..+..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+.........+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--- 263 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--- 263 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC---
Confidence 986643221 1122345788999999877 558999999999999999998 999998766554444433210000
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
......+..+.+||.+||..||.+|||+.+++.
T Consensus 264 ----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 ----------------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 001124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=321.55 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=194.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC-------CCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEee
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR-------TDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVG 432 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~-------tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~ 432 (1028)
.++|.+.+.||+|+||.||+|.+.. +...||+|.++.... ......+.+|+.++..+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3689999999999999999998753 235799999975432 11234567899999999 79999999988754
Q ss_pred cCCCeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee
Q psy18163 433 SNMDKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499 (1028)
Q Consensus 433 ~~~~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL 499 (1028)
. +.+|+||||+.+ +|.+++..... ....++..++..++.||+.||.|||++||+||||||+|||+
T Consensus 96 ~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 96 D--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 3 479999999986 55544432111 11247788899999999999999999999999999999999
Q ss_pred cCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy18163 500 SHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQL 576 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l 576 (1028)
+.++.+||+|||++..+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 9999999999999976543211 1112234568999999987 568999999999999999998 88999876654433
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
..+... .. + . ....++..+.+||.+||..+|.+|||+.+++.+
T Consensus 253 ~~~~~~--~~----~---------------~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEG--HR----M---------------D-----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcC--CC----C---------------C-----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 333211 00 0 0 011245778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=315.74 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=199.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCe----EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDE----IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~----~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
..+|++++.||+|+||+||+|.+..++. .||+|.+..... ......+.+|+.++..+.||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 3679999999999999999999876665 689998865532 1123456789999999999999999998865 5
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
..++||||+.+ ++|.+.+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~~v~e~~~~--g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 82 QVQLITQLMPL--GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ceEEEEecCCC--CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 78999999976 5666666655556899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCccc--ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 517 GSPLKHYT--PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 517 ~~~~~~~t--~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
........ ...++..|+|||.+.. ..++.++|||||||++|+|++ |.+||.+....+....+.... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~------ 231 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLP------ 231 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CCC------
Confidence 53322221 1223567999999876 568999999999999999998 999998877655444433210 000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+..+.++|.+||..||..|||+.++++
T Consensus 232 -------------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 232 -------------------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00113456789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=331.02 Aligned_cols=257 Identities=22% Similarity=0.345 Sum_probs=193.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEE-----CCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d-----~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
.++|++.+.||.|+||+||+|.+ ..+++.||||+++..... .....+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 36899999999999999999985 356789999999754321 1234567899999999 689999999877543
Q ss_pred CCeEEEEEecccc-chHHHHHHHhh-------------------------------------------------------
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRS------------------------------------------------------- 458 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~------------------------------------------------------- 458 (1028)
...+++|||||.+ +|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 3478999999986 45444432110
Q ss_pred --------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC--ccccccc
Q psy18163 459 --------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK--HYTPIVV 528 (1028)
Q Consensus 459 --------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~--~~t~~vG 528 (1028)
....++...+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++..+..... ......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 012356778889999999999999999999999999999999999999999999986533211 1122345
Q ss_pred CccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcccc
Q psy18163 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAE 607 (1028)
Q Consensus 529 T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~ 607 (1028)
+..|+|||++.+ ..++.++|||||||++|+|++ |..||........+...+.....+ .
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------~ 302 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------R 302 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC--------------------C
Confidence 678999999877 568999999999999999997 999997754333222222110000 0
Q ss_pred CCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 608 YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 608 ~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. ...+++.+.+++..||..||.+|||+.+|++|
T Consensus 303 ~-----------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 A-----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred C-----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 01145678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=361.13 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=197.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++|+++++||+|+||.||+|.+..+++.||||++...... ......+.+|+.++..++||||+++++++.. .+.+|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 6799999999999999999999999999999999754322 1223456789999999999999999988754 458999
Q ss_pred EEecccc-chHHHHHHHhhc-------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSK-------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~-------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGl 512 (1028)
||||+.+ +|.+++...... ...++...+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999986 666666543221 12244567788999999999999999999999999999999999999999999
Q ss_pred ccccCCC------------------CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy18163 513 AREYGSP------------------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE 574 (1028)
Q Consensus 513 Ar~~~~~------------------~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d 574 (1028)
++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|+||.+||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9865211 011123579999999999987 568999999999999999999999998754432
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 575 QLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 575 ~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.... .....+.. . . ....+++.+.+++.+||..||.+|++..+.|.+
T Consensus 239 i~~~--~~i~~P~~--~--------------~------------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYR--DVILSPIE--V--------------A------------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhh--hhccChhh--c--------------c------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2211 00000000 0 0 001256778899999999999999877666544
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=316.37 Aligned_cols=266 Identities=22% Similarity=0.257 Sum_probs=194.7
Q ss_pred CCe-EEEEEeeecCcEEEEEEE----ECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 362 EEF-KCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 362 d~Y-~il~~LG~G~FG~Vyla~----d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
++| ++++.||+|+||+||++. ...++..||+|+++.... ......+.+|+.+|..++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 455 999999999999998865 345788999999975432 11234567899999999999999999987665556
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+++||||+.+ ++|.+.+.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+
T Consensus 82 ~~~lv~e~~~~--~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 82 GLQLIMEYVPL--GSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred eEEEEecCCCC--CCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 78999999976 445444433 24899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCc---ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 517 GSPLKH---YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 517 ~~~~~~---~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..+.... .. .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~---~~-~~~~ 230 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPK---QG-QMTV 230 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhccc---cc-ccch
Confidence 432211 122345677999999876 56899999999999999999999998654321 11111100 00 0000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
........... . ......++..+.+|+.+||..||..|||+.+++.
T Consensus 231 ----~~~~~~~~~~~------~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 231 ----VRLIELLERGM------R-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ----hhhhhhhhcCC------C-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000000000 0 0011235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.53 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=204.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec---CCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS---NMD 436 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~---~~~ 436 (1028)
..++|++.++||+|||+-||+++...++..||+|.+..... ......++|++..++++||||++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 45789999999999999999999999999999999976652 2345678999999999999999997765422 334
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecCCCcEEEeccCCc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSHRGILKVGDFGLA 513 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~~g~lKL~DFGlA 513 (1028)
..||+++|... +|.+.++.+..++..+++.++..|+.+|+.||++||+.. ++||||||.|||+...+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 68999999874 577777777777778999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC---------CCcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q psy18163 514 REYGSP---------LKHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT 582 (1028)
Q Consensus 514 r~~~~~---------~~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~ 582 (1028)
+...-. .........|..|+|||++.- ....+.++|||||||+||.|+.|..||.. ++..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------Hhhc
Confidence 754211 112233456889999998742 13468899999999999999999999953 2221
Q ss_pred cCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.|...--+..+ .+.+ |. ...+++.+..||..||++||.+||++.++|.+
T Consensus 248 GgSlaLAv~n~--------q~s~---P~---------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLALAVQNA--------QISI---PN---------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEEeeecc--------cccc---CC---------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11100000000 0011 11 12378889999999999999999999999975
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=312.15 Aligned_cols=254 Identities=26% Similarity=0.464 Sum_probs=203.8
Q ss_pred CeEEEEEeeecCcEEEEEEEECC-CCeEEEEEEeecccccc--------CCccchHHHHHHHHH-cCCCCeeEEEEEEee
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKR-TDEIVALKRLKMEKEKE--------GFPITSLREINTLLK-AQHPNIVTVREIVVG 432 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~-tg~~VAIKvlk~~~~~~--------~~~~~~lrEi~iL~~-l~HPNIV~L~~i~~~ 432 (1028)
.|++.+.||+|+||.||+|.+.. ++..||+|.+....... .....+..|+.++.+ +.||||+.+++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 78899999986543211 112335568887765 789999999998854
Q ss_pred cCCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEecc
Q psy18163 433 SNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDF 510 (1028)
Q Consensus 433 ~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DF 510 (1028)
.+.+|+||||+.+ +|.+++..+......+++..++.++.||+.||.|||+ .+|+|+||||.|||++.++.++|+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 4589999999975 7777777666666678999999999999999999996 68999999999999999999999999
Q ss_pred CCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 511 GLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 511 GlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
|++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+......+.
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 233 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--- 233 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC---
Confidence 9998765432 4456678999999999987 5689999999999999999999999987766554444433211000
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++..+.+||.+||..||.+||++.++..+
T Consensus 234 ----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 ----------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ----------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 001245678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=310.43 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=195.4
Q ss_pred EEeeecCcEEEEEEEECC-CC--eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEec
Q psy18163 368 NRIEEGTYGVVYRAKDKR-TD--EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDY 444 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~-tg--~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy 444 (1028)
+.||.|+||.||+|.+.. .+ ..||||++...... .....+.+|+.++.+++||||+++++++.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999999865 33 36999999765543 334466789999999999999999998865 589999999
Q ss_pred cccchHHHHHHHhhcC-CcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc-
Q psy18163 445 VEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH- 522 (1028)
Q Consensus 445 ~~gdLgsLl~~l~~~~-~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~- 522 (1028)
+.+ ++|...+.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+......
T Consensus 77 ~~~--~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 77 APL--GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred cCC--CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 975 45555554443 46788999999999999999999999999999999999999999999999999876543221
Q ss_pred --ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 523 --YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 523 --~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+..... .+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----~~~------- 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-----RLE------- 221 (257)
T ss_pred ecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----cCC-------
Confidence 123457788999999876 568999999999999999998 9999988777766555543100 000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..+|.+|||+.++++
T Consensus 222 -------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 222 -------------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -------------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=309.05 Aligned_cols=244 Identities=27% Similarity=0.397 Sum_probs=192.2
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecccc
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH 447 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~g 447 (1028)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+.+++.+.|+||+.+++++... ...++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence 369999999999999987 999999998765432 2234567899999999999999999887543 478999999976
Q ss_pred chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcc--cc
Q psy18163 448 DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY--TP 525 (1028)
Q Consensus 448 dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~--t~ 525 (1028)
++|...+......++...+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......... ..
T Consensus 77 --~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 77 --GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred --CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 45555555545567888899999999999999999999999999999999999999999999998654221111 11
Q ss_pred cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhc
Q psy18163 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604 (1028)
Q Consensus 526 ~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~ 604 (1028)
..++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+......+
T Consensus 155 ~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~------------------ 215 (251)
T cd05041 155 KQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP------------------ 215 (251)
T ss_pred CcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC------------------
Confidence 233567999999877 568999999999999999999 889998776544443332110000
Q ss_pred cccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 605 ~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..+|.+|||+.++|+
T Consensus 216 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 216 --------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 01124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=317.84 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=197.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..+|.+.+.||.|+||.||+|.+. .++..|++|.+...... ....+.+|+.++..++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREAELLTNLQHEHIVKFYGVCGD--G 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH--HHHHHHHHHHHHhcCCCCCcceEEEEEcc--C
Confidence 357999999999999999999864 34567999988644321 12346789999999999999999998854 4
Q ss_pred CeEEEEEecccc-chHHHHHHHh------------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMR------------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~------------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~ 502 (1028)
+.+++||||+.+ +|.+++.... .....+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 579999999975 5554443211 012347888999999999999999999999999999999999999
Q ss_pred CcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy18163 503 GILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRI 579 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI 579 (1028)
+.++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543221 1234566888999999887 568999999999999999998 99999887766655443
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.... +.. ....++..+.+||.+||..||.+|||+.++++
T Consensus 239 ~~~~-------~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGR-------VLE-------------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCC-------CCC-------------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 2210 000 00124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.03 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=196.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||.|+||.||+|... ++.||||.++.... ....+.+|+.++..++|+||+++++++.. .+..++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 467999999999999999999875 78899999976532 23457789999999999999999988764 457999
Q ss_pred EEecccc-chHHHHHHHhhcC-CcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~-~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||+.+ +|.+++ .... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 78 VTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEEecCCCcHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 9999985 554444 3322 3588999999999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.... . +
T Consensus 155 ~~---~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~-----~------ 218 (256)
T cd05039 155 GQ---DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-R-----M------ 218 (256)
T ss_pred cc---ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-C-----C------
Confidence 21 23345677999999876 568899999999999999997 999998776555443332110 0 0
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....+++.+.+||.+||..||.+|||+.+++.
T Consensus 219 ---------~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 ---------E-----------APEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------C-----------CccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 00124577889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=317.15 Aligned_cols=268 Identities=22% Similarity=0.301 Sum_probs=196.0
Q ss_pred CeEEEEEeeecCcEEEEEEEE----CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKD----KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d----~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
.|++++.||+|+||.||+|.. ..++..||+|.++.... ......+.+|+.++..+.||||+++++++.......+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 478999999999999999984 46788999999875432 2223456789999999999999999998866555678
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
++||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+..
T Consensus 84 ~lv~e~~~g--~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPS--GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCC--CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999975 344444433344578889999999999999999999999999999999999999999999999987654
Q ss_pred CCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 PLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
... ......++..|+|||++.+ ..++.++|||||||++|+|+++..|+..... .+ ....+.........
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~~~~-- 233 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQMTVT-- 233 (284)
T ss_pred CccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccccHH--
Confidence 321 1223456778999999877 5689999999999999999998876533211 11 11111111000000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
........... ......++..+.+||.+||..||.+|||+.+++.+
T Consensus 234 --~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 234 --RLVRVLEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred --HHHHHHHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000000000 00112356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=306.99 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=196.8
Q ss_pred eEEEEEeeecCcEEEEEEEECCCC----eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTD----EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg----~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
|++.+.||.|+||.||+|.+..++ ..||+|++....... ....+..|+.++..+.|+||+++++++... +..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeE
Confidence 356789999999999999998766 899999996553221 234567899999999999999999888644 5899
Q ss_pred EEEeccccchHHHHHHHhhcCCc-CCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQV-FIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~-~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
++|||+.+ ++|.+.+...... +++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~i~e~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 78 IVMEYMEG--GDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEEeccCC--CCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999976 3444433332322 78999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccc-ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 PLKHYT-PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~~~~t-~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
...... ...+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+....+..+......
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL----------- 223 (258)
T ss_pred ccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-----------
Confidence 311111 2336789999999865 668999999999999999998 88999887666655554321100
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....++..+.++|.+||..||.+|||+.++++
T Consensus 224 ----------~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 ----------P-----------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------C-----------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0 00115677889999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=336.21 Aligned_cols=255 Identities=20% Similarity=0.255 Sum_probs=194.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC-----CeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT-----DEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t-----g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~ 434 (1028)
.++|++++.||.|+||.||+|.+... +..||||+++.... ......+++|+.+|..+. ||||+++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 46899999999999999999987533 45799999965432 222345778999999996 9999999998853
Q ss_pred CCeEEEEEecccc-chHHHHHHHhh-------------------------------------------------------
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRS------------------------------------------------------- 458 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~------------------------------------------------------- 458 (1028)
...+|||||||.+ +|.+++..-..
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 4579999999976 55444432110
Q ss_pred -------------------------------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC
Q psy18163 459 -------------------------------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501 (1028)
Q Consensus 459 -------------------------------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~ 501 (1028)
....+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 0123677788999999999999999999999999999999999
Q ss_pred CCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy18163 502 RGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSR 578 (1028)
Q Consensus 502 ~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~k 578 (1028)
++.+||+|||+++.+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||........+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 99999999999986643221 1223456788999999977 568999999999999999997 9999977543333322
Q ss_pred HHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 579 I~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.+.....+ . ....++..+.+||.+||..||.+|||+.++.+
T Consensus 352 ~~~~~~~~--------------------~-----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRM--------------------A-----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCC--------------------C-----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22210000 0 01125677889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.50 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=197.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCe---EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~---~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
..+|++.+.||.|+||.||+|.+..++. .||||+++.... ......+..|+.+++.+.||||+++++++. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCc
Confidence 3569999999999999999999887664 699999875422 222345678999999999999999998874 4457
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+++||||+.+ ++|...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.
T Consensus 80 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 80 VMIITEFMEN--GALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred eEEEEecCCC--CcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 8999999986 34444444445568889999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--cccccc---cCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 518 SPLK--HYTPIV---VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 518 ~~~~--~~t~~v---GT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
.... ...... .+..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 232 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP---- 232 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC----
Confidence 3211 111111 2457999999876 568999999999999999886 9999988776665555432110000
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
...++..+.+|+.+||..||.+||++.+++.
T Consensus 233 ----------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 ----------------------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0114566789999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=315.99 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=195.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.+|.+..+||+|+||.||++... .++..||+|.+..... .....+.+|+.++..++|+||+++++++.. .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIVRFYGVCTE--GR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--HHHHHHHHHHHHHhcCCCCCCceEEEEEec--CC
Confidence 57889999999999999999753 3567899998865432 223456789999999999999999887754 35
Q ss_pred eEEEEEecccc-chHHHHHHHhh-----------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRS-----------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI 504 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~-----------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~ 504 (1028)
.+++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 78999999975 55555443211 0124778889999999999999999999999999999999999999
Q ss_pred EEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy18163 505 LKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFK 581 (1028)
Q Consensus 505 lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~ 581 (1028)
+||+|||+++...... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 9999999997653221 11223345788999999887 568999999999999999998 9999987776665555432
Q ss_pred hcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 582 TMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 582 ~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.. +.. ....+++.+.+||.+||..||.+||++.+++.
T Consensus 240 ~~--~~~------------------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GR--ELE------------------------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred Cc--cCC------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 000 00124567889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=319.00 Aligned_cols=260 Identities=19% Similarity=0.306 Sum_probs=196.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCC--------------eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTD--------------EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVR 427 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg--------------~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~ 427 (1028)
.+|++.+.||+|+||.||+|++..++ ..||||+++.... ......+.+|+.++..++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 57999999999999999999876432 3599999875422 11223467899999999999999999
Q ss_pred EEEeecCCCeEEEEEecccc-chHHHHHHHhh--------cCCcCCHHHHHHHHHHHHHHHHHHHhCCccccccccccee
Q psy18163 428 EIVVGSNMDKIFIVMDYVEH-DMKSLMETMRS--------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLL 498 (1028)
Q Consensus 428 ~i~~~~~~~~l~LVmEy~~g-dLgsLl~~l~~--------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNIL 498 (1028)
+++.. ...+++||||+.+ +|.+++..... ....+.+..+..++.||+.||.|||++||+|+||||+|||
T Consensus 84 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 98854 4578999999986 55555532110 0123577788999999999999999999999999999999
Q ss_pred ecCCCcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChHH
Q psy18163 499 LSHRGILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC--MEPLFTGKSDLE 574 (1028)
Q Consensus 499 Ld~~g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT--G~pPF~g~sd~d 574 (1028)
++.++.+||+|||++..+.... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999997653321 11122345778999999877 568999999999999999988 668998877666
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 575 QLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 575 ~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.+..+...........+ ......+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIY-------------------------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhcccccc-------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55554332110000000 0011225678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=312.01 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=197.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC---CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT---DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t---g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|.+.+.||.|+||.||+|.+... ...||||.+..... ......+.+|+.++..+.||||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CC
Confidence 35799999999999999999987644 45799998865432 1123456789999999999999999988743 45
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
.|+||||+.+ ++|.+.+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 81 VWIVMELAPL--GELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred cEEEEEcCCC--CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 7899999975 45555554445568899999999999999999999999999999999999999999999999998654
Q ss_pred CCCC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 518 SPLK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 518 ~~~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... ..+...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 228 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP--------- 228 (270)
T ss_pred cccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---------
Confidence 3311 1122334568999999876 568999999999999999986 999998887766555443210000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++..+.+||.+||..+|.+|||+.+++..
T Consensus 229 -----------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 229 -----------------------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011256778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=372.53 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=210.5
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+++-..+||.|.||.||-|.+..||...|+|-++...........+.+|+.+|..++|||+|.++++-+.. +.++|.|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIFM 1313 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH--HHHHHHH
Confidence 56677899999999999999999999999999987765555555677999999999999999998887644 4789999
Q ss_pred ecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC-
Q psy18163 443 DYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL- 520 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~- 520 (1028)
|||.+ +|.+|++. +....+...+.|..||+.||.|||++|||||||||.||||+.+|.+|++|||.|..+....
T Consensus 1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99986 66666654 4446667788899999999999999999999999999999999999999999998876542
Q ss_pred ---CcccccccCccccCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCCCC
Q psy18163 521 ---KHYTPIVVTLWYRSPELLLGCK--EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL-EQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 521 ---~~~t~~vGT~~Y~APEvL~g~~--~ys~ksDIWSLGvILyELLTG~pPF~g~sd~-d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
......+||+-|||||+|.+.+ +...+.|||||||++.||+||+-||..-+.. .++..+.. |
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--g---------- 1457 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--G---------- 1457 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--c----------
Confidence 2345679999999999998744 5678999999999999999999999765433 22222211 1
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..+.+| ..++.++.|||..||.-||.+|.++.|||+|-|-+.
T Consensus 1458 ---------h~Pq~P-----------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1458 ---------HKPQIP-----------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred ---------CCCCCc-----------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 111222 227899999999999999999999999999999764
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=313.08 Aligned_cols=240 Identities=23% Similarity=0.267 Sum_probs=183.0
Q ss_pred EEeeecCcEEEEEEEECC------------CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 368 NRIEEGTYGVVYRAKDKR------------TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~------------tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.++..++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 368999999999998542 23368889876543 22334567788999999999999999988644
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc-------EEEe
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI-------LKVG 508 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~-------lKL~ 508 (1028)
...++||||+.+ +.|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++. ++|+
T Consensus 77 ~~~~lv~e~~~~--~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 77 VENIMVEEFVEF--GPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCCEEEEecccC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 467999999986 2333333334456889999999999999999999999999999999999987664 8999
Q ss_pred ccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 509 DFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL-CMEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 509 DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELL-TG~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
|||++...... ....+|..|+|||++.+...++.++|||||||++|+|+ +|..||......+.. .+....
T Consensus 155 d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~---- 225 (262)
T cd05077 155 DPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ---- 225 (262)
T ss_pred CCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC----
Confidence 99998765422 23567889999999875567899999999999999998 588888765433221 111100
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
+ . .....+..+.+||.+||..||.+||++.+||++
T Consensus 226 ------~--------------~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 ------C--------------M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ------c--------------c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0 001123567899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.99 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=194.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
+|++.+.||+|+||.||+|.+.. ....||+|.+....... ....+.+|+.++..+.||||+++++.+.. .+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-ELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47889999999999999998753 33579999886543221 12456789999999999999999988754 346
Q ss_pred EEEEEecccc-chHHHHHHHhh--------------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccc
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRS--------------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSN 496 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~--------------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeN 496 (1028)
.++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 8999999985 56655543211 11346788899999999999999999999999999999
Q ss_pred eeecCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q psy18163 497 LLLSHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDL 573 (1028)
Q Consensus 497 ILLd~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~ 573 (1028)
||++.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999986533211 1123355778999999877 568999999999999999998 99999887665
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 574 EQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 574 d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+..... + . ....++..+.+||.+||..||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~------~---------------~-----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGYR------M---------------E-----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCCC------C---------------C-----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 54433221100 0 0 00124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=315.52 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=199.6
Q ss_pred CeEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccc--cCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCC
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEK--EGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~--~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~ 436 (1028)
+|++.+.||.|+||.||++.+. .++..||||+++..... ......+.+|+.++..+ .||||+.+++++. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence 4899999999999999999864 46789999999754321 12234456899999999 5999999987774 445
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+||||+.+ ++|...+.. ...+++..++.++.||+.||.|||+.||+|+||||.|||++.++.++|+|||++..+
T Consensus 79 ~~~lv~e~~~~--~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 79 KLHLILDYVNG--GELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEEEecCCC--CcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 89999999986 455555443 345888899999999999999999999999999999999999999999999998765
Q ss_pred CCCCC-cccccccCccccCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 517 GSPLK-HYTPIVVTLWYRSPELLLGCK-EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 517 ~~~~~-~~t~~vGT~~Y~APEvL~g~~-~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
..... .....+|+..|+|||.+.+.. .++.++|||||||++|+|++|..||...........+........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK------- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-------
Confidence 43221 122356899999999986632 368899999999999999999999965332211112211100000
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC---HHHHHhCCCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT---ADEALRHDYFSESPL 659 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT---A~ElL~HPfF~e~p~ 659 (1028)
.. ....++..+.+||.+||..||.+||| +.++|+||||+...+
T Consensus 229 -----------~~-----------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 229 -----------PP-----------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred -----------CC-----------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 00 01125567889999999999999998 567799999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.14 Aligned_cols=255 Identities=18% Similarity=0.253 Sum_probs=197.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC----CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.++..+.|+||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-EIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 4789999999999999999999876 368899998864321 22234467899999999999999999877543 35
Q ss_pred eEEEEEecccc-chHHHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccC
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSK----KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFG 511 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~----~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFG 511 (1028)
..+++++|+.+ +|.+++...... ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 78999999874 555555433221 1458899999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCc--ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 512 LAREYGSPLKH--YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 512 lAr~~~~~~~~--~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
+++.+...... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.... .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-- 238 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RL-- 238 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CC--
Confidence 99865332111 122345778999999977 568999999999999999999 999998876655433332110 00
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....+++.+.+||.+||..||.+|||+.+++.
T Consensus 239 ---~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 ---A--------------------------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ---C--------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.68 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=191.3
Q ss_pred EeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccccc
Q psy18163 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHD 448 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~gd 448 (1028)
.||.|+||.||+|... ++..||+|++...... .....+.+|+.++..+.||||+++++++... ..+++||||+.+
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~- 76 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELVPG- 76 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECCCC-
Confidence 6899999999999865 6788999998654321 1223567899999999999999999987544 478999999986
Q ss_pred hHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcc-cccc
Q psy18163 449 MKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY-TPIV 527 (1028)
Q Consensus 449 LgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~-t~~v 527 (1028)
++|...+......+.+..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......... ....
T Consensus 77 -~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 77 -GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred -CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 55555555445567889999999999999999999999999999999999999999999999997543321111 1224
Q ss_pred cCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccc
Q psy18163 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606 (1028)
Q Consensus 528 GT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~ 606 (1028)
++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.... ..
T Consensus 156 ~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~------------------ 213 (250)
T cd05085 156 IPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---RM------------------ 213 (250)
T ss_pred CcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---CC------------------
Confidence 4667999999876 568999999999999999998 999998876655544442210 00
Q ss_pred cCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 607 EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 607 ~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....++..+.+|+.+||..||.+|||+.++++
T Consensus 214 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 -----------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 001124577889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=339.36 Aligned_cols=236 Identities=25% Similarity=0.391 Sum_probs=194.1
Q ss_pred EEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 367 l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
++-||.|+-|.||+|+.. ++.||||.++.-+ ..+|.-|++|+||||+.+.+++... .++|||||||.
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqs--PcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQS--PCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCC--ceeEEeeeccc
Confidence 566999999999999986 7889999886432 2578889999999999999999644 48999999998
Q ss_pred cchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccccc
Q psy18163 447 HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526 (1028)
Q Consensus 447 gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~ 526 (1028)
. |.|++.++. +..++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... .....+
T Consensus 196 ~--GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSF 271 (904)
T KOG4721|consen 196 Q--GQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSF 271 (904)
T ss_pred c--ccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhh
Confidence 7 788887765 456888899999999999999999999999999999999999999999999999987654 445679
Q ss_pred ccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccc
Q psy18163 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606 (1028)
Q Consensus 527 vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~ 606 (1028)
+||..|||||+|.+ .+.+.++|||||||+|||||||..||..-+.. .-| |---+. . +.+
T Consensus 272 aGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AII-----------wGVGsN---s--L~L- 330 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AII-----------WGVGSN---S--LHL- 330 (904)
T ss_pred hhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchh---eeE-----------EeccCC---c--ccc-
Confidence 99999999999988 77999999999999999999999999754322 111 210000 0 000
Q ss_pred cCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 607 EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 607 ~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
......++-++=||..||.-.|..||++.+||.|
T Consensus 331 -----------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 331 -----------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred -----------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 0112245567789999999999999999999999
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.74 Aligned_cols=239 Identities=18% Similarity=0.263 Sum_probs=185.2
Q ss_pred EeeecCcEEEEEEEECCCCe-------EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 369 RIEEGTYGVVYRAKDKRTDE-------IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~tg~-------~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.||.|+||.||+|.+..++. .||+|.+.... ......+.+|+.++..+.||||+.+++++... ...++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEEE
Confidence 59999999999999876544 38888875432 12233556789999999999999999988654 478999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc--------EEEeccCCc
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI--------LKVGDFGLA 513 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~--------lKL~DFGlA 513 (1028)
|||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 78 ~e~~~~--g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 78 QEYVKF--GSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EecCCC--CcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999986 4555555555556888889999999999999999999999999999999987654 699999998
Q ss_pred cccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 514 REYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 514 r~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~-pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
..... .....++..|+|||++.+...++.++|||||||++|+|++|. +||...+...... +.....
T Consensus 156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~-------- 222 (258)
T cd05078 156 ITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRH-------- 222 (258)
T ss_pred cccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccc--------
Confidence 75532 123568889999999987666899999999999999999995 7776554433222 111100
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.++ ...+..+.+||.+||..||.+|||+.++++.
T Consensus 223 --------------~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 223 --------------QLP-----------APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred --------------cCC-----------CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 000 1134567899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.62 Aligned_cols=247 Identities=21% Similarity=0.274 Sum_probs=186.5
Q ss_pred EEeeecCcEEEEEEEECC---CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEec
Q psy18163 368 NRIEEGTYGVVYRAKDKR---TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDY 444 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~---tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy 444 (1028)
+.||+|+||.||+|.+.. .+..||||.+..... ......+.+|+.+++.++||||+++++++... ....++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 368999999999998753 346799998854221 11224556899999999999999999876533 3457899999
Q ss_pred cccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC----
Q psy18163 445 VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL---- 520 (1028)
Q Consensus 445 ~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~---- 520 (1028)
+.+ ++|...+......+.+..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 ~~~--~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 79 MKH--GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 976 44555444444446677788899999999999999999999999999999999999999999997653321
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.... +.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~--~~------------ 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--RL------------ 221 (262)
T ss_pred cccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--CC------------
Confidence 11123456778999999877 568999999999999999999 567887766555443332210 00
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. ....++..+.+|+.+||..||.+||++.+++..
T Consensus 222 -------~-----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 222 -------L-----------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred -------C-----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 001245678899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.75 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=194.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC-------CCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEee
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR-------TDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVG 432 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~-------tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~ 432 (1028)
.++|.+.+.||+|+||.||+|.+.. ....||+|+++..... .....+..|+.++..+ .||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-HHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3689999999999999999998642 3457999998754321 1233467899999998 59999999988754
Q ss_pred cCCCeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee
Q psy18163 433 SNMDKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499 (1028)
Q Consensus 433 ~~~~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL 499 (1028)
...+|+||||+.+ +|.+++..... ....++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 --EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 3478999999976 45444433110 12347788899999999999999999999999999999999
Q ss_pred cCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy18163 500 SHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQL 576 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l 576 (1028)
+.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986543211 1122234567999999977 568999999999999999999 88999887765555
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
..+..... + . ....++..+++||.+||..||.+|||+.+++.
T Consensus 247 ~~~~~~~~------~---------------~-----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHR------M---------------D-----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCC------C---------------C-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 54432100 0 0 00124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.62 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=197.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEEC-------CCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDK-------RTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVV 431 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~-------~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~ 431 (1028)
..++|.+...||+|+||.||+|++. .++..||+|.+..... ......+.+|+.++..+ .||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3578999999999999999999753 2345799999875422 12234567899999999 7999999998875
Q ss_pred ecCCCeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCccccccccccee
Q psy18163 432 GSNMDKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLL 498 (1028)
Q Consensus 432 ~~~~~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNIL 498 (1028)
. ...+|+||||+.+ +|.+++..... ....++...+..++.||+.||.|||++||+||||||+|||
T Consensus 92 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 92 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred c--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 4 3478999999976 55555543211 1124677788999999999999999999999999999999
Q ss_pred ecCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy18163 499 LSHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQ 575 (1028)
Q Consensus 499 Ld~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~ 575 (1028)
++.++.+||+|||+++.+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999987643221 1223355778999999977 568999999999999999998 8899988776665
Q ss_pred HHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 576 LSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 576 l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
...+..... .. ....++..+.+||.+||..+|.+|||+.+++..
T Consensus 249 ~~~~~~~~~--~~------------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHR--MD------------------------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCc--CC------------------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 554422100 00 001245778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.24 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=196.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|+++..||.|+||.||+|.+.. ++..||||++..... ......+.+|+.++..+.||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAV--G 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcC--C
Confidence 4689999999999999999998753 678999999875432 1122446789999999999999999988753 4
Q ss_pred CeEEEEEecccc-chHHHHHHHhh------------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRS------------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSN 496 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~------------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeN 496 (1028)
+.+|+||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+||||||.|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 578999999986 55555432110 11236778889999999999999999999999999999
Q ss_pred eeecCCCcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q psy18163 497 LLLSHRGILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDL 573 (1028)
Q Consensus 497 ILLd~~g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~ 573 (1028)
||++.++.++|+|||++..+.... ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999997654321 11122345677999999877 568999999999999999997 88899877766
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 574 EQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 574 d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+.+..+.... .++ ....++..+.+||.+||..||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~------~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGN------VLS--------------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCC------CCC--------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6554443210 000 00124567889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=312.83 Aligned_cols=248 Identities=31% Similarity=0.445 Sum_probs=190.8
Q ss_pred EEEEEeeecCcEEEEEEEEC----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 365 KCLNRIEEGTYGVVYRAKDK----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 365 ~il~~LG~G~FG~Vyla~d~----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.+.+.||.|.||.||+|... ..+..|+||+++.... ......+++|+.++.+++||||+++++++. ....+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-cccceeeeeccccccccccccccccccccc--ccccccc
Confidence 46789999999999999987 4567899999965322 112456788999999999999999999997 3346999
Q ss_pred EEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ ++|.+.+... ...+++.....|+.||+.||.|||+++|+|+||++.|||++.++.+||+|||++......
T Consensus 79 v~e~~~~--g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 79 VMEYCPG--GSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEE--TT--EBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999975 3444444444 456889999999999999999999999999999999999999999999999999876322
Q ss_pred C--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 520 L--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 520 ~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. .......+...|+|||++.+ ..++.++||||||+++|||++ |..||...+..+.+..+.+....+
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---------- 225 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---------- 225 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT----------
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccce----------
Confidence 1 11223456778999999977 458999999999999999999 789998887777666663321100
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||..||..||.+|||+.++++
T Consensus 226 ----------------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 ----------------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----------------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----------------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01125677889999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.08 Aligned_cols=260 Identities=16% Similarity=0.176 Sum_probs=187.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC---CeEEEEEEeeccccccCCc---------cchHHHHHHHHHcCCCCeeEEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT---DEIVALKRLKMEKEKEGFP---------ITSLREINTLLKAQHPNIVTVRE 428 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t---g~~VAIKvlk~~~~~~~~~---------~~~lrEi~iL~~l~HPNIV~L~~ 428 (1028)
..+|++.++||+|+||+||+|.+..+ +..+|+|+........... .....++..+..+.|+||+.+++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999999887 6778888654332111000 01122333445568999999988
Q ss_pred EEeecCC--CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEE
Q psy18163 429 IVVGSNM--DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILK 506 (1028)
Q Consensus 429 i~~~~~~--~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lK 506 (1028)
+...... ...+++|+++..++.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 6543322 245788898877776666543 2356778899999999999999999999999999999999999999
Q ss_pred EeccCCccccCCCC-------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy18163 507 VGDFGLAREYGSPL-------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579 (1028)
Q Consensus 507 L~DFGlAr~~~~~~-------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI 579 (1028)
|+|||+|+.+.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+......+...
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999998764221 11233579999999999887 66899999999999999999999999876432222211
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
...- ++ ..+.... ......+..+.+|+..|+.++|.+||+..++++
T Consensus 246 ~~~~------~~---------~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCD------FI---------KRLHEGK----------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHH------HH---------HHhhhhh----------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1100 00 0000000 000124567889999999999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=350.17 Aligned_cols=276 Identities=22% Similarity=0.299 Sum_probs=179.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCC----CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEE----e
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRT----DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIV----V 431 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~t----g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~----~ 431 (1028)
..++|.+.+.||+|+||.||+|.+..+ +..||||++...... .....+ .+....+.+++.+...+ .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 568999999999999999999999988 899999987542210 001111 12222222222221111 1
Q ss_pred ecCCCeEEEEEecccc-chHHHHHHHhhcCCc-------------------CCHHHHHHHHHHHHHHHHHHHhCCccccc
Q psy18163 432 GSNMDKIFIVMDYVEH-DMKSLMETMRSKKQV-------------------FIPGEVKCLMQQLLNAVAHLHDNWILHRD 491 (1028)
Q Consensus 432 ~~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~-------------------~se~ev~~il~QLl~AL~yLHs~gIVHRD 491 (1028)
......++|||||+.+ +|.+++. ..... .....+..|+.||+.||.|||++||+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~---~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQ---SKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHH---hcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 1345679999999986 4444432 22111 12334678999999999999999999999
Q ss_pred ccccceeecC-CCcEEEeccCCccccCCCC-CcccccccCccccCcccccCCC---------------------CCCchh
Q psy18163 492 LKTSNLLLSH-RGILKVGDFGLAREYGSPL-KHYTPIVVTLWYRSPELLLGCK---------------------EYSTPI 548 (1028)
Q Consensus 492 LKPeNILLd~-~g~lKL~DFGlAr~~~~~~-~~~t~~vGT~~Y~APEvL~g~~---------------------~ys~ks 548 (1028)
|||+||||+. ++.+||+|||+|+.+.... ......++|+.|+|||++.... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 6899999999998654321 2234568999999999764321 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHH
Q psy18163 549 DMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGY 628 (1028)
Q Consensus 549 DIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~ 628 (1028)
||||||||||||+++..++ .++...+..++...+.... .|... .............. ........++
T Consensus 361 DVwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~-~~~~~---------~~~~~~~~~~~~~~-~~d~~~~~~~ 427 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLV-AWRKL---------VEPRASPDLRRGFE-VLDLDGGAGW 427 (566)
T ss_pred ccHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHH-HHHHh---------hccccchhhhhhhh-hccccchHHH
Confidence 9999999999999865543 4445555555544332111 11000 00000000000000 0111344678
Q ss_pred HHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 629 DLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 629 DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+||.+||.+||.+|||+.++|+||||+..
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCC
Confidence 99999999999999999999999999874
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.77 Aligned_cols=237 Identities=21% Similarity=0.265 Sum_probs=185.0
Q ss_pred EEeeecCcEEEEEEEECCCC----------eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 368 NRIEEGTYGVVYRAKDKRTD----------EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg----------~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.+|+.+.||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 36999999999999998777 35888877644321 4567789999999999999999998765 46
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-------cEEEecc
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-------ILKVGDF 510 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-------~lKL~DF 510 (1028)
.++||||+.+ ++|...+......++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 75 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 75 NIMVEEYVKF--GPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred cEEEEEcCCC--CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 7999999986 455555544444688889999999999999999999999999999999999887 8999999
Q ss_pred CCccccCCCCCcccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 511 GLAREYGSPLKHYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 511 GlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
|++..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+........ .. ..
T Consensus 153 g~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~---~~- 223 (259)
T cd05037 153 GIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QD---QH- 223 (259)
T ss_pred Cccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hc---CC-
Confidence 99987643 2234567789999999774 368999999999999999999 57888765432222111 10 00
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
..+. .....+.+||.+||..||.+|||+.++++
T Consensus 224 ------------------~~~~-----------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 ------------------RLPM-----------PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------------------CCCC-----------CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 01156789999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.02 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=194.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.++||+|+||.||++.+. .+..||+|.+..... ....+.+|+.+++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh---HHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 468999999999999999999865 455699998865321 22456789999999999999999888754 57899
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++.. .....++...+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 78 ITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999975 45444432 12344677888999999999999999999999999999999999999999999999766432
Q ss_pred CC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 LK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 223 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----------- 223 (260)
T ss_pred CcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-----------
Confidence 11 1122345678999999976 568999999999999999998 999998877665554442211000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+|+.+||..||.+||++.+++.
T Consensus 224 ---------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 224 ---------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ---------------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00124567889999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.62 Aligned_cols=252 Identities=20% Similarity=0.262 Sum_probs=195.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCe----EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDE----IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~----~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.++|+.++.||.|+||.||+|.+..++. .||+|++..... ......+.+|+.++..+.||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 3679999999999999999999987776 468888764322 11223467899999999999999999988532
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
..++|++|+.+ +++.+.+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~~v~e~~~~--g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 TIQLVTQLMPH--GCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred CceeeehhcCC--CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 46799999986 5555555555556888899999999999999999999999999999999999999999999999876
Q ss_pred CCCCCc--ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 517 GSPLKH--YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 517 ~~~~~~--~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.. .+......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~------ 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERLP------ 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCCC------
Confidence 432221 223455778999999877 568999999999999999997 89999876543332 2222110000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.....+..+.+||.+||..||.+||++.+++..
T Consensus 232 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 -------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001134567899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.63 Aligned_cols=260 Identities=20% Similarity=0.317 Sum_probs=193.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECC----------------CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKR----------------TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVT 425 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~----------------tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~ 425 (1028)
++|++.+.||+|+||.||++.+.. ++..||+|++..... ......+.+|+.+|..++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986542 345799999875422 122345678999999999999999
Q ss_pred EEEEEeecCCCeEEEEEecccc-chHHHHHHHhhc-------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccce
Q psy18163 426 VREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSK-------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNL 497 (1028)
Q Consensus 426 L~~i~~~~~~~~l~LVmEy~~g-dLgsLl~~l~~~-------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNI 497 (1028)
+++++... +.+|+||||+.+ +|.+++...... ...+++..+..++.||+.||.|||++||+|+||||+||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99988544 478999999975 555554432111 12366778999999999999999999999999999999
Q ss_pred eecCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChH
Q psy18163 498 LLSHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC--MEPLFTGKSDL 573 (1028)
Q Consensus 498 LLd~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT--G~pPF~g~sd~ 573 (1028)
|++.++.++|+|||+++.+..... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999986543211 1122344678999998876 468999999999999999998 77999877665
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 574 EQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 574 d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+.+......+..-... .. .+ ....++..+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~-------------~~---~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQ-------------VY---LP---------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhcccc-------------cc---CC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5544332211000000 00 00 01124567889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.76 Aligned_cols=239 Identities=23% Similarity=0.301 Sum_probs=183.3
Q ss_pred EeeecCcEEEEEEEECCC------------------------CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCee
Q psy18163 369 RIEEGTYGVVYRAKDKRT------------------------DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIV 424 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~t------------------------g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV 424 (1028)
+||+|+||.||+|....+ ...||+|++..... .....+.+|+.++..++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999985322 24588998865432 2234566788899999999999
Q ss_pred EEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-
Q psy18163 425 TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG- 503 (1028)
Q Consensus 425 ~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g- 503 (1028)
++++++... ...||||||+.+ +.|...+......+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~--~~~~lv~ey~~~--g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 80 FVHGVCVRG--SENIMVEEFVEH--GPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred eEEEEEEeC--CceEEEEecCCC--CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 999988654 478999999987 445555544455688899999999999999999999999999999999997543
Q ss_pred ------cEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHH
Q psy18163 504 ------ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL-CMEPLFTGKSDLEQL 576 (1028)
Q Consensus 504 ------~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELL-TG~pPF~g~sd~d~l 576 (1028)
.+||+|||++...... ....++..|+|||++.+...++.++|||||||++|+|+ +|.+||......+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred ccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 4899999998654322 23467888999999876566899999999999999985 799999876554332
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. ++..... .+ ......+.+||.+||..||.+|||+.++|++
T Consensus 232 ~-~~~~~~~----------------------~~-----------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 232 R-FYEKKHR----------------------LP-----------EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred H-HHHhccC----------------------CC-----------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2 2111000 00 0123467899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=359.41 Aligned_cols=262 Identities=28% Similarity=0.425 Sum_probs=197.3
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEee------
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG------ 432 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~------ 432 (1028)
+-..+|+.+..||+||||.||+++++-+|+.||||.|.... .......+++|+..|.+|+|||||.++..++.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34678999999999999999999999999999999998775 34455678899999999999999987533210
Q ss_pred -------------------------------------------------c---------------------CC-------
Q psy18163 433 -------------------------------------------------S---------------------NM------- 435 (1028)
Q Consensus 433 -------------------------------------------------~---------------------~~------- 435 (1028)
. ++
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0 00
Q ss_pred ----------------------------------CeEEEEEeccccchHHHHHHHhhcCCcC-CHHHHHHHHHHHHHHHH
Q psy18163 436 ----------------------------------DKIFIVMDYVEHDMKSLMETMRSKKQVF-IPGEVKCLMQQLLNAVA 480 (1028)
Q Consensus 436 ----------------------------------~~l~LVmEy~~gdLgsLl~~l~~~~~~~-se~ev~~il~QLl~AL~ 480 (1028)
-.+||-||||+.++ +..+...+..+ ....++.+++||+.||.
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~l---l~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTL---LRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhH---HHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 13689999998633 22222222222 35679999999999999
Q ss_pred HHHhCCcccccccccceeecCCCcEEEeccCCccccC------------------CCCCcccccccCccccCcccccCCC
Q psy18163 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG------------------SPLKHYTPIVVTLWYRSPELLLGCK 542 (1028)
Q Consensus 481 yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~------------------~~~~~~t~~vGT~~Y~APEvL~g~~ 542 (1028)
|+|+.|||||||||.||+|+.++.|||+|||+|+... ......|+.+||..|+|||++.+..
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999999998721 1223567899999999999998766
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCcccccc
Q psy18163 543 --EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAG 620 (1028)
Q Consensus 543 --~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~ 620 (1028)
.|+.++|||||||||+||+ .||...-+. ..-+ ..+..+.-+..++|. .
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMER--a~iL-~~LR~g~iP~~~~f~------------------------~ 841 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEML---YPFGTSMER--ASIL-TNLRKGSIPEPADFF------------------------D 841 (1351)
T ss_pred cccccchhhhHHHHHHHHHHh---ccCCchHHH--HHHH-HhcccCCCCCCcccc------------------------c
Confidence 6999999999999999998 457543322 2212 211111100001110 0
Q ss_pred ccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 621 SILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 621 ~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
+.. +....+|..||..||++||||.|+|++.||-
T Consensus 842 ~~~-~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 842 PEH-PEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ccc-hHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 111 2345899999999999999999999999984
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=307.38 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=184.9
Q ss_pred EeeecCcEEEEEEEEC--CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 369 RIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~--~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
.||+|+||.||+|... .++..+|+|.++..... .....+.+|+.++..++||||+++++++.. ...+++||||+.
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCC
Confidence 5899999999999864 35678999988754321 122356789999999999999999887743 457899999998
Q ss_pred c-chHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC--c
Q psy18163 447 H-DMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK--H 522 (1028)
Q Consensus 447 g-dLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~--~ 522 (1028)
+ +|.+++...... ...+.+..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++....... .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 5 555554432211 22345667788999999999999999999999999999999999999999999975433211 1
Q ss_pred ccccccCccccCcccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 523 YTPIVVTLWYRSPELLLGC------KEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~------~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.....++..|+|||++.+. ..++.++|||||||++|+|++ |.+||......+............ .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~----- 230 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK---L----- 230 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCC---C-----
Confidence 2235678889999998642 135789999999999999996 999998766655443322211000 0
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+. ......++..+.+||..|+ .||.+|||+.+|+.
T Consensus 231 -------------~~------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 231 -------------PK------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -------------CC------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00 0001124567789999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.15 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=184.7
Q ss_pred EeeecCcEEEEEEEECC--CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 369 RIEEGTYGVVYRAKDKR--TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~--tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
.||+|+||+||+|.... ....+|+|.+..... ......+++|+.+++.+.|+||+++++.+.. ...+|+||||+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCC
Confidence 59999999999996542 445788887754322 2223456789999999999999999988754 457999999997
Q ss_pred c-chHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC--Cc
Q psy18163 447 H-DMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL--KH 522 (1028)
Q Consensus 447 g-dLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~--~~ 522 (1028)
+ +|.+++...... ...+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 5 555554432211 1224567788999999999999999999999999999999999999999999987542211 11
Q ss_pred ccccccCccccCcccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 523 YTPIVVTLWYRSPELLLG------CKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g------~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.....++..|+|||++.. ...++.++|||||||++|+|++ |.+||....+.+.+..+..........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------ 232 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK------ 232 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC------
Confidence 123456778999998743 2457889999999999999999 789998877766666554321110000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
......++....+++..|+ .||.+|||+.++++
T Consensus 233 ---------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 233 ---------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---------------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0011225566778888888 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.39 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=185.9
Q ss_pred EeeecCcEEEEEEEECCCCe--EEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 369 RIEEGTYGVVYRAKDKRTDE--IVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~tg~--~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
.||+|+||.||+|.+..++. .+|+|.++.... ......+.+|+.++.++ .||||+++++++... ..+|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeC
Confidence 58999999999999988775 468888764321 12233566899999999 799999999988654 4689999999
Q ss_pred cc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCC
Q psy18163 446 EH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512 (1028)
Q Consensus 446 ~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGl 512 (1028)
.+ +|.+++..... ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 75 45444432110 112477889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.... ..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------~~ 230 (270)
T cd05047 159 SRGQEVYV-KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------RL 230 (270)
T ss_pred ccccchhh-hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC------CC
Confidence 86332111 1112234667999999876 568999999999999999997 999998776555444432110 00
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....++..+.+||.+||..||.+|||+.+++.
T Consensus 231 ---------------~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 ---------------E-----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ---------------C-----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 00124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.15 Aligned_cols=268 Identities=21% Similarity=0.315 Sum_probs=196.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEEC----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDK----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
..|++++.||+|+||.||+|... .++..||||++...... .....+.+|+.++..+.|+||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46888999999999999999864 45889999999765432 22345678999999999999999999886655668
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
.++||||+.+ ++|...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~--~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPS--GSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCC--CCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999975 34444444444458888999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcc---cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 518 SPLKHY---TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 518 ~~~~~~---t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.....+ ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||....... ....+... +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~-----~~ 229 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQ-----GQ 229 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccc-----cc
Confidence 322211 12344567999999877 468999999999999999999999886533211 00000000 00
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
............... ......++..+.+|+.+||..||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 230 MIVTRLLELLKEGER-------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ccHHHHHHHHHcCCc-------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000000000000 0001124567889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=319.21 Aligned_cols=254 Identities=19% Similarity=0.277 Sum_probs=195.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCC-------CeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeec
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRT-------DEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGS 433 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~t-------g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~ 433 (1028)
.+|++.+.||+|+||.||+|++... +..||+|+++..... .....+.+|+.++.++ .||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-HHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 5799999999999999999987432 237999988753221 1234567899999999 79999999988754
Q ss_pred CCCeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec
Q psy18163 434 NMDKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS 500 (1028)
Q Consensus 434 ~~~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd 500 (1028)
...+++||||+.+ +|.+++..... ....+....+..++.||+.||.|||++||+||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 3479999999976 55555543211 112366778889999999999999999999999999999999
Q ss_pred CCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy18163 501 HRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLS 577 (1028)
Q Consensus 501 ~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~ 577 (1028)
.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999986543211 1122334567999999977 568999999999999999998 889998877665554
Q ss_pred HHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 578 RIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 578 kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.+...... .. ...++..+.+||.+||..+|.+|||+.++|.+
T Consensus 248 ~~~~~~~~---------------------~~-----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHRM---------------------DK-----------PANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCCC---------------------CC-----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 44321000 00 01245678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=307.02 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=197.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
++|+++..||.|+||.||+|+... +...||+|.+..... ......+.+|+.++.+++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CC
Confidence 579999999999999999999754 346799998864322 1123456789999999999999999987743 35
Q ss_pred eEEEEEecccc-chHHHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEecc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKK-----QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDF 510 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~-----~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DF 510 (1028)
..|+||||+.+ +|.+++....... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 78999999985 5555544322111 15789999999999999999999999999999999999999999999999
Q ss_pred CCccccCCC-CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 511 GLAREYGSP-LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 511 GlAr~~~~~-~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
|++...... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||....+...+..+.... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~--~-- 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK--L-- 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC--c--
Confidence 998754321 122334567788999999876 558899999999999999998 789998766655444432110 0
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.|+ ....++..+.+||.+||..||.+|||+.+++.+
T Consensus 237 -~~~--------------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 -ELP--------------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -CCC--------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 000 011255678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.23 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=192.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
..+|++.+.||.|+||.||++.. +++.||+|+++.... ...+.+|+.++..++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~ 75 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT----AQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYI 75 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcch----HHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEE
Confidence 36799999999999999999864 678899999865422 2456789999999999999999988743 34799
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++.. .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 76 VMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEECCCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999975 55555432 12334788889999999999999999999999999999999999999999999999764321
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
......+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..... +
T Consensus 154 ---~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~------------ 216 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-M------------ 216 (254)
T ss_pred ---CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-C------------
Confidence 222344678999999876 568999999999999999997 9999988766554433322100 0
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....++..+.+||.+||..+|..|||+.+++.
T Consensus 217 --------~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 217 --------E-----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------C-----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00124577889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=330.02 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=197.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~ 434 (1028)
.++|.+.++||+|+||.||+|++. .++..||||+++..... .....+.+|+.+|..+. ||||+.+++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 467889999999999999999964 35578999999764322 22235678999999997 99999999888543
Q ss_pred CCeEEEEEecccc-chHHHHHHHhh-------------------------------------------------------
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRS------------------------------------------------------- 458 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~------------------------------------------------------- 458 (1028)
..+|||||||.+ +|.+++.....
T Consensus 114 -~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 114 -GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred -CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 479999999986 44444432110
Q ss_pred ---------------------------------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee
Q psy18163 459 ---------------------------------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499 (1028)
Q Consensus 459 ---------------------------------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL 499 (1028)
....++...+..|+.||+.||.|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 11235667788999999999999999999999999999999
Q ss_pred cCCCcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy18163 500 SHRGILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQL 576 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l 576 (1028)
+.++.+||+|||+++.+.... ......+++..|+|||++.+ ..++.++|||||||++|||++ |..||......+.+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 999999999999998653321 12233467889999999977 568999999999999999998 88999876655544
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
...+.....+ . ....++..+.+||.+||..||.+||++.+|+..
T Consensus 352 ~~~~~~~~~~--------------------~-----------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRM--------------------A-----------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCC--------------------C-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4433210000 0 011256788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.26 Aligned_cols=229 Identities=26% Similarity=0.355 Sum_probs=180.9
Q ss_pred cCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccccchHHH
Q psy18163 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSL 452 (1028)
Q Consensus 373 G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~gdLgsL 452 (1028)
|.||.||++++..+++.||+|++..... ..+|...+....||||+++++++.. .+.+|+||||+.+ ++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~--~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEG--GKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCC--CCH
Confidence 8999999999999999999999976431 1234555556679999999988754 4589999999986 344
Q ss_pred HHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccccccCccc
Q psy18163 453 METMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWY 532 (1028)
Q Consensus 453 l~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y 532 (1028)
.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .....++..|
T Consensus 73 ~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y 148 (237)
T cd05576 73 WSHISK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMY 148 (237)
T ss_pred HHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccc
Confidence 443333 234889999999999999999999999999999999999999999999999988766432 2344667889
Q ss_pred cCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCC
Q psy18163 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVG 612 (1028)
Q Consensus 533 ~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~ 612 (1028)
+|||++.+ ..++.++|||||||++|+|++|..||...... + .... .+
T Consensus 149 ~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~~~------~~--------- 195 (237)
T cd05576 149 CAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NTHT------TL--------- 195 (237)
T ss_pred cCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cccc------cc---------
Confidence 99999866 56899999999999999999999887532110 0 0000 00
Q ss_pred CCccccccccccHHHHHHHHHhcccCcCCCCCH-----HHHHhCCCC
Q psy18163 613 GLKTKVAGSILTELGYDLLCKFLTYDPVTRITA-----DEALRHDYF 654 (1028)
Q Consensus 613 ~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA-----~ElL~HPfF 654 (1028)
.....++..+.+||.+||..||.+|+|+ .++++||||
T Consensus 196 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 -----NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -----CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0112356788999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.08 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=193.5
Q ss_pred eEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC----C
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM----D 436 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~----~ 436 (1028)
|++.+.||+|+||.||+|.+. .++..||||++............+.+|+.++..+.||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999864 467899999997654333233456789999999999999999998764322 1
Q ss_pred eEEEEEecccc-chHHHHHHH--hhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETM--RSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA 513 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l--~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlA 513 (1028)
..+++++|+.+ +|..++..- ......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 34788899875 444333211 112234678889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 514 REYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 514 r~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
+....... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---- 234 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RL---- 234 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cC----
Confidence 86643211 1223345678999999876 568999999999999999999 889998776655444433210 00
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. .....+..+.+|+.+||..+|..|||+.+++.+
T Consensus 235 ----~-----------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 ----K-----------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ----C-----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 001245678899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=305.57 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=189.5
Q ss_pred EeeecCcEEEEEEEECCCC------eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 369 RIEEGTYGVVYRAKDKRTD------EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~tg------~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
.||.|+||.||+|.+.... ..||||.+..... ......+.+|+.++..++||||+++++++.. ....++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEE
Confidence 5999999999999986544 7899998865422 1223456789999999999999999988754 34799999
Q ss_pred ecccc-chHHHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-----cEEEeccCCc
Q psy18163 443 DYVEH-DMKSLMETMRS---KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-----ILKVGDFGLA 513 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~---~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-----~lKL~DFGlA 513 (1028)
||+.+ +|.+++..... ....+++..+..++.||+.||.|||+++|+|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99975 55544433211 123467888999999999999999999999999999999999877 8999999999
Q ss_pred cccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 514 REYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 514 r~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
..+..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.... .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~---- 232 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL---- 232 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc----
Confidence 76543211 1123355788999999977 568999999999999999998 999998777665544432110 00
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....++..+.+||.+||..+|.+||++.++++
T Consensus 233 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 ---------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001125567889999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.40 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=184.4
Q ss_pred EeeecCcEEEEEEEECCC--CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 369 RIEEGTYGVVYRAKDKRT--DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~t--g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
.||+|+||+||+|..... ...+++|.+..... ......+.+|+.++..++||||+++++.+.. ...+|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 599999999999975433 33566776654322 1223467789999999999999999988754 457899999998
Q ss_pred c-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC--CCcc
Q psy18163 447 H-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP--LKHY 523 (1028)
Q Consensus 447 g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~--~~~~ 523 (1028)
+ +|.+++.........+.+..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++...... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 5 555444332222234566678899999999999999999999999999999999999999999998643211 1122
Q ss_pred cccccCccccCcccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 524 TPIVVTLWYRSPELLLGC------KEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~------~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
...+++..|+|||++... ..++.++|||||||++|+|++ |.+||...++.+.+..+...... ..+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~---- 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV---KLFK---- 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc---ccCC----
Confidence 345788999999998531 235789999999999999997 57899887777766665432110 0000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
......+++.+.+||..|+ .||.+|||+.++++
T Consensus 232 --------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 232 --------------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred --------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0001124567789999999 78999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=324.76 Aligned_cols=206 Identities=25% Similarity=0.350 Sum_probs=172.4
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
....++|.-.+.||+|+||.||+|....+ ..||||.+....... ...+.+|+.+|.+++|||+|+|++||..... .
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~ 146 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-H 146 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-e
Confidence 34557888889999999999999998754 889999886654321 3458899999999999999999999975443 6
Q ss_pred EEEEEeccccchHHHHHHHhhcCC-cCCHHHHHHHHHHHHHHHHHHHhCC---cccccccccceeecCCCcEEEeccCCc
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQ-VFIPGEVKCLMQQLLNAVAHLHDNW---ILHRDLKTSNLLLSHRGILKVGDFGLA 513 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~-~~se~ev~~il~QLl~AL~yLHs~g---IVHRDLKPeNILLd~~g~lKL~DFGlA 513 (1028)
.+||+|||.. |+|-+.+..... .++|.....|+.+++.||.|||... |||||||++|||||.+++.||+|||+|
T Consensus 147 ~~LVYEym~n--GsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa 224 (361)
T KOG1187|consen 147 RLLVYEYMPN--GSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLA 224 (361)
T ss_pred EEEEEEccCC--CCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCc
Confidence 9999999986 667666666555 7899999999999999999999966 999999999999999999999999999
Q ss_pred cccCCCCCccccc-ccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy18163 514 REYGSPLKHYTPI-VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK 570 (1028)
Q Consensus 514 r~~~~~~~~~t~~-vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~ 570 (1028)
+............ .||.+|+|||.+.. ...+.++|||||||+|+||+||+.+.+..
T Consensus 225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 6654311222222 89999999999976 56899999999999999999999888753
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=325.63 Aligned_cols=264 Identities=23% Similarity=0.381 Sum_probs=207.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-----cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-----EGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-----~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|-++++||+|+|+.||+|.+...+++||+|+-...+.+ .++.....+|..|.+.|.||.||++|++|.-. .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-t 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-T 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-c
Confidence 47899999999999999999999999999999997665432 23334567899999999999999999998654 3
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecC---CCcEEEecc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSH---RGILKVGDF 510 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~---~g~lKL~DF 510 (1028)
+.+|-|+|||+|+-.++ ++ .....+++.+++.|+.||+.||.||.... |||-||||.||||-+ .|.+||+||
T Consensus 541 dsFCTVLEYceGNDLDF--YL-KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDF--YL-KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccceeeeeecCCCchhH--HH-HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 57999999999832222 22 23557899999999999999999999875 999999999999953 578999999
Q ss_pred CCccccCCCCC-------cccccccCccccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy18163 511 GLAREYGSPLK-------HYTPIVVTLWYRSPELLLGC---KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580 (1028)
Q Consensus 511 GlAr~~~~~~~-------~~t~~vGT~~Y~APEvL~g~---~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~ 580 (1028)
||++...+... ......||.||++||+|.-. ...+.++||||+|||+|.+|.|+.||..+.....+.+.-
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 99998754321 12346899999999998532 347889999999999999999999997654322222111
Q ss_pred HhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 581 ~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
.++ +.....|+.- +.++.++++||.+||.+--..|+.+.++..||||.
T Consensus 698 TIl---------------kAtEVqFP~K------------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 698 TIL---------------KATEVQFPPK------------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred chh---------------cceeccCCCC------------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 111 0111122221 34788999999999999999999999999999996
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=325.27 Aligned_cols=282 Identities=32% Similarity=0.565 Sum_probs=212.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECC---CCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKR---TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~---tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~ 437 (1028)
..|.++++||+|+|++||++.+.. ..++||+|.+.... .+..+..|+++|..+. +.||+.+.+.+ .+.++
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~--rnnd~ 109 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCF--RNNDQ 109 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhh--ccCCe
Confidence 569999999999999999999987 78899999997653 3456789999998875 89999998776 45679
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEeccCCcccc
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLAREY 516 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~DFGlAr~~ 516 (1028)
+++||||+++ ....+.+. .++..+++.|++.++.||.++|.+|||||||||.|||++. .+.-.|+|||||..+
T Consensus 110 v~ivlp~~~H--~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 110 VAIVLPYFEH--DRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eEEEecccCc--cCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 9999999998 33333222 2557789999999999999999999999999999999984 567889999999722
Q ss_pred CC----------------C-----------------C-----------CcccccccCccccCcccccCCCCCCchhhHHH
Q psy18163 517 GS----------------P-----------------L-----------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWS 552 (1028)
Q Consensus 517 ~~----------------~-----------------~-----------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWS 552 (1028)
.. + . .......||++|+|||++..+...++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 00 0 0 00013478999999999999999999999999
Q ss_pred HHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCC--------C--CCCC--CCCChhhhhhccccC--CCCCC----
Q psy18163 553 VGCIFAEFLCMEPL-FTGKSDLEQLSRIFKTMGTPNE--------K--IWPG--FSKLPAVQKMTFAEY--PNVGG---- 613 (1028)
Q Consensus 553 LGvILyELLTG~pP-F~g~sd~d~l~kI~~~lg~p~~--------~--~w~~--~s~lp~~~~l~~~~~--p~~~~---- 613 (1028)
.|||++-++++..| |...++.+.+..|+..+|.-.. . +|.. +..++... ..|... .....
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~-~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELR-VNFETLHIESIYKSRQP 342 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHH-hchhccChhhccccccc
Confidence 99999999999865 5667788888888887765321 1 3321 00111110 001111 00000
Q ss_pred -CccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 614 -LKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 614 -l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..........+..+.|||.+||++||.+|+||+++|.||||.+
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 1112223446668999999999999999999999999999984
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=338.19 Aligned_cols=204 Identities=34% Similarity=0.473 Sum_probs=173.2
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----CCeE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----MDKI 438 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~~~l 438 (1028)
.|...+.||+|+||.||+++++.||+.||||.++.... ........+|+++|++++|+|||+++++-.... ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 45667889999999999999999999999999987553 223445678999999999999999988755444 4567
Q ss_pred EEEEeccccchHHHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec--CCC--cEEEeccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRS--KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS--HRG--ILKVGDFGL 512 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~--~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd--~~g--~lKL~DFGl 512 (1028)
++|||||.+ |+|...+.. +...+++.++..++..|..||.|||++|||||||||.||++- .+| ..||+|||.
T Consensus 93 vlvmEyC~g--GsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSG--GSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCC--CcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999987 566555543 234589999999999999999999999999999999999984 233 579999999
Q ss_pred ccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK 570 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~ 570 (1028)
|+.+.+. ..+++++||+.|.+||++...+.|+..+|.|||||++|+++||..||...
T Consensus 171 Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 171 ARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9998765 57899999999999999985578999999999999999999999999653
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=331.70 Aligned_cols=263 Identities=25% Similarity=0.425 Sum_probs=217.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeec---CCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGS---NMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~---~~~ 436 (1028)
.+-|++...||.|.||.||+++++.+++.+|+|++..... ....+..|.++|+.. .|||++.++++|... .++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 3669999999999999999999999999999999876532 334455678888775 599999999998743 467
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+|||||||++ +.-+|+..+. +..+.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||.+..
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 89999999986 6667777665 66789999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccccccCccccCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGC----KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~----~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+.......++++|||.|||||++... ..|+..+|+||||++..||.-|.|||-...+.-.+..| ...|++..-
T Consensus 173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPkLk 249 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPKLK 249 (953)
T ss_pred eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcccc
Confidence 88777777889999999999999542 34778899999999999999999999766554443333 222222110
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
-+..-+..+.+||..||.+|-.+||+..++|.|||+++.+
T Consensus 250 ---------------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 250 ---------------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred ---------------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 0112356788999999999999999999999999998643
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=323.95 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=206.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCe---E-EEEEEeeccc-cccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDE---I-VALKRLKMEK-EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~---~-VAIKvlk~~~-~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++-.+.++||+|+||.||+|.....+. . ||+|..+... ........+++|..+|++++|||||.+|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~- 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE- 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-
Confidence 4556677999999999999998875422 3 8999988632 33344567789999999999999999999886544
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.++||||+|.| |+|.++++.....++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||||++.
T Consensus 235 -Pl~ivmEl~~g--GsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 -PLMLVMELCNG--GSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred -ccEEEEEecCC--CcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 79999999998 788888877776789999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
-..........-....|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+...+|........
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~------- 383 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP------- 383 (474)
T ss_pred CcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC-------
Confidence 4311111111235678999999987 479999999999999999998 8899999999988888854211100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+..+..++.+|+..||+.|||+.++.+
T Consensus 384 ------------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 ------------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ------------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 00124466778999999999999999999876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=320.55 Aligned_cols=278 Identities=22% Similarity=0.370 Sum_probs=185.9
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEEC----------------CCCeEEEEEEeeccccc------------cCCccchH
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDK----------------RTDEIVALKRLKMEKEK------------EGFPITSL 409 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~----------------~tg~~VAIKvlk~~~~~------------~~~~~~~l 409 (1028)
....++|.+.++||+|+||+||+|.+. ..++.||||.+...... ........
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 346789999999999999999999753 23567999998654211 01122334
Q ss_pred HHHHHHHHcCCCCe-----eEEEEEEeec------CCCeEEEEEecccc-chHHHHHHHh------------hc------
Q psy18163 410 REINTLLKAQHPNI-----VTVREIVVGS------NMDKIFIVMDYVEH-DMKSLMETMR------------SK------ 459 (1028)
Q Consensus 410 rEi~iL~~l~HPNI-----V~L~~i~~~~------~~~~l~LVmEy~~g-dLgsLl~~l~------------~~------ 459 (1028)
.|+.++.++.|.++ +.++++|... .....+|||||+.+ +|.+++.... ..
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777777776654 5555555422 23468999999986 5555553210 00
Q ss_pred --CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccc--cccCccccCc
Q psy18163 460 --KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP--IVVTLWYRSP 535 (1028)
Q Consensus 460 --~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~--~vGT~~Y~AP 535 (1028)
...+.+..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++....... .... ..+|+.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence 1123456788999999999999999999999999999999999999999999997653321 1222 2448899999
Q ss_pred ccccCCCC-------------------CC--chhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 536 ELLLGCKE-------------------YS--TPIDMWSVGCIFAEFLCMEP-LFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 536 EvL~g~~~-------------------ys--~ksDIWSLGvILyELLTG~p-PF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
|++..... |+ ..+||||+|||||+|++|.. ||.+............ . ....|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~---~-~~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD---N-DLNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc---c-hHHHHHh
Confidence 99854211 22 24799999999999999984 7754322111100000 0 0001110
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCc---CCCCCHHHHHhCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDP---VTRITADEALRHDYFSE 656 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP---~kRPTA~ElL~HPfF~e 656 (1028)
+.. ....+. .....++.++|||.+||..+| .+|+|+.|+|+||||..
T Consensus 456 ~~~----~~~~~~------------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YKG----QKYDFS------------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hcc----cCCCcc------------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 000000 123367889999999999876 68999999999999953
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=335.49 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=206.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCC-----eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTD-----EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg-----~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.+.-++...||+|.||.||.|....-. ..||||.++.... ......+++|..+|.++.|||||++++++.. .
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--S 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecC--C
Confidence 356788999999999999999876432 2499999876543 3345678899999999999999999999976 4
Q ss_pred CeEEEEEeccccchHHHHHHHhhc------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEec
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSK------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGD 509 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~D 509 (1028)
...+|++|||.+ |+|+.++++. ...++..+...++.+|+.|+.||+++++|||||-..|+||+....+||+|
T Consensus 768 ~~~~i~leyM~g--GDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEG--GDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhccc--CcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 478999999998 7888888776 56688999999999999999999999999999999999999999999999
Q ss_pred cCCccccCC-CCCcccc-cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q psy18163 510 FGLAREYGS-PLKHYTP-IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTP 586 (1028)
Q Consensus 510 FGlAr~~~~-~~~~~t~-~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p 586 (1028)
||||+.+-. ....... ..-...|||||.|.. ..++.++|||||||+|||++| |..||.+.++.+.+.-..+.-.-+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 999994422 1111111 122457999999987 679999999999999999998 889999999988887665531111
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ...+++.+.+||..|++.+|+.||++..|++
T Consensus 925 ~--------------------------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 P--------------------------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred C--------------------------------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 0 1235667889999999999999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=278.18 Aligned_cols=243 Identities=38% Similarity=0.606 Sum_probs=193.2
Q ss_pred CcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecccc-chHHH
Q psy18163 374 TYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSL 452 (1028)
Q Consensus 374 ~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~g-dLgsL 452 (1028)
+||.||+|.+..++..||+|++........ ...+.+|+..+..++|+||+++++++... ...++||||+.+ +|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 589999999999999999999976543221 35667899999999999999998887543 589999999987 55554
Q ss_pred HHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccccccCccc
Q psy18163 453 METMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWY 532 (1028)
Q Consensus 453 l~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y 532 (1028)
+.. .. .++...+..++.+|+.+|.|||+.+|+|+||+|.||+++.++.++|+|||++....... ......++..|
T Consensus 78 ~~~---~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~ 152 (244)
T smart00220 78 LKK---RG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEY 152 (244)
T ss_pred HHh---cc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCC
Confidence 432 22 27888999999999999999999999999999999999999999999999998775432 34556789999
Q ss_pred cCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCC
Q psy18163 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVG 612 (1028)
Q Consensus 533 ~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~ 612 (1028)
++||++.+ ..++.++||||||+++|+|++|..||....+...+....... .....
T Consensus 153 ~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~---~~~~~--------------------- 207 (244)
T smart00220 153 MAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP---KPPFP--------------------- 207 (244)
T ss_pred CCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc---CCCCc---------------------
Confidence 99999876 567889999999999999999999998744433333322210 00000
Q ss_pred CCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 613 GLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 613 ~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.....++..+.+|+.+||..||.+||++.++++||||
T Consensus 208 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 208 -----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -----cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0000145678899999999999999999999999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.30 Aligned_cols=265 Identities=22% Similarity=0.313 Sum_probs=208.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHH-cCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~-l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++.+-+..||.|+||+|++..++.+|+..|||.|+.... .....+++.|.+...+ -.+||||++|+..+.+. ..||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWi 140 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWI 140 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceee
Confidence 456667889999999999999999999999999987654 2234456677766544 56999999999875443 5799
Q ss_pred EEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 441 VMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
.||+|.-+|..|+.....- ...+++..+-.|....+.||.||... .||||||||+||||+..|.+||||||++..+..
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9999998888877766432 44578888888999999999999965 799999999999999999999999999987644
Q ss_pred CCCcccccccCccccCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCK-EYSTPIDMWSVGCIFAEFLCMEPLFTGKSD-LEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~-~ys~ksDIWSLGvILyELLTG~pPF~g~sd-~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. -..+.-.|...|||||.+.... .|+-.+|+||||++|||+.||..|+.+-+. .+++.+++. |.|+.-..
T Consensus 221 S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~----- 292 (361)
T KOG1006|consen 221 S-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLF----- 292 (361)
T ss_pred H-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecC-----
Confidence 2 2334567888999999996533 499999999999999999999999987543 344444433 22221111
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....-..+..++.||.-||.+|-..||...+++.+||++..
T Consensus 293 --------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 293 --------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred --------------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 01112356778999999999999999999999999999854
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=328.64 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=204.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..+.++.+.||+|.||+||+|+.. .....||||.++.... ......+.+|+.+|..++|||||+|++++. .+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~--~~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCR--EG 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEc--cC
Confidence 456678899999999999999864 3346899999986653 224567889999999999999999999995 45
Q ss_pred CeEEEEEeccccchHHHHHHHhhcC---------C----cCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKK---------Q----VFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~---------~----~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~ 502 (1028)
+.+|||||||.+ |||-+.++... . +++..+...|+.||+.|+.||-++.+|||||-..|+||+.+
T Consensus 562 ~P~~MvFEYm~~--GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 562 DPLCMVFEYMDH--GDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred CeeEEEEEeccc--ccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 589999999986 66666555321 2 27788999999999999999999999999999999999999
Q ss_pred CcEEEeccCCccccCCC-CCccc-ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy18163 503 GILKVGDFGLAREYGSP-LKHYT-PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRI 579 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~-~~~~t-~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI 579 (1028)
..|||+||||++.+-+. ..... ...-...|||||.|+- ..|++++||||+||+|||+++ |..||.+.++.+.+..|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 99999999999865432 11111 2234678999999988 569999999999999999997 88999999999999988
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHH
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL 649 (1028)
.... .|+ .....+..+.+|+..|+..+|.+||++.||=
T Consensus 719 ~~g~------lL~--------------------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAGQ------LLS--------------------------CPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcCC------ccc--------------------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 6531 111 1123567889999999999999999999984
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=326.76 Aligned_cols=398 Identities=22% Similarity=0.264 Sum_probs=283.6
Q ss_pred EeeecCcEEEEEEEE---CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEEEEEec
Q psy18163 369 RIEEGTYGVVYRAKD---KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIFIVMDY 444 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d---~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~LVmEy 444 (1028)
.+|.|+||.|++++- ...+..||+|++++.............|..++..++ ||.+|.+...| +....++++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhh
Confidence 379999999998754 356788999999877654433334456777787777 99999997655 455589999999
Q ss_pred cccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCccc
Q psy18163 445 VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT 524 (1028)
Q Consensus 445 ~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t 524 (1028)
+.+ ++++..+.. ...+.+..++.+...++.+++++|..+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 79 ~rg--g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 79 LRG--GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred ccc--chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 987 777776643 44578889999999999999999999999999999999999999999999999987643222
Q ss_pred ccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhc
Q psy18163 525 PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604 (1028)
Q Consensus 525 ~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~ 604 (1028)
.|||..|||||++.+ +..++|+||||+++|+|+||..||.+ +.+..|.+..-.
T Consensus 153 -~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~------------------- 205 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE------------------- 205 (612)
T ss_pred -cccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC-------------------
Confidence 299999999999974 78899999999999999999999988 666666652110
Q ss_pred cccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCCCCCCCCCCCCCccchhHHHhh
Q psy18163 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKK 679 (1028)
Q Consensus 605 ~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p~p~~p~~~pt~p~~~~~~~~~ 679 (1028)
+...++..+.+|+..|+..+|..|.. +.++++|+||+...|. +...+.
T Consensus 206 --------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~-------------~l~~r~ 258 (612)
T KOG0603|consen 206 --------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN-------------ELEARS 258 (612)
T ss_pred --------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh-------------hHhhcC
Confidence 11236778999999999999999984 5899999999875332 111111
Q ss_pred hhcCCCCCCCCCCCcccccccc-c-----cccccccccCC-CCCCcccccccccchhhHHhhhcCCCCCCCCCCCCCccc
Q psy18163 680 AAMASPKPPSGGHNYKQLEDNE-E-----GFHMGMMERSR-APVPGFSWGELDQDVDMEIELEKDTLPPYLPAIQGCRSV 752 (1028)
Q Consensus 680 ~~~~sp~pp~gg~~~~~~~~~~-~-----~~~~~~~~~~~-~~~pGFSl~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (1028)
+ .+.++|.++...-....+.+ . .-.......+. ..+-||++....-.- ....-...
T Consensus 259 ~-~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~il~----------------~~~~~~~~ 321 (612)
T KOG0603|consen 259 R-PPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPGVLE----------------DAVTAPFT 321 (612)
T ss_pred C-CCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChHHhh----------------ccccCCcc
Confidence 1 11122221111000011110 0 00000011111 223455444433000 00111134
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------cccCCchhhhhhHhhhcCcCcEEEEecC-CC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------WLENFPSRIRTYHLQVESELNHLVTENP-GG 821 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------~~~~~p~~vr~~e~~~~~~~~hlV~E~~-~G 821 (1028)
+.|++...||+|+|++|..|.+..|++..|+|.|.+... ....|||++...+++.+....|+|||.+ ||
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG 401 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence 679999999999999999999999999999999986521 1126899999999999999999999988 77
Q ss_pred CCCcccCCCCCCCCCCCchhhhhhcc
Q psy18163 822 PLNKKEQPKWRPMQISNPSTKLRQAR 847 (1028)
Q Consensus 822 ~L~~~~~~~~~~~~~~~~~~~~~~~~ 847 (1028)
.|.+.+.+.-.. -++-+.|++|.-
T Consensus 402 ell~ri~~~~~~--~~e~~~w~~~lv 425 (612)
T KOG0603|consen 402 ELLRRIRSKPEF--CSEASQWAAELV 425 (612)
T ss_pred HHHHHHHhcchh--HHHHHHHHHHHH
Confidence 888877753222 255566777643
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=301.56 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=200.8
Q ss_pred eEEEEEeeecCcEEEEEEEECCC----CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRT----DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~t----g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..+.++||.|-||.||.|....- .--||||..+.+....+ ...++.|..+|+++.||||++|++++.. ..+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e---~P~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeec---ccee
Confidence 34557899999999999986432 33699999987655443 6678999999999999999999999954 4689
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||++. +|.|..++..+...++......|+.||+.||.|||++.+|||||-..|||+....-|||+|||+++.+.+.
T Consensus 467 ivmEL~~--~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 467 IVMELAP--LGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEEeccc--chhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 9999996 48888888888888888889999999999999999999999999999999999999999999999988654
Q ss_pred CCccccccc--CccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 520 LKHYTPIVV--TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 520 ~~~~t~~vG--T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. -+....| ..-|||||.+.- ..+++++|||.|||++||+|. |..||.+..+.|.+-.|-+.-..|
T Consensus 545 ~-yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP---------- 612 (974)
T KOG4257|consen 545 A-YYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP---------- 612 (974)
T ss_pred c-hhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC----------
Confidence 2 2222233 557999999865 669999999999999999875 889999977666554442211111
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
..+.+++.+..|+.+|+.+||.+||++.+|..
T Consensus 613 ----------------------~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 613 ----------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ----------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 12346778889999999999999999887754
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=306.20 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=211.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCC-C--eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRT-D--EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~t-g--~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
+..++.++||+|.||+|++|.+... | ..||||+++...... ....+++|+.+|.+|+|+|+++||+++.+ ..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc---chh
Confidence 4556678999999999999988643 3 479999998766543 44578999999999999999999999965 368
Q ss_pred EEEEeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
.||||++.. |+|+++++. ....|.......|+.||+.|+.||.++++|||||-..||||-....||||||||.+-++
T Consensus 186 mMV~ELapl--GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 186 MMVFELAPL--GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hHHhhhccc--chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999975 999999987 45668888889999999999999999999999999999999999999999999999887
Q ss_pred CCCCcccc---cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPLKHYTP---IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~~~~t~---~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.....|.. .-....|+|||.|.. ..++.++|+|++||+||||++ |.-||.|.....++.+|-+.-..+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp------- 335 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP------- 335 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC-------
Confidence 65544421 223567999999976 569999999999999999998 679999999888877763211000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
-...+++++.+++..|+..+|..|||+..|...-++.+
T Consensus 336 -------------------------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 336 -------------------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred -------------------------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 01236788999999999999999999999876545443
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=316.84 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=188.2
Q ss_pred EEeeecCcEE-EEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGV-VYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~-Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
+.+|.|+-|+ ||+|... |+.||||.+-.+. .....+||..|+... |||||+++ +...+...+||.+|.|
T Consensus 515 eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyy--c~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE--GREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYY--CSEQDRQFLYIALELC 585 (903)
T ss_pred HHcccCCCCcEEEEEeeC--CceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEE--eeccCCceEEEEehHh
Confidence 5689999886 7999885 7899999886443 334578999998874 99999984 5556777899999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---C--CcEEEeccCCccccCCCC
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---R--GILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~--g~lKL~DFGlAr~~~~~~ 520 (1028)
..+|.++++.-.........-+.+.++.|++.||++||+.+||||||||.||||.. + ..++|+|||+|+.+....
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999998762000000111346889999999999999999999999999999975 3 368999999999886543
Q ss_pred C---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 521 K---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 521 ~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG-~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. ...+..||-+|+|||+|.. ..-+.++||||||||+|..++| ..||...-. .-..|+.... .
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~-----------~ 731 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNY-----------T 731 (903)
T ss_pred chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCcc-----------c
Confidence 2 3456789999999999987 3457799999999999999987 799975432 2223332100 0
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
+ ....+....++.|||.+||.+||..||+|.++|.||||-.
T Consensus 732 L-------------------~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 732 L-------------------VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred e-------------------eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 0 0001111227899999999999999999999999999964
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=302.84 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=214.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCC---eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTD---EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg---~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.....+.+.||.|.||.||+|+.+..+ ..||||.++.... +.....++.|..||-++.||||+.|.+++... ..
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks--~P 704 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS--KP 704 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecC--ce
Confidence 445678899999999999999998666 4799999986543 44567789999999999999999999998544 47
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+.||.|||+. +.|-.+++.+.+.|+.-+..-+++.|+.|++||-+.|+|||||-..|||++.+-.+||+||||++.+.
T Consensus 705 vMIiTEyMEN--GsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 705 VMIITEYMEN--GSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred eEEEhhhhhC--CcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 8999999987 66666677777779999999999999999999999999999999999999999999999999999886
Q ss_pred CCC-Cccccccc--CccccCcccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPL-KHYTPIVV--TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL-CMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~-~~~t~~vG--T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELL-TG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
+.. ..+++.-| ...|.|||.|.- ..++.++||||+|++|||.+ .|.-||..-++.+.+..|-+....|++..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD--- 858 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD--- 858 (996)
T ss_pred cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC---
Confidence 544 33444333 468999999976 56999999999999999966 49999999999999999987655444322
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.+..+..|+..|+++|-++||.+.+|+.+
T Consensus 859 -----------------------------CP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 859 -----------------------------CPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -----------------------------CcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 44667899999999999999999999874
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=291.04 Aligned_cols=257 Identities=21% Similarity=0.298 Sum_probs=200.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+...+.++||+|-||.|.+|.-.. +..||+|.++..... +....+..||.+|.+|+||||+.|++++..+ +.+|+|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchHHH
Confidence 346788999999999999998763 689999999866543 2356788999999999999999999998754 479999
Q ss_pred EeccccchHHHHHHHhhcCCcC-CHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVF-IPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~-se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
+|||+. |+|-..+....-+. .-.....|+.||+.|+.||.+.++|||||-+.|+|++.++++||+|||+++.+-+..
T Consensus 614 ~EYmEn--GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 614 TEYMEN--GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHhc--CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999986 55555554432222 233456699999999999999999999999999999999999999999999553321
Q ss_pred --CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 521 --KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL--CMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 521 --~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELL--TG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
..-...+-...|||||.|+- ..+++++|+|+||+++||++ |...||...++.+........+........
T Consensus 692 yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~----- 765 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV----- 765 (807)
T ss_pred ceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee-----
Confidence 11123455788999999887 46999999999999999975 577999888887776665544322221111
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
-.....++..+..||.+|+.+|-.+||+++++-.
T Consensus 766 --------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 766 --------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1112335667889999999999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=317.33 Aligned_cols=253 Identities=18% Similarity=0.233 Sum_probs=182.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
..|...+.||+|+||.||+|++..++..||||.+..... ....|+.++.+++|||||++++++... ...|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEE
Confidence 346677899999999999999999999999999864321 223578899999999999999998644 478999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH---DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLH---s~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||+.+ ++|.+.+. .+++..+..|+.||+.||.||| +.+|+||||||+|||++.++..+++ ||.+.....
T Consensus 762 ~Ey~~~--g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEG--KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCC--CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999986 44444432 2678889999999999999999 6699999999999999998888775 666544321
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcC-CCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL-EQLSRIFKTMG-TPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~-d~l~kI~~~lg-~p~~~~w~~~s~ 596 (1028)
.....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||...... ..+........ ......|
T Consensus 835 ----~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 904 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW----- 904 (968)
T ss_pred ----CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe-----
Confidence 123478999999999887 66999999999999999999999999542210 11111111100 0000000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
..+..... ..........+.+|+.+||..||.+|||+.++++.
T Consensus 905 -------~~~~~~~~-----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 -------IDPSIRGD-----VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -------eCccccCC-----CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000000 00001112356789999999999999999999874
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=264.28 Aligned_cols=217 Identities=20% Similarity=0.376 Sum_probs=182.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
++...+..||.|+||.|-+.++..+|...|+|.+..... .....+.++|+++.... .+|++|.+|+.+... ..++|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwI 122 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWI 122 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEE
Confidence 445567889999999999999999999999999986643 22345567788876554 699999999866433 47999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
.||.|.-+|..++......+..+++..+-.|+..++.||.|||++ .|||||+||+||||+..|++||||||++-.+.+.
T Consensus 123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 999999999999888888888999999999999999999999987 6999999999999999999999999999877543
Q ss_pred CCcccccccCccccCcccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLG---CKEYSTPIDMWSVGCIFAEFLCMEPLFTG-KSDLEQLSRIFKT 582 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g---~~~ys~ksDIWSLGvILyELLTG~pPF~g-~sd~d~l~kI~~~ 582 (1028)
. ..+-..|.-.|||||.+.. ...|+-++||||||+.+.||.+++.||.. .++.+++.++++.
T Consensus 203 i-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 203 I-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred h-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 2 2233467778999999843 34699999999999999999999999976 6788999998874
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=291.86 Aligned_cols=203 Identities=27% Similarity=0.388 Sum_probs=174.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc------CCccchHHHHHHHHHcC---CCCeeEEEEEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE------GFPITSLREINTLLKAQ---HPNIVTVREIV 430 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~------~~~~~~lrEi~iL~~l~---HPNIV~L~~i~ 430 (1028)
...+|..+..||+|+||.|++|.++.....|+||.|.+++.-. ...-+.--||+||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3467999999999999999999999999999999998775211 11223446999999987 99999999998
Q ss_pred eecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEecc
Q psy18163 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDF 510 (1028)
Q Consensus 431 ~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DF 510 (1028)
. +.+.+||+||--+.. -+|++.+.. ...+.|.+++.|++||+.|+++||+.||||||||-+|+.++.+|-+||+||
T Consensus 639 E--ddd~yyl~te~hg~g-IDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 639 E--DDDYYYLETEVHGEG-IDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred e--cCCeeEEEecCCCCC-cchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 5 556899999988752 344444432 456899999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy18163 511 GLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT 568 (1028)
Q Consensus 511 GlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~ 568 (1028)
|.|....+ ..+..++||..|.|||+|.|.++.+..-|||+||++||.++....||.
T Consensus 715 gsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987764 456788999999999999998888999999999999999999988874
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=300.04 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=210.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|+++..+|.|+||.||+|+++.+++..|+|+++...... ...+..||-+++.++|||||.+++.|... +.+++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~--dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhh--cCcEE
Confidence 378999999999999999999999999999999999875432 23445789999999999999998887544 47999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
+||||++ ++|-+ +..-.+++++.++..+++..+.||+|||+.|=+|||||-.|||++..|.+||+|||.+..++.-.
T Consensus 90 cMEycgg--gslQd-iy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 90 CMEYCGG--GSLQD-IYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEecCC--Ccccc-eeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999997 44433 22345678999999999999999999999999999999999999999999999999998887666
Q ss_pred CcccccccCccccCcccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 KHYTPIVVTLWYRSPELL--LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL--~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
....++.||+.|||||+- .....|+..+|||++|+...|+---.+|.........+..+-+....|+.. .
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l--------k 238 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL--------K 238 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc--------c
Confidence 666789999999999985 223569999999999999999988787765544444443333322111100 0
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
....-++.+.+|+..+|.++|++|||++-+|.|||...
T Consensus 239 --------------------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 239 --------------------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred --------------------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 00113567889999999999999999999999999864
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=281.42 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=195.9
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
+..+.++||-|-||.||.|.+++....||||.++.+.. ....++.|..+|+.+.|||+|+|+++|..+. .+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep--PFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--PFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCC--CeEEEE
Confidence 45677899999999999999999999999999986543 2356789999999999999999999996543 789999
Q ss_pred eccccchHHHHHHHhhcCC-cCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEHDMKSLMETMRSKKQ-VFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~-~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||.. |.|+++++.... .++.-....++-||..|+.||..+++|||||-..|+|+..+..|||+||||++.... .
T Consensus 343 EfM~y--GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg--D 418 (1157)
T KOG4278|consen 343 EFMCY--GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG--D 418 (1157)
T ss_pred ecccC--ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC--C
Confidence 99976 777777776543 344445566778999999999999999999999999999999999999999998753 3
Q ss_pred ccccccc---CccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 522 HYTPIVV---TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 522 ~~t~~vG---T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.|+...| ..-|.|||-|.- ..++.++|||+|||+|||+.| |-.||.|-+-......+-+. +.
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-----------yR-- 484 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-----------YR-- 484 (1157)
T ss_pred ceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-----------cc--
Confidence 4555555 456999999865 458999999999999999987 67999886543333222111 00
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
|.- ...+++.+..|+..|+.++|..||++.|+-+
T Consensus 485 -----M~~--------------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 485 -----MDG--------------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -----ccC--------------CCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 000 0125677889999999999999999988743
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=239.94 Aligned_cols=213 Identities=38% Similarity=0.582 Sum_probs=178.7
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEeccc-cc
Q psy18163 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE-HD 448 (1028)
Q Consensus 370 LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~-gd 448 (1028)
||.|.||.||++.+..++..+++|++....... ....+.+|+..+..+.|++|+++++++... ...+++|||+. ++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 689999999999999889999999997654321 234567899999999999999999888543 58999999999 46
Q ss_pred hHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEeccCCccccCCCCCcccccc
Q psy18163 449 MKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLAREYGSPLKHYTPIV 527 (1028)
Q Consensus 449 LgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~DFGlAr~~~~~~~~~t~~v 527 (1028)
|.+++.. ....++...+..++.+|+.+|.+||+.|++|+||+|.||+++. ++.++|+|||++..............
T Consensus 78 l~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 78 LKDLLKE---NEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 6555543 2245788899999999999999999999999999999999999 89999999999987654322234456
Q ss_pred cCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcccc
Q psy18163 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAE 607 (1028)
Q Consensus 528 GT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~ 607 (1028)
+...|++||.+.....++.+.|+|+||+++|+|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 788999999987743788999999999999999
Q ss_pred CCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCC
Q psy18163 608 YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHD 652 (1028)
Q Consensus 608 ~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HP 652 (1028)
..+.++|.+||..||.+||++.++++|+
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1245899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=283.26 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=196.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEEC---C----CCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeec
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDK---R----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGS 433 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~---~----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~ 433 (1028)
++..+.+.||+|.||.||+|... . ....||||.++..... .....+..|+++|..+. |+||+.|++.+..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 34456679999999999999743 1 1457999999866544 34456788999999885 9999999998865
Q ss_pred CCCeEEEEEeccccchHHHHHHHhhcC---------------CcCCHHHHHHHHHHHHHHHHHHHhCCccccccccccee
Q psy18163 434 NMDKIFIVMDYVEHDMKSLMETMRSKK---------------QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLL 498 (1028)
Q Consensus 434 ~~~~l~LVmEy~~gdLgsLl~~l~~~~---------------~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNIL 498 (1028)
...+++|+||+.. |+|+..++..+ ..++..+...++.||+.|++||++..+|||||-..|||
T Consensus 374 -~~~~~~v~Ey~~~--G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEH--GDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred -CCceEEEEEeccC--CcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 5689999999987 66666666655 34888899999999999999999999999999999999
Q ss_pred ecCCCcEEEeccCCccccCCCCCcc-ccccc--CccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-hH
Q psy18163 499 LSHRGILKVGDFGLAREYGSPLKHY-TPIVV--TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKS-DL 573 (1028)
Q Consensus 499 Ld~~g~lKL~DFGlAr~~~~~~~~~-t~~vG--T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~s-d~ 573 (1028)
|..+..+||+|||+|+.......-. ....| ...|||||.+.. ..|+.++||||+||+||||++ |..||.+-. ..
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 9999999999999998654321111 11222 345999999988 679999999999999999998 779998844 44
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 574 EQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 574 d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+.+..+.... . +. .....+.+..+|+..|+..+|.+||++.++..
T Consensus 530 ~l~~~l~~G~-----------r-------~~--------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 ELLEFLKEGN-----------R-------ME--------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHhcCC-----------C-------CC--------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4433232210 0 00 01235678889999999999999999999876
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=263.32 Aligned_cols=207 Identities=26% Similarity=0.332 Sum_probs=162.5
Q ss_pred cCCCCCCCCccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHH--HHHcCCCC
Q psy18163 345 KDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINT--LLKAQHPN 422 (1028)
Q Consensus 345 ~~~lp~y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~i--L~~l~HPN 422 (1028)
......-+|.+.......+..+++.||+|.||.||+|.++ |+.||||++..... ....+|.+| -..|+|+|
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHEN 266 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHEN 266 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch-----hhhhhHHHHHHHHHhccch
Confidence 3334445666666666778999999999999999999997 88899999975432 233455544 45579999
Q ss_pred eeEEEEEEeecC--CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-----C---cccccc
Q psy18163 423 IVTVREIVVGSN--MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-----W---ILHRDL 492 (1028)
Q Consensus 423 IV~L~~i~~~~~--~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-----g---IVHRDL 492 (1028)
|+.+++.-..++ -..++||.+|.+. |+|++++.. ..++...+..++..++.||.|||.. | |.||||
T Consensus 267 ILgFIaaD~~~~gs~TQLwLvTdYHe~--GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 267 ILGFIAADNKDNGSWTQLWLVTDYHEH--GSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred hhhhhhccccCCCceEEEEEeeecccC--CcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 999876543322 2469999999986 888888754 4578888999999999999999953 3 999999
Q ss_pred cccceeecCCCcEEEeccCCccccCCCC----CcccccccCccccCcccccCCCC-----CCchhhHHHHHHHHHHHHh
Q psy18163 493 KTSNLLLSHRGILKVGDFGLAREYGSPL----KHYTPIVVTLWYRSPELLLGCKE-----YSTPIDMWSVGCIFAEFLC 562 (1028)
Q Consensus 493 KPeNILLd~~g~lKL~DFGlAr~~~~~~----~~~t~~vGT~~Y~APEvL~g~~~-----ys~ksDIWSLGvILyELLT 562 (1028)
|..|||+..+|..-|+|||||....... ...+..+||-.|||||+|...-. --..+||||||.|+||++.
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9999999999999999999997665432 23567899999999999965221 1135899999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=238.51 Aligned_cols=210 Identities=36% Similarity=0.555 Sum_probs=171.4
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
|.+.+.||.|+||.||++.+..++..||||.+...... .....+.+|+..+..+.|+|++.+++++... ...++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEe
Confidence 66789999999999999999988999999999765432 1234567899999999999999998887543 57899999
Q ss_pred cccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC-C
Q psy18163 444 YVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL-K 521 (1028)
Q Consensus 444 y~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~-~ 521 (1028)
|+.+ +|.+++.. ....+++..+..++.+++.+|.|||+++|+|+||+|.||+++.++.++|+|||++..+.... .
T Consensus 78 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRK---KGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9987 55555443 22227888899999999999999999999999999999999999999999999998775432 1
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHH
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG-KSDL-EQLSRI 579 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g-~sd~-d~l~kI 579 (1028)
......++..|++||++.+...++.++|||+||+++|+|++|+.||.. .++. .+...|
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 234567888999999984446688899999999999999999999977 4444 334444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=268.96 Aligned_cols=197 Identities=24% Similarity=0.354 Sum_probs=156.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHH--HHHHHHcCCCCeeEEEEEEeecC--C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLRE--INTLLKAQHPNIVTVREIVVGSN--M 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrE--i~iL~~l~HPNIV~L~~i~~~~~--~ 435 (1028)
.+...+++.+||+|.||.||+|... ++.||||++..... ..+..| |.-+-.+.|+||++++..-...+ .
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k-----qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK-----QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH-----HHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 3567888999999999999999885 69999999976532 223444 44445678999999865543222 3
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC---------CcccccccccceeecCCCcEE
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN---------WILHRDLKTSNLLLSHRGILK 506 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~---------gIVHRDLKPeNILLd~~g~lK 506 (1028)
-.++||++|... |+|.+++..+ .+++.+...++..|+.||+|||+. .|+|||||..||||.++++..
T Consensus 281 ~eywLVt~fh~k--GsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 281 MEYWLVTEFHPK--GSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred cceeEEeeeccC--CcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 368999999875 6666666543 578999999999999999999963 399999999999999999999
Q ss_pred EeccCCccccCC--CCCcccccccCccccCcccccCCCCCC-----chhhHHHHHHHHHHHHhCCCCC
Q psy18163 507 VGDFGLAREYGS--PLKHYTPIVVTLWYRSPELLLGCKEYS-----TPIDMWSVGCIFAEFLCMEPLF 567 (1028)
Q Consensus 507 L~DFGlAr~~~~--~~~~~t~~vGT~~Y~APEvL~g~~~ys-----~ksDIWSLGvILyELLTG~pPF 567 (1028)
|+|||||..+.. +.......+||..|||||+|.|.-.+. ..+||||+|.+||||++....+
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999999987742 223334579999999999998865554 3689999999999999876544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-28 Score=300.71 Aligned_cols=202 Identities=17% Similarity=0.238 Sum_probs=144.4
Q ss_pred cCC-CCeeEEEEEEee-----cCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q psy18163 418 AQH-PNIVTVREIVVG-----SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491 (1028)
Q Consensus 418 l~H-PNIV~L~~i~~~-----~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRD 491 (1028)
+.| .||+.++++|.. .....++++|||++++|.+++. .....+++.+++.|+.||+.||.|||++||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLD---NPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHh---cccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 344 577777776521 1224688899999877766664 3345689999999999999999999999999999
Q ss_pred ccccceeecC-------------------CCcEEEeccCCccccCCCC----------------CcccccccCccccCcc
Q psy18163 492 LKTSNLLLSH-------------------RGILKVGDFGLAREYGSPL----------------KHYTPIVVTLWYRSPE 536 (1028)
Q Consensus 492 LKPeNILLd~-------------------~g~lKL~DFGlAr~~~~~~----------------~~~t~~vGT~~Y~APE 536 (1028)
|||+||||+. ++.+||+|||+++...... ......+||++|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999954 3456666777765421100 0011246899999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCcc
Q psy18163 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKT 616 (1028)
Q Consensus 537 vL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~ 616 (1028)
++.+ ..|+.++||||||||||||++|.+||.... ..+..+.... .++ ..
T Consensus 186 ~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~~-------------------------- 234 (793)
T PLN00181 186 EDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-QI-------------------------- 234 (793)
T ss_pred hhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-hh--------------------------
Confidence 9987 568999999999999999999998875422 1222221110 000 00
Q ss_pred ccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 617 KVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 617 ~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..-...+.+|+.+||..||.+|||+.++|+||||.+.
T Consensus 235 ----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 235 ----LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred ----hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0012335689999999999999999999999999763
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=279.62 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=203.4
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCe----EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDE----IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~----~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..+..++||.|+||+||+|.+.-.|+ +||||++..... ......+++|+.+|..+.|||+++|++++..+. +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST---L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch---H
Confidence 35567899999999999999865554 789998865433 233567889999999999999999999986554 7
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
-||++|+.. |.|+++++..+..+-..+...|..||++||.|||.+.+|||||-..|||+..-.++||+|||+|+.+..
T Consensus 773 qlvtq~mP~--G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 773 QLVTQLMPL--GCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHhccc--chHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 899999986 888888888888888899999999999999999999999999999999999999999999999998876
Q ss_pred CCCccccccc--CccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVV--TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~~~~t~~vG--T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
....++...| .+-|||=|.+.. ..|+.++|||||||++|||+| |..|+.+..-.++ ..+++.- ..
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~g---eR------- 918 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEKG---ER------- 918 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhcc---cc-------
Confidence 6666554444 566999998877 679999999999999999998 8899988765443 2333210 00
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+ ...++.+-++.-++.+||..|+..||+++++..
T Consensus 919 ---------L------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 ---------L------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ---------C------------CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0 012346677889999999999999999998865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=227.62 Aligned_cols=262 Identities=33% Similarity=0.534 Sum_probs=203.1
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-CccchHHHHHHHHHcCCC-CeeEEEEEEeecCCCeEEEE
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-FPITSLREINTLLKAQHP-NIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-~~~~~lrEi~iL~~l~HP-NIV~L~~i~~~~~~~~l~LV 441 (1028)
|.+...||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+.+++++. .....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEE
Confidence 788999999999999999998 7799999987655443 456678899999999988 7999998884 33358999
Q ss_pred EeccccchHHHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-cEEEeccCCccccCC
Q psy18163 442 MDYVEHDMKSLMETMRSKK--QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYGS 518 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~--~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-~lKL~DFGlAr~~~~ 518 (1028)
++|+.+ +.+...+.... ..+....+..++.||+.+|.|+|+.+++||||||+|||++..+ .++++|||+++.+..
T Consensus 77 ~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 77 MEYVDG--GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred EecCCC--CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 999987 33443333322 2688899999999999999999999999999999999999888 799999999986544
Q ss_pred CCC------cccccccCccccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC-
Q psy18163 519 PLK------HYTPIVVTLWYRSPELLLGC--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---LEQLSRIFKTMGTP- 586 (1028)
Q Consensus 519 ~~~------~~t~~vGT~~Y~APEvL~g~--~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---~d~l~kI~~~lg~p- 586 (1028)
... .....+||..|+|||++.+. ..+....|+||+|++++++++|..||..... .......+.....+
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 321 34678999999999999874 5789999999999999999999999888764 33344433332221
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..... . .. ........+.+++..|+..+|..|.+..+...++|+..
T Consensus 235 ~~~~~---~-------------~~--------~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 235 LASPL---S-------------PS--------NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred ccccc---C-------------cc--------ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 00000 0 00 00112346789999999999999999999999977654
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=247.17 Aligned_cols=258 Identities=22% Similarity=0.278 Sum_probs=187.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l 438 (1028)
..+.|.+.+.||+|.||.+.+|+++.++..++||.+..... ....+.+|...---| .|.||+.-|++. +++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~va-Fqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVA-FQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHH-hhcCceE
Confidence 45789999999999999999999999999999999976532 234456666543333 389999887654 4566789
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC--CCcEEEeccCCcccc
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH--RGILKVGDFGLAREY 516 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~--~g~lKL~DFGlAr~~ 516 (1028)
++++||+.. |+|-..+... .+-+...+.++.||++||.|||++++||||||.+||||-. .-.|||||||+.+..
T Consensus 98 vF~qE~aP~--gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 98 VFVQEFAPR--GDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEeeccCcc--chhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999975 6776655443 3677788999999999999999999999999999999953 347999999999877
Q ss_pred CCCCCcccccccCccccCcccccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCK----EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ-LSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~----~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~-l~kI~~~lg~p~~~~w 591 (1028)
+..... .--+..|.+||++.... ...+.+|||.||+|+|.+|||.+||......+. ..+.....+...+
T Consensus 174 g~tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~--- 247 (378)
T KOG1345|consen 174 GTTVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP--- 247 (378)
T ss_pred Cceehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---
Confidence 643222 12355699999874321 246789999999999999999999974322111 1111111111111
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCC---CCHHHHHhCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR---ITADEALRHDYF 654 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kR---PTA~ElL~HPfF 654 (1028)
..| .....+++.+..+..+.|..+|++| -++......-|.
T Consensus 248 ---------------~~P--------~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 248 ---------------ALP--------KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ---------------cCc--------hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 111 1123477889999999999999999 566666666664
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=225.74 Aligned_cols=165 Identities=21% Similarity=0.248 Sum_probs=125.3
Q ss_pred chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCcccccc
Q psy18163 448 DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527 (1028)
Q Consensus 448 dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~v 527 (1028)
+|.+++ ...+..+++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 2 sL~~~l---~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 2 SLADIL---EVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred cHHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 444444 334556999999999999999999999999 999999999999999 9999876432 237
Q ss_pred cCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCCCCCCChhhhhhccc
Q psy18163 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE-QLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606 (1028)
Q Consensus 528 GT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d-~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~ 606 (1028)
||+.|+|||++.+ ..|+.++|||||||++|||++|.+||....... .+..+....... ......
T Consensus 66 g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~----------- 130 (176)
T smart00750 66 VDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---DPRDRS----------- 130 (176)
T ss_pred CcccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---Cccccc-----------
Confidence 8999999999987 668999999999999999999999997654432 222332211100 000000
Q ss_pred cCCCCCCCccccccccccH--HHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 607 EYPNVGGLKTKVAGSILTE--LGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 607 ~~p~~~~l~~~~~~~~Ls~--~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
....++. .+.+||.+||..||.+|||+.+++.|+|+.
T Consensus 131 ------------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 131 ------------NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ------------cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0011222 578999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-25 Score=267.24 Aligned_cols=266 Identities=26% Similarity=0.359 Sum_probs=192.7
Q ss_pred CCe-EEEEEeeecCcEEEEEEEECCCCeEEEEEEeecc----ccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 362 EEF-KCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME----KEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 362 d~Y-~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~----~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
+.| .....+|.|+||.|+.+......+.++.|..... .........+..|+.+-..+.|||++....++.. ..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--ID 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cc
Confidence 335 4567899999999999988877777777765421 1111111114456666677889998776554432 22
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
..+-+||||..||.+++.. ...+...++.+++.||+.||.|||+.||.|||||++|+|+...|.+||+|||.+..+
T Consensus 395 ~~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 395 GILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred cchhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence 3334499998766555543 235788899999999999999999999999999999999999999999999999765
Q ss_pred CCCC----CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 517 GSPL----KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 517 ~~~~----~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
..+. ......+|+..|+|||++.+..+....+||||.|++++.|++|+.||......+.... ...+ ..|
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--~~~~----~~~- 543 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--TNNY----SDQ- 543 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--hhcc----ccc-
Confidence 4332 3356789999999999999866566789999999999999999999976543322210 0000 000
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+.. ..........|+...+.+|.+||++||.+|+|+++||+.+||+..
T Consensus 544 -~~~----------------~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 544 -RNI----------------FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred -ccc----------------ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 000 000112223466778899999999999999999999999999875
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=227.49 Aligned_cols=208 Identities=27% Similarity=0.267 Sum_probs=168.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCC-eEEEEEEeeccccccCCccchHHHHHHHHHcCC----CCeeEEEEEEeecCCCe
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTD-EIVALKRLKMEKEKEGFPITSLREINTLLKAQH----PNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg-~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H----PNIV~L~~i~~~~~~~~ 437 (1028)
.|++..+||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.++..+.. .++..+++... .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 8999999999999999999998775 68999988765432211 45678888888762 57888866553 34557
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC-----CcEEEeccCC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR-----GILKVGDFGL 512 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~-----g~lKL~DFGl 512 (1028)
-||||+.++.+|.+|..... ...|+...+..++.|++.+|.+||+.|+|||||||.|+++... ..+.|.|||+
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred eEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 89999999999999876543 4679999999999999999999999999999999999999864 4699999999
Q ss_pred cc--ccCCCC-------Cc-ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy18163 513 AR--EYGSPL-------KH-YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576 (1028)
Q Consensus 513 Ar--~~~~~~-------~~-~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l 576 (1028)
|+ .+.... .. ...+.||..|.++.+..+ ...+...|+||++.++.+|+.|..||.+.......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 98 332111 11 234669999999999988 66899999999999999999999999776644333
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=224.97 Aligned_cols=199 Identities=24% Similarity=0.367 Sum_probs=170.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
-.|++.++||+|+||++++|.+..++++||||.-..... ...+..|....+.| ..++|..+ ||+++++-+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~v--YYFGqeG~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQV--YYFGQEGKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCce--eeeccccchhhh
Confidence 369999999999999999999999999999998654322 22334566666655 47889887 566778778899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC-----CcEEEeccCCccc
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR-----GILKVGDFGLARE 515 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~-----g~lKL~DFGlAr~ 515 (1028)
|||+++.+|.+|++.. +..|+...+..++.|++.-|+|+|++.+|+|||||+|+||... ..|.|+|||+|+.
T Consensus 102 VidLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999999999875 6679999999999999999999999999999999999999754 3689999999999
Q ss_pred cCCCCC-------cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy18163 516 YGSPLK-------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK 570 (1028)
Q Consensus 516 ~~~~~~-------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~ 570 (1028)
+-++.. ...+..||..||+=.-.+| .+.+...|+-|||-+++.+|.|..||.|-
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hcCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 876532 2356789999999998888 77899999999999999999999999884
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=234.15 Aligned_cols=170 Identities=21% Similarity=0.138 Sum_probs=129.3
Q ss_pred ccccccCCeEEEEEeeecCcEEEEEEEECC-CCeEEEEEEeecccc---ccCCccchHHHHHHHHHcCCCCeeEEEEEEe
Q psy18163 356 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKR-TDEIVALKRLKMEKE---KEGFPITSLREINTLLKAQHPNIVTVREIVV 431 (1028)
Q Consensus 356 ~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~-tg~~VAIKvlk~~~~---~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~ 431 (1028)
+.....+.|.+.+.||+|+||+||+|++.. ++..||||++..... .......+.+|+.+|..+.|+||+..+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 334456789999999999999999999876 788889998753311 111234467999999999999998532111
Q ss_pred ecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccc-cccceeecCCCcEEEecc
Q psy18163 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDL-KTSNLLLSHRGILKVGDF 510 (1028)
Q Consensus 432 ~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDL-KPeNILLd~~g~lKL~DF 510 (1028)
+..|||||||.+ ++|. .+. . .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+||
T Consensus 91 ----~~~~LVmE~~~G--~~L~-~~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 ----GKDGLVRGWTEG--VPLH-LAR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred ----CCcEEEEEccCC--CCHH-HhC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 357999999987 3332 111 1 11 2568899999999999999999999 999999999999999999
Q ss_pred CCccccCCCC--------CcccccccCccccCcccccC
Q psy18163 511 GLAREYGSPL--------KHYTPIVVTLWYRSPELLLG 540 (1028)
Q Consensus 511 GlAr~~~~~~--------~~~t~~vGT~~Y~APEvL~g 540 (1028)
|+|+.+.... ...++.++++.|+|||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9998764432 12246788999999999853
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=251.85 Aligned_cols=225 Identities=31% Similarity=0.473 Sum_probs=168.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
-++|+.+++|-.|+||-||+++++.+.+.+|+|+-+... ||+ ||.. |. +..++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------------ilR-----nilt----~a----~npfv 134 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------------ILR-----NILT----FA----GNPFV 134 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch--------------hhh-----cccc----cc----CCcce
Confidence 368999999999999999999999999999995433211 121 1222 11 12334
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
| +|-..++.. -+.++.. ++.+++|||+-||+|||+||+|+||..-|++|++|||+++......
T Consensus 135 v-----gDc~tllk~----~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 135 V-----GDCATLLKN----IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred e-----chhhhhccc----CCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 3 333344332 1233322 2779999999999999999999999999999999999987432110
Q ss_pred -------------C--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q psy18163 521 -------------K--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 521 -------------~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
. .-...|||+.|+||||+.. +.|+..+|||+||+|+|++|.|..||.+.+..+.+..++....
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i- 275 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI- 275 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-
Confidence 0 0124699999999999987 6799999999999999999999999999999998888776432
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC---CHHHHHhCCCCCCCCCC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI---TADEALRHDYFSESPLP 660 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP---TA~ElL~HPfF~e~p~p 660 (1028)
.|+.- ...+.+++.++|..||+.+|..|. .+-++.+|+||+.-.|-
T Consensus 276 ----~wpE~-------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 276 ----EWPEE-------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ----ccccc-------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 22211 122667899999999999999997 67788999999865443
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=209.16 Aligned_cols=202 Identities=26% Similarity=0.303 Sum_probs=165.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCC-CCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH-PNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H-PNIV~L~~i~~~~~~~~l~ 439 (1028)
...|+++++||.|+||.+|+|....+|+.||||+-..... ......|..+...+++ ..|..++.+. .+...-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhc--cccccce
Confidence 4689999999999999999999999999999998765432 1234567777777764 4555554333 4455779
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEeccCCcccc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDFGLAREY 516 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DFGlAr~~ 516 (1028)
|||++++.+|.+|+... ...|+...+.-++.|++.-|+|+|.+++|||||||+|+|+.- ...+.|+|||+|+.+
T Consensus 88 lVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999999999876 345888899999999999999999999999999999999973 457999999999977
Q ss_pred CCC-------CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q psy18163 517 GSP-------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD 572 (1028)
Q Consensus 517 ~~~-------~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd 572 (1028)
.+. ...-....||..|.+=-...+ ...+...|+-|+|.+|..+..|..||.+-..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 542 223456789999999888777 5678999999999999999999999998543
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=221.55 Aligned_cols=254 Identities=20% Similarity=0.251 Sum_probs=189.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCC-----eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTD-----EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg-----~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
+++++...+-+|+||.||.|.++... +.|-+|.++.... .-....++.|-.+|..+.|||+..+.++.... ..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cC
Confidence 45888889999999999999876433 2355565543322 11223456777778888999999999887654 45
Q ss_pred eEEEEEeccc-cchHHHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccC
Q psy18163 437 KIFIVMDYVE-HDMKSLMETMRS----KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFG 511 (1028)
Q Consensus 437 ~l~LVmEy~~-gdLgsLl~~l~~----~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFG 511 (1028)
..++++.+++ +||..++...+. ..+.++..+...++.||+.|+.|||++||||.||-..|++|+..-++||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 6788888887 366665554332 12345666788899999999999999999999999999999999999999999
Q ss_pred CccccCCCCCcc--cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 512 LAREYGSPLKHY--TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 512 lAr~~~~~~~~~--t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
+++.+-....++ ....-...||+||.+.+ ..|+.++|+|||||+||||+| |+.|+..-++.++...+.+...
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR---- 516 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR---- 516 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce----
Confidence 998653221111 11123557999999988 679999999999999999998 8899988888776655533210
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+. ..-.+++++..++..|+..+|+.||+..|+..
T Consensus 517 -la---------------------------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 -LA---------------------------QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -ec---------------------------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 00 00126678899999999999999999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=208.25 Aligned_cols=240 Identities=21% Similarity=0.278 Sum_probs=151.6
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCc-cchHHHHHHHHHcC----------CCCeeEEEEEEe
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFP-ITSLREINTLLKAQ----------HPNIVTVREIVV 431 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~-~~~lrEi~iL~~l~----------HPNIV~L~~i~~ 431 (1028)
.+.....||.|+|+.||.+.+..||+.+|||++.......... ..+.+|.-....+. |-.++.-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4567788999999999999999999999999986554221111 12222222221111 111111111111
Q ss_pred ----------ecCCC-----eEEEEEeccccchHHHHHHHhhcCCc-CCHH-HH-HHHHHHHHHHHHHHHhCCccccccc
Q psy18163 432 ----------GSNMD-----KIFIVMDYVEHDMKSLMETMRSKKQV-FIPG-EV-KCLMQQLLNAVAHLHDNWILHRDLK 493 (1028)
Q Consensus 432 ----------~~~~~-----~l~LVmEy~~gdLgsLl~~l~~~~~~-~se~-ev-~~il~QLl~AL~yLHs~gIVHRDLK 493 (1028)
..... +.+++|+-+.+||..++..+...... .... .+ ..+..|++..+++||+.||||+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 01001 35889999999999998887655433 1111 22 3455899999999999999999999
Q ss_pred ccceeecCCCcEEEeccCCccccCCCCCcccccccCccccCcccccCC-------CCCCchhhHHHHHHHHHHHHhCCCC
Q psy18163 494 TSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC-------KEYSTPIDMWSVGCIFAEFLCMEPL 566 (1028)
Q Consensus 494 PeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~-------~~ys~ksDIWSLGvILyELLTG~pP 566 (1028)
|+|||++.+|.++|+||+.....+... .....+..|.+||+.... ..++.+.|.|+||++||.|.||..|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999999999988776432 113456779999976331 2478899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCC
Q psy18163 567 FTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR 642 (1028)
Q Consensus 567 F~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kR 642 (1028)
|....... ...+ .+..+. .+++..++||..||..||.+|
T Consensus 250 f~~~~~~~----------------~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEA----------------DPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGS----------------TSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccc----------------cccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 97643210 0000 112233 477889999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=194.58 Aligned_cols=144 Identities=22% Similarity=0.243 Sum_probs=107.3
Q ss_pred EEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCC-------cc-----------------chHHHHHHHHHcCCCC
Q psy18163 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF-------PI-----------------TSLREINTLLKAQHPN 422 (1028)
Q Consensus 367 l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~-------~~-----------------~~lrEi~iL~~l~HPN 422 (1028)
...||+|+||.||+|.+. +|+.||||+++........ .. ....|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8999999999765321111 00 1124889999998777
Q ss_pred eeEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH-HhCCcccccccccceeecC
Q psy18163 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL-HDNWILHRDLKTSNLLLSH 501 (1028)
Q Consensus 423 IV~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yL-Hs~gIVHRDLKPeNILLd~ 501 (1028)
+.....+.. . ..+|||||+++. .+..... ....++..++..++.||+.+|.|| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~--~--~~~iVmE~i~g~--~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL--K--SHVLVMEFIGDD--GWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe--c--CCEEEEEEeCCC--CCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 643322221 1 238999999873 2222211 234688889999999999999999 799999999999999998
Q ss_pred CCcEEEeccCCccccCCC
Q psy18163 502 RGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 502 ~g~lKL~DFGlAr~~~~~ 519 (1028)
++.++|+|||+|.....+
T Consensus 153 ~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CCcEEEEEccccccCCCc
Confidence 588999999999765443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=186.96 Aligned_cols=143 Identities=20% Similarity=0.197 Sum_probs=108.7
Q ss_pred EEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCC------------------------ccchHHHHHHHHHcCCCC
Q psy18163 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF------------------------PITSLREINTLLKAQHPN 422 (1028)
Q Consensus 367 l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~------------------------~~~~lrEi~iL~~l~HPN 422 (1028)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 8999999999865321000 001236888899999998
Q ss_pred eeEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecC
Q psy18163 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSH 501 (1028)
Q Consensus 423 IV~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~ 501 (1028)
|.....+... ..||||||+++. .+...... ...++..++..++.||+.+|.+||. .||+||||||+|||++
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~--~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDD--GSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCC--Cchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 7654433322 248999999873 11111111 2346778899999999999999999 9999999999999998
Q ss_pred CCcEEEeccCCccccCC
Q psy18163 502 RGILKVGDFGLAREYGS 518 (1028)
Q Consensus 502 ~g~lKL~DFGlAr~~~~ 518 (1028)
++.++|+|||+|.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.7e-20 Score=195.52 Aligned_cols=173 Identities=12% Similarity=0.167 Sum_probs=129.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-Cccc------hHHHHHHHHHcCCCCeeEEEEEEeec
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-FPIT------SLREINTLLKAQHPNIVTVREIVVGS 433 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-~~~~------~lrEi~iL~~l~HPNIV~L~~i~~~~ 433 (1028)
..+|++++.||.|+||.||++.. ++..||||++........ .... +.+|+..+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999755 366799999975432221 1111 45888899999999999998886533
Q ss_pred C------CCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEE
Q psy18163 434 N------MDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILK 506 (1028)
Q Consensus 434 ~------~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lK 506 (1028)
. ....+|||||++| +|.++. .+++ ..+.+|+.+|..||..||+|+||||.|||++.+| ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 2 2358999999997 443331 1222 3466999999999999999999999999999988 99
Q ss_pred EeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHH
Q psy18163 507 VGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL 561 (1028)
Q Consensus 507 L~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELL 561 (1028)
|+|||......... ... -+++. ..|+.++|||||||++..+.
T Consensus 175 liDfg~~~~~~e~~-a~d-----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRK-AKD-----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchh-hHH-----------HHHHH-hHhcccccccceeEeehHHH
Confidence 99999987553221 110 02333 45778999999999987654
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-20 Score=225.88 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=173.2
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC--CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG--FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~--~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+|...+.||.+.|=+|.+|++.. |. |+||++-+....-. .....++|+. ...+++||++++..+.+ .....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~--t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV--TDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH--hhHHHHH
Confidence 68889999999999999999874 44 99999865542211 1123345555 56678999999855433 3335688
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC--
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS-- 518 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~-- 518 (1028)
|-+|+.++|.+ ++. .+..+...+-+.|+.||+.||.-||..||+|+|||.+||||..-+-+.|+||...+..--
T Consensus 99 vRqyvkhnLyD---RlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 99 VRQYVKHNLYD---RLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHhhhhhh---hhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 99999876544 432 233355667889999999999999999999999999999999999999999988763211
Q ss_pred -CCCccccccc----CccccCcccccCCC----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q psy18163 519 -PLKHYTPIVV----TLWYRSPELLLGCK----------EYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKT 582 (1028)
Q Consensus 519 -~~~~~t~~vG----T~~Y~APEvL~g~~----------~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~ 582 (1028)
....++.+.- -..|+|||-|.... ..+++.||||+||+++||++ |.|||.- .+++.-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aY 247 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAY 247 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhH
Confidence 1122332222 34699999986522 15678999999999999987 6899942 222221
Q ss_pred cCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
-. +-...+ ...+. .+-+...+.||..|++.||.+|.+|++.|+-
T Consensus 248 r~--------~~~~~~---e~~Le--------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RS--------GNADDP---EQLLE--------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hc--------cCccCH---HHHHH--------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 000000 00011 1122346799999999999999999999984
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-21 Score=230.60 Aligned_cols=365 Identities=22% Similarity=0.259 Sum_probs=250.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-CCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l 438 (1028)
...|.+...||+|+|+.|-++... .+...+|+|.+............+-.|+.+-..+. |.|++.+++... .....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~--~~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS--SPRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC--CCccc
Confidence 346888899999999999999874 44557788877655422333333344666666666 999999977663 45578
Q ss_pred EEEEeccccchHHHHHHH-hhcCCcCCHHHHHHHHHHHHHHHHHHH-hCCcccccccccceeecCCC-cEEEeccCCccc
Q psy18163 439 FIVMDYVEHDMKSLMETM-RSKKQVFIPGEVKCLMQQLLNAVAHLH-DNWILHRDLKTSNLLLSHRG-ILKVGDFGLARE 515 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l-~~~~~~~se~ev~~il~QLl~AL~yLH-s~gIVHRDLKPeNILLd~~g-~lKL~DFGlAr~ 515 (1028)
+++++|..+ ++++..+ ......++...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..
T Consensus 97 ~~~~~~s~g--~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 97 LLSLSYSDG--GSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccCcccc--cccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999765 6666665 332224667789999999999999999 99999999999999999999 999999999987
Q ss_pred cCC-C--CCccccccc-CccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 516 YGS-P--LKHYTPIVV-TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 516 ~~~-~--~~~~t~~vG-T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+.. . .......+| ++.|+|||.+.+........|+||+|+++.-|++|..|+......+.. ...|
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----------~~~~ 243 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----------YSSW 243 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----------ceee
Confidence 654 2 223445688 999999999988667788999999999999999999998664432200 0001
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCCCCCcc
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPA 671 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~pt~p~ 671 (1028)
.... .......+..++..+.+++.++|..+|..|.+.+++..+||+....
T Consensus 244 ~~~~-----------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~------------- 293 (601)
T KOG0590|consen 244 KSNK-----------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKR------------- 293 (601)
T ss_pred cccc-----------------cccccCccccCChhhhhcccccccCCchhccccccccccccccccc-------------
Confidence 1000 0000112234667788999999999999999999999999997500
Q ss_pred chhHHHhhhhcCCCCCCCCCCCccccccccccccccccccCCCCCCcccccccccchhhHHhhhcCCCCCCCCCCCCCcc
Q psy18163 672 KSELAHKKAAMASPKPPSGGHNYKQLEDNEEGFHMGMMERSRAPVPGFSWGELDQDVDMEIELEKDTLPPYLPAIQGCRS 751 (1028)
Q Consensus 672 ~~~~~~~~~~~~sp~pp~gg~~~~~~~~~~~~~~~~~~~~~~~~~pGFSl~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (1028)
. ..+..+ .. .+. - .+ .....+|
T Consensus 294 --------------~-~~~~~n--~~-~~~--~---~~---~~~~~~~-------------------------------- 315 (601)
T KOG0590|consen 294 --------------N-GFSKSN--PC-ADS--L---TI---AKSPIGF-------------------------------- 315 (601)
T ss_pred --------------c-cccccc--cc-ccc--c---cc---ccCcccc--------------------------------
Confidence 0 000000 00 000 0 00 0000111
Q ss_pred ccce-eEeeeeeccceeEEEEEEEccCCcEEEeeecCC----Ccc---cc------------cCCchhhhhhHhhhcCcC
Q psy18163 752 VEEF-KCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGN----GKF---WL------------ENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 752 ~~~Y-~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~----~~~---~~------------~~~p~~vr~~e~~~~~~~ 811 (1028)
...| .....+|.|+||.|+.+....-...++.|..+. ... .. -.||+++....++.....
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 1234 345688999999998888888777777776541 100 00 047888777766655555
Q ss_pred cEEEEecCCCCCCcccC
Q psy18163 812 NHLVTENPGGPLNKKEQ 828 (1028)
Q Consensus 812 ~hlV~E~~~G~L~~~~~ 828 (1028)
..-+||||.+||+..+.
T Consensus 396 ~~~~mE~~~~Dlf~~~~ 412 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVM 412 (601)
T ss_pred chhhhhcccHHHHHHHh
Confidence 55559999779988554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=184.78 Aligned_cols=189 Identities=15% Similarity=0.075 Sum_probs=137.4
Q ss_pred EEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC--CccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEEEE
Q psy18163 365 KCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG--FPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 365 ~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~--~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.+...|+.|+||+||++.. .+..|+.+.+........ ....+.+|+.+|.++. |++|+.++++ +..|++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEE
Confidence 3567899999999997766 577788777765433111 0113568999999996 4788888764 246999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccc-cccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDL-KTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDL-KPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|+|+.| .+|.... .. ....++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.......
T Consensus 77 meyI~G--~~L~~~~-------~~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 77 RSYLAG--AAMYQRP-------PR-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EeeecC--ccHHhhh-------hh-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999987 3333221 11 12457889999999999999999999 7999999999999999999998654322
Q ss_pred Cc----c---------cccccCccccCcccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q psy18163 521 KH----Y---------TPIVVTLWYRSPELLLGCKEYS-TPIDMWSVGCIFAEFLCMEPLFTGKS 571 (1028)
Q Consensus 521 ~~----~---------t~~vGT~~Y~APEvL~g~~~ys-~ksDIWSLGvILyELLTG~pPF~g~s 571 (1028)
.. . .-...++.|++|+.-.-....+ ...++++.|+.+|.++|+..|+.+.+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0 0122578888888643322334 56789999999999999998876543
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-18 Score=189.42 Aligned_cols=196 Identities=23% Similarity=0.360 Sum_probs=138.9
Q ss_pred CCCCeeEEEEEEeec-------------------------CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHH
Q psy18163 419 QHPNIVTVREIVVGS-------------------------NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ 473 (1028)
Q Consensus 419 ~HPNIV~L~~i~~~~-------------------------~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~ 473 (1028)
.|||||.+...|.++ ....+|+||....++|..++.. ...+....+-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 499999998776532 1235899999999888777653 2245567888999
Q ss_pred HHHHHHHHHHhCCcccccccccceeecC--C--CcEEEeccCCccccCC---C---CCcccccccCccccCcccccCCCC
Q psy18163 474 QLLNAVAHLHDNWILHRDLKTSNLLLSH--R--GILKVGDFGLAREYGS---P---LKHYTPIVVTLWYRSPELLLGCKE 543 (1028)
Q Consensus 474 QLl~AL~yLHs~gIVHRDLKPeNILLd~--~--g~lKL~DFGlAr~~~~---~---~~~~t~~vGT~~Y~APEvL~g~~~ 543 (1028)
|++.|+.|||.+||.|||||.+||||.- + -.+.|+|||.|---.. . ....-..-|....||||+......
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999999999999999999952 3 3689999998742211 0 112234456778999999854221
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCcccc
Q psy18163 544 -----YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKV 618 (1028)
Q Consensus 544 -----ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~ 618 (1028)
.-.++|.|+.|.+.||+++...||.+..+...-.. .++...++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r--------------------~Yqe~qLPal---------- 478 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR--------------------TYQESQLPAL---------- 478 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechh--------------------hhhhhhCCCC----------
Confidence 12378999999999999999999977433211000 0111111222
Q ss_pred ccccccHHHHHHHHHhcccCcCCCCCHH---HHHh
Q psy18163 619 AGSILTELGYDLLCKFLTYDPVTRITAD---EALR 650 (1028)
Q Consensus 619 ~~~~Ls~~a~DLL~kcL~~DP~kRPTA~---ElL~ 650 (1028)
...+++.+++|+..+|+.||++|+++. .+|+
T Consensus 479 -p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 479 -PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -cccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 234678899999999999999999854 4554
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=206.77 Aligned_cols=196 Identities=24% Similarity=0.302 Sum_probs=152.7
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC---CCCeeEEEEEEeecC
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ---HPNIVTVREIVVGSN 434 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~---HPNIV~L~~i~~~~~ 434 (1028)
....+.|.|-+.||+|+||+||+|.... |+.||||+-+-....+-+.. .+ ++.+|+ -+.|..+...+++.+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~---~q--~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC---LQ--VMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh---HH--HHHhhchhhhcchHHHHHHHccCC
Confidence 3456789999999999999999999987 99999998876654433222 21 222222 233444433344444
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-------CCcEEE
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-------RGILKV 507 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-------~g~lKL 507 (1028)
..+||+||... |+|++.+. ....+.+..+..|+.|++..|+.||..+|||+||||+|+||.. .--++|
T Consensus 768 --~S~lv~ey~~~--Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 768 --ASVLVSEYSPY--GTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred --cceeeeecccc--ccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 56899999986 77777664 4556889999999999999999999999999999999999953 235999
Q ss_pred eccCCccccC--CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q psy18163 508 GDFGLAREYG--SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEP 565 (1028)
Q Consensus 508 ~DFGlAr~~~--~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~p 565 (1028)
+|||.+..+. .+...+...++|-.|-.+|+..| ..+++.+|.|.|..+++.||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999986432 22356778899999999999988 779999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=173.48 Aligned_cols=138 Identities=18% Similarity=0.154 Sum_probs=101.9
Q ss_pred EEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-----CCCCeeEEEEEEeecCC-CeEE-
Q psy18163 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-----QHPNIVTVREIVVGSNM-DKIF- 439 (1028)
Q Consensus 367 l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-----~HPNIV~L~~i~~~~~~-~~l~- 439 (1028)
...||+|+||.||. +..++.. +||++..... .....+.+|+.+++.+ .||||+.+++++....+ ..+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 36799999999995 7777665 6998876432 1234578999999999 57999999999976542 2334
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHH-HHHHhCCcccccccccceeecC----CCcEEEeccCCc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV-AHLHDNWILHRDLKTSNLLLSH----RGILKVGDFGLA 513 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL-~yLHs~gIVHRDLKPeNILLd~----~g~lKL~DFGlA 513 (1028)
+||||++..-++|.+.+... .+.+. ..++.|++.++ .|||+++||||||||+|||++. ++.++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999652114444444332 35554 46688888888 9999999999999999999974 348999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.6e-17 Score=177.94 Aligned_cols=148 Identities=18% Similarity=0.159 Sum_probs=108.8
Q ss_pred CeEEEEEeeecCcEEEEEEE-ECCCCeEEEEEEeeccccccC----------------------CccchHHHHHHHHHcC
Q psy18163 363 EFKCLNRIEEGTYGVVYRAK-DKRTDEIVALKRLKMEKEKEG----------------------FPITSLREINTLLKAQ 419 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~-d~~tg~~VAIKvlk~~~~~~~----------------------~~~~~lrEi~iL~~l~ 419 (1028)
-|.+.+.||+|+||.||+|. +..+|+.||||+++....... ......+|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999999 677899999999976432100 0012347999999987
Q ss_pred CCCeeEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC-ccccccccccee
Q psy18163 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW-ILHRDLKTSNLL 498 (1028)
Q Consensus 420 HPNIV~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g-IVHRDLKPeNIL 498 (1028)
+..+. +..++... ..+|||||+++. ++...+. ....+...++..++.||+.+|.+||+.| |+|+||||+|||
T Consensus 109 ~~~i~-~p~~~~~~---~~~lV~E~~~g~--~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVP-VPKPIAWR---RNVLVMEFIGGD--GLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCC-CCeeeEec---CceEEEEEecCC--ccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 63322 22222211 348999999982 2222111 1233556667899999999999999999 999999999999
Q ss_pred ecCCCcEEEeccCCccccCC
Q psy18163 499 LSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 499 Ld~~g~lKL~DFGlAr~~~~ 518 (1028)
++ ++.++|+|||+|...+.
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 88999999999976554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=163.83 Aligned_cols=136 Identities=26% Similarity=0.318 Sum_probs=104.9
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC------CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG------FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~------~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.||+|+||.||+|.+ .+..|+||+......... ......+|+.++..+.|++|.....++... ...++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEE
Confidence 5799999999999987 577799998653321110 012356789999999999887665555433 367899
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
|||+.| +|.+++.. . .. ....++.+|+.+|.+||+.||+|+||+|.|||++ ++.++|+|||++...
T Consensus 78 ~e~~~G~~L~~~~~~---~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 78 MEYIEGEPLKDLINS---N----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEeCCcCHHHHHHh---c----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999987 55544432 1 11 6788999999999999999999999999999999 789999999998753
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-17 Score=189.22 Aligned_cols=178 Identities=29% Similarity=0.432 Sum_probs=128.6
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
++||.|++|.. +|.+++.. +......+...+..++.||..|++| +|.+|||+||.||++..+..+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 58999999975 34444321 1223335667789999999999999 9999999999999999999999999999876
Q ss_pred cCCCC------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCC
Q psy18163 516 YGSPL------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL-EQLSRIFKTMGTPNE 588 (1028)
Q Consensus 516 ~~~~~------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~-d~l~kI~~~lg~p~~ 588 (1028)
..... ...+..+||.+||+||.|.+ ..|+.++||||||+|||||+. +|....+. ..+..+.. |..++
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~--g~ip~ 479 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRD--GIIPP 479 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhc--CCCCh
Confidence 54322 24567799999999999998 679999999999999999996 23221111 11111110 11110
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+|. -.+...+||.+||...|..||++.+.--|+|.
T Consensus 480 ~~~~------------------------------d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 480 EFLQ------------------------------DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHhh------------------------------cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1100 01234589999999999999988888888875
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-16 Score=169.01 Aligned_cols=245 Identities=18% Similarity=0.192 Sum_probs=183.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.....++.+|.+...|..|+|++.. ..++.|++............+-+|.-.|+-+.||||+.+++.+. ...++.+
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn--sppnlv~ 264 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN--SPPNLVI 264 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc--CCCCceE
Confidence 4456678889999999999999974 45778888776655555566777888899999999999988774 4458999
Q ss_pred EEeccccchHHHHHHHhhcC-CcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecCCCcEEE--eccCCccc
Q psy18163 441 VMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSHRGILKV--GDFGLARE 515 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~-~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~~g~lKL--~DFGlAr~ 515 (1028)
+..||.. ++|+..+.... ......++..++..|+.|+.|||+.. |.---|....++||.+-+.+| +|--++-.
T Consensus 265 isq~mp~--gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 265 ISQYMPF--GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eeeeccc--hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence 9999986 77777765543 23456789999999999999999986 545568889999998876665 33333211
Q ss_pred cCCCCCcccccccCccccCcccccCCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEY--STPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~y--s~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
. ....-.|.||+||.|...+.. -.++|||||.++||||.|...||..-++.+.-.+|.-. | ..
T Consensus 343 e-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale-g-lr------ 407 (448)
T KOG0195|consen 343 E-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE-G-LR------ 407 (448)
T ss_pred c-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc-c-cc------
Confidence 1 122346789999999774332 35799999999999999999999988877655554321 0 00
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHH
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL 649 (1028)
....+.++.....|+.-|+.-||.+||.++.++
T Consensus 408 -----------------------v~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 408 -----------------------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----------------------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 112234667788999999999999999887654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.1e-16 Score=160.47 Aligned_cols=139 Identities=18% Similarity=0.213 Sum_probs=104.1
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC--------------------CccchHHHHHHHHHcCCCC-
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG--------------------FPITSLREINTLLKAQHPN- 422 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~--------------------~~~~~lrEi~iL~~l~HPN- 422 (1028)
|.+.+.||.|+||.||+|.+. +|+.||||++........ ......+|+.++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999875 799999999865431000 0012456888888887774
Q ss_pred -eeEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC
Q psy18163 423 -IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501 (1028)
Q Consensus 423 -IV~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~ 501 (1028)
+..++. ....++||||+.+ .++.... . ......++.+|+.+|.++|..||+|+||||.||||+.
T Consensus 96 ~v~~~~~------~~~~~lv~e~~~g--~~L~~~~-~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPID------WNRHAVVMEYIDG--VELYRVR-V------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceee------cCCceEEEEEeCC--cchhhcc-c------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence 333322 1245899999987 2332211 0 1346778899999999999999999999999999999
Q ss_pred CCcEEEeccCCccccCC
Q psy18163 502 RGILKVGDFGLAREYGS 518 (1028)
Q Consensus 502 ~g~lKL~DFGlAr~~~~ 518 (1028)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-15 Score=156.82 Aligned_cols=133 Identities=25% Similarity=0.299 Sum_probs=98.1
Q ss_pred EeeecCcEEEEEEEECCCCeEEEEEEeeccccccC------CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG------FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 369 ~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~------~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
.||+|+||.||+|.. ++..|++|+......... ......+|+.++..+.|+++....-++... +..+|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEE
Confidence 389999999999985 567899998654321110 012345799999999888755444344332 3568999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
||+.+ .+|.+.+.... . .++.+|+.+|.+||+.||+|+||+|.|||++ ++.++|+|||++...
T Consensus 77 e~~~g--~~l~~~~~~~~-------~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEG--KPLKDVIEEGN-------D-ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECC--ccHHHHHhhcH-------H-HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99987 33433332111 1 7899999999999999999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-15 Score=154.54 Aligned_cols=138 Identities=21% Similarity=0.260 Sum_probs=97.4
Q ss_pred EEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccc----------------------hHHHHHHHHHcCCCC--
Q psy18163 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT----------------------SLREINTLLKAQHPN-- 422 (1028)
Q Consensus 367 l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~----------------------~lrEi~iL~~l~HPN-- 422 (1028)
.+.||+|+||+||+|.+. +++.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 8899999998754321111111 124555555554433
Q ss_pred eeEEEEEEeecCCCeEEEEEeccccc-h-HHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceee
Q psy18163 423 IVTVREIVVGSNMDKIFIVMDYVEHD-M-KSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLL 499 (1028)
Q Consensus 423 IV~L~~i~~~~~~~~l~LVmEy~~gd-L-gsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILL 499 (1028)
+..++.+ ...+|||||+.+. + ...+..+.. ..++..++.+++.++.+||. .||+|+||||+|||+
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~------~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRL------LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhh------cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 3333221 2459999999871 1 122222111 15688999999999999999 999999999999999
Q ss_pred cCCCcEEEeccCCccccCC
Q psy18163 500 SHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~ 518 (1028)
+ ++.++|+|||++.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.9e-15 Score=175.84 Aligned_cols=138 Identities=23% Similarity=0.229 Sum_probs=102.7
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc------CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE------GFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~------~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.|...+.||+|+||+||+|.+.... +++|+........ .....+.+|+.++..++|++|+..+.++... .
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~ 409 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--E 409 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--C
Confidence 3566788999999999999876443 4444332111110 0113456899999999999998876555432 3
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
..++||||+.+ ++|.+.+. ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 410 ~~~lv~E~~~g--~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGG--KDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCC--CcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 57899999987 34433332 356789999999999999999999999999999 6789999999999753
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.1e-14 Score=167.92 Aligned_cols=206 Identities=24% Similarity=0.313 Sum_probs=150.0
Q ss_pred HHHcCCCCeeEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCc-cccccc
Q psy18163 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI-LHRDLK 493 (1028)
Q Consensus 415 L~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gI-VHRDLK 493 (1028)
|+.+.|.|+.++++.+... ..+++|.+||.. |+|.+.+......+..--...+++.|+.||.|||..-| .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~r--Gsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSR--GSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecC--ccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence 3567899999999998765 589999999987 66666666656566777778899999999999998876 999999
Q ss_pred ccceeecCCCcEEEeccCCccccCC--CCCcccccccCccccCcccccCCCC------CCchhhHHHHHHHHHHHHhCCC
Q psy18163 494 TSNLLLSHRGILKVGDFGLAREYGS--PLKHYTPIVVTLWYRSPELLLGCKE------YSTPIDMWSVGCIFAEFLCMEP 565 (1028)
Q Consensus 494 PeNILLd~~g~lKL~DFGlAr~~~~--~~~~~t~~vGT~~Y~APEvL~g~~~------ys~ksDIWSLGvILyELLTG~p 565 (1028)
..|++++....+||+|||+...... .........-..-|.|||++.+... -+.+.||||+|+|+||+++..-
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999999876532 1111122223456999999876311 3567999999999999999999
Q ss_pred CCCCCC----hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC
Q psy18163 566 LFTGKS----DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT 641 (1028)
Q Consensus 566 PF~g~s----d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k 641 (1028)
||.... ..+.+..+.+ .+. ..+.|.. .. . . .+.+.+..++..|+..+|..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-~~~--~~~rP~i------~~-----------~-----~-e~~~~l~~l~~~cw~e~P~~ 210 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-GGS--NPFRPSI------EL-----------L-----N-ELPPELLLLVARCWEEIPEK 210 (484)
T ss_pred ccccccccCChHHHHHHHHh-cCC--CCcCcch------hh-----------h-----h-hcchHHHHHHHHhcccChhh
Confidence 997633 2223333322 111 0011100 00 0 0 23446779999999999999
Q ss_pred CCCHHHHHh
Q psy18163 642 RITADEALR 650 (1028)
Q Consensus 642 RPTA~ElL~ 650 (1028)
||+++++-.
T Consensus 211 rPs~~~i~~ 219 (484)
T KOG1023|consen 211 RPSIEQIRS 219 (484)
T ss_pred CccHHHHHh
Confidence 999998854
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.5e-15 Score=181.90 Aligned_cols=265 Identities=21% Similarity=0.290 Sum_probs=197.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
+.+.|.+.+-+-.|.|+.++.+.-..++...++|+......-.. .......+-+++..-.+|.++... +.+......
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~--~s~~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSF--PSFPCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceeccc--CCCCCCCCc
Confidence 56788899999999999999999988898888887765432221 122233343444334456666442 112355678
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+|||+|+++ ++|...+.... .....-++.++..+..+++|||...++|||++|.|+|+..+|+.+++|||.....+.
T Consensus 880 ~L~~~~~~~--~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 880 PLVGHYLNG--GDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred chhhHHhcc--CCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999987 66666655443 456667888999999999999999999999999999999999999999985433211
Q ss_pred C-------------------------------CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy18163 519 P-------------------------------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLF 567 (1028)
Q Consensus 519 ~-------------------------------~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF 567 (1028)
- ...-...+||+.|.+||.+++ ...+.++|+|++|+++++.|+|.+||
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 001123578999999999998 56899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHH-
Q psy18163 568 TGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD- 646 (1028)
Q Consensus 568 ~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~- 646 (1028)
+.......+..|... ..-|+.. ....+..+.+++..+|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~-----~~~~p~g-------------------------~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNR-----DIPWPEG-------------------------PEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred CCcchhhhhhccccC-----CCCCCCC-------------------------ccccChhhhhhhhhhhccCchhccCccc
Confidence 998877666554331 1123221 122567889999999999999999888
Q ss_pred --HHHhCCCCCCCCCC
Q psy18163 647 --EALRHDYFSESPLP 660 (1028)
Q Consensus 647 --ElL~HPfF~e~p~p 660 (1028)
++-.||||+..+|.
T Consensus 1086 ~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1086 AAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred ccccccCCccCCCCcc
Confidence 99999999987664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.2e-14 Score=134.70 Aligned_cols=132 Identities=23% Similarity=0.246 Sum_probs=104.1
Q ss_pred EEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCC--CCeeEEEEEEeecCCCeEEEEEe
Q psy18163 366 CLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH--PNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 366 il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H--PNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
+++.||.|.++.||++.... ..++||++..... ...+..|+.++..+.+ .+++.++.++.. .+..+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 35789999999999999854 6799998865432 3456789999999876 488888766543 357899999
Q ss_pred ccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC---CcccccccccceeecCCCcEEEeccCCccc
Q psy18163 444 YVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN---WILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 444 y~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~---gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
|+.+. .+.. ++......++.+++.+|.+||.. +|+|+||+|.|||++..+.++|+|||++..
T Consensus 74 ~~~g~--~~~~--------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGE--TLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCe--eccc--------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99862 1211 13345677889999999999985 699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-13 Score=146.76 Aligned_cols=137 Identities=17% Similarity=0.167 Sum_probs=98.5
Q ss_pred EEee-ecCcEEEEEEEECCCCeEEEEEEeecccc-----c------cCCccchHHHHHHHHHcCCCCe--eEEEEEEeec
Q psy18163 368 NRIE-EGTYGVVYRAKDKRTDEIVALKRLKMEKE-----K------EGFPITSLREINTLLKAQHPNI--VTVREIVVGS 433 (1028)
Q Consensus 368 ~~LG-~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-----~------~~~~~~~lrEi~iL~~l~HPNI--V~L~~i~~~~ 433 (1028)
..|| .|+.|+||.+... +..++||.+..... . ........+|+.++..+.|++| +..+.+....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 8888899988774 67799998853210 0 0112345689999999998875 5555543332
Q ss_pred CC--CeEEEEEecccc--chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEec
Q psy18163 434 NM--DKIFIVMDYVEH--DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGD 509 (1028)
Q Consensus 434 ~~--~~l~LVmEy~~g--dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~D 509 (1028)
.. ...+|||||+.+ +|..++. . ..+++. .+.||+.+|.+||++||+||||||.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~---~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQ---E--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHh---c--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 22 123699999985 4444432 2 234443 367899999999999999999999999999889999999
Q ss_pred cCCccc
Q psy18163 510 FGLARE 515 (1028)
Q Consensus 510 FGlAr~ 515 (1028)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999864
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-13 Score=162.16 Aligned_cols=256 Identities=21% Similarity=0.205 Sum_probs=185.2
Q ss_pred CCeEEEEEeee--cCcEEEEEEEE--CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCC
Q psy18163 362 EEFKCLNRIEE--GTYGVVYRAKD--KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 362 d~Y~il~~LG~--G~FG~Vyla~d--~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~ 436 (1028)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+...........-++|+....++. |+|.+..+..+. ..+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e--~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE--GSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc--cCC
Confidence 35677788999 99999999998 889999999985443332233334456766666654 888888655554 445
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHH----HHHHHHhCCcccccccccceeecCC-CcEEEeccC
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN----AVAHLHDNWILHRDLKTSNLLLSHR-GILKVGDFG 511 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~----AL~yLHs~gIVHRDLKPeNILLd~~-g~lKL~DFG 511 (1028)
.+|+-+|+|+.+|..+.. .....++...++.++.+... ||.++|+.+|+|-|+||.||++..+ ...+++|||
T Consensus 192 ~lfiqtE~~~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cceeeeccccchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 899999999865544443 33444777889999999999 9999999999999999999999988 889999999
Q ss_pred CccccCCCCCcccc-----cccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q psy18163 512 LAREYGSPLKHYTP-----IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586 (1028)
Q Consensus 512 lAr~~~~~~~~~t~-----~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p 586 (1028)
+...++...-.... ..|..-|++||++.+ -++...||++||.++.+-.++-.++...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g---------------- 330 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVG---------------- 330 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCC----------------
Confidence 99988764322111 245667999999877 4899999999999999988877554332
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
...+|..+.... .-.++ + ...+..+...+..||..||..|+++..+++|+|...
T Consensus 331 ---~~~~W~~~r~~~--ip~e~----------~-~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 331 ---KNSSWSQLRQGY--IPLEF----------C-EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ---CCCCcccccccc--Cchhh----------h-cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 001111111100 00000 1 112333445899999999999999999999999873
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.3e-12 Score=159.27 Aligned_cols=302 Identities=20% Similarity=0.236 Sum_probs=185.3
Q ss_pred HHHHHHHHcCCCCeeEEEEEEeecCCCe--EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC
Q psy18163 410 REINTLLKAQHPNIVTVREIVVGSNMDK--IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486 (1028)
Q Consensus 410 rEi~iL~~l~HPNIV~L~~i~~~~~~~~--l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g 486 (1028)
-|+..+.++.|+|++.++.|-...-... +.+..++|.. ++.+++.. -...+...++.+..+++.||.|+|+..
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3666788889999999876654322111 2233455554 33333332 345677889999999999999999996
Q ss_pred ccccccccc---ceeecCCCcEEEe--ccCCccccCCCCCcccccccCccccCcccccCCCCCCc--hhhHHHHHHHHHH
Q psy18163 487 ILHRDLKTS---NLLLSHRGILKVG--DFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST--PIDMWSVGCIFAE 559 (1028)
Q Consensus 487 IVHRDLKPe---NILLd~~g~lKL~--DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~--ksDIWSLGvILyE 559 (1028)
..|.=|... +..++..+.+.++ ||+....+....... ....+..+.++|.+.. ..+.. ..|+|.+|..+..
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-SDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccch-hhcCcccccccccccc-ccchhhhhhHHHHHHHHHhh
Confidence 555544444 3444556677777 999988776543333 2344556788887754 33443 3699999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCc
Q psy18163 560 FLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDP 639 (1028)
Q Consensus 560 LLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP 639 (1028)
+..|..+-... ..+...+ .........+++.+|+.-|+
T Consensus 385 ~~~~~~i~~~~------~~~~~~l------------------------------------~~~~~~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 385 LSQGEDISEKS------AVPVSLL------------------------------------DVLSTSELLDALPKCLDEDS 422 (1351)
T ss_pred hhhcCcccccc------cchhhhh------------------------------------ccccchhhhhhhhhhcchhh
Confidence 98876432110 0000000 00011145689999999999
Q ss_pred CCCCCHHHHHhCCCCCCCCCCCCCCCCCCCccchhHHHhhhhcCCCCCCCCCCCccccccccccccccccccCCCCCCcc
Q psy18163 640 VTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQLEDNEEGFHMGMMERSRAPVPGF 719 (1028)
Q Consensus 640 ~kRPTA~ElL~HPfF~e~p~p~~p~~~pt~p~~~~~~~~~~~~~sp~pp~gg~~~~~~~~~~~~~~~~~~~~~~~~~pGF 719 (1028)
.+|+++.++|.|+|.+....-... +-.|.. ... .+.-++
T Consensus 423 ~~Rl~~~~ll~~~f~~~~~~~~~~---------------------~~~~~~-------~~~-------------~~~~~~ 461 (1351)
T KOG1035|consen 423 EERLSALELLTHPFLRFPTDNESS---------------------EFAPND-------ETS-------------VPQFRL 461 (1351)
T ss_pred hhccchhhhhhchhcccccccccc---------------------cccCcc-------ccc-------------cCccCC
Confidence 999999999999998742110000 000000 000 001111
Q ss_pred cccccccchhhHHhhhcCCCCCCCCCCCCCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------
Q psy18163 720 SWGELDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------- 791 (1028)
Q Consensus 720 Sl~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------- 791 (1028)
..+..+ ++....+ .+-..+|+.+..||+|+||.||+++++..|..||||+|..+..
T Consensus 462 r~~~~~--------------s~~~r~~--SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~ 525 (1351)
T KOG1035|consen 462 RFSGAM--------------SPLQRQF--SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKIL 525 (1351)
T ss_pred CCcccc--------------Cccccch--hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHH
Confidence 111111 1111111 2335689999999999999999999999999999999986521
Q ss_pred -------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 792 -------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 792 -------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
.. .|||+||+|-.........-++|
T Consensus 526 rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 526 REVKLLARL-NHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred HHHHHHhhc-CCcceeeeehhhhccCCcccccc
Confidence 11 68888888765444444444444
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.1e-12 Score=145.50 Aligned_cols=121 Identities=25% Similarity=0.373 Sum_probs=96.8
Q ss_pred CCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcC
Q psy18163 748 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 748 ~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~ 811 (1028)
.+..+.+|++.++||.|+||+||+|+++.++..||||+|.+.+. .. .|||+|+++++++..+.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCe
Confidence 45667899999999999999999999999999999999986531 12 59999999999999999
Q ss_pred cEEEEecC-CCCCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHHHHHHHhh
Q psy18163 812 NHLVTENP-GGPLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVKLLREAEQ 890 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1028)
+||||||| ||||..++.. -| .+||-...+.-.|+..|+++++ .
T Consensus 84 i~lVMEyC~gGDLs~yi~~-----------------------------~~-~l~e~t~r~Fm~QLA~alq~L~------~ 127 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRR-----------------------------RG-RLPEATARHFMQQLASALQFLH------E 127 (429)
T ss_pred EEEEEEeCCCCCHHHHHHH-----------------------------cC-CCCHHHHHHHHHHHHHHHHHHH------H
Confidence 99999999 8999997662 11 3556555566668888888876 4
Q ss_pred cCCChhhh---HHhhccC
Q psy18163 891 NGFTAEDL---TIALSHC 905 (1028)
Q Consensus 891 ~~~~~~~~---~~~~~~~ 905 (1028)
+|+.=-|+ -|-|++.
T Consensus 128 ~~IiHRDLKPQNiLLs~~ 145 (429)
T KOG0595|consen 128 NNIIHRDLKPQNILLSTT 145 (429)
T ss_pred CCeeeccCCcceEEeccC
Confidence 66666666 4566665
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.6e-12 Score=142.80 Aligned_cols=243 Identities=18% Similarity=0.256 Sum_probs=161.5
Q ss_pred EEEEEEECCCCeEEEEEEeeccccccCCccchH--HHHHHHHHcCCCCeeEEEEEEeec---CCCeEEEEEecccc-chH
Q psy18163 377 VVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL--REINTLLKAQHPNIVTVREIVVGS---NMDKIFIVMDYVEH-DMK 450 (1028)
Q Consensus 377 ~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~l--rEi~iL~~l~HPNIV~L~~i~~~~---~~~~l~LVmEy~~g-dLg 450 (1028)
.||++.+...|..|..-.+.....+....+... .-...|..+-|.|||+++.|+... +...+.++.|||.. ++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 478888887777766554433222111111111 123445666799999998887532 34568899999984 777
Q ss_pred HHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecCCCcEEEeccCCccccCCCC-----Ccc
Q psy18163 451 SLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL-----KHY 523 (1028)
Q Consensus 451 sLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~-----~~~ 523 (1028)
.++...+.+...+.....++|+-||+.||.|||+.. |+|++|..+-|++..+|-+||.---.. .+.... ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhh
Confidence 788888777777888889999999999999999986 999999999999999999998421111 000000 000
Q ss_pred cccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPL-FTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 524 t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pP-F~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
.-..+-++|.|||.=.. ...+.++|||++|+...+|..+..- =.+.+..+.-..|....
T Consensus 240 ~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------- 299 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------- 299 (458)
T ss_pred hccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence 11234678999996443 3467799999999999999887632 33332222111111110
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+. + -...-.+++.+||.-.|+.||+|.++|.||-+-+.
T Consensus 300 --~~-----------l----en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 300 --IG-----------L----ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred --ee-----------c----cCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 00 0 00112478999999999999999999999987654
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.24 E-value=9e-11 Score=139.40 Aligned_cols=184 Identities=17% Similarity=0.268 Sum_probs=134.8
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmE 443 (1028)
|++ ...+-++.+..-.|..+.++.+|.|.+++.... .......+.+..|+.++||||+++++.+... ..+|||+|
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEee
Confidence 444 334444444222567778889999998876544 2334456788899999999999998877544 48999999
Q ss_pred ccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH-hCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 444 YVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH-DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 444 y~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLH-s~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
.+.. |...+..+ ....+...+.||+.||.||| +.+++|++|.-.-|+|+..|..||++|-++.....-...
T Consensus 90 rV~P-l~~~lk~l-------~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 90 RVRP-LETVLKEL-------GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP 161 (690)
T ss_pred cccc-HHHHHHHh-------HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc
Confidence 9974 55555543 25567888999999999998 567999999999999999999999999988654322111
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhC
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG 563 (1028)
.....---.|..|+.+.. -....|.|-|||++++++.|
T Consensus 162 ~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 AKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 111122234777876643 23678999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.8e-11 Score=139.48 Aligned_cols=142 Identities=18% Similarity=0.265 Sum_probs=92.1
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeecccccc---------------------C--C---------------ccchH
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE---------------------G--F---------------PITSL 409 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~---------------------~--~---------------~~~~l 409 (1028)
+.||.|++|.||+|+.. +|+.||||+.+...... . . ...+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46999999999999875 78999999986432100 0 0 00123
Q ss_pred HHHHHHHHc----CCCCeeEEEEEEeecCCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHH-HHHHHH
Q psy18163 410 REINTLLKA----QHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLN-AVAHLH 483 (1028)
Q Consensus 410 rEi~iL~~l----~HPNIV~L~~i~~~~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~-AL~yLH 483 (1028)
+|...+..+ .+.+-+.+-.+|...+ ...+|||||+.| +|.++... ... .+ ....++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~-~~~--~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAAL-DEA--GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHH-Hhc--CC---CHHHHHHHHHHHHHHHHH
Confidence 344444443 2333333333443222 346999999987 44443321 111 11 13345555555 467899
Q ss_pred hCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 484 s~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
..|++|+|+||.|||++.+|.++|+|||++..+.
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.7e-11 Score=119.47 Aligned_cols=127 Identities=17% Similarity=0.211 Sum_probs=92.1
Q ss_pred EEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeE-EEEEEeecCCCeEEEEEecc
Q psy18163 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVT-VREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 367 l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~-L~~i~~~~~~~~l~LVmEy~ 445 (1028)
++.|+.|.++.||++... +..|+||+...... .......|+.++..+.+.++++ ++.+. . ..-++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEec
Confidence 467899999999999875 77899998754321 1234467888888887655543 33222 2 2347999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCc-----ccccccccceeecCCCcEEEeccCCcc
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI-----LHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gI-----VHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
++ ..+... ......++.+|+.+|..||..++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 74 ~G--~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EG--SELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CC--Cccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 97 222211 01124467899999999999985 9999999999998 6789999999975
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=9.9e-11 Score=123.56 Aligned_cols=142 Identities=22% Similarity=0.250 Sum_probs=97.8
Q ss_pred EEeeecCcEEEEEEEECC------CCeEEEEEEeeccccc-----------cCC---------ccch----HHHHHHHHH
Q psy18163 368 NRIEEGTYGVVYRAKDKR------TDEIVALKRLKMEKEK-----------EGF---------PITS----LREINTLLK 417 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~------tg~~VAIKvlk~~~~~-----------~~~---------~~~~----lrEi~iL~~ 417 (1028)
..||.|--+.||.|.... .+..+|||+.+..... ... ...+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 3578999998653210 000 0111 268888888
Q ss_pred cCC--CCeeEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH-HhCCcccccccc
Q psy18163 418 AQH--PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL-HDNWILHRDLKT 494 (1028)
Q Consensus 418 l~H--PNIV~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yL-Hs~gIVHRDLKP 494 (1028)
+.. -++..++.+ ..-+|||||++++..- ...+. ...+...++..++.+++.+|..| |..||||+||++
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~-~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVP-APKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCcc-chhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 753 344444432 2458999999863110 11111 12345556778889999999998 899999999999
Q ss_pred cceeecCCCcEEEeccCCccccCCC
Q psy18163 495 SNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 495 eNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
.|||+. ++.++|+|||.|.....+
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCCCC
Confidence 999996 578999999999766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.8e-11 Score=143.97 Aligned_cols=254 Identities=23% Similarity=0.211 Sum_probs=180.2
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEEC-CCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCC
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDK-RTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~-~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~ 436 (1028)
....+|..+..||.|.|+.|+.+... .++..|++|-+..........+..+.|+.+...+ .|.+++.++..+. ...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~r 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QLR 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--ccc
Confidence 44678999999999999999998755 6788999998876554444445556777766665 4888887654442 334
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC-CcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR-GILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~-g~lKL~DFGlAr~ 515 (1028)
+.|+-.|||.+....|...+ ...+.+...+.++.|++.++.++|++.++|+|+||+||++.++ +..++.|||++..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 67799999976322332222 2336677889999999999999999999999999999999886 7889999999875
Q ss_pred cCCCCCcccccccCcccc-CcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYR-SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~-APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
+... ......+-++. ..|+++....+..+.|++|||.-+++.+++.+.-...... ..|..
T Consensus 417 ~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~------------- 477 (524)
T KOG0601|consen 417 LAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRS------------- 477 (524)
T ss_pred ccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeec-------------
Confidence 3221 12233444555 3666766678899999999999999999988543221110 00000
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..++. .+.....+..++..++..|+..|+.+.++..|.=|-.
T Consensus 478 -----------~~~p~---------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 478 -----------GDTPN---------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred -----------ccccC---------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00000 0112256778999999999999999999999876643
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.7e-12 Score=140.27 Aligned_cols=83 Identities=47% Similarity=0.579 Sum_probs=69.4
Q ss_pred CCCCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc---------------CCchhhhhhHhhhcC-
Q psy18163 746 IQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE---------------NFPSRIRTYHLQVES- 809 (1028)
Q Consensus 746 ~~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~---------------~~p~~vr~~e~~~~~- 809 (1028)
+++|++++.|+++++|++|+||+||+|+++.|+++||+|+|+..+.... +|||||...++..-.
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 7899999999999999999999999999999999999999986553210 478888777775443
Q ss_pred -cCcEEEEecCCCCCCcccC
Q psy18163 810 -ELNHLVTENPGGPLNKKEQ 828 (1028)
Q Consensus 810 -~~~hlV~E~~~G~L~~~~~ 828 (1028)
+..|||||||..||...+-
T Consensus 149 ~d~iy~VMe~~EhDLksl~d 168 (419)
T KOG0663|consen 149 MDKIYIVMEYVEHDLKSLME 168 (419)
T ss_pred cceeeeeHHHHHhhHHHHHH
Confidence 3569999999999987544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.4e-11 Score=140.62 Aligned_cols=146 Identities=16% Similarity=0.278 Sum_probs=95.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc---------------------c-----------CCc----
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK---------------------E-----------GFP---- 405 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~---------------------~-----------~~~---- 405 (1028)
..|+. +-||.|++|.||+|+.+.+|+.||||+++..... . ...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34555 6799999999999999988999999999754210 0 001
Q ss_pred --cchHHHHHHHHHcC----CCCeeEEEEEEeecCCCeEEEEEecccc-chHHHHHHHhhcCC---cCCHHHHHHHHHHH
Q psy18163 406 --ITSLREINTLLKAQ----HPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQ---VFIPGEVKCLMQQL 475 (1028)
Q Consensus 406 --~~~lrEi~iL~~l~----HPNIV~L~~i~~~~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~---~~se~ev~~il~QL 475 (1028)
..+.+|...+.++. +.+.+.+-.+|..- ....+|||||+.| .+.++ ..+...+. .+.+..+..++.||
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~-~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDV-AALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhH-HHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 11233444443332 44444444444322 2357899999998 33332 22222221 24444555666666
Q ss_pred HHHHHHHHhCCcccccccccceeecCCC----cEEEeccCCccccC
Q psy18163 476 LNAVAHLHDNWILHRDLKTSNLLLSHRG----ILKVGDFGLAREYG 517 (1028)
Q Consensus 476 l~AL~yLHs~gIVHRDLKPeNILLd~~g----~lKL~DFGlAr~~~ 517 (1028)
+ ..|++|+|+||.|||++.+| .++++|||++..+.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5 58999999999999999888 99999999987664
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.13 E-value=2e-11 Score=133.22 Aligned_cols=77 Identities=23% Similarity=0.256 Sum_probs=66.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
|+.|+.+.++|||+||+||+|+++.||++||||++....+.. -.|||.|.++|+|..+...|||+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 678999999999999999999999999999999986433210 05899999999999999999999
Q ss_pred ecCCCCCCcccC
Q psy18163 817 ENPGGPLNKKEQ 828 (1028)
Q Consensus 817 E~~~G~L~~~~~ 828 (1028)
|||+..+.....
T Consensus 81 E~~dhTvL~eLe 92 (396)
T KOG0593|consen 81 EYCDHTVLHELE 92 (396)
T ss_pred eecchHHHHHHH
Confidence 999987777444
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.5e-10 Score=133.34 Aligned_cols=80 Identities=30% Similarity=0.322 Sum_probs=67.7
Q ss_pred CCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc---------------CCchhhhhhHhhhcC--c
Q psy18163 748 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE---------------NFPSRIRTYHLQVES--E 810 (1028)
Q Consensus 748 ~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~---------------~~p~~vr~~e~~~~~--~ 810 (1028)
.+++++.|+++++||+|+||.||+|++..||.+||+|+|++.....+ .|||+|++.++.... .
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 56678899999999999999999999999999999999986542111 689999998876544 6
Q ss_pred CcEEEEecCCCCCCccc
Q psy18163 811 LNHLVTENPGGPLNKKE 827 (1028)
Q Consensus 811 ~~hlV~E~~~G~L~~~~ 827 (1028)
.+|||+|||..||....
T Consensus 192 siYlVFeYMdhDL~GLl 208 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLL 208 (560)
T ss_pred eEEEEEecccchhhhhh
Confidence 78999999999999843
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.8e-10 Score=120.87 Aligned_cols=74 Identities=30% Similarity=0.321 Sum_probs=65.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
+++|..+++||||+||+||+|++..||+.||||+|+..+... -.|+|+|.++++|-.....+||+
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 357999999999999999999999999999999998654221 05899999999999999999999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||+..||..
T Consensus 81 Efm~tdLe~ 89 (318)
T KOG0659|consen 81 EFMPTDLEV 89 (318)
T ss_pred EeccccHHH
Confidence 999988876
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.7e-08 Score=115.55 Aligned_cols=216 Identities=14% Similarity=0.142 Sum_probs=152.9
Q ss_pred cEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec--CCCeEEEEEecccc--chH
Q psy18163 375 YGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--NMDKIFIVMDYVEH--DMK 450 (1028)
Q Consensus 375 FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~--~~~~l~LVmEy~~g--dLg 450 (1028)
-.+.|+|....+|..|++|.+...+.. .......-+++++++.|+|||++.++|... ....++||++|..+ +|+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 357899999999999999999443321 222334557789999999999999998622 23468999999986 444
Q ss_pred HHHHHHh-----------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 451 SLMETMR-----------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 451 sLl~~l~-----------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+++-.-. ..+...++..+|.|+.||..||.++|+.|+.-+-|.|.+||+..+..++|.-.|+...+...
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4432110 11223567899999999999999999999999999999999998889999877776554332
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPL-FTGKSDLEQ-LSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pP-F~g~sd~d~-l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. -+.+.+ -.+-|.=.||.+++.|.||..- +........ +.
T Consensus 447 ~--------------~~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~-------------------- 488 (655)
T KOG3741|consen 447 P--------------TEPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT-------------------- 488 (655)
T ss_pred C--------------CcchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------------------
Confidence 1 022332 2357999999999999998531 111111111 11
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
...+..+.++.++|.-+...++.. -++.++|.|
T Consensus 489 --------------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 489 --------------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 112336678889999999998887 688888876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.5e-08 Score=105.64 Aligned_cols=141 Identities=19% Similarity=0.248 Sum_probs=92.1
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCC--CeeEEEEEEeecC-CCeEEEEEec
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP--NIVTVREIVVGSN-MDKIFIVMDY 444 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HP--NIV~L~~i~~~~~-~~~l~LVmEy 444 (1028)
+.||.|.++.||++.... |..|+||+....... ........|+.++..+.+. ++..++.+..... .+..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998753 578999987654321 1344567899999888753 3455554442211 1356899999
Q ss_pred ccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy18163 445 VEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD--------------------------------------- 484 (1028)
Q Consensus 445 ~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs--------------------------------------- 484 (1028)
+.+ ++...+ .. ..+++.+...++.+|+.+|.+||+
T Consensus 82 i~G~~l~~~~---~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 82 VDGRVLRDRL---LR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred eCCEecCCCC---CC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 987 222111 00 123333444444455555544442
Q ss_pred -----------------CCcccccccccceeecC--CCcEEEeccCCccc
Q psy18163 485 -----------------NWILHRDLKTSNLLLSH--RGILKVGDFGLARE 515 (1028)
Q Consensus 485 -----------------~gIVHRDLKPeNILLd~--~g~lKL~DFGlAr~ 515 (1028)
.+++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34799999999999998 67789999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=98.80 E-value=3e-10 Score=123.15 Aligned_cols=93 Identities=23% Similarity=0.301 Sum_probs=72.2
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhH-hhhcC-cCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYH-LQVES-ELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e-~~~~~-~~~h 813 (1028)
+..+|+++++||.|+||.||++.+..+|..||.|.|...... .-.|||+|+++. .|... +.++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 457899999999999999999999999999999999743210 116999999997 45554 4589
Q ss_pred EEEecC-CCCCCcccCC-CCCCCCCCCchhhh
Q psy18163 814 LVTENP-GGPLNKKEQP-KWRPMQISNPSTKL 843 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~~~-~~~~~~~~~~~~~~ 843 (1028)
|||||| +|||++++.- +-..--|+|+..|-
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk 128 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWK 128 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHH
Confidence 999999 8999997710 00122389999883
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.2e-09 Score=125.18 Aligned_cols=108 Identities=25% Similarity=0.433 Sum_probs=84.8
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-c--------------ccCCchhhhhhHhhhcCc-CcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-W--------------LENFPSRIRTYHLQVESE-LNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-~--------------~~~~p~~vr~~e~~~~~~-~~hl 814 (1028)
.|++|.++++||.|+||.||+|..+.+|+.||||++++... | ...|||+|++.|++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 46899999999999999999999999999999999985331 1 214999999999998887 9999
Q ss_pred EEecCCCCCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHHHHHHHhhcCC
Q psy18163 815 VTENPGGPLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVKLLREAEQNGF 893 (1028)
Q Consensus 815 V~E~~~G~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 893 (1028)
|||||...|++.+-- |.--.+|.+++ . +--||-||+..|| ++||
T Consensus 88 VfE~Md~NLYqLmK~--R~r~fse~~ir--------------------------n-im~QilqGL~hiH------k~Gf 131 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKD--RNRLFSESDIR--------------------------N-IMYQILQGLAHIH------KHGF 131 (538)
T ss_pred eHHhhhhhHHHHHhh--cCCcCCHHHHH--------------------------H-HHHHHHHHHHHHH------hcCc
Confidence 999999999995542 22223333332 1 2248899999998 6887
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.1e-10 Score=123.56 Aligned_cols=98 Identities=23% Similarity=0.287 Sum_probs=83.0
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc----------------cCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL----------------ENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~----------------~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+|+++++||.|+||.|.+|+...+|..||||.|++.+... -.||+||.+|++|+.++...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 47999999999999999999999999999999998754211 16999999999999999999999
Q ss_pred ecC-CCCCCcccCCCCCCCCCCCchhh--hhhcccCCCcc
Q psy18163 817 ENP-GGPLNKKEQPKWRPMQISNPSTK--LRQARSMPHWV 853 (1028)
Q Consensus 817 E~~-~G~L~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 853 (1028)
||. +|+|++++- +--++||-.|+ .||.-|--|+.
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYC 169 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYC 169 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHH
Confidence 999 999999875 44568888876 57776666654
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.9e-09 Score=117.48 Aligned_cols=76 Identities=22% Similarity=0.206 Sum_probs=67.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc--------------------cCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL--------------------ENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~--------------------~~~p~~vr~~e~~~~~~~~ 812 (1028)
+.|.+.+.||.|+||.|.+|..+.||+.||||.|.+.+... -.||++|+++++|...+-.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 57899999999999999999999999999999997543211 0689999999999999999
Q ss_pred EEEEecC-CCCCCcccC
Q psy18163 813 HLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~~ 828 (1028)
||||||+ ||+|++++.
T Consensus 252 YmVlE~v~GGeLfd~vv 268 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVV 268 (475)
T ss_pred EEEEEEecCccHHHHHH
Confidence 9999999 999999776
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=98.62 Aligned_cols=143 Identities=25% Similarity=0.282 Sum_probs=98.0
Q ss_pred EEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc------CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 366 CLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE------GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 366 il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~------~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.+..|-+|+-+.|+++.+. |+.+.||.-....... -......+|+.+|.++.--.|..-.-+|.+.+ .-+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQ 86 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCe
Confidence 5678889999999999885 7878888542221111 01123457888888876444443333444333 457
Q ss_pred EEEecccc--chHHHHHHHhhcCCcCCHHH-HHHHHHHHHHHHHHHHhCCcccccccccceeecCCC---cEEEeccCCc
Q psy18163 440 IVMDYVEH--DMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLA 513 (1028)
Q Consensus 440 LVmEy~~g--dLgsLl~~l~~~~~~~se~e-v~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g---~lKL~DFGlA 513 (1028)
|+|||+.+ ++.+++...-. .-.+.+ ...++..|-..|.-||.++|||+||..+||||..+| .+.|+|||++
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEEEeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 88999987 55554433221 112223 378899999999999999999999999999997655 3589999998
Q ss_pred cc
Q psy18163 514 RE 515 (1028)
Q Consensus 514 r~ 515 (1028)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 53
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=9e-08 Score=99.71 Aligned_cols=132 Identities=27% Similarity=0.332 Sum_probs=85.5
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCc-----cchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFP-----ITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~-----~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
..|++|+-+.||.+... |..+.+|.=..... ..... ....+|..+|.++.--.|..-.-+++ +.+...|+
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCCCEEE
Confidence 35789999999999664 44466664321111 11111 22356888888876433333222233 23467899
Q ss_pred Eeccccc-hHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 442 MDYVEHD-MKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 442 mEy~~gd-LgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
|||++|. |.+++.. . ...++..|-.-+.-||..||||+||.++||++...+ +.++||||+..
T Consensus 78 me~I~G~~lkd~l~~---~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEE---A--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHh---c--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999972 2223321 1 134666677778899999999999999999997655 89999999864
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.9e-09 Score=121.23 Aligned_cols=90 Identities=22% Similarity=0.275 Sum_probs=71.2
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
++++|++|..||+|+||.||+|+-+.||.++|||++++.... ....|.+|++|=.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 468999999999999999999999999999999999874321 1134788888877899999999
Q ss_pred EEecC-CCCCCcccCCCCCCCCCCCchhhh
Q psy18163 815 VTENP-GGPLNKKEQPKWRPMQISNPSTKL 843 (1028)
Q Consensus 815 V~E~~-~G~L~~~~~~~~~~~~~~~~~~~~ 843 (1028)
||||+ |||+...+. .+. .++|..|+.
T Consensus 219 iMEylPGGD~mTLL~-~~~--~L~e~~arf 245 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM-RKD--TLTEDWARF 245 (550)
T ss_pred EEEecCCccHHHHHH-hcC--cCchHHHHH
Confidence 99988 888766332 122 266666664
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=98.68 E-value=6.1e-09 Score=116.78 Aligned_cols=93 Identities=23% Similarity=0.239 Sum_probs=77.5
Q ss_pred CccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCc
Q psy18163 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 749 ~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
....++|++++.||+|+||+||+++.+.|++++|+|++++...- .-.||++|.++-.|.+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 34568999999999999999999999999999999999864311 11589999998779999999
Q ss_pred EEEEecC-CCCCCcccCCCCCCCCCCCchhhhh
Q psy18163 813 HLVTENP-GGPLNKKEQPKWRPMQISNPSTKLR 844 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~~~~~~~~~~~~~~~~~~ 844 (1028)
|||+||+ ||+|+..+. +--..+|..+++-
T Consensus 101 ylVld~~~GGeLf~hL~---~eg~F~E~~arfY 130 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQ---REGRFSEDRARFY 130 (357)
T ss_pred EEEEeccCCccHHHHHH---hcCCcchhHHHHH
Confidence 9999999 889998665 4445888888873
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2e-07 Score=103.13 Aligned_cols=135 Identities=17% Similarity=0.124 Sum_probs=89.1
Q ss_pred EEEEEEECCCCeEEEEEEeeccccc----c----CCc-cchHHHHHHHHHcCCCCeeE--EEEEEeec---CCCeEEEEE
Q psy18163 377 VVYRAKDKRTDEIVALKRLKMEKEK----E----GFP-ITSLREINTLLKAQHPNIVT--VREIVVGS---NMDKIFIVM 442 (1028)
Q Consensus 377 ~Vyla~d~~tg~~VAIKvlk~~~~~----~----~~~-~~~lrEi~iL~~l~HPNIV~--L~~i~~~~---~~~~l~LVm 442 (1028)
.|+++.. .|+.|.||........ . ..+ ....+|...+..|..-+|.. ++.+.... ....-+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555544 4667888866332211 0 011 13567888877764333322 22233211 123578999
Q ss_pred ecccc--chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-------CCcEEEeccCCc
Q psy18163 443 DYVEH--DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-------RGILKVGDFGLA 513 (1028)
Q Consensus 443 Ey~~g--dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-------~g~lKL~DFGlA 513 (1028)
|++++ +|.+++.... ...........++.+|+..+.-||..||+|+||++.||||+. .+.+.|+||+.+
T Consensus 115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99997 5666664332 223456677899999999999999999999999999999975 468999999988
Q ss_pred cc
Q psy18163 514 RE 515 (1028)
Q Consensus 514 r~ 515 (1028)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.4e-07 Score=99.17 Aligned_cols=128 Identities=25% Similarity=0.355 Sum_probs=79.4
Q ss_pred EEEEEEECCCCeEEEEEEeeccccc---------cCCc---------------cchHHHHHHHHHcCCCC--eeEEEEEE
Q psy18163 377 VVYRAKDKRTDEIVALKRLKMEKEK---------EGFP---------------ITSLREINTLLKAQHPN--IVTVREIV 430 (1028)
Q Consensus 377 ~Vyla~d~~tg~~VAIKvlk~~~~~---------~~~~---------------~~~lrEi~iL~~l~HPN--IV~L~~i~ 430 (1028)
.||.|... .|..+|||+.+..... .... ....+|...|..+..-+ +..++.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999885 5779999998653210 0000 11246899999987653 44554332
Q ss_pred eecCCCeEEEEEeccc--cc-hHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHH-HHhCCcccccccccceeecCCCcEE
Q psy18163 431 VGSNMDKIFIVMDYVE--HD-MKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH-LHDNWILHRDLKTSNLLLSHRGILK 506 (1028)
Q Consensus 431 ~~~~~~~l~LVmEy~~--gd-LgsLl~~l~~~~~~~se~ev~~il~QLl~AL~y-LHs~gIVHRDLKPeNILLd~~g~lK 506 (1028)
. -+|||||++ |. +..|.. .. +...+...++.+++..+.. +|..||||+||.+.|||++.+ .+.
T Consensus 80 --~----~~ivME~I~~~G~~~~~l~~-~~-----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 --R----NVIVMEYIGEDGVPLPRLKD-VD-----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --T----TEEEEE--EETTEEGGCHHH-CG-----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEE
T ss_pred --C----CEEEEEecCCCccchhhHHh-cc-----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEE
Confidence 2 379999999 52 222222 11 1134567788888885555 689999999999999999876 899
Q ss_pred EeccCCccccCC
Q psy18163 507 VGDFGLAREYGS 518 (1028)
Q Consensus 507 L~DFGlAr~~~~ 518 (1028)
|+|||.+.....
T Consensus 147 iIDf~qav~~~~ 158 (188)
T PF01163_consen 147 IIDFGQAVDSSH 158 (188)
T ss_dssp E--GTTEEETTS
T ss_pred EEecCcceecCC
Confidence 999999976543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.3e-08 Score=108.80 Aligned_cols=97 Identities=22% Similarity=0.244 Sum_probs=77.0
Q ss_pred CCCCCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhc
Q psy18163 745 AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVE 808 (1028)
Q Consensus 745 ~~~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~ 808 (1028)
....+.++++|++.+.||.|-||.||+|+.+.++.+||+|++.+.+.. .-.||||+++|.+|.+
T Consensus 14 ~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 14 RATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred ccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 334777899999999999999999999999999999999999864311 1158999999999999
Q ss_pred CcCcEEEEecC-CCCCCcccCCCCCCCCCCCchhh
Q psy18163 809 SELNHLVTENP-GGPLNKKEQPKWRPMQISNPSTK 842 (1028)
Q Consensus 809 ~~~~hlV~E~~-~G~L~~~~~~~~~~~~~~~~~~~ 842 (1028)
+...||++||. +|+|++... .-+.-+.+|.-++
T Consensus 94 ~~riyLilEya~~gel~k~L~-~~~~~~f~e~~~a 127 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQ-EGRMKRFDEQRAA 127 (281)
T ss_pred cceeEEEEEecCCchHHHHHH-hcccccccccchh
Confidence 99999999988 888888332 1133335555443
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.4e-09 Score=107.18 Aligned_cols=76 Identities=25% Similarity=0.277 Sum_probs=63.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc---------------CCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE---------------NFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~---------------~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
|.+|.+.++||||+||+||+|+++.|+++||+|.++....... .|-|+||++++......+.+|+
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 4679999999999999999999999999999999986543221 3678888888888888889999
Q ss_pred ecCCCCCCccc
Q psy18163 817 ENPGGPLNKKE 827 (1028)
Q Consensus 817 E~~~G~L~~~~ 827 (1028)
|||..+|-++-
T Consensus 81 e~cdqdlkkyf 91 (292)
T KOG0662|consen 81 EFCDQDLKKYF 91 (292)
T ss_pred HHhhHHHHHHH
Confidence 99988886644
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.65 E-value=2e-08 Score=120.28 Aligned_cols=157 Identities=21% Similarity=0.321 Sum_probs=114.9
Q ss_pred HHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCCC----CCcccc-----cccCccccCcccccCCC
Q psy18163 473 QQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP----LKHYTP-----IVVTLWYRSPELLLGCK 542 (1028)
Q Consensus 473 ~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~----~~~~t~-----~vGT~~Y~APEvL~g~~ 542 (1028)
.++..||.|+|.. ++||+.|.|++|.++..|..||+.|+++.....+ ...+++ ..-...|.|||++.+ .
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 3444899999976 7999999999999999999999999998655432 111221 123567999999988 5
Q ss_pred CCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccc
Q psy18163 543 EYSTPIDMWSVGCIFAEFL-CMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGS 621 (1028)
Q Consensus 543 ~ys~ksDIWSLGvILyELL-TG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~ 621 (1028)
..+.++|++||||++|.+. .|+..|...........-.... +........
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-----------------------------~~~~~~~s~ 235 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-----------------------------NAGAFGYSN 235 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-----------------------------ccccccccc
Confidence 5789999999999999998 6777776654322211111110 000011123
Q ss_pred cccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 622 ILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 622 ~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
.++.++++=|.++|..|+..||++..++.-|||.....
T Consensus 236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 236 NLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGL 273 (700)
T ss_pred cCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchh
Confidence 47788999999999999999999999999999987543
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=98.63 E-value=9.4e-09 Score=119.66 Aligned_cols=76 Identities=24% Similarity=0.221 Sum_probs=66.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
|.+|.+.+.||+|+||+||+|+.+.|++.||||.|.+..... -.|||+|..+++|+.+...++|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 578999999999999999999999999999999998643211 16999999999999999999999
Q ss_pred ecCCCCCCccc
Q psy18163 817 ENPGGPLNKKE 827 (1028)
Q Consensus 817 E~~~G~L~~~~ 827 (1028)
|||-|+|+...
T Consensus 81 e~a~g~L~~il 91 (808)
T KOG0597|consen 81 EYAVGDLFTIL 91 (808)
T ss_pred hhhhhhHHHHH
Confidence 99988988743
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.2e-08 Score=112.02 Aligned_cols=106 Identities=25% Similarity=0.306 Sum_probs=80.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc---------------CCch-hhhhhHhhhcCc-----
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE---------------NFPS-RIRTYHLQVESE----- 810 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~---------------~~p~-~vr~~e~~~~~~----- 810 (1028)
+..|+.+++||+|+||+||+|+++.||+.||+|+|+....... .|++ +|++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 5679999999999999999999999999999999997544210 3566 777777776666
Q ss_pred -CcEEEEecCCCCCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHH
Q psy18163 811 -LNHLVTENPGGPLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVK 883 (1028)
Q Consensus 811 -~~hlV~E~~~G~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (1028)
..+||+||+.-||.+.+-.+..+ . ..-|+.+|.+++ .|+-.|+.++|
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~------~-------------------~g~~~~~ik~~m-~Qll~gl~~~H 137 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKK------P-------------------QGLPPRLIKSFM-RQLLRGLAFLH 137 (323)
T ss_pred ceEEEEEEeecccHHHHHHhcccc------c-------------------cCCCHHHHHHHH-HHHHHHHHHHH
Confidence 77899999999999877542222 1 223347777765 47777888877
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.1e-08 Score=114.23 Aligned_cols=78 Identities=26% Similarity=0.240 Sum_probs=66.6
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---c----------------ccCCchhhhhhHhhhcCcC
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---W----------------LENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---~----------------~~~~p~~vr~~e~~~~~~~ 811 (1028)
....|.+.+.||+|+||+|++|.+..||..||||.|.+... . ...|||++++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 35689999999999999999999999999999998765311 0 0028999999999998888
Q ss_pred cEEEEecC-CCCCCcccC
Q psy18163 812 NHLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~~ 828 (1028)
.+|||||| ||+|++++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~ 112 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV 112 (370)
T ss_pred EEEEEEecCCccHHHHHH
Confidence 99999999 789999776
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.1e-07 Score=113.61 Aligned_cols=93 Identities=23% Similarity=0.269 Sum_probs=75.2
Q ss_pred CccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-----------------ccCCchhhhhhHhhhcCcC
Q psy18163 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-----------------LENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 749 ~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-----------------~~~~p~~vr~~e~~~~~~~ 811 (1028)
--.+++|.+++.||+|+||+|+++..+.|++.+|||++++...- ...||+.+.++..|.+.+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 33578999999999999999999999999999999999875311 1169999999999999999
Q ss_pred cEEEEecC-CCCCCcccCCCCCC-CCCCCchhhhhhc
Q psy18163 812 NHLVTENP-GGPLNKKEQPKWRP-MQISNPSTKLRQA 846 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~~~~~~~-~~~~~~~~~~~~~ 846 (1028)
+++||||+ |||+.. |.. -..||+.|++-.|
T Consensus 444 l~fvmey~~Ggdm~~-----~~~~~~F~e~rarfyaA 475 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMH-----HIHTDVFSEPRARFYAA 475 (694)
T ss_pred EEEEEEecCCCcEEE-----EEecccccHHHHHHHHH
Confidence 99999999 777333 333 4577777766444
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.2e-07 Score=102.56 Aligned_cols=74 Identities=20% Similarity=0.179 Sum_probs=62.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
.++|+++++||+|+||.||+|.++.+|+.||||++...... .-.||++++.++++......+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999999999999999998743210 0057999998888888888999999
Q ss_pred cCCCCCCc
Q psy18163 818 NPGGPLNK 825 (1028)
Q Consensus 818 ~~~G~L~~ 825 (1028)
|++|+|..
T Consensus 84 ~~~~~l~~ 91 (303)
T cd07869 84 YVHTDLCQ 91 (303)
T ss_pred CCCcCHHH
Confidence 99988766
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.5e-06 Score=92.22 Aligned_cols=105 Identities=24% Similarity=0.352 Sum_probs=75.4
Q ss_pred chHHHHHHHHHcCC-----CCeeEEEEEEeecCCCeEEEEEecccc--chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHH
Q psy18163 407 TSLREINTLLKAQH-----PNIVTVREIVVGSNMDKIFIVMDYVEH--DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479 (1028)
Q Consensus 407 ~~lrEi~iL~~l~H-----PNIV~L~~i~~~~~~~~l~LVmEy~~g--dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL 479 (1028)
...+|...+..+.. |.++-+...-.+ .....+||+|++.+ +|.+++..... +.......++.+|+..+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence 45677777766643 334333211111 11356899999986 45555543211 45566788999999999
Q ss_pred HHHHhCCcccccccccceeecCCC---cEEEeccCCcccc
Q psy18163 480 AHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREY 516 (1028)
Q Consensus 480 ~yLHs~gIVHRDLKPeNILLd~~g---~lKL~DFGlAr~~ 516 (1028)
.-||..||+|+||++.|||++.++ .+.|+||+-++..
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999999887 8999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.48 E-value=7.8e-08 Score=108.98 Aligned_cols=73 Identities=22% Similarity=0.296 Sum_probs=61.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+|++++.||+|+||.||+|++..+|+.||||++.+... ..-.||+++++++++......+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 379999999999999999999999999999999974210 0015899999988888888999999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ +|+|..
T Consensus 81 E~~~~g~L~~ 90 (364)
T cd05599 81 EYLPGGDMMT 90 (364)
T ss_pred CCCCCcHHHH
Confidence 998 778876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-07 Score=108.36 Aligned_cols=72 Identities=15% Similarity=0.108 Sum_probs=60.9
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
.|++++.||+|+||+||+|++..+++.||||++.+... ..-.||++++++..+......+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999964210 01157899999888888888999999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|..
T Consensus 82 ~~~gg~L~~ 90 (381)
T cd05626 82 YIPGGDMMS 90 (381)
T ss_pred cCCCCcHHH
Confidence 99 778876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.9e-07 Score=99.95 Aligned_cols=74 Identities=20% Similarity=0.225 Sum_probs=62.7
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
+++|+++++||.|+||.||+|++..++..||||++...... .-.||+++++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 67899999999999999999999999999999998743210 0157999998888887888899999
Q ss_pred cCCCCCCc
Q psy18163 818 NPGGPLNK 825 (1028)
Q Consensus 818 ~~~G~L~~ 825 (1028)
|++|+|..
T Consensus 84 ~~~~~l~~ 91 (288)
T cd07871 84 YLDSDLKQ 91 (288)
T ss_pred CCCcCHHH
Confidence 99888776
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.3e-07 Score=105.97 Aligned_cols=74 Identities=15% Similarity=0.132 Sum_probs=61.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+|+++++||+|+||.||+|++..+++.||||++.+... ..-.||+++++++.+......+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 379999999999999999999999999999999864210 0015788999888888888999999
Q ss_pred ecC-CCCCCcc
Q psy18163 817 ENP-GGPLNKK 826 (1028)
Q Consensus 817 E~~-~G~L~~~ 826 (1028)
||+ +|+|...
T Consensus 81 E~~~~g~L~~~ 91 (376)
T cd05598 81 DYIPGGDMMSL 91 (376)
T ss_pred eCCCCCcHHHH
Confidence 999 7888773
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.2e-08 Score=111.31 Aligned_cols=138 Identities=20% Similarity=0.353 Sum_probs=94.8
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc-----------CCchhhhhhHhhhcCcCcEEEEecC-CC
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE-----------NFPSRIRTYHLQVESELNHLVTENP-GG 821 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~-----------~~p~~vr~~e~~~~~~~~hlV~E~~-~G 821 (1028)
-|.++.+||+|+||.||+|.|+.+|..||||++.-.....+ ..|..|++|..+.-..-++|||||| .|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 48899999999999999999999999999999875432111 3478899998876667779999999 78
Q ss_pred CCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHHHHHHH-------------
Q psy18163 822 PLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVKLLREA------------- 888 (1028)
Q Consensus 822 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 888 (1028)
++++-+ ++|.. | ---.-|.|+++.-+| |++.+|.||.-
T Consensus 114 SiSDI~--------------R~R~K---~-----------L~E~EIs~iL~~TLK-GL~YLH~~~KIHRDIKAGNILLNT 164 (502)
T KOG0574|consen 114 SISDIM--------------RARRK---P-----------LSEQEISAVLRDTLK-GLQYLHDLKKIHRDIKAGNILLNT 164 (502)
T ss_pred cHHHHH--------------HHhcC---C-----------ccHHHHHHHHHHHHh-HHHHHHHHHHHHhhcccccEEEcc
Confidence 887722 22211 1 112357777777765 78877777643
Q ss_pred ------hhcCCChhhh--HHhhccCCCCCchhHHHhhHHHHHHHH
Q psy18163 889 ------EQNGFTAEDL--TIALSHCGDGPPVTWLINNWRHMIDTV 925 (1028)
Q Consensus 889 ------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (1028)
..||+- -.+ +||-...--++|+ |+- ++||++|
T Consensus 165 ~G~AKLADFGVA-GQLTDTMAKRNTVIGTPF-WMA---PEVI~EI 204 (502)
T KOG0574|consen 165 DGIAKLADFGVA-GQLTDTMAKRNTVIGTPF-WMA---PEVIEEI 204 (502)
T ss_pred cchhhhhhcccc-chhhhhHHhhCccccCcc-ccc---HHHHHHh
Confidence 234543 233 6665555566775 654 4555543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.7e-07 Score=107.33 Aligned_cols=72 Identities=17% Similarity=0.143 Sum_probs=61.0
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
.|+++++||+|+||.||+|++..+++.||||++.+... ..-.||++|++++.+......+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 59999999999999999999999999999999864210 01157899999888888888999999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|..
T Consensus 82 ~~~gg~L~~ 90 (382)
T cd05625 82 YIPGGDMMS 90 (382)
T ss_pred CCCCCcHHH
Confidence 99 778876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.5e-07 Score=105.93 Aligned_cols=126 Identities=20% Similarity=0.215 Sum_probs=93.1
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCc-CcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESE-LNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~-~~hl 814 (1028)
+.++.+.+..||+|+.|+||+|+|+.|++++|+|.|..+.. .. .+|++|.+|+.|.... ...|
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence 35688899999999999999999999999999999954321 12 6799999999988777 4999
Q ss_pred EEecC-CCCCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHHH-HH------
Q psy18163 815 VTENP-GGPLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVKL-LR------ 886 (1028)
Q Consensus 815 V~E~~-~G~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~------ 886 (1028)
+|||| ||+|.. .+. . +| .-||-+-.-+-++|-+|+.-+|- .+
T Consensus 156 ~mEYMDgGSLd~-~~k---------------~-------------~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDI 205 (364)
T KOG0581|consen 156 CMEYMDGGSLDD-ILK---------------R-------------VG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDI 205 (364)
T ss_pred ehhhcCCCCHHH-HHh---------------h-------------cC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccC
Confidence 99999 777766 220 0 01 24677777788999999887773 11
Q ss_pred ---------HH----hhcCCChhhh-HHhhccCCC
Q psy18163 887 ---------EA----EQNGFTAEDL-TIALSHCGD 907 (1028)
Q Consensus 887 ---------~~----~~~~~~~~~~-~~~~~~~~~ 907 (1028)
-| ..||+|-+=| ++|=+.-|+
T Consensus 206 KPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT 240 (364)
T KOG0581|consen 206 KPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGT 240 (364)
T ss_pred CHHHeeeccCCCEEeccccccHHhhhhhccccccc
Confidence 01 2588887777 555444444
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.4e-07 Score=111.55 Aligned_cols=86 Identities=23% Similarity=0.312 Sum_probs=71.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
..|++.+.||+|+|+.||.+++..||+.||+|+|.+... .. .|||+|+.++.|++++..|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence 569999999999999999999999999999999986221 11 699999999999999999999
Q ss_pred EecC-CCCCCcccCCCCCCCCCCCchhh
Q psy18163 816 TENP-GGPLNKKEQPKWRPMQISNPSTK 842 (1028)
Q Consensus 816 ~E~~-~G~L~~~~~~~~~~~~~~~~~~~ 842 (1028)
+|+| .|+|....- |.-.++||.++
T Consensus 97 LELC~~~sL~el~K---rrk~ltEpEar 121 (592)
T KOG0575|consen 97 LELCHRGSLMELLK---RRKPLTEPEAR 121 (592)
T ss_pred EEecCCccHHHHHH---hcCCCCcHHHH
Confidence 9988 888876222 33447777665
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.1e-08 Score=112.37 Aligned_cols=77 Identities=18% Similarity=0.225 Sum_probs=67.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhcCcC-cEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVESEL-NHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~~~~-~hlV 815 (1028)
|+.|++++.||+|+||.+++++++..+..|++|+|....... -.||++|.+++++..+.+ .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 678999999999999999999999999999999998654211 168999999999988887 8999
Q ss_pred EecC-CCCCCcccC
Q psy18163 816 TENP-GGPLNKKEQ 828 (1028)
Q Consensus 816 ~E~~-~G~L~~~~~ 828 (1028)
|+|| ||+|.+.+.
T Consensus 83 m~Y~eGg~l~~~i~ 96 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIK 96 (426)
T ss_pred EeecCCCCHHHHHH
Confidence 9999 889998554
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.3e-07 Score=104.74 Aligned_cols=74 Identities=23% Similarity=0.253 Sum_probs=62.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
++|.++++||+|+||.||+|.+..+|+.||||++.+... ..-.||++|++++++......+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 379999999999999999999999999999999864210 0115899999988888888999999
Q ss_pred ecC-CCCCCcc
Q psy18163 817 ENP-GGPLNKK 826 (1028)
Q Consensus 817 E~~-~G~L~~~ 826 (1028)
||+ +|+|...
T Consensus 81 E~~~gg~L~~~ 91 (377)
T cd05629 81 EFLPGGDLMTM 91 (377)
T ss_pred eCCCCCcHHHH
Confidence 999 7888773
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.1e-07 Score=108.62 Aligned_cols=89 Identities=19% Similarity=0.182 Sum_probs=74.3
Q ss_pred CccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc---------------CCchhhhhhHhhhcCcCcE
Q psy18163 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE---------------NFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 749 ~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~---------------~~p~~vr~~e~~~~~~~~h 813 (1028)
-..+..|.++.+||.|.||.|.+|++..||.-||||.|.+...... .|||||+++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3456789999999999999999999999999999999987542111 6899999999999899999
Q ss_pred EEEecC-CCCCCcccCCCCCCCCCCCch
Q psy18163 814 LVTENP-GGPLNKKEQPKWRPMQISNPS 840 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~~~~~~~~~~~~~~ 840 (1028)
+||||+ +|+++++.. +.-.+.|..
T Consensus 132 lV~eya~~ge~~~yl~---~~gr~~e~~ 156 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV---KHGRMKEKE 156 (596)
T ss_pred EEEEeccCchhHHHHH---hcccchhhh
Confidence 999999 999999887 344455533
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.2e-07 Score=107.53 Aligned_cols=94 Identities=20% Similarity=0.261 Sum_probs=79.6
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----c--------------------ccCCchhhhhhHhh
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----W--------------------LENFPSRIRTYHLQ 806 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----~--------------------~~~~p~~vr~~e~~ 806 (1028)
...+|..++.+|+|+||.|++|.++.....|+||.|++.+. | ...|+|||+++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34679999999999999999999999999999999987652 1 11489999999999
Q ss_pred hcCcCcEEEEecC-CC-CCCcccCCCCCCCCCCCchhhh--hhcc
Q psy18163 807 VESELNHLVTENP-GG-PLNKKEQPKWRPMQISNPSTKL--RQAR 847 (1028)
Q Consensus 807 ~~~~~~hlV~E~~-~G-~L~~~~~~~~~~~~~~~~~~~~--~~~~ 847 (1028)
++.+.+||+||-= .| ||++.+. +.+.|+||-+|+ +|.+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~ 680 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVV 680 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHH
Confidence 9999999999955 44 9999776 677899999997 4543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.6e-07 Score=101.88 Aligned_cols=73 Identities=21% Similarity=0.126 Sum_probs=60.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
++|++++.||+|+||+||++++..+++.||||++.+... ..-.||+++.+++++......+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 479999999999999999999999999999999863110 0115788888877788788899999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ +|+|..
T Consensus 81 e~~~g~~L~~ 90 (331)
T cd05597 81 DYYVGGDLLT 90 (331)
T ss_pred ecCCCCcHHH
Confidence 998 888877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.4e-07 Score=101.96 Aligned_cols=75 Identities=20% Similarity=0.165 Sum_probs=63.1
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+.+|++.+.||+|+||.||+|+++.+|+.||||++..... ..-.||+++++++++......+|
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 46789999999999999999999999999999999864210 00158999999888888889999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|..
T Consensus 96 v~e~~~~~~L~~ 107 (329)
T PTZ00263 96 LLEFVVGGELFT 107 (329)
T ss_pred EEcCCCCChHHH
Confidence 99988 778876
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.3e-07 Score=101.27 Aligned_cols=73 Identities=25% Similarity=0.331 Sum_probs=61.4
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
++|.+++.||+|+||.||+|++..+|+.||||++.+... ..-.||+++++++++......+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 379999999999999999999999999999999864210 0115899999988888888899999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ +|+|..
T Consensus 81 e~~~~~~L~~ 90 (350)
T cd05573 81 EYMPGGDLMN 90 (350)
T ss_pred cCCCCCCHHH
Confidence 998 778876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=98.33 E-value=1e-06 Score=97.53 Aligned_cols=75 Identities=20% Similarity=0.207 Sum_probs=62.9
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+.+|.++++||+|+||.||+|+++.++..||||++...... .-.||+++++++++......+|||
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 467899999999999999999999999999999998743211 015789999888888788899999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||++|+|..
T Consensus 84 e~~~~~l~~ 92 (309)
T cd07872 84 EYLDKDLKQ 92 (309)
T ss_pred eCCCCCHHH
Confidence 999887766
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.7e-07 Score=108.66 Aligned_cols=85 Identities=25% Similarity=0.301 Sum_probs=71.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-----------------ccCCchhhhhhHhhhcCcCcEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-----------------LENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-----------------~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
..|++.+.||.|.||+||+|.++.||+.||+|.|.+.... ..+|||+|.+++++.+....|||
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 4799999999999999999999999999999999864321 22499999999999999999999
Q ss_pred EecC-CCCCCcccCCCCCCCCCCCchh
Q psy18163 816 TENP-GGPLNKKEQPKWRPMQISNPST 841 (1028)
Q Consensus 816 ~E~~-~G~L~~~~~~~~~~~~~~~~~~ 841 (1028)
||+| ||+|++.++.. ..+|.++
T Consensus 115 mEL~~GGeLfd~i~~~----~~sE~da 137 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK----HYSERDA 137 (382)
T ss_pred EEecCCchHHHHHHHc----cCCHHHH
Confidence 9999 89999988753 1555544
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.5e-07 Score=107.60 Aligned_cols=75 Identities=23% Similarity=0.259 Sum_probs=63.7
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc--------------CCchhhhhhHhhhcCcCcEEEEecC
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE--------------NFPSRIRTYHLQVESELNHLVTENP 819 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~--------------~~p~~vr~~e~~~~~~~~hlV~E~~ 819 (1028)
.|..+..||+|+||.||+|.+..|++.||||+|.......+ ..+++.++|..++....++|+||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 58889999999999999999999999999999986432211 3588889999999999999999999
Q ss_pred -CCCCCcccC
Q psy18163 820 -GGPLNKKEQ 828 (1028)
Q Consensus 820 -~G~L~~~~~ 828 (1028)
||++.+...
T Consensus 94 ~gGsv~~lL~ 103 (467)
T KOG0201|consen 94 GGGSVLDLLK 103 (467)
T ss_pred cCcchhhhhc
Confidence 778887543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.5e-07 Score=103.19 Aligned_cols=94 Identities=20% Similarity=0.267 Sum_probs=75.8
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.++++|+.++.||.|+||+|.+++++.+|..+|+|++.+.+. ..-.||++|+++..+.+...++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 457899999999999999999999999999999999976431 0114799999988888899999
Q ss_pred EEEecC-CCCCCcccCCCCCCCCCCCchhhhhhc
Q psy18163 814 LVTENP-GGPLNKKEQPKWRPMQISNPSTKLRQA 846 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~~~~~~~~~~~~~~~~~~~~ 846 (1028)
|||||. ||.|+...- +.-..||+.|+.-.|
T Consensus 121 mvmeyv~GGElFS~Lr---k~~rF~e~~arFYAA 151 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLR---KSGRFSEPHARFYAA 151 (355)
T ss_pred EEEeccCCccHHHHHH---hcCCCCchhHHHHHH
Confidence 999999 888887443 223378888776544
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.3e-07 Score=100.79 Aligned_cols=74 Identities=20% Similarity=0.146 Sum_probs=59.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
++|.+++.||+|+||.||++++..++..||||++.+... ....|+++++++..+......+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999864210 0114677777776777778889999
Q ss_pred ecC-CCCCCcc
Q psy18163 817 ENP-GGPLNKK 826 (1028)
Q Consensus 817 E~~-~G~L~~~ 826 (1028)
||+ ||+|...
T Consensus 81 Ey~~gg~L~~~ 91 (331)
T cd05624 81 DYYVGGDLLTL 91 (331)
T ss_pred eCCCCCcHHHH
Confidence 998 8888873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=98.30 E-value=2e-06 Score=93.63 Aligned_cols=72 Identities=25% Similarity=0.212 Sum_probs=60.3
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEEec
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVTEN 818 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~E~ 818 (1028)
+|++++.||+|+||.||+|+++.+++.||||++...... .-.||+++++++++......+|||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 699999999999999999999999999999998743211 01579999998888888889999999
Q ss_pred CCCCCCc
Q psy18163 819 PGGPLNK 825 (1028)
Q Consensus 819 ~~G~L~~ 825 (1028)
+.|.+..
T Consensus 82 ~~~~~l~ 88 (287)
T cd07848 82 VEKNMLE 88 (287)
T ss_pred CCCCHHH
Confidence 9765544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.6e-07 Score=105.22 Aligned_cols=75 Identities=19% Similarity=0.162 Sum_probs=61.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
++|++++.||+|+||+||+|.+..+++.||||++.+... ..-.||+++++++.+......+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 479999999999999999999999999999999864210 0115788888887888888899999
Q ss_pred ecC-CCCCCccc
Q psy18163 817 ENP-GGPLNKKE 827 (1028)
Q Consensus 817 E~~-~G~L~~~~ 827 (1028)
||+ ||+|...+
T Consensus 81 E~~~gg~L~~~l 92 (363)
T cd05628 81 EFLPGGDMMTLL 92 (363)
T ss_pred cCCCCCcHHHHH
Confidence 999 77887744
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.3e-07 Score=110.32 Aligned_cols=94 Identities=19% Similarity=0.206 Sum_probs=78.2
Q ss_pred CccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcC
Q psy18163 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 749 ~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~ 811 (1028)
.+++.+|...+.||+|+|.+|++|+++.|+..||||++.+.-. ...+||.+|++|--|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 6678899999999999999999999999999999999875211 12379999999988999999
Q ss_pred cEEEEecC-CCCCCcccCCCCCCCCCCCchhhhhh
Q psy18163 812 NHLVTENP-GGPLNKKEQPKWRPMQISNPSTKLRQ 845 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~~~~~~~~~~~~~~~~~~~ 845 (1028)
+|+||||+ +|+|++.+- +--.++|-.|+.-.
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YA 180 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYA 180 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHH
Confidence 99999988 999999664 44557776666543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-06 Score=97.44 Aligned_cols=79 Identities=39% Similarity=0.475 Sum_probs=63.1
Q ss_pred CCCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhcC--
Q psy18163 747 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVES-- 809 (1028)
Q Consensus 747 ~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~~-- 809 (1028)
+.|+.+++|++++.||+|+||.||+|.+..+|+.||||.+....... -.|+++++.++++...
T Consensus 1 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 1 GRCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred CCcccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 46999999999999999999999999999999999999986432110 0467777777665443
Q ss_pred cCcEEEEecCCCCCCc
Q psy18163 810 ELNHLVTENPGGPLNK 825 (1028)
Q Consensus 810 ~~~hlV~E~~~G~L~~ 825 (1028)
...+|||||++|+|..
T Consensus 81 ~~~~lv~e~~~~~l~~ 96 (309)
T cd07845 81 DSIFLVMEYCEQDLAS 96 (309)
T ss_pred CeEEEEEecCCCCHHH
Confidence 4579999999887765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.6e-07 Score=95.96 Aligned_cols=73 Identities=18% Similarity=0.236 Sum_probs=60.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
++|++++.||+|+||.||++.+..+|+.||||++..... ....||+++++++.+......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 379999999999999999999999999999999875321 01157888888877777778899999
Q ss_pred cCCCCCCc
Q psy18163 818 NPGGPLNK 825 (1028)
Q Consensus 818 ~~~G~L~~ 825 (1028)
|++|+|..
T Consensus 81 ~~~~~l~~ 88 (283)
T cd06617 81 VMDTSLDK 88 (283)
T ss_pred hhcccHHH
Confidence 99887755
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.2e-07 Score=109.54 Aligned_cols=89 Identities=21% Similarity=0.165 Sum_probs=75.2
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
.-|.+-+.||+|-|++|.+|+|.-||++||||+|.+.+.. .-+|||+||+||++.....+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3588999999999999999999999999999999976531 1168999999999999999999999
Q ss_pred cC-CCCCCcccCCCCCCCCCCCchhhh
Q psy18163 818 NP-GGPLNKKEQPKWRPMQISNPSTKL 843 (1028)
Q Consensus 818 ~~-~G~L~~~~~~~~~~~~~~~~~~~~ 843 (1028)
+- +|||++++.. +---+.|.-+|-
T Consensus 98 LGD~GDl~DyImK--He~Gl~E~La~k 122 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK--HEEGLNEDLAKK 122 (864)
T ss_pred ecCCchHHHHHHh--hhccccHHHHHH
Confidence 88 7899998875 333377776664
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.4e-07 Score=99.93 Aligned_cols=73 Identities=26% Similarity=0.329 Sum_probs=60.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+|++++.||+|+||.||+|++..+|+.||||++.+... ..-.||+++++++++......+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 369999999999999999999999999999999864210 0114789999888888888899999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ +|+|..
T Consensus 81 e~~~g~~L~~ 90 (333)
T cd05600 81 EYVPGGDFRT 90 (333)
T ss_pred eCCCCCCHHH
Confidence 998 778877
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.4e-07 Score=98.04 Aligned_cols=74 Identities=18% Similarity=0.241 Sum_probs=61.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
++|++++.||+|+||.||+|.+..+|+.||||++..... ..-.||+++++++++......+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 379999999999999999999999999999999863210 0015899999998888888899999
Q ss_pred ecC-CCCCCcc
Q psy18163 817 ENP-GGPLNKK 826 (1028)
Q Consensus 817 E~~-~G~L~~~ 826 (1028)
||+ +|+|.+.
T Consensus 81 e~~~~~~L~~~ 91 (291)
T cd05612 81 EYVPGGELFSY 91 (291)
T ss_pred eCCCCCCHHHH
Confidence 988 7788763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.3e-07 Score=103.37 Aligned_cols=81 Identities=17% Similarity=0.220 Sum_probs=66.4
Q ss_pred CCCCCCCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------------------ccC
Q psy18163 743 LPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------------------LEN 795 (1028)
Q Consensus 743 ~~~~~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------------------~~~ 795 (1028)
....+.|..+.+|+++..||.|.||+|.+|++..+++.||||+|.+.... .-.
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 34566888999999999999999999999999999999999999753210 004
Q ss_pred CchhhhhhHhhhcC--cCcEEEEecC-CCCC
Q psy18163 796 FPSRIRTYHLQVES--ELNHLVTENP-GGPL 823 (1028)
Q Consensus 796 ~p~~vr~~e~~~~~--~~~hlV~E~~-~G~L 823 (1028)
|||+|+++|+..+. +.+|||+||| .|.+
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v 197 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEV 197 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCcc
Confidence 79999999887654 5779999999 6654
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.8e-06 Score=95.00 Aligned_cols=75 Identities=23% Similarity=0.230 Sum_probs=63.2
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc--------------cCCchhhhhhHhhhcCcCcEEEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL--------------ENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~--------------~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+++|.++++||+|+||.||+|.+..+++.||||.+....... -.||+++++++++......+|||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4678999999999999999999999999999999987432110 05799999988888888889999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||++|+|..
T Consensus 84 e~~~~~l~~ 92 (301)
T cd07873 84 EYLDKDLKQ 92 (301)
T ss_pred eccccCHHH
Confidence 999887765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1028 | ||||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-69 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-68 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-68 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-68 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-68 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-68 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-68 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-68 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-68 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-68 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-68 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-68 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-68 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-68 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-68 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-68 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-68 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-68 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-68 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-68 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-68 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-68 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-68 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-68 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-68 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-68 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-68 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-67 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-67 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-67 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-67 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-67 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-67 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-67 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-67 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-66 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-66 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-65 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-65 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-65 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-62 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-61 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-61 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-61 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-60 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-60 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-60 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-60 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-58 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-56 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-55 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-54 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-54 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-53 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-53 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-52 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-52 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-50 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-42 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-41 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-40 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-40 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-40 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-40 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-40 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-40 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-39 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-39 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-39 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-39 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-39 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-39 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-39 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-39 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-39 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-39 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-39 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-39 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-39 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-39 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-39 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-38 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-38 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-38 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-37 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-36 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-36 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-36 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-36 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-36 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-36 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-36 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-36 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-36 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-36 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-36 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-35 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-35 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-35 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-35 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-35 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-35 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-35 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-35 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-35 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-35 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-35 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-35 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-35 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-35 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-35 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-35 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-35 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-35 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-35 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-35 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-35 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-35 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-34 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-34 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-34 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-34 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-34 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-34 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-34 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-34 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-34 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-34 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-34 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-34 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-34 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-34 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-34 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-34 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-34 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-34 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-34 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-34 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-34 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-34 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-34 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-34 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-34 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-34 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-34 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-34 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-34 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-34 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-34 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-34 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-34 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-34 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-34 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-34 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-34 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-34 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-34 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-34 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-34 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-34 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-34 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-34 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-34 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-34 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-34 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-34 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-34 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-34 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-33 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-33 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-33 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-33 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-33 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-33 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-33 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-32 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-32 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-32 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-32 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-32 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-32 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-32 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-32 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-31 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-31 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-31 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-31 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-31 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-31 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-31 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-31 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-31 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-31 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-31 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-30 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-30 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-30 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-30 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-30 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-30 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-30 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-30 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-28 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-25 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-24 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-24 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-24 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-23 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-23 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-23 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-23 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-22 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-22 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-22 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-22 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-22 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-22 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-22 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-22 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-22 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-22 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-22 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-22 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-22 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-22 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-21 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-20 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-20 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-16 | ||
| 4dbg_B | 162 | Crystal Structure Of Hoil-1l-Ubl Complexed With A H | 1e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-15 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-15 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-13 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-13 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 7e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-13 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 8e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-04 |
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DBG|B Chain B, Crystal Structure Of Hoil-1l-Ubl Complexed With A Hoip-Uba Derivative Length = 162 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 511 bits (1318), Expect = e-174
Identities = 122/332 (36%), Positives = 183/332 (55%), Gaps = 14/332 (4%)
Query: 353 PAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREI 412
C V +++ L +I +GT+G V++A+ ++T + VALK++ ME EKEGFPIT+LREI
Sbjct: 8 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 67
Query: 413 NTLLKAQHPNIVTVREIVV------GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPG 466
L +H N+V + EI I++V D+ EHD+ L+ + K F
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLS 124
Query: 467 EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH---- 522
E+K +MQ LLN + ++H N ILHRD+K +N+L++ G+LK+ DFGLAR +
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT 582
YT VVTLWYR PELLLG ++Y PID+W GCI AE P+ G ++ QL+ I +
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 583 MGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR 642
G+ ++WP +K+ + +K ++ + DL+ K L DP R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQK-RKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303
Query: 643 ITADEALRHDYFSESPLPIDPAMFPTWPAKSE 674
I +D+AL HD+F P+P D + S
Sbjct: 304 IDSDDALNHDFFWSDPMPSDLKGMLSTHLTSM 335
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-13
Identities = 12/39 (30%), Positives = 24/39 (61%)
Query: 744 PAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
C V +++ L +I +GT+G V++A+ ++T + VA
Sbjct: 8 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA 46
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 505 bits (1302), Expect = e-172
Identities = 130/353 (36%), Positives = 192/353 (54%), Gaps = 19/353 (5%)
Query: 354 AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLR 410
A+ + ++ L+ + EG + VY+A+DK T++IVA+K++K+ + K+G T+LR
Sbjct: 2 ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 411 EINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKC 470
EI L + HPNI+ + + I +V D++E D++ +++ V P +K
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKA 116
Query: 471 LMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL 530
M L + +LH +WILHRDLK +NLLL G+LK+ DFGLA+ +GSP + YT VVT
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR 176
Query: 531 WYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590
WYR+PELL G + Y +DMW+VGCI AE L P G SDL+QL+RIF+T+GTP E+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236
Query: 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650
WP LP TF +P + L S + DL+ ++P RITA +AL+
Sbjct: 237 WPDMCSLPDYV--TFKSFPGI-PLHHIF--SAAGDDLLDLIQGLFLFNPCARITATQALK 291
Query: 651 HDYFSESPLPIDPAMFPTWPAKSELAHKKAAMA------SPKPPSGGHNYKQL 697
YFS P P P E +++ A + G K+L
Sbjct: 292 MKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKKL 344
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 13/38 (34%), Positives = 24/38 (63%)
Query: 745 AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
A+ + ++ L+ + EG + VY+A+DK T++IVA
Sbjct: 2 ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVA 39
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 491 bits (1267), Expect = e-167
Identities = 121/319 (37%), Positives = 181/319 (56%), Gaps = 8/319 (2%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ 419
S +FK L ++ GTY VY+ +K T VALK +K++ E EG P T++REI+ + + +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELK 61
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK--KQVFIPGEVKCLMQQLLN 477
H NIV + +++ N K+ +V +++++D+K M++ + VK QLL
Sbjct: 62 HENIVRLYDVIHTEN--KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+A H+N ILHRDLK NLL++ RG LK+GDFGLAR +G P+ ++ VVTLWYR+P++
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
L+G + YST ID+WS GCI AE + +PLF G +D EQL IF MGTPNE +WP +KL
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 598 PAVQKMTFAEYP--NVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655
P + P ++ + L D L L +P R++A +AL H +F+
Sbjct: 240 PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
Query: 656 ESPLPIDPAMFPTWPAKSE 674
E +
Sbjct: 299 EYYHHASMGGSRSHHHHHH 317
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 13/32 (40%), Positives = 18/32 (56%)
Query: 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
S +FK L ++ GTY VY+ +K T VA
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVA 34
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 491 bits (1267), Expect = e-167
Identities = 121/328 (36%), Positives = 189/328 (57%), Gaps = 19/328 (5%)
Query: 357 GCRSVEEFKCLNRIEEGTYGVVYRAKD-KRTDEIVALKRLKMEKEKEGFPITSLREINTL 415
CR+ ++++C+ I EG YG V++A+D K VALKR++++ +EG P++++RE+ L
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 416 L---KAQHPNIVTVREIVVGSNMD---KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVK 469
+HPN+V + ++ S D K+ +V ++V+ D+ + ++ + +K
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIK 123
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVT 529
+M QLL + LH + ++HRDLK N+L++ G +K+ DFGLAR Y + T +VVT
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVT 182
Query: 530 LWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589
LWYR+PE+LL Y+TP+D+WSVGCIFAE +PLF G SD++QL +I +G P E+
Sbjct: 183 LWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
WP LP + F ++ V + + ELG DLL K LT++P RI+A AL
Sbjct: 242 DWPRDVALP---RQAFHSKS-AQPIEKFV--TDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 650 RHDYFSESPLPIDPAM--FPTWPAKSEL 675
H YF + + P SEL
Sbjct: 296 SHPYFQDLERCKENLDSHLPPSQNTSEL 323
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 7e-12
Identities = 14/36 (38%), Positives = 23/36 (63%), Gaps = 1/36 (2%)
Query: 748 GCRSVEEFKCLNRIEEGTYGVVYRAKD-KRTDEIVA 782
CR+ ++++C+ I EG YG V++A+D K VA
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVA 41
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 1e-10
Identities = 17/31 (54%), Positives = 25/31 (80%)
Query: 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+E F+ + +I EGTYGVVY+A++K T E+VA
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVA 32
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 485 bits (1251), Expect = e-165
Identities = 127/301 (42%), Positives = 183/301 (60%), Gaps = 10/301 (3%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
+++++ L +I EGTYG V++AK++ T EIVALKR++++ + EG P ++LREI L + +H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
NIV + +++ K+ +V ++ + D+K ++ P VK + QLL +
Sbjct: 61 KNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLG 115
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
H +LHRDLK NLL++ G LK+ +FGLAR +G P++ Y+ VVTLWYR P++L G
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 541 CKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
K YST IDMWS GCIFAE PLF G +QL RIF+ +GTP E+ WP +KLP
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659
+ + YP L V L G DLL L +PV RI+A+EAL+H YFS+
Sbjct: 236 YK--PYPMYPATTSLVNVVPK--LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 660 P 660
P
Sbjct: 292 P 292
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 1e-10
Identities = 15/31 (48%), Positives = 25/31 (80%)
Query: 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+++++ L +I EGTYG V++AK++ T EIVA
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVA 31
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 485 bits (1252), Expect = e-165
Identities = 125/307 (40%), Positives = 193/307 (62%), Gaps = 9/307 (2%)
Query: 355 IQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINT 414
+ +E+++ L ++ EGTYGVVY+AKD IVALKR++++ E EG P T++REI+
Sbjct: 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISL 72
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
L + HPNIV++ +++ + +V +++E D+K +++ + ++K + Q
Sbjct: 73 LKELHHPNIVSLIDVIHSER--CLTLVFEFMEKDLKKVLDENK---TGLQDSQIKIYLYQ 127
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
LL VAH H + ILHRDLK NLL++ G LK+ DFGLAR +G P++ YT VVTLWYR+
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
P++L+G K+YST +D+WS+GCIFAE + +PLF G +D +QL +IF +GTPN + WP
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+LP ++ TF + + + + G DLL L +DP RI+A +A+ H YF
Sbjct: 248 QELPLWKQRTFQVFEKK-PWSSII--PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304
Query: 655 SESPLPI 661
+ I
Sbjct: 305 KDLDPQI 311
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 6e-10
Identities = 16/37 (43%), Positives = 24/37 (64%), Gaps = 1/37 (2%)
Query: 746 IQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ +E+++ L ++ EGTYGVVY+AKD IVA
Sbjct: 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVA 49
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 485 bits (1252), Expect = e-164
Identities = 123/317 (38%), Positives = 193/317 (60%), Gaps = 14/317 (4%)
Query: 349 PPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS 408
+ A S++ ++ + ++ EGTYG VY+A D T+E VA+KR+++E E+EG P T+
Sbjct: 21 SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA 80
Query: 409 LREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEV 468
+RE++ L + QH NI+ ++ ++ ++ ++ ++ +Y E+D+K M+ +
Sbjct: 81 IREVSLLKELQHRNIIELKSVIHHNH--RLHLIFEYAENDLKKYMDKNPD----VSMRVI 134
Query: 469 KCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS-----HRGILKVGDFGLAREYGSPLKHY 523
K + QL+N V H LHRDLK NLLLS +LK+GDFGLAR +G P++ +
Sbjct: 135 KSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTM 583
T ++TLWYR PE+LLG + YST +D+WS+ CI+AE L PLF G S+++QL +IF+ +
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI 643
G P++ WPG + LP K +F ++ LK + ++L + G DLL L DPV RI
Sbjct: 255 GLPDDTTWPGVTALPDW-KQSFPKFRG-KTLKRVLG-ALLDDEGLDLLTAMLEMDPVKRI 311
Query: 644 TADEALRHDYFSESPLP 660
+A AL H YFS +
Sbjct: 312 SAKNALEHPYFSHNDFD 328
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 15/43 (34%), Positives = 25/43 (58%)
Query: 740 PPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ A S++ ++ + ++ EGTYG VY+A D T+E VA
Sbjct: 21 SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVA 63
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-161
Identities = 113/316 (35%), Positives = 174/316 (55%), Gaps = 19/316 (6%)
Query: 354 AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG---FPITSLR 410
G + ++ + I G YG VY+A+D + VALK +++ G PI+++R
Sbjct: 1 GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 411 EINTLLK---AQHPNIVTVREIVVGSNMD---KIFIVMDYVEHDMKSLMETMRSKKQVFI 464
E+ L + +HPN+V + ++ S D K+ +V ++V+ D+++ ++
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LP 118
Query: 465 PGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT 524
+K LM+Q L + LH N I+HRDLK N+L++ G +K+ DFGLAR Y + T
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LT 177
Query: 525 PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMG 584
P+VVTLWYR+PE+LL Y+TP+DMWSVGCIFAE +PLF G S+ +QL +IF +G
Sbjct: 178 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 585 TPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT 644
P E WP LP + F +++ V + E G LL + LT++P RI+
Sbjct: 237 LPPEDDWPRDVSLP---RGAFPPRG-PRPVQSVVPE--MEESGAQLLLEMLTFNPHKRIS 290
Query: 645 ADEALRHDYFSESPLP 660
A AL+H Y +
Sbjct: 291 AFRALQHSYLHKDEGN 306
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 11/38 (28%), Positives = 18/38 (47%)
Query: 745 AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
G + ++ + I G YG VY+A+D + VA
Sbjct: 1 GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA 38
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-161
Identities = 130/297 (43%), Positives = 191/297 (64%), Gaps = 10/297 (3%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
+E++ L +I EGTYGVVY+A++ E ALK++++EKE EG P T++REI+ L + +H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
NIV + +++ ++ +V ++++ D+K L++ + K + QLLN +A
Sbjct: 60 SNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIA 114
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
+ HD +LHRDLK NLL++ G LK+ DFGLAR +G P++ YT +VTLWYR+P++L+G
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
K+YST ID+WSVGCIFAE + PLF G S+ +QL RIF+ +GTPN K WP ++LP
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657
F Y + ++ + L E G DLL K L DP RITA +AL H YF E+
Sbjct: 235 -DPNFTVYEPL-PWESFL--KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 7e-09
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+E++ L +I EGTYGVVY+A++ E A
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFA 30
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-160
Identities = 122/332 (36%), Positives = 180/332 (54%), Gaps = 14/332 (4%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
+E + L+++ EGTY VY+ K K TD +VALK +++E E EG P T++RE++ L +H
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKH 59
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
NIVT+ +I+ + +V +Y++ D+K ++ + VK + QLL +A
Sbjct: 60 ANIVTLHDIIHTEK--SLTLVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLA 114
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
+ H +LHRDLK NLL++ RG LK+ DFGLAR P K Y VVTLWYR P++LLG
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
+YST IDMW VGCIF E PLF G + EQL IF+ +GTP E+ WPG
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP-- 658
+ + +Y L + L G DLL K L ++ RI+A++A++H +F
Sbjct: 235 KTYNYPKYR-AEALLSHA--PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291
Query: 659 ---LPIDPAMFPTWPAKSELAHKKAAMASPKP 687
LP ++F + + +
Sbjct: 292 IHKLPDTTSIFALKEIQLQKEASLRSAHHHHH 323
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 14/31 (45%), Positives = 21/31 (67%)
Query: 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+E + L+++ EGTY VY+ K K TD +VA
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVA 31
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 467 bits (1205), Expect = e-158
Identities = 99/317 (31%), Positives = 167/317 (52%), Gaps = 7/317 (2%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
+E+++ + +I EG+YGVV++ +++ T +IVA+K+ ++ +LREI L + +H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
PN+V + E+ ++ +V +Y +H + ++ ++ VK + Q L AV
Sbjct: 62 PNLVNLLEVFRRKR--RLHLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVN 116
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
H + +HRD+K N+L++ ++K+ DFG AR P +Y V T WYRSPELL+G
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
+Y P+D+W++GC+FAE L PL+ GKSD++QL I KT+G + FS
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660
+ + ++ L+ K ++ LL L DP R+T ++ L H YF
Sbjct: 237 SGVKIPDPEDMEPLELKFPN--ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294
Query: 661 IDPAMFPTWPAKSELAH 677
D A PA++
Sbjct: 295 EDLAKEHDKPAENLYFQ 311
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 12/31 (38%), Positives = 25/31 (80%)
Query: 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+E+++ + +I EG+YGVV++ +++ T +IVA
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVA 32
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 466 bits (1201), Expect = e-157
Identities = 93/318 (29%), Positives = 160/318 (50%), Gaps = 7/318 (2%)
Query: 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
+S+E+++ L + EG+YG+V + ++K T IVA+K+ + + ++REI L
Sbjct: 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK 79
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+ +H N+V + E+ + ++V ++V+H + +E V+ + Q++
Sbjct: 80 QLRHENLVNLLEVCKKKK--RWYLVFEFVDHTILDDLELFP---NGLDYQVVQKYLFQII 134
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
N + H + I+HRD+K N+L+S G++K+ DFG AR +P + Y V T WYR+PE
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
LL+G +Y +D+W++GC+ E EPLF G SD++QL I +G + F+K
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
P + E L+ + L+E+ DL K L DP R E L HD+F
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPK--LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312
Query: 657 SPLPIDPAMFPTWPAKSE 674
+ + +
Sbjct: 313 DGFAERFSQELQLKVQKD 330
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 13/35 (37%), Positives = 24/35 (68%)
Query: 748 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+S+E+++ L + EG+YG+V + ++K T IVA
Sbjct: 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVA 54
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 443 bits (1140), Expect = e-147
Identities = 127/396 (32%), Positives = 200/396 (50%), Gaps = 38/396 (9%)
Query: 354 AIQGCRSVEEFKCLN-RIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEKEGFPITSLR 410
+ + R + F+ ++ GTYG VY+AK K + D+ ALK++ E G +++ R
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACR 67
Query: 411 EINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMR-----SKKQVFIP 465
EI L + +HPN+++++++ + K++++ DY EHD+ +++ R K
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 466 GEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS----HRGILKVGDFGLAREYGSPLK 521
G VK L+ Q+L+ + +LH NW+LHRDLK +N+L+ RG +K+ D G AR + SPLK
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 522 ---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD------ 572
P+VVT WYR+PELLLG + Y+ ID+W++GCIFAE L EP+F + +
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 573 ---LEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM----TFAEYPNVGGLKT-KVAGSILT 624
+QL RIF MG P +K W K+P + Y N +K +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 625 ELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPT---WPAKSELAHKKAA 681
+ LL K LT DP+ RIT+++A++ YF E PLP +P + L ++
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPD 367
Query: 682 MASPKPPSGGHNYKQLEDNEEGFHMGMMERSRAPVP 717
K + H G + S P
Sbjct: 368 DKGDKKNQ--QQQQGNNHTNGTGHPGNQDSSHTQGP 401
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 20/73 (27%), Positives = 30/73 (41%), Gaps = 11/73 (15%)
Query: 745 AIQGCRSVEEFKCLN-RIEEGTYGVVYRAKDK--RTDEIVAPCKSGNGKFWLENFP-SRI 800
+ + R + F+ ++ GTYG VY+AK K + D+ A K + S
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYA-LK----QIEGTGISMSAC 66
Query: 801 RTYHLQVESELNH 813
R L EL H
Sbjct: 67 REIALL--RELKH 77
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 307 bits (787), Expect = 4e-95
Identities = 95/308 (30%), Positives = 149/308 (48%), Gaps = 36/308 (11%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
+ I G++GVVY+AK + E+VA+K++ +K + RE+ + K H NI
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMRKLDHCNI 109
Query: 424 VTVREIV--VGSNMDKIFI--VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
V +R G D++++ V+DYV + + KQ VK M QL ++
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 480 AHLHDNWILHRDLKTSNLLL-SHRGILKVGDFGLAREY--GSPLKHYTPIVVTLWYRSPE 536
A++H I HRD+K NLLL +LK+ DFG A++ G P Y + + +YR+PE
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 226
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS- 595
L+ G +Y++ ID+WS GC+ AE L +P+F G S ++QL I K +GTP + +
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286
Query: 596 -----KLPAVQKMTFAE--YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA 648
K P ++ + + P L + L Y P R+T EA
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPR------------TPPEAIALCSRLLEYTPTARLTPLEA 334
Query: 649 LRHDYFSE 656
H +F E
Sbjct: 335 CAHSFFDE 342
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = 1e-94
Identities = 95/311 (30%), Positives = 153/311 (49%), Gaps = 29/311 (9%)
Query: 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
G + + I G++GVV++AK +DE VA+K++ +K + RE+ +
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMR 87
Query: 417 KAQHPNIVTVREIVV----GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLM 472
+HPN+V ++ + + +V++YV + KQ +K M
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 473 QQLLNAVAHLHDNWILHRDLKTSNLLL-SHRGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
QLL ++A++H I HRD+K NLLL G+LK+ DFG A+ + + + +
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRY 206
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591
YR+PEL+ G Y+T ID+WS GC+ AE + +PLF G+S ++QL I K +GTP+ +
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 592 PGFS------KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA 645
+ K P ++ F+ KV DL+ + L Y P R+TA
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFS----------KVFRPRTPPDAIDLISRLLEYTPSARLTA 316
Query: 646 DEALRHDYFSE 656
EAL H +F E
Sbjct: 317 IEALCHPFFDE 327
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 8e-88
Identities = 89/332 (26%), Positives = 153/332 (46%), Gaps = 36/332 (10%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA 418
+ ++ F+ +GT+G V K+K T VA+K++ + F L+ + L
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVL 76
Query: 419 QHPNIVTVREIVV---GSNMDKIF--IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ 473
HPNIV ++ + I+ +VM+YV + ++ P +K +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 474 QLLNAVAHLHDNW--ILHRDLKTSNLLL-SHRGILKVGDFGLAREYGSPLKHYTPIVVTL 530
QL+ ++ LH + HRD+K N+L+ G LK+ DFG A++ SP + + +
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAYICSR 195
Query: 531 WYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590
+YR+PEL+ G + Y+T +D+WSVGCIFAE + EP+F G + QL I + +G P+ ++
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255
Query: 591 WPGFS------KLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI 643
+ L + + ++ + + + YDLL L Y P R+
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDH--------SLKDAKEAYDLLSALLQYLPEERM 307
Query: 644 TADEALRHDYFSE---------SPLPIDPAMF 666
EAL H YF E + + +F
Sbjct: 308 KPYEALCHPYFDELHDPATKLPNNKDLPEDLF 339
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 10/33 (30%), Positives = 17/33 (51%)
Query: 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ ++ F+ +GT+G V K+K T VA
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVA 52
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 5e-86
Identities = 84/310 (27%), Positives = 148/310 (47%), Gaps = 35/310 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK--AQ 419
++++ + ++ G Y V+ A + +E V +K LK K+K+ REI +L+
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREI-KILENLRG 89
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
PNI+T+ +IV +V ++V + D K L Q +++ M ++L A
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKA 142
Query: 479 VAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ + H I+HRD+K N+++ H L++ D+GLA + P + Y V + +++ PEL
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPEL 201
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
L+ + Y +DMWS+GC+ A + EP F G + +QL RI K +GT + +
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 597 ----------LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD 646
L + + + + +++ D L K L YD +R+TA
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVH------SENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 647 EALRHDYFSE 656
EA+ H YF
Sbjct: 316 EAMEHPYFYT 325
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 3e-84
Identities = 81/339 (23%), Positives = 147/339 (43%), Gaps = 62/339 (18%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+++ + G++G+V D + + ALK++ + RE++ + H
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHV 60
Query: 422 NIVTVREIV------------------------------------VGSNMDKIFIVMDYV 445
NI+ + + S + ++M+YV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL-SHRGI 504
+ ++++ + + + QL AV +H I HRD+K NLL+ S
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 505 LKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME 564
LK+ DFG A++ P + + + +YR+PEL+LG EY+ ID+WS+GC+F E + +
Sbjct: 181 LKLCDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 565 PLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS------KLPAVQKMTFAE-YPNVGGLKTK 617
PLF+G++ ++QL RI + MGTP ++ + + P ++ + + P
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG------ 293
Query: 618 VAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
L DLL + L Y+P RI EA+ H +F
Sbjct: 294 -----TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 1e-79
Identities = 110/445 (24%), Positives = 176/445 (39%), Gaps = 116/445 (26%)
Query: 284 SSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIEL 343
SS +++++ + + + +++ ++++ + P + D +I
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPT--------ASMPRPHSDWQIP- 52
Query: 344 EKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG 403
+ ++ + I G+YG V A DK +VA+K++ E
Sbjct: 53 ------------------DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI 94
Query: 404 FPITSLREINTLLKA-QHPNIVTVREIVV---GSNMDKIFIVMDYVEHDMKSLMETMRSK 459
LREI +L H ++V V +IV+ D++++V++ + D K L T
Sbjct: 95 DCKRILREI-AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT---- 149
Query: 460 KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519
+K L+ LL V ++H ILHRDLK +N L++ +KV DFGLAR P
Sbjct: 150 PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209
Query: 520 ---------------------------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWS 552
+ T VVT WYR+PEL+L + Y+ ID+WS
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWS 269
Query: 553 VGCIFAEFLCME-----------PLFTGKSDLE--------------------QLSRIFK 581
+GCIFAE L M PLF G S QL+ IF
Sbjct: 270 IGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN 329
Query: 582 TMGTPNEKIWPGFS---------KLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLL 631
+GTP+E+ P + AE +P + LL
Sbjct: 330 ILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS------------SADAIHLL 377
Query: 632 CKFLTYDPVTRITADEALRHDYFSE 656
+ L ++P RIT +E L H +F E
Sbjct: 378 KRMLVFNPNKRITINECLAHPFFKE 402
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 9e-78
Identities = 94/320 (29%), Positives = 153/320 (47%), Gaps = 44/320 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ L + G G+V+ A D D+ VA+K++ + + +LREI + + H
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ--SVKHALREIKIIRRLDHD 68
Query: 422 NIVTVREIV------------VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVK 469
NIV V EI+ + ++ ++IV +Y+E D+ +++ ++ + +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL-----EQGPLLEEHAR 123
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLL-SHRGILKVGDFGLAREYGSPLKHY---TP 525
M QLL + ++H +LHRDLK +NL + + +LK+GDFGLAR H +
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585
+VT WYRSP LLL Y+ IDMW+ GCIFAE L + LF G +LEQ+ I +++
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 586 PNE----KIWPGFSK----LPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLT 636
+E ++ + P + + D L + LT
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI------------SREAVDFLEQILT 291
Query: 637 YDPVTRITADEALRHDYFSE 656
+ P+ R+TA+EAL H Y S
Sbjct: 292 FSPMDRLTAEEALSHPYMSI 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-77
Identities = 95/309 (30%), Positives = 151/309 (48%), Gaps = 35/309 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ + + G YG V A DKR+ E VA+K+L + E F + RE+ L QH
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 422 NIVTVREIVV----GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
N++ + ++ N ++VM +++ D++ +M F +++ L+ Q+L
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLK 137
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ ++H ++HRDLK NL ++ LK+ DFGLAR + + Y VVT WYR+PE+
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEV 194
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP---------NE 588
+L Y+ +D+WSVGCI AE L + LF GK L+QL++I K G P ++
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 589 KIWPGFSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
LP + F + +P + DLL K L D R+TA +
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRA------------SPQAADLLEKMLELDVDKRLTAAQ 302
Query: 648 ALRHDYFSE 656
AL H +F
Sbjct: 303 ALTHPFFEP 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 2e-76
Identities = 99/309 (32%), Positives = 150/309 (48%), Gaps = 34/309 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++ L + G YG V A D RT VA+K+L + E F + RE+ L +H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 422 NIVTVREIVV----GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
N++ + ++ + ++VM ++ D+ LM K + ++ L+ Q+L
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 139
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ ++H I+HRDLK NL ++ LK+ DFGLAR+ S + Y VVT WYR+PE+
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY---VVTRWYRAPEV 196
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP---------NE 588
+L Y+ +D+WSVGCI AE + + LF G L+QL I K GTP ++
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 589 KIWPGFSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
+ LP ++K FA N + L +LL K L D R+TA E
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNA------------SPLAVNLLEKMLVLDAEQRVTAGE 304
Query: 648 ALRHDYFSE 656
AL H YF
Sbjct: 305 ALAHPYFES 313
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 2e-75
Identities = 107/311 (34%), Positives = 154/311 (49%), Gaps = 34/311 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ L+ I EG YG+V A D VA+K++ E + + +LREI LL+ +H
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHE 85
Query: 422 NIVTVREIVV---GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
NI+ + +I+ M ++IV D +E D+ L+ K Q + + Q+L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRG 140
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY---TPIVVTLWYRSP 535
+ ++H +LHRDLK SNLLL+ LK+ DFGLAR H T V T WYR+P
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP--------- 586
E++L K Y+ ID+WSVGCI AE L P+F GK L+QL+ I +G+P
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 587 NEKIWPGFSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA 645
N K LP K+ + +PN DLL K LT++P RI
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEV 308
Query: 646 DEALRHDYFSE 656
++AL H Y +
Sbjct: 309 EQALAHPYLEQ 319
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 2e-75
Identities = 105/320 (32%), Positives = 152/320 (47%), Gaps = 44/320 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQH 420
+F+ + + EG YGVV A K T EIVA+K K+E +K F + +LREI L +H
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KIEPFDKPLFALRTLREIKILKHFKH 68
Query: 421 PNIVTVREIVV---GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
NI+T+ I N ++++I+ + ++ D+ ++ Q+ ++ + Q L
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSDDHIQYFIYQTLR 123
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY----------TPIV 527
AV LH + ++HRDLK SNLL++ LKV DFGLAR V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP- 586
T WYR+PE++L +YS +D+WS GCI AE P+F G+ QL IF +GTP
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 587 ---------NEKIWPGFSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLT 636
+ + LP + +P V G DLL + L
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV------------NPKGIDLLQRMLV 291
Query: 637 YDPVTRITADEALRHDYFSE 656
+DP RITA EAL H Y
Sbjct: 292 FDPAKRITAKEALEHPYLQT 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 8e-75
Identities = 94/307 (30%), Positives = 146/307 (47%), Gaps = 34/307 (11%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
++ L+ + G YG V A D +T VA+K+L + + RE+ L +H N+
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 424 VTVREIVV----GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
+ + ++ + +++V + D+ +++ K Q V+ L+ Q+L +
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILRGL 145
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
++H I+HRDLK SNL ++ LK+ DFGLAR + Y V T WYR+PE++L
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAPEIML 202
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP---------NEKI 590
Y+ +D+WSVGCI AE L LF G ++QL I + +GTP +E
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262
Query: 591 WPGFSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
L + KM FA + L DLL K L D RITA +AL
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 650 RHDYFSE 656
H YF++
Sbjct: 311 AHAYFAQ 317
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 9e-75
Identities = 88/318 (27%), Positives = 141/318 (44%), Gaps = 40/318 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPIT---------SLREI 412
+ I G+YG V D VA+KR+ LREI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 413 NTLLKAQHPNIVTVREIVV---GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVK 469
L HPNI+ +R+I V M K+++V + + D+ ++ ++ V P ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI---HDQRIVISPQHIQ 137
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVT 529
M +L + LH+ ++HRDL N+LL+ + + DF LARE + + T V
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED-TADANKTHYVTH 196
Query: 530 LWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589
WYR+PEL++ K ++ +DMWS GC+ AE + LF G + QL++I + +GTP +
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 590 IWPGF----------SKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYD 638
F + L V + P + DL+ K L ++
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA------------DPVALDLIAKMLEFN 304
Query: 639 PVTRITADEALRHDYFSE 656
P RI+ ++ALRH YF
Sbjct: 305 PQRRISTEQALRHPYFES 322
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 1e-74
Identities = 87/308 (28%), Positives = 149/308 (48%), Gaps = 21/308 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ ++ L I G G+V A D D VA+K+L + + + RE+ + H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 422 NIVTVREIVV----GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
NI+++ + +++VM+ ++ ++ ++ + + L+ Q+L
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 175
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ HLH I+HRDLK SN+++ LK+ DFGLAR G+ TP VVT +YR+PE+
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEV 234
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP--------NEK 589
+LG Y +D+WSVGCI E + + LF G+ ++Q +++ + +GTP
Sbjct: 235 ILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 590 IWPGFSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA 648
+ P +TF + +P+ + DLL K L DP RI+ D+A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 649 LRHDYFSE 656
L+H Y +
Sbjct: 354 LQHPYINV 361
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-74
Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 21/308 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ ++ L I G G+V A D + VA+K+L + + + RE+ + H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 422 NIVTVREIVV----GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
NI+ + + ++IVM+ ++ ++ ++ + + L+ Q+L
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLC 138
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ HLH I+HRDLK SN+++ LK+ DFGLAR TP VVT +YR+PE+
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEV 197
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS-- 595
+LG Y +D+WSVGCI E + LF G ++Q +++ + +GTP +
Sbjct: 198 ILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 596 ------KLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA 648
P +F + +P+V + DLL K L D RI+ DEA
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 649 LRHDYFSE 656
L+H Y +
Sbjct: 317 LQHPYINV 324
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-74
Identities = 94/332 (28%), Positives = 165/332 (49%), Gaps = 43/332 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK--AQ 419
+++ + ++ +G YG+V+++ D+RT E+VA+K++ + + REI +L +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREI-MILTELSG 67
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
H NIV + ++ N +++V DY+E D+ +++ + + P + ++ QL+ +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI-----RANILEPVHKQYVVYQLIKVI 122
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY---------------- 523
+LH +LHRD+K SN+LL+ +KV DFGL+R + + +
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 524 -----TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSR 578
T V T WYR+PE+LLG +Y+ IDMWS+GCI E LC +P+F G S + QL R
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 579 IFKTMGTP---------NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSIL-----T 624
I + P + L ++ + ++ + I
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 625 ELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
E DLL K L ++P RI+A++AL+H + S
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-69
Identities = 101/358 (28%), Positives = 158/358 (44%), Gaps = 79/358 (22%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ + + I G+YG VY A DK T++ VA+K++ E LREI L + +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 422 NIVTVREIVVGSNMDK---IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
I+ + ++++ ++ K ++IV++ + D+K L +T +K ++ LL
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLG 141
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY--------------- 523
+H++ I+HRDLK +N LL+ +KV DFGLAR S
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 524 -------TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-----------EP 565
T VVT WYR+PEL+L + Y+ ID+WS GCIFAE L M P
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
Query: 566 LFTGKSDLE-----------------QLSRIFKTMGTP---------NEKIWPGFSKLPA 599
LF G S QL+ IF +GTP ++ P
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH 321
Query: 600 VQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
+ + + YP++ ++ G +LL L ++P RIT D+AL H Y +
Sbjct: 322 RKPINLKQKYPSI------------SDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-60
Identities = 69/321 (21%), Positives = 121/321 (37%), Gaps = 61/321 (19%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA 418
R +F+ + + +G +G V +A++ A+K+++ +EK T L E+ L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASL 59
Query: 419 QHPNIVTVRE-----------IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE 467
H +V + +FI M+Y E+ +L + + S+ E
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCEN--GTLYDLIHSENLNQQRDE 117
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
L +Q+L A++++H I+HRDLK N+ + +K+GDFGLA+ L
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 528 V--------------TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL 573
T Y + E+L G Y+ IDM+S+G IF E + P TG +
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERV 235
Query: 574 EQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCK 633
L ++ K+ +K ++
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKV---EK--------------------------KIIRL 266
Query: 634 FLTYDPVTRITADEALRHDYF 654
+ +DP R A L +
Sbjct: 267 LIDHDPNKRPGARTLLNSGWL 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-57
Identities = 79/305 (25%), Positives = 130/305 (42%), Gaps = 47/305 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM----EKEKEGFPITSLREINTLLK 417
E+++ L I G+YG + + K +I+ K L E EK+ + E+N L +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ----MLVSEVNLLRE 61
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+HPNIV + ++ ++IVM+Y E D+ S++ ++Q V +M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 477 NAVAHLHD-----NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
A+ H + +LHRDLK +N+ L + +K+GDFGLAR V T +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591
Y SPE + Y+ D+WS+GC+ E + P FT S E +I + G +I
Sbjct: 182 YMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKF-RRIP 237
Query: 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
+S L +++ + L R + +E L +
Sbjct: 238 YRYSD----------------ELN-------------EIITRMLNLKDYHRPSVEEILEN 268
Query: 652 DYFSE 656
E
Sbjct: 269 PLILE 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-54
Identities = 73/313 (23%), Positives = 120/313 (38%), Gaps = 62/313 (19%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA 418
R +FK + I G +G V++AK + + +KR+K EK + RE+ L K
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKL 61
Query: 419 QHPNIV--------------TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFI 464
H NIV T + S +FI M++ + +L + + ++ +
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDK--GTLEQWIEKRRGEKL 119
Query: 465 P-GEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY 523
L +Q+ V ++H +++RDLK SN+ L +K+GDFGL + K
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 524 TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTM 583
TL Y SPE + ++Y +D++++G I AE L T + + +
Sbjct: 180 R-SKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLH--VCDTAFETSKFFTDL---- 231
Query: 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI 643
+ I F K K LL K L+ P R
Sbjct: 232 --RDGIISDIFDK----------------KEK-------------TLLQKLLSKKPEDRP 260
Query: 644 TADEALRHDYFSE 656
E LR +
Sbjct: 261 NTSEILRTLTVWK 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-53
Identities = 79/329 (24%), Positives = 129/329 (39%), Gaps = 68/329 (20%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTL 415
R + +F+ + + G +GVV+ AK+K D A+KR++ E +E +RE+ L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE----KVMREVKAL 57
Query: 416 LKAQHPNIV----------TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP 465
K +HP IV T ++ S ++I M ++L + M + +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRK--ENLKDWMNGRCTIEER 115
Query: 466 GEVKCL--MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR--------- 514
CL Q+ AV LH ++HRDLK SN+ + ++KVGDFGL
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 515 ---EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS 571
+T V T Y SPE + G YS +D++S+G I E L P T
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQME 232
Query: 572 DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLL 631
+ L+ + N K P F++ + ++
Sbjct: 233 RVRTLTDV------RNLKFPPLFTQKYPCEY--------------------------VMV 260
Query: 632 CKFLTYDPVTRITADEALRHDYFSESPLP 660
L+ P+ R A + + F + P
Sbjct: 261 QDMLSPSPMERPEAINIIENAVFEDLDFP 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-52
Identities = 80/350 (22%), Positives = 146/350 (41%), Gaps = 48/350 (13%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM----EKEKEGFPITSLREINT 414
+S+E++ L +I EG++G K +K + + KE+E S RE+
Sbjct: 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE----ESRREVAV 76
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQ 473
L +HPNIV RE + ++IVMDY E D+ + K +F ++
Sbjct: 77 LANMKHPNIVQYRESFEENG--SLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFV 132
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
Q+ A+ H+HD ILHRD+K+ N+ L+ G +++GDFG+AR S ++ + T +Y
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYL 192
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
SPE+ K Y+ D+W++GC+ E ++ F S ++ L + K + +
Sbjct: 193 SPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNL--VLKIISGSFPPVSLH 248
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
+S L+ L+ + +P R + + L +
Sbjct: 249 YSY----------------DLR-------------SLVSQLFKRNPRDRPSVNSILEKGF 279
Query: 654 FSESPLPIDPAMFPTWPAKSELAHKKAAMASP--KPPSGGHNYKQLEDNE 701
++ + K + P +P SG ++ + +
Sbjct: 280 IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQK 329
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-52
Identities = 76/319 (23%), Positives = 127/319 (39%), Gaps = 48/319 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ L +I G V++ ++ +I A+K + +E+ + EI L K Q
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
+ +R I++VM+ D+ S ++ KK+ P E K + +L AV
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 142
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY--GSPLKHYTPIVVTLWYRSPELLL 539
+H + I+H DLK +N L+ G+LK+ DFG+A + + V T+ Y PE +
Sbjct: 143 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 540 GC----------KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589
+ S D+WS+GCI + F + Q+S++ + PN +
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA-IIDPNHE 258
Query: 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
I E+P I + D+L L DP RI+ E L
Sbjct: 259 I----------------EFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELL 291
Query: 650 RHDYFSESPLPIDPAMFPT 668
H Y P++ T
Sbjct: 292 AHPYVQIQTHPVNQMAKGT 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 1e-51
Identities = 50/323 (15%), Positives = 93/323 (28%), Gaps = 56/323 (17%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQHPNIVTVRE-- 428
G VV+ +D E ALK M E + L + + R+
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 429 -------IVVGSNMDKI---------------FIVMDYVEHDMKSLMETMR---SKKQVF 463
V + ++M D++ L T+ +
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDE 191
Query: 464 IPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY 523
+ L QL+ A+L ++H NL + G L +GD + G+
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--- 248
Query: 524 TPIVVTLWYRSPELLLG-CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT 582
V + Y E L ++ ++ W +G C+ F + + S +
Sbjct: 249 PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 583 MGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR 642
+ P F + + L+ +FL +D R
Sbjct: 309 LRVPGTDSLA------------FGSCTPLP------------DFVKTLIGRFLNFDRRRR 344
Query: 643 ITADEALRHDYFSESPLPIDPAM 665
+ EA+ F + I ++
Sbjct: 345 LLPLEAMETPEFLQLQNEISSSL 367
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-51
Identities = 75/309 (24%), Positives = 117/309 (37%), Gaps = 43/309 (13%)
Query: 349 PPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS 408
P Y P+ + F+ L+R+ G+YG V++ + K + A+KR
Sbjct: 44 PGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARK 103
Query: 409 LREINTLLK-AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE 467
L E+ + K QHP V + + +++ + SL + + +
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTELCGP---SLQQHCEAWGASLPEAQ 158
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
V ++ L A+AHLH ++H D+K +N+ L RG K+GDFGL E G+
Sbjct: 159 VWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QE 217
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
Y +PELL G Y T D++S+G E C L G +QL + G
Sbjct: 218 GDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ-----GYLP 270
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
+ G S EL +L L DP R TA+
Sbjct: 271 PEFTAGLSS----------------------------EL-RSVLVMMLEPDPKLRATAEA 301
Query: 648 ALRHDYFSE 656
L +
Sbjct: 302 LLALPVLRQ 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-50
Identities = 78/339 (23%), Positives = 135/339 (39%), Gaps = 52/339 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ L +I G V++ ++ +I A+K + +E+ + EI L K Q
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 422 N--IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
+ I+ + + + I++VM+ D+ S ++ KK+ P E K + +L AV
Sbjct: 68 SDKIIRLYDYEI--TDQYIYMVMECGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAV 121
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY--GSPLKHYTPIVVTLWYRSPEL 537
+H + I+H DLK +N L+ G+LK+ DFG+A + + V T+ Y PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 538 LLG----------CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
+ + S D+WS+GCI + F + Q+S++ + PN
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA-IIDPN 237
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
+I E+P I + D+L L DP RI+ E
Sbjct: 238 HEI----------------EFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPE 270
Query: 648 ALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPK 686
L H Y P++ T + + + SP
Sbjct: 271 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 309
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 6e-50
Identities = 66/306 (21%), Positives = 128/306 (41%), Gaps = 42/306 (13%)
Query: 352 LPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM-----EKEKEGFPI 406
L G ++ F+ +I G + VYRA VALK++++ K +
Sbjct: 22 LRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA---- 77
Query: 407 TSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIP 465
++EI+ L + HPN++ + +++ IV++ + D+ +++ + +K++
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPE 135
Query: 466 GEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP 525
V QL +A+ H+H ++HRD+K +N+ ++ G++K+GD GL R + S
Sbjct: 136 RTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195
Query: 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585
+V T +Y SPE + Y+ D+WS+GC+ E ++ F G
Sbjct: 196 LVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDK-------------- 240
Query: 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA 645
+ +K+ +YP + +E L+ + DP R
Sbjct: 241 --------MNLYSLCKKIEQCDYP-------PLPSDHYSEELRQLVNMCINPDPEKRPDV 285
Query: 646 DEALRH 651
Sbjct: 286 TYVYDV 291
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 74/312 (23%), Positives = 127/312 (40%), Gaps = 46/312 (14%)
Query: 353 PAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALK---RLKMEKEKEGFPITSL 409
+ RS + + +G + + D T E+ A K + + K + ++
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-- 63
Query: 410 REINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVK 469
EI+ H ++V + D +F+V++ +SL+E + +K E +
Sbjct: 64 MEISIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRR--RSLLELHKRRKA-LTEPEAR 118
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP-LKHYTPIVV 528
++Q++ +LH N ++HRDLK NL L+ +K+GDFGLA + + +
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCG 177
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE 588
T Y +PE+L K +S +D+WS+GCI L +P F E RI K NE
Sbjct: 178 TPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NE 231
Query: 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA 648
P + + L+ K L DP R T +E
Sbjct: 232 YSIPKH----------------------------INPVAASLIQKMLQTDPTARPTINEL 263
Query: 649 LRHDYFSESPLP 660
L ++F+ +P
Sbjct: 264 LNDEFFTSGYIP 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-48
Identities = 54/296 (18%), Positives = 109/296 (36%), Gaps = 27/296 (9%)
Query: 372 EGTYGVVYRAKDKRTDEIVALK---RLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
+G V+R + K+T ++ A+K + + + +RE L K H NIV +
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKLNHKNIVKLFA 74
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE--VKCLMQQLLNAVAHLHDNW 486
I + ++M++ SL + + E +++ ++ + HL +N
Sbjct: 75 IEEETTTRHKVLIMEFCPC--GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 487 ILHRDLKTSNLLLS----HRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC- 541
I+HR++K N++ + + K+ DFG ARE + + + T Y P++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-LYGTEEYLHPDMYERAV 191
Query: 542 ------KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
K+Y +D+WS+G F F + + + T
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
+ + ++ V ++ +LT +L L D D+
Sbjct: 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLT----PVLANILEADQEKCWGFDQFFAE 303
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-48
Identities = 80/351 (22%), Positives = 138/351 (39%), Gaps = 47/351 (13%)
Query: 344 EKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALK---RLKMEKE 400
+ RS + + +G + + D T E+ A K + + K
Sbjct: 23 AAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP 82
Query: 401 KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK 460
+ ++ EI+ H ++V + D +F+V++ +SL+E + +K
Sbjct: 83 HQREKMS--MEISIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRR--RSLLELHKRRK 136
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP- 519
E + ++Q++ +LH N ++HRDLK NL L+ +K+GDFGLA +
Sbjct: 137 A-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
Query: 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
+ + T Y +PE+L K +S +D+WS+GCI L +P F E RI
Sbjct: 196 ERKKV-LCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253
Query: 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDP 639
K NE P + + L+ K L DP
Sbjct: 254 KK-----NEYSIPKH----------------------------INPVAASLIQKMLQTDP 280
Query: 640 VTRITADEALRHDYFSESPLPID-PAMFPTWPAKSELAHKKAAMASPKPPS 689
R T +E L ++F+ +P P T P + +A ++ KP +
Sbjct: 281 TARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLT 331
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-47
Identities = 86/322 (26%), Positives = 143/322 (44%), Gaps = 47/322 (14%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTL--LKAQHP----NIVT 425
+G++G V +A D + + VALK ++ ++ F + EI L L+ Q N++
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLHD 484
+ E N I + + + +L E ++ K Q F V+ +L + LH
Sbjct: 164 MLENFTFRN--HICMTFELLS---MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 485 NWILHRDLKTSNLLLSH--RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCK 542
N I+H DLK N+LL R +KV DFG + + + + +YR+PE++LG +
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQSRFYRAPEVILGAR 275
Query: 543 EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI------------ 590
Y PIDMWS+GCI AE L PL G+ + +QL+ + + +G P++K+
Sbjct: 276 -YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS 334
Query: 591 WPGFSKLPAVQKMTFAEYPNVGG------LKTKVAGSILTELG--------YDLLCKFLT 636
G+ + V ++ GG L+ D L + L
Sbjct: 335 SKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 637 YDPVTRITADEALRHDYFSESP 658
+DP R+T +ALRH +
Sbjct: 395 WDPAVRMTPGQALRHPWLRRRL 416
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 3e-47
Identities = 77/337 (22%), Positives = 131/337 (38%), Gaps = 48/337 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ L +I G V++ ++ +I A+K + +E+ + EI L K Q
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
+ +R I++VM+ D+ S ++ KK+ P E K + +L AV
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 170
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY--GSPLKHYTPIVVTLWYRSPELLL 539
+H + I+H DLK +N L+ G+LK+ DFG+A + + V + Y PE +
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 540 G----------CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589
+ S D+WS+GCI + F + Q+S++ + PN +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA-IIDPNHE 286
Query: 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
I E+P I + D+L L DP RI+ E L
Sbjct: 287 I----------------EFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELL 319
Query: 650 RHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPK 686
H Y P++ T + + + SP
Sbjct: 320 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 356
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 4e-47
Identities = 75/304 (24%), Positives = 133/304 (43%), Gaps = 41/304 (13%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLK 417
+E+FK N + +G++ VYRA+ T VA+K + K K G E+ +
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
+HP+I+ + + + +++V++ + + ++++ + F E + M Q++
Sbjct: 68 LKHPSILELYN--YFEDSNYVYLVLEMCHN--GEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP-LKHYTPIVVTLWYRSPE 536
+ +LH + ILHRDL SNLLL+ +K+ DFGLA + P KHYT + T Y SPE
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
+ + D+WS+GC+F L P F + L+++ + P F
Sbjct: 183 IATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----ADYEMPSFLS 236
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
+ A DL+ + L +P R++ L H + S
Sbjct: 237 IEAK----------------------------DLIHQLLRRNPADRLSLSSVLDHPFMSR 268
Query: 657 SPLP 660
+
Sbjct: 269 NSST 272
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 53/313 (16%), Positives = 106/313 (33%), Gaps = 46/313 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ + + ++ EG + V + ALKR+ ++++ + RE + HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHP 86
Query: 422 NIVTVRE--IVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
NI+ + + + ++++ + + + + +E ++ K ++ L+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV---------T 529
+ +H HRDLK +N+LL G + D G + ++ + T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 530 LWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
+ YR+PEL D+WS+GC+ + E + + S +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF-QKGDSVALAVQNQLS 265
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
P S L LL +T DP R
Sbjct: 266 IPQSPRHSS----------------ALW-------------QLLNSMMTVDPHQRPHIPL 296
Query: 648 ALRHDYFSESPLP 660
L + P P
Sbjct: 297 LLSQLEALQPPAP 309
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-46
Identities = 82/340 (24%), Positives = 129/340 (37%), Gaps = 74/340 (21%)
Query: 372 EGTYGVVYRAKD-KRTDEIVALKRLKMEKEKEGFPITSLREINTL--LKAQHP----NIV 424
EG +G V D K VA+K +K + + + EI L L P V
Sbjct: 24 EGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 425 TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAVAHLH 483
+ E I IV + + S + ++ + + ++ + Q+ +V LH
Sbjct: 81 QMLEWFEHHG--HICIVFELLG---LSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135
Query: 484 DNWILHRDLKTSNLLLSH-------------------RGILKVGDFGLA---REYGSPLK 521
N + H DLK N+L +KV DFG A E+
Sbjct: 136 SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----- 190
Query: 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
H T +V T YR+PE++L +S P D+WS+GCI E+ +F E L+ + +
Sbjct: 191 HST-LVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 582 TMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGL---------KTKVAGS----------- 621
+G + + +QK +Y + L +
Sbjct: 249 ILGPLPKHM---------IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 622 ILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPI 661
+ E +DL+ K L YDP RIT EAL+H +F I
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >4dbg_B Ring finger protein 31; ubiquitin fold, ubiquitination, ligase; 2.71A {Homo sapiens} Length = 162 | Back alignment and structure |
|---|
Score = 161 bits (407), Expect = 9e-46
Identities = 49/149 (32%), Positives = 78/149 (52%), Gaps = 7/149 (4%)
Query: 877 QGMEMVKLLREAEQNGFTAEDLTIALSHCGDGPPVTWLINNWRHMIDTVVTLATNYGHER 936
+G+++V ++RE E G E++ AL + G P+ WL + ++++ V LA
Sbjct: 13 EGLQLVSMIREGEAAGACPEEIFSALQYSGTEVPLQWLRSELPYVLEMVAELAGQQ---- 68
Query: 937 SENNVGTLSAVEARDALRLHNGNVWAAVTECVETRQKKFNDLMSRGNFTREDIVTVLTAN 996
+ +G S EAR A +GN+ AV ECV TR++K +L S G E + L +
Sbjct: 69 -DPGLGAFSCQEARRAWLDRHGNLDEAVEECVRTRRRKVQELQSLGFGPEEGSLQALFQH 127
Query: 997 HGNVESAYVELNKTQLKPFLMRIW--GPP 1023
G+V A EL + +L+PF R+W GP
Sbjct: 128 GGDVSRALTELQRQRLEPFRQRLWDSGPE 156
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-45
Identities = 69/331 (20%), Positives = 130/331 (39%), Gaps = 62/331 (18%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-----------AQH 420
G + V+ AKD + VA+K ++ + + + EI L +
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 421 PNIVTVRE--IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+I+ + + G N + +V + + ++ +L++ + + + VK + +QLL
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLG 143
Query: 479 VAHLHDNW-ILHRDLKTSNLLLSH------RGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
+ ++H I+H D+K N+L+ +K+ D G A Y +HYT + T
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTRE 200
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS------DLEQLSRIFKTMGT 585
YRSPE+LLG + D+WS C+ E + + LF D + +++I + +G
Sbjct: 201 YRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259
Query: 586 PNEKIWPGFSKLPAVQKMTFA--------EYPNVGGLKTKVAGSILTELG---------- 627
+ ++ + N+ LK +LTE
Sbjct: 260 LPSYL---------LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 628 YDLLCKFLTYDPVTRITADEALRHDYFSESP 658
D L L DP R A + H + ++
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-45
Identities = 89/350 (25%), Positives = 154/350 (44%), Gaps = 54/350 (15%)
Query: 351 YLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR 410
G + ++ ++ + I +G++G V +A D+ E VA+K +K K+ F +
Sbjct: 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQI 99
Query: 411 EINTL--LKAQHP----NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRS-KKQVF 463
E+ L + IV ++ + N + +V + + +L + +R+ +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRN--HLCLVFEMLS---YNLYDLLRNTNFRGV 154
Query: 464 IPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSH--RGILKVGDFGLAREYGSP 519
+ QQ+ A+ L I+H DLK N+LL + R +K+ DFG + + G
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-- 212
Query: 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
+ + + +YRSPE+LLG Y IDMWS+GCI E EPLF+G ++++Q+++I
Sbjct: 213 -QRIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
Query: 580 FKTMGTPNEKI------------------WP--------GFSKLPAVQKMTFAEYPNVGG 613
+ +G P I W K P +K+ GG
Sbjct: 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330
Query: 614 LKTKVAGSILTELG-----YDLLCKFLTYDPVTRITADEALRHDYFSESP 658
+ AG + DL+ + L YDP TRI AL+H +F ++
Sbjct: 331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-45
Identities = 69/342 (20%), Positives = 120/342 (35%), Gaps = 70/342 (20%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTL--LKAQHP 421
F + ++ +GT+G V + + A+K + + + + ++ E + L ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK---VVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEH-----DM--KSLMETMRSKKQVFIPGE-VKCLMQ 473
N +N+ K Y +H + SL E + E +K
Sbjct: 94 N---------NNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCI 144
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSH-------------------------RGILKVG 508
++L A+ +L + H DLK N+LL +K+
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 509 DFGLA---REYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEP 565
DFG A +Y H + I+ T YR+PE++L + DMWS GC+ AE
Sbjct: 205 DFGCATFKSDY-----HGS-IINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSL 257
Query: 566 LFTGKSDLEQLSRIFKTMGTPNEKI-------------WPGFSKLPAVQKMTFAEYPNVG 612
LF +E L+ + + + + KL + +
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 613 GLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ I EL D L L DP R + E L+H +
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-44
Identities = 53/296 (17%), Positives = 106/296 (35%), Gaps = 27/296 (9%)
Query: 372 EGTYGVVYRAKDKRTDEIVALK---RLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
+G V+R + K+T ++ A+K + + + +RE L K H NIV +
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKLNHKNIVKLFA 74
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE--VKCLMQQLLNAVAHLHDNW 486
I + ++M++ SL + + E +++ ++ + HL +N
Sbjct: 75 IEEETTTRHKVLIMEFCP--CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 487 ILHRDLKTSNLLLS----HRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC- 541
I+HR++K N++ + + K+ DFG ARE + + + T Y P++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-LYGTEEYLHPDMYERAV 191
Query: 542 ------KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
K+Y +D+WS+G F F + + + T
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
+ + ++ + L L +L L D D+
Sbjct: 252 QKAENGPIDWSGDM----PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-44
Identities = 84/351 (23%), Positives = 133/351 (37%), Gaps = 74/351 (21%)
Query: 372 EGTYGVVYRAKD-KRTDEIVALKRLKMEKEKEGFPITSLREINTL--LKAQHP----NIV 424
EGT+G V D R VALK + + + + EIN L +K + V
Sbjct: 29 EGTFGKVVECLDHARGKSQVALK---IIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 425 TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLLNAVAHLH 483
+ + + I + + K+ E ++ P V+ + QL +A+ LH
Sbjct: 86 LMSDWFNFHG--HMCIAFELLG---KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140
Query: 484 DNWILHRDLKTSNLLLSH-------------------RGILKVGDFGLA---REYGSPLK 521
+N + H DLK N+L + ++V DFG A E+
Sbjct: 141 ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----- 195
Query: 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
H T IV T YR PE++L ++ P D+WS+GCI E+ LF + E L + K
Sbjct: 196 HTT-IVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253
Query: 582 TMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGL--------------KTKVAGSILT--- 624
+G + + + +Y GGL K S +
Sbjct: 254 ILGPIPSHM---------IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 625 ---ELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWPAK 672
+DL+ + L +DP RIT EAL H +F+ P++
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-44
Identities = 80/325 (24%), Positives = 134/325 (41%), Gaps = 53/325 (16%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
G YG V +DK T A+K ++ L E+ L HPNI+ + +
Sbjct: 47 SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD--F 104
Query: 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491
+ ++VM+ + L + + + + F + +++Q+L+ V +LH + I+HRD
Sbjct: 105 FEDKRNYYLVMECYKG--GELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 492 LKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPI 548
LK NLLL + ++K+ DFGL+ + K + T +Y +PE+L Y
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERLGTAYYIAPEVLRKK--YDEKC 218
Query: 549 DMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEY 608
D+WS+G I L P F G++D E L ++ K T + W S+ A
Sbjct: 219 DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE-GAK-------- 269
Query: 609 PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE--------SPLP 660
DL+ + L +D RI+A +AL H + E LP
Sbjct: 270 --------------------DLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELP 309
Query: 661 IDPAMFP---TWPAKSELAHKKAAM 682
+ +L +AA+
Sbjct: 310 SLANAIENMRKFQNSQKL--AQAAL 332
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-44
Identities = 83/301 (27%), Positives = 127/301 (42%), Gaps = 56/301 (18%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEK--EKEGFPITSLREINTLLKAQHPNIVTVREIV 430
G++G V A K T A K++ + + F +EI + HPNI+ + E
Sbjct: 20 GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF----KQEIEIMKSLDHPNIIRLYETF 75
Query: 431 VGSNMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI 487
+ I++VM+ E L E + K+ F + +M+ +L+AVA+ H +
Sbjct: 76 --EDNTDIYLVMELCTGGE-----LFERVVHKRV-FRESDAARIMKDVLSAVAYCHKLNV 127
Query: 488 LHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEY 544
HRDLK N L LK+ DFGLA + P K V T +Y SP++L G Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQVLEGL--Y 184
Query: 545 STPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604
D WS G + LC P F+ +D E + +I + T EK W S
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP-------- 236
Query: 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE----SPLP 660
+ + L+ + LT P RIT+ +AL H++F + SP
Sbjct: 237 ----------QAE-----------SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275
Query: 661 I 661
+
Sbjct: 276 L 276
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 9e-44
Identities = 82/326 (25%), Positives = 139/326 (42%), Gaps = 53/326 (16%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
+G++G V + KD+ T + A+K + K T LRE+ L K HPNI+ + E +
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE--I 89
Query: 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491
+ +IV + L + + +K+ F + +++Q+ + + ++H + I+HRD
Sbjct: 90 LEDSSSFYIVGELYTG--GELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 492 LKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPI 548
LK N+LL + +K+ DFGL+ + + T +Y +PE+L G Y
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEVLRGT--YDEKC 203
Query: 549 DMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEY 608
D+WS G I L P F GK++ + L R+ + W S A
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD-DAK-------- 254
Query: 609 PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE--------SPLP 660
DL+ K LT+ P RITA + L H + + S LP
Sbjct: 255 --------------------DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLP 294
Query: 661 IDPAMFP---TWPAKSELAHKKAAMA 683
+ + A+ +L +AA+
Sbjct: 295 SLESAMTNIRQFQAEKKL--AQAALL 318
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-44
Identities = 95/404 (23%), Positives = 157/404 (38%), Gaps = 71/404 (17%)
Query: 266 SAESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNESER 325
S+ G+E ++S S S E E AD E+ K K+ A +
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 326 DVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEE---GTYGVVYRAK 382
+P D I K +V F +++ E G +G V++ +
Sbjct: 69 PPAP-------FDHRIVTAKQG------------AVNSFYTVSKTEILGGGRFGQVHKCE 109
Query: 383 DKRTDEIVALK--RLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440
+ T +A K + + K+KE EI+ + + H N++ + + + + I +
Sbjct: 110 ETATGLKLAAKIIKTRGMKDKEEV----KNEISVMNQLDHANLIQLYDAF--ESKNDIVL 163
Query: 441 VMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNL 497
VM+YV E L + + + + M+Q+ + H+H +ILH DLK N+
Sbjct: 164 VMEYVDGGE-----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENI 218
Query: 498 LLSHRG--ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGC 555
L +R +K+ DFGLAR Y P + T + +PE++ S P DMWSVG
Sbjct: 219 LCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGV 276
Query: 556 IFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLK 615
I L F G +D E L+ I ++ + S
Sbjct: 277 IAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDIS-------------------- 316
Query: 616 TKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659
E + + K L + RI+A EAL+H + S+ L
Sbjct: 317 ---------EEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 73/298 (24%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRL---KMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
G +G V+ +++ + +K + + + E EI L HPNI+ + E
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI----EAEIEVLKSLDHPNIIKIFE 87
Query: 429 IVVGSNMDKIFIVMDYV---EHDMKSLMETMRSKKQV---FIPGEVKCLMQQLLNAVAHL 482
+ + ++IVM+ E L+E + S + G V LM+Q++NA+A+
Sbjct: 88 VF--EDYHNMYIVMETCEGGE-----LLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 483 HDNWILHRDLKTSNLLLSHR---GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
H ++H+DLK N+L +K+ DFGLA + +H T T Y +PE+
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTALYMAPEVFK 199
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
+ + D+WS G + L FTG S E + +K
Sbjct: 200 R--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE----VQ-------QKATYK------ 240
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657
+ +A LT DLL + LT DP R +A + L H++F ++
Sbjct: 241 --EPNYAVEC-----------RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-43
Identities = 83/325 (25%), Positives = 140/325 (43%), Gaps = 53/325 (16%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQHPNIVTVREIV 430
+G++G V KDK T + A+K + + K+ SL RE+ L + HPNI+ + E
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE-- 93
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHR 490
+ ++V + L + + S+K+ F + +++Q+L+ + ++H N I+HR
Sbjct: 94 FFEDKGYFYLVGEVYTG--GELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHR 150
Query: 491 DLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTP 547
DLK NLLL + +++ DFGL+ + K + T +Y +PE+L G Y
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVLHGT--YDEK 207
Query: 548 IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAE 607
D+WS G I L P F G ++ + L ++ K T W S+ A
Sbjct: 208 CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE-SAK------- 259
Query: 608 YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS-------ESPLP 660
DL+ K LTY P RI+A +AL H++ +P
Sbjct: 260 ---------------------DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
Query: 661 IDPAMFP---TWPAKSELAHKKAAM 682
+ +L +AA+
Sbjct: 299 SLDNAILNIRQFQGTQKL--AQAAL 321
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 46/286 (16%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
+G++G V + KD+ T + A+K + K T LRE+ L K HPNI+ + EI+
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL- 90
Query: 432 GSNMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWIL 488
+ +IV + E L + + +K+ F + +++Q+ + + ++H + I+
Sbjct: 91 -EDSSSFYIVGELYTGGE-----LFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 489 HRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYS 545
HRDLK N+LL + +K+ DFGL+ + + T +Y +PE+L Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLR--GTYD 200
Query: 546 TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF 605
D+WS G I L P F GK++ + L R+ + W S A K
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD-DA--K--- 254
Query: 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
DL+ K LT+ P RITA + L H
Sbjct: 255 -----------------------DLIRKMLTFHPSLRITATQCLEH 277
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-43
Identities = 78/335 (23%), Positives = 135/335 (40%), Gaps = 63/335 (18%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS-----------LREINTLLKAQH 420
G YG V K+K A+K +K + +G EI+ L H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
PNI+ + + V + ++V ++ E L E + ++ + F + +M+Q+L+ +
Sbjct: 106 PNIIKLFD--VFEDKKYFYLVTEFYEG--GELFEQIINRHK-FDECDAANIMKQILSGIC 160
Query: 481 HLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+LH + I+HRD+K N+LL ++ +K+ DFGL+ + S + T +Y +PE+
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKLRDRLGTAYYIAPEV 219
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
L Y+ D+WS G I LC P F G++D + + ++ K + W S
Sbjct: 220 LKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD- 276
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE- 656
A +L+ LTYD R TA+EAL + +
Sbjct: 277 EAK----------------------------ELIKLMLTYDYNKRCTAEEALNSRWIKKY 308
Query: 657 ------SPLPIDPAMFP---TWPAKSELAHKKAAM 682
S + +L +AA+
Sbjct: 309 ANNINKSDQKTLCGALSNMRKFEGSQKL--AQAAI 341
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 74/298 (24%), Positives = 136/298 (45%), Gaps = 42/298 (14%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKA 418
++E+F+ + +G +G VY A++K++ I+ALK L + EK G RE+
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+HPNI+ + + +++++++Y ++ ++ K F + +L NA
Sbjct: 67 RHPNILRLYGYFHDAT--RVYLILEYAPL--GTVYRELQ-KLSKFDEQRTATYITELANA 121
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+++ H ++HRD+K NLLL G LK+ DFG + S + + TL Y PE++
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTD-LCGTLDYLPPEMI 179
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
G + + +D+WS+G + EFL +P F + E RI +
Sbjct: 180 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 222
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
+ TF ++ +TE DL+ + L ++P R E L H + +
Sbjct: 223 ---EFTFPDF--------------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-43
Identities = 72/332 (21%), Positives = 117/332 (35%), Gaps = 78/332 (23%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS---LREINTLLKAQHPNIVTVRE 428
+G+YGVV A + +T I A+K + K ++ P E+ + K HPNI + E
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95
Query: 429 IVVGSNMDKIFIVMDYVE-------------------------------------HDMKS 451
V + I +VM+ S
Sbjct: 96 --VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 452 LMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG--ILKVGD 509
+ S V + +M+Q+ +A+ +LH+ I HRD+K N L S +K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 510 FGLAREYGSP----LKHYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCME 564
FGL++E+ T T ++ +PE+L + Y D WS G + L
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 565 PLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILT 624
F G +D + +S++ + S
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLS----------------------------- 304
Query: 625 ELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
L DLL L + R A AL+H + S+
Sbjct: 305 PLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-43
Identities = 79/341 (23%), Positives = 134/341 (39%), Gaps = 75/341 (21%)
Query: 370 IEEGTYGVVYRAKDKRTDEIVALKRLKMEK--EKEGFPITSL-REINTLLKAQHPNIVTV 426
I +G + VV R ++ T + A+K + + K G L RE + +HP+IV +
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 427 REIVVGSNMDKIFIVMDYVE------------HDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
E S+ +++V ++++ E M+Q
Sbjct: 92 LETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA-----------VASHYMRQ 138
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLW 531
+L A+ + HDN I+HRD+K +LL+ + +K+G FG+A + G V T
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591
+ +PE++ + Y P+D+W G I L F G + R+F E I
Sbjct: 199 FMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLF-------EGII 245
Query: 592 PGFSKLPAVQKMTF--AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
G K ++ ++ +E DL+ + L DP RIT EAL
Sbjct: 246 KG--------KYKMNPRQWSHI------------SESAKDLVRRMLMLDPAERITVYEAL 285
Query: 650 RH----DYFSESPLPIDPAMFP---TWPAKSELAHKKAAMA 683
H + + P + A+ +L K A +A
Sbjct: 286 NHPWLKERDRYAYKIHLPETVEQLRKFNARRKL--KGAVLA 324
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-43
Identities = 58/315 (18%), Positives = 106/315 (33%), Gaps = 64/315 (20%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK- 417
R EF L +I G +G V++ + I A+KR K +LRE+
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
QH ++V D + I +Y + + F E+K L+ Q+
Sbjct: 68 GQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGIL-------------------KVGDFGLAREYG 517
+ ++H ++H D+K SN+ +S I K+GD G
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 518 SPLKHYTPIVV-TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576
SP + + + E+L + D++++ EPL + +Q
Sbjct: 186 SP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQW 237
Query: 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLT 636
I + ++P +L++ +LL +
Sbjct: 238 HEIRQGR----------LPRIP----------------------QVLSQEFTELLKVMIH 265
Query: 637 YDPVTRITADEALRH 651
DP R +A ++H
Sbjct: 266 PDPERRPSAMALVKH 280
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 58/318 (18%), Positives = 125/318 (39%), Gaps = 51/318 (16%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG 432
G +G+V+R + + + K +K++ + +EI+ L A+H NI+ + E
Sbjct: 16 GEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIARHRNILHLHESF-- 70
Query: 433 SNMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILH 489
+M+++ ++ +++ + + E + + E+ + Q+ A+ LH + I H
Sbjct: 71 ESMEELVMIFEFISGLD-----IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125
Query: 490 RDLKTSNLLLSHR--GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTP 547
D++ N++ R +K+ +FG AR+ P ++ + Y +PE+ ST
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQH-DVVSTA 183
Query: 548 IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN--EKIWPGFSKLPAVQKMTF 605
DMWS+G + L F +++ + + I E+ + S
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--AEYTFDEEAFKEIS---------- 231
Query: 606 AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAM 665
D + + L + +R+TA EAL+H + + + +
Sbjct: 232 -------------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
Query: 666 FPTWPAKSEL-AHKKAAM 682
T + K +
Sbjct: 273 IRTLKHRRYYHTLIKKDL 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 77/291 (26%), Positives = 119/291 (40%), Gaps = 58/291 (19%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
G + V+ K + T ++ ALK +K K + EI L K +H NIVT+ +I
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLKKIKHENIVTLEDIY- 75
Query: 432 GSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ ++VM V + E S ++QQ+L+AV +LH
Sbjct: 76 -ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-----------VIQQVLSAVKYLH 123
Query: 484 DNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
+N I+HRDLK NLL + + DFGL++ + + + T Y +PE+L
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEVLAQ 181
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
K YS +D WS+G I LC P F +++ + +I + W S+ A
Sbjct: 182 -KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE-SA- 238
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
K D +C L DP R T ++AL H
Sbjct: 239 -K--------------------------DFICHLLEKDPNERYTCEKALSH 262
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 9e-42
Identities = 57/295 (19%), Positives = 105/295 (35%), Gaps = 53/295 (17%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPNIVTVREIV 430
G G + + + VA+KR+ E + RE+ L + +HPN++
Sbjct: 34 HGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTE 87
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHR 490
+ +I ++ +L E + K + E L+QQ + +AHLH I+HR
Sbjct: 88 --KDRQFQYIAIELCA---ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHR 142
Query: 491 DLKTSNLLLSHRG-----ILKVGDFGLAREYG---SPLKHYTPIVVTLWYRSPELLLGC- 541
DLK N+L+S + DFGL ++ + + T + +PE+L
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202
Query: 542 -KEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
+ + +D++S GC+F + F + +
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-GACSLDCLHPEKHED---- 257
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+ +L+ K + DP R +A L+H +F
Sbjct: 258 -------------------------VIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 77/295 (26%), Positives = 117/295 (39%), Gaps = 63/295 (21%)
Query: 372 EGTYGVVYRAKDKRTDEIVALK----RLKMEKEKEGFPITSLREINTLLKAQHPNIVTVR 427
+G + VV R K T A K + ++ + RE K QHPNIV +
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL----EREARICRKLQHPNIVRLH 71
Query: 428 EIVVGSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
+ + ++V D V + E + +QQ+L ++
Sbjct: 72 DSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEA-----------DASHCIQQILESI 118
Query: 480 AHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
A+ H N I+HR+LK NLLL+ + +K+ DFGLA E + + T Y SPE
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE 177
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
+L YS P+D+W+ G I L P F + R++ +I G
Sbjct: 178 VLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLY-------AQIKAGAYD 225
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
P+ E+ V T L+ LT +P RITAD+AL+
Sbjct: 226 YPS------PEWDTV------------TPEAKSLIDSMLTVNPKKRITADQALKV 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 79/314 (25%), Positives = 141/314 (44%), Gaps = 42/314 (13%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKA 418
++++F + +G +G VY A++K+ I+ALK L K + EKEG REI
Sbjct: 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+HPNI+ + + +I++++++ L + ++ K F M++L +A
Sbjct: 72 RHPNILRMYN--YFHDRKRIYLMLEFAPR--GELYKELQ-KHGRFDEQRSATFMEELADA 126
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+ + H+ ++HRD+K NLL+ ++G LK+ DFG + S L+ T + TL Y PE++
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRT-MCGTLDYLPPEMI 184
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
G K + +D+W G + EFL P F S E RI
Sbjct: 185 EG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---------------- 227
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658
+ F + L++ DL+ K L Y P R+ + H + +
Sbjct: 228 ---DLKFPPF--------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270
Query: 659 LPIDPAMFPTWPAK 672
+ P ++ + +K
Sbjct: 271 RRVLPPVYQSTQSK 284
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-41
Identities = 77/372 (20%), Positives = 137/372 (36%), Gaps = 53/372 (14%)
Query: 288 SSSSDEEENDENEDKADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDT 347
+ + + E + K+R+ D V + D D
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYD-----NYVFDI 139
Query: 348 LPPYLPAIQGCRSV---EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF 404
Y P + + + + G +GVV+R ++ T A K + E +
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 405 PITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV---EHDMKSLMETMRSKKQ 461
+ +EI T+ +HP +V + + + +++ ++ +++ E L E + +
Sbjct: 200 TV--RKEIQTMSVLRHPTLVNLHDAF--EDDNEMVMIYEFMSGGE-----LFEKVADEHN 250
Query: 462 VFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG--ILKVGDFGLAREYGSP 519
E M+Q+ + H+H+N +H DLK N++ + + LK+ DFGL P
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DP 309
Query: 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
+ T + +PE+ G K DMWSVG + L F G++D E L +
Sbjct: 310 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368
Query: 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDP 639
++ + G S E G D + K L DP
Sbjct: 369 KSCDWNMDDSAFSGIS-----------------------------EDGKDFIRKLLLADP 399
Query: 640 VTRITADEALRH 651
TR+T +AL H
Sbjct: 400 NTRMTIHQALEH 411
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 44/324 (13%), Positives = 91/324 (28%), Gaps = 80/324 (24%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLRE-------------------- 411
+ A D+ T E + + I ++E
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 412 ------INTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQV--- 462
+ + Q ++ VR + F + ++ ++++ E + S
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 463 FIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522
+ L Q++ +A LH ++H L+ +++L RG + + F G
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----A 258
Query: 523 YTPIVVTLWYRSPELL----------LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD 572
V+ + PEL + D W++G + C + T +
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318
Query: 573 LEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLC 632
L IF++ V+ LL
Sbjct: 319 LGGSEWIFRS--------CKNIP--QPVR---------------------------ALLE 341
Query: 633 KFLTYDPVTRITADEALRHDYFSE 656
FL Y R+ +A+ + +
Sbjct: 342 GFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-41
Identities = 61/329 (18%), Positives = 136/329 (41%), Gaps = 59/329 (17%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSL------ 409
+ + +++ + + +G + + + ++ ALK+ + +EK+++ +
Sbjct: 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 410 ------REINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVE-----HDMKSLMETMRS 458
E+ + ++ +T I+ +N D+++I+ +Y+E + ++
Sbjct: 86 KYDDFKNELQIITDIKNEYCLTCEGII--TNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 459 KKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREY- 516
+KC+++ +LN+ +++H+ I HRD+K SN+L+ G +K+ DFG +
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 517 --------GSPLKHYTPIVVTLWYRSPELLLGCKEYSTP-IDMWSVGCIFAEFLCMEPLF 567
G+ + P PE Y+ +D+WS+G F
Sbjct: 204 DKKIKGSRGTY--EFMP---------PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252
Query: 568 TGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELG 627
+ K L +L I + P + N K+ + + L+
Sbjct: 253 SLKISLVELFN----------NIRTKNIEYPLDRNHFLYPLTN---KKSTCSNNFLSNED 299
Query: 628 YDLLCKFLTYDPVTRITADEALRHDYFSE 656
D L FL +P RIT+++AL+H++ ++
Sbjct: 300 IDFLKLFLRKNPAERITSEDALKHEWLAD 328
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 78/329 (23%), Positives = 123/329 (37%), Gaps = 68/329 (20%)
Query: 353 PAIQGCRSVEEFKCLNRIEE----GTYGVVYRAKDKRTDEIVALKRLKMEKEK------- 401
A+ G S F +E G VV R K T + A+K + +
Sbjct: 4 AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63
Query: 402 EGFPITSLREINTLLK-AQHPNIVTVREIVVGSNMDKIFIVMDYVE--------HDMKSL 452
+ +L+E++ L K + HPNI+ +++ F+V D ++ + +L
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 453 METMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512
E E + +M+ LL + LH I+HRDLK N+LL +K+ DFG
Sbjct: 122 SEK-----------ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 513 AREYGSPLKHYTPIVVTLWYRSPELLLGC-----KEYSTPIDMWSVGCIFAEFLCMEPLF 567
+ + P + + T Y +PE++ Y +DMWS G I L P F
Sbjct: 171 SCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
Query: 568 TGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELG 627
+ + L I W +S K
Sbjct: 230 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV---K------------------------- 261
Query: 628 YDLLCKFLTYDPVTRITADEALRHDYFSE 656
DL+ +FL P R TA+EAL H +F +
Sbjct: 262 -DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-41
Identities = 68/295 (23%), Positives = 122/295 (41%), Gaps = 60/295 (20%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRL---KMEKEKEGFPITSL-REINTLLKAQHPNIVTVRE 428
G + +V + + K T + A K + ++ + G + RE+N L + +HPNI+T+ +
Sbjct: 16 GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75
Query: 429 IVVGSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
I N + ++++ V + +SL E E ++Q+L+ V
Sbjct: 76 IF--ENKTDVVLILELVSGGELFDFLAEKESLTED-----------EATQFLKQILDGVH 122
Query: 481 HLHDNWILHRDLKTSNLLLSHRGI----LKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+LH I H DLK N++L + + +K+ DFG+A + + I T + +PE
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGTPEFVAPE 181
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
++ + DMWS+G I L F G++ E L+ I +E+ + S
Sbjct: 182 IVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS- 239
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
EL D + + L DP R+T ++L H
Sbjct: 240 ----------------------------ELAKDFIRRLLVKDPKRRMTIAQSLEH 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-40
Identities = 68/317 (21%), Positives = 118/317 (37%), Gaps = 76/317 (23%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPNIVTVREIV 430
G+ G V + VA+KR+ ++ +L EI L + HPN++
Sbjct: 25 YGSSGTVV-FQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHPNVIRYYCSE 78
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKK------QVFIPGEVKCLMQQLLNAVAHLHD 484
+ ++I ++ +L + + SK ++ L++Q+ + VAHLH
Sbjct: 79 --TTDRFLYIALELCN---LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 485 NWILHRDLKTSNLLLSHRGI-------------LKVGDFGLAREYG----SPLKHYTPIV 527
I+HRDLK N+L+S + + DFGL ++ S +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 528 VTLWYRSPELLLGC------KEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIF 580
T +R+PELL + + ID++S+GC+F L + F K E S I
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNII 251
Query: 581 K---TMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTY 637
+ ++ DL+ + + +
Sbjct: 252 RGIFSLDEMKCLHDRSLI-----------------------------AEATDLISQMIDH 282
Query: 638 DPVTRITADEALRHDYF 654
DP+ R TA + LRH F
Sbjct: 283 DPLKRPTAMKVLRHPLF 299
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 72/348 (20%), Positives = 121/348 (34%), Gaps = 64/348 (18%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKR-LKMEKEKEGFPITSLREINTLLK-AQHP 421
+ + EG + VY A+D + ALKR L E+EK ++E+ + K + HP
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGHP 86
Query: 422 NIVT------VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
NIV + + + + ++ + + + ++ M S+ V + Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQT 145
Query: 476 LNAVAHLHDN--WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV----- 528
AV H+H I+HRDLK NLLLS++G +K+ DFG A +
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 529 -------TLWYRSPEL--LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
T YR+PE+ L D+W++GCI + F + L RI
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RI 261
Query: 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDP 639
G + L+ L +P
Sbjct: 262 VN--GKYSIPPHDTQYT----------------VFH-------------SLIRAMLQVNP 290
Query: 640 VTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKP 687
R++ E + + ++P P + +A S P
Sbjct: 291 EERLSIAEVVHQLQEIAAARNVNP-KSPITELLEQNGGYGSATLSRGP 337
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 52/306 (16%)
Query: 372 EGTYGVVYRAKDKRTDEIVALK-----RLKMEKEKEGFPITSL-REINTLLKAQHPNIVT 425
G G V A +++T + VA+K + + +E P ++ EI L K HP I+
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 426 VREIVVGSNMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
++ + + +IV++ + E L + + K+ K Q+L AV +L
Sbjct: 80 IKNFF---DAEDYYIVLELMEGGE-----LFDKVVGNKR-LKEATCKLYFYQMLLAVQYL 130
Query: 483 HDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
H+N I+HRDLK N+LLS + ++K+ DFG ++ G + T Y +PE+L+
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLV 189
Query: 540 GC--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
Y+ +D WS+G I L P F+ L ++I G
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK----------DQITSGKYNF 239
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657
+ V +E DL+ K L DP R T +EALRH + +
Sbjct: 240 IP------EVWAEV------------SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281
Query: 658 PLPIDP 663
+
Sbjct: 282 DMKRKF 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 60/302 (19%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS----LREINTLLKAQHPNIVTVRE 428
G + +V + ++K T A K +K + + S RE++ L + H N++T+ +
Sbjct: 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 429 IVVGSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
+ N + ++++ V +SL E E ++Q+L+ V
Sbjct: 83 VY--ENRTDVVLILELVSGGELFDFLAQKESLSEE-----------EATSFIKQILDGVN 129
Query: 481 HLHDNWILHRDLKTSNLLLSHR----GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+LH I H DLK N++L + +K+ DFGLA E + I T + +PE
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPE 188
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
++ + DMWS+G I L F G + E L+ I +E+ + S
Sbjct: 189 IVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS- 246
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
EL D + K L + R+T EALRH + +
Sbjct: 247 ----------------------------ELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 657 SP 658
Sbjct: 279 VD 280
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 61/327 (18%), Positives = 126/327 (38%), Gaps = 50/327 (15%)
Query: 334 DQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEE----GTYGVVYRAKDKRTDEI 389
++ + +D Y+P + I E G +GVV+R +K T +
Sbjct: 20 GPKINDYDKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVHRCVEKATGRV 78
Query: 390 VALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV---E 446
K + + + + EI+ + + HP ++ + + + ++ ++++++ E
Sbjct: 79 FVAKFINTPYPLDKYTV--KNEISIMNQLHHPKLINLHDAF--EDKYEMVLILEFLSGGE 134
Query: 447 HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG--I 504
L + + ++ EV M+Q + H+H++ I+H D+K N++ +
Sbjct: 135 -----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 189
Query: 505 LKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME 564
+K+ DFGLA + P + T + +PE++ + DMW++G + L
Sbjct: 190 VKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGL 247
Query: 565 PLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILT 624
F G+ DLE L + + +E + S
Sbjct: 248 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVS----------------------------- 278
Query: 625 ELGYDLLCKFLTYDPVTRITADEALRH 651
D + L +P R+T +AL H
Sbjct: 279 PEAKDFIKNLLQKEPRKRLTVHDALEH 305
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 72/314 (22%), Positives = 126/314 (40%), Gaps = 68/314 (21%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEK--EKEGFPITSLREINTLLKAQHPNIVTVREI 429
EG+YG V D T A+K LK +K +EI L + +H N++ + ++
Sbjct: 15 EGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74
Query: 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILH 489
+ K+++VM+Y M+ +++++ K+ F + QL++ + +LH I+H
Sbjct: 75 LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYLHSQGIVH 132
Query: 490 RDLKTSNLLLSHRGILKVGDFGLAREY-------------GSPLKHYTPIVVTLWYRSPE 536
+D+K NLLL+ G LK+ G+A GSP + P PE
Sbjct: 133 KDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP--AFQP---------PE 181
Query: 537 LLLGCKEYSTP-IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
+ G +S +D+WS G F + + + ++F+ I G
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF----EGDNIYKLFE-------NIGKGSY 230
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF- 654
+P DLL L Y+P R + + +H +F
Sbjct: 231 AIP----------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
Query: 655 -----SESPLPIDP 663
+E+P+PI P
Sbjct: 269 KKHPPAEAPVPIPP 282
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-40
Identities = 76/303 (25%), Positives = 127/303 (41%), Gaps = 52/303 (17%)
Query: 372 EGTYGVVYRAKDKRTDEIVALK-----RLKMEKEKEGFPITSL-REINTLLKAQHPNIVT 425
G G V A +++T + VA++ + + +E P ++ EI L K HP I+
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 426 VREIVVGSNMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
++ + + +IV++ + E L + + K+ K Q+L AV +L
Sbjct: 205 IKNFF---DAEDYYIVLELMEGGE-----LFDKVVGNKR-LKEATCKLYFYQMLLAVQYL 255
Query: 483 HDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
H+N I+HRDLK N+LLS + ++K+ DFG ++ G + T Y +PE+L+
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLV 314
Query: 540 G--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
Y+ +D WS+G I L P F+ L ++I G
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK----------DQITSGKYNF 364
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657
+ V +E DL+ K L DP R T +EALRH + +
Sbjct: 365 IP------EVWAEV------------SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
Query: 658 PLP 660
+
Sbjct: 407 DMK 409
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 82/317 (25%), Positives = 131/317 (41%), Gaps = 44/317 (13%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIV 430
EG++ + + K++++ A+K + E +EI L + HPNIV + E
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----KEITALKLCEGHPNIVKLHE-- 73
Query: 431 VGSNMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWI 487
V + F+VM+ + E L E ++ KK F E +M++L++AV+H+HD +
Sbjct: 74 VFHDQLHTFLVMELLNGGE-----LFERIKKKKH-FSETEASYIMRKLVSAVSHMHDVGV 127
Query: 488 LHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEY 544
+HRDLK NLL + +K+ DFG AR + TL Y +PELL Y
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGY 186
Query: 545 STPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT 604
D+WS+G I L + F + + M +KI G
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM----KKIKKGDFSFEG----- 237
Query: 605 FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE-SPLPIDP 663
+ NV ++ DL+ LT DP R+ +++ + S L +P
Sbjct: 238 -EAWKNV------------SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284
Query: 664 AMFPTWPAKSELAHKKA 680
M P S A
Sbjct: 285 LMTPDILGSSGAAVHTC 301
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 60/296 (20%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRL---KMEKEKEGFPITSL-REINTLLKAQHPNIVTVR 427
G + VV + ++K T A K + + + + G + RE++ L + QHPN++T+
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 428 EIVVGSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
E+ N + ++++ V + +SL E E ++Q+LN V
Sbjct: 81 EVY--ENKTDVILILELVAGGELFDFLAEKESLTEE-----------EATEFLKQILNGV 127
Query: 480 AHLHDNWILHRDLKTSNLLLSHR----GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
+LH I H DLK N++L R +K+ DFGLA + + I T + +P
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVAP 186
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
E++ + DMWS+G I L F G + E L+ + ++ + S
Sbjct: 187 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
L D + + L DP R+T ++L+H
Sbjct: 246 -----------------------------ALAKDFIRRLLVKDPKKRMTIQDSLQH 272
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-40
Identities = 83/391 (21%), Positives = 135/391 (34%), Gaps = 75/391 (19%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
+G + VV R + A + +K RE +HPNIV + + +
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI- 79
Query: 432 GSNMDKIFIVMDYVE-----HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
S +++ D V D+ ++ + + +QQ+L AV H H
Sbjct: 80 -SEEGHHYLIFDLVTGGELFEDIV--------AREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 487 ILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
++HR+LK NLLL+ + +K+ DFGLA E + + T Y SPE+L
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DP 189
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603
Y P+D+W+ G I L P F + +I W + A K
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP-EA--K- 245
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE----SPL 659
DL+ K LT +P RITA EAL+H + S +
Sbjct: 246 -------------------------DLINKMLTINPSKRITAAEALKHPWISHRSTVASC 280
Query: 660 PIDPAMFP---TWPAKSELAHKKAAMASPKPPSGGHNYKQLEDNEEGFHMGMMERSRAPV 716
+ A+ +L K A + KQ E + +
Sbjct: 281 MHRQETVDCLKKFNARRKL--KGAILTVMLATRNFSVRKQ-EIIKVTEQL---------- 327
Query: 717 PGFSWGELDQDVDMEIELEKDTLPPYLPAIQ 747
++ + + E P + A +
Sbjct: 328 -------IEAISNGDFESYTKMCDPGMTAFE 351
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-40
Identities = 83/397 (20%), Positives = 146/397 (36%), Gaps = 72/397 (18%)
Query: 281 SEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDME 340
D+ + + ++++++A R D + + D
Sbjct: 10 GVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGT 69
Query: 341 IELEKDTLPPYLPAIQGCRSVEEFKCLNRIEE----GTYGVVYRAKDKRTDEIVALKRLK 396
L ++ P + + +EF ++ G VV R + T A+K ++
Sbjct: 70 ENLYFQSMGP-EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME 128
Query: 397 MEKEK------EGFPITSLREINTLLK-AQHPNIVTVREIVVGSNMDKIFIVMDYVE--- 446
+ E+ E + RE + L + A HP+I+T+ + + +F+V D +
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGE 186
Query: 447 -----HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501
+ +L E E + +M+ LL AV+ LH N I+HRDLK N+LL
Sbjct: 187 LFDYLTEKVALSEK-----------ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235
Query: 502 RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC-----KEYSTPIDMWSVGCI 556
+++ DFG + P + + T Y +PE+L Y +D+W+ G I
Sbjct: 236 NMQIRLSDFGFSCHLE-PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 557 FAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN--EKIWPGFSKLPAVQKMTFAEYPNVGGL 614
L P F + + L I + G W S K
Sbjct: 295 LFTLLAGSPPFWHRRQILMLRMIME--GQYQFSSPEWDDRSSTV---K------------ 337
Query: 615 KTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
DL+ + L DP R+TA++AL+H
Sbjct: 338 --------------DLISRLLQVDPEARLTAEQALQH 360
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 68/293 (23%), Positives = 112/293 (38%), Gaps = 59/293 (20%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPNIVTVREIV 430
G+Y V R K T+ A+K + K EI LL+ QHPNI+T+++
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKD-- 83
Query: 431 VGSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
V + +++V + ++ K E E ++ + V +L
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----------EASAVLFTITKTVEYL 132
Query: 483 HDNWILHRDLKTSNLLLSHRG----ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
H ++HRDLK SN+L +++ DFG A++ + T + +PE+L
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
+ Y D+WS+G + L F D + I +I G L
Sbjct: 193 ER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEIL-------ARIGSGKFSLS 243
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
+ +V ++ DL+ K L DP R+TA LRH
Sbjct: 244 G------GYWNSV------------SDTAKDLVSKMLHVDPHQRLTAALVLRH 278
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-39
Identities = 78/307 (25%), Positives = 122/307 (39%), Gaps = 23/307 (7%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLK 417
++ ++ R+ G +G V R + T E VA+K+ + E + EI + K
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKK 68
Query: 418 AQHPNIVTVREIVVGSNM----DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLM 472
HPN+V+ RE+ G D + M+Y E D++ + G ++ L+
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLL 127
Query: 473 QQLLNAVAHLHDNWILHRDLKTSNLLLS---HRGILKVGDFGLAREYGSPLKHYTPIVVT 529
+ +A+ +LH+N I+HRDLK N++L R I K+ D G A+E V T
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGT 186
Query: 530 LWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589
L Y +PELL K+Y+ +D WS G + E + F Q + NE
Sbjct: 187 LQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR--EKSNEH 243
Query: 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
I AV+ + PN IL L L + R T +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPN-------HLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296
Query: 650 RHDYFSE 656
F
Sbjct: 297 NVGCFQA 303
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 70/295 (23%), Positives = 117/295 (39%), Gaps = 60/295 (20%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRL---KMEKEKEGFPITSL-REINTLLKAQHPNIVTVRE 428
G + +V + ++K T A K + + + G + RE++ L + HPNI+T+ +
Sbjct: 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82
Query: 429 IVVGSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
+ N + ++++ V +SL E E ++Q+L+ V
Sbjct: 83 VY--ENRTDVVLILELVSGGELFDFLAQKESLSEE-----------EATSFIKQILDGVN 129
Query: 481 HLHDNWILHRDLKTSNLLLSHR----GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+LH I H DLK N++L + +K+ DFGLA E + I T + +PE
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPE 188
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
++ + DMWS+G I L F G + E L+ I +E+ + S
Sbjct: 189 IVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS- 246
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
EL D + K L + R+T EALRH
Sbjct: 247 ----------------------------ELAKDFIRKLLVKETRKRLTIQEALRH 273
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 69/296 (23%), Positives = 112/296 (37%), Gaps = 62/296 (20%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK-AQHPNIVTVREIV 430
G G V +RT + ALK L + +E++ + + P+IV + ++
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDSPKAR-------QEVDHHWQASGGPHIVCILDVY 91
Query: 431 --VGSNMDKIFIVMDY----------VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+ + I+M+ E ++ E E +M+ + A
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER-----------EAAEIMRDIGTA 140
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
+ LH + I HRD+K NLL + + +LK+ DFG A+E TP T +Y +P
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTP-CYTPYYVAP 198
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
E+L K Y DMWS+G I LC P F + + + +I G
Sbjct: 199 EVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-------RIRLGQY 250
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
P E+ V +E L+ L DP R+T + + H
Sbjct: 251 GFPN------PEWSEV------------SEDAKQLIRLLLKTDPTERLTITQFMNH 288
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-39
Identities = 73/291 (25%), Positives = 109/291 (37%), Gaps = 55/291 (18%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
+G + VV R K T A K + +K RE K QHPNIV + + +
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI- 97
Query: 432 GSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
++V D V + E + +QQ+L ++A+ H
Sbjct: 98 -QEESFHYLVFDLVTGGELFEDIVAREFYSEA-----------DASHCIQQILESIAYCH 145
Query: 484 DNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
N I+HR+LK NLLL+ + +K+ DFGLA E + + T Y SPE+L
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKK 204
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
YS P+D+W+ G I L P F + ++I W +
Sbjct: 205 -DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT----- 258
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
L+ LT +P RITAD+AL+
Sbjct: 259 ------------------------PEAKSLIDSMLTVNPKKRITADQALKV 285
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-39
Identities = 83/293 (28%), Positives = 125/293 (42%), Gaps = 62/293 (21%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
G +VYR K K T + ALK LK +K+ EI LL+ HPNI+ ++EI
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLSHPNIIKLKEIF- 117
Query: 432 GSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+I +V++ V + E + ++Q+L AVA+LH
Sbjct: 118 -ETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD-----------AVKQILEAVAYLH 165
Query: 484 DNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
+N I+HRDLK NLL + LK+ DFGL++ + T + T Y +PE+L G
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGTPGYCAPEILRG 224
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
C Y +DMWSVG I LC F + + +F +I
Sbjct: 225 CA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMF-------RRILNC------- 266
Query: 601 QKMTF-AEY-PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
+ F + + V + DL+ K + DP R+T +AL+H
Sbjct: 267 -EYYFISPWWDEV------------SLNAKDLVRKLIVLDPKKRLTTFQALQH 306
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-39
Identities = 76/328 (23%), Positives = 127/328 (38%), Gaps = 60/328 (18%)
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH-PNIVTVREIVV 431
G + VV + K T + A K LK + + L EI L A+ P ++ + E V
Sbjct: 40 GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE--V 97
Query: 432 GSNMDKIFIVMDY----------VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
N +I ++++Y + + + E +V L++Q+L V +
Sbjct: 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSEN-----------DVIRLIKQILEGVYY 146
Query: 482 LHDNWILHRDLKTSNLLLSHR---GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
LH N I+H DLK N+LLS G +K+ DFG++R+ G I+ T Y +PE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAPEIL 205
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
+T DMW++G I L F G+ + E I + +E+ + S
Sbjct: 206 NY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS--- 261
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658
+L D + L +P R TA+ L H + +
Sbjct: 262 --------------------------QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW- 294
Query: 659 LPIDPAMFPTWPAKSELAHKKAAMASPK 686
+ P + S + +S
Sbjct: 295 -DFENLFHPEETSSSSQTQDHSVRSSED 321
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-38
Identities = 48/356 (13%), Positives = 103/356 (28%), Gaps = 74/356 (20%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLRE----INTLLKAQHP------ 421
+ A D+ T E + + I ++E + L ++
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 422 -NIVTVREIVVGSNMDKI---------------FIVMDYVEHDMKSLMETMRSKKQV--- 462
+ ++V K+ F + ++ ++++ E + S
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 463 FIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK- 521
+ L Q++ +A LH ++H L+ +++L RG + + F G+
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS 267
Query: 522 HYTPIVVTLWYRSPELLLGCKE----YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLS 577
+ +L + + D W++G C + T + L
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE 327
Query: 578 RIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTY 637
IF++ V+ LL FL Y
Sbjct: 328 WIFRS--------CKNIP--QPVR---------------------------ALLEGFLRY 350
Query: 638 DPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMAS--PKPPSGG 691
R+ +A+ + + + A+ P + E + A S +P G
Sbjct: 351 PKEDRLLPLQAMETPEYEQLRTELSAAL-PLYQTDGEPTREGGAPPSGTSQPDEAG 405
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 65/321 (20%), Positives = 117/321 (36%), Gaps = 66/321 (20%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIV 430
EG + V + T + A+K +EK+ RE+ L + Q H N++ + E
Sbjct: 23 EGAHARVQTCINLITSQEYAVK--IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 431 VGSNMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
D+ ++V + + H + E E ++Q + +A+ L
Sbjct: 81 --EEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----------EASVVVQDVASALDFL 127
Query: 483 HDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVV--------TLW 531
H+ I HRDLK N+L H +K+ DF L +PI +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI-KLNGDCSPISTPELLTPCGSAE 186
Query: 532 YRSPELLLGC----KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
Y +PE++ Y D+WS+G I L P F G+ + +
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 588 EKIWPGFSKLPAVQKMTF----AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI 643
+ ++Q+ + ++ ++ + DL+ K L D R+
Sbjct: 247 NML------FESIQEGKYEFPDKDWAHI------------SCAAKDLISKLLVRDAKQRL 288
Query: 644 TADEALRH----DYFSESPLP 660
+A + L+H E+ LP
Sbjct: 289 SAAQVLQHPWVQGCAPENTLP 309
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 69/309 (22%), Positives = 122/309 (39%), Gaps = 61/309 (19%)
Query: 372 EGTYGVVYRAKDKRTDEIVALK---RLKMEKEKEGFPITSL------------------- 409
+G+YGVV A ++ + A+K + K+ ++
Sbjct: 23 KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 410 --REINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE 467
+EI L K HPN+V + E++ N D +++V + V +ME K +
Sbjct: 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ--GPVMEVPTLKP--LSEDQ 138
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
+ Q L+ + +LH I+HRD+K SNLL+ G +K+ DFG++ E+ + V
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 528 VTLWYRSPELLLGC-KEYSTP-IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585
T + +PE L K +S +D+W++G F+ + F + + S+I
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS--QA 256
Query: 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA 645
P ++ LK DL+ + L +P +RI
Sbjct: 257 LEFPDQPDIAE----------------DLK-------------DLITRMLDKNPESRIVV 287
Query: 646 DEALRHDYF 654
E H +
Sbjct: 288 PEIKLHPWV 296
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 6e-38
Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 63/297 (21%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREI 429
G G V + +KRT E ALK L K + RE+ +A P+IV + ++
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVELHWRASQCPHIVRIVDV 123
Query: 430 V--VGSNMDKIFIVMDY----------VEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
+ + + IVM+ + ++ E E +M+ +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----------EASEIMKSIGE 172
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
A+ +LH I HRD+K NLL + + ILK+ DFG A+E S TP T +Y +
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVA 231
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
PE +LG ++Y DMWS+G I LC P F L + +I G
Sbjct: 232 PE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------TRIRMGQ 283
Query: 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
+ P E+ V +E L+ L +P R+T E + H
Sbjct: 284 YEFPN------PEWSEV------------SEEVKMLIRNLLKTEPTQRMTITEFMNH 322
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 71/350 (20%), Positives = 123/350 (35%), Gaps = 66/350 (18%)
Query: 313 RKKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEE 372
K +S + + + P ++ V + +L+ V R+
Sbjct: 16 LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREE-------VHWMTHQPRVGR 68
Query: 373 GTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG 432
G++G V+R KDK+T A+K++++E + E+ P IV + V
Sbjct: 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVRE 121
Query: 433 SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDL 492
+ I M+ +E SL + ++ + Q L + +LH ILH D+
Sbjct: 122 G--PWVNIFMELLE--GGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 493 KTSNLLLSHRGIL-KVGDFGLAR-----EYGSPLKHYTPIVVTLWYRSPELLLGCKEYST 546
K N+LLS G + DFG A G L I T + +PE+++G K
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDA 235
Query: 547 PIDMWSVGCIFAEFLCMEPLFTGK---SDLEQLSRIFK--TMGTPNEKIWPGFSKLPAVQ 601
+D+WS C+ + G + + K + P +I P +
Sbjct: 236 KVDIWSSCCMMLH------MLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA------ 283
Query: 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
L + + L +PV R +A E R
Sbjct: 284 -----------------------PLTAQAIQEGLRKEPVHRASAMELRRK 310
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 48/288 (16%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
+GTYG+VY +D +A+K + + P+ EI +H NIV
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL--HEEIALHKHLKHKNIVQYLGSFS 89
Query: 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE--VKCLMQQLLNAVAHLHDNWILH 489
+ I I M+ V SL +RSK E + +Q+L + +LHDN I+H
Sbjct: 90 EN--GFIKIFMEQVPGG--SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 490 RDLKTSNLLL-SHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE-YSTP 547
RD+K N+L+ ++ G+LK+ DFG ++ TL Y +PE++ Y
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 548 IDMWSVGCIFAEFLCMEPLFTGK---SDL-EQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603
D+WS+GC E + TGK +L E + +FK K+ P ++P
Sbjct: 206 ADIWSLGCTIIE------MATGKPPFYELGEPQAAMFK---VGMFKVHP---EIP----- 248
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
++ + K DP R A++ L
Sbjct: 249 -----------------ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 71/291 (24%), Positives = 110/291 (37%), Gaps = 72/291 (24%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRL-KMEKEKEGFPITSLREINTLLK-AQHPNIVTVREI 429
G G V + +KRT E ALK L K + RE+ + +Q P+IV + ++
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVELHWRASQCPHIVRIVDV 79
Query: 430 V--VGSNMDKIFIVMDYV---EHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLH 483
+ + + IVM+ + E L ++ + Q F E +M+ + A+ +LH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGE-----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 484 DNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
I HRD+K NLL + + ILK+ DFG A E
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------------KETTG- 172
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
++Y DMWS+G I LC P F L + +I G + P
Sbjct: 173 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------TRIRMGQYEFPN- 223
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
E+ V +E L+ L +P R+T E + H
Sbjct: 224 -----PEWSEV------------SEEVKMLIRNLLKTEPTQRMTITEFMNH 257
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 70/366 (19%), Positives = 118/366 (32%), Gaps = 109/366 (29%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTD----------------------EIVALKRL- 395
R + +F+ + + G +GVV+ AK+K D E+ AL +L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 396 ---------------------------------KMEKEKEGFPITSLREINTLLKAQHPN 422
+I + N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCL--MQQLLNAVA 480
V ++ S ++I M ++L + M + + CL Q+ AV
Sbjct: 123 TV--GQLQPSSPKVYLYIQMQLCRK--ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR------------EYGSPLKHYTPIVV 528
LH ++HRDLK SN+ + ++KVGDFGL +T V
Sbjct: 179 FLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE 588
T Y SPE + G YS +D++S+G I E L T + ++ + N
Sbjct: 239 TKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV------RNL 289
Query: 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA 648
K F++ +YP + ++ L+ P R A +
Sbjct: 290 KFPLLFTQ----------KYPQE----------------HMMVQDMLSPSPTERPEATDI 323
Query: 649 LRHDYF 654
+ + F
Sbjct: 324 IENAIF 329
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 81/295 (27%), Positives = 121/295 (41%), Gaps = 62/295 (21%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQHPNIVTVREIV 430
GT+G V + + T VA+K L +K REI L +HP+I+ + +++
Sbjct: 21 VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHR 490
S F+VM+YV L + + K E + L QQ+L+AV + H + ++HR
Sbjct: 81 --STPTDFFMVMEYVSG--GELFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHR 135
Query: 491 DLKTSNLLLSHRGILKVGDFGLAREY----------GSPLKHYTPIVVTLWYRSPELLLG 540
DLK N+LL K+ DFGL+ GSP Y +PE++ G
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-----------YAAPEVISG 184
Query: 541 CKEYSTP-IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
+ Y+ P +D+WS G I LC F D E + +FK KI G +P
Sbjct: 185 -RLYAGPEVDIWSCGVILYALLCGTLPF----DDEHVPTLFK-------KIRGGVFYIP- 231
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
L LL L DP+ R T + H++F
Sbjct: 232 ---------------------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 67/304 (22%), Positives = 128/304 (42%), Gaps = 51/304 (16%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
+G + V A+ T VA+K + + RE+ + HPNIV + E++
Sbjct: 25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI- 83
Query: 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491
++++M+Y + + + + ++ E + +Q+++AV + H I+HRD
Sbjct: 84 -ETEKTLYLIMEYASG--GEVFDYLVAHGRM-KEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 492 LKTSNLLLSHRGILKVGDFGLAREY--GSPLKHY--TPIVVTLWYRSPELLLGCKEYSTP 547
LK NLLL +K+ DFG + E+ G L + P Y +PEL G K+Y P
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP-----PYAAPELFQG-KKYDGP 193
Query: 548 -IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFA 606
+D+WS+G I + F G++ L + + ++ G ++P
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQN----LKELRE-------RVLRGKYRIP-------- 234
Query: 607 EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF--SESPLPIDPA 664
++ +LL +FL +P+ R T ++ ++ + + P
Sbjct: 235 --------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPF 280
Query: 665 MFPT 668
+ P
Sbjct: 281 VEPE 284
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 76/305 (24%), Positives = 131/305 (42%), Gaps = 64/305 (20%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQHPNIVTVREIV 430
EG++G V A +T + VALK + + +K + REI+ L +HP+I+ + +++
Sbjct: 19 EGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHR 490
+ I +V++Y ++ + +K+ E + QQ++ A+ + H + I+HR
Sbjct: 79 --TTPTDIVMVIEYAGGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 491 DLKTSNLLLSHRGILKVGDFGLAREY----------GSPLKHYTPIVVTLWYRSPELLLG 540
DLK NLLL +K+ DFGL+ GSP Y +PE++ G
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVING 181
Query: 541 CKEYSTP-IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
K Y+ P +D+WS G + L F D E + +FK K+ +P
Sbjct: 182 -KLYAGPEVDVWSCGIVLYVMLVGRLPF----DDEFIPNLFK-------KVNSCVYVMP- 228
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES-P 658
L+ L+ + + DP+ RIT E R +F+ + P
Sbjct: 229 ---------------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267
Query: 659 LPIDP 663
+ P
Sbjct: 268 DYLRP 272
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 47/275 (17%), Positives = 95/275 (34%), Gaps = 28/275 (10%)
Query: 344 EKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAK-----DKRTDEIVALKRLKME 398
+ LP P + + + + EG + VY A D + + LK K
Sbjct: 47 WQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA 106
Query: 399 KEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMR 457
E + T L E L + + + + +V + + + + + +
Sbjct: 107 NPWEFYIGTQLMER--LKPSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYK 162
Query: 458 SKKQVFIP-GEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI-----------L 505
+ + +P G V ++L + +HD I+H D+K N +L + + L
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222
Query: 506 KVGDFGLAREYGSPLKHYTPIVV--TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563
+ D G + + K T ++ E+L K ++ ID + V L
Sbjct: 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFG 281
Query: 564 EPLFTGKSDLE-QLSRIFKTMGTPNEKIWPGFSKL 597
+ E + +F+ P+ +W F +
Sbjct: 282 TYMKVKNEGGECKPEGLFR--RLPHLDMWNEFFHV 314
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 69/392 (17%), Positives = 130/392 (33%), Gaps = 84/392 (21%)
Query: 339 MEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME 398
M +E + A +++ ++ + G +G V+ A DK ++ V +K +K E
Sbjct: 1 MALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKE 60
Query: 399 KEKEGFPITSL------REINTLLKAQHPNIVTVREIVVGSNMDKIFIVM---------- 442
K E I EI L + +H NI+ V +I N +VM
Sbjct: 61 KVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--ENQGFFQLVMEKHGSGLDLF 118
Query: 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502
+++ + + +QL++AV +L I+HRD+K N++++
Sbjct: 119 AFID------------RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED 166
Query: 503 GILKVGDFGLAREY--GSPLKHY--TPIVVTLWYRSPELLLGCKEYSTP-IDMWSVGCIF 557
+K+ DFG A G + T Y +PE+L+G Y P ++MWS+G
Sbjct: 167 FTIKLIDFGSAAYLERGKLFYTFCGTIE-----YCAPEVLMG-NPYRGPELEMWSLGVTL 220
Query: 558 AEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTK 617
+ E F E+ P
Sbjct: 221 YTLVFEENPFCEL-----------------EETVEAAIHPP------------------- 244
Query: 618 VAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE----SPLPIDPAMFPTWPAKS 673
++++ L+ L P R T ++ + + ++ + + P
Sbjct: 245 ---YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESG 301
Query: 674 ELAHKKAAMASPKPPSGGHNYKQLEDNEEGFH 705
L+ M + + H
Sbjct: 302 VLSAASLEMGNRSLSDVAQAQELCGGEGHHHH 333
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+E + + G +GVV +AK + + VA+K+++ E E++ F + E+ L + HP
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAF----IVELRQLSRVNHP 61
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQV--FIPGEVKCLMQQLLNAV 479
NIV + G+ ++ + +VM+Y E SL + + + + Q V
Sbjct: 62 NIVKL----YGACLNPVCLVMEYAEGG--SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 480 AHLHD---NWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
A+LH ++HRDLK NLLL G +LK+ DFG A + + H T + + +P
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAP 172
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ 575
E+ G YS D++S G I E + F
Sbjct: 173 EVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 68/297 (22%), Positives = 107/297 (36%), Gaps = 62/297 (20%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
EG YG V A ++ T+E VA+K + M++ P +EI H N+V
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR- 74
Query: 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491
+ ++ ++Y L + + + + QL+ V +LH I HRD
Sbjct: 75 -REGNIQYLFLEYCSG--GELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 492 LKTSNLLLSHRGILKVGDFGLAREY-------------GSPLKHYTPIVVTLWYRSPELL 538
+K NLLL R LK+ DFGLA + G+ Y +PELL
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP-----------YVAPELL 179
Query: 539 LGCKEYS-TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
+E+ P+D+WS G + L E + SD Q +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------DWKEKKTYLN 229
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
P + + LL K L +P RIT + + ++
Sbjct: 230 PWKKIDSAPL---------------------ALLHKILVENPSARITIPDIKKDRWY 265
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 57/321 (17%), Positives = 112/321 (34%), Gaps = 68/321 (21%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL----REINTLLK----AQHPNI 423
+G +G V+ VA+K + + P++ E+ L K HP +
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 424 VTVREIVVGSNMDKIFIVMDYVEH--DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
+ + + + +V++ D+ + +K G +C Q++ A+ H
Sbjct: 101 IRLLDWF--ETQEGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAIQH 154
Query: 482 LHDNWILHRDLKTSNLLL-SHRGILKVGDFGLAREY-GSPLKHY--TPIVVTLWYRSPEL 537
H ++HRD+K N+L+ RG K+ DFG P + T + Y PE
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV-----YSPPEW 209
Query: 538 LLGCKEYS-TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
+ +Y P +WS+G + + +C + F ++I
Sbjct: 210 ISR-HQYHALPATVWSLGILLYDMVCGDIPFERD-----------------QEILEAELH 251
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
P + ++ L+ + L P +R + +E L +
Sbjct: 252 FP----------------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289
Query: 657 --SPLPIDPAMFPTWPAKSEL 675
+P++P+ P L
Sbjct: 290 PAEDVPLNPSKGGPAPLAWSL 310
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 56/304 (18%), Positives = 107/304 (35%), Gaps = 60/304 (19%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL----REINTLLKAQH--PNIVT 425
G +G VY + VA+K ++ ++ + + + E+ L K ++
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+ + D ++++ E L + + +++ + Q+L AV H H+
Sbjct: 113 LLDWF--ERPDSFVLILERPEPVQ-DLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 486 WILHRDLKTSNLLL-SHRGILKVGDFGLAREY-GSPLKHY--TPIVVTLWYRSPELLLGC 541
+LHRD+K N+L+ +RG LK+ DFG + + T + Y PE +
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV-----YSPPEWIRY- 222
Query: 542 KEYS-TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
Y +WS+G + + +C + F E+I G
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----------------EEIIRGQVFFR-- 263
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660
++ L+ L P R T +E H + + LP
Sbjct: 264 --------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303
Query: 661 IDPA 664
+ A
Sbjct: 304 QETA 307
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 40/305 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++++ I G VV A E VA+KR+ +EK + L+EI + + HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHP 73
Query: 422 NIVTVRE-IVVGSNMDKIFIVMDY-----VEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
NIV+ VV D++++VM V +K ++ K V + +++++
Sbjct: 74 NIVSYYTSFVVK---DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA------REYGSPLKHYTPIVVT 529
L + +LH N +HRD+K N+LL G +++ DFG++ + T V T
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-FVGT 189
Query: 530 LWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589
+ +PE++ + Y D+WS G E + + + T+
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQND--- 243
Query: 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
P + K +Y + ++ LC L DP R TA E L
Sbjct: 244 --PPSLETGVQDKEMLKKYGKS--FRKMIS-----------LC--LQKDPEKRPTAAELL 286
Query: 650 RHDYF 654
RH +F
Sbjct: 287 RHKFF 291
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 8/30 (26%), Positives = 12/30 (40%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++++ I G VV A E VA
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVA 44
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 47/226 (20%), Positives = 92/226 (40%), Gaps = 22/226 (9%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-----REINTLL 416
E + +I +G +G+V++ + + +VA+K L + + + RE+ +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
HPNIV + G + +VM++V L + K LM +
Sbjct: 79 NLNHPNIVK----LYGLMHNPPRMVMEFVPCG--DLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 477 NAVAHLHDN--WILHRDLKTSNLLLSHRG-----ILKVGDFGLAREYGSPLKHYTPIVVT 529
+ ++ + I+HRDL++ N+ L KV DFGL+++ + + ++
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGN 189
Query: 530 LWYRSPELLLG-CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE 574
+ +PE + + Y+ D +S I L E F S +
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 68/297 (22%), Positives = 107/297 (36%), Gaps = 62/297 (20%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVV 431
EG YG V A ++ T+E VA+K + M++ P +EI H N+V
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR- 74
Query: 432 GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491
+ ++ ++Y L + + + + QL+ V +LH I HRD
Sbjct: 75 -REGNIQYLFLEYCSG--GELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 492 LKTSNLLLSHRGILKVGDFGLAREY-------------GSPLKHYTPIVVTLWYRSPELL 538
+K NLLL R LK+ DFGLA + G+ Y +PELL
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP-----------YVAPELL 179
Query: 539 LGCKEYS-TPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
+E+ P+D+WS G + L E + SD Q +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------DWKEKKTYLN 229
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
P + + LL K L +P RIT + + ++
Sbjct: 230 PWKKIDSAPL---------------------ALLHKILVENPSARITIPDIKKDRWY 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-32
Identities = 78/293 (26%), Positives = 116/293 (39%), Gaps = 54/293 (18%)
Query: 372 EGTYGVVYRAKDKRTDEIVALK---RLKMEKEKEGFPITSLREINTLLKAQHPNIVTVRE 428
G +GV +DK T E+VA+K R E + REI +HPNIV +E
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQ--REIINHRSLRHPNIVRFKE 83
Query: 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWIL 488
++ + I+M+Y L E + F E + QQLL+ V++ H I
Sbjct: 84 VI--LTPTHLAIIMEYASG--GELYERI-CNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138
Query: 489 HRDLKTSNLLL--SHRGILKVGDFGLAREY--GSPLKHY--TPIVVTLWYRSPELLLGCK 542
HRDLK N LL S LK+ DFG ++ S K TP Y +PE+LL +
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLR-Q 192
Query: 543 EYSTP-IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601
EY D+WS G L F + + R ++ ++I +P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPRDYRKT---IQRILSVKYSIPDDI 245
Query: 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
+++ L+ + DP TRI+ E H +F
Sbjct: 246 RIS-------PECC-------------HLISRIFVADPATRISIPEIKTHSWF 278
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 70/298 (23%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+++ +I +G G VY A D T + VA++++ ++++ + I + EI + + ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77
Query: 422 NIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
NIV + S D++++VM+Y+ SL + + G++ + ++ L A+
Sbjct: 78 NIVNY----LDSYLVGDELWVVMEYLA--GGSLTDVVTETC--MDEGQIAAVCRECLQAL 129
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
LH N ++HRD+K+ N+LL G +K+ DFG + + +V T ++ +PE++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK--TMGTPNEKIWPGFSKL 597
K Y +D+WS+G + E + EP + + L ++ T GTP + S +
Sbjct: 190 R-KAYGPKVDIWSLGIMAIEMIEGEPPY---LNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655
+ D L + L D R +A E L+H +
Sbjct: 246 ----------------FR-------------DFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 52/303 (17%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
K I G++ VY+ D T VA L+ K + E L QHPNI
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 424 VTVR--EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
V I +V + + +L +T + +V ++ +Q+L +
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSG--TL-KTYLKRFKVMKIKVLRSWCRQILKGLQF 144
Query: 482 LHDN--WILHRDLKTSNLLLSHR-GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
LH I+HRDLK N+ ++ G +K+GD GLA + ++ T + +PE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPE-- 200
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK---SDLEQLSRIFK--TMGTPNEKIWPG 593
+ ++Y +D+++ G CM + T + S+ + ++I++ T G
Sbjct: 201 MYEEKYDESVDVYAFGM------CMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
P V+ +++ + + R + + L H +
Sbjct: 255 AI--PEVK---------------------------EIIEGCIRQNKDERYSIKDLLNHAF 285
Query: 654 FSE 656
F E
Sbjct: 286 FQE 288
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 82/313 (26%), Positives = 125/313 (39%), Gaps = 62/313 (19%)
Query: 372 EGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQHPNIVTVREIV 430
GT+G V K + T VA+K L +K REI L +HP+I+ + +++
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85
Query: 431 VGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHR 490
S IF+VM+YV L + + K E + L QQ+L+ V + H + ++HR
Sbjct: 86 --STPSDIFMVMEYVSG--GELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHR 140
Query: 491 DLKTSNLLLSHRGILKVGDFGLAREY----------GSPLKHYTPIVVTLWYRSPELLLG 540
DLK N+LL K+ DFGL+ GSP Y +PE++ G
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-----------YAAPEVISG 189
Query: 541 CKEYSTP-IDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
+ Y+ P +D+WS G I LC F D + + +FK KI G P
Sbjct: 190 -RLYAGPEVDIWSSGVILYALLCGTLPF----DDDHVPTLFK-------KICDGIFYTP- 236
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659
L LL L DP+ R T + H++F +
Sbjct: 237 ---------------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275
Query: 660 PIDPAMFPTWPAK 672
P++ +
Sbjct: 276 KYLFPEDPSYSST 288
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 67/301 (22%), Positives = 139/301 (46%), Gaps = 43/301 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+I EG+ G+V A++K + VA+K + + K++ + E+ + QH
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHF 102
Query: 422 NIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
N+V + S ++++++M++++ +L + + + ++ + + +L A+
Sbjct: 103 NVVEM----YKSYLVGEELWVLMEFLQ--GGALTDIVSQVR--LNEEQIATVCEAVLQAL 154
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
A+LH ++HRD+K+ ++LL+ G +K+ DFG + + +V T ++ +PE++
Sbjct: 155 AYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
Y+T +D+WS+G + E + EP + S ++ + R+ + P K S +
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPPKLKNSHKVSPV-- 270
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659
L+ D L + L DP R TA E L H + ++ L
Sbjct: 271 --------------LR-------------DFLERMLVRDPQERATAQELLDHPFLLQTGL 303
Query: 660 P 660
P
Sbjct: 304 P 304
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 67/306 (21%), Positives = 134/306 (43%), Gaps = 50/306 (16%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E ++ + + +G +G VY+AK+K T + A K ++ + E+E + EI L HP
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--IVEIEILATCDHP 76
Query: 422 NIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
IV + +G+ + K++I++++ ++ M + +++ + +Q+L A+
Sbjct: 77 YIVKL----LGAYYHDGKLWIMIEFCP--GGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
LH I+HRDLK N+L++ G +++ DFG++ + L+ + T ++ +PE+++
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 540 GC----KEYSTPIDMWSVGCIFA-EFLCMEPLFTGKSDLEQLSRIFK--TMGTPNEKIWP 592
Y D+WS+G I E +EP +L + + K P
Sbjct: 191 CETMKDTPYDYKADIWSLG-ITLIEMAQIEPPH---HELNPMRVLLKIAKSDPPTLLTPS 246
Query: 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHD 652
+S F ++ + + L +P TR +A + L H
Sbjct: 247 KWSV-------EFRDF---------LK-----------IA--LDKNPETRPSAAQLLEHP 277
Query: 653 YFSESP 658
+ S
Sbjct: 278 FVSSIT 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 10/30 (33%), Positives = 19/30 (63%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
E ++ + + +G +G VY+AK+K T + A
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAA 48
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 75/302 (24%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E F L ++ EG+YG VY+A K T +IVA+K++ +E + + ++EI+ + + P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IKEISIMQQCDSP 84
Query: 422 NIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
++V GS ++IVM+Y S+ + +R + + E+ ++Q L +
Sbjct: 85 HVVKY----YGSYFKNTDLWIVMEYCG--AGSVSDIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+LH +HRD+K N+LL+ G K+ DFG+A + + ++ T ++ +PE++
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 198
Query: 540 GCKEYSTPIDMWSVGCIFA-EFLCMEPLFTGKSDLEQLSRIFK--TMGTPNEKIWPGFSK 596
Y+ D+WS+G I A E +P + +D+ + IF T P + +S
Sbjct: 199 E-IGYNCVADIWSLG-ITAIEMAEGKPPY---ADIHPMRAIFMIPTNPPPTFRKPELWSD 253
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
F ++ V C L P R TA + L+H +
Sbjct: 254 -------NFTDF---------VK-----------QC--LVKSPEQRATATQLLQHPFVRS 284
Query: 657 SP 658
+
Sbjct: 285 AK 286
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKME-KEKEGFPITSLREINTLLKAQHPNIVT 425
++++ G VY A+D + VA+K + + +EKE RE++ + H NIV+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 426 VREIVVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD 484
+ + V D ++VM+Y+E + +E Q+L+ + H HD
Sbjct: 76 MID--VDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV-TLWYRSPELLLGCKE 543
I+HRD+K N+L+ LK+ DFG+A+ T V+ T+ Y SPE G E
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG--E 187
Query: 544 YSTP-IDMWSVGCIFAEFLCMEPLFTGKS 571
+ D++S+G + E L EP F G++
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGET 216
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSL-REINTLLKAQH 420
+ F L I G++G VY A+D R E+VA+K++ ++ + +E+ L K +H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 421 PNIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
PN + G ++VM+Y S + + K+ E+ + L
Sbjct: 114 PNTIQY----RGCYLREHTAWLVMEYCL---GSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+A+LH + ++HRD+K N+LLS G++K+GDFG A + V T ++ +PE++
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANS-FVGTPYWMAPEVI 222
Query: 539 LGCKE--YSTPIDMWSVGCIFA-EFLCMEP 565
L E Y +D+WS+G I E +P
Sbjct: 223 LAMDEGQYDGKVDVWSLG-ITCIELAERKP 251
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 60/366 (16%), Positives = 127/366 (34%), Gaps = 29/366 (7%)
Query: 362 EEFKCLNRIEEG--TYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ 419
++ L I +G V A+ K T E V ++R+ +E E++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-GEVKCLMQQLLNA 478
HPNIV R + +++++V ++ + S + + + + + ++Q +L A
Sbjct: 85 HPNIVPYRATFI--ADNELWVVTSFMAYG--SAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYT------PIVVTLW 531
+ ++H +HR +K S++L+S G + + + V L
Sbjct: 141 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 532 YRSPELLL-GCKEYSTPIDMWSVGCI----------FAEFLCMEPLF-TGKSDLEQL--S 577
+ SPE+L + Y D++SVG F + + L + L +
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260
Query: 578 RIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTY 637
+ + T P+ G + + + + + L
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320
Query: 638 DPVTRITADEALRHDYFSESPLPIDPAMFPTWPAKSELAHKKAAMASPKPPSGGHNYKQL 697
+P R +A L H +F + A+ + + + + + + G L
Sbjct: 321 NPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLV-TNL 379
Query: 698 EDNEEG 703
E+ E
Sbjct: 380 EELEVD 385
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 49/232 (21%), Positives = 103/232 (44%), Gaps = 22/232 (9%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFP-ITSLREINTLLKA 418
++ + + + G YGVV + + + +I+A+KR++ + + L +++ ++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL--LMDLDISMRT 62
Query: 419 -QHPNIVT-----VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLM 472
P VT RE ++I M+ ++ + + + K Q + +
Sbjct: 63 VDCPFTVTFYGALFRE-------GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 473 QQLLNAVAHLHDNW-ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
++ A+ HLH ++HRD+K SN+L++ G +K+ DFG++ +
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DAGCKP 174
Query: 532 YRSPELLLG---CKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRI 579
Y +PE + K YS D+WS+G E + P + + +QL ++
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 71/315 (22%), Positives = 123/315 (39%), Gaps = 66/315 (20%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPIT-SLREINTL 415
E+FK + EG++ V A++ T A+K L+ + KE + + RE + +
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK---VPYVTRERDVM 84
Query: 416 LKAQHPNIVTVREIVVGS--NMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKC 470
+ HP V + + + +K++ + Y E L++ +R K F +
Sbjct: 85 SRLDHPFFVKLY----FTFQDDEKLYFGLSYAKNGE-----LLKYIR-KIGSFDETCTRF 134
Query: 471 LMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE---YGSPLKHYTPIV 527
++++A+ +LH I+HRDLK N+LL+ +++ DFG A+ + + V
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FV 193
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
T Y SPELL K D+W++GCI + + P F ++ IF
Sbjct: 194 GTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IF------- 241
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT--- 644
+KI + F E DL+ K L D R+
Sbjct: 242 QKIIKL--------EYDFPEK--------------FFPKARDLVEKLLVLDATKRLGCEE 279
Query: 645 ---ADEALRHDYFSE 656
H +F
Sbjct: 280 MEGYGPLKAHPFFES 294
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 88/404 (21%), Positives = 146/404 (36%), Gaps = 86/404 (21%)
Query: 328 SPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTD 387
I+ D D + + Y G + + ++ G + V+ + D +
Sbjct: 3 QEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGK 62
Query: 388 EIVALKRLKMEKEKEGFPITSLREINTLLK-----AQHPNIVTVREI-----VVGSNMDK 437
+ VA+K +K E + T+L EI L PN V ++ + G N
Sbjct: 63 KFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119
Query: 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH-DNWILHRDLKTSN 496
I +V + + H + + +S Q VK ++QQ+L + +LH I+H D+K N
Sbjct: 120 ICMVFEVLGHHLLKWII--KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177
Query: 497 LLL-------------------------------------------------SHRGILKV 507
+LL + + +K+
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 508 GDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLF 567
D G A KH+T + T YRS E+L+G Y+TP D+WS C+ E + LF
Sbjct: 238 ADLGNAC---WVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLF 293
Query: 568 TGKS------DLEQLSRIFKTMGTPNEKIWPG-------FSK---LPAVQKMTFAEYPNV 611
S D + ++ I + +G K+ F+K L + K+ V
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 612 GGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655
K + + D L L P R TA E LRH + +
Sbjct: 354 LVEKYEWSQEEAAGF-TDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E F L +I +G++G V++ D RT ++VA+K + +E+ ++ +EI L + P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSP 80
Query: 422 NIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
+ GS K++I+M+Y+ S ++ + ++ +++++L +
Sbjct: 81 YVTKY----YGSYLKDTKLWIIMEYLG--GGSALDLLEPGP--LDETQIATILREILKGL 132
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+LH +HRD+K +N+LLS G +K+ DFG+A + V T ++ +PE++
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEP 565
Y + D+WS+G E EP
Sbjct: 193 Q-SAYDSKADIWSLGITAIELARGEP 217
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 12/30 (40%), Positives = 20/30 (66%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
E F L +I +G++G V++ D RT ++VA
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVA 51
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 38/218 (17%), Positives = 77/218 (35%), Gaps = 14/218 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++ L ++ E G +++ + + D + +K LK+ E L HP
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLM-QQLLNAVA 480
N++ V ++ ++ + SL + + + +A
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPY--GSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 481 HLH--DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
LH + I L + ++++ ++ + + SP + Y P W +PE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP----AWV-APEAL 180
Query: 539 LGCKE--YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE 574
E DMWS + E + E F S++E
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-29
Identities = 65/316 (20%), Positives = 127/316 (40%), Gaps = 33/316 (10%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ 419
++F+ ++ + G GVV++ K + ++A K + +E + +RE+ L +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHECN 89
Query: 420 HPNIVT-----VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
P IV + +I I M+++ D SL + ++ ++ + +
Sbjct: 90 SPYIVGFYGAFYSD-------GEISICMEHM--DGGSLDQVLKKAGRIPEQ-ILGKVSIA 139
Query: 475 LLNAVAHLHDNW-ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
++ + +L + I+HRD+K SN+L++ RG +K+ DFG++ + + + + V T Y
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-S-FVGTRSYM 197
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
SPE L G YS D+WS+G E D ++L +F + P
Sbjct: 198 SPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPP 255
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDL--------LCKFLTY----DPVT 641
+ P F ++ I+ E L F+ +P
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 642 RITADEALRHDYFSES 657
R + + H + S
Sbjct: 316 RADLKQLMVHAFIKRS 331
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 60/233 (25%), Positives = 105/233 (45%), Gaps = 23/233 (9%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME-KEKEGFPITSLREINTLLKA 418
+ E+ K L I G YG V + K + +I+A+KR++ EKE + L +++ ++++
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL--LMDLDVVMRS 77
Query: 419 -QHPNIVT-----VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEV-KCL 471
P IV RE +I M+ + + + S IP E+ +
Sbjct: 78 SDCPYIVQFYGALFRE-------GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 472 MQQLLNAVAHLHDNW-ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL 530
+ A+ HL +N I+HRD+K SN+LL G +K+ DFG++ + + T
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCR 189
Query: 531 WYRSPELLLG---CKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRI 579
Y +PE + + Y D+WS+G E P S +QL+++
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 14/219 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ RI G++G VY+ K VA+K L + E+ L K +H
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 422 NIVTVREIVVGSNMD-KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
NI+ +G + ++ IV + E SL + + + F ++ + +Q +
Sbjct: 81 NILLF----MGYSTAPQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE--YGSPLKHYTPIVVTLWYRSPELL 538
+LH I+HRDLK++N+ L +K+GDFGLA E S + + ++ + +PE++
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 539 LG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ 575
YS D+++ G + E + + ++ ++ +Q
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 12/207 (5%)
Query: 369 RIEEGTYGVVYRAKDKRTDEIVALKRLKME-KEKEGFPITSLREINTLLKAQHPNIVTVR 427
+ G G VY A+D + IVALK + F RE T + Q P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 428 EIVVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
+ G ++++ M + D+ +++ ++ P +++Q+ +A+ H
Sbjct: 101 D--FGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV-TLWYRSPELLLGCKEYS 545
HRD+K N+L+S + DFG+A V TL+Y +PE ++
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE--SHA 212
Query: 546 TP-IDMWSVGCIFAEFLCMEPLFTGKS 571
T D++++ C+ E L P + G
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 14/213 (6%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKME-KEKEGFPITSLREINTLLKAQHPNIVT 425
+ G V+ A+D R VA+K L+ + F + RE HP IV
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 426 VREI--VVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
V + +IVM+YV+ ++ ++ + P ++ A+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 132
Query: 483 HDNWILHRDLKTSNLLLSHRGILKVGDFGLAR---EYGSPLKHYTPIVVTLWYRSPELLL 539
H N I+HRD+K +N+++S +KV DFG+AR + G+ + ++ T Y SPE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 540 GCKEYSTP-IDMWSVGCIFAEFLCMEPLFTGKS 571
G + D++S+GC+ E L EP FTG S
Sbjct: 193 G--DSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 49/204 (24%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QH 420
F+ + + GTYG VY+ + +T ++ A+K + + ++E +EIN L K H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHH 80
Query: 421 PNIVT-----VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-GEVKCLMQQ 474
NI T +++ G + D++++VM++ S+ + +++ K + + + ++
Sbjct: 81 RNIATYYGAFIKKNPPGMD-DQLWLVMEFCG--AGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
+L ++HLH + ++HRD+K N+LL+ +K+ DFG++ + + + T ++ +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 535 PELLLGCKE----YSTPIDMWSVG 554
PE++ + Y D+WS+G
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLG 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 9/30 (30%), Positives = 17/30 (56%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
F+ + + GTYG VY+ + +T ++ A
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAA 53
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 45/217 (20%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM--EKEKEGFPITSLREINTLLKAQ 419
+ + +G +G + + T E++ +K L E+ + F L+E+ + +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF----LKEVKVMRCLE 65
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
HPN++ + I V ++ + +Y++ +L ++S + + + + + +
Sbjct: 66 HPNVL--KFIGVLYKDKRLNFITEYIKGG--TLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY--------------GSPLKHYTP 525
A+LH I+HRDL + N L+ + V DFGLAR K
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC 562
+V ++ +PE++ G + Y +D++S G + E +
Sbjct: 182 VVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIG 217
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 55/234 (23%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFP-ITSLREINTLLKA 418
+ + + L + GT G V++ + ++T ++A+K+++ KE I L +++ +LK+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI--LMDLDVVLKS 80
Query: 419 -QHPNIVT-----VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEV-KCL 471
P IV + +FI M+ M + E ++ + Q IP + +
Sbjct: 81 HDCPYIVQCFGTFITN-------TDVFIAMEL----MGTCAEKLKKRMQGPIPERILGKM 129
Query: 472 MQQLLNAVAHLHDNW-ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL 530
++ A+ +L + ++HRD+K SN+LL RG +K+ DFG++
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCA 188
Query: 531 WYRSPELLLGCKE----YSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRI 579
Y +PE + Y D+WS+G E + P K+D E L+++
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-27
Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 369 RIEEGTYGVVYRAKDKRTDE-IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVR 427
I G G +Y A D+ + V LK L + ++ E L + HP+IV +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 428 EIVVGSNMDKI---FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD 484
V ++ +IVM+YV +SL + Q E + ++L A+++LH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGG--QSLKRSKG---QKLPVAEAIAYLLEILPALSYLHS 200
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEY 544
+++ DLK N++L+ + K+ D G + + + T +++PE++
Sbjct: 201 IGLVYNDLKPENIMLTEEQL-KLIDLGAVS----RINSFGYLYGTPGFQAPEIVRT--GP 253
Query: 545 STPIDMWSVGCIFAEFLCMEPLFTGKS 571
+ D+++VG A P G+
Sbjct: 254 TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ +I G++G V+RA+ +D VA+K L + LRE+ + + +HP
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 422 NIVTVREIVVGSNMD--KIFIVMDYVEHDMKSLMETMRSKKQVF-IPGEVKCLM-QQLLN 477
NIV +G+ + IV +Y+ SL + + + M +
Sbjct: 95 NIVLF----MGAVTQPPNLSIVTEYLSR--GSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 478 AVAHLHDN--WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
+ +LH+ I+HR+LK+ NLL+ + +KV DFGL+R S T + +P
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE 574
E+L + + D++S G I E ++ + + +
Sbjct: 209 EVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS--LREINTLLKAQ 419
E I G +G VYRA + VA+K + + +++ +E +
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLM-QQLLNA 478
HPNI+ + V + +VM++ L + K+ IP ++ Q+
Sbjct: 65 HPNIIAL--RGVCLKEPNLCLVMEFARGG--PLNRVLSGKR---IPPDILVNWAVQIARG 117
Query: 479 VAHLHDN---WILHRDLKTSNLLLS--------HRGILKVGDFGLAREYGSPLKHYTPIV 527
+ +LHD I+HRDLK+SN+L+ ILK+ DFGLARE+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA 175
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE 574
+ +PE++ +S D+WS G + E L E F G L
Sbjct: 176 GAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 48/223 (21%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E+ + I +G +G VY + VA++ + +E++ E RE+ + +H
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 422 NIVTVREIVVGSNMD--KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
N+V +G+ M + I+ + ++L +R K V + + + Q+++ +
Sbjct: 90 NVVLF----MGACMSPPHLAIITSLCKG--RTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL---WYR--S 534
+LH ILH+DLK+ N+ + G + + DFGL G + + W +
Sbjct: 144 GYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 535 PELL--------LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG 569
PE++ +S D++++G I+ E E F
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-26
Identities = 76/340 (22%), Positives = 129/340 (37%), Gaps = 58/340 (17%)
Query: 334 DQDVDMEIELEKDTLPPYLPAIQGCR----SVEEFKCLNRIEEGTYGVVYRAKDKRTDEI 389
D + + + L Y I R E+++ + I G +G V + K T ++
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV 96
Query: 390 VALKRLK---MEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--NMDKIFIVMDY 444
A+K L M K + R+I + A P +V + + + +++VM+Y
Sbjct: 97 YAMKLLSKFEMIKRSDSAFFWEERDI--MAFANSPWVVQLF----YAFQDDRYLYMVMEY 150
Query: 445 VE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG 503
+ D+ +LM + +++ A+ +H +HRD+K N+LL G
Sbjct: 151 MPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 205
Query: 504 ILKVGDFGLAREYGSPLKHYTPIVV-TLWYRSPELLL---GCKEYSTPIDMWSVGCIFAE 559
LK+ DFG + V T Y SPE+L G Y D WSVG E
Sbjct: 206 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
Query: 560 FLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVA 619
L + F + L + KI + L +P+
Sbjct: 266 MLVGDTPFYA----DSLVGTY-------SKIMNHKNSLT---------FPD--------- 296
Query: 620 GSILTELGYDLLCKFLTYDPVTRIT---ADEALRHDYFSE 656
+ +++ +L+C FLT D R+ +E RH +F
Sbjct: 297 DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 335
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-26
Identities = 62/305 (20%), Positives = 117/305 (38%), Gaps = 48/305 (15%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK--EKEGFPITSLREINTLLK 417
+ + F+ L I +G++G V + T ++ A+K + +K E+ +E+ +
Sbjct: 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV-FKELQIMQG 71
Query: 418 AQHPNIVTVREIVVGS--NMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQ 474
+HP +V + S + + +F+V+D + D++ + + F VK + +
Sbjct: 72 LEHPFLVNLW----YSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICE 123
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
L+ A+ +L + I+HRD+K N+LL G + + DF +A + T + T Y +
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMA 182
Query: 535 PELLL--GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592
PE+ YS +D WS+G E L + +S I
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIV-------HTFET 234
Query: 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-TADEALRH 651
P S ++ LL K L +P R +
Sbjct: 235 TVVTYP----------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272
Query: 652 DYFSE 656
Y ++
Sbjct: 273 PYMND 277
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 62/345 (17%), Positives = 120/345 (34%), Gaps = 62/345 (17%)
Query: 334 DQDVDMEIELEKDTLPPYLPAIQGCR----SVEEFKCLNRIEEGTYGVVYRAKDKRTDEI 389
+ + D L P + + ++F+ L I G + V K K+T ++
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88
Query: 390 VALKRLK---MEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--NMDKIFIVMDY 444
A+K + M K E R++ L+ I + + + + +++VM+Y
Sbjct: 89 YAMKIMNKWDMLKRGEVSCFREERDV--LVNGDRRWITQLH----FAFQDENYLYLVMEY 142
Query: 445 V---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501
+ L+ + + + + +++ A+ +H +HRD+K N+LL
Sbjct: 143 YVGGD-----LLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR 197
Query: 502 RGILKVGDFGLAREYGSPLKHYTPIVV-TLWYRSPELLLG------CKEYSTPIDMWSVG 554
G +++ DFG + + + + V T Y SPE+L Y D W++G
Sbjct: 198 CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 555 CIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGL 614
E + F S E +I + P +
Sbjct: 258 VFAYEMFYGQTPFYADSTAETYGKI---VHYKEHLSLPLVDE------------------ 296
Query: 615 KTKVAGSILTELGYDLLCKFLTYDPVTRIT---ADEALRHDYFSE 656
+ E D + + L P TR+ A + H +F
Sbjct: 297 -------GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 53/238 (22%), Positives = 95/238 (39%), Gaps = 38/238 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++ + + +I +G YG V+ K + E VA+K +E F EI + +H
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWF---RETEIYQTVLMRHE 91
Query: 422 NIVTVREIVVGSNMD------KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKC-LMQQ 474
NI+ + +++ +++++ DY H+ SL + ++S + + L
Sbjct: 92 NILGF----IAADIKGTGSWTQLYLITDY--HENGSLYDYLKSTT---LDAKSMLKLAYS 142
Query: 475 LLNAVAHLHDNW--------ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY--- 523
++ + HLH I HRDLK+ N+L+ G + D GLA ++ S
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 524 -TPIVVTLWYRSPELLLG-----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ 575
V T Y PE+L + DM+S G I E + +
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ L + +G YG V+R + E VA+K EK E+ + +H
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKS---WFRETELYNTVMLRHE 62
Query: 422 NIVTVR--EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
NI+ ++ + +++++ Y H+M SL + + + ++ + + +
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHY--HEMGSLYDYL--QLTTLDTVSCLRIVLSIASGL 118
Query: 480 AHLHDNW--------ILHRDLKTSNLLLSHRGILKVGDFGLAREY----GSPLKHYTPIV 527
AHLH I HRDLK+ N+L+ G + D GLA + P V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 528 VTLWYRSPELL-----LGCKEYSTPIDMWSVGCIFAEFLC 562
T Y +PE+L + C + +D+W+ G + E
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 13/243 (5%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME--KEKEGFPITSLREINTLLK 417
+ F + G +G V+ + K T ++ A K+L + K+++G+ + E L K
Sbjct: 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAK 241
Query: 418 AQHPNIVTVR---EIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQ 473
IV++ E + +VM + D++ + + F
Sbjct: 242 VHSRFIVSLAYAFE-----TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
Q+++ + HLH I++RDLK N+LL G +++ D GLA E + T +
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
+PELLLG +EY +D +++G E + F + + + + + +
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415
Query: 594 FSK 596
FS
Sbjct: 416 FSP 418
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 67/343 (19%), Positives = 124/343 (36%), Gaps = 60/343 (17%)
Query: 334 DQDVDMEIELEKDTLPPYLPAIQGCR----SVEEFKCLNRIEEGTYGVVYRAKDKRTDEI 389
+ + + L P + E+F+ L I G +G V K K D++
Sbjct: 42 NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101
Query: 390 VALKRLK---MEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--NMDKIFIVMDY 444
A+K L M K E R++ L+ I T+ + + + +++VMDY
Sbjct: 102 FAMKILNKWEMLKRAETACFREERDV--LVNGDSKWITTLH----YAFQDDNNLYLVMDY 155
Query: 445 V---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501
+ L+ + + + + +++ A+ +H +HRD+K N+L+
Sbjct: 156 YVGGD-----LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 210
Query: 502 RGILKVGDFGLAREYGSPLKHYTPIVV-TLWYRSPELLLGCKE----YSTPIDMWSVGCI 556
G +++ DFG + + + V T Y SPE+L + Y D WS+G
Sbjct: 211 NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 557 FAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKT 616
E L E F E L + KI + F
Sbjct: 271 MYEMLYGETPFYA----ESLVETY-------GKIMNHKERFQ------FPTQV------- 306
Query: 617 KVAGSILTELGYDLLCKFLTYDPVTRIT---ADEALRHDYFSE 656
+ ++E DL+ + + R+ ++ +H +FS
Sbjct: 307 ----TDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSG 344
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLK--MEKEKEGFPITSLREINTL 415
K L ++ +G +G V + T E+VA+K+L+ E+ F REI L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEIL 65
Query: 416 LKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
QH NIV + + + + ++M+Y+ + SL + ++ K+ ++ Q+
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG--SLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIVV 528
+ +L +HRDL T N+L+ + +K+GDFGL + + + PI
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI-- 181
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVG 554
WY +PE L K +S D+WS G
Sbjct: 182 -FWY-APESLTESK-FSVASDVWSFG 204
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 71/332 (21%), Positives = 130/332 (39%), Gaps = 70/332 (21%)
Query: 342 ELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK 401
+ ++D L + Q +++F + + G++G V K K + A+K L +K
Sbjct: 21 KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-- 78
Query: 402 EGFPITSLREI-------NTLLKAQHPNIVTVREIVVGS--NMDKIFIVMDYV---EHDM 449
+ L++I L P +V + S + +++VM+YV E
Sbjct: 79 ----VVKLKQIEHTLNEKRILQAVNFPFLVKLE----FSFKDNSNLYMVMEYVAGGE--- 127
Query: 450 KSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGD 509
+ +R + F + Q++ +LH +++RDLK NLL+ +G ++V D
Sbjct: 128 --MFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 510 FGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG 569
FG A+ + +T + T +PE++L K Y+ +D W++G + E P F
Sbjct: 185 FGFAKRVKG--RTWT-LCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 570 KSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYD 629
+Q +I+ EKI G + P S + D
Sbjct: 241 ----DQPIQIY-------EKIVSGKVRFP----------------------SHFSSDLKD 267
Query: 630 LLCKFLTYDPVTRI-----TADEALRHDYFSE 656
LL L D R ++ H +F+
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 52/220 (23%), Positives = 86/220 (39%), Gaps = 28/220 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
I +G +G V+R K + E VA+K +E+ EI + +H
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS---WFREAEIYQTVMLRHE 96
Query: 422 NIVTVR--EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
NI+ + ++++V DY H+ SL + + + + L + +
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDY--HEHGSLFDYL--NRYTVTVEGMIKLALSTASGL 152
Query: 480 AHLHDNW--------ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY----TPIV 527
AHLH I HRDLK+ N+L+ G + D GLA + S V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 528 VTLWYRSPELLLG-----CKEYSTPIDMWSVGCIFAEFLC 562
T Y +PE+L E D++++G +F E
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 70/314 (22%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREI------- 412
S+++F+ L + G++G V+ + + A+K LK E + L+++
Sbjct: 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI------VVRLKQVEHTNDER 57
Query: 413 NTLLKAQHPNIVTVREIVVGS--NMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGE 467
L HP I+ + G+ + +IF++MDY+ E L +R K Q F
Sbjct: 58 LMLSIVTHPFIIRMW----GTFQDAQQIFMIMDYIEGGE-----LFSLLR-KSQRFPNPV 107
Query: 468 VKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
K ++ A+ +LH I++RDLK N+LL G +K+ DFG A+ YT +
Sbjct: 108 AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYT-LC 164
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
T Y +PE++ K Y+ ID WS G + E L F + ++ +
Sbjct: 165 GTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TY------- 212
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI---- 643
EKI + P E DLL + +T D R+
Sbjct: 213 EKILNAELRFP----------------------PFFNEDVKDLLSRLITRDLSQRLGNLQ 250
Query: 644 -TADEALRHDYFSE 656
++ H +F E
Sbjct: 251 NGTEDVKNHPWFKE 264
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 60/240 (25%), Positives = 95/240 (39%), Gaps = 32/240 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLK---MEKEKEGFPITSLREINT 414
K + + EG +G V + T E VA+K LK +EI
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL----KKEIEI 76
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
L H NIV + I + I ++M+++ SL E + K + Q
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG--SLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIV 527
+ + +L +HRDL N+L+ +K+GDFGL + + ++YT P+
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV- 193
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT-GKSDLEQLSRIFKTMGTP 586
WY +PE L+ K + D+WS G E L T SD ++ K +G
Sbjct: 194 --FWY-APECLMQSK-FYIASDVWSFG-----VTLHE-LLTYCDSDSSPMALFLKMIGPT 243
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 49/222 (22%), Positives = 82/222 (36%), Gaps = 35/222 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ K L I G YG VY+ + VA+K + + + I + +H
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQN---FINEKNIYRVPLMEHD 67
Query: 422 NIV---TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
NI E V + +VM+Y + SL + + L +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPN--GSLXKYLS--LHTSDWVSSCRLAHSVTRG 123
Query: 479 VAHLHDNW---------ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY------ 523
+A+LH I HRDL + N+L+ + G + DFGL+
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 524 --TPIVVTLWYRSPELLLG------CKEYSTPIDMWSVGCIF 557
V T+ Y +PE+L G + +DM+++G I+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLK--MEKEKEGFPITSLREINTL 415
K L ++ +G +G V + T E+VA+K+L+ E+ F REI L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEIL 96
Query: 416 LKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
QH NIV + + + + ++M+Y+ + SL + ++ K+ ++ Q+
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG--SLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIVV 528
+ +L +HRDL T N+L+ + +K+GDFGL + ++Y PI
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI-- 212
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVG 554
WY +PE L K +S D+WS G
Sbjct: 213 -FWY-APESLTESK-FSVASDVWSFG 235
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 54/233 (23%), Positives = 102/233 (43%), Gaps = 27/233 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ L G +G V++A+ +E VA+K ++ +K+ + + E+ +L +H
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-DKQSW--QNEYEVYSLPGMKHE 78
Query: 422 NIVTVR--EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
NI+ E S ++++ + E SL + + K V E+ + + + +
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEK--GSLSDFL--KANVVSWNELCHIAETMARGL 134
Query: 480 AHLHDNW----------ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY--TPIV 527
A+LH++ I HRD+K+ N+LL + + DFGLA ++ + V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 528 VTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576
T Y +PE+L G ++ IDM+++G + E G D L
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 50/240 (20%), Positives = 101/240 (42%), Gaps = 10/240 (4%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME--KEKEGFPITSLREINTLLK 417
+ F+ + +G +G V + + T ++ A K+L+ + K+++G + L E L K
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEK 240
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+V++ D + +V+ + D+K + F ++
Sbjct: 241 VNSRFVVSLAYAY--ETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEIC 296
Query: 477 NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
+ LH I++RDLK N+LL G +++ D GLA V T+ Y +PE
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPE 355
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
++ + Y+ D W++GC+ E + + F + + + + + E+ FS
Sbjct: 356 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 49/340 (14%), Positives = 95/340 (27%), Gaps = 64/340 (18%)
Query: 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREI----- 412
C E+ + +I EG +G V++ T + + ++ G + EI
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 413 --------NTLLKAQHPNIVTVRE--IVVGSNMDKIFIVMDYVEHDMKSLMET--MRSKK 460
+ + + + + V GS + D+ S +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 461 QVFI--------------------PGEVKCLMQQLLNAVAHLHDNW-ILHRDLKTSNLLL 499
Q+FI K ++ QL ++A + HRDL N+LL
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 500 SHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAE 559
+ K+ + P ++ Y+ +F +
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIID--------------YTLSRLERDGIVVFCD 241
Query: 560 FLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTF-----AEYPNVGGL 614
E LFTG D + I++ M N W + V + + +
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299
Query: 615 KTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
A + + L + +A + L
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 69/308 (22%), Positives = 122/308 (39%), Gaps = 55/308 (17%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLR-EINTL 415
++ +F L + +GT+G V ++K T A+K L+ E + E + E L
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE---VAHTVTESRVL 59
Query: 416 LKAQHPNIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ 473
+HP + ++ + D++ VM+Y L + S+++VF +
Sbjct: 60 QNTRHPFLTALK----YAFQTHDRLCFVMEYANGG--ELFFHL-SRERVFTEERARFYGA 112
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
++++A+ +LH +++RD+K NL+L G +K+ DFGL +E S T Y
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
+PE+L +Y +D W +G + E +C F + I E+I
Sbjct: 173 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEEI--- 222
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEA 648
+P L+ LL L DP R+ A E
Sbjct: 223 -------------RFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 649 LRHDYFSE 656
+ H +F
Sbjct: 259 MEHRFFLS 266
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 28/222 (12%), Positives = 54/222 (24%), Gaps = 38/222 (17%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKME-KEKEGFPITSLREINTLLKAQHPNIVT 425
L ++A D D VAL + + + +L L + P +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 426 VREIVVGSNMDKIFIVMDYVE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD 484
V + V +V +++ ++ + +T S P MQ L A H
Sbjct: 96 VLD--VVHTRAGGLVVAEWIRGGSLQEVADTSPS------PVGAIRAMQSLAAAADAAHR 147
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEY 544
+ S + +S G + +
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPA----TMPDANPQD-------------------- 183
Query: 545 STPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586
D+ +G L L+ +
Sbjct: 184 ----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ 221
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 26/207 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLK---MEKEKEGFPITSLREINT 414
K ++++ +G +G V + T +VA+K+L+ +++++ F REI
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-F----QREIQI 77
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
L IV R + G + +VM+Y+ L + ++ + + Q
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG--CLRDFLQRHRARLDASRLLLYSSQ 135
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIV 527
+ + +L +HRDL N+L+ +K+ DFGLA+ +Y PI
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI- 194
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVG 554
WY +PE L +S D+WS G
Sbjct: 195 --FWY-APESLSDNI-FSRQSDVWSFG 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 34/240 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLK---MEKEKEGFPITSLREINT 414
K + + EG +G V + T E+VA+K LK + + G+ +EI+
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQEIDI 86
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
L H +I+ + + + +VM+YV SL + + ++ QQ
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLG--SLRDYLPRHS--IGLAQLLLFAQQ 142
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIV 527
+ +A+LH +HRDL N+LL + ++K+GDFGLA+ ++Y P+
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV- 201
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT-GKSDLEQLSRIFKTMGTP 586
WY +PE L K + D+WS G E L T S ++ + +G
Sbjct: 202 --FWY-APECLKEYK-FYYASDVWSFG-----VTLYE-LLTHCDSSQSPPTKFLELIGIA 251
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-22
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
E+ +I G +G V+ + + + +VA+K + K F L+E L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQY 169
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HPNIV R I V + I+IVM+ V+ + +R++ + ++
Sbjct: 170 SHPNIV--RLIGVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE------YGSPLKHYTPIVVTLWY 532
+ +L +HRDL N L++ + +LK+ DFG++RE S P+ W
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV---KWT 282
Query: 533 RSPELLLGCKEYSTPIDMWSVG 554
+PE L + YS+ D+WS G
Sbjct: 283 -APEALNYGR-YSSESDVWSFG 302
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 9e-22
Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 18/281 (6%)
Query: 300 EDKADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCR 359
E +++E + D ++ ++ D E+E P
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRV----- 145
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR-EINTLLKA 418
++ EF+ L + +GT+G V K+K T A+K LK E + E L +
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 419 QHPNIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+HP + ++ S D++ VM+Y L + S+++VF + +++
Sbjct: 206 RHPFLTALK----YSFQTHDRLCFVMEYANGG--ELFFHL-SRERVFSEDRARFYGAEIV 258
Query: 477 NAVAHLH-DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
+A+ +LH + +++RDLK NL+L G +K+ DFGL +E T Y +P
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576
E+L +Y +D W +G + E +C F + D E+L
Sbjct: 319 EVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKL 357
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 1e-21
Identities = 70/352 (19%), Positives = 127/352 (36%), Gaps = 53/352 (15%)
Query: 316 EDASPNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCR-SVEEFKCLNRIEEGT 374
E + NE R + Q E +T+ + R + +F L + +G+
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGS 353
Query: 375 YGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR-EINTL-LKAQHPNIVTVREIVVG 432
+G V ++ K TDE+ A+K LK + + + E L L + P + +
Sbjct: 354 FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH----S 409
Query: 433 S--NMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILH 489
MD+++ VM+YV D LM + + F ++ + L I++
Sbjct: 410 CFQTMDRLYFVMEYVNGGD---LMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 490 RDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPID 549
RDLK N++L G +K+ DFG+ +E T Y +PE++ + Y +D
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVD 524
Query: 550 MWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYP 609
W+ G + E L + F G+ + E I + YP
Sbjct: 525 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHNV----------------AYP 562
Query: 610 NVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSE 656
+++ + +T P R+ + H +F
Sbjct: 563 -----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 72/318 (22%), Positives = 124/318 (38%), Gaps = 78/318 (24%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME---KEKEGFPITSLR-EINTL 415
+E+F + +G++G V+ A+ K+T++ A+K LK + + + + E L
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMVEKRVL 71
Query: 416 LKA-QHPNIVTVREIVVGS--NMDKIFIVMDYVE--------HDMKSLMETMRSKKQVFI 464
A +HP + + + + +F VM+Y+ + R+ F
Sbjct: 72 SLAWEHPFLTHMF----CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-RAT---FY 123
Query: 465 PGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE---YGSPLK 521
E+ + LH I++RDLK N+LL G +K+ DFG+ +E +
Sbjct: 124 AAEIIL-------GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176
Query: 522 HY--TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI 579
+ TP Y +PE+LLG ++Y+ +D WS G + E L + F G+ + E I
Sbjct: 177 TFCGTPD-----YIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
Query: 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDP 639
+ YP L + DLL K +P
Sbjct: 231 R------MDNP----------------FYP-----------RWLEKEAKDLLVKLFVREP 257
Query: 640 VTRITADEALR-HDYFSE 656
R+ +R H F E
Sbjct: 258 EKRLGVRGDIRQHPLFRE 275
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 27/206 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRA----KDKRTDEIVALKRLK---MEKEKEGFPITSLREINT 414
EFK + + G +G VY+ + ++ VA+K L+ K + L E
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYV 70
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
+ +P++ + I + + ++ + L++ +R K + Q
Sbjct: 71 MASVDNPHVCRLLGICLT---STVQLITQLMPFG--CLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT------PIVV 528
+ + +L D ++HRDL N+L+ +K+ DFGLA+ G+ K Y PI
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK- 184
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVG 554
W + E +L Y+ D+WS G
Sbjct: 185 --WM-ALESILHRI-YTHQSDVWSYG 206
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 4e-21
Identities = 61/235 (25%), Positives = 116/235 (49%), Gaps = 27/235 (11%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAK---DKRTDEIVALKRLK----MEKEKEGFPITSLR-E 411
E F+ L + +G YG V++ + T +I A+K LK + K+ + E
Sbjct: 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD---TAHTKAE 71
Query: 412 INTLLKAQHPNIVTVREIVVGS--NMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPG 466
N L + +HP IV + + K++++++Y+ E L + ++ +F+
Sbjct: 72 RNILEEVKHPFIVDLI----YAFQTGGKLYLILEYLSGGE-----LFMQL-EREGIFMED 121
Query: 467 EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526
+ ++ A+ HLH I++RDLK N++L+H+G +K+ DFGL +E
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181
Query: 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
T+ Y +PE+L+ ++ +D WS+G + + L P FTG++ + + +I K
Sbjct: 182 CGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 6e-21
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR-EINTLLKA 418
+++F L I G+Y V + K+TD I A+K +K E + I ++ E + +A
Sbjct: 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 419 -QHPNIVTVREIVVGS--NMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLM 472
HP +V + ++F V++YV + LM M +++ +
Sbjct: 67 SNHPFLVGLH----SCFQTESRLFFVIEYVNGGD-----LMFHM-QRQRKLPEEHARFYS 116
Query: 473 QQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWY 532
++ A+ +LH+ I++RDLK N+LL G +K+ D+G+ +E P + T Y
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ 575
+PE+L G ++Y +D W++G + E + F +
Sbjct: 177 IAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 74/310 (23%), Positives = 130/310 (41%), Gaps = 57/310 (18%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAK---DKRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
+F+ L + +G++G V+ K ++ A+K LK K + + E + L+
Sbjct: 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 417 KAQHPNIVTVREIVVGS--NMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCL 471
+ HP IV + + K+++++D++ + L T SK+ +F +VK
Sbjct: 82 EVNHPFIVKLH----YAFQTEGKLYLILDFLRGGD-----LF-TRLSKEVMFTEEDVKFY 131
Query: 472 MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
+ +L A+ HLH I++RDLK N+LL G +K+ DFGL++E K T+
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591
Y +PE++ + ++ D WS G + E L F GK E ++ I K
Sbjct: 192 YMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK---------- 240
Query: 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TAD 646
K+ ++ L+ LL +P R+ +
Sbjct: 241 ---------AKLGMPQF--------------LSPEAQSLLRMLFKRNPANRLGAGPDGVE 277
Query: 647 EALRHDYFSE 656
E RH +FS
Sbjct: 278 EIKRHSFFST 287
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-20
Identities = 61/307 (19%), Positives = 113/307 (36%), Gaps = 52/307 (16%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR-EINTLLKA 418
+ +F L + +G++G V ++ K TDE+ A+K LK + + + E L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 419 -QHPNIVTVREIVVGS--NMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQ 474
+ P + + MD+++ VM+YV D LM + + F +
Sbjct: 78 GKPPFLTQLH----SCFQTMDRLYFVMEYVNGGD---LMYHI-QQVGRFKEPHAVFYAAE 129
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRS 534
+ + L I++RDLK N++L G +K+ DFG+ +E T Y +
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 189
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
PE++ + Y +D W+ G + E L + F G+ + E I +
Sbjct: 190 PEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHNV---- 238
Query: 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEAL 649
YP +++ + +T P R+ +
Sbjct: 239 ------------AYP-----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275
Query: 650 RHDYFSE 656
H +F
Sbjct: 276 EHAFFRY 282
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
E + I G +G+V+ D+ VA+K ++ M +E F + E ++K
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--F----IEEAEVMMKL 60
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HP +V + V I +V +++EH L + +R+++ +F + + +
Sbjct: 61 SHPKLV--QLYGVCLEQAPICLVTEFMEHG--CLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYR 533
+A+L + ++HRDL N L+ ++KV DFG+ R +Y S P+ W
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK---WA- 172
Query: 534 SPELLLGCKEYSTPIDMWSVG 554
SPE+ + YS+ D+WS G
Sbjct: 173 SPEVFSFSR-YSSKSDVWSFG 192
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 18/229 (7%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR-EINTLLKA 418
++ F+ + + +G++G V A+ K T ++ A+K LK + + + E L A
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 419 -QHPNIVTVREIVVGS--NMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLM 472
HP + + D++F VM++V + LM + K + F +
Sbjct: 81 RNHPFLTQLF----CCFQTPDRLFFVMEFVNGGD-----LMFHI-QKSRRFDEARARFYA 130
Query: 473 QQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWY 532
++++A+ LHD I++RDLK N+LL H G K+ DFG+ +E T Y
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581
+PE+L Y +D W++G + E LC F +++ + I
Sbjct: 191 IAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 59/264 (22%), Positives = 117/264 (44%), Gaps = 19/264 (7%)
Query: 320 PNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCR-SVEEFKCLNRIEEGTYGVV 378
++ + + ++ + IE EK+ + +++F L I G+Y V
Sbjct: 9 HHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKV 68
Query: 379 YRAKDKRTDEIVALKRLKMEKEKEGFPITSLR-EINTLLKA-QHPNIVTVREIVVGS--N 434
+ K+TD I A++ +K E + I ++ E + +A HP +V +
Sbjct: 69 LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH----SCFQT 124
Query: 435 MDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491
++F V++YV + LM M +++ + ++ A+ +LH+ I++RD
Sbjct: 125 ESRLFFVIEYVNGGD-----LMFHM-QRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 178
Query: 492 LKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMW 551
LK N+LL G +K+ D+G+ +E P + T Y +PE+L G ++Y +D W
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWW 237
Query: 552 SVGCIFAEFLCMEPLFTGKSDLEQ 575
++G + E + F +
Sbjct: 238 ALGVLMFEMMAGRSPFDIVGSSDN 261
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 28/201 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+E K L I +G +G V + VA+K +K + + F L E + + + +H
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAF----LAEASVMTQLRHS 74
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVA 480
N+V + V+ ++IV +Y+ SL++ +RS+ + V + + A+
Sbjct: 75 NLVQL-LGVIVEEKGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-----YGS--PLKHYTPIVVTLWYR 533
+L N +HRDL N+L+S + KV DFGL +E P+K W
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---------WT- 181
Query: 534 SPELLLGCKEYSTPIDMWSVG 554
+PE L K +ST D+WS G
Sbjct: 182 APEALREKK-FSTKSDVWSFG 201
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 6e-20
Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME--KEKEGFPITSLREINTLLK 417
++ +F I G +G VY + T ++ A+K L + K K+G + L E L
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSL 245
Query: 418 ---AQHPNIVTVREIVVGS--NMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL 471
P IV + + DK+ ++D + D+ + S+ VF +++
Sbjct: 246 VSTGDCPFIVCMS----YAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFY 297
Query: 472 MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLW 531
+++ + H+H+ ++++RDLK +N+LL G +++ D GLA + S K + V T
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD-FSKKKPHA-SVGTHG 355
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG--KSDLEQLSR 578
Y +PE+L Y + D +S+GC+ + L F D ++ R
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 7e-20
Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 24/202 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
+ +++ G YG VY K+ VA+K LK ME E+ F L+E + +
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--F----LKEAAVMKEI 273
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLN 477
+HPN+V + + V + +I+ +++ + +L++ +R +Q + + Q+ +
Sbjct: 274 KHPNLV--QLLGVCTREPPFYIITEFMTYG--NLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWY 532
A+ +L +HR+L N L+ ++KV DFGL+R Y + PI W
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWT 386
Query: 533 RSPELLLGCKEYSTPIDMWSVG 554
PE L ++S D+W+ G
Sbjct: 387 A-PESLA-YNKFSIKSDVWAFG 406
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
EE L + G +GVV K K + VA+K +K M +++ F +E T++K
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDE--F----FQEAQTMMKL 60
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HP +V + V S I+IV +Y+ + L+ +RS + P ++ + +
Sbjct: 61 SHPKLV--KFYGVCSKEYPIYIVTEYISNG--CLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYR 533
+A L + +HRDL N L+ +KV DFG+ R +Y S + P+ W
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK---WS- 172
Query: 534 SPELLLGCKEYSTPIDMWSVG 554
+PE+ K YS+ D+W+ G
Sbjct: 173 APEVFHYFK-YSSKSDVWAFG 192
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
+ +++ G YG VY K+ VA+K LK ME E+ F L+E + +
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--F----LKEAAVMKEI 66
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLN 477
+HPN+V + + V + +I+ +++ + +L++ +R +Q + + Q+ +
Sbjct: 67 KHPNLV--QLLGVCTREPPFYIITEFMTYG--NLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL----WYR 533
A+ +L +HRDL N L+ ++KV DFGL+R YT W
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT- 179
Query: 534 SPELLLGCKEYSTPIDMWSVG 554
+PE L K +S D+W+ G
Sbjct: 180 APESLAYNK-FSIKSDVWAFG 199
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLK---MEKEKEGFPITSLREINTL 415
I G G V + + + VA+K LK E+++ F L E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIM 104
Query: 416 LKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
+ HPNI+ R V + IV +Y+E+ SL +R+ F ++ +++ +
Sbjct: 105 GQFDHPNII--RLEGVVTRGRLAMIVTEYMEN--GSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYT------PIVV 528
+ +L D +HRDL N+L+ + KV DFGL+R P YT PI
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI-- 218
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVG 554
W +PE + +S+ D+WS G
Sbjct: 219 -RWT-APEAIAFRT-FSSASDVWSFG 241
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
++ L + G +GVV K + + VA+K +K M +++ F + E ++
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE--F----IEEAKVMMNL 76
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
H +V + V + IFI+ +Y+ + L+ +R + F ++ + + + A
Sbjct: 77 SHEKLV--QLYGVCTKQRPIFIITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWYR 533
+ +L LHRDL N L++ +G++KV DFGL+R EY S + P+ W
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWS- 188
Query: 534 SPELLLGCKEYSTPIDMWSVG 554
PE+L+ K +S+ D+W+ G
Sbjct: 189 PPEVLMYSK-FSSKSDIWAFG 208
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+E K L I +G +G V + VA+K +K + + F L E + + + +H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAF----LAEASVMTQLRHS 246
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVA 480
N+V + V+ ++IV +Y+ SL++ +RS+ + V + + A+
Sbjct: 247 NLVQL-LGVIVEEKGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYTPIVVTLWYRSPELLL 539
+L N +HRDL N+L+S + KV DFGL +E + P+ W +PE L
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---WT-APEALR 359
Query: 540 GCKEYSTPIDMWSVG 554
K +ST D+WS G
Sbjct: 360 EKK-FSTKSDVWSFG 373
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLK---MEKEKEGFPITSLREINTL 415
+ G +G V + K + VA+K LK EK++ F L E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIM 100
Query: 416 LKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
+ HPNI+ R V + + IV +Y+E+ SL +R F ++ +++ +
Sbjct: 101 GQFDHPNII--RLEGVVTKSKPVMIVTEYMEN--GSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIVV 528
+ + +L D +HRDL N+L++ + KV DFGL R + PI
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI-- 214
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVG 554
W SPE + K +++ D+WS G
Sbjct: 215 -RWT-SPEAIAYRK-FTSASDVWSYG 237
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRA----KDKRTDEIVALKRLK---MEKEKEGFPITSLREINT 414
EFK + + G +G VY+ + ++ VA+K L+ K + L E
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYV 70
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
+ +P++ + I + + ++ + L++ +R K + Q
Sbjct: 71 MASVDNPHVCRLLGICLT---STVQLITQLMPFG--CLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT------PIVV 528
+ + +L D ++HRDL N+L+ +K+ DFGLA+ G+ K Y PI
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK- 184
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVG 554
W + E +L + Y+ D+WS G
Sbjct: 185 --WM-ALESIL-HRIYTHQSDVWSYG 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 77/365 (21%), Positives = 147/365 (40%), Gaps = 67/365 (18%)
Query: 313 RKKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEE 372
++ +S + +Q + ++ EL L + + +E F+ L +
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKV----GIENFELLKVLGT 64
Query: 373 GTYGVVYRAK---DKRTDEIVALKRLK----MEKEKEGFPITSLREINTLLKAQH-PNIV 424
G YG V+ + T ++ A+K LK ++K K + R++ L + P +V
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV--LEHIRQSPFLV 122
Query: 425 TVREIVVGS--NMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
T+ + K+ +++DY+ E L + +++ F EV+ + +++ A+
Sbjct: 123 TLH----YAFQTETKLHLILDYINGGE-----LFTHLS-QRERFTEHEVQIYVGEIVLAL 172
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE--YGSPLKHYTPIVVTLWYRSPEL 537
HLH I++RD+K N+LL G + + DFGL++E + Y T+ Y +P++
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDI 231
Query: 538 LLGCKE-YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596
+ G + +D WS+G + E L FT + + I +I
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-------RRILKSEPP 284
Query: 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRH 651
P ++ L DL+ + L DP R+ ADE H
Sbjct: 285 YP----------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322
Query: 652 DYFSE 656
+F +
Sbjct: 323 LFFQK 327
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 38/217 (17%), Positives = 75/217 (34%), Gaps = 43/217 (19%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEI-------VALKRLK---MEKEKEGFPITSLRE 411
E+ + +GT+ +++ + + V LK L + F
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-F----FEA 62
Query: 412 INTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCL 471
+ + K H ++V V D+ +V ++V+ SL ++ K +
Sbjct: 63 ASMMSKLSHKHLV--LNYGVCVCGDENILVQEFVKFG--SLDTYLKKNKNCINILWKLEV 118
Query: 472 MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG--------ILKVGDFGLARE------YG 517
+QL A+ L +N ++H ++ N+LL +K+ D G++
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVG 554
+ W PE + K + D WS G
Sbjct: 179 ERIP---------WV-PPECIENPKNLNLATDKWSFG 205
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEI----VALKRLK---MEKEKEGFPITSLREINT 414
I G +G VY+ K + VA+K LK EK++ F L E
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGI 99
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
+ + H NI+ R V S + I+ +Y+E+ +L + +R K F ++ +++
Sbjct: 100 MGQFSHHNII--RLEGVISKYKPMMIITEYMEN--GALDKFLREKDGEFSVLQLVGMLRG 155
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIV 527
+ + +L + +HRDL N+L++ + KV DFGL+R + PI
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI- 214
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVG 554
W +PE + K +++ D+WS G
Sbjct: 215 --RWT-APEAISYRK-FTSASDVWSFG 237
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-19
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREI------- 412
+F L I +G++G V A+ K + A+K L+ K+ I +E
Sbjct: 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKA----ILKKKEEKHIMSER 89
Query: 413 NTLLKA-QHPNIVTVREIVVGS--NMDKIFIVMDYV---EHDMKSLMETMRSKKQVFIPG 466
N LLK +HP +V + S DK++ V+DY+ E L + +++ F+
Sbjct: 90 NVLLKNVKHPFLVGLH----FSFQTADKLYFVLDYINGGE-----LFYHL-QRERCFLEP 139
Query: 467 EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526
+ ++ +A+ +LH I++RDLK N+LL +G + + DFGL +E +
Sbjct: 140 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF 199
Query: 527 VVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK 570
T Y +PE+L + Y +D W +G + E L P F +
Sbjct: 200 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 26/195 (13%)
Query: 372 EGTYGVVYRAKDKRTDEI--VALKRLK---MEKEKEGFPITSLREINTLLKAQHPNIVTV 426
G +G V + + + VA+K LK + + E +RE + + +P IV +
Sbjct: 20 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYIVRL 75
Query: 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW 486
+ + + +VM+ L + + K++ V L+ Q+ + +L +
Sbjct: 76 IGVCQA---EALMLVMEMAGGG--PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 487 ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIVVTLWYRSPELLL 539
+HRDL N+LL +R K+ DFGL++ G+ +YT P+ WY +PE +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWY-APECIN 186
Query: 540 GCKEYSTPIDMWSVG 554
K +S+ D+WS G
Sbjct: 187 FRK-FSSRSDVWSYG 200
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRA--KDKRTDEI-VALKRLKM-----EKEKEGFPITSLREIN 413
++ + L ++ +G++GVV R + VA+K LK + + F +RE+N
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF----IREVN 73
Query: 414 TLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ 473
+ H N++ + +V+ + +V + SL++ +R + F+ G +
Sbjct: 74 AMHSLDHRNLIRLYGVVLT---PPMKMVTELAPLG--SLLDRLRKHQGHFLLGTLSRYAV 128
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PI 526
Q+ + +L +HRDL NLLL+ R ++K+GDFGL R HY P
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 527 VVTLWYRSPELLLGCKEYSTPIDMWSVG 554
W +PE L +S D W G
Sbjct: 189 A---WC-APESLKTRT-FSHASDTWMFG 211
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEI---VALKRLK---MEKEKEGFPITSLREINTL 415
E + I EG +G V++ + VA+K K + +E F L+E T+
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF----LQEALTM 70
Query: 416 LKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
+ HP+IV + ++ + ++I+M+ L ++ +K + QL
Sbjct: 71 RQFDHPHIVKLIGVITEN---PVWIIMELCTLG--ELRSFLQVRKYSLDLASLILYAYQL 125
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTL 530
A+A+L +HRD+ N+L+S +K+GDFGL+R Y K PI
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---K 182
Query: 531 WYRSPELLLGCKEYSTPIDMWSVG 554
W +PE + + +++ D+W G
Sbjct: 183 WM-APESIN-FRRFTSASDVWMFG 204
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRA--KDKRTDEI-VALKRLK---MEKEKEGFPITSLREINTL 415
E+ + EG +G VY + + ++I VA+K K KE F + E +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIM 67
Query: 416 LKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
HP+IV + I+ +I+M+ + L + K + Q+
Sbjct: 68 KNLDHPHIVKLIGIIEEEP---TWIIMELYPY--GELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL----W 531
A+A+L +HRD+ N+L++ +K+GDFGL+R + Y VT W
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVTRLPIKW 180
Query: 532 YRSPELLLGCKEYSTPIDMWSVG 554
SPE + + ++T D+W
Sbjct: 181 M-SPESINFRR-FTTASDVWMFA 201
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
E + ++ +G +G V+ T VA+K LK M E F L+E + K
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA--F----LQEAQVMKKL 236
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLN 477
+H +V + +V + I+IV +Y+ SL++ ++ + + ++ + Q+ +
Sbjct: 237 RHEKLVQLYAVVSE---EPIYIVTEYMSKG--SLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWY 532
+A++ +HRDL+ +N+L+ + KV DFGLAR EY + PI W
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWT 348
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAE 559
+PE L ++ D+WS G + E
Sbjct: 349 -APEAAL-YGRFTIKSDVWSFGILLTE 373
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQH 420
E K ++ G +G V+ A + + VA+K +K E F L E N + QH
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAF----LAEANVMKTLQH 242
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAV 479
+V + +V + I+I+ +++ SL++ ++S + ++ Q+ +
Sbjct: 243 DKLVKLHAVVTK---EPIYIITEFMAKG--SLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL----WYRSP 535
A + +HRDL+ +N+L+S + K+ DFGLAR YT W +P
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWT-AP 354
Query: 536 ELLLGCKEYSTPIDMWSVG 554
E + ++ D+WS G
Sbjct: 355 EAINFGS-FTIKSDVWSFG 372
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 5e-18
Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 26/198 (13%)
Query: 369 RIEEGTYGVVYRA--KDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
+ G +G V + + ++ VA+K LK + + E +RE + + +P I
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYI 398
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
V + + + +VM+ L + + K++ V L+ Q+ + +L
Sbjct: 399 VRLIGVCQAEAL---MLVMEMAGGG--PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 453
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-------PIVVTLWYRSPE 536
+ +HR+L N+LL +R K+ DFGL++ G+ +YT P+ WY +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWY-APE 509
Query: 537 LLLGCKEYSTPIDMWSVG 554
+ +++S+ D+WS G
Sbjct: 510 CIN-FRKFSSRSDVWSYG 526
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
E K + R+ G +G V+ + VA+K LK M + F L E N + +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA--F----LAEANLMKQL 65
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQLLN 477
QH +V + +V + I+I+ +Y+E+ SL++ +++ ++ + Q+
Sbjct: 66 QHQRLVRLYAVVTQ---EPIYIITEYMENG--SLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL----WYR 533
+A + + +HRDL+ +N+L+S K+ DFGLAR YT W
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWT- 177
Query: 534 SPELLLGCKEYSTPIDMWSVG 554
+PE + ++ D+WS G
Sbjct: 178 APEAINYGT-FTIKSDVWSFG 197
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 43/274 (15%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH-PN 422
F+ +I G +G + K+ T+E VA+K +E K P E +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAP-QLHLEYRFYKQLGSGDG 66
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
I V G +V++ + SL + + F V + QL++ + ++
Sbjct: 67 IPQVYYF--GPCGKYNAMVLELLG---PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 483 HDNWILHRDLKTSNLLLSHRG-----ILKVGDFGLAREYGSP--LKHY-----TPIVVTL 530
H +++RD+K N L+ G ++ + DF LA+EY P KH + T
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 531 WYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG---------KSDLEQLSRIFK 581
Y S LG KE S D+ ++G +F FL G + E+ +I
Sbjct: 182 RYMSINTHLG-KEQSRRDDLEALGHMFMYFL------RGSLPWQGLKADTLKERYQKIGD 234
Query: 582 T-MGTPNEKI---WPGFSK-LPAVQKMTFAEYPN 610
T TP E + +P + L V+++ F E P+
Sbjct: 235 TKRATPIEVLCENFPEMATYLRYVRRLDFFEKPD 268
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 52/316 (16%), Positives = 100/316 (31%), Gaps = 56/316 (17%)
Query: 344 EKDTLPPYLPA--IQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK 401
P + ++ +I G +G++Y A E A +K+E ++
Sbjct: 17 NLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE 76
Query: 402 EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI-----------------FIVMDY 444
G E+ + + + + I F+VM+
Sbjct: 77 NG---PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER 133
Query: 445 VEHDMKSLMETMR--SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502
+ D++ + K V L ++L+ + ++H+N +H D+K +NLLL ++
Sbjct: 134 LGIDLQKISGQNGTFKKSTVL------QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187
Query: 503 GILKV--GDFGLAREYGSPLKH-------YTPIVVTLWYRSPELLLGCKEYSTPIDMWSV 553
+V D+GL+ Y H T+ + S + G S D+ +
Sbjct: 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEIL 246
Query: 554 GCIFAEFLC---------MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK-----LPA 599
G +LC +P+ + L L
Sbjct: 247 GYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDE--LPQSVLKWAPSGSSCCEIAQFLVC 304
Query: 600 VQKMTFAEYPNVGGLK 615
+ + E PN LK
Sbjct: 305 AHSLAYDEKPNYQALK 320
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 48/193 (24%), Positives = 87/193 (45%), Gaps = 22/193 (11%)
Query: 372 EGTYGVVYRA--KDKRTDEIVALKRLK---MEKE-KEGFPITSLREINTLLKAQHPNIVT 425
G +G V + + K+ + VA+K LK + K+ L E N + + +P IV
Sbjct: 27 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL----LAEANVMQQLDNPYIVR 82
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+ I + +VM+ E L + ++ + V + L+ Q+ + +L ++
Sbjct: 83 MIGICEA---ESWMLVMEMAELG--PLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLEES 136
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL----WYRSPELLLGC 541
+HRDL N+LL + K+ DFGL++ + +Y WY +PE +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYY 195
Query: 542 KEYSTPIDMWSVG 554
K +S+ D+WS G
Sbjct: 196 K-FSSKSDVWSFG 207
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 30/209 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKA 418
E + ++ +G +G V+ T VA+K LK M E F L+E + K
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA--F----LQEAQVMKKL 319
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ---QL 475
+H +V + +V + I+IV +Y+ SL++ ++ + ++ + L+ Q+
Sbjct: 320 RHEKLVQLYAVVSE---EPIYIVTEYMSKG--SLLDFLKGETGKYLR--LPQLVDMAAQI 372
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTL 530
+ +A++ +HRDL+ +N+L+ + KV DFGLAR EY + PI
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---K 429
Query: 531 WYRSPELLLGCKEYSTPIDMWSVGCIFAE 559
W +PE L ++ D+WS G + E
Sbjct: 430 WT-APEAAL-YGRFTIKSDVWSFGILLTE 456
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 57/262 (21%), Positives = 110/262 (41%), Gaps = 26/262 (9%)
Query: 305 KKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLPPYLPAIQGCR-SVEE 363
+++ + N ++ V H + + D E+ + +P+ + E
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391
Query: 364 FKCLNRIEEGTYGVVYRA--KDKRTDEI-VALKRLK---MEKEKEGFPITSLREINTLLK 417
+ I EG +G V++ + VA+K K + +E F L+E T+ +
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF----LQEALTMRQ 447
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
HP+IV + ++ + + +I+M+ L ++ +K + QL
Sbjct: 448 FDHPHIVKLIGVITENPV---WIIMELCTLG--ELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR-----EYGSPLKHYTPIVVTLWY 532
A+A+L +HRD+ N+L+S +K+GDFGL+R Y K PI W
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWM 559
Query: 533 RSPELLLGCKEYSTPIDMWSVG 554
+PE + + +++ D+W G
Sbjct: 560 -APESIN-FRRFTSASDVWMFG 579
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 42/206 (20%), Positives = 84/206 (40%), Gaps = 27/206 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLK---MEKEKEGFPITSLREINT 414
E + L + G +G V++ + V +K ++ + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV----TDHMLA 68
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
+ H +IV + + GS + +V Y+ SL++ +R + P + Q
Sbjct: 69 IGSLDHAHIVRLLGLCPGS---SLQLVTQYLPLG--SLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR------EYGSPLKHYTPIVV 528
+ + +L ++ ++HR+L N+LL ++V DFG+A + + TPI
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI-- 181
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVG 554
W + E + K Y+ D+WS G
Sbjct: 182 -KWM-ALESIHFGK-YTHQSDVWSYG 204
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 63/272 (23%), Positives = 108/272 (39%), Gaps = 30/272 (11%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH-PN 422
++ +I G++G +Y D E VA+K +E K P E Q
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHP-QLHIESKIYKMMQGGVG 66
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
I T+R G+ D +VM+ + SL + + F V L Q+++ + ++
Sbjct: 67 IPTIRWC--GAEGDYNVMVMELLG---PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 483 HDNWILHRDLKTSNLLL---SHRGILKVGDFGLAREYGS-------PLKHYTPIVVTLWY 532
H +HRD+K N L+ ++ + DFGLA++Y P + + T Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCME---PLFTGKSDLEQLSRIFKT-MGTPNE 588
S LG E S D+ S+G + F + ++ RI + M TP E
Sbjct: 182 ASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240
Query: 589 KIWPGFSK-----LPAVQKMTFAEYPNVGGLK 615
+ G+ L + + F + P+ L+
Sbjct: 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 272
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 51/220 (23%), Positives = 81/220 (36%), Gaps = 55/220 (25%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLK--AQHP 421
G +G V A VA+K LK E+E + E+ +L H
Sbjct: 33 AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL----MSELK-VLSYLGNHM 87
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMR-------SKKQVFIPGEVKCLMQ 473
NIV + + ++ +Y + D+ + + R + + E+ ++
Sbjct: 88 NIV--NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 474 QLL-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526
LL +A L +HRDL N+LL+H I K+ DFGLAR+ I
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD----------I 195
Query: 527 VVTLWYR------------SPELLLGCKEYSTPIDMWSVG 554
Y +PE + C Y+ D+WS G
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYG 234
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 44/280 (15%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH-PN 422
+K RI EG++GV++ + ++ VA+K E + P E T
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAP-QLRDEYRTYKLLAGCTG 67
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
I V G +V+D + SL + + + F V +Q+L V +
Sbjct: 68 IPNVYYF--GQEGLHNVLVIDLLG---PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 483 HDNWILHRDLKTSNLLL-----SHRGILKVGDFGLAREYGS-------PLKHYTPIVVTL 530
H+ +++RD+K N L+ + ++ V DFG+ + Y P + + T
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 531 WYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG---------KSDLEQLSRIFK 581
Y S LG +E S D+ ++G +F FL G ++ ++ RI +
Sbjct: 183 RYMSINTHLG-REQSRRDDLEALGHVFMYFL------RGSLPWQGLKAATNKQKYERIGE 235
Query: 582 T-MGTPNEKIWPGFSK-----LPAVQKMTFAEYPNVGGLK 615
TP ++ GF + + + + F P+ L+
Sbjct: 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 275
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 349 PPYLPAIQGCRSVEEFKCLNRIE---EGTYGVVYRA--KDKRTDEI-VALKRLK---MEK 399
P + A+Q ++ E G +G VY D +I A+K L
Sbjct: 9 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68
Query: 400 EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSK 459
E F L E + HPN++++ + + +V+ Y++H L +R++
Sbjct: 69 EVSQF----LTEGIIMKDFSHPNVLSL-LGICLRSEGSPLVVLPYMKHG--DLRNFIRNE 121
Query: 460 KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR----- 514
++ Q+ + +L +HRDL N +L + +KV DFGLAR
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181
Query: 515 EYGSPLKHYT---PIVVTLWYRSPELLLGCKEYSTPIDMWSVG 554
EY S P+ W + E L ++++T D+WS G
Sbjct: 182 EYYSVHNKTGAKLPV---KWM-ALESLQ-TQKFTTKSDVWSFG 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 37/159 (23%), Positives = 72/159 (45%), Gaps = 21/159 (13%)
Query: 372 EGTYGVVYRAKDKRTDE-----IVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
+G++G+VY K + VA+K + +E+ F L E + + + ++
Sbjct: 35 QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF----LNEASVMKEFNCHHV 90
Query: 424 VTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV--- 479
V R + V S ++M+ + D+KS + ++R L + + A
Sbjct: 91 V--RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 480 ---AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515
A+L+ N +HRDL N +++ +K+GDFG+ R+
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 29/227 (12%)
Query: 345 KDTLPPYLPAIQGC---RSVEEFKCLNRIEEGTYGVVYRA--KDKRTDEI-VALKRLK-- 396
+D L ++ I +G +GVVY D+ + I A+K L
Sbjct: 1 RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 397 -MEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMET 455
++ E F LRE + HPN++ + ++ +++ Y+ H L++
Sbjct: 61 TEMQQVEAF----LREGLLMRGLNHPNVLAL-IGIMLPPEGLPHVLLPYMCHG--DLLQF 113
Query: 456 MRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR- 514
+RS ++ ++ Q+ + +L + +HRDL N +L +KV DFGLAR
Sbjct: 114 IRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
Query: 515 ----EYGSPLKHYT---PIVVTLWYRSPELLLGCKEYSTPIDMWSVG 554
EY S +H P+ W + E L + ++T D+WS G
Sbjct: 174 ILDREYYSVQQHRHARLPVK---WT-ALESLQTYR-FTTKSDVWSFG 215
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 31/224 (13%)
Query: 349 PPYLPAIQGCRSVEEFKCLNRIE---EGTYGVVYRA--KDKRTDEI-VALKRLK---MEK 399
P + A+Q ++ E G +G VY D +I A+K L
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132
Query: 400 EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRS 458
E F L E + HPN++++ + + +V+ Y++H D+++ + R+
Sbjct: 133 EVSQF----LTEGIIMKDFSHPNVLSL-LGICLRSEGSPLVVLPYMKHGDLRNFI---RN 184
Query: 459 KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR---- 514
+ ++ Q+ + L +HRDL N +L + +KV DFGLAR
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 515 -EYGSPLKHYT---PIVVTLWYRSPELLLGCKEYSTPIDMWSVG 554
E+ S P+ W + E L ++++T D+WS G
Sbjct: 245 KEFDSVHNKTGAKLPV---KWM-ALESLQ-TQKFTTKSDVWSFG 283
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 43/218 (19%), Positives = 81/218 (37%), Gaps = 52/218 (23%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLK-AQHPN 422
G +G V A T VA+K LK E + E+ L+ H N
Sbjct: 37 RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELKILIHIGHHLN 92
Query: 423 IVTVREIVVGSNMDK-IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL-----MQQL 475
+V + + + +++++ + ++ + + + R++ + ++ L
Sbjct: 93 VV--NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 476 L-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVV 528
+ + L +HRDL N+LLS + ++K+ DFGLAR+ I
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD----------IYK 200
Query: 529 TLWYR------------SPELLLGCKEYSTPIDMWSVG 554
Y +PE + Y+ D+WS G
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFG 237
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 43/219 (19%), Positives = 84/219 (38%), Gaps = 53/219 (24%)
Query: 372 EGTYGVVYRAK-------DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLK-AQH 420
EG +G V A+ + VA+K LK EK+ + E+ + +H
Sbjct: 45 EGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIGKH 100
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL-----MQQ 474
NI+ + + ++++++Y +++ + R + + +
Sbjct: 101 KNII--NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 475 LL-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
L+ + +L +HRDL N+L++ ++K+ DFGLAR+ I
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD----------IN 208
Query: 528 VTLWYR------------SPELLLGCKEYSTPIDMWSVG 554
+Y+ +PE L Y+ D+WS G
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 246
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 36/164 (21%), Positives = 71/164 (43%), Gaps = 20/164 (12%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDE---IVALKRLK----MEKEKEGFPITSLREINTLLKAQ 419
+ +G +G V A+ K+ D VA+K LK + E F LRE + +
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF----LREAACMKEFD 83
Query: 420 HPNIVT----VREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQ- 473
HP++ + +++ +++H D+ + + R + F ++ L++
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL-PLQTLVRF 142
Query: 474 --QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515
+ + +L +HRDL N +L+ + V DFGL+R+
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 36/209 (17%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
E +G VY+ + VA+K LK +E F E + QHPN+
Sbjct: 19 EDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF----RHEAMLRARLQHPNV 74
Query: 424 VTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL-----MQQLLN 477
V + V + + ++ Y H D+ + V + + + ++
Sbjct: 75 V--CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 478 AV-------AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYTPIVVT 529
V +L + ++H+DL T N+L+ + +K+ D GL RE Y + +Y + +
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA--DYYKLLGNS 190
Query: 530 L----WYRSPELLLGCKEYSTPIDMWSVG 554
L W +PE ++ K +S D+WS G
Sbjct: 191 LLPIRWM-APEAIMYGK-FSIDSDIWSYG 217
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 62/318 (19%), Positives = 113/318 (35%), Gaps = 52/318 (16%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRT--------DEIVALK------RLKMEKE--KEGFP 405
++K + G++Y A T + +LK RL E+ +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 406 ITSLREINTLLKAQHPNIVTVREIVVGSNMDKI-FIVMDYVEHDMKSLMETMRSKKQVFI 464
+ + L I T G + DK F+V+ + ++S ++ S K V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGF--GVHQDKYRFLVLPSLGRSLQSALD--VSPKHVLS 157
Query: 465 PGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL--SHRGILKVGDFGLAREYGSPLKH 522
V + +LL+A+ LH+N +H ++ N+ + + + + +G A Y KH
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 523 -------YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPL----FTGKS 571
+P L + S +L GC S D+ S+G ++L L +
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGF-LPWTNCLPNT 275
Query: 572 DLEQLSRI-FKTMGTPNEKIWPGFSKLPA--------VQKMTFAEYPNVGGLKTKVAGSI 622
+ + F P + + V +T+ E P L+ +
Sbjct: 276 EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLR-----NN 330
Query: 623 LTELGYDLLCKFLTYDPV 640
L L DL + YDP+
Sbjct: 331 LEALLQDL--RVSPYDPI 346
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 44/224 (19%), Positives = 82/224 (36%), Gaps = 58/224 (25%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
EG +G V +A + VA+K LK E L E N L + HP++
Sbjct: 33 EGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFNVLKQVNHPHV 88
Query: 424 VTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL----------- 471
+ + S + ++++Y ++ ++ + R ++
Sbjct: 89 I--KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 472 --MQQLL-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522
M L+ + +L + ++HRDL N+L++ +K+ DFGL+R+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD------- 199
Query: 523 YTPIVVTLWYR------------SPELLLGCKEYSTPIDMWSVG 554
+ Y + E L Y+T D+WS G
Sbjct: 200 ---VYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFG 239
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 50/216 (23%), Positives = 83/216 (38%), Gaps = 51/216 (23%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLK--AQHP 421
G +G V A + VA+K LK EKE + E+ ++ QH
Sbjct: 56 AGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELK-IMSHLGQHE 110
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEH-DMKS-LMETMRSKKQVFIPGEVKCL--MQQLL- 476
NIV + ++ + ++ +Y + D+ + L R + + LL
Sbjct: 111 NIV--NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 477 ------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL 530
+A L +HRD+ N+LL++ + K+GDFGLAR+ I+
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD----------IMNDS 218
Query: 531 WYR------------SPELLLGCKEYSTPIDMWSVG 554
Y +PE + C Y+ D+WS G
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYG 253
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 36/206 (17%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
G +G VY + + + VA+K L E+++ F L E + K H NI
Sbjct: 40 HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKFNHQNI 95
Query: 424 VTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQ---QLLNAV 479
V R I V FI+M+ + D+KS + R + + L+ +
Sbjct: 96 V--RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 480 AHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLARE------YGSPLKHYTPIVVTL 530
+L +N +HRD+ N LL+ G + K+GDFG+AR+ Y P+
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV---- 209
Query: 531 WYR--SPELLLGCKEYSTPIDMWSVG 554
+ PE + +++ D WS G
Sbjct: 210 --KWMPPEAFMEGI-FTSKTDTWSFG 232
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 55/220 (25%)
Query: 372 EGTYGVVYRA------KDKRTDEI-VALKRLK---MEKEKEGFPITSLREINTLLK--AQ 419
EG +G V A KDK VA+K LK EK+ + E+ ++K +
Sbjct: 79 EGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL----ISEME-MMKMIGK 133
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL-----MQ 473
H NI+ + + ++++++Y +++ ++ R + +
Sbjct: 134 HKNII--NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 474 QLL-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI 526
L+ + +L +HRDL N+L++ ++K+ DFGLAR+ I
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD----------I 241
Query: 527 VVTLWYR------------SPELLLGCKEYSTPIDMWSVG 554
+Y+ +PE L Y+ D+WS G
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFG 280
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK--MEKEKEGFPITSLREINTLLKAQHPNIV 424
EG +G V+ A+ ++ +VA+K LK E ++ F RE L QH +IV
Sbjct: 51 EGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF----QREAELLTMLQHQHIV 106
Query: 425 TVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL----MQQLLNAV 479
R V + + +V +Y+ H D+ + + ++ GE + QLL
Sbjct: 107 --RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 480 -------AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515
+L +HRDL T N L+ ++K+GDFG++R+
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 207
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 36/206 (17%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
G +G VY + + + VA+K L E+++ F L E + K H NI
Sbjct: 81 HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKFNHQNI 136
Query: 424 VTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQ---QLLNAV 479
V R I V FI+++ + D+KS + R + + L+ +
Sbjct: 137 V--RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 480 AHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLARE------YGSPLKHYTPIVVTL 530
+L +N +HRD+ N LL+ G + K+GDFG+AR+ Y P+
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV---- 250
Query: 531 WYR--SPELLLGCKEYSTPIDMWSVG 554
+ PE + +++ D WS G
Sbjct: 251 --KWMPPEAFMEGI-FTSKTDTWSFG 273
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 37/217 (17%)
Query: 362 EEFKCLNRIEEGTYGVVYRA--KDKRTDEIVALKRLK---MEKEKEGFPITSLREINTLL 416
+ K + I EG +G V +A K A+KR+K + + F E+ L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF----AGELEVLC 80
Query: 417 K-AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL--- 471
K HPNI+ + + +++ ++Y H ++ + R +
Sbjct: 81 KLGHHPNII--NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 472 --MQQLL-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR---EYGSP 519
QQLL + +L +HRDL N+L+ + K+ DFGL+R Y
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 520 LKHYTPIVVTLWYR--SPELLLGCKEYSTPIDMWSVG 554
P+ R + E L Y+T D+WS G
Sbjct: 199 TMGRLPV------RWMAIESLN-YSVYTTNSDVWSYG 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 60/225 (26%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLK--AQHP 421
G +G V A VA+K LK E+E + E+ ++ H
Sbjct: 55 SGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----MSELK-MMTQLGSHE 109
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMR-----------SKKQVFIPGEVK 469
NIV + + + I+++ +Y + D+ + + + R ++K++ ++
Sbjct: 110 NIVNL--LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 470 CL-MQQLL-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521
L + LL + L +HRDL N+L++H ++K+ DFGLAR+
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD------ 221
Query: 522 HYTPIVVTLWYR------------SPELLLGCKEYSTPIDMWSVG 554
I+ Y +PE L Y+ D+WS G
Sbjct: 222 ----IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYG 261
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 35/162 (21%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEI---VALKRLKME----KEKEGFPITSLREINTLLKAQ 419
+ EG +G V K+ D VA+K +K++ +E E F L E +
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF----LSEAACMKDFS 94
Query: 420 HPNIVTVREIVVGS---NMDKIFIVMDYVEH-DMKSLMETMR--SKKQVFIPGEVKCLMQ 473
HPN++ + + + + K +++ ++++ D+ + + R + + + M
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515
+ + +L + LHRDL N +L + V DFGL+++
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 35/208 (16%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK--MEKEKEGFPITSLREINTLLKAQHPNIV 424
EG +G V+ A+ + +VA+K LK ++ F RE L QH +IV
Sbjct: 25 EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF----QREAELLTNLQHEHIV 80
Query: 425 TVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL-----MQQLLNA 478
+ V + D + +V +Y++H D+ + + + G+ + + Q+L+
Sbjct: 81 --KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 479 V-------AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYTPIVVTL 530
+L +HRDL T N L+ ++K+GDFG++R+ Y + +Y T+
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD--YYRVGGHTM 196
Query: 531 ----WYRSPELLLGCKEYSTPIDMWSVG 554
W PE ++ K ++T D+WS G
Sbjct: 197 LPIRWM-PPESIMYRK-FTTESDVWSFG 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 53/219 (24%)
Query: 372 EGTYGVVYRA------KDKRTDEI-VALKRLK---MEKEKEGFPITSLREINTLLK-AQH 420
EG +G V A KDK + + VA+K LK EK+ + E+ + +H
Sbjct: 91 EGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIGKH 146
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL-----MQQ 474
NI+ + + ++++++Y +++ + R + + +
Sbjct: 147 KNII--NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 475 LL-------NAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIV 527
L+ + +L +HRDL N+L++ ++K+ DFGLAR+ I
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD----------IN 254
Query: 528 VTLWYR------------SPELLLGCKEYSTPIDMWSVG 554
+Y+ +PE L Y+ D+WS G
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 292
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 37/173 (21%), Positives = 69/173 (39%), Gaps = 35/173 (20%)
Query: 372 EGTYGVVYRAK-----DKRTDEIVALKRLK---MEKEKEGFPITSLREINTLLKAQHPNI 423
EG +G V++A+ +VA+K LK + F RE + + +PNI
Sbjct: 57 EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----QREAALMAEFDNPNI 112
Query: 424 VTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCL----------- 471
V + + V + + ++ +Y+ + D+ + +M +
Sbjct: 113 V--KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 472 --MQQLLNAV-------AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515
+ L A+L + +HRDL T N L+ ++K+ DFGL+R
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 7e-14
Identities = 67/278 (24%), Positives = 107/278 (38%), Gaps = 42/278 (15%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPN 422
F+ +I G++G +Y + +T+E VA+K +E K P L E Q
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKIYRILQGGTG 64
Query: 423 IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHL 482
I VR G D +VMD + SL + + V L Q++N V +
Sbjct: 65 IPNVRWF--GVEGDYNVLVMDLLG---PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 483 HDNWILHRDLKTSNLLL---SHRGILKVGDFGLAREYGS-------PLKHYTPIVVTLWY 532
H LHRD+K N L+ + + DFGLA++Y P + + T Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK---------SDLEQLSRIFKT- 582
S LG E S D+ S+G + FL G + ++ +I +
Sbjct: 180 ASVNTHLG-IEQSRRDDLESLGYVLMYFL------RGSLPWQGLKAGTKKQKYEKISEKK 232
Query: 583 MGTPNEKIWPGFSK-----LPAVQKMTFAEYPNVGGLK 615
+ T E + G+ + + F + P+ LK
Sbjct: 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLK 270
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 59/321 (18%), Positives = 108/321 (33%), Gaps = 63/321 (19%)
Query: 344 EKDTLPPYLPA--IQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKR---LKME 398
K L I + +K I +G +G +Y A D + E V +K+E
Sbjct: 15 AKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVE 73
Query: 399 KEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI-----------------FIV 441
G E+ +A P + + F++
Sbjct: 74 PSDNG---PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130
Query: 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501
MD D++ + E + F V L ++L+ + ++H++ +H D+K SNLLL++
Sbjct: 131 MDRFGSDLQKIYEANAKR---FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187
Query: 502 RGILKV--GDFGLAREYGSP--LKHY-----TPIVVTLWYRSPELLLGCKEYSTPIDMWS 552
+ +V D+GLA Y K Y T+ + S + G S D+
Sbjct: 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEI 246
Query: 553 VGCIFAEFLCMEPLFTGK---------SDLEQLSRI-FKTMGTPNEKIWPGFSKLPA--- 599
+G ++L G + S+I ++ + P
Sbjct: 247 LGYCMIQWLT------GHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIA 300
Query: 600 -----VQKMTFAEYPNVGGLK 615
V+ + + E P L+
Sbjct: 301 KYMETVKLLDYTEKPLYENLR 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 36/200 (18%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG------FPITSLREI 412
N++ EG +GVVY K + VA+K+L + F +EI
Sbjct: 28 DERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQF----DQEI 81
Query: 413 NTLLKAQHPNIVTVREIVVG--SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKC 470
+ K QH N+V + +G S+ D + +V Y+ + SL ++
Sbjct: 82 KVMAKCQHENLVEL----LGFSSDGDDLCLVYVYMPN--GSL------LDRLSCLDGTPP 129
Query: 471 L-----MQQLLNA---VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK- 521
L + A + LH+N +HRD+K++N+LL K+ DFGLAR +
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 522 HYTPIVV-TLWYRSPELLLG 540
T +V T Y +PE L G
Sbjct: 190 VMTSRIVGTTAYMAPEALRG 209
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 8e-12
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 41/194 (21%)
Query: 364 FKCLNRIEEGTYGVVYRA--KDKRTDEIVALKRLKMEK----EKEGFPITSLREINTLLK 417
F N + G +G VY+ D +VA+KRLK E+ E + F E+ +
Sbjct: 32 FSNKNILGRGGFGKVYKGRLADGT---LVAVKRLKEERTQGGELQ-F----QTEVEMISM 83
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-----------G 466
A H N++ +R + + +V Y+ + S+ +R + + P G
Sbjct: 84 AVHRNLLRLRGFCMTPT--ERLLVYPYMAN--GSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 467 EVKCLMQQLLNAVAHLHDNW---ILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH- 522
+ L A+LHD+ I+HRD+K +N+LL VGDFGLA+ H
Sbjct: 140 SARGL--------AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 523 YTPIVVTLWYRSPE 536
T + T+ + +PE
Sbjct: 192 TTAVRGTIGHIAPE 205
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 20/159 (12%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK---EKEGFPITSLREINTLLKAQH 420
F I G +G VY+ R VALKR E +E F EI TL +H
Sbjct: 41 FDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEE-F----ETEIETLSFCRH 94
Query: 421 PNIVTVREIVVG--SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
P++V++ +G +++ ++ Y+E+ +L + + + ++ + A
Sbjct: 95 PHLVSL----IGFCDERNEMILIYKYMEN--GNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 479 ---VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514
+ +LH I+HRD+K+ N+LL + K+ DFG+++
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 3e-10
Identities = 30/170 (17%), Positives = 56/170 (32%)
Query: 22 HKSHHRSHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNK 81
+ R + S R S S ++++ S+ +S + R R R R + + K
Sbjct: 247 ERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRERARRERERK 306
Query: 82 SDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKRYS 141
+ GG + D+ E E + +E R ER+R
Sbjct: 307 EELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSHRSERERRR 366
Query: 142 NPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRS 191
+ R++++ R ER E R + +D + +R
Sbjct: 367 DRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMYME 416
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 18/189 (9%), Positives = 56/189 (29%)
Query: 3 DEDTPDSLEIKPPQASTQLHKSHHRSHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRH 62
+ + + + + + + S R S S+ + + + + +
Sbjct: 226 SPLPHRDRDRDRERERRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKD 285
Query: 63 RDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREID 122
RD + R +E+ R + + G + + + +
Sbjct: 286 RDRKRRSSRSRERARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEE 345
Query: 123 ELKAKEADLRARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKR 182
+ + ++ + R +R R++++ K +ER ++ + + +
Sbjct: 346 KGRDRDRERRRSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEG 405
Query: 183 YRTRSRSRS 191
SR
Sbjct: 406 LGNDSRDMY 414
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 4e-09
Identities = 22/170 (12%), Positives = 47/170 (27%)
Query: 22 HKSHHRSHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNK 81
+ RS + S +++S + + R R R + KE R
Sbjct: 253 ERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRERARRERERKEELRGG 312
Query: 82 SDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKRYS 141
++ +D + ++ R+ + ++ ++ R +R R
Sbjct: 313 GGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSHRSERERRRDRDRDR 372
Query: 142 NPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRS 191
+ RE ++ ER + R R Y
Sbjct: 373 DRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMYMESEGGDG 422
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 1e-08
Identities = 30/203 (14%), Positives = 54/203 (26%), Gaps = 4/203 (1%)
Query: 22 HKSHHRSHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNK 81
+ RS + R S ++ S + RSR R + R + R R +
Sbjct: 239 RERRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRER 298
Query: 82 SDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKRYS 141
+ + + R D E +E ER+R
Sbjct: 299 ARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSH 358
Query: 142 NPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNEMD 201
RE+ + R K + + ++ R + + +M
Sbjct: 359 RSERERRRDRDRDRDRD----REHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMY 414
Query: 202 VDEAHQRGEDDGARTPPGPAAPE 224
++ G AAPE
Sbjct: 415 MESEGGDGYLAPENGYLMEAAPE 437
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 30/196 (15%), Positives = 58/196 (29%), Gaps = 6/196 (3%)
Query: 22 HKSHHRSHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNK 81
+ H ++ + + + RSR RD R R ++ER R++
Sbjct: 219 YDERPGPSPLPHRDRDRDRERERRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSR 278
Query: 82 SDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKRYS 141
D RR R+ + R+ +
Sbjct: 279 ERSKDKDRDRKRRSSRSRERARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPD 338
Query: 142 NPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRK-----RYRTRSRSRSPINKA 196
P +EK R+ +ER +E ++R +D ++ R+ R R R +
Sbjct: 339 GPDGPEEK-GRDRDRERRRSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGG 397
Query: 197 KNEMDVDEAHQRGEDD 212
+ ++ D
Sbjct: 398 GQDNGLEGLGNDSRDM 413
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 6e-06
Identities = 42/262 (16%), Positives = 72/262 (27%), Gaps = 16/262 (6%)
Query: 13 KPPQASTQLHKSHHRSHKDKHSSHRTHGSSSSSQQDKSSSQHKSHHRSRHRDERDRRHHH 72
+P + L + +S ++ S ER R
Sbjct: 188 RPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRERERRERSRE 247
Query: 73 KEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLR 132
++KER+R +S D +S R E+R+ ER + + K ++R R
Sbjct: 248 RDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRS-----------R 296
Query: 133 ARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSP 192
R R+R + E + + ++ R R R R
Sbjct: 297 ERARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERR- 355
Query: 193 INKAKNEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDE 252
++ E + + D R R EA G D
Sbjct: 356 ----RSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSR 411
Query: 253 KPGTGQEEGELAGSAESSAGSE 274
E G+ + E+ E
Sbjct: 412 DMYMESEGGDGYLAPENGYLME 433
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 8e-10
Identities = 72/502 (14%), Positives = 147/502 (29%), Gaps = 135/502 (26%)
Query: 330 HVIMDQDVDMEIELE-KDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGV--------VYR 380
H MD + E + + KD L + A V+ F C +++ + +
Sbjct: 4 HHHMDFETG-EHQYQYKDILSVFEDAF-----VDNFDC-KDVQDMPKSILSKEEIDHIIM 56
Query: 381 AKDK--RTDEIVALKRLKMEKEKEGFPITSLRE----INTLLKAQH--PNIVTV-----R 427
+KD T + K E+ + F LR + + +K + P+++T R
Sbjct: 57 SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR 116
Query: 428 EIVVGSN--MDKIFI-----------------VMDYVE-HDM----KSLM--ETMRSKK- 460
+ + N K + V + K+ + + S K
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV 176
Query: 461 QVFIPGEV------KC-----LMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGD 509
Q + ++ C +++ L + + NW D ++ L H ++
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 510 FGLAREYGSPLKHYTPIVV-TLWYRSPELL----LGCK-----EYSTPIDMWSVGCIFAE 559
++ Y + L +V+ + + + L CK + D +
Sbjct: 237 LLKSKPYENCL-----LVLLNVQ--NAKAWNAFNLSCKILLTTRFKQVTD--FLSAATTT 287
Query: 560 FLCMEPL---FTGKSDLEQLSRIF--KTMGTPNE--KIWP----GFSKLPAVQKMTFAEY 608
+ ++ T L + + P E P ++ T+ +
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 609 PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY-----FSESPLPIDP 663
+V K+ I E ++L +P E R + F S I
Sbjct: 348 KHVN--CDKLTTII--ESSLNVL------EP------AE-YRKMFDRLSVFPPS-AHIPT 389
Query: 664 AMFPT-WPAKS---------ELAHKKAAMASPKPPSGG-HN----YKQLEDNEEGFHMGM 708
+ W +L PK + + K +NE H +
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449
Query: 709 MERSRAPVPGFSWGELDQDVDM 730
++ P S + +D
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 1e-06
Identities = 70/556 (12%), Positives = 150/556 (26%), Gaps = 213/556 (38%)
Query: 57 HHRSRHRDERDRRHHHKEKE-----RDRNKSDQSDGGHKSHRRRDEDRKH-RDERKAREA 110
HH H D H ++ K+ D + D K +D K+
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILSVFEDAFV-------------DNFDCKDVQDMPKS--- 44
Query: 111 QKSKEYTAREIDELKAKEADLRARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYK 170
+ EID + + K+ + LR L +++ +E +
Sbjct: 45 ----ILSKEEIDHI-------------------IMSKDAVSGTLRLFWTLLSKQ-EEMVQ 80
Query: 171 ERVKDVEQKR-----KRYRTRSRSRSPINKAKNEMDVDEAHQRGEDDGARTPPGPAAPES 225
+ V++V + +T R S + + E R +D S
Sbjct: 81 KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI-----EQRDRLYNDNQVFAKYNV---S 132
Query: 226 RSR---------QDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAESSAGSEES 276
R + +L A V++ D G+G+ +A S +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLI-----------DGVLGSGKT--WVALDVCLSYKVQCK 179
Query: 277 SQD-------GSEDSSQ-------------DSSSSDEEENDENEDKADKKEKKAKKRKKE 316
+ +S + D + + ++ N + +R +
Sbjct: 180 MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 317 DASPNESERDVSPHVIMDQDV-DMEIELEKDTLPPYLPAIQGCRSVEEF--KCLNRIEEG 373
+++ +V + + F C +I
Sbjct: 240 SKPYENC------LLVLL-NVQNAKA-------------------WNAFNLSC--KIL-- 269
Query: 374 TYGVVYRAKDKR-TDEIVAL--KRLKMEKEKEGFPITSLREINTLL------KAQ----- 419
+ R K+ TD + A + ++ + E+ +LL + Q
Sbjct: 270 ---LTTR--FKQVTDFLSAATTTHISLDHHSMTL---TPDEVKSLLLKYLDCRPQDLPRE 321
Query: 420 ----HPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSK---------KQVF-- 463
+P ++ ++ ++ D +H + L + S +++F
Sbjct: 322 VLTTNPRRLS----IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR 377
Query: 464 ---------IPGEVKCL-------------MQQLLNA----------VAHLHDNWILHRD 491
IP + L + +L + ++ +
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS---IYLE 434
Query: 492 LKT--SNLLLSHRGIL 505
LK N HR I+
Sbjct: 435 LKVKLENEYALHRSIV 450
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 4e-04
Identities = 82/570 (14%), Positives = 145/570 (25%), Gaps = 216/570 (37%)
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
H H + H D +T ++ IL + V
Sbjct: 1 HHHHH---HMDFETGEHQYQYKDILS---------------VFEDAFVDN--------FD 34
Query: 541 CKEYSTPIDMWSVGCIF--AEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
CK+ DM I E + + K + R+F T+ + E++
Sbjct: 35 CKDVQ---DM--PKSILSKEEI---DHIIMSKDAVSGTLRLFWTLLSKQEEM-------- 78
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE-- 656
VQK F E L+ Y L P+ ++ + E
Sbjct: 79 -VQK--FVE----EVLRIN----------YKFL-----MSPIKTEQRQPSMMTRMYIEQR 116
Query: 657 SPLPIDPAMFPTWP---AKSELAHKKAAMASPKPPSGGHNYKQLEDNEE-GFHMGMMERS 712
L D +F + + L ++A + +L + G+
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALL-------------ELRPAKNVLID-GV---- 158
Query: 713 RAPVPGFSWGELDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRA 772
G G K + A+ C S Y V
Sbjct: 159 ----LGS--G-------------KTWV-----ALDVCLS--------------YKVQ--- 177
Query: 773 KDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVE--SELNHLVTENPGGPLNKKEQPK 830
CK FWL N + +E +L + + N + K
Sbjct: 178 -----------CKMDFKIFWL-NL-KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 831 WRPMQISNPSTKLRQARSMPH--------WVPNVRRA---GSQPPEYITT---LVQNQVK 876
R I +L +++ + A + +TT V + +
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI--LLTTRFKQVTDFLS 282
Query: 877 QGMEMVKLLREAEQNGFT-AEDLTI----------ALSH--CGDGP-------------P 910
+ + T E ++ L P
Sbjct: 283 -AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGL 341
Query: 911 VTWLINNWRHM-IDTVVTLATNYGHERSENNVGTLSAVEAR---DALRLHNGNV------ 960
TW +NW+H+ D + T+ E+++ L E R D L + +
Sbjct: 342 ATW--DNWKHVNCDKLTTI--------IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391
Query: 961 ----WAA-VTECVETRQKKFND--LMSRGN 983
W + V K + L+ +
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQP 421
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 47/262 (17%), Positives = 85/262 (32%), Gaps = 34/262 (12%)
Query: 301 DKADKKEKKAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEKDTLP-PYLPAIQGCR 359
DK A K KE A+ +E + E+++ + + G
Sbjct: 47 DKTATCRTVAVKMLKEGATHSEHR-----------ALMSELKILIHIGHHLNVVNLLGAC 95
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ 419
+ + +E +G + L+ + E R+ + A
Sbjct: 96 TKPGGPLMVIVEFCKFG----------NLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMR-SKKQVFIPGEVKCLMQQLLNA 478
++ + + S ++ E K + C Q+
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR------EYGSPLKHYTPIVVTLWY 532
+ L +HRDL N+LLS + ++K+ DFGLAR +Y P+ W
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL---KWM 262
Query: 533 RSPELLLGCKEYSTPIDMWSVG 554
+PE + Y+ D+WS G
Sbjct: 263 -APETIFDRV-YTIQSDVWSFG 282
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 32/277 (11%), Positives = 102/277 (36%), Gaps = 35/277 (12%)
Query: 72 HKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADL 131
K + R+ + + + R++ + E K+ QK + + +A +
Sbjct: 832 RKRYQCMRDATIALQALLRGYLVRNKYQMMLREHKSIIIQKHVRGWLARVHYHRTLKAIV 891
Query: 132 RARLERKRYSNPLREKEKIERELRKE--RLLEAERVKEAYKERVKDVEQKRKRYRTRSRS 189
+ +R ++ ++L+ E + +++ + ++ +++K +S
Sbjct: 892 YLQCCYRR-----MMAKRELKKLKIEARSVERYKKLHIGLENKIMQLQRKIDEQNKEYKS 946
Query: 190 RSPINKAKNEMDVDEAHQRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQ 249
+ + N +++ + + + R D+E L + +E+++ T +
Sbjct: 947 ---LLEKMNNLEITYSTE----------------TEKLRSDVER--LRMSEEEAKNATNR 985
Query: 250 RDEKPGTGQEEGELAGSAESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKAD-KKEK 308
+ E+A + ++ + E + + +++ ++ E K EK
Sbjct: 986 VLSL------QEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLLKTEK 1039
Query: 309 KAKKRKKEDASPNESERDVSPHVIMDQDVDMEIELEK 345
+ R+ D + +E V + +++++ E+
Sbjct: 1040 EELNRRIHDQAKEITETMEKKLVEETKQLELDLNDER 1076
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 43/302 (14%), Positives = 99/302 (32%), Gaps = 33/302 (10%)
Query: 46 QQDKSSSQHKSHHRSRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRD--------E 97
Q+ K Q + + K +++ +++ R E
Sbjct: 867 QRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAKKQELE 926
Query: 98 DRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKRYSNPLREKEKIERELRKE 157
+ H E + E ++ + E +++ + DL +LE + + + EK+ + + +
Sbjct: 927 EILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEEEAARQKLQLEKVTADGKIK 986
Query: 158 RLLEA-----------ERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKNEMDVDEAH 206
++ + + ++ +ERV D+ ++++ + + K K+E + E
Sbjct: 987 KMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKL-KNKHESMISELE 1045
Query: 207 QRGEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAGS 266
R + E +SRQ+LE L ES Q E E
Sbjct: 1046 VRLKK------------EEKSRQELEKI-KRKLEGESSDLHEQIAELQAQIAELKAQLAK 1092
Query: 267 AESSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNESERD 326
E + + + ++ E D + E + R K + + +
Sbjct: 1093 KEEELQAALARLEDETSQKNNALKKIRELESHISDLQEDLESEKAARNKAEKQKRDLSEE 1152
Query: 327 VS 328
+
Sbjct: 1153 LE 1154
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 44/260 (16%), Positives = 83/260 (31%), Gaps = 47/260 (18%)
Query: 91 SHRRRDEDRKHRDERKAREAQKSKEYTAREIDELKAKEADLRARLERKRYSNPLREKEKI 150
R++E+ + K E Q++KE + ELK E E K N L+EK +
Sbjct: 851 KVTRQEEEMQ----AKDEELQRTKERQQKAEAELKELEQKHTQLCEEK---NLLQEKLQA 903
Query: 151 ERELRKERLLEAERVKEAYKERVKDVEQKRKRYRTRSRSRSPINKAKN--EMDVDEAHQR 208
E EL E R+ +E + + + R + K + + + ++
Sbjct: 904 ETELYAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQ 963
Query: 209 GEDDGARTPPGPAAPESRSRQDLEAAGLVVLTDESRSPTPQRDEKPGTGQEEGELAGSAE 268
E+ E +RQ L+ EK +G++
Sbjct: 964 LEE------------EEAARQKLQL------------------EK---VTADGKI----- 985
Query: 269 SSAGSEESSQDGSEDSSQDSSSSDEEENDENEDKADKKEKKAKKRKKEDASPNESERDVS 328
+ + + EE + ++E+KAK K ++
Sbjct: 986 KKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELE 1045
Query: 329 PHVIMDQDVDMEIELEKDTL 348
+ ++ E+E K L
Sbjct: 1046 VRLKKEEKSRQELEKIKRKL 1065
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 20/127 (15%), Positives = 45/127 (35%), Gaps = 9/127 (7%)
Query: 61 RHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDE-----RKAREAQKSKE 115
+ R E ++ E E ++ + + + K +E + + K
Sbjct: 1053 KSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQKN 1112
Query: 116 YTAREIDELKAKEADLRARL--ERKRYSNPLREKEKIERELR--KERLLEAERVKEAYKE 171
++I EL++ +DL+ L E+ + ++K + EL K L + +E
Sbjct: 1113 NALKKIRELESHISDLQEDLESEKAARNKAEKQKRDLSEELEALKTELEDTLDTTATQQE 1172
Query: 172 RVKDVEQ 178
+
Sbjct: 1173 LRGSDYK 1179
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1028 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4dbg_B | 162 | Ring finger protein 31; ubiquitin fold, ubiquitina | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.24 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.14 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.12 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.09 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.08 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.04 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.02 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 98.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 98.94 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 98.93 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 98.92 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 98.88 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 98.84 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 98.83 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 98.77 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.76 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.69 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 98.66 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 98.62 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 98.6 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 98.59 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 98.58 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 98.57 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 98.54 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 98.53 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 98.53 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 98.52 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 98.52 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 98.51 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 98.51 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 98.51 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 98.5 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 98.5 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 98.5 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 98.49 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 98.49 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 98.48 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 98.48 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 98.48 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 98.47 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 98.47 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 98.47 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 98.46 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 98.46 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 98.45 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 98.45 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 98.45 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 98.45 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 98.44 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 98.44 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 98.44 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 98.43 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 98.43 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 98.43 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 98.43 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 98.42 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 98.42 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 98.42 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 98.41 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 98.41 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 98.41 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 98.4 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 98.4 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 98.4 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 98.4 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 98.39 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 98.39 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 98.39 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 98.39 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 98.39 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 98.38 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 98.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.37 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 98.36 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 98.36 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 98.35 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 98.35 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 98.35 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 98.35 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 98.34 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 98.33 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 98.33 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 98.33 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 98.33 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 98.33 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 98.32 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 98.32 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 98.32 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 98.32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 98.32 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 98.31 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 98.3 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 98.3 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 98.3 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 98.3 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 98.3 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 98.3 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 98.3 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 98.3 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 98.29 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 98.29 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 98.29 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 98.29 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 98.29 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 98.29 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 98.29 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 98.29 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 98.28 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 98.28 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 98.28 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 98.28 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 98.27 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 98.27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 98.26 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 98.26 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 98.26 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 98.26 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 98.25 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 98.25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 98.25 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 98.25 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 98.25 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 98.25 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 98.24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 98.24 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 98.23 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 98.23 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 98.23 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 98.23 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 98.23 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 98.23 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 98.22 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 98.22 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 98.22 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 98.22 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 98.22 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 98.21 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 98.2 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 98.2 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 98.2 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 98.2 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 98.2 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 98.19 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 98.19 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 98.19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 98.18 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 98.18 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 98.18 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 98.17 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 98.17 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 98.16 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 98.16 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 98.16 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 98.16 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 98.16 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 98.16 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 98.16 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 98.15 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 98.15 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 98.14 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 98.14 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 98.14 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 98.14 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 98.14 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 98.13 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 98.13 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 98.13 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 98.13 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 98.12 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 98.12 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 98.12 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 98.12 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 98.12 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 98.12 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 98.11 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 98.11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 98.11 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 98.11 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 98.1 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 98.1 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 98.09 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 98.09 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 98.09 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 98.08 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 98.08 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 98.07 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 98.07 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 98.07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 98.07 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 98.07 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 98.07 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 98.06 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 98.04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 98.04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 98.04 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 98.03 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 98.03 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 98.03 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 98.02 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 98.01 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 98.01 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 98.01 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 98.01 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 98.01 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 98.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 98.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 98.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 98.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 98.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 97.99 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 97.97 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 97.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 97.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 97.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 97.94 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 97.93 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 97.93 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 97.93 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 97.92 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 97.92 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 97.92 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.91 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 97.91 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 97.89 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 97.89 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.88 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 97.88 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 97.87 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 97.85 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 97.85 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.85 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 97.85 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 97.85 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 97.84 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 97.84 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 97.84 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 97.83 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 97.83 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-57 Score=519.42 Aligned_cols=293 Identities=32% Similarity=0.566 Sum_probs=240.6
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec----CCCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS----NMDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~----~~~~ 437 (1028)
++|++++.||+|+||+||+|+++.||+.||||+++...........+++|+.+|+.++|||||++++++... +...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 679999999999999999999999999999999976544333345678999999999999999999987532 3468
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|||||||+++|.+++ . ....+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~g~L~~~i---~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLMESDLHQII---H-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCSEEHHHHH---T-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCCCCHHHHH---H-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 9999999987654444 3 34579999999999999999999999999999999999999999999999999998764
Q ss_pred CC----CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SP----LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~----~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.. ....++.+||++|||||++.+..+|+.++|||||||||||||+|.+||.+.+..+++..|+...+.|+...|..
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 23456789999999999999877889999999999999999999999999999999999999999998887766
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
......... ...++......+....+.+++.++|||.+||.+||.+||||.|+|+||||++...|
T Consensus 290 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 290 VGAERVRAY--IQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp ----CHHHH--HHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhh--hhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 543222111 11122222222233345678999999999999999999999999999999986543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-57 Score=506.60 Aligned_cols=258 Identities=24% Similarity=0.443 Sum_probs=223.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.|+++++||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.++|||||+++++|... +.+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 469999999999999999999999999999999976543 3345678999999999999999999998654 589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||||.+ ++|.+.+.. ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 150 mEy~~g--g~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 150 MEFLEG--GALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp ECCCTT--EEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EeCCCC--CcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999987 444444433 3589999999999999999999999999999999999999999999999999998876666
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
..++.|||+.|||||++.+ ..|+.++||||||||||||++|.+||.+.+..+.+..|..... +...
T Consensus 226 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~------------ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLK------------ 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCS------------
T ss_pred cccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCC------------
Confidence 6778899999999999977 6799999999999999999999999999998888887765321 1000
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
....+++.+++||.+||.+||.+|||+.|+|+||||++..
T Consensus 292 -----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 292 -----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp -----------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 0123678999999999999999999999999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=499.49 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=224.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|..++|||||+++++|.. .+.+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 107 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKL 107 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEE
Confidence 45789999999999999999999999999999999986543 23344567899999999999999999998854 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||.+ |+|.+.+... ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 108 yivmEy~~g--G~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 108 YFGLSYAKN--GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEECCCTT--EEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCC--CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999987 5555555443 4699999999999999999999999999999999999999999999999999998753
Q ss_pred C--CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 P--LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~--~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. .....+.|||+.|||||++.+ ..|+.++||||||||||+||||.+||.+.+..+.+.+|.+.-..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------- 252 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD----------- 252 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----------
T ss_pred CCCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 2 234567899999999999987 67999999999999999999999999999998888888763110
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHH------HHhCCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE------ALRHDYFSESPL 659 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~E------lL~HPfF~e~p~ 659 (1028)
+ ...+++.+++||.+||.+||.+|||+.| |++||||++..|
T Consensus 253 -----------~-----------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 253 -----------F-----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp -----------C-----------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred -----------C-----------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 0 1126788999999999999999999987 689999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=509.95 Aligned_cols=260 Identities=27% Similarity=0.465 Sum_probs=218.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
++++|+++++||+|+||+||+|+++.+|+.||||++.+..........+.+|+.+|..++|||||+++++|.. .+.+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEE
Confidence 3579999999999999999999999999999999998765443334567899999999999999999999864 45899
Q ss_pred EEEeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||.+ ++|.+.+.. ....+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 100 iVmEy~~g--g~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 100 IVMDYCEG--GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEECCTT--CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEeCCCC--CcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999986 445554443 345678999999999999999999999999999999999999999999999999987754
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.....++.+||+.|||||++.+ ..|+.++|||||||||||||||.+||.+.+..+.+.+|......+
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------ 244 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP------------ 244 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC------------
T ss_pred CcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC------------
Confidence 3334456799999999999988 679999999999999999999999999999998888887632110
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
....+++.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 245 --------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 245 --------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 01226788999999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=486.20 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=204.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
+++|++++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+|+.++|||||+++++|.. .+.+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 57899999999999999999999999999999999765432 2334567899999999999999999998864 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||||+|+|.+++ .. ...+++.+++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 90 ivmEy~~g~L~~~l---~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 90 MVIEYAGNELFDYI---VQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEECCCEEHHHHH---HH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEeCCCCCHHHHH---HH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99999987655544 33 456999999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
...++.+||+.|||||++.+..+++.++|||||||+||+|+||.+||.+.+..+.+..|......
T Consensus 166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~-------------- 230 (275)
T 3hyh_A 166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT-------------- 230 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------------
T ss_pred -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 34556899999999999988555678999999999999999999999998888777777653110
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
+ ...+++.+++||.+||+.||.+|||+.|+|+||||+.
T Consensus 231 --------~-----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 231 --------L-----------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --------C-----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --------C-----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0 1126788999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=508.65 Aligned_cols=258 Identities=24% Similarity=0.439 Sum_probs=223.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.|+++++||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.++|||||+++++|... +.+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEEE
Confidence 569999999999999999999999999999999976542 3345678999999999999999999998754 589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||||.+ ++|.+.+.. ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 227 mEy~~g--G~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 227 MEFLEG--GALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EECCTT--EEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EeCCCC--CcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999987 444444433 3489999999999999999999999999999999999999999999999999998876666
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
..++.|||+.|||||++.+ ..|+.++||||||||||||++|.+||.+.+..+.+..|..... +....
T Consensus 303 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~----------- 369 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKN----------- 369 (423)
T ss_dssp CBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSC-----------
T ss_pred cccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcc-----------
Confidence 6778899999999999987 6799999999999999999999999999999888887765321 11111
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
...+++.+++||.+||.+||.+|||+.|||+||||++..
T Consensus 370 ------------------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 370 ------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp ------------------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 123678899999999999999999999999999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=490.14 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=213.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|++++.||+|+||+||+|++. .+++.||||++++..........+.+|+.+|..++|||||+++++|... +.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET--TE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CE
Confidence 368999999999999999999984 4788999999987654443445677899999999999999999988654 58
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|||||||.+ ++|.+.+.. ...+++.+++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 101 ~~ivmEy~~g--g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 101 LYLILDFLRG--GDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEECCCTT--CEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEcCCC--CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999986 444444433 3468999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
......++.+||+.|||||++.+ ..|+.++||||||||||||+||.+||.+.+..+.+..|.+....
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------------ 244 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG------------ 244 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------
T ss_pred CCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC------------
Confidence 55555677899999999999987 67999999999999999999999999999998888888763110
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESP 658 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p 658 (1028)
+ ...+++.+.+||.+||+.||.+||| ++|+|+||||+...
T Consensus 245 ----------~-----------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 245 ----------M-----------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp ----------C-----------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ----------C-----------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 0 1126788999999999999999998 58999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=474.99 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=210.8
Q ss_pred CCe-EEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec--CCCeE
Q psy18163 362 EEF-KCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--NMDKI 438 (1028)
Q Consensus 362 d~Y-~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~--~~~~l 438 (1028)
.+| ++.++||+|+||+||+|.+..++..||||++............+.+|+.+|..++|||||+++++|... ....+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 345 788899999999999999999999999999976554333345678999999999999999999998643 34578
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecC-CCcEEEeccCCccc
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSH-RGILKVGDFGLARE 515 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~-~g~lKL~DFGlAr~ 515 (1028)
|||||||.+ ++|.+.+.. ...+++..++.|+.||+.||.|||++| ||||||||+||||+. +|.+||+|||+|+.
T Consensus 105 ~lvmEy~~g--g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 105 VLVTELMTS--GTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCS--CBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEeCCCC--CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999986 444444433 346899999999999999999999999 999999999999984 79999999999986
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
... ...++.+||+.|||||++.+ .|+.++||||||||||||+||.+||.+.++...+...+.....|
T Consensus 182 ~~~--~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--------- 248 (290)
T 3fpq_A 182 KRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------- 248 (290)
T ss_dssp CCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred CCC--CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC---------
Confidence 543 34556899999999999875 49999999999999999999999998776655554433211000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
......+++.+.+||.+||..||.+|||+.|+|+||||++.
T Consensus 249 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 249 ---------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ---------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ---------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 00112356789999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=477.20 Aligned_cols=256 Identities=25% Similarity=0.286 Sum_probs=211.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.+.|++.++||+|+||+||+|+++.+|+.||||+++... ...+|+.+|..++|||||+++++|.. .+.+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------~~~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------FRVEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------CCTHHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------hHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 467999999999999999999999999999999997642 22579999999999999999998864 458999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-cEEEeccCCccccCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-~lKL~DFGlAr~~~~ 518 (1028)
|||||.+ +|.+++. . ...|++.+++.|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.+..
T Consensus 128 vmEy~~gg~L~~~l~---~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 128 FMELLEGGSLGQLIK---Q-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EECCCTTCBHHHHHH---H-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEeccCCCcHHHHHH---H-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999986 5555443 3 34699999999999999999999999999999999999999988 699999999987653
Q ss_pred CCC-----cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 519 PLK-----HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 519 ~~~-----~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
... .....+||+.|||||++.+ ..|+.++|||||||||||||||.+||.+.+..+.+.+|.... ++
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~------ 274 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PP------ 274 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CG------
T ss_pred CCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CC------
Confidence 211 1234689999999999988 679999999999999999999999999887776676665521 00
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHH-------------HhCCCCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA-------------LRHDYFSESPLP 660 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~El-------------L~HPfF~e~p~p 660 (1028)
+ ....+.+++.+.+||.+||.+||.+|||+.|+ |+|||+.+...|
T Consensus 275 -----------~-----------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 275 -----------I-----------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp -----------G-----------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred -----------c-----------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 0 01123367889999999999999999999998 569999875433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=476.40 Aligned_cols=286 Identities=31% Similarity=0.484 Sum_probs=216.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~ 436 (1028)
.+.|+++++||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|..+ .|||||.++++|.. .+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~ 93 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK--ND 93 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TT
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CC
Confidence 367999999999999999999875 568899999986542 234567899999988 69999999988864 45
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC-CcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR-GILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~-g~lKL~DFGlAr~ 515 (1028)
++|||||||.+ ++|.+.+. .+++.+++.|+.||+.||.|||++|||||||||+||||+.+ +.+||+|||+|+.
T Consensus 94 ~~~lvmE~~~g--~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 94 HVVIAMPYLEH--ESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEEECCCC--CCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeCCCc--ccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 89999999986 44554442 38999999999999999999999999999999999999876 8999999999986
Q ss_pred cCCCC----------------------------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy18163 516 YGSPL----------------------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLF 567 (1028)
Q Consensus 516 ~~~~~----------------------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF 567 (1028)
..... ...++.+||++|||||++.+...|+.++||||||||+|+||+|++||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 54321 12345689999999999998778999999999999999999999877
Q ss_pred -CCCChHHHHHHHHHhcCCCCCCCCCC--------CCCCh------hhhhhcc--ccCCCC-----CCCccccccccccH
Q psy18163 568 -TGKSDLEQLSRIFKTMGTPNEKIWPG--------FSKLP------AVQKMTF--AEYPNV-----GGLKTKVAGSILTE 625 (1028)
Q Consensus 568 -~g~sd~d~l~kI~~~lg~p~~~~w~~--------~s~lp------~~~~l~~--~~~p~~-----~~l~~~~~~~~Ls~ 625 (1028)
.+.++.+++..|+..+|.+....+.. ....| ....... ...|.. ...........+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 56778899999998877543211100 00000 0000000 000000 00000112345789
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 626 LGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 626 ~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.++|||.+||++||.+||||+|+|+||||++.+
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=496.19 Aligned_cols=274 Identities=25% Similarity=0.386 Sum_probs=235.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.+++|++++.||+|+||+||+|+++.+|+.||||++...... ....+.+|+.+|..++|||||+|+++|.. ...+|
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 230 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMV 230 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEE
Confidence 457899999999999999999999999999999999765422 23456789999999999999999998864 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC--CcEEEeccCCccccC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR--GILKVGDFGLAREYG 517 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~--g~lKL~DFGlAr~~~ 517 (1028)
||||||.+ ++|++.+......|++.+++.|+.||+.||.|||++||+||||||+||||+.+ |.+||+|||+|+.+.
T Consensus 231 iv~E~~~g--g~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 231 MIYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEECCCC--CBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEeecCC--CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999987 67777776666679999999999999999999999999999999999999854 899999999999875
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ......+||+.|||||++.+ ..|+.++||||||||||+||+|.+||.+.+..+++..|......+....|
T Consensus 309 ~~-~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------ 380 (573)
T 3uto_A 309 PK-QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF------ 380 (573)
T ss_dssp TT-SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG------
T ss_pred CC-CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc------
Confidence 43 44567899999999999988 67999999999999999999999999999999988888764332222111
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCCCCCc
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPTWP 670 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~pt~p 670 (1028)
..+++.+++||.+||.+||.+|||+.|+|+||||+...+|.....+|...
T Consensus 381 -----------------------~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~~p~~~ 430 (573)
T 3uto_A 381 -----------------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSR 430 (573)
T ss_dssp -----------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCEECGGG
T ss_pred -----------------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhhCCCcc
Confidence 23678899999999999999999999999999999888776665555433
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=458.20 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=194.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC-----
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM----- 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~----- 435 (1028)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+|..++|||||+++++|...+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 4679999999999999999999999999999999976532 1223457799999999999999999999865432
Q ss_pred -----CeEEEEEeccccchHHHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEe
Q psy18163 436 -----DKIFIVMDYVEHDMKSLMETMRSKK--QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVG 508 (1028)
Q Consensus 436 -----~~l~LVmEy~~gdLgsLl~~l~~~~--~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~ 508 (1028)
..+|||||||.+ ++|.+.+.... ....+..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+
T Consensus 83 ~~~~~~~l~ivmE~~~g--g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRK--ENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ----CEEEEEEEECCCS--CCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCcEEEEEEecCCC--CcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 257999999986 44444443332 123456688999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCC------------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy18163 509 DFGLAREYGSPL------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576 (1028)
Q Consensus 509 DFGlAr~~~~~~------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l 576 (1028)
|||+|+.+.... ...++.+||+.|||||++.+ ..|+.++|||||||||||||+ ||.+.. +..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHH
Confidence 999998765321 12345789999999999988 679999999999999999996 776432 222
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..+....... .|. .....++.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 235 ~~~~~~~~~~----------~p~-------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 235 RTLTDVRNLK----------FPP-------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHHHTTC----------CCH-------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHHHhcCC----------CCC-------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 2222221100 000 01123466789999999999999999999999999987
Q ss_pred CCCC
Q psy18163 657 SPLP 660 (1028)
Q Consensus 657 ~p~p 660 (1028)
..+|
T Consensus 286 ~~~p 289 (299)
T 4g31_A 286 LDFP 289 (299)
T ss_dssp C---
T ss_pred CCCC
Confidence 6443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=486.30 Aligned_cols=261 Identities=22% Similarity=0.349 Sum_probs=212.4
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHH---HHHHHHcCCCCeeEEEEEEeecC
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLRE---INTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrE---i~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
.++++|++++.||+|+||+||+|+++.||+.||||++.+..... .......+| +.++..++|||||+|+++|. +
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~--~ 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--T 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--C
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE--E
Confidence 35689999999999999999999999999999999998654322 222233344 45556678999999998885 4
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
.+.+|||||||.| |+|...+... ..|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 264 ~~~lylVmEy~~G--GdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 PDKLSFILDLMNG--GDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp SSEEEEEECCCCS--CBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCC--CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence 5689999999987 5555555443 469999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---LEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---~d~l~kI~~~lg~p~~~~w 591 (1028)
.+... ...+.|||+.|||||++.+...|+.++|||||||||||||+|.+||.+.+. ......+... ...
T Consensus 341 ~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~----~~~-- 412 (689)
T 3v5w_A 341 DFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----AVE-- 412 (689)
T ss_dssp ECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----CCC--
T ss_pred ecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----CCC--
Confidence 87543 345679999999999997656799999999999999999999999976432 2223333221 000
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESPL 659 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p~ 659 (1028)
+...+++.+++||.+||+.||.+|++ +.||++||||+...|
T Consensus 413 ---------------------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 413 ---------------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp ---------------------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred ---------------------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 11236789999999999999999998 899999999998644
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=426.86 Aligned_cols=288 Identities=43% Similarity=0.785 Sum_probs=242.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.++..++||||+++++++... ..+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEEE
Confidence 689999999999999999999999999999999987655444446677999999999999999999988644 589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.+++...+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....+..
T Consensus 80 ~e~~~~~l~~~~---~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 80 FEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHH---HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EecCCCCHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 999997555444 34456799999999999999999999999999999999999999999999999999998876666
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~-pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
.....+||+.|+|||++.+...|+.++|||||||++|+|++|. ++|.+.+..+.+..++..++.+....|+....++..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 6677899999999999988666899999999999999999876 557888888999999999999998888876654433
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
... ..++.. .......+.++..+.+||.+||..||.+|||+.|+|+||||++..
T Consensus 237 ~~~--~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPY--PMYPAT--TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCC--CCCCTT--CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccc--ccccCC--cchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 211 111111 111222345788999999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=434.06 Aligned_cols=292 Identities=43% Similarity=0.788 Sum_probs=242.0
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
+....++|++++.||+|+||+||+|++. +++.||||++............+.+|+.+|..++||||+++++++. ...
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 92 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH--SER 92 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC--CSS
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc--cCC
Confidence 3445689999999999999999999996 5899999999766544444456789999999999999999999885 445
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+||||||+.++|.+++ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 93 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp CEEEEEECCSEEHHHHH---HTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EEEEEEcCCCCCHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 89999999997655544 444556899999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
..+....+..+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.++.+.+..++..++.+....|+....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 76656667778999999999998767799999999999999999999999999999999999999999999988888777
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
++......+..+. ........+.+++.+.+||.+||.+||.+|||+.|+|+||||++.
T Consensus 250 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 250 LPLWKQRTFQVFE---KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp SHHHHSCCCCCCC---CCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cchhhhccccccc---CCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 6654433322211 111222334577889999999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=445.00 Aligned_cols=256 Identities=22% Similarity=0.253 Sum_probs=204.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.++||+|+||+||+|++.. .||||+++...........+.+|+.+|.+++|||||++++++. .+.+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~---~~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT---KDNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE---CCeEEE
Confidence 4689999999999999999998653 4999999765433333456789999999999999999999873 346899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC-
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP- 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~- 519 (1028)
|||||.+ ++|.+.+......+++.++..|+.||+.||.|||+++||||||||+||||+.++++||+|||+|+.....
T Consensus 109 VmEy~~g--GsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 109 VTQWCEG--SSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEECCSS--CBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEcCCC--CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999987 6666666666677999999999999999999999999999999999999999999999999999876432
Q ss_pred -CCcccccccCccccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 520 -LKHYTPIVVTLWYRSPELLLGC--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 520 -~~~~t~~vGT~~Y~APEvL~g~--~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
....+..+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+....+..++.....++. ..
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-----~~- 260 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-----LS- 260 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-----ST-
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-----cc-
Confidence 2234567999999999999642 35899999999999999999999999988777666665543111100 00
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.....+++.+.+||.+||..||.+|||+.+|+++
T Consensus 261 ---------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 261 ---------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ---------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ---------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0112366788999999999999999999987653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=425.20 Aligned_cols=285 Identities=45% Similarity=0.803 Sum_probs=234.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||+|+||+||+|.+ .+++.||||++............+.+|+.++..++||||+++++++.. .+.+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 6899999999999999999999 678999999997765545555667899999999999999999998864 4589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.++|.+++. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....+..
T Consensus 79 ~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 79 FEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEecCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 9999987666654 3345689999999999999999999999999999999999999999999999999998765555
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
..+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|+....++...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 56667899999999999876679999999999999999999999999999999999999999988888887655443221
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
. .+.......+......+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 236 ~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 P----NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp T----TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred c----ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 1 11111111222333457889999999999999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=432.13 Aligned_cols=296 Identities=40% Similarity=0.705 Sum_probs=229.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|.+..+++.||||+++.... ......+.+|+.+|..++||||+++++++.. .+.+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEE
Confidence 4689999999999999999999999999999999976542 2334567799999999999999999998854 458999
Q ss_pred EEeccccchHHHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 441 VMDYVEHDMKSLMETMRSK--KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~--~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||+.++|.+++...... ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+..
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 9999999888877654321 23588999999999999999999999999999999999999999999999999998766
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
+.......+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.++.+.+..++..++.+....|+....++
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 55556677899999999999876679999999999999999999999999999999999999999999888887665443
Q ss_pred hhhhhccccCCC-CCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 599 AVQKMTFAEYPN-VGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 599 ~~~~l~~~~~p~-~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
..........+. ............++..+.+||.+||..||.+|||+.++|+||||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 321100000000 0000001122347789999999999999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=429.78 Aligned_cols=293 Identities=42% Similarity=0.834 Sum_probs=231.3
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.....++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+|..++||||+++++++... .
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 106 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--H 106 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET--T
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC--C
Confidence 34456899999999999999999999999999999999987655454556678999999999999999999988654 5
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec-----CCCcEEEeccC
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS-----HRGILKVGDFG 511 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd-----~~g~lKL~DFG 511 (1028)
.+||||||+.++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+ ..+.+||+|||
T Consensus 107 ~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 8999999999877666543 34589999999999999999999999999999999999994 45569999999
Q ss_pred CccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+++.+.......+..+||+.|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+.+..++..++.+....|
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 99988765556667789999999999988667999999999999999999999999999999999999999999988888
Q ss_pred CCCCCChhhhhhccccCCCCCC-CccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGG-LKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~-l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
+....++.... .++.... .........+++.+.+||.+||..||.+|||+.|+|+||||+...+
T Consensus 263 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 263 PGVTALPDWKQ----SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TTGGGSTTCCT----TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhh----hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 76654443221 1111111 1112223447889999999999999999999999999999997644
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=435.41 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=206.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|.+.+.||+|+||+||+|++. .++..||||+++.... .....+.+|+.+|.+++|||||++++++.. .
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVE--G 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--HHHHHHHHHHHHHHhCCCCCCccEEEEEee--C
Confidence 368999999999999999999875 4688999999975432 223567899999999999999999999864 4
Q ss_pred CeEEEEEecccc-chHHHHHHHh---------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcE
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMR---------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGIL 505 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~---------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~l 505 (1028)
+.+|||||||.+ +|.+++.... .....+++.++..|+.||+.||.|||+++||||||||+||||+.++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 579999999986 5555543321 123468999999999999999999999999999999999999999999
Q ss_pred EEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q psy18163 506 KVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKT 582 (1028)
Q Consensus 506 KL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~ 582 (1028)
||+|||+|+....... .....+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999987643221 2234579999999999987 569999999999999999998 89999999988888777653
Q ss_pred cCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
...+ . ...+++.+.+||.+||..||.+|||+.+|+ +||+
T Consensus 247 ~~~~---------------------~-----------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 247 RVLQ---------------------R-----------PRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp CCCC---------------------C-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred CCCC---------------------C-----------CccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 1100 0 112567889999999999999999999994 4554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=437.06 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=200.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|.+.++||+|+||+||+|++. .++..||||+++.... .....+.+|+.+|.+++|||||++++++.. .
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTMLQHQHIVRFFGVCTE--G 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 367999999999999999999875 4688999999975432 223467899999999999999999999854 4
Q ss_pred CeEEEEEecccc-chHHHHHHHh-----------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMR-----------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG 503 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~-----------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g 503 (1028)
+.+|||||||.+ +|.+++.... ....++++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 579999999986 4544443211 1124589999999999999999999999999999999999999999
Q ss_pred cEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy18163 504 ILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIF 580 (1028)
Q Consensus 504 ~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~ 580 (1028)
++||+|||+|+.+.... ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999998764322 22345789999999999987 679999999999999999999 899999999888887776
Q ss_pred HhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 581 KTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 581 ~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.....+ . ...+++.+.+||.+||..||.+|||+.||+.+
T Consensus 275 ~g~~~~---------------------~-----------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELE---------------------R-----------PRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCC---------------------C-----------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCC---------------------C-----------cccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 531100 0 11256788999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=451.97 Aligned_cols=294 Identities=35% Similarity=0.550 Sum_probs=221.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec---CCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS---NMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~---~~~~ 437 (1028)
.++|++++.||+|+||+||+|++..+++.||||++............+++|+.+|..++||||+.+++++... ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999999999999999999976433333335577899999999999999999988543 3357
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+||||||++++|..++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 132 ~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEeccccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99999999887666553 34568999999999999999999999999999999999999999999999999998764
Q ss_pred CCC---------------------------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh--------
Q psy18163 518 SPL---------------------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-------- 562 (1028)
Q Consensus 518 ~~~---------------------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-------- 562 (1028)
... ...+..+||++|+|||++.....|+.++||||||||||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 321 134567899999999988665779999999999999999999
Q ss_pred ---CCCCCCCCC--------------------hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccc
Q psy18163 563 ---MEPLFTGKS--------------------DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVA 619 (1028)
Q Consensus 563 ---G~pPF~g~s--------------------d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~ 619 (1028)
|.++|.+.+ ..+++..|++.+|.|....+.......... ....++..........
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKR--YIRIFPKREGTDLAER 365 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHH--HHTTSCCCCCCCGGGG
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHH--HHHhcCCCCCCCHHHH
Confidence 788888765 368889999999988766554433211111 0111122222222233
Q ss_pred cccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 620 GSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 620 ~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
.+.+++.+++||.+||.+||.+|||+.|+|+||||++..++
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 35578899999999999999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=442.12 Aligned_cols=294 Identities=32% Similarity=0.581 Sum_probs=223.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|.+..+++.||||++.............++|+.+|..+. ||||+++++++...+...+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999999999999999999654333333455678999999997 9999999999987776789
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+..
T Consensus 87 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999999877666542 3588999999999999999999999999999999999999999999999999986532
Q ss_pred C---------------------CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy18163 519 P---------------------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLS 577 (1028)
Q Consensus 519 ~---------------------~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~ 577 (1028)
. ....+..+||++|+|||++.+...|+.++||||||||||+|++|.+||.+.+..+++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 1224557899999999999886779999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCChhhhh-hccccCCCCCCCccc-------------cccccccHHHHHHHHHhcccCcCCCC
Q psy18163 578 RIFKTMGTPNEKIWPGFSKLPAVQK-MTFAEYPNVGGLKTK-------------VAGSILTELGYDLLCKFLTYDPVTRI 643 (1028)
Q Consensus 578 kI~~~lg~p~~~~w~~~s~lp~~~~-l~~~~~p~~~~l~~~-------------~~~~~Ls~~a~DLL~kcL~~DP~kRP 643 (1028)
.|+..++.|....+........... ..+............ .....+++.+.+||.+||..||.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 9999988887544322211000000 000000000000000 01124678999999999999999999
Q ss_pred CHHHHHhCCCCCCCC
Q psy18163 644 TADEALRHDYFSESP 658 (1028)
Q Consensus 644 TA~ElL~HPfF~e~p 658 (1028)
|+.|+|+||||+...
T Consensus 322 t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 322 SANDALKHPFVSIFH 336 (388)
T ss_dssp CHHHHTTSTTTTTTC
T ss_pred CHHHHhCCHHHHHhc
Confidence 999999999998643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=433.35 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=207.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
..++++++++||+|+||+||+|... .+++.||||+++.... ......+.+|+.+|.+++|||||++++++..
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-- 100 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTK-- 100 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--
Confidence 3467999999999999999999864 4678999999975432 2334567899999999999999999999854
Q ss_pred CCeEEEEEeccccchHHHHHHHhhc---------------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSK---------------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~---------------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL 499 (1028)
.+.+|||||||.+ |+|.+.+... ...+++.++..|+.||+.||.|||+++||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~--G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSH--GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSS--CBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCC--CcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 4578999999986 4444444321 2458899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCCccccCCC--CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy18163 500 SHRGILKVGDFGLAREYGSP--LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQL 576 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~~--~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l 576 (1028)
+.++++||+|||+|+.+... ....+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999866432 223455789999999999987 569999999999999999998 89999999988877
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
..+......+ . ...+++.+.+||.+||..||.+|||+.+|+++
T Consensus 258 ~~i~~~~~~~---------------------~-----------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 258 EMIRNRQVLP---------------------C-----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHTTCCCC---------------------C-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCC---------------------C-----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7765421110 0 11256778899999999999999999999886
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=429.09 Aligned_cols=288 Identities=41% Similarity=0.720 Sum_probs=232.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||+|+||+||+|.+..+++.||||++...... .....+.+|+.+|..++||||+++++++.. ...+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEE
Confidence 6899999999999999999999999999999999765432 223344579999999999999999998864 4579999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
|||+.++|.+++. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....+..
T Consensus 79 ~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 79 FEYLDKDLKQYLD---DCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ecccccCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999976665554 4455689999999999999999999999999999999999999999999999999987765555
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.....+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|+.........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 56667899999999999886779999999999999999999999999999999999999999999999888765444333
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
...+..+. ..........+++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus 236 ~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYR---AEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCC---CCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccc---chhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 32222211 1111122345788999999999999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=418.63 Aligned_cols=290 Identities=39% Similarity=0.723 Sum_probs=233.8
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc---cCCccchHHHHHHHHHcC---CCCeeEEEEEEe
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK---EGFPITSLREINTLLKAQ---HPNIVTVREIVV 431 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~---~~~~~~~lrEi~iL~~l~---HPNIV~L~~i~~ 431 (1028)
....++|++++.||+|+||+||+|++..+++.||||++...... ........+|+.++..+. ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34567999999999999999999999999999999999755421 223345667888777765 999999999987
Q ss_pred ecCCC---eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEe
Q psy18163 432 GSNMD---KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVG 508 (1028)
Q Consensus 432 ~~~~~---~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~ 508 (1028)
..... .+++||||+.++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp ECCSSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred ccCCCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 54422 58999999998777666532 22348999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 509 DFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 509 DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
|||+++.+... ...+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..++..++.+..
T Consensus 163 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCC-cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99999876543 34466789999999999987 56899999999999999999999999999999999999999999988
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..|+....++.. .++...........+.+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 241 DDWPRDVSLPRG------AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTSCSSCSSCGG------GSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhccchhhcccc------ccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 888766544321 111111111222335578899999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=427.99 Aligned_cols=300 Identities=40% Similarity=0.733 Sum_probs=243.7
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN---- 434 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~---- 434 (1028)
...++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|..++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 3468999999999999999999999999999999999776655555667789999999999999999999986543
Q ss_pred --CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCC
Q psy18163 435 --MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512 (1028)
Q Consensus 435 --~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGl 512 (1028)
...+||||||+.++|.+++ ......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l---~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHH---HCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cCCceEEEEEeccCCCHHHHH---hhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4579999999997665554 34445689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC----CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 513 AREYGSP----LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 513 Ar~~~~~----~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
++.+... .......+||+.|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+.+..+...++.+..
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9876422 233456789999999999987677899999999999999999999999999999999999999999888
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPID 662 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~ 662 (1028)
..|+..........+....... ............++.+.+||.+||..||.+|||+.|+|+||||+..+.|..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQK-RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCC-CCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred hhccccccchhhcccccccccc-cCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 8887665433222211111000 000000111123677899999999999999999999999999998765543
|
| >4dbg_B Ring finger protein 31; ubiquitin fold, ubiquitination, ligase; 2.71A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=392.40 Aligned_cols=142 Identities=33% Similarity=0.549 Sum_probs=139.3
Q ss_pred HhhHHHHHHHHHHhhcCCChhhhHHhhccCCCCCchhHHHhhHHHHHHHHHHHhhccCCCCCCCCcCcccHHHHHHHHHH
Q psy18163 876 KQGMEMVKLLREAEQNGFTAEDLTIALSHCGDGPPVTWLINNWRHMIDTVVTLATNYGHERSENNVGTLSAVEARDALRL 955 (1028)
Q Consensus 876 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 955 (1028)
.+|++||+||||||+.|||||||++||.+|++..|++||++||+|+|++|++||+++|.. .|.+|++|||.||+.
T Consensus 12 e~Gl~lV~liREaEk~GfspEEV~aAl~~~g~~~P~~WLk~ewp~ll~~V~~la~~~~~~-----~g~~s~~EAr~Aw~~ 86 (162)
T 4dbg_B 12 EEGLQLVSMIREGEAAGACPEEIFSALQYSGTEVPLQWLRSELPYVLEMVAELAGQQDPG-----LGAFSCQEARRAWLD 86 (162)
T ss_dssp HHHHHHHHTTSTTCCSCCCHHHHHHHHHHHTCCCCHHHHHHHSCSHHHHHHHHHHHHCGG-----GCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCHHHHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHHHHhCCC-----CCcccHHHHHHHHHH
Confidence 589999999999999999999999999999999999999999999999999999999944 999999999999999
Q ss_pred hcCChHHHHHHHHHHHHHHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHhhccccchhhhhhcCC
Q psy18163 956 HNGNVWAAVTECVETRQKKFNDLMSRGNFTREDIVTVLTANHGNVESAYVELNKTQLKPFLMRIWGP 1022 (1028)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1028)
++||+|+||++||++|++||+||+++||++.+||++||++|||||++||.+|||++|+||||||||+
T Consensus 87 ~~Gd~~~Av~~ci~~R~~K~~eL~s~G~~~~~~~~~aL~~~~Gdv~~Al~eLqr~lLePF~~RIW~~ 153 (162)
T 4dbg_B 87 RHGNLDEAVEECVRTRRRKVQELQSLGFGPEEGSLQALFQHGGDVSRALTELQRQRLEPFRQRLWDS 153 (162)
T ss_dssp TTTCHHHHHHHHHHHHHHHHHHHHHTTCCGGGTHHHHHHHTTTCHHHHHHHHHHHHTHHHHHHHHCC
T ss_pred ccCChHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHHHcCCcHHHHHHHHHHHHhhHHHHHhccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=441.75 Aligned_cols=295 Identities=34% Similarity=0.564 Sum_probs=233.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC---C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM---D 436 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~---~ 436 (1028)
..++|++++.||+|+||+||+|++..+++.||||++............+++|+.+|..++||||+.+++++..... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4578999999999999999999999999999999997643333334567899999999999999999998865432 5
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+||||||++++|..++. ....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 104 ~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCCcCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 799999999987666553 2456899999999999999999999999999999999999999999999999999876
Q ss_pred CCCC----------------------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-----------C
Q psy18163 517 GSPL----------------------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-----------M 563 (1028)
Q Consensus 517 ~~~~----------------------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-----------G 563 (1028)
.... ...+..+||++|+|||++.....|+.++||||||||||||++ |
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 5432 124678999999999998766789999999999999999998 6
Q ss_pred CCCCCCCC-----------------hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHH
Q psy18163 564 EPLFTGKS-----------------DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTEL 626 (1028)
Q Consensus 564 ~pPF~g~s-----------------d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~ 626 (1028)
.++|.+.+ ..+++..|+..+|.|....+............. ..+...........+.+++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK--LFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH--TSCCCCCCCHHHHSTTSCHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH--hCCCCCCCCHHHHCCCCCHH
Confidence 67777755 478899999999998876555443322111111 11111111112223457899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 627 GYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 627 a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
+.+||.+||..||.+|||+.|+|+||||++...+
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 9999999999999999999999999999986554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=424.43 Aligned_cols=296 Identities=41% Similarity=0.767 Sum_probs=240.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc---cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK---EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~---~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 86 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSN 86 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CCc
Confidence 47899999999999999999999999999999999754322 2223456799999999999999999998854 457
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+++||||+.++|..+ +......+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+.
T Consensus 87 ~~lv~e~~~~~l~~~---~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVI---IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHH---HTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHH---HHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999999755444 44455568889999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
......+..+||+.|+|||++.+...|+.++||||||||+|+|++|.+||.+.++.+.+..++...+.+....|+....+
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 66556677899999999999987667899999999999999999999999999999999999999999998888877655
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMF 666 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~ 666 (1028)
+.... +..++. .........++..+.+||.+||..||.+|||+.|+|+||||+..+.|......
T Consensus 244 ~~~~~--~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~ 307 (346)
T 1ua2_A 244 PDYVT--FKSFPG---IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 307 (346)
T ss_dssp TTCCC--CCCCCC---CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSS
T ss_pred ccccc--ccccCC---CChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccC
Confidence 43311 111111 11112234577899999999999999999999999999999987766544433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=421.62 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=219.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEE
Confidence 4578999999999999999999999999999999998765433334556789999999999999999998854 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ ++|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~--~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASG--GEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTT--CBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCC--CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999975 3444443332 45899999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------------- 232 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-------------- 232 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 34567799999999999988655568999999999999999999999999887777776552110
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
+ ...+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 233 --------~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 233 --------I-----------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp --------C-----------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred --------C-----------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 0 012567899999999999999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=446.84 Aligned_cols=287 Identities=30% Similarity=0.551 Sum_probs=226.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----M 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~ 435 (1028)
..++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... .
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 457899999999999999999999999999999999865433334456779999999999999999999986432 3
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+||||||+.++|..++ . ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 140 ~~~~lv~E~~~~~l~~~~---~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVI---Q---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEEHHHHH---T---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCCHHHHH---h---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 578999999997654443 2 2488999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... ...+..+||++|+|||++.+ ..|+.++||||||||||+|++|++||.+.+..+++..|++.+|.|....+....
T Consensus 214 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---C-CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCC-cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 7543 34566899999999999988 579999999999999999999999999999999999999999998776655432
Q ss_pred CChhhhhhccccCCCCCCCccc------------cccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTK------------VAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~------------~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
. ..... ....+........ ......++.+++||.+||.+||.+|||+.|+|+||||+..
T Consensus 292 ~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 292 P--TVRNY-VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp H--HHHHH-HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred h--hhhhH-hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 1 11110 0011111100000 0011126779999999999999999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=431.75 Aligned_cols=289 Identities=33% Similarity=0.524 Sum_probs=230.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----CC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----MD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~~ 436 (1028)
.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|..++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999999999999999999654433333455678999999999999999999986442 24
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+||||||++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 6799999998788777653 35889999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. ..+..+||++|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..|+...+.++..++.....
T Consensus 179 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 53 345678999999999998866799999999999999999999999999999999999999999887665544332
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
.....- ....+......+......+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 256 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 256 DEAKNY--MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHH--HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHH--HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 111100 0111111111222333457889999999999999999999999999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=432.21 Aligned_cols=257 Identities=21% Similarity=0.329 Sum_probs=205.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC-----CeEEEEEEeeccccccCCccchHHHHHHHHHcCC-CCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT-----DEIVALKRLKMEKEKEGFPITSLREINTLLKAQH-PNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t-----g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H-PNIV~L~~i~~~~~ 434 (1028)
.++|++.+.||+|+||+||+|.+..+ ++.||||+++...... ....+.+|+.+|.++.| ||||++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-HHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 47899999999999999999998654 4689999997643321 23457789999999976 8999999987543
Q ss_pred CCeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~ 501 (1028)
.+.+|||||||.+ +|.+++..... ....+++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 3468999999986 55555443221 1234789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy18163 502 RGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSR 578 (1028)
Q Consensus 502 ~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~k 578 (1028)
++++||+|||+|+.+..... ..+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987644322 2345789999999999987 679999999999999999998 9999998765444444
Q ss_pred HHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 579 I~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
++.....+. . ...+++.+.+||.+||..||.+|||+.+|++|
T Consensus 300 ~i~~g~~~~--------------------~-----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMR--------------------A-----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCC--------------------C-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC--------------------C-----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 443211110 0 11256788999999999999999999999997
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=423.67 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=213.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~ 437 (1028)
..++|++++.||+|+||+||+|++..+++.||||++++... .........+|+.+|..+ .||||+++++++.. .+.
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCE
Confidence 46899999999999999999999999999999999986532 223344567899999887 69999999988854 458
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|||||||.+ ++|...+... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 99 ~~lv~E~~~g--g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNG--GDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCS--CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCC--CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999986 4444444333 458999999999999999999999999999999999999999999999999998655
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------ 242 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV------------ 242 (353)
T ss_dssp C---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------
T ss_pred cCCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 44445567899999999999987 56999999999999999999999999999998888888663110
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH------HHHHhCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA------DEALRHDYFSESP 658 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA------~ElL~HPfF~e~p 658 (1028)
+ ...++..+.+||.+||..||.+||++ .++++||||++..
T Consensus 243 ----------~-----------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 243 ----------Y-----------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp ----------C-----------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred ----------C-----------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 0 11256789999999999999999999 9999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=418.43 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=219.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|++..+++.||||++++... .........+|+.+|..++||||+.+++++.. .+.+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEE
Confidence 45789999999999999999999999999999999976532 22334566789999999999999999988854 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||+.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 81 ~lv~E~~~g--g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANG--GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTT--CBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999986 344444433 34689999999999999999999999999999999999999999999999999987554
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
........+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+.......|......
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------- 223 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------------- 223 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------
T ss_pred CCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 4455667899999999999987 56899999999999999999999999998877777766542100
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
+ ...+++.+.+||.+||..||.+|| ++.++++||||+...
T Consensus 224 ---------~-----------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 224 ---------F-----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp ---------C-----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ---------C-----------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 0 112678899999999999999999 999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=423.33 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=220.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC----CccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG----FPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~----~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..+.|++++.||+|+||+||+|.+..+|..||||+++....... ....+.+|+.+|..+.||||+++++++.. .
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 87 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--R 87 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--C
Confidence 45789999999999999999999999999999999987643221 22456789999999999999999998854 4
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC----cEEEeccC
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG----ILKVGDFG 511 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g----~lKL~DFG 511 (1028)
..+||||||+.+ ++|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~lv~e~~~g--g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 88 TDVVLILELVSG--GELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp SEEEEEEECCCS--CBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred CEEEEEEEcCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 589999999975 445544433 45689999999999999999999999999999999999998776 79999999
Q ss_pred CccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
++..+... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......+...
T Consensus 165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 240 (361)
T 2yab_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE-- 240 (361)
T ss_dssp SCEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH--
T ss_pred CceEcCCC-CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch--
Confidence 99877543 34556789999999999977 569999999999999999999999999999888888776532221111
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 ---------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 241 ---------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp ---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred ---------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 112367889999999999999999999999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=430.53 Aligned_cols=298 Identities=39% Similarity=0.752 Sum_probs=225.5
Q ss_pred cCCeEEE-EEeeecCcEEEEEEEEC--CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCL-NRIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il-~~LG~G~FG~Vyla~d~--~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.+.|++. ++||+|+||+||+|++. .++..||||++.... ....+.+|+.+|..++||||+++++++.......
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 3567774 47999999999999976 578899999997532 3345779999999999999999999998777789
Q ss_pred EEEEEeccccchHHHHHHHhhc-----CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee----cCCCcEEEe
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSK-----KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL----SHRGILKVG 508 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~-----~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL----d~~g~lKL~ 508 (1028)
+||||||+.++|.+++...... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 9999999999888877654322 2248899999999999999999999999999999999999 677899999
Q ss_pred ccCCccccCCCC---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHH
Q psy18163 509 DFGLAREYGSPL---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---------LEQL 576 (1028)
Q Consensus 509 DFGlAr~~~~~~---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---------~d~l 576 (1028)
|||+|+.+.... ......+||++|+|||++.+...|+.++||||||||||+|++|.+||.+.+. .+++
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 999998765432 2345678999999999998867799999999999999999999999987654 4889
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhcc----ccCCCCCCCc-cccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTF----AEYPNVGGLK-TKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~----~~~p~~~~l~-~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
..|+..++.|....|..+..++....... ..+....... ........++.+.+||.+||.+||.+|||+.|||+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 99999999999998887765543322110 0011000000 000112236788999999999999999999999999
Q ss_pred CCCCCCCCCCC
Q psy18163 652 DYFSESPLPID 662 (1028)
Q Consensus 652 PfF~e~p~p~~ 662 (1028)
|||++.++|..
T Consensus 335 p~f~~~~~~~~ 345 (405)
T 3rgf_A 335 PYFLEDPLPTS 345 (405)
T ss_dssp GGGTSSSCCCS
T ss_pred hhhccCCCCcc
Confidence 99998877654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=432.31 Aligned_cols=285 Identities=33% Similarity=0.532 Sum_probs=231.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec----CCCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS----NMDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~----~~~~ 437 (1028)
.+|++++.||+|+||+||+|++..+++.||||++.... ....+|+.+|+.++|||||+++++|... +...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 47999999999999999999999999999999986532 1234799999999999999999988542 2234
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC-CcEEEeccCCcccc
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR-GILKVGDFGLAREY 516 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~-g~lKL~DFGlAr~~ 516 (1028)
++|||||+.++|..++..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.+
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998888877766667789999999999999999999999999999999999999954 67899999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ......+||++|+|||++.+...|+.++||||||||||||++|.+||.+.+..+++.+|++.++.|....|....
T Consensus 208 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~- 285 (420)
T 1j1b_A 208 VRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 285 (420)
T ss_dssp CTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC-
T ss_pred ccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC-
Confidence 543 234557899999999999876679999999999999999999999999999999999999998887643321110
Q ss_pred ChhhhhhccccCCCCCCC-ccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGL-KTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l-~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
+.+.... ++..... ....+...+++.+.+||.+||.+||.+|||+.|+|+||||.+..
T Consensus 286 -~~~~~~~---~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 286 -PNYTEFK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp -SCCCCCC---CCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred -hhhhhhc---cCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000001 1111110 01123345788999999999999999999999999999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=409.37 Aligned_cols=290 Identities=33% Similarity=0.573 Sum_probs=220.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.++..++||||+++++++... ..+++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEEE
Confidence 4689999999999999999999999999999999876543333344567899999999999999999998643 58999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ +.+...+ .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 v~e~~~~--~~l~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDH--TVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSE--EHHHHHH-HTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEeCCC--chHHHHH-hhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999987 3333322 334568999999999999999999999999999999999999999999999999998876555
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++......+..+......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 55567789999999999987677899999999999999999999999999999988888877665432211111000000
Q ss_pred hhhccccCCCCCC-CccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGG-LKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 601 ~~l~~~~~p~~~~-l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
... ..+.... .......+.++..+.+||.+||..||.+|||+.++|+||||++..
T Consensus 237 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 237 SGV---KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TTC---CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccC---cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 000 0010000 001111234778899999999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=423.13 Aligned_cols=285 Identities=28% Similarity=0.534 Sum_probs=232.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec------
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS------ 433 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~------ 433 (1028)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+.+|+.++||||++++++|...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34689999999999999999999999999999999865422 223799999999999999999988542
Q ss_pred ------------------------------CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH
Q psy18163 434 ------------------------------NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483 (1028)
Q Consensus 434 ------------------------------~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLH 483 (1028)
....++|||||+.++|.+++..+......+++..++.|+.||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 23358999999999888888877677778999999999999999999999
Q ss_pred hCCcccccccccceeec-CCCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh
Q psy18163 484 DNWILHRDLKTSNLLLS-HRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC 562 (1028)
Q Consensus 484 s~gIVHRDLKPeNILLd-~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT 562 (1028)
++||+||||||+||||+ .++.+||+|||+|+.+... ......+||+.|+|||++.+...|+.++|||||||++|+|++
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 99999999999999998 6899999999999876543 334567889999999999886779999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCC-ccccccccccHHHHHHHHHhcccCcCC
Q psy18163 563 MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGL-KTKVAGSILTELGYDLLCKFLTYDPVT 641 (1028)
Q Consensus 563 G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l-~~~~~~~~Ls~~a~DLL~kcL~~DP~k 641 (1028)
|.+||.+.+..+++..++..++.|....+.... +..... .++..... ....+...+++.+.+||.+||.+||.+
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEV---RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC--TTC--C---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhC--cccccc---cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999999999999999999887643221110 000000 11111111 112233447888999999999999999
Q ss_pred CCCHHHHHhCCCCCC
Q psy18163 642 RITADEALRHDYFSE 656 (1028)
Q Consensus 642 RPTA~ElL~HPfF~e 656 (1028)
|||+.|+|+||||++
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=428.61 Aligned_cols=289 Identities=31% Similarity=0.503 Sum_probs=219.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec----CCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS----NMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~----~~~ 436 (1028)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|..++||||+.+++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999999999999999975433222334567899999999999999999988543 235
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+||||++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 6899999998888777642 45899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. ..+..+||++|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..|+..+|.|....+.....
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 AD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred cc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 53 245678999999999998767799999999999999999999999999999999999999999987766655443
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
.....- ....+.............+++.+.+||.+||..||.+|||+.++|+||||++...
T Consensus 260 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 260 ESARNY--IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHH--HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHH--HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 211100 0111111111112223446789999999999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=415.15 Aligned_cols=268 Identities=20% Similarity=0.340 Sum_probs=225.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||+|+||+||+|.+..++..||+|++..... ....+.+|+.+|..++||||+++++++... +.+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc---cHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEEE
Confidence 4789999999999999999999999999999999975432 223467899999999999999999988654 58999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC--CCcEEEeccCCccccCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH--RGILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~--~g~lKL~DFGlAr~~~~ 518 (1028)
|||||.+ ++|.+.+......+++.++..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+..
T Consensus 79 v~e~~~g--~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 79 IFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EECCCCC--CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEeCCC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999987 5666666555567999999999999999999999999999999999999987 78999999999987754
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------- 226 (321)
T 1tki_A 157 G-DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------- 226 (321)
T ss_dssp T-CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH--------
T ss_pred C-CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh--------
Confidence 3 34556789999999999987 5689999999999999999999999999998888888776432211111
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMF 666 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~ 666 (1028)
...++..+.+||.+||..||.+|||+.++|+||||++...+..+..+
T Consensus 227 ---------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~ 273 (321)
T 1tki_A 227 ---------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273 (321)
T ss_dssp ---------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSCCCCC
T ss_pred ---------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcccccHHHH
Confidence 12367889999999999999999999999999999876544444433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=422.34 Aligned_cols=288 Identities=32% Similarity=0.534 Sum_probs=231.1
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN---- 434 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~---- 434 (1028)
....+|++++.||+|+||+||+|++..++. ||+|++..... ...+|+.+|+.++||||+++++++....
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 345689999999999999999999987776 88887754321 2237999999999999999999986533
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec-CCCcEEEeccCCc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS-HRGILKVGDFGLA 513 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd-~~g~lKL~DFGlA 513 (1028)
...+||||||+.+++...+.........+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 234889999999877766666555667799999999999999999999999999999999999999 7999999999999
Q ss_pred cccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 514 REYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 514 r~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
+.+... ......+||+.|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..|++.++.|....+..
T Consensus 190 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876443 3345678999999999998867799999999999999999999999999999999999999988876543211
Q ss_pred CCCChhhhhhccccCCCCCCCc-cccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLK-TKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~-~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
.. +..... .++...... ...+...+++.+.+||.+||.+||.+|||+.++|+||||++...
T Consensus 269 ~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 269 MN--PNYMEH---KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HC--GGGSSS---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hC--hhhhhh---ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 10 010000 111111111 12233457889999999999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=403.87 Aligned_cols=257 Identities=25% Similarity=0.464 Sum_probs=218.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|.+..+++.||||++..... .....+.+|+.++..++||||+++++++... +.+|+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC--CEEEE
Confidence 4689999999999999999999999999999999976542 2344567899999999999999999988654 48999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++. . ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 95 v~e~~~~~~L~~~~~---~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVT---E--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEECCTTCBHHHHHH---H--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEECCCCCCHHHHHh---h--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999965 5555443 2 24889999999999999999999999999999999999999999999999999887665
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+..+..... +...
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~---------- 237 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQ---------- 237 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCS----------
T ss_pred ccccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCC----------
Confidence 555667799999999999987 5689999999999999999999999999888777766654321 1000
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 238 -------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 238 -------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 012367788999999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=430.47 Aligned_cols=263 Identities=29% Similarity=0.421 Sum_probs=222.4
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
...++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++. ..+.+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~ 85 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS--EEGHH 85 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE--CSSEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE--ECCEE
Confidence 3457899999999999999999999999999999999866543333445678999999999999999999885 44589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec---CCCcEEEeccCCccc
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS---HRGILKVGDFGLARE 515 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd---~~g~lKL~DFGlAr~ 515 (1028)
|||||||.+ ++|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..
T Consensus 86 ~lv~E~~~g--g~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 86 YLIFDLVTG--GELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EEEECCCBC--CBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEEEeCCC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999987 455555544 34689999999999999999999999999999999999998 467899999999988
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
...........+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+......++...|
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---- 237 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW---- 237 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT----
T ss_pred ecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc----
Confidence 7765555667899999999999987 56899999999999999999999999999988888887765333222222
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 238 -------------------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 238 -------------------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp -------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred -------------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 225678999999999999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=424.73 Aligned_cols=266 Identities=25% Similarity=0.362 Sum_probs=220.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|++..+++.||||++++... .......+.+|+.+|..++||||+++++++. +...+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--DDRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE--CSSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEE
Confidence 45789999999999999999999999999999999976432 2333455778999999999999999998885 45589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||.+ ++|...+.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+..
T Consensus 145 ~lV~E~~~g--g~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 145 YMVMEYMPG--GDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEECCCTT--EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCC--CcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 999999965 344444433 2489999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-cccccccCccccCcccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 519 PLK-HYTPIVVTLWYRSPELLLGCK---EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 519 ~~~-~~t~~vGT~~Y~APEvL~g~~---~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
... ...+.+||+.|+|||++.+.. .|+.++||||||||||+|++|.+||.+.+..+.+.+|........
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------- 293 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT------- 293 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-------
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc-------
Confidence 322 244679999999999997632 278999999999999999999999999998888888865321100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC--CCCHHHHHhCCCCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEALRHDYFSESPLP 660 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k--RPTA~ElL~HPfF~e~p~p 660 (1028)
+|. ...++..+++||.+||..+|.+ |+++.+|++||||+...|.
T Consensus 294 -------------~p~---------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 294 -------------FPD---------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp -------------CCT---------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred -------------CCC---------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 000 0136788999999999999999 9999999999999986553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=403.89 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=212.7
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc------------------------CCccchHHHHHH
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE------------------------GFPITSLREINT 414 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~------------------------~~~~~~lrEi~i 414 (1028)
...++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34678999999999999999999999999999999997653211 112456789999
Q ss_pred HHHcCCCCeeEEEEEEeecCCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Q psy18163 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLK 493 (1028)
Q Consensus 415 L~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLK 493 (1028)
|..++||||+++++++.......+||||||+.+ +|.++ + ....+++.++..++.||+.||.|||++||+|||||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~---~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---P--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCS---S--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHH---h--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 999999999999999987667789999999975 44332 1 23468999999999999999999999999999999
Q ss_pred ccceeecCCCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy18163 494 TSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE--YSTPIDMWSVGCIFAEFLCMEPLFTGKS 571 (1028)
Q Consensus 494 PeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~--ys~ksDIWSLGvILyELLTG~pPF~g~s 571 (1028)
|+||||+.++.+||+|||+++.+..........+||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999999887654444566789999999999976432 4788999999999999999999999887
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 572 DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 572 d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.......+...... ++. ...+++.+.+||.+||..||.+|||+.++|+|
T Consensus 245 ~~~~~~~~~~~~~~----------------------~~~---------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMCLHSKIKSQALE----------------------FPD---------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHHCCCC----------------------CCS---------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHHhcccCC----------------------CCC---------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 66655555432110 000 12366789999999999999999999999999
Q ss_pred CCCC
Q psy18163 652 DYFS 655 (1028)
Q Consensus 652 PfF~ 655 (1028)
|||+
T Consensus 294 p~~~ 297 (298)
T 2zv2_A 294 PWVT 297 (298)
T ss_dssp HHHH
T ss_pred cccc
Confidence 9995
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=417.19 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=217.9
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCC
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~ 436 (1028)
...++|++++.||+|+||+||+|+++.+++.||||++++... ..........|+.+|..+ .||||+++++++.. ..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CC
Confidence 456899999999999999999999999999999999986532 122334566788888876 89999999988854 45
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+||||||+.+ +|..++. . ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus 92 ~~~lv~E~~~gg~L~~~l~---~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQ---S-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEEECCTTCBHHHHHH---H-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEEeCCCCCcHHHHHH---H-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 89999999976 5544443 3 24589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|.... +
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~--------- 235 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--P--------- 235 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C---------
T ss_pred cccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--C---------
Confidence 5444445567899999999999987 568999999999999999999999999988887777775421 0
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHH-HHHhCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD-EALRHDYFSESP 658 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~-ElL~HPfF~e~p 658 (1028)
.+ ...++..+.+||.+||..||.+||++. ++++||||+...
T Consensus 236 -----------~~-----------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 236 -----------FY-----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp -----------CC-----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -----------CC-----------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 00 112678899999999999999999998 999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=397.71 Aligned_cols=289 Identities=38% Similarity=0.728 Sum_probs=237.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEEC-CCCeEEEEEEeeccccccCCccchHHHHHHHHHc---CCCCeeEEEEEEee---
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDK-RTDEIVALKRLKMEKEKEGFPITSLREINTLLKA---QHPNIVTVREIVVG--- 432 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~-~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l---~HPNIV~L~~i~~~--- 432 (1028)
..++|++++.||+|+||+||+|++. .+++.||||++..............+|+.++..+ .||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999987654444455667888887776 89999999998862
Q ss_pred cCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCC
Q psy18163 433 SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512 (1028)
Q Consensus 433 ~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGl 512 (1028)
.....+++||||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 2445799999999988877775432 33488999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|+
T Consensus 167 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 167 ARIYSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCCGG-GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccccCC-CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 9876532 23456789999999999987 568999999999999999999999999999999999999998888877776
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.....+... + ..............++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 245 ~~~~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 245 RDVALPRQA---F---HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp TTCSSCGGG---S---CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhh---h---cccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 544333211 0 00011111223355788999999999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=415.85 Aligned_cols=288 Identities=35% Similarity=0.576 Sum_probs=234.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC---CCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN---MDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~---~~~l 438 (1028)
++|++++.||+|+||.||+|.+..++..||||++..... ......+.+|+.+|..++||||+++++++.... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 689999999999999999999999999999999975322 122345678999999999999999999886432 2468
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+||||++++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999999877666542 3589999999999999999999999999999999999999999999999999987653
Q ss_pred CC---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 PL---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.. ...+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....+....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 21 123456899999999998776779999999999999999999999999999999999999998888765554433
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....... ....+...........+.++..+.+||.+||..||.+|||+.++|+||||++.
T Consensus 261 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 261 NLKARNY--LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CHHHHHH--HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhHHHH--HHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 2221111 11111111222223334578899999999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=404.41 Aligned_cols=295 Identities=35% Similarity=0.563 Sum_probs=230.4
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec---CC
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS---NM 435 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~---~~ 435 (1028)
...++|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+|..++||||+++++++... ..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 345789999999999999999999999999999999964321 11234556899999999999999999887533 23
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+|+||||+.++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 87 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCEEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67999999999877666543 3589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC----------cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q psy18163 516 YGSPLK----------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 516 ~~~~~~----------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
+..... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 643211 1234688999999999876677999999999999999999999999999999999999988887
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
+...........+..... ....+...........+.+++.+.+||.+||..||.+|||+.++|+||||+....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREY-IKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp CCSTTTTTTCCCHHHHHH-HHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred CchhccccccccchhhHH-hhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 764322211111111110 00111111111112234578899999999999999999999999999999876443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=414.36 Aligned_cols=264 Identities=27% Similarity=0.376 Sum_probs=216.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc---CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE---GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~---~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.+.|++++.||+|+||+||+|.+..+++.||||++....... .....+.+|+.++..++||||+++++++... ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 367999999999999999999999999999999997654221 1234567899999999999999999988654 58
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc---EEEeccCCc
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI---LKVGDFGLA 513 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~---lKL~DFGlA 513 (1028)
+|||||||.+ +|.+++.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999985 666655544444556899999999999999999999999999999999999986554 999999999
Q ss_pred cccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 514 REYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 514 r~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
..+..........+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.. .+.+..+..........
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~---- 254 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR---- 254 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH----
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc----
Confidence 887665444566789999999999987 568999999999999999999999998753 34455554421111000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....++..+.+||.+||..||.+|||+.++|+||||++.
T Consensus 255 -------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 255 -------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 112367889999999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=411.84 Aligned_cols=292 Identities=29% Similarity=0.508 Sum_probs=223.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC-----
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----- 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----- 434 (1028)
..++|++.+.||+|+||+||+|.+..++..||||++.... .......+++..+..++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 4678999999999999999999999999999999986542 23345667888888999999999999986432
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH--hCCcccccccccceeecC-CCcEEEeccC
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH--DNWILHRDLKTSNLLLSH-RGILKVGDFG 511 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLH--s~gIVHRDLKPeNILLd~-~g~lKL~DFG 511 (1028)
...+|+||||+.++|...+.........+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 2248999999999877666655556677899999999999999999999 999999999999999996 8999999999
Q ss_pred CccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+++.+... ......+||+.|+|||++.+...++.++||||||||+|+|++|.+||.+.+..+.+..++..++.+....+
T Consensus 178 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 178 SAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp TCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 99877543 33456789999999999987667999999999999999999999999999999999999998887765443
Q ss_pred CCCCCChhhhhhccccCCCCCCCcc----ccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKT----KVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~----~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
....... ....+.. .....+ .......++.+.+||.+||..||.+|||+.|+|+||||++...+
T Consensus 257 ~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 257 RKLNPSH--TDVDLYN---SKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HHHCTTC--CCGGGGC---CCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred Hhcccch--hhccccc---cccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 2211000 0000000 000000 01112356789999999999999999999999999999875443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=420.81 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=212.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~ 437 (1028)
..++|++++.||+|+||+||+|++..+++.||||++++..... .....+.+|+.+|..+ +||||++++++|.. ...
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCE
Confidence 4578999999999999999999999999999999998764322 2334567899998876 89999999988854 458
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|||||||.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 128 ~~lV~E~~~g--g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNG--GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTT--CBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999987 444444433 3458999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---------LEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---------~d~l~kI~~~lg~p~~ 588 (1028)
.........+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+... ......+....
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred cCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 44455667899999999999988 6799999999999999999999999965321 11222222210
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH------HHHHhCCCCCCCCC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA------DEALRHDYFSESPL 659 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA------~ElL~HPfF~e~p~ 659 (1028)
.. +...++..+.+||.+||..||.+||++ .+|++||||+...|
T Consensus 279 -----------------~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 279 -----------------IR-----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp -----------------CC-----------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred -----------------cC-----------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 00 112367889999999999999999985 89999999987543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=418.54 Aligned_cols=287 Identities=30% Similarity=0.530 Sum_probs=217.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----M 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~ 435 (1028)
..++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.++..++||||+++++++.... .
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357899999999999999999999999999999999765433333345678999999999999999999986433 2
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+||||||+.++|.+++. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 4789999999986665542 2478999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... ...+..+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..++..++.+....+....
T Consensus 177 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccc-cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 6543 23456789999999999987 569999999999999999999999999999999999999888877655443332
Q ss_pred CChhhhhhccccCCCCCCCcc------------ccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKT------------KVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~------------~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
. ..... ....+....... .......+..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 255 ~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 255 P--TVRTY-VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp H--HHHHH-HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred h--HHHHH-HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 1 00000 000000000000 00011236788999999999999999999999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=426.71 Aligned_cols=269 Identities=23% Similarity=0.335 Sum_probs=223.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|+++++||+|+||+||+|++..+++.||||++++... .......+.+|+.+|..+.||||+.+++++.. ...+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~ 149 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNL 149 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEE
Confidence 45789999999999999999999999999999999976432 22334457789999999999999999988754 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||.+ ++|...+......+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 150 ~lV~Ey~~g--g~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 150 YLVMDYYVG--GDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEECCCTT--CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCC--CcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999976 455555554456799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-cccccccCccccCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 519 PLK-HYTPIVVTLWYRSPELLL----GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 519 ~~~-~~t~~vGT~~Y~APEvL~----g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
... ..+..+||+.|+|||++. +...|+.++|||||||+||||++|.+||.+.+..+.+.+|+.....+
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------- 300 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------- 300 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-------
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-------
Confidence 322 234578999999999997 23568999999999999999999999999999888888886532110
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC--CCCHHHHHhCCCCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT--RITADEALRHDYFSESPLP 660 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k--RPTA~ElL~HPfF~e~p~p 660 (1028)
.+ |. ....+++.+++||.+||+.+|.+ |++++++++||||+...|.
T Consensus 301 ----------~~---p~--------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 301 ----------QF---PT--------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp ----------CC---CS--------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred ----------cC---Cc--------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 00 00 01236788999999999999998 9999999999999986553
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=407.05 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=217.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|++..+|+.||||++++.... ........+|+.+|..+.||||+++++++. +...+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE--eCCEE
Confidence 457899999999999999999999999999999999865422 223345668999999999999999998885 44589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
||||||+.+ +|.+++. . ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 82 ~lv~e~~~gg~L~~~l~---~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLR---K-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEECCCCSCBHHHHHH---H-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEEEeCCCCCCHHHHHH---H-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999986 5544443 3 3468999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------ 221 (318)
T 1fot_A 158 D---VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR------------ 221 (318)
T ss_dssp S---CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC------------
T ss_pred C---ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 3 2345789999999999987 56899999999999999999999999998888888777653110
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
+ ...+++.+.+||.+||..||.+|| +++++++||||+...
T Consensus 222 ----------~-----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 222 ----------F-----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp ----------C-----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ----------C-----------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 0 112567899999999999999999 999999999998753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=414.13 Aligned_cols=299 Identities=26% Similarity=0.320 Sum_probs=228.2
Q ss_pred CCCCCccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC--------C
Q psy18163 349 PPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ--------H 420 (1028)
Q Consensus 349 p~y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~--------H 420 (1028)
.+|++...+....++|+++++||+|+||+||+|++..+++.||||++..... ....+.+|+.+|..+. |
T Consensus 24 ~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~ 100 (397)
T 1wak_A 24 GGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH---YTETALDEIRLLKSVRNSDPNDPNR 100 (397)
T ss_dssp --CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred CCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc---chHHHHHHHHHHHHHhhcCCCCCCc
Confidence 4677777777778999999999999999999999999999999999975421 2345678999999886 7
Q ss_pred CCeeEEEEEEeec--CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-Ccccccccccce
Q psy18163 421 PNIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNL 497 (1028)
Q Consensus 421 PNIV~L~~i~~~~--~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNI 497 (1028)
+||+++++++... +...+||||||++++|.+.+.. .....+++..++.|+.||+.||.|||++ ||+||||||+||
T Consensus 101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NI 178 (397)
T 1wak_A 101 EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178 (397)
T ss_dssp GGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGE
T ss_pred ceeeeeecceeecCCCCceEEEEEeccCccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHe
Confidence 8899999988632 4568999999998766555432 2335689999999999999999999998 999999999999
Q ss_pred eecCCC-------------------------------------------------cEEEeccCCccccCCCCCccccccc
Q psy18163 498 LLSHRG-------------------------------------------------ILKVGDFGLAREYGSPLKHYTPIVV 528 (1028)
Q Consensus 498 LLd~~g-------------------------------------------------~lKL~DFGlAr~~~~~~~~~t~~vG 528 (1028)
||+.++ .+||+|||+++.... ..+..+|
T Consensus 179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~g 255 (397)
T 1wak_A 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQ 255 (397)
T ss_dssp EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCS
T ss_pred eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---cCccCCC
Confidence 999775 799999999987653 3456689
Q ss_pred CccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCCCCCCCCCCChhhh-
Q psy18163 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS------DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ- 601 (1028)
Q Consensus 529 T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s------d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~- 601 (1028)
|+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+ ..+.+..+...++.++...+..........
T Consensus 256 t~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 256 TRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp CGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 999999999988 569999999999999999999999998765 567788888887776543221100000000
Q ss_pred -hhccccCCCCCCCc-------cccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 602 -KMTFAEYPNVGGLK-------TKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 602 -~l~~~~~p~~~~l~-------~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.............. ........+..+.+||.+||..||.+|||+.+||+||||++
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00000000000000 00012234567899999999999999999999999999963
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=414.01 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=217.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~ 437 (1028)
..++|++++.||+|+||+||+|++..+++.||||++++... ..........|+.+|..+ .||||+.+++++.. .+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 46889999999999999999999999999999999987542 223344567888888877 79999999988754 458
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
+||||||+.+ +|..++ ... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..
T Consensus 96 ~~lv~E~~~gg~L~~~l---~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHI---QQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEECCCSCBHHHHH---HHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHH---Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999976 554444 332 35899999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
..........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----------- 239 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----------- 239 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred ccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 444445567899999999999987 56899999999999999999999999999888888777652110
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
+ ...++..+.+||.+||..||.+|| ++.++++||||+...
T Consensus 240 -----------~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 240 -----------Y-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp -----------C-----------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred -----------C-----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 0 112678899999999999999999 579999999998653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=423.01 Aligned_cols=268 Identities=22% Similarity=0.304 Sum_probs=220.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|+++.+++.||||++++... .......+.+|+.+|..+.||||+++++++.. .+.+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~ 136 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYL 136 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 45789999999999999999999999999999999976432 22234456789999999999999999888754 4589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|||||||.+ +|.+++ ......+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 137 ~lVmE~~~gg~L~~~l---~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLL---SKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHH---HHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 999999965 555444 4444568999999999999999999999999999999999999999999999999998775
Q ss_pred CCCC-cccccccCccccCcccccC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 518 SPLK-HYTPIVVTLWYRSPELLLG------CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 518 ~~~~-~~t~~vGT~~Y~APEvL~g------~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
.... .....+||+.|+|||++.+ ...|+.++||||||||+|||++|.+||.+.+..+.+.+|.......
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---- 289 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL---- 289 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc----
Confidence 4322 2345799999999999973 2468999999999999999999999999999888888876521100
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCC---CCHHHHHhCCCCCCCCCCC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR---ITADEALRHDYFSESPLPI 661 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kR---PTA~ElL~HPfF~e~p~p~ 661 (1028)
.+ | .....+++.+++||.+||+ ||.+| ++++++++||||+...|..
T Consensus 290 -------------~~---p--------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 290 -------------SL---P--------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp -------------CC---C------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred -------------CC---C--------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 00 0 0012367899999999999 99998 5999999999999876643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=421.75 Aligned_cols=291 Identities=29% Similarity=0.461 Sum_probs=227.7
Q ss_pred ccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc------CCCCeeEEEEE
Q psy18163 356 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA------QHPNIVTVREI 429 (1028)
Q Consensus 356 ~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l------~HPNIV~L~~i 429 (1028)
.+.....+|++++.||+|+||+||+|.+..+++.||||+++.... ......+|+.++..+ .|+||+.++++
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc---hHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 344456789999999999999999999999999999999975432 223456788888776 57799999998
Q ss_pred EeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc--EEE
Q psy18163 430 VVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI--LKV 507 (1028)
Q Consensus 430 ~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~--lKL 507 (1028)
+... ..+||||||+.++|.+++... ....+++..++.|+.||+.||.|||++|||||||||+||||+.++. +||
T Consensus 168 ~~~~--~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 168 FTFR--NHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp EEET--TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEE
T ss_pred cccC--CeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEE
Confidence 8654 589999999998777776542 2345899999999999999999999999999999999999999887 999
Q ss_pred eccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 508 GDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 508 ~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
+|||+|+.... .....+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+++..++..++.+.
T Consensus 244 ~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 244 IDFGSSCYEHQ---RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp CCCTTCEETTC---CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccceecCC---cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999987653 2345689999999999988 5699999999999999999999999999999999999999988887
Q ss_pred CCCCCCCCCChhhhh-hccccCCC-------------------------CCCCccccccccccHHHHHHHHHhcccCcCC
Q psy18163 588 EKIWPGFSKLPAVQK-MTFAEYPN-------------------------VGGLKTKVAGSILTELGYDLLCKFLTYDPVT 641 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~-l~~~~~p~-------------------------~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k 641 (1028)
..++........+.. ..++.+.. ........+....++.+.+||.+||.+||.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 654432221111000 00000000 0000001112234678999999999999999
Q ss_pred CCCHHHHHhCCCCCCC
Q psy18163 642 RITADEALRHDYFSES 657 (1028)
Q Consensus 642 RPTA~ElL~HPfF~e~ 657 (1028)
|||+.|+|+||||+..
T Consensus 400 Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRR 415 (429)
T ss_dssp SCCHHHHHTSTTTC--
T ss_pred CCCHHHHhCChhhccC
Confidence 9999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=414.28 Aligned_cols=261 Identities=28% Similarity=0.391 Sum_probs=219.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||+||+|.+..++..||||++............+.+|+.+|..++||||+++++++.. ...+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 3468999999999999999999999999999999998654332233456789999999999999999998854 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC---CcEEEeccCCcccc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR---GILKVGDFGLAREY 516 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~---g~lKL~DFGlAr~~ 516 (1028)
||||||.+ ++|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..+
T Consensus 105 lv~e~~~g--g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 105 LVFDLVTG--GELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEECCCCS--CBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEecCCC--CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999987 555555543 3568999999999999999999999999999999999999864 45999999999877
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+......++...
T Consensus 182 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 253 (362)
T 2bdw_A 182 NDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------ 253 (362)
T ss_dssp TTC-CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG------
T ss_pred cCC-cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc------
Confidence 543 34456789999999999987 5699999999999999999999999999888877777765422211111
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
...+++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 254 -----------------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 254 -----------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp -----------------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred -----------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 1236788999999999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=410.03 Aligned_cols=291 Identities=23% Similarity=0.330 Sum_probs=224.6
Q ss_pred ccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-----CCCeeEEEE
Q psy18163 354 AIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-----HPNIVTVRE 428 (1028)
Q Consensus 354 ~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-----HPNIV~L~~ 428 (1028)
...+....++|+++++||+|+||+||+|++..+++.||||+++.... .......|+.++..+. ||||+++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK---YTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH---HHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh---hhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 33555667899999999999999999999999999999999974321 2234467899999986 999999999
Q ss_pred EEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-------
Q psy18163 429 IVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH------- 501 (1028)
Q Consensus 429 i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~------- 501 (1028)
++... +.+||||||++++|.+++... ....+++.+++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 104 ~~~~~--~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 104 KFMYY--DHMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEET--TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred eeeEC--CeeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 88654 489999999987877777542 2335889999999999999999999999999999999999975
Q ss_pred ------------------CCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhC
Q psy18163 502 ------------------RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM 563 (1028)
Q Consensus 502 ------------------~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG 563 (1028)
++.+||+|||+|+..... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHC
Confidence 789999999999876432 345689999999999988 5699999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhc----cccCCCCCCC---------ccccccccccHHHHHH
Q psy18163 564 EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMT----FAEYPNVGGL---------KTKVAGSILTELGYDL 630 (1028)
Q Consensus 564 ~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~----~~~~p~~~~l---------~~~~~~~~Ls~~a~DL 630 (1028)
.+||.+.+..+.+..+....+.++...+............. ...++..... .........++.+.+|
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 335 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence 99999999999998888877655432211100000000000 0000100000 0001112234678899
Q ss_pred HHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 631 LCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 631 L~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
|.+||..||.+|||+.|+|+||||+
T Consensus 336 i~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 336 LYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHhcCChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999995
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=404.36 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=217.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC----CccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG----FPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~----~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..+.|++.+.||+|+||+||+|.+..++..||||++........ ....+.+|+.+|..++||||+++++++.. .
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 86 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--K 86 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--C
Confidence 34679999999999999999999999999999999976543221 23456789999999999999999998854 4
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC----cEEEeccC
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG----ILKVGDFG 511 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g----~lKL~DFG 511 (1028)
..+|+||||+.+ ++|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+||||+.++ .+||+|||
T Consensus 87 ~~~~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 87 TDVILILELVAG--GELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SEEEEEEECCCS--CBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCC--CCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 589999999975 344444433 45689999999999999999999999999999999999999877 89999999
Q ss_pred CccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+++.+... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+......+..
T Consensus 164 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 238 (326)
T 2y0a_A 164 LAHKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED--- 238 (326)
T ss_dssp TCEECCTT-SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH---
T ss_pred CCeECCCC-CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc---
Confidence 99877543 33456789999999999976 56999999999999999999999999998888877777653211110
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 --------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 239 --------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp --------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred --------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 0112356788999999999999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=414.27 Aligned_cols=287 Identities=32% Similarity=0.516 Sum_probs=228.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC---
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD--- 436 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~--- 436 (1028)
..++|.+.+.||+|+||+||+|.+..+|+.||||++............+.+|+.++..++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34789999999999999999999999999999999976543333345667899999999999999999998644321
Q ss_pred -eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 -KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 -~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+|+||||+.++|..++ ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 34999999997655443 23489999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... .+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....+..+.
T Consensus 194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 194 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 6532 3456899999999999876679999999999999999999999999999999999999998888766554443
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...... .....+...........+.+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 271 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 271 DKAAKS--YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CHHHHH--HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhh--hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 211100 011111111111122234578899999999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=409.43 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=210.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~ 437 (1028)
..++|++++.||+|+||.||+|++..+++.||||++++..... .....+.+|+.+|..+ +||||+++++++.. ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 4578999999999999999999999999999999998654322 1223456799999887 89999999998854 458
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
+||||||+.+ +|..++ .. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..
T Consensus 85 ~~lv~e~~~gg~L~~~l---~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHM---QR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEECCCCSCBHHHHH---HH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEEEeCCCCCcHHHHH---HH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999976 554444 33 245899999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS---------DLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s---------d~d~l~kI~~~lg~p~ 587 (1028)
..........+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.... .......+....
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 235 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 235 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred cCCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence 444445567899999999999987 568999999999999999999999997521 112222222210
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH------HHHHhCCCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA------DEALRHDYFSESP 658 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA------~ElL~HPfF~e~p 658 (1028)
.. +...++..+.+||.+||..||.+||++ .++++||||+...
T Consensus 236 ------------------~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 236 ------------------IR-----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp ------------------CC-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred ------------------CC-----------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 00 112367889999999999999999995 8999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=404.48 Aligned_cols=268 Identities=26% Similarity=0.350 Sum_probs=213.1
Q ss_pred CCCCCCCccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeE
Q psy18163 347 TLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVT 425 (1028)
Q Consensus 347 ~lp~y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~ 425 (1028)
..+.|.|...+....++|+++++||+|+||+||+|++..+++.||||++.............+.|+..+..+ .||||++
T Consensus 42 ~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~ 121 (311)
T 3p1a_A 42 QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121 (311)
T ss_dssp CCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEE
Confidence 345777777777777899999999999999999999999999999999865433222233445566666555 8999999
Q ss_pred EEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcE
Q psy18163 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGIL 505 (1028)
Q Consensus 426 L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~l 505 (1028)
+++++.. ...+||||||++++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+
T Consensus 122 l~~~~~~--~~~~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 122 LEQAWEE--GGILYLQTELCGPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp EEEEEEE--TTEEEEEEECCCCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCE
T ss_pred EEEEEEe--CCEEEEEEeccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCE
Confidence 9998864 458999999998776665543 35568999999999999999999999999999999999999999999
Q ss_pred EEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q psy18163 506 KVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 506 KL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..+... .
T Consensus 197 kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~--~ 268 (311)
T 3p1a_A 197 KLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQG--Y 268 (311)
T ss_dssp EECCCTTCEECC-------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTT--C
T ss_pred EEccceeeeecccC-CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhcc--C
Confidence 99999999877543 33445679999999999876 5899999999999999999998776553322 222110 0
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.+ ......+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 269 -----------~~------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 269 -----------LP------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----------CC------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----------CC------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 00 0111236788999999999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=410.25 Aligned_cols=290 Identities=32% Similarity=0.554 Sum_probs=221.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||.||+|++..+++.||||++............+.+|+.++..++||||+++++++.. ...+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEE
Confidence 3578999999999999999999999999999999997654333333446789999999999999999998864 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+.+ +. .+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 101 lv~e~~~~~~--l~-~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 101 LVFEFVDHTI--LD-DLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEECCSEEH--HH-HHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecCCcch--HH-HHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999998732 22 22333456899999999999999999999999999999999999999999999999999877655
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..++...+......+..+...+.
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 55556678999999999998765789999999999999999999999999999999988888776543322111111111
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
......+..... .......+.+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 258 ~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKER--EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSC--CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCcccccc--chhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 111111111000 0111122357889999999999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=401.75 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=206.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccc--cCCccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEK--EGFPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~--~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
..++|++++.||+|+||.||+|++. .+++.||||+++..... ......+.+|+.+|..++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 3578999999999999999999985 68999999999765321 1223446689999999999999999988854
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
.+.+||||||+.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSG--GELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTT--EEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCC--CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 4589999999975 344444433 3458899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--------- 239 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN--------- 239 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------
T ss_pred ccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 65444444556789999999999987 56899999999999999999999999998888888777653110
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
....++..+.+||.+||..||.+|| ++.++|+||||+..
T Consensus 240 ------------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 240 ------------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ------------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 0112567899999999999999999 89999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=409.28 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=218.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|..+.||||+++++++.. ...+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence 45789999999999999999999999999999999976542 22334566789999999999999999888854 4589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
||||||+.+ +|.+++. .. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 117 ~lv~e~~~gg~L~~~l~---~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLR---RI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHH---HH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEcCCCCCcHHHHHH---Hc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999975 5554443 32 358999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......
T Consensus 193 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------ 256 (350)
T 1rdq_E 193 GR---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------------ 256 (350)
T ss_dssp SC---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------
T ss_pred CC---cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 32 345789999999999987 56899999999999999999999999998888887777653110
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESP 658 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p 658 (1028)
+ ...++..+.+||.+||..||.+||+ +.+|++||||+...
T Consensus 257 ----------~-----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 257 ----------F-----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ----------C-----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ----------C-----------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 0 1125678999999999999999998 99999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=414.37 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=212.6
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
...++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|..++||||+++++++.. ...
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTD 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCE
Confidence 3467899999999999999999999999999999999765422 2334567799999999999999999998864 458
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+||||||++++|.+++. . ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~lv~E~~~g~l~~~l~---~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIV---E-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEEECCCCEEHHHHHH---H-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEEEEECCCCcHHHHHH---H-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999999876655543 2 2458999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+........ .+..+.
T Consensus 160 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-----------~i~~~~--- 224 (336)
T 3h4j_B 160 DG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-----------KVNSCV--- 224 (336)
T ss_dssp TS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----------CCCSSC---
T ss_pred CC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----------HHHcCC---
Confidence 43 344567899999999999885545889999999999999999999997643211000 000000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
......+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 225 -------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 225 -------------------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -------------------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -------------------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 01123467889999999999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=413.47 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=211.6
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHH-HHHcCCCCeeEEEEEEeecCCC
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINT-LLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~i-L~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
...++|++++.||+|+||+||+|++..+++.||||++++.... .......++|..+ +..+.||||+++++++.. .+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--AD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CC
Confidence 3568999999999999999999999999999999999876432 2223344566665 466899999999888754 45
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+||||||+.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++..
T Consensus 113 ~~~lv~E~~~g--g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYING--GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCS--CBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEEEEeCCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 89999999986 444444433 345889999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
..........+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----------- 257 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----------- 257 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC-----------
T ss_pred ccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC-----------
Confidence 444445567899999999999987 66999999999999999999999999998888888777653100
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH----HHHHhCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA----DEALRHDYFSESP 658 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA----~ElL~HPfF~e~p 658 (1028)
+...++..+.+||.+||..||.+||++ .++++||||+...
T Consensus 258 ----------------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 258 ----------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp ----------------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred ----------------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 012367789999999999999999986 6999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=412.31 Aligned_cols=263 Identities=21% Similarity=0.355 Sum_probs=221.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..+.|++++.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.+|..++||||+++++++.. ...+|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 124 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMV 124 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--hHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEE
Confidence 457899999999999999999999999999999999764321 12356789999999999999999998854 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC--CCcEEEeccCCccccC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH--RGILKVGDFGLAREYG 517 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~--~g~lKL~DFGlAr~~~ 517 (1028)
||||||.+ ++|.+.+......+++.++..++.||+.||.|||++||+||||||+||||+. .+.+||+|||+++.+.
T Consensus 125 lv~E~~~g--g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 125 LILEFLSG--GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEECCCC--CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEcCCC--CcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999987 5666666555557899999999999999999999999999999999999974 5789999999998775
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ......+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.+.+..+.+..+......+....
T Consensus 203 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------- 273 (387)
T 1kob_A 203 PD-EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA------- 273 (387)
T ss_dssp TT-SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST-------
T ss_pred CC-cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc-------
Confidence 43 33445689999999999987 5689999999999999999999999999988888877765322111111
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
...+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 274 ----------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 274 ----------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp ----------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred ----------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 1236788999999999999999999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=405.85 Aligned_cols=268 Identities=24% Similarity=0.278 Sum_probs=188.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC--CeEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM--DKIF 439 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~--~~l~ 439 (1028)
.+|.+.++||+|+||+||+|++ +|+.||||+++...... .....|+..+..++|||||++++++...+. ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~---~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhh---HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4689999999999999999988 58999999997543211 122345666677899999999999875543 3689
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC--------CcccccccccceeecCCCcEEEeccC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN--------WILHRDLKTSNLLLSHRGILKVGDFG 511 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~--------gIVHRDLKPeNILLd~~g~lKL~DFG 511 (1028)
||||||.+ ++|.+.+.. ..+++..+..|+.||+.||.|||++ +||||||||+||||+.++++||+|||
T Consensus 78 lV~Ey~~~--gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 78 LVSDYHEH--GSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTT--CBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecCCCC--CcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 99999986 444444433 3488899999999999999999987 89999999999999999999999999
Q ss_pred CccccCCCCCc----ccccccCccccCcccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q psy18163 512 LAREYGSPLKH----YTPIVVTLWYRSPELLLGCK-----EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT 582 (1028)
Q Consensus 512 lAr~~~~~~~~----~t~~vGT~~Y~APEvL~g~~-----~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~ 582 (1028)
+|+........ ....+||+.|||||++.+.. .|+.++||||||||||||+||.+||....+..
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~-------- 225 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ-------- 225 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC--------
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc--------
Confidence 99876543221 23468999999999997632 36789999999999999999998875433210
Q ss_pred cCCCCCCCCCCCCCChhhhhhcc-cc-CCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMTF-AE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~~-~~-~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.|.....+............. .. .|.. ............+.+||.+||..||.+|||+.+|++.
T Consensus 226 --~p~~~~~~~~~~~~~~~~~~~~~~~rp~~---p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 226 --LPYYDLVPSDPSVEEMRKVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp --CTTTTTSCSSCCHHHHHHHHTTSCCCCCC---CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred --ccchhcccccchHHHHHHHHhcccCCCCC---CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000000000000000000000 00 0000 0001111234567899999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=421.02 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=209.5
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
...++|++++.||+|+||.||+|.+..+++.||||+++.... .......+++|+.+|..++||||+.+++++... +.
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~ 222 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DR 222 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET--TE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CE
Confidence 346789999999999999999999999999999999986532 222334567899999999999999999988644 48
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
+|||||||.+ ++|...+.. ...+++..++.|+.||+.||.|||+ +|||||||||+||||+.++.+||+|||+|+..
T Consensus 223 ~~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANG--GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSS--CBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEEEeeCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999987 344444433 3468999999999999999999998 99999999999999999999999999999875
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
..........+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+....+..+......
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------- 367 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----------- 367 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred cCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 554455667899999999999987 66999999999999999999999999998887777776542110
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
+...+++.+.+||.+||..||.+|| |+.++|+||||+..
T Consensus 368 ----------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 368 ----------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ----------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 0112567899999999999999999 99999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=387.03 Aligned_cols=262 Identities=29% Similarity=0.413 Sum_probs=217.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||.||+|.+..++..||+|++............+.+|+.++..++||||+++++++. .....|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHY 81 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE--cCCEEE
Confidence 357899999999999999999999999999999999766543333345678999999999999999999885 445889
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc---EEEeccCCcccc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI---LKVGDFGLAREY 516 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~---lKL~DFGlAr~~ 516 (1028)
+||||+.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 82 ~v~e~~~~--~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 82 LVFDLVTG--GELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEECCCCS--CBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEecCCC--CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999986 344443333 245899999999999999999999999999999999999986655 999999999877
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+...|
T Consensus 159 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 231 (284)
T 3kk8_A 159 NDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW----- 231 (284)
T ss_dssp CSS-CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT-----
T ss_pred ccC-ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh-----
Confidence 543 33456789999999999987 56899999999999999999999999998888777776654322111111
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 232 ------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 232 ------------------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp ------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred ------------------------cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 2256788999999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=404.73 Aligned_cols=287 Identities=32% Similarity=0.518 Sum_probs=228.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC----C
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM----D 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~----~ 436 (1028)
.++|.+.+.||.|+||.||+|.+..+|+.||||++............+.+|+.++..++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999997654333334456789999999999999999998864432 2
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+||||+.++|..++ ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 46999999998776554 234899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... .+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+...++..+..
T Consensus 177 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 177 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 432 34568999999999998766799999999999999999999999999999999999999888876655544332
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
..... .....+.............+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 254 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 254 KAAKS--YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHH--HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHH--HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 11100 0011111111111122345788999999999999999999999999999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=404.89 Aligned_cols=293 Identities=30% Similarity=0.518 Sum_probs=222.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCC---------ccchHHHHHHHHHcCCCCeeEEEEEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF---------PITSLREINTLLKAQHPNIVTVREIV 430 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~---------~~~~lrEi~iL~~l~HPNIV~L~~i~ 430 (1028)
..++|++++.||+|+||.||+|.+.. +..||||++......... ...+.+|+.+|..++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 35789999999999999999999865 899999999664432211 14567899999999999999999988
Q ss_pred ee---cCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEE
Q psy18163 431 VG---SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKV 507 (1028)
Q Consensus 431 ~~---~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL 507 (1028)
.. .....+|+||||+.++|.+++ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVI---HDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHH---HCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EeccCCCcceEEEEEccCCCCHHHHH---HhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 64 334579999999997655544 445557899999999999999999999999999999999999999999999
Q ss_pred eccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 508 GDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 508 ~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+.
T Consensus 176 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 176 CDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999999865433 3345578999999999998767799999999999999999999999999999999999999888765
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
...+..+.. +......................+.+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 255 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 255 IEDVVMFSS-PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHTSC-HHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHhhhccc-hhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 432221111 0000000000111111111222345678899999999999999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=400.15 Aligned_cols=262 Identities=27% Similarity=0.366 Sum_probs=209.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+.++..++||||+++++++.. .+.+|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 357899999999999999999999999999999999755432 223567799999999999999999998854 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||||.+ ++|.+.+. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 82 lv~e~~~~--~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSG--GELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTT--EEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEcCCC--CcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999976 33433332 3445899999999999999999999999999999999999999999999999999865322
Q ss_pred --CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 --LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 --~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+................
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS----------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC----------
Confidence 22345678999999999998855568899999999999999999999987665432222222110000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 229 --------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 229 --------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp --------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred --------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 0012367788999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=422.74 Aligned_cols=262 Identities=28% Similarity=0.453 Sum_probs=219.2
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
...++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEE
Confidence 34578999999999999999999999999999999997665444445667899999999999999999998854 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec---CCCcEEEeccCCccc
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS---HRGILKVGDFGLARE 515 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd---~~g~lKL~DFGlAr~ 515 (1028)
|+|||||.+ ++|...+... ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 97 ~lv~e~~~~--~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 97 YIVGELYTG--GELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEEECCCCS--CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEEcCCC--CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999986 4444444333 4589999999999999999999999999999999999995 456799999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
+... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......+....
T Consensus 174 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----- 245 (486)
T 3mwu_A 174 FQQN-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ----- 245 (486)
T ss_dssp BCCC-----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG-----
T ss_pred CCCC-CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc-----
Confidence 6543 34456789999999999976 489999999999999999999999999998888888766422211111
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 246 ------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 246 ------------------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ------------------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ------------------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 12367889999999999999999999999999999763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=406.19 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=210.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|.+..+++.||||++..... ...+|+.+|..+ .||||+++++++. +...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYD--DGKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEE--CSSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEE--cCCEE
Confidence 35789999999999999999999999999999999976432 346789988887 7999999999885 44589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC----CcEEEeccCCcc
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR----GILKVGDFGLAR 514 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~----g~lKL~DFGlAr 514 (1028)
|||||||.+ ++|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+|||+... +.+||+|||+++
T Consensus 92 ~lv~E~~~g--g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 92 YVVTELMKG--GELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEECCCCS--CBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEeCCCC--CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999986 555555544 3468999999999999999999999999999999999998532 359999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK---SDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~---sd~d~l~kI~~~lg~p~~~~w 591 (1028)
.+..........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+. +..+.+..+......+....
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 246 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY- 246 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT-
T ss_pred cCcCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc-
Confidence 77655455567799999999999977 55899999999999999999999999863 34455555543221111111
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
...+++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 247 ----------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 ----------------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ----------------------------TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ----------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 1236788999999999999999999999999999965
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=410.55 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=215.4
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
....++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|..++|||||.++++|.. ..
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~ 88 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EE 88 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 3456899999999999999999999999999999999976542 23334567789999999999999999988854 45
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+||||+.+ ++|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+
T Consensus 89 ~~~lv~e~~~g--g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 89 DMFMVVDLLLG--GDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEEECCCTT--EEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 89999999976 455444433 456899999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---LEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---~d~l~kI~~~lg~p~~~~w 591 (1028)
... ......+||+.|+|||++.+ ...|+.++||||||||||+|++|.+||.+.+. .+.+..+.....
T Consensus 166 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------- 237 (384)
T 4fr4_A 166 PRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV------- 237 (384)
T ss_dssp CTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC-------
T ss_pred cCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc-------
Confidence 543 44567899999999999974 24589999999999999999999999976432 222222221100
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-HHHHHhCCCCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-ADEALRHDYFSESPL 659 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-A~ElL~HPfF~e~p~ 659 (1028)
. ....++..+.+||.+||..||.+||+ +.++++||||+...|
T Consensus 238 ---------------~-----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 238 ---------------T-----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp ---------------C-----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred ---------------C-----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 0 01235788999999999999999998 999999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=389.40 Aligned_cols=263 Identities=20% Similarity=0.329 Sum_probs=203.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||+||+|.+..+++.||||+++.............++...+..+.||||+++++++.. ...+|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEE
Confidence 3578999999999999999999999999999999997653322222223344445777899999999998864 45799
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+||||+.++|.+++.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9999999998888887777777899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccCccccCcccc---cCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELL---LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG-KSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL---~g~~~ys~ksDIWSLGvILyELLTG~pPF~g-~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
. ......+||+.|+|||++ .....++.++|||||||++|+|++|..||.. ......+..+.......
T Consensus 163 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 233 (290)
T 3fme_A 163 D-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-------- 233 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--------
T ss_pred c-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC--------
Confidence 3 223345899999999997 3446789999999999999999999999987 34444444444321000
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 234 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 -----------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -----------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -----------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 001225678899999999999999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=387.57 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=211.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|.+.+.||+|+||+||+|.+..++..||+|++...... .....+.+|+.+|..++||||+++++++.. ...+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEE
Confidence 47899999999999999999999999999999999865432 223556789999999999999999998854 458999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee---cCCCcEEEeccCCcccc
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL---SHRGILKVGDFGLAREY 516 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL---d~~g~lKL~DFGlAr~~ 516 (1028)
||||+.+ +|.+++.........+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999986 6666665554555679999999999999999999999999999999999999 45678999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 178 ~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 245 (285)
T 3is5_A 178 KSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA--------- 245 (285)
T ss_dssp ----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred CCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc---------
Confidence 543 33456789999999999864 589999999999999999999999999887666555443211000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.....+++.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 246 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 ---------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 001125678899999999999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=408.59 Aligned_cols=263 Identities=27% Similarity=0.390 Sum_probs=197.7
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
...++|++++.||+|+||+||+|++..+++.||||++..... ....+.+|+.+++.++||||+++++++.. ...+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHL 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEE
Confidence 345789999999999999999999999999999999975432 23456799999999999999999998864 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc--EEEeccCCcccc
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI--LKVGDFGLAREY 516 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~--lKL~DFGlAr~~ 516 (1028)
||||||+.+ ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++..
T Consensus 92 ~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 92 AIIMEYASG--GELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEECCCS--CBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEEEeCCC--CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999976 344444333 335899999999999999999999999999999999999987665 999999999754
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+......+..++.........
T Consensus 169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 240 (361)
T 3uc3_A 169 VLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS------- 240 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC-------
T ss_pred ccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC-------
Confidence 322 233456899999999999885544555999999999999999999998765433232322221100000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
++. ...+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 241 -----------~~~---------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 241 -----------IPD---------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -----------CCT---------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -----------CCC---------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000 11267889999999999999999999999999999653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=391.89 Aligned_cols=286 Identities=27% Similarity=0.456 Sum_probs=219.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|++..+++.||||+++... ...+.+|+.+|..+. ||||+.+++++.......+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 3578999999999999999999999999999999997432 345678999999997 9999999999987667789
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-cEEEeccCCccccC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-~lKL~DFGlAr~~~ 517 (1028)
++||||+.+ ++|...+. .+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.+.
T Consensus 109 ~lv~e~~~~--~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 109 ALVFEHVNN--TDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEECCCC--CCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEeccCc--hhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999986 33433332 378899999999999999999999999999999999999776 89999999998765
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCCCCC---CC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLF-TGKSDLEQLSRIFKTMGTPNEKIW---PG 593 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF-~g~sd~d~l~kI~~~lg~p~~~~w---~~ 593 (1028)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+...++.+....+ ..
T Consensus 183 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 183 PG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 43 34456789999999999987677999999999999999999999888 455666777776665543211000 00
Q ss_pred CCCChhhhhhcc-ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 594 FSKLPAVQKMTF-AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 594 ~s~lp~~~~l~~-~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....+....... .................+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 000000000000 0000000000111223478899999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=393.51 Aligned_cols=262 Identities=25% Similarity=0.371 Sum_probs=218.1
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC----CccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG----FPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~----~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
...++|++.+.||+|+||.||+|.+..++..||||++........ ....+.+|+.+|..+.||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 86 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-- 86 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 345789999999999999999999999999999999976543221 23446789999999999999999998854
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC----cEEEec
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG----ILKVGD 509 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g----~lKL~D 509 (1028)
...+|+||||+.+ +|.+++ .. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l---~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFL---AQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHH---HT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHH---Hh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 4589999999965 555544 33 45688999999999999999999999999999999999999887 799999
Q ss_pred cCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 510 FGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 510 FGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 163 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~- 239 (321)
T 2a2a_A 163 FGLAHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE- 239 (321)
T ss_dssp CTTCEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-
T ss_pred CccceecCcc-ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-
Confidence 9999877543 33456789999999999977 56899999999999999999999999998888877776543211110
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 240 ----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 240 ----------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp ----------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ----------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 0112356788999999999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=406.74 Aligned_cols=294 Identities=21% Similarity=0.239 Sum_probs=213.6
Q ss_pred cCCeEEEEEeeec--CcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 361 VEEFKCLNRIEEG--TYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 361 ~d~Y~il~~LG~G--~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
.++|++++.||+| +||+||+|++..+++.||||++............+.+|+.+|+.++|||||++++++... +.+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--CEE
Confidence 4789999999999 999999999999999999999987654333345567899999999999999999998654 489
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|||||||.+ +|.+++... ....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999985 666655432 23458999999999999999999999999999999999999999999999999986542
Q ss_pred CC-------CCcccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC----
Q psy18163 518 SP-------LKHYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT---- 585 (1028)
Q Consensus 518 ~~-------~~~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~---- 585 (1028)
.. .......+||+.|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+..+.+..++.....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 21 1112335899999999999764 46899999999999999999999999987766655544332110
Q ss_pred ----CCCCCCCCCCCChhhh----hhc-cccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 586 ----PNEKIWPGFSKLPAVQ----KMT-FAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 586 ----p~~~~w~~~s~lp~~~----~l~-~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
+............... ... ....+.............+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0000000000000000 000 0000000000111123457889999999999999999999999999999987
Q ss_pred CC
Q psy18163 657 SP 658 (1028)
Q Consensus 657 ~p 658 (1028)
..
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 54
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=420.19 Aligned_cols=260 Identities=29% Similarity=0.474 Sum_probs=214.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..+.|++++.||+|+||+||+|++..++..||||++............+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 112 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYY 112 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 3468999999999999999999999999999999998765444445667899999999999999999998854 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEeccCCcccc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDFGLAREY 516 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DFGlAr~~ 516 (1028)
||||||.+ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+
T Consensus 113 lv~e~~~~--g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 113 LVMECYKG--GELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEEECCCS--CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEecCCC--CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999987 4444444333 45899999999999999999999999999999999999975 456999999999877
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......+....|
T Consensus 190 ~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 261 (494)
T 3lij_A 190 ENQ-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW----- 261 (494)
T ss_dssp BTT-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG-----
T ss_pred CCC-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc-----
Confidence 543 34556789999999999864 5899999999999999999999999999998888887764332222111
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
..+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 262 ------------------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 262 ------------------------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp ------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred ------------------------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 235778999999999999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=394.05 Aligned_cols=295 Identities=34% Similarity=0.568 Sum_probs=220.5
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEee----
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG---- 432 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~---- 432 (1028)
+....++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++..++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh--HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 33456789999999999999999999999999999999875432 223456789999999999999999998742
Q ss_pred --------cCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec-CCC
Q psy18163 433 --------SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS-HRG 503 (1028)
Q Consensus 433 --------~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd-~~g 503 (1028)
.....+|+||||+.++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred cccccccccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 2346899999999987666553 34588999999999999999999999999999999999997 567
Q ss_pred cEEEeccCCccccCCC---CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy18163 504 ILKVGDFGLAREYGSP---LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580 (1028)
Q Consensus 504 ~lKL~DFGlAr~~~~~---~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~ 580 (1028)
.+||+|||+++..... ........+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..++
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999876432 1223456789999999998776679999999999999999999999999999988888888
Q ss_pred HhcCCCCCCCCCCCC-CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 581 KTMGTPNEKIWPGFS-KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 581 ~~lg~p~~~~w~~~s-~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
.....+....+.... .++........ .+ ..........++..+.+||.+||..||.+|||+.++|+||||+...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMT-EP---HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTT-SC---CCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HhcCCCchhhhhhhhhcCccccccccc-CC---CCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 765443322111100 00000000000 00 00011122347889999999999999999999999999999998766
Q ss_pred CCC
Q psy18163 660 PID 662 (1028)
Q Consensus 660 p~~ 662 (1028)
|..
T Consensus 315 p~~ 317 (320)
T 2i6l_A 315 PMD 317 (320)
T ss_dssp ---
T ss_pred ccC
Confidence 543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=397.71 Aligned_cols=259 Identities=31% Similarity=0.428 Sum_probs=197.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..+.|++.+.||+|+||+||+|.+..+++.||||+++.... ...+.+|+.+|..+.||||+++++++.. ...+|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEIS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEE
Confidence 45789999999999999999999999999999999976432 2345689999999999999999998864 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEeccCCcccc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDFGLAREY 516 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DFGlAr~~ 516 (1028)
|||||+.+ ++|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++..
T Consensus 125 lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTG--GELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCS--CBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEeCCC--CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999976 445554443 345899999999999999999999999999999999999975 889999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE-QLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d-~l~kI~~~lg~p~~~~w~~~s 595 (1028)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+..+...........
T Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~----- 274 (349)
T 2w4o_A 202 EHQ-VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW----- 274 (349)
T ss_dssp ------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT-----
T ss_pred Ccc-cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch-----
Confidence 542 23455789999999999987 568999999999999999999999998766554 4444443211111111
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
...++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 275 ------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 275 ------------------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ------------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ------------------------hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 123567889999999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=420.91 Aligned_cols=262 Identities=29% Similarity=0.452 Sum_probs=221.2
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
...++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|..++||||+++++++.. ...
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 100 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGY 100 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 3457899999999999999999999999999999999765432 2334567799999999999999999998854 458
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee---cCCCcEEEeccCCcc
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL---SHRGILKVGDFGLAR 514 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL---d~~g~lKL~DFGlAr 514 (1028)
+|+|||||.+ ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~--~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 101 FYLVGEVYTG--GELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEEEECCCCS--CBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEEEecCCC--CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999986 555555544 3468999999999999999999999999999999999999 467899999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.+... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......+....
T Consensus 178 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---- 250 (484)
T 3nyv_A 178 HFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ---- 250 (484)
T ss_dssp HBCCC-CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG----
T ss_pred Ecccc-cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc----
Confidence 77543 34456789999999999976 589999999999999999999999999999888888766422211111
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...+++.+.+||.+||.+||.+|||+.++|+||||+..
T Consensus 251 -------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 251 -------------------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp -------------------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred -------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 12367889999999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=382.77 Aligned_cols=264 Identities=28% Similarity=0.421 Sum_probs=221.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.++..++||||+++++++.......+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 47899999999999999999999999999999999865433333445678999999999999999999887766778999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC-----cccccccccceeecCCCcEEEeccCCcc
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW-----ILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g-----IVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
||||+.+ +|.+++.........+++..+..++.||+.||.|||+.| |+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999975 888887765555566899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+......
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--------- 234 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--------- 234 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred eeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc---------
Confidence 77654333345689999999999987 56899999999999999999999999998877666666542110
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
. ....++..+.+||.+||..||.+|||+.++|+|+||.+.
T Consensus 235 ------------~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 235 ------------R-----------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ------------C-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ------------c-----------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 0 011256788999999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=392.06 Aligned_cols=256 Identities=24% Similarity=0.448 Sum_probs=214.9
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
.|...+.||+|+||.||+|++..+|+.||||++..... .....+.+|+.++..++||||+.+++++... +.+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence 48888999999999999999999999999999975432 2334567899999999999999999988654 4899999
Q ss_pred ecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 443 DYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 443 Ey~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||+.+ +|.+++ . ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 122 e~~~~~~L~~~l---~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 122 EFLQGGALTDIV---S--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp CCCCSCBHHHHH---T--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred ecCCCCCHHHHH---H--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 99976 444443 2 23589999999999999999999999999999999999999999999999999988765544
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..... + . +.
T Consensus 197 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~--~----~~------ 262 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-P--K----LK------ 262 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-C--C----CT------
T ss_pred ccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C--C----cC------
Confidence 5566789999999999977 5689999999999999999999999998888777666654210 0 0 00
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
....+++.+.+||.+||..||.+|||+.++|+||||.+..
T Consensus 263 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 263 -----------------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp -----------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred -----------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 0122567889999999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=403.11 Aligned_cols=290 Identities=29% Similarity=0.463 Sum_probs=225.0
Q ss_pred CccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CC-----CeeEE
Q psy18163 353 PAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HP-----NIVTV 426 (1028)
Q Consensus 353 p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HP-----NIV~L 426 (1028)
+...+....++|++++.||+|+||+||+|++..+++.||||+++.... ......+|+.++..+. |+ +|+.+
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA---FLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH---HHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH---HHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 444566677899999999999999999999999999999999975421 1234456888887775 44 49999
Q ss_pred EEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH--hCCcccccccccceeec--CC
Q psy18163 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH--DNWILHRDLKTSNLLLS--HR 502 (1028)
Q Consensus 427 ~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLH--s~gIVHRDLKPeNILLd--~~ 502 (1028)
++++... +.+||||||++++|.+++... ....+++..++.++.||+.||.||| ..|||||||||+||||+ .+
T Consensus 122 ~~~~~~~--~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 122 KRHFMFR--NHLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp EEEEEET--TEEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred eeeeccC--CceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence 9888654 589999999998877776543 2245889999999999999999999 57899999999999995 47
Q ss_pred CcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q psy18163 503 GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT 582 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~ 582 (1028)
+.+||+|||+++..... ....+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+.+..|+..
T Consensus 198 ~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp CCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CcEEEEeccCceecccc---cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 88999999999887543 345789999999999988 56999999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCCCCCChhhhhhccccCCCC--------------CCCcccc---------------------ccccccHHH
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMTFAEYPNV--------------GGLKTKV---------------------AGSILTELG 627 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~~~~~p~~--------------~~l~~~~---------------------~~~~Ls~~a 627 (1028)
++.++...++........ +..++.. ....... ......+.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (382)
T 2vx3_A 274 LGIPPAHILDQAPKARKF----FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKF 349 (382)
T ss_dssp HCSCCHHHHTTCTTHHHH----EEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHH
T ss_pred hCCCCHHHHHhhHHHHHH----HHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHH
Confidence 887765544322211000 0000000 0000000 000112478
Q ss_pred HHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 628 YDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 628 ~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
++||.+||.+||.+|||+.|+|+||||++.
T Consensus 350 ~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 350 KDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 899999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=407.19 Aligned_cols=258 Identities=29% Similarity=0.422 Sum_probs=199.3
Q ss_pred ccCCeEEE-EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHH-HcCCCCeeEEEEEEee--cCC
Q psy18163 360 SVEEFKCL-NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLL-KAQHPNIVTVREIVVG--SNM 435 (1028)
Q Consensus 360 ~~d~Y~il-~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~-~l~HPNIV~L~~i~~~--~~~ 435 (1028)
..++|.++ +.||.|+||+||+|.+..+++.||||++... ....+|+.++. ..+||||++++++|.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 35678887 7899999999999999999999999999632 24567888874 4589999999998853 334
Q ss_pred CeEEEEEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEeccC
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDFG 511 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DFG 511 (1028)
.++|||||||.+ ++|.+.+... ...+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||
T Consensus 132 ~~~~lv~E~~~g--g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 132 KCLLIVMECLDG--GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEEECCCS--EEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred cEEEEEEEeCCC--CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 579999999986 4555555443 245899999999999999999999999999999999999997 7899999999
Q ss_pred CccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE----QLSRIFKTMGTPN 587 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d----~l~kI~~~lg~p~ 587 (1028)
+++..... ...+..+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+... ....+........
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 210 FAKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp TCEECC------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred cccccCCC-CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 99876543 34456799999999999977 669999999999999999999999998754321 2222222111000
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.. ....++..+.+||.+||..||.+|||+.++|+||||.+.
T Consensus 288 ~~-----------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 NP-----------------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TT-----------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred Cc-----------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 00 112367889999999999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=407.45 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=210.0
Q ss_pred CeEE--EEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 363 EFKC--LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 363 ~Y~i--l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.|.+ .+.||+|+||.||+|.+..+|..||||+++..... ....+.+|+.+|..++||||+++++++.. .+.+||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 163 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVL 163 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 3444 67899999999999999999999999999764321 23456789999999999999999998864 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee--cCCCcEEEeccCCccccCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL--SHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL--d~~g~lKL~DFGlAr~~~~ 518 (1028)
||||+.+ ++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+..
T Consensus 164 v~E~~~~--~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 164 VMEYVDG--GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEECCTT--CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEeCCCC--CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999976 34444444445568999999999999999999999999999999999999 5678999999999987754
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. ......+||+.|+|||++.+ ..++.++||||||||||+|++|..||.+.++.+.+..+......+....
T Consensus 242 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-------- 311 (373)
T 2x4f_A 242 R-EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE-------- 311 (373)
T ss_dssp T-CBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG--------
T ss_pred c-cccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh--------
Confidence 3 33455689999999999876 6689999999999999999999999999999888888876422211110
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 312 ---------------------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 312 ---------------------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ---------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ---------------------hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 12367889999999999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=390.94 Aligned_cols=296 Identities=26% Similarity=0.378 Sum_probs=227.4
Q ss_pred CCCCCccccccccCCeEEEEEeeecCcEEEEEEEECCCC-eEEEEEEeeccccccCCccchHHHHHHHHHcCCCC-----
Q psy18163 349 PPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTD-EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN----- 422 (1028)
Q Consensus 349 p~y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg-~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPN----- 422 (1028)
.++++...+....++|++++.||+|+||+||+|.+..++ ..||||+++.... ....+.+|+.++..+.|++
T Consensus 6 ~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 6 EGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp TSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred CCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc---chhHHHHHHHHHHHHhhcCCCCce
Confidence 356667677777899999999999999999999998777 7999999975321 2334567899999887766
Q ss_pred -eeEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee--
Q psy18163 423 -IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL-- 499 (1028)
Q Consensus 423 -IV~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL-- 499 (1028)
++.+++++... ..+||||||++++|.+.+.. .....+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 83 ~~~~~~~~~~~~--~~~~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 83 LCVLMSDWFNFH--GHMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158 (355)
T ss_dssp CBCCEEEEEEET--TEEEEEEECCCCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESC
T ss_pred eEEEeeeeeeeC--CeEEEEEeccCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 88888877543 48999999998766655433 223468999999999999999999999999999999999999
Q ss_pred -----------------cCCCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh
Q psy18163 500 -----------------SHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC 562 (1028)
Q Consensus 500 -----------------d~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT 562 (1028)
+.++.+||+|||+++.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHh
Confidence 5678999999999987543 2345689999999999987 568999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh-------------hhhccccCCCCCCCccccccccccHHHHH
Q psy18163 563 MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV-------------QKMTFAEYPNVGGLKTKVAGSILTELGYD 629 (1028)
Q Consensus 563 G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~-------------~~l~~~~~p~~~~l~~~~~~~~Ls~~a~D 629 (1028)
|.+||.+.+..+.+..+...++.++...+......... ........+.. ..........+..+.+
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ 312 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL--KSYMLQDSLEHVQLFD 312 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG--GGGCSCCSHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc--cccccccchhHHHHHH
Confidence 99999999998888888887776554322111100000 00000000000 0000111234567899
Q ss_pred HHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 630 LLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 630 LL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
||.+||..||.+|||+.++|+||||++.
T Consensus 313 li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 313 LMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 9999999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=380.04 Aligned_cols=257 Identities=21% Similarity=0.264 Sum_probs=209.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|.+..+++.||||++.............++|+.++..+ .||||+++++++... +.+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence 34789999999999999999999999999999999986544333445677899999998 899999999988644 489
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC---------------
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR--------------- 502 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~--------------- 502 (1028)
|+||||+.+ +|.+++.........+++.+++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999976 8888777655545678999999999999999999999999999999999999844
Q ss_pred ----CcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy18163 503 ----GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSR 578 (1028)
Q Consensus 503 ----g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~k 578 (1028)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+||..... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~ 239 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE 239 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH
T ss_pred cCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH
Confidence 47999999999877543 2346999999999998755677899999999999999999988755432 222
Q ss_pred HHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 579 I~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+.... ... ....+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 240 ~~~~~---------------------~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 240 IRQGR---------------------LPR-----------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHTTC---------------------CCC-----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHcCC---------------------CCC-----------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 22110 000 112367889999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=418.38 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=215.9
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-----------CCccchHHHHHHHHHcCCCCeeEE
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-----------GFPITSLREINTLLKAQHPNIVTV 426 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-----------~~~~~~lrEi~iL~~l~HPNIV~L 426 (1028)
....++|+++++||+|+||+||+|.+..++..||||++....... .....+.+|+.+|..++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345688999999999999999999999999999999997654221 223456789999999999999999
Q ss_pred EEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC---
Q psy18163 427 REIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG--- 503 (1028)
Q Consensus 427 ~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g--- 503 (1028)
++++.. ...+|||||||.+ ++|...+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++
T Consensus 112 ~~~~~~--~~~~~lv~e~~~g--g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 112 FDVFED--KKYFYLVTEFYEG--GELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEEEC--SSEEEEEEECCTT--CBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred EEEEEc--CCEEEEEEecCCC--CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 999854 4589999999976 4444444333 4589999999999999999999999999999999999998776
Q ss_pred cEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q psy18163 504 ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTM 583 (1028)
Q Consensus 504 ~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~l 583 (1028)
.+||+|||+++.+... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+....
T Consensus 187 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp SEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 6999999999877543 34556789999999999875 58999999999999999999999999999888888876532
Q ss_pred CCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 584 g~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..+.... ...+++.+++||.+||.+||.+|||+.++|+||||+..
T Consensus 264 ~~~~~~~-----------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 264 YYFDFND-----------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCCCHHH-----------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCCCccc-----------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 2111100 12367889999999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=392.98 Aligned_cols=266 Identities=27% Similarity=0.400 Sum_probs=216.1
Q ss_pred cccCCeEEE-EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCC
Q psy18163 359 RSVEEFKCL-NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 359 ~~~d~Y~il-~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~ 436 (1028)
...+.|.+. +.||+|+||+||+|.+..+++.||||++............+.+|+.++..+. ||||+++++++. ...
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--~~~ 102 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE--NTS 102 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSS
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE--eCC
Confidence 345678888 8999999999999999999999999999876544444556788999999985 699999999885 445
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEeccCC
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDFGL 512 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DFGl 512 (1028)
.+|+||||+.+ +|.+++. ......+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+
T Consensus 103 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCL--PELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEEECCTTEEGGGGGS--SCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred eEEEEEEecCCCcHHHHHH--HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 89999999986 4444431 122356899999999999999999999999999999999999987 78999999999
Q ss_pred ccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+....+
T Consensus 181 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~- 257 (327)
T 3lm5_A 181 SRKIGHA-CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF- 257 (327)
T ss_dssp CEEC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT-
T ss_pred ccccCCc-cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh-
Confidence 9877543 23455789999999999987 56899999999999999999999999999888887777664332221111
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
..++..+.+||.+||..||.+|||+.++|+||||++..+
T Consensus 258 ----------------------------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 258 ----------------------------SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp ----------------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred ----------------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 225678899999999999999999999999999987644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=383.07 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=189.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++..++||||+++++++.. .+.+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeEE
Confidence 47899999999999999999999999999999999765322 2333566789999999999999999998854 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ ++|...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 88 lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 88 LVLEMCHN--GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEECCTT--EEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEecCCC--CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999976 3444445555567899999999999999999999999999999999999999999999999999877654
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+.. .
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------~------- 227 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----------A------- 227 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----------S-------
T ss_pred CCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----------c-------
Confidence 444455789999999999987 5689999999999999999999999987553322221100 0
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.+ .....++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 228 -------~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 -------DY---------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -------CC---------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -------cc---------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00 0112367789999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=382.51 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=211.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|.+..++..||||++...... ......+.+|+.++..++||||+++++++.. ...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEE
Confidence 568899999999999999999999999999999999764322 2334556789999999999999999998854 4589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|+||||+.+ +|.+++. .. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~---~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQ---KL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEECCCTTEEHHHHHH---HH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEEecCCCCcHHHHHH---hc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999985 4444443 32 458899999999999999999999999999999999999999999999999986654
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 226 (279)
T 3fdn_A 161 SS--RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----------- 226 (279)
T ss_dssp ---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-----------
T ss_pred cc--cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC-----------
Confidence 32 3345689999999999987 668999999999999999999999999988777776665421110
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 227 ----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 227 ----------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp ----------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ----------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 11256778999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=398.25 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=187.6
Q ss_pred CCeEEE---EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCe
Q psy18163 362 EEFKCL---NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 362 d~Y~il---~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~ 437 (1028)
++|++. +.||+|+||+||+|.+..+++.||||++.... .....+|+.++..+. ||||+++++++.. ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHD--QLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCE
Confidence 567775 78999999999999999999999999997542 234568999999997 9999999998854 458
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC---cEEEeccCCcc
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG---ILKVGDFGLAR 514 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g---~lKL~DFGlAr 514 (1028)
+||||||+.+ ++|.+.+.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+++
T Consensus 81 ~~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 81 TFLVMELLNG--GELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEEEECCCCS--CBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEEEccCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 9999999986 444444433 35689999999999999999999999999999999999998765 89999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD-------LEQLSRIFKTMGTPN 587 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd-------~d~l~kI~~~lg~p~ 587 (1028)
............+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+. .+.+..+......+.
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp ECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred ecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 77655555667789999999999977 5699999999999999999999999987543 233333322110000
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
......+++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 237 -----------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 237 -----------------------------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp -----------------------------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred -----------------------------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 00112367889999999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=417.50 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=221.4
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
+....++|.+.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.+|+.++||||+++++++.. .
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~ 88 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--P 88 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 445678999999999999999999999999999999999765432 2334467789999999999999999998864 4
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+||||||+.+ ++|.+.+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 89 ~~~~lv~E~~~g--g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 89 SDIFMVMEYVSG--GELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp SEEEEEEECCSS--EEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CEEEEEEeCCCC--CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 589999999976 455555433 45689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... ......+||+.|+|||++.+...++.++||||||||+|+|++|.+||.+.+....+..+......
T Consensus 166 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 234 (476)
T 2y94_A 166 MSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY---------- 234 (476)
T ss_dssp CCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC----------
T ss_pred cccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC----------
Confidence 7543 34456799999999999988555688999999999999999999999998877777776542110
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 235 -----------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 -----------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -----------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 011256789999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=388.07 Aligned_cols=290 Identities=26% Similarity=0.385 Sum_probs=221.9
Q ss_pred cccccccCCeEEEEEeeecCcEEEEEEEE-CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCC------eeEEE
Q psy18163 355 IQGCRSVEEFKCLNRIEEGTYGVVYRAKD-KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN------IVTVR 427 (1028)
Q Consensus 355 ~~g~~~~d~Y~il~~LG~G~FG~Vyla~d-~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPN------IV~L~ 427 (1028)
..|....++|++++.||+|+||+||+|.+ ..+++.||||+++.... ......+|+.++..+.|++ |+.++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR---YCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH---HHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 34556678999999999999999999999 56899999999975321 2344568899988887654 99999
Q ss_pred EEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC------
Q psy18163 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH------ 501 (1028)
Q Consensus 428 ~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~------ 501 (1028)
+++... +.+||||||++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 84 EWFEHH--GHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEET--TEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred cccccC--CcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 888644 489999999987777666432 2235889999999999999999999999999999999999987
Q ss_pred -------------CCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy18163 502 -------------RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT 568 (1028)
Q Consensus 502 -------------~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~ 568 (1028)
++.+||+|||+++.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 66899999999987543 2345689999999999987 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCC-----------CC-CccccccccccHHHHHHHHHhcc
Q psy18163 569 GKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNV-----------GG-LKTKVAGSILTELGYDLLCKFLT 636 (1028)
Q Consensus 569 g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~-----------~~-l~~~~~~~~Ls~~a~DLL~kcL~ 636 (1028)
+.+..+.+..+....+.++...+............. ..+... .. ..........++.+.+||.+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDR-LDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTE-ECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcc-ccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 999888888887777665443221111000000000 000000 00 00011122346788999999999
Q ss_pred cCcCCCCCHHHHHhCCCCCC
Q psy18163 637 YDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 637 ~DP~kRPTA~ElL~HPfF~e 656 (1028)
.||.+|||+.|+|+||||+.
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGG
T ss_pred cCcccccCHHHHhcCHHHHH
Confidence 99999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=434.98 Aligned_cols=261 Identities=23% Similarity=0.364 Sum_probs=220.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~ 437 (1028)
..++|++++.||+|+||+||+|++..+++.||||++++... ..........|+.+|..+ .||||+.++++|. +.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eCCE
Confidence 46889999999999999999999999999999999986532 233345567888888876 6999999987774 4568
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+||||||+.+ ++|...+... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 417 ~~lV~E~~~g--g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNG--GDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCS--CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCC--CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999986 4444444433 458999999999999999999999999999999999999999999999999998755
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.........+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.+..+++..|......
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------------ 560 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA------------ 560 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC------------
T ss_pred cCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 44455667899999999999987 67999999999999999999999999999988888887652110
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCH-----HHHHhCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA-----DEALRHDYFSESPL 659 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA-----~ElL~HPfF~e~p~ 659 (1028)
+ ...++..+.+||.+||..||.+||++ .+|++||||+...|
T Consensus 561 ----------~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 561 ----------Y-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp ----------C-----------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred ----------C-----------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 0 12367889999999999999999997 99999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=395.51 Aligned_cols=266 Identities=26% Similarity=0.372 Sum_probs=212.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc---cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK---EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~---~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|++++.||+|+||+||+|.+..++..||||++...... ......+.+|+.+|..++||||+++++++.. ...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence 46899999999999999999999999999999999765321 2233466789999999999999999998854 458
Q ss_pred EEEEEeccccchHHHHHHHhh---------------------------------------cCCcCCHHHHHHHHHHHHHH
Q psy18163 438 IFIVMDYVEHDMKSLMETMRS---------------------------------------KKQVFIPGEVKCLMQQLLNA 478 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~---------------------------------------~~~~~se~ev~~il~QLl~A 478 (1028)
+|||||||.+ ++|.+.+.. ....+++..++.++.||+.|
T Consensus 103 ~~lv~e~~~g--g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 103 ICLVMELCHG--GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp EEEEEECCCS--CBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCC--CcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999976 344443321 01124567788999999999
Q ss_pred HHHHHhCCcccccccccceeecCCC--cEEEeccCCccccCCCC----CcccccccCccccCcccccCC-CCCCchhhHH
Q psy18163 479 VAHLHDNWILHRDLKTSNLLLSHRG--ILKVGDFGLAREYGSPL----KHYTPIVVTLWYRSPELLLGC-KEYSTPIDMW 551 (1028)
Q Consensus 479 L~yLHs~gIVHRDLKPeNILLd~~g--~lKL~DFGlAr~~~~~~----~~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIW 551 (1028)
|.|||++||+||||||+||||+.++ .+||+|||++..+.... ......+||+.|+|||++.+. ..|+.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998766 89999999998653211 123567899999999998652 5689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHH
Q psy18163 552 SVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLL 631 (1028)
Q Consensus 552 SLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL 631 (1028)
||||++|+|++|..||.+.+..+.+..+......+... ....+++.+.+||
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li 311 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-----------------------------NYNVLSPLARDLL 311 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-----------------------------GGGGSCHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-----------------------------ccccCCHHHHHHH
Confidence 99999999999999999999888888776632211110 0122678899999
Q ss_pred HHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 632 CKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 632 ~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
.+||..||.+|||+.++|+||||++...
T Consensus 312 ~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 312 SNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHcCCChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999999999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=390.02 Aligned_cols=260 Identities=26% Similarity=0.377 Sum_probs=201.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC----
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM---- 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~---- 435 (1028)
..++|++++.||+|+||.||+|++..+++.||||+++.... ......+.+|+.+|..++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 45789999999999999999999999999999999976542 2234567899999999999999999998754322
Q ss_pred ---------------------------------------------------CeEEEEEecccc-chHHHHHHHhhcCCcC
Q psy18163 436 ---------------------------------------------------DKIFIVMDYVEH-DMKSLMETMRSKKQVF 463 (1028)
Q Consensus 436 ---------------------------------------------------~~l~LVmEy~~g-dLgsLl~~l~~~~~~~ 463 (1028)
..+|+|||||.+ +|.+++.... .....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~ 161 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDR 161 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGS
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccch
Confidence 248999999987 5555544211 12234
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC------------CcccccccCcc
Q psy18163 464 IPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL------------KHYTPIVVTLW 531 (1028)
Q Consensus 464 se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~------------~~~t~~vGT~~ 531 (1028)
.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......+||+.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 556789999999999999999999999999999999999999999999998775432 22345689999
Q ss_pred ccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCC
Q psy18163 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNV 611 (1028)
Q Consensus 532 Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~ 611 (1028)
|+|||++.+ ..++.++|||||||++|+|++|..|+.. ....+..+... . .+
T Consensus 242 y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~---~----------~~------------- 292 (332)
T 3qd2_B 242 YMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL---K----------FP------------- 292 (332)
T ss_dssp GSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT---C----------CC-------------
T ss_pred ccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc---C----------CC-------------
Confidence 999999987 5689999999999999999998776522 11111111110 0 00
Q ss_pred CCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 612 GGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 612 ~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
......++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 293 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 293 ------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp ------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ------cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 011124567789999999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=380.85 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=217.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.++..++||||+++++++.. ...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEE
Confidence 457899999999999999999999999999999999765322 2334567789999999999999999998864 4589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|+||||+.+ +|.+++. .. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQ---KH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEECCCTTEEHHHHHH---HH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEeCCCCcHHHHHH---hc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999976 5555443 22 358999999999999999999999999999999999999999999999999997664
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 230 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK------------ 230 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC------------
T ss_pred cc--ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC------------
Confidence 32 2345689999999999987 56899999999999999999999999988877766665432100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPID 662 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~ 662 (1028)
....++..+.+||.+||..||.+|||+.++|+||||+.......
T Consensus 231 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~ 274 (284)
T 2vgo_A 231 ---------------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274 (284)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCC
T ss_pred ---------------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccC
Confidence 01225678899999999999999999999999999986544433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=390.34 Aligned_cols=282 Identities=20% Similarity=0.277 Sum_probs=216.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||+||+|.+..+++.||||++....... ....+.+|+.+|..++||||+++++++.......+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 4578999999999999999999999999999999997654322 234567899999999999999999998877777899
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee----cCCCcEEEeccCCcc
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL----SHRGILKVGDFGLAR 514 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL----d~~g~lKL~DFGlAr 514 (1028)
|||||+.+ +|.+++.... ....+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 86 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999975 6666554322 12238999999999999999999999999999999999999 788899999999998
Q ss_pred ccCCCCCcccccccCccccCcccccC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhc
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLG-------CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS----DLEQLSRIFKTM 583 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g-------~~~ys~ksDIWSLGvILyELLTG~pPF~g~s----d~d~l~kI~~~l 583 (1028)
.+... ......+||+.|+|||++.. ...|+.++||||||||+|+|++|..||.... ..+.+..+...
T Consensus 165 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~- 242 (319)
T 4euu_A 165 ELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG- 242 (319)
T ss_dssp ECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH-
T ss_pred ecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC-
Confidence 77553 34456789999999999862 2568999999999999999999999997533 34445555443
Q ss_pred CCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCC
Q psy18163 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHD 652 (1028)
Q Consensus 584 g~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HP 652 (1028)
.+...|................++.. ......++..+.+||.+||..||.+|||+.|+|+||
T Consensus 243 --~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 243 --KPSGAISGVQKAENGPIDWSGDMPVS-----CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp --CCTTCCEEEECSTTCCEEEESSCCTT-----CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred --CCcccchhhhcccCCccccCccCCcc-----cccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 22222222211111000000011110 112244677899999999999999999999999996
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=385.08 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=217.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc--cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK--EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~--~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
.++|++.+.||+|+||.||+|.+..++..||||+++..... ......+.+|+.++..++||||+++++++.......+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 57899999999999999999999999999999999765422 1233456789999999999999999999876666789
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||+.++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999987666665532 34689999999999999999999999999999999999999999999999999987643
Q ss_pred C--CCcccccccCccccCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 P--LKHYTPIVVTLWYRSPELLLGCK-EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~--~~~~t~~vGT~~Y~APEvL~g~~-~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
. ........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~---------- 231 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA---------- 231 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC----------
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC----------
Confidence 2 22334567999999999987632 3478999999999999999999999998877766665442100
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
....+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 232 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 232 -----------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -----------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -----------------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 01125677889999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=421.79 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=216.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+|..++||||+.+++++.. ...+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 260 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTDL 260 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCEE
Confidence 357899999999999999999999999999999999765432 2334556789999999999999999888754 4589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
||||||+.+ +|..++.........+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999986 5544443322224468999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS----DLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s----d~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.........+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+ ..+....+.....
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--------- 410 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--------- 410 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC---------
T ss_pred CCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc---------
Confidence 54444456799999999999988 679999999999999999999999998753 2334444433110
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESPL 659 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p~ 659 (1028)
. +...++..+.+||.+||..||.+||+ +.+|++||||+...|
T Consensus 411 -------------~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 411 -------------T-----------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp -------------C-----------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred -------------C-----------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 0 01236788999999999999999995 589999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=378.44 Aligned_cols=256 Identities=30% Similarity=0.394 Sum_probs=215.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.++..++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEE
Confidence 4679999999999999999999999999999999976542 224456789999999999999999998854 458999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee---cCCCcEEEeccCCcccc
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL---SHRGILKVGDFGLAREY 516 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL---d~~g~lKL~DFGlAr~~ 516 (1028)
||||+.+ +|.+++ .. ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+
T Consensus 84 v~e~~~~~~L~~~~---~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 84 VMELCTGGELFERV---VH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEECCCSCBHHHHH---HH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHH---HH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999976 444444 33 3458999999999999999999999999999999999999 78899999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++..
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 229 (277)
T 3f3z_A 160 KPG-KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK------- 229 (277)
T ss_dssp CTT-SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-------
T ss_pred cCc-cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-------
Confidence 543 34456789999999999876 38999999999999999999999999988888777776532211110
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
....+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 230 ----------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 230 ----------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ----------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 01125678899999999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=394.89 Aligned_cols=299 Identities=23% Similarity=0.347 Sum_probs=223.6
Q ss_pred CCCCCcccccc-ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC--------
Q psy18163 349 PPYLPAIQGCR-SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-------- 419 (1028)
Q Consensus 349 p~y~p~~~g~~-~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-------- 419 (1028)
.+|+|...+.. ..++|++++.||+|+||+||+|.+..+++.||||++..... ......+|+.++..+.
T Consensus 5 ~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~ 81 (373)
T 1q8y_A 5 GGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKED 81 (373)
T ss_dssp --CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred CCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc---chhhhhHHHHHHHHhhcccccchh
Confidence 36777766654 35699999999999999999999999999999999975432 1234567888888776
Q ss_pred ---CCCeeEEEEEEeec--CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-Cccccccc
Q psy18163 420 ---HPNIVTVREIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLK 493 (1028)
Q Consensus 420 ---HPNIV~L~~i~~~~--~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLK 493 (1028)
||||+++++++... +...+++||||++++|.+++.... ...+++..+..++.||+.||.|||++ ||+|||||
T Consensus 82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dik 159 (373)
T 1q8y_A 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159 (373)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCS
T ss_pred ccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence 89999999988643 334789999999878877776532 34488999999999999999999998 99999999
Q ss_pred ccceeec------CCCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy18163 494 TSNLLLS------HRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLF 567 (1028)
Q Consensus 494 PeNILLd------~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF 567 (1028)
|+||||+ ..+.+||+|||+++.... ..+..+||+.|+|||++.+ ..++.++||||||||||+|++|.+||
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCC---CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 9999995 344899999999987753 2445689999999999988 56899999999999999999999999
Q ss_pred CCCC------hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCc----------cccccccccHHHHHHH
Q psy18163 568 TGKS------DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLK----------TKVAGSILTELGYDLL 631 (1028)
Q Consensus 568 ~g~s------d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~----------~~~~~~~Ls~~a~DLL 631 (1028)
.+.+ +.+.+..++..++.++...+........... ....+....... ...+...++..+.+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 314 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN-SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBC-C--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcC-CcchhcccccccccchhhhhhhcccCCcchHHHHHHHH
Confidence 8754 5677788888777665432211100000000 000000000000 0011234567889999
Q ss_pred HHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 632 CKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 632 ~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.+||..||.+|||+.++|+||||++.
T Consensus 315 ~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 315 SPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp GGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHhccCccccCCHHHHhhChhhhcc
Confidence 99999999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=394.83 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=214.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+.|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|..++||||+++++++... +.+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEEE
Confidence 4699999999999999999999999999999999754321 12224567899999999999999999988654 48999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 132 v~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 132 VMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 999999877666543 345689999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 KHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
....+||+.|+|||++.+ ...++.++||||||||+|+|++|.+||.+.+..+.+..+..... +.
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~----------- 272 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA----------- 272 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC-----------
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC-----------
Confidence 245689999999999853 35689999999999999999999999998888777766654211 00
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 273 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0011256788999999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=382.36 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=213.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||.||+|.+..+++.||||+++..... ....+.+|+.++..++||||+++++++.. ...+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 82 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYY 82 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEE
Confidence 346899999999999999999999999999999999864321 23456789999999999999999998854 45899
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee---cCCCcEEEeccCCccc
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL---SHRGILKVGDFGLARE 515 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL---d~~g~lKL~DFGlAr~ 515 (1028)
+||||+.+ +|.+++. . ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~l~---~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 83 LVMQLVSGGELFDRIL---E-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEECCCCSCBHHHHHH---H-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEcCCCccHHHHHH---H-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999975 5544443 2 2358899999999999999999999999999999999999 6788999999999976
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+....
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----- 230 (304)
T 2jam_A 159 EQN--GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF----- 230 (304)
T ss_dssp CCC--BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT-----
T ss_pred cCC--CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc-----
Confidence 543 23345679999999999987 5689999999999999999999999999888877777765422211111
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 231 ------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 231 ------------------------WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ------------------------TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 12356788999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=386.03 Aligned_cols=261 Identities=22% Similarity=0.338 Sum_probs=200.4
Q ss_pred ccCCeEEE-EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCL-NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il-~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~ 437 (1028)
..+.|++. +.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+|.++ .||||+++++++... +.
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~ 85 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DR 85 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CE
Confidence 34689996 78999999999999999999999999997643 23345677899999884 799999999998654 58
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc---EEEeccCCc
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI---LKVGDFGLA 513 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~---lKL~DFGlA 513 (1028)
+||||||+.+ +|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999975 55555433 245899999999999999999999999999999999999987765 999999999
Q ss_pred cccCCCC-------CcccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------
Q psy18163 514 REYGSPL-------KHYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL--------- 573 (1028)
Q Consensus 514 r~~~~~~-------~~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~--------- 573 (1028)
..+.... ......+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 7653211 12334679999999999864 134789999999999999999999999876421
Q ss_pred ------HHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHH
Q psy18163 574 ------EQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647 (1028)
Q Consensus 574 ------d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~E 647 (1028)
..+..+...... ++ ......++..+.+||.+||..||.+|||+.+
T Consensus 242 ~~~~~~~~~~~i~~~~~~----------------------~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYE----------------------FP-------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp CHHHHHHHHHHHHHCCCC----------------------CC-------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred chhHHHHHHHHHhccCcc----------------------cC-------chhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 112222211000 00 0011236788999999999999999999999
Q ss_pred HHhCCCCCCC
Q psy18163 648 ALRHDYFSES 657 (1028)
Q Consensus 648 lL~HPfF~e~ 657 (1028)
+|+||||++.
T Consensus 293 ~l~hp~~~~~ 302 (316)
T 2ac3_A 293 VLQHPWVQGC 302 (316)
T ss_dssp HHHSTTCC--
T ss_pred HhcChhhcCC
Confidence 9999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=376.72 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=210.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec--CCCeEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--NMDKIF 439 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~--~~~~l~ 439 (1028)
..|++.+.||+|+||+||+|.+..++..||+|++............+.+|+.+|..++||||+++++++... ....+|
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 458999999999999999999999999999999986554333345567899999999999999999988643 345789
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeec-CCCcEEEeccCCccc
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLS-HRGILKVGDFGLARE 515 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd-~~g~lKL~DFGlAr~ 515 (1028)
+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++| |+|+||||+||||+ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999976 66666543 245889999999999999999999999 99999999999998 789999999999976
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.....+
T Consensus 182 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 248 (290)
T 1t4h_A 182 KRAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------- 248 (290)
T ss_dssp CCTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred cccc--ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc---------
Confidence 5432 3345689999999998875 48999999999999999999999998866555444333211000
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.......++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 249 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 ---------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ---------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ---------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 01112355778999999999999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=380.55 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=210.0
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
...++|++++.||+|+||.||+|.+..++..||+|++.... ......+.+|+.++..+.||||+++++++... +.+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 91 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GKL 91 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--CeE
Confidence 34578999999999999999999999999999999987543 22345667899999999999999999988643 489
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|+||||+.+ +|..++ ......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 92 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEEECCTTEEHHHHH---HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEEEeCCCCcHHHHH---HhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999976 444443 3335568999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccCccccCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLL----GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~----g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.........+||+.|+|||++. ....++.++|||||||++|+|++|.+||...+....+..+...... ..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~---- 242 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP--TL---- 242 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CC----
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc--cc----
Confidence 2222234468999999999984 3356899999999999999999999999998877766665542110 00
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 243 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 243 ------------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp ------------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ------------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 0112356788999999999999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=391.61 Aligned_cols=261 Identities=27% Similarity=0.363 Sum_probs=202.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCC--CCeeEEEEEEeecCCCeE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH--PNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H--PNIV~L~~i~~~~~~~~l 438 (1028)
..+|++++.||+|+||+||+|.+. ++..||||++............+.+|+.+|..+.| |||+.+++++.. ...+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 84 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 84 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEE
Confidence 467999999999999999999885 68899999998654333333456789999999987 999999998864 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||.+++|.+++.. ...+++.++..|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+..
T Consensus 85 ~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99999887777666643 45689999999999999999999999999999999999997 68899999999987654
Q ss_pred CCC--cccccccCccccCcccccC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCC
Q psy18163 519 PLK--HYTPIVVTLWYRSPELLLG----------CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL-EQLSRIFKTMGT 585 (1028)
Q Consensus 519 ~~~--~~t~~vGT~~Y~APEvL~g----------~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~-d~l~kI~~~lg~ 585 (1028)
... .....+||+.|+|||++.+ ...|+.++||||||||+|+|++|.+||....+. ..+..++. .
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~ 236 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---P 236 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---T
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---C
Confidence 322 2345689999999999854 246899999999999999999999999875432 22333221 1
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
..... .....+..+.+||.+||..||.+|||+.++|+||||+....|
T Consensus 237 ~~~~~----------------------------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 237 NHEIE----------------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp TSCCC----------------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred CcccC----------------------------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 10000 111245678899999999999999999999999999865444
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=423.56 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=213.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||.||+|++..+|+.||||++.+.... ......+.+|+.+|..++||||+.+++++.. .+.+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCEE
Confidence 457899999999999999999999999999999999765422 2334456789999999999999999888754 4589
Q ss_pred EEEEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
||||||+.+ ++|...+... ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 260 ~lVmEy~~g--g~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 260 CLVLTLMNG--GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEECCCCS--CBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEcCCC--CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999976 4444444333 2348999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD----LEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd----~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.. ......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+. ......+... ...
T Consensus 338 ~~-~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~~~---- 407 (576)
T 2acx_A 338 EG-QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PEE---- 407 (576)
T ss_dssp TT-CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----CCC----
T ss_pred cC-ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----ccc----
Confidence 43 33456799999999999987 5699999999999999999999999987642 2222222211 000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
+...+++.+.+||.+||..||.+|| ++.+|++||||+...
T Consensus 408 -------------------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 408 -------------------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp -------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred -------------------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 0123678899999999999999999 899999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=381.87 Aligned_cols=262 Identities=21% Similarity=0.381 Sum_probs=208.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC----
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN---- 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~---- 434 (1028)
..++|++++.||.|+||.||+|.+..+++.||||++.... .....+.+|+.++..+ .||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 3578999999999999999999999999999999997543 2335667899999998 7999999999987643
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCc
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA 513 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlA 513 (1028)
...+||||||+.+ +|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 4689999999986 666666543 2346889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 514 REYGSPLKHYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 514 r~~~~~~~~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
..+..........+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+..... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~ 253 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA---PR 253 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CC
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---cc
Confidence 876544344456789999999999862 25689999999999999999999999998887766655543210 00
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 254 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 ----------------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ----------------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ----------------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0012356788999999999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=378.49 Aligned_cols=262 Identities=26% Similarity=0.365 Sum_probs=218.2
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++..+.||||+++++++.. .+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDF 89 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCE
Confidence 3457899999999999999999999999999999999765322 1223456789999999999999999998854 458
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
+|+||||+.+ +|.+++. . ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~~~---~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHK---R-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEEECCTTCBHHHHHH---H-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHH---h-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999985 5554443 2 345899999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------- 233 (294)
T 2rku_A 166 EYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS----------- 233 (294)
T ss_dssp CSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-----------
T ss_pred ccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC-----------
Confidence 654444556789999999999977 56899999999999999999999999988877666555331100
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
....++..+.+||.+||..||.+|||+.++|+||||...+.|
T Consensus 234 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 234 ----------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ----------------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 011256778899999999999999999999999999876544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=399.69 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=203.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC--CCCeeEEEEEEeecCCCeEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ--HPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~--HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.+|++++.||+|+||+||+|.+.. ++.||||++............+.+|+.+|..+. ||||+.+++++... +.+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIY 132 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEE
Confidence 569999999999999999999875 899999999765433333456678999999997 59999999988654 4799
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+...
T Consensus 133 lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999877677666543 34688889999999999999999999999999999999995 689999999999876533
Q ss_pred CC--cccccccCccccCcccccCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCC
Q psy18163 520 LK--HYTPIVVTLWYRSPELLLGC----------KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD-LEQLSRIFKTMGTP 586 (1028)
Q Consensus 520 ~~--~~t~~vGT~~Y~APEvL~g~----------~~ys~ksDIWSLGvILyELLTG~pPF~g~sd-~d~l~kI~~~lg~p 586 (1028)
.. .....+||+.|+|||++.+. ..|+.++||||||||||+|++|.+||.+..+ ...+..++...
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~--- 284 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN--- 284 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT---
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc---
Confidence 21 23457899999999998652 3589999999999999999999999987543 33333333210
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
... .+ ....+..+.+||.+||..||.+|||+.++|+||||+....|
T Consensus 285 ~~~-----------------~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 285 HEI-----------------EF-----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp SCC-----------------CC-----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred ccC-----------------CC-----------CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 000 00 11235678899999999999999999999999999865443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=375.73 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=216.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-------CCccchHHHHHHHHHcC-CCCeeEEEEEEe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-------GFPITSLREINTLLKAQ-HPNIVTVREIVV 431 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-------~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~ 431 (1028)
..++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999999999999999997653211 11234568999999996 999999999885
Q ss_pred ecCCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEecc
Q psy18163 432 GSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDF 510 (1028)
Q Consensus 432 ~~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DF 510 (1028)
. ...+|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+||
T Consensus 95 ~--~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 T--NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred c--CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 4 4589999999975 66555542 345899999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCcccccccCccccCccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q psy18163 511 GLAREYGSPLKHYTPIVVTLWYRSPELLL-----GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 511 GlAr~~~~~~~~~t~~vGT~~Y~APEvL~-----g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
|++..+... ......+||+.|+|||++. ....++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 169 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 169 GFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp TTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 999876543 3345678999999999985 2356889999999999999999999999998887777766553211
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
+... ....++..+.+||.+||..||.+|||+.++|+||||++.
T Consensus 248 ~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 248 FGSP-----------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CCTT-----------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cCcc-----------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 1110 012356788999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=406.03 Aligned_cols=262 Identities=28% Similarity=0.427 Sum_probs=200.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc------cCCccchHHHHHHHHHcCCCCeeEEEEEEeec
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK------EGFPITSLREINTLLKAQHPNIVTVREIVVGS 433 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~------~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~ 433 (1028)
..++|.+.+.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|..++||||+++++++.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-- 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 357899999999999999999999999999999999765321 122235678999999999999999999874
Q ss_pred CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC---cEEEecc
Q psy18163 434 NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG---ILKVGDF 510 (1028)
Q Consensus 434 ~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g---~lKL~DF 510 (1028)
...+||||||+.+ ++|.+.+. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+||
T Consensus 211 -~~~~~lv~e~~~~--g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 -AEDYYIVLELMEG--GELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp -SSEEEEEEECCTT--CBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred -cCceEEEEEcCCC--CcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence 3468999999976 44444433 345689999999999999999999999999999999999997544 5999999
Q ss_pred CCccccCCCCCcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 511 GLAREYGSPLKHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 511 GlAr~~~~~~~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
|+|+.+... ......+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+......+...+.... .
T Consensus 287 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~-~-- 362 (419)
T 3i6u_A 287 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-Y-- 362 (419)
T ss_dssp STTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC-C--
T ss_pred ccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC-C--
Confidence 999877543 33456789999999999863 35688999999999999999999999987544332322222100 0
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
...+ .....+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 363 ------~~~~-------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 363 ------NFIP-------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ------CCCH-------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ------CCCc-------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 0000 011236788999999999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=373.02 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=207.6
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
+....++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++..++||||+++++++.. .
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 83 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--P 83 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--C
Confidence 344568999999999999999999999999999999999765422 2334466789999999999999999998854 4
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..+|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccc
Confidence 589999999975 66555543 2358899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
..... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||...+....+..+......
T Consensus 160 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 229 (276)
T 2h6d_A 160 MMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY--------- 229 (276)
T ss_dssp CCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred ccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc---------
Confidence 76543 23345689999999999987544578999999999999999999999988776666555432100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....++..+.+||.+||..||.+|||+.++|+||||++.
T Consensus 230 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 230 ------------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 011256778899999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=392.76 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=214.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc------CCccchHHHHHHHHHc-CCCCeeEEEEEEeec
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE------GFPITSLREINTLLKA-QHPNIVTVREIVVGS 433 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~------~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~ 433 (1028)
.++|++.+.||.|+||.||+|.+..+|+.||||++....... .....+.+|+.++..+ .||||+.+++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES- 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence 467999999999999999999999999999999997653211 1123456899999998 79999999998854
Q ss_pred CCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCC
Q psy18163 434 NMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512 (1028)
Q Consensus 434 ~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGl 512 (1028)
...+||||||+.+ +|.+++. . ...+++..+..++.||+.||.|||+.||+|+||||+||||+.+|.+||+|||+
T Consensus 172 -~~~~~lv~e~~~g~~L~~~l~---~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 172 -SSFMFLVFDLMRKGELFDYLT---E-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp -SSEEEEEECCCTTCBHHHHHH---H-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred -CCEEEEEEEeCCCCcHHHHHH---h-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 4589999999986 5555543 2 34589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCccccCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLG-----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g-----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
+..+... ......+||+.|+|||++.+ ...|+.++||||||||+|+|++|.+||.+.+....+..+......+.
T Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 247 SCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp CEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred ccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9877543 34456789999999999863 23588999999999999999999999999888777777655321111
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
... ...++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 326 ~~~-----------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 326 SPE-----------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHH-----------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred Ccc-----------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 000 1125678899999999999999999999999999973
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=392.49 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=207.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc------CCccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE------GFPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~------~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
.++|++++.||+|+||+||+|++..+++.||||++....... .....+.+|+.+|..++||||+++++++. .
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--~ 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE--N 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--C
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--e
Confidence 478999999999999999999999999999999998764322 13345678999999999999999999885 4
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
...+++||||+.+. .+|...+.. ...+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~g-~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 101 QGFFQLVMEKHGSG-LDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SSEEEEEEECCTTS-CBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 45899999998651 134443333 4468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.+... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||..... +.. ..
T Consensus 179 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~-----------~~ 240 (335)
T 3dls_A 179 YLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE-----------AA 240 (335)
T ss_dssp ECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT-----------TC
T ss_pred ECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh-----------hc
Confidence 77543 3345678999999999998855558999999999999999999999965211 000 00
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
......+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 241 ----------------------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 241 ----------------------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ----------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ----------------------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0001126788999999999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=387.93 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=218.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
...+|.+.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++..+.||||+++++++.. .+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeE
Confidence 457899999999999999999999999999999999765321 1223456789999999999999999998864 4589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|+||||+.+ +|.+++.. ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 117 ~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999985 55554432 3458999999999999999999999999999999999999999999999999998776
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+......
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 259 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------------ 259 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------------
T ss_pred cCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC------------
Confidence 44444556789999999999987 56899999999999999999999999988877766655442100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
....++..+.+||.+||..||.+|||+.++|+||||+....|
T Consensus 260 ---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 260 ---------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ---------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 011256778899999999999999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=374.84 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=210.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC----CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG----FPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~----~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
++|++++.||+|+||+||+|.+..+++.||||+++....... ....+.+|+.++..++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 579999999999999999999999999999999976543221 23456789999999999999999998864 458
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC----cEEEeccCC
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG----ILKVGDFGL 512 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g----~lKL~DFGl 512 (1028)
+|+||||+.+ +|.+++.. ...+++.++..++.||+.||.|||++||+|+||||+|||++.++ .+||+|||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999964 66655532 34589999999999999999999999999999999999998877 899999999
Q ss_pred ccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
+...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 232 (283)
T 3bhy_A 159 AHKIEAG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE---- 232 (283)
T ss_dssp CEECC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH----
T ss_pred ceeccCC-CcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc----
Confidence 9876543 33455689999999999977 56899999999999999999999999998887777666442111100
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 233 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 233 -------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp -------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred -------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 011235678899999999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=378.05 Aligned_cols=257 Identities=25% Similarity=0.445 Sum_probs=210.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.++..+.||||+++++++... ..+|+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 101 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN--TDLWI 101 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEE
Confidence 468999999999999999999999999999999997642 234578899999999999999999988653 48999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 102 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEECCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EeecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999986 5555543 34566899999999999999999999999999999999999999999999999999877654
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+.... + .. +
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-~~----~----- 245 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--P-PT----F----- 245 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C-CC----C-----
T ss_pred ccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--C-cc----c-----
Confidence 444556789999999999987 568999999999999999999999999877766554443311 0 00 0
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 246 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 246 ------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp ------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0012256788999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=385.78 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=208.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCC--C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNM--D 436 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~--~ 436 (1028)
..++|++++.||+|+||.||+|++..+++.||||++....... .....+.+|+.++..++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999999999999999997653221 222356789999999999999999998865432 3
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+||||||+.+ +|.+++.. ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 56999999965 66655542 24589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCC---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 516 YGSPL---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 516 ~~~~~---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
+.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 240 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS---- 240 (311)
T ss_dssp ----------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH----
T ss_pred ccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc----
Confidence 65432 22334679999999999987 56999999999999999999999999998887776666543211100
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.....++..+.+||.+||..||.+||++.++|.|+|++.
T Consensus 241 -------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 -------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 011236778999999999999999999999999999964
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=372.06 Aligned_cols=259 Identities=27% Similarity=0.374 Sum_probs=209.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++..++||||+++++++.. ...+|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEE
Confidence 4689999999999999999999999999999999976543 2233456789999999999999999998864 358999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++ . ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 83 v~e~~~~~~L~~~l---~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 83 FLEYCSGGELFDRI---E-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEECCTTEEGGGGS---B-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEecCCCcHHHHH---h-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999976 554443 2 2346899999999999999999999999999999999999999999999999999865322
Q ss_pred C--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCCCCC
Q psy18163 520 L--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ-LSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 520 ~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~-l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.... +..+..... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~------ 227 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-----Y------ 227 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-----T------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-----c------
Confidence 1 2244568999999999998755558899999999999999999999987654322 222211100 0
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
. .....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 228 ~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 228 L--------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp S--------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred c--------------------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0 0012367788999999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=374.71 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=199.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec-------
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS------- 433 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~------- 433 (1028)
.++|++++.||+|+||.||+|++..+++.||||++..... ....+.+|+.++..++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE---KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHH---HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4689999999999999999999999999999999965321 234567899999999999999999987542
Q ss_pred ----CCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEe
Q psy18163 434 ----NMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVG 508 (1028)
Q Consensus 434 ----~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~ 508 (1028)
....+|+||||+.+ +|.+++. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHH---HSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhh---ccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence 24578999999976 5555554 345567888999999999999999999999999999999999999999999
Q ss_pred ccCCccccCCC--------------CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChH
Q psy18163 509 DFGLAREYGSP--------------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK-SDL 573 (1028)
Q Consensus 509 DFGlAr~~~~~--------------~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~-sd~ 573 (1028)
|||++...... .......+||+.|+|||++.+...++.++|||||||++|+|++ ||... +..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99999866422 1223456899999999999876679999999999999999998 55432 223
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCC
Q psy18163 574 EQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653 (1028)
Q Consensus 574 d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPf 653 (1028)
..+..+.......+. ......+..+.+||.+||..||.+|||+.++|+|||
T Consensus 236 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 236 NILKKLRSVSIEFPP-----------------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp HHHHHHHSTTCCCCT-----------------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred HHHHhccccccccCc-----------------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 333333221100000 011224567889999999999999999999999999
Q ss_pred CCC
Q psy18163 654 FSE 656 (1028)
Q Consensus 654 F~e 656 (1028)
|+.
T Consensus 287 ~~~ 289 (303)
T 1zy4_A 287 LPV 289 (303)
T ss_dssp SCC
T ss_pred cCC
Confidence 975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=379.94 Aligned_cols=272 Identities=25% Similarity=0.375 Sum_probs=195.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||+||+|.+..+++.||||++...... .....+.+|+.++..++||||+++++++... +.+|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--DELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS--SCEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--CCcE
Confidence 457899999999999999999999999999999998755332 2234567899999999999999999988644 4799
Q ss_pred EEEecccc-chHHHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 440 IVMDYVEH-DMKSLMETMRSK----KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~----~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
+||||+.+ +|.+++..+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999964 777777654332 3458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC-----CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 515 EYGSPL-----KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 515 ~~~~~~-----~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
.+.... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+....... + ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~-~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--P-PS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--C-CC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--C-Cc
Confidence 764321 122346899999999998764568999999999999999999999999877665554443211 1 00
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..... ........++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 247 ~~~~~--------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 247 LETGV--------------------QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TTC-------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccccc--------------------ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 00000 0001112367788999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=391.00 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=205.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeecccc--ccCCccchHHHHHHHHHc-CCCCeeEEEEEEeec
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKE--KEGFPITSLREINTLLKA-QHPNIVTVREIVVGS 433 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~--~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~ 433 (1028)
..++|++++.||+|+||+||+|++. .+++.||||+++.... .......+.+|+.+|..+ .||||+.+++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 4578999999999999999999995 5899999999976432 122334556799999999 699999999888544
Q ss_pred CCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCC
Q psy18163 434 NMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512 (1028)
Q Consensus 434 ~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGl 512 (1028)
..+||||||+.+ +|.+++. .. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 132 --~~~~lv~e~~~~~~L~~~l~---~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 132 --TKLHLILDYINGGELFTHLS---QR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp --TEEEEEECCCCSCBHHHHHH---HH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred --ceEEEEeecCCCCCHHHHHH---Hc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 489999999986 5554443 32 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-CCcccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCC
Q psy18163 513 AREYGSP-LKHYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD----LEQLSRIFKTMGTP 586 (1028)
Q Consensus 513 Ar~~~~~-~~~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd----~d~l~kI~~~lg~p 586 (1028)
++.+... .......+||+.|+|||++.+. ..++.++||||||||||+|++|..||..... ......+.... +
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~ 283 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--P 283 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--C
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--C
Confidence 9866432 1223456899999999999862 4578999999999999999999999975432 22222222110 0
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
. ....++..+.+||.+||..||.+|| |+.++|+||||+..
T Consensus 284 --------------------~-----------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 284 --------------------P-----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp --------------------C-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred --------------------C-----------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 0 0122567889999999999999999 99999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=383.24 Aligned_cols=261 Identities=29% Similarity=0.434 Sum_probs=204.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc------cCCccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK------EGFPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~------~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|..+.||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 46899999999999999999999999999999999754321 12234567899999999999999999988533
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc---EEEeccC
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI---LKVGDFG 511 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~---lKL~DFG 511 (1028)
.+|+||||+.+ ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||
T Consensus 88 --~~~lv~e~~~~--~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 --DYYIVLELMEG--GELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp --SEEEEEECCTT--EETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred --ceEEEEecCCC--CcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 48999999976 344444433 456899999999999999999999999999999999999987654 9999999
Q ss_pred CccccCCCCCcccccccCccccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLL--GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~--g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
++...... ......+||+.|+|||++. +...++.++|||||||++|+|++|.+||........+...+.... .
T Consensus 163 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~--- 237 (322)
T 2ycf_A 163 HSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-Y--- 237 (322)
T ss_dssp TCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC-C---
T ss_pred cceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc-c---
Confidence 99877542 2234568999999999984 345689999999999999999999999987544322222222100 0
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
...+ .....++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 238 -----~~~~-------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 238 -----NFIP-------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----CCCH-------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----ccCc-------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 0000 011236778999999999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=371.47 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=215.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.++..++||||+++++++.. ...+|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 97 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFY 97 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEE
Confidence 3478999999999999999999999999999999998765544445567899999999999999999998854 45899
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC---CcEEEeccCCccc
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR---GILKVGDFGLARE 515 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~---g~lKL~DFGlAr~ 515 (1028)
+||||+.+ +|.+++ ... ..+++.++..++.||+.||.|||++||+|+||||+||||+.+ +.+||+|||++..
T Consensus 98 lv~e~~~~~~L~~~l---~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 98 IVGELYTGGELFDEI---IKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEECCCCSCBHHHHH---HHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEccCCCCHHHHH---Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999975 444443 332 358999999999999999999999999999999999999754 4799999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+...
T Consensus 174 ~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 244 (287)
T 2wei_A 174 FQQN-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP------ 244 (287)
T ss_dssp BCCC-SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG------
T ss_pred ecCC-CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch------
Confidence 6543 33445679999999999876 38999999999999999999999999988877777665532111100
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
....++..+.+||.+||..||.+|||+.++|+||||++.
T Consensus 245 -----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 245 -----------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -----------------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -----------------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 012256788999999999999999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=372.31 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=214.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.+.|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.++..+.||||+++++++... ..+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEE
Confidence 36799999999999999999999999999999999765432 2345667899999999999999999988654 48999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|.+.+. ...+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+....
T Consensus 98 v~e~~~~--~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 98 IMEYLGG--GSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EEECCTT--EEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EEEeCCC--CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999986 33333333 3468999999999999999999999999999999999999999999999999998776544
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+.... +.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------------- 237 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--PP------------- 237 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC-------------
T ss_pred cccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--CC-------------
Confidence 44456789999999999987 568999999999999999999999999887766555543311 00
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 238 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 -----------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----------------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----------------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0112256778999999999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=391.14 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=189.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHc--CCCCeeEEE-------EEEe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKA--QHPNIVTVR-------EIVV 431 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l--~HPNIV~L~-------~i~~ 431 (1028)
..|++++.||+|+||+||+|.+..+++.||||++....... .....+.+|+.++..+ .||||+.++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45999999999999999999999999999999998754311 2223445665444444 699988855 3443
Q ss_pred ecCC---------------CeEEEEEeccccchHHHHHHHhhcCCcCCHHHH------HHHHHHHHHHHHHHHhCCcccc
Q psy18163 432 GSNM---------------DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEV------KCLMQQLLNAVAHLHDNWILHR 490 (1028)
Q Consensus 432 ~~~~---------------~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev------~~il~QLl~AL~yLHs~gIVHR 490 (1028)
.... ..+|||||||.++|.+++..... .+..... ..++.||+.||.|||++||+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 2221 45899999999888888775422 2333334 4666999999999999999999
Q ss_pred cccccceeecCCCcEEEeccCCccccCCCCCcccccccCccccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy18163 491 DLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG-CKEYSTPIDMWSVGCIFAEFLCMEPLFTG 569 (1028)
Q Consensus 491 DLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g-~~~ys~ksDIWSLGvILyELLTG~pPF~g 569 (1028)
||||+||||+.+|.+||+|||+|+..+.. .....+|+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999877532 224567899999999975 24689999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHH
Q psy18163 570 KSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649 (1028)
Q Consensus 570 ~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL 649 (1028)
..... ...|...... . ... ..... .....+++.+.+||.+||..||.+|||+.++|
T Consensus 296 ~~~~~-------------~~~~~~~~~~---~-~~~------~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 296 VTPGI-------------KGSWKRPSLR---V-PGT------DSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp CCTTC-------------TTCCCBCCTT---S-CCC------CSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred cCccc-------------ccchhhhhhh---h-ccc------cccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 64210 0001100000 0 000 00000 01134788999999999999999999999999
Q ss_pred hCCCCCC
Q psy18163 650 RHDYFSE 656 (1028)
Q Consensus 650 ~HPfF~e 656 (1028)
+||||++
T Consensus 352 ~hp~f~~ 358 (371)
T 3q60_A 352 ETPEFLQ 358 (371)
T ss_dssp TSHHHHH
T ss_pred cCHHHHH
Confidence 9999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=388.21 Aligned_cols=289 Identities=21% Similarity=0.301 Sum_probs=210.8
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
...++|++++.||+|+||+||+|.+..++..||+|++..... ......+.+|+.+|..++||||+++++++... ..+
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 106 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 106 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEE
Confidence 345789999999999999999999999999999999976532 22234567899999999999999999988654 589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
||||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..+
T Consensus 107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999976 66666543 23588999999999999999999996 9999999999999999999999999999765
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTM-GTPNEKIWPGFS 595 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~l-g~p~~~~w~~~s 595 (1028)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... +......+....
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 183 IDS--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHH--C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred ccc--cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 322 2345689999999999987 569999999999999999999999998877654433221111 111100000000
Q ss_pred CChhhhhhccccCCCC----------CCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNV----------GGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~----------~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.............+.. ...........++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 0000000000000000 0000011123467889999999999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=402.89 Aligned_cols=255 Identities=16% Similarity=0.209 Sum_probs=197.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHH---HHHHHcCCCCeeEEE-------EE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREI---NTLLKAQHPNIVTVR-------EI 429 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi---~iL~~l~HPNIV~L~-------~i 429 (1028)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+ .+|..+.|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999999754322 22334566888 455556899999987 55
Q ss_pred EeecCC----------C-----eEEEEEeccccchHHHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q psy18163 430 VVGSNM----------D-----KIFIVMDYVEHDMKSLMETMRSK---KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491 (1028)
Q Consensus 430 ~~~~~~----------~-----~l~LVmEy~~gdLgsLl~~l~~~---~~~~se~ev~~il~QLl~AL~yLHs~gIVHRD 491 (1028)
+...+. . ..||||||++++|.+++...... ...+++..+..|+.||+.||.|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 543321 1 37999999988888877654221 11233477888999999999999999999999
Q ss_pred ccccceeecCCCcEEEeccCCccccCCCCCcccccccCccccCcccccCC----------CCCCchhhHHHHHHHHHHHH
Q psy18163 492 LKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC----------KEYSTPIDMWSVGCIFAEFL 561 (1028)
Q Consensus 492 LKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~----------~~ys~ksDIWSLGvILyELL 561 (1028)
|||+||||+.+|.+||+|||+|+..+. ..+..+| +.|+|||++.+. ..|+.++||||||||||+|+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 999999999999999999999987543 3455678 999999999873 26999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCC
Q psy18163 562 CMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVT 641 (1028)
Q Consensus 562 TG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~k 641 (1028)
+|..||.+.+....+..+. . ....+++.+.+||.+||..||.+
T Consensus 308 tg~~Pf~~~~~~~~~~~~~-------------------------~------------~~~~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 308 CADLPITKDAALGGSEWIF-------------------------R------------SCKNIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HSSCCC------CCSGGGG-------------------------S------------SCCCCCHHHHHHHHHHTCSSGGG
T ss_pred HCCCCCcccccccchhhhh-------------------------h------------hccCCCHHHHHHHHHHcCCCchh
Confidence 9999997644321111000 0 01236788999999999999999
Q ss_pred CCCHHHHHhCCCCCC
Q psy18163 642 RITADEALRHDYFSE 656 (1028)
Q Consensus 642 RPTA~ElL~HPfF~e 656 (1028)
|||+.++|+||||++
T Consensus 351 Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 351 RLLPLQAMETPEYEQ 365 (377)
T ss_dssp CCCHHHHHTSHHHHH
T ss_pred CCCHHHHhhChHHHH
Confidence 999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=378.21 Aligned_cols=260 Identities=21% Similarity=0.249 Sum_probs=200.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||+||+|.+ ++..||||++............+.+|+.+|..++||||+++++++.. ...+|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNLS 110 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCCE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCceE
Confidence 457899999999999999999987 58899999997654333333456789999999999999999998853 45789
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecCCCcEEEeccCCcccc
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
+||||+.+ +|.+++.... ....+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999976 5555543211 1123889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------- 258 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---------- 258 (309)
T ss_dssp ------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred cccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Confidence 554444556789999999999987 568999999999999999999999999988777666553321110
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh--CCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR--HDYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~--HPfF~e 656 (1028)
.....+++.+.+||.+||..||.+|||+.++++ +++++.
T Consensus 259 ---------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ---------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 011236678899999999999999999999998 566654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=381.64 Aligned_cols=280 Identities=20% Similarity=0.355 Sum_probs=216.1
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCc---------------cchHHHHHHHHHcCCCC
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFP---------------ITSLREINTLLKAQHPN 422 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~---------------~~~lrEi~iL~~l~HPN 422 (1028)
....++|++++.||+|+||.||+|.+ +++.||||++.......... ..+.+|+.++..++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34568999999999999999999999 89999999997654322111 56678999999999999
Q ss_pred eeEEEEEEeecCCCeEEEEEecccc-chHHHHHH---Hhh-cCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccc
Q psy18163 423 IVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMET---MRS-KKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSN 496 (1028)
Q Consensus 423 IV~L~~i~~~~~~~~l~LVmEy~~g-dLgsLl~~---l~~-~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeN 496 (1028)
|+++++++.. .+.+|+||||+.+ +|.+++.. +.. ....+++..++.++.||+.||.|||+ +||+|+||||+|
T Consensus 105 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 105 CLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp BCCCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred cceEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999998864 4589999999987 66554211 222 14568999999999999999999999 999999999999
Q ss_pred eeecCCCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCh-HH
Q psy18163 497 LLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYST-PIDMWSVGCIFAEFLCMEPLFTGKSD-LE 574 (1028)
Q Consensus 497 ILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~-ksDIWSLGvILyELLTG~pPF~g~sd-~d 574 (1028)
||++.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||.+.+. .+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 99999999999999999876443 4456789999999999987545666 99999999999999999999998776 55
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 575 QLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 575 ~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.+..+.......+. .+..+. ... ...........++..+.+||.+||..||.+|||+.++|+||||
T Consensus 261 ~~~~i~~~~~~~~~-~~~~~~----------~~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 261 LFNNIRTKNIEYPL-DRNHFL----------YPL---TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp HHHHHTSCCCCCCC-SSSSST----------TTT---CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHhccCcCCcc-chhhhh----------ccc---cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 55554332111110 000000 000 0000111224578899999999999999999999999999999
Q ss_pred CCC
Q psy18163 655 SES 657 (1028)
Q Consensus 655 ~e~ 657 (1028)
++.
T Consensus 327 ~~~ 329 (348)
T 2pml_X 327 ADT 329 (348)
T ss_dssp TTC
T ss_pred cCC
Confidence 874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=370.81 Aligned_cols=261 Identities=21% Similarity=0.333 Sum_probs=193.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||.||+|.+..+++.||||++..............++..++..+.||||+++++++... +.+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEE
Confidence 45789999999999999999999999999999999976543222222233444567778999999999988643 5899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||+++.+..+.... ...+++..+..++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++..+..
T Consensus 101 lv~e~~~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEECCCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEeccCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999976555554432 45689999999999999999999995 999999999999999999999999999987654
Q ss_pred CCCcccccccCccccCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLL----GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK-SDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~----g~~~ys~ksDIWSLGvILyELLTG~pPF~g~-sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
. ......+||+.|+|||++. ....++.++|||||||++|+|++|..||... ...+.+..+...... .++.
T Consensus 178 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~ 252 (318)
T 2dyl_A 178 D-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP----LLPG 252 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC----CCCS
T ss_pred C-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC----CCCc
Confidence 3 2334568999999999985 2356899999999999999999999999874 455555555442110 0000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
...++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 253 --------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 253 --------------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp --------------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred --------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 0125678899999999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.26 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=203.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|.....||+|+||.||+|.+..++..||||++.... ......+.+|+.++..++||||+++++++... +.+++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEE
Confidence 45555668999999999999999999999999997643 22345577899999999999999999988644 489999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEeccCCccccCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~DFGlAr~~~~~ 519 (1028)
|||+.+ +|.+++... .....+++..+..++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 98 MEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999964 666665432 11234668889999999999999999999999999999999987 899999999999877554
Q ss_pred CCcccccccCccccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGC-KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~-~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
........||+.|+|||++.+. ..++.++|||||||++|+|++|..||....................
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 245 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP----------- 245 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC-----------
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc-----------
Confidence 3344566899999999998653 2488999999999999999999999976543322111111111000
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 246 -------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 246 -------------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 0112356788999999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=373.68 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=208.5
Q ss_pred CCCccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc----CCccchHHHHHHHHHcC--CCCee
Q psy18163 351 YLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE----GFPITSLREINTLLKAQ--HPNIV 424 (1028)
Q Consensus 351 y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~----~~~~~~lrEi~iL~~l~--HPNIV 424 (1028)
+.|...+....++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.++..+. |+||+
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 3444455566789999999999999999999999999999999997664322 12345668999999996 59999
Q ss_pred EEEEEEeecCCCeEEEEEeccc--cchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec-C
Q psy18163 425 TVREIVVGSNMDKIFIVMDYVE--HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS-H 501 (1028)
Q Consensus 425 ~L~~i~~~~~~~~l~LVmEy~~--gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd-~ 501 (1028)
++++++.. .+.+++||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .
T Consensus 112 ~~~~~~~~--~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 112 RLLDWFER--PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 185 (320)
T ss_dssp CEEEEEEC--SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred EEEEEEec--CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC
Confidence 99998864 458999999997 456555543 34588999999999999999999999999999999999999 7
Q ss_pred CCcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy18163 502 RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581 (1028)
Q Consensus 502 ~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~ 581 (1028)
++.+||+|||+++.+.. .......||+.|+|||++.+...++.++|||||||++|+|++|..||.... .+..
T Consensus 186 ~~~~kL~Dfg~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~ 257 (320)
T 3a99_A 186 RGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR 257 (320)
T ss_dssp TTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH
T ss_pred CCCEEEeeCcccccccc--ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc
Confidence 89999999999987754 234557899999999999875556889999999999999999999997532 1111
Q ss_pred hcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 582 TMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 582 ~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.. . .....+++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 258 ~~--~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 258 GQ--V-------------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CC--C-------------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred cc--c-------------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 10 0 0012356788999999999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=377.50 Aligned_cols=265 Identities=22% Similarity=0.337 Sum_probs=189.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHH-HHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREIN-TLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~-iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||.||+|.+..+++.||||++....... .......|+. +++.+.||||+++++++... +.+
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDC 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--Cce
Confidence 4578999999999999999999999999999999997653221 1223445555 56668899999999988644 589
Q ss_pred EEEEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhC-CcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 439 FIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDN-WILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~-gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
||||||+.++|.+++...... ...+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||+++.+
T Consensus 97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999999999888887765433 45689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLL---GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL-EQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~---g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~-d~l~kI~~~lg~p~~~~w~ 592 (1028)
... ......+||+.|+|||++. ....++.++|||||||++|+|++|..||.+.... +.+..+ . .
T Consensus 177 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~--------~ 244 (327)
T 3aln_A 177 VDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV---V--------K 244 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC---C--------C
T ss_pred ccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH---h--------c
Confidence 543 2234458999999999984 2356899999999999999999999999864321 111100 0 0
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
+ ....++ ......++..+.+||.+||..||.+|||+.++|+||||..
T Consensus 245 ~----------~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 245 G----------DPPQLS-------NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp S----------CCCCCC-------CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred C----------CCCCCC-------CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 0 000000 0111236788999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.84 Aligned_cols=264 Identities=24% Similarity=0.362 Sum_probs=206.5
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
|....++|++++.||+|+||.||+|++..++..||||++...... ......+.+|+.++..++||||+++++++. ..
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~ 83 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE--ED 83 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE--CS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee--eC
Confidence 445568899999999999999999999999999999998654322 122345678999999999999999999875 44
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
+.+|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred CeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence 589999999976 66655543 2468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 515 EYGSPL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 515 ~~~~~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.+.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....++....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 229 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV--------- 229 (294)
T ss_dssp TC-------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC---------
T ss_pred ccccccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC---------
Confidence 765432 22345679999999999988 5689999999999999999999999999887766555443210
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
+... ......+++.+.+||.+||..||.+||+..+.|.+.|..
T Consensus 230 ----~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 230 ----PNVT---------------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp ----CCHH---------------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred ----CCcc---------------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 0000 011223678899999999999999999666666666643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=378.45 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=179.5
Q ss_pred cccCCeEEEE-EeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHH-HHHHcCCCCeeEEEEEEeec--C
Q psy18163 359 RSVEEFKCLN-RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREIN-TLLKAQHPNIVTVREIVVGS--N 434 (1028)
Q Consensus 359 ~~~d~Y~il~-~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~-iL~~l~HPNIV~L~~i~~~~--~ 434 (1028)
...++|++++ .||+|+||+||+|.+..+++.||||++.... ...+|+. .+..+.||||+.+++++... .
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 4568899976 5999999999999999999999999996532 1223333 45667899999999988642 2
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEec
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGD 509 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~D 509 (1028)
...+||||||+.+ +|.+++ ... ...+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l---~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRI---QERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHH---HTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred CceEEEEEeccCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 4468999999987 554444 333 246899999999999999999999999999999999999976 45699999
Q ss_pred cCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 510 FGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 510 FGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
||+++.... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+........
T Consensus 175 fg~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 249 (336)
T 3fhr_A 175 FGFAKETTQ--NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-- 249 (336)
T ss_dssp CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred cccceeccc--cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc--
Confidence 999987653 23345688999999999876 5689999999999999999999999977654432221111100000
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
..++. .....++..+.+||.+||..||.+|||+.++|+||||++.
T Consensus 250 ----------------~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 250 ----------------YGFPN-------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----------------CCCT-------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ----------------cccCc-------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00000 0112367889999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=359.92 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=206.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|.+. ++..||||++..... ....+.+|+.++..++||||+++++++.. ...+|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEE
Confidence 468999999999999999999997 577799999976532 22457789999999999999999998854 457999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+ ++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 v~e~~~~--~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 83 VFEFMEH--GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEECCTT--CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEeCCC--CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999976 34444444555678999999999999999999999999999999999999999999999999998764321
Q ss_pred -CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 -KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 -~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 227 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------------ 227 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------
T ss_pred cccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC------------
Confidence 12334567889999999976 568999999999999999999 999999988877776665421110
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++..+.+||.+||..||.+|||+.++++|
T Consensus 228 --------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 228 --------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 011256778999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.16 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=192.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCe---EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC-
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD- 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~---~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~- 436 (1028)
.++|++.+.||+|+||+||+|.+..++. .||||+++...........+.+|+.++..++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4689999999999999999999887765 899999976543333345678999999999999999999988654321
Q ss_pred ---eEEEEEecccc-chHHHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEecc
Q psy18163 437 ---KIFIVMDYVEH-DMKSLMETMRS--KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDF 510 (1028)
Q Consensus 437 ---~l~LVmEy~~g-dLgsLl~~l~~--~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DF 510 (1028)
.+++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 34999999986 66666654332 1225889999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 511 GLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 511 GlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
|+++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~- 259 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK- 259 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-
T ss_pred cccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC-
Confidence 9998764322 12234567889999999987 568999999999999999999 999999988777666664421100
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-------HHHHHhCCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-------ADEALRHDYFSES 657 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-------A~ElL~HPfF~e~ 657 (1028)
....+++.+.+||.+||..||.+||| +++++.|||+...
T Consensus 260 -------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 260 -------------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp -------------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred -------------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 01225678899999999999999999 7888899999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=376.94 Aligned_cols=258 Identities=22% Similarity=0.349 Sum_probs=204.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEE-----ECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeec
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAK-----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGS 433 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~-----d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~ 433 (1028)
..++|++.+.||+|+||.||+|. +..+++.||||+++..... .....+.+|+.+|..+ .||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH-HHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 35789999999999999999999 5567799999999754321 1234567899999999 789999999988643
Q ss_pred CCCeEEEEEecccc-chHHHHHHHhhc-----------------------------------------------------
Q psy18163 434 NMDKIFIVMDYVEH-DMKSLMETMRSK----------------------------------------------------- 459 (1028)
Q Consensus 434 ~~~~l~LVmEy~~g-dLgsLl~~l~~~----------------------------------------------------- 459 (1028)
...+++|||||.+ +|.+++......
T Consensus 99 -~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 99 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred -CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 3468999999986 555554432110
Q ss_pred ---------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC--Cccccccc
Q psy18163 460 ---------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL--KHYTPIVV 528 (1028)
Q Consensus 460 ---------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~--~~~t~~vG 528 (1028)
...+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... .......|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 1128889999999999999999999999999999999999999999999999998664322 23345678
Q ss_pred CccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhcccc
Q psy18163 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAE 607 (1028)
Q Consensus 529 T~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~ 607 (1028)
|+.|+|||++.+ ..|+.++||||||||+|+|++ |.+||.+....+.+...+.....+.
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 316 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-------------------- 316 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--------------------
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--------------------
Confidence 999999999987 568999999999999999998 9999988765555444443211110
Q ss_pred CCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 608 YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 608 ~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+++.+.+||.+||..||.+|||+.++++|
T Consensus 317 -----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 -----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 012256788999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=373.15 Aligned_cols=253 Identities=20% Similarity=0.222 Sum_probs=201.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeE----EEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEI----VALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~----VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..++|++++.||+|+||+||+|.+..++.. ||+|++..... ......+.+|+.++..++||||+++++++. .
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~ 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---G 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---B
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---C
Confidence 457899999999999999999999988876 66676644322 223355678999999999999999999884 3
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+++||||+.+ ++|...+......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~~~~~v~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 87 SSLQLVTQYLPL--GSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp SSEEEEEECCTT--CBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CccEEEEEeCCC--CCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 468999999986 455555555556788999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 516 YGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 516 ~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 238 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ----- 238 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC-----
T ss_pred cCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC-----
Confidence 754322 2345678889999999987 569999999999999999999 9999998776665555433210000
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
...++..+.+||.+||..||.+|||+.++++|
T Consensus 239 ---------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 ---------------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01134456699999999999999999999997
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=371.58 Aligned_cols=251 Identities=22% Similarity=0.216 Sum_probs=203.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.++|++++.||+|+||+||+|.+..+++.||||++..... ...+.+|+.++..+ .||||+.+++++.. ...+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccE
Confidence 4689999999999999999999999999999999875432 33567899999999 99999999988765 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc-----EEEeccCCcc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI-----LKVGDFGLAR 514 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~-----lKL~DFGlAr 514 (1028)
|||||++++|.+++... ...+++..+..|+.||+.||.|||++||+||||||+||||+.++. +||+|||+++
T Consensus 82 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999977888777643 456899999999999999999999999999999999999998887 9999999998
Q ss_pred ccCCCCC-------cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcC
Q psy18163 515 EYGSPLK-------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---LEQLSRIFKTMG 584 (1028)
Q Consensus 515 ~~~~~~~-------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---~d~l~kI~~~lg 584 (1028)
.+..... .....+||+.|+|||++.+ ..++.++||||||||||+|++|..||.+.+. .+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 7644322 1346789999999999988 6689999999999999999999999988543 333333332110
Q ss_pred CCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 585 TPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
..+. ......++ .+.+||..||..||.+||++.+|++
T Consensus 238 ~~~~----------------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPI----------------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCH----------------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCH----------------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0000 00011133 7889999999999999999998876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=373.39 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=205.3
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCe---EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~---~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
....++|++.+.||+|+||+||+|.+..++. .||||+++.... ......+.+|+.+|..++||||+++++++..
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-- 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--
Confidence 3345789999999999999999999986554 599999975432 1223456789999999999999999998853
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCc
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA 513 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlA 513 (1028)
...+||||||+.+ +|.++ +......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTF---LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHH---HHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHH---HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 4578999999976 55544 4444567899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 514 REYGSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 514 r~~~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
+.+..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+.
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 275 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-- 275 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC--
T ss_pred cccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC--
Confidence 87754322 1233456888999999977 568999999999999999999 9999999888877776654321110
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
...+++.+.+||.+||..||.+|||+.++++
T Consensus 276 ------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 ------------------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1125678899999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=356.26 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=205.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||+||+|.+. ++..||||+++.... ....+.+|+.++..++||||+++++++. ....+|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCS--KEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCceE
Confidence 3478999999999999999999887 577899999976432 2345678999999999999999999884 445799
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+||||+.+ +|.+++ ......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 80 IVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEECCTTCBHHHHH---HHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEEccCCCcHHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999975 455554 34445689999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 PLK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 225 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY---------- 225 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC----------
T ss_pred hhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC----------
Confidence 321 2234456788999999977 568999999999999999999 999999988877766654321100
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+++.+.+||.+||..||.+|||+.++++|
T Consensus 226 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 226 ----------------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011246778899999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=366.94 Aligned_cols=262 Identities=27% Similarity=0.361 Sum_probs=201.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC--CCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ--HPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~--HPNIV~L~~i~~~~~~~~ 437 (1028)
..++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.++..+. ||||+++++++.. ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 102 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 102 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCE
Confidence 4468999999999999999999986 5889999999765433333345678999999997 5999999998864 458
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|||||+.+++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+.
T Consensus 103 ~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred EEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999999887777766653 34688999999999999999999999999999999999996 4899999999998764
Q ss_pred CCCC--cccccccCccccCcccccCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcC
Q psy18163 518 SPLK--HYTPIVVTLWYRSPELLLGC----------KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL-EQLSRIFKTMG 584 (1028)
Q Consensus 518 ~~~~--~~t~~vGT~~Y~APEvL~g~----------~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~-d~l~kI~~~lg 584 (1028)
.... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~- 256 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN- 256 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT-
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc-
Confidence 4322 22356799999999998652 36889999999999999999999999875432 2333222110
Q ss_pred CCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCC
Q psy18163 585 TPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p 660 (1028)
... ......+..+.+||.+||..||.+|||+.++|+||||+....|
T Consensus 257 --~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 257 --HEI----------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp --SCC----------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred --ccc----------------------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 000 0011245678899999999999999999999999999876544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=367.03 Aligned_cols=253 Identities=21% Similarity=0.355 Sum_probs=198.3
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc----CCccchHHHHHHHHHc----CCCCeeEEEEEE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE----GFPITSLREINTLLKA----QHPNIVTVREIV 430 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~----~~~~~~lrEi~iL~~l----~HPNIV~L~~i~ 430 (1028)
...++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.++..+ .||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999999999999999997653221 1234456799999998 899999999987
Q ss_pred eecCCCeEEEEEec-cc-cchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec-CCCcEEE
Q psy18163 431 VGSNMDKIFIVMDY-VE-HDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS-HRGILKV 507 (1028)
Q Consensus 431 ~~~~~~~l~LVmEy-~~-gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd-~~g~lKL 507 (1028)
... +.+++|||| +. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 108 ~~~--~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQ--EGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred ecC--CeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence 543 478999998 54 355555443 23589999999999999999999999999999999999999 8899999
Q ss_pred eccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 508 GDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 508 ~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.... .+.....
T Consensus 182 ~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~--- 250 (312)
T 2iwi_A 182 IDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL--- 250 (312)
T ss_dssp CCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCC---
T ss_pred EEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhcc---
Confidence 999999877542 34567899999999999875555669999999999999999999997532 1211100
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.+...++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 251 ------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 251 ------------------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ------------------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ------------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 00122567889999999999999999999999999998743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=379.45 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=205.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-------CCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEee
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-------RTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVG 432 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-------~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~ 432 (1028)
.++|++.+.||+|+||+||+|.+. .++..||||+++.... ......+.+|+.+|..+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 478999999999999999999974 3566899999976532 12234567899999999 89999999998854
Q ss_pred cCCCeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee
Q psy18163 433 SNMDKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499 (1028)
Q Consensus 433 ~~~~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL 499 (1028)
.+.+||||||+.+ +|.+++..... ....+++.++..++.||+.||.|||++||+||||||+||||
T Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 4579999999986 66666554211 12347889999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy18163 500 SHRGILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQL 576 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l 576 (1028)
+.+|.+||+|||+++.+.... .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+..+.+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999998765432 22344567899999999987 569999999999999999999 99999987766655
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
..+...... . ....++..+.+||.+||..||.+|||+.+++++
T Consensus 316 ~~~~~~~~~---------------------~-----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRM---------------------D-----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCC---------------------C-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC---------------------C-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 544332100 0 011256788999999999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=382.07 Aligned_cols=259 Identities=20% Similarity=0.295 Sum_probs=207.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEE-----ECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAK-----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~-----d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|++++.||+|+||+||+|. +..++..||||+++.... ......+.+|+.++..++||||+++++++.. .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQ--S 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--C
Confidence 4789999999999999999999 456788999999965322 1223456789999999999999999998854 4
Q ss_pred CeEEEEEecccc-chHHHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC---cEEEe
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRS---KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG---ILKVG 508 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~---~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g---~lKL~ 508 (1028)
...|||||||.+ +|.+++..... ....+++.++..++.||+.||.|||++||+||||||+||||+.+| .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 478999999965 66666655432 123588899999999999999999999999999999999999555 59999
Q ss_pred ccCCccccCC--CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q psy18163 509 DFGLAREYGS--PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 509 DFGlAr~~~~--~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
|||+|+.+.. ........+||+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+.+..+.+..+......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999985422 1122344678999999999987 569999999999999999998 99999998887777666542110
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
. ....++..+.+||.+||..||.+|||+.+|++|.++.
T Consensus 306 ~--------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 306 D--------------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp C--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C--------------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 0112567788999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=358.42 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=203.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||+||+|.+. ++..||||+++.... ....+.+|+.++..++||||+++++++. ....+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEe--cCCCeE
Confidence 3578999999999999999999887 677899999976532 2345678999999999999999999884 445799
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ ++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 96 IITEYMAN--GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEECCCTT--CBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EEEeccCC--CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999975 3444444443456899999999999999999999999999999999999999999999999999876432
Q ss_pred C-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 L-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+........
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 242 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---------- 242 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----------
T ss_pred ccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC----------
Confidence 1 12234467888999999987 568999999999999999998 9999999888777776654321110
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
...+++.+.+||.+||..||.+|||+.++|+|
T Consensus 243 ----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 ----------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 11246778899999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.22 Aligned_cols=254 Identities=20% Similarity=0.214 Sum_probs=206.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+|+.++..+ .|+||+.+++++. ....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~ 81 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHN 81 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCcee
Confidence 4578999999999999999999999999999999986543 234567899999998 7999999988775 44589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc-----EEEeccCCc
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI-----LKVGDFGLA 513 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~-----lKL~DFGlA 513 (1028)
|+||||++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 82 ~lv~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 82 VLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEecCCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99999997777777654 3456899999999999999999999999999999999999987765 999999999
Q ss_pred cccCCCCC-------cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhc
Q psy18163 514 REYGSPLK-------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS---DLEQLSRIFKTM 583 (1028)
Q Consensus 514 r~~~~~~~-------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s---d~d~l~kI~~~l 583 (1028)
+.+..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+ ....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 87654322 2345689999999999987 568999999999999999999999998843 334444443321
Q ss_pred CCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 584 g~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
..+. .......+++.+.+||.+||..||.+|||+.++++.
T Consensus 238 ~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 QSTP----------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHSC----------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cCcc----------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1000 000112367789999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.50 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=202.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-----CccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-----FPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-----~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
..++|++.+.||+|+||+||+|.+..+++.||||++........ ....+.+|+.++..++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 45789999999999999999999999999999999976443221 114567899999999999999999988432
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecCCCc-----EEE
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSHRGI-----LKV 507 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~~g~-----lKL 507 (1028)
.++||||+.+ ++|...+......+++..+..++.||+.||.|||++| |+||||||+||||+.++. +||
T Consensus 96 ---~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 ---PRMVMEFVPC--GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp ---TEEEEECCTT--CBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred ---CeEEEEecCC--CCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 2799999986 5566666666667999999999999999999999999 999999999999987776 999
Q ss_pred eccCCccccCCCCCcccccccCccccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcC
Q psy18163 508 GDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG-CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ--LSRIFKTMG 584 (1028)
Q Consensus 508 ~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g-~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~--l~kI~~~lg 584 (1028)
+|||+++.... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.... ...+... +
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~ 246 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-G 246 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-C
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-C
Confidence 99999986543 3455789999999999843 24578999999999999999999999987653332 2222221 1
Q ss_pred CCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 585 TPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.. . .....+++.+.+||.+||..||.+|||+.++++
T Consensus 247 ~~-~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LR-P-----------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CC-C-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-C-----------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0 011235678899999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=386.21 Aligned_cols=281 Identities=20% Similarity=0.280 Sum_probs=211.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||+||+|++..+++.||||++...... .....+.+|+.+|..++||||+++++++.......+|
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 457899999999999999999999999999999999764432 2234567899999999999999999998877667899
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee----cCCCcEEEeccCCcc
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL----SHRGILKVGDFGLAR 514 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL----d~~g~lKL~DFGlAr 514 (1028)
||||||.+ +|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 86 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999975 5554443221 12238999999999999999999999999999999999999 778889999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhc
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGC-------KEYSTPIDMWSVGCIFAEFLCMEPLFTGK----SDLEQLSRIFKTM 583 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~-------~~ys~ksDIWSLGvILyELLTG~pPF~g~----sd~d~l~kI~~~l 583 (1028)
..... ......+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||.+. ...+.+..+...
T Consensus 165 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~- 242 (396)
T 4eut_A 165 ELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG- 242 (396)
T ss_dssp ECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS-
T ss_pred EccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC-
Confidence 77543 344567899999999998641 45788999999999999999999999753 334455555432
Q ss_pred CCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 584 g~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.+...+..+.............++.. ......++..+.+||.+||..||.+|||+.+++++
T Consensus 243 --~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 --KPSGAISGVQKAENGPIDWSGDMPVS-----CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp --CCTTCCEEEECSTTCCEEEESSCCTT-----CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred --CCcccchhheeccCCCcccCccCCcc-----cccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 22222222211110000000011110 11223466788999999999999999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=364.96 Aligned_cols=269 Identities=20% Similarity=0.312 Sum_probs=198.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEE----ECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~----d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..++|++++.||+|+||+||+|+ +..+++.||||++..... .....+.+|+.+|..++||||+++++++.....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 45789999999999999999998 567899999999975432 123456789999999999999999999876555
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..+++||||+.+ +|.+++ ......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHH---HHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHH---HhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 678999999965 555554 3444568999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 515 EYGSPL---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 515 ~~~~~~---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
.+.... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||..... ..... .+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~---~~~~~~~~~ 236 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRM---IGNDKQGQM 236 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHHHH---HCTTCCTHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChH--HHHhh---hcCccccch
Confidence 765432 12234567888999999987 5689999999999999999999999865321 11111 111000000
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.. ........... .......+++.+.+||.+||..||.+|||+.++++
T Consensus 237 ~~---~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 237 IV---FHLIELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HH---HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hH---HHHHHHHhccC--------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 00000000000 00012236788999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=361.78 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=196.3
Q ss_pred ccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 358 ~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
+...++|++.++||+|+||+||+|.+.. .||||+++...........+.+|+.+|..++||||+.++++. ....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---~~~~ 93 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS---TAPQ 93 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE---CSSS
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec---cCCc
Confidence 3345789999999999999999998753 499999976644333345567899999999999999998865 3446
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+++||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 94 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 94 LAIVTQWCEG--SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp CEEEEECCCE--EEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred cEEEEEecCC--CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 8999999986 55666665556678999999999999999999999999999999999999999999999999998654
Q ss_pred CC--CCcccccccCccccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SP--LKHYTPIVVTLWYRSPELLL--GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~--~~~~t~~vGT~~Y~APEvL~--g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.. .......+||+.|+|||++. ....++.++|||||||++|+|++|..||.+....+.+..++........
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 246 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD----- 246 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-----
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-----
Confidence 31 22344568999999999986 2356889999999999999999999999987776666665543211100
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 247 ~----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 L----------------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp T----------------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h----------------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0011235678899999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=366.10 Aligned_cols=253 Identities=18% Similarity=0.292 Sum_probs=200.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||+||+|.+..++..||+|++.... ......+.+|+.+|..++||||+++++++... ..++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 83 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLN 83 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeE
Confidence 3578999999999999999999999999999999985432 22334567899999999999999999988654 5899
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+||||+.+ +|.+++ ......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 84 lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 84 FITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEECCTTCBHHHHH---HHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEecCCCcHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999976 555554 44456689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCc--------------ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q psy18163 519 PLKH--------------YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMG 584 (1028)
Q Consensus 519 ~~~~--------------~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg 584 (1028)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~---------- 229 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT---------- 229 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC----------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH----------
Confidence 2211 125689999999999987 678999999999999999999999986532110
Q ss_pred CCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 585 TPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.. +.. ....... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 230 ----~~---~~~--~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 230 ----MD---FGL--NVRGFLD-----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ----TT---SSB--CHHHHHH-----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HH---Hhh--hhhcccc-----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 000 0000000 0011235667889999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=369.64 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=198.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEE----EEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIV----ALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~V----AIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..++|++++.||+|+||+||+|++..++..| |+|.+..... ......+.+|+.++..++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 4578999999999999999999998887765 6666653322 23345678899999999999999999998643
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..++||+|+.+ ++|...+......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 90 -~~~~v~e~~~~--g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 -TVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp -SEEEEEECCTT--CBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred -CeEEEEEecCC--CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 47889999986 566666666566789999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc--ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 516 YGSPLKH--YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 516 ~~~~~~~--~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
+...... .....||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------ 239 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------ 239 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC------
T ss_pred ccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC------
Confidence 7543322 234466889999999987 669999999999999999999 999999877655444433211000
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++..+.+||.+||..||.+|||+.+++.+
T Consensus 240 --------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 --------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp --------------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred --------------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 012256778899999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=359.80 Aligned_cols=261 Identities=24% Similarity=0.434 Sum_probs=198.1
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
+....++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.++..++||||+++++++...
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 104 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-- 104 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--
Confidence 33456789999999999999999999999999999999975322 112234567899999999999999999988654
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
+.+++||||+.+ +|.+++.........+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 489999999986 8888887776667778999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS--DLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s--d~d~l~kI~~~lg~p~~~~w~ 592 (1028)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. .......+.. ...+.
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~----- 257 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPP----- 257 (310)
T ss_dssp --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCC-----
T ss_pred eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCC-----
Confidence 77654444455689999999999987 568999999999999999999999997643 2222222221 11000
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 258 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 258 -------------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0012356788999999999999999999999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=360.38 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=194.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCC---CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRT---DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~t---g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
..++|++.+.||+|+||.||+|.+..+ +..||||++..... ......+.+|+.++..++||||+++++++. .+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT---EN 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc---cC
Confidence 347899999999999999999999754 56799999875422 122345678999999999999999999873 34
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+||||+.+ ++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 89 PVWIIMELCTL--GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SCEEEEECCTT--EEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred ccEEEEecCCC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 68999999986 3444444444556899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 517 GSPLK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 517 ~~~~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~-------- 237 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------- 237 (281)
T ss_dssp ------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC--------
T ss_pred CcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC--------
Confidence 54321 2234467889999999976 568999999999999999996 999999888777666654321000
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+++.+.+||.+||..||.+|||+.+++++
T Consensus 238 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 238 ------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012356788999999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.05 Aligned_cols=250 Identities=15% Similarity=0.174 Sum_probs=204.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||+||+|.+. +..||||+++...........+.+|+.++..++||||+++++++.......++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 4578999999999999999999985 88999999987543333344577899999999999999999998766557899
Q ss_pred EEEecccc-chHHHHHHHhhcC-CcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecCCCcEEEeccCCccc
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKK-QVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~-~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
+||||+.+ +|.+++. ... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEEECCTTCBHHHHHH---SCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eeecccCCCcHHHHHh---hcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999986 5555553 332 25899999999999999999999999 99999999999999999999999998754
Q ss_pred cCCCCCcccccccCccccCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCK--EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~--~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
... ...+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 231 (271)
T 3kmu_A 163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------ 231 (271)
T ss_dssp TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC------
T ss_pred ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC------
Confidence 322 3457899999999998732 233489999999999999999999999888777666654211110
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 232 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 -------------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01225678899999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=366.64 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=203.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEE-----CCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeec
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGS 433 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d-----~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~ 433 (1028)
..++|++.+.||+|+||.||+|.+ ..++..||||++..... ......+.+|+.+|..+ .||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTL- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence 347899999999999999999997 34677899999975432 23345678999999999 89999999998854
Q ss_pred CCCeEEEEEecccc-chHHHHHHHhhc-------------------CCcCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Q psy18163 434 NMDKIFIVMDYVEH-DMKSLMETMRSK-------------------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLK 493 (1028)
Q Consensus 434 ~~~~l~LVmEy~~g-dLgsLl~~l~~~-------------------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLK 493 (1028)
.+.+||||||+.+ +|.+++...... ...+++..+..++.||+.||.|||++||+|||||
T Consensus 121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 121 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred -CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 4579999999976 666555432110 1237888999999999999999999999999999
Q ss_pred ccceeecCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy18163 494 TSNLLLSHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGK 570 (1028)
Q Consensus 494 PeNILLd~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~ 570 (1028)
|+||||+.++.+||+|||++..+..... ......||+.|+|||++.+ ..++.++|||||||++|+|+| |..||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999986643322 2334567889999999977 569999999999999999998 99999887
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 571 SDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 571 sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+..++.....+. ....+++.+.+||.+||..||.+|||+.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMD-------------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp CCSHHHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcHHHHHHHHhcCCCCC-------------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 75555555443211000 01125678899999999999999999999998
Q ss_pred CC
Q psy18163 651 HD 652 (1028)
Q Consensus 651 HP 652 (1028)
|-
T Consensus 328 ~l 329 (344)
T 1rjb_A 328 FL 329 (344)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=356.72 Aligned_cols=268 Identities=20% Similarity=0.301 Sum_probs=200.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEE----ECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~----d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
...|++++.||+|+||.||+|+ +..+++.||||++..... ......+.+|+.+|..++||||+++++++......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 4679999999999999999999 567899999999976542 22335667899999999999999999999876667
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+++||||+.+ +|.+++ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 99 ~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHH---HHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHH---HhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 89999999976 555554 33455689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 516 YGSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 516 ~~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
+..... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||... ...+.. ..+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~---~~~~~~~~~-- 247 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSP--MALFLK---MIGPTHGQM-- 247 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH--HHHHHH---HHCSCCGGG--
T ss_pred ccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcch--hhHHhh---ccCCccccc--
Confidence 754432 2345678899999999987 56889999999999999999999987432 111111 111110000
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
............. .......+++.+.+||.+||..||.+|||+.++++
T Consensus 248 ---~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 248 ---TVTRLVNTLKEGK-------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp ---HHHHHHHHHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ---CHHHHHHHHhccC-------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0000000000000 00112346788999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=367.18 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=206.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
..++|++++.||+|+||.||+|.+. .++..||||+++.... ......+.+|+.++..++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 4578999999999999999999997 4558999999975432 1223456789999999999999999998854
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhc--------------------CCcCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSK--------------------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLK 493 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~--------------------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLK 493 (1028)
...+||||||+.+ +|.+++...... ...+++.++..++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 4579999999976 777666543111 1568899999999999999999999999999999
Q ss_pred ccceeecCCCcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy18163 494 TSNLLLSHRGILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGK 570 (1028)
Q Consensus 494 PeNILLd~~g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~ 570 (1028)
|+||||+.++.+||+|||+++.+.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 999999999999999999998664321 22334578999999999987 569999999999999999999 99999998
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 571 SDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 571 sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+..+.+..+...... . ....++..+.+||.+||..||.+|||+.++++
T Consensus 281 ~~~~~~~~~~~~~~~---------------------~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 281 AHEEVIYYVRDGNIL---------------------A-----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp CHHHHHHHHHTTCCC---------------------C-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ChHHHHHHHhCCCcC---------------------C-----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 877766665432100 0 01125678899999999999999999999987
Q ss_pred C
Q psy18163 651 H 651 (1028)
Q Consensus 651 H 651 (1028)
+
T Consensus 329 ~ 329 (343)
T 1luf_A 329 I 329 (343)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.38 Aligned_cols=247 Identities=16% Similarity=0.228 Sum_probs=198.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCC-------eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEee
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTD-------EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG 432 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg-------~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~ 432 (1028)
..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ......+.+|+.++..++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3578999999999999999999998877 579999996543 2234567789999999999999999998864
Q ss_pred cCCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc-------
Q psy18163 433 SNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI------- 504 (1028)
Q Consensus 433 ~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~------- 504 (1028)
.+..|+||||+.+ +|.+++. .....+++..+..++.||+.||.|||++||+||||||+||||+.++.
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHH---HTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred --CCCCEEEEECCCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 4478999999985 6655554 34445899999999999999999999999999999999999998876
Q ss_pred -EEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHh
Q psy18163 505 -LKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRIFKT 582 (1028)
Q Consensus 505 -lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~-pPF~g~sd~d~l~kI~~~ 582 (1028)
+||+|||++..... .....||+.|+|||++.+...++.++|||||||++|+|++|. +||........ ..+...
T Consensus 159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~ 233 (289)
T 4fvq_A 159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYED 233 (289)
T ss_dssp EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHT
T ss_pred eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhc
Confidence 99999999976532 234578999999999987567999999999999999999954 66655544333 333221
Q ss_pred cCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.... ....+..+.+||.+||..||.+|||+.++++|
T Consensus 234 ~~~~---------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQL---------------------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCC---------------------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCC---------------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1100 01123456799999999999999999999997
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.87 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=186.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEee------cC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVG------SN 434 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~------~~ 434 (1028)
.+|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.++..+. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 579999999999999999999999999999999855422 22345678999999996 9999999998852 33
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeecCCCcEEEeccCC
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLSHRGILKVGDFGL 512 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd~~g~lKL~DFGl 512 (1028)
...+++||||+.++|.+++..... ...+++.++..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 456899999999988888776543 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCC------------cccccccCccccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy18163 513 AREYGSPLK------------HYTPIVVTLWYRSPELLL--GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSR 578 (1028)
Q Consensus 513 Ar~~~~~~~------------~~t~~vGT~~Y~APEvL~--g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~k 578 (1028)
++.+..... .....+||+.|+|||++. ....++.++|||||||++|+|++|..||........+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 987653211 112457999999999983 235688999999999999999999999976543322111
Q ss_pred HHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCC
Q psy18163 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653 (1028)
Q Consensus 579 I~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPf 653 (1028)
.. .. + .....+..+.+||.+||..||.+|||+.++++|-+
T Consensus 265 ~~---~~-----------------------~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 KY---SI-----------------------P---------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -C---CC-----------------------C---------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cc---cC-----------------------C---------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 00 00 0 00113345679999999999999999999999743
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=376.68 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=204.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||.||+|.+..++..||||+++.... ......+.+|+.+|..++||||+++++++.. ...+|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcE
Confidence 35789999999999999999999999999999999875422 1223456789999999999999999998853 45789
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 189 lv~e~~~~--g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 189 IVMELVQG--GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEEECCTT--CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEEcCCC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999975 3444444444556899999999999999999999999999999999999999999999999999865432
Q ss_pred CCc--ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 520 LKH--YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 520 ~~~--~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... .....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------- 335 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP---------- 335 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC----------
T ss_pred ceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 111 112345778999999976 568999999999999999998 999999888766555443221000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 336 ----------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 336 ----------------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01125677889999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.08 Aligned_cols=256 Identities=19% Similarity=0.289 Sum_probs=205.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
..++|++.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.+|..++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEec--
Confidence 3478999999999999999999983 4568999999975432 1223456789999999999999999998854
Q ss_pred CCeEEEEEecccc-chHHHHHHHhh--------------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRS--------------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLK 493 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~--------------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLK 493 (1028)
.+.+|+||||+.+ +|.+++..... ....+++.++..++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 4579999999974 67666654322 12347889999999999999999999999999999
Q ss_pred ccceeecCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy18163 494 TSNLLLSHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGK 570 (1028)
Q Consensus 494 PeNILLd~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~ 570 (1028)
|+||||+.++.+||+|||++........ ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987654322 2234567889999999987 568999999999999999999 99999987
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 571 SDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 571 sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+.......+...... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 257 PPERLFNLLKTGHRM--------------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp CGGGHHHHHHTTCCC--------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHhhcCCcC--------------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 766555444321100 001235678899999999999999999999987
Q ss_pred C
Q psy18163 651 H 651 (1028)
Q Consensus 651 H 651 (1028)
+
T Consensus 305 ~ 305 (314)
T 2ivs_A 305 D 305 (314)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=353.45 Aligned_cols=254 Identities=19% Similarity=0.177 Sum_probs=202.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..+.|++++..+.++.. ....+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccC-CCCceE
Confidence 34789999999999999999999999999999999875432 2356789999999999887776655433 446889
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee---cCCCcEEEeccCCcccc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL---SHRGILKVGDFGLAREY 516 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL---d~~g~lKL~DFGlAr~~ 516 (1028)
+||||++++|.+++.. ....+++.++..++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 82 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999997788777753 34568999999999999999999999999999999999999 47899999999999876
Q ss_pred CCCCC-------cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC
Q psy18163 517 GSPLK-------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---LEQLSRIFKTMGTP 586 (1028)
Q Consensus 517 ~~~~~-------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---~d~l~kI~~~lg~p 586 (1028)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+. ...+..+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 54322 2345689999999999987 5689999999999999999999999987432 22233332211000
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+ .......+++.+.+||.+||..||.+|||+.++++
T Consensus 238 ~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 P----------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp C----------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred c----------------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0 00111236678999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=370.35 Aligned_cols=256 Identities=20% Similarity=0.287 Sum_probs=207.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCC-------CeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRT-------DEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVV 431 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~t-------g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~ 431 (1028)
..++|++.+.||+|+||+||+|.+..+ +..||||+++..... .....+.+|+.++..+ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-HHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 457899999999999999999997543 368999999765321 2234567899999999 8999999999885
Q ss_pred ecCCCeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCccccccccccee
Q psy18163 432 GSNMDKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLL 498 (1028)
Q Consensus 432 ~~~~~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNIL 498 (1028)
. .+.+||||||+.+ +|.+++..... ....+++.+++.|+.||+.||.|||++||+||||||+|||
T Consensus 146 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 146 Q--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred c--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 4 4578999999976 66666654321 1135899999999999999999999999999999999999
Q ss_pred ecCCCcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy18163 499 LSHRGILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQ 575 (1028)
Q Consensus 499 Ld~~g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~ 575 (1028)
|+.++.+||+|||+++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999998765432 22344577899999999987 669999999999999999999 9999998887766
Q ss_pred HHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 576 LSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 576 l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
+..+....... ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 303 ~~~~~~~~~~~--------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 303 FKLLKEGHRMD--------------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHTTCCCC--------------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCC--------------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 65554321100 012256788999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=353.32 Aligned_cols=253 Identities=19% Similarity=0.180 Sum_probs=199.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.++..+.|++++..+.++.. ..+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecC-CCCceEE
Confidence 4789999999999999999999999999999998765432 2356789999999999888777665543 4468899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee---cCCCcEEEeccCCccccC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL---SHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL---d~~g~lKL~DFGlAr~~~ 517 (1028)
||||++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+.
T Consensus 83 v~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 83 VMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999997777777653 34568999999999999999999999999999999999999 788999999999998765
Q ss_pred CCCC-------cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCC
Q psy18163 518 SPLK-------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL---EQLSRIFKTMGTPN 587 (1028)
Q Consensus 518 ~~~~-------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~---d~l~kI~~~lg~p~ 587 (1028)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 4321 2345689999999999987 56899999999999999999999999874422 22222221100000
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.......+++.+.+||.+||..||.+|||+.++++
T Consensus 239 ----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 ----------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ----------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ----------------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00111235778999999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=358.54 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=205.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEE-----CCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d-----~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
.++|++.+.||+|+||.||+|.+ ..++..||||+++..... .....+.+|+.+|..+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 46899999999999999999985 457889999999754321 1234567899999999 89999999998854
Q ss_pred CCeEEEEEecccc-chHHHHHHHhh--------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRS--------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~--------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL 499 (1028)
.+.+++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 4578999999976 66665543221 11248899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy18163 500 SHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQL 576 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l 576 (1028)
+.++.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 9999999999999987754322 1234567889999999987 569999999999999999999 99999887655555
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
..++.....+. ....++..+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRML-------------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCCC-------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCCC-------------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55444311100 012256788999999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=349.04 Aligned_cols=249 Identities=25% Similarity=0.345 Sum_probs=191.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc--CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE--GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~--~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
..++|++.+.||+|+||.||+|.+. +..||||+++...... .....+.+|+.++..++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCc
Confidence 3578999999999999999999985 8899999987653322 223456789999999999999999998854 447
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC---cccccccccceeecC--------CCcE
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW---ILHRDLKTSNLLLSH--------RGIL 505 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g---IVHRDLKPeNILLd~--------~g~l 505 (1028)
+|+||||+.+ +|.+++ . ...+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+
T Consensus 81 ~~lv~e~~~~~~L~~~~---~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVL---S--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp CEEEEECCTTEEHHHHH---T--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred eEEEEEcCCCCCHHHHh---h--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 8999999975 444433 2 346899999999999999999999999 999999999999985 7789
Q ss_pred EEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q psy18163 506 KVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 506 KL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
||+|||++..+.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 156 kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 156 KITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232 (271)
T ss_dssp EECCCCC---------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred EEccCCccccccccc--ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence 999999998765432 235689999999999987 56899999999999999999999999988876665554332100
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
+ .....+++.+.+||.+||..||.+|||+.++++|
T Consensus 233 ~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 L-------------------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp C-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-------------------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0 0012356788999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=348.68 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=205.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||.||+|.+. ++..||||++...... ...+.+|+.++..++||||+++++++.. .+.+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEE
Confidence 468999999999999999999997 6778999999765322 2456789999999999999999998854 457899
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++ ......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 81 VTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EECCCTTCBHHHHH---HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEeCCCCCcHHHHH---hhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999975 555554 444556899999999999999999999999999999999999999999999999999876432
Q ss_pred C-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 L-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.......
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~----------- 225 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----------- 225 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-----------
T ss_pred cccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC-----------
Confidence 1 12234567889999999976 568999999999999999999 899999988777766664421100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++..+.+||.+||..||.+|||+.+++++
T Consensus 226 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 226 ---------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011246778899999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=366.45 Aligned_cols=269 Identities=20% Similarity=0.273 Sum_probs=197.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC--CCe
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN--MDK 437 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~--~~~ 437 (1028)
..++|++++.||+|+||+||+|++. ++.||||++...... .....+|+.+|..++||||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH---HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3478999999999999999999886 789999999754321 223456888899999999999999987544 346
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC----------CcccccccccceeecCCCcEE
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN----------WILHRDLKTSNLLLSHRGILK 506 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~----------gIVHRDLKPeNILLd~~g~lK 506 (1028)
+||||||+.+ +|.+++. . ..+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~---~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLK---A--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEECCTTCBHHHHHH---H--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEecCCCCCHHHHHH---h--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 8999999976 6655553 2 3489999999999999999999999 999999999999999999999
Q ss_pred EeccCCccccCCCCC--cccccccCccccCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy18163 507 VGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGC----KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580 (1028)
Q Consensus 507 L~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~----~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~ 580 (1028)
|+|||+++.+..... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+..+...+....
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999987654322 23446899999999999763 345678899999999999999999998754321110000
Q ss_pred HhcCCCCCCCCCCCCCChhhhhhcc--ccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 581 KTMGTPNEKIWPGFSKLPAVQKMTF--AEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 581 ~~lg~p~~~~w~~~s~lp~~~~l~~--~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+. ......... ...+.. .........+..+.+||.+||..||.+|||+.++++
T Consensus 252 ~~~~~~~---------~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPS---------LEDMQEVVVHKKKRPVL---RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCC---------HHHHHHHHTTSCCCCCC---CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCc---------hhhhhhhhhcccCCCCc---cccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000000 000000000 000000 000011123456889999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.88 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=205.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEee-------
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVG------- 432 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~------- 432 (1028)
...+|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 3468999999999999999999999999999999997542 346789999999999999999998753
Q ss_pred -------cCCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc
Q psy18163 433 -------SNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI 504 (1028)
Q Consensus 433 -------~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~ 504 (1028)
.....+|+||||+.+ +|.+++... ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 223468999999987 676666542 2346889999999999999999999999999999999999999999
Q ss_pred EEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q psy18163 505 LKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMG 584 (1028)
Q Consensus 505 lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg 584 (1028)
+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ......+...
T Consensus 161 ~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~-- 234 (284)
T 2a19_B 161 VKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG-- 234 (284)
T ss_dssp EEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--
T ss_pred EEECcchhheecccc-ccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--
Confidence 999999999877543 23445689999999999987 56899999999999999999999887431 1111111100
Q ss_pred CCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 585 TPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.....++..+.+||.+||..||.+|||+.++++|.|+-.
T Consensus 235 ---------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 ---------------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ---------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ---------------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 001225677889999999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=353.87 Aligned_cols=251 Identities=20% Similarity=0.301 Sum_probs=206.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||+||+|.+..++..||||++..... ....+.+|+.++..++||||+++++++. ....+|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCEE
Confidence 45789999999999999999999999999999999975422 2345678999999999999999999885 445799
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+||||+.+ +|.+++... ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 86 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999985 565555431 234589999999999999999999999999999999999999999999999999987654
Q ss_pred CC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 PL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.......
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 232 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---------- 232 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC----------
T ss_pred CccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC----------
Confidence 32 22344567889999999987 568999999999999999999 999998877655554443221000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 233 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 233 ----------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 01225678899999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=363.39 Aligned_cols=269 Identities=20% Similarity=0.265 Sum_probs=205.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEE----ECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~----d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..++|++++.||+|+||.||+|+ +..++..||||++..... .....+.+|+.++..++||||+.+++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--DQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 34789999999999999999999 567899999999975432 123456789999999999999999999887777
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..+||||||+.+ +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 889999999954 66666543 34458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 515 EYGSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 515 ~~~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ....... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~--~~ 247 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGCER--DV 247 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC------C
T ss_pred ecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhccccc--cc
Confidence 7754322 2334578899999999987 5689999999999999999999999975432211 0000000 00
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
+ ............. .......+++.+.+||.+||..||.+|||+.+++++
T Consensus 248 ~---~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 248 P---ALSRLLELLEEGQ-------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp C---HHHHHHHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c---cHHHHHHHhhccc-------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0000000000000 001123467889999999999999999999999664
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=358.23 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=202.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEE-----CCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d-----~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
.++|++.+.||+|+||+||+|.+ ..+++.||||+++..... .....+.+|+.++..+ .||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 47899999999999999999985 457789999999754321 1223567899999999 699999999988543
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhc------------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSK------------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~------------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~ 501 (1028)
...+|+||||+.+ +|.+++...... ...+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 3468999999986 555555432111 112788999999999999999999999999999999999999
Q ss_pred CCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy18163 502 RGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSR 578 (1028)
Q Consensus 502 ~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~k 578 (1028)
++.+||+|||+++.+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+..
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 99999999999987644322 2334678999999999987 568999999999999999998 9999988764444433
Q ss_pred HHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 579 I~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.+.....+. ....+++.+.+||.+||..||.+|||+.++++|
T Consensus 263 ~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRMR-------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCCC-------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccCC-------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333211000 011256778999999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=364.18 Aligned_cols=253 Identities=23% Similarity=0.299 Sum_probs=197.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEE----EEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIV----ALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~V----AIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..++|++++.||+|+||+||+|.+..++..| |+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence 3578999999999999999999999888766 555554322 123345677899999999999999999988643
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..++||+|+.+ ++|.+.+......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 90 -~~~~v~~~~~~--g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 -TVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp -SEEEEECCCSS--CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred -CceEEEEecCC--CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 47889999886 556666655566789999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 516 YGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 516 ~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
+..... ......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+....+....+......+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------ 239 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------ 239 (327)
T ss_dssp -------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC------
T ss_pred ccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 654322 2234567889999999987 569999999999999999999 999999877666554443221100
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++..+.+||.+||..||.+|||+.++++.
T Consensus 240 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 240 --------------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp --------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 012256778999999999999999999999973
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=353.64 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=200.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECC---CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKR---TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~---tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
..++|++.+.||+|+||+||+|.+.. ++..||||++...... .....+.+|+.++..++||||+++++++.. +
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-HHHHHHHHHHHHHHHHCCTTBCCEEEEECS---S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-hHHHHHHHHHHHHHhCCCCCcceEEEEEcC---C
Confidence 35789999999999999999998753 3457999999765321 123456789999999999999999998743 3
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..|+||||+.+ +|.+++. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHH---HHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHH---hccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 56999999985 5555553 4455689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 516 YGSPLK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 516 ~~~~~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+......+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~------- 234 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP------- 234 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-------
T ss_pred cccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-------
Confidence 654321 2334567889999999976 568999999999999999998 999998777666555544321100
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+++.+.+||.+||..||.+|||+.+++++
T Consensus 235 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 -------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 011256778999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=353.01 Aligned_cols=254 Identities=21% Similarity=0.258 Sum_probs=206.1
Q ss_pred cCCeEEEE-EeeecCcEEEEEEEEC--CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLN-RIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~-~LG~G~FG~Vyla~d~--~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|.++. .||+|+||.||+|.+. .++..||||+++.... ......+.+|+.++..++||||+++++++. .+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCC
Confidence 46788887 9999999999999864 5688999999976432 122345678999999999999999999883 346
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+++||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 84 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 84 LMLVMEMAGG--GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEEECCTT--EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred cEEEEEeCCC--CCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 8999999987 44555554555678999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCc---ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPLKH---YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~~~---~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~-------- 232 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------- 232 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--------
T ss_pred cCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC--------
Confidence 43221 233456899999999976 568999999999999999998 99999988877766555432100
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPf 653 (1028)
. ....+++.+.+||.+||..||.+|||+.++++|.+
T Consensus 233 -------------~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 233 -------------E-----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -------------C-----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -------------C-----------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0 01235678899999999999999999999998743
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=379.34 Aligned_cols=259 Identities=27% Similarity=0.363 Sum_probs=191.1
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .....+|+.+|..+ +||||+++++++. ....+||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSET--TDRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCeEEE
Confidence 456778899999999998764 4579999999987543 23457899999876 8999999988775 4458999
Q ss_pred EEeccccchHHHHHHHhhcCC---cCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC-------------Cc
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQ---VFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR-------------GI 504 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~---~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~-------------g~ 504 (1028)
|||||+++|.+++........ ...+..+..++.||+.||.|||++||+||||||+||||+.+ +.
T Consensus 87 v~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 87 ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp EECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 999998887777653221111 11233467899999999999999999999999999999754 48
Q ss_pred EEEeccCCccccCCCCC----cccccccCccccCcccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q psy18163 505 LKVGDFGLAREYGSPLK----HYTPIVVTLWYRSPELLLG------CKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDL 573 (1028)
Q Consensus 505 lKL~DFGlAr~~~~~~~----~~t~~vGT~~Y~APEvL~g------~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~ 573 (1028)
+||+|||+++.+..... .....+||+.|+|||++.+ ...++.++||||||||+|+|++ |..||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987754322 2335689999999999965 2468999999999999999999 99999776543
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCC
Q psy18163 574 EQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653 (1028)
Q Consensus 574 d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPf 653 (1028)
. ..+......... . + ......++..+.+||.+||..||.+|||+.++|+|||
T Consensus 247 ~--~~i~~~~~~~~~-----~--------------~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 247 E--SNIIRGIFSLDE-----M--------------K-------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp H--HHHHHTCCCCCC-----C--------------T-------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred H--HHHhcCCCCccc-----c--------------c-------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 3 233332111000 0 0 0011235678999999999999999999999999999
Q ss_pred CCC
Q psy18163 654 FSE 656 (1028)
Q Consensus 654 F~e 656 (1028)
|..
T Consensus 299 f~~ 301 (434)
T 2rio_A 299 FWP 301 (434)
T ss_dssp GSC
T ss_pred cCC
Confidence 964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=361.68 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=211.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
..++|++.+.||+|+||.||+|.+. .++..||||++...... .....+.+|+.++..++||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 99 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 99 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECS--
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--
Confidence 4578999999999999999999886 46789999999754321 122346789999999999999999998853
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhc------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEE
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSK------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKV 507 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL 507 (1028)
...+|+||||+.+ +|.+++...... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 4578999999975 777777654321 134688899999999999999999999999999999999999999999
Q ss_pred eccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q psy18163 508 GDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMG 584 (1028)
Q Consensus 508 ~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg 584 (1028)
+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 9999998654321 12234567899999999987 568999999999999999999 8999999887776666543210
Q ss_pred CCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC------CCCCCCC
Q psy18163 585 TPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH------DYFSESP 658 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H------PfF~e~p 658 (1028)
.+ ....++..+.+||.+||..||.+|||+.++++| +||++..
T Consensus 259 ~~--------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~ 306 (322)
T 1p4o_A 259 LD--------------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306 (322)
T ss_dssp CC--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred CC--------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence 00 011256788999999999999999999999987 6665443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=355.11 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=193.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHH--cCCCCeeEEEEEEeec--CC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK--AQHPNIVTVREIVVGS--NM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~--l~HPNIV~L~~i~~~~--~~ 435 (1028)
..++|++++.||+|+||+||+|.+ +++.||||++.... .....+|.+++.. ++||||+++++++... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 457899999999999999999988 68999999996542 2334567777666 7899999999886543 34
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH--------hCCcccccccccceeecCCCcEEE
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH--------DNWILHRDLKTSNLLLSHRGILKV 507 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLH--------s~gIVHRDLKPeNILLd~~g~lKL 507 (1028)
..+|+||||+.+ ++|.+.+. ...+++..+..++.||+.||.||| ++||+||||||+||||+.++.+||
T Consensus 79 ~~~~lv~e~~~~--g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEM--GSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEECCCTT--CBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred ceeEEehhhccC--CCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 568999999986 34444443 345899999999999999999999 999999999999999999999999
Q ss_pred eccCCccccCCCCCc----ccccccCccccCcccccCCC-----CCCchhhHHHHHHHHHHHHhC----------CCCCC
Q psy18163 508 GDFGLAREYGSPLKH----YTPIVVTLWYRSPELLLGCK-----EYSTPIDMWSVGCIFAEFLCM----------EPLFT 568 (1028)
Q Consensus 508 ~DFGlAr~~~~~~~~----~t~~vGT~~Y~APEvL~g~~-----~ys~ksDIWSLGvILyELLTG----------~pPF~ 568 (1028)
+|||+|+........ ....+||+.|+|||++.+.. .++.++|||||||++|+|++| .+||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999866443222 23458999999999998743 345799999999999999999 78885
Q ss_pred CCC----hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC
Q psy18163 569 GKS----DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT 644 (1028)
Q Consensus 569 g~s----d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT 644 (1028)
... ....+..+........ .. .........+..+.+||.+||..||.+|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRP-------------------NI------PNRWFSDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCC-------------------CC------CGGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred ccCCCCcchhhhhHHHhccCCCC-------------------CC------ChhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence 532 2222322221111000 00 001112235678899999999999999999
Q ss_pred HHHHHh
Q psy18163 645 ADEALR 650 (1028)
Q Consensus 645 A~ElL~ 650 (1028)
+.++++
T Consensus 290 ~~~i~~ 295 (301)
T 3q4u_A 290 ALRIKK 295 (301)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=358.21 Aligned_cols=258 Identities=18% Similarity=0.240 Sum_probs=197.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC---CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC--
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR---TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM-- 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~---tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~-- 435 (1028)
.++|++.+.||+|+||.||+|.+.. ++..||||+++...........+.+|+.++..++||||+++++++.....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4689999999999999999998765 56689999997654333333456789999999999999999998865433
Q ss_pred -CeEEEEEecccc-chHHHHHHHh--hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccC
Q psy18163 436 -DKIFIVMDYVEH-DMKSLMETMR--SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFG 511 (1028)
Q Consensus 436 -~~l~LVmEy~~g-dLgsLl~~l~--~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFG 511 (1028)
..+|+||||+.+ +|.+++.... .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 256999999986 6666654322 234568999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q psy18163 512 LAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNE 588 (1028)
Q Consensus 512 lAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~ 588 (1028)
++..+.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-- 269 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK-- 269 (313)
T ss_dssp CC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC--
T ss_pred cceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC--
Confidence 998764332 12234567889999999987 669999999999999999999 899999887766666554321100
Q ss_pred CCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 589 ~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+++.+.+||.+||..||.+|||+.+++++
T Consensus 270 ------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 270 ------------------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012256788999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=378.89 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=191.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.+|.+.+.||+|+||+||. ....+++.||||++.... .....+|+.+|+.+ .|||||++++++.. ...+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEE
Confidence 4699999999999999764 344578999999996532 23457899999999 79999999988754 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---C--CcEEEeccCCccc
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---R--GILKVGDFGLARE 515 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~--g~lKL~DFGlAr~ 515 (1028)
|||||.++|.+++. .....+.+.++..++.||+.||.|||++||+||||||+||||+. + ..+||+|||+|+.
T Consensus 96 v~E~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 96 AIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEECCSEEHHHHHH---SSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEECCCCCHHHHHH---hcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999876665553 44444555567899999999999999999999999999999953 2 3588999999987
Q ss_pred cCCCC---CcccccccCccccCcccccC--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 516 YGSPL---KHYTPIVVTLWYRSPELLLG--CKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 516 ~~~~~---~~~t~~vGT~~Y~APEvL~g--~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
+.... ...+..+||+.|+|||++.+ ...++.++||||||||+|+|++ |.+||........ ..+ .+.....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~---~~~~~~~ 248 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NIL---LGACSLD 248 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHH---TTCCCCT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHH---hccCCcc
Confidence 65332 23345789999999999974 3457889999999999999999 9999966544322 211 1111100
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.. ......+..+.+||.+||..||.+|||+.++|+||||..
T Consensus 249 ~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 249 CL--------------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TS--------------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cc--------------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 00 001124566889999999999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.68 Aligned_cols=257 Identities=19% Similarity=0.268 Sum_probs=205.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCe-----EEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeec
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDE-----IVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGS 433 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~-----~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~ 433 (1028)
..++|++.+.||.|+||+||+|.+..++. .||+|++...... .....+.+|+.+|..+ .||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 35789999999999999999999987664 7999999754321 1234567899999999 89999999998854
Q ss_pred CCCeEEEEEecccc-chHHHHHHHhh----------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC
Q psy18163 434 NMDKIFIVMDYVEH-DMKSLMETMRS----------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502 (1028)
Q Consensus 434 ~~~~l~LVmEy~~g-dLgsLl~~l~~----------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~ 502 (1028)
.+.+||||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 4579999999976 77766654322 13457899999999999999999999999999999999999999
Q ss_pred CcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy18163 503 GILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRI 579 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI 579 (1028)
+.+||+|||++..+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 9999999999986543221 2234567889999999987 568999999999999999998 99999887665555555
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
......+. ....++..+.+||.+||..||.+|||+.+++++
T Consensus 280 ~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 280 VKDGYQMA-------------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHTCCCC-------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCC-------------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 44321110 011246778899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=359.57 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=202.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEE--EEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIV--ALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~V--AIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|++.+.||+|+||.||+|++..++..+ |||+++.... ......+.+|+.+|..+ .||||+++++++... +.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 100 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 100 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--Cc
Confidence 478999999999999999999999888865 9999875432 22345577899999999 899999999988644 58
Q ss_pred EEEEEecccc-chHHHHHHHh------------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc
Q psy18163 438 IFIVMDYVEH-DMKSLMETMR------------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI 504 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~------------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~ 504 (1028)
+||||||+.+ +|.+++.... .....+++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 9999999975 6666654321 12246899999999999999999999999999999999999999999
Q ss_pred EEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q psy18163 505 LKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTM 583 (1028)
Q Consensus 505 lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~l 583 (1028)
+||+|||+++..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEEcccCcCcccccc-ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 999999999754322 22234567889999999976 568999999999999999998 999999888766555443211
Q ss_pred CCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 584 GTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 584 g~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.. .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 259 ~~--------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 RL--------------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CC--------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC--------------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 0011256788999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=368.56 Aligned_cols=265 Identities=16% Similarity=0.133 Sum_probs=198.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCC-----CeEEEEEEeecccccc---------CCccchHHHHHHHHHcCCCCeeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRT-----DEIVALKRLKMEKEKE---------GFPITSLREINTLLKAQHPNIVT 425 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~t-----g~~VAIKvlk~~~~~~---------~~~~~~lrEi~iL~~l~HPNIV~ 425 (1028)
..++|++++.||+|+||+||+|.+..+ ++.||||++....... ......+.|+..+..+.||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346899999999999999999999765 5789999987543210 01112334555666778999999
Q ss_pred EEEEEeecC--CCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec--C
Q psy18163 426 VREIVVGSN--MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS--H 501 (1028)
Q Consensus 426 L~~i~~~~~--~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd--~ 501 (1028)
+++++.... ...+||||||++++|.+++.. ....+++..+..|+.||+.||.|||++||+||||||+||||+ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999886543 256899999997677666643 446799999999999999999999999999999999999999 8
Q ss_pred CCcEEEeccCCccccCCCC-------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy18163 502 RGILKVGDFGLAREYGSPL-------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE 574 (1028)
Q Consensus 502 ~g~lKL~DFGlAr~~~~~~-------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d 574 (1028)
++.+||+|||+++.+.... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8999999999998654321 11244569999999999987 569999999999999999999999998643322
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 575 QLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 575 ~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
............ .++.+.. ..+ ....++..+.+||..||..||.+|||+.+|++
T Consensus 269 ~~~~~~~~~~~~---------~~~~~~~---~~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRE---------NIASLMD---KCF----------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHH---------CHHHHHH---HHS----------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhh---------hHHHHHH---Hhc----------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 222221110000 0000000 000 01235778999999999999999999999886
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=354.64 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=193.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.++..++||||+++++++.. .+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeE
Confidence 4578999999999999999999999999999999997654322 123456789999999999999999998865 3589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|+||||+.+ +|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999986 66665543 2458999999999999999999999999999999999999999999999999998765
Q ss_pred CCC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 518 SPL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 518 ~~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.. .+...+.......
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~--------- 254 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRP--------- 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCG---------
T ss_pred ccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCc---------
Confidence 432 23345689999999999987 56899999999999999999999999886554 3333322111000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-CHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-TADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-TA~ElL~ 650 (1028)
......++..+.+||.+||..||.+|| |++++++
T Consensus 255 --------------------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 255 --------------------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --------------------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --------------------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 011123667889999999999999999 8888876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=362.06 Aligned_cols=260 Identities=20% Similarity=0.290 Sum_probs=202.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEE-----ECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAK-----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~-----d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~ 434 (1028)
..++|++++.||+|+||.||+|. +..++..||||++..... ......+.+|+.++..+.||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence 34789999999999999999999 567788999999964322 1223456789999999999999999998854
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEE
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSK---KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKV 507 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~---~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL 507 (1028)
...+||||||+.+ +|.+++...... ...+++.++..++.||+.||.|||++||+||||||+||||+. ++.+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 4478999999954 666666543211 134788999999999999999999999999999999999984 446999
Q ss_pred eccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q psy18163 508 GDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMG 584 (1028)
Q Consensus 508 ~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg 584 (1028)
+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 9999998653321 22334578999999999977 568999999999999999998 9999998887776665543211
Q ss_pred CCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 585 TPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 585 ~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
.. ....++..+.+||.+||..||.+|||+.++++|.|+.
T Consensus 264 ~~--------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 MD--------------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CC--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC--------------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00 0112567789999999999999999999999998874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=358.91 Aligned_cols=258 Identities=19% Similarity=0.305 Sum_probs=202.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec--CCCeE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--NMDKI 438 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~--~~~~l 438 (1028)
.++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++..++||||+++++++... ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4689999999999999999999999999999999865322 2234567899999999999999999988633 34578
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
|+||||+.+ +|.+++.........+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999987 8888887766667789999999999999999999999999999999999999999999999999987653
Q ss_pred CCCC---------cccccccCccccCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCC
Q psy18163 518 SPLK---------HYTPIVVTLWYRSPELLLGCK--EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL-EQLSRIFKTMGT 585 (1028)
Q Consensus 518 ~~~~---------~~t~~vGT~~Y~APEvL~g~~--~ys~ksDIWSLGvILyELLTG~pPF~g~sd~-d~l~kI~~~lg~ 585 (1028)
.... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... +.+........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~- 264 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL- 264 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC-
Confidence 2111 112356799999999987532 3688999999999999999999999531100 00111111000
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
..+ ....++..+.+||.+||..||.+|||+.+++++
T Consensus 265 ---------------------~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 ---------------------SIP---------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ----------------------CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCC---------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 000 012356789999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=364.09 Aligned_cols=256 Identities=17% Similarity=0.138 Sum_probs=200.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC--------CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeE-------
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT--------DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVT------- 425 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t--------g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~------- 425 (1028)
.++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 47899999999999999999999874 889999999754 35678999999999999987
Q ss_pred --------EEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccce
Q psy18163 426 --------VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNL 497 (1028)
Q Consensus 426 --------L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNI 497 (1028)
+++++.. ....+||||||++++|.+++... ....+++.++..|+.||+.||.|||++||+||||||+||
T Consensus 114 ~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 114 TPLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp CTTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred CCccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 4555543 34689999999977777777542 135689999999999999999999999999999999999
Q ss_pred eecCCC--cEEEeccCCccccCCCC-------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy18163 498 LLSHRG--ILKVGDFGLAREYGSPL-------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFT 568 (1028)
Q Consensus 498 LLd~~g--~lKL~DFGlAr~~~~~~-------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~ 568 (1028)
||+.++ .+||+|||+++.+.... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999988 99999999998664321 12245689999999999987 568999999999999999999999998
Q ss_pred CCC-hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHH
Q psy18163 569 GKS-DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647 (1028)
Q Consensus 569 g~s-d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~E 647 (1028)
+.. ....+......+......+... ......++..+.+||.+||..||.+|||+.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGP-----------------------CGHWIRPSETLQKYLKVVMALTYEEKPPYAM 326 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECT-----------------------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhh-----------------------ccccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence 764 3333333322111110000000 0011236788999999999999999999999
Q ss_pred HHh
Q psy18163 648 ALR 650 (1028)
Q Consensus 648 lL~ 650 (1028)
+++
T Consensus 327 l~~ 329 (352)
T 2jii_A 327 LRN 329 (352)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=349.46 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=200.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCe---EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~---~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.|++.+.||+|+||+||+|.+..++. .||+|++..... ......+.+|+.++..++||||+++++++.... ...+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcE
Confidence 57888999999999999999765544 899999865332 112345678999999999999999999886433 3458
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 100 ~v~e~~~~--~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 100 VLLPYMCH--GDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EEECCCTT--CBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEEecccC--CCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999975 4555555555667889999999999999999999999999999999999999999999999999865432
Q ss_pred ----CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 520 ----LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 520 ----~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-------- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP-------- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC--------
T ss_pred cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC--------
Confidence 123345678999999999987 568999999999999999999 557777766655555443321100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+++.+.+||.+||..||.+|||+.++++.
T Consensus 249 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 249 ------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011256788999999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.52 Aligned_cols=255 Identities=19% Similarity=0.292 Sum_probs=203.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-------CCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEee
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-------RTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVG 432 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-------~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~ 432 (1028)
.++|++.+.||+|+||+||+|.+. .++..||||+++..... .....+.+|+.++..+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-HHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 478999999999999999999986 46778999999754321 1234567899999999 89999999998854
Q ss_pred cCCCeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee
Q psy18163 433 SNMDKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499 (1028)
Q Consensus 433 ~~~~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL 499 (1028)
.+.+|+||||+.+ +|.+++..... ....+++.++..++.||+.||.|||++||+||||||+||||
T Consensus 113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 4579999999976 66666543211 01247889999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy18163 500 SHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQL 576 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l 576 (1028)
+.++.+||+|||+++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999987654321 2234567889999999977 568999999999999999999 99999988877666
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
..+....... ....++..+.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~--------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMD--------------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCC--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCC--------------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5554421100 011256778999999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.41 Aligned_cols=250 Identities=22% Similarity=0.267 Sum_probs=199.9
Q ss_pred cCCeEEEE-EeeecCcEEEEEEEE--CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLN-RIEEGTYGVVYRAKD--KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~-~LG~G~FG~Vyla~d--~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|++.+ .||+|+||+||+|.+ ..++..||||+++...........+.+|+.++..++||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC---EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE---ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE---CCCC
Confidence 46899998 999999999999954 56788999999976543333345677899999999999999999988 3347
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
+|+||||+.+ +|.+++. . ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 92 ~~lv~e~~~~~~L~~~l~---~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQ---Q-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEEECCTTEEHHHHHH---H-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHH---h-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 8999999985 5555543 2 345899999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCc---ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 517 GSPLKH---YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 517 ~~~~~~---~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..... +
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~------ 239 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-M------ 239 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-C------
T ss_pred ccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C------
Confidence 543221 223456789999999977 558999999999999999999 9999999887665555433110 0
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ....++..+.+||.+||..||.+|||+.++++
T Consensus 240 --------------~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 --------------G-----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp --------------C-----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------C-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 01225678899999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=345.40 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=202.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||.||+|.+. ++..||||++..... ....+.+|+.+|..++||||+++++++. .+.+++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT---QEPIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc---CCCcEE
Confidence 478999999999999999999986 567899999975432 2345678999999999999999999874 346899
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||+.+ +|.+++... ....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999965 555554321 1125889999999999999999999999999999999999999999999999999876543
Q ss_pred C-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 L-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.......
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 230 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV----------- 230 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred ccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC-----------
Confidence 2 12234567889999999976 568999999999999999999 999999988777666554321000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+|||+.++++
T Consensus 231 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 231 ---------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01125678899999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.49 Aligned_cols=253 Identities=20% Similarity=0.259 Sum_probs=199.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC---CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT---DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t---g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
..+|++.+.||+|+||+||+|.+..+ ...||+|++..... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-CCCc
Confidence 35799999999999999999997543 34699999875322 1223456789999999999999999998654 3457
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
.|+||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 102 ~~~v~e~~~~--~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 102 PLVVLPYMKH--GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CEEEEECCTT--CBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred eEEEEeCCCC--CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 8999999987 34444444555668899999999999999999999999999999999999999999999999998664
Q ss_pred CCC----CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 518 SPL----KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 518 ~~~----~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
... ...+...||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 252 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------ 252 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC------
T ss_pred ccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC------
Confidence 321 22345577899999999977 568999999999999999999 678888877666655554321110
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+|||+.++++
T Consensus 253 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 253 --------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01125677889999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=371.03 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=193.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEEC---CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDK---RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~---~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
..++|++.+.||+|+||.||+|++. .++..||||+++.... ......+.+|+.+|..++||||+++++++.. ..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SK 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CC
Confidence 4568999999999999999999987 5677899999975432 1223457789999999999999999998854 45
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+||||||+.+ +|.+++ ......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 120 ~~~lv~e~~~~~sL~~~l---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHH---HTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 78999999965 555544 44455689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 516 YGSPLKH---YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 516 ~~~~~~~---~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---- 271 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---- 271 (373)
T ss_dssp -----------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC----
T ss_pred cccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 6543221 122345778999999987 569999999999999999998 9999998887776665543211100
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
...++..+.+||.+||..||.+|||+.++++
T Consensus 272 ----------------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 ----------------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----------------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0125677889999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=379.65 Aligned_cols=255 Identities=15% Similarity=0.164 Sum_probs=195.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCC-CC----------------
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQH-PN---------------- 422 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~H-PN---------------- 422 (1028)
...|.+.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+.| .|
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34688999999999999999999999999999998744322 2234456788888888876 21
Q ss_pred -----eeEEEEEEeecC---CCeEEEEEeccccchHHHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q psy18163 423 -----IVTVREIVVGSN---MDKIFIVMDYVEHDMKSLMETMRS---KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRD 491 (1028)
Q Consensus 423 -----IV~L~~i~~~~~---~~~l~LVmEy~~gdLgsLl~~l~~---~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRD 491 (1028)
...+..++.... ...+|++|+++.++|.+++..+.. ....+++..+..++.||+.||.|||++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111111111111 335799999999999999877643 234567778888999999999999999999999
Q ss_pred ccccceeecCCCcEEEeccCCccccCCCCCcccccccCccccCccccc---------CCCCCCchhhHHHHHHHHHHHHh
Q psy18163 492 LKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL---------GCKEYSTPIDMWSVGCIFAEFLC 562 (1028)
Q Consensus 492 LKPeNILLd~~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~---------g~~~ys~ksDIWSLGvILyELLT 562 (1028)
|||+||||+.++.+||+|||+++..+.. ....+| +.|+|||++. ....|+.++|||||||+||+|++
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999999876543 455688 9999999993 33568899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCC
Q psy18163 563 MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTR 642 (1028)
Q Consensus 563 G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kR 642 (1028)
|+.||.+.+..+....+ +.. ...+++.+.+||.+||..||.+|
T Consensus 313 g~~Pf~~~~~~~~~~~~-------------------------~~~------------~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI-------------------------FRS------------CKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp SSCCCCTTGGGSCSGGG-------------------------GSS------------CCCCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCcchhhhHHHH-------------------------Hhh------------cccCCHHHHHHHHHHccCChhhC
Confidence 99999775432111000 000 01356889999999999999999
Q ss_pred CCHHHHHhCCCCCC
Q psy18163 643 ITADEALRHDYFSE 656 (1028)
Q Consensus 643 PTA~ElL~HPfF~e 656 (1028)
||+.++|+||||++
T Consensus 356 pt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 356 LLPLQAMETPEYEQ 369 (413)
T ss_dssp CCHHHHTTSHHHHH
T ss_pred cCHHHHHhCHHHHH
Confidence 99999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=362.47 Aligned_cols=273 Identities=22% Similarity=0.228 Sum_probs=203.1
Q ss_pred cccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 359 ~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
...++|++.+.||+|+||+||+|.+. +++.||||++....... ....+.+|+.++..+.||||+++++++.. ....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 102 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 102 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSCC
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEec--CCce
Confidence 34578999999999999999999854 68899999997654322 23357889999999999999999998854 4478
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC---CcccccccccceeecCCCcEEEeccCCcc
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN---WILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~---gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
++||||+.+ +|.+++.........+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 999999976 66665544333344589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCCCC
Q psy18163 515 EYGSPLK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS----DLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 515 ~~~~~~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s----d~d~l~kI~~~lg~p~~~ 589 (1028)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+...+... ....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~ 259 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL--LKEK 259 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT--TSSC
T ss_pred ccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH--hhch
Confidence 7654322 2345679999999999977 558999999999999999999999995211 000011111100 0000
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
...... . ...........+..+.+||.+||..||.+|||+.++++|-.-
T Consensus 260 ~~~~~~--------------~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 260 KLEALV--------------D--VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSTTSS--------------C--TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhc--------------C--hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 000000 0 000011122345678999999999999999999999998553
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=356.53 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=198.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCC----eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTD----EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg----~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..++|++.+.||+|+||+||+|.+..++ ..||||+++.... ......+.+|+.++..++||||+++++++. ..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KY 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEe--cC
Confidence 4578999999999999999999987553 4699999975432 122345678999999999999999999885 34
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..+||||||+.+ +|.+++ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHH---HHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 589999999986 555444 4445678999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 515 EYGSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 515 ~~~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
.+..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~--- 271 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT--- 271 (333)
T ss_dssp ---------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---
T ss_pred hhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC---
Confidence 7654321 1223356889999999977 568999999999999999999 9999998887776666543211000
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
...++..+.+||.+||..||.+|||+.+++++
T Consensus 272 -----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 272 -----------------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -----------------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01256778999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=363.99 Aligned_cols=271 Identities=20% Similarity=0.229 Sum_probs=203.5
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.....++|++.+.||+|+||+||+|.+. ++..||||++..... .....+.+|+.++..++||||+++++++. ..+
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 108 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCD--ERN 108 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECC--CTT
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCC
Confidence 3345688999999999999999999965 688999998865432 22345678999999999999999999875 345
Q ss_pred eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 437 KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+|+||||+.+ +|.+++.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 78999999975 66555432212223588999999999999999999999999999999999999999999999999986
Q ss_pred cCCC--CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHhcCCCCCCC
Q psy18163 516 YGSP--LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRI---FKTMGTPNEKI 590 (1028)
Q Consensus 516 ~~~~--~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI---~~~lg~p~~~~ 590 (1028)
.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+ ....... ..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 265 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG--QL 265 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT--CC
T ss_pred cccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc--cH
Confidence 5432 122345679999999999977 56899999999999999999999999765432211100 0000000 00
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHD 652 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HP 652 (1028)
... .............+..+.+||.+||..||.+|||+.++++|-
T Consensus 266 ---------------~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 266 ---------------EQI--VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp ---------------CSS--SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---------------HHh--cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000 000000112233567788999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.10 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=194.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECC-CC--eEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKR-TD--EIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~-tg--~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..++|++++.||+|+||+||+|.+.. ++ ..||||+++..... ......+.+|+.++..++||||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-- 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--
Confidence 34689999999999999999998643 33 36999998765322 22234567899999999999999999988543
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
.+++||||+.+ ++|.+.+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 94 -~~~~v~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 -PMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp -SCEEEEECCTT--CBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -CceeeEecccC--CCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 48999999975 344444444455689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 516 YGSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 516 ~~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 245 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---- 245 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC----
T ss_pred ccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC----
Confidence 754322 1234567889999999977 568999999999999999999 9999999888777666643211000
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++..+.+||.+||..||.+|||+.+++++
T Consensus 246 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 246 ---------------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 011256788999999999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.06 Aligned_cols=263 Identities=16% Similarity=0.131 Sum_probs=195.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECC---CCeEEEEEEeecccccc---------CCccchHHHHHHHHHcCCCCeeEEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKR---TDEIVALKRLKMEKEKE---------GFPITSLREINTLLKAQHPNIVTVR 427 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~---tg~~VAIKvlk~~~~~~---------~~~~~~lrEi~iL~~l~HPNIV~L~ 427 (1028)
..++|++.+.||+|+||+||+|.+.. ++..||||++....... .....+.+|+.++..+.||||+.++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34689999999999999999999987 78899999987653210 1122355788888899999999999
Q ss_pred EEEeec--CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC--
Q psy18163 428 EIVVGS--NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-- 503 (1028)
Q Consensus 428 ~i~~~~--~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-- 503 (1028)
+++... ....+||||||++++|.+++. .. ..+++.++..|+.||+.||.|||++||+||||||+||||+.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~---~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERLGIDLQKISG---QN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEESSSCEEEEEEEECEEEEHHHHCB---GG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred cccccccCCCcEEEEEEeccCCCHHHHHH---hc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 988652 356899999999656655543 22 3689999999999999999999999999999999999999877
Q ss_pred cEEEeccCCccccCCC-------CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHH
Q psy18163 504 ILKVGDFGLAREYGSP-------LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS-DLEQ 575 (1028)
Q Consensus 504 ~lKL~DFGlAr~~~~~-------~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s-d~d~ 575 (1028)
.+||+|||+++.+... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. +...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999866321 112245689999999999987 568999999999999999999999996532 2222
Q ss_pred HHHHHHh-cCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 576 LSRIFKT-MGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 576 l~kI~~~-lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
+...... .... +.... . ......++..+.+||.+||..||.+|||+.++++.
T Consensus 270 ~~~~~~~~~~~~-----------~~~~~---~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 270 VQTAKTNLLDEL-----------PQSVL---K----------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHHTT-----------THHHH---H----------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHhhcccc-----------cHHHH---h----------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 2222111 1000 00000 0 00011367889999999999999999999999873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=373.29 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=203.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||+||+|.+. ++..||||+++.... ....+.+|+.+|..++||||+++++++. ...+|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccE
Confidence 4578999999999999999999986 467899999976432 2456789999999999999999999874 45689
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||.+ +|.+++... ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 259 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999975 555555322 123578889999999999999999999999999999999999999999999999987643
Q ss_pred CC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 PL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. .......+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+..+......+.
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~--------- 406 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR--------- 406 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---------
T ss_pred CceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---------
Confidence 21 11233456789999999976 569999999999999999999 9999999888877776654321110
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
...+++.+.+||.+||..||.+|||+.+|+.
T Consensus 407 -----------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 -----------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 0125678899999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=370.32 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=200.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||.||+|.+. +..||||+++... ....+.+|+.+|..++||||+++++++... ...+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceE
Confidence 4578999999999999999999985 7799999997543 345678999999999999999999987643 34799
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||.+ +|.+++... ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 264 iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999976 555555432 223478899999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. .....+|+.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+.+..+......+
T Consensus 342 ~---~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 406 (450)
T 1k9a_A 342 T---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD----------- 406 (450)
T ss_dssp --------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC-----------
T ss_pred c---ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2 223467899999999987 569999999999999999998 999999877666665554321000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....+++.+.+||.+||..||.+|||+.+++.
T Consensus 407 ---------------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 407 ---------------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01125678899999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=350.12 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=190.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||+|+||+||+|.+. ++.||||++.... ....+.+|+.+|..++||||+++++++. +.+||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYGACL----NPVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT----HHHHHHHHHHHHHHCCCTTBCCEEEBCT----TTTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh----HHHHHHHHHHHHhcCCCCCcCeEEEEEc----CCcEE
Confidence 468999999999999999999985 7889999986432 2345678999999999999999988764 34799
Q ss_pred EEecccc-chHHHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHh---CCcccccccccceeecCCCc-EEEeccCCc
Q psy18163 441 VMDYVEH-DMKSLMETMRSKK--QVFIPGEVKCLMQQLLNAVAHLHD---NWILHRDLKTSNLLLSHRGI-LKVGDFGLA 513 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~--~~~se~ev~~il~QLl~AL~yLHs---~gIVHRDLKPeNILLd~~g~-lKL~DFGlA 513 (1028)
||||+.+ +|.+++. ... ..++...+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++
T Consensus 77 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 77 VMEYAEGGSLYNVLH---GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp EEECCTTCBHHHHHH---CSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred EEEcCCCCCHHHHHh---ccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 9999976 5555543 322 236788899999999999999999 89999999999999998886 799999999
Q ss_pred cccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCC
Q psy18163 514 REYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDL--EQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 514 r~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~--d~l~kI~~~lg~p~~~~w 591 (1028)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..+..+.. +...
T Consensus 154 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~---- 223 (307)
T 2eva_A 154 CDIQTH---MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTRP---- 223 (307)
T ss_dssp --------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCCC----
T ss_pred cccccc---cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCCC----
Confidence 866432 334579999999999987 56899999999999999999999999764322 22222111 1000
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC-----CCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH-----DYFSESP 658 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H-----PfF~e~p 658 (1028)
.....++..+.+||.+||..||.+|||+.+++++ .+|....
T Consensus 224 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 224 --------------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp --------------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred --------------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 0012256788999999999999999999999984 6665543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=353.00 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=194.1
Q ss_pred CCCccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHH--cCCCCeeEEEE
Q psy18163 351 YLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK--AQHPNIVTVRE 428 (1028)
Q Consensus 351 y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~--l~HPNIV~L~~ 428 (1028)
.+|...+....++|++++.||+|+||.||+|.+. ++.||||++..... ....+|.+++.. ++||||+++++
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEE
Confidence 4444455556689999999999999999999985 89999999965422 233455555544 48999999999
Q ss_pred EEeecCC--CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC--------Ccccccccccce
Q psy18163 429 IVVGSNM--DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN--------WILHRDLKTSNL 497 (1028)
Q Consensus 429 i~~~~~~--~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~--------gIVHRDLKPeNI 497 (1028)
++..... ..+||||||+.+ +|.+++. . ..+++..+..++.||+.||.|||++ ||+||||||+||
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Ni 173 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK---S--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHH---H--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGE
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhh---c--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHE
Confidence 8875533 589999999976 6655553 2 2588999999999999999999999 999999999999
Q ss_pred eecCCCcEEEeccCCccccCCCCCc----ccccccCccccCcccccCCCCCCc------hhhHHHHHHHHHHHHhC----
Q psy18163 498 LLSHRGILKVGDFGLAREYGSPLKH----YTPIVVTLWYRSPELLLGCKEYST------PIDMWSVGCIFAEFLCM---- 563 (1028)
Q Consensus 498 LLd~~g~lKL~DFGlAr~~~~~~~~----~t~~vGT~~Y~APEvL~g~~~ys~------ksDIWSLGvILyELLTG---- 563 (1028)
||+.++.+||+|||+++.+...... ....+||+.|+|||++.+.. +.. ++||||||||+|+|++|
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcc
Confidence 9999999999999999876543222 23568999999999997733 444 49999999999999999
Q ss_pred ------CCCCCCCC----hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHH
Q psy18163 564 ------EPLFTGKS----DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCK 633 (1028)
Q Consensus 564 ------~pPF~g~s----d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~k 633 (1028)
..||.... ....+..+....... ..++ .......++..+.+||.+
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~------~~~~~~~~~~~l~~li~~ 307 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR-------------------PSFP------NRWSSDECLRQMGKLMTE 307 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-------------------CCCC------GGGGGSHHHHHHHHHHHH
T ss_pred cccccccccHhhhcCCCCchhhhHHHHhhhccC-------------------cccc------ccchhhHHHHHHHHHHHH
Confidence 55554321 112222221110000 0000 011112356778999999
Q ss_pred hcccCcCCCCCHHHHHhC
Q psy18163 634 FLTYDPVTRITADEALRH 651 (1028)
Q Consensus 634 cL~~DP~kRPTA~ElL~H 651 (1028)
||..||.+|||+.++++|
T Consensus 308 ~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 308 CWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HSCSSGGGSCCHHHHHHH
T ss_pred hhhhChhhCCCHHHHHHH
Confidence 999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=378.81 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=205.1
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||.||+|.+..++..||||+++.... ....+.+|+.+|..++||||+++++++.. ...+|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEE
Confidence 34689999999999999999999999999999999975432 24567899999999999999999998854 45789
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||.+ +|.+++... ....+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 293 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999985 555554321 234588999999999999999999999999999999999999999999999999987643
Q ss_pred CC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 PL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. .......+|+.|+|||++.+ ..|+.++|||||||+||||++ |..||.+.+..+....+......
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------- 438 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM----------- 438 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-----------
T ss_pred CceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 22 12234456789999999977 568999999999999999999 99999987766555444321100
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+++.+.+||.+||..||.+|||+.+|++
T Consensus 439 ---------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 ---------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 001225678899999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=349.95 Aligned_cols=243 Identities=29% Similarity=0.434 Sum_probs=187.0
Q ss_pred cccCCeEEE-EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHH-HHcCCCCeeEEEEEEee--cC
Q psy18163 359 RSVEEFKCL-NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTL-LKAQHPNIVTVREIVVG--SN 434 (1028)
Q Consensus 359 ~~~d~Y~il-~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL-~~l~HPNIV~L~~i~~~--~~ 434 (1028)
...++|.++ +.||+|+||.||+|.+..+++.||||++... ....+|+.++ +.+.||||+++++++.. ..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 345789888 7799999999999999999999999999642 2456788887 55689999999998854 33
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEecc
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDF 510 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DF 510 (1028)
...+||||||+.+ +|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 4579999999976 66655543 12346899999999999999999999999999999999999997 789999999
Q ss_pred CCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy18163 511 GLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590 (1028)
Q Consensus 511 GlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~ 590 (1028)
|++..... ..|+.++|||||||++|+|++|.+||.+.+.......+ ....
T Consensus 165 g~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-------~~~~ 214 (299)
T 3m2w_A 165 GFAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRI 214 (299)
T ss_dssp TTCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-------CCSS
T ss_pred cccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-------HHHH
Confidence 99865431 34788999999999999999999999775543211100 0000
Q ss_pred CCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 591 w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
.......+ ......+++.+.+||.+||..||.+|||+.++|+||||++..
T Consensus 215 ~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 215 RMGQYEFP------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CTTCCSSC------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhccccCC------------------chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00000000 001133678899999999999999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=360.21 Aligned_cols=251 Identities=16% Similarity=0.186 Sum_probs=194.2
Q ss_pred ccccccCCeEEEEEeeecCcEEEEEE-----EECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC---CCCeeEEE
Q psy18163 356 QGCRSVEEFKCLNRIEEGTYGVVYRA-----KDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ---HPNIVTVR 427 (1028)
Q Consensus 356 ~g~~~~d~Y~il~~LG~G~FG~Vyla-----~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~---HPNIV~L~ 427 (1028)
......++|.+.+.||+|+||+||+| .+..+++.||||+++... ...+.+|+.++..+. |+||+.++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 33345678999999999999999999 467789999999997542 234567788887776 99999999
Q ss_pred EEEeecCCCeEEEEEecccc-chHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC----
Q psy18163 428 EIVVGSNMDKIFIVMDYVEH-DMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---- 501 (1028)
Q Consensus 428 ~i~~~~~~~~l~LVmEy~~g-dLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---- 501 (1028)
+++... +..|||||||.+ +|.+++..... ....+++..+..|+.||+.||.|||++|||||||||+||||+.
T Consensus 134 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 134 SAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEECS--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred eeeecC--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 888644 478999999975 77777665443 2456899999999999999999999999999999999999998
Q ss_pred -------CCcEEEeccCCccccC--CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q psy18163 502 -------RGILKVGDFGLAREYG--SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD 572 (1028)
Q Consensus 502 -------~g~lKL~DFGlAr~~~--~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd 572 (1028)
++.+||+|||+|+.+. ......+..+||+.|+|||++.+ ..|+.++||||||||+|+|+||.+||.....
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997543 22344567789999999999988 5599999999999999999999999965322
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 573 LEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 573 ~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.. |.- ...+..+ ..++...+|+..||..+|.+|++..+.|.+
T Consensus 291 ~~----------------~~~--------~~~~~~~-------------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 291 GE----------------CKP--------EGLFRRL-------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp TE----------------EEE--------CSCCTTC-------------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred Cc----------------eee--------chhcccc-------------CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 00 000 0000000 134567799999999999999765554443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=343.96 Aligned_cols=246 Identities=23% Similarity=0.321 Sum_probs=193.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||+||+|.+. +..||||+++... ....+.+|+.++..++||||+++++++... ...+|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceE
Confidence 3578999999999999999999884 8899999997532 334567899999999999999999987543 34789
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
+||||+.+ +|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999986 6766665322 22378889999999999999999999999999999999999999999999999986643
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+..... .
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~--------- 233 (278)
T 1byg_A 170 T---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---M--------- 233 (278)
T ss_dssp ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---C---------
T ss_pred c---ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---C---------
Confidence 2 233467899999999977 568999999999999999998 9999988776555544422100 0
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 234 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 234 --------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 001235678899999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=353.42 Aligned_cols=273 Identities=22% Similarity=0.279 Sum_probs=189.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHH--HHHHHHcCCCCeeEEEEEEe---ecC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLRE--INTLLKAQHPNIVTVREIVV---GSN 434 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrE--i~iL~~l~HPNIV~L~~i~~---~~~ 434 (1028)
..++|++++.||+|+||+||+|.+ +++.||||++..... .....| +..+..+.||||+++++.+. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 468999999999999999999987 689999999975432 122333 33344589999999987553 233
Q ss_pred CCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC---------CcccccccccceeecCCCc
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN---------WILHRDLKTSNLLLSHRGI 504 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~---------gIVHRDLKPeNILLd~~g~ 504 (1028)
...+||||||+.+ +|.+++. .. .+++..+..++.||+.||.|||+. ||+||||||+||||+.++.
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~---~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLS---LH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHH---HC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred CceEEEEEecCCCCcHHHHHh---hc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 4468999999965 6655553 22 357888999999999999999999 9999999999999999999
Q ss_pred EEEeccCCccccCCC--------CCcccccccCccccCcccccCC------CCCCchhhHHHHHHHHHHHHhCCCC-CCC
Q psy18163 505 LKVGDFGLAREYGSP--------LKHYTPIVVTLWYRSPELLLGC------KEYSTPIDMWSVGCIFAEFLCMEPL-FTG 569 (1028)
Q Consensus 505 lKL~DFGlAr~~~~~--------~~~~t~~vGT~~Y~APEvL~g~------~~ys~ksDIWSLGvILyELLTG~pP-F~g 569 (1028)
+||+|||+++.+... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999876432 1223356899999999999763 3466789999999999999999655 443
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhh-----ccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC
Q psy18163 570 KSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM-----TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT 644 (1028)
Q Consensus 570 ~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l-----~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT 644 (1028)
....+....+....+..+ ........ ....++.. ......+++.+.+||.+||..||.+|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHP--------TFEDMQVLVSREKQRPKFPEA-----WKENSLAVRSLKETIEDCWDQDAEARLT 305 (336)
T ss_dssp SCCCCCCCTTHHHHCSSC--------CHHHHHHHHTTSCCCCCCCTT-----CCCCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred cchhHHHHhhhcccCCCc--------hHHHHHhhhcccccCCCCCcc-----cccccchHHHHHHHHHHHhcCChhhCcc
Confidence 321110000000000000 00000000 00000100 0011235567999999999999999999
Q ss_pred HHHHH------hCCCCCCC
Q psy18163 645 ADEAL------RHDYFSES 657 (1028)
Q Consensus 645 A~ElL------~HPfF~e~ 657 (1028)
+.+++ -++|-++.
T Consensus 306 ~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 306 AQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HHHHHHHHHHHHHCCCC--
T ss_pred hHHHHHHHHHHHHHHHhcc
Confidence 99994 57888764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=368.50 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=202.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|..++||||+++++++.. ..+|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceE
Confidence 34789999999999999999999975 46699999976432 23457899999999999999999998743 5689
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||+.+ +|.+++... ....+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999976 555555321 234588999999999999999999999999999999999999999999999999987643
Q ss_pred CC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 PL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. .......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+.+..+......+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---------- 401 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------- 401 (452)
T ss_dssp ----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------
T ss_pred CceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 21 12234457889999999987 569999999999999999999 999999988877776664321100
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh--CCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR--HDYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~--HPfF~e~ 657 (1028)
....+++.+.+||.+||..||.+|||+.+++. ..+|...
T Consensus 402 ----------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 402 ----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 01125677889999999999999999999987 3676543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=350.81 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=200.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||.||+|.+.. .||+|+++...........+.+|+.++..++||||+++++++... ..++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 105 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--PHLA 105 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS--SCEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CceE
Confidence 45789999999999999999999864 399999987654444455677899999999999999999988644 4799
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC-
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS- 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~- 518 (1028)
+||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 106 iv~e~~~~--~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 106 IITSLCKG--RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EECBCCCS--EEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred EEeecccC--CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999976 445555555555689999999999999999999999999999999999998 68999999999876532
Q ss_pred ----CCCcccccccCccccCcccccC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q psy18163 519 ----PLKHYTPIVVTLWYRSPELLLG--------CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586 (1028)
Q Consensus 519 ----~~~~~t~~vGT~~Y~APEvL~g--------~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p 586 (1028)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 1123344579999999999875 2458999999999999999999999999888776665554321100
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. ....++..+.+||.+||..||.+|||+.++++.
T Consensus 263 ~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 L-------------------------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp C-------------------------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred C-------------------------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 001245567899999999999999999999983
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=352.67 Aligned_cols=264 Identities=21% Similarity=0.268 Sum_probs=196.2
Q ss_pred eEEEEEeeecCcEEEEEEEE----CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 364 FKCLNRIEEGTYGVVYRAKD----KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d----~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
|++++.||+|+||+||++.. ..+++.||||+++.... ......+.+|+.+|..++||||+++++++.......++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 49999999999999988754 45789999999976532 12234567899999999999999999999877677899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||||+.+ ++|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 112 lv~e~~~~--~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 112 LVMEYVPL--GSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEECCCTT--CBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEEecccC--CcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999976 344444433 24899999999999999999999999999999999999999999999999999877543
Q ss_pred CC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 520 LK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 520 ~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .... ...... . .
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~---~~~~~~----~-~ 256 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF--LELI---GIAQGQ----M-T 256 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHH---CSCCHH----H-H
T ss_pred ccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhh--hhhh---cccccc----h-h
Confidence 22 1234568899999999987 558899999999999999999999997532210 0000 000000 0 0
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
............ .......++..+.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 VLRLTELLERGE-------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccc-------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000000000000 00011236788999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=365.15 Aligned_cols=253 Identities=20% Similarity=0.266 Sum_probs=191.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCC---CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRT---DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~t---g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..|++.+.||+|+||+||+|.+..+ +..||||.++.... ......+.+|+.+|..++||||+++++++... .+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC-SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCCe
Confidence 4689999999999999999987543 34789999865322 22234567899999999999999999886533 3478
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+||||+.+ ++|.+.+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 167 ~lv~e~~~~--g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 167 LVVLPYMKH--GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEEEECCTT--CBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEECCCC--CCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999986 444455555556688899999999999999999999999999999999999999999999999986643
Q ss_pred CC----CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 519 PL----KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 519 ~~----~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
.. ...+...+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~------- 316 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------- 316 (373)
T ss_dssp -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC-------
T ss_pred cccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 21 12234567889999999987 568999999999999999999 789998876655554443321000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++..+.+||.+||..||.+|||+.+++++
T Consensus 317 -------------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 -------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011256778999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=358.06 Aligned_cols=252 Identities=18% Similarity=0.204 Sum_probs=192.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc------cCCccchHHHHHHHHHcC---------CCCee
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK------EGFPITSLREINTLLKAQ---------HPNIV 424 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~------~~~~~~~lrEi~iL~~l~---------HPNIV 424 (1028)
..++|++++.||+|+||+||+|++ +|+.||||++...... ......+.+|+.+|+.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 347899999999999999999998 6899999999875421 112245678999998885 99999
Q ss_pred EEEEEEeec----------------------------CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHH
Q psy18163 425 TVREIVVGS----------------------------NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476 (1028)
Q Consensus 425 ~L~~i~~~~----------------------------~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl 476 (1028)
.+.+++... ....+|||||||.+ ++++..+.. ..+++..++.|+.||+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~--g~ll~~~~~--~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG--GIDLEQMRT--KLSSLATAKSILHQLT 171 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC--CEETGGGTT--TCCCHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC--CccHHHHHh--cCCCHHHHHHHHHHHH
Confidence 988876421 25689999999975 333333322 4589999999999999
Q ss_pred HHHHHHH-hCCcccccccccceeecCCC--------------------cEEEeccCCccccCCCCCcccccccCccccCc
Q psy18163 477 NAVAHLH-DNWILHRDLKTSNLLLSHRG--------------------ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535 (1028)
Q Consensus 477 ~AL~yLH-s~gIVHRDLKPeNILLd~~g--------------------~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~AP 535 (1028)
.||.||| ++|||||||||+||||+.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 9999999 99999999999999999887 8999999999877532 35899999999
Q ss_pred ccccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCC
Q psy18163 536 ELLLGCKEYSTPIDMWSVGCI-FAEFLCMEPLFTGKSD-LEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGG 613 (1028)
Q Consensus 536 EvL~g~~~ys~ksDIWSLGvI-LyELLTG~pPF~g~sd-~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~ 613 (1028)
|++.+. . +.++||||||++ .+++++|..||.+... ......+........ ..
T Consensus 247 E~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~------------------ 300 (336)
T 2vuw_A 247 DLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT------KC------------------ 300 (336)
T ss_dssp GGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS------CC------------------
T ss_pred hhhcCC-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc------cc------------------
Confidence 999873 3 889999998777 7889999999954211 112222222111000 00
Q ss_pred CccccccccccHHHHHHHHHhcccCcCCCCCHHHHH-hCCCCC
Q psy18163 614 LKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL-RHDYFS 655 (1028)
Q Consensus 614 l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL-~HPfF~ 655 (1028)
.......+++.+.+||.+||++| ||.|+| +||||+
T Consensus 301 --~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 --NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp --CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred --chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 00112347788999999999988 999999 999995
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.33 Aligned_cols=268 Identities=20% Similarity=0.304 Sum_probs=199.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEE----ECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAK----DKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~----d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
..++|++++.||+|+||.||+|. +..+++.||||++.... ......+.+|+.+|..++||||+++++++.....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 34679999999999999999998 46789999999997542 2223456789999999999999999998876655
Q ss_pred CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..+++||||+.+ +|.+++ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp -CCEEEECCCTTCBHHHHH---HHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEECCCCCCHHHHH---HhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 678999999976 555554 4444568999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCc---ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 515 EYGSPLKH---YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 515 ~~~~~~~~---~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
........ .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.. ..+......+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~~~---~~~~~~~~~~ 267 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPP--AEFMR---MIGNDKQGQM 267 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHHHH---HHCTTCCTHH
T ss_pred hccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHHHH---hhccccchhh
Confidence 77543221 234567888999999987 458999999999999999999999986421 11111 1111000000
Q ss_pred CCCCCChhh-hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 592 PGFSKLPAV-QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 592 ~~~s~lp~~-~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
. ...+ ........ ......++..+.+||.+||..||.+|||+.++++
T Consensus 268 ~----~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 268 I----VFHLIELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp H----HHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h----HHHHHHHhhcCCC--------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0000 00000000 0011236788999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=382.06 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=198.6
Q ss_pred CeEEE-EEeeecCcEEEEEEEE--CCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 363 EFKCL-NRIEEGTYGVVYRAKD--KRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 363 ~Y~il-~~LG~G~FG~Vyla~d--~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.+.+. +.||+|+||+||+|.+ ..+++.||||+++...........+.+|+.+|..++|||||++++++.. +.++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~ 445 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWM 445 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEE
Confidence 34443 4899999999999955 4667899999998765444445667899999999999999999998843 3589
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||||.+ ++|.+.+.. ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+...
T Consensus 446 lv~E~~~~--g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 446 LVMEMAEL--GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEECCTT--EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEEccCC--CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 99999986 444444433 446899999999999999999999999999999999999999999999999999877543
Q ss_pred CC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 520 LK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 520 ~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.. ..+...+|+.|+|||++.+ ..|+.++||||||||||||++ |..||.+.+..+....+......+
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 592 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 592 (635)
T ss_dssp ------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---------
T ss_pred ccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 22 2334467889999999977 569999999999999999998 999999988877666654421100
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+|||+.+|++
T Consensus 593 -----------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 -----------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01125678899999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=369.86 Aligned_cols=253 Identities=21% Similarity=0.210 Sum_probs=200.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|+++++||+|+||.||+|++..+++.||||++..... ...+.+|+.++..+.|++++..+.++. ...+..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~-~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFG-VEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEE-EETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEE-eeCCEEEE
Confidence 4789999999999999999999999999999999876432 235678999999998755444443332 34568899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee---cCCCcEEEeccCCccccC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL---SHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL---d~~g~lKL~DFGlAr~~~ 517 (1028)
||||++++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+.
T Consensus 81 vme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999988888877643 4568999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCC-------cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCC
Q psy18163 518 SPLK-------HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---LEQLSRIFKTMGTPN 587 (1028)
Q Consensus 518 ~~~~-------~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---~d~l~kI~~~lg~p~ 587 (1028)
.... .....+||+.|+|||++.+ ..++.++||||||||||+|++|..||.+... ...+..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 4322 1236789999999999988 5699999999999999999999999987543 333333332110000
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.......++..+.+||..||..||.+||++.+|++
T Consensus 237 ----------------------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 ----------------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ----------------------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ----------------------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00011235678899999999999999999998865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=380.19 Aligned_cols=256 Identities=21% Similarity=0.273 Sum_probs=203.4
Q ss_pred cCCeEEEE-EeeecCcEEEEEEEEC--CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLN-RIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~-~LG~G~FG~Vyla~d~--~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|.+.+ .||+|+||.||+|.+. .++..||||+++.... ......+.+|+.+|..++|||||++++++.. +.
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SS
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CC
Confidence 35677776 8999999999999875 4567899999976532 2234567899999999999999999998853 46
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|||||||.+ ++|...+......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 410 ~~lv~E~~~~--g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 410 LMLVMEMAGG--GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEEECCTT--CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred eEEEEEeCCC--CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999987 55555565556678999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCc---ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q psy18163 518 SPLKH---YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593 (1028)
Q Consensus 518 ~~~~~---~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~ 593 (1028)
..... .....+|+.|+|||++.+ ..|+.++||||||||||||++ |..||.+.+..+.+..+......+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------- 559 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME------- 559 (613)
T ss_dssp --------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC-------
T ss_pred CCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 43221 122345789999999976 569999999999999999998 999999988877776664321000
Q ss_pred CCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHH---hCCCCC
Q psy18163 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL---RHDYFS 655 (1028)
Q Consensus 594 ~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL---~HPfF~ 655 (1028)
....+++.+.+||.+||..||.+|||+.+|+ ++.|+.
T Consensus 560 -------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 560 -------------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -------------------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0112567889999999999999999999985 445543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=345.30 Aligned_cols=266 Identities=22% Similarity=0.269 Sum_probs=202.4
Q ss_pred CCCCCccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHH--cCCCCeeEE
Q psy18163 349 PPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK--AQHPNIVTV 426 (1028)
Q Consensus 349 p~y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~--l~HPNIV~L 426 (1028)
+..+|...+....++|++.+.||+|+||+||+|.+ +++.||||++.... .....+|+.++.. ++||||+++
T Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~ 101 (342)
T 1b6c_B 29 GSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGF 101 (342)
T ss_dssp CSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCE
T ss_pred CCCCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEE
Confidence 34556655666678999999999999999999998 48999999996432 2345678888887 789999999
Q ss_pred EEEEeecCC--CeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH--------hCCccccccccc
Q psy18163 427 REIVVGSNM--DKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH--------DNWILHRDLKTS 495 (1028)
Q Consensus 427 ~~i~~~~~~--~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLH--------s~gIVHRDLKPe 495 (1028)
++++..... ..+|+||||+.+ +|.+++. . ..+++..+..++.||+.||.||| ++||+||||||+
T Consensus 102 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~ 176 (342)
T 1b6c_B 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---R--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176 (342)
T ss_dssp EEEEECCCSSCCCEEEEECCCTTCBHHHHHH---H--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGG
T ss_pred EeeecccCCccceeEEEEeecCCCcHHHHHh---c--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHH
Confidence 998865443 379999999987 6666553 2 35889999999999999999999 899999999999
Q ss_pred ceeecCCCcEEEeccCCccccCCCCC----cccccccCccccCcccccCCCC-----CCchhhHHHHHHHHHHHHhC---
Q psy18163 496 NLLLSHRGILKVGDFGLAREYGSPLK----HYTPIVVTLWYRSPELLLGCKE-----YSTPIDMWSVGCIFAEFLCM--- 563 (1028)
Q Consensus 496 NILLd~~g~lKL~DFGlAr~~~~~~~----~~t~~vGT~~Y~APEvL~g~~~-----ys~ksDIWSLGvILyELLTG--- 563 (1028)
||||+.++.+||+|||++........ .....+||+.|+|||++.+... ++.++|||||||++|+|++|
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~ 256 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence 99999999999999999987654322 2345689999999999976322 33689999999999999999
Q ss_pred -------CCCCCCCC----hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHH
Q psy18163 564 -------EPLFTGKS----DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLC 632 (1028)
Q Consensus 564 -------~pPF~g~s----d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~ 632 (1028)
..||.... ..+.+...+.... . .+. ++. ..........+.+||.
T Consensus 257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~----~~~--------------~~~------~~~~~~~~~~l~~li~ 311 (342)
T 1b6c_B 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK-L----RPN--------------IPN------RWQSCEALRVMAKIMR 311 (342)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-C----CCC--------------CCG------GGGTSHHHHHHHHHHH
T ss_pred CCcccccccCccccCcCcccHHHHHHHHHHHH-h----CCC--------------Ccc------cccchhHHHHHHHHHH
Confidence 67776542 1222222221100 0 000 000 0011224567889999
Q ss_pred HhcccCcCCCCCHHHHHhC
Q psy18163 633 KFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 633 kcL~~DP~kRPTA~ElL~H 651 (1028)
+||..||.+|||+.++++|
T Consensus 312 ~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 312 ECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHCCSSGGGSCCHHHHHHH
T ss_pred HHhccChhhCCCHHHHHHH
Confidence 9999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=372.79 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=206.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.++||+|+||.||+|.+.. +..||||+++.... ....+++|+.+|+.++||||+++++++.. ..+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccce
Confidence 35689999999999999999999975 46699999976432 23467899999999999999999998743 5689
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||.+ +|.+++... ....+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..
T Consensus 338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999976 555554321 224588999999999999999999999999999999999999999999999999987643
Q ss_pred CC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 519 PL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 519 ~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. .......+|..|+|||++.+ ..|+.++||||||||||||++ |..||.+....+.+..+......+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---------- 484 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------- 484 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC----------
T ss_pred CceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 21 11223456889999999987 569999999999999999999 999999988877776664321100
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC--CCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH--DYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H--PfF~e 656 (1028)
....++..+.+||.+||..||.+|||+.+|+.. .||..
T Consensus 485 ----------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 ----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 011256788999999999999999999999874 66654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.15 Aligned_cols=263 Identities=24% Similarity=0.299 Sum_probs=198.3
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc--ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE--KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~--~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
|...+.||+|+||+||+|.+ ++..||||++..... .......+.+|+.++..++||||+++++++.. .+.+|+|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEEE
Confidence 34458899999999999986 578999999975432 12233456789999999999999999998854 4578999
Q ss_pred Eecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 442 MDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 442 mEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||+.+ +|.+++.... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 109 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp EECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred EEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 999964 6666654432 23468899999999999999999999999999999999999999999999999998765422
Q ss_pred C--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 K--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+......... .+.
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~ 258 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK-------TIE 258 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC-------CHH
T ss_pred ccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh-------hhh
Confidence 2 1234679999999999876 4899999999999999999999999876543333233222111000 000
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. ...... .......+..+.+||.+||..||.+|||+.+++++
T Consensus 259 ~---~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 259 D---YIDKKM--------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp H---HSCSSC--------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred h---hccccc--------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 000000 01122355678899999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=393.62 Aligned_cols=293 Identities=25% Similarity=0.331 Sum_probs=205.1
Q ss_pred CCCCccccccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEE
Q psy18163 350 PYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREI 429 (1028)
Q Consensus 350 ~y~p~~~g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i 429 (1028)
+|.|...+. ..++|++.+.||.|+||+||+|.+..+|..||||++..... ......+.+|+.+|..++||||+.++++
T Consensus 3 G~~p~~pg~-~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~v 80 (676)
T 3qa8_A 3 GRSPSLPTQ-TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSAREV 80 (676)
T ss_dssp ---------------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCCBTTBCCEEEC
T ss_pred CCCCCCCCC-CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCceeee
Confidence 344444433 35889999999999999999999999999999999875422 1223456789999999999999999988
Q ss_pred Eee----cCCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCc
Q psy18163 430 VVG----SNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGI 504 (1028)
Q Consensus 430 ~~~----~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~ 504 (1028)
+.. ...+..|||||||.+ +|.+++.... ....+++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 81 ~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~ 159 (676)
T 3qa8_A 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159 (676)
T ss_dssp CTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSS
T ss_pred ecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCC
Confidence 643 225678999999965 6655554321 1235888899999999999999999999999999999999997664
Q ss_pred ---EEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy18163 505 ---LKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK 581 (1028)
Q Consensus 505 ---lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~ 581 (1028)
+||+|||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........+.
T Consensus 160 ~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~ 237 (676)
T 3qa8_A 160 RLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237 (676)
T ss_dssp SCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC
T ss_pred ceeEEEcccccccccccc-cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh
Confidence 999999999877543 33456789999999999987 5699999999999999999999999987654322111100
Q ss_pred hcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 582 TMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 582 ~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.........+..... ...+.... . ........+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 238 ~~~~~~~~~~~~l~g-----~~~~~~~l---p-~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 238 EKSNEHIVVYDDLTG-----AVKFSSVL---P-TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp ------CCSCCCCSS-----SCCCCSSS---C-CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred cccchhhhhhhhhcc-----cccccccc---C-CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000000000000000 00000000 0 011223447788999999999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=374.45 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=202.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCC---CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRT---DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~t---g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
..++|++.+.||+|+||+||+|.+..+ +..||||+++.... ......+.+|+.+|..++||||+++++++. .+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT---EN 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---cC
Confidence 357899999999999999999998654 56799999865432 122345678999999999999999999873 34
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+||||||+.+ ++|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 464 ~~~lv~E~~~~--g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 464 PVWIIMELCTL--GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SCEEEEECCTT--CBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred ceEEEEEcCCC--CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 68999999985 4444444444556889999999999999999999999999999999999999999999999999876
Q ss_pred CCCCC-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 517 GSPLK-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 517 ~~~~~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
..... ......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+..+.+..+......+
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 612 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------- 612 (656)
T ss_dssp CC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC--------
T ss_pred CCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 54321 2234567889999999976 569999999999999999997 999999988888777765431110
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+++.+.+||.+||..||.+|||+.++++.
T Consensus 613 ------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 613 ------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 011256788999999999999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=371.90 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=196.4
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECC-CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKR-TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~-tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
|....++|++++.||+|+||+||+|.+.. +++.||||++..... ......+.+|+.+|..++||||+++++++.....
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 44456899999999999999999999986 789999999865322 1223356789999999999999999999875432
Q ss_pred C---eEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccC
Q psy18163 436 D---KIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFG 511 (1028)
Q Consensus 436 ~---~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFG 511 (1028)
. .+||||||+.+ +|.+++ . ..+++.++..|+.||+.||.|||++|||||||||+||||+.+ .+||+|||
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~---~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSK---G---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCCceeEEEEEeCCCCcHHHHH---h---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecc
Confidence 1 27999999986 444432 2 258999999999999999999999999999999999999874 89999999
Q ss_pred CccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+++..... ...+||+.|+|||++.+ .++.++||||||||||+|++|.+||.+... .. .
T Consensus 227 ~a~~~~~~----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------------~~-~ 284 (681)
T 2pzi_A 227 AVSRINSF----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYV---------------DG-L 284 (681)
T ss_dssp TCEETTCC----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------------SS-C
T ss_pred cchhcccC----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCccccc---------------cc-c
Confidence 99877543 45689999999999876 358999999999999999999999865210 00 0
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
+ ... .....++.+.+||.+||..||.+||++.++|.|+|+.
T Consensus 285 ~--~~~---------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 P--EDD---------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp C--TTC---------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred c--ccc---------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 000 0011356788999999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=327.00 Aligned_cols=229 Identities=13% Similarity=0.052 Sum_probs=177.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.++..+.||||+++++++... +.+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 106 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGG 106 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcE
Confidence 447899999999999999999999999999999999765432 11224567899999999999999999988654 589
Q ss_pred EEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 439 FIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
||||||+.+ +|.+++ .. . ....++..|+.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l---~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVA---DT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEEEECCCEEEHHHHH---TT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEEEecCCCCHHHHH---hc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999975 555544 22 2 3566789999999999999999999999999999999999999998554
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
|++ .++.++|||||||+||+|++|..||.+.+..+.+.. .......
T Consensus 175 --------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------~~~~~~~- 220 (286)
T 3uqc_A 175 --------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------AERDTAG- 220 (286)
T ss_dssp --------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------CCBCTTS-
T ss_pred --------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------HHHHhcc-
Confidence 333 378999999999999999999999987543210000 0000000
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.. .........+++.+.+||.+||..||.+| |+.++++.
T Consensus 221 ---------~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 221 ---------QP-----IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp ---------CB-----CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ---------CC-----CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 00 00011223477889999999999999999 99999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-31 Score=315.22 Aligned_cols=191 Identities=16% Similarity=0.043 Sum_probs=132.5
Q ss_pred EEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc--------CCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCC
Q psy18163 366 CLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE--------GFPITSLREINTLLKA-QHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 366 il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~--------~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~ 436 (1028)
....++.|++|.+..++...+|+.||+|++.+..... .....+.+|+++|+++ .|+||+++++++. +..
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e--d~~ 315 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE--NAQ 315 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE--CSS
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--ECC
Confidence 3455788899999888888899999999997653211 1123467899999999 6999999998885 455
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|||||||.| ++|.+.+.. ..++.+ ..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus 316 ~~yLVMEyv~G--~~L~d~i~~-~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 316 SGWLVMEKLPG--RLLSDMLAA-GEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEEEECCCS--EEHHHHHHT-TCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEEEEEecCCC--CcHHHHHHh-CCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 89999999998 555555544 345654 358999999999999999999999999999999999999999999987
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPL 566 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pP 566 (1028)
.......++.+||+.|||||++.+ .+..++|+||+|+++|+|+++..+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred CCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 766566677899999999999987 367889999999999988766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-25 Score=264.55 Aligned_cols=186 Identities=19% Similarity=0.176 Sum_probs=136.2
Q ss_pred EEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC------CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 365 KCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG------FPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 365 ~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~------~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
...+.||+|+||+||+|.. .+..+|+|++........ ....+.+|+.+|..++||||+.+..++... +..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--DNK 414 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--TTT
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--Ccc
Confidence 3456899999999999943 578899998754321110 122357899999999999999443344333 356
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||.+ ++|.+.+.. +..|+.||+.||.|||++||+||||||+|||++. .+||+|||+|+....
T Consensus 415 ~lVmE~~~g--gsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 415 RIMMSYING--KLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEEECCCS--EEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EEEEECCCC--CCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999975 344444322 5689999999999999999999999999999998 999999999998754
Q ss_pred CCCc-------ccccccCccccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy18163 519 PLKH-------YTPIVVTLWYRSPELLLG-CKEYSTPIDMWSVGCIFAEFLCMEPLF 567 (1028)
Q Consensus 519 ~~~~-------~t~~vGT~~Y~APEvL~g-~~~ys~ksDIWSLGvILyELLTG~pPF 567 (1028)
.... ....+||+.|||||++.+ ...|+..+|+||..+-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3211 236789999999999864 134788899999999988888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-22 Score=222.11 Aligned_cols=145 Identities=19% Similarity=0.145 Sum_probs=111.8
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC----------------CccchHHHHHHHHHcCCCCeeEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG----------------FPITSLREINTLLKAQHPNIVTV 426 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~----------------~~~~~lrEi~iL~~l~HPNIV~L 426 (1028)
.|.+.+.||.|+||.||+|.+ .+|+.||||+++....... ....+.+|+.+|..+.| +.+
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 456669999999999999999 8899999999975432110 12346789999999984 444
Q ss_pred EEEEeecCCCeEEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcE
Q psy18163 427 REIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGIL 505 (1028)
Q Consensus 427 ~~i~~~~~~~~l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~l 505 (1028)
.+++.. +..|+|||||.+ +|.+ +. ..+...++.||+.||.|||++||+||||||+||||+ +|.+
T Consensus 167 ~~~~~~---~~~~lvmE~~~g~~L~~----l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 167 PKVYAW---EGNAVLMELIDAKELYR----VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp CCEEEE---ETTEEEEECCCCEEGGG----CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred CeEEec---cceEEEEEecCCCcHHH----cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 444432 356999999976 5544 21 123567999999999999999999999999999999 9999
Q ss_pred EEeccCCccccCCCCCcccccccCccccCccccc
Q psy18163 506 KVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539 (1028)
Q Consensus 506 KL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~ 539 (1028)
||+|||+|+.. ..|+|||++.
T Consensus 232 kl~DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp EECCCTTCEET-------------TSTTHHHHHH
T ss_pred EEEECCCCeEC-------------CCCCHHHHHH
Confidence 99999999633 3478999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.6e-20 Score=197.59 Aligned_cols=143 Identities=19% Similarity=0.209 Sum_probs=106.0
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeE--EEEEEeeccccccCC----------------------ccchHHHHHHHHHc
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEI--VALKRLKMEKEKEGF----------------------PITSLREINTLLKA 418 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~--VAIKvlk~~~~~~~~----------------------~~~~lrEi~iL~~l 418 (1028)
-|.+.+.||.|+||.||+|.+..+|+. ||||+++........ ...+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999999778999 999998654211000 01456899999999
Q ss_pred CCCCe--eEEEEEEeecCCCeEEEEEeccccc--hH-HHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH-hCCcccccc
Q psy18163 419 QHPNI--VTVREIVVGSNMDKIFIVMDYVEHD--MK-SLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH-DNWILHRDL 492 (1028)
Q Consensus 419 ~HPNI--V~L~~i~~~~~~~~l~LVmEy~~gd--Lg-sLl~~l~~~~~~~se~ev~~il~QLl~AL~yLH-s~gIVHRDL 492 (1028)
.|++| ..++.+ ...||||||++++ +. .|...... +++..+..++.||+.||.||| +.|||||||
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 88764 333221 2468999999531 11 22222111 234568899999999999999 999999999
Q ss_pred cccceeecCCCcEEEeccCCccccC
Q psy18163 493 KTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 493 KPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
||+|||++. .++|+|||+|....
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETT
T ss_pred CHHHEEEcC--cEEEEECcccccCC
Confidence 999999988 99999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.4e-16 Score=178.05 Aligned_cols=140 Identities=14% Similarity=0.156 Sum_probs=98.8
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCC-----------c-c--------chHHHHHHHHHcCCCCe
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGF-----------P-I--------TSLREINTLLKAQHPNI 423 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~-----------~-~--------~~lrEi~iL~~l~HPNI 423 (1028)
|.+...||.|+||.||+|.+. +|+.||||+++........ . . ...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999985 6999999998754221000 0 0 01246666776655444
Q ss_pred eEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC
Q psy18163 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG 503 (1028)
Q Consensus 424 V~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g 503 (1028)
....-+... ..+|||||+++ ..+.. + ....++..++.||+.+|.|||.+|||||||||.||||+.+|
T Consensus 176 ~vp~p~~~~----~~~LVME~i~G--~~L~~-l------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQS----RHTIVMSLVDA--LPMRQ-V------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEEE----TTEEEEECCSC--EEGGG-C------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCCeeeecc----CceEEEEecCC--ccHhh-h------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 322111111 23799999987 22211 1 12234677899999999999999999999999999998776
Q ss_pred ----------cEEEeccCCccccC
Q psy18163 504 ----------ILKVGDFGLAREYG 517 (1028)
Q Consensus 504 ----------~lKL~DFGlAr~~~ 517 (1028)
.+.|+||+.+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 38999999886543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=3.8e-12 Score=143.70 Aligned_cols=77 Identities=19% Similarity=0.248 Sum_probs=61.4
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+|++|+++++||+|+||+||+|+++.||+.||||+|.+.... . .|||+|++++++.+....|
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEE
Confidence 3478999999999999999999999999999999999754311 1 6999999999999999999
Q ss_pred EEEecC-CCCCCccc
Q psy18163 814 LVTENP-GGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~ 827 (1028)
|||||| ||+|.+.+
T Consensus 100 iVmEy~~gg~L~~~i 114 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRI 114 (350)
T ss_dssp EEEECCTTCBHHHHH
T ss_pred EEEeCCCCCcHHHHH
Confidence 999999 78998843
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.14 E-value=5e-12 Score=138.25 Aligned_cols=80 Identities=20% Similarity=0.242 Sum_probs=61.4
Q ss_pred CCCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcC
Q psy18163 747 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVES 809 (1028)
Q Consensus 747 ~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~ 809 (1028)
..++.+.+|++++.||+|+||+||+|+++.||+.||||+|.+... .. .|||+|++++++...
T Consensus 7 ~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 7 ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSK 85 (275)
T ss_dssp -------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred CCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC
Confidence 345668899999999999999999999999999999999974321 11 589999999999999
Q ss_pred cCcEEEEecCCCCCCccc
Q psy18163 810 ELNHLVTENPGGPLNKKE 827 (1028)
Q Consensus 810 ~~~hlV~E~~~G~L~~~~ 827 (1028)
...+||||||+|+|.+.+
T Consensus 86 ~~~~ivmEy~~g~L~~~l 103 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYI 103 (275)
T ss_dssp SEEEEEEECCCEEHHHHH
T ss_pred CEEEEEEeCCCCCHHHHH
Confidence 999999999999988743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.12 E-value=5.4e-12 Score=140.37 Aligned_cols=77 Identities=21% Similarity=0.186 Sum_probs=66.5
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCc
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~ 812 (1028)
...++|++++.||+|+||+||+|+++.||+.||||+|.+... .. .|||+|++++++.+....
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEE
Confidence 345789999999999999999999999999999999964210 12 699999999999999999
Q ss_pred EEEEecC-CCCCCccc
Q psy18163 813 HLVTENP-GGPLNKKE 827 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~ 827 (1028)
||||||| ||+|.+.+
T Consensus 108 yivmEy~~gG~L~~~i 123 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYI 123 (311)
T ss_dssp EEEECCCTTEEHHHHH
T ss_pred EEEEecCCCCCHHHHH
Confidence 9999999 78998843
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=3.4e-10 Score=120.15 Aligned_cols=140 Identities=16% Similarity=0.179 Sum_probs=105.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~ 439 (1028)
++.|++...+|.|+++.||++... +..|+||+...... .....+.+|+.+|..+. +..+..++.++.. .+..|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~ 86 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSN 86 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceE
Confidence 457999999999999999999754 67899999875321 12335678999998885 5667777766643 45789
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD----------------------------------- 484 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs----------------------------------- 484 (1028)
+||||+.| ..+...+. +......++.++..+|..||+
T Consensus 87 lv~e~i~G--~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 87 LLMSEADG--VLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSS--EEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEecCC--eehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999998 33333211 122345788899999999998
Q ss_pred ------------------------CCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 485 ------------------------NWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 485 ------------------------~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876667799999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=9e-11 Score=131.83 Aligned_cols=75 Identities=27% Similarity=0.254 Sum_probs=65.5
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------ccCCchhhhhhHhhhcCcCcEEEEecC-CC
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------LENFPSRIRTYHLQVESELNHLVTENP-GG 821 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------~~~~p~~vr~~e~~~~~~~~hlV~E~~-~G 821 (1028)
.+..|++.++||+|+||+||+|+++.||+.||||+|.+.... .-.|||+|++++++.+....||||||| ||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 456899999999999999999999999999999999754321 116999999999999889999999999 78
Q ss_pred CCCc
Q psy18163 822 PLNK 825 (1028)
Q Consensus 822 ~L~~ 825 (1028)
+|.+
T Consensus 136 ~L~~ 139 (336)
T 4g3f_A 136 SLGQ 139 (336)
T ss_dssp BHHH
T ss_pred cHHH
Confidence 9988
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.08 E-value=5.5e-11 Score=137.47 Aligned_cols=73 Identities=22% Similarity=0.221 Sum_probs=63.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc-------------cCCchhhhhhHhhhcCcCcEEEEecC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL-------------ENFPSRIRTYHLQVESELNHLVTENP 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~-------------~~~p~~vr~~e~~~~~~~~hlV~E~~ 819 (1028)
..|+++++||+|+||+||+|+++.||+.||||+|.+..... -.|||+|++++++.....+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999999999999999997543211 15899999999999999999999999
Q ss_pred -CCCCCc
Q psy18163 820 -GGPLNK 825 (1028)
Q Consensus 820 -~G~L~~ 825 (1028)
||+|.+
T Consensus 231 ~gG~L~~ 237 (423)
T 4fie_A 231 EGGALTD 237 (423)
T ss_dssp TTEEHHH
T ss_pred CCCcHHH
Confidence 778876
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=4.4e-11 Score=134.85 Aligned_cols=73 Identities=22% Similarity=0.221 Sum_probs=63.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc-------------cCCchhhhhhHhhhcCcCcEEEEecC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL-------------ENFPSRIRTYHLQVESELNHLVTENP 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~-------------~~~p~~vr~~e~~~~~~~~hlV~E~~ 819 (1028)
..|+++++||+|+||+||+|+++.||+.||||+|.+..... -.|||+|++++++......|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 47999999999999999999999999999999997432110 05899999999999999999999999
Q ss_pred -CCCCCc
Q psy18163 820 -GGPLNK 825 (1028)
Q Consensus 820 -~G~L~~ 825 (1028)
||+|.+
T Consensus 154 ~gg~L~~ 160 (346)
T 4fih_A 154 EGGALTD 160 (346)
T ss_dssp TTEEHHH
T ss_pred CCCcHHH
Confidence 778876
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=8.3e-11 Score=129.73 Aligned_cols=77 Identities=21% Similarity=0.226 Sum_probs=60.9
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCc----
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESE---- 810 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~---- 810 (1028)
+.+.+|++++.||+|+||+||+|+++.||+.||||+|..... .. .|||+|++++++...+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC----
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCcccc
Confidence 346789999999999999999999999999999999974321 12 6999999998775443
Q ss_pred --------CcEEEEecC-CCCCCccc
Q psy18163 811 --------LNHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 811 --------~~hlV~E~~-~G~L~~~~ 827 (1028)
..||||||| ||+|.+.+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l 106 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWM 106 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHH
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHH
Confidence 269999999 78988733
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.3e-10 Score=131.13 Aligned_cols=76 Identities=21% Similarity=0.171 Sum_probs=62.4
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhc------CcC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVE------SEL 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~------~~~ 811 (1028)
++|++++.||+|+||+||+|+++.||+.||||+|.+..... -.|||+|++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 47999999999999999999999999999999997533110 158999999887543 356
Q ss_pred cEEEEecCCCCCCcccC
Q psy18163 812 NHLVTENPGGPLNKKEQ 828 (1028)
Q Consensus 812 ~hlV~E~~~G~L~~~~~ 828 (1028)
.|||||||+|+|...+.
T Consensus 134 ~~ivmE~~~g~L~~~i~ 150 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIH 150 (398)
T ss_dssp EEEEEECCSEEHHHHHT
T ss_pred EEEEEeCCCCCHHHHHH
Confidence 79999999999887443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=2.7e-09 Score=111.67 Aligned_cols=135 Identities=13% Similarity=0.095 Sum_probs=91.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCe--eEEEEEEeecCCCeE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI--VTVREIVVGSNMDKI 438 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNI--V~L~~i~~~~~~~~l 438 (1028)
...|.+....+.|.++.||++.. .+|..|+||+.... ......+|+.++..+.+.++ ..++.+.. ..+..
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~--~~~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEecc--CCCCC
Confidence 34566655545667799999964 46778999987543 12346689999988865454 44665553 33568
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW-------------------------------- 486 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g-------------------------------- 486 (1028)
|+||||+.| ..+ . +. ... ...++.+|...|..||+..
T Consensus 91 ~~v~e~i~G--~~l-~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 91 WLLLGEVPG--QDL-L-SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp EEEEECCSS--EET-T-TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred EEEEEecCC--ccc-C-cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 999999987 222 1 10 011 2245566666666666543
Q ss_pred --------------------------cccccccccceeecCCCcEEEeccCCcc
Q psy18163 487 --------------------------ILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 487 --------------------------IVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
++|+||+|.|||++.++.+.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=7.5e-11 Score=130.72 Aligned_cols=74 Identities=18% Similarity=0.205 Sum_probs=62.5
Q ss_pred cceeEeeeeeccceeEEEEEEEc---cCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK---RTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~---~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
++|++++.||+|+||+||+|++. .|++.||||+|.+... ..-.|||+|++++++.+....||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 58999999999999999999984 4788999999964221 01158999999999999999999
Q ss_pred EEecC-CCCCCcc
Q psy18163 815 VTENP-GGPLNKK 826 (1028)
Q Consensus 815 V~E~~-~G~L~~~ 826 (1028)
||||| ||+|.+.
T Consensus 104 vmEy~~gg~L~~~ 116 (304)
T 3ubd_A 104 ILDFLRGGDLFTR 116 (304)
T ss_dssp EECCCTTCEEHHH
T ss_pred EEEcCCCCCHHHH
Confidence 99999 8899873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=98.94 E-value=8.9e-11 Score=142.45 Aligned_cols=89 Identities=15% Similarity=0.176 Sum_probs=71.5
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-------------------cccCCchhhhhhHhhhcCcC
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------------------WLENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------------------~~~~~p~~vr~~e~~~~~~~ 811 (1028)
++++|++++.||+|+||+||+|+++.||+.||||+|.+... ..-.||++|++++++.+...
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 47899999999999999999999999999999999964210 01158999999999999999
Q ss_pred cEEEEecC-CCCCCcccCCCCCCCCCCCchhh
Q psy18163 812 NHLVTENP-GGPLNKKEQPKWRPMQISNPSTK 842 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~~~~~~~~~~~~~~~~ 842 (1028)
+||||||| ||+|...+. +...++|..++
T Consensus 267 lylVmEy~~GGdL~~~l~---~~~~l~E~~a~ 295 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLS---QHGVFSEADMR 295 (689)
T ss_dssp EEEEECCCCSCBHHHHHH---HHCCCCHHHHH
T ss_pred EEEEEecCCCCcHHHHHH---hcCCCCHHHHH
Confidence 99999999 889987543 22235555544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=98.93 E-value=4.8e-10 Score=134.19 Aligned_cols=78 Identities=17% Similarity=0.190 Sum_probs=67.3
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
.+++|++++.||+|+||+||+|+++.||+.||||+|.+.... .-.|||+|++++++......+||||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 357899999999999999999999999999999999754311 1168999999999999999999999
Q ss_pred cC-CCCCCcccC
Q psy18163 818 NP-GGPLNKKEQ 828 (1028)
Q Consensus 818 ~~-~G~L~~~~~ 828 (1028)
|| ||+|++.+.
T Consensus 235 ~~~gg~L~~~i~ 246 (573)
T 3uto_A 235 FMSGGELFEKVA 246 (573)
T ss_dssp CCCCCBHHHHHT
T ss_pred ecCCCcHHHHHH
Confidence 99 889988554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.3e-09 Score=120.87 Aligned_cols=76 Identities=12% Similarity=0.099 Sum_probs=61.1
Q ss_pred cceeEeeeeeccceeEEEEEEEc-----cCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~-----~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.++.++++||+|+||+||+|... .+++.||||++...... .-.|||+|++++++......+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 57889999999999999999853 57789999999743211 016999999999988888899
Q ss_pred EEEecC-CCCCCcccC
Q psy18163 814 LVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~~ 828 (1028)
|||||| +|+|.+.+.
T Consensus 106 lV~Ey~~~G~L~~~L~ 121 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLV 121 (308)
T ss_dssp EEEECCSSCBHHHHHH
T ss_pred EEEEcCCCCcHHHHHH
Confidence 999999 889988553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=7.5e-10 Score=122.24 Aligned_cols=74 Identities=23% Similarity=0.212 Sum_probs=59.9
Q ss_pred cceeEeeeeeccceeEEEEEEEc-----cCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~-----~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
++|.+.++||+|+||+||+|++. .++..||||++..... .. .|||+|++++++......+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEE
Confidence 57999999999999999999875 4688999999975321 12 6999999999998888999
Q ss_pred EEEecC-CCCCCccc
Q psy18163 814 LVTENP-GGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~ 827 (1028)
|||||| +|+|.+.+
T Consensus 92 lV~Ey~~~G~L~~~l 106 (299)
T 4asz_A 92 MVFEYMKHGDLNKFL 106 (299)
T ss_dssp EEEECCTTCBHHHHH
T ss_pred EEEEcCCCCcHHHHH
Confidence 999999 88998844
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.84 E-value=2.9e-09 Score=119.11 Aligned_cols=74 Identities=20% Similarity=0.196 Sum_probs=61.6
Q ss_pred cceeEeeeeeccceeEEEEEEEc-----cCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~-----~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+|.+.++||+|+||+||+|+++ .+++.||||+|..... .. .|||+|++++++......+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 57899999999999999999865 4789999999975321 12 6999999999998888999
Q ss_pred EEEecC-CCCCCccc
Q psy18163 814 LVTENP-GGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~ 827 (1028)
|||||| +|+|.+.+
T Consensus 120 lV~Ey~~~G~L~~~l 134 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFL 134 (329)
T ss_dssp EEEECCTTCBHHHHH
T ss_pred EEEEcCCCCcHHHHH
Confidence 999999 88998744
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.4e-09 Score=119.70 Aligned_cols=71 Identities=31% Similarity=0.379 Sum_probs=58.4
Q ss_pred ce-eEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhc----CcCc
Q psy18163 754 EF-KCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVE----SELN 812 (1028)
Q Consensus 754 ~Y-~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~----~~~~ 812 (1028)
+| ++.++||+|+||+||+|.++.|+..||||+|..... .. .|||+|++++++.. ....
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEE
Confidence 44 677789999999999999999999999999964321 12 69999999988754 3457
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||| ||+|.+
T Consensus 105 ~lvmEy~~gg~L~~ 118 (290)
T 3fpq_A 105 VLVTELMTSGTLKT 118 (290)
T ss_dssp EEEEECCCSCBHHH
T ss_pred EEEEeCCCCCCHHH
Confidence 9999999 789887
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.8e-09 Score=122.11 Aligned_cols=74 Identities=15% Similarity=0.065 Sum_probs=62.3
Q ss_pred cceeEeeeeeccceeEEEEEEEc---cCCcEEEeeecCCCcc------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK---RTDEIVAPCKSGNGKF------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~---~tg~~VAIK~I~~~~~------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
+.|+++++||+|+||+||+|+++ .+++.||||+|..... ....|||+|++++++......+||||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 47999999999999999999986 4688999999875431 12268999999999998999999999
Q ss_pred cC-CCCCCcc
Q psy18163 818 NP-GGPLNKK 826 (1028)
Q Consensus 818 ~~-~G~L~~~ 826 (1028)
|| ||+|.+.
T Consensus 101 ~~~g~~L~~~ 110 (361)
T 4f9c_A 101 YLEHESFLDI 110 (361)
T ss_dssp CCCCCCHHHH
T ss_pred CCCcccHHHH
Confidence 99 7788773
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.5e-08 Score=113.08 Aligned_cols=142 Identities=15% Similarity=0.250 Sum_probs=98.4
Q ss_pred EEEEeeecCcEEEEEEEECCCCeEEEEEEee--ccccccCCccchHHHHHHHHHcC--CCCeeEEEEEEeecCC-CeEEE
Q psy18163 366 CLNRIEEGTYGVVYRAKDKRTDEIVALKRLK--MEKEKEGFPITSLREINTLLKAQ--HPNIVTVREIVVGSNM-DKIFI 440 (1028)
Q Consensus 366 il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk--~~~~~~~~~~~~lrEi~iL~~l~--HPNIV~L~~i~~~~~~-~~l~L 440 (1028)
.+..|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+|..+. +..+.+++.++...+. +..|+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4678999999999998764 4568888775 32211 12235678999998887 3456777666543321 45799
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD------------------------------------ 484 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs------------------------------------ 484 (1028)
||||++|. .+... ....++..+...++.+++.+|..||.
T Consensus 119 vme~v~G~--~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGR--VLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCB--CCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCe--ecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 99999872 11110 11235677788899999999999997
Q ss_pred ----------------------CCcccccccccceeecCCC--cEEEeccCCccc
Q psy18163 485 ----------------------NWILHRDLKTSNLLLSHRG--ILKVGDFGLARE 515 (1028)
Q Consensus 485 ----------------------~gIVHRDLKPeNILLd~~g--~lKL~DFGlAr~ 515 (1028)
.+++|+|+++.|||++.++ .+.|+||+++..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 3599999999999999765 368999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.69 E-value=7e-09 Score=113.13 Aligned_cols=184 Identities=17% Similarity=0.175 Sum_probs=109.7
Q ss_pred EEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCC--eeEEEEEEeecC-CCeEEEEEe
Q psy18163 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPN--IVTVREIVVGSN-MDKIFIVMD 443 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPN--IV~L~~i~~~~~-~~~l~LVmE 443 (1028)
..|+.|.+..||++. ..+++|+.... .....+.+|+.+|..+. +.. +..++....... ....|+||+
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 458999999999874 34889986533 11234568999988873 322 223322221111 123488999
Q ss_pred cccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q psy18163 444 YVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-------------------------------------- 484 (1028)
Q Consensus 444 y~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-------------------------------------- 484 (1028)
++.| .+.... + ..++..+...++.+|...|..||+
T Consensus 97 ~i~G~~l~~~~--~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 97 KIKGVPLTPLL--L----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CCCCEECCHHH--H----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred ccCCeECCccc--c----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 9998 232211 0 124555666667777777777764
Q ss_pred --------------------CCcccccccccceeecC--CCcEEEeccCCccccCCCCCcccccccCccccCcccc---c
Q psy18163 485 --------------------NWILHRDLKTSNLLLSH--RGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL---L 539 (1028)
Q Consensus 485 --------------------~gIVHRDLKPeNILLd~--~g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL---~ 539 (1028)
..++|+|++|.|||++. .+.+.|+||+.+... .+............-..|+.+ .
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPDNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChHHHHHHHHhhccccCHHHHHHHH
Confidence 23799999999999997 567889999998653 222111111100000222211 1
Q ss_pred C-CCC---------CCchhhHHHHHHHHHHHHhCCCCC
Q psy18163 540 G-CKE---------YSTPIDMWSVGCIFAEFLCMEPLF 567 (1028)
Q Consensus 540 g-~~~---------ys~ksDIWSLGvILyELLTG~pPF 567 (1028)
. ... ...-.++|++|+++|.+.+|.++|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 000 112268999999999999998776
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=2.4e-08 Score=112.69 Aligned_cols=75 Identities=16% Similarity=0.100 Sum_probs=59.2
Q ss_pred cceeEeeeeeccceeEEEEEEEccCC-----cEEEeeecCCCcc---------------cccCCchhhhhhHhhhc-CcC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTD-----EIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVE-SEL 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg-----~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~-~~~ 811 (1028)
++|++.++||+|+||+||+|.+..++ +.||||++..... ....|||+|++++++.. ...
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 58999999999999999999987544 6899999975321 11135899999987654 456
Q ss_pred cEEEEecC-CCCCCccc
Q psy18163 812 NHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~ 827 (1028)
.+|||||| +|+|.+.+
T Consensus 144 ~~iV~Ey~~~G~L~~~L 160 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYL 160 (353)
T ss_dssp CEEEEECCTTEEHHHHH
T ss_pred EEEEEEcCCCCCHHHHH
Confidence 89999999 88998844
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=98.62 E-value=2.8e-08 Score=106.84 Aligned_cols=74 Identities=28% Similarity=0.313 Sum_probs=63.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
+++|+++++||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++......+|||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 46899999999999999999999999999999999743211 115899999998888888899999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||++|+|..
T Consensus 81 e~~~~~l~~ 89 (292)
T 3o0g_A 81 EFCDQDLKK 89 (292)
T ss_dssp ECCSEEHHH
T ss_pred ecCCCCHHH
Confidence 999887766
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=8.9e-09 Score=113.44 Aligned_cols=72 Identities=18% Similarity=0.121 Sum_probs=57.4
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc------------cccCCchhhhhhHhhhcCc----CcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF------------WLENFPSRIRTYHLQVESE----LNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~------------~~~~~p~~vr~~e~~~~~~----~~hlV~ 816 (1028)
.+|.+.++||+|+||+||+|++ +|+.||||++..... ..-.|||+|++++++.... ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688999999999999999987 699999999974321 0115999999988765543 469999
Q ss_pred ecC-CCCCCcc
Q psy18163 817 ENP-GGPLNKK 826 (1028)
Q Consensus 817 E~~-~G~L~~~ 826 (1028)
||| +|+|.+.
T Consensus 81 Ey~~~gsL~~~ 91 (303)
T 3hmm_A 81 DYHEHGSLFDY 91 (303)
T ss_dssp ECCTTCBHHHH
T ss_pred cCCCCCcHHHH
Confidence 999 7898873
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.59 E-value=2.7e-08 Score=110.35 Aligned_cols=71 Identities=21% Similarity=0.098 Sum_probs=55.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
++|++.++||+|+||+||+|++. ..||||+++..... .-.|||+|++++++. ....+||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence 47889999999999999999864 35999998743211 116999999988654 456799999
Q ss_pred cC-CCCCCccc
Q psy18163 818 NP-GGPLNKKE 827 (1028)
Q Consensus 818 ~~-~G~L~~~~ 827 (1028)
|| ||+|.+.+
T Consensus 112 y~~gGsL~~~l 122 (307)
T 3omv_A 112 WCEGSSLYKHL 122 (307)
T ss_dssp CCSSCBHHHHH
T ss_pred cCCCCCHHHHH
Confidence 99 88998743
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=6.4e-08 Score=106.54 Aligned_cols=77 Identities=26% Similarity=0.317 Sum_probs=63.8
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+++|++++.||+|+||.||+|.+..+++.||||++...... .-.||+++++++++......+|||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 357899999999999999999999999999999998643210 015899999998888888889999
Q ss_pred ecC-CCCCCccc
Q psy18163 817 ENP-GGPLNKKE 827 (1028)
Q Consensus 817 E~~-~G~L~~~~ 827 (1028)
||+ +|+|.+.+
T Consensus 85 e~~~~~~L~~~l 96 (323)
T 3tki_A 85 EYCSGGELFDRI 96 (323)
T ss_dssp ECCTTEEGGGGS
T ss_pred EcCCCCcHHHHH
Confidence 999 66887733
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.57 E-value=5.2e-08 Score=106.90 Aligned_cols=75 Identities=24% Similarity=0.223 Sum_probs=62.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
+++|.++++||+|+||.||+|.+..+++.||||++...... .-.||+++++++++......+||||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 46899999999999999999999999999999998643210 0158999999988888888999999
Q ss_pred cCCCCCCcc
Q psy18163 818 NPGGPLNKK 826 (1028)
Q Consensus 818 ~~~G~L~~~ 826 (1028)
|++|+|...
T Consensus 81 ~~~~~l~~~ 89 (324)
T 3mtl_A 81 YLDKDLKQY 89 (324)
T ss_dssp CCSEEHHHH
T ss_pred ccccCHHHH
Confidence 999887763
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=98.54 E-value=5e-08 Score=104.07 Aligned_cols=74 Identities=16% Similarity=0.205 Sum_probs=62.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ..-.||+++++++++......+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 3689999999999999999999999999999999874321 1126899999998888888899999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||++|+|..
T Consensus 86 e~~~~~l~~ 94 (290)
T 3fme_A 86 ELMDTSLDK 94 (290)
T ss_dssp ECCSEEHHH
T ss_pred ehhccchHH
Confidence 999887765
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=98.53 E-value=1.9e-08 Score=112.15 Aligned_cols=78 Identities=23% Similarity=0.181 Sum_probs=66.3
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------ccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------LENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
..++|++++.||+|+||+||+|.++.+|+.||||++.+.... ...||+++++++++......+|||||+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 356899999999999999999999999999999999754321 126999999999998888999999999
Q ss_pred CCCCCcccC
Q psy18163 820 GGPLNKKEQ 828 (1028)
Q Consensus 820 ~G~L~~~~~ 828 (1028)
||+|.+.+.
T Consensus 100 gg~L~~~i~ 108 (342)
T 2qr7_A 100 GGELLDKIL 108 (342)
T ss_dssp SCBHHHHHH
T ss_pred CCcHHHHHH
Confidence 778877543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=6.8e-08 Score=106.22 Aligned_cols=78 Identities=26% Similarity=0.299 Sum_probs=64.4
Q ss_pred CCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCc
Q psy18163 748 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 748 ~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
....+++|.++++||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++......
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 345578999999999999999999999999999999999743211 01589999998888888889
Q ss_pred EEEEecCCCCCCc
Q psy18163 813 HLVTENPGGPLNK 825 (1028)
Q Consensus 813 hlV~E~~~G~L~~ 825 (1028)
+|||||++|+|.+
T Consensus 109 ~lv~e~~~~~L~~ 121 (329)
T 3gbz_A 109 HLIFEYAENDLKK 121 (329)
T ss_dssp EEEEECCSEEHHH
T ss_pred EEEEecCCCCHHH
Confidence 9999999988777
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=98.52 E-value=6.9e-08 Score=108.20 Aligned_cols=77 Identities=22% Similarity=0.309 Sum_probs=65.2
Q ss_pred CccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc------------cCCchhhhhhHhhhcCcCcEEEE
Q psy18163 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL------------ENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 749 ~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~------------~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
+...++|.+++.||+|+||+||+|+++.+|+.||||++....... -.||++|++++++......+|||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 344578999999999999999999999999999999997533211 15899999999988888899999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ +|+|..
T Consensus 96 e~~~~~~L~~ 105 (361)
T 3uc3_A 96 EYASGGELYE 105 (361)
T ss_dssp ECCCSCBHHH
T ss_pred EeCCCCCHHH
Confidence 999 778866
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=4.1e-08 Score=107.38 Aligned_cols=76 Identities=26% Similarity=0.245 Sum_probs=50.0
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
+..+|++++.||+|+||.||+|.++.+|+.||||++...... .-.||+++++++++......+|||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 456899999999999999999999999999999998743211 015899999999888888899999
Q ss_pred ecCCCCCCcc
Q psy18163 817 ENPGGPLNKK 826 (1028)
Q Consensus 817 E~~~G~L~~~ 826 (1028)
||++|+|.+.
T Consensus 83 e~~~~~L~~~ 92 (317)
T 2pmi_A 83 EFMDNDLKKY 92 (317)
T ss_dssp ECCCCBHHHH
T ss_pred EecCCCHHHH
Confidence 9999988763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.51 E-value=9.7e-08 Score=104.15 Aligned_cols=73 Identities=25% Similarity=0.322 Sum_probs=62.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+|+++++||+|+||+||+|++..+|+.||||++...... ...||+++++++++......+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999998643211 115899999988888888899999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||++|+|..
T Consensus 137 e~~~~~L~~ 145 (311)
T 3p1a_A 137 ELCGPSLQQ 145 (311)
T ss_dssp ECCCCBHHH
T ss_pred eccCCCHHH
Confidence 999998876
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=98.51 E-value=4.1e-08 Score=109.33 Aligned_cols=72 Identities=21% Similarity=0.238 Sum_probs=61.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-------------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
+.|++++.||+|+||+||+|.++.+|+.||||++..... .. .||+++++++++......+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEE
Confidence 579999999999999999999999999999999853110 11 5899999999888888999
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ ||+|..
T Consensus 103 lv~e~~~g~~L~~ 115 (351)
T 3c0i_A 103 MVFEFMDGADLCF 115 (351)
T ss_dssp EEEECCSSCBHHH
T ss_pred EEEeCCCCCCHHH
Confidence 999999 678866
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.50 E-value=4.6e-08 Score=107.99 Aligned_cols=75 Identities=17% Similarity=0.261 Sum_probs=63.7
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
++.+|++++.||+|+||.||+|+++.+|+.||||++.+... ..-.||+++++++++......+|
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 46799999999999999999999999999999999864210 01168999999988888888999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ ||+|..
T Consensus 84 v~e~~~gg~L~~ 95 (318)
T 1fot_A 84 IMDYIEGGELFS 95 (318)
T ss_dssp EECCCCSCBHHH
T ss_pred EEeCCCCCCHHH
Confidence 99999 678876
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=7.3e-08 Score=101.94 Aligned_cols=74 Identities=23% Similarity=0.305 Sum_probs=63.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
..+|++++.||+|+||.||+|.+..+++.||||++...... ...||+++++++++......+||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46899999999999999999999999999999998753210 11689999999888888899999
Q ss_pred EecC-CCCCCc
Q psy18163 816 TENP-GGPLNK 825 (1028)
Q Consensus 816 ~E~~-~G~L~~ 825 (1028)
|||+ +|+|.+
T Consensus 90 ~e~~~~~~L~~ 100 (289)
T 1x8b_A 90 NEYCNGGSLAD 100 (289)
T ss_dssp EECCTTCBHHH
T ss_pred EEecCCCcHHH
Confidence 9999 668887
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.50 E-value=9.8e-08 Score=105.11 Aligned_cols=76 Identities=11% Similarity=0.049 Sum_probs=64.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENP 819 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~ 819 (1028)
.++|.+++.||+|+||.||+|.+..+|..||+|.+...... .-.|||++++++++......+|||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 36899999999999999999999999999999998743211 115899999999988888999999999
Q ss_pred -CCCCCccc
Q psy18163 820 -GGPLNKKE 827 (1028)
Q Consensus 820 -~G~L~~~~ 827 (1028)
||+|.+.+
T Consensus 84 ~g~~L~~~l 92 (321)
T 1tki_A 84 SGLDIFERI 92 (321)
T ss_dssp CCCBHHHHH
T ss_pred CCCCHHHHH
Confidence 67887743
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=6e-08 Score=109.20 Aligned_cols=77 Identities=16% Similarity=0.082 Sum_probs=65.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------------ccCCchhhhhhHhhhcCcCc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
.+.|++++.||+|+||+||+|.++.+|+.||||++.+.... .-.||++|++++++......
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46799999999999999999999999999999999753210 00589999999998888889
Q ss_pred EEEEecC-CCCCCcccC
Q psy18163 813 HLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~~ 828 (1028)
+|||||+ ||+|.+.+.
T Consensus 91 ~lv~e~~~gg~L~~~l~ 107 (361)
T 2yab_A 91 VLILELVSGGELFDFLA 107 (361)
T ss_dssp EEEEECCCSCBHHHHHT
T ss_pred EEEEEcCCCCcHHHHHH
Confidence 9999999 889887543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=98.49 E-value=8.8e-08 Score=107.69 Aligned_cols=74 Identities=14% Similarity=0.149 Sum_probs=58.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------cCCchhhhhhHhhhc--------------
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------ENFPSRIRTYHLQVE-------------- 808 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------~~~p~~vr~~e~~~~-------------- 808 (1028)
..+|.+++.||+|+||+||+|.+..+|+.||||++....... -.|||+|++++++..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 358999999999999999999999999999999986432211 168999998876632
Q ss_pred ------------------------CcCcEEEEecCCCCCCc
Q psy18163 809 ------------------------SELNHLVTENPGGPLNK 825 (1028)
Q Consensus 809 ------------------------~~~~hlV~E~~~G~L~~ 825 (1028)
....+|||||++|+|.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~ 126 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126 (383)
T ss_dssp ------------------------CCEEEEEECCCSEEHHH
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCccHHH
Confidence 22378999999988766
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.48 E-value=5.1e-08 Score=112.01 Aligned_cols=74 Identities=20% Similarity=0.125 Sum_probs=62.8
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... ..-.||++++++.++......+||
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 4689999999999999999999999999999999864210 011589999998888888889999
Q ss_pred EecC-CCCCCc
Q psy18163 816 TENP-GGPLNK 825 (1028)
Q Consensus 816 ~E~~-~G~L~~ 825 (1028)
|||+ ||+|..
T Consensus 140 mE~~~gg~L~~ 150 (412)
T 2vd5_A 140 MEYYVGGDLLT 150 (412)
T ss_dssp ECCCCSCBHHH
T ss_pred EcCCCCCcHHH
Confidence 9999 888877
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=98.48 E-value=1.5e-07 Score=100.96 Aligned_cols=74 Identities=30% Similarity=0.324 Sum_probs=62.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
+++|++++.||+|+||.||+|.+ .+|+.||||++....... -.||+++++++++......+|||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 46899999999999999999998 789999999996432110 15899999998888888899999
Q ss_pred ecCCCCCCcc
Q psy18163 817 ENPGGPLNKK 826 (1028)
Q Consensus 817 E~~~G~L~~~ 826 (1028)
||++|+|...
T Consensus 80 e~~~~~l~~~ 89 (288)
T 1ob3_A 80 EHLDQDLKKL 89 (288)
T ss_dssp ECCSEEHHHH
T ss_pred EecCCCHHHH
Confidence 9998887763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=98.48 E-value=1.4e-07 Score=103.71 Aligned_cols=74 Identities=19% Similarity=0.173 Sum_probs=59.7
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------------cc--------------
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------------LE-------------- 794 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------------~~-------------- 794 (1028)
...+|++++.||+|+||+||+|++ +|+.||||++...... ..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999998 7899999999753210 00
Q ss_pred -----------CCchhhhhhHhhhc-------------CcCcEEEEecC-CCCCCcc
Q psy18163 795 -----------NFPSRIRTYHLQVE-------------SELNHLVTENP-GGPLNKK 826 (1028)
Q Consensus 795 -----------~~p~~vr~~e~~~~-------------~~~~hlV~E~~-~G~L~~~ 826 (1028)
.||++|++++++.. ....+|||||+ +|+|...
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~ 152 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQ 152 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGG
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHH
Confidence 16999999988876 67889999998 7777763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.47 E-value=6.2e-08 Score=110.79 Aligned_cols=75 Identities=24% Similarity=0.212 Sum_probs=64.0
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-----------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-----------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-----------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+.+|++++.||+|+||.||+|+++.+++.||||++.+.... ...||++|++++++......+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 467999999999999999999999999999999999743210 116899999998888888999
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ ||+|..
T Consensus 130 lV~E~~~gg~L~~ 142 (396)
T 4dc2_A 130 FVIEYVNGGDLMF 142 (396)
T ss_dssp EEEECCTTCBHHH
T ss_pred EEEEcCCCCcHHH
Confidence 999999 778865
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=7.8e-08 Score=111.38 Aligned_cols=75 Identities=21% Similarity=0.121 Sum_probs=63.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.++|+++++||+|+||+||+|+++.+++.||||++.+... ..-.||++++++.++......+||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 3689999999999999999999999999999999864110 011589999998888888889999
Q ss_pred EecC-CCCCCcc
Q psy18163 816 TENP-GGPLNKK 826 (1028)
Q Consensus 816 ~E~~-~G~L~~~ 826 (1028)
|||+ ||+|...
T Consensus 153 ~Ey~~gg~L~~~ 164 (437)
T 4aw2_A 153 MDYYVGGDLLTL 164 (437)
T ss_dssp ECCCTTCBHHHH
T ss_pred EecCCCCcHHHH
Confidence 9999 8888873
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=98.47 E-value=4.5e-08 Score=108.47 Aligned_cols=77 Identities=18% Similarity=0.239 Sum_probs=65.0
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.+.+|.+++.||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++......+||
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 467899999999999999999999999999999998643211 01589999999998888889999
Q ss_pred EecC-CCCCCccc
Q psy18163 816 TENP-GGPLNKKE 827 (1028)
Q Consensus 816 ~E~~-~G~L~~~~ 827 (1028)
|||+ +|+|.+.+
T Consensus 93 ~e~~~~~~L~~~l 105 (328)
T 3fe3_A 93 MEYASGGEVFDYL 105 (328)
T ss_dssp ECCCTTCBHHHHH
T ss_pred EECCCCCcHHHHH
Confidence 9999 77887643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.46 E-value=3.7e-08 Score=110.46 Aligned_cols=75 Identities=20% Similarity=0.262 Sum_probs=62.9
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+++|++++.||+|+||.||+|+++.+|+.||||++.+... ....||+++++++++......+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 35789999999999999999999999999999999864210 1126899999998888888999
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ ||+|..
T Consensus 101 lv~E~~~gg~L~~ 113 (353)
T 3txo_A 101 FVMEFVNGGDLMF 113 (353)
T ss_dssp EEEECCCSCBHHH
T ss_pred EEEeCCCCCcHHH
Confidence 999999 778876
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=98.46 E-value=8.1e-08 Score=107.80 Aligned_cols=76 Identities=22% Similarity=0.261 Sum_probs=64.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.++|++++.||+|+||.||+|.++.+|..||||++...... . .||++|++++++......+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999753211 2 589999999988888889999
Q ss_pred EecC-CCCCCcccC
Q psy18163 816 TENP-GGPLNKKEQ 828 (1028)
Q Consensus 816 ~E~~-~G~L~~~~~ 828 (1028)
|||+ ||+|.+.+.
T Consensus 107 ~e~~~gg~L~~~l~ 120 (362)
T 2bdw_A 107 FDLVTGGELFEDIV 120 (362)
T ss_dssp ECCCCSCBHHHHHT
T ss_pred EecCCCCCHHHHHH
Confidence 9999 678877443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.3e-07 Score=104.61 Aligned_cols=80 Identities=20% Similarity=0.180 Sum_probs=64.0
Q ss_pred CCCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhcC--
Q psy18163 747 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVES-- 809 (1028)
Q Consensus 747 ~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~~-- 809 (1028)
..|..+.+|+++++||+|+||.||+|++..+|+.||||++....... -.||+++++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp TTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred cccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 35677899999999999999999999999999999999986432211 0478888887766542
Q ss_pred ------cCcEEEEecCCCCCCcc
Q psy18163 810 ------ELNHLVTENPGGPLNKK 826 (1028)
Q Consensus 810 ------~~~hlV~E~~~G~L~~~ 826 (1028)
...+|||||++|+|...
T Consensus 91 ~~~~~~~~~~lv~e~~~~~l~~~ 113 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEHDLAGL 113 (351)
T ss_dssp ------CEEEEEEECCSEEHHHH
T ss_pred ccccCCceEEEEEeccCCCHHHH
Confidence 35789999999877763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.45 E-value=1.4e-07 Score=102.17 Aligned_cols=73 Identities=15% Similarity=0.206 Sum_probs=62.8
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
..+|.+.+.||+|+||.||+|.+..+++.||+|++..... .. .||+++++++++......+||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEE
Confidence 4689999999999999999999999999999998864221 12 58999999998888888999999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|.+
T Consensus 88 ~~~~~~L~~ 96 (310)
T 3s95_A 88 YIKGGTLRG 96 (310)
T ss_dssp CCTTCBHHH
T ss_pred ecCCCcHHH
Confidence 99 668876
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.45 E-value=2.2e-07 Score=105.60 Aligned_cols=79 Identities=20% Similarity=0.195 Sum_probs=66.3
Q ss_pred CCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 748 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 748 ~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.....+.|++++.||+|+||.||+|.++.+|+.||+|++..... .. .||++|++++++......+
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEE
Confidence 34456789999999999999999999999999999999875321 12 5899999999888888899
Q ss_pred EEEecC-CCCCCccc
Q psy18163 814 LVTENP-GGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~ 827 (1028)
|||||+ +|+|.+.+
T Consensus 125 lv~E~~~gg~L~~~l 139 (387)
T 1kob_A 125 LILEFLSGGELFDRI 139 (387)
T ss_dssp EEEECCCCCBHHHHT
T ss_pred EEEEcCCCCcHHHHH
Confidence 999999 77887743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.2e-07 Score=107.37 Aligned_cols=75 Identities=19% Similarity=0.159 Sum_probs=63.7
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCc-----------------ccccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGK-----------------FWLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~-----------------~~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+.+|++++.||+|+||.||+|+++.+++.||||++.+.. ...-.||++++++.++......+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 4679999999999999999999999999999999986421 01126899999988888888999
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ ||+|..
T Consensus 116 lv~E~~~gg~L~~ 128 (373)
T 2r5t_A 116 FVLDYINGGELFY 128 (373)
T ss_dssp EEEECCCSCBHHH
T ss_pred EEEeCCCCCcHHH
Confidence 999999 778866
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.44 E-value=5.6e-08 Score=105.34 Aligned_cols=57 Identities=25% Similarity=0.346 Sum_probs=45.9
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhh
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQV 807 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~ 807 (1028)
+.+.+|++++.||+|+||.||+|+++.+|+.||||++..... .. .|||+|++++++.
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 74 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWL 74 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEE
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEE
Confidence 346789999999999999999999999999999999874321 11 5899999877653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=98.44 E-value=1.2e-07 Score=104.84 Aligned_cols=74 Identities=18% Similarity=0.123 Sum_probs=63.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-------------cc----cCCchhhhhhHhhhcCcCcEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------------WL----ENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------------~~----~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.+|.++++||+|+||.||+|++..+++.||||++..... .. -.||++|++++++......+||
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv 114 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence 589999999999999999999999999999999864221 01 0389999999888888889999
Q ss_pred EecCCCCCCcc
Q psy18163 816 TENPGGPLNKK 826 (1028)
Q Consensus 816 ~E~~~G~L~~~ 826 (1028)
|||++|+|...
T Consensus 115 ~e~~~~~L~~~ 125 (360)
T 3llt_A 115 FEPLGPSLYEI 125 (360)
T ss_dssp ECCCCCBHHHH
T ss_pred EcCCCCCHHHH
Confidence 99999998873
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.6e-07 Score=102.55 Aligned_cols=74 Identities=30% Similarity=0.321 Sum_probs=60.5
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhcCcCcEEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.+++|+++++||+|+||+||+|.+. +|+.||||++....... -.||+++++++++......+||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3578999999999999999999985 59999999997432110 1589999999988888889999
Q ss_pred EecCCCCCCc
Q psy18163 816 TENPGGPLNK 825 (1028)
Q Consensus 816 ~E~~~G~L~~ 825 (1028)
|||++|+|..
T Consensus 98 ~e~~~~~l~~ 107 (311)
T 3niz_A 98 FEFMEKDLKK 107 (311)
T ss_dssp EECCSEEHHH
T ss_pred EcCCCCCHHH
Confidence 9999987776
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=7.9e-08 Score=107.26 Aligned_cols=74 Identities=24% Similarity=0.214 Sum_probs=63.6
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
+.+|++++.||+|+||.||+|+++.+|+.||||++.+... ....||+++++++++......+|
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 5789999999999999999999999999999999975321 11268999999988888889999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ ||+|..
T Consensus 88 v~e~~~gg~L~~ 99 (345)
T 3a8x_A 88 VIEYVNGGDLMF 99 (345)
T ss_dssp EECCCCSCBHHH
T ss_pred EEeCCCCCcHHH
Confidence 99999 778866
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=98.43 E-value=5.8e-08 Score=108.21 Aligned_cols=75 Identities=20% Similarity=0.171 Sum_probs=63.1
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+++|++++.||+|+||.||+|+++.+|+.||||++.+... ..-.||+++++++++......+|
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999864210 01158999999888888888999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ ||+|..
T Consensus 83 v~E~~~gg~L~~ 94 (337)
T 1o6l_A 83 VMEYANGGELFF 94 (337)
T ss_dssp EEECCTTCBHHH
T ss_pred EEeCCCCCcHHH
Confidence 99999 778865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-07 Score=105.87 Aligned_cols=74 Identities=20% Similarity=0.082 Sum_probs=63.2
Q ss_pred ccceeEeeeeecc--ceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEG--TYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeG--syG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
..+|+++++||+| +||.||+|+++.+|+.||||++...... .-.|||+|++++++......+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 9999999999999999999999743210 0158999999999888888999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|.+
T Consensus 104 v~e~~~~~~L~~ 115 (389)
T 3gni_B 104 VTSFMAYGSAKD 115 (389)
T ss_dssp EEECCTTCBHHH
T ss_pred EEEccCCCCHHH
Confidence 99999 677776
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=5.3e-08 Score=108.97 Aligned_cols=76 Identities=21% Similarity=0.234 Sum_probs=64.0
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+++|++++.||+|+||.||+|+++.+|+.||||++.+... ....||+++++++++......+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999999999999999999864210 0116899999998888888999
Q ss_pred EEEecC-CCCCCcc
Q psy18163 814 LVTENP-GGPLNKK 826 (1028)
Q Consensus 814 lV~E~~-~G~L~~~ 826 (1028)
|||||+ ||+|...
T Consensus 95 lv~E~~~gg~L~~~ 108 (345)
T 1xjd_A 95 FVMEYLNGGDLMYH 108 (345)
T ss_dssp EEEECCTTCBHHHH
T ss_pred EEEeCCCCCcHHHH
Confidence 999999 7788763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=98.42 E-value=6.4e-08 Score=104.98 Aligned_cols=73 Identities=18% Similarity=0.068 Sum_probs=62.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+|++++.||+|+||.||+|++..+|+.||||++...... .-.|||++++++++......+|||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 4799999999999999999999999999999999754211 116899999998888888899999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ ||+|.+
T Consensus 111 e~~~g~~L~~ 120 (286)
T 3uqc_A 111 EWIRGGSLQE 120 (286)
T ss_dssp ECCCEEEHHH
T ss_pred EecCCCCHHH
Confidence 999 667776
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=6.1e-08 Score=105.22 Aligned_cols=75 Identities=21% Similarity=0.239 Sum_probs=63.4
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
...+|.+++.||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++......+||||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999999999999999998643211 1168999999988888888999999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|.+
T Consensus 98 ~~~~~~L~~ 106 (297)
T 3fxz_A 98 YLAGGSLTD 106 (297)
T ss_dssp CCTTCBHHH
T ss_pred CCCCCCHHH
Confidence 99 778776
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=98.41 E-value=4.1e-08 Score=109.51 Aligned_cols=78 Identities=23% Similarity=0.243 Sum_probs=65.7
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
..+.+|.+++.||+|+||.||+|.+..+|+.||||++..... ..-.||+++++++++......+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 456799999999999999999999999999999999853210 0115899999999988888899
Q ss_pred EEEecCCCCCCccc
Q psy18163 814 LVTENPGGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~~G~L~~~~ 827 (1028)
|||||++|+|.+.+
T Consensus 86 lv~E~~~g~l~~~l 99 (336)
T 3h4j_B 86 MVIEYAGGELFDYI 99 (336)
T ss_dssp EEECCCCEEHHHHH
T ss_pred EEEECCCCcHHHHH
Confidence 99999999988754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=98.41 E-value=1.1e-07 Score=108.21 Aligned_cols=77 Identities=21% Similarity=0.207 Sum_probs=61.7
Q ss_pred cccceeEe-eeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------cccCCchhhhhhHhhhc----CcCcEEEE
Q psy18163 751 SVEEFKCL-NRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------WLENFPSRIRTYHLQVE----SELNHLVT 816 (1028)
Q Consensus 751 ~~~~Y~~l-~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------~~~~~p~~vr~~e~~~~----~~~~hlV~ 816 (1028)
.+++|.++ +.||+|+||+||+|.++.||+.||||++..... ....||+++++++++.. ....+|||
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 45789887 689999999999999999999999999864221 12268999998877654 56789999
Q ss_pred ecC-CCCCCccc
Q psy18163 817 ENP-GGPLNKKE 827 (1028)
Q Consensus 817 E~~-~G~L~~~~ 827 (1028)
||+ ||+|.+.+
T Consensus 139 E~~~gg~L~~~l 150 (400)
T 1nxk_A 139 ECLDGGELFSRI 150 (400)
T ss_dssp ECCCSEEHHHHH
T ss_pred EeCCCCcHHHHH
Confidence 999 67888743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.40 E-value=2.2e-07 Score=100.41 Aligned_cols=73 Identities=25% Similarity=0.325 Sum_probs=60.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
+++|+++++||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++......+|||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 46899999999999999999999999999999998643211 015899999988888888889999
Q ss_pred ecCCCCCC
Q psy18163 817 ENPGGPLN 824 (1028)
Q Consensus 817 E~~~G~L~ 824 (1028)
||++|.+.
T Consensus 82 e~~~~~~l 89 (311)
T 4agu_A 82 EYCDHTVL 89 (311)
T ss_dssp ECCSEEHH
T ss_pred EeCCCchH
Confidence 99965443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.40 E-value=1.1e-07 Score=108.10 Aligned_cols=74 Identities=22% Similarity=0.273 Sum_probs=63.4
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCc-----------------ccccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGK-----------------FWLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~-----------------~~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+++|++++.||+|+||.||+|.+..+|+.||||++.+.. ... .||++|++++++......+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEE
Confidence 4579999999999999999999999999999999986321 011 5899999998888888999
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ ||+|..
T Consensus 92 lv~e~~~gg~L~~ 104 (384)
T 4fr4_A 92 MVVDLLLGGDLRY 104 (384)
T ss_dssp EEECCCTTEEHHH
T ss_pred EEEecCCCCcHHH
Confidence 999999 778866
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.40 E-value=2.7e-07 Score=100.50 Aligned_cols=72 Identities=21% Similarity=0.278 Sum_probs=59.4
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCc--CcEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESE--LNHLV 815 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~--~~hlV 815 (1028)
.+|.+++.||+|+||.||+|.+..+|+.||||++..... .. .||+++++++++.... ..+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEEE
Confidence 579999999999999999999999999999999874221 11 5899999887765544 66999
Q ss_pred EecC-CCCCCc
Q psy18163 816 TENP-GGPLNK 825 (1028)
Q Consensus 816 ~E~~-~G~L~~ 825 (1028)
|||+ +|+|..
T Consensus 88 ~e~~~~~~L~~ 98 (319)
T 4euu_A 88 MEFCPCGSLYT 98 (319)
T ss_dssp EECCTTCBHHH
T ss_pred EeCCCCCCHHH
Confidence 9999 678876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.8e-07 Score=105.73 Aligned_cols=73 Identities=30% Similarity=0.294 Sum_probs=61.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcC-----c
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVES-----E 810 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~-----~ 810 (1028)
.++|.+++.||+|+||.||+|.++.+|+.||||++..... .. .||++|++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCC
Confidence 4689999999999999999999999999999999975321 11 589999998877655 4
Q ss_pred CcEEEEecCCCCCCc
Q psy18163 811 LNHLVTENPGGPLNK 825 (1028)
Q Consensus 811 ~~hlV~E~~~G~L~~ 825 (1028)
..+|||||++|+|..
T Consensus 104 ~~~lv~e~~~~~L~~ 118 (432)
T 3n9x_A 104 ELYIVLEIADSDLKK 118 (432)
T ss_dssp CEEEEEECCSEEHHH
T ss_pred eEEEEEecCCcCHHH
Confidence 679999999998877
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.6e-07 Score=100.84 Aligned_cols=77 Identities=14% Similarity=0.173 Sum_probs=64.2
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEE
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
+..+.|.+.++||+|+||.||+|.++.+|..||||++...... .-.||+++++++++......+||
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 3457899999999999999999999999999999998753211 01589999999888888888999
Q ss_pred EecC-CCCCCcc
Q psy18163 816 TENP-GGPLNKK 826 (1028)
Q Consensus 816 ~E~~-~G~L~~~ 826 (1028)
|||+ +|+|...
T Consensus 99 ~e~~~~~~L~~~ 110 (285)
T 3is5_A 99 METCEGGELLER 110 (285)
T ss_dssp ECCCSCCBHHHH
T ss_pred EEeCCCCcHHHH
Confidence 9999 6688773
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.5e-07 Score=108.24 Aligned_cols=73 Identities=22% Similarity=0.200 Sum_probs=51.8
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhc-----Cc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVE-----SE 810 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~-----~~ 810 (1028)
.++|++++.||+|+||+||+|+++.+|+.||||+|..... .. .|||+|++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCc
Confidence 4689999999999999999999999999999999864321 11 68999999887733 35
Q ss_pred CcEEEEecCCCCCCc
Q psy18163 811 LNHLVTENPGGPLNK 825 (1028)
Q Consensus 811 ~~hlV~E~~~G~L~~ 825 (1028)
..+|||||++|+|..
T Consensus 131 ~~~lv~e~~~~~L~~ 145 (458)
T 3rp9_A 131 ELYVVLEIADSDFKK 145 (458)
T ss_dssp CEEEEECCCSEEHHH
T ss_pred eEEEEEeccccchhh
Confidence 679999999998877
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=6e-08 Score=111.32 Aligned_cols=74 Identities=20% Similarity=0.264 Sum_probs=63.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.++|++++.||+|+||.||+|+++.+++.||||++.+... ..-.||++|++++++......+||
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999864110 011689999999888888889999
Q ss_pred EecC-CCCCCc
Q psy18163 816 TENP-GGPLNK 825 (1028)
Q Consensus 816 ~E~~-~G~L~~ 825 (1028)
|||+ ||+|..
T Consensus 148 ~E~~~gg~L~~ 158 (410)
T 3v8s_A 148 MEYMPGGDLVN 158 (410)
T ss_dssp ECCCTTEEHHH
T ss_pred EeCCCCCcHHH
Confidence 9999 778876
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.6e-07 Score=101.13 Aligned_cols=78 Identities=21% Similarity=0.323 Sum_probs=59.2
Q ss_pred CCCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------------------------
Q psy18163 747 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------------------------- 791 (1028)
Q Consensus 747 ~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------------------------- 791 (1028)
+.|-.+.+|.+++.||+|+||.||+|.+..+|+.||||++.....
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 345567899999999999999999999999999999999864321
Q ss_pred -----cccCCchhhhhhHhhhc--CcCcEEEEecC-CCCCCc
Q psy18163 792 -----WLENFPSRIRTYHLQVE--SELNHLVTENP-GGPLNK 825 (1028)
Q Consensus 792 -----~~~~~p~~vr~~e~~~~--~~~~hlV~E~~-~G~L~~ 825 (1028)
.. .||+++++++++.. ....+|||||+ +|+|..
T Consensus 87 ~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 127 (298)
T 2zv2_A 87 IAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME 127 (298)
T ss_dssp HHHHHTC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCC
T ss_pred HHHHHhC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHH
Confidence 01 58999998887765 45679999999 667665
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.3e-07 Score=100.30 Aligned_cols=78 Identities=21% Similarity=0.190 Sum_probs=63.2
Q ss_pred CCccccceeEe-eeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------cccCCchhhhhhHhhhc----CcCcE
Q psy18163 748 GCRSVEEFKCL-NRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------WLENFPSRIRTYHLQVE----SELNH 813 (1028)
Q Consensus 748 ~~~~~~~Y~~l-~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------~~~~~p~~vr~~e~~~~----~~~~h 813 (1028)
....+.+|.++ +.||+|+||.||+|.+..+|+.||||++..... ....||+++++++++.. ....+
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 34457889998 779999999999999999999999999974321 12268999998887765 56789
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ +|+|..
T Consensus 92 lv~e~~~~~~L~~ 104 (299)
T 3m2w_A 92 IVMECLDGGELFS 104 (299)
T ss_dssp EEECCCCSCBHHH
T ss_pred EEEeecCCCcHHH
Confidence 999999 668877
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=98.38 E-value=1.5e-07 Score=103.78 Aligned_cols=75 Identities=20% Similarity=0.197 Sum_probs=49.8
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc------------CCchhhhhhHhhhcCcC-------
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE------------NFPSRIRTYHLQVESEL------- 811 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~------------~~p~~vr~~e~~~~~~~------- 811 (1028)
.+++|.+++.||+|+||.||+|.+..+|+.||||++........ .||+++++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 46789999999999999999999999999999999864322110 58999998877644322
Q ss_pred cEEEEecCCCCCCc
Q psy18163 812 NHLVTENPGGPLNK 825 (1028)
Q Consensus 812 ~hlV~E~~~G~L~~ 825 (1028)
.+|||||++|+|..
T Consensus 101 ~~lv~e~~~~~l~~ 114 (360)
T 3e3p_A 101 LNVVMEYVPDTLHR 114 (360)
T ss_dssp EEEEEECCSCBHHH
T ss_pred EEEEeecccccHHH
Confidence 68999999887655
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2.6e-07 Score=101.34 Aligned_cols=73 Identities=22% Similarity=0.167 Sum_probs=61.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecCC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENPG 820 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~~ 820 (1028)
.+|.+++.||+|+||.||+|.+..+|+.||||++...... ...||+++++++++......+|||||++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLG 88 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCC
Confidence 5799999999999999999999999999999998643211 1168899888888877888899999998
Q ss_pred CCCCc
Q psy18163 821 GPLNK 825 (1028)
Q Consensus 821 G~L~~ 825 (1028)
|+|.+
T Consensus 89 ~~L~~ 93 (330)
T 2izr_A 89 PSLED 93 (330)
T ss_dssp CBHHH
T ss_pred CCHHH
Confidence 88887
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.9e-07 Score=103.19 Aligned_cols=77 Identities=14% Similarity=0.102 Sum_probs=60.6
Q ss_pred cccceeEee-eeeccceeEEEEEEEccCCcEEEeeecCCCcc---------cccCCchhhhhhHhhhc----CcCcEEEE
Q psy18163 751 SVEEFKCLN-RIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------WLENFPSRIRTYHLQVE----SELNHLVT 816 (1028)
Q Consensus 751 ~~~~Y~~l~-~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------~~~~~p~~vr~~e~~~~----~~~~hlV~ 816 (1028)
..++|.+++ .||+|+||.||+|.++.+|+.||||++..... ....||+++++++++.. ....+|||
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 357899976 59999999999999999999999999865321 11268999988877654 44579999
Q ss_pred ecC-CCCCCccc
Q psy18163 817 ENP-GGPLNKKE 827 (1028)
Q Consensus 817 E~~-~G~L~~~~ 827 (1028)
||+ +|+|...+
T Consensus 106 e~~~gg~L~~~l 117 (336)
T 3fhr_A 106 ECMEGGELFSRI 117 (336)
T ss_dssp ECCTTEEHHHHH
T ss_pred eccCCCCHHHHH
Confidence 999 66887733
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=98.36 E-value=5.5e-07 Score=103.00 Aligned_cols=74 Identities=28% Similarity=0.261 Sum_probs=60.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------------cccCCchhhhhhHhhhcC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------------WLENFPSRIRTYHLQVES 809 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------------~~~~~p~~vr~~e~~~~~ 809 (1028)
.++|.+++.||+|+||.||+|.+..+++.||||++.+... .. .||+++++++++. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD-A 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe-c
Confidence 3689999999999999999999999999999999864210 01 5899999887764 4
Q ss_pred cCcEEEEecC-CCCCCccc
Q psy18163 810 ELNHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 810 ~~~hlV~E~~-~G~L~~~~ 827 (1028)
...+|||||+ +|+|.+.+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l 230 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKV 230 (419)
T ss_dssp SEEEEEEECCTTCBGGGGT
T ss_pred CceEEEEEcCCCCcHHHHH
Confidence 4468999999 77887743
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=98.35 E-value=2e-07 Score=100.88 Aligned_cols=73 Identities=21% Similarity=0.154 Sum_probs=61.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+|++++.||+|+||.||+|.+..++..||||++...... .-.||+++++++++......+|||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5799999999999999999999999999999998542210 115899999998888888899999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ ||+|.+
T Consensus 91 e~~~g~~L~~ 100 (294)
T 4eqm_A 91 EYIEGPTLSE 100 (294)
T ss_dssp ECCCSCBHHH
T ss_pred eCCCCCCHHH
Confidence 999 668876
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.35 E-value=3.6e-07 Score=101.73 Aligned_cols=74 Identities=23% Similarity=0.194 Sum_probs=61.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-----------ccCCchhhhhhHhhhcCcCcEEEEecC-C
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-----------LENFPSRIRTYHLQVESELNHLVTENP-G 820 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-----------~~~~p~~vr~~e~~~~~~~~hlV~E~~-~ 820 (1028)
+.|++.+.||+|+||.||+|.+..+++.||||++...... .-.||+++++++++......+|||||+ +
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 5799999999999999999999999999999998753210 005899999998888888899999999 6
Q ss_pred CCCCcc
Q psy18163 821 GPLNKK 826 (1028)
Q Consensus 821 G~L~~~ 826 (1028)
|+|.+.
T Consensus 133 ~~L~~~ 138 (349)
T 2w4o_A 133 GELFDR 138 (349)
T ss_dssp CBHHHH
T ss_pred CCHHHH
Confidence 788763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=98.35 E-value=1.8e-07 Score=111.32 Aligned_cols=75 Identities=16% Similarity=0.078 Sum_probs=62.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.++|.+++.||+|+||.||+|+++.||+.||||++.+.... .-.||++++++.++......+||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 57899999999999999999999999999999999642100 11589999998888888889999
Q ss_pred EecC-CCCCCcc
Q psy18163 816 TENP-GGPLNKK 826 (1028)
Q Consensus 816 ~E~~-~G~L~~~ 826 (1028)
|||+ ||+|...
T Consensus 264 mE~~~gg~L~~~ 275 (543)
T 3c4z_A 264 MTIMNGGDIRYH 275 (543)
T ss_dssp ECCCTTCBHHHH
T ss_pred EEeccCCCHHHH
Confidence 9999 7788763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.5e-07 Score=102.79 Aligned_cols=72 Identities=18% Similarity=0.245 Sum_probs=62.0
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
++|.+.+.||+|+||.||+|.+..+++.||||.+..... .. .||++|++++++......+||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEE
Confidence 589999999999999999999999999999999874311 11 58999999988888888999999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|..
T Consensus 193 ~~~~g~L~~ 201 (377)
T 3cbl_A 193 LVQGGDFLT 201 (377)
T ss_dssp CCTTCBHHH
T ss_pred cCCCCCHHH
Confidence 99 778876
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=98.34 E-value=1.2e-07 Score=106.01 Aligned_cols=75 Identities=20% Similarity=0.248 Sum_probs=63.6
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+++|++++.||+|+||.||+|+++.+|+.||||++.+... ..-.||+++++++++......+|
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 46899999999999999999999999999999999863210 01168999999888888888999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ ||+|..
T Consensus 119 v~e~~~gg~L~~ 130 (350)
T 1rdq_E 119 VMEYVAGGEMFS 130 (350)
T ss_dssp EEECCTTCBHHH
T ss_pred EEcCCCCCcHHH
Confidence 99999 778876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=5.3e-07 Score=96.47 Aligned_cols=73 Identities=23% Similarity=0.251 Sum_probs=59.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecCC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENPG 820 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~~ 820 (1028)
.+|++++.||+|+||.||+|.+..+|+.||||++...... ...+++++++++++......+|||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 89 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecC
Confidence 5799999999999999999999999999999998643221 1146777777666666778899999999
Q ss_pred CCCCc
Q psy18163 821 GPLNK 825 (1028)
Q Consensus 821 G~L~~ 825 (1028)
|+|.+
T Consensus 90 ~~L~~ 94 (298)
T 1csn_A 90 PSLED 94 (298)
T ss_dssp CBHHH
T ss_pred CCHHH
Confidence 88887
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=4.9e-07 Score=97.75 Aligned_cols=76 Identities=26% Similarity=0.315 Sum_probs=61.5
Q ss_pred CccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcC
Q psy18163 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 749 ~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~ 811 (1028)
...+.+|.+++.||+|+||.||+|.+..+|..||||++..... .. .||+++++++++.....
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCc
Confidence 3456789999999999999999999999999999999874211 11 58999999888888888
Q ss_pred cEEEEecC-CCCCCc
Q psy18163 812 NHLVTENP-GGPLNK 825 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~ 825 (1028)
.+|||||+ +|+|.+
T Consensus 107 ~~lv~e~~~~~~L~~ 121 (310)
T 2wqm_A 107 LNIVLELADAGDLSR 121 (310)
T ss_dssp EEEEEECCCSCBHHH
T ss_pred EEEEEecCCCCCHHH
Confidence 99999999 567766
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.33 E-value=1.7e-07 Score=103.08 Aligned_cols=75 Identities=17% Similarity=0.116 Sum_probs=63.0
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
+.|.+.+.||+|+||.||+|.++.+|..||||++...... .-.||+++++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5799999999999999999999999999999998743210 005899999988888888899
Q ss_pred EEEecC-CCCCCccc
Q psy18163 814 LVTENP-GGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~ 827 (1028)
|||||+ +|+|.+.+
T Consensus 91 lv~e~~~~~~L~~~l 105 (326)
T 2y0a_A 91 LILELVAGGELFDFL 105 (326)
T ss_dssp EEEECCCSCBHHHHH
T ss_pred EEEEcCCCCCHHHHH
Confidence 999999 77887743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.3e-07 Score=106.23 Aligned_cols=75 Identities=21% Similarity=0.172 Sum_probs=63.0
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCc-----------------ccccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGK-----------------FWLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~-----------------~~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+.+|++++.||+|+||.||+|+++.+|+.||||++.+.. .....||++++++.++......+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999986421 01125899999988888888899
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ ||+|..
T Consensus 98 lv~E~~~gg~L~~ 110 (353)
T 2i0e_A 98 FVMEYVNGGDLMY 110 (353)
T ss_dssp EEEECCCSCBHHH
T ss_pred EEEeCCCCCcHHH
Confidence 999999 778876
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.33 E-value=8.4e-08 Score=111.18 Aligned_cols=76 Identities=21% Similarity=0.256 Sum_probs=63.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.++|++++.||+|+||+||+|.++.+|+.||+|++...... .-.|||+|++++++......+|||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999999999999999999754311 016899999999998888999999
Q ss_pred ecC-CCCCCccc
Q psy18163 817 ENP-GGPLNKKE 827 (1028)
Q Consensus 817 E~~-~G~L~~~~ 827 (1028)
||+ ||+|.+.+
T Consensus 90 E~~~gg~L~~~i 101 (444)
T 3soa_A 90 DLVTGGELFEDI 101 (444)
T ss_dssp CCCBCCBHHHHH
T ss_pred EeCCCCCHHHHH
Confidence 999 77887654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.32 E-value=2.7e-07 Score=99.85 Aligned_cols=75 Identities=25% Similarity=0.312 Sum_probs=59.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------------cc--CCchhhhhhHhhhcCc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------------LE--NFPSRIRTYHLQVESE 810 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------------~~--~~p~~vr~~e~~~~~~ 810 (1028)
..+|+++++||+|+||.||+|++..+|+.||||++...... .. .||+++++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 36899999999999999999999999999999998632100 00 3899999888776544
Q ss_pred -----CcEEEEecCCCCCCcc
Q psy18163 811 -----LNHLVTENPGGPLNKK 826 (1028)
Q Consensus 811 -----~~hlV~E~~~G~L~~~ 826 (1028)
..+|||||++|+|...
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~ 108 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTY 108 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHH
T ss_pred CCCceeEEEEehhhhcCHHHH
Confidence 4699999999988773
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=98.32 E-value=5.5e-07 Score=101.20 Aligned_cols=76 Identities=14% Similarity=0.086 Sum_probs=62.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEc-------cCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDK-------RTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVES 809 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~-------~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~ 809 (1028)
.++|++.+.||+|+||.||+|++. .++..||||++...... ...||++|++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999975 35668999999754211 11599999999988888
Q ss_pred cCcEEEEecC-CCCCCccc
Q psy18163 810 ELNHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 810 ~~~hlV~E~~-~G~L~~~~ 827 (1028)
...+|||||+ +|+|.+.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l 178 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYL 178 (370)
T ss_dssp SSCEEEEECCTTCBHHHHH
T ss_pred CCEEEEEEcCCCCCHHHHH
Confidence 8999999999 77887744
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=5e-07 Score=99.22 Aligned_cols=75 Identities=16% Similarity=0.118 Sum_probs=61.3
Q ss_pred cceeEe-eeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEEE
Q psy18163 753 EEFKCL-NRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 753 ~~Y~~l-~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
..|.+. +.||+|+||.||+|.+..+|+.||||++...... ...||+++++++++......+||
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 357777 8899999999999999999999999998753211 11469999998888888889999
Q ss_pred EecC-CCCCCccc
Q psy18163 816 TENP-GGPLNKKE 827 (1028)
Q Consensus 816 ~E~~-~G~L~~~~ 827 (1028)
|||+ +|+|....
T Consensus 108 ~e~~~~~~L~~~~ 120 (327)
T 3lm5_A 108 LEYAAGGEIFSLC 120 (327)
T ss_dssp EECCTTEEGGGGG
T ss_pred EEecCCCcHHHHH
Confidence 9999 66887743
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=98.32 E-value=1.5e-07 Score=105.92 Aligned_cols=74 Identities=20% Similarity=0.293 Sum_probs=53.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcC--cCcE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVES--ELNH 813 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~--~~~h 813 (1028)
+.+|++++.||+|+||.||+|.+..+|+.||||++..... ...+||++|++++++... ...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 4689999999999999999999999999999999864321 121499999998887543 3679
Q ss_pred EEEecCCCCCCc
Q psy18163 814 LVTENPGGPLNK 825 (1028)
Q Consensus 814 lV~E~~~G~L~~ 825 (1028)
|||||++|+|..
T Consensus 88 lv~e~~~~~L~~ 99 (388)
T 3oz6_A 88 LVFDYMETDLHA 99 (388)
T ss_dssp EEEECCSEEHHH
T ss_pred EEecccCcCHHH
Confidence 999999988766
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.8e-07 Score=96.79 Aligned_cols=73 Identities=25% Similarity=0.388 Sum_probs=60.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhh--cCcCcE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQV--ESELNH 813 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~--~~~~~h 813 (1028)
+++|++++.||+|+||.||+|.+..+|+.||+|++..... .. .||+++++++++. .....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 5789999999999999999999999999999999974321 11 5899999887653 346779
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ +|+|.+
T Consensus 84 lv~e~~~~~~L~~ 96 (279)
T 2w5a_A 84 IVMEYCEGGDLAS 96 (279)
T ss_dssp EEEECCTTEEHHH
T ss_pred EEEeCCCCCCHHH
Confidence 999999 568877
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=98.31 E-value=2.7e-07 Score=101.63 Aligned_cols=74 Identities=16% Similarity=0.222 Sum_probs=61.9
Q ss_pred ccceeEe---eeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 752 VEEFKCL---NRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 752 ~~~Y~~l---~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
.++|++. +.||+|+||.||+|.++.+|+.||||++..... ...+||+++++++++......+||||
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 3568775 789999999999999999999999999975321 12259999999999988888999999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|.+
T Consensus 87 ~~~~~~L~~ 95 (325)
T 3kn6_A 87 LLNGGELFE 95 (325)
T ss_dssp CCCSCBHHH
T ss_pred ccCCCcHHH
Confidence 99 668876
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.9e-07 Score=108.97 Aligned_cols=75 Identities=24% Similarity=0.278 Sum_probs=59.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
..|.++++||+|+||+||+|+++.++..||||++.+.... .-.|||+|++++++......+||||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999999999999999998753210 1168999999999988888999999
Q ss_pred cC-CCCCCccc
Q psy18163 818 NP-GGPLNKKE 827 (1028)
Q Consensus 818 ~~-~G~L~~~~ 827 (1028)
|| +|+|.+.+
T Consensus 117 ~~~~g~L~~~~ 127 (494)
T 3lij_A 117 CYKGGELFDEI 127 (494)
T ss_dssp CCCSCBHHHHH
T ss_pred cCCCCcHHHHH
Confidence 99 77886643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.30 E-value=3.4e-07 Score=99.24 Aligned_cols=72 Identities=14% Similarity=0.135 Sum_probs=56.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhh----cCcCcEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQV----ESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~----~~~~~hl 814 (1028)
.+|++++.||+|+||.||+|.+..+|+.||||++..... .. .||+++++++++. .....+|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEE
Confidence 479999999999999999999999999999998853221 11 5899999887765 2346789
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|.+
T Consensus 108 v~e~~~~~~L~~ 119 (317)
T 2buj_A 108 LLPFFKRGTLWN 119 (317)
T ss_dssp EEECCTTCBHHH
T ss_pred EEEeCCCCcHHH
Confidence 99999 668876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.30 E-value=6.2e-07 Score=98.65 Aligned_cols=73 Identities=22% Similarity=0.211 Sum_probs=61.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcE---EEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEI---VAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~---VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
..+|.+.+.||+|+||.||+|.+..+|.. ||||++..... .. .||+++++++++......+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccE
Confidence 35899999999999999999999876664 99999975321 12 5899999998888888999
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ +|+|..
T Consensus 127 lv~e~~~~~~L~~ 139 (325)
T 3kul_A 127 IVTEYMENGSLDT 139 (325)
T ss_dssp EEEECCTTCBHHH
T ss_pred EEeeCCCCCcHHH
Confidence 999999 778876
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.5e-07 Score=109.08 Aligned_cols=76 Identities=24% Similarity=0.285 Sum_probs=64.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.++|++++.||+|+||.||+|.++.+|+.||||++.+... .. .||++|++++++......+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEE
Confidence 3589999999999999999999999999999999864321 11 68999999999888889999
Q ss_pred EEecC-CCCCCcccC
Q psy18163 815 VTENP-GGPLNKKEQ 828 (1028)
Q Consensus 815 V~E~~-~G~L~~~~~ 828 (1028)
||||+ +|+|.+.+.
T Consensus 104 v~e~~~~~~L~~~~~ 118 (484)
T 3nyv_A 104 VGEVYTGGELFDEII 118 (484)
T ss_dssp EECCCCSCBHHHHHH
T ss_pred EEecCCCCCHHHHHH
Confidence 99988 788877543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=98.30 E-value=2.4e-07 Score=108.35 Aligned_cols=76 Identities=24% Similarity=0.267 Sum_probs=61.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------------------ccCCchhhhhhHh
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------------------LENFPSRIRTYHL 805 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------------------~~~~p~~vr~~e~ 805 (1028)
...|.++++||+|+||.||+|.++.++..||||++.+.... .-.||++|+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46899999999999999999999999999999998743210 0058999999999
Q ss_pred hhcCcCcEEEEecC-CCCCCccc
Q psy18163 806 QVESELNHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 806 ~~~~~~~hlV~E~~-~G~L~~~~ 827 (1028)
+......+|||||| ||+|...+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l 137 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQI 137 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHH
T ss_pred EEcCCEEEEEEecCCCCcHHHHH
Confidence 98888999999999 77886644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=98.30 E-value=4.1e-07 Score=104.10 Aligned_cols=73 Identities=23% Similarity=0.209 Sum_probs=57.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------cCCchhhhhhHhhhcC------cCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------ENFPSRIRTYHLQVES------ELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------~~~p~~vr~~e~~~~~------~~~hlV~E 817 (1028)
..|++++.||+|+||+||+|++..+|+.||||++....... -.|||+|++++++... ...+||||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 47999999999999999999999999999999987533211 1589999987766321 23579999
Q ss_pred cCCCCCCc
Q psy18163 818 NPGGPLNK 825 (1028)
Q Consensus 818 ~~~G~L~~ 825 (1028)
|++|+|..
T Consensus 134 ~~~~~l~~ 141 (420)
T 1j1b_A 134 YVPETVYR 141 (420)
T ss_dssp CCCEEHHH
T ss_pred cccccHHH
Confidence 99887655
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.8e-07 Score=101.54 Aligned_cols=75 Identities=15% Similarity=0.094 Sum_probs=60.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------------ccCCchhhhhhHhhh----c
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------------LENFPSRIRTYHLQV----E 808 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------------~~~~p~~vr~~e~~~----~ 808 (1028)
.+|.++++||+|+||+||+|++..+++.||||++...... ..+||+++++++++. .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 5899999999999999999999999999999999753210 002677888877665 4
Q ss_pred CcCcEEEEecCCCCCCccc
Q psy18163 809 SELNHLVTENPGGPLNKKE 827 (1028)
Q Consensus 809 ~~~~hlV~E~~~G~L~~~~ 827 (1028)
....+|||||++|+|....
T Consensus 117 ~~~~~lv~e~~~~~l~~~~ 135 (397)
T 1wak_A 117 GTHICMVFEVLGHHLLKWI 135 (397)
T ss_dssp EEEEEEEECCCCCBHHHHH
T ss_pred CceEEEEEeccCccHHHHH
Confidence 5578999999999888743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=5e-07 Score=98.74 Aligned_cols=116 Identities=16% Similarity=0.080 Sum_probs=77.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCc-----EEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDE-----IVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~-----~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~ 812 (1028)
.+|.+.+.||+|+||.||+|.+..++. .||||.+..... ....||+++++++++......
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 589999999999999999999987775 799999875321 011589999999888888899
Q ss_pred EEEEecC-CCCCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHHH
Q psy18163 813 HLVTENP-GGPLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVKL 884 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (1028)
+|||||+ +|+|.+.+. .......|.+...-++...++.....+-.|+-.|+..+|-
T Consensus 126 ~lv~e~~~~g~L~~~l~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLR----------------RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp EEEEECCTTEEHHHHHH----------------HHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCCcHHHHHH----------------HhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 9999998 668877332 1111122223333333333443333344567777777773
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.29 E-value=1.2e-07 Score=110.93 Aligned_cols=81 Identities=23% Similarity=0.205 Sum_probs=67.1
Q ss_pred CCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcC
Q psy18163 748 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 748 ~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~ 811 (1028)
+...+.+|.+++.||+|+||.||+|.+..||+.||||++..... ..-.||+++++++++.....
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 33456899999999999999999999999999999999863210 01158999999999888888
Q ss_pred cEEEEecC-CCCCCcccC
Q psy18163 812 NHLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~~ 828 (1028)
.+|||||+ ||+|.+.+.
T Consensus 91 ~~lv~E~~~gg~L~~~l~ 108 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYIC 108 (476)
T ss_dssp EEEEEECCSSEEHHHHTT
T ss_pred EEEEEeCCCCCcHHHHHH
Confidence 99999999 789887554
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=98.29 E-value=2.5e-07 Score=99.20 Aligned_cols=74 Identities=34% Similarity=0.372 Sum_probs=61.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
+++|++++.||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++......+|||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 67899999999999999999999999999999998643211 015899999988888888899999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||++|+|.+
T Consensus 82 e~~~~~L~~ 90 (299)
T 2r3i_A 82 EFLHQDLKK 90 (299)
T ss_dssp ECCSEEHHH
T ss_pred EcccCCHHH
Confidence 999888766
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=5.2e-07 Score=96.23 Aligned_cols=73 Identities=16% Similarity=0.166 Sum_probs=61.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCc-------EEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDE-------IVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~-------~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
++|.+.+.||+|+||.||+|.+..+++ .||+|.+...... .-.||+++++++++......
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 689999999999999999999999884 6999998643210 11589999999888888889
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||+ +|+|.+
T Consensus 88 ~lv~e~~~~~~L~~ 101 (289)
T 4fvq_A 88 ILVQEFVKFGSLDT 101 (289)
T ss_dssp EEEEECCTTCBHHH
T ss_pred EEEEECCCCCCHHH
Confidence 9999999 678877
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=2.6e-07 Score=100.48 Aligned_cols=74 Identities=19% Similarity=0.108 Sum_probs=60.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCc---
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELN--- 812 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~--- 812 (1028)
.++|++++.||+|+||.||+|++..+++.||||++...... .-.||+++++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999999999999999999753210 01589999998877655544
Q ss_pred -EEEEecC-CCCCCc
Q psy18163 813 -HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 -hlV~E~~-~G~L~~ 825 (1028)
+|||||+ +|+|.+
T Consensus 91 ~~lv~e~~~g~~L~~ 105 (311)
T 3ork_A 91 PYIVMEYVDGVTLRD 105 (311)
T ss_dssp EEEEEECCCEEEHHH
T ss_pred cEEEEecCCCCCHHH
Confidence 9999999 678876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=98.29 E-value=9.6e-07 Score=96.98 Aligned_cols=75 Identities=15% Similarity=0.100 Sum_probs=60.1
Q ss_pred cceeEeeeeeccceeEEEEEEEc-------cCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK-------RTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESE 810 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~-------~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~ 810 (1028)
++|.+.+.||+|+||.||+|.+. .++..||||++...... ...||+++++++++....
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 58999999999999999999986 56789999999753211 116899999998888888
Q ss_pred CcEEEEecC-CCCCCccc
Q psy18163 811 LNHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 811 ~~hlV~E~~-~G~L~~~~ 827 (1028)
..+|||||+ +|+|.+.+
T Consensus 115 ~~~lv~e~~~~~~L~~~l 132 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYL 132 (334)
T ss_dssp CCEEEEECCTTCBHHHHH
T ss_pred ceEEEEECCCCCcHHHHH
Confidence 899999999 67887744
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.29 E-value=4.7e-07 Score=100.19 Aligned_cols=73 Identities=27% Similarity=0.297 Sum_probs=58.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-------------------cccCCchhhhhhHhhhcCcCc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------------------WLENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------------------~~~~~p~~vr~~e~~~~~~~~ 812 (1028)
..+|++++.||+|+||.||+|.+..+|+.||||++..... .. .||+++++++++......
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCce
Confidence 4689999999999999999999999999999999974211 01 589999998888888899
Q ss_pred EEEEecCCCCCCc
Q psy18163 813 HLVTENPGGPLNK 825 (1028)
Q Consensus 813 hlV~E~~~G~L~~ 825 (1028)
+|||||++|+|..
T Consensus 88 ~lv~e~~~~~l~~ 100 (346)
T 1ua2_A 88 SLVFDFMETDLEV 100 (346)
T ss_dssp EEEEECCSEEHHH
T ss_pred EEEEEcCCCCHHH
Confidence 9999999887766
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.29 E-value=2.3e-07 Score=105.06 Aligned_cols=75 Identities=19% Similarity=0.220 Sum_probs=60.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCc--CcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESE--LNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~--~~hlV~ 816 (1028)
..|.+.+.||+|+||.||+|++..+|+.||||++...... .-.||+++++++++.... ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 5799999999999999999999999999999998742210 015899999987765544 669999
Q ss_pred ecC-CCCCCccc
Q psy18163 817 ENP-GGPLNKKE 827 (1028)
Q Consensus 817 E~~-~G~L~~~~ 827 (1028)
||+ +|+|...+
T Consensus 89 e~~~~g~L~~~l 100 (396)
T 4eut_A 89 EFCPCGSLYTVL 100 (396)
T ss_dssp CCCTTEEHHHHT
T ss_pred ecCCCCCHHHHH
Confidence 999 67887744
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4.7e-07 Score=101.03 Aligned_cols=73 Identities=27% Similarity=0.291 Sum_probs=61.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
..|.+++.||+|+||.||+|++..+|+.||||++...... .-.||++|++++++......+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4699999999999999999999999999999998643210 015899999988888888899999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||+.|+|.+
T Consensus 134 e~~~g~l~~ 142 (348)
T 1u5q_A 134 EYCLGSASD 142 (348)
T ss_dssp ECCSEEHHH
T ss_pred ecCCCCHHH
Confidence 999887766
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.2e-07 Score=110.02 Aligned_cols=75 Identities=17% Similarity=0.108 Sum_probs=63.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
..+|++++.||+|+||.||+|+++.||+.||||++.+... ..-.||++|+++.++......+||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 4689999999999999999999999999999999864210 001589999998888888889999
Q ss_pred EecC-CCCCCcc
Q psy18163 816 TENP-GGPLNKK 826 (1028)
Q Consensus 816 ~E~~-~G~L~~~ 826 (1028)
|||+ ||+|...
T Consensus 263 mEy~~gg~L~~~ 274 (576)
T 2acx_A 263 LTLMNGGDLKFH 274 (576)
T ss_dssp ECCCCSCBHHHH
T ss_pred EEcCCCCcHHHH
Confidence 9999 7888763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=4.2e-07 Score=99.67 Aligned_cols=76 Identities=22% Similarity=0.213 Sum_probs=62.7
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEE
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
..+++|++++.||+|+||.||+|++..+|+.||||++...... .-.||+++++++++......+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 4578999999999999999999999999999999998543211 0158999999988888888999
Q ss_pred EEecCCCCCCc
Q psy18163 815 VTENPGGPLNK 825 (1028)
Q Consensus 815 V~E~~~G~L~~ 825 (1028)
||||++|.+..
T Consensus 102 v~e~~~~~~l~ 112 (331)
T 4aaa_A 102 VFEFVDHTILD 112 (331)
T ss_dssp EEECCSEEHHH
T ss_pred EEecCCcchHH
Confidence 99999665444
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.1e-07 Score=107.07 Aligned_cols=74 Identities=23% Similarity=0.178 Sum_probs=61.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCc----------------ccccCCchhhhhhHhhhcCcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGK----------------FWLENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~----------------~~~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
+.+|++++.||+|+||.||+|.+..+|+.||||++.+.. ...-.||+++++++++......+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 568999999999999999999999999999999986310 0011589999998888888889999
Q ss_pred EecC-CCCCCc
Q psy18163 816 TENP-GGPLNK 825 (1028)
Q Consensus 816 ~E~~-~G~L~~ 825 (1028)
|||+ +|+|..
T Consensus 227 ~e~~~~~~L~~ 237 (446)
T 4ejn_A 227 MEYANGGELFF 237 (446)
T ss_dssp ECCCSSCBHHH
T ss_pred EeeCCCCcHHH
Confidence 9999 667755
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=98.28 E-value=8e-07 Score=96.81 Aligned_cols=76 Identities=18% Similarity=0.210 Sum_probs=61.1
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------cccCCchhhhhhHhhhc--CcCcEEEE
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------WLENFPSRIRTYHLQVE--SELNHLVT 816 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------~~~~~p~~vr~~e~~~~--~~~~hlV~ 816 (1028)
...++|+++++||+|+||.||+|.+..+++.||||++..... ...+||+++++++++.. ....+|||
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 345789999999999999999999999999999999974321 12258999998887765 55679999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ +|+|..
T Consensus 113 e~~~~~~l~~ 122 (330)
T 3nsz_A 113 EHVNNTDFKQ 122 (330)
T ss_dssp ECCCCCCHHH
T ss_pred eccCchhHHH
Confidence 999 556655
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.27 E-value=4.8e-07 Score=96.16 Aligned_cols=74 Identities=30% Similarity=0.369 Sum_probs=62.4
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+.+|.+++.||+|+||.||+|.+..+|+.||||++..... .. .||+++++++++......+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEE
Confidence 46789999999999999999999999999999999863210 11 5899999988888888889
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ +|+|..
T Consensus 88 lv~e~~~~~~L~~ 100 (278)
T 3cok_A 88 LVLEMCHNGEMNR 100 (278)
T ss_dssp EEEECCTTEEHHH
T ss_pred EEEecCCCCcHHH
Confidence 999999 567765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=98.27 E-value=2.5e-07 Score=97.87 Aligned_cols=74 Identities=27% Similarity=0.342 Sum_probs=62.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
+++|++++.||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++......+||||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46899999999999999999999999999999998642210 1158999999888888888899999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|.+
T Consensus 86 ~~~~~~L~~ 94 (276)
T 2yex_A 86 YCSGGELFD 94 (276)
T ss_dssp CCTTEEGGG
T ss_pred ecCCCcHHH
Confidence 99 568877
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.5e-07 Score=109.41 Aligned_cols=77 Identities=21% Similarity=0.285 Sum_probs=64.5
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
...++|.++++||+|+||+||+|.++.+|+.||||++.+... .. .||++|++++++......+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEE
Confidence 345789999999999999999999999999999999853210 11 5899999999988888999
Q ss_pred EEEecC-CCCCCccc
Q psy18163 814 LVTENP-GGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~ 827 (1028)
|||||+ +|+|...+
T Consensus 98 lv~e~~~~~~L~~~~ 112 (486)
T 3mwu_A 98 IVGELYTGGELFDEI 112 (486)
T ss_dssp EEECCCCSCBHHHHH
T ss_pred EEEEcCCCCcHHHHH
Confidence 999998 77886643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=98.26 E-value=1.1e-06 Score=98.96 Aligned_cols=72 Identities=26% Similarity=0.248 Sum_probs=55.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcC------c
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVES------E 810 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~------~ 810 (1028)
.+|.+++.||+|+||.||+|.+..+|+.||||++..... .. .|||++++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccCC
Confidence 589999999999999999999999999999999964321 11 589999988776432 5
Q ss_pred CcEEEEecCCCCCCc
Q psy18163 811 LNHLVTENPGGPLNK 825 (1028)
Q Consensus 811 ~~hlV~E~~~G~L~~ 825 (1028)
..+|||||++|+|..
T Consensus 108 ~~~lv~e~~~~~L~~ 122 (367)
T 2fst_X 108 DVYLVTHLMGADLNN 122 (367)
T ss_dssp CCEEEEECCCEECC-
T ss_pred eEEEEecccCCCHHH
Confidence 579999999998877
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.4e-06 Score=96.39 Aligned_cols=73 Identities=23% Similarity=0.150 Sum_probs=59.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcC------
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESEL------ 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~------ 811 (1028)
.+|.+.+.||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5799999999999999999999999999999998653211 0158999998887765543
Q ss_pred cEEEEecCCCCCCc
Q psy18163 812 NHLVTENPGGPLNK 825 (1028)
Q Consensus 812 ~hlV~E~~~G~L~~ 825 (1028)
.+|||||++|+|..
T Consensus 104 ~~lv~e~~~~~l~~ 117 (353)
T 3coi_A 104 FYLVMPFMQTDLQK 117 (353)
T ss_dssp CEEEEECCSEEGGG
T ss_pred EEEEeccccCCHHH
Confidence 49999999998876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.26 E-value=6e-07 Score=98.18 Aligned_cols=75 Identities=19% Similarity=0.183 Sum_probs=62.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEc-----cCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~-----~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~ 811 (1028)
..+|++++.||+|+||.||+|.+. .++..||||++..... .. .||+++++++++.....
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCc
Confidence 368999999999999999999998 4568999999975321 11 58999999988888889
Q ss_pred cEEEEecC-CCCCCccc
Q psy18163 812 NHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~ 827 (1028)
.+|||||+ +|+|.+.+
T Consensus 125 ~~lv~e~~~~~~L~~~l 141 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFL 141 (343)
T ss_dssp CEEEEECCTTCBHHHHH
T ss_pred eEEEEecCCCCcHHHHH
Confidence 99999999 67888744
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=3.3e-07 Score=106.63 Aligned_cols=76 Identities=22% Similarity=0.113 Sum_probs=61.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCc------
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESE------ 810 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~------ 810 (1028)
+.+|+++++||+|+||+||+|.+..+|+.||||++...... .-.|||+|++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56899999999999999999999999999999999743110 016899999988875443
Q ss_pred CcEEEEecCCCCCCccc
Q psy18163 811 LNHLVTENPGGPLNKKE 827 (1028)
Q Consensus 811 ~~hlV~E~~~G~L~~~~ 827 (1028)
..+|||||++|+|....
T Consensus 141 ~~~lv~E~~~~~l~~~~ 157 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVI 157 (464)
T ss_dssp EEEEEEECCSEEHHHHH
T ss_pred eEEEEEeCCCCCHHHHH
Confidence 35999999988776633
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=98.25 E-value=5.6e-07 Score=105.33 Aligned_cols=74 Identities=18% Similarity=0.161 Sum_probs=63.2
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc------------cCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL------------ENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~------------~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
.+|.+.++||+|+||.||+|.++.++..||||.+....... -.||++|++++++......+|||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence 47999999999999999999999999999999997543210 15899999999888888899999999
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|.+.
T Consensus 300 ~g~L~~~ 306 (495)
T 1opk_A 300 YGNLLDY 306 (495)
T ss_dssp TCBHHHH
T ss_pred CCCHHHH
Confidence 6888773
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=8.4e-07 Score=96.76 Aligned_cols=73 Identities=27% Similarity=0.250 Sum_probs=58.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------------cccCCchhhhhhHhhhcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------------WLENFPSRIRTYHLQVESE 810 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------------~~~~~p~~vr~~e~~~~~~ 810 (1028)
++|.+++.||+|+||.||+|.+..+|+.||||++..... .. .||+++++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC-
Confidence 579999999999999999999999999999999864211 01 589999888776544
Q ss_pred CcEEEEecC-CCCCCccc
Q psy18163 811 LNHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 811 ~~hlV~E~~-~G~L~~~~ 827 (1028)
..+|||||+ +|+|.+.+
T Consensus 88 ~~~lv~e~~~~~~L~~~~ 105 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKV 105 (322)
T ss_dssp SEEEEEECCTTEETHHHH
T ss_pred ceEEEEecCCCCcHHHHH
Confidence 479999999 66887633
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4.5e-07 Score=99.84 Aligned_cols=74 Identities=22% Similarity=0.177 Sum_probs=61.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEc---cCCcEEEeeecCCCcc-----c------------ccCCchhhhhhHhhhcCcC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDK---RTDEIVAPCKSGNGKF-----W------------LENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~---~tg~~VAIK~I~~~~~-----~------------~~~~p~~vr~~e~~~~~~~ 811 (1028)
.++|++++.||+|+||.||+|++. .+|+.||||++.+... . .-.||+++++++++.....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 468999999999999999999986 7899999999875321 0 0058999999888888889
Q ss_pred cEEEEecC-CCCCCc
Q psy18163 812 NHLVTENP-GGPLNK 825 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~ 825 (1028)
.+|||||+ +|+|..
T Consensus 96 ~~lv~e~~~~~~L~~ 110 (327)
T 3a62_A 96 LYLILEYLSGGELFM 110 (327)
T ss_dssp EEEEEECCTTEEHHH
T ss_pred EEEEEeCCCCCcHHH
Confidence 99999999 677766
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.25 E-value=4e-07 Score=98.79 Aligned_cols=73 Identities=19% Similarity=0.170 Sum_probs=58.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhh--------hcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQ--------VESE 810 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~--------~~~~ 810 (1028)
.+|.+.+.||+|+||.||+|.+..+|+.||||++..... ....||+++++++++ ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 379999999999999999999999999999999854321 111489999887665 3334
Q ss_pred CcEEEEecCCCCCCc
Q psy18163 811 LNHLVTENPGGPLNK 825 (1028)
Q Consensus 811 ~~hlV~E~~~G~L~~ 825 (1028)
..+|||||++|+|.+
T Consensus 108 ~~~lv~e~~~g~L~~ 122 (337)
T 3ll6_A 108 EFLLLTELCKGQLVE 122 (337)
T ss_dssp EEEEEEECCSEEHHH
T ss_pred eEEEEEEecCCCHHH
Confidence 579999999998877
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=98.25 E-value=1e-06 Score=98.70 Aligned_cols=73 Identities=23% Similarity=0.150 Sum_probs=60.4
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCc-----
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELN----- 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~----- 812 (1028)
.+|.+++.||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 5899999999999999999999999999999999753211 01589999998887665544
Q ss_pred -EEEEecCCCCCCc
Q psy18163 813 -HLVTENPGGPLNK 825 (1028)
Q Consensus 813 -hlV~E~~~G~L~~ 825 (1028)
+|||||++|+|..
T Consensus 122 ~~lv~e~~~~~l~~ 135 (371)
T 4exu_A 122 FYLVMPFMQTDLQK 135 (371)
T ss_dssp CEEEEECCCEEHHH
T ss_pred EEEEEccccccHHH
Confidence 9999999988766
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=2.6e-07 Score=101.98 Aligned_cols=76 Identities=16% Similarity=0.104 Sum_probs=60.8
Q ss_pred cceeEeeeeeccceeEEEEEE-----EccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCc-C
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAK-----DKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESE-L 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~-----~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~-~ 811 (1028)
++|++++.||+|+||.||+|+ +..+++.||||++...... ...||++|++++++.... .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 689999999999999999999 5667799999999753211 115899999988766544 4
Q ss_pred cEEEEecC-CCCCCcccC
Q psy18163 812 NHLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~~ 828 (1028)
.+|||||+ +|+|.+.+.
T Consensus 102 ~~iv~e~~~~g~L~~~l~ 119 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLR 119 (359)
T ss_dssp CEEEEECCTTEEHHHHHH
T ss_pred eEEEEEecCCCcHHHHHH
Confidence 89999999 778887554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=98.24 E-value=3.1e-07 Score=99.51 Aligned_cols=74 Identities=15% Similarity=0.056 Sum_probs=62.2
Q ss_pred ccceeEe-eeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCL-NRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l-~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.+.|.++ +.||+|+||.||+|.+..+|+.||||++..... ....||+++++++++......+|||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4579986 789999999999999999999999999965321 1125899999999888888999999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ +|+|..
T Consensus 91 e~~~~~~L~~ 100 (316)
T 2ac3_A 91 EKMRGGSILS 100 (316)
T ss_dssp ECCTTCBHHH
T ss_pred EcCCCCcHHH
Confidence 999 678876
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.23 E-value=8.4e-07 Score=98.92 Aligned_cols=75 Identities=20% Similarity=0.271 Sum_probs=60.7
Q ss_pred cccceeEeeeeeccceeEEEEEEEc---cCCcEEEeeecCCCcc------------------cccCCchhhhhhHhhhcC
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDK---RTDEIVAPCKSGNGKF------------------WLENFPSRIRTYHLQVES 809 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~---~tg~~VAIK~I~~~~~------------------~~~~~p~~vr~~e~~~~~ 809 (1028)
.+.+|++++.||+|+||.||+|++. .+|+.||||++.+... ....||++++++.++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3578999999999999999999995 5899999999864210 011478888888777777
Q ss_pred cCcEEEEecC-CCCCCc
Q psy18163 810 ELNHLVTENP-GGPLNK 825 (1028)
Q Consensus 810 ~~~hlV~E~~-~G~L~~ 825 (1028)
...+|||||+ +|+|.+
T Consensus 132 ~~~~lv~e~~~~~~L~~ 148 (355)
T 1vzo_A 132 TKLHLILDYINGGELFT 148 (355)
T ss_dssp TEEEEEECCCCSCBHHH
T ss_pred ceEEEEeecCCCCCHHH
Confidence 8889999999 668766
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=6e-07 Score=103.08 Aligned_cols=74 Identities=20% Similarity=0.104 Sum_probs=61.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc------------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF------------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~------------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+|++++.||+|+||.||+|.+..+++.||||++..... ....+++++++++.+......+|
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 579999999999999999999999999999999975321 01156788888877777788899
Q ss_pred EEecCCCCCCcc
Q psy18163 815 VTENPGGPLNKK 826 (1028)
Q Consensus 815 V~E~~~G~L~~~ 826 (1028)
||||++|+|.+.
T Consensus 177 v~e~~~~~L~~~ 188 (429)
T 3kvw_A 177 TFELLSMNLYEL 188 (429)
T ss_dssp EECCCCCBHHHH
T ss_pred EEeccCCCHHHH
Confidence 999999988773
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.23 E-value=5.6e-07 Score=97.20 Aligned_cols=72 Identities=14% Similarity=0.225 Sum_probs=54.7
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.+.+|++++.||+|+||.||+|.+..+|+.||||++..... ..-.||+++++++++......+||
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 46789999999999999999999999999999999975321 011689999999888888889999
Q ss_pred EecCCCC
Q psy18163 816 TENPGGP 822 (1028)
Q Consensus 816 ~E~~~G~ 822 (1028)
|||+++.
T Consensus 103 ~e~~~~~ 109 (318)
T 2dyl_A 103 MELMGTC 109 (318)
T ss_dssp ECCCSEE
T ss_pred EeccCCc
Confidence 9999543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=1.2e-06 Score=93.39 Aligned_cols=73 Identities=22% Similarity=0.246 Sum_probs=58.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------------ccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
.+|++.+.||+|+||.||+|.+..+++.||||++...... .-.||+++++++++.. ..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PP 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT--TT
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC--CC
Confidence 5899999999999999999999999999999998642210 0158899888877653 34
Q ss_pred EEEEecC-CCCCCccc
Q psy18163 813 HLVTENP-GGPLNKKE 827 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~ 827 (1028)
+|||||+ +|+|....
T Consensus 97 ~lv~e~~~~~~L~~~l 112 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRL 112 (287)
T ss_dssp EEEEECCTTCBHHHHH
T ss_pred eEEEEecCCCCHHHHH
Confidence 8999999 67886633
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=1.6e-06 Score=94.50 Aligned_cols=75 Identities=19% Similarity=0.175 Sum_probs=61.6
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCcEEEEec
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELNHLVTEN 818 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~hlV~E~ 818 (1028)
..+|.+.+.||+|+||.||+|.+ .+|..||||++...... .-.||+++++++++......+|||||
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 116 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence 46899999999999999999986 47999999998743210 11589999999888888889999999
Q ss_pred C-CCCCCccc
Q psy18163 819 P-GGPLNKKE 827 (1028)
Q Consensus 819 ~-~G~L~~~~ 827 (1028)
+ +|+|.+.+
T Consensus 117 ~~~~~L~~~l 126 (321)
T 2qkw_B 117 MENGNLKRHL 126 (321)
T ss_dssp CTTCBTGGGS
T ss_pred CCCCcHHHHH
Confidence 9 77888743
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.23 E-value=8.4e-07 Score=98.78 Aligned_cols=74 Identities=16% Similarity=0.082 Sum_probs=57.9
Q ss_pred cceeEeeeeeccceeEEEEE-----EEccCCcEEEeeecCCCcc-------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRA-----KDKRTDEIVAPCKSGNGKF-------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a-----~~~~tg~~VAIK~I~~~~~-------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+|.+.+.||+|+||.||+| .+..+++.||||++..... ....|++++++++++......+|
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 57999999999999999999 5788999999999975431 11137888888888777888899
Q ss_pred EEecC-CCCCCcc
Q psy18163 815 VTENP-GGPLNKK 826 (1028)
Q Consensus 815 V~E~~-~G~L~~~ 826 (1028)
||||+ +|+|.+.
T Consensus 145 v~e~~~~g~L~~~ 157 (365)
T 3e7e_A 145 VGELYSYGTLLNA 157 (365)
T ss_dssp EECCCCSCBHHHH
T ss_pred EEeccCCCcHHHH
Confidence 99999 7888873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=98.22 E-value=4.3e-07 Score=101.90 Aligned_cols=75 Identities=9% Similarity=-0.044 Sum_probs=57.2
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCc-----------------cccc--CCchhhhhhH-------hh
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGK-----------------FWLE--NFPSRIRTYH-------LQ 806 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~-----------------~~~~--~~p~~vr~~e-------~~ 806 (1028)
.+|.+.+.||+|+||.||+|++..+|+.||||++.... .... .|||+|+++. ++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 58999999999999999999999999999999986321 0011 5899999873 33
Q ss_pred hcCc-----------------CcEEEEecCCCCCCccc
Q psy18163 807 VESE-----------------LNHLVTENPGGPLNKKE 827 (1028)
Q Consensus 807 ~~~~-----------------~~hlV~E~~~G~L~~~~ 827 (1028)
.... ..+|||||++|+|.+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l 190 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHH
T ss_pred hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHH
Confidence 2221 37899999999988733
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=98.22 E-value=2.3e-07 Score=101.74 Aligned_cols=74 Identities=30% Similarity=0.357 Sum_probs=63.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-------------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+|++++.||+|+||.||+|.+..++..||||++..... .. .||+++++++++......+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEE
Confidence 579999999999999999999999999999999863210 11 5899999999988888899
Q ss_pred EEEecC-CCCCCccc
Q psy18163 814 LVTENP-GGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~ 827 (1028)
|||||+ +|+|.+.+
T Consensus 105 lv~e~~~gg~L~~~l 119 (345)
T 3hko_A 105 LVMELCHGGHLLDKL 119 (345)
T ss_dssp EEEECCCSCBHHHHE
T ss_pred EEEeCCCCCcHHHHH
Confidence 999999 88887744
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=98.22 E-value=6.9e-07 Score=95.90 Aligned_cols=73 Identities=21% Similarity=0.228 Sum_probs=59.0
Q ss_pred cceeEeeeeeccceeEEEEEE----EccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhc--CcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAK----DKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVE--SELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~----~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~--~~~~ 812 (1028)
.+|++++.||+|+||.||+|+ +..+++.||||++..... .. .||+++++++++.. ....
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCce
Confidence 689999999999999999999 677999999999875321 11 58999998876533 3567
Q ss_pred EEEEecC-CCCCCcc
Q psy18163 813 HLVTENP-GGPLNKK 826 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~ 826 (1028)
+|||||+ +|+|.+.
T Consensus 89 ~lv~e~~~~~~L~~~ 103 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDY 103 (295)
T ss_dssp EEEEECCTTCBHHHH
T ss_pred EEEEEeCCCCCHHHH
Confidence 9999999 7788773
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.22 E-value=1.2e-06 Score=96.08 Aligned_cols=76 Identities=17% Similarity=0.012 Sum_probs=61.5
Q ss_pred cceeEeeeeeccceeEEEEEEEc-----cCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~-----~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
.+|.+.+.||+|+||.||+|.+. .++..||||++...... ...||+++++++++......
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 58999999999999999999983 46678999999743210 11589999999888888899
Q ss_pred EEEEecC-CCCCCcccC
Q psy18163 813 HLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~~ 828 (1028)
+|||||+ +|+|.+.+.
T Consensus 125 ~lv~e~~~~g~L~~~l~ 141 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLR 141 (344)
T ss_dssp EEEEECCTTCBHHHHHH
T ss_pred EEEEecCCCCcHHHHHh
Confidence 9999999 779987554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.5e-06 Score=92.08 Aligned_cols=72 Identities=22% Similarity=0.218 Sum_probs=59.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
++|++++.||+|+||.||+|.+. ++..||||++...... .-.||+++++++++......+|||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 58999999999999999999987 5778999999754311 115899999998888888899999999
Q ss_pred CCCCCc
Q psy18163 820 GGPLNK 825 (1028)
Q Consensus 820 ~G~L~~ 825 (1028)
+|+|.+
T Consensus 89 ~~~L~~ 94 (269)
T 4hcu_A 89 HGCLSD 94 (269)
T ss_dssp TCBHHH
T ss_pred CCcHHH
Confidence 667766
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.21 E-value=4.9e-07 Score=101.47 Aligned_cols=73 Identities=26% Similarity=0.155 Sum_probs=53.4
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCc------C
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESE------L 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~------~ 811 (1028)
..|.+++.||+|+||.||+|.+..+|+.||||++...... .-.|||++++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 5799999999999999999999999999999999643211 005899999888765542 3
Q ss_pred cEEEEecCCCCCCc
Q psy18163 812 NHLVTENPGGPLNK 825 (1028)
Q Consensus 812 ~hlV~E~~~G~L~~ 825 (1028)
.+|||||++|+|..
T Consensus 105 ~~lv~e~~~~~L~~ 118 (367)
T 1cm8_A 105 FYLVMPFMGTDLGK 118 (367)
T ss_dssp CEEEEECCSEEHHH
T ss_pred EEEEEecCCCCHHH
Confidence 59999999888876
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=98.20 E-value=5.5e-07 Score=98.32 Aligned_cols=75 Identities=15% Similarity=0.063 Sum_probs=62.7
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc-------------------cCCchhhhhhHhhhcCcCc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL-------------------ENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~-------------------~~~p~~vr~~e~~~~~~~~ 812 (1028)
.+.|++++.||+|+||.||+|.+..+|+.||||++....... -.||+++++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999999999999999987432110 0579999998888888889
Q ss_pred EEEEecC-CCCCCcc
Q psy18163 813 HLVTENP-GGPLNKK 826 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~ 826 (1028)
+|||||+ +|+|.+.
T Consensus 91 ~lv~e~~~~~~L~~~ 105 (321)
T 2a2a_A 91 VLILELVSGGELFDF 105 (321)
T ss_dssp EEEECCCCSCBHHHH
T ss_pred EEEEEcCCCCcHHHH
Confidence 9999999 7788763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=6.3e-07 Score=95.35 Aligned_cols=73 Identities=23% Similarity=0.288 Sum_probs=61.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.++|.+++.||+|+||.||+|.+..+|..||+|++..... .. .||+++++++++......+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEE
Confidence 4689999999999999999999999999999999864321 11 589999998888888888999
Q ss_pred EecC-CCCCCc
Q psy18163 816 TENP-GGPLNK 825 (1028)
Q Consensus 816 ~E~~-~G~L~~ 825 (1028)
|||+ +|+|..
T Consensus 84 ~e~~~~~~l~~ 94 (284)
T 3kk8_A 84 FDLVTGGELFE 94 (284)
T ss_dssp ECCCCSCBHHH
T ss_pred EecCCCCCHHH
Confidence 9999 667765
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=3.8e-07 Score=99.54 Aligned_cols=74 Identities=20% Similarity=0.230 Sum_probs=61.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.++|++++.||+|+||.||+|.++.+|+.||||++..... ..-.||+++++++++......+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 3689999999999999999999999999999999975321 1126899999998888888889999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||++|+|..
T Consensus 101 e~~~~~l~~ 109 (327)
T 3aln_A 101 ELMSTSFDK 109 (327)
T ss_dssp CCCSEEHHH
T ss_pred eecCCChHH
Confidence 999887655
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=98.20 E-value=7.4e-07 Score=94.49 Aligned_cols=73 Identities=15% Similarity=0.127 Sum_probs=58.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------cCCchhhhhhHhhhc---------------
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------ENFPSRIRTYHLQVE--------------- 808 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------~~~p~~vr~~e~~~~--------------- 808 (1028)
.+|++++.||+|+||.||+|.+..+|+.||||++....... -.||+++++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 57999999999999999999999999999999997543211 158888888765532
Q ss_pred -CcCcEEEEecC-CCCCCc
Q psy18163 809 -SELNHLVTENP-GGPLNK 825 (1028)
Q Consensus 809 -~~~~hlV~E~~-~G~L~~ 825 (1028)
....+|||||+ +|+|.+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~ 109 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQ 109 (284)
T ss_dssp EEEEEEEEECCCCSCBHHH
T ss_pred CcceEEEEEeccCCCCHHH
Confidence 34579999999 568877
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=7.4e-07 Score=95.51 Aligned_cols=75 Identities=19% Similarity=0.049 Sum_probs=62.9
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------------cccCCchhhhhhHhhh
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------------WLENFPSRIRTYHLQV 807 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------------~~~~~p~~vr~~e~~~ 807 (1028)
...+|++++.||+|+||.||+|.++.+|+.||||++..... ...+||+++++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35789999999999999999999999999999999864320 0114899999988888
Q ss_pred cCcCcEEEEecC-CCCCCc
Q psy18163 808 ESELNHLVTENP-GGPLNK 825 (1028)
Q Consensus 808 ~~~~~hlV~E~~-~G~L~~ 825 (1028)
.....+|||||+ +|+|.+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~ 113 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFD 113 (298)
T ss_dssp CSSEEEEEEECCTTCBHHH
T ss_pred cCCeEEEEEeccCCCcHHH
Confidence 888899999999 567766
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=98.19 E-value=1.1e-06 Score=95.46 Aligned_cols=77 Identities=26% Similarity=0.424 Sum_probs=60.9
Q ss_pred CccccceeEeeeeeccceeEEEEEEEc-cCCcEEEeeecCCCccc----------------c--cCCchhhhhhHhhh--
Q psy18163 749 CRSVEEFKCLNRIEEGTYGVVYRAKDK-RTDEIVAPCKSGNGKFW----------------L--ENFPSRIRTYHLQV-- 807 (1028)
Q Consensus 749 ~~~~~~Y~~l~~IGeGsyG~Vy~a~~~-~tg~~VAIK~I~~~~~~----------------~--~~~p~~vr~~e~~~-- 807 (1028)
|....+|++++.||+|+||.||+|.+. .+|+.||||++...... . -.||+++++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 445578999999999999999999996 78899999998632110 0 05889998887765
Q ss_pred ---cCcCcEEEEecCCCCCCc
Q psy18163 808 ---ESELNHLVTENPGGPLNK 825 (1028)
Q Consensus 808 ---~~~~~hlV~E~~~G~L~~ 825 (1028)
.....+|||||++|+|..
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~ 107 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTT 107 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHH
T ss_pred ccCCCceEEEEEecCCCCHHH
Confidence 456779999999998877
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.1e-06 Score=94.42 Aligned_cols=74 Identities=19% Similarity=0.263 Sum_probs=59.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCcEEEEec
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELNHLVTEN 818 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~hlV~E~ 818 (1028)
.+.|++++.||+|+||.||+|.+..+|..||+|++...... .-.||+++++++++......+|||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46899999999999999999999999999999998643210 01589999998888888889999999
Q ss_pred C-CCCCCc
Q psy18163 819 P-GGPLNK 825 (1028)
Q Consensus 819 ~-~G~L~~ 825 (1028)
+ +|+|..
T Consensus 98 ~~~~~l~~ 105 (302)
T 2j7t_A 98 CPGGAVDA 105 (302)
T ss_dssp CTTEEHHH
T ss_pred CCCCcHHH
Confidence 9 556654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=98.19 E-value=4.7e-07 Score=101.46 Aligned_cols=74 Identities=20% Similarity=0.116 Sum_probs=60.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCc------
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESE------ 810 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~------ 810 (1028)
+.+|++++.||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 57899999999999999999999999999999998643210 015899999887765543
Q ss_pred CcEEEEecCCCCCCc
Q psy18163 811 LNHLVTENPGGPLNK 825 (1028)
Q Consensus 811 ~~hlV~E~~~G~L~~ 825 (1028)
..+|||||++|+|..
T Consensus 104 ~~~lv~e~~~~~l~~ 118 (371)
T 2xrw_A 104 DVYIVMELMDANLCQ 118 (371)
T ss_dssp EEEEEEECCSEEHHH
T ss_pred ceEEEEEcCCCCHHH
Confidence 569999999887766
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.18 E-value=3.2e-07 Score=101.63 Aligned_cols=74 Identities=19% Similarity=0.291 Sum_probs=62.3
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------------cccCCchhhhhhHhhhc
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------------WLENFPSRIRTYHLQVE 808 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------------~~~~~p~~vr~~e~~~~ 808 (1028)
...+|.+++.||+|+||.||+|.++.+|+.||||++..... .. .||+++++++++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee
Confidence 34689999999999999999999999999999999875421 11 58999999998888
Q ss_pred CcCcEEEEecC-CC-CCCc
Q psy18163 809 SELNHLVTENP-GG-PLNK 825 (1028)
Q Consensus 809 ~~~~hlV~E~~-~G-~L~~ 825 (1028)
....+|||||+ +| +|..
T Consensus 101 ~~~~~lv~e~~~~g~~l~~ 119 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFA 119 (335)
T ss_dssp SSEEEEEEECCTTSCBHHH
T ss_pred CCEEEEEEEeCCCCccHHH
Confidence 88899999987 44 6655
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=98.18 E-value=5.3e-07 Score=97.40 Aligned_cols=73 Identities=15% Similarity=0.173 Sum_probs=61.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCcEEEEecC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELNHLVTENP 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~hlV~E~~ 819 (1028)
.+|.+++.||+|+||.||+|++..+|+.||||++...... .-.||+++++++++......+|||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 5799999999999999999999999999999999753211 015899999988888888889999999
Q ss_pred -CCCCCc
Q psy18163 820 -GGPLNK 825 (1028)
Q Consensus 820 -~G~L~~ 825 (1028)
+|+|.+
T Consensus 89 ~~~~L~~ 95 (304)
T 2jam_A 89 SGGELFD 95 (304)
T ss_dssp CSCBHHH
T ss_pred CCccHHH
Confidence 678866
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=98.18 E-value=6.1e-07 Score=99.45 Aligned_cols=74 Identities=19% Similarity=0.218 Sum_probs=62.7
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
..+|++++.||+|+||.||+|.+..+|..||+|++..... ..-.||+++++++++......+||||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 3689999999999999999999999999999999874311 01168999999988888888999999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|..
T Consensus 112 ~~~~~~L~~ 120 (360)
T 3eqc_A 112 HMDGGSLDQ 120 (360)
T ss_dssp CCTTCBHHH
T ss_pred CCCCCCHHH
Confidence 99 668876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=2.3e-06 Score=91.89 Aligned_cols=72 Identities=21% Similarity=0.171 Sum_probs=57.1
Q ss_pred cceeEeeeeeccceeEEEEEE----EccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcC--cC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAK----DKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVES--EL 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~----~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~--~~ 811 (1028)
..|++++.||+|+||.||+|+ +..+++.||||++..... .. .||+++++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCce
Confidence 569999999999999999999 678999999999974321 11 589999988777655 56
Q ss_pred cEEEEecC-CCCCCc
Q psy18163 812 NHLVTENP-GGPLNK 825 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~ 825 (1028)
.+|||||+ +|+|.+
T Consensus 100 ~~lv~e~~~~~~L~~ 114 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKE 114 (302)
T ss_dssp EEEEEECCTTCBHHH
T ss_pred EEEEEEeCCCCcHHH
Confidence 79999999 668877
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=98.17 E-value=3.5e-07 Score=97.45 Aligned_cols=75 Identities=21% Similarity=0.296 Sum_probs=62.4
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+++|++++.||+|+||.||+|.+..++..||||++..... ..-.||+++++++++......+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 46799999999999999999999999999999999853210 01158999999988888888999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|..
T Consensus 87 v~e~~~~~~l~~ 98 (279)
T 3fdn_A 87 ILEYAPLGTVYR 98 (279)
T ss_dssp EECCCTTEEHHH
T ss_pred EEecCCCCcHHH
Confidence 99999 567766
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=8.1e-07 Score=93.32 Aligned_cols=74 Identities=11% Similarity=0.108 Sum_probs=59.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcC--cCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVES--ELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~--~~~hl 814 (1028)
+++|.+++.||+|+||.||+|.+. |..||||++...... .-.||+++++++++... ...+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 578999999999999999999984 889999998753210 11589999998887665 67799
Q ss_pred EEecC-CCCCCccc
Q psy18163 815 VTENP-GGPLNKKE 827 (1028)
Q Consensus 815 V~E~~-~G~L~~~~ 827 (1028)
||||+ +|+|.+.+
T Consensus 87 v~e~~~~~~L~~~l 100 (271)
T 3kmu_A 87 ITHWMPYGSLYNVL 100 (271)
T ss_dssp EEECCTTCBHHHHH
T ss_pred eecccCCCcHHHHH
Confidence 99999 67888743
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.16 E-value=5.6e-07 Score=100.92 Aligned_cols=74 Identities=18% Similarity=0.180 Sum_probs=59.4
Q ss_pred cceeEeeeeeccceeEEEEEE-----EccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAK-----DKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~-----~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+|.+++.||+|+||+||+|. +..++..||||++...... .-.||++|++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 589999999999999999999 5668889999998643210 016899999998888888889
Q ss_pred EEEecC-CCCCCcc
Q psy18163 814 LVTENP-GGPLNKK 826 (1028)
Q Consensus 814 lV~E~~-~G~L~~~ 826 (1028)
|||||+ +|+|...
T Consensus 151 lv~e~~~~g~L~~~ 164 (367)
T 3l9p_A 151 ILLELMAGGDLKSF 164 (367)
T ss_dssp EEEECCTTEEHHHH
T ss_pred EEEEeCCCCCHHHH
Confidence 999999 7788773
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.3e-06 Score=96.68 Aligned_cols=75 Identities=13% Similarity=0.150 Sum_probs=56.4
Q ss_pred cceeEeeeeeccceeEEEEEEEccC--------CcEEEeeecCCCccc--------ccCCchhhhhhHhhhc--------
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRT--------DEIVAPCKSGNGKFW--------LENFPSRIRTYHLQVE-------- 808 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~t--------g~~VAIK~I~~~~~~--------~~~~p~~vr~~e~~~~-------- 808 (1028)
.+|.+++.||+|+||.||+|.+..| ++.||||++...... .-.||++|+++..+..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 6899999999999999999999985 889999999754211 0158899886544321
Q ss_pred --------CcCcEEEEecCCCCCCccc
Q psy18163 809 --------SELNHLVTENPGGPLNKKE 827 (1028)
Q Consensus 809 --------~~~~hlV~E~~~G~L~~~~ 827 (1028)
....+|||||++|+|.+.+
T Consensus 122 ~~~~~~~~~~~~~lv~e~~~~~L~~~l 148 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSLGRSLQSAL 148 (352)
T ss_dssp CCEEEEETTTEEEEEEECCCEEHHHHH
T ss_pred hhhccccCCcEEEEEecCCCcCHHHHH
Confidence 4567999999988998843
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.6e-06 Score=91.58 Aligned_cols=72 Identities=26% Similarity=0.221 Sum_probs=59.2
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc------------cCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL------------ENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~------------~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
++|++++.||+|+||.||+|.+. ++..||||++....... -.||+++++++++......+|||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 68999999999999999999775 57789999997543110 15899999988888888889999999
Q ss_pred CCCCCc
Q psy18163 820 GGPLNK 825 (1028)
Q Consensus 820 ~G~L~~ 825 (1028)
+|+|.+
T Consensus 87 ~~~L~~ 92 (268)
T 3sxs_A 87 NGCLLN 92 (268)
T ss_dssp TCBHHH
T ss_pred CCcHHH
Confidence 677766
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.16 E-value=8.9e-07 Score=99.82 Aligned_cols=70 Identities=20% Similarity=0.180 Sum_probs=54.2
Q ss_pred eeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 755 Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
|...+.||+|+||.||+|.+..+|+.||||++..... .. .||++|++++++......+|||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 4457889999999999999999999999999975321 12 6899999999888888899999999
Q ss_pred CCCCCc
Q psy18163 820 GGPLNK 825 (1028)
Q Consensus 820 ~G~L~~ 825 (1028)
+|+|.+
T Consensus 170 ~~~L~~ 175 (373)
T 2x4f_A 170 GGELFD 175 (373)
T ss_dssp TCEEHH
T ss_pred CCcHHH
Confidence 678876
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=98.16 E-value=4.3e-07 Score=110.67 Aligned_cols=76 Identities=21% Similarity=0.183 Sum_probs=62.9
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+.+|++++.||+|+||.||+|+++.+++.||||++.+... ....+|++++++.++......+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 46789999999999999999999999999999999864210 1125788888888888888899
Q ss_pred EEEecC-CCCCCcc
Q psy18163 814 LVTENP-GGPLNKK 826 (1028)
Q Consensus 814 lV~E~~-~G~L~~~ 826 (1028)
|||||+ ||+|...
T Consensus 419 lV~E~~~gg~L~~~ 432 (674)
T 3pfq_A 419 FVMEYVNGGDLMYH 432 (674)
T ss_dssp EEEECCCSCBHHHH
T ss_pred EEEeCcCCCcHHHH
Confidence 999999 7788763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.2e-06 Score=95.33 Aligned_cols=74 Identities=19% Similarity=0.230 Sum_probs=60.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhc------CcCc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVE------SELN 812 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~------~~~~ 812 (1028)
...|++++.||+|+||.||+|.+..+|+.||||++...... ...||+++++++++.. ....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 35899999999999999999999999999999998643211 1158999998877655 3567
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||+ +|+|.+
T Consensus 103 ~lv~e~~~~~~L~~ 116 (326)
T 2x7f_A 103 WLVMEFCGAGSVTD 116 (326)
T ss_dssp EEEEECCTTEEHHH
T ss_pred EEEEEcCCCCcHHH
Confidence 9999999 558876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1e-06 Score=95.91 Aligned_cols=73 Identities=16% Similarity=0.211 Sum_probs=59.0
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEEec
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVTEN 818 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~E~ 818 (1028)
.+|.+.+.||+|+||.||+|.+ .+|+.||||++...... .-.||+++++++++......+|||||
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 108 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence 5799999999999999999974 47999999998753211 11589999999888888889999999
Q ss_pred C-CCCCCcc
Q psy18163 819 P-GGPLNKK 826 (1028)
Q Consensus 819 ~-~G~L~~~ 826 (1028)
+ +|+|...
T Consensus 109 ~~~~~L~~~ 117 (326)
T 3uim_A 109 MANGSVASC 117 (326)
T ss_dssp CTTCBHHHH
T ss_pred ccCCCHHHH
Confidence 9 6688763
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=98.15 E-value=8.4e-07 Score=94.35 Aligned_cols=73 Identities=16% Similarity=0.183 Sum_probs=61.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
++|.+++.||+|+||.||+|.+..+|+.||||++...... .-.||+++++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4799999999999999999999999999999998643210 004899999988888888889
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ +|+|.+
T Consensus 85 lv~e~~~~~~L~~ 97 (283)
T 3bhy_A 85 LILELVSGGELFD 97 (283)
T ss_dssp EEEECCCSCBHHH
T ss_pred EEEeecCCCcHHH
Confidence 999999 678776
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=5.6e-07 Score=96.34 Aligned_cols=74 Identities=22% Similarity=0.154 Sum_probs=54.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
..+|++++.||+|+||.||+|.+..+++.||||++..... ..-.||+++++++++......+||||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 4689999999999999999999999999999999864210 00158999999988888888999999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|.+
T Consensus 94 ~~~~~~L~~ 102 (303)
T 2vwi_A 94 LLSGGSVLD 102 (303)
T ss_dssp CCTTCBHHH
T ss_pred hccCCchHH
Confidence 99 778876
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.4e-06 Score=94.54 Aligned_cols=74 Identities=16% Similarity=0.091 Sum_probs=57.7
Q ss_pred cceeEeeeeeccceeEEEEEEE-ccCCcEEEeeecCCCccc------------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKD-KRTDEIVAPCKSGNGKFW------------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~-~~tg~~VAIK~I~~~~~~------------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+|++++.||+|+||.||+|.+ ..+|+.||||++...... ...+++++++++++......+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 5899999999999999999999 568999999999743210 002234566666666677889
Q ss_pred EEEecCCCCCCcc
Q psy18163 814 LVTENPGGPLNKK 826 (1028)
Q Consensus 814 lV~E~~~G~L~~~ 826 (1028)
|||||++|+|.+.
T Consensus 94 lv~e~~~~~l~~~ 106 (339)
T 1z57_A 94 IVFELLGLSTYDF 106 (339)
T ss_dssp EEEECCCCBHHHH
T ss_pred EEEcCCCCCHHHH
Confidence 9999999988873
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=98.14 E-value=1e-06 Score=99.27 Aligned_cols=73 Identities=22% Similarity=0.230 Sum_probs=60.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEc---cCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDK---RTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~---~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
..+|.+.+.||+|+||.||+|++. .++..||||++..... .. .||+++++++++......+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceE
Confidence 358999999999999999999987 5677899999875321 11 5899999998888888899
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ +|+|.+
T Consensus 123 lv~e~~~~~sL~~ 135 (373)
T 2qol_A 123 IVTEYMENGSLDS 135 (373)
T ss_dssp EEEECCTTCBHHH
T ss_pred EEEeCCCCCcHHH
Confidence 999999 778876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=98.14 E-value=2.1e-06 Score=94.18 Aligned_cols=72 Identities=7% Similarity=0.119 Sum_probs=60.8
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-------------------------------cccCCchhh
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------------------------------WLENFPSRI 800 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------------------------------~~~~~p~~v 800 (1028)
+.+|.+++.||+|+||.||+|.+ +|+.||||++..... .. .||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence 57899999999999999999999 999999999863210 11 589999
Q ss_pred hhhHhhhcCcCcEEEEecC-CCCCCcc
Q psy18163 801 RTYHLQVESELNHLVTENP-GGPLNKK 826 (1028)
Q Consensus 801 r~~e~~~~~~~~hlV~E~~-~G~L~~~ 826 (1028)
++++++......+|||||+ +|+|.+.
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~ 133 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKF 133 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHH
Confidence 9988888888899999999 6688884
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=98.14 E-value=5.4e-07 Score=96.05 Aligned_cols=74 Identities=18% Similarity=0.140 Sum_probs=62.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
.+|++.+.||+|+||.||+|.+..++..||||.+...... .-.||+++++++++......+|||||+
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 92 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 92 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence 5899999999999999999999999999999999754321 015899999988888888899999999
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|.+.
T Consensus 93 ~~~L~~~ 99 (288)
T 3kfa_A 93 YGNLLDY 99 (288)
T ss_dssp TEEHHHH
T ss_pred CCcHHHH
Confidence 5788773
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=98.13 E-value=7.8e-07 Score=96.73 Aligned_cols=77 Identities=16% Similarity=0.046 Sum_probs=61.8
Q ss_pred CccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCc
Q psy18163 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 749 ~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
+..+.+|.+++.||+|+||.||+|.+..+++.||||++...... .-.||+++++++++......
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 44567999999999999999999999999999999998643210 01589999998888888888
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||+ +|+|.+
T Consensus 110 ~lv~e~~~~~~L~~ 123 (309)
T 2h34_A 110 YVDMRLINGVDLAA 123 (309)
T ss_dssp EEEEECCCCEEHHH
T ss_pred EEEEEecCCCCHHH
Confidence 9999999 557776
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=8.8e-07 Score=94.04 Aligned_cols=73 Identities=29% Similarity=0.208 Sum_probs=62.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... .. .||+++++++++......+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEe
Confidence 3579999999999999999999999999999999864221 12 68999999888888888999999
Q ss_pred cC-CCCCCc
Q psy18163 818 NP-GGPLNK 825 (1028)
Q Consensus 818 ~~-~G~L~~ 825 (1028)
|+ +|+|.+
T Consensus 87 ~~~~~~L~~ 95 (277)
T 3f3z_A 87 LCTGGELFE 95 (277)
T ss_dssp CCCSCBHHH
T ss_pred ccCCCcHHH
Confidence 99 667766
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=9.7e-07 Score=97.25 Aligned_cols=76 Identities=13% Similarity=0.080 Sum_probs=62.8
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
....+|.+++.||+|+||.||+|.+..+++.||+|++..... ..-.||+++++++++......+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 345789999999999999999999999999999999864311 0116899999998888888899
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ +|+|.+
T Consensus 118 lv~e~~~~~~L~~ 130 (335)
T 2owb_A 118 VVLELCRRRSLLE 130 (335)
T ss_dssp EEECCCTTCBHHH
T ss_pred EEEecCCCCCHHH
Confidence 999999 566655
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.13 E-value=4.1e-06 Score=94.17 Aligned_cols=75 Identities=16% Similarity=0.081 Sum_probs=61.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCC-------cEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTD-------EIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESE 810 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg-------~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~ 810 (1028)
++|.++++||+|+||.||+|.+..++ ..||||++...... ...||++|++++++....
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 58999999999999999999986543 57999999753211 116899999998888888
Q ss_pred CcEEEEecC-CCCCCccc
Q psy18163 811 LNHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 811 ~~hlV~E~~-~G~L~~~~ 827 (1028)
..+|||||+ +|+|.+.+
T Consensus 149 ~~~lv~e~~~~g~L~~~l 166 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYL 166 (382)
T ss_dssp SCEEEEECCTTCBHHHHH
T ss_pred ceEEEEEecCCCcHHHHH
Confidence 899999999 67887744
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.1e-06 Score=94.32 Aligned_cols=75 Identities=12% Similarity=0.064 Sum_probs=61.9
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
...+|.+.+.||+|+||.||+|.+..+++.||+|.+...... .-.||+++++++++......+|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 346899999999999999999999999999999998643110 1168999999888888888899
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|..
T Consensus 93 v~e~~~~~~L~~ 104 (294)
T 2rku_A 93 VLELCRRRSLLE 104 (294)
T ss_dssp EEECCTTCBHHH
T ss_pred EEecCCCCCHHH
Confidence 99999 466655
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.3e-06 Score=98.86 Aligned_cols=73 Identities=23% Similarity=0.248 Sum_probs=56.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------cCCchhhhhhHhhhcCc------CcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------ENFPSRIRTYHLQVESE------LNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------~~~p~~vr~~e~~~~~~------~~hlV~ 816 (1028)
..+|.+++.||+|+||+||+|++..++. ||+|++....... -.|||++++++++.... ..+|||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 3579999999999999999999988877 8888886433211 15899999987764332 378999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||++|+|..
T Consensus 118 e~~~~~l~~ 126 (394)
T 4e7w_A 118 EYVPETVYR 126 (394)
T ss_dssp ECCSEEHHH
T ss_pred eccCccHHH
Confidence 999887655
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=8.6e-07 Score=95.53 Aligned_cols=73 Identities=23% Similarity=0.293 Sum_probs=60.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEEec
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVTEN 818 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~E~ 818 (1028)
+.|++++.||+|+||.||+|.+..+++.||||++...... .-.||+++++++++......+|||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 5699999999999999999999999999999998643211 01578999988888778888999999
Q ss_pred C-CCCCCc
Q psy18163 819 P-GGPLNK 825 (1028)
Q Consensus 819 ~-~G~L~~ 825 (1028)
+ +|+|.+
T Consensus 102 ~~~~~L~~ 109 (303)
T 3a7i_A 102 LGGGSALD 109 (303)
T ss_dssp CTTEEHHH
T ss_pred CCCCcHHH
Confidence 9 557766
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.3e-06 Score=96.60 Aligned_cols=72 Identities=19% Similarity=0.193 Sum_probs=59.0
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------cc-CCchhhhhhHhhhcCcCcEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LE-NFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~-~~p~~vr~~e~~~~~~~~hlV 815 (1028)
..|++++.||+|+||.||+|.+ .+++.||||++...... .. .+|+++++++++......+||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4699999999999999999988 56899999998643211 11 238889998888888889999
Q ss_pred EecCCCCCCc
Q psy18163 816 TENPGGPLNK 825 (1028)
Q Consensus 816 ~E~~~G~L~~ 825 (1028)
|||++|+|.+
T Consensus 88 ~e~~~~~L~~ 97 (343)
T 3dbq_A 88 MECGNIDLNS 97 (343)
T ss_dssp ECCCSEEHHH
T ss_pred EeCCCCCHHH
Confidence 9988998887
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.1e-06 Score=96.38 Aligned_cols=72 Identities=22% Similarity=0.193 Sum_probs=60.1
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
.|....+||+|+||.||+|++..+|+.||||++...... .-.||+++++++++......+|||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 588889999999999999999999999999998743211 015899999988888888899999999
Q ss_pred CCCCCc
Q psy18163 820 GGPLNK 825 (1028)
Q Consensus 820 ~G~L~~ 825 (1028)
+|+|.+
T Consensus 126 ~~~L~~ 131 (321)
T 2c30_A 126 GGALTD 131 (321)
T ss_dssp SCBHHH
T ss_pred CCCHHH
Confidence 667765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=98.12 E-value=1.2e-06 Score=97.67 Aligned_cols=73 Identities=14% Similarity=0.173 Sum_probs=56.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccC-----CcEEEeeecCCCcc------------------------cccCCchhhhhh
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRT-----DEIVAPCKSGNGKF------------------------WLENFPSRIRTY 803 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~t-----g~~VAIK~I~~~~~------------------------~~~~~p~~vr~~ 803 (1028)
.+|.+++.||+|+||.||+|.+..+ ++.||||++..... ..-.||++++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 3899999999999999999999775 58899999764321 001478888888
Q ss_pred HhhhcC----cCcEEEEecCCCCCCc
Q psy18163 804 HLQVES----ELNHLVTENPGGPLNK 825 (1028)
Q Consensus 804 e~~~~~----~~~hlV~E~~~G~L~~ 825 (1028)
+++... ...+|||||+||+|.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~g~~L~~ 140 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRFGSDLQK 140 (364)
T ss_dssp EEEEEEETTEEEEEEEEECEEEEHHH
T ss_pred eeeeeccCCcceEEEEEeCCCCCHHH
Confidence 776543 4479999999888877
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=1.5e-06 Score=94.93 Aligned_cols=72 Identities=21% Similarity=0.166 Sum_probs=59.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
.+|.+++.||+|+||.||+|++ +|..||||++...... .-.||+++++++++......+||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 5899999999999999999976 6889999998753311 0158999999988888888999999
Q ss_pred cC-CCCCCcc
Q psy18163 818 NP-GGPLNKK 826 (1028)
Q Consensus 818 ~~-~G~L~~~ 826 (1028)
|+ +|+|.+.
T Consensus 115 ~~~~~~L~~~ 124 (309)
T 3p86_A 115 YLSRGSLYRL 124 (309)
T ss_dssp CCTTCBHHHH
T ss_pred cCCCCcHHHH
Confidence 99 6788773
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=6.8e-07 Score=94.69 Aligned_cols=75 Identities=23% Similarity=0.232 Sum_probs=62.3
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+.+|.+++.||+|+||.||+|.+..+|+.||||++..... ..-.||+++++++++......+|
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999853210 01158999999888888888999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|.+
T Consensus 89 v~e~~~~~~L~~ 100 (276)
T 2h6d_A 89 VMEYVSGGELFD 100 (276)
T ss_dssp EEECCCSCBHHH
T ss_pred EEeccCCCcHHH
Confidence 99999 668876
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=8.2e-07 Score=99.73 Aligned_cols=76 Identities=21% Similarity=0.133 Sum_probs=58.7
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc-------------CCc-----hhhhhhHhhhcCcCc
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE-------------NFP-----SRIRTYHLQVESELN 812 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~-------------~~p-----~~vr~~e~~~~~~~~ 812 (1028)
...+|.+++.||+|+||.||+|.+..+++.||||++........ .++ +++++++.+......
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 35789999999999999999999999999999999975321100 122 355555556666778
Q ss_pred EEEEecCCCCCCcc
Q psy18163 813 HLVTENPGGPLNKK 826 (1028)
Q Consensus 813 hlV~E~~~G~L~~~ 826 (1028)
+|||||++|+|.+.
T Consensus 132 ~lv~e~~~~~L~~~ 145 (382)
T 2vx3_A 132 CLVFEMLSYNLYDL 145 (382)
T ss_dssp EEEEECCCCBHHHH
T ss_pred EEEEecCCCCHHHH
Confidence 99999999988773
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=3.4e-06 Score=88.68 Aligned_cols=72 Identities=24% Similarity=0.240 Sum_probs=60.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
.+|.+++.||+|+||.||+|.+. ++..||||++...... .-.||+++++++++......+|||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 58999999999999999999986 6789999999854311 015899999988888888899999999
Q ss_pred CCCCCc
Q psy18163 820 GGPLNK 825 (1028)
Q Consensus 820 ~G~L~~ 825 (1028)
+|+|.+
T Consensus 87 ~~~L~~ 92 (267)
T 3t9t_A 87 HGCLSD 92 (267)
T ss_dssp TCBHHH
T ss_pred CCcHHH
Confidence 667776
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.10 E-value=9.5e-07 Score=95.55 Aligned_cols=74 Identities=27% Similarity=0.344 Sum_probs=56.8
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-----------ccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-----------LENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-----------~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
-+.|++++.||+|+||.||+|.+..+|+.||||.+...... .-.||+++++++++......+|||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 35799999999999999999999999999999998753311 015899999988887788889999999
Q ss_pred CCCCCc
Q psy18163 820 GGPLNK 825 (1028)
Q Consensus 820 ~G~L~~ 825 (1028)
+|+|.+
T Consensus 108 ~~~L~~ 113 (314)
T 3com_A 108 AGSVSD 113 (314)
T ss_dssp TEEHHH
T ss_pred CCCHHH
Confidence 557766
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=98.10 E-value=1.2e-06 Score=98.07 Aligned_cols=73 Identities=19% Similarity=0.106 Sum_probs=61.4
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------------ccCCchhhhhhHhhhcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------------LENFPSRIRTYHLQVESE 810 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------------~~~~p~~vr~~e~~~~~~ 810 (1028)
.+|.+.+.||+|+||.||+|.++.+|+.||||++...... ...||+++++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999999999999998643210 115899999888888788
Q ss_pred CcEEEEecC-CCCCCc
Q psy18163 811 LNHLVTENP-GGPLNK 825 (1028)
Q Consensus 811 ~~hlV~E~~-~G~L~~ 825 (1028)
..+|||||+ ||+|.+
T Consensus 174 ~~~lv~e~~~g~~L~~ 189 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFD 189 (365)
T ss_dssp EEEEEECCCTTCBHHH
T ss_pred EEEEEEEeCCCCcHHH
Confidence 889999999 667776
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.2e-06 Score=94.43 Aligned_cols=74 Identities=20% Similarity=0.146 Sum_probs=61.6
Q ss_pred cceeEeeeeeccceeEEEEEEEc-----cCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~-----~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~ 812 (1028)
.+|.+.+.||+|+||.||+|.+. .++..||||++..... .. .||+++++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSC
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCce
Confidence 58999999999999999999984 4568999999975321 12 589999999888888899
Q ss_pred EEEEecC-CCCCCccc
Q psy18163 813 HLVTENP-GGPLNKKE 827 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~ 827 (1028)
+|||||+ +|+|.+.+
T Consensus 102 ~lv~e~~~~~~L~~~l 117 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFL 117 (314)
T ss_dssp EEEEECCTTCBHHHHH
T ss_pred EEEEeecCCCCHHHHH
Confidence 9999999 67887744
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=98.09 E-value=7e-07 Score=95.32 Aligned_cols=74 Identities=24% Similarity=0.367 Sum_probs=62.4
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+++|++++.||+|+||.||+|.+..++..||||++..... .. .||+++++++++......+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEE
Confidence 46789999999999999999999999999999999853210 11 5899999988888888889
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||+ +|+|..
T Consensus 91 lv~e~~~~~~L~~ 103 (284)
T 2vgo_A 91 LMLEFAPRGELYK 103 (284)
T ss_dssp EEECCCTTEEHHH
T ss_pred EEEEeCCCCcHHH
Confidence 999999 668876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=3.6e-06 Score=92.14 Aligned_cols=74 Identities=19% Similarity=0.096 Sum_probs=57.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcE----EEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEI----VAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~----VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
..+|++++.||+|+||.||+|.+..+++. ||+|.+...... .-.||+++++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 36899999999999999999999999886 777776432110 015899999988765 45678
Q ss_pred EEEecC-CCCCCcc
Q psy18163 814 LVTENP-GGPLNKK 826 (1028)
Q Consensus 814 lV~E~~-~G~L~~~ 826 (1028)
+||||+ +|+|.+.
T Consensus 91 ~v~e~~~~~~L~~~ 104 (325)
T 3kex_A 91 LVTQYLPLGSLLDH 104 (325)
T ss_dssp EEEECCTTCBSHHH
T ss_pred EEEEeCCCCCHHHH
Confidence 999988 7888773
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=98.08 E-value=1.1e-06 Score=97.24 Aligned_cols=75 Identities=16% Similarity=0.089 Sum_probs=59.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc-----------------------cCCchhhhhhHhhhc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL-----------------------ENFPSRIRTYHLQVE 808 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~-----------------------~~~p~~vr~~e~~~~ 808 (1028)
..+|.+++.||+|+||.||+|.+..+|+.||||++....... -+||+++++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 358999999999999999999999999999999997432100 025777777766654
Q ss_pred Cc----CcEEEEecCCCCCCcc
Q psy18163 809 SE----LNHLVTENPGGPLNKK 826 (1028)
Q Consensus 809 ~~----~~hlV~E~~~G~L~~~ 826 (1028)
.. ..+|||||++|+|...
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~ 119 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLAL 119 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHH
T ss_pred cCCCCceEEEEEecCCCCHHHH
Confidence 33 6799999998888873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=98.08 E-value=1.5e-06 Score=96.92 Aligned_cols=72 Identities=22% Similarity=0.166 Sum_probs=59.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcC-----cCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVES-----ELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~-----~~~ 812 (1028)
.+|.+++.||+|+||.||+|.+..++..||||++..... .. .||+++++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccceE
Confidence 479999999999999999999999999999999974221 11 589999888776443 357
Q ss_pred EEEEecCCCCCCc
Q psy18163 813 HLVTENPGGPLNK 825 (1028)
Q Consensus 813 hlV~E~~~G~L~~ 825 (1028)
+|||||++|+|..
T Consensus 106 ~iv~e~~~~~L~~ 118 (364)
T 3qyz_A 106 YIVQDLMETDLYK 118 (364)
T ss_dssp EEEEECCSEEHHH
T ss_pred EEEEcccCcCHHH
Confidence 9999999998776
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.07 E-value=9.5e-07 Score=94.99 Aligned_cols=73 Identities=19% Similarity=0.117 Sum_probs=57.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc------------------cccCCchhhhhhHhh--hcCcC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF------------------WLENFPSRIRTYHLQ--VESEL 811 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~------------------~~~~~p~~vr~~e~~--~~~~~ 811 (1028)
+.+|.+++.||+|+||.||+|.+..++..||||++..... .. .||+++++++++ .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence 5689999999999999999999999999999999864210 11 589999998876 34457
Q ss_pred cEEEEecCCCCCCc
Q psy18163 812 NHLVTENPGGPLNK 825 (1028)
Q Consensus 812 ~hlV~E~~~G~L~~ 825 (1028)
.+|||||+.|.|..
T Consensus 83 ~~lv~e~~~~~l~~ 96 (305)
T 2wtk_C 83 MYMVMEYCVCGMQE 96 (305)
T ss_dssp EEEEEECCSEEHHH
T ss_pred EEEEehhccCCHHH
Confidence 79999999776554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=98.07 E-value=2.1e-06 Score=92.56 Aligned_cols=76 Identities=16% Similarity=0.101 Sum_probs=59.4
Q ss_pred cceeEeeeeeccceeEEEEEEE-----ccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcC-cC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVES-EL 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~-----~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~-~~ 811 (1028)
++|.+.+.||+|+||.||+|.+ ..+++.||||++...... ...||+++++++++... ..
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 5899999999999999999985 467789999999753211 11579999988776554 45
Q ss_pred cEEEEecC-CCCCCcccC
Q psy18163 812 NHLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~~ 828 (1028)
.+|||||+ +|+|.+.+.
T Consensus 107 ~~lv~e~~~~~~L~~~l~ 124 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLR 124 (316)
T ss_dssp CEEEEECCTTEEHHHHHH
T ss_pred eEEEEEcCCCCcHHHHHH
Confidence 89999999 668887443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=98.07 E-value=1.8e-06 Score=91.99 Aligned_cols=72 Identities=19% Similarity=0.196 Sum_probs=57.0
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
.+|++++.||+|+||.||+|.+. ++..||||++...... .-.||+++++++++......+|||||+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 58999999999999999999776 6778999999854321 015899999988888888899999999
Q ss_pred CCCCCc
Q psy18163 820 GGPLNK 825 (1028)
Q Consensus 820 ~G~L~~ 825 (1028)
+|+|.+
T Consensus 103 ~~~L~~ 108 (283)
T 3gen_A 103 NGCLLN 108 (283)
T ss_dssp TCBHHH
T ss_pred CCcHHH
Confidence 778876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=3e-06 Score=92.59 Aligned_cols=76 Identities=21% Similarity=0.137 Sum_probs=62.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEE--EeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIV--APCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~V--AIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
..+|++.+.||+|+||.||+|++..+|..| |||.+..... ....||+++++++++......+|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 468999999999999999999999999865 9999864211 11158999999988888888999
Q ss_pred EEecC-CCCCCccc
Q psy18163 815 VTENP-GGPLNKKE 827 (1028)
Q Consensus 815 V~E~~-~G~L~~~~ 827 (1028)
||||+ +|+|.+.+
T Consensus 104 v~e~~~~~~L~~~l 117 (327)
T 1fvr_A 104 AIEYAPHGNLLDFL 117 (327)
T ss_dssp EECCCTTCBHHHHH
T ss_pred EEecCCCCCHHHHH
Confidence 99999 77888744
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.4e-06 Score=93.18 Aligned_cols=74 Identities=20% Similarity=0.277 Sum_probs=61.6
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
..+|.+++.||+|+||.||+|.+..+++.||||++...... .-.||+++++++++......+|||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 46899999999999999999999999999999998642210 015899999988888888889999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ +|+|.+
T Consensus 101 e~~~~~~L~~ 110 (287)
T 2wei_A 101 ELYTGGELFD 110 (287)
T ss_dssp CCCCSCBHHH
T ss_pred EccCCCCHHH
Confidence 998 677765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=9.9e-07 Score=96.64 Aligned_cols=73 Identities=16% Similarity=0.063 Sum_probs=57.8
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc------------cccCCchhhhhhHhhhcCcC----cEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF------------WLENFPSRIRTYHLQVESEL----NHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~------------~~~~~p~~vr~~e~~~~~~~----~hlV 815 (1028)
..+|+++++||+|+||.||+|++. ++.||||++..... ..-.|||+|++++++..... .+||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999875 89999999864321 01158999999888765443 5999
Q ss_pred EecC-CCCCCcc
Q psy18163 816 TENP-GGPLNKK 826 (1028)
Q Consensus 816 ~E~~-~G~L~~~ 826 (1028)
|||+ +|+|.+.
T Consensus 101 ~e~~~~g~L~~~ 112 (322)
T 3soc_A 101 TAFHEKGSLSDF 112 (322)
T ss_dssp EECCTTCBHHHH
T ss_pred EecCCCCCHHHH
Confidence 9999 7788773
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=98.06 E-value=7e-07 Score=95.23 Aligned_cols=73 Identities=21% Similarity=0.248 Sum_probs=58.6
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-------------cccCCchhhhhhHhhhc----------
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------------WLENFPSRIRTYHLQVE---------- 808 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------------~~~~~p~~vr~~e~~~~---------- 808 (1028)
..+|++++.||+|+||.||+|.+..+|+.||||++..... .. .||+++++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcc
Confidence 4689999999999999999999999999999999864221 12 58899888765432
Q ss_pred ---CcCcEEEEecC-CCCCCc
Q psy18163 809 ---SELNHLVTENP-GGPLNK 825 (1028)
Q Consensus 809 ---~~~~hlV~E~~-~G~L~~ 825 (1028)
....+|||||+ +|+|.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~ 104 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYD 104 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHH
T ss_pred cccCCceEEEEecCCCCCHHH
Confidence 45679999999 678877
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=2.5e-06 Score=93.77 Aligned_cols=73 Identities=26% Similarity=0.285 Sum_probs=59.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcC-----cC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVES-----EL 811 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~-----~~ 811 (1028)
..+|.+++.||+|+||.||+|.+..+|+.||||++..... .. .||+++++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccce
Confidence 3689999999999999999999999999999999964321 11 589998887665432 56
Q ss_pred cEEEEecCCCCCCc
Q psy18163 812 NHLVTENPGGPLNK 825 (1028)
Q Consensus 812 ~hlV~E~~~G~L~~ 825 (1028)
.+|||||++|+|..
T Consensus 89 ~~lv~e~~~~~L~~ 102 (353)
T 2b9h_A 89 VYIIQELMQTDLHR 102 (353)
T ss_dssp EEEEECCCSEEHHH
T ss_pred EEEEEeccCccHHH
Confidence 79999999988766
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=98.04 E-value=5.1e-06 Score=88.72 Aligned_cols=74 Identities=22% Similarity=0.199 Sum_probs=54.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc-----------CCchhhhhhHh-hhcCcCcEEEEecC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE-----------NFPSRIRTYHL-QVESELNHLVTENP 819 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~-----------~~p~~vr~~e~-~~~~~~~hlV~E~~ 819 (1028)
..+|++++.||+|+||.||+|++..+|+.||||++........ .+++.+..+.. .......+|||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 3589999999999999999999999999999999864322110 23333322222 23345669999999
Q ss_pred CCCCCc
Q psy18163 820 GGPLNK 825 (1028)
Q Consensus 820 ~G~L~~ 825 (1028)
+|+|.+
T Consensus 88 ~~~L~~ 93 (296)
T 3uzp_A 88 GPSLED 93 (296)
T ss_dssp CCBHHH
T ss_pred CCCHHH
Confidence 888877
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.04 E-value=1.2e-06 Score=94.38 Aligned_cols=73 Identities=21% Similarity=0.170 Sum_probs=54.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhh----------
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQV---------- 807 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~---------- 807 (1028)
..+|.+++.||+|+||.||+|.+..+|+.||||++..... .. .||+++++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccc
Confidence 3689999999999999999999999999999999864321 11 5899988876542
Q ss_pred ----cCcCcEEEEecCCCCCCc
Q psy18163 808 ----ESELNHLVTENPGGPLNK 825 (1028)
Q Consensus 808 ----~~~~~hlV~E~~~G~L~~ 825 (1028)
.....+|||||++|+|.+
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~ 110 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLAN 110 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHH
T ss_pred ccccccCceeEEeeccCCCHHH
Confidence 235669999999988776
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.2e-06 Score=97.77 Aligned_cols=76 Identities=17% Similarity=0.053 Sum_probs=51.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------ccc-CCchhhhhhHhhh------
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLE-NFPSRIRTYHLQV------ 807 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~-~~p~~vr~~e~~~------ 807 (1028)
...|.+++.||+|+||+||+|.+..+|+.||||++..... ... .||++|+++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3469999999999999999999999999999999986331 000 4888877542221
Q ss_pred -cC-----------------cCcEEEEecCCCCCCccc
Q psy18163 808 -ES-----------------ELNHLVTENPGGPLNKKE 827 (1028)
Q Consensus 808 -~~-----------------~~~hlV~E~~~G~L~~~~ 827 (1028)
.. ...+|||||++|+|.+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l 178 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHH
Confidence 11 236999999999998843
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=98.03 E-value=3.9e-06 Score=96.86 Aligned_cols=72 Identities=24% Similarity=0.189 Sum_probs=57.7
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-----------ccCCchhhhhhHhhhcCc-CcEEEEecC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-----------LENFPSRIRTYHLQVESE-LNHLVTENP 819 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-----------~~~~p~~vr~~e~~~~~~-~~hlV~E~~ 819 (1028)
..+|++++.||+|+||.||+|.+. |+.||||++...... .-.|||+|++++++.... ..+|||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 468999999999999999999874 789999999754311 015899999988755444 689999999
Q ss_pred -CCCCCc
Q psy18163 820 -GGPLNK 825 (1028)
Q Consensus 820 -~G~L~~ 825 (1028)
+|+|.+
T Consensus 270 ~~g~L~~ 276 (450)
T 1k9a_A 270 AKGSLVD 276 (450)
T ss_dssp TTCBHHH
T ss_pred CCCcHHH
Confidence 778877
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.3e-06 Score=94.14 Aligned_cols=75 Identities=16% Similarity=0.059 Sum_probs=62.0
Q ss_pred cceeEeeeeeccceeEEEEEEE-----ccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~-----~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
.+|.+.+.||+|+||.||+|.+ ..++..||||++...... ...||+++++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5899999999999999999985 467889999999753210 11689999999888888899
Q ss_pred EEEEecC-CCCCCccc
Q psy18163 813 HLVTENP-GGPLNKKE 827 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~ 827 (1028)
+|||||+ +|+|.+.+
T Consensus 103 ~lv~e~~~~~~L~~~l 118 (313)
T 1t46_A 103 LVITEYCCYGDLLNFL 118 (313)
T ss_dssp EEEEECCTTEEHHHHH
T ss_pred EEEEecCCCCCHHHHH
Confidence 9999999 66888744
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.2e-06 Score=99.23 Aligned_cols=73 Identities=19% Similarity=0.190 Sum_probs=59.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------cc-CCchhhhhhHhhhcCcCcEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LE-NFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~-~~p~~vr~~e~~~~~~~~hlV 815 (1028)
..|.+++.||+|+||.||+|.+.. ++.||||++...... .. .+|++|++++++......+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 359999999999999999999865 999999998643211 11 268999998888878889999
Q ss_pred EecCCCCCCcc
Q psy18163 816 TENPGGPLNKK 826 (1028)
Q Consensus 816 ~E~~~G~L~~~ 826 (1028)
|||++|+|.+.
T Consensus 135 ~E~~~~~L~~~ 145 (390)
T 2zmd_A 135 MECGNIDLNSW 145 (390)
T ss_dssp EECCSEEHHHH
T ss_pred EecCCCCHHHH
Confidence 99888888774
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.01 E-value=1.7e-06 Score=94.54 Aligned_cols=73 Identities=25% Similarity=0.164 Sum_probs=55.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc------------cccCCchhhhhhHh-----hhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF------------WLENFPSRIRTYHL-----QVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~------------~~~~~p~~vr~~e~-----~~~~~~~hl 814 (1028)
+++|++++.||+|+||.||+|++ +++.||||++..... ..-.||+++++++. .......+|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 57899999999999999999976 789999999863221 11268899888642 222335689
Q ss_pred EEecC-CCCCCcc
Q psy18163 815 VTENP-GGPLNKK 826 (1028)
Q Consensus 815 V~E~~-~G~L~~~ 826 (1028)
||||+ +|+|.+.
T Consensus 90 v~e~~~~g~L~~~ 102 (336)
T 3g2f_A 90 VMEYYPNGSLXKY 102 (336)
T ss_dssp EECCCTTCBHHHH
T ss_pred EEecCCCCcHHHH
Confidence 99999 7788773
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.6e-06 Score=94.66 Aligned_cols=73 Identities=18% Similarity=0.226 Sum_probs=56.7
Q ss_pred cceeEeeeeeccceeEEEEEE-----EccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAK-----DKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~-----~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~ 812 (1028)
.+|.+++.||+|+||.||+|. +..++..||||.+..... .. .||+++++++++......
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSC
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCc
Confidence 589999999999999999999 667899999999964321 11 689999999888888888
Q ss_pred EEEEecC-CCCCCcc
Q psy18163 813 HLVTENP-GGPLNKK 826 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~ 826 (1028)
+|||||+ +|+|.+.
T Consensus 109 ~lv~e~~~~~~L~~~ 123 (327)
T 2yfx_A 109 FILMELMAGGDLKSF 123 (327)
T ss_dssp EEEEECCTTEEHHHH
T ss_pred EEEEecCCCCcHHHH
Confidence 9999999 7788773
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.01 E-value=1.7e-06 Score=93.69 Aligned_cols=73 Identities=19% Similarity=0.162 Sum_probs=55.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------c---------------cCCchhhhhhHhhhcC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------L---------------ENFPSRIRTYHLQVES 809 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------~---------------~~~p~~vr~~e~~~~~ 809 (1028)
.+|.+++.||+|+||.||+|.+..+|+.||||++...... . ..||+++++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 5799999999999999999999999999999999643210 0 0589999998888888
Q ss_pred cCcEEEEec-C-CCCCCc
Q psy18163 810 ELNHLVTEN-P-GGPLNK 825 (1028)
Q Consensus 810 ~~~hlV~E~-~-~G~L~~ 825 (1028)
...++|||| + +|+|.+
T Consensus 111 ~~~~~v~e~~~~~~~L~~ 128 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFD 128 (312)
T ss_dssp --CEEEEECCSSEEEHHH
T ss_pred CeEEEEEEecCCCCCHHH
Confidence 889999997 4 678876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=98.01 E-value=5.2e-06 Score=88.46 Aligned_cols=74 Identities=22% Similarity=0.204 Sum_probs=52.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc-----------CCchhhhhhHh-hhcCcCcEEEEecCC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE-----------NFPSRIRTYHL-QVESELNHLVTENPG 820 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~-----------~~p~~vr~~e~-~~~~~~~hlV~E~~~ 820 (1028)
++|++++.||+|+||.||+|.+..+++.||||++........ .++++|..+.. .......+|||||++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 88 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 88 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccC
Confidence 589999999999999999999999999999998754322110 23333333222 244566799999999
Q ss_pred CCCCcc
Q psy18163 821 GPLNKK 826 (1028)
Q Consensus 821 G~L~~~ 826 (1028)
|+|.+.
T Consensus 89 ~~L~~~ 94 (296)
T 4hgt_A 89 PSLEDL 94 (296)
T ss_dssp CBHHHH
T ss_pred CCHHHH
Confidence 988873
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=98.01 E-value=2.1e-06 Score=93.16 Aligned_cols=74 Identities=18% Similarity=0.216 Sum_probs=61.1
Q ss_pred cceeEeeeeeccceeEEEEEEEc-----cCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~-----~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
.+|.+.+.||+|+||.||+|.+. .++..||||.+...... .-.||+++++++++......+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 57999999999999999999987 47889999999743210 115899999988888888899
Q ss_pred EEEecC-CCCCCcc
Q psy18163 814 LVTENP-GGPLNKK 826 (1028)
Q Consensus 814 lV~E~~-~G~L~~~ 826 (1028)
|||||+ +|+|.+.
T Consensus 105 lv~e~~~~~~L~~~ 118 (322)
T 1p4o_A 105 VIMELMTRGDLKSY 118 (322)
T ss_dssp EEEECCTTCBHHHH
T ss_pred EEEEeCCCCcHHHH
Confidence 999999 6788773
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.00 E-value=8.2e-07 Score=94.83 Aligned_cols=73 Identities=19% Similarity=0.209 Sum_probs=59.2
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCcEEEEecC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELNHLVTENP 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~hlV~E~~ 819 (1028)
.+|.....||+|+||.||+|.+..++..||||++...... .-.||+++++++++......+|||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999999999999999998643211 015899999988888888889999999
Q ss_pred -CCCCCc
Q psy18163 820 -GGPLNK 825 (1028)
Q Consensus 820 -~G~L~~ 825 (1028)
+|+|..
T Consensus 102 ~~~~L~~ 108 (295)
T 2clq_A 102 PGGSLSA 108 (295)
T ss_dssp SEEEHHH
T ss_pred CCCCHHH
Confidence 677776
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.00 E-value=3.1e-06 Score=99.26 Aligned_cols=74 Identities=22% Similarity=0.236 Sum_probs=53.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc------------CCchhhhhhHhhhcCcCcEEEEecCC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE------------NFPSRIRTYHLQVESELNHLVTENPG 820 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~------------~~p~~vr~~e~~~~~~~~hlV~E~~~ 820 (1028)
.+|.++++||+|+||.||+|.+..+++.||||++........ .++++..+..+.......+|||||++
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g 86 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG 86 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCC
Confidence 589999999999999999999999999999998764332110 11122111122334456689999999
Q ss_pred CCCCcc
Q psy18163 821 GPLNKK 826 (1028)
Q Consensus 821 G~L~~~ 826 (1028)
|+|.+.
T Consensus 87 ~sL~~l 92 (483)
T 3sv0_A 87 PSLEDL 92 (483)
T ss_dssp CBHHHH
T ss_pred CCHHHH
Confidence 988873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.00 E-value=1.2e-06 Score=95.46 Aligned_cols=73 Identities=19% Similarity=0.186 Sum_probs=58.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc------------cccCCchhhhhhHhhhcC----cCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF------------WLENFPSRIRTYHLQVES----ELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~------------~~~~~p~~vr~~e~~~~~----~~~hlV 815 (1028)
..+|++++.||+|+||.||+|.+. |+.||||++..... ..-.||+++++++++... ...+||
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 468999999999999999999875 89999999864221 111689999988776655 567999
Q ss_pred EecC-CCCCCcc
Q psy18163 816 TENP-GGPLNKK 826 (1028)
Q Consensus 816 ~E~~-~G~L~~~ 826 (1028)
|||+ +|+|.+.
T Consensus 114 ~e~~~~g~L~~~ 125 (337)
T 3mdy_A 114 TDYHENGSLYDY 125 (337)
T ss_dssp ECCCTTCBHHHH
T ss_pred EeccCCCcHHHH
Confidence 9999 7788773
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1.7e-06 Score=92.62 Aligned_cols=74 Identities=19% Similarity=0.131 Sum_probs=57.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhc----CcCcEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVE----SELNHLV 815 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~----~~~~hlV 815 (1028)
..+|.+++.||+|+||.||+|++ +|+.||||++...... .-.|||++++++++.. ....+||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 35899999999999999999987 7999999998643210 0268999998766433 3457899
Q ss_pred EecC-CCCCCccc
Q psy18163 816 TENP-GGPLNKKE 827 (1028)
Q Consensus 816 ~E~~-~G~L~~~~ 827 (1028)
|||+ +|+|.+.+
T Consensus 85 ~e~~~~g~L~~~l 97 (301)
T 3q4u_A 85 THYHEMGSLYDYL 97 (301)
T ss_dssp ECCCTTCBHHHHH
T ss_pred hhhccCCCHHHHH
Confidence 9999 67888743
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=3.9e-06 Score=91.66 Aligned_cols=74 Identities=19% Similarity=0.049 Sum_probs=54.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCC-cEEEeeecCCCccccc------------------CCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTD-EIVAPCKSGNGKFWLE------------------NFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg-~~VAIK~I~~~~~~~~------------------~~p~~vr~~e~~~~~~~~h 813 (1028)
.+|++++.||+|+||.||+|.+..++ ..||||++........ .++.++..++++......+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 58999999999999999999999887 7899999975321100 1112444444555566779
Q ss_pred EEEecCCCCCCcc
Q psy18163 814 LVTENPGGPLNKK 826 (1028)
Q Consensus 814 lV~E~~~G~L~~~ 826 (1028)
|||||++|+|...
T Consensus 99 lv~e~~~~~l~~~ 111 (355)
T 2eu9_A 99 IAFELLGKNTFEF 111 (355)
T ss_dssp EEEECCCCBHHHH
T ss_pred EEEeccCCChHHH
Confidence 9999999888773
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=97.99 E-value=2.9e-06 Score=89.54 Aligned_cols=72 Identities=28% Similarity=0.261 Sum_probs=55.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-----------------ccCCchhhhhhHhhhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-----------------LENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-----------------~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
..+|.+.+.||+|+||.||+|.+. |..||||++...... .-.||+++++++++......+|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 468999999999999999999974 899999998743210 0158999999888888888999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|..
T Consensus 84 v~e~~~~~~L~~ 95 (271)
T 3dtc_A 84 VMEFARGGPLNR 95 (271)
T ss_dssp EEECCTTEEHHH
T ss_pred EEEcCCCCCHHH
Confidence 99999 666655
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=5.2e-06 Score=91.85 Aligned_cols=72 Identities=22% Similarity=0.167 Sum_probs=57.0
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-------------------------cccCCchhhhhhHhhh
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------------------------WLENFPSRIRTYHLQV 807 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------------------------~~~~~p~~vr~~e~~~ 807 (1028)
.+|.+++.||+|+||.||+|.+.. |..||||++..... .. .||+++++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFV 99 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeEE
Confidence 589999999999999999998865 99999999863211 01 5899998887763
Q ss_pred c-----CcCcEEEEecCCCCCCcc
Q psy18163 808 E-----SELNHLVTENPGGPLNKK 826 (1028)
Q Consensus 808 ~-----~~~~hlV~E~~~G~L~~~ 826 (1028)
. ....+|||||++|+|...
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~ 123 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQV 123 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHH
T ss_pred eccCCCcceEEEEEccCCCCHHHH
Confidence 3 235699999999988773
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=4.2e-05 Score=83.89 Aligned_cols=71 Identities=15% Similarity=-0.019 Sum_probs=47.0
Q ss_pred EEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCC---CeeEEEEEEeecCCCeEEEEEe
Q psy18163 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP---NIVTVREIVVGSNMDKIFIVMD 443 (1028)
Q Consensus 367 l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HP---NIV~L~~i~~~~~~~~l~LVmE 443 (1028)
+..|+.|....||+. +..+++|+.... .....+.+|..+|..+.+. .|..++.+.. ...+..|+||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEe
Confidence 355889999999988 455888875321 1223456899999988752 2334443332 23456789999
Q ss_pred cccc
Q psy18163 444 YVEH 447 (1028)
Q Consensus 444 y~~g 447 (1028)
|+.|
T Consensus 94 ~i~G 97 (306)
T 3tdw_A 94 KVQG 97 (306)
T ss_dssp CCCS
T ss_pred ccCC
Confidence 9987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.97 E-value=6.9e-06 Score=89.79 Aligned_cols=74 Identities=19% Similarity=0.188 Sum_probs=57.4
Q ss_pred ccceeEeeeeeccceeEEEEEE----EccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcC--cCc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAK----DKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVES--ELN 812 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~----~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~--~~~ 812 (1028)
..+|++++.||+|+||.||+|+ +..+|+.||||++...... .-.||+++++++++... ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 3579999999999999999998 4678999999998753210 01578998887765443 367
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||+ +|+|.+
T Consensus 120 ~lv~e~~~~~~L~~ 133 (326)
T 2w1i_A 120 KLIMEYLPYGSLRD 133 (326)
T ss_dssp EEEECCCTTCBHHH
T ss_pred EEEEECCCCCCHHH
Confidence 9999999 678877
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.95 E-value=5.4e-06 Score=91.31 Aligned_cols=73 Identities=22% Similarity=0.143 Sum_probs=57.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCC----cEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTD----EIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg----~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
..|.+.+.||+|+||.||+|.+..++ ..||||.+...... .-.||+++++++++......+|
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 57999999999999999999987664 35999998753210 0158999999888888888999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|.+
T Consensus 124 v~e~~~~~~L~~ 135 (333)
T 1mqb_A 124 ITEYMENGALDK 135 (333)
T ss_dssp EEECCTTEEHHH
T ss_pred EEeCCCCCcHHH
Confidence 99999 557776
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=7.2e-06 Score=87.44 Aligned_cols=71 Identities=18% Similarity=0.122 Sum_probs=56.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccC---CcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRT---DEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~t---g~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+|++.+.||+|+||.||+|.+..+ +..||||.+..... .. .||+++++++++. ....+|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-cCccEE
Confidence 5899999999999999999999764 45799999874321 11 5899999987763 456799
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|.+
T Consensus 93 v~e~~~~~~L~~ 104 (281)
T 1mp8_A 93 IMELCTLGELRS 104 (281)
T ss_dssp EEECCTTEEHHH
T ss_pred EEecCCCCCHHH
Confidence 99999 568776
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=97.93 E-value=3.6e-06 Score=90.10 Aligned_cols=72 Identities=29% Similarity=0.332 Sum_probs=58.0
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhc----CcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVE----SELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~----~~~~ 812 (1028)
..|.+.+.||+|+||.||+|.+..++..||+|++..... .. .||+++++++++.. ....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceE
Confidence 358999999999999999999999999999999864221 11 58999998876543 3557
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||+ +|+|..
T Consensus 105 ~lv~e~~~~~~L~~ 118 (290)
T 1t4h_A 105 VLVTELMTSGTLKT 118 (290)
T ss_dssp EEEEECCCSCBHHH
T ss_pred EEEEEecCCCCHHH
Confidence 9999999 668776
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.93 E-value=1.1e-05 Score=86.17 Aligned_cols=73 Identities=18% Similarity=0.094 Sum_probs=56.6
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCc---EEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCc-EEE
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDE---IVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELN-HLV 815 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~---~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~-hlV 815 (1028)
.|.+.++||+|+||.||+|.+..++. .||||.+...... .-.||+++++++++...... ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 57888999999999999999876655 7999998743210 01589999998887655544 999
Q ss_pred EecC-CCCCCcc
Q psy18163 816 TENP-GGPLNKK 826 (1028)
Q Consensus 816 ~E~~-~G~L~~~ 826 (1028)
|||+ +|+|.+.
T Consensus 102 ~e~~~~~~L~~~ 113 (298)
T 3pls_A 102 LPYMCHGDLLQF 113 (298)
T ss_dssp ECCCTTCBHHHH
T ss_pred EecccCCCHHHH
Confidence 9988 7888773
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=97.93 E-value=1e-05 Score=86.74 Aligned_cols=73 Identities=15% Similarity=0.032 Sum_probs=54.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCC---cEEEeeecCCCccc--------------ccCCchhhhhhHh-hhcCcCcEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTD---EIVAPCKSGNGKFW--------------LENFPSRIRTYHL-QVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg---~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~-~~~~~~~hl 814 (1028)
..|++.+.||+|+||.||+|.+..++ ..||+|.+...... .-.||++++++++ +......+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 47999999999999999999976443 46999998743210 0158999999887 444567799
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|.+
T Consensus 105 v~e~~~~~~L~~ 116 (298)
T 3f66_A 105 VLPYMKHGDLRN 116 (298)
T ss_dssp EEECCTTCBHHH
T ss_pred EEeCCCCCCHHH
Confidence 99999 668877
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=2.8e-06 Score=92.86 Aligned_cols=74 Identities=16% Similarity=0.140 Sum_probs=58.7
Q ss_pred ccceeEeeeeeccceeEEEEEE----EccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhh--cCcCc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAK----DKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQV--ESELN 812 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~----~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~--~~~~~ 812 (1028)
..+|++++.||+|+||.||+|+ +..++..||||++...... .-.||+++++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 3689999999999999999999 5789999999999754211 015788888877654 34567
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||+ +|+|.+
T Consensus 102 ~lv~e~~~~~~L~~ 115 (327)
T 3lxl_A 102 RLVMEYLPSGCLRD 115 (327)
T ss_dssp EEEEECCTTCBHHH
T ss_pred EEEEeecCCCCHHH
Confidence 8999999 778876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.92 E-value=3.7e-06 Score=91.43 Aligned_cols=73 Identities=18% Similarity=0.181 Sum_probs=50.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCc---EEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCc-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDE---IVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELN- 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~---~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~- 812 (1028)
.+|.+++.||+|+||.||+|.+..++. .||||++..... .. .||+++++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeecccccc
Confidence 479999999999999999999988876 899999874311 12 589999998877665544
Q ss_pred -----EEEEecC-CCCCCcc
Q psy18163 813 -----HLVTENP-GGPLNKK 826 (1028)
Q Consensus 813 -----hlV~E~~-~G~L~~~ 826 (1028)
++||||+ +|+|...
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~ 121 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAF 121 (323)
T ss_dssp ---CEEEEEECCTTCBHHHH
T ss_pred CCCccEEEEEeccCCcHHHH
Confidence 8999998 6688773
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=97.92 E-value=4.3e-06 Score=101.56 Aligned_cols=73 Identities=18% Similarity=0.212 Sum_probs=58.6
Q ss_pred cceeEeeeeeccceeEEEEEEEcc-CCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcC-----c
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKR-TDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESEL-----N 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~-tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~-----~ 812 (1028)
.+|.+++.||+|+||.||+|.+.. +|+.||||++..... ..-.||++|++++++..... .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999986 899999999864321 01158999999888766554 6
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||+ ||+|.+
T Consensus 160 ~lv~E~~~g~~L~~ 173 (681)
T 2pzi_A 160 YIVMEYVGGQSLKR 173 (681)
T ss_dssp EEEEECCCCEECC-
T ss_pred EEEEEeCCCCcHHH
Confidence 9999999 667776
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=5.1e-06 Score=90.06 Aligned_cols=72 Identities=19% Similarity=0.197 Sum_probs=58.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------cc-CCchhhhhhHhhhcCcCcEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LE-NFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~-~~p~~vr~~e~~~~~~~~hlV 815 (1028)
.+|.+++.||+|+||.||+|.+. +++.||||++...... .. .+|+++++++++......+||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 47999999999999999999885 5899999998643210 11 258888888888778888999
Q ss_pred EecCCCCCCc
Q psy18163 816 TENPGGPLNK 825 (1028)
Q Consensus 816 ~E~~~G~L~~ 825 (1028)
||+++|+|.+
T Consensus 107 ~e~~~~~L~~ 116 (313)
T 3cek_A 107 MECGNIDLNS 116 (313)
T ss_dssp ECCCSEEHHH
T ss_pred EecCCCcHHH
Confidence 9988988877
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=97.89 E-value=7.1e-06 Score=94.71 Aligned_cols=72 Identities=21% Similarity=0.182 Sum_probs=57.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc------------cCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL------------ENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~------------~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
.+|.+.++||+|+||.||+|.+.. +..||||++....... -.||+++++++++.. ...+|||||+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 579999999999999999999875 4579999997533110 058999999877654 6679999999
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|.+.
T Consensus 262 ~gsL~~~ 268 (452)
T 1fmk_A 262 KGSLLDF 268 (452)
T ss_dssp TCBHHHH
T ss_pred CCCHHHH
Confidence 7788873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=8e-06 Score=88.35 Aligned_cols=75 Identities=19% Similarity=0.062 Sum_probs=54.2
Q ss_pred cceeEeeeeeccceeEEEEEEEcc---CCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCc----
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKR---TDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESE---- 810 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~---tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~---- 810 (1028)
.+|.+.+.||+|+||.||+|.+.. ++..||||.+...... .-.||+++++++++....
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 579999999999999999998876 5668999998743211 015899999887765443
Q ss_pred -CcEEEEecC-CCCCCccc
Q psy18163 811 -LNHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 811 -~~hlV~E~~-~G~L~~~~ 827 (1028)
..++||||+ +|+|...+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l 132 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYL 132 (313)
T ss_dssp -CEEEEEECCTTCBHHHHH
T ss_pred cccEEEEecccCCCHHHHH
Confidence 349999998 67887743
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=2.6e-05 Score=88.06 Aligned_cols=78 Identities=18% Similarity=0.214 Sum_probs=47.4
Q ss_pred EEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc--c---cCCccchHHHHHHHHHcCC--CCee-EEEEEEeecCCCe
Q psy18163 366 CLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE--K---EGFPITSLREINTLLKAQH--PNIV-TVREIVVGSNMDK 437 (1028)
Q Consensus 366 il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~--~---~~~~~~~lrEi~iL~~l~H--PNIV-~L~~i~~~~~~~~ 437 (1028)
.++.||.|.++.||++....++..|+||....... . .........|..+|..+.. +.++ .++. + . .+.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~-d--~~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-S-D--TEM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E-E--TTT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-E-c--CCc
Confidence 35789999999999997765678899998653211 0 1122344678888887642 3333 4432 2 2 224
Q ss_pred EEEEEecccc
Q psy18163 438 IFIVMDYVEH 447 (1028)
Q Consensus 438 l~LVmEy~~g 447 (1028)
.++||||+.+
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 5899999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.89 E-value=1.3e-06 Score=96.53 Aligned_cols=75 Identities=16% Similarity=0.110 Sum_probs=54.9
Q ss_pred cceeEeeeeeccceeEEEEEEEcc---CCcEEEeeecCCCccc------------------------ccCCchhhhhhHh
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKR---TDEIVAPCKSGNGKFW------------------------LENFPSRIRTYHL 805 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~---tg~~VAIK~I~~~~~~------------------------~~~~p~~vr~~e~ 805 (1028)
.+|.+++.||+|+||.||+|.+.. ++..||||++...... .-.||++++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999988 8889999998754210 0157899988877
Q ss_pred hhc----CcCcEEEEecCCCCCCccc
Q psy18163 806 QVE----SELNHLVTENPGGPLNKKE 827 (1028)
Q Consensus 806 ~~~----~~~~hlV~E~~~G~L~~~~ 827 (1028)
+.. ....+|||||++|+|.+.+
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l 142 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKIS 142 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHC
T ss_pred cccccCCCcEEEEEEeccCCCHHHHH
Confidence 665 6778999999988888743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=97.88 E-value=3.5e-06 Score=92.21 Aligned_cols=74 Identities=18% Similarity=0.188 Sum_probs=60.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------------ccCCchhhhhhHhhhcCc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------------LENFPSRIRTYHLQVESE 810 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------------~~~~p~~vr~~e~~~~~~ 810 (1028)
..+|++++.||+|+||.||+|.+..+|+.||||++...... ...||+++++++++....
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 35799999999999999999999999999999998643210 004688999888888888
Q ss_pred CcEEEEecCC--CCCCc
Q psy18163 811 LNHLVTENPG--GPLNK 825 (1028)
Q Consensus 811 ~~hlV~E~~~--G~L~~ 825 (1028)
..++|||++. |+|.+
T Consensus 122 ~~~lv~e~~~~~~~L~~ 138 (320)
T 3a99_A 122 SFVLILERPEPVQDLFD 138 (320)
T ss_dssp EEEEEEECCSSEEEHHH
T ss_pred cEEEEEEcCCCCccHHH
Confidence 8899999884 67766
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.6e-06 Score=90.03 Aligned_cols=72 Identities=25% Similarity=0.273 Sum_probs=56.9
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-----------ccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-----------LENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-----------~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
..+|++.+.||+|+||.||+|.+. ++.||||++...... .-.||+++++++++. +..+|||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 368999999999999999999874 789999999753211 015899999887665 4579999999
Q ss_pred CCCCCccc
Q psy18163 820 GGPLNKKE 827 (1028)
Q Consensus 820 ~G~L~~~~ 827 (1028)
+|+|.+.+
T Consensus 83 ~~~L~~~l 90 (307)
T 2eva_A 83 GGSLYNVL 90 (307)
T ss_dssp TCBHHHHH
T ss_pred CCCHHHHH
Confidence 77887743
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.85 E-value=3.8e-06 Score=95.06 Aligned_cols=73 Identities=23% Similarity=0.258 Sum_probs=52.9
Q ss_pred cceeE-eeeeeccceeEEEEEEEc--cCCcEEEeeecCCCcc------------cccCCchhhhhhHhhh--cCcCcEEE
Q psy18163 753 EEFKC-LNRIEEGTYGVVYRAKDK--RTDEIVAPCKSGNGKF------------WLENFPSRIRTYHLQV--ESELNHLV 815 (1028)
Q Consensus 753 ~~Y~~-l~~IGeGsyG~Vy~a~~~--~tg~~VAIK~I~~~~~------------~~~~~p~~vr~~e~~~--~~~~~hlV 815 (1028)
+.|++ .++||+|+||.||+|+++ .++..||||++..... .. .||++|++++++. .....+||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence 45777 458999999999999976 5789999999975431 12 5899999988873 45678999
Q ss_pred EecCCCCCCcc
Q psy18163 816 TENPGGPLNKK 826 (1028)
Q Consensus 816 ~E~~~G~L~~~ 826 (1028)
|||++|+|...
T Consensus 99 ~e~~~~~l~~~ 109 (405)
T 3rgf_A 99 FDYAEHDLWHI 109 (405)
T ss_dssp EECCSEEHHHH
T ss_pred EeCCCCCHHHH
Confidence 99999988763
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=97.85 E-value=1.1e-05 Score=88.42 Aligned_cols=73 Identities=23% Similarity=0.184 Sum_probs=50.8
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcE----EEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEI----VAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~----VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
..+|++++.||+|+||.||+|++..+|+. ||+|.+...... .-.||+++++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 36899999999999999999999888875 588877532110 015899999988776554 56
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
+|+||+ +|+|.+
T Consensus 93 ~v~e~~~~g~L~~ 105 (327)
T 3poz_A 93 LITQLMPFGCLLD 105 (327)
T ss_dssp EEEECCTTCBHHH
T ss_pred EEEEecCCCcHHH
Confidence 777766 888877
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=0.00017 Score=76.43 Aligned_cols=131 Identities=18% Similarity=0.221 Sum_probs=81.4
Q ss_pred EeeecCcE-EEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCC-CCeeEEEEEEeecCCCeEEEEEeccc
Q psy18163 369 RIEEGTYG-VVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH-PNIVTVREIVVGSNMDKIFIVMDYVE 446 (1028)
Q Consensus 369 ~LG~G~FG-~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H-PNIV~L~~i~~~~~~~~l~LVmEy~~ 446 (1028)
.+..|..+ .||+......+..+.+|+-.... ...+.+|..+|+.+.. --+.+++.+.. ..+..|+||+++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-----~~~~~~E~~~l~~l~~~vPVP~v~~~~~--~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV-----ANDVTDEMVRLNWLTAFMPLPTIKHFIR--TPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH-----HHHHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC-----HhHHHHHHHHHHHhccCCCcCeEEEEEE--ECCeEEEEEEeeC
Confidence 34445444 79998887777789999876432 2345678888887742 22444554443 3457899999998
Q ss_pred c-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q psy18163 447 H-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN---------------------------------------- 485 (1028)
Q Consensus 447 g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~---------------------------------------- 485 (1028)
| ++.+.... .......+..++...|.-||..
T Consensus 104 G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 104 GKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp SEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred CccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 7 22222111 0011222333333333334321
Q ss_pred ------------------CcccccccccceeecCCCcEEEeccCCcc
Q psy18163 486 ------------------WILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 486 ------------------gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
.++|+|+.+.|||++..+.+-|+||+.+.
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16999999999999987777899999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=1e-05 Score=86.66 Aligned_cols=72 Identities=26% Similarity=0.221 Sum_probs=55.4
Q ss_pred cceeEee-eeeccceeEEEEEEE--ccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEE
Q psy18163 753 EEFKCLN-RIEEGTYGVVYRAKD--KRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~-~IGeGsyG~Vy~a~~--~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+|.+.. .||+|+||.||+|.+ ..++..||||++...... .-.||+++++++++ .....+|
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5799998 999999999999954 567889999999753210 01589999988777 5567799
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ +|+|.+
T Consensus 95 v~e~~~~~~L~~ 106 (291)
T 1xbb_A 95 VMEMAELGPLNK 106 (291)
T ss_dssp EEECCTTEEHHH
T ss_pred EEEeCCCCCHHH
Confidence 99999 567766
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.85 E-value=1.5e-05 Score=85.27 Aligned_cols=72 Identities=25% Similarity=0.286 Sum_probs=56.1
Q ss_pred cceeEee-eeeccceeEEEEEEEc--cCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 753 EEFKCLN-RIEEGTYGVVYRAKDK--RTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~-~IGeGsyG~Vy~a~~~--~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+|.++. .||+|+||.||+|.+. .++..||||++..... .. .||+++++++++ .....+|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcEE
Confidence 5788887 9999999999999864 5788999999975321 11 589999988777 4566899
Q ss_pred EEecC-CCCCCcc
Q psy18163 815 VTENP-GGPLNKK 826 (1028)
Q Consensus 815 V~E~~-~G~L~~~ 826 (1028)
||||+ +|+|...
T Consensus 87 v~e~~~~~~L~~~ 99 (287)
T 1u59_A 87 VMEMAGGGPLHKF 99 (287)
T ss_dssp EEECCTTEEHHHH
T ss_pred EEEeCCCCCHHHH
Confidence 99999 5677763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=97.84 E-value=7.9e-06 Score=86.75 Aligned_cols=72 Identities=22% Similarity=0.251 Sum_probs=56.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc------------cCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL------------ENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~------------~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
++|.+++.||+|+||.||+|.+. ++..||||++....... -.||+++++++++. ....+|||||+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 58999999999999999999875 67789999997543110 15899998887654 45679999999
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|.+.
T Consensus 91 ~~~L~~~ 97 (279)
T 1qpc_A 91 NGSLVDF 97 (279)
T ss_dssp TCBHHHH
T ss_pred CCCHHHH
Confidence 7788773
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=3.3e-06 Score=92.25 Aligned_cols=71 Identities=18% Similarity=0.128 Sum_probs=57.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------c-ccCCchhhhhhHhhhcCc----CcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------W-LENFPSRIRTYHLQVESE----LNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------~-~~~~p~~vr~~e~~~~~~----~~hlV~ 816 (1028)
.+|.+.+.||+|+||.||+|.+ +|+.||||++..... . .-.||+++++++++.... ..+|||
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~ 119 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence 5899999999999999999988 599999999864321 0 026899999987776554 679999
Q ss_pred ecC-CCCCCc
Q psy18163 817 ENP-GGPLNK 825 (1028)
Q Consensus 817 E~~-~G~L~~ 825 (1028)
||+ +|+|.+
T Consensus 120 e~~~~g~L~~ 129 (342)
T 1b6c_B 120 DYHEHGSLFD 129 (342)
T ss_dssp CCCTTCBHHH
T ss_pred eecCCCcHHH
Confidence 999 668877
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=97.84 E-value=8.4e-06 Score=96.36 Aligned_cols=72 Identities=21% Similarity=0.182 Sum_probs=57.2
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc------------cCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL------------ENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~------------~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
.+|.+.++||+|+||.||+|.+.. +..||||++....... -.||++|++++++.. ...+|||||+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 479999999999999999999875 4679999997533110 158999999877654 6679999999
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|.+.
T Consensus 345 ~gsL~~~ 351 (535)
T 2h8h_A 345 KGSLLDF 351 (535)
T ss_dssp TEEHHHH
T ss_pred CCcHHHH
Confidence 6788873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=97.83 E-value=7.5e-06 Score=94.47 Aligned_cols=72 Identities=19% Similarity=0.171 Sum_probs=57.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
.+|.+.+.||+|+||.||+|.+. ++..||||++...... .-.||++|++++++. ....+|||||+
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 57999999999999999999885 4678999999753311 115899999887764 56789999999
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|.+.
T Consensus 266 ~g~L~~~ 272 (454)
T 1qcf_A 266 KGSLLDF 272 (454)
T ss_dssp TCBHHHH
T ss_pred CCcHHHH
Confidence 7788873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.83 E-value=2e-05 Score=88.84 Aligned_cols=73 Identities=15% Similarity=0.043 Sum_probs=56.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCC---cEEEeeecCCCcc---------------cccCCchhhhhhHhh-hcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTD---EIVAPCKSGNGKF---------------WLENFPSRIRTYHLQ-VESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg---~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~-~~~~~~h 813 (1028)
..|.+.+.||+|+||.||+|.+..++ ..||||.+..... .. .|||++++++++ ......+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeE
Confidence 46899999999999999999986543 4699999864221 11 589999998874 4455779
Q ss_pred EEEecC-CCCCCcc
Q psy18163 814 LVTENP-GGPLNKK 826 (1028)
Q Consensus 814 lV~E~~-~G~L~~~ 826 (1028)
|||||+ +|+|.+.
T Consensus 168 lv~e~~~~g~L~~~ 181 (373)
T 3c1x_A 168 VVLPYMKHGDLRNF 181 (373)
T ss_dssp EEEECCTTCBHHHH
T ss_pred EEEECCCCCCHHHH
Confidence 999999 6788773
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1028 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-80 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-06 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-76 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 0.003 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-73 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-05 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-68 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-68 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-04 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-05 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-64 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-64 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 0.004 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-04 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-62 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-62 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 0.002 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-04 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 0.003 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-04 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-60 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 0.002 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-04 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 0.002 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-59 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-04 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-59 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-59 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 0.003 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-04 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 0.001 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 0.002 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-04 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 0.004 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-04 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 0.002 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-04 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-04 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-04 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-45 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-04 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 0.001 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-24 | |
| d1f5na1 | 300 | a.114.1.1 (A:284-583) Interferon-induced guanylate | 0.002 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (667), Expect = 5e-80
Identities = 121/316 (38%), Positives = 180/316 (56%), Gaps = 14/316 (4%)
Query: 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK 417
C V +++ L +I +GT+G V++A+ ++T + VALK++ ME EKEGFPIT+LREI L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 418 AQHPNIVTVREIVV------GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCL 471
+H N+V + EI I++V D+ EHD L + + F E+K +
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD---LAGLLSNVLVKFTLSEIKRV 122
Query: 472 MQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG----SPLKHYTPIV 527
MQ LLN + ++H N ILHRD+K +N+L++ G+LK+ DFGLAR + S YT V
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587
VTLWYR PELLLG ++Y PID+W GCI AE P+ G ++ QL+ I + G+
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
++WP +K+ + +K ++ + DL+ K L DP RI +D+
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 648 ALRHDYFSESPLPIDP 663
AL HD+F P+P D
Sbjct: 302 ALNHDFFWSDPMPSDL 317
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (114), Expect = 2e-06
Identities = 18/65 (27%), Positives = 34/65 (52%), Gaps = 2/65 (3%)
Query: 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVE 808
C V +++ L +I +GT+G V++A+ ++T + VA K + E FP +++
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA-LKKVLMENEKEGFPITALR-EIKIL 63
Query: 809 SELNH 813
L H
Sbjct: 64 QLLKH 68
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 2e-76
Identities = 121/304 (39%), Positives = 176/304 (57%), Gaps = 13/304 (4%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK---EKEGFPITSLREINTLLKAQHPNI 423
L+ + EG + VY+A+DK T++IVA+K++K+ K+G T+LREI L + HPNI
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ + + + I +V D++E D++ ++ + V P +K M L + +LH
Sbjct: 63 IGLLD--AFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKE 543
+WILHRDLK +NLLL G+LK+ DFGLA+ +GSP + YT VVT WYR+PELL G +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 544 YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKM 603
Y +DMW+VGCI AE L P G SDL+QL+RIF+T+GTP E+ WP LP
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD---- 233
Query: 604 TFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDP 663
+ + + G+ S + DL+ ++P RITA +AL+ YFS P P
Sbjct: 234 -YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 664 AMFP 667
P
Sbjct: 293 CQLP 296
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.003
Identities = 12/25 (48%), Positives = 19/25 (76%)
Query: 758 LNRIEEGTYGVVYRAKDKRTDEIVA 782
L+ + EG + VY+A+DK T++IVA
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVA 27
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 7e-73
Identities = 129/300 (43%), Positives = 190/300 (63%), Gaps = 8/300 (2%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E F+ + +I EGTYGVVY+A++K T E+VALK+++++ E EG P T++REI+ L + HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV + + V +K+++V +++ D+K M+ S +K + QLL +A
Sbjct: 62 NIVKLLD--VIHTENKLYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
H + +LHRDLK NLL++ G +K+ DFGLAR +G P++ YT VVTLWYR+PE+LLGC
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601
K YST +D+WS+GCIFAE + LF G S+++QL RIF+T+GTP+E +WPG + +P +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPI 661
+P L E G LL + L YDP RI+A AL H +F + P+
Sbjct: 238 P----SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 8e-05
Identities = 25/61 (40%), Positives = 34/61 (55%), Gaps = 2/61 (3%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVESELN 812
E F+ + +I EGTYGVVY+A++K T E+VA K E PS + + ELN
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVA-LKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 813 H 813
H
Sbjct: 60 H 60
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 227 bits (580), Expect = 4e-68
Identities = 129/295 (43%), Positives = 183/295 (62%), Gaps = 10/295 (3%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E++ L +I EGTYGVVY+A++ E ALK++++EKE EG P T++REI+ L + +H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV + + V ++ +V ++++ D L + + + K + QLLN +A+
Sbjct: 61 NIVKLYD--VIHTKKRLVLVFEHLDQD---LKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
HD +LHRDLK NLL++ G LK+ DFGLAR +G P++ YT +VTLWYR+P++L+G
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601
K+YST ID+WSVGCIFAE + PLF G S+ +QL RIF+ +GTPN K WP ++LP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656
+ L + L E G DLL K L DP RITA +AL H YF E
Sbjct: 236 P----NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 9e-68
Identities = 129/300 (43%), Positives = 180/300 (60%), Gaps = 10/300 (3%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++++ L +I EGTYG V++AK++ T EIVALKR++++ + EG P ++LREI L + +H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV R V + K+ +V ++ + D+K ++ P VK + QLL +
Sbjct: 62 NIV--RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGF 116
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
H +LHRDLK NLL++ G LK+ +FGLAR +G P++ Y+ VVTLWYR P++L G
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 542 KEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
K YST IDMWS GCIFAE PLF G +QL RIF+ +GTP E+ WP +KLP
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP-- 234
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLP 660
+ YP L V L G DLL L +PV RI+A+EAL+H YFS+ P
Sbjct: 235 DYKPYPMYPATTSLVNVVPK--LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 1e-04
Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVESELN 812
++++ L +I EGTYG V++AK++ T EIVA K E PS + + EL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVA-LKRVRLDDDDEGVPSSALR-EICLLKELK 59
Query: 813 H 813
H
Sbjct: 60 H 60
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 1e-65
Identities = 114/306 (37%), Positives = 182/306 (59%), Gaps = 17/306 (5%)
Query: 358 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTD-EIVALKRLKMEKEKEGFPITSLREIN--- 413
CR+ ++++C+ I EG YG V++A+D + VALKR++++ +EG P++++RE+
Sbjct: 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62
Query: 414 TLLKAQHPNIVTVREIVVGSNMD---KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKC 470
L +HPN+V + ++ S D K+ +V ++V+ D+ + + + + +K
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKD 120
Query: 471 LMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTL 530
+M QLL + LH + ++HRDLK N+L++ G +K+ DFGLAR Y + + +VVTL
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTL 179
Query: 531 WYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKI 590
WYR+PE+LL Y+TP+D+WSVGCIFAE +PLF G SD++QL +I +G P E+
Sbjct: 180 WYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 591 WPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650
WP LP + + P + + ELG DLL K LT++P RI+A AL
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTD------IDELGKDLLLKCLTFNPAKRISAYSALS 292
Query: 651 HDYFSE 656
H YF +
Sbjct: 293 HPYFQD 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 2e-05
Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 4/70 (5%)
Query: 749 CRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVE 808
CR+ ++++C+ I EG YG V++A+D + K + ++ + ++
Sbjct: 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIREV 58
Query: 809 SELNHLVTEN 818
+ L HL T
Sbjct: 59 AVLRHLETFE 68
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-64
Identities = 101/330 (30%), Positives = 152/330 (46%), Gaps = 18/330 (5%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
+ I G++GVVY+AK + E+VA+K++ +K + RE+ + K H NI
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMRKLDHCNI 75
Query: 424 VTVREIVVGSNMDK----IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAV 479
V +R S K + +V+DYV + + KQ VK M QL ++
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 480 AHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
A++H I HRD+K NLLL +LK+ DFG A++ + + I +YR+PEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPELI 194
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
G +Y++ ID+WS GC+ AE L +P+F G S ++QL I K +GTP + + P
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--P 252
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658
+ F + TKV L + L Y P R+T EA H +F E
Sbjct: 253 NYTEFKFPQIKAHP--WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
Query: 659 LPIDPAMFPTWPAKSELAHKKAAMASPKPP 688
P P L + S PP
Sbjct: 311 DPNVK--LPNGRDTPALFNFTTQELSSNPP 338
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 6e-64
Identities = 102/307 (33%), Positives = 152/307 (49%), Gaps = 14/307 (4%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ L+ I EG YG+V A D VA+K++ E + + +LREI LL+ +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHE 66
Query: 422 NIVTVREIVVGSN---MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
NI+ + +I+ M +++V + D+ L+ K Q + + Q+L
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-----KTQHLSNDHICYFLYQILRG 121
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY---TPIVVTLWYRSP 535
+ ++H +LHRDLK SNLLL+ LK+ DFGLAR H T V T WYR+P
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
E++L K Y+ ID+WSVGCI AE L P+F GK L+QL+ I +G+P+++
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655
L A + + N DLL K LT++P RI ++AL H Y
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPN--ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299
Query: 656 ESPLPID 662
+ P D
Sbjct: 300 QYYDPSD 306
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.004
Identities = 11/30 (36%), Positives = 14/30 (46%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ L+ I EG YG+V A D VA
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVA 37
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 3e-63
Identities = 64/308 (20%), Positives = 122/308 (39%), Gaps = 21/308 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++F+ ++ + G GVV++ K + ++A K + +E K +RE+ L + P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 64
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
IV + +I I M++++ ++ + K + + ++ + +
Sbjct: 65 YIVGFYG--AFYSDGEISICMEHMDGG---SLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 482 LHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
L + + I+HRD+K SN+L++ RG +K+ DFG++ + + V T Y SPE L G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQG 177
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLE-QLSRIFKTMGTPNEKIWPGFSKLPA 599
YS D+WS+G E E +L + G E +
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 600 VQKMTFAEYPN----------VGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
+ P V K+ + + D + K L +P R + +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 650 RHDYFSES 657
H + S
Sbjct: 297 VHAFIKRS 304
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (98), Expect = 3e-04
Identities = 7/30 (23%), Positives = 18/30 (60%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++F+ ++ + G GVV++ K + ++A
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMA 35
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 214 bits (547), Expect = 1e-62
Identities = 75/334 (22%), Positives = 131/334 (39%), Gaps = 42/334 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ + + G +GVV+R ++ T A K + E + T +EI T+ +HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHP 83
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
+V + + + +++ ++ +++ L E + + E M+Q+ + H
Sbjct: 84 TLVNLHD--AFEDDNEMVMIYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 482 LHDNWILHRDLKTSNLLLSHR--GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+H+N +H DLK N++ + + LK+ DFGL T + +PE+
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEVAE 198
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
G K DMWSVG + L F G++D E L + ++ + G S
Sbjct: 199 G-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS---- 253
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659
E G D + K L DP TR+T +AL H + +
Sbjct: 254 -------------------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288
Query: 660 PIDPAMFPTW---PAKSELAHKKAAMASPKPPSG 690
P + P+ + + K A P PP G
Sbjct: 289 PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLG 322
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 3e-62
Identities = 96/313 (30%), Positives = 148/313 (47%), Gaps = 6/313 (1%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E ++ L+ + G YG V A D +T VA+K+L + + RE+ L +H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
N++ + ++ + + F + V H M + + + K Q V+ L+ Q+L + +
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKY 136
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
+H I+HRDLK SNL ++ LK+ DFGLAR T V T WYR+PE++L
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 193
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601
Y+ +D+WSVGCI AE L LF G ++QL I + +GTP ++ S A
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA-- 251
Query: 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPI 661
+ + + L DLL K L D RITA +AL H YF++ P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 662 DPAMFPTWPAKSE 674
D + + E
Sbjct: 312 DEPVADPYDQSFE 324
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 0.002
Identities = 16/61 (26%), Positives = 25/61 (40%), Gaps = 2/61 (3%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVESELN 812
E ++ L+ + G YG V A D +T VA K + F R L++ +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVA-VKKLSRPFQSIIHAKRTYR-ELRLLKHMK 75
Query: 813 H 813
H
Sbjct: 76 H 76
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 9e-62
Identities = 74/302 (24%), Positives = 119/302 (39%), Gaps = 39/302 (12%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH 420
VE++ + + EG YG V A ++ T+E VA+K + M++ + P +EI H
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 62
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
N+V + ++ ++Y + + + QL+ V
Sbjct: 63 ENVVKFYG--HRREGNIQYLFLEYCSGG---ELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAR--EYGSPLKHYTPIVVTLWYRSPELL 538
+LH I HRD+K NLLL R LK+ DFGLA Y + + + TL Y +PELL
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
+ ++ P+D+WS G + L E + SD Q +K T W
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKID--- 233
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658
LL K L +P RIT + + ++++ P
Sbjct: 234 --------------------------SAPLALLHKILVENPSARITIPDIKKDRWYNK-P 266
Query: 659 LP 660
L
Sbjct: 267 LK 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (98), Expect = 2e-04
Identities = 12/31 (38%), Positives = 19/31 (61%)
Query: 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
VE++ + + EG YG V A ++ T+E VA
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVA 34
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-61
Identities = 68/307 (22%), Positives = 137/307 (44%), Gaps = 41/307 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ ++ + + +G +G VY+A++K T + A K + + E+E + EI+ L HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHP 69
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV + + + ++I++++ ++ M ++ +++ + +Q L+A+ +
Sbjct: 70 NIVKLLD--AFYYENNLWILIEFCAGG--AVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
LHDN I+HRDLK N+L + G +K+ DFG++ + ++ + T ++ +PE+++
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 542 ----KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
+ Y D+WS+G E +EP + + L +I K+ P +S
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWS-- 242
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS-E 656
D L K L + R T + L+H + + +
Sbjct: 243 ---------------------------SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
Query: 657 SPLPIDP 663
S PI
Sbjct: 276 SNKPIRE 282
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (89), Expect = 0.003
Identities = 8/30 (26%), Positives = 19/30 (63%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ ++ + + +G +G VY+A++K T + A
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAA 41
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-61
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 39/298 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E+++ L I G+YG + + K +I+ K L E + E+N L + +HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
NIV + ++ ++IVM+Y E D+ S++ ++Q V +M QL A+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 481 HLHD-----NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
H + +LHRDLK +N+ L + +K+GDFGLAR V T +Y SP
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
E + Y+ D+WS+GC+ E + P FT S E +I + +I +S
Sbjct: 184 EQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---KFRRIPYRYS 239
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
EL +++ + L R + +E L +
Sbjct: 240 D----------------------------EL-NEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (98), Expect = 2e-04
Identities = 13/61 (21%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVESELN 812
E+++ L I G+YG + + K +I+ K + E + + + + EL
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILV-WKELDYGSMTEAEKQMLVS-EVNLLRELK 61
Query: 813 H 813
H
Sbjct: 62 H 62
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-60
Identities = 97/313 (30%), Positives = 145/313 (46%), Gaps = 14/313 (4%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++ L + G YG V A D RT VA+K+L + E F + RE+ L +H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 422 NIVTVREIVVGSN----MDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
N++ + ++ ++VM ++ D+ LM K + ++ L+ Q+L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ ++H I+HRDLK NL ++ LK+ DFGLAR+ S T VVT WYR+PE+
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEV 189
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
+L Y+ +D+WSVGCI AE + + LF G L+QL I K GTP +
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657
A M P + + + L +LL K L D R+TA EAL H YF
Sbjct: 250 EAKNYMK--GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307
Query: 658 PLPIDPAMFPTWP 670
D +
Sbjct: 308 HDTEDEPQVQKYD 320
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 0.002
Identities = 18/61 (29%), Positives = 24/61 (39%), Gaps = 2/61 (3%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVESELN 812
++ L + G YG V A D RT VA K F E F R L++ +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVA-IKKLYRPFQSELFAKRAYR-ELRLLKHMR 75
Query: 813 H 813
H
Sbjct: 76 H 76
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-60
Identities = 73/299 (24%), Positives = 131/299 (43%), Gaps = 42/299 (14%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKA 418
++E+F+ + +G +G VY A++K++ I+ALK L + EK G RE+
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+HPNI+ + + +++++++Y + K F + +L NA
Sbjct: 64 RHPNILRLYG--YFHDATRVYLILEYAPLG---TVYRELQKLSKFDEQRTATYITELANA 118
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+++ H ++HRD+K NLLL G LK+ DFG + +P T + TL Y PE++
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMI 176
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
G + + +D+WS+G + EFL +P F + E RI + T + + G
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA---- 231
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657
DL+ + L ++P R E L H + + +
Sbjct: 232 -----------------------------RDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (99), Expect = 1e-04
Identities = 10/32 (31%), Positives = 22/32 (68%)
Query: 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++E+F+ + +G +G VY A++K++ I+A
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILA 35
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-59
Identities = 75/314 (23%), Positives = 142/314 (45%), Gaps = 43/314 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+++ +I +G G VY A D T + VA++++ ++++ + I + EI + + ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV + D++++VM+Y+ SL + + G++ + ++ L A+
Sbjct: 78 NIVNYLD--SYLVGDELWVVMEYLAGG--SLTDVVTETCMD--EGQIAAVCRECLQALEF 131
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGC 541
LH N ++HRD+K+ N+LL G +K+ DFG + + +V T ++ +PE++
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR- 190
Query: 542 KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601
K Y +D+WS+G + E + EP + ++ L L I GTP + S
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS------ 243
Query: 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES-PLP 660
+ D L + L D R +A E L+H + + PL
Sbjct: 244 -----------------------AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL- 279
Query: 661 IDPAMFPTWPAKSE 674
++ P A E
Sbjct: 280 --SSLTPLIAAAKE 291
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (91), Expect = 0.002
Identities = 10/30 (33%), Positives = 16/30 (53%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+++ +I +G G VY A D T + VA
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVA 49
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 204 bits (519), Expect = 3e-59
Identities = 81/305 (26%), Positives = 145/305 (47%), Gaps = 19/305 (6%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLK- 417
+ ++++ + ++ G Y V+ A + +E V +K LK K+K+ REI L
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENL 86
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
PNI+T+ +IV +V ++V + + Q +++ M ++L
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILK 140
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPE 536
A+ + H I+HRD+K N+++ H L++ D+GLA Y P + Y V + +++ PE
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPE 199
Query: 537 LLLGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
LL+ + Y +DMWS+GC+ A + + P F G + +QL RI K +GT + +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGS----ILTELGYDLLCKFLTYDPVTRITADEALRH 651
+ + + + S +++ D L K L YD +R+TA EA+ H
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
Query: 652 DYFSE 656
YF
Sbjct: 320 PYFYT 324
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 40.6 bits (94), Expect = 7e-04
Identities = 6/33 (18%), Positives = 17/33 (51%)
Query: 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ ++++ + ++ G Y V+ A + +E V
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 64
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-59
Identities = 60/337 (17%), Positives = 134/337 (39%), Gaps = 45/337 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
E++ + G +G+V+R + + + K +K++ + + +EI+ L A+H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHR 61
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NI+ + E +M+++ ++ +++ + E + + E+ + Q+ A+
Sbjct: 62 NILHLHE--SFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 482 LHDNWILHRDLKTSNLLLSHR--GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
LH + I H D++ N++ R +K+ +FG AR+ ++ + Y +PE+
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQ 176
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
ST DMWS+G + L F +++ + + I T +E+ + S
Sbjct: 177 HDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS---- 231
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659
D + + L + +R+TA EAL+H + +
Sbjct: 232 -------------------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
Query: 660 PIDPAMFPTWPAKSELAHK-----KAAMASPKPPSGG 691
+ + T + +++ + GG
Sbjct: 267 RVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGG 303
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 204 bits (520), Expect = 4e-59
Identities = 63/333 (18%), Positives = 132/333 (39%), Gaps = 41/333 (12%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ + L + G +GVV+R +K T + K + + + + EI+ + + HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV--KNEISIMNQLHHP 86
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
++ + + + ++ ++++++ L + + ++ EV M+Q + H
Sbjct: 87 KLINLHD--AFEDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 482 LHDNWILHRDLKTSNLLLSHR--GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLL 539
+H++ I+H D+K N++ + +K+ DFGLA + +P + T + +PE++
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVD 201
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
+ DMW++G + L F G+ DLE L + + +E + S
Sbjct: 202 R-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS---- 256
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE--S 657
D + L +P R+T +AL H + S
Sbjct: 257 -------------------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291
Query: 658 PLPIDPAMFPTWPAKSELAHKKAAMASPKPPSG 690
L + ++ K A +P+P G
Sbjct: 292 NLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIG 324
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 38.9 bits (90), Expect = 0.003
Identities = 8/30 (26%), Positives = 15/30 (50%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ + L + G +GVV+R +K T +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFV 58
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 196 bits (499), Expect = 4e-57
Identities = 74/308 (24%), Positives = 122/308 (39%), Gaps = 48/308 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME-------KEKEGFPITSLREINT 414
E ++ + G VV R K T + A+K + + +E + +L+E++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 415 LLKAQ-HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ 473
L K HPNI+ +++ F+V D ++ L + + +K E + +M+
Sbjct: 63 LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKG--ELFDYLT-EKVTLSEKETRKIMR 117
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
LL + LH I+HRDLK N+LL +K+ DFG + + P + + T Y
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYL 176
Query: 534 SPELLLGC-----KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNE 588
+PE++ Y +DMWS G I L P F + + L I
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 589 KIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA 648
W +S + DL+ +FL P R TA+EA
Sbjct: 237 PEWDDYS-----------------------------DTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 649 LRHDYFSE 656
L H +F +
Sbjct: 268 LAHPFFQQ 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 40.8 bits (95), Expect = 6e-04
Identities = 11/62 (17%), Positives = 20/62 (32%), Gaps = 1/62 (1%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVESELN 812
E ++ + G VV R K T + A K + ++ E++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYA-VKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 813 HL 814
L
Sbjct: 62 IL 63
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-57
Identities = 90/331 (27%), Positives = 158/331 (47%), Gaps = 21/331 (6%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ ++ L I G G+V A D D VA+K+L + + + RE+ + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 422 NIVTVREIVVGSNM----DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
NI+++ + +++VM+ ++ ++ +++ ++ + L+ Q+L
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQMLC 130
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPEL 537
+ HLH I+HRDLK SN+++ LK+ DFGLAR G+ TP VVT +YR+PE+
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEV 189
Query: 538 LLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG---- 593
+LG Y +D+WSVGCI E + + LF G+ ++Q +++ + +GTP +
Sbjct: 190 ILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 594 ----FSKLPAVQKMTFAE-YPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA 648
P +TF + +P+ + DLL K L DP RI+ D+A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 649 LRHDYFSESPLPIDPAMFPTWPAKSELAHKK 679
L+H Y + P + P +L ++
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDERE 339
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 2e-56
Identities = 69/302 (22%), Positives = 123/302 (40%), Gaps = 43/302 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS-LREINTLLKAQH 420
+ F L I G++G VY A+D R E+VA+K++ ++ ++E+ L K +H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
PN + R ++VM+Y S + + K+ E+ + L +A
Sbjct: 75 PNTIQYRG--CYLREHTAWLVMEYCLG---SASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
+LH + ++HRD+K N+LLS G++K+GDFG A + V T ++ +PE++L
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANSFVGTPYWMAPEVILA 185
Query: 541 C--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
+Y +D+WS+G E +P + + L I + +S
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQSGHWS--- 240
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658
E + + L P R T++ L+H +
Sbjct: 241 --------------------------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
Query: 659 LP 660
P
Sbjct: 275 PP 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.0 bits (93), Expect = 0.001
Identities = 13/30 (43%), Positives = 18/30 (60%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ F L I G++G VY A+D R E+VA
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVA 44
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 7e-56
Identities = 77/302 (25%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ + + + G + V A+DKRT ++VA+K + + EG + EI L K +HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKA-LEGKEGSMENEIAVLHKIKHP 67
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NIV + + + + ++++M V L + + +K + + L+ Q+L+AV +
Sbjct: 68 NIVALDD--IYESGGHLYLIMQLVSG--GELFDRIV-EKGFYTERDASRLIFQVLDAVKY 122
Query: 482 LHDNWILHRDLKTSNLLLSHR---GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
LHD I+HRDLK NLL + + DFGL++ P + T Y +PE+L
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAPEVL 181
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
K YS +D WS+G I LC P F ++D + +I K + W S
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS--- 237
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658
+ D + + DP R T ++AL+H + +
Sbjct: 238 --------------------------DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271
Query: 659 LP 660
Sbjct: 272 AL 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.2 bits (91), Expect = 0.002
Identities = 9/30 (30%), Positives = 17/30 (56%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ + + + G + V A+DKRT ++VA
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVA 38
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-55
Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 42/303 (13%)
Query: 359 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLK 417
+ E+FK + EG++ V A++ T A+K L+ KE RE + + +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
HP V + + +K++ + Y ++ L++ +R F + ++++
Sbjct: 65 LDHPFFVKLYF--TFQDDEKLYFGLSYAKNG--ELLKYIRKIGS-FDETCTRFYTAEIVS 119
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY--GSPLKHYTPIVVTLWYRSP 535
A+ +LH I+HRDLK N+LL+ +++ DFG A+ S V T Y SP
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
ELL K D+W++GCI + + P F ++ +I K EK +P
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA- 237
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655
DL+ K L D R+ +E +
Sbjct: 238 --------------------------------RDLVEKLLVLDATKRLGCEEMEGYGPLK 265
Query: 656 ESP 658
P
Sbjct: 266 AHP 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (97), Expect = 3e-04
Identities = 15/64 (23%), Positives = 26/64 (40%), Gaps = 1/64 (1%)
Query: 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLENFPSRIRTYHLQVES 809
+ E+FK + EG++ V A++ T A K + ++ T V S
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYA-IKILEKRHIIKENKVPYVTRERDVMS 63
Query: 810 ELNH 813
L+H
Sbjct: 64 RLDH 67
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-53
Identities = 68/301 (22%), Positives = 124/301 (41%), Gaps = 44/301 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLK---MEKEKEGFPITSL-REINTLLK 417
+ + + G + VV + ++K T A K +K + + G + RE++ L +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
QHPN++T+ E V N + ++++ V + ++K+ E ++Q+LN
Sbjct: 70 IQHPNVITLHE--VYENKTDVILILELVAGGE---LFDFLAEKESLTEEEATEFLKQILN 124
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGI----LKVGDFGLAREYGSPLKHYTPIVVTLWYR 533
V +LH I H DLK N++L R + +K+ DFGLA + + I T +
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFV 183
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
+PE++ + DMWS+G I L F G + E L+ + ++ +
Sbjct: 184 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDY 653
S L D + + L DP R+T ++L+H +
Sbjct: 243 TS-----------------------------ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273
Query: 654 F 654
Sbjct: 274 I 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (88), Expect = 0.004
Identities = 6/30 (20%), Positives = 13/30 (43%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ + + G + VV + ++K T A
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYA 39
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 58/296 (19%), Positives = 108/296 (36%), Gaps = 42/296 (14%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
K I G++ VY+ D T VA L+ K + E L QHPNI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 424 VTVREIVVGSNMDK--IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
V + + K I +V + + ++T + +V ++ +Q+L +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSG---TLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 482 LHDN--WILHRDLKTSNLLLSHR-GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
LH I+HRDLK N+ ++ G +K+GD GLA + ++ T + +PE+
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMY 185
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
+Y +D+++ G E E ++ + Q+ R + G
Sbjct: 186 EE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFDKVAIP-- 240
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654
E+ +++ + + R + + L H +F
Sbjct: 241 --------------------------EV-KEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-50
Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 39/294 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
+ RI G++G VY+ K VA+K L + E+ L K +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
NI+ ++ IV + E SL + + F ++ + +Q + +
Sbjct: 65 NILLFMGYSTA---PQLAIVTQWCEG--SSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY--GSPLKHYTPIVVTLWYRSPELLL 539
LH I+HRDLK++N+ L +K+GDFGLA S + + ++ + +PE++
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 540 GCKE--YSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
+ YS D+++ G + E + + ++ ++ +Q+ + + P SK+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----RGYLSPDLSKV 234
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
S + L+ + L R + L
Sbjct: 235 R----------------------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-49
Identities = 87/356 (24%), Positives = 151/356 (42%), Gaps = 51/356 (14%)
Query: 361 VEEFKCLNR-IEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA- 418
++++K ++ + G G V + +KRT E ALK L+ + + RE+ +A
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 62
Query: 419 QHPNIVTVREIV--VGSNMDKIFIVMDYVEHDMKSLMETMRSKK-QVFIPGEVKCLMQQL 475
Q P+IV + ++ + + + IVM+ ++ L ++ + Q F E +M+ +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDG--GELFSRIQDRGDQAFTEREASEIMKSI 120
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHR---GILKVGDFGLAREYGSPLKHYTPIVVTLWY 532
A+ +LH I HRD+K NLL + + ILK+ DFG A+E S TP T +Y
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPYY 179
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592
+PE+L ++Y DMWS+G I LC P F L + +I
Sbjct: 180 VAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------RIRM 231
Query: 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHD 652
G + P E+ V +E L+ L +P R+T E + H
Sbjct: 232 GQYEFP------NPEWSEV------------SEEVKMLIRNLLKTEPTQRMTITEFMNHP 273
Query: 653 YFSES------PLPIDPAMFPTWPAKSELAHK-KAAMASPKPPSGGHNYKQLEDNE 701
+ +S PL + ++ + +A+A+ + K++ED
Sbjct: 274 WIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDAS 329
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 176 bits (448), Expect = 3e-49
Identities = 60/306 (19%), Positives = 116/306 (37%), Gaps = 46/306 (15%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKME----KEKEGFPITSLREINTL 415
++ +F I G +G VY + T ++ A+K L + K+ E + ++ +
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 416 LKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQL 475
P IV + DK+ ++D + + S+ VF +++ ++
Sbjct: 62 STGDCPFIVCMSY--AFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEI 116
Query: 476 LNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
+ + H+H+ ++++RDLK +N+LL G +++ D GLA ++ H + T Y +P
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG--THGYMAP 174
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
E+L Y + D +S+GC+ + L F ++ I + T ++ FS
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFS 233
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALR 650
LL L D R+ A E
Sbjct: 234 -----------------------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 651 HDYFSE 656
+F
Sbjct: 265 SPFFRS 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.9 bits (95), Expect = 7e-04
Identities = 8/32 (25%), Positives = 15/32 (46%)
Query: 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++ +F I G +G VY + T ++ A
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYA 33
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 172 bits (437), Expect = 9e-49
Identities = 70/297 (23%), Positives = 116/297 (39%), Gaps = 39/297 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQH 420
+ ++ + G V+ A+D R VA+K L+ + F + RE H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 421 PNIVTVREIVV--GSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
P IV V + +IVM+YV+ +L + + ++ P ++ A
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGV--TLRDIVHTEGP-MTPKRAIEVIADACQA 123
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY---GSPLKHYTPIVVTLWYRSP 535
+ H N I+HRD+K +N+++S +KV DFG+AR G+ + ++ T Y SP
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
E G D++S+GC+ E L EP FTG S + + + P G S
Sbjct: 184 EQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHD 652
+L ++ K L +P R +R D
Sbjct: 243 A----------------------------DL-DAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 39.0 bits (90), Expect = 0.002
Identities = 7/30 (23%), Positives = 13/30 (43%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ ++ + G V+ A+D R VA
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVA 36
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 9e-49
Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 42/299 (14%)
Query: 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK--EKEGFPITSLREINTLLKA 418
+E+F + +G++G V+ A+ K+T++ A+K LK + + T + + L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+HP + + + +F VM+Y+ LM ++S + F +++
Sbjct: 61 EHPFLTHMFC--TFQTKENLFFVMEYLNGG--DLMYHIQSCHK-FDLSRATFYAAEIILG 115
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+ LH I++RDLK N+LL G +K+ DFG+ +E T Y +PE+L
Sbjct: 116 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
LG ++Y+ +D WS G + E L + F G+ + E I +
Sbjct: 176 LG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA---- 230
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITA-DEALRHDYFSE 656
DLL K +P R+ + +H F E
Sbjct: 231 -----------------------------KDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 4e-04
Identities = 9/31 (29%), Positives = 20/31 (64%)
Query: 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+E+F + +G++G V+ A+ K+T++ A
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFA 31
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 53/309 (17%), Positives = 111/309 (35%), Gaps = 52/309 (16%)
Query: 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITS----LREINTL--L 416
+++ + G +G VY + VA+K ++ ++ + + + E+ L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLL 476
+ ++ + + D ++++ E + +++ + Q+L
Sbjct: 65 SSGFSGVIRLLD--WFERPDSFVLILERPE--PVQDLFDFITERGALQEELARSFFWQVL 120
Query: 477 NAVAHLHDNWILHRDLKTSNLLLS-HRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSP 535
AV H H+ +LHRD+K N+L+ +RG LK+ DFG YT T Y P
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPP 178
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595
E + + + +WS+G + + +C + F ++ + F+
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-------------- 224
Query: 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655
++ L+ L P R T +E H +
Sbjct: 225 -------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
Query: 656 ESPLPIDPA 664
+ LP + A
Sbjct: 260 DVLLPQETA 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 8e-47
Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 45/303 (14%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKA 418
++ +F L + +GT+G V ++K T A+K L+ E + ++ E L
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
+HP + + D++ VM+Y + S+++VF + ++++A
Sbjct: 63 RHPFLTAL--KYAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSA 117
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+ +LH +++RD+K NL+L G +K+ DFGL +E S T Y +PE+L
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
+Y +D W +G + E +C F + I + P
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA---- 232
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDY 653
LL L DP R+ A E + H +
Sbjct: 233 -----------------------------KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 654 FSE 656
F
Sbjct: 264 FLS 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (95), Expect = 5e-04
Identities = 9/32 (28%), Positives = 17/32 (53%)
Query: 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
++ +F L + +GT+G V ++K T A
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYA 34
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (425), Expect = 1e-46
Identities = 64/303 (21%), Positives = 112/303 (36%), Gaps = 48/303 (15%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKA 418
S+++F+ L + G++G V+ + + A+K LK E + + E L
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HP I+ + + +IF++MDY+E + + K ++ A
Sbjct: 62 THPFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLA 116
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+ +LH I++RDLK N+LL G +K+ DFG A+ + T Y +PE++
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVV 173
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
K Y+ ID WS G + E L F + ++ +I
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV---- 228
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDY 653
DLL + +T D R+ ++ H +
Sbjct: 229 -----------------------------KDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259
Query: 654 FSE 656
F E
Sbjct: 260 FKE 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 41.6 bits (97), Expect = 3e-04
Identities = 7/32 (21%), Positives = 17/32 (53%)
Query: 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
S+++F+ L + G++G V+ + + A
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYA 33
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 64/308 (20%), Positives = 119/308 (38%), Gaps = 47/308 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQH 420
E + ++ +G +G V+ T VA+K LK E F L+E + K +H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF----LQEAQVMKKLRH 71
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
+V + +V + + I+IV +Y+ + K + +P ++ + Q+ + +A
Sbjct: 72 EKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP-QLVDMAAQIASGMA 127
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYTPIVVTLWYRSPELLL 539
++ +HRDL+ +N+L+ + KV DFGLAR + + + +PE L
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 540 GCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
++ D+WS G + E + G + E L ++ + P P
Sbjct: 188 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP------ 240
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR--HDYFSE 656
E +DL+C+ +P R T + DYF+
Sbjct: 241 --------------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
Query: 657 SPLPIDPA 664
+ P
Sbjct: 275 TEPQYQPG 282
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-45
Identities = 62/294 (21%), Positives = 118/294 (40%), Gaps = 47/294 (15%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ 419
+++E K L I +G +G V + VA+K +K + + F L E + + + +
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF----LAEASVMTQLR 58
Query: 420 HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGE-VKCLMQQLLNA 478
H N+V + ++V ++IV +Y+ SL++ +RS+ + + G+ + + A
Sbjct: 59 HSNLVQLLGVIVEEK-GGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+ +L N +HRDL N+L+S + KV DFGL +E S + + + +PE L
Sbjct: 116 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK---LPVKWTAPEAL 172
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
K++ST D+WS G + E + + + R+ K
Sbjct: 173 RE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------------- 215
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
G K + Y+++ D R + +
Sbjct: 216 ---------------GYKMDAPDGCPPAV-YEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (404), Expect = 1e-43
Identities = 58/325 (17%), Positives = 109/325 (33%), Gaps = 48/325 (14%)
Query: 338 DMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKM 397
+ + ++D L + Q +++F + + G++G V K K + A+K L
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 398 EK-EKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETM 456
+K K +L E L P +V + + + +E+ M +
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF-----SFKDNSNLYMVMEYVAGGEMFSH 131
Query: 457 RSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516
+ F + Q++ +LH +++RDLK NLL+ +G ++V DFG A+
Sbjct: 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQL 576
+PE++L K Y+ +D W++G + E P F ++
Sbjct: 192 KGRTWTLCGTP---EALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLT 636
+I DLL L
Sbjct: 248 EKIVSGKVRFPSHFSSDL---------------------------------KDLLRNLLQ 274
Query: 637 YDPVTRI-----TADEALRHDYFSE 656
D R ++ H +F+
Sbjct: 275 VDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.9 bits (100), Expect = 1e-04
Identities = 11/60 (18%), Positives = 25/60 (41%)
Query: 723 ELDQDVDMEIELEKDTLPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
E + + + ++D L + Q +++F + + G++G V K K + A
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (399), Expect = 7e-43
Identities = 72/338 (21%), Positives = 134/338 (39%), Gaps = 43/338 (12%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN- 422
+ + ++ G + V+ AKD + VA+K ++ +K + + EI L + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADN 71
Query: 423 ----------IVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLM 472
I+ + + + + +VM + L + + + VK +
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 473 QQLLNAVAHLHDNW-ILHRDLKTSNLLLSHRGI------LKVGDFGLAREYGSPLKHYTP 525
+QLL + ++H I+H D+K N+L+ +K+ D G A Y +HYT
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTN 188
Query: 526 IVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS------DLEQLSRI 579
+ T YRSPE+LLG + D+WS C+ E + + LF D + +++I
Sbjct: 189 SIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 580 FKTMGTPNEKIWPG----------FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYD 629
+ +G + L + K+ F +V K K + E+ D
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI-SD 306
Query: 630 LLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFP 667
L L DP R A + H + ++ L ++ P
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDT-LGMEEIRVP 343
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (394), Expect = 8e-43
Identities = 55/286 (19%), Positives = 107/286 (37%), Gaps = 31/286 (10%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
+K RI EG++GV++ + ++ VA+K + E T
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLAGCTG 62
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ G +V+D + ++ L+ + F V +Q+L V +H
Sbjct: 63 I-PNVYYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 484 DNWILHRDLKTSNLLLS-----HRGILKVGDFGLAREYGSPLKH-------YTPIVVTLW 531
+ +++RD+K N L+ + ++ V DFG+ + Y P+ + T
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 532 YRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFK----TMGTPN 587
Y S LG +E S D+ ++G +F FL + G + + TP
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 588 EKIWPGFSK-----LPAVQKMTFAEYPNVGGLKTKVAGSILTELGY 628
++ GF + + + + F P+ L+ + +L L
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ-GLFSKVLERLNT 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 55/292 (18%), Positives = 108/292 (36%), Gaps = 43/292 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHP 421
++ L + G +GVV K R VA+K +K E + E ++ H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHE 59
Query: 422 NIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAH 481
+V + V + IFI+ +Y+ + L+ +R + F ++ + + + A+ +
Sbjct: 60 KLVQLYG--VCTKQRPIFIITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 482 LHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYTPIVVTLWYRSPELLLG 540
L LHRDL N L++ +G++KV DFGL+R + + PE+L+
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 541 CKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
++S+ D+W+ G + E + + + ++ E I + + +
Sbjct: 176 -SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS------- 227
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
E Y ++ R T L +
Sbjct: 228 -------------------------EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 60/296 (20%), Positives = 114/296 (38%), Gaps = 45/296 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTD---EIVALKRLKMEK-EKEGFPITSLREINTLLK 417
++ + L ++ +G++GVV R + VA+K LK + + +RE+N +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
H N++ + +V+ + +V + SL++ +R + F+ G + Q+
Sbjct: 68 LDHRNLIRLYGVVL---TPPMKMVTELAPLG--SLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY---TPIVVTLWYRS 534
+ +L +HRDL NLLL+ R ++K+GDFGL R HY V + +
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
PE L + +S D W G E + + G + + L +I K
Sbjct: 183 PESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPRPED 239
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
+ ++ Y+++ + + P R T
Sbjct: 240 CPQ----------------------------DI-YNVMVQCWAHKPEDRPTFVALR 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-42
Identities = 64/309 (20%), Positives = 116/309 (37%), Gaps = 45/309 (14%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKD---KRTDEIVALKRLKMEK--EKEGFPITSLREINT 414
+E F+ L + G YG V+ + T ++ A+K LK +K + E
Sbjct: 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81
Query: 415 LLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQ 474
L + + V K+ +++DY+ + T S+++ F EV+ + +
Sbjct: 82 LEHIRQSPFL-VTLHYAFQTETKLHLILDYINGG---ELFTHLSQRERFTEHEVQIYVGE 137
Query: 475 LLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPI--VVTLWY 532
++ A+ HLH I++RD+K N+LL G + + DFGL++E+ + +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 533 RSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592
+ G + +D WS+G + E L FT + + I + +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADE 647
S L DL+ + L DP R+ ADE
Sbjct: 258 EMS-----------------------------ALAKDLIQRLLMKDPKKRLGCGPRDADE 288
Query: 648 ALRHDYFSE 656
H +F +
Sbjct: 289 IKEHLFFQK 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 8e-42
Identities = 60/302 (19%), Positives = 117/302 (38%), Gaps = 49/302 (16%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQH 420
E K + R+ G +G V+ VA+K LK + F L E N + + QH
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAF----LAEANLMKQLQH 67
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIP-GEVKCLMQQLLNAV 479
+V + +V + I+I+ +Y+E+ SL++ +++ + + ++ + Q+ +
Sbjct: 68 QRLVRLYAVVTQ---EPIYIITEYMENG--SLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 480 AHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE-YGSPLKHYTPIVVTLWYRSPELL 538
A + + +HRDL+ +N+L+S K+ DFGLAR + + + +PE +
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
++ D+WS G + E + + G ++ E + + + P
Sbjct: 183 NY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP----- 236
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR--HDYFS 655
E Y L+ P R T D D+F+
Sbjct: 237 ---------------------------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
Query: 656 ES 657
+
Sbjct: 270 AT 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 9e-42
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 48/297 (16%)
Query: 368 NRIEEGTYGVVYRA--KDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVT 425
+ G +G V + + K+ + VA+K LK E L E N + + +P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 426 VREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDN 485
+ I + +VM+ E + + + + L+ Q+ + +L ++
Sbjct: 73 MIGIC---EAESWMLVMEMAELG---PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 486 WILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY---TPIVVTLWYRSPELLLGCK 542
+HRDL N+LL + K+ DFGL++ + +Y T + + +PE + K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 543 EYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601
+S+ D+WS G + E + + G E + + K G +
Sbjct: 187 -FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPR----- 237
Query: 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE---ALRHDYFS 655
E+ YDL+ TYD R LR+ Y+
Sbjct: 238 -----------------------EM-YDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 56/293 (19%), Positives = 109/293 (37%), Gaps = 45/293 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQH 420
E + I G +G+V+ D+ VA+K ++ +E F + E ++K H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDF----IEEAEVMMKLSH 59
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
P +V + V I +V +++EH L + +R+++ +F + + + +A
Sbjct: 60 PKLVQLYG--VCLEQAPICLVFEFMEHG--CLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP-IVVTLWYRSPELLL 539
+L + ++HRDL N L+ ++KV DFG+ R + + + SPE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 540 GCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598
+ YS+ D+WS G + E + + +S+ E + I ++
Sbjct: 176 FSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS------ 228
Query: 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
Y ++ P R LR
Sbjct: 229 --------------------------THVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 2e-40
Identities = 55/310 (17%), Positives = 102/310 (32%), Gaps = 55/310 (17%)
Query: 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNI 423
++ +I G++G +Y D E VA+K ++ + E Q
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----HIESKIYKMMQGGVG 64
Query: 424 VTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLH 483
+ G+ D +VM+ + SL + + F V L Q+++ + ++H
Sbjct: 65 I-PTIRWCGAEGDYNVMVMELLGP---SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 484 DNWILHRDLKTSNLLLSHRG---ILKVGDFGLAREYGSPLKH-------YTPIVVTLWYR 533
+HRD+K N L+ ++ + DFGLA++Y H + T Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 534 SPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT----MGTPNEK 589
S LG E S D+ S+G + F + G + + + M TP E
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD--- 646
+ G+ E L + +
Sbjct: 240 LCKGYPS----------------------------EF-ATYLNFCRSLRFDDKPDYSYLR 270
Query: 647 EALRHDYFSE 656
+ R+ + +
Sbjct: 271 QLFRNLFHRQ 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.4 bits (96), Expect = 4e-04
Identities = 20/103 (19%), Positives = 33/103 (32%), Gaps = 12/103 (11%)
Query: 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVA----PCKSGNGKFWLE-------NFPSRIRTY 803
++ +I G++G +Y D E VA K+ + + +E I T
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 804 H-LQVESELNHLVTENPGGPLNKKEQPKWRPMQISNPSTKLRQ 845
E + N +V E G L R + Q
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQ 111
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (374), Expect = 3e-40
Identities = 59/302 (19%), Positives = 109/302 (36%), Gaps = 41/302 (13%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK-EKEGFPITSLREINTLLKAQH 420
+ +++ G YG VY K+ VA+K LK + E E F L+E + + +H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKH 72
Query: 421 PNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVA 480
PN+V + + V + +I+ +++ + L +Q + + Q+ +A+
Sbjct: 73 PNLV--QLLGVCTREPPFYIITEFMTYGN-LLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 481 HLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLG 540
+L +HRDL N L+ ++KV DFGL+R + L
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 541 CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600
++S D+W+ G + E DL Q+ + + + G
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGCP----- 242
Query: 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR--HDYFSESP 658
E Y+L+ ++P R + E + F ES
Sbjct: 243 ------------------------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
Query: 659 LP 660
+
Sbjct: 279 IS 280
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.3 bits (91), Expect = 0.001
Identities = 8/30 (26%), Positives = 13/30 (43%)
Query: 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVA 782
+ +++ G YG VY K+ VA
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVA 46
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 61/305 (20%), Positives = 114/305 (37%), Gaps = 52/305 (17%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDE--IVALKRLKMEKEKEGFPITSLREINTLLK 417
+ + + + G +G V + + + VA+K LK EK +RE + +
Sbjct: 11 LIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQ 65
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
+P IV + + + + +VM+ L + + K++ V L+ Q+
Sbjct: 66 LDNPYIVRLIGVC---QAEALMLVMEMAGGG--PLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTP---IVVTLWYRS 534
+ +L + +HRDL N+LL +R K+ DFGL++ G+ +YT L + +
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
PE + +++S+ D+WS G E L + + E ++ I + + P
Sbjct: 181 PECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPE 236
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE---ALR 650
EL Y L+ Y R +R
Sbjct: 237 CPP----------------------------EL-YALMSDCWIYKWEDRPDFLTVEQRMR 267
Query: 651 HDYFS 655
Y+S
Sbjct: 268 ACYYS 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 1e-38
Identities = 56/304 (18%), Positives = 113/304 (37%), Gaps = 53/304 (17%)
Query: 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLK---MEKEKEGFPITSLREIN 413
+ K I G +G V K + VA+K LK EK++ F L E +
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF----LSEAS 79
Query: 414 TLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQ 473
+ + HPN++ V + + I+ +++E+ SL +R F ++ +++
Sbjct: 80 IMGQFDHPNVI--HLEGVVTKSTPVMIITEFMENG--SLDSFLRQNDGQFTVIQLVGMLR 135
Query: 474 QLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYT-----PIVV 528
+ + +L D +HRDL N+L++ + KV DFGL+R T +
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195
Query: 529 TLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL-CMEPLFTGKSDLEQLSRIFKTMGTPN 587
+ + +PE + +++++ D+WS G + E + E + ++ + ++ I + P
Sbjct: 196 PIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254
Query: 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE 647
P + L+ D R +
Sbjct: 255 PMDCP--------------------------------SALHQLMLDCWQKDRNHRPKFGQ 282
Query: 648 ALRH 651
+
Sbjct: 283 IVNT 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 57/321 (17%), Positives = 108/321 (33%), Gaps = 68/321 (21%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEI-----VALKRLKMEKEKEGFPITSLREINTLL 416
E + + G +G V A + VA+K LK EK + E+ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMT 95
Query: 417 K-AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPG--------- 466
+ H NIV + + I+++ +Y + L+ +RSK++ F
Sbjct: 96 QLGSHENIVNLLG--ACTLSGPIYLIFEYCCY--GDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 467 -------------EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA 513
++ C Q+ + L +HRDL N+L++H ++K+ DFGLA
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 514 REY--GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGK 570
R+ S + + + +PE L Y+ D+WS G + E + + G
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 571 SDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDL 630
++ + ++ + TE Y +
Sbjct: 271 PVDANFYKLIQNGFKMDQPFY-------------------------------ATEEIYII 299
Query: 631 LCKFLTYDPVTRITADEALRH 651
+ +D R +
Sbjct: 300 MQSCWAFDSRKRPSFPNLTSF 320
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-38
Identities = 60/301 (19%), Positives = 103/301 (34%), Gaps = 35/301 (11%)
Query: 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426
I +G +G V+R K E VA+K +E+ F EI + +H NI+
Sbjct: 8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENILGF 62
Query: 427 REIVVGSN--MDKIFIVMDYVEHDMKSLMETMRSKK------QVFIPGEVKCLMQQLLNA 478
N ++++V DY EH SL + + L +
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHG--SLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY----TPIVVTLWYRS 534
V I HRDLK+ N+L+ G + D GLA + S V T Y +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 535 PELLLGC-----KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589
PE+L E D++++G +F E + D QL P+ +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-YQLPYYDLVPSDPSVE 239
Query: 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649
++ + + L+ + ++ + + R+TA
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALR----------VMAKIMRECWYANGAARLTALRIK 289
Query: 650 R 650
+
Sbjct: 290 K 290
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 9e-38
Identities = 58/294 (19%), Positives = 102/294 (34%), Gaps = 42/294 (14%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLKMEKEKEGFPITSLREINTLLKA 418
E + I EG +G V++ + VA+K K + L+E T+ +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 65
Query: 419 QHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNA 478
HP+IV + ++ + ++I+M+ L ++ +K + QL A
Sbjct: 66 DHPHIVKLIGVI---TENPVWIIMELCTLG--ELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 479 VAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELL 538
+A+L +HRD+ N+L+S +K+GDFGL+R +
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 539 LGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597
+ + +++ D+W G E L F G + + + RI P + P
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCP-- 235
Query: 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
Y L+ K YDP R E
Sbjct: 236 ---------------------------PTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 7e-37
Identities = 61/332 (18%), Positives = 117/332 (35%), Gaps = 67/332 (20%)
Query: 348 LPPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKE 402
L P L +++ R + + I EG +G V++A+ +VA+K LK E
Sbjct: 1 LNPKLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SA 57
Query: 403 GFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMRSK-- 459
RE + + +PNIV + + V + + ++ +Y+ + D+ + +M
Sbjct: 58 DMQADFQREAALMAEFDNPNIV--KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115
Query: 460 ------------------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH 501
E C+ +Q+ +A+L + +HRDL T N L+
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE 175
Query: 502 RGILKVGDFGLAREY--GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAE 559
++K+ DFGL+R K + + + PE + + Y+T D+W+ G + E
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWE 234
Query: 560 FLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKV 618
+ G + E + + + P
Sbjct: 235 IFSYGLQPYYGMAHEEVIYYVRDGNILACPENCP-------------------------- 268
Query: 619 AGSILTELGYDLLCKFLTYDPVTRITADEALR 650
Y+L+ + P R + R
Sbjct: 269 ------LELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 9e-37
Identities = 58/297 (19%), Positives = 104/297 (35%), Gaps = 46/297 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDE----IVALKRLKMEKEKEGFPITSLREINTLLK 417
EFK + + G +G VY+ E VA+K L+ + L E +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMAS 67
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
+P++ + I + S + ++ + L++ +R K + Q+
Sbjct: 68 VDNPHVCRLLGICLTST---VQLITQLMPFG--CLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY--TPIVVTLWYRSP 535
+ +L D ++HRDL N+L+ +K+ DFGLA+ G+ K Y V + + +
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 536 ELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594
E +L + Y+ D+WS G E + + G E S + K P I
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT-- 239
Query: 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
Y ++ K D +R E +
Sbjct: 240 ------------------------------IDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 5e-36
Identities = 60/313 (19%), Positives = 106/313 (33%), Gaps = 58/313 (18%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTD-----EIVALKRLKMEKEKEGFPITSLREINTLL 416
+ K + G +G V A D VA+K LK + E+ L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL-MSELKILI 71
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPG---------- 466
H V + +++++ + +L +RSK+ F+P
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG--NLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 467 -----EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521
+ C Q+ + L +HRDL N+LLS + ++K+ DFGLAR+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 522 HY--TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSR 578
+ + L + +PE + + Y+ D+WS G + E + G E+ R
Sbjct: 190 YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYD 638
+++ T P+ T Y + +
Sbjct: 249 R--------------------LKEGTRMRAPD-----------YTTPEMYQTMLDCWHGE 277
Query: 639 PVTRITADEALRH 651
P R T E + H
Sbjct: 278 PSQRPTFSELVEH 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-35
Identities = 56/320 (17%), Positives = 107/320 (33%), Gaps = 58/320 (18%)
Query: 349 PPYLPAIQGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEI--VALKRLKMEKEKEGFPI 406
P P + + K + I EG +G V +A+ K+ A+KR+K K+
Sbjct: 1 PTIYPVL----DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 407 TSLREINTLLK-AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-------------DMKSL 452
E+ L K HPNI+ + + +++ ++Y H +
Sbjct: 57 F-AGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 453 METMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512
S ++ + + +L +HRDL N+L+ + K+ DFGL
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 513 AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL-CMEPLFTGKS 571
+R +K + + + + E L Y+T D+WS G + E + + G +
Sbjct: 174 SRGQEVYVKKTM-GRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 572 DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLL 631
E ++ + + + YDL+
Sbjct: 232 CAELYEKLPQ---GYRLEKPLNCD-----------------------------DEVYDLM 259
Query: 632 CKFLTYDPVTRITADEALRH 651
+ P R + + L
Sbjct: 260 RQCWREKPYERPSFAQILVS 279
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 4e-35
Identities = 54/292 (18%), Positives = 102/292 (34%), Gaps = 45/292 (15%)
Query: 368 NRIEEGTYGVVYRAKDKRTD---EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIV 424
I G +G VY D A+K L + G L E + HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVL 91
Query: 425 TVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD 484
++ I + S +V+ Y++H L +R++ ++ Q+ + L
Sbjct: 92 SLLGICLRSE-GSPLVVLPYMKHG--DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP----LKHYTPIVVTLWYRSPELLLG 540
+HRDL N +L + +KV DFGLAR+ + + T + + + + E L
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 541 CKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599
K ++T D+WS G + E + P + + + + + + P
Sbjct: 209 QK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP------- 260
Query: 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651
+ Y+++ K R + E +
Sbjct: 261 -------------------------DPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-34
Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 46/297 (15%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDE----IVALKRLKMEKEKEGFPITSLREINTLLK 417
I G +G VY+ K + VA+K LK E + L E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQ 65
Query: 418 AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
H NI+ + V S + I+ +Y+E+ +L + +R K F ++ +++ +
Sbjct: 66 FSHHNIIRLEG--VISKYKPMMIITEYMENG--ALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY---TPIVVTLWYRS 534
+ +L + +HRDL N+L++ + KV DFGL+R + + + + + +
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 535 PELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPG 593
PE + +++++ D+WS G + E + E + S+ E + I P P
Sbjct: 182 PEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP- 239
Query: 594 FSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650
Y L+ + + R + +
Sbjct: 240 -------------------------------SAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 8e-34
Identities = 56/305 (18%), Positives = 118/305 (38%), Gaps = 51/305 (16%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
E+ + +G++G+VY K + VA+K + E I L E + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMK 78
Query: 417 KAQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMR------SKKQVFIPGEVK 469
+ ++V R + V S ++M+ + D+KS + ++R ++
Sbjct: 79 EFNCHHVV--RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 470 CLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP--LKHYTPIV 527
+ ++ + +A+L+ N +HRDL N +++ +K+GDFG+ R+ + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 528 VTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFL-CMEPLFTGKSDLEQLSRIFKTMGTP 586
+ + + SPE L ++T D+WS G + E E + G S+ + L + +
Sbjct: 197 LPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255
Query: 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD 646
P ++ ++L+ Y+P R +
Sbjct: 256 KPDNCP--------------------------------DMLFELMRMCWQYNPKMRPSFL 283
Query: 647 EALRH 651
E +
Sbjct: 284 EIISS 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-32
Identities = 59/315 (18%), Positives = 104/315 (33%), Gaps = 63/315 (20%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKD-----KRTDEIVALKRLKMEKEKEGFPITSLREINTLL 416
+ G +G V A VA+K LK + E+ L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL-MSELKVLS 81
Query: 417 K-AQHPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPG--------- 466
H NIV + + ++ +Y + L+ +R K+ FI
Sbjct: 82 YLGNHMNIVNLLG--ACTIGGPTLVITEYCCY--GDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 467 --------EVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518
++ Q+ +A L +HRDL N+LL+H I K+ DFGLAR+ +
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 519 PLKHY--TPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQ 575
+ + + + +PE + C Y+ D+WS G E + + G +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 576 LSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFL 635
++ K G + E+ YD++
Sbjct: 257 FYKMIK------------------------------EGFRMLSPEHAPAEM-YDIMKTCW 285
Query: 636 TYDPVTRITADEALR 650
DP+ R T + ++
Sbjct: 286 DADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-32
Identities = 50/313 (15%), Positives = 111/313 (35%), Gaps = 58/313 (18%)
Query: 362 EEFKCLNRIEEGTYGVVYRAKDKRTDE-------IVALKRLKMEKEKEGFPITSLREINT 414
+ + EG +G V A+ D+ VA+K LK + ++ + E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL-ISEMEM 71
Query: 415 LLK-AQHPNIVTVREIVVGSNMDKIFIVMDYVEH-DMKSLMETMR------------SKK 460
+ +H NI+ + + ++++++Y +++ ++ R + +
Sbjct: 72 MKMIGKHKNII--NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 461 QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520
+ ++ Q+ + +L +HRDL N+L++ ++K+ DFGLAR+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 521 KHYT--PIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSR 578
+ + + + +PE L Y+ D+WS G + E + +E+L +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 579 IFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYD 638
+ K + EL Y ++
Sbjct: 249 LLKEGHRM--DKPSNCTN----------------------------EL-YMMMRDCWHAV 277
Query: 639 PVTRITADEALRH 651
P R T + +
Sbjct: 278 PSQRPTFKQLVED 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 98.7 bits (245), Expect = 3e-24
Identities = 27/201 (13%), Positives = 63/201 (31%), Gaps = 34/201 (16%)
Query: 368 NRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK--------EKEGFPITSLREINTLLKAQ 419
+ EG V+ + +K K+ +++ + + +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 420 HPNIVTVREIVVGSNMD--KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLN 477
+ ++ + V ++M+ ++ + + ++ +L
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE----------VLDMILE 114
Query: 478 AVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKHY----TPIVVTLWYR 533
VA + I+H DL N+L+S GI + DF + E G + ++
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
Query: 534 SPELLLGCKEYSTPIDMWSVG 554
+ Y T D+ S
Sbjct: 174 --------RTYRTEKDINSAI 186
|
| >d1f5na1 a.114.1.1 (A:284-583) Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 300 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain superfamily: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain family: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain domain: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 0.002
Identities = 24/149 (16%), Positives = 55/149 (36%), Gaps = 10/149 (6%)
Query: 52 SQHKSHHRSRHRDERDRRHHHKEKERDRNKSDQSDGGHKSHRRRDEDRKHRDERKAREAQ 111
++ R + E + + K KE + Q+D + E + + E A+
Sbjct: 162 KKYYEEPRKGIQAEEILQTYLKSKESMTDAILQTDQTLTEKEKEIEVERVKAESAQASAK 221
Query: 112 KSKEYTAREIDELKAKEADLRARLERKRYSNPLREKEKIERELRKERLLEAERVKEAYKE 171
E + ++ KE + L++ EK+E + R + L E ER +
Sbjct: 222 MLHEMQRKNEQMMEQKERSYQEHLKQ--------LTEKMEND-RVQLLKEQERTLALKLQ 272
Query: 172 RVKDVEQKRKRYRTRSRSRSPINKAKNEM 200
+ + ++ + + ++ I + +M
Sbjct: 273 EQEQLLKEGFQ-KESRIMKNEIQDLQTKM 300
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1028 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.11 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.08 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.08 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.07 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.06 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.05 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.05 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.05 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.02 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.02 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.01 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 98.99 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 98.98 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 98.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 98.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 98.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 98.94 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 98.93 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 98.92 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 98.9 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 98.89 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 98.88 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 98.86 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 98.84 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 98.82 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 98.82 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 98.82 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 98.82 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 98.79 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 98.78 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 98.78 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 98.77 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 98.77 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 98.77 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 98.73 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 98.73 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 98.71 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 98.71 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 98.69 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 98.69 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 98.68 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 98.68 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 98.68 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 98.66 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 98.64 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 98.64 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 98.63 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 98.63 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 98.58 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 98.57 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 98.56 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 98.56 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 98.54 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 98.54 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 98.5 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 98.45 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 98.45 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 98.42 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 98.33 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 98.25 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 98.16 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 97.97 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 97.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.29 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.15 | |
| d2daha1 | 41 | Ubiquilin-3 {Human (Homo sapiens) [TaxId: 9606]} | 96.59 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.74 | |
| d2bwba1 | 44 | DSK2 {Baker's yeast (Saccharomyces cerevisiae) [Ta | 95.64 | |
| d2dnaa1 | 50 | Ubiquilin-like protein Ubqlnl {Mouse (Mus musculus | 95.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.92 | |
| d1oqya1 | 41 | DNA repair protein Hhr23a {Human (Homo sapiens) [T | 94.85 | |
| d1veja1 | 61 | 4931431F19Rik {Mouse (Mus musculus) [TaxId: 10090] | 94.69 | |
| d1vg5a_ | 73 | Rhomboid family protein At3g58460 {Thale cress (Ar | 94.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.78 | |
| d1wgna_ | 63 | Ubiquitin-associated protein 1, UBAP1 {Human (Homo | 92.43 | |
| d1wiva_ | 73 | Ubiquitin isopeptidase T {Thale cress (Arabidopsis | 91.22 | |
| d1aipc1 | 52 | Elongation factor Ts (EF-Ts), N-terminal domain {T | 88.61 | |
| d1wjia_ | 63 | Tudor domain containing protein 3, TDRD3 {Human (H | 88.39 | |
| d2g3qa1 | 43 | Endocytic protein Ede1, YBL047C {Saccharomyces cer | 85.81 | |
| d1efub3 | 54 | Elongation factor Ts (EF-Ts), N-terminal domain {E | 84.89 | |
| d1oqya1 | 41 | DNA repair protein Hhr23a {Human (Homo sapiens) [T | 84.8 | |
| d1xb2b1 | 56 | Elongation factor Ts (EF-Ts), N-terminal domain {C | 84.08 | |
| d1wiva_ | 73 | Ubiquitin isopeptidase T {Thale cress (Arabidopsis | 80.44 | |
| d1wgna_ | 63 | Ubiquitin-associated protein 1, UBAP1 {Human (Homo | 80.33 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-56 Score=483.64 Aligned_cols=292 Identities=41% Similarity=0.764 Sum_probs=241.2
Q ss_pred EEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc---cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEE
Q psy18163 366 CLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK---EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVM 442 (1028)
Q Consensus 366 il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~---~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVm 442 (1028)
.+++||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|..++|||||++++++.. .+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeehh
Confidence 478999999999999999999999999999765432 2234567899999999999999999998864 45799999
Q ss_pred eccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc
Q psy18163 443 DYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH 522 (1028)
Q Consensus 443 Ey~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~ 522 (1028)
|||.++ . +..+......+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 80 E~~~~~--~-~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 80 DFMETD--L-EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp ECCSEE--H-HHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hhhcch--H-HhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 999873 2 3334455667899999999999999999999999999999999999999999999999999887766555
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQK 602 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~ 602 (1028)
....+||+.|+|||++.+...|+.++||||||||+|+|++|.+||.+.++.+++.+|++.++.|....|+.....+....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 66789999999999998767899999999999999999999999999999999999999999999888877665433221
Q ss_pred hccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCCC
Q psy18163 603 MTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFP 667 (1028)
Q Consensus 603 l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~p 667 (1028)
. ..++ ..........+++.+++||.+||++||++||||.|+|+||||++.|.|.++..+|
T Consensus 237 ~--~~~~---~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p 296 (299)
T d1ua2a_ 237 F--KSFP---GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296 (299)
T ss_dssp C--CCCC---CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred h--ccCC---CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCC
Confidence 1 1111 1111222345788999999999999999999999999999999988877766554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-55 Score=475.87 Aligned_cols=294 Identities=44% Similarity=0.833 Sum_probs=245.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+|+|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|++++|||||++++++... +++||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--cceeE
Confidence 3789999999999999999999999999999999987655555566788999999999999999999998654 58999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||||+.+++..++.. .....+++.+++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 79 v~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 999998865555432 335568999999999999999999999999999999999999999999999999999887666
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+++..++...+.+....|+.....+..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 66777899999999999888777899999999999999999999999999999999999999999988888765543322
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPID 662 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~ 662 (1028)
.. .++.............++..++|||.+||.+||.+|||+.|+|+||||++.+.|++
T Consensus 237 ~~----~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 237 KP----SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp CT----TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred cc----ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 11 11111111122233457889999999999999999999999999999998776644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=465.66 Aligned_cols=291 Identities=38% Similarity=0.730 Sum_probs=240.5
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCC-CeEEEEEEeeccccccCCccchHHHHHHHHHc---CCCCeeEEEEEEee
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRT-DEIVALKRLKMEKEKEGFPITSLREINTLLKA---QHPNIVTVREIVVG 432 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~t-g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l---~HPNIV~L~~i~~~ 432 (1028)
.|+..++|+++++||+|+||+||+|++..+ ++.||||+++.............+|+.+|+.+ +||||++++++|..
T Consensus 2 ~c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CCCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 366778999999999999999999999765 67899999987765555556677888887766 79999999998853
Q ss_pred ---cCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEec
Q psy18163 433 ---SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGD 509 (1028)
Q Consensus 433 ---~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~D 509 (1028)
.....+|++||||.+++..+.. ......+++..++.|+.||+.||.|||++|||||||||+|||++..+.+||+|
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHH--HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cccccCceEEEEEEeccCCchhhhh--hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecc
Confidence 2345789999999985444333 34455689999999999999999999999999999999999999999999999
Q ss_pred cCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q psy18163 510 FGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEK 589 (1028)
Q Consensus 510 FGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~ 589 (1028)
||+++..... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.++.+++..|+..++.+...
T Consensus 160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhhccc-ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9999865432 34567899999999999988 679999999999999999999999999999999999999999998887
Q ss_pred CCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 590 IWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 590 ~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.|+.....+..... .............+++.+.+||.+||++||.+||||.|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 238 DWPRDVALPRQAFH------SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCTTCSSCGGGSC------CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhhc------cccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 77655443322111 111111223345578999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=469.45 Aligned_cols=261 Identities=28% Similarity=0.424 Sum_probs=211.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|..++|||||++++++.......+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47899999999999999999999999999999999876543333455778999999999999999999988766678999
Q ss_pred EEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC-----cccccccccceeecCCCcEEEeccCCcc
Q psy18163 441 VMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW-----ILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 441 VmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g-----IVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
|||||.+ +|.+++.........+++..++.|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999975 777777666556677999999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.+.......+..+||+.|+|||++.+ ..|+.++|||||||+||+|+||.+||.+.+..+.+..|......
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~--------- 232 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--------- 232 (269)
T ss_dssp HC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------
T ss_pred ecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 87665555567899999999999977 66999999999999999999999999998888877777553100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
. ....+++.+.+||.+||..||.+|||+.|+|+|||+
T Consensus 233 ------------~-----------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 ------------R-----------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ------------C-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------------C-----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0 011267889999999999999999999999999995
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=469.90 Aligned_cols=260 Identities=27% Similarity=0.380 Sum_probs=212.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|+++.+|+.||||++....... ....+.+|+.+|+.++|||||++++++... +.+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREG--NIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeEE
Confidence 478999999999999999999999999999999997654322 335678999999999999999999998654 58999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC-
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP- 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~- 519 (1028)
|||||.+ ++|.+.+. ....+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 81 vmEy~~g--g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSG--GELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTT--EEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEeccCC--CcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999986 34444443 3456999999999999999999999999999999999999999999999999999876432
Q ss_pred -CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 520 -LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 520 -~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
....+..+||+.|||||++.+...++.++||||||||||+|++|.+||.+.++.............. .
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-~---------- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-L---------- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-S----------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-C----------
Confidence 2335567999999999999885556789999999999999999999998766544333333211100 0
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.....+++.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 227 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 227 -------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 001236788999999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=464.21 Aligned_cols=256 Identities=28% Similarity=0.474 Sum_probs=219.0
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
++++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|..++|||||++++++.. .+.+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 81 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 81 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEE
Confidence 46889999999999999999999999999999999976543 23445567789999999999999999999864 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||.+ ++|...+.. ...+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 82 ~ivmEy~~~--g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 82 YLILEYAPL--GTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEEECCTT--CBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EEEEeecCC--CcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999986 344444433 34589999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..+.+....
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------------- 222 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------------- 222 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-------------
T ss_pred --CcccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 23456789999999999988 66899999999999999999999999998888877776542100
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
+ ...+++.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 223 ---------~-----------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 ---------F-----------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---------C-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---------C-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 0 1226788999999999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-53 Score=476.30 Aligned_cols=272 Identities=25% Similarity=0.388 Sum_probs=231.3
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.+++|++++.||+|+||+||+|+++.+|+.||||++...... ....+.+|+.+|..++|||||++++++... +.+|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 468999999999999999999999999999999999765322 234567899999999999999999988654 5899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC--CCcEEEeccCCccccC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH--RGILKVGDFGLAREYG 517 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~--~g~lKL~DFGlAr~~~ 517 (1028)
||||||.+ ++|.+.+......+++.+++.|+.||+.||.|||++|||||||||+||||+. +|.+||+|||+|+.+.
T Consensus 100 ivmE~~~g--g~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 100 MIYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEECCCCS--CBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEcCCC--CCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999987 6666666555667999999999999999999999999999999999999964 6889999999999876
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ....+.+||+.|||||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......+...
T Consensus 178 ~~-~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------- 247 (350)
T d1koaa2 178 PK-QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-------- 247 (350)
T ss_dssp TT-SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG--------
T ss_pred cc-cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--------
Confidence 43 44556799999999999988 668999999999999999999999999999988888887643222111
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPIDPAMFPT 668 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~~p~~~pt 668 (1028)
....+++.+++||.+||..||.+|||+.|||+||||+....+..+...|.
T Consensus 248 ---------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~ 297 (350)
T d1koaa2 248 ---------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 297 (350)
T ss_dssp ---------------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCBCT
T ss_pred ---------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhCCC
Confidence 11236788999999999999999999999999999998777655554443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=468.13 Aligned_cols=256 Identities=26% Similarity=0.469 Sum_probs=219.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|+++++||+|+||+||+|++..+|+.||||+++.... .....+.+|+.+|+.++|||||+++++|... +.+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEEEE
Confidence 479999999999999999999999999999999976542 2234578999999999999999999998654 489999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||||.+ ++|...+.. ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 96 mEy~~g--g~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 96 MEYLAG--GSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp EECCTT--CBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEecCC--CcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999987 344443332 3589999999999999999999999999999999999999999999999999998765555
Q ss_pred cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 522 HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+..... +...
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~------------ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQ------------ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCS------------
T ss_pred cccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCC------------
Confidence 5667899999999999988 6789999999999999999999999999988888777765321 1100
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
....+++.+++||.+||..||.+|||+.|+|+||||+.
T Consensus 238 -----------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 238 -----------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -----------------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----------------CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 01236788999999999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-54 Score=467.44 Aligned_cols=259 Identities=24% Similarity=0.418 Sum_probs=218.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
+.|++++.||+|+||+||+|+++.++..||||+++.... .....+.+|+.+|+.++|||||++++++... +.+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CeEEEE
Confidence 569999999999999999999999999999999976532 2345678999999999999999999988654 489999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||||.+ ++|...+......+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.......
T Consensus 88 mEy~~~--g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 88 IEFCAG--GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EECCTT--EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred EecCCC--CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 999986 444444444456799999999999999999999999999999999999999999999999999986543333
Q ss_pred cccccccCccccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 522 HYTPIVVTLWYRSPELLLG----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
...+.+||+.|+|||++.+ ...|+.++|||||||+||+|+||.+||.+.+..+.+.++..... +. +
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~--~~-----~--- 235 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP--PT-----L--- 235 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--CC-----C---
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--CC-----C---
Confidence 3456789999999999852 35689999999999999999999999999988888877765311 00 0
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.....+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 236 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 236 --------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 001236788999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-53 Score=459.54 Aligned_cols=286 Identities=45% Similarity=0.796 Sum_probs=237.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+++|+++++||+|+||+||+|+++ +|+.||||+++...........+.+|+.+|..++|||||++++++... +.+|+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--CceeE
Confidence 378999999999999999999996 789999999987765555667788999999999999999999888644 58999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||+|+.+.+. ..+......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|.....+.
T Consensus 78 ~~e~~~~~~~---~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 78 VFEHLDQDLK---KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEECCSEEHH---HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EEEeehhhhH---HHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9999987433 3334556679999999999999999999999999999999999999999999999999999887655
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAV 600 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~ 600 (1028)
......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.++.+++.+++..++.+....|+....++..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 55566789999999999988788899999999999999999999999999999999999999999988888765543322
Q ss_pred hhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 601 QKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 601 ~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.. .+..............+++.+.|||.+||++||.+||||.|+|+||||++
T Consensus 235 ~~----~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 235 DP----NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CT----TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cc----ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11 11111122223344567889999999999999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-53 Score=463.48 Aligned_cols=301 Identities=39% Similarity=0.725 Sum_probs=238.2
Q ss_pred cccccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec---
Q psy18163 357 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--- 433 (1028)
Q Consensus 357 g~~~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~--- 433 (1028)
.|..+++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||+.+++++...
T Consensus 5 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp TSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 34567899999999999999999999999999999999987766666667788999999999999999999987542
Q ss_pred ---CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEecc
Q psy18163 434 ---NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDF 510 (1028)
Q Consensus 434 ---~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DF 510 (1028)
..+++|+|||||.+++.. .+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~---~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ------CEEEEEECCCEEHHH---HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ccccCceEEEEEeccCCCccc---hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeec
Confidence 235789999999874433 33445567899999999999999999999999999999999999999999999999
Q ss_pred CCccccCCC----CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q psy18163 511 GLAREYGSP----LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTP 586 (1028)
Q Consensus 511 GlAr~~~~~----~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p 586 (1028)
|+++.+... .....+.+||++|+|||++.+...|+.++|||||||++|+|++|.+||.+.++.+.+..+...++.+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999866532 1233456899999999999887789999999999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCCCC
Q psy18163 587 NEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPLPI 661 (1028)
Q Consensus 587 ~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~p~ 661 (1028)
....+................... ............++.++|||.+||.+||++||||.|+|+||||+..|.|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQK-RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCC-BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred Chhhccccchhhhhhhhccccccc-ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 887776655433222211111000 00000011122467889999999999999999999999999999876654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=471.93 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=223.7
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
++++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|..++||||++++++|.. .+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--cccc
Confidence 46899999999999999999999999999999999987543 23344567899999999999999999988864 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||.+ ++|...+.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 81 ~iv~ey~~g--g~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 81 CFVMEYANG--GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTT--CBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ccceeccCC--Cchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999987 555555444 34689999999999999999999999999999999999999999999999999998766
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
........+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.+..+.+..+......
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~------------- 223 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------------- 223 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------
T ss_pred CCcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC-------------
Confidence 5556677899999999999988 67899999999999999999999999999988877776553110
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
+ ...+++.+++||.+||++||.+|+ ++.++|+||||++.
T Consensus 224 ---------~-----------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 224 ---------F-----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ---------C-----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---------C-----------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 0 122678899999999999999999 49999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.8e-53 Score=473.25 Aligned_cols=261 Identities=21% Similarity=0.383 Sum_probs=226.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|++..+|+.||||+++...... ...+.+|+.+|..++|||||+++++|.. .+.+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 478999999999999999999999999999999997654221 2456789999999999999999998864 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec--CCCcEEEeccCCccccCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS--HRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd--~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||.+ ++|.+.+......+++.+++.|+.||+.||.|||++|||||||||+||||+ .+|.+||+|||+|+.+..
T Consensus 104 vmE~~~g--g~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 104 ILEFLSG--GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEECCCC--CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEcCCC--ChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999987 677777766666799999999999999999999999999999999999998 578999999999998764
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. ......+||+.|+|||++.+ ..|+.++|||||||+||+|+||.+||.+.+..+.+..|......++...+
T Consensus 182 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------- 252 (352)
T d1koba_ 182 D-EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------- 252 (352)
T ss_dssp T-SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT-------
T ss_pred C-CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc-------
Confidence 3 34556789999999999987 67999999999999999999999999999999988888765333222221
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
..+++.+.+||.+||++||.+|||+.|+|+||||+...
T Consensus 253 ----------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 253 ----------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp ----------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ----------------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 23678899999999999999999999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=462.95 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=217.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|.+++|||||+++++|.. .+.+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEE
Confidence 4789999999999999999999999999999999976542 23344567899999999999999999998854 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
||||||.+ ++|.+.+.. ...+++.+++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 85 ivmEy~~g--g~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKN--GELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTT--EEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEccCC--CCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999986 444444433 346899999999999999999999999999999999999999999999999999877532
Q ss_pred --CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 --LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 --~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
....++.+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|.+....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~------------ 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD------------ 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC------------
T ss_pred CcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC------------
Confidence 233456789999999999988 67999999999999999999999999999988888877642100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHH------HHhCCCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADE------ALRHDYFSESPL 659 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~E------lL~HPfF~e~p~ 659 (1028)
+ ...+++.+.+||.+||+.||.+|||++| +++||||+...|
T Consensus 229 ----------~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 229 ----------F-----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp ----------C-----------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ----------C-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 0 1126788999999999999999999987 688999987544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-53 Score=464.57 Aligned_cols=260 Identities=28% Similarity=0.434 Sum_probs=202.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.+.|++++.||+|+||+||+|+++.+++.||||++....... ....+.+|+.+|..++|||||++++++.. .+.+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 366999999999999999999999999999999998654322 23456689999999999999999998854 458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeec---CCCcEEEeccCCccccC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLS---HRGILKVGDFGLAREYG 517 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd---~~g~lKL~DFGlAr~~~ 517 (1028)
|||||.+ ++|.+.+.. ...+++.+++.|+.||+.||.|||++|||||||||+|||+. .+|.+||+|||+|+...
T Consensus 85 vmE~~~g--g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 85 IMQLVSG--GELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EECCCCS--CBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEeccCC--CcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999986 444444433 45699999999999999999999999999999999999995 47899999999998765
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ....+.+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+....|......+....
T Consensus 162 ~~-~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------- 232 (307)
T d1a06a_ 162 PG-SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY------- 232 (307)
T ss_dssp ------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTT-------
T ss_pred CC-CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcc-------
Confidence 43 34456789999999999987 6799999999999999999999999999988888877765422211111
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...+++.+.+||.+||.+||.+|||+.|+|+||||++.
T Consensus 233 ----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 233 ----------------------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ----------------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ----------------------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 12367889999999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=471.22 Aligned_cols=287 Identities=21% Similarity=0.300 Sum_probs=210.6
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|+++++||+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+|+.++|||||+++++|.. .+++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEE
Confidence 35789999999999999999999999999999999976532 2334567899999999999999999999864 45899
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
||||||.+ +|.+++. . ...+++..++.|+.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+.
T Consensus 81 iVmEy~~gg~L~~~l~---~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLK---K-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEECCTTEEHHHHHH---H-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEcCCCCcHHHHHh---h-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999986 5555443 3 3458999999999999999999997 599999999999999999999999999998764
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQ-LSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~-l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. ...++.+||++|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+.... +..+....+.+..........
T Consensus 157 ~--~~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 D--SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp H--HTC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred C--CccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 3 23356799999999999998 5699999999999999999999999987654322 222222222211110000000
Q ss_pred ChhhhhhccccCCCC----------CCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNV----------GGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~----------~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
............+.. ...........++..++|||.+||.+||.+||||+|+|+||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000000000000 000001122346889999999999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=466.98 Aligned_cols=289 Identities=33% Similarity=0.528 Sum_probs=232.2
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC----C
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN----M 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~----~ 435 (1028)
..++|+++++||+|+||+||+|.++.+|+.||||+++...........+++|+.+|+.++|||||+++++|.... .
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 457899999999999999999999999999999999765443334456789999999999999999999986432 3
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..+|||||||+.+|..++. ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus 96 ~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 4689999999876665543 23589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
... ..+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++..++....
T Consensus 171 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 171 ADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 754 34567899999999999887778999999999999999999999999999999999999998888766654443
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
....... ....+.............+++.++|||.+||.+||.+||||.|||+||||++..
T Consensus 248 ~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 248 SDEAKNY--MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CHHHHHH--HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred chhhhhh--hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 2211110 011111111122223345788999999999999999999999999999998743
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=453.38 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=218.0
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC----CccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG----FPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~----~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
++|++++.||+|+||+||+|+++.+|+.||||++++...... ....+.+|+.+|+.++|||||+++++|.. .+.
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 679999999999999999999999999999999976543222 23456789999999999999999998864 458
Q ss_pred EEEEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC----cEEEeccCC
Q psy18163 438 IFIVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG----ILKVGDFGL 512 (1028)
Q Consensus 438 l~LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g----~lKL~DFGl 512 (1028)
+|||||||.+ +|.+++ ... ..+++.+++.|+.||+.||.|||++|||||||||+|||++.+| .+||+|||+
T Consensus 88 ~~iv~E~~~gg~L~~~i---~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 88 VILILELVAGGELFDFL---AEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEECCCSCBHHHHH---HHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCccccchh---ccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999986 554444 333 4689999999999999999999999999999999999998776 599999999
Q ss_pred ccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
|+.+... ....+.+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|......+..
T Consensus 164 a~~~~~~-~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---- 237 (293)
T d1jksa_ 164 AHKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED---- 237 (293)
T ss_dssp CEECTTS-CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH----
T ss_pred hhhcCCC-ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc----
Confidence 9887543 34556789999999999987 67899999999999999999999999999988888877653211110
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....++..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 238 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 238 -------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp -------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred -------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0112367889999999999999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=449.25 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=208.6
Q ss_pred Ce-EEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec--CCCeEE
Q psy18163 363 EF-KCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS--NMDKIF 439 (1028)
Q Consensus 363 ~Y-~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~--~~~~l~ 439 (1028)
+| ++..+||+|+||+||+|++..++..||+|++............+.+|+.+|.+++|||||++++++... ....+|
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 45 778899999999999999999999999999976543333344577899999999999999999998643 345789
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCC--cccccccccceeec-CCCcEEEeccCCcccc
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNW--ILHRDLKTSNLLLS-HRGILKVGDFGLAREY 516 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~g--IVHRDLKPeNILLd-~~g~lKL~DFGlAr~~ 516 (1028)
||||||.+ ++|...+.. ...+++.+++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|+..
T Consensus 89 ivmE~~~~--g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 89 LVTELMTS--GTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEECCCS--CBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEeCCCC--CcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999987 344443333 346899999999999999999999999 99999999999996 5789999999999865
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.. ....+.+||+.|+|||++.+ .|+.++||||||||||+|++|.+||.+..+...+.+.+.. +..+.
T Consensus 166 ~~--~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~-------- 232 (270)
T d1t4ha_ 166 RA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA-------- 232 (270)
T ss_dssp CT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG--------
T ss_pred cC--CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc--------
Confidence 43 33456799999999999876 4999999999999999999999999877665554443321 00000
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFS 655 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~ 655 (1028)
.+....++.+.+||.+||..||.+|||+.|+|+||||+
T Consensus 233 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 ---------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 01123567889999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-52 Score=459.71 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=220.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
++++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|..++|||||++++++.. .+.+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 79 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQI 79 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCee
Confidence 45789999999999999999999999999999999986543 23344567789999999999999999998864 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|+|||||.+ +++...+. ....+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 80 ~ivmE~~~g--g~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 80 FMIMDYIEG--GELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp EEEECCCCS--CBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeEeeecCC--cccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999987 44444333 345688899999999999999999999999999999999999999999999999988753
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
..++.+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|......
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------------- 219 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR------------- 219 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-------------
T ss_pred ---ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-------------
Confidence 3456799999999999987 66999999999999999999999999999988888887653110
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
....+++.+.+||.+||..||.+|+ |++++|+||||++..
T Consensus 220 --------------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 220 --------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred --------------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 0122678899999999999999996 999999999998753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=462.03 Aligned_cols=284 Identities=32% Similarity=0.517 Sum_probs=232.5
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec----CCCeE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS----NMDKI 438 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~----~~~~l 438 (1028)
+|+.+++||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||++++++|... +..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999976432 224799999999999999999998532 34568
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-cEEEeccCCccccC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-~lKL~DFGlAr~~~ 517 (1028)
|||||||++++...+.........+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999999877666665555666799999999999999999999999999999999999999775 89999999998775
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ....+.+||+.|+|||++.+...|+.++||||||||+|||++|.+||.+.+..+++..|++.+|.+....|.....
T Consensus 175 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~- 252 (350)
T d1q5ka_ 175 RG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP- 252 (350)
T ss_dssp TT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred CC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc-
Confidence 43 3455679999999999998877899999999999999999999999999999999999999988876554432111
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
......+..... ..........+++.+++||.+||.+||.+||||.|+|+||||++.
T Consensus 253 -~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 -NYTEFKFPQIKA--HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ----CCCCCCCCC--CCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred -chhhcccccccc--CchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000111111100 001122334578899999999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-52 Score=463.81 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=220.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+++|+.+|+.++|||||++++++.. ...++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--ccccc
Confidence 4789999999999999999999999999999999976542 23334567899999999999999999998854 45899
Q ss_pred EEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 440 IVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
+||||+.+ +++...+... ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 118 ~v~e~~~~--g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 118 MVMEYVAG--GEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEECCTT--CBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred cccccccc--cchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999987 4555555443 3589999999999999999999999999999999999999999999999999998753
Q ss_pred CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 520 LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 520 ~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.....+||+.|||||++.+ ..|+.++||||||||||+|+||.+||.+.+....+..|......+
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 257 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF------------- 257 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred --ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC-------------
Confidence 2346799999999999988 678999999999999999999999999999888888876532110
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSESP 658 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~p 658 (1028)
...+++.+.+||.+||..||.+|+ |+++||+||||+...
T Consensus 258 --------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 258 --------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp --------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred --------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 112678899999999999999995 999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-52 Score=456.93 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=214.8
Q ss_pred CeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|..++|||||++++++... +.+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEEE
Confidence 599999999999999999999999999999999765432 22234567899999999999999999998654 589999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLK 521 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~ 521 (1028)
||||.+++ +. .+......+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 94 ~E~~~~g~--l~-~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 94 MEYCLGSA--SD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp EECCSEEH--HH-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EEecCCCc--hH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 99998733 32 2223356799999999999999999999999999999999999999999999999999986543
Q ss_pred cccccccCccccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 522 HYTPIVVTLWYRSPELLLGC--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 522 ~~t~~vGT~~Y~APEvL~g~--~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
....+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~------------- 233 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------------- 233 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------------
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence 3456899999999999652 458999999999999999999999999988888877776531100
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.....+++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 234 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 ------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 0012367889999999999999999999999999999763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=441.18 Aligned_cols=288 Identities=41% Similarity=0.729 Sum_probs=239.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
+++|+++++||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++||||+++++++.. ...+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~i 78 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeE
Confidence 368999999999999999999999999999999998766545555677899999999999999999998864 448999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
||+++.+ +.+.. +......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......
T Consensus 79 v~~~~~~--~~l~~-~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 79 VFEFCDQ--DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSE--EHHHH-HHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred Eeeeccc--ccccc-ccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999987 33333 33445678999999999999999999999999999999999999999999999999999887665
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPL-FTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pP-F~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
.......+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+++..+....+.+....|+.....+.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 5666678899999999998867789999999999999999999865 677888888999999999888887776554332
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
........ . ..........+++.+.+||.+||++||.+||||+|+|+||||++.
T Consensus 236 ~~~~~~~~--~--~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 236 YKPYPMYP--A--TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCC--T--TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccc--c--cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 21111110 0 111122334578899999999999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=459.40 Aligned_cols=259 Identities=21% Similarity=0.365 Sum_probs=222.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|+++.+++.||||+++..... ...+.+|+.+|..++|||||+++++|... +.+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEE
Confidence 47899999999999999999999999999999999765432 23467899999999999999999988654 58999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC--CcEEEeccCCccccCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR--GILKVGDFGLAREYGS 518 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~--g~lKL~DFGlAr~~~~ 518 (1028)
|||||.+ ++|.+.+......+++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++....
T Consensus 79 vmE~~~g--g~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 79 IFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EECCCCC--CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEecCCC--CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999987 56666666666679999999999999999999999999999999999999854 5899999999987754
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. ......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+.+..|.+....++...
T Consensus 157 ~-~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------- 226 (321)
T d1tkia_ 157 G-DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------- 226 (321)
T ss_dssp T-CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH--------
T ss_pred C-CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh--------
Confidence 3 34456789999999999987 5699999999999999999999999999999998888877432222111
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
...+++.+++||.+||.+||.+|||+.|+|+||||++.
T Consensus 227 ---------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 227 ---------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 12367889999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.8e-51 Score=441.51 Aligned_cols=261 Identities=27% Similarity=0.408 Sum_probs=219.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC-------CccchHHHHHHHHHcC-CCCeeEEEEEEee
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG-------FPITSLREINTLLKAQ-HPNIVTVREIVVG 432 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~-------~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~ 432 (1028)
.++|++++.||+|+||+||+|++..+|+.||||++++...... ....+++|+.+|.++. |||||++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE- 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence 3789999999999999999999999999999999987643221 1224678999999997 999999999886
Q ss_pred cCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCC
Q psy18163 433 SNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGL 512 (1028)
Q Consensus 433 ~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGl 512 (1028)
+.+.+|||||||.+ ++|.+.+.. ...+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+
T Consensus 81 -~~~~~~ivmE~~~~--g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 -TNTFFFLVFDLMKK--GELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp -CSSEEEEEEECCTT--CBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred -cCcceEEEEEcCCC--chHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 44589999999976 344444433 34689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCccccCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q psy18163 513 AREYGSPLKHYTPIVVTLWYRSPELLLG-----CKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPN 587 (1028)
Q Consensus 513 Ar~~~~~~~~~t~~vGT~~Y~APEvL~g-----~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~ 587 (1028)
|+.+... ...+..+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+.+..+.+..+......+.
T Consensus 157 a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9987653 34566789999999999853 34578999999999999999999999999998888887776421111
Q ss_pred CCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCC
Q psy18163 588 EKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSE 656 (1028)
Q Consensus 588 ~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e 656 (1028)
.. ....+++.+++||.+||..||.+|||+.|||+||||++
T Consensus 236 ~~-----------------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SP-----------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TT-----------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred Cc-----------------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 00 11237789999999999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-51 Score=459.38 Aligned_cols=262 Identities=23% Similarity=0.356 Sum_probs=209.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccc-cCCccchHHH---HHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEK-EGFPITSLRE---INTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~-~~~~~~~lrE---i~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
++++|++++.||+|+||+||+|++..+|+.||||++.+.... ........+| +.++..+.|||||+++++|.. .
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--P 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--S
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--C
Confidence 468999999999999999999999999999999999765322 1222233344 556666789999999998864 4
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
+.+|||||||.+ ++|...+.. ...+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 80 ~~~~ivmE~~~g--g~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 80 DKLSFILDLMNG--GDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp SEEEEEECCCCS--CBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred CEEEEEEEecCC--CcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 589999999986 444444433 34688999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 516 YGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 516 ~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
+... .....+||+.|+|||++.+...|+.++||||||||||+||||.+||.+.+..+... +..........
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~------ 227 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVE------ 227 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCC------
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCC------
Confidence 7543 34567899999999999865679999999999999999999999998765433222 22221111110
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCC-----HHHHHhCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRIT-----ADEALRHDYFSESP 658 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPT-----A~ElL~HPfF~e~p 658 (1028)
....+++.+.+||.+||.+||.+||| |+++|+||||+...
T Consensus 228 -----------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 228 -----------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp -----------------------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred -----------------------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 11236788999999999999999999 89999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=450.69 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=218.0
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccc-ccCCccchHHHHHHHH-HcCCCCeeEEEEEEeecCCCeE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKE-KEGFPITSLREINTLL-KAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~-~~~~~~~~lrEi~iL~-~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
+++|++++.||+|+||+||+|+++.+++.||||++++... ........+.|+.++. .++|||||++++++.. .+.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCce
Confidence 3789999999999999999999999999999999976542 2233344566776665 6899999999998864 4589
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||.+ ++|...+.. ...+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 79 yivmEy~~~--g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 79 FFVMEYLNG--GDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EEEEECCTT--CBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred eEEEeecCC--CcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999987 444444433 34589999999999999999999999999999999999999999999999999997766
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
.....+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|... .+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~----------- 221 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPF----------- 221 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC-----------
T ss_pred ccccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC-----------
Confidence 5566677899999999999988 67999999999999999999999999999988888777542 110
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHH-HHHhCCCCCCC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD-EALRHDYFSES 657 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~-ElL~HPfF~e~ 657 (1028)
+ ...+++.+.+||.+||.+||.+|||+. ++++||||++.
T Consensus 222 ---------~-----------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 222 ---------Y-----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp ---------C-----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ---------C-----------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 0 112678899999999999999999995 89999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=436.38 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=206.7
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc----CCccchHHHHHHHHHcC--CCCeeEEEEEEeecCC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE----GFPITSLREINTLLKAQ--HPNIVTVREIVVGSNM 435 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~----~~~~~~lrEi~iL~~l~--HPNIV~L~~i~~~~~~ 435 (1028)
++|++.+.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|++++ |||||++++++.. .
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--P 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--S
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--C
Confidence 68999999999999999999999999999999998654321 12234668999999987 8999999998864 4
Q ss_pred CeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-CCcEEEeccCCcc
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-RGILKVGDFGLAR 514 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-~g~lKL~DFGlAr 514 (1028)
+.+|+||||+.+. +++...+.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+|+
T Consensus 82 ~~~~lv~e~~~~~-~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPV-QDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSE-EEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CeEEEEEEeccCc-chHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 5899999999741 233333332 346899999999999999999999999999999999999985 5799999999998
Q ss_pred ccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 515 EYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 515 ~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
.... ...++.+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+ .+.....
T Consensus 160 ~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~---------- 221 (273)
T d1xwsa_ 160 LLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV---------- 221 (273)
T ss_dssp ECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC----------
T ss_pred eccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhccc----------
Confidence 7653 345678999999999999876667888999999999999999999997632 2222100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
.+...+++.+.+||.+||..||.+|||++|+|+||||++.
T Consensus 222 -----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 222 -----------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -----------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0112367889999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=451.17 Aligned_cols=262 Identities=29% Similarity=0.442 Sum_probs=208.3
Q ss_pred ccCCeEEEE-EeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEee--cCC
Q psy18163 360 SVEEFKCLN-RIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVG--SNM 435 (1028)
Q Consensus 360 ~~d~Y~il~-~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~--~~~ 435 (1028)
.+++|+++. .||+|+||+||+|++..+++.||||+++.. ....+|+.++.++ +|||||+++++|.. ...
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 468899986 599999999999999999999999999643 2456899887654 79999999999864 334
Q ss_pred CeEEEEEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEeccC
Q psy18163 436 DKIFIVMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDFG 511 (1028)
Q Consensus 436 ~~l~LVmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DFG 511 (1028)
..+|||||||.+ ++|.+.+... ...|++.+++.|+.||+.||.|||++||+||||||+|||++. .+.+||+|||
T Consensus 82 ~~~~ivmEy~~g--g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 82 KCLLIVMECLDG--GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEEECCCS--EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEECCCC--CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 679999999986 4555555443 346999999999999999999999999999999999999985 5679999999
Q ss_pred CccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 512 LAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 512 lAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+|+..... ......+||+.|+|||++.+ ..|+.++||||||||||+|+||.+||.+.+.......+........
T Consensus 160 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~---- 233 (335)
T d2ozaa1 160 FAKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ---- 233 (335)
T ss_dssp TCEECCCC-CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS----
T ss_pred eeeeccCC-CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC----
Confidence 99877553 34566799999999999987 6699999999999999999999999988766554444432211000
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSES 657 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~ 657 (1028)
. .++ ......+++.+.+||.+||+.||.+|||+.|+|+||||.+.
T Consensus 234 ---~-----------~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 ---Y-----------EFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ---S-----------SCC-------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ---C-----------CCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0 000 01123478899999999999999999999999999999753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=448.18 Aligned_cols=289 Identities=31% Similarity=0.502 Sum_probs=228.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeec----CCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGS----NMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~----~~~ 436 (1028)
.++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|+.++|||||++++++... +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4789999999999999999999999999999999986543333344577999999999999999999988532 233
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+|+++++++++|.+++ . ...+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 97 ~~~i~~~~~gg~L~~~~---~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIV---K--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHH---T--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhc---c--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 56666666666665554 2 345999999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 517 GSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 517 ~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
. ....+.+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......|....+.+....+.....
T Consensus 172 ~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 172 D---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp T---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred C---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 4 3345678999999999988877789999999999999999999999999999999999999888776555443332
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
...... ....+.............+++.++|||.+||++||.+||||.|||+||||++...
T Consensus 249 ~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 249 ESARNY--IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHH--HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhh--hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 211111 0111111111112223457889999999999999999999999999999997543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=453.48 Aligned_cols=298 Identities=29% Similarity=0.505 Sum_probs=227.3
Q ss_pred CCCCcccccc---ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEE
Q psy18163 350 PYLPAIQGCR---SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTV 426 (1028)
Q Consensus 350 ~y~p~~~g~~---~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L 426 (1028)
.|+|+..|.. ..++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|..++|||||++
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~ 81 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEE
Confidence 3566666663 3478999999999999999999999999999999998765433334567799999999999999999
Q ss_pred EEEEeec----CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC
Q psy18163 427 REIVVGS----NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502 (1028)
Q Consensus 427 ~~i~~~~----~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~ 502 (1028)
+++|... +..++|+|||||.+++...+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 82 ~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~ 155 (355)
T d2b1pa1 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155 (355)
T ss_dssp SEEECSCCSTTTCCEEEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred EEEEecccccccCceeEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc
Confidence 9998643 34689999999987554433 2458999999999999999999999999999999999999999
Q ss_pred CcEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q psy18163 503 GILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKT 582 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~ 582 (1028)
+.+||+|||+++..... ...+..+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.++..++.+++..
T Consensus 156 ~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~ 233 (355)
T d2b1pa1 156 CTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_dssp CCEEECCCCC----------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cceeeechhhhhccccc-cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999876543 44566789999999999988 57999999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCCCCCChhhhhhccccC-----------CCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMTFAEY-----------PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~~~~~-----------p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
++.+....|...... ......... +..............++.+++||.+||.+||.+||||+|||+|
T Consensus 234 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 234 LGTPCPEFMKKLQPT--VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HCCCCHHHHTTSCHH--HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCCHHHHHHhhhh--HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 888776666543321 000000000 0000000011122357789999999999999999999999999
Q ss_pred CCCCCC
Q psy18163 652 DYFSES 657 (1028)
Q Consensus 652 PfF~e~ 657 (1028)
|||++.
T Consensus 312 pw~~~~ 317 (355)
T d2b1pa1 312 PYINVW 317 (355)
T ss_dssp TTTGGG
T ss_pred cccCCC
Confidence 999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-50 Score=442.70 Aligned_cols=287 Identities=27% Similarity=0.431 Sum_probs=221.4
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l 438 (1028)
..++|+++++||+|+||+||+|++..+|+.||||+++... ...+.+|+.+|..+. ||||++++++|.......+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 3478999999999999999999999999999999997532 245678999999996 9999999999987777789
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC-cEEEeccCCccccC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG-ILKVGDFGLAREYG 517 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g-~lKL~DFGlAr~~~ 517 (1028)
|+|||||.+ ++|... ...+++.+++.|+.||+.||.|||++|||||||||+||||+.++ .+||+|||+|+.+.
T Consensus 108 ~~v~e~~~~--~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 108 ALVFEHVNN--TDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEECCCS--CBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eEEEeecCC--CcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999986 333221 34589999999999999999999999999999999999998655 69999999998775
Q ss_pred CCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCCCCC-
Q psy18163 518 SPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGK-SDLEQLSRIFKTMGTPNEKIWPGFS- 595 (1028)
Q Consensus 518 ~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~-sd~d~l~kI~~~lg~p~~~~w~~~s- 595 (1028)
.. ......+||+.|+|||++.+...|+.++|||||||++|+|++|..||... +..++...+...++.+....+....
T Consensus 182 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 182 PG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 43 34566789999999999988777999999999999999999999988654 4566667777666543211110000
Q ss_pred --CChhhhhhccc-cCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 596 --KLPAVQKMTFA-EYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 596 --~lp~~~~l~~~-~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
..+........ ................++++++|||.+||++||.+||||+|||+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 00000000000 0000000011112244788999999999999999999999999999998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=446.63 Aligned_cols=290 Identities=34% Similarity=0.553 Sum_probs=228.2
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecC---CCeE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSN---MDKI 438 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~---~~~l 438 (1028)
++|+++++||+|+||+||+|+++.+|+.||||++.+... ......+++|+.+|+.++||||+++++++.... ...+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 679999999999999999999999999999999975432 222345678999999999999999999886443 2457
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||+|++++++|.+++.. ..+++.+++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 88888777777766642 2589999999999999999999999999999999999999999999999999986543
Q ss_pred CC---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 519 PL---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 519 ~~---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
.. ......+||+.|+|||++.....|+.++||||+||++|+|++|.+||.+.+..++...+...+..+.........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 21 224557899999999999776788999999999999999999999999999999988888877766544332222
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCCCCCCC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYFSESPL 659 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF~e~p~ 659 (1028)
...... .....+......+....+.+++.+++||.+||++||.+||||.|+|+||||++...
T Consensus 242 ~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 242 NLKARN--YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CHHHHH--HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhc--ccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 211111 11112222222222334557889999999999999999999999999999986543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=425.83 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=205.2
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||+|+||+||+|+.. ..||||+++...........+.+|+.+|.+++|||||++++++. .+.+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe---ccEEEE
Confidence 367999999999999999999754 35999999866544444556778999999999999999998763 346899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC-
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP- 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~- 519 (1028)
|||||.+ ++|.+.+......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 81 v~Ey~~~--g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 81 VTQWCEG--SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEECCCE--EEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEecCCC--CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999986 5566666555667999999999999999999999999999999999999999999999999999876432
Q ss_pred -CCcccccccCccccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 520 -LKHYTPIVVTLWYRSPELLLGC--KEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 520 -~~~~t~~vGT~~Y~APEvL~g~--~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
....+..+||+.|||||++.+. ..|+.++|||||||+||||+||..||.+.+....+..++.....++. .
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-----~-- 231 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-----L-- 231 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-----G--
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-----c--
Confidence 2234567899999999998642 35899999999999999999999999998877666665543211110 0
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
......+++.+.+||.+||..||.+|||+.+|+.+
T Consensus 232 --------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 232 --------------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01112367789999999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-48 Score=422.09 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=205.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCC--Ce
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNM--DK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~--~~ 437 (1028)
.++|++++.||+|+||+||+|++..+|+.||||+++...... .....+.+|+.+|..++|||||++++++...+. ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998654322 223457789999999999999999999876543 35
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|||||||.+ ++|...+.. ...+++.+++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||++....
T Consensus 86 ~~lvmE~~~g--~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDG--VTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCE--EEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCC--CEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 8999999987 444444433 3468999999999999999999999999999999999999999999999999987654
Q ss_pred CCC---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 518 SPL---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 518 ~~~---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
... ......+||+.|+|||++.+ ..|+.++||||||||||+|+||.+||.+.+..+.+.+++.....+..
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~------ 235 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS------ 235 (277)
T ss_dssp ----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG------
T ss_pred cccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc------
Confidence 322 23456789999999999987 56999999999999999999999999999988888777653221111
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRHDYF 654 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~HPfF 654 (1028)
.....+++.+.+||.+||..||.+||+..+.|.|+|+
T Consensus 236 -----------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 -----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp -----------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -----------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 1112367889999999999999999944444456664
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=412.55 Aligned_cols=250 Identities=21% Similarity=0.349 Sum_probs=198.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|++. ++..||||+++.... ....+.+|+.++..++|||||++++++... +.+||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccC--CceEE
Confidence 368999999999999999999987 567899999975432 234678999999999999999999998643 47899
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL 520 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~ 520 (1028)
|||||.+ ++|.+.+......+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+......
T Consensus 78 v~E~~~~--g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 78 VFEFMEH--GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEECCTT--CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEecCC--CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999986 55555555566778999999999999999999999999999999999999999999999999998765432
Q ss_pred C-cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCh
Q psy18163 521 K-HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLP 598 (1028)
Q Consensus 521 ~-~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp 598 (1028)
. ......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||...+..+.+..+......+.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~----------- 223 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------- 223 (263)
T ss_dssp ---------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-----------
T ss_pred ceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Confidence 2 2334678999999999987 569999999999999999999 5788888887777776654311100
Q ss_pred hhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 599 AVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 599 ~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....++.+.+||.+||..||.+|||+.+||+|
T Consensus 224 ---------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 224 ---------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01246778999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=425.49 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=204.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCe-----EEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDE-----IVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~-----~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
.++|++.+.||+|+||+||+|++..+++ .||+|++..... ......+.+|+.+|.++ +|||||++++++..
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 3789999999999999999999876543 799999865433 23345678899999998 89999999998854
Q ss_pred CCeEEEEEeccccchHHHHHHHhhcC----------------------CcCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Q psy18163 435 MDKIFIVMDYVEHDMKSLMETMRSKK----------------------QVFIPGEVKCLMQQLLNAVAHLHDNWILHRDL 492 (1028)
Q Consensus 435 ~~~l~LVmEy~~gdLgsLl~~l~~~~----------------------~~~se~ev~~il~QLl~AL~yLHs~gIVHRDL 492 (1028)
.+.+|||||||.+ ++|.+.+.... ..+++.+++.|+.||+.||.|||++|||||||
T Consensus 113 ~~~~~lv~Ey~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 113 SGPIYLIFEYCCY--GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp SSSCEEEEECCTT--CBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred CCeEEEEEEcCCC--CcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4579999999986 44444444332 34788899999999999999999999999999
Q ss_pred cccceeecCCCcEEEeccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q psy18163 493 KTSNLLLSHRGILKVGDFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTG 569 (1028)
Q Consensus 493 KPeNILLd~~g~lKL~DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g 569 (1028)
||+|||++.++.+||+|||+|+....... ...+.+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986644322 2345678999999999987 569999999999999999997 8999998
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHH
Q psy18163 570 KSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEAL 649 (1028)
Q Consensus 570 ~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL 649 (1028)
.+....+.+++.....+. ....+++.+.+||.+||..||.+|||+.||+
T Consensus 270 ~~~~~~~~~~~~~~~~~~-------------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMD-------------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp CCCSHHHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCHHHHHHHHHhcCCCCC-------------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 777666666655311110 0122578899999999999999999999999
Q ss_pred hC
Q psy18163 650 RH 651 (1028)
Q Consensus 650 ~H 651 (1028)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=414.80 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=207.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++++.||+|+||+||+|.++ ++..||||+++.... ....+.+|+.+|.+++|||||++++++. .+.+||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~---~~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT---QEPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeec---cCCeEE
Confidence 368999999999999999999986 678899999975432 2346789999999999999999999873 346799
Q ss_pred EEeccccchHHHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRSK-KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~-~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||||.+ ++|.+.+... ...+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 85 v~Ey~~~--g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 85 ITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEECCTT--CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEeCCC--CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999986 4444433222 235899999999999999999999999999999999999999999999999999977543
Q ss_pred C-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 L-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG-~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. ...+...||+.|+|||++.+ ..|+.++|||||||+||||+|| .+||...+..+.+..+......+
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~----------- 230 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV----------- 230 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred ccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 2 23345678999999999987 5689999999999999999995 67777777777666654321100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh--CCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR--HDYFSE 656 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~--HPfF~e 656 (1028)
....+++.+.+||.+||..||.+|||+.+|++ |+||+.
T Consensus 231 ---------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 ---------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 01225678899999999999999999999998 888853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-47 Score=416.13 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=205.9
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++.+.||+|+||+||+|++..+++.||||+++.... ....+.+|+.+|..++|||||++++++. ..+.+|
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEe--eCCeeE
Confidence 34789999999999999999999999999999999975432 2345789999999999999999999885 345899
Q ss_pred EEEeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
||||||.+ +++...+.. ....+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 90 iv~E~~~~--g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 90 IITEFMTY--GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEEECCTT--CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EEeecccC--cchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999986 444444433 345689999999999999999999999999999999999999999999999999987754
Q ss_pred CC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 519 PL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 519 ~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
.. ...+...||+.|+|||++.+ ..|+.++|||||||++|||++|..||....+...+..++.....+ .
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~--~-------- 236 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--E-------- 236 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--C--------
T ss_pred CCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC--C--------
Confidence 32 22344568999999999987 569999999999999999999665544444444444433321000 0
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh--CCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR--HDYFSE 656 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~--HPfF~e 656 (1028)
....+++.+.+||.+||..||.+|||+.++++ ..++++
T Consensus 237 ---------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 237 ---------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 01235678999999999999999999999987 244443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-47 Score=418.97 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=196.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCe---EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDE---IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~---~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|++.+.||+|+||+||+|+++.+++ .||||++...... .....+++|+.+|.+++|||||++++++.. .+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCE
Confidence 4689999999999999999999987664 6899988654322 223457899999999999999999998854 457
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|||||||.+ ++|...+......+++.++..|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus 102 ~~iv~Ey~~~--g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 102 VMIITEFMEN--GSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp CEEEEECCTT--EEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEEEecCC--CcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999987 55555555556678999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCc-----ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 518 SPLKH-----YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 518 ~~~~~-----~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
..... .....||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..+......+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 254 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---- 254 (299)
T ss_dssp ----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----
T ss_pred CCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 42211 223467999999999987 679999999999999999998 8999999988887777654211110
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
...++..+.+||.+||..||.+|||+.+|+++
T Consensus 255 ----------------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 ----------------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01256788999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=416.83 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=209.4
Q ss_pred CCeEEEEE-eeecCcEEEEEEEECC--CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeE
Q psy18163 362 EEFKCLNR-IEEGTYGVVYRAKDKR--TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 362 d~Y~il~~-LG~G~FG~Vyla~d~~--tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l 438 (1028)
++|.+.+. ||+|+||+||+|.++. ++..||||+++..... .....+++|+.+|.+++|||||++++++.. +.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-HHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeE
Confidence 67888885 9999999999998764 4568999999754322 223457899999999999999999998843 368
Q ss_pred EEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 439 FIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 439 ~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||||.+ ++|...+......+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+..
T Consensus 84 ~lvmE~~~~--g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 84 MLVMEMAGG--GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEECCTT--EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEeCCC--CcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999987 555555555566799999999999999999999999999999999999999999999999999997754
Q ss_pred CCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 519 PLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 519 ~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..|.+....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~--------- 231 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--------- 231 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---------
T ss_pred cccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 322 2234578999999999987 569999999999999999998 99999998887777666432100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHH---HhCCCCC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA---LRHDYFS 655 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~El---L~HPfF~ 655 (1028)
. ....+++.+.+||.+||..||.+|||+.+| |+|+|+.
T Consensus 232 ------------~-----------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 ------------E-----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ------------C-----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------C-----------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 012356788999999999999999999888 6788874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=423.22 Aligned_cols=264 Identities=25% Similarity=0.426 Sum_probs=212.8
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEE---CCCCeEEEEEEeecccc--ccCCccchHHHHHHHHHcCC-CCeeEEEEEEeec
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKD---KRTDEIVALKRLKMEKE--KEGFPITSLREINTLLKAQH-PNIVTVREIVVGS 433 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d---~~tg~~VAIKvlk~~~~--~~~~~~~~lrEi~iL~~l~H-PNIV~L~~i~~~~ 433 (1028)
.+++|++++.||+|+||+||+|++ ..+|+.||||+++.... .......+.+|+.+|.+++| |||+++++++...
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 458899999999999999999998 45789999999976542 22344567789999999977 8999998888654
Q ss_pred CCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCc
Q psy18163 434 NMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLA 513 (1028)
Q Consensus 434 ~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlA 513 (1028)
..+++||||+.+ ++|...+... ..+.+..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 102 --~~~~~v~e~~~~--~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 102 --TKLHLILDYING--GELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp --TEEEEEECCCCS--CBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred --Cceeeeeecccc--cHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 489999999986 4555544433 35788899999999999999999999999999999999999999999999999
Q ss_pred cccCCC-CCcccccccCccccCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 514 REYGSP-LKHYTPIVVTLWYRSPELLLGCK-EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 514 r~~~~~-~~~~t~~vGT~~Y~APEvL~g~~-~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
+.+... .....+..||+.|+|||++.+.. .++.++|||||||+||+|++|..||.+.+..+....+......+...
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~-- 254 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-- 254 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC--
Confidence 876432 23345678999999999997643 47889999999999999999999998876655555554432111100
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCC-----CHHHHHhCCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRI-----TADEALRHDYFSES 657 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRP-----TA~ElL~HPfF~e~ 657 (1028)
....+++.+.+||.+||.+||.+|| ||+|+|+||||++.
T Consensus 255 ---------------------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 255 ---------------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp ---------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ---------------------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 1123678999999999999999999 59999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=407.23 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=210.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|+++++||+|+||+||+|+++ ++..||||+++.... ....+++|+.++..++|||||++++++.. .+.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEE
Confidence 68999999999999999999985 788999999986543 23567899999999999999999998854 4579999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC-
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL- 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~- 520 (1028)
|||+.+ +++...+......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 78 ~Ey~~~--g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 78 TEYMAN--GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EECCTT--EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEccCC--CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999986 45555555556678899999999999999999999999999999999999999999999999998664432
Q ss_pred CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChh
Q psy18163 521 KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPA 599 (1028)
Q Consensus 521 ~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~ 599 (1028)
......+||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....+.+....+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------------ 222 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------ 222 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC------------
T ss_pred eeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 23345679999999999987 569999999999999999998 8999999998887777754321110
Q ss_pred hhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 600 VQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 600 ~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
...+++.+.+||.+||..||.+|||+.+||+|
T Consensus 223 --------------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 223 --------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01255778999999999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=413.86 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=197.5
Q ss_pred EEeeecCcEEEEEEEEC--CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEEEecc
Q psy18163 368 NRIEEGTYGVVYRAKDK--RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 368 ~~LG~G~FG~Vyla~d~--~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
++||+|+||+||+|.+. .+++.||||+++...........+++|+.+|.+++|||||++++++.. +..|||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 46999999999999864 456789999997654433334567899999999999999999998843 3579999999
Q ss_pred ccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCCCc---
Q psy18163 446 EHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPLKH--- 522 (1028)
Q Consensus 446 ~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~~~--- 522 (1028)
.+ ++|...+.. ...+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+......
T Consensus 90 ~~--g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 EL--GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TT--EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CC--CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 86 444444433 456899999999999999999999999999999999999999999999999999876543222
Q ss_pred ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCChhhh
Q psy18163 523 YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKLPAVQ 601 (1028)
Q Consensus 523 ~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~lp~~~ 601 (1028)
.....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+.+....
T Consensus 167 ~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---------------- 229 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------------- 229 (277)
T ss_dssp ----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------------
T ss_pred ccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 234578999999999987 568999999999999999998 89999998887766665432100
Q ss_pred hhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHH---HhCCCC
Q psy18163 602 KMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEA---LRHDYF 654 (1028)
Q Consensus 602 ~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~El---L~HPfF 654 (1028)
.. ...+++.+.+||.+||..||.+|||+.+| |+|+||
T Consensus 230 -----~~-----------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 230 -----GC-----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -----CC-----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CC-----------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 00 11256788999999999999999999998 567665
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=408.07 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=198.1
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCC---CeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRT---DEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~t---g~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
.++|++.+.||+|+||+||+|++..+ +..||||+++.... ......+.+|+.+|++++|||||++++++. .+.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCe
Confidence 36899999999999999999998754 35789998865432 222345779999999999999999999883 357
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
+|||||||.+ +++...+......+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+.+.
T Consensus 82 ~~iv~E~~~~--g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 82 VWIIMELCTL--GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp CEEEEECCTT--EEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEEEeccC--CcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 8999999986 55555555556678999999999999999999999999999999999999999999999999998765
Q ss_pred CCC-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q psy18163 518 SPL-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFS 595 (1028)
Q Consensus 518 ~~~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s 595 (1028)
... ...+..+||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..+...... .
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~------ 229 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---P------ 229 (273)
T ss_dssp -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---C------
T ss_pred CCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---C------
Confidence 322 23345678999999999987 569999999999999999998 89999998888877776542110 0
Q ss_pred CChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 596 KLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 596 ~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+++.+.+||.+||..||.+|||+.+|++|
T Consensus 230 -----------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 230 -----------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 012356789999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=413.53 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=200.9
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCe----EEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCe
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDE----IVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~----~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~ 437 (1028)
++|+++++||+|+||+||+|.+..+|+ .||+|.++.... ......+.+|+.+|.+++|||||++++++... .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 579999999999999999999988876 578887764332 23345678999999999999999999998643 4
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccC
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYG 517 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~ 517 (1028)
.+++|+|+.+ ++|...+......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 85 ~~~v~e~~~~--~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 85 VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEEECCTT--CBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eeEEEEeccC--CcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 6777888775 55556666667789999999999999999999999999999999999999999999999999999775
Q ss_pred CCCCc--ccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q psy18163 518 SPLKH--YTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGF 594 (1028)
Q Consensus 518 ~~~~~--~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~ 594 (1028)
..... .....||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+....+......+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-------- 233 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-------- 233 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC--------
T ss_pred cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 43322 234578999999999987 569999999999999999998 889999887766555554321100
Q ss_pred CCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 595 SKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 595 s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
....+++.+.+||.+||..||.+|||+.+|+.|
T Consensus 234 ------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 234 ------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 012366788999999999999999999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=408.44 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=202.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~L 440 (1028)
.++|++.+.||+|+||+||+|++..+ ..||||+++.... ....+.+|+.+|.+++|||||++++++. .+.+++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~---~~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEe---cCCeEE
Confidence 47899999999999999999999765 5699999975532 2356789999999999999999999873 245799
Q ss_pred EEeccccchHHHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCC
Q psy18163 441 VMDYVEHDMKSLMETMRS-KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSP 519 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~-~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~ 519 (1028)
|||||.+ +++...+.. ....+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 89 v~Ey~~~--g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 89 VTEYMSK--GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EECCCTT--CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEecCC--CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 9999986 344333332 2345899999999999999999999999999999999999999999999999999876432
Q ss_pred C-CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 520 L-KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 520 ~-~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG-~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. ...+..+||+.|+|||++.+ ..++.++|||||||+||||+|| .+||.+....+.+..+......+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~----------- 234 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------- 234 (285)
T ss_dssp ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred CceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 2 23345689999999999987 5689999999999999999995 57777777777776665432111
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh--CCCCCCC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR--HDYFSES 657 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~--HPfF~e~ 657 (1028)
....+++.+.+||.+||..||.+|||+.+|+. |+||+..
T Consensus 235 ---------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 ---------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 01225678899999999999999999999998 8999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=402.18 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=196.3
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCC----eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTD----EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg----~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.+.|++.++||+|+||+||+|.++.++ ..||||++....... ....+++|+.+|..++|||||++++++.. .+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVISK--YK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-HHHHHHHHHHHHHhcCCCCEeeeeEEEec--CC
Confidence 367999999999999999999987654 479999997543322 23456799999999999999999998854 45
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+++|||||.+ +.+...+......+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+
T Consensus 83 ~~~~v~e~~~~--~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 83 PMMIITEYMEN--GALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SEEEEEECCTT--EEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceEEEEEeccc--CcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 79999999987 4555555556667999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 517 GSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 517 ~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG-~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
..... ......||+.|+|||++.+ ..|+.++|||||||+||||++| .+||.+.+..+.+..+......+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~------ 233 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------ 233 (283)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC------
Confidence 43221 2234578999999999987 6799999999999999999995 56666666666655554321100
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+|||+.+|++
T Consensus 234 --------------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 --------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01125677899999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=402.78 Aligned_cols=256 Identities=22% Similarity=0.349 Sum_probs=193.3
Q ss_pred CCeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCC
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~ 435 (1028)
++|+++++||+|+||+||+|.+.. +++.||||+++...... ....+++|+.++.++ .|+||+.+++++.. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTK-PG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-HHHHHHHHHHHHHhhcCCCeEEEeeeeecc-CC
Confidence 689999999999999999999754 45789999997543322 233456777777776 68899999877643 34
Q ss_pred CeEEEEEecccc-chHHHHHHHhh------------cCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCC
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRS------------KKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHR 502 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~------------~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~ 502 (1028)
..+++|||||.+ +|.+++..... ....+++.++..|+.||+.||.|||++|||||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 578999999985 55555543221 12347899999999999999999999999999999999999999
Q ss_pred CcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q psy18163 503 GILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRI 579 (1028)
Q Consensus 503 g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG-~pPF~g~sd~d~l~kI 579 (1028)
+++||+|||+|+...... ...+..+||+.|+|||++.+ ..|+.++|||||||++|||+|| .+||.+.+..+.+..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999998764432 23345789999999999987 6699999999999999999986 5789887655555555
Q ss_pred HHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 580 FKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 580 ~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
+.....+. ....+++.+.+||.+||..||.+|||+.+|++|
T Consensus 250 ~~~~~~~~-------------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRMR-------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCCC-------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCC-------------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44311110 012256789999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-45 Score=407.81 Aligned_cols=300 Identities=23% Similarity=0.323 Sum_probs=221.1
Q ss_pred CCCcccccccc-CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC----------
Q psy18163 351 YLPAIQGCRSV-EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ---------- 419 (1028)
Q Consensus 351 y~p~~~g~~~~-d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~---------- 419 (1028)
|+|+..|+... .+|+++++||+|+||+||+|++..+|+.||||+++.... ......+|+.+|+.+.
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~ 77 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSM 77 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhc
Confidence 67887888755 469999999999999999999999999999999976532 1234567888887765
Q ss_pred -CCCeeEEEEEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-CCcccccccccce
Q psy18163 420 -HPNIVTVREIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD-NWILHRDLKTSNL 497 (1028)
Q Consensus 420 -HPNIV~L~~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs-~gIVHRDLKPeNI 497 (1028)
|+||+.+++++........+++|.++.................+++..++.++.||+.||.|||+ .||+||||||+||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence 57899999888766666777777776542222333334445678999999999999999999998 8999999999999
Q ss_pred eecCCC------cEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy18163 498 LLSHRG------ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKS 571 (1028)
Q Consensus 498 LLd~~g------~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~s 571 (1028)
||+.++ .++|+|||.+..... .....+||+.|+|||++.+ ..|+.++|||||||++++|++|++||...+
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeeccCcccccceeeEeeccccccccc---ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 998655 499999999986643 3355789999999999987 568999999999999999999999997543
Q ss_pred ------hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCc----------cccccccccHHHHHHHHHhc
Q psy18163 572 ------DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLK----------TKVAGSILTELGYDLLCKFL 635 (1028)
Q Consensus 572 ------d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~----------~~~~~~~Ls~~a~DLL~kcL 635 (1028)
..+.+..++..+|.++...+............ ........... ........++.++|||.+||
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS-RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC---CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhccccccccccc-chhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 45667777777777654332111100000000 00000000000 01112345678999999999
Q ss_pred ccCcCCCCCHHHHHhCCCCCCCC
Q psy18163 636 TYDPVTRITADEALRHDYFSESP 658 (1028)
Q Consensus 636 ~~DP~kRPTA~ElL~HPfF~e~p 658 (1028)
++||.+||||.|||+||||++..
T Consensus 313 ~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTCT
T ss_pred CCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=397.38 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=196.9
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC-CC--eEEEEEEeecccccc-CCccchHHHHHHHHHcCCCCeeEEEEEEeecCCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR-TD--EIVALKRLKMEKEKE-GFPITSLREINTLLKAQHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~-tg--~~VAIKvlk~~~~~~-~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~ 436 (1028)
.++|++++.||+|+||.||+|++.. ++ ..||||+++...... .....+.+|+.+|.+++|||||++++++.. .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---c
Confidence 3679999999999999999998653 33 478999987654322 223457899999999999999999998843 3
Q ss_pred eEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCcccc
Q psy18163 437 KIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREY 516 (1028)
Q Consensus 437 ~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~ 516 (1028)
.+++|||||.+ +++...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 84 ~~~lv~e~~~~--~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTT--CBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecC--cchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 67999999986 5555555555667999999999999999999999999999999999999999999999999999977
Q ss_pred CCCCC---cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy18163 517 GSPLK---HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWP 592 (1028)
Q Consensus 517 ~~~~~---~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~ 592 (1028)
..... ......||..|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+......++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~----- 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP----- 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-----
T ss_pred ccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC-----
Confidence 54322 2234567889999999987 679999999999999999998 8999999999888887765311110
Q ss_pred CCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 593 GFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 593 ~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
....++..+.+||.+||..||.+|||+.+|++
T Consensus 236 --------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 --------------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01235678899999999999999999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-44 Score=396.00 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=204.4
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|++++.||+|+||+||+|+++ .+++.||||+++.... ......+.+|+.+|..++||||+.+++++.. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeecc--C
Confidence 368999999999999999999975 3568999999975432 2234567899999999999999999998854 4
Q ss_pred CeEEEEEecccc-chHHHHHHHh--------------------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccc
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMR--------------------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKT 494 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~--------------------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKP 494 (1028)
..+++||||+.+ +|.+++.... .....+++..+..|+.||+.||.|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 579999999985 5666554221 1122478889999999999999999999999999999
Q ss_pred cceeecCCCcEEEeccCCccccCCC--CCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCC
Q psy18163 495 SNLLLSHRGILKVGDFGLAREYGSP--LKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKS 571 (1028)
Q Consensus 495 eNILLd~~g~lKL~DFGlAr~~~~~--~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~-pPF~g~s 571 (1028)
+||||+.++.+||+|||+|+..... ....++.+||+.|+|||++.+ ..|+.++|||||||+||||++|. +||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999866432 223345789999999999987 56999999999999999999995 7899998
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 572 DLEQLSRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 572 d~d~l~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+.+.+..+.+.... .. ...+++.+.+||.+||..||.+|||+.||++
T Consensus 248 ~~e~~~~v~~~~~~---------------------~~-----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNIL---------------------AC-----------PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCCC---------------------CC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCC---------------------CC-----------CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88887776542110 00 1225678899999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=390.07 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=195.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEE
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~ 439 (1028)
..++|++++.||+|+||.||+|.+. |..||||+++.+. ....+.+|+.+|.+++|||||++++++... .+.+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEE
Confidence 4578999999999999999999985 7789999997543 234578999999999999999999987543 24689
Q ss_pred EEEecccc-chHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCC
Q psy18163 440 IVMDYVEH-DMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGS 518 (1028)
Q Consensus 440 LVmEy~~g-dLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~ 518 (1028)
|||||+.+ +|.+++..- ....+++..+..|+.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 99999976 555554322 223588999999999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q psy18163 519 PLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQLSRIFKTMGTPNEKIWPGFSKL 597 (1028)
Q Consensus 519 ~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l~kI~~~lg~p~~~~w~~~s~l 597 (1028)
. .....+|+.|+|||++.+ ..|+.++|||||||++|||+| |.+||...+..+.+..+.+....
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~------------ 219 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------------ 219 (262)
T ss_dssp ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC------------
T ss_pred C---CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 2 344578999999999987 569999999999999999998 78999888777666665321100
Q ss_pred hhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 598 PAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 598 p~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
. ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 220 ---------~-----------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 ---------D-----------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------C-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------C-----------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 112356788999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=393.98 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=202.5
Q ss_pred ccCCeEEEEEeeecCcEEEEEEEECCCCeE--EEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecCCC
Q psy18163 360 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEI--VALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSNMD 436 (1028)
Q Consensus 360 ~~d~Y~il~~LG~G~FG~Vyla~d~~tg~~--VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~~~ 436 (1028)
..++|++.++||+|+||+||+|+++.++.. ||||.++..... .....+.+|+.+|..+ +|||||++++++... +
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~ 84 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 84 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--T
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--C
Confidence 358999999999999999999999988875 667776543332 2345678999999998 799999999998754 5
Q ss_pred eEEEEEecccc-chHHHHHHH------------hhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCC
Q psy18163 437 KIFIVMDYVEH-DMKSLMETM------------RSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRG 503 (1028)
Q Consensus 437 ~l~LVmEy~~g-dLgsLl~~l------------~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g 503 (1028)
.+||||||+.+ +|.+++... ......+++..+..++.||+.||.|||+++||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 89999999986 555544211 12345689999999999999999999999999999999999999999
Q ss_pred cEEEeccCCccccCCCCCcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHh
Q psy18163 504 ILKVGDFGLAREYGSPLKHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCME-PLFTGKSDLEQLSRIFKT 582 (1028)
Q Consensus 504 ~lKL~DFGlAr~~~~~~~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~-pPF~g~sd~d~l~kI~~~ 582 (1028)
.+||+|||+|+..... ......+||..|+|||++.+ ..|+.++||||||||+|||++|. +||.+.+..+.+..+.+.
T Consensus 165 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred ceEEcccccccccccc-ccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 9999999999865432 22234578999999999987 56899999999999999999965 789888877766665432
Q ss_pred cCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 583 MGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 583 lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.. + . ....+++.+.+||.+||..||++|||+.+||+|
T Consensus 243 ~~-~--------------------~-----------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YR-L--------------------E-----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CC-C--------------------C-----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-C--------------------C-----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 0 0 012267889999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=390.83 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=197.7
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCC-------eEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEee
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTD-------EIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVG 432 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg-------~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~ 432 (1028)
.++|++.+.||+|+||.||+|++..++ ..||||+++...... ....+.+|+..+.++ +|||||++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-HHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 478999999999999999999986554 479999997654322 234567788888887 79999999998864
Q ss_pred cCCCeEEEEEecccc-chHHHHHHHh------------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee
Q psy18163 433 SNMDKIFIVMDYVEH-DMKSLMETMR------------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499 (1028)
Q Consensus 433 ~~~~~l~LVmEy~~g-dLgsLl~~l~------------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL 499 (1028)
.+.+|+|||||.+ +|.+++.... .....+++.++..|+.||+.||.|||+++||||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 4579999999986 4444443211 112458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy18163 500 SHRGILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQL 576 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l 576 (1028)
+.++.+||+|||+++...... ......+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 999999999999998664322 23345689999999999987 679999999999999999998 78999888776655
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
..+.... .+. ....+++.+.+||.+||..||.+|||+.|||+
T Consensus 248 ~~i~~~~-~~~-------------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGH-RMD-------------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTC-CCC-------------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCC-CCC-------------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5443211 100 01125678899999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-44 Score=389.44 Aligned_cols=261 Identities=19% Similarity=0.195 Sum_probs=200.5
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
++|++++.||+|+||+||+|++..+|+.||||++..... ...+..|+.++..++|+|++.++..+.. ..+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEe-cCCEEEEE
Confidence 579999999999999999999999999999999876432 2356789999999988776655444432 34588999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC---CCcEEEeccCCccccCC
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH---RGILKVGDFGLAREYGS 518 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~---~g~lKL~DFGlAr~~~~ 518 (1028)
|||+++++...+ ......+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+..
T Consensus 82 me~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELLGPSLEDLF---NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECCCCBHHHHH---HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEcCCchhhhh---hhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999987655443 344567999999999999999999999999999999999999864 45799999999987654
Q ss_pred CC-------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy18163 519 PL-------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIFKTMGTPNEKIW 591 (1028)
Q Consensus 519 ~~-------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~~~lg~p~~~~w 591 (1028)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||+||.+||.+.........+......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~------ 231 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------ 231 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH------
T ss_pred cccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc------
Confidence 22 22345689999999999988 66999999999999999999999999886654443333221100
Q ss_pred CCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHH---HHHhCCCCCC
Q psy18163 592 PGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITAD---EALRHDYFSE 656 (1028)
Q Consensus 592 ~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~---ElL~HPfF~e 656 (1028)
.+..+ .......+++.+.+||..||..||.+||++. ++|+|+|.+.
T Consensus 232 ----------~~~~~---------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 232 ----------KMSTP---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ----------HHHSC---------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----------cCCCC---------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00000 0111223678899999999999999999987 5578887654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=389.27 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=205.6
Q ss_pred cCCeEEEEEeeecCcEEEEEEEEC-----CCCeEEEEEEeeccccccCCccchHHHHHHHHHc-CCCCeeEEEEEEeecC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVALKRLKMEKEKEGFPITSLREINTLLKA-QHPNIVTVREIVVGSN 434 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~-----~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l-~HPNIV~L~~i~~~~~ 434 (1028)
.++|++.++||+|+||.||+|++. .+++.||||+++..... .....+.+|+.++..+ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-HHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 378999999999999999999863 56789999999765432 2234567899999998 69999999999854
Q ss_pred CCeEEEEEecccc-chHHHHHHHh--------------hcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceee
Q psy18163 435 MDKIFIVMDYVEH-DMKSLMETMR--------------SKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLL 499 (1028)
Q Consensus 435 ~~~l~LVmEy~~g-dLgsLl~~l~--------------~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILL 499 (1028)
...++||||||.+ +|.+++.... .....+++.++..|+.||+.||.|||++|||||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 4578999999986 4444443221 112358889999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCCccccCCCC--CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy18163 500 SHRGILKVGDFGLAREYGSPL--KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLC-MEPLFTGKSDLEQL 576 (1028)
Q Consensus 500 d~~g~lKL~DFGlAr~~~~~~--~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLT-G~pPF~g~sd~d~l 576 (1028)
+.++.+||+|||+++...... ...+..+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999998765432 22345789999999999987 679999999999999999998 77888887776777
Q ss_pred HHHHHhcCCCCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 577 SRIFKTMGTPNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 577 ~kI~~~lg~p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
.+++.....+. ....+++.+.+||.+||..||.+|||+.+||+
T Consensus 258 ~~~i~~~~~~~-------------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRML-------------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCC-------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCC-------------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66665321110 01225678899999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=391.26 Aligned_cols=260 Identities=21% Similarity=0.314 Sum_probs=209.8
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECC-----CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCC
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNM 435 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~-----tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~ 435 (1028)
.++|++.+.||+|+||+||+|.+.. ++..||||+++..... .....+++|+.++.+++|||||++++++.. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-HHHHHHHHHHHHHHHcCCCCEeeeeeEEec--C
Confidence 4789999999999999999998853 3578999999754322 223456799999999999999999998854 4
Q ss_pred CeEEEEEecccc-chHHHHHHHhhc------CCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEe
Q psy18163 436 DKIFIVMDYVEH-DMKSLMETMRSK------KQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVG 508 (1028)
Q Consensus 436 ~~l~LVmEy~~g-dLgsLl~~l~~~------~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~ 508 (1028)
+.+++|||||.+ +|.+++...... ...++...+..|+.||+.||.|||+++|+||||||+||||+.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 578999999975 666655433211 1235778899999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCCC--cccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCC
Q psy18163 509 DFGLAREYGSPLK--HYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCM-EPLFTGKSDLEQLSRIFKTMGT 585 (1028)
Q Consensus 509 DFGlAr~~~~~~~--~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG-~pPF~g~sd~d~l~kI~~~lg~ 585 (1028)
|||+|+.+..... ..+..+||+.|+|||++.+ ..|+.++|||||||+||||+|| .+||.+.+..+.+..+.+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999986643222 2344578999999999987 5689999999999999999998 5899998888887777542110
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh------CCCCCC
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR------HDYFSE 656 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~------HPfF~e 656 (1028)
+ ....+++.+.+||.+||..||.+|||+.+|++ +|+|++
T Consensus 255 ~--------------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 255 D--------------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp C--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred C--------------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 0 01125678999999999999999999999998 677654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=381.24 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=197.8
Q ss_pred EEEEEeeecCcEEEEEEEECCCC---eEEEEEEeeccccccCCccchHHHHHHHHHcCCCCeeEEEEEEeecCCCeEEEE
Q psy18163 365 KCLNRIEEGTYGVVYRAKDKRTD---EIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIVTVREIVVGSNMDKIFIV 441 (1028)
Q Consensus 365 ~il~~LG~G~FG~Vyla~d~~tg---~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV~L~~i~~~~~~~~l~LV 441 (1028)
.+.++||+|+||+||+|++..++ ..||||+++.... ......+.+|+.+|.+++|||||++++++... ...+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEE
Confidence 34678999999999999987543 4699999975322 22235678999999999999999999987543 3478999
Q ss_pred EeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEEeccCCccccCCCC-
Q psy18163 442 MDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKVGDFGLAREYGSPL- 520 (1028)
Q Consensus 442 mEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~~~~~~- 520 (1028)
||||.+ +++.+.+......+.+..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++......
T Consensus 108 ~E~~~~--g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 108 LPYMKH--GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EECCTT--CBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEeec--CchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999987 45555555556667788899999999999999999999999999999999999999999999998764321
Q ss_pred ---CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCCCCCC
Q psy18163 521 ---KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTG-KSDLEQLSRIFKTMGTPNEKIWPGFSK 596 (1028)
Q Consensus 521 ---~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g-~sd~d~l~kI~~~lg~p~~~~w~~~s~ 596 (1028)
.......||+.|+|||++.+ ..++.++|||||||+||||+||..||.. .+..+....+..... +
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~---------- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-L---------- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-C----------
T ss_pred ccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-C----------
Confidence 12334678999999999887 5699999999999999999997766654 333344444332110 0
Q ss_pred ChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC------CCCCCC
Q psy18163 597 LPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH------DYFSES 657 (1028)
Q Consensus 597 lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H------PfF~e~ 657 (1028)
.....+++.+.+||.+||..||++|||+.|+++| .|..+.
T Consensus 254 ---------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 254 ---------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred ---------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 0012256788999999999999999999999998 666553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.6e-42 Score=371.74 Aligned_cols=251 Identities=21% Similarity=0.241 Sum_probs=200.4
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCC-CCeeEEEEEEeecCCCeEEE
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQH-PNIVTVREIVVGSNMDKIFI 440 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~H-PNIV~L~~i~~~~~~~~l~L 440 (1028)
++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.++..+.| +||+.+++++. .....|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEee--cCCccEE
Confidence 689999999999999999999999999999999865432 2346789999999876 89999987775 4458999
Q ss_pred EEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecC-----CCcEEEeccCCccc
Q psy18163 441 VMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSH-----RGILKVGDFGLARE 515 (1028)
Q Consensus 441 VmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~-----~g~lKL~DFGlAr~ 515 (1028)
||||++++|.+++.. ....++...+..++.||+.||.|||++|||||||||+||||+. .+.+||+|||+|+.
T Consensus 79 vme~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 79 VIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 999998877776543 3556899999999999999999999999999999999999974 57899999999987
Q ss_pred cCCCC-------CcccccccCccccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCC
Q psy18163 516 YGSPL-------KHYTPIVVTLWYRSPELLLGCKEYSTPIDMWSVGCIFAEFLCMEPLFTGKSD---LEQLSRIFKTMGT 585 (1028)
Q Consensus 516 ~~~~~-------~~~t~~vGT~~Y~APEvL~g~~~ys~ksDIWSLGvILyELLTG~pPF~g~sd---~d~l~kI~~~lg~ 585 (1028)
+.... ......+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+... .....++......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 64321 22345789999999999988 6799999999999999999999999986543 3333333321100
Q ss_pred CCCCCCCCCCCChhhhhhccccCCCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHh
Q psy18163 586 PNEKIWPGFSKLPAVQKMTFAEYPNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALR 650 (1028)
Q Consensus 586 p~~~~w~~~s~lp~~~~l~~~~~p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~ 650 (1028)
+. .......+++.+.+||..|+..+|..||+...+.+
T Consensus 235 ~~----------------------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TP----------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SC----------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CC----------------------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00 00011235678899999999999999998776644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-42 Score=374.61 Aligned_cols=266 Identities=24% Similarity=0.288 Sum_probs=187.8
Q ss_pred CCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHH--HHHHHHHcCCCCeeEEEEEEeecCC--Ce
Q psy18163 362 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLR--EINTLLKAQHPNIVTVREIVVGSNM--DK 437 (1028)
Q Consensus 362 d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lr--Ei~iL~~l~HPNIV~L~~i~~~~~~--~~ 437 (1028)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... ....+ |+..+..++|||||++++++...+. ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 5799999999999999999987 588999999965432 22333 4445567899999999999875543 46
Q ss_pred EEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh--------CCcccccccccceeecCCCcEEEec
Q psy18163 438 IFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHD--------NWILHRDLKTSNLLLSHRGILKVGD 509 (1028)
Q Consensus 438 l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs--------~gIVHRDLKPeNILLd~~g~lKL~D 509 (1028)
+|||||||.+ ++|...+... .+++.....++.|++.||.|||+ +|||||||||+||||+.+|.+||+|
T Consensus 76 ~~lv~Ey~~~--g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 76 LWLVSDYHEH--GSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEECCTT--CBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEecccC--CCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 8999999976 4444444333 47889999999999999999996 5999999999999999999999999
Q ss_pred cCCccccCCCCC----cccccccCccccCcccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy18163 510 FGLAREYGSPLK----HYTPIVVTLWYRSPELLLGCK-----EYSTPIDMWSVGCIFAEFLCMEPLFTGKSDLEQLSRIF 580 (1028)
Q Consensus 510 FGlAr~~~~~~~----~~t~~vGT~~Y~APEvL~g~~-----~ys~ksDIWSLGvILyELLTG~pPF~g~sd~d~l~kI~ 580 (1028)
||+++.+..... .....+||+.|+|||++.+.. .++.++|||||||+||||+||.+||.......
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~------ 225 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ------ 225 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC------
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc------
Confidence 999987644322 234578999999999987532 26778999999999999999998885433210
Q ss_pred HhcCCCCCCCCCCCCCChhhhhhcc-ccC-CCCCCCccccccccccHHHHHHHHHhcccCcCCCCCHHHHHhC
Q psy18163 581 KTMGTPNEKIWPGFSKLPAVQKMTF-AEY-PNVGGLKTKVAGSILTELGYDLLCKFLTYDPVTRITADEALRH 651 (1028)
Q Consensus 581 ~~lg~p~~~~w~~~s~lp~~~~l~~-~~~-p~~~~l~~~~~~~~Ls~~a~DLL~kcL~~DP~kRPTA~ElL~H 651 (1028)
.+................... ... |.. ............+.+||.+||..||.+|||+.||+++
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~~p~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 226 ----LPYYDLVPSDPSVEEMRKVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp ----CTTTTTSCSSCCHHHHHHHHTTSCCCCCC---CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ----cchhhcccccchHHHHHHHHhccccCCCC---CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000000000000000000000 000 000 0001111233568899999999999999999999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=3.8e-23 Score=209.90 Aligned_cols=166 Identities=18% Similarity=0.101 Sum_probs=119.2
Q ss_pred eEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccC--------C--------ccchHHHHHHHHHcCCCCeeEEE
Q psy18163 364 FKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEG--------F--------PITSLREINTLLKAQHPNIVTVR 427 (1028)
Q Consensus 364 Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~--------~--------~~~~lrEi~iL~~l~HPNIV~L~ 427 (1028)
|-+.++||+|+||+||+|.+. +|+.||||+++....... . .....+|+..|..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999985 689999999864321100 0 01123577888899999999886
Q ss_pred EEEeecCCCeEEEEEeccccchHHHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhCCcccccccccceeecCCCcEEE
Q psy18163 428 EIVVGSNMDKIFIVMDYVEHDMKSLMETMRSKKQVFIPGEVKCLMQQLLNAVAHLHDNWILHRDLKTSNLLLSHRGILKV 507 (1028)
Q Consensus 428 ~i~~~~~~~~l~LVmEy~~gdLgsLl~~l~~~~~~~se~ev~~il~QLl~AL~yLHs~gIVHRDLKPeNILLd~~g~lKL 507 (1028)
++. . .+|||||+++.. + ..+....+..++.||+.+|.|||++||+||||||+|||++.+ .++|
T Consensus 81 ~~~--~----~~lvme~~~~~~--~--------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 81 AWE--G----NAVLMELIDAKE--L--------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EEE--T----TEEEEECCCCEE--G--------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEE
T ss_pred Eec--C----CEEEEEeecccc--c--------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEE
Confidence 543 1 279999998721 1 113445678899999999999999999999999999999865 4889
Q ss_pred eccCCccccCCCCCcccccccCccccC------cccccCCCCCCchhhHHHHHHHH
Q psy18163 508 GDFGLAREYGSPLKHYTPIVVTLWYRS------PELLLGCKEYSTPIDMWSVGCIF 557 (1028)
Q Consensus 508 ~DFGlAr~~~~~~~~~t~~vGT~~Y~A------PEvL~g~~~ys~ksDIWSLGvIL 557 (1028)
+|||+|.....+... .|.. .+.+ . +.|+..+|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~--------~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR--------EILERDVRNIITYF-S-RTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH--------HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH--------HHHHHHHHHHHHHH-c-CCCCCcccHHHHHHHH
Confidence 999999876543211 1111 1122 2 4589999999986544
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.11 E-value=1.1e-11 Score=132.26 Aligned_cols=77 Identities=26% Similarity=0.317 Sum_probs=65.4
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
++++|++++.||+|+||+||+|+++.||+.||||++.+.... .-.|||+|++++++.+....+|||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 357899999999999999999999999999999998753210 016899999999999999999999
Q ss_pred ecC-CCCCCccc
Q psy18163 817 ENP-GGPLNKKE 827 (1028)
Q Consensus 817 E~~-~G~L~~~~ 827 (1028)
||| +|+|.+.+
T Consensus 83 Ey~~gg~L~~~l 94 (271)
T d1nvra_ 83 EYCSGGELFDRI 94 (271)
T ss_dssp ECCTTEEGGGGS
T ss_pred eccCCCcHHHHH
Confidence 999 77998844
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.08 E-value=3.3e-11 Score=131.39 Aligned_cols=77 Identities=10% Similarity=0.052 Sum_probs=66.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENP 819 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~ 819 (1028)
.++|++++.||+|+||+||+|.++.||+.||||+|.+.... .-.|||+|++++++......|||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 36899999999999999999999999999999999854311 116899999999999999999999999
Q ss_pred -CCCCCcccC
Q psy18163 820 -GGPLNKKEQ 828 (1028)
Q Consensus 820 -~G~L~~~~~ 828 (1028)
||+|.+.+.
T Consensus 84 ~gg~L~~~i~ 93 (321)
T d1tkia_ 84 SGLDIFERIN 93 (321)
T ss_dssp CCCBHHHHHT
T ss_pred CCCcHHHHHH
Confidence 679888443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.08 E-value=5e-11 Score=131.70 Aligned_cols=77 Identities=21% Similarity=0.213 Sum_probs=66.3
Q ss_pred ccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------cccCCchhhhhhHhhhcCcCcEEE
Q psy18163 750 RSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------WLENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 750 ~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------~~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
...++|++++.||+|+||+||+|+++.||+.||||+|.+... .. .|||+|++++++......+||
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 345789999999999999999999999999999999975431 12 689999999999988999999
Q ss_pred EecC-CCCCCccc
Q psy18163 816 TENP-GGPLNKKE 827 (1028)
Q Consensus 816 ~E~~-~G~L~~~~ 827 (1028)
|||| ||+|.+.+
T Consensus 105 mE~~~gg~L~~~~ 117 (352)
T d1koba_ 105 LEFLSGGELFDRI 117 (352)
T ss_dssp EECCCCCBHHHHT
T ss_pred EEcCCCChHHHHH
Confidence 9999 78887743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.07 E-value=5.1e-11 Score=131.55 Aligned_cols=80 Identities=18% Similarity=0.196 Sum_probs=68.3
Q ss_pred CCCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCc
Q psy18163 747 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 747 ~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
....-+++|++++.||+|+||+||+|+++.||+.||||+|.+.... . .|||+|++++++......
T Consensus 20 ~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEE
T ss_pred CCCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence 3344578999999999999999999999999999999999754321 1 589999999999988999
Q ss_pred EEEEecC-CCCCCccc
Q psy18163 813 HLVTENP-GGPLNKKE 827 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~ 827 (1028)
+|||||| ||+|.+.+
T Consensus 99 ~ivmE~~~gg~L~~~l 114 (350)
T d1koaa2 99 VMIYEFMSGGELFEKV 114 (350)
T ss_dssp EEEECCCCSCBHHHHH
T ss_pred EEEEEcCCCCCHHHHH
Confidence 9999999 78998744
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.06 E-value=4.1e-11 Score=127.42 Aligned_cols=107 Identities=19% Similarity=0.228 Sum_probs=78.0
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhc--CcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVE--SELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~--~~~~hl 814 (1028)
.++|++++.||+|+||+||+|+++.||+.||||+|...... .-.|||+|++++++.+ ....+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 57899999999999999999999999999999999754311 1168999999987754 356799
Q ss_pred EEecC-CCCCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHHH
Q psy18163 815 VTENP-GGPLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVKL 884 (1028)
Q Consensus 815 V~E~~-~G~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (1028)
||||| +|+|.+.+.. .++.+..-||.....+=.|+-.|+..+|-
T Consensus 83 vmEy~~~g~L~~~i~~--------------------------~~~~~~~l~e~~~~~i~~qi~~al~ylH~ 127 (269)
T d2java1 83 VMEYCEGGDLASVITK--------------------------GTKERQYLDEEFVLRVMTQLTLALKECHR 127 (269)
T ss_dssp EEECCTTEEHHHHHHH--------------------------HHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCcHHHHHHh--------------------------ccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999 7788873320 01111223444444556788889988884
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.05 E-value=6.5e-11 Score=126.46 Aligned_cols=103 Identities=16% Similarity=0.017 Sum_probs=80.8
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-----------------------ccCCchhhhhhHhhhc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-----------------------LENFPSRIRTYHLQVE 808 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-----------------------~~~~p~~vr~~e~~~~ 808 (1028)
-++|++++.||+|+||+||+|+++.+|+.||||+|.+.... ...|||+|++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999999999999999999754311 1258999999999999
Q ss_pred CcCcEEEEecC-CCCCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHHH
Q psy18163 809 SELNHLVTENP-GGPLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVKL 884 (1028)
Q Consensus 809 ~~~~hlV~E~~-~G~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (1028)
....+|||||| +|+|...+. . .|.- ||-....+=-||-+|+..||-
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~----------------~-------------~~~l-~e~~~~~~~~qi~~al~~lH~ 128 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT----------------E-------------KVTL-SEKETRKIMRALLEVICALHK 128 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH----------------H-------------HSSC-CHHHHHHHHHHHHHHHHHHHH
T ss_pred CcceEEEEEcCCCchHHHHHH----------------h-------------cCCC-CHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999 779887321 1 1222 344445555688889888884
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.05 E-value=6.5e-11 Score=126.88 Aligned_cols=87 Identities=17% Similarity=0.163 Sum_probs=70.5
Q ss_pred CCCCCCCCCCc-cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc------------cCCchhhhhhHhh
Q psy18163 740 PPYLPAIQGCR-SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL------------ENFPSRIRTYHLQ 806 (1028)
Q Consensus 740 ~~~~~~~~~~~-~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~------------~~~p~~vr~~e~~ 806 (1028)
.|..|.++... ..++|++.++||+|+||+||+|.++.+|+.||||+|....... -.|||+|++++++
T Consensus 3 ~p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp CTTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccE
Confidence 45566665432 2358999999999999999999999999999999997543211 1699999999999
Q ss_pred hcCcCcEEEEecC-CCCCCcc
Q psy18163 807 VESELNHLVTENP-GGPLNKK 826 (1028)
Q Consensus 807 ~~~~~~hlV~E~~-~G~L~~~ 826 (1028)
......+|||||| +|+|...
T Consensus 83 ~~~~~~~iv~E~~~~g~l~~~ 103 (287)
T d1opja_ 83 TREPPFYIITEFMTYGNLLDY 103 (287)
T ss_dssp CSSSSCEEEEECCTTCBHHHH
T ss_pred eeCCeeEEEeecccCcchHHH
Confidence 8889999999999 7788773
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=3.4e-11 Score=127.74 Aligned_cols=74 Identities=23% Similarity=0.350 Sum_probs=64.4
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
++++|++++.||+|+||+||+|+++.||+.||||+|.+... .. .|||+|++++++.+....+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEE
Confidence 47899999999999999999999999999999999863210 11 6899999999999889999
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||| +|+|.+
T Consensus 83 ivmEy~~~g~L~~ 95 (263)
T d2j4za1 83 LILEYAPLGTVYR 95 (263)
T ss_dssp EEEECCTTCBHHH
T ss_pred EEEeecCCCcHHH
Confidence 999999 778876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=5.5e-11 Score=129.55 Aligned_cols=75 Identities=21% Similarity=0.216 Sum_probs=64.7
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCc----c-------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGK----F-------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~----~-------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
|++|++++.||+|+||+||+|+++.||+.||||+|.+.. . ..-.||++|++++++......+|
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 578999999999999999999999999999999996321 0 01279999999999999999999
Q ss_pred EEecC-CCCCCcc
Q psy18163 815 VTENP-GGPLNKK 826 (1028)
Q Consensus 815 V~E~~-~G~L~~~ 826 (1028)
||||| +|+|...
T Consensus 81 vmEy~~~g~L~~~ 93 (320)
T d1xjda_ 81 VMEYLNGGDLMYH 93 (320)
T ss_dssp EEECCTTCBHHHH
T ss_pred EEeecCCCcHHHH
Confidence 99999 7788873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=1.3e-10 Score=124.52 Aligned_cols=72 Identities=18% Similarity=0.183 Sum_probs=62.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc--------------------cccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF--------------------WLENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~--------------------~~~~~p~~vr~~e~~~~~~~~ 812 (1028)
+.|++++.||+|+||+||+|+++.||+.||||+|.+... .. .|||+|++++++.+....
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence 469999999999999999999999999999999864221 01 589999999999999999
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||| ||+|..
T Consensus 89 ~iv~E~~~gg~L~~ 102 (293)
T d1jksa_ 89 ILILELVAGGELFD 102 (293)
T ss_dssp EEEEECCCSCBHHH
T ss_pred EEEEEcCCCccccc
Confidence 9999999 778887
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=6.1e-11 Score=130.32 Aligned_cols=75 Identities=20% Similarity=0.171 Sum_probs=64.6
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
++++|++++.||+|+||+||+|+++.||+.||||+|.+... ..-.||++|++++++.+....||
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 46899999999999999999999999999999999974210 01158999999999999999999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||| ||+|..
T Consensus 83 v~ey~~gg~L~~ 94 (337)
T d1o6la_ 83 VMEYANGGELFF 94 (337)
T ss_dssp EEECCTTCBHHH
T ss_pred ceeccCCCchhh
Confidence 99999 778866
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.99 E-value=7.1e-11 Score=128.46 Aligned_cols=75 Identities=17% Similarity=0.261 Sum_probs=63.6
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
++++|++++.||+|+||+||+|+++.||+.||||+|.+... ..-.|||+|++++++......+|
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 57899999999999999999999999999999999863210 01168999999999999999999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||| ||+|..
T Consensus 82 vmE~~~gg~l~~ 93 (316)
T d1fota_ 82 IMDYIEGGELFS 93 (316)
T ss_dssp EECCCCSCBHHH
T ss_pred EeeecCCccccc
Confidence 99999 555555
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=1.1e-10 Score=125.16 Aligned_cols=74 Identities=34% Similarity=0.372 Sum_probs=62.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
|++|++++.||+|+||+||+|+++.||+.||||+|...... .-.||++|++++++......+|||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 57999999999999999999999999999999999643210 116899999999999899999999
Q ss_pred ecCCCCCCc
Q psy18163 817 ENPGGPLNK 825 (1028)
Q Consensus 817 E~~~G~L~~ 825 (1028)
||++|.+..
T Consensus 81 e~~~~~~~~ 89 (298)
T d1gz8a_ 81 EFLHQDLKK 89 (298)
T ss_dssp ECCSEEHHH
T ss_pred eecCCchhh
Confidence 999876655
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=3.3e-11 Score=131.11 Aligned_cols=73 Identities=19% Similarity=0.215 Sum_probs=63.3
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEEEec
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLVTEN 818 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV~E~ 818 (1028)
++|+++++||+|+||+||+|+++.||+.||||++.+.... .-.|||+|++++++......+|||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5899999999999999999999999999999998743210 11689999999999988899999999
Q ss_pred C-CCCCCc
Q psy18163 819 P-GGPLNK 825 (1028)
Q Consensus 819 ~-~G~L~~ 825 (1028)
+ ||+|..
T Consensus 86 ~~gg~L~~ 93 (322)
T d1s9ja_ 86 MDGGSLDQ 93 (322)
T ss_dssp CTTEEHHH
T ss_pred CCCCcHHH
Confidence 8 678877
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=1.4e-10 Score=124.42 Aligned_cols=73 Identities=16% Similarity=0.260 Sum_probs=62.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCcEEEEecC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELNHLVTENP 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~hlV~E~~ 819 (1028)
+.|++++.||+|+||+||+|+++.||+.||||++...... .-.|||+|++++++......+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4699999999999999999999999999999999753211 015899999999998889999999999
Q ss_pred -CCCCCc
Q psy18163 820 -GGPLNK 825 (1028)
Q Consensus 820 -~G~L~~ 825 (1028)
+|+|..
T Consensus 92 ~~g~L~~ 98 (288)
T d2jfla1 92 AGGAVDA 98 (288)
T ss_dssp TTEEHHH
T ss_pred CCCcHHH
Confidence 777766
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.95 E-value=6e-11 Score=128.56 Aligned_cols=75 Identities=19% Similarity=0.224 Sum_probs=63.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
+.|++++.||+|+||+||+|+++.||+.||||+|.+... .. .|||+|++++++......+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEe
Confidence 359999999999999999999999999999999974321 11 68999999999998899999999
Q ss_pred cC-CCCCCcccC
Q psy18163 818 NP-GGPLNKKEQ 828 (1028)
Q Consensus 818 ~~-~G~L~~~~~ 828 (1028)
|| ||+|.+.+.
T Consensus 88 ~~~gg~L~~~l~ 99 (307)
T d1a06a_ 88 LVSGGELFDRIV 99 (307)
T ss_dssp CCCSCBHHHHHH
T ss_pred ccCCCcHHHhhh
Confidence 99 789987543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=9.9e-11 Score=128.30 Aligned_cols=77 Identities=21% Similarity=0.223 Sum_probs=63.1
Q ss_pred cccceeEeee-eeccceeEEEEEEEccCCcEEEeeecCCCcc---------cccCCchhhhhhHhhhc----CcCcEEEE
Q psy18163 751 SVEEFKCLNR-IEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF---------WLENFPSRIRTYHLQVE----SELNHLVT 816 (1028)
Q Consensus 751 ~~~~Y~~l~~-IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~---------~~~~~p~~vr~~e~~~~----~~~~hlV~ 816 (1028)
-+++|+++.+ ||+|+||+||+|+++.||+.||||+|..... ....|||+|++++++.. ....+|||
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 4689999865 9999999999999999999999999975321 12269999999988754 45679999
Q ss_pred ecC-CCCCCccc
Q psy18163 817 ENP-GGPLNKKE 827 (1028)
Q Consensus 817 E~~-~G~L~~~~ 827 (1028)
||| ||+|.+.+
T Consensus 89 Ey~~gg~L~~~i 100 (335)
T d2ozaa1 89 ECLDGGELFSRI 100 (335)
T ss_dssp ECCCSEEHHHHH
T ss_pred ECCCCCcHHHHH
Confidence 999 78998843
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=1.1e-10 Score=125.54 Aligned_cols=73 Identities=22% Similarity=0.207 Sum_probs=63.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.++|++++.||+|+||+||+|+++.||+.||||+|.+... .. .|||+|++++++......||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEE
Confidence 3689999999999999999999999999999999863210 11 68999999999988889999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||| ||+|.+
T Consensus 86 vmEy~~gg~L~~ 97 (288)
T d1uu3a_ 86 GLSYAKNGELLK 97 (288)
T ss_dssp EECCCTTEEHHH
T ss_pred EEEccCCCCHHH
Confidence 99999 778877
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.92 E-value=4.3e-11 Score=132.76 Aligned_cols=77 Identities=16% Similarity=0.192 Sum_probs=65.3
Q ss_pred cccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-------------------cccCCchhhhhhHhhhcCcC
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-------------------WLENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-------------------~~~~~p~~vr~~e~~~~~~~ 811 (1028)
++++|++++.||+|+||.||+|+++.||+.||||+|.+... ..-.||++|++++++.....
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 47899999999999999999999999999999999853210 01158999999999988889
Q ss_pred cEEEEecC-CCCCCccc
Q psy18163 812 NHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~ 827 (1028)
.+|||||| ||+|...+
T Consensus 82 ~~ivmE~~~gg~L~~~l 98 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHL 98 (364)
T ss_dssp EEEEECCCCSCBHHHHH
T ss_pred EEEEEEecCCCcHHHHH
Confidence 99999999 78888743
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.90 E-value=3.3e-10 Score=120.06 Aligned_cols=73 Identities=21% Similarity=0.134 Sum_probs=59.2
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc----------------ccCCchhhhhhHhhhcCc----Cc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW----------------LENFPSRIRTYHLQVESE----LN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~----------------~~~~p~~vr~~e~~~~~~----~~ 812 (1028)
++|++++.||+|+||+||+|+++.||+.||||+|.+.... .-.|||+|++++++.... ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 4699999999999999999999999999999999753211 116899999988775543 36
Q ss_pred EEEEecC-CCCCCc
Q psy18163 813 HLVTENP-GGPLNK 825 (1028)
Q Consensus 813 hlV~E~~-~G~L~~ 825 (1028)
+|||||| ||+|..
T Consensus 87 ~lvmE~~~g~~L~~ 100 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRD 100 (277)
T ss_dssp EEEEECCCEEEHHH
T ss_pred EEEEECCCCCEehh
Confidence 8999999 567665
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=1.5e-10 Score=124.78 Aligned_cols=73 Identities=22% Similarity=0.251 Sum_probs=62.8
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc-------------ccCCchhhhhhHhhhcCcCcEEEEecC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW-------------LENFPSRIRTYHLQVESELNHLVTENP 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~-------------~~~~p~~vr~~e~~~~~~~~hlV~E~~ 819 (1028)
.+|+++++||+|+||+||+|.++.||+.||||++.+.... .-.|||+|++++++......+||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999999999999999998743211 016899999999999889999999999
Q ss_pred -CCCCCc
Q psy18163 820 -GGPLNK 825 (1028)
Q Consensus 820 -~G~L~~ 825 (1028)
||+|..
T Consensus 100 ~gg~L~~ 106 (293)
T d1yhwa1 100 AGGSLTD 106 (293)
T ss_dssp TTCBHHH
T ss_pred CCCcHHH
Confidence 777765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=98.88 E-value=8.3e-10 Score=119.42 Aligned_cols=74 Identities=19% Similarity=0.216 Sum_probs=60.5
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------cccCCchhhhhhHhhhc--CcCcEEEEec
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------WLENFPSRIRTYHLQVE--SELNHLVTEN 818 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------~~~~~p~~vr~~e~~~~--~~~~hlV~E~ 818 (1028)
.++|+++++||+|+||+||+|+++.||+.||||+|..... ...+||+++++++++.. ....++||||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 4689999999999999999999999999999999975431 12258999999888753 4567999999
Q ss_pred C-CCCCCc
Q psy18163 819 P-GGPLNK 825 (1028)
Q Consensus 819 ~-~G~L~~ 825 (1028)
| +|+|..
T Consensus 114 ~~~~~L~~ 121 (328)
T d3bqca1 114 VNNTDFKQ 121 (328)
T ss_dssp CCSCBGGG
T ss_pred cCCCcHHH
Confidence 9 556654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.86 E-value=5.7e-10 Score=120.93 Aligned_cols=69 Identities=30% Similarity=0.353 Sum_probs=59.8
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
.|+++++||+|+||+||+|+++.||+.||||+|.+... .. .|||+|++++++......+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEE
Confidence 59999999999999999999999999999999975321 12 5899999999998888999999
Q ss_pred ecC-CCCC
Q psy18163 817 ENP-GGPL 823 (1028)
Q Consensus 817 E~~-~G~L 823 (1028)
||| +|+|
T Consensus 95 E~~~~g~l 102 (309)
T d1u5ra_ 95 EYCLGSAS 102 (309)
T ss_dssp ECCSEEHH
T ss_pred EecCCCch
Confidence 999 4444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=7.9e-10 Score=121.16 Aligned_cols=104 Identities=21% Similarity=0.215 Sum_probs=75.0
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc---------CCchhhhhhHhhhcC------cCcEEEEec
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE---------NFPSRIRTYHLQVES------ELNHLVTEN 818 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~---------~~p~~vr~~e~~~~~------~~~hlV~E~ 818 (1028)
+|..+++||+|+||+||+|+++.||+.||||+|.+...... .|||+|++++++... ...+|||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 69999999999999999999999999999999975432111 689999998776332 235899999
Q ss_pred CCCCCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHH
Q psy18163 819 PGGPLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVK 883 (1028)
Q Consensus 819 ~~G~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (1028)
|+|++...... ..+....-||.....+--|+-+|++.+|
T Consensus 101 ~~~~~~~~l~~--------------------------~~~~~~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 101 VPETVYRVARH--------------------------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp CSEEHHHHHHH--------------------------HHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cCCccHHHHHh--------------------------hhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 98876552220 0111223345444555668888998888
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=1.7e-09 Score=113.92 Aligned_cols=73 Identities=23% Similarity=0.232 Sum_probs=61.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc------------CCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE------------NFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~------------~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
++|++++.||+|+||.||+|+++ +++.||||++.......+ .|||+|++++++......+|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 57999999999999999999876 577899999985432111 6899999999988888999999999
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|.+.
T Consensus 84 ~g~L~~~ 90 (263)
T d1sm2a_ 84 HGCLSDY 90 (263)
T ss_dssp TCBHHHH
T ss_pred CCcHHHH
Confidence 7888773
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.82 E-value=4.8e-10 Score=123.58 Aligned_cols=73 Identities=21% Similarity=0.260 Sum_probs=63.2
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCc-----------------ccccCCchhhhhhHhhhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGK-----------------FWLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~-----------------~~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
+++|++++.||+|+||+||+|+++.||+.||||+|.+.. ... .||++|++++++......++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccc
Confidence 689999999999999999999999999999999986321 012 68999999999988889999
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||+ ||+|..
T Consensus 119 v~e~~~~g~l~~ 130 (350)
T d1rdqe_ 119 VMEYVAGGEMFS 130 (350)
T ss_dssp EEECCTTCBHHH
T ss_pred ccccccccchhh
Confidence 99988 777766
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=98.82 E-value=5.4e-10 Score=118.59 Aligned_cols=75 Identities=29% Similarity=0.310 Sum_probs=62.4
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
+++|+++++||+|+||+||+|+++ +|+.||||+|...... .-.|||+|++++++......+|||
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 478999999999999999999985 8899999999753211 115899999999999899999999
Q ss_pred ecCCCCCCccc
Q psy18163 817 ENPGGPLNKKE 827 (1028)
Q Consensus 817 E~~~G~L~~~~ 827 (1028)
||++|.+....
T Consensus 80 e~~~~~~~~~~ 90 (286)
T d1ob3a_ 80 EHLDQDLKKLL 90 (286)
T ss_dssp ECCSEEHHHHH
T ss_pred EeehhhhHHHH
Confidence 99977665533
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=9.4e-10 Score=117.59 Aligned_cols=70 Identities=27% Similarity=0.236 Sum_probs=56.6
Q ss_pred eEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 756 KCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 756 ~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
|.+++||+|+||+||+|+++.||+.||||+|...... .-.|||+|++++++......+||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 5789999999999999999999999999999643210 0058999999999999999999999
Q ss_pred cCCCCCCc
Q psy18163 818 NPGGPLNK 825 (1028)
Q Consensus 818 ~~~G~L~~ 825 (1028)
|+.|.+..
T Consensus 81 ~~~~~~~~ 88 (299)
T d1ua2a_ 81 FMETDLEV 88 (299)
T ss_dssp CCSEEHHH
T ss_pred hhcchHHh
Confidence 99665544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.79 E-value=1.6e-09 Score=115.66 Aligned_cols=78 Identities=24% Similarity=0.380 Sum_probs=60.3
Q ss_pred CCCccccceeEeeeeeccceeEEEEEEEccC-CcEEEeeecCCCccc------------------ccCCchhhhhhHhhh
Q psy18163 747 QGCRSVEEFKCLNRIEEGTYGVVYRAKDKRT-DEIVAPCKSGNGKFW------------------LENFPSRIRTYHLQV 807 (1028)
Q Consensus 747 ~~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~t-g~~VAIK~I~~~~~~------------------~~~~p~~vr~~e~~~ 807 (1028)
+.|++-++|+++++||+|+||+||+|++..+ ++.||||+|...... .-.|||+|++++++.
T Consensus 1 g~c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 1 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCCCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 3589989999999999999999999999766 678999998632110 014899999988764
Q ss_pred c-----CcCcEEEEecCCCCCC
Q psy18163 808 E-----SELNHLVTENPGGPLN 824 (1028)
Q Consensus 808 ~-----~~~~hlV~E~~~G~L~ 824 (1028)
. ....+|||||++|.+.
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~ 102 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLT 102 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHH
T ss_pred ccccccCceEEEEEEeccCCch
Confidence 3 2456999999966544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=1.1e-09 Score=115.55 Aligned_cols=73 Identities=19% Similarity=0.210 Sum_probs=61.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc------------CCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE------------NFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~------------~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
++|+++++||+|+||+||+|+++ ++..||||++.+.....+ .|||+|++++++......+|||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 58999999999999999999984 788999999986432111 6899999999988888999999999
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|...
T Consensus 83 ~g~l~~~ 89 (258)
T d1k2pa_ 83 NGCLLNY 89 (258)
T ss_dssp TEEHHHH
T ss_pred CCcHHHh
Confidence 6787764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=8.3e-10 Score=118.77 Aligned_cols=78 Identities=21% Similarity=0.195 Sum_probs=59.5
Q ss_pred CCccccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc---------------cCCchhhhhhHhhhc----
Q psy18163 748 GCRSVEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL---------------ENFPSRIRTYHLQVE---- 808 (1028)
Q Consensus 748 ~~~~~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~---------------~~~p~~vr~~e~~~~---- 808 (1028)
.|..+++|+++++||+|+||+||+|+++.+|+.||||+|.+..... -.||+++++++++..
T Consensus 5 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp TSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 6888999999999999999999999999999999999986432211 057888887665433
Q ss_pred ----CcCcEEEEecCCCCCCc
Q psy18163 809 ----SELNHLVTENPGGPLNK 825 (1028)
Q Consensus 809 ----~~~~hlV~E~~~G~L~~ 825 (1028)
....+|||||+++.+..
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~ 105 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAG 105 (318)
T ss_dssp ------CEEEEEECCCEEHHH
T ss_pred ccccCceEEEEEeccCCCccc
Confidence 34579999999776655
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=2.5e-09 Score=112.98 Aligned_cols=72 Identities=28% Similarity=0.303 Sum_probs=60.8
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVT 816 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~ 816 (1028)
|++|+++++||+|+||+||+|+++.+|+.||||+++..... .-.|||+|++++++......+|||
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 57899999999999999999999999999999998643211 116899999998898888999999
Q ss_pred ecCCCCC
Q psy18163 817 ENPGGPL 823 (1028)
Q Consensus 817 E~~~G~L 823 (1028)
|++.|.+
T Consensus 81 ~~~~~~~ 87 (292)
T d1unla_ 81 EFCDQDL 87 (292)
T ss_dssp ECCSEEH
T ss_pred eeccccc
Confidence 9985533
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=1.7e-09 Score=118.68 Aligned_cols=74 Identities=23% Similarity=0.125 Sum_probs=58.7
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhc------Cc
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVE------SE 810 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~------~~ 810 (1028)
+.+|+++++||+|+||+||+|+++.||+.||||+|.+.... .-.||++|++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36899999999999999999999999999999999743210 1168999999888743 35
Q ss_pred CcEEEEecCCCCCCc
Q psy18163 811 LNHLVTENPGGPLNK 825 (1028)
Q Consensus 811 ~~hlV~E~~~G~L~~ 825 (1028)
..+||||||.|+|..
T Consensus 96 ~~~iv~Ey~~~~l~~ 110 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ 110 (355)
T ss_dssp EEEEEEECCSEEHHH
T ss_pred eeEEEEeccchHHHH
Confidence 669999999887766
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=3.3e-09 Score=115.19 Aligned_cols=76 Identities=17% Similarity=0.029 Sum_probs=62.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCc-----EEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDE-----IVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~-----~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~ 812 (1028)
++|++++.||+|+||+||+|++..+++ .||+|.+..... ....|||+|++++++......
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 579999999999999999999987654 699999864321 112689999999999989999
Q ss_pred EEEEecC-CCCCCcccC
Q psy18163 813 HLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~~ 828 (1028)
+|||||| +|+|.+.+.
T Consensus 117 ~lv~Ey~~~g~L~~~l~ 133 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLR 133 (325)
T ss_dssp EEEEECCTTCBHHHHHH
T ss_pred EEEEEcCCCCcHHHHHH
Confidence 9999999 889988554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=3.7e-09 Score=111.97 Aligned_cols=72 Identities=22% Similarity=0.277 Sum_probs=58.0
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc------------CCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE------------NFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~------------~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
++|+++++||+|+||.||+|.++ ++..||||++.......+ .|||+|++++++. ....+|||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 58999999999999999999975 678999999975432111 5899999988764 45669999999
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|.+.
T Consensus 91 ~g~L~~~ 97 (272)
T d1qpca_ 91 NGSLVDF 97 (272)
T ss_dssp TCBHHHH
T ss_pred CCcHHHH
Confidence 7888773
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.73 E-value=3.4e-09 Score=113.88 Aligned_cols=73 Identities=22% Similarity=0.215 Sum_probs=59.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCc---EEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDE---IVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~---~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
...|++.+.||+|+||+||+|+++.+|+ .||||++..... .. .|||+|++++++......+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEE
Confidence 3579999999999999999999988775 699999864321 12 6999999999998888999
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
|||||| +|+|..
T Consensus 104 iv~Ey~~~g~L~~ 116 (299)
T d1jpaa_ 104 IITEFMENGSLDS 116 (299)
T ss_dssp EEEECCTTEEHHH
T ss_pred EEEEecCCCccee
Confidence 999999 777766
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.71 E-value=3.1e-09 Score=115.53 Aligned_cols=75 Identities=20% Similarity=0.283 Sum_probs=61.4
Q ss_pred cccceeEeeeeeccceeEEEEEEE---ccCCcEEEeeecCCCcc------------------cccCCchhhhhhHhhhcC
Q psy18163 751 SVEEFKCLNRIEEGTYGVVYRAKD---KRTDEIVAPCKSGNGKF------------------WLENFPSRIRTYHLQVES 809 (1028)
Q Consensus 751 ~~~~Y~~l~~IGeGsyG~Vy~a~~---~~tg~~VAIK~I~~~~~------------------~~~~~p~~vr~~e~~~~~ 809 (1028)
.+++|+++++||+|+||+||+|++ +.||+.||||+|.+... ....+|+++++++++...
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 368899999999999999999998 45799999999864211 011348999998888888
Q ss_pred cCcEEEEecC-CCCCCc
Q psy18163 810 ELNHLVTENP-GGPLNK 825 (1028)
Q Consensus 810 ~~~hlV~E~~-~G~L~~ 825 (1028)
...++||||+ +|+|..
T Consensus 102 ~~~~~v~e~~~~~~L~~ 118 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFT 118 (322)
T ss_dssp TEEEEEECCCCSCBHHH
T ss_pred CceeeeeecccccHHHH
Confidence 9999999998 778876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.71 E-value=3.4e-09 Score=112.44 Aligned_cols=70 Identities=30% Similarity=0.358 Sum_probs=56.8
Q ss_pred eeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhc----CcCcEE
Q psy18163 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVE----SELNHL 814 (1028)
Q Consensus 755 Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~----~~~~hl 814 (1028)
|++.++||+|+||+||+|.++.|++.||||++..... .. .|||+|++++++.. ....+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEE
Confidence 4677789999999999999999999999999864321 11 58999999988654 345699
Q ss_pred EEecC-CCCCCc
Q psy18163 815 VTENP-GGPLNK 825 (1028)
Q Consensus 815 V~E~~-~G~L~~ 825 (1028)
||||| +|+|..
T Consensus 90 vmE~~~~g~L~~ 101 (270)
T d1t4ha_ 90 VTELMTSGTLKT 101 (270)
T ss_dssp EEECCCSCBHHH
T ss_pred EEeCCCCCcHHH
Confidence 99999 778876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.69 E-value=2e-09 Score=117.09 Aligned_cols=74 Identities=26% Similarity=0.173 Sum_probs=58.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhc------CcC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVE------SEL 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~------~~~ 811 (1028)
++|+++++||+|+||+||+|+++.||+.||||+|.+.... .-.||++|++++++.. ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 5799999999999999999999999999999999754211 0158999988877532 234
Q ss_pred cEEEEecCCCCCCcc
Q psy18163 812 NHLVTENPGGPLNKK 826 (1028)
Q Consensus 812 ~hlV~E~~~G~L~~~ 826 (1028)
.+||||++||+|.+.
T Consensus 98 ~~i~~~~~gg~L~~~ 112 (348)
T d2gfsa1 98 VYLVTHLMGADLNNI 112 (348)
T ss_dssp CEEEEECCSEEHHHH
T ss_pred EEEEEeecCCchhhh
Confidence 677777779998873
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.69 E-value=6.5e-09 Score=111.98 Aligned_cols=76 Identities=16% Similarity=0.055 Sum_probs=62.7
Q ss_pred cceeEeeeeeccceeEEEEEEEc-----cCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~-----~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~ 812 (1028)
++|++.++||+|+||.||+|.+. .++..||||+|...... ...|||+|++++++......
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 68999999999999999999863 56779999999753310 12599999999999888889
Q ss_pred EEEEecC-CCCCCcccC
Q psy18163 813 HLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~~ 828 (1028)
+|||||| +|+|...+.
T Consensus 103 ~lvmE~~~~g~l~~~l~ 119 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLR 119 (311)
T ss_dssp EEEEECCTTEEHHHHHH
T ss_pred EEEEEcCCCCCHHHHHH
Confidence 9999999 778777543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.68 E-value=5.5e-09 Score=114.12 Aligned_cols=101 Identities=21% Similarity=0.147 Sum_probs=71.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcC-----cCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVES-----ELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~-----~~~h 813 (1028)
.+|+++++||+|+||+||+|+++.||+.||||+|.+.... .-.||++|++++++... ...+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4699999999999999999999999999999999753211 00689999988776443 2357
Q ss_pred EEEecCCCCCCcccCCCCCCCCCCCchhhhhhcccCCCccccccccCCCCChhHHHHHHHHHHhhHHHHHH
Q psy18163 814 LVTENPGGPLNKKEQPKWRPMQISNPSTKLRQARSMPHWVPNVRRAGSQPPEYITTLVQNQVKQGMEMVKL 884 (1028)
Q Consensus 814 lV~E~~~G~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (1028)
||||+++|+|.+.+. .+ ..|+...-.+-.|+-+|+..+|-
T Consensus 88 l~~~~~~g~L~~~l~-----------------~~--------------~l~~~~i~~i~~qil~al~yLH~ 127 (345)
T d1pmea_ 88 LVTHLMGADLYKLLK-----------------TQ--------------HLSNDHICYFLYQILRGLKYIHS 127 (345)
T ss_dssp EEEECCCEEHHHHHH-----------------HC--------------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeecCCchhhhhh-----------------cC--------------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 788888999987221 01 12455555566788888888884
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.68 E-value=7.9e-09 Score=110.41 Aligned_cols=73 Identities=23% Similarity=0.251 Sum_probs=58.9
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc------------ccCCchhhhhhHhhhcCcCcEEEEecCC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW------------LENFPSRIRTYHLQVESELNHLVTENPG 820 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~------------~~~~p~~vr~~e~~~~~~~~hlV~E~~~ 820 (1028)
.+|+++++||+|+||+||+|++..+|+.||||++...... ...+++++.++.+.......++||||++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~ 84 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 84 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecC
Confidence 3799999999999999999999999999999998643211 1134666666666677788899999999
Q ss_pred CCCCc
Q psy18163 821 GPLNK 825 (1028)
Q Consensus 821 G~L~~ 825 (1028)
|+|..
T Consensus 85 ~~l~~ 89 (293)
T d1csna_ 85 PSLED 89 (293)
T ss_dssp CBHHH
T ss_pred CCHHH
Confidence 98877
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.68 E-value=3e-09 Score=115.92 Aligned_cols=73 Identities=26% Similarity=0.155 Sum_probs=53.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCc------C
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESE------L 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~------~ 811 (1028)
++|+++++||+|+||+||+|.++.||+.||||+|.+.... .-.||++|++++++.... .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 5899999999999999999999999999999999753211 016899999988875543 4
Q ss_pred cEEEEecCCCCCCc
Q psy18163 812 NHLVTENPGGPLNK 825 (1028)
Q Consensus 812 ~hlV~E~~~G~L~~ 825 (1028)
.+|||||++++|..
T Consensus 98 ~~lv~e~~~~~l~~ 111 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGK 111 (346)
T ss_dssp CEEEEECCSEEHHH
T ss_pred EEEEEecccccHHH
Confidence 69999999776655
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66 E-value=6.8e-09 Score=111.22 Aligned_cols=77 Identities=17% Similarity=0.082 Sum_probs=58.3
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCC-------cEEEeeecCCCccc---------------ccCCchhhhhhHhhhcC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTD-------EIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVES 809 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg-------~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~ 809 (1028)
.++|++.+.||+|+||.||+|++..++ ..||||++.+.... ...|||+|++++++...
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 368999999999999999999987665 37999999754321 11699999999999888
Q ss_pred cCcEEEEecC-CCCCCcccC
Q psy18163 810 ELNHLVTENP-GGPLNKKEQ 828 (1028)
Q Consensus 810 ~~~hlV~E~~-~G~L~~~~~ 828 (1028)
...++||||+ +|+|...+.
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~ 111 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQ 111 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHH
T ss_pred CeEEEEEEccCCCcHHHHHH
Confidence 8999999999 889988654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=6.1e-09 Score=110.17 Aligned_cols=69 Identities=17% Similarity=0.205 Sum_probs=58.6
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------------ccCCchhhhhhHhhhcCcC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------------LENFPSRIRTYHLQVESEL 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------------~~~~p~~vr~~e~~~~~~~ 811 (1028)
.+|++.+.||+|+||+||+|+++.||+.||||+|.+.... ...|||+|++++++.....
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4799999999999999999999999999999998642110 1148999999999998899
Q ss_pred cEEEEecCCC
Q psy18163 812 NHLVTENPGG 821 (1028)
Q Consensus 812 ~hlV~E~~~G 821 (1028)
.+|||||+.|
T Consensus 84 ~~lv~e~~~~ 93 (273)
T d1xwsa_ 84 FVLILERPEP 93 (273)
T ss_dssp EEEEEECCSS
T ss_pred EEEEEEeccC
Confidence 9999998843
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.64 E-value=1.2e-08 Score=108.71 Aligned_cols=73 Identities=22% Similarity=0.201 Sum_probs=55.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccccc-----------CCchhhhh-hHhhhcCcCcEEEEecCC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWLE-----------NFPSRIRT-YHLQVESELNHLVTENPG 820 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~~-----------~~p~~vr~-~e~~~~~~~~hlV~E~~~ 820 (1028)
++|++++.||+|+||+||+|+++.+|+.||||++........ .++++|.. ..+.......+|||||++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 479999999999999999999999999999999875332111 24444433 334556677899999999
Q ss_pred CCCCc
Q psy18163 821 GPLNK 825 (1028)
Q Consensus 821 G~L~~ 825 (1028)
|+|..
T Consensus 87 ~~l~~ 91 (299)
T d1ckia_ 87 PSLED 91 (299)
T ss_dssp CBHHH
T ss_pred Cchhh
Confidence 88765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=8.3e-09 Score=110.31 Aligned_cols=72 Identities=22% Similarity=0.193 Sum_probs=57.5
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc------------cCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL------------ENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~------------~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
++|++.+.||+|+||.||+|+++.+ ..||||+|....... -.|||+|++++++.. ...+|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 6899999999999999999998766 569999997543211 168999999987754 5579999988
Q ss_pred CCCCCcc
Q psy18163 820 GGPLNKK 826 (1028)
Q Consensus 820 ~G~L~~~ 826 (1028)
+|+|...
T Consensus 95 ~g~l~~~ 101 (285)
T d1fmka3 95 KGSLLDF 101 (285)
T ss_dssp TCBHHHH
T ss_pred CCchhhh
Confidence 7776653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=7.4e-09 Score=111.45 Aligned_cols=77 Identities=21% Similarity=0.135 Sum_probs=63.1
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcE--EEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEI--VAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~--VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.++|++.+.||+|+||+||+|.++.||.. ||||++..... ....|||+|++++++......+|
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 36899999999999999999999999874 78888753210 11258999999999988889999
Q ss_pred EEecC-CCCCCcccC
Q psy18163 815 VTENP-GGPLNKKEQ 828 (1028)
Q Consensus 815 V~E~~-~G~L~~~~~ 828 (1028)
||||+ +|+|.+.+.
T Consensus 89 V~ey~~~g~L~~~l~ 103 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLR 103 (309)
T ss_dssp EECCCTTCBHHHHHH
T ss_pred EEEecCCCcHHHHHh
Confidence 99998 789988543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=2.1e-08 Score=108.24 Aligned_cols=72 Identities=25% Similarity=0.261 Sum_probs=52.4
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCc----EEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDE----IVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~----~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
.+|++++.||+|+||+||+|.+..+|+ .||||++...... .-.|||+|++++++..... ++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-EE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-eE
Confidence 579999999999999999999998887 5889888642210 0068999999988876554 55
Q ss_pred EEe-cCCCCCCc
Q psy18163 815 VTE-NPGGPLNK 825 (1028)
Q Consensus 815 V~E-~~~G~L~~ 825 (1028)
||| |++|+|..
T Consensus 88 v~e~~~~~~l~~ 99 (317)
T d1xkka_ 88 ITQLMPFGCLLD 99 (317)
T ss_dssp EEECCTTCBHHH
T ss_pred EEEeccCCcccc
Confidence 555 55888876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=2.9e-08 Score=105.75 Aligned_cols=75 Identities=16% Similarity=0.071 Sum_probs=55.1
Q ss_pred cceeEeeeeeccceeEEEEEEEcc-----CCcEEEeeecCCCcc---------------cccCCchhhhhhHhhh-cCcC
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQV-ESEL 811 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~-----tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~-~~~~ 811 (1028)
++|+++++||+|+||.||+|.+.. +++.||||++..... ....||++|+++.+.. ....
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 579999999999999999999764 456899999974321 1114778888766543 3456
Q ss_pred cEEEEecC-CCCCCccc
Q psy18163 812 NHLVTENP-GGPLNKKE 827 (1028)
Q Consensus 812 ~hlV~E~~-~G~L~~~~ 827 (1028)
.+|||||| +|+|...+
T Consensus 93 ~~iv~E~~~~g~L~~~l 109 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYL 109 (299)
T ss_dssp CEEEEECCTTCBHHHHH
T ss_pred EEEEEEecCCCcHHHHH
Confidence 89999999 78888744
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.56 E-value=1.9e-08 Score=107.73 Aligned_cols=75 Identities=19% Similarity=0.156 Sum_probs=61.5
Q ss_pred cceeEeeeeeccceeEEEEEEEc-----cCCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDK-----RTDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~-----~tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
++|++++.||+|+||+||+|+.+ .++..||||+|...... .-.|||+|++++++......+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 47999999999999999999975 46689999999743210 015899999998888888999
Q ss_pred EEEecC-CCCCCccc
Q psy18163 814 LVTENP-GGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~ 827 (1028)
+||||+ +|+|.+.+
T Consensus 93 ~v~e~~~~g~L~~~l 107 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFL 107 (301)
T ss_dssp EEEECCTTCBHHHHH
T ss_pred EEEEecCCCcHHHHH
Confidence 999998 78888754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=2.2e-08 Score=106.85 Aligned_cols=72 Identities=25% Similarity=0.251 Sum_probs=55.7
Q ss_pred cceeEee-eeeccceeEEEEEEEcc--CCcEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcEE
Q psy18163 753 EEFKCLN-RIEEGTYGVVYRAKDKR--TDEIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNHL 814 (1028)
Q Consensus 753 ~~Y~~l~-~IGeGsyG~Vy~a~~~~--tg~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~hl 814 (1028)
++|.+.. +||+|+||+||+|.++. ++..||||++..... .. .|||+|++++++. .+..+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~-~~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQ-AEALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeec-cCeEEE
Confidence 4688888 49999999999998764 455899999975321 12 6899999998775 456799
Q ss_pred EEecC-CCCCCcc
Q psy18163 815 VTENP-GGPLNKK 826 (1028)
Q Consensus 815 V~E~~-~G~L~~~ 826 (1028)
||||| +|+|.+.
T Consensus 86 vmE~~~~g~L~~~ 98 (285)
T d1u59a_ 86 VMEMAGGGPLHKF 98 (285)
T ss_dssp EEECCTTEEHHHH
T ss_pred EEEeCCCCcHHHH
Confidence 99999 6788774
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=1e-08 Score=108.27 Aligned_cols=74 Identities=23% Similarity=0.140 Sum_probs=58.6
Q ss_pred ccceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcccc-----------cCCchhhhhhHhhhc-CcCcEEEEecC
Q psy18163 752 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFWL-----------ENFPSRIRTYHLQVE-SELNHLVTENP 819 (1028)
Q Consensus 752 ~~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~~-----------~~~p~~vr~~e~~~~-~~~~hlV~E~~ 819 (1028)
+++|+++++||+|+||.||+|.+ +|..||||+|++..... -.|||+|++++++.. ....+|||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 57899999999999999999998 58899999997543211 158999999987654 45679999999
Q ss_pred -CCCCCccc
Q psy18163 820 -GGPLNKKE 827 (1028)
Q Consensus 820 -~G~L~~~~ 827 (1028)
+|+|.+.+
T Consensus 84 ~~g~L~~~l 92 (262)
T d1byga_ 84 AKGSLVDYL 92 (262)
T ss_dssp TTEEHHHHH
T ss_pred CCCCHHHHH
Confidence 88888843
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=1.6e-08 Score=107.45 Aligned_cols=71 Identities=18% Similarity=0.099 Sum_probs=54.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCccc---------------ccCCchhhhhhHhhhcCcCcEEEEe
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKFW---------------LENFPSRIRTYHLQVESELNHLVTE 817 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~~---------------~~~~p~~vr~~e~~~~~~~~hlV~E 817 (1028)
++|++.+.||+|+||+||+|+.. ..||||+++..... .-.|||+|+++++.. ....+||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 47999999999999999999753 46999999743211 015899999987653 456799999
Q ss_pred cC-CCCCCccc
Q psy18163 818 NP-GGPLNKKE 827 (1028)
Q Consensus 818 ~~-~G~L~~~~ 827 (1028)
|| +|+|.+.+
T Consensus 84 y~~~g~L~~~l 94 (276)
T d1uwha_ 84 WCEGSSLYHHL 94 (276)
T ss_dssp CCCEEEHHHHH
T ss_pred cCCCCCHHHHH
Confidence 99 68988743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=3.6e-08 Score=103.89 Aligned_cols=72 Identities=18% Similarity=0.088 Sum_probs=56.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCC---cEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTD---EIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNHLV 815 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg---~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~hlV 815 (1028)
++|++.+.||+|+||+||+|++..++ ..||||.+...... .-.|||+|++++++. ....+||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 58999999999999999999987654 57999998643211 116999999998875 4677999
Q ss_pred EecC-CCCCCc
Q psy18163 816 TENP-GGPLNK 825 (1028)
Q Consensus 816 ~E~~-~G~L~~ 825 (1028)
|||+ +|+|..
T Consensus 86 ~E~~~~g~l~~ 96 (273)
T d1mp8a_ 86 MELCTLGELRS 96 (273)
T ss_dssp EECCTTEEHHH
T ss_pred EEeccCCcHHh
Confidence 9999 677765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=2.7e-08 Score=106.98 Aligned_cols=75 Identities=17% Similarity=0.194 Sum_probs=61.7
Q ss_pred cceeEeeeeeccceeEEEEEEEcc-----CCcEEEeeecCCCccc--------------ccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKR-----TDEIVAPCKSGNGKFW--------------LENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~-----tg~~VAIK~I~~~~~~--------------~~~~p~~vr~~e~~~~~~~~h 813 (1028)
++|++.++||+|+||.||+|.+.. +++.||||++...... .-+|||+|++++++......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 689999999999999999999863 4678999999753211 116899999999888888899
Q ss_pred EEEecC-CCCCCccc
Q psy18163 814 LVTENP-GGPLNKKE 827 (1028)
Q Consensus 814 lV~E~~-~G~L~~~~ 827 (1028)
|||||+ +|+|...+
T Consensus 100 lv~e~~~~g~l~~~~ 114 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYL 114 (308)
T ss_dssp EEEECCTTCBHHHHH
T ss_pred EEEeecCCCCHHHHH
Confidence 999999 88888744
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=6e-08 Score=102.92 Aligned_cols=72 Identities=22% Similarity=0.187 Sum_probs=57.1
Q ss_pred cceeEeeeeeccceeEEEEEEEccCC----cEEEeeecCCCcc---------------cccCCchhhhhhHhhhcCcCcE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTD----EIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVESELNH 813 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg----~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~~~~~h 813 (1028)
+.|++.+.||+|+||.||+|.++.++ ..||||++..... .. .|||+|++++++......+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceE
Confidence 46999999999999999999988766 4799999864321 11 5899999999988888899
Q ss_pred EEEecC-CCCCCc
Q psy18163 814 LVTENP-GGPLNK 825 (1028)
Q Consensus 814 lV~E~~-~G~L~~ 825 (1028)
+||||+ +|.|..
T Consensus 86 ~v~e~~~~~~l~~ 98 (283)
T d1mqba_ 86 IITEYMENGALDK 98 (283)
T ss_dssp EEEECCTTEEHHH
T ss_pred EEEEecccCcchh
Confidence 999999 545544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.42 E-value=5.1e-08 Score=103.39 Aligned_cols=65 Identities=28% Similarity=0.275 Sum_probs=50.1
Q ss_pred eeeeccceeEEEEEEEc--cCCcEEEeeecCCCcc----------------cccCCchhhhhhHhhhcCcCcEEEEecC-
Q psy18163 759 NRIEEGTYGVVYRAKDK--RTDEIVAPCKSGNGKF----------------WLENFPSRIRTYHLQVESELNHLVTENP- 819 (1028)
Q Consensus 759 ~~IGeGsyG~Vy~a~~~--~tg~~VAIK~I~~~~~----------------~~~~~p~~vr~~e~~~~~~~~hlV~E~~- 819 (1028)
++||+|+||+||+|.++ .+++.||||++..... .. .|||+|++++++. .+..+||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~-~~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE-AESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEec-cCCEEEEEEcCC
Confidence 46999999999999865 4567899999964221 11 6899999998775 45568999999
Q ss_pred CCCCCc
Q psy18163 820 GGPLNK 825 (1028)
Q Consensus 820 ~G~L~~ 825 (1028)
+|+|.+
T Consensus 91 ~g~L~~ 96 (277)
T d1xbba_ 91 LGPLNK 96 (277)
T ss_dssp TEEHHH
T ss_pred CCcHHH
Confidence 778877
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=6.5e-08 Score=103.79 Aligned_cols=73 Identities=18% Similarity=0.106 Sum_probs=57.7
Q ss_pred cceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCCcc------------cccCCchhhhhhHhhhcCc----CcEEEE
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNGKF------------WLENFPSRIRTYHLQVESE----LNHLVT 816 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~~~------------~~~~~p~~vr~~e~~~~~~----~~hlV~ 816 (1028)
.+|.+.+.||+|+||.||+|+. +|+.||||++..... ..-.|||+|++++++.... ..+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4789999999999999999986 789999999864321 1116999999988765443 468999
Q ss_pred ecC-CCCCCccc
Q psy18163 817 ENP-GGPLNKKE 827 (1028)
Q Consensus 817 E~~-~G~L~~~~ 827 (1028)
||+ +|+|...+
T Consensus 81 Ey~~~g~L~~~l 92 (303)
T d1vjya_ 81 DYHEHGSLFDYL 92 (303)
T ss_dssp ECCTTCBHHHHH
T ss_pred ecccCCCHHHHH
Confidence 999 77888743
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.25 E-value=1.3e-07 Score=99.93 Aligned_cols=73 Identities=23% Similarity=0.292 Sum_probs=50.0
Q ss_pred cceeEeeeeeccceeEEEEEEEcc-CC--cEEEeeecCCCcc-----------------cccCCchhhhhhHhhhcCcCc
Q psy18163 753 EEFKCLNRIEEGTYGVVYRAKDKR-TD--EIVAPCKSGNGKF-----------------WLENFPSRIRTYHLQVESELN 812 (1028)
Q Consensus 753 ~~Y~~l~~IGeGsyG~Vy~a~~~~-tg--~~VAIK~I~~~~~-----------------~~~~~p~~vr~~e~~~~~~~~ 812 (1028)
.+|++++.||+|+||.||+|+... ++ ..||||++.+... .. .|||+|++++++.. ...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cch
Confidence 579999999999999999998754 33 3699999874321 01 58999999988864 466
Q ss_pred EEEEecC-CCCCCccc
Q psy18163 813 HLVTENP-GGPLNKKE 827 (1028)
Q Consensus 813 hlV~E~~-~G~L~~~~ 827 (1028)
+|||||+ +|+|.+..
T Consensus 86 ~lv~e~~~~~~l~~~~ 101 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRL 101 (273)
T ss_dssp EEEEECCTTCBHHHHH
T ss_pred heeeeeecCcchhhhh
Confidence 8999988 77877643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.16 E-value=7.9e-07 Score=95.66 Aligned_cols=67 Identities=16% Similarity=0.110 Sum_probs=50.3
Q ss_pred eeeeeccceeEEEEEEEccCC---cEEEeeecCCCcc---------------cccCCchhhhhhHhhhc-CcCcEEEEec
Q psy18163 758 LNRIEEGTYGVVYRAKDKRTD---EIVAPCKSGNGKF---------------WLENFPSRIRTYHLQVE-SELNHLVTEN 818 (1028)
Q Consensus 758 l~~IGeGsyG~Vy~a~~~~tg---~~VAIK~I~~~~~---------------~~~~~p~~vr~~e~~~~-~~~~hlV~E~ 818 (1028)
-++||+|+||+||+|++..++ ..||||++.+... .. .|||+|+++++... ....+|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEEE
Confidence 578999999999999987654 3699999974221 11 68999999887654 4467999999
Q ss_pred C-CCCCCc
Q psy18163 819 P-GGPLNK 825 (1028)
Q Consensus 819 ~-~G~L~~ 825 (1028)
| +|+|.+
T Consensus 111 ~~~g~l~~ 118 (311)
T d1r0pa_ 111 MKHGDLRN 118 (311)
T ss_dssp CTTCBHHH
T ss_pred eecCchhh
Confidence 9 666655
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.97 E-value=5e-07 Score=97.85 Aligned_cols=36 Identities=19% Similarity=0.241 Sum_probs=34.1
Q ss_pred ceeEeeeeeccceeEEEEEEEccCCcEEEeeecCCC
Q psy18163 754 EFKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGNG 789 (1028)
Q Consensus 754 ~Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~~ 789 (1028)
+|+++++||+|+||+||+|+++.||+.||||+|++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~ 49 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD 49 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc
Confidence 599999999999999999999999999999999764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.97 E-value=2.9e-05 Score=79.33 Aligned_cols=81 Identities=17% Similarity=0.203 Sum_probs=52.5
Q ss_pred cCCeEEEEEeeecCcEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcC-CCCeeEEEEEEeecCCCeEE
Q psy18163 361 VEEFKCLNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQ-HPNIVTVREIVVGSNMDKIF 439 (1028)
Q Consensus 361 ~d~Y~il~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~-HPNIV~L~~i~~~~~~~~l~ 439 (1028)
++.|++.+..+.++.+.||+... .+..+.||+...... .......+|...|..+. +--+..++.+.. ..+..|
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~~~~ 86 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSN 86 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEe--cCCceE
Confidence 46788888776666789998853 455678887764432 22345567888877664 222344444333 345789
Q ss_pred EEEecccc
Q psy18163 440 IVMDYVEH 447 (1028)
Q Consensus 440 LVmEy~~g 447 (1028)
+||++++|
T Consensus 87 lv~~~l~G 94 (263)
T d1j7la_ 87 LLMSEADG 94 (263)
T ss_dssp EEEECCSS
T ss_pred EEEEeccc
Confidence 99999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=97.35 E-value=9.1e-05 Score=72.95 Aligned_cols=33 Identities=9% Similarity=-0.121 Sum_probs=29.1
Q ss_pred eeEeeeeeccceeEEEEEEEccCCcEEEeeecCC
Q psy18163 755 FKCLNRIEEGTYGVVYRAKDKRTDEIVAPCKSGN 788 (1028)
Q Consensus 755 Y~~l~~IGeGsyG~Vy~a~~~~tg~~VAIK~I~~ 788 (1028)
|.+.++||+|+||+||+|.+. +|+.||||+++.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~ 34 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKV 34 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEec
Confidence 467899999999999999885 799999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.29 E-value=0.00049 Score=69.59 Aligned_cols=138 Identities=14% Similarity=0.127 Sum_probs=77.4
Q ss_pred EeeecC-cEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCC--eeEEEEEEeecCCCeEEEEEecc
Q psy18163 369 RIEEGT-YGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPN--IVTVREIVVGSNMDKIFIVMDYV 445 (1028)
Q Consensus 369 ~LG~G~-FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPN--IV~L~~i~~~~~~~~l~LVmEy~ 445 (1028)
.+..|. -+.||+.... ++..+.+|..... ....+..|...|+.+.... +..++.+. .+.+..++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeec--ccccceEEEEEee
Confidence 344454 4689988764 5666888876533 2234567888777664333 34454443 3445789999999
Q ss_pred cc-c--------------hHHHHHHHhhcC---CcCC--HHH----HH-HHH---------------HHHHHHHHHHHhC
Q psy18163 446 EH-D--------------MKSLMETMRSKK---QVFI--PGE----VK-CLM---------------QQLLNAVAHLHDN 485 (1028)
Q Consensus 446 ~g-d--------------LgsLl~~l~~~~---~~~s--e~e----v~-~il---------------~QLl~AL~yLHs~ 485 (1028)
.| + ++.++..+.... ..+. ... .. .+. ..+...+..+...
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 75 1 222333332110 0000 000 00 000 0112223334332
Q ss_pred -------CcccccccccceeecCCCcEEEeccCCcc
Q psy18163 486 -------WILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 486 -------gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999987777899999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.15 E-value=0.00042 Score=76.14 Aligned_cols=77 Identities=18% Similarity=0.225 Sum_probs=44.8
Q ss_pred EEEeeecCcEEEEEEEECCCCeEEEEEEeeccc--cccCC---ccchHHHHHHHHHcC--CC-CeeEEEEEEeecCCCeE
Q psy18163 367 LNRIEEGTYGVVYRAKDKRTDEIVALKRLKMEK--EKEGF---PITSLREINTLLKAQ--HP-NIVTVREIVVGSNMDKI 438 (1028)
Q Consensus 367 l~~LG~G~FG~Vyla~d~~tg~~VAIKvlk~~~--~~~~~---~~~~lrEi~iL~~l~--HP-NIV~L~~i~~~~~~~~l 438 (1028)
.+.||.|....||++.+..+++.|+||.-.... ..... ......|...|..+. -| .+..++.+ .. +..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~--~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC--CCC
Confidence 456899999999999988788889999753211 11111 223456887776653 22 34444322 22 245
Q ss_pred EEEEecccc
Q psy18163 439 FIVMDYVEH 447 (1028)
Q Consensus 439 ~LVmEy~~g 447 (1028)
++|||++.+
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 789999975
|
| >d2daha1 a.5.2.1 (A:8-48) Ubiquilin-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: Ubiquilin-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.59 E-value=0.00083 Score=50.81 Aligned_cols=37 Identities=30% Similarity=0.423 Sum_probs=34.4
Q ss_pred HHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHhhc
Q psy18163 973 KKFNDLMSRGNFTREDIVTVLTANHGNVESAYVELNK 1009 (1028)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1028)
.++..|...||.+.+.+++||.+++|||+.|+..|.|
T Consensus 4 ~QL~~L~~MGF~d~~~Ni~AL~~t~Gdv~~Aie~Ll~ 40 (41)
T d2daha1 4 VQLEQLRSMGFLNREANLQALIATGGDVDAAVEKLRQ 40 (41)
T ss_dssp HHHHHHHHHTCCCHHHHHHHHHHHTSCHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCHHHHHHHHHHcCCCHHHHHHHHHh
Confidence 5678899999999999999999999999999999876
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.74 E-value=0.0077 Score=63.80 Aligned_cols=135 Identities=19% Similarity=0.161 Sum_probs=72.1
Q ss_pred cEEEEEEEECCCCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCee--EEEEE---EeecCCCeEEEEEeccccc-
Q psy18163 375 YGVVYRAKDKRTDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIV--TVREI---VVGSNMDKIFIVMDYVEHD- 448 (1028)
Q Consensus 375 FG~Vyla~d~~tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV--~L~~i---~~~~~~~~l~LVmEy~~gd- 448 (1028)
--.||++... +|..|++|+.+.... ....+..|+..|..|....|. ..... .........+.|++++.|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 3579999774 678899999864321 233456788777766422221 11000 0011234678889988751
Q ss_pred -----------hHHHHHHHhhcC--------CcC-------------------CHH---HHHHHHHHHHHHHHHHH----
Q psy18163 449 -----------MKSLMETMRSKK--------QVF-------------------IPG---EVKCLMQQLLNAVAHLH---- 483 (1028)
Q Consensus 449 -----------LgsLl~~l~~~~--------~~~-------------------se~---ev~~il~QLl~AL~yLH---- 483 (1028)
+|.++..+.... ..+ +.. .....+..++..+.-+-
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 233333332210 011 111 11222333333332221
Q ss_pred hCCcccccccccceeecCCCcEEEeccCCccc
Q psy18163 484 DNWILHRDLKTSNLLLSHRGILKVGDFGLARE 515 (1028)
Q Consensus 484 s~gIVHRDLKPeNILLd~~g~lKL~DFGlAr~ 515 (1028)
..++||+|+.+.|||++. + ..|+||+.|+.
T Consensus 191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 135899999999999974 4 45789998863
|
| >d2bwba1 a.5.2.1 (A:328-371) DSK2 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: DSK2 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=95.64 E-value=0.0051 Score=47.05 Aligned_cols=35 Identities=26% Similarity=0.347 Sum_probs=31.5
Q ss_pred HHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHh
Q psy18163 973 KKFNDLMSRGNFTREDIVTVLTANHGNVESAYVEL 1007 (1028)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1028)
.-+..|...||.+.+.+++||.+++|||..|+..|
T Consensus 7 ~QL~qL~~MGF~d~~~Ni~AL~~t~GdV~~Aie~L 41 (44)
T d2bwba1 7 HQLRQLNDMGFFDFDRNVAALRRSGGSVQGALDSL 41 (44)
T ss_dssp HHHHHHHHTTCCCHHHHHHHHHHHTTCHHHHHHHH
T ss_pred HHHHHHHHcCCCcHHHHHHHHHHcCCCHHHHHHHH
Confidence 34678899999999999999999999999998765
|
| >d2dnaa1 a.5.2.1 (A:12-61) Ubiquilin-like protein Ubqlnl {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: Ubiquilin-like protein Ubqlnl species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.45 E-value=0.006 Score=47.82 Aligned_cols=37 Identities=22% Similarity=0.293 Sum_probs=33.2
Q ss_pred HHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHhhc
Q psy18163 973 KKFNDLMSRGNFTREDIVTVLTANHGNVESAYVELNK 1009 (1028)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1028)
.-+..|...||.+.+.+++||.+++|||..|+..|..
T Consensus 10 ~QL~qL~~MGF~d~~~Ni~AL~~t~GdV~~Aie~Ll~ 46 (50)
T d2dnaa1 10 KEMECLQAMGFVNYNANLQALIATDGDTNAAIYKLKS 46 (50)
T ss_dssp HHHHHHHHHTCCCHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCHHHHHHHHHHcCCCHHHHHHHHHh
Confidence 4467889999999999999999999999999988764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.92 E-value=0.047 Score=59.00 Aligned_cols=74 Identities=12% Similarity=0.114 Sum_probs=46.9
Q ss_pred CeEEEEEeeecCcEEEEEEEECC-------CCeEEEEEEeeccccccCCccchHHHHHHHHHcCCCCee-EEEEEEeecC
Q psy18163 363 EFKCLNRIEEGTYGVVYRAKDKR-------TDEIVALKRLKMEKEKEGFPITSLREINTLLKAQHPNIV-TVREIVVGSN 434 (1028)
Q Consensus 363 ~Y~il~~LG~G~FG~Vyla~d~~-------tg~~VAIKvlk~~~~~~~~~~~~lrEi~iL~~l~HPNIV-~L~~i~~~~~ 434 (1028)
++++ +.|+.|-.-.+|++.... ....|.+++.-.. .......+|..+++.+.-.+++ +++.++ ++
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~~ 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIF--SG 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEc--CC
Confidence 3444 678888889999998753 2456777776421 1223345788888877533443 555444 32
Q ss_pred CCeEEEEEecccc
Q psy18163 435 MDKIFIVMDYVEH 447 (1028)
Q Consensus 435 ~~~l~LVmEy~~g 447 (1028)
++||+|+.|
T Consensus 117 ----g~I~efi~g 125 (395)
T d1nw1a_ 117 ----GRLEEYIPS 125 (395)
T ss_dssp ----EEEECCCCE
T ss_pred ----ceEEEEecc
Confidence 688999876
|
| >d1oqya1 a.5.2.1 (A:160-200) DNA repair protein Hhr23a {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: DNA repair protein Hhr23a species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.85 E-value=0.0093 Score=44.94 Aligned_cols=36 Identities=31% Similarity=0.431 Sum_probs=31.2
Q ss_pred HHHHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHh
Q psy18163 971 RQKKFNDLMSRGNFTREDIVTVLTANHGNVESAYVEL 1007 (1028)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1028)
...+|..|++.| |+++.|+.||+.+++||++|.--|
T Consensus 4 ~e~~i~~L~~MG-F~~~~a~~AL~~~~~N~e~A~~~L 39 (41)
T d1oqya1 4 YETMLTEIMSMG-YERERVVAALRASYNNPHRAVEYL 39 (41)
T ss_dssp HHHHHHHHHTTT-CCSHHHHHHHHHSCSSTTHHHHTT
T ss_pred HHHHHHHHHHcC-CCHHHHHHHHHHhCCCHHHHHHHH
Confidence 456789999999 589999999999999999998643
|
| >d1veja1 a.5.2.1 (A:8-68) 4931431F19Rik {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: 4931431F19Rik species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.69 E-value=0.013 Score=47.77 Aligned_cols=36 Identities=25% Similarity=0.398 Sum_probs=32.5
Q ss_pred HHHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHh
Q psy18163 972 QKKFNDLMSRGNFTREDIVTVLTANHGNVESAYVEL 1007 (1028)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1028)
+.-+..|...||.+.+.+++||.+++|||..|+..|
T Consensus 23 ~~QL~qL~eMGF~d~~~Nl~AL~~t~Gdv~~Aie~L 58 (61)
T d1veja1 23 QQELEELKALGFANRDANLQALVATDGDIHAAIEML 58 (61)
T ss_dssp HHHHHHHHHHTCCCHHHHHHHHHHTTSCHHHHHHHH
T ss_pred HHHHHHHHHcCCCCHHHHHHHHHHcCCCHHHHHHHH
Confidence 456788999999999999999999999999998765
|
| >d1vg5a_ a.5.2.1 (A:) Rhomboid family protein At3g58460 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: Rhomboid family protein At3g58460 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=94.21 E-value=0.017 Score=48.71 Aligned_cols=35 Identities=20% Similarity=0.313 Sum_probs=31.4
Q ss_pred HHHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHh
Q psy18163 972 QKKFNDLMSRGNFTREDIVTVLTANHGNVESAYVEL 1007 (1028)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1028)
...|..|+..|| +++.|++||.++++||++|.-.|
T Consensus 30 ee~i~~L~~MGF-~~~~a~~AL~~~~~n~e~A~~~L 64 (73)
T d1vg5a_ 30 EEQIQKLVAMGF-DRTQVEVALAAADDDLTVAVEIL 64 (73)
T ss_dssp HHHHHHHHTTTC-CHHHHHHHHHHHTSCHHHHHHHH
T ss_pred HHHHHHHHHhCC-CHHHHHHHHHHhCCCHHHHHHHH
Confidence 456788999998 89999999999999999998766
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.78 E-value=0.15 Score=52.56 Aligned_cols=30 Identities=23% Similarity=0.276 Sum_probs=27.1
Q ss_pred CCcccccccccceeecCCCcEEEeccCCcc
Q psy18163 485 NWILHRDLKTSNLLLSHRGILKVGDFGLAR 514 (1028)
Q Consensus 485 ~gIVHRDLKPeNILLd~~g~lKL~DFGlAr 514 (1028)
.||||+|+.++|||++.+...-|+||+.|+
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 469999999999999988888899999985
|
| >d1wgna_ a.5.2.1 (A:) Ubiquitin-associated protein 1, UBAP1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: Ubiquitin-associated protein 1, UBAP1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.43 E-value=0.041 Score=45.05 Aligned_cols=35 Identities=14% Similarity=0.224 Sum_probs=31.7
Q ss_pred HHHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHh
Q psy18163 972 QKKFNDLMSRGNFTREDIVTVLTANHGNVESAYVEL 1007 (1028)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1028)
...|..|+..|| +++.|.+||+.+++||+.|.--|
T Consensus 20 e~~v~~L~~MGF-~~~~a~~AL~~~~~n~e~A~~~L 54 (63)
T d1wgna_ 20 RQCVETVVNMGY-SYECVLRAMKKKGENIEQILDYL 54 (63)
T ss_dssp HHHHHHHHHHHC-CHHHHHHHHHHHCSCHHHHHHHH
T ss_pred HHHHHHHHHcCC-CHHHHHHHHHHcCCCHHHHHHHH
Confidence 567999999999 79999999999999999998655
|
| >d1wiva_ a.5.2.1 (A:) Ubiquitin isopeptidase T {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: Ubiquitin isopeptidase T species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=91.22 E-value=0.078 Score=44.54 Aligned_cols=34 Identities=24% Similarity=0.264 Sum_probs=30.4
Q ss_pred HHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHh
Q psy18163 973 KKFNDLMSRGNFTREDIVTVLTANHGNVESAYVEL 1007 (1028)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1028)
.+|..|++.|| +++.|..||+.+++||+.|.--|
T Consensus 31 ~~i~~L~~MGF-~~~~a~~AL~~~~~n~e~Av~~L 64 (73)
T d1wiva_ 31 SSVDTLLSFGF-AEDVARKALKASGGDIEKATDWV 64 (73)
T ss_dssp HHHHHHHHHTC-CHHHHHHHHHHTTSCHHHHHHHH
T ss_pred HHHHHHHhcCC-CHHHHHHHHHHcCCCHHHHHHHH
Confidence 46899999996 89999999999999999998655
|
| >d1aipc1 a.5.2.2 (C:2-53) Elongation factor Ts (EF-Ts), N-terminal domain {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: TS-N domain domain: Elongation factor Ts (EF-Ts), N-terminal domain species: Thermus thermophilus [TaxId: 274]
Probab=88.61 E-value=0.11 Score=40.77 Aligned_cols=40 Identities=15% Similarity=0.032 Sum_probs=33.1
Q ss_pred HHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHhhcccc
Q psy18163 973 KKFNDLMSRGNFTREDIVTVLTANHGNVESAYVELNKTQL 1012 (1028)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1028)
..|++|-.+-..+--+|-+||.+++||++.|...|...|+
T Consensus 4 elvK~LR~~Tga~~~dcKkAL~e~~gD~ekA~e~Lr~~G~ 43 (52)
T d1aipc1 4 ELIKKLREATGAGMMDVKRALEDAGWDEEKAVQLLRERGA 43 (52)
T ss_dssp HHHHHHHHHHCCCHHHHHHHHHHTTTCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCHHHHHHHHHHcCCCHHHHHHHHHHHhH
Confidence 3567777777778889999999999999999999987654
|
| >d1wjia_ a.5.2.1 (A:) Tudor domain containing protein 3, TDRD3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: Tudor domain containing protein 3, TDRD3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.39 E-value=0.2 Score=40.73 Aligned_cols=36 Identities=28% Similarity=0.369 Sum_probs=30.9
Q ss_pred HHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHhhc
Q psy18163 973 KKFNDLMSRGNFTREDIVTVLTANHGNVESAYVELNK 1009 (1028)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1028)
..|..|+..| |+++.|..||+++++||+.|+.-|--
T Consensus 11 ~~v~~L~~MG-F~~~~a~~AL~~~~~~~e~A~~wL~~ 46 (63)
T d1wjia_ 11 KALKHITEMG-FSKEASRQALMDNGNNLEAALNVLLT 46 (63)
T ss_dssp HHHHHHHTTT-CCHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHcC-CCHHHHHHHHHHhCCCHHHHHHHHHH
Confidence 4688899999 58999999999999999999876643
|
| >d2g3qa1 a.5.2.1 (A:1339-1381) Endocytic protein Ede1, YBL047C {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: Endocytic protein Ede1, YBL047C species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=85.81 E-value=0.31 Score=36.30 Aligned_cols=25 Identities=28% Similarity=0.202 Sum_probs=22.6
Q ss_pred ccHHHHHHHHHHhcCChHHHHHHHH
Q psy18163 944 LSAVEARDALRLHNGNVWAAVTECV 968 (1028)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1028)
|+..|||+||..|++|+++|+---|
T Consensus 16 F~e~~A~~AL~k~~wnleaAtN~LL 40 (43)
T d2g3qa1 16 FTEEEAHNALEKCNWDLEAATNFLL 40 (43)
T ss_dssp SCHHHHHHHHHHHTSCHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHHHHHHHHH
Confidence 8899999999999999999986544
|
| >d1efub3 a.5.2.2 (B:1-54) Elongation factor Ts (EF-Ts), N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: TS-N domain domain: Elongation factor Ts (EF-Ts), N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=84.89 E-value=0.22 Score=39.33 Aligned_cols=40 Identities=23% Similarity=0.235 Sum_probs=31.8
Q ss_pred HHHHhhhcCCCChhHHHHHHHhccCchhhhHHHhhccccc
Q psy18163 974 KFNDLMSRGNFTREDIVTVLTANHGNVESAYVELNKTQLK 1013 (1028)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1028)
-|++|-.+-..+--+|-+||.+++||++.|...|...|+.
T Consensus 7 ~iK~LR~~Tgag~~dCKkAL~e~~gD~ekA~e~Lr~kG~~ 46 (54)
T d1efub3 7 LVKELRERTGAGMMDCKKALTEANGDIELAIENMRKSGAI 46 (54)
T ss_dssp HHHHHHHHHCCCHHHHHHHHHHTTTCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCHHHHHHHHHHcCCCHHHHHHHHHHHhHH
Confidence 3566666666677889999999999999999998877654
|
| >d1oqya1 a.5.2.1 (A:160-200) DNA repair protein Hhr23a {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: DNA repair protein Hhr23a species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.80 E-value=0.22 Score=37.12 Aligned_cols=22 Identities=27% Similarity=0.167 Sum_probs=21.1
Q ss_pred ccHHHHHHHHHHhcCChHHHHH
Q psy18163 944 LSAVEARDALRLHNGNVWAAVT 965 (1028)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~ 965 (1028)
|++..|+.||+.++||++.|+.
T Consensus 16 F~~~~a~~AL~~~~~N~e~A~~ 37 (41)
T d1oqya1 16 YERERVVAALRASYNNPHRAVE 37 (41)
T ss_dssp CCSHHHHHHHHHSCSSTTHHHH
T ss_pred CCHHHHHHHHHHhCCCHHHHHH
Confidence 8999999999999999999985
|
| >d1xb2b1 a.5.2.2 (B:56-111) Elongation factor Ts (EF-Ts), N-terminal domain {Cow (Bos taurus), mitochondrial [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: TS-N domain domain: Elongation factor Ts (EF-Ts), N-terminal domain species: Cow (Bos taurus), mitochondrial [TaxId: 9913]
Probab=84.08 E-value=0.25 Score=39.28 Aligned_cols=40 Identities=15% Similarity=0.153 Sum_probs=32.5
Q ss_pred HHHHHhhhcCCCChhHHHHHHHhccCchhhhHHHhhcccc
Q psy18163 973 KKFNDLMSRGNFTREDIVTVLTANHGNVESAYVELNKTQL 1012 (1028)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1028)
..|++|-.+-.-+--||-.||.+++||++.|...|...++
T Consensus 6 ~lvk~LRe~Tga~~~dcKkAL~e~~gD~ekA~e~LrkkG~ 45 (56)
T d1xb2b1 6 ELLMKLRRKTGYSFINCKKALETCGGDLKQAESWLHKQAQ 45 (56)
T ss_dssp HHHHHHHHHHCCCHHHHHHHHHHTTTCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCHHHHHHHHHHcCCCHHHHHHHHHHHHH
Confidence 3466777777777889999999999999999999887654
|
| >d1wiva_ a.5.2.1 (A:) Ubiquitin isopeptidase T {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: Ubiquitin isopeptidase T species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=80.44 E-value=0.55 Score=39.15 Aligned_cols=27 Identities=22% Similarity=0.259 Sum_probs=24.9
Q ss_pred ccHHHHHHHHHHhcCChHHHHHHHHHH
Q psy18163 944 LSAVEARDALRLHNGNVWAAVTECVET 970 (1028)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1028)
|++..|++||+.++||+++||.-++.+
T Consensus 41 F~~~~a~~AL~~~~~n~e~Av~~Lls~ 67 (73)
T d1wiva_ 41 FAEDVARKALKASGGDIEKATDWVFNN 67 (73)
T ss_dssp CCHHHHHHHHHHTTSCHHHHHHHHHHS
T ss_pred CCHHHHHHHHHHcCCCHHHHHHHHHcC
Confidence 899999999999999999999987754
|
| >d1wgna_ a.5.2.1 (A:) Ubiquitin-associated protein 1, UBAP1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: RuvA C-terminal domain-like superfamily: UBA-like family: UBA domain domain: Ubiquitin-associated protein 1, UBAP1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.33 E-value=0.49 Score=38.36 Aligned_cols=36 Identities=19% Similarity=0.205 Sum_probs=29.9
Q ss_pred HHHHHHHHHHhhccCCCCCCCCcCcccHHHHHHHHHHhcCChHHHHHHHH
Q psy18163 919 RHMIDTVVTLATNYGHERSENNVGTLSAVEARDALRLHNGNVWAAVTECV 968 (1028)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1028)
.++|++++.|- |++..|++||+.|+||+++|+.--+
T Consensus 20 e~~v~~L~~MG--------------F~~~~a~~AL~~~~~n~e~A~~~Ll 55 (63)
T d1wgna_ 20 RQCVETVVNMG--------------YSYECVLRAMKKKGENIEQILDYLF 55 (63)
T ss_dssp HHHHHHHHHHH--------------CCHHHHHHHHHHHCSCHHHHHHHHH
T ss_pred HHHHHHHHHcC--------------CCHHHHHHHHHHcCCCHHHHHHHHH
Confidence 46777777762 7899999999999999999987644
|